PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Laurent, LC; Ulitsky, I; Slavin, I; Tran, H; Schork, A; Morey, R; Lynch, C; Harness, JV; Lee, S; Barrero, MJ; Ku, S; Martynova, M; Semechkin, R; Galat, V; Gottesfeld, J; Belmonte, JCI; Murry, C; Keirstead, HS; Park, HS; Schmidt, U; Laslett, AL; Muller, FJ; Nievergelt, CM; Shamir, R; Loring, JF				Laurent, Louise C.; Ulitsky, Igor; Slavin, Ileana; Tran, Ha; Schork, Andrew; Morey, Robert; Lynch, Candace; Harness, Julie V.; Lee, Sunray; Barrero, Maria J.; Ku, Sherman; Martynova, Marina; Semechkin, Ruslan; Galat, Vasiliy; Gottesfeld, Joel; Belmonte, Juan Carlos Izpisua; Murry, Chuck; Keirstead, Hans S.; Park, Hyun-Sook; Schmidt, Uli; Laslett, Andrew L.; Muller, Franz-Josef; Nievergelt, Caroline M.; Shamir, Ron; Loring, Jeanne F.			Dynamic Changes in the Copy Number of Pluripotency and Cell Proliferation Genes in Human ESCs and iPSCs during Reprogramming and Time in Culture	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; CHROMOSOMAL-ABNORMALITIES; LUNG-CANCER; EXPRESSION; IDENTIFICATION; AMPLIFICATION; HYBRIDIZATION; MICROARRAY; REGION; TUMORS	Genomic stability is critical for the clinical use of human embryonic and induced pluripotent stem cells. We performed high-resolution SNP (single-nucleotide polymorphism) analysis on 186 pluripotent and 119 nonpluripotent samples. We report a higher frequency of subchromosomal copy number variations in pluripotent samples compared to nonpluripotent samples, with variations enriched in specific genomic regions. The distribution of these variations differed between hESCs and hiPSCs, characterized by large numbers of duplications found in a few hESC samples and moderate numbers of deletions distributed across many hiPSC samples. For hiPSCs, the reprogramming process was associated with deletions of tumor-suppressor genes, whereas time in culture was associated with duplications of oncogenic genes. We also observed duplications that arose during a differentiation protocol. Our results illustrate the dynamic nature of genomic abnormalities in pluripotent stem cells and the need for frequent genomic monitoring to assure phenotypic stability and clinical safety.	[Laurent, Louise C.; Morey, Robert] Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA; [Schork, Andrew; Nievergelt, Caroline M.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Laurent, Louise C.; Slavin, Ileana; Tran, Ha; Morey, Robert; Lynch, Candace; Muller, Franz-Josef; Shamir, Ron] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Laurent, Louise C.; Slavin, Ileana; Tran, Ha; Morey, Robert; Lynch, Candace; Muller, Franz-Josef; Shamir, Ron] Scripps Res Inst, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Ku, Sherman; Gottesfeld, Joel] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Ulitsky, Igor] Whitehead Inst, Cambridge, MA 02142 USA; [Ulitsky, Igor; Shamir, Ron] Tel Aviv Univ, Dept Comp Sci, IL-69978 Tel Aviv, Israel; [Harness, Julie V.; Keirstead, Hans S.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Ctr, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Lee, Sunray; Park, Hyun-Sook] Modern Cell & Tissue Technol MCTT Inc, Seoul 139240, South Korea; [Barrero, Maria J.; Belmonte, Juan Carlos Izpisua] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Barrero, Maria J.; Belmonte, Juan Carlos Izpisua] Ctr Med Regenerat Barcelona, E-08003 Barcelona, Spain; [Martynova, Marina; Semechkin, Ruslan] Int Stem Cell Corp, Oceanside, CA 92056 USA; [Galat, Vasiliy] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Galat, Vasiliy] Northwestern Univ, Childrens Mem Res Ctr, IPS, Chicago, IL 60614 USA; [Galat, Vasiliy] Northwestern Univ, Childrens Mem Res Ctr, Human Stem Cell Core Facil, Chicago, IL 60614 USA; [Murry, Chuck] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Schmidt, Uli] Sydney IVF, Stem Cell Lab, Sydney, NSW 2000, Australia; [Laslett, Andrew L.] CSIRO, Clayton, Vic 3168, Australia; [Laslett, Andrew L.] Monash Univ, Dept Anat & Dev Biol, Clayton, Vic 3168, Australia; [Laslett, Andrew L.] Australian Stem Cell Ctr, Clayton, Vic 3168, Australia	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Tel Aviv University; University of California System; University of California Irvine; Salk Institute; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Northwestern University; Feinberg School of Medicine; Northwestern University; Northwestern University; University of Washington; University of Washington Seattle; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Monash University	Laurent, LC (corresponding author), Univ Calif San Diego, Dept Reprod Med, La Jolla, CA 92093 USA.	llaurent@ucsd.edu	Martynova, Marina/AAI-7670-2021; Shamir, Ron/E-6514-2011; Laslett, Andrew L/A-9760-2011; Loring, Jeanne F/A-1620-2011; Müller, Franz-Josef/E-3336-2010; Ulitsky, Igor/HCH-7453-2022; Barrero, Maria J./Q-1785-2017	Martynova, Marina/0000-0001-6911-619X; Shamir, Ron/0000-0003-1889-9870; Laslett, Andrew L/0000-0003-4729-8193; Loring, Jeanne F/0000-0001-6226-9767; Müller, Franz-Josef/0000-0001-9478-8430; Ulitsky, Igor/0000-0003-0555-6561; Barrero, Maria J./0000-0002-5990-7040; Nievergelt, Caroline/0000-0001-5766-8923; Galat, Vasiliy/0000-0003-3612-098X; Laurent, Louise/0000-0002-2095-7534; Gottesfeld, Joel/0000-0002-4643-5777	NIH/NICHD; Hartwell Foundation; CIRM [CL1-00502, RT1-01108, TR1-01250, RN2-00931-1]; NIH [R21MH087925, R01 HL64387, P01 HL094374, R01 HL084642, P01 GM081719]; Millipore Foundation; Esther O'Keefe Foundation; Edmond J. Safra foundation in Tel Aviv University; Legacy stem cell research fund; PEW Charitable Trust; Ministry of Education, Science and Technology [SC2250]; Ministerio de Ciencia e Innovacion of Spain [RYC-2007-01510, SAF2009-08588]; MICINN Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis; NHLBI [RC1HL100168]; Israel Science Foundation [802/08]; Australian Stem Cell Centre; Victoria-California Stem Cell Alliance, CIRM [TR101250]; Victoria-California Stem Cell Alliance, state government of Victoria, Australia [TR101250]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD001259] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100168, P01HL094374, R01HL064387, R01HL084642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS062856] Funding Source: NIH RePORTER	NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hartwell Foundation; CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Millipore Foundation; Esther O'Keefe Foundation; Edmond J. Safra foundation in Tel Aviv University; Legacy stem cell research fund; PEW Charitable Trust; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MICINN Fundacion Cellex; G. Harold and Leila Y. Mathers Charitable Foundation; Sanofi-Aventis(Sanofi-Aventis); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Israel Science Foundation(Israel Science Foundation); Australian Stem Cell Centre; Victoria-California Stem Cell Alliance, CIRM(California Institute for Regenerative Medicine); Victoria-California Stem Cell Alliance, state government of Victoria, Australia; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to acknowledge all of the collaborators who contributed samples to this study, including Eirini Papapetrou (Sadelain lab), Dongbao Chen, Ralph Graichen, Jerold Chun, Martin Pera, James Shen, Scott McKercher, Timo Otonkoski, and Sheng Ding. We would like to thank Gulsah Altun for invaluable assistance. We would like to thank the NICHD Brain and Tissue Bank for Developmental Disorders, Planned Parenthood of San Diego and Riverside Counties, and Christopher Barry for generously providing tissue specimens for this study. L.C.L. was supported by an NIH/NICHD K12 Career Development Award and the Hartwell Foundation. J.F.L., I.S., H.T., CL., and F.-J.M. are supported by CIRM (CL1-00502, RT1-01108, TR1-01250, RN2-00931-1), NIH (R21MH087925), the Millipore Foundation, and the Esther O'Keefe Foundation. I.U. was supported in part by a fellowship from the Edmond J. Safra foundation in Tel Aviv University and by the Legacy stem cell research fund. I.S. was supported by the PEW Charitable Trust. H.-S.P. and S.L. were supported by a SCRC Grant (SC2250) of the 21st Century Frontier Research Program funded by the Ministry of Education, Science and Technology. M.J.B. was partially supported by grants RYC-2007-01510 and SAF2009-08588 from the Ministerio de Ciencia e Innovacion of Spain. Work in the laboratory of J.C.I.B. was supported by grants from MICINN Fundacion Cellex, the G. Harold and Leila Y. Mathers Charitable Foundation, and Sanofi-Aventis. C.M. was supported by NIH grants R01 HL64387, P01 HL094374, R01 HL084642, and P01 GM081719. V.G. was partially supported by NHLBI, RC1HL100168. R. Shamir was supported in part by the Israel Science Foundation (grant no. 802/08). A.L.L. was supported by grants from the Australian Stem Cell Centre and from the Victoria-California Stem Cell Alliance (TR101250) between CIRM and the state government of Victoria, Australia. H.S.K. is the chairman of the scientific advisory board of California Stem Cell, Inc. R. Semechkin and M.M. are employees and shareholders of International Stem Cell Corporation.	ATKIN NB, 1982, LANCET, V2, P1349; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Booth HAF, 2004, GENOMICS, V84, P229, DOI 10.1016/j.ygeno.2004.02.014; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Elliman SJ, 2006, J BIOL CHEM, V281, P16, DOI 10.1074/jbc.C500415200; Fox JL, 2008, NAT BIOTECHNOL, V26, P598, DOI 10.1038/nbt0608-598; Guan XY, 1996, BLOOD, V88, P1418, DOI 10.1182/blood.V88.4.1418.bloodjournal8841418; Hirotsune S, 2003, NATURE, V423, P91, DOI 10.1038/nature01535; Hurst CD, 2004, ONCOGENE, V23, P2250, DOI 10.1038/sj.onc.1207260; Iejima D, 2010, ONCOGENE, V29, P3087, DOI 10.1038/onc.2010.69; *ILL, 2008, TECHN NOT DNA COP NU; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Koynova DK, 2007, MELANOMA RES, V17, P37, DOI 10.1097/CMR.0b013e3280141617; Kresse Stine H, 2010, BMC Res Notes, V3, P223, DOI 10.1186/1756-0500-3-223; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Liedtke S, 2007, CELL STEM CELL, V1, P364, DOI 10.1016/j.stem.2007.09.003; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Mayshar Y, 2010, CELL STEM CELL, V7, P521, DOI 10.1016/j.stem.2010.07.017; Midorikawa Y, 2006, ONCOGENE, V25, P5581, DOI 10.1038/sj.onc.1209537; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Pain D, 2005, J BIOL CHEM, V280, P6265, DOI 10.1074/jbc.C400587200; RODRIGUEZ E, 1993, GENE CHROMOSOME CANC, V8, P230, DOI 10.1002/gcc.2870080405; Scotto L, 2008, GENE CHROMOSOME CANC, V47, P755, DOI 10.1002/gcc.20577; Skotheim RI, 2002, CANCER RES, V62, P2359; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Tanner MM, 1996, CANCER RES, V56, P3441; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; Wu H, 2008, STEM CELLS, V26, P1484, DOI 10.1634/stemcells.2007-0993	33	632	661	1	92	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					106	118		10.1016/j.stem.2010.12.003	http://dx.doi.org/10.1016/j.stem.2010.12.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211785	Green Accepted, Bronze			2022-12-28	WOS:000286786200015
J	Noble, M; Proschel, C; Mayer-Proschel, M				Noble, Mark; Proeschel, Chris; Mayer-Proeschel, Margot			Oxidative-Reductionist Approaches to Stem and Progenitor Cell Function	CELL STEM CELL			English	Editorial Material								Redox status is a critical modulator of stem and progenitor cell function. In this issue of Cell Stem Cell, Le Belle et al. (2011) demonstrate that oxidation promotes self-renewal of neuroepithelial stem cells, revealing fascinating differences and surprising similarities with how redox pathways regulate glial progenitor cells.	[Noble, Mark; Proeschel, Chris; Mayer-Proeschel, Margot] Univ Rochester, Dept Biomed Genet, Stem Cell & Regenerat Med Inst, Med Ctr, Rochester, NY 14642 USA	University of Rochester	Noble, M (corresponding author), Univ Rochester, Dept Biomed Genet, Stem Cell & Regenerat Med Inst, Med Ctr, 601 Elmwood Ave, Rochester, NY 14642 USA.	mark_noble@urmc.rochester.edu						Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; LI Z, 2004, J R P NATL ACAD SCI, V101, P16052, DOI DOI 10.1371/J0URNAL.PBI0.0050035.LIM0; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; MAYER M, 1994, P NATL ACAD SCI USA, V91, P7496, DOI 10.1073/pnas.91.16.7496; Mazumdar J, 2009, J CELL MOL MED, V13, P4319, DOI 10.1111/j.1582-4934.2009.00963.x; MOHYEDIN A, 2010, CELL STEM CELL, V6, P150; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; Sauer H, 2001, CELL PHYSIOL BIOCHEM, V11, P173, DOI 10.1159/000047804; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797	11	11	12	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					1	2		10.1016/j.stem.2010.12.005	http://dx.doi.org/10.1016/j.stem.2010.12.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211773	Bronze			2022-12-28	WOS:000286786200001
J	Bonig, H; Papayannopoulou, T				Bonig, Halvard; Papayannopoulou, Thalia			Vagrant Stem Cells Draft Their Gene Companions	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM; CXCR4; MOBILIZATION; EGFR	In a recent issue of Nature Medicine, Ryan et al. (2010) uncover genetic modifiers of G-CSF responses by hematopoietic progenitors. The authors document a negative role of EGFR signaling and, provided an analogous pathway functions in humans, propose a potential new angle to promote clinical blood stem cell mobilization.	[Bonig, Halvard; Papayannopoulou, Thalia] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98915 USA; [Bonig, Halvard] German Red Cross Blood Serv, Dept Cellular Therapeut Cell Proc GMP, D-60528 Frankfurt, Germany	University of Washington; University of Washington Seattle	Papayannopoulou, T (corresponding author), Univ Washington, Dept Med, Div Hematol, Seattle, WA 98915 USA.	thalp@uw.edu	Bönig, Halvard/AAG-3029-2021	Bönig, Halvard/0000-0003-0088-2675	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058734] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094702] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL058734] Funding Source: Medline; NIDDK NIH HHS [R01 DK094702] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Guo ZG, 2007, COLLOID SURFACE B, V60, P1, DOI 10.1016/j.colsurfb.2007.05.013; LEUNG A, 2010, BR MED B, V93, P95; Mosadegh B, 2008, BIOTECHNOL BIOENG, V100, P1205, DOI 10.1002/bit.21851; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Pattarozzi A, 2008, MOL PHARMACOL, V73, P191, DOI 10.1124/mol.107.039974; Ryan MA, 2010, NAT MED, V16, P1141, DOI 10.1038/nm.2217; Woerner BM, 2005, CANCER RES, V65, P11392, DOI 10.1158/0008-5472.CAN-05-0847; Wu J, 2010, INVEST NEW DRUG, V28, P268, DOI 10.1007/s10637-009-9242-8	10	0	0	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					547	548		10.1016/j.stem.2010.10.006	http://dx.doi.org/10.1016/j.stem.2010.10.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040892	Green Accepted, Bronze			2022-12-28	WOS:000284390500002
J	Chaffer, CL; Weinberg, RA				Chaffer, Christine L.; Weinberg, Robert A.			Cancer Cell of Origin: Spotlight on Luminal Progenitors	CELL STEM CELL			English	Editorial Material							BRCA1	Does basal type breast cancer arise from oncogenic transformation of a basal cell type? In this issue of Cell Stem Cell, Molyneux et al. (2010) investigate the provenance of the basal-type BRCA1 breast carcinoma and come up with unanticipated results.	[Chaffer, Christine L.; Weinberg, Robert A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chaffer, Christine L.; Weinberg, Robert A.] MIT, Ludwig Ctr Mol Oncol, Cambridge, MA 02139 USA; [Weinberg, Robert A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Weinberg, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	weinberg@wi.mit.edu			NCI NIH HHS [U54 CA126515, U54 CA126515-040003] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA126515] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Goldstein AS, 2010, SCIENCE, V329, P568, DOI 10.1126/science.1189992; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Molyneux G, 2010, CELL STEM CELL, V7, P403, DOI 10.1016/j.stem.2010.07.010; Petersen OW, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003160; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509	8	21	22	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					271	272		10.1016/j.stem.2010.08.008	http://dx.doi.org/10.1016/j.stem.2010.08.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804960	Bronze, Green Accepted, Green Published			2022-12-28	WOS:000282037800001
J	Peljto, M; Dasen, JS; Mazzoni, EO; Jessell, TM; Wichterle, H				Peljto, Mirza; Dasen, Jeremy S.; Mazzoni, Esteban O.; Jessell, Thomas M.; Wichterle, Hynek			Functional Diversity of ESC-Derived Motor Neuron Subtypes Revealed through Intraspinal Transplantation	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DIRECTED DIFFERENTIATION; POSITIONAL IDENTITY; GENE-EXPRESSION; IDENTIFICATION; SPECIFICATION; INNERVATION; MOTONEURONS; PROJECTIONS; INHIBITOR	Cultured ESCs can form different classes of neurons, but whether these neurons can acquire specialized subtype features typical of neurons in vivo remains unclear. We show here that mouse ESCs can be directed to form highly specific motor neuron subtypes in the absence of added factors, through a differentiation program that relies on endogenous Wnts, FGFs, and Hh-mimicking the normal program of motor neuron subtype differentiation. Molecular markers that characterize motor neuron subtypes anticipate the functional properties of these neurons in vivo: ESC-derived motor neurons grafted isochronically into chick spinal cord settle in appropriate columnar domains and select axonal trajectories with a fidelity that matches that of their in vivo generated counterparts. ESC-derived motor neurons can therefore be programmed in a predictive manner to acquire molecular and functional properties that characterize one of the many dozens of specialized motor neuron subtypes that exist in vivo.	[Peljto, Mirza; Mazzoni, Esteban O.; Wichterle, Hynek] Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA; [Jessell, Thomas M.] Columbia Univ, Med Ctr, Kavli Inst Brain Sci, Dept Neurosci & Biochem & Mol Biophys, New York, NY 10032 USA; [Dasen, Jeremy S.; Jessell, Thomas M.] NYU, Sch Med, Howard Hughes Med Inst, New York, NY 10016 USA; [Dasen, Jeremy S.] NYU, Sch Med, Smilow Neurosci Program, Dept Physiol & Neurosci, New York, NY 10016 USA	Columbia University; Columbia University; Howard Hughes Medical Institute; New York University; New York University	Wichterle, H (corresponding author), Columbia Univ, Med Ctr, Dept Pathol & Cell Biol, Ctr Motor Neuron Biol & Dis, New York, NY 10032 USA.	hw350@columbia.edu	Califano, Andrea/F-7239-2012	mazzoni, esteban/0000-0001-8994-681X; Wichterle, Hynek/0000-0002-7817-0080	A.L.S. grant; NINDS [NS058502, NS055923, NS033245]; NIH [T32 HD055165]; Ruth L. Kirschstein National Research Service; Damon Runyon Cancer Research Foundation [DRG-1937-07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [T32HD055165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033245, P01NS055923, R37NS033245, R01NS058502] Funding Source: NIH RePORTER	A.L.S. grant; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth L. Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Roger Tsien for mCherry plasmid, Stephane Nedelec for Hb9-RFP plasmid, Susan Brenner-Morton for antibodies, Ira Schieren for FACS analysis, and members of H.W. and Doetsch labs for critical discussion. This work was supported by Project A.L.S. grant (T.M.J. and H.W.), NINDS NS058502, NS055923 (H.W.), and NS033245 (T.M.J.) grants, and NIH T32 HD055165 Ruth L. Kirschstein National Research Service Award (M.P.). J.S.D. is HHMI Early Career Scientist, E.O.M. is the David and Sylvia Lieb Fellow of the Damon Runyon Cancer Research Foundation (DRG-1937-07), and T.M.J. is a HHMI investigator.	Agalliu D, 2009, NEURON, V61, P708, DOI 10.1016/j.neuron.2008.12.026; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4; BAIN G, 1995, DEV BIOL, V168, P342, DOI 10.1006/dbio.1995.1085; BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X; Dasen JS, 2008, CELL, V134, P304, DOI 10.1016/j.cell.2008.06.019; Dasen JS, 2009, CURR TOP DEV BIOL, V88, P169, DOI 10.1016/S0070-2153(09)88006-X; Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009; Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; FERNS MJ, 1995, J COMP NEUROL, V357, P272, DOI 10.1002/cne.903570207; Finley MFA, 1999, J NEUROBIOL, V40, P271, DOI 10.1002/(SICI)1097-4695(19990905)40:3<271::AID-NEU1>3.0.CO;2-C; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JONES CL, 1979, J MORPHOL, V162, P275, DOI 10.1002/jmor.1051620207; Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2; Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7; Kanning KC, 2010, ANNU REV NEUROSCI, V33, P409, DOI 10.1146/annurev.neuro.051508.135722; Lako M, 2001, MECH DEVELOP, V103, P49, DOI 10.1016/S0925-4773(01)00331-8; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Liss B, 2008, BRAIN RES REV, V58, P314, DOI 10.1016/j.brainresrev.2007.10.004; Liu JP, 2001, NEURON, V32, P997, DOI 10.1016/S0896-6273(01)00544-X; Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2; MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Nordstrom U, 2006, PLOS BIOL, V4, P1438, DOI 10.1371/journal.pbio.0040252; Rockhill RL, 2002, J NEUROSCI, V22, P3831; Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90; Sharma K, 1998, CELL, V95, P817, DOI 10.1016/S0092-8674(00)81704-3; Sockanathan S, 2003, NEURON, V40, P97, DOI 10.1016/S0896-6273(03)00532-4; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soundararajan P, 2006, J NEUROSCI, V26, P3256, DOI 10.1523/JNEUROSCI.5537-05.2006; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Wichterle Hynek, 2009, V482, P171, DOI 10.1007/978-1-59745-060-7_11; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	43	91	94	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					355	366		10.1016/j.stem.2010.07.013	http://dx.doi.org/10.1016/j.stem.2010.07.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804971	Green Accepted, Bronze			2022-12-28	WOS:000282037800012
J	Martinez-Cerdeno, V; Noctor, SC; Espinosa, A; Ariza, J; Parker, P; Orasji, S; Daadi, MM; Bankiewicz, K; Alvarez-Buylla, A; Kriegstein, AR				Martinez-Cerdeno, Veronica; Noctor, Stephen C.; Espinosa, Ana; Ariza, Jeanelle; Parker, Philip; Orasji, Samantha; Daadi, Marcel M.; Bankiewicz, Krystof; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.			Embryonic MGE Precursor Cells Grafted into Adult Rat Striatum Integrate and Ameliorate Motor Symptoms in 6-OHDA-Lesioned Rats	CELL STEM CELL			English	Article							MEDIAL GANGLIONIC EMINENCE; PARKINSONS-DISEASE; PROJECTION NEURONS; GABAERGIC INTERNEURONS; GENE-THERAPY; DLX GENES; GAD GENE; MODEL; NEOSTRIATUM; FOREBRAIN	We investigated a strategy to ameliorate the motor symptoms of rats that received 6-hydroxydopamine (6-OHDA) lesions, a rodent model of Parkinson's disease, through transplantation of embryonic medial ganglionic eminence (MGE) cells into the striatum. During brain development, embryonic MGE cells migrate into the striatum and neocortex where they mature into GABAergic interneurons and play a key role in establishing the balance between excitation and inhibition. Unlike most other embryonic neurons, MGE cells retain the capacity for migration and integration when transplanted into the postnatal and adult brain. We performed MGE cell transplantation into the basal ganglia of control and 6-OHDA-lesioned rats. Transplanted MGE cells survived, differentiated into GABA(+) neurons, integrated into host circuitry, and modifed motor behavior in both lesioned and control rats. Our data suggest that MGE cell transplantation into the striatum is a promising approach to investigate the potential benefits of remodeling basal ganglia circuitry in neurodegenerative diseases.	[Martinez-Cerdeno, Veronica; Noctor, Stephen C.; Ariza, Jeanelle; Parker, Philip; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Espinosa, Ana] Univ Miguel Hernandez, E-03550 Alacant, Spain; [Espinosa, Ana] CSIC, Inst Neurociencias Alicante, E-03550 Alacant, Spain; [Orasji, Samantha] Leiden Univ, Med Ctr, NL-2300 Leiden, Netherlands; [Daadi, Marcel M.; Bankiewicz, Krystof; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Martinez-Cerdeno, Veronica; Noctor, Stephen C.; Ariza, Jeanelle; Parker, Philip; Alvarez-Buylla, Arturo; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; Universidad Miguel Hernandez de Elche; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Martinez-Cerdeno, V (corresponding author), Univ Calif Davis, Shriners Hosp No Calif, Inst Pediat Regenerat Med, 2425 Stockton BLVD, Sacramento, CA 95817 USA.	vmartinezcerdeno@ucdavis.edu; kriegsteina@stemcell.ucsf.edu	Espinosa Martínez, Ana Belén/AAD-4487-2021	Espinosa Martínez, Ana Belén/0000-0002-3738-3514; Parker, Philip R. L./0000-0002-6224-9747; Alvarez-Buylla, Arturo/0000-0003-4426-8925	Rudd Foundation; Bernard Osher Foundation; FPI fellowship [BFU2004-04660]; Neurona Therapeutics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478] Funding Source: NIH RePORTER	Rudd Foundation; Bernard Osher Foundation; FPI fellowship(Spanish Government); Neurona Therapeutics; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank William Walantus and Eduardo Esquenazi for technical assistance, Dr. Joseph Lo Turco and Dr. John Rubenstein for helpful comments on the manuscript, Dr. John Rubenstein, Dr. Scott Baraban, and the UCSF MGE group for helpful advice on this project, and Francoise Chanut for editing an early version of the manuscript. The authors would like to acknowledge support from the Rudd Foundation, the Bernard Osher Foundation, and the FPI fellowship (associated to project BFU2004-04660) to A.E. A.R.K. and A.A.-B. are cofounders of and have a financial interest in Neurona Therapeutics.	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson S, 1999, CEREB CORTEX, V9, P646, DOI 10.1093/cercor/9.6.646; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Anderson SA, 1997, NEURON, V19, P27, DOI 10.1016/S0896-6273(00)80345-1; Benabid AL, 2000, ARCH MED RES, V31, P282, DOI 10.1016/S0188-4409(00)00077-1; BERGER K, 1991, BRAIN RES BULL, V26, P301, DOI 10.1016/0361-9230(91)90242-C; Butt SJB, 2005, NEURON, V48, P591, DOI 10.1016/j.neuron.2005.09.034; Campbell K, 1995, NEURON, V15, P1259, DOI 10.1016/0896-6273(95)90006-3; CREESE I, 1977, SCIENCE, V197, P596, DOI 10.1126/science.877576; Daadi MM, 2009, CELL TRANSPLANT, V18, P815, DOI 10.3727/096368909X470829; DAHL CB, 1989, PHARMACOL TOXICOL, V64, P302, DOI 10.1111/j.1600-0773.1989.tb00652.x; DEACON TW, 1994, BRAIN RES, V668, P211, DOI 10.1016/0006-8993(94)90526-6; DeFelipe J, 1999, J COMP NEUROL, V412, P515, DOI 10.1002/(SICI)1096-9861(19990927)412:3<515::AID-CNE10>3.0.CO;2-1; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Du YZ, 2002, J NEUROSCI RES, V68, P647, DOI 10.1002/jnr.10245; During M J, 2001, Hum Gene Ther, V12, P1589; Goto S, 1997, EXP NEUROL, V147, P503, DOI 10.1006/exnr.1997.6628; GrasbonFrodl EM, 1997, NEUROBIOL DIS, V3, P299, DOI 10.1006/nbdi.1996.0124; HUDSON JL, 1993, BRAIN RES, V626, P167, DOI 10.1016/0006-8993(93)90576-9; Kaplitt MG, 2007, LANCET, V369, P2097, DOI 10.1016/S0140-6736(07)60982-9; Kawaguchi Y, 1997, NEUROSCI RES, V27, P1, DOI 10.1016/S0168-0102(96)01134-0; KAWAGUCHI Y, 1995, TRENDS NEUROSCI, V18, P527, DOI 10.1016/0166-2236(95)98374-8; KAWAGUCHI Y, 1993, J NEUROSCI, V13, P4908; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Koos T, 2004, J NEUROSCI, V24, P7916, DOI 10.1523/JNEUROSCI.2163-04.2004; KUBOTA Y, 1994, BRAIN RES, V649, P159, DOI 10.1016/0006-8993(94)91060-X; Larsson E, 2001, BRAIN RES, V913, P117, DOI 10.1016/S0006-8993(01)02762-7; Lavdas AA, 1999, J NEUROSCI, V19, P7881; Lee B, 2005, GENE THER, V12, P1215, DOI 10.1038/sj.gt.3302520; Litvan I, 2007, J NEUROPATH EXP NEUR, V66, P251, DOI 10.1097/nen.0b013e3180415e42; LJUNGBERG T, 1976, EUR J PHARMACOL, V36, P181, DOI 10.1016/0014-2999(76)90270-3; Luk KC, 2001, NEUROSCIENCE, V104, P93, DOI 10.1016/S0306-4522(01)00038-0; Luo J, 2002, SCIENCE, V298, P425, DOI 10.1126/science.1074549; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Marin O, 2000, J NEUROSCI, V20, P6063; Modo M, 2003, NEUROREPORT, V14, P39, DOI 10.1097/00001756-200301200-00007; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Olsson M, 1998, NEUROSCIENCE, V84, P867, DOI 10.1016/S0306-4522(97)00532-0; Olsson M, 1997, NEUROSCIENCE, V79, P57, DOI 10.1016/S0306-4522(96)00606-9; OLSSON M, 1995, NEUROSCIENCE, V69, P1169, DOI 10.1016/0306-4522(95)00325-D; Paxinos G., 2004, J CHEM INF MODEL, V5th; Piccini P, 2002, LANCET NEUROL, V1, P472, DOI 10.1016/S1474-4422(02)00235-1; Plenz D, 1998, J NEUROSCI, V18, P266; Pow DV, 2005, CELL TISSUE RES, V320, P379, DOI 10.1007/s00441-004-0928-0; Rymar VV, 2004, J COMP NEUROL, V469, P325, DOI 10.1002/cne.11008; Salin P, 2009, NEUROBIOL DIS, V34, P545, DOI 10.1016/j.nbd.2009.03.006; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Terpstra BT, 2007, J NEUROSCI METH, V166, P13, DOI 10.1016/j.jneumeth.2007.06.022; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P49; UNGERSTEDT U, 1970, Brain Research, V24, P485, DOI 10.1016/0006-8993(70)90187-3; West MJ, 1996, J COMP NEUROL, V370, P11; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wilkins A, 2003, J NEUROSCI, V23, P4967, DOI 10.1523/jneurosci.23-12-04967.2003; Winkler C, 1999, EXP NEUROL, V155, P165, DOI 10.1006/exnr.1998.6916; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100	55	82	84	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					238	250		10.1016/j.stem.2010.01.004	http://dx.doi.org/10.1016/j.stem.2010.01.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207227	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000276254600011
J	Choi, J; Artandi, S				Choi, Jinkuk; Artandi, Steven			Stem Cell Aging and Aberrant Differentiation within the Niche	CELL STEM CELL			English	Editorial Material							DNA-DAMAGE; AGE; MAINTENANCE; MECHANISMS; OLD	Stem cells age, but the underlying mechanisms remain unclear. In a recent issue of Cell, Inomata and colleagues (2009) show that DNA damage, a prime suspect in stem cell aging, causes graying and loss of melanocyte stem cells by inducing premature differentiation, without inducing apoptosis or senescence.	[Choi, Jinkuk; Artandi, Steven] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA; [Choi, Jinkuk; Artandi, Steven] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA	Stanford University; Stanford University	Artandi, S (corresponding author), Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA.	sartandi@stanford.edu		Choi, Jinkuk/0000-0002-2449-8291				Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Garinis GA, 2008, NAT CELL BIOL, V10, P1241, DOI 10.1038/ncb1108-1241; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; JOHNSON R, 1992, NAT GENET, V1, P226, DOI 10.1038/ng0692-226; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241	10	9	9	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					6	8		10.1016/j.stem.2009.06.006	http://dx.doi.org/10.1016/j.stem.2009.06.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570507	Bronze			2022-12-28	WOS:000267879200004
J	Guilak, F; Cohen, DM; Estes, BT; Gimble, JM; Liedtke, W; Chen, CS				Guilak, Farshid; Cohen, Daniel M.; Estes, Bradley T.; Gimble, Jeffrey M.; Liedtke, Wolfgang; Chen, Christopher S.			Control of Stem Cell Fate by Physical Interactions with the Extracellular Matrix	CELL STEM CELL			English	Review							MESENCHYMAL PROGENITOR CELLS; MARROW STROMAL CELLS; CYCLIC STRAIN; CHONDROGENIC DIFFERENTIATION; CA2+ ENTRY; IN-VITRO; CHONDROCYTE DIFFERENTIATION; PHENOTYPIC TRAITS; TISSUE; SHAPE	A diverse array of environmental factors contributes to the overall control of stem cell activity. In particular, new data continue to mount on the influence of the extracellular matrix (ECM) on stem cell fate through physical interactions with cells, such as the control of cell geometry, ECM geometry/topography at the nanoscale, ECM mechanical properties, and the transmission of mechanical or other biophysical factors to the cell. Here, we review some of the physical processes by which cues from the ECM can influence stem cell fate, with particular relevance to the use of stem cells in tissue engineering and regenerative medicine.	[Guilak, Farshid; Estes, Bradley T.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Guilak, Farshid; Estes, Bradley T.] Duke Univ, Med Ctr, Dept Biomed Engn, Durham, NC 27710 USA; [Liedtke, Wolfgang] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Cohen, Daniel M.; Chen, Christopher S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Gimble, Jeffrey M.] Louisiana State Univ Syst, Pennington Biomed Res Ctr, Stem Cell Lab, Baton Rouge, LA 70808 USA	Duke University; Duke University; Duke University; University of Pennsylvania; Louisiana State University System; Louisiana State University; Pennington Biomedical Research Center	Guilak, F (corresponding author), Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA.	guilak@duke.edu	Liedtke, Wolfgang/GNH-1878-2022; Chen, Christopher S./ABD-8499-2021; Guilak, Farshid/AAF-8558-2020; Liedtke, Wolfgang B/G-4633-2011	Chen, Christopher S./0000-0003-2445-8449; Guilak, Farshid/0000-0001-7380-0330; Cohen, Daniel/0000-0002-7963-668X; Estes, Bradley/0000-0003-0325-3989	NIH [AG15768, AR048852, AR48182, AR50245, GM74048, EB00262, E13001046]; Coulter Foundation; Duke Translational Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR048852, R01AR048182, P01AR050245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000262, P41EB001046] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG015768] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Coulter Foundation; Duke Translational Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported in part by NIH grants AG15768, AR048852, AR48182, AR50245, GM74048, EB00262, and E13001046; the Coulter Foundation; and the Duke Translational Research Institute.	ABBOTT J, 1966, J CELL BIOL, V28, P473, DOI 10.1083/jcb.28.3.473; Adams GB, 2008, GENE THER, V15, P96, DOI 10.1038/sj.gt.3303063; Alhadlaq A, 2004, STEM CELLS DEV, V13, P436, DOI 10.1089/1547328041797552; Angele P, 2003, J ORTHOPAED RES, V21, P451, DOI 10.1016/S0736-0266(02)00230-9; Arnold M, 2004, CHEMPHYSCHEM, V5, P383, DOI 10.1002/cphc.200301014; Atala A, 2008, CURR STEM CELL RES T, V3, P21, DOI 10.2174/157488808783489435; Awad HA, 2004, BIOMATERIALS, V25, P3211, DOI 10.1016/j.biomaterials.2003.10.045; Baharvand H, 2007, MOL VIS, V13, P1711; Barnes WG, 2005, J BIOL CHEM, V280, P8041, DOI 10.1074/jbc.M412924200; Battista S, 2005, BIOMATERIALS, V26, P6194, DOI 10.1016/j.biomaterials.2005.04.003; Beech DJ, 2005, PFLUG ARCH EUR J PHY, V451, P53, DOI 10.1007/s00424-005-1441-3; BENYA PD, 1982, CELL, V30, P215, DOI 10.1016/0092-8674(82)90027-7; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Brisken C, 2007, STEM CELL REV, V3, P147, DOI 10.1007/s12015-007-0019-1; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Caterina MJ, 2001, ANNU REV NEUROSCI, V24, P487, DOI 10.1146/annurev.neuro.24.1.487; Chen CS, 1998, BIOTECHNOL PROGR, V14, P356, DOI 10.1021/bp980031m; Chen CS, 2003, BIOCHEM BIOPH RES CO, V307, P355, DOI 10.1016/S0006-291X(03)01165-3; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Christopherson GT, 2009, BIOMATERIALS, V30, P556, DOI 10.1016/j.biomaterials.2008.10.004; COHEN DM, 2008, STEM CELL RES COMMUN, DOI DOI 10.3824/STEM-B00K.1.26.1; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; David V, 2007, ENDOCRINOLOGY, V148, P2553, DOI 10.1210/en.2006-1704; Dellatore SM, 2008, CURR OPIN BIOTECH, V19, P534, DOI 10.1016/j.copbio.2008.07.010; Deroanne CF, 2001, CARDIOVASC RES, V49, P647, DOI 10.1016/S0008-6363(00)00233-9; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Elder SH, 2001, ANN BIOMED ENG, V29, P476, DOI 10.1114/1.1376696; Elder SH, 2000, J ORTHOPAED RES, V18, P78, DOI 10.1002/jor.1100180112; Elisseeff J, 2006, STEM CELLS DEV, V15, P295, DOI 10.1089/scd.2006.15.295; EMERMAN JT, 1979, TISSUE CELL, V11, P109, DOI 10.1016/0040-8166(79)90011-9; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Engler AJ, 2004, J CELL BIOL, V166, P877, DOI 10.1083/jcb.200405004; Erickson GR, 2002, BIOCHEM BIOPH RES CO, V290, P763, DOI 10.1006/bbrc.2001.6270; Estes BT, 2004, CURR TOP DEV BIOL, V60, P91; Fan LZ, 2007, MOL BIOL CELL, V18, P1083, DOI 10.1091/mbc.E06-07-0602; FANG JM, 1995, INT J DEV BIOL, V39, P519; FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0; Gao X, 2003, J BIOL CHEM, V278, P27129, DOI 10.1074/jbc.M302517200; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Ghosh K, 2007, ADV DRUG DELIVER REV, V59, P1306, DOI 10.1016/j.addr.2007.08.014; Glucksmann A, 1942, J ANAT, V76, P231; Gong ZD, 2008, FASEB J, V22, P1635, DOI 10.1096/fj.07-087924; GUILAK F, 1995, J ORTHOP RES, V13, P410, DOI 10.1002/jor.1100130315; Guilak Farshid, 1997, P179; Guo WH, 2006, BIOPHYS J, V90, P2213, DOI 10.1529/biophysj.105.070144; Hadjipanayi E, 2009, J TISSUE ENG REGEN M, V3, P77, DOI 10.1002/term.136; HALL BK, 1990, J MORPHOL, V206, P45, DOI 10.1002/jmor.1052060105; Hamilton DW, 2004, TISSUE ENG, V10, P361, DOI 10.1089/107632704323061726; Hayman MW, 2005, J BIOCHEM BIOPH METH, V62, P231, DOI 10.1016/j.jbbm.2004.12.001; Hoben GM, 2008, STEM CELLS, V26, P422, DOI 10.1634/stemcells.2007-0641; HOLTZER H, 1960, P NATL ACAD SCI USA, V46, P1533, DOI 10.1073/pnas.46.12.1533; Huang CYC, 2004, STEM CELLS, V22, P313, DOI 10.1634/stemcells.22-3-313; Hwang NS, 2006, TISSUE ENG, V12, P2695, DOI 10.1089/ten.2006.12.2695; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Hwang Nathaniel S., 2007, V407, P351, DOI 10.1007/978-1-59745-536-7_24; INGBER D, 1991, J CELL BIOCHEM, V47, P236, DOI 10.1002/jcb.240470309; Ingber D E, 2004, Mech Chem Biosyst, V1, P53; Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333; Jakkaraju S, 2005, DEV CELL, V9, P39, DOI 10.1016/j.devcel.2005.04.015; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kasper S, 2008, STEM CELL REV, V4, P193, DOI 10.1007/s12015-008-9033-1; Kitsberg Daniel, 2007, V140, P33; Kloxin AM, 2009, SCIENCE, V324, P59, DOI 10.1126/science.1169494; Knippenberg M, 2005, TISSUE ENG, V11, P1780, DOI 10.1089/ten.2005.11.1780; Kronenberg HM, 2007, ADV EXP MED BIOL, V602, P57; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee WCC, 2007, BIOMECH MODEL MECHAN, V6, P265, DOI 10.1007/s10237-006-0053-y; Liedtke W., 2007, V179, P473; Liedtke W, 2005, CELL MOL LIFE SCI, V62, P2985, DOI 10.1007/s00018-005-5181-5; Liedtke W, 2003, P NATL ACAD SCI USA, V100, P14531, DOI 10.1073/pnas.2235619100; Mack CP, 2001, J BIOL CHEM, V276, P341, DOI 10.1074/jbc.M005505200; MANASEK FJ, 1972, DEV BIOL, V29, P349, DOI 10.1016/0012-1606(72)90077-2; Mauck RL, 2007, BIOMECH MODEL MECHAN, V6, P113, DOI 10.1007/s10237-006-0042-1; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; McBride SH, 2008, TISSUE ENG PT A, V14, P1561, DOI 10.1089/ten.tea.2008.0112; Mehta D, 2003, J BIOL CHEM, V278, P33492, DOI 10.1074/jbc.M302401200; Metallo CM, 2007, BIOTECHNOL PROGR, V23, P18, DOI 10.1021/bp060350a; Meyers J, 2006, CURR BIOL, V16, P1685, DOI 10.1016/j.cub.2006.07.056; Muramatsu S, 2007, J BIOL CHEM, V282, P32158, DOI 10.1074/jbc.M706158200; MURRAY PDF, 1969, J EMBRYOL EXP MORPH, V22, P349; Mutai H, 2003, CELL CALCIUM, V33, P471, DOI 10.1016/S0143-4160(03)00062-9; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; NEWMAN P, 1988, EXP CELL RES, V178, P199, DOI 10.1016/0014-4827(88)90391-6; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B, 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohyama M, 2006, J CLIN INVEST, V116, P249, DOI 10.1172/JCI26043; Park JS, 2004, BIOTECHNOL BIOENG, V88, P359, DOI 10.1002/bit.20250; Pedersen SF, 2007, METHOD ENZYMOL, V428, P183, DOI 10.1016/S0076-6879(07)28010-3; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Pla AF, 2005, J NEUROSCI, V25, P2687, DOI 10.1523/JNEUROSCI.0951-04.2005; Polak JM, 2006, ANN NY ACAD SCI, V1068, P352, DOI 10.1196/annals.1346.001; Poteser M, 2008, FEBS LETT, V582, P2696, DOI 10.1016/j.febslet.2008.06.049; Recknor JB, 2006, BIOMATERIALS, V27, P4098, DOI 10.1016/j.biomaterials.2006.03.029; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Saha S, 2006, J CELL PHYSIOL, V206, P126, DOI 10.1002/jcp.20441; Saha S, 2008, BIOPHYS J, V94, P4123, DOI 10.1529/biophysj.107.119891; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Sen B, 2008, ENDOCRINOLOGY, V149, P6065, DOI 10.1210/en.2008-0687; Shimizu N, 2008, J APPL PHYSIOL, V104, P766, DOI 10.1152/japplphysiol.00870.2007; Simmons CA, 2003, J BIOMECH, V36, P1087, DOI 10.1016/S0021-9290(03)00110-6; Sordella R, 2002, DEV CELL, V2, P553, DOI 10.1016/S1534-5807(02)00162-4; Sordella R, 2003, CELL, V113, P147, DOI 10.1016/S0092-8674(03)00271-X; Tai YL, 2009, PFLUG ARCH EUR J PHY, V458, P283, DOI 10.1007/s00424-008-0618-y; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Terraciano V, 2007, STEM CELLS, V25, P2730, DOI 10.1634/stemcells.2007-0228; Thomas GP, 1996, CALCIFIED TISSUE INT, V58, P101, DOI 10.1007/s002239900018; Titushkin I, 2007, BIOPHYS J, V93, P3693, DOI 10.1529/biophysj.107.107797; Vacanti JP, 1999, LANCET, V354, pSI32; Wang DZ, 2004, CURR OPIN GENET DEV, V14, P558, DOI 10.1016/j.gde.2004.08.003; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345; Wang JHC, 2008, INT REV CEL MOL BIO, V271, P301, DOI 10.1016/S1937-6448(08)01207-0; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Winer JP, 2009, TISSUE ENG PT A, V15, P147, DOI 10.1089/ten.tea.2007.0388; Yang Y, 2000, J CLIN INVEST, V106, P1321, DOI 10.1172/JCI8893; Yim EKF, 2007, EXP CELL RES, V313, P1820, DOI 10.1016/j.yexcr.2007.02.031; Yoshikawa T, 1997, BIO-MED MATER ENG, V7, P369; Yourek G, 2007, ASAIO J, V53, P219, DOI 10.1097/MAT.0b013e31802deb2d; ZANETTI NC, 1984, J CELL BIOL, V99, P115, DOI 10.1083/jcb.99.1.115; Zhang ZZ, 2008, J NEUROSCI, V28, P9536, DOI 10.1523/JNEUROSCI.1495-08.2008	126	1393	1443	12	465	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					17	26		10.1016/j.stem.2009.06.016	http://dx.doi.org/10.1016/j.stem.2009.06.016			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570510	Green Accepted, Bronze			2022-12-28	WOS:000267879200007
J	Merrill, BJ				Merrill, Bradley J.			Develop-WNTs in Somatic Cell Reprogramming	CELL STEM CELL			English	Editorial Material							SELF-RENEWAL; STEM-CELLS; PLURIPOTENCY; MOUSE	Two manuscripts published recently in Cell Stem Cell (Lluis et al., 2008 [this issue]; Marson et al., 2008) show that Wnt-beta-catenin signaling stimulates nuclear reprogramming. These two studies, using distinct reprogramming methods, offer insights into the mechanisms underlying acquisition and maintenance of pluripotency.	Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Merrill, BJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Chicago, IL 60607 USA.	merrillb@uic.edu						Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	10	11	19	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					465	466		10.1016/j.stem.2008.10.011	http://dx.doi.org/10.1016/j.stem.2008.10.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983957	Bronze			2022-12-28	WOS:000260895100001
J	ten Berge, D; Koole, W; Fuerer, C; Fish, M; Eroglu, E; Nusse, R				ten Berge, Derk; Koole, Wouter; Fuerer, Christophe; Fish, Matt; Eroglu, Elif; Nusse, Roel			Wnt Signaling Mediates Self-Organization and Axis Formation in Embryoid Bodies	CELL STEM CELL			English	Article							STEM-CELLS; TRANSCRIPTION FACTOR; BETA-CATENIN; MOUSE EMBRYOGENESIS; CYTOSKELETAL ELEMENTS; TESTICULAR TERATOMAS; VISCERAL ENDODERM; NODAL ANTAGONISTS; GERM-CELLS; E-CADHERIN	Embryonic stem cells (ESCs) form descendants of all three germ layers when differentiated as aggregates, termed embryoid bodies. In vivo, differentiation of cells depends on signals and morphogen gradients that provide instructive and positional cues, but do such gradients exist in embryoid bodies? We report here the establishment of anteroposterior polarity and the formation of a primitive streak-like region in the embryoid body, dependent on local activation of the Wnt pathway. In this region, cells undergo an epithelial-to-mesenchymal transition and differentiate into mesendodermal progenitors. Exogenous Wnt3a protein posteriorizes the embryoid body, resulting in predominantly mesendodermal differentiation. Conversely, inhibiting Wnt signaling promotes anterior character and results in neurectodermal differentiation. The activation of Wnt signaling and primitive streak formation requires external signals but is self-reinforcing after initiation. Our findings show that the Wnt pathway mediates the local execution of a gastrulation-like process in the embryoid body, which displays an unexpected degree of self-organization.	[ten Berge, Derk; Koole, Wouter; Fuerer, Christophe; Fish, Matt; Eroglu, Elif; Nusse, Roel] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA; [ten Berge, Derk; Koole, Wouter; Fuerer, Christophe; Fish, Matt; Eroglu, Elif; Nusse, Roel] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	ten Berge, D (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	derk@stanford.edu; rnusse@stanford.edu	Berge, Derk ten/C-1967-2012; Koole, Wouter/P-9299-2015; Berge, Derk ten/ABF-2591-2020	Koole, Wouter/0000-0002-8065-0630; Berge, Derk ten/0000-0002-5863-0860; Fuerer, Christophe/0000-0003-1717-6718; Eroglu, Elif/0000-0003-3952-3178	Howard Hughes Medical Institute; California Institute of Regenerative Medicine [RC1-00133-1]; National Institutes of Health [DK67834-01]; Swiss National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067834] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	These studies were supported by the Howard Hughes Medical Institute, a grant from the California Institute of Regenerative Medicine (RC1-00133-1), a grant from the National Institutes of Health (DK67834-01), and the Swiss National Science Foundation (C. Fuerer). Axin2<SUP>lacZ/+</SUP> ESCs and Brachyury-GFP ESCs were kindly provided by Drs. W. Birchmeier and G. Keller, respectively.	ANG SL, 1993, DEVELOPMENT, V119, P1301; ANG SL, 1994, DEVELOPMENT, V120, P2979; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Ben-Haim N, 2006, DEV CELL, V11, P313, DOI 10.1016/j.devcel.2006.07.005; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Brugmann SA, 2007, DEVELOPMENT, V134, P3283, DOI 10.1242/dev.005132; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; BURKERT U, 1991, NEW BIOL, V3, P698; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; DAMJANOV I, 1986, DEV BIOL, V116, P194, DOI 10.1016/0012-1606(86)90056-4; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Dufort D, 1998, DEVELOPMENT, V125, P3015; DUMONT DJ, 1995, DEV DYNAM, V203, P80, DOI 10.1002/aja.1002030109; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; FRANKE WW, 1983, DIFFERENTIATION, V25, P121; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Galceran J, 1999, GENE DEV, V13, P709, DOI 10.1101/gad.13.6.709; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Greco TL, 1996, GENE DEV, V10, P313, DOI 10.1101/gad.10.3.313; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hart AH, 2002, DEVELOPMENT, V129, P3597; HERRMANN BG, 1994, TRENDS GENET, V10, P280, DOI 10.1016/0168-9525(90)90011-T; Hsieh JC, 1999, P NATL ACAD SCI USA, V96, P3546, DOI 10.1073/pnas.96.7.3546; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; JACKSON BW, 1981, DIFFERENTIATION, V20, P203, DOI 10.1111/j.1432-0436.1981.tb01177.x; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kelly OG, 2004, DEVELOPMENT, V131, P2803, DOI 10.1242/dev.01137; Kemler R, 2004, DEVELOPMENT, V131, P5817, DOI 10.1242/dev.01458; Kimura-Yoshida C, 2005, DEV CELL, V9, P639, DOI 10.1016/j.devcel.2005.09.011; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Li XF, 2001, J CELL BIOL, V153, P811, DOI 10.1083/jcb.153.4.811; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; MARTIN GR, 1977, DEV BIOL, V61, P230, DOI 10.1016/0012-1606(77)90294-9; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mohn D, 2003, DEV DYNAM, V226, P446, DOI 10.1002/dvdy.10263; Morkel M, 2003, DEVELOPMENT, V130, P6283, DOI 10.1242/dev.00859; Murray P, 2001, DIFFERENTIATION, V68, P227, DOI 10.1046/j.1432-0436.2001.680410.x; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; NIETO MA, 1992, DEVELOPMENT, V116, P227; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Pearce JJH, 1999, MECH DEVELOP, V87, P189, DOI 10.1016/S0925-4773(99)00135-5; Perea-Gomez A, 2002, DEV CELL, V3, P745, DOI 10.1016/S1534-5807(02)00321-0; Pevny LH, 1998, DEVELOPMENT, V125, P1967; PIERCE GB, 1959, CANCER, V12, P573, DOI 10.1002/1097-0142(195905/06)12:3<573::AID-CNCR2820120316>3.0.CO;2-M; Robb L, 2000, DEV DYNAM, V219, P497, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1070>3.0.CO;2-O; Robertson SM, 2000, DEVELOPMENT, V127, P2447; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; SMITH DE, 1992, DEVELOPMENT, V116, P1033; STEVENS LC, 1959, J NATL CANCER I, V23, P1249; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; WALTHER C, 1991, DEVELOPMENT, V113, P1435; WEINSTEIN DC, 1994, CELL, V78, P575, DOI 10.1016/0092-8674(94)90523-1; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; WILEY LM, 1978, DEV BIOL, V63, P1, DOI 10.1016/0012-1606(78)90108-2; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; WINNIER G, 1995, GENE DEV, V9, P2105, DOI 10.1101/gad.9.17.2105; Wood HB, 1999, MECH DEVELOP, V86, P197, DOI 10.1016/S0925-4773(99)00116-1; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamamoto M, 2004, NATURE, V428, P387, DOI 10.1038/nature02418; Yoshikawa Y, 1997, DEV BIOL, V183, P234, DOI 10.1006/dbio.1997.8502	78	323	326	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					508	518		10.1016/j.stem.2008.09.013	http://dx.doi.org/10.1016/j.stem.2008.09.013			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983966	Bronze, Green Accepted			2022-12-28	WOS:000260895100010
J	Seguin, CA; Draper, JS; Nagy, A; Rossant, J				Seguin, Cheryle A.; Draper, Jonathan S.; Nagy, Andras; Rossant, Janet			Establishment of endoderm progenitors by SOX transcription factor expression in human embryonic stem cells	CELL STEM CELL			English	Article							VISCERAL ENDODERM; PARIETAL ENDODERM; MOUSE EMBRYO; DIFFERENTIATION; LIVER; MEMBRANE; PANCREAS; LINEAGE; PLAYS; GENE	In this study, we explore endoderm cell fate regulation through the expression of lineage-determining transcription factors. We demonstrate that stable endoderm progenitors can be established from human ES cells by constitutive expression of SOX7 or SOX17, producing extraembryonic endoderm and definitive endoderm progenitors, respectively. In teratoma assays and growth factor-mediated differentiation, SOX7 cells appear restricted to the extraembryonic endoderm, and SOX17 cells demonstrate a mesendodermal phenotype in teratomas and the ability to undergo endoderm maturation in vitro in the absence of cytokine-mediated endoderm induction. These endoderm progenitor cells maintain a stable phenotype through many passages in culture, thereby providing new tools to explore the pathways of endoderm differentiation.	[Seguin, Cheryle A.; Draper, Jonathan S.; Rossant, Janet] Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada; [Draper, Jonathan S.; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Nagy, Andras; Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Seguin, CA (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1L7, Canada.	cseguin@sickkids.ca; janet.rossant@sickkids.ca	Seguin, Cheryle A/G-4511-2013; Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413; Draper, Jonathan/0000-0002-3241-7009; Seguin, Cheryle/0000-0001-6503-9107	Natural Sciences and Engineering Research Council of Canada; Stem Cell Network; Juvenile Diabetes Research Foundation; Biotechnology and Biological Sciences Research Council, UK; Canadian Institutes of Health Research [31210016364]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Stem Cell Network; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	C.A.S. was funded by the Natural Sciences and Engineering Research Council of Canada, the Stem Cell Network, and the Juvenile Diabetes Research Foundation. J.S.D. was funded by the Biotechnology and Biological Sciences Research Council, UK. This work was supported by grants from the Canadian Institutes of Health Research (grant #31210016364) and the Stem Cell Network. We would like to thank Marina Gertenstein and Jorge Cabezas for assistance with teratoma assays; Nina Nouraeyan, Alison Hirukawa, and Malgosia Kownacka for cell culture; Brian Cox for assistance in microarray analysis; and Geoffrey Wood for histological evaluation of teratomas.	Assady S, 2001, DIABETES, V50, P1691, DOI 10.2337/diabetes.50.8.1691; Ber I, 2003, J BIOL CHEM, V278, P31950, DOI 10.1074/jbc.M303127200; Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Debacker C, 1999, MECH DEVELOP, V85, P183, DOI 10.1016/S0925-4773(99)00088-X; Deutsch G, 2001, DEVELOPMENT, V128, P871; Ferber S, 2000, NAT MED, V6, P568, DOI 10.1038/75050; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; Futaki S, 2003, J BIOL CHEM, V278, P50691, DOI 10.1074/jbc.M304985200; George SHL, 2007, P NATL ACAD SCI USA, V104, P4455, DOI 10.1073/pnas.0609277104; Grapin-Botton A, 2007, MECH DEVELOP, V124, P253, DOI 10.1016/j.mod.2007.01.001; Hart AH, 2002, DEVELOPMENT, V129, P3597; HOGAN BLM, 1980, DEV BIOL, V80, P289, DOI 10.1016/0012-1606(80)90405-4; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Hui HX, 2002, EUR J ENDOCRINOL, V146, P129, DOI 10.1530/eje.0.1460129; Jiang JJ, 2007, STEM CELLS, V25, P1940, DOI 10.1634/stemcells.2006-0761; Jiang W, 2007, CELL RES, V17, P333, DOI 10.1038/cr.2007.28; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; KISPERT A, 1994, DEV BIOL, V161, P179, DOI 10.1006/dbio.1994.1019; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kuo CT, 1997, GENE DEV, V11, P1048, DOI 10.1101/gad.11.8.1048; Lavon N, 2004, DIFFERENTIATION, V72, P230, DOI 10.1111/j.1432-0436.2004.07205002.x; Lavon N, 2006, STEM CELLS, V24, P1923, DOI 10.1634/stemcells.2005-0397; LAWSON KA, 1987, DEVELOPMENT, V101, P627; LAWSON KA, 1986, DEV BIOL, V115, P325, DOI 10.1016/0012-1606(86)90253-8; LevinsonDushnik M, 1997, MOL CELL BIOL, V17, P3817, DOI 10.1128/MCB.17.7.3817; Liew CG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001783; Lin HT, 2007, WORLD J GASTROENTERO, V13, P1672, DOI 10.3748/wjg.v13.i11.1672; Lioubinski O, 2003, DEV DYNAM, V227, P402, DOI 10.1002/dvdy.10311; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; MASON IJ, 1986, EMBO J, V5, P1465, DOI 10.1002/j.1460-2075.1986.tb04383.x; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rossant J, 2004, DEV CELL, V7, P155, DOI 10.1016/j.devcel.2004.07.012; Sapir T, 2005, P NATL ACAD SCI USA, V102, P7964, DOI 10.1073/pnas.0405277102; Schwartz RE, 2005, STEM CELLS DEV, V14, P643, DOI 10.1089/scd.2005.14.643; SEMOFF S, 1982, EMBO J, V1, P1171, DOI 10.1002/j.1460-2075.1982.tb00009.x; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; Shirahashi H, 2004, CELL TRANSPLANT, V13, P197, DOI 10.3727/000000004783984016; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tam PPL, 2006, CURR OPIN GENET DEV, V16, P419, DOI 10.1016/j.gde.2006.06.008; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; Wells JM, 2000, DEVELOPMENT, V127, P1563; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; YODER MC, 1994, BLOOD, V83, P2436; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang C, 2007, DIFFERENTIATION, V75, P536, DOI 10.1111/j.1432-0436.2007.00190.x	58	148	153	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					182	195		10.1016/j.stem.2008.06.018	http://dx.doi.org/10.1016/j.stem.2008.06.018			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682240	Bronze			2022-12-28	WOS:000258523300013
J	Keyes, WM; Pecoraro, M; Aranda, V; Vernersson-Lindahl, E; Li, WZ; Vogel, H; Guo, XC; Garcia, EL; Michurina, TV; Enikolopov, G; Muthuswamy, SK; Mills, AA				Keyes, William M.; Pecoraro, Matte; Aranda, Victoria; Vernersson-Lindahl, Emma; Li, Wangzhi; Vogel, Hannes; Guo, Xuecui; Garcia, Elvin L.; Michurina, Tatyana V.; Enikolopov, Grigori; Muthuswamy, Senthil K.; Mills, Alea A.			Delta Np630 alpha Is an Oncogene that Targets Chromatin Remodeler Lsh to Drive Skin Stem Cell Proliferation and Tumorigenesis	CELL STEM CELL			English	Article							P53 HOMOLOG; KERATINOCYTE GROWTH; HAIR FOLLICLE; SELF-RENEWAL; SNF2 FAMILY; IN-VIVO; P63; MICE; SENESCENCE; DIFFERENTIATION	The p53 homolog p63 is essential for development, yet its role in cancer is not clear. We discovered that p63 deficiency evokes the tumor-suppressive mechanism of cellular senescence, causing a striking absence of stratified epithelia such as the skin. Here we identify the predominant p63 isoform, Delta Np63 alpha, as a protein that bypasses oncogene-induced senescence to drive tumorigenesis in vivo. Interestingly, bypass of senescence promotes stem-like proliferation and maintains survival of the keratin 15-positive stem cell population. Furthermore, we identify the chromatin-remodeling protein Lsh as a new target of Delta Np63 alpha that is an essential mediator of senescence bypass. These findings indicate that Delta Np63 alpha is an oncogene that cooperates with Ras to promote tumor-initiating stem-like proliferation and suggest that Lsh-mediated chromatin-remodeling events are critical to this process.	[Keyes, William M.; Pecoraro, Matte] UPF, CRG, Barcelona 08003, Spain; [Vogel, Hannes] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Muthuswamy, Senthil K.] Univ Toronto, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Keyes, William M.; Aranda, Victoria; Vernersson-Lindahl, Emma; Li, Wangzhi; Guo, Xuecui; Garcia, Elvin L.; Michurina, Tatyana V.; Enikolopov, Grigori; Muthuswamy, Senthil K.; Mills, Alea A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cold Spring Harbor Laboratory	Keyes, WM (corresponding author), UPF, CRG, Barcelona 08003, Spain.	bill.keyes@crg.es; mills@cshl.edu	Muthuswamy, Senthil K/AGY-2834-2022; Li, Wangzhi/A-1390-2015; Enikolopov, Grigori/P-5731-2019	Muthuswamy, Senthil K/0000-0001-6564-9634; Enikolopov, Grigori/0000-0001-8178-8917; Keyes, William M./0000-0002-8917-2268; Vogel, Otto Hannes/0000-0002-0960-3508	Spanish Ministry of Science and Innovation [SAF2010-18829]; ACS [RSG-06-190-01-MGO]; NATIONAL CANCER INSTITUTE [R01CA098830] Funding Source: NIH RePORTER	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); ACS(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Johannes Zuber, Michael Hemann, and Scott Lowe for assistance and advice; Yuri Lazebnik and Dominik Duelli for DMBA-treated tissues; Chris Johns and Sohail Khan for microarray analysis; and Leif Ellisen and James W. Rocco for HNSCC cell lines. W.M.K. was funded by the Spanish Ministry of Science and Innovation (Plan Nacional -SAF2010-18829). A.A.M. was funded by an ACS Research Scholar Award (RSG-06-190-01-MGO).	Aranda V, 2006, NAT CELL BIOL, V8, P1235, DOI 10.1038/ncb1485; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Brunner HG, 2002, J MED GENET, V39, P377, DOI 10.1136/jmg.39.6.377; Cao L, 2003, GENE DEV, V17, P201, DOI 10.1101/gad.1050003; Carriere C, 2007, P NATL ACAD SCI USA, V104, P4437, DOI 10.1073/pnas.0701117104; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dennis K, 2001, GENE DEV, V15, P2940, DOI 10.1101/gad.929101; Di Como CJ, 2002, CLIN CANCER RES, V8, P494; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dotto GP, 1999, CRIT REV ORAL BIOL M, V10, P442; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Geiman TM, 2001, BBA-GEN SUBJECTS, V1526, P211, DOI 10.1016/S0304-4165(01)00129-5; Gemenetzidis E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004849; Guo XC, 2009, NAT CELL BIOL, V11, P1451, DOI 10.1038/ncb1988; Hibi K, 2000, P NATL ACAD SCI USA, V97, P5462, DOI 10.1073/pnas.97.10.5462; Huang JQ, 2004, NUCLEIC ACIDS RES, V32, P5019, DOI 10.1093/nar/gkh821; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Keyes WM, 2006, P NATL ACAD SCI USA, V103, P8435, DOI 10.1073/pnas.0602477103; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Mignone JL, 2007, CELL CYCLE, V6, P2161, DOI 10.4161/cc.6.17.4593; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Mills AA, 2002, GENESIS, V32, P138, DOI 10.1002/gene.10067; Missero C, 1996, GENE DEV, V10, P3065, DOI 10.1101/gad.10.23.3065; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muegge K, 2005, BIOCHEM CELL BIOL, V83, P548, DOI 10.1139/O05-119; Myant K, 2008, MOL CELL BIOL, V28, P215, DOI 10.1128/MCB.01073-07; Narita M, 2005, NAT MED, V11, P920, DOI 10.1038/nm0905-920; Ortt K, 2006, FEBS LETT, V580, P4544, DOI 10.1016/j.febslet.2006.07.004; Pellegrini G, 2001, P NATL ACAD SCI USA, V98, P3156, DOI 10.1073/pnas.061032098; Rocco JW, 2006, CANCER CELL, V9, P45, DOI 10.1016/j.ccr.2005.12.013; Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Tonon G, 2005, COLD SH Q B, V70, P11, DOI 10.1101/sqb.2005.70.021; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Xi SC, 2007, P NATL ACAD SCI USA, V104, P14366, DOI 10.1073/pnas.0703669104; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yang AN, 1998, MOL CELL, V2, P305, DOI 10.1016/S1097-2765(00)80275-0; Yang A, 2006, MOL CELL, V24, P593, DOI 10.1016/j.molcel.2006.10.018	53	153	159	0	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					164	176		10.1016/j.stem.2010.12.009	http://dx.doi.org/10.1016/j.stem.2010.12.009			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295273	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000287633400010
J	Ku, S; Soragni, E; Campau, E; Thomas, EA; Altun, G; Laurent, LC; Loring, JF; Napierala, M; Gottesfeld, JM				Ku, Sherman; Soragni, Elisabetta; Campau, Erica; Thomas, Elizabeth A.; Altun, Gulsah; Laurent, Louise C.; Loring, Jeanne F.; Napierala, Marek; Gottesfeld, Joel M.			Friedreich's Ataxia Induced Pluripotent Stem Cells Model Intergenerational GAA.TTC Triplet Repeat Instability	CELL STEM CELL			English	Article							MISMATCH REPAIR; DEFINED FACTORS; DEFICIENT MICE; SOMATIC-CELLS; EXPANSION; GENE; DISEASE; TRANSCRIPTION; REPLICATION; FIBROBLASTS	The inherited neurodegenerative disease Friedreich's ataxia (FRDA) is caused by GAA.TTC triplet repeat hyperexpansions within the first intron of the FXN gene, encoding the mitochondrial protein frataxin. Long GAA.TTC repeats cause heterochromatin-mediated gene silencing and loss of frataxin in affected individuals. We report the derivation of induced pluripotent stem cells (iPSCs) from FRDA patient fibroblasts by transcription factor reprogramming. FXN gene repression is maintained in the iPSCs, as are the global gene expression signatures reflecting the human disease. GAA.TTC repeats uniquely in FXN in the iPSCs exhibit repeat instability similar to patient families, where they expand and/or contract with discrete changes in length between generations. The mismatch repair enzyme MSH2, implicated in repeat instability in other triplet repeat diseases, is highly expressed in pluripotent cells and occupies FXN intron 1, and shRNA silencing of MSH2 impedes repeat expansion, providing a possible molecular explanation for repeat expansion in FRDA.	[Ku, Sherman; Soragni, Elisabetta; Campau, Erica; Thomas, Elizabeth A.; Gottesfeld, Joel M.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Altun, Gulsah; Laurent, Louise C.; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Laurent, Louise C.] Univ Calif San Diego, Dept Reprod Med, San Diego, CA 92035 USA; [Napierala, Marek] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA	Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; University of Texas System; UTMD Anderson Cancer Center	Gottesfeld, JM (corresponding author), Scripps Res Inst, Dept Mol Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	joelg@scripps.edu	Loring, Jeanne F/A-1620-2011	Loring, Jeanne F/0000-0001-6226-9767; Gottesfeld, Joel/0000-0002-4643-5777; Laurent, Louise/0000-0002-2095-7534	National Institutes of Neurological Disorders and Stroke (NIH); Friedreich's Ataxia Research Alliance (FARA); GoFAR; Ataxia UK; Friedreich's Ataxia Society Ireland; Repligen Corporation (Waltham, MA); Families of Spinal Muscular Atrophy; NIH WRHR [R21MH087925]; Hartwell Foundation; CIRM [CL1-00502, RT1-01108, TR1-01250]; Millipore Foundation; Esther O'Keefe Foundation; National Ataxia Foundation; FARA; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH087925] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS055158, R01NS062856] Funding Source: NIH RePORTER	National Institutes of Neurological Disorders and Stroke (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Friedreich's Ataxia Research Alliance (FARA); GoFAR; Ataxia UK; Friedreich's Ataxia Society Ireland; Repligen Corporation (Waltham, MA); Families of Spinal Muscular Atrophy; NIH WRHR; Hartwell Foundation; CIRM(California Institute for Regenerative Medicine); Millipore Foundation; Esther O'Keefe Foundation; National Ataxia Foundation; FARA; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Perlman (UCLA) for providing skin biopsies and I. Singec, J. Clark, and C. Desponts for valuable advice and guidance. Additionally, we thank V. Lukiyanchuk for virus expertise, K. Clingerman for veterinary assistance, and C. Lynch for microarray analysis. This work was supported by the National Institutes of Neurological Disorders and Stroke (NIH), The Friedreich's Ataxia Research Alliance (FARA), GoFAR, Ataxia UK, Friedreich's Ataxia Society Ireland, and Repligen Corporation (Waltham, MA) to J.M.G. and by a fellowship from Families of Spinal Muscular Atrophy (to S.K.). L.C.L. is supported by NIH WRHR K12 Career Development Award and the Hartwell Foundation, and G.A. and J.F.L. are supported by CIRM (CL1-00502, RT1-01108, TR1-01250), NIH (R21MH087925), the Millipore Foundation, and the Esther O'Keefe Foundation. M.N. is supported by the National Ataxia Foundation and the FARA "Kyle Bryant Translational Research Award." J.M.G. serves as a consultant to Repligen Corporation, which is involved in the development of therapeutics for FRDA, and has a competing financial interest in this work.	Al-Mahdawi S, 2004, GENOMICS, V84, P301, DOI 10.1016/j.ygeno.2004.04.003; Al-Mahdawi S, 2008, HUM MOL GENET, V17, P735, DOI 10.1093/hmg/ddm346; Bidichandani SI, 1998, AM J HUM GENET, V62, P111, DOI 10.1086/301680; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Coppola G, 2006, NEUROBIOL DIS, V22, P302, DOI 10.1016/j.nbd.2005.11.014; De Biase I, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007914; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dion V, 2009, TRENDS GENET, V25, P288, DOI 10.1016/j.tig.2009.04.007; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Dragileva E, 2009, NEUROBIOL DIS, V33, P37, DOI 10.1016/j.nbd.2008.09.014; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Gottesfeld JM, 2007, PHARMACOL THERAPEUT, V116, P236, DOI 10.1016/j.pharmthera.2007.06.014; Haugen AC, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000812; Herman D, 2006, NAT CHEM BIOL, V2, P551, DOI 10.1038/nchembio815; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iyer RR, 1999, J BIOL CHEM, V274, P3865, DOI 10.1074/jbc.274.6.3865; Kim HM, 2008, EMBO J, V27, P2896, DOI 10.1038/emboj.2008.205; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Kramer PR, 1996, HUM GENET, V98, P151, DOI 10.1007/s004390050179; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Miranda CJ, 2002, FEBS LETT, V512, P291, DOI 10.1016/S0014-5793(02)02251-2; Mirkin SM, 2007, NATURE, V447, P932, DOI 10.1038/nature05977; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pianese L, 1997, AM J HUM GENET, V60, P460; Rai M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001958; Rindler PM, 2006, NUCLEIC ACIDS RES, V34, P6352, DOI 10.1093/nar/gkl846; Savouret C, 2003, EMBO J, V22, P2264, DOI 10.1093/emboj/cdg202; Shishkin AA, 2009, MOL CELL, V35, P82, DOI 10.1016/j.molcel.2009.06.017; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Wells RD, 2008, FASEB J, V22, P1625, DOI 10.1096/fj.07-097857; Zhao JH, 2009, NUCLEIC ACIDS RES, V37, P4420, DOI 10.1093/nar/gkp399	35	167	174	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					631	637		10.1016/j.stem.2010.09.014	http://dx.doi.org/10.1016/j.stem.2010.09.014			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040903	Bronze, Green Accepted			2022-12-28	WOS:000284390500014
J	Lee, JY; Nakada, D; Yilmaz, OH; Tothova, Z; Joseph, NM; Lim, MS; Gilliland, DG; Morrison, SJ				Lee, Jae Y.; Nakada, Daisuke; Yilmaz, Omer H.; Tothova, Zuzana; Joseph, Nancy M.; Lim, Megan S.; Gilliland, D. Gary; Morrison, Sean J.			mTOR Activation Induces Tumor Suppressors that Inhibit Leukemogenesis and Deplete Hematopoietic Stem Cells after Pten Deletion	CELL STEM CELL			English	Article							OXIDATIVE STRESS; SELF-RENEWAL; INK4A LOCUS; AKT; LEUKEMIA; P53; TRANSCRIPTION; SENESCENCE; DIFFERENTIATION; SURVIVAL	Pten deficiency depletes hematopoietic stem cells (HSCs) but expands leukemia-initiating cells, and the mTOR inhibitor, rapamycin, blocks these effects. Understanding the opposite effects of mTOR activation on HSCs versus leukemia-initiating cells could improve antileukemia therapies. We found that the depletion of Pten-deficient HSCs was not caused by oxidative stress and could not be blocked by N-acetyl-cysteine. Instead, Pten deletion induced, and rapamycin attenuated, the expression of p16(Ink4a) and p53 in HSCs, and p19(Arf) and p53 in other hematopoietic cells. p53 suppressed leukemogenesis and promoted HSC depletion after Pten deletion. p16(Ink4a) also promoted HSC depletion but had a limited role suppressing leukemogenesis. p19(Arf) strongly suppressed leukemogenesis but did not deplete HSCs. Secondary mutations attenuated this tumor suppressor response in some leukemias that arose after Pten deletion. mTOR activation therefore depletes HSCs by a tumor suppressor response that is attenuated by secondary mutations in leukemogenic clones.	[Lee, Jae Y.; Nakada, Daisuke; Yilmaz, Omer H.; Joseph, Nancy M.; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA; [Lee, Jae Y.; Nakada, Daisuke; Yilmaz, Omer H.; Joseph, Nancy M.; Morrison, Sean J.] Univ Michigan, Dept Internal Med, Ann Arbor, MI 48109 USA; [Lim, Megan S.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA; [Tothova, Zuzana; Gilliland, D. Gary] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Harvard University; Brigham & Women's Hospital	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329; Nakada, Daisuke/0000-0001-6010-7094; Lim, Megan/0000-0002-0415-2867; Lee, Jae/0000-0003-2264-9620	Howard Hughes Medical Institute; University of Michigan (UM); Japan Society for the Promotion of Science; UM-Comprehensive Cancer NIH [CA46592]; Medical Scientist Training Program; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of Michigan (UM)(University of Michigan System); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); UM-Comprehensive Cancer NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Howard Hughes Medical Institute. J.Y.L. was supported by predoctoral fellowships from the University of Michigan (UM) Biology of Aging Training Grant and the Medical Scientist Training Program. D.N. was supported by a postdoctoral fellowship from the Japan Society for the Promotion of Science. Flow cytometry was partially supported by the UM-Comprehensive Cancer NIH CA46592. Thanks to David Adams and Martin White for flow cytometry. Thanks to Chris Mountford and Sara Grove for mouse colony management and to Michael Smith and Mayya Malakh for help with genotyping. J.Y.L. and D.N. performed all experiments and participated in the design and interpretation of experiments. O.H.Y. initiated the project and generated the compound mutant mice. M.S.L. analyzed mouse pathology with help from J.Y.L. Z.T. and D.G.G. participated in the conception and interpretation of experiments. S.J.M. participated in the design and interpretation of Pten experiments and wrote the paper with J.Y.L. and D.N.	Aggerholm A, 2000, EUR J HAEMATOL, V65, P109, DOI 10.1034/j.1600-0609.2000.90181.x; Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chang H, 2006, LEUKEMIA RES, V30, P262, DOI 10.1016/j.leukres.2005.07.008; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chen ZB, 2005, NATURE, V436, P725, DOI 10.1038/nature03918; Chen ZB, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000053; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; de Stanchina E, 1998, GENE DEV, V12, P2434, DOI 10.1101/gad.12.15.2434; Di Cristofano A, 2000, CELL, V100, P387, DOI 10.1016/S0092-8674(00)80674-1; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017; Gutierrez A, 2009, BLOOD, V114, P647, DOI 10.1182/blood-2009-02-206722; Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kharas MG, 2010, BLOOD, V115, P1406, DOI 10.1182/blood-2009-06-229443; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lin AW, 1998, GENE DEV, V12, P3008, DOI 10.1101/gad.12.19.3008; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Olsson A, 2007, CELL DEATH DIFFER, V14, P1561, DOI 10.1038/sj.cdd.4402196; Sakai A, 1998, BLOOD, V92, P3410, DOI 10.1182/blood.V92.9.3410.421a06_3410_3415; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Sherr CJ, 2001, NAT REV MOL CELL BIO, V2, P731, DOI 10.1038/35096061; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	48	148	159	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					593	605		10.1016/j.stem.2010.09.015	http://dx.doi.org/10.1016/j.stem.2010.09.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040901	Green Accepted, Bronze			2022-12-28	WOS:000284390500011
J	Kerr, CL; Cheng, LZ				Kerr, Candace L.; Cheng, Linzhao			Multiple, Interconvertible States of Human Pluripotent Stem Cells	CELL STEM CELL			English	Editorial Material								Three recent studies, including Buecker et al. (2010), in this issue of Cell Stem Cell, report that human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) can exist in distinct but interconvertible states and describe a robust expansion of human ESCs/iPSCs that resemble mouse ESCs.	[Kerr, Candace L.; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Kerr, Candace L.; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Div Dev Genet, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Med, Div Hematol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cheng, LZ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA.	lcheng@welch.jhu.edu						Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; Kerr CL, 2006, SEMIN REPROD MED, V24, P304, DOI 10.1055/s-2006-952152; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	10	12	15	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					497	499		10.1016/j.stem.2010.05.014	http://dx.doi.org/10.1016/j.stem.2010.05.014			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569683	Bronze			2022-12-28	WOS:000278840700004
J	Lathia, JD; Gallagher, J; Heddleston, JM; Wang, JL; Eyler, CE; MacSwords, J; Wu, QL; Vasanji, A; McLendon, RE; Hjelmeland, AB; Rich, JN				Lathia, Justin D.; Gallagher, Joseph; Heddleston, John M.; Wang, Jialiang; Eyler, Christine E.; MacSwords, Jennifer; Wu, Qiulian; Vasanji, Amit; McLendon, Roger E.; Hjelmeland, Anita B.; Rich, Jeremy N.			Integrin Alpha 6 Regulates Glioblastoma Stem Cells	CELL STEM CELL			English	Article							CANCER-CELLS; BRAIN; TUMORS; GROWTH; IDENTIFICATION; EXPRESSION; PATHWAY; MARKER; NICHE; ANGIOGENESIS	Cancer stem cells (CSCs) are a subpopulation of tumor cells suggested to be critical for tumor maintenance, metastasis, and therapeutic resistance. Prospective identification and targeting of CSCs are therefore priorities for the development of novel therapeutic paradigms. Although CSC enrichment has been achieved with cell surface proteins including CD133 (Prominin-1), the roles of current CSC markers in tumor maintenance remain unclear. We examined the glioblastoma stem cell (GSC) perivascular microenvironment in patient specimens to identify enrichment markers with a functional significance and identified integrin alpha 6 as a candidate. Integrin alpha 6 is coexpressed with conventional GSC markers and enriches for GSCs. Targeting integrin alpha 6 in GSCs inhibits self-renewal, proliferation, and tumor formation capacity. Our results provide evidence that GSCs express high levels of integrin alpha 6, which can serve not only as an enrichment marker but also as a promising antiglioblastoma therapy.	[Lathia, Justin D.; Gallagher, Joseph; Heddleston, John M.; Eyler, Christine E.; MacSwords, Jennifer; Wu, Qiulian; Hjelmeland, Anita B.; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA; [Wang, Jialiang] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27705 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27705 USA; [McLendon, Roger E.] Duke Univ, Med Ctr, Dept Pathol, Durham, NC 27705 USA	Cleveland Clinic Foundation; Duke University; Duke University; Duke University	Rich, JN (corresponding author), Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA.	richj@ccf.org	Rich, Jeremy N./A-9501-2012; Rich, Jeremy/AAM-1445-2021; Lathia, Justin/AHB-8296-2022; Eyler, Christine E/A-2921-2010		Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH [NSO47409, NS054276, CA112958, CA116659]; Damon Runyon Cancer Research Foundation; Sidney Kimmel Foundation; National Brain Tumor Society; National Institutes of Neurological Disorders and Stroke (NINDS) [F30 NS063496]; American Brain Tumor Association; National Service Research Award [NCI F32 CA142159]; Duke University; Cleveland Clinic Foundation Tissue Procurement Service; NATIONAL CANCER INSTITUTE [F32CA142159, R01CA116659, R01CA129958] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F30NS063496, R01NS054276, K02NS047409] Funding Source: NIH RePORTER	Childhood Brain Tumor Foundation; Pediatric Brain Tumor Foundation of the United States; Accelerate Brain Cancer Cure; Alexander and Margaret Stewart Trust; Brain Tumor Society; Goldhirsh Foundation; Duke Comprehensive Cancer Center Stem Cell Initiative; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Sidney Kimmel Foundation; National Brain Tumor Society; National Institutes of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Brain Tumor Association; National Service Research Award; Duke University; Cleveland Clinic Foundation Tissue Procurement Service; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Dr. Mike Cook, Dr. Beth Harvat, Cathy Shemo, Moneen Morgan, and Sage O'Bryant for flow cytometry assistance, Linda Vargo for histology assistance, and the members of the Rich laboratory for technical assistance and critical review of the manuscript. We are also grateful to Dr. Michael Forrester for advice on the DNA fragmentation assay and to Drs. Mahendra S. Rao, Richard Ransohoff, Thomas Egelhoff, Yogen Saunthararajah, and Jeongwu Lee for valuable insight and comments on the manuscript. Work in the J.N.R. laboratory is supported by the Childhood Brain Tumor Foundation, the Pediatric Brain Tumor Foundation of the United States, Accelerate Brain Cancer Cure, Alexander and Margaret Stewart Trust, Brain Tumor Society, Goldhirsh Foundation, Duke Comprehensive Cancer Center Stem Cell Initiative Grant, and NIH grants NSO47409, NS054276, CA112958, and CA116659. J.N.R. is a Damon Runyon-Lilly Clinical Investigator supported by the Damon Runyon Cancer Research Foundation and a Sidney Kimmel Foundation for Cancer Research Scholar. A.B.H. is supported by the National Brain Tumor Society. C.E.E. is supported by a National Research Service Award from the National Institutes of Neurological Disorders and Stroke (NINDS F30 NS063496). J.D.L. is supported by an American Brain Tumor Association Basic Research Fellowship (sponsored by the Joelle Syverson Fund) and a National Service Research Award (NCI F32 CA142159). The Duke University Brain Tumor Tissue Bank is supported by the Duke University Brain Cancer SPORE, and we thank D. Satterfield, L. Ehinger, J. Funkhouser, and J. Faison for technical assistance. Studies were also supported by the Cleveland Clinic Foundation Tissue Procurement Service, and we thank S. Staugatis, R. Weil, and M. McGraw for their assistance.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; ALOISI F, 1992, J NEUROSCI RES, V32, P494, DOI 10.1002/jnr.490320405; Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Fortunel NO, 2003, SCIENCE, V302, P393; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Georges-Labouesse E, 1998, CURR BIOL, V8, P983, DOI 10.1016/S0960-9822(98)70402-6; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GINGRAS MC, 1995, J NEUROIMMUNOL, V57, P143, DOI 10.1016/0165-5728(94)00178-Q; Graus-Porta D, 2001, NEURON, V31, P367, DOI 10.1016/S0896-6273(01)00374-9; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Hall PE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-71; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Jaksch M, 2008, CANCER RES, V68, P7882, DOI 10.1158/0008-5472.CAN-08-0723; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Lathia JD, 2007, DEV DYNAM, V236, P3267, DOI 10.1002/dvdy.21319; Lathia JD, 2007, J COMP NEUROL, V505, P630, DOI 10.1002/cne.21520; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee TH, 2006, J BIOL CHEM, V281, P40450, DOI 10.1074/jbc.M607525200; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Loulier K, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000176; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; PAULUS W, 1993, AM J PATHOL, V143, P154; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Piccirillo SGM, 2009, ONCOGENE, V28, P1807, DOI 10.1038/onc.2009.27; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reardon DA, 2008, J CLIN ONCOL, V26, P5610, DOI 10.1200/JCO.2008.16.7510; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Schmid RS, 2003, CEREB CORTEX, V13, P219, DOI 10.1093/cercor/13.3.219; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shu Q, 2008, STEM CELLS, V26, P1414, DOI 10.1634/stemcells.2007-1009; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Son MJ, 2009, CELL STEM CELL, V4, P440, DOI 10.1016/j.stem.2009.03.003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; VAILLANT F, 2003, CANCER RES, V68, P7711; Vitolo D, 1996, HISTOPATHOLOGY, V28, P521, DOI 10.1046/j.1365-2559.1996.d01-471.x; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443	60	463	471	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					421	432		10.1016/j.stem.2010.02.018	http://dx.doi.org/10.1016/j.stem.2010.02.018			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452317	Green Accepted, Bronze			2022-12-28	WOS:000277844800010
J	Spradling, A; Fan, CM				Spradling, Allan; Fan, Chen-Ming			Counterfeiting the Family Jewels	CELL STEM CELL			English	Editorial Material							STEM-CELLS; IN-VIVO	In art and literature, originals are revered and copies frowned upon. But do men use germline stem cell copies to pass traits to their children? In Science, Nakagawa et al. (2010) show that new stem cell copies regularly arise in mouse testes by fragmentation of downstream germ cell clusters.	[Spradling, Allan; Fan, Chen-Ming] Carnegie Inst, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science	Spradling, A (corresponding author), Carnegie Inst, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu			NIAMS NIH HHS [R01 AR060042, R01 AR060042-01] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060042] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; CLERMONT Y, 1972, PHYSIOL REV, V52, P198, DOI 10.1152/physrev.1972.52.1.198; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328	10	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					405	406		10.1016/j.stem.2010.04.012	http://dx.doi.org/10.1016/j.stem.2010.04.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452312	Bronze			2022-12-28	WOS:000277844800005
J	Issigonis, M; Matunis, E				Issigonis, Melanie; Matunis, Erika			Niche Today, Gone Tomorrow-Progenitors Create Short-Lived Niche for Stem Cell Specification	CELL STEM CELL			English	Editorial Material							DROSOPHILA; MIDGUT	Establishing tissue-specific adult stem cells during organogenesis is important for maintenance of tissue homeostasis throughout the lifetime of the organism. In a recent study in Science, Mathur et al. (2010) describe how progenitor cells in the Drosophila larval midgut create a temporary niche to maintain stem cell fate during development.	[Issigonis, Melanie; Matunis, Erika] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, E (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA.	matunis@jhmi.edu			NICHD NIH HHS [R01 HD040307] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		ELSHATOURY HH, 1957, J EMBRYOL EXP MORPH, V5, P134; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; HARTENSTEIN V, 1992, ROUX ARCH DEV BIOL, V201, P194, DOI 10.1007/BF00188752; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Li TR, 2003, DEV CELL, V5, P59, DOI 10.1016/S1534-5807(03)00192-8; Mathur D, 2010, SCIENCE, V327, P210, DOI 10.1126/science.1181958; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Slack JMW, 2008, SCIENCE, V322, P1498, DOI 10.1126/science.1162782	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					191	193		10.1016/j.stem.2010.02.010	http://dx.doi.org/10.1016/j.stem.2010.02.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207220	Bronze			2022-12-28	WOS:000276254600006
J	Oguro, H; Yuan, J; Ichikawa, H; Ikawa, T; Yamazaki, S; Kawamoto, H; Nakauchi, H; Iwama, A				Oguro, Hideyuki; Yuan, Jin; Ichikawa, Hitoshi; Ikawa, Tonnokatsu; Yamazaki, Satoshi; Kawamoto, Hiroshi; Nakauchi, Hiromitsu; Iwama, Atsushi			Poised Lineage Specification in Multipotential Hematopoietic Stem and Progenitor Cells by the Polycomb Protein Bmi1	CELL STEM CELL			English	Article							DEVELOPMENTAL REGULATORS; SELF-RENEWAL; EXPRESSION; PROLIFERATION; LYMPHOPOIESIS; MAINTENANCE; INK4A; GENES; FATE; EBF	Polycomb group (PcG) proteins are essential regulators of stem cells. PcG and trithorax group proteins mark developmental regulator gene promoters with bivalent domains consisting of overlapping repressive and activating histone modifications to keep them poised for activation in embryonic stem cells. Bmi1, a component of PcG complexes, maintains the self-renewal capacity of adult stem cells, but its role in multipotency remains obscure. Here we show that Bmi1 is critical for multipotency of hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs). B cell lineage developmental regulator genes, Ebf1 and Pax5, appeared to be transcriptionally repressed by bivalent domains before lineage commitment. Loss of Bmi1 resulted in a resolution of bivalent domains at the Ebf1 and Pax5 loci, leading to their premature expression in HSC/MPPs accompanied by accelerated lymphoid specification and a marked reduction in HSC/MPPs. Thus, Bmi1 is required to reinforce bivalent domains at key developmental regulator gene loci to maintain lineage specification poised for activation in adult stem cells.	[Oguro, Hideyuki; Yuan, Jin; Iwama, Atsushi] Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan; [Oguro, Hideyuki; Yuan, Jin; Iwama, Atsushi] CREST, JST, Chiyoda Ku, Tokyo 1020075, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] ERATO, JST, Chiyoda Ku, Tokyo 1020075, Japan; [Ichikawa, Hitoshi] Natl Canc Ctr, Res Inst, Div Genet, Tokyo 1040045, Japan; [Ikawa, Tonnokatsu; Kawamoto, Hiroshi] RIKEN Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Yokohama, Kanagawa 2300045, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Lab Stem Cell Therapy, Tokyo 1088679, Japan	Chiba University; Japan Science & Technology Agency (JST); Japan Science & Technology Agency (JST); National Cancer Center - Japan; RIKEN; University of Tokyo	Iwama, A (corresponding author), Chiba Univ, Grad Sch Med, Dept Cellular & Mol Med, Chiba 2608670, Japan.	aiwama@faculty.chiba-u.jp	Oguro, Hideyuki/Q-5478-2019	Oguro, Hideyuki/0000-0002-9070-4575	Japanese Society for the Promotion of Science; Global COE Program; MEXT, Japan; Japan Science and Technology Corporation (JST); Takeda Science Foundation;  [20052009]	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Global COE Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)); Takeda Science Foundation(Takeda Science Foundation (TSF)); 	We thank Maarten van Lohuizen and Ronald A. DePinho for providing Bmi1<SUP>+/-</SUP> mice and Ink4a<SUP>+/-</SUP> mice, respectively, Naohito Nozaki for the Bmi1 antibody, and Yuji Yamazaki for flow cytometric sorting. H.O. is supported by a postdoctoral fellowship from the Japanese Society for the Promotion of Science. This work was supported in part by Grants-in-Aid for Scientific Research (#20052009) and for the Global COE Program (Global Center for Education and Research in Immune System Regulation and Treatment), MEXT, Japan, a Grant-in-Aid for the Core Research for Evolutional Science and Technology (CREST) from the Japan Science and Technology Corporation (JST), and a grant from the Takeda Science Foundation.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Dias S, 2008, CURR OPIN GENET DEV, V18, P441, DOI 10.1016/j.gde.2008.07.015; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liu HF, 2007, GENE DEV, V21, P1179, DOI 10.1101/gad.1529307; Masuda K, 2005, EMBO J, V24, P4052, DOI 10.1038/sj.emboj.7600878; Mendenhall EM, 2008, CURR OPIN GENET DEV, V18, P109, DOI 10.1016/j.gde.2008.01.010; Miyazaki M, 2008, IMMUNITY, V28, P231, DOI 10.1016/j.immuni.2007.12.013; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Pongubala JMR, 2008, NAT IMMUNOL, V9, P203, DOI 10.1038/ni1555; Raaphorst FM, 2001, TRENDS IMMUNOL, V22, P682, DOI 10.1016/S1471-4906(01)02082-8; Roessler S, 2007, MOL CELL BIOL, V27, P579, DOI 10.1128/MCB.01192-06; Souabni A, 2002, IMMUNITY, V17, P781, DOI 10.1016/S1074-7613(02)00472-7; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Voncken JW, 1999, J CELL SCI, V112, P4627; Zhang Z, 2003, EMBO J, V22, P4759, DOI 10.1093/emboj/cdg464	28	147	152	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					279	286		10.1016/j.stem.2010.01.005	http://dx.doi.org/10.1016/j.stem.2010.01.005			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207230	Bronze			2022-12-28	WOS:000276254600014
J	Schroeder, T				Schroeder, Timm			Hematopoietic Stem Cell Heterogeneity: Subtypes, Not Unpredictable Behavior	CELL STEM CELL			English	Review							SELF-RENEWAL; LONG-TERM; PROGENITOR CELLS; IN-VIVO; DIFFERENTIATION; RECONSTITUTION	Thanks to well-established quantitative functional assays and prospective isolation methods, hematopoietic stem cells (HSCs) are among the best understood stem cells. Nevertheless, recent studies have identified new HSC subtypes with distinct properties within previously characterized populations, leading us to question long-held views on the underlying basis of HSC heterogeneity.	Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Schroeder, T (corresponding author), Helmholtz Ctr Munich, Inst Stem Cell Res, Ingolstaedter Landstr 1, D-85764 Neuherberg, Germany.	timm.schroeder@helmholtz-muenchen.de	Schroeder, Timm/F-8448-2010	Schroeder, Timm/0000-0001-9320-0252	Deutsche Forschungsgemeinschaft (DFG)	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was in part supported by the Deutsche Forschungsgemeinschaft (DFG).	Balazs AB, 2006, BLOOD, V107, P2317, DOI 10.1182/blood-2005-06-2249; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; OGAWA M, 1983, BLOOD, V61, P823; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396	20	80	84	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					203	207		10.1016/j.stem.2010.02.006	http://dx.doi.org/10.1016/j.stem.2010.02.006			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207223	Bronze			2022-12-28	WOS:000276254600008
J	Saha, K; Jaenisch, R				Saha, Krishanu; Jaenisch, Rudolf			Technical Challenges in Using Human Induced Pluripotent Stem Cells to Model Disease	CELL STEM CELL			English	Review							HUMAN SOMATIC-CELLS; IN-VITRO DIFFERENTIATION; HUMAN IPS CELLS; LENTIVIRAL VECTOR; PHYSIOLOGICAL-PARAMETERS; GENETIC-MODIFICATION; LABORATORY-ANIMALS; MOTOR-NEURONS; MOUSE MODEL; GENERATION	Reprogramming of human somatic cells uses readily accessible tissue, such as skin or blood, to generate embryonic-like induced pluripotent stem cells (iPSCs). This procedure has been applied to somatic cells from patients who are classified into a disease group, thus creating "disease-specific" iPSCs. Here, we examine the challenges and assumptions in creating a disease model from a single cell of the patient. Both the kinetics of disease onset and progression as well as the spatial localization of disease in the patient's body are challenges to disease modeling. New tools in genetic modification, reprogramming, biomaterials, and animal models can be used for addressing these challenges.	[Saha, Krishanu; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Saha, Krishanu/J-3980-2014	Saha, Krishanu/0000-0003-2837-0858	NIH [RO1-HDO45022, R37-CA084198, RO1-CA087869]; Society in Science: The Branco-Weiss; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198, R01CA084198] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society in Science: The Branco-Weiss; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank Vikram Khurana, Tom DiCesare, Frank Soldner, Julien Muffat, Ben Hurlbut, Meelad Dawlaty, and members of the Jaenisch lab for helpful discussions and illustrations. R.J. is supported by NIH grants RO1-HDO45022, R37-CA084198, and RO1-CA087869. K.S. is supported by the Society in Science: The Branco-Weiss fellowship. R.J. is an advisor to Stem-gent and a cofounder of Fate Therapeutics.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Andersson ER, 2009, J INTERN MED, V266, P303, DOI 10.1111/j.1365-2796.2009.02157.x; Behringer RR, 2007, CELL STEM CELL, V1, P259, DOI 10.1016/j.stem.2007.07.021; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Cantz T, 2008, BIOL CHEM, V389, P889, DOI 10.1515/BC.2008.107; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Chen M, 1996, NAT GENET, V12, P448, DOI 10.1038/ng0496-448; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; DAVIES B, 1993, PHARMACEUT RES, V10, P1093, DOI 10.1023/A:1018943613122; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Freund C, 2009, J CELL BIOCHEM, V107, P592, DOI 10.1002/jcb.22164; Friese MA, 2006, CURR OPIN IMMUNOL, V18, P704, DOI 10.1016/j.coi.2006.09.003; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Gearhart J, 1998, SCIENCE, V282, P1061, DOI 10.1126/science.282.5391.1061; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Green JJ, 2008, NANO LETT, V8, P3126, DOI 10.1021/nl8012665; Grimm S, 2004, NAT REV GENET, V5, P179, DOI 10.1038/nrg1291; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hester ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007044; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Khetani SR, 2008, NAT BIOTECHNOL, V26, P120, DOI 10.1038/nbt1361; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kiuru M, 2009, CELL STEM CELL, V4, P289, DOI 10.1016/j.stem.2009.03.010; Kneteman NM, 2005, HEPATOLOGY, V41, P703, DOI 10.1002/hep.20681; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Lacoste A, 2009, CELL STEM CELL, V5, P332, DOI 10.1016/j.stem.2009.07.011; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Loerch PM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003329; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Maehr R, 2009, P NATL ACAD SCI USA, V106, P15768, DOI 10.1073/pnas.0906894106; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Nelson DL, 2004, SCIENCE, V306, P619, DOI 10.1126/science.1105226; O'Malley J, 2009, CURR OPIN BIOTECH, V20, P516, DOI 10.1016/j.copbio.2009.09.005; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pickering SJ, 2005, REPROD BIOMED ONLINE, V10, P390, DOI 10.1016/S1472-6483(10)61801-9; Placantonakis DG, 2009, STEM CELLS, V27, P521, DOI 10.1634/stemcells.2008-0884; Raya A, 2009, NATURE, V460, P53, DOI 10.1038/nature08129; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Schenke-Layland K, 2008, STEM CELLS, V26, P1537, DOI 10.1634/stemcells.2008-0033; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Smith-Arica JR, 2003, CLONING STEM CELLS, V5, P51, DOI 10.1089/153623003321512166; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; SOTHERN RB, 1994, PHARMACEUT RES, V11, P349, DOI 10.1023/A:1018992432608; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stockwell BR, 2004, NATURE, V432, P846, DOI 10.1038/nature03196; SULLIVAN G, 2009, HEPATOLOGY IN PRESS, DOI DOI 10.1002/HEP.23335; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Taura D, 2009, FEBS LETT, V583, P1029, DOI 10.1016/j.febslet.2009.02.031; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xia XF, 2007, STEM CELLS DEV, V16, P167, DOI 10.1089/scd.2006.0057; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Ye L, 2009, P NATL ACAD SCI USA, V106, P9826, DOI 10.1073/pnas.0904689106; YE Z, 2009, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	113	285	328	0	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					584	595		10.1016/j.stem.2009.11.009	http://dx.doi.org/10.1016/j.stem.2009.11.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951687	Bronze, Green Submitted, Green Accepted			2022-12-28	WOS:000273616700007
J	Zeve, D; Tang, W; Graff, J				Zeve, Daniel; Tang, Wei; Graff, Jon			Fighting Fat with Fat: The Expanding Field of Adipose Stem Cells	CELL STEM CELL			English	Review							CIRCULATING PROGENITOR CELLS; BODY-FAT; IN-VIVO; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; ENDOTHELIAL-CELLS; BROWN FAT; ASSISTED LIPOTRANSFER; POSTMENOPAUSAL WOMEN; INSULIN-RESISTANCE	We are in the midst of a dire, unprecedented, and global epidemic of obesity and secondary sequelae, most prominently diabetes and hyperlipidemia. Underlying this epidemic is the most hated of cells, adipocytes, and their inherent dynamic ability to expand and renew. This capacity highlights a heretofore undefined stem compartment. Recent in vivo studies, relying upon lineage tracing and flow cytometry methods, have begun to unravel the identity of adipose stem cells, their niche, and the dynamism central to adipose expansion. Thus, the field is moving in a direction that may allow us to manipulate adipose stem cells to beneficial therapeutic ends.	[Zeve, Daniel; Tang, Wei; Graff, Jon] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Graff, Jon] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Graff, Jon] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Graff, J (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, 6000 Harry Hines Blvd,NB5-118, Dallas, TX 75390 USA.	jon.graff@utsouthwestern.edu		Zeve, Daniel/0000-0002-4117-1282	NIDDK; NIH [DK066556, DK064261]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK064261, R01DK066556, R56DK064261] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We wish to thank Drs. Debbie Clegg, William Dauer, Jeffrey Friedman, Jeffrey Kreuger, Jaemyoung Suh, and Michelle Tallquist, as well as former and current members of the Graff lab who have very much enlightened, informed, and refined our notions. Lewis Calver and the UTSW Biomedical Communications Graduate Program, which he directs, (Figure 1) and Roshanak Mehdibeigi (Figures 2 and 3) graciously produced all artwork. We also thank the NIDDK and NIH for support (DK066556, DK064261). J.G. is a founder of Reata Pharmaceuticals. We apologize for the inability to cite a vast number of papers that have paved the way for the studies reviewed above and for many of the notions put forth, but space limits preclude us from doing so.	Allison DB, 1999, JAMA-J AM MED ASSOC, V282, P1530, DOI 10.1001/jama.282.16.1530; Atit R, 2006, DEV BIOL, V296, P164, DOI 10.1016/j.ydbio.2006.04.449; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JCI32239; Cepko CL, 2000, METHOD ENZYMOL, V327, P118, DOI 10.1016/S0076-6879(00)27272-8; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crossno JT, 2006, J CLIN INVEST, V116, P3220, DOI 10.1172/JCI28510; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; DERIDDER CM, 1990, J CLIN ENDOCR METAB, V70, P888, DOI 10.1210/jcem-70-4-888; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Elabd C, 2009, STEM CELLS, V27, P2753, DOI 10.1002/stem.200; Elbers JMH, 1999, AM J PHYSIOL-ENDOC M, V276, pE317, DOI 10.1152/ajpendo.1999.276.2.E317; Fukumura D, 2003, CIRC RES, V93, pE88, DOI 10.1161/01.RES.0000099243.20096.FA; Gambacciani M, 1997, J CLIN ENDOCR METAB, V82, P414, DOI 10.1210/jc.82.2.414; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Graff JM, 1997, CELL, V89, P171, DOI 10.1016/S0092-8674(00)80196-8; GRANNEMAN JG, 1991, J PHARMACOL EXP THER, V256, P421; GRAUER WO, 1984, AM J CLIN NUTR, V39, P631, DOI 10.1093/ajcn/39.4.631; Gregoire FM, 1998, PHYSIOL REV, V78, P783, DOI 10.1152/physrev.1998.78.3.783; Grinspoon S, 2005, NEW ENGL J MED, V352, P48, DOI 10.1056/NEJMra041811; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; HELLMAN B, 1961, ACTA PATHOL MIC SC, V51, P347; HIRSCH J, 1976, CLIN ENDOCRINOL META, V5, P299, DOI 10.1016/S0300-595X(76)80023-0; HOLLENBERG CH, 1969, J CLIN INVEST, V47, P2485; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; IYAMA KI, 1979, VIRCHOWS ARCH B, V31, P143, DOI 10.1007/BF02889932; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Javazon EH, 2004, EXP HEMATOL, V32, P414, DOI 10.1016/j.exphem.2004.02.004; Joe AWB, 2009, STEM CELLS, V27, P2563, DOI 10.1002/stem.190; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; KLIEWER SA, 1994, P NATL ACAD SCI USA, V91, P7355, DOI 10.1073/pnas.91.15.7355; Koh YJ, 2007, J CLIN INVEST, V117, P3684, DOI 10.1172/JCI32504; Kolonin MG, 2004, NAT MED, V10, P625, DOI 10.1038/nm1048; Koutnikova H, 2003, P NATL ACAD SCI USA, V100, P14457, DOI 10.1073/pnas.2336090100; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; LONCAR D, 1988, J ULTRA MOL STRUCT R, V101, P109, DOI 10.1016/0889-1605(88)90001-8; Lu F, 2008, PLAST RECONSTR SURG, V121, P50, DOI 10.1097/01.prs.0000293876.10700.b8; MacDougald OA, 2002, TRENDS ENDOCRIN MET, V13, P5, DOI 10.1016/S1043-2760(01)00517-3; Matsumoto D, 2006, TISSUE ENG, V12, P3375, DOI 10.1089/ten.2006.12.3375; Mauer MM, 2001, NEUROSCI BIOBEHAV R, V25, P15, DOI 10.1016/S0149-7634(00)00047-6; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Munoz J, 2002, OBES RES, V10, P424, DOI 10.1038/oby.2002.59; Nambu M, 2007, WOUND REPAIR REGEN, V15, P505, DOI 10.1111/j.1524-475X.2007.00258.x; NAPOLITANO L, 1963, J CELL BIOL, V18, P663, DOI 10.1083/jcb.18.3.663; Nawrocki AR, 2004, CURR OPIN PHARMACOL, V4, P281, DOI 10.1016/j.coph.2004.03.003; Neels JG, 2004, FASEB J, V18, P983, DOI 10.1096/fj.03-1101fje; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Orci L, 2004, P NATL ACAD SCI USA, V101, P2058, DOI 10.1073/pnas.0308258100; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; RICHARDSON RL, 1982, ACTA ANAT, V114, P41; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; ROHLFS EM, 1995, J BIOL CHEM, V270, P10723, DOI 10.1074/jbc.270.18.10723; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; SALANS LB, 1973, J CLIN INVEST, V52, P929, DOI 10.1172/JCI107258; Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Sengenes C, 2005, J CELL PHYSIOL, V205, P114, DOI 10.1002/jcp.20381; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shi H, 2009, PHYSIOL BEHAV, V97, P199, DOI 10.1016/j.physbeh.2009.02.017; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Spiegelman BM, 2001, CELL, V104, P531, DOI 10.1016/S0092-8674(01)00240-9; Stern CD, 2001, NAT CELL BIOL, V3, pE216, DOI 10.1038/ncb0901-e216; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Sun TW, 2009, MOL ENDOCRINOL, V23, P925, DOI 10.1210/me.2008-0298; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Tchkonia T, 2007, AM J PHYSIOL-ENDOC M, V292, pE298, DOI 10.1152/ajpendo.00202.2006; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Tran TT, 2008, CELL METAB, V7, P410, DOI 10.1016/j.cmet.2008.04.004; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; Yamamoto N, 2007, J DERMATOL SCI, V48, P43, DOI 10.1016/j.jdermsci.2007.05.015; Yoshimura K, 2008, AESTHET PLAST SURG, V32, P48, DOI 10.1007/s00266-007-9019-4; Yoshimura K, 2006, J CELL PHYSIOL, V208, P64, DOI 10.1002/jcp.20636; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	100	76	76	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					472	481		10.1016/j.stem.2009.10.014	http://dx.doi.org/10.1016/j.stem.2009.10.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896439	Bronze, Green Accepted			2022-12-28	WOS:000272019500010
J	Deng, WB				Deng, Wenbin			PARylation: Strengthening the Connection between Cancer and Pluripotency	CELL STEM CELL			English	Editorial Material							STEM-CELLS; CHROMATIN; ACTIVATION; MICE	Pluripotency and tumorgenicity appear fundamentally linked. Recent investigations into the role of PARylation in chromatin remodeling (Ahel et al., 2009; Gottschalk et al., 2009), combined with the demonstration that p53 serves as a barrier to pluripotency (Banito et al., 2009), further strengthen this connection.	Univ Calif Davis, Dept Cell Biol & Human Anat, Inst Pediat Regenerat Med, Sch Med, Sacramento, CA 95817 USA	University of California System; University of California Davis	Deng, WB (corresponding author), Univ Calif Davis, Dept Cell Biol & Human Anat, Inst Pediat Regenerat Med, Sch Med, 2425 Stockton Blvd, Sacramento, CA 95817 USA.	wbdeng@ucdavis.edu						Ahel D, 2009, SCIENCE, V325, P1240, DOI 10.1126/science.1177321; Banito A, 2009, GENE DEV, V23, P2134, DOI 10.1101/gad.1811609; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gottschalk AJ, 2009, P NATL ACAD SCI USA, V106, P13770, DOI 10.1073/pnas.0906920106; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Timinszky G, 2009, NAT STRUCT MOL BIOL, V16, P923, DOI 10.1038/nsmb.1664; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	11	10	10	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					349	350		10.1016/j.stem.2009.09.002	http://dx.doi.org/10.1016/j.stem.2009.09.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796612	Bronze			2022-12-28	WOS:000271401900004
J	Sipp, D				Sipp, Douglas			Gold Standards in the Diamond Age: The Commodification of Pluripotency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; IPS CELLS; LINES; EXPRESSION; CLINICS	Human embryonic stem cells have been characterized as a rare and precious resource because of the scarcity of the materials used in their creation and the many restrictions that have been placed on their derivation and use. With the advent of induced pluripotent stem cells, however, pluripotency stands to become a plentiful and unencumbered commodity.	RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan	RIKEN	Sipp, D (corresponding author), RIKEN, Ctr Dev Biol, Chuo Ku, 2-2-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	sipp@cdb.riken.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938				Aalto-Setala K, 2009, PLOS BIOL, V7, P204, DOI 10.1371/journal.pbio.1000042; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kiatpongsan S, 2009, SCIENCE, V323, P1564, DOI 10.1126/science.1168451; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mathews DJH, 2009, CELL STEM CELL, V5, P11, DOI 10.1016/j.stem.2009.06.005; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	17	9	9	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					360	363		10.1016/j.stem.2009.09.005	http://dx.doi.org/10.1016/j.stem.2009.09.005			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796616	Bronze			2022-12-28	WOS:000271401900008
J	Pittenger, M				Pittenger, Mark			Sleuthing the Source of Regeneration by MSCs	CELL STEM CELL			English	Editorial Material							MESENCHYMAL STEM-CELLS; LUNG	Mesenchymal stem cells (MSCs) can differentiate into useful cell types and also have the ability to modulate inflammation. In this issue of Cell Stem Cell, Lee et al. (2009) investigate the production of the soluble inflammation inhibitor TSG-6 by MSCs.	Pearl LifeSci Partners LLC, Baltimore, MD 21227 USA		Pittenger, M (corresponding author), Pearl LifeSci Partners LLC, 1450 S Rolling Rd, Baltimore, MD 21227 USA.	mfpittenger@comcast.net						Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Amado LC, 2006, J AM COLL CARDIOL, V48, P2116, DOI 10.1016/j.jacc.2006.06.073; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Kadri T, 2005, STEM CELLS DEV, V14, P204, DOI 10.1089/scd.2005.14.204; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Nasef A, 2007, TRANSPLANTATION, V84, P231, DOI 10.1097/01.tp.0000267918.07906.08; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Toma C, 2009, CIRC RES, V104, P398, DOI 10.1161/CIRCRESAHA.108.187724	10	41	44	1	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					8	10		10.1016/j.stem.2009.06.013	http://dx.doi.org/10.1016/j.stem.2009.06.013			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570508	Bronze			2022-12-28	WOS:000267879200005
J	Gao, J; Graves, S; Koch, U; Liu, SQ; Jankovic, V; Buonamici, S; El Andaloussi, A; Nimer, SD; Kee, BL; Taichman, R; Radtke, F; Aifantis, I				Gao, Jie; Graves, Stephanie; Koch, Ute; Liu, Suqing; Jankovic, Vladimir; Buonamici, Silvia; El Andaloussi, Abdeljabar; Nimer, Stephen D.; Kee, Barbara L.; Taichman, Russell; Radtke, Freddy; Aifantis, Iannis			Hedgehog Signaling Is Dispensable for Adult Hematopoietic Stem Cell Function	CELL STEM CELL			English	Article							SELF-RENEWAL; GENE-EXPRESSION; MAINTENANCE; REVEALS; NOTCH; SHH; COMMITMENT; ACTIVATION; MUTATIONS; PATHWAY	The Hedgehog (Hh) signaling pathway is a developmentally conserved regulator of stem cell function. Several reports suggested that Hh signaling is an important regulator of hematopoietic stem cell (HSC) maintenance and differentiation. Here we test this hypothesis in vivo using both gain- and loss-of-function Hh genetic models. Surprisingly, our studies demonstrate that conditional Smoothened (Smo) deletion or overactivation has no significant effects on adult HSC self-renewal and function. Moreover, they indicate a lack of synergism between the Notch and Hh pathways in HSC function, as compound RBPJ and Smo deficiency does not affect hematopoiesis. In agreement with this notion, detailed genome-wide transcriptome analysis reveals that silencing of Hh signaling does not significantly alter the HSC-specific gene expression "signature." Our studies demonstrate that the Hh signaling pathway is dispensable for adult HSC function and suggest that Hh inhibition on leukemia-initiating cell maintenance can be targeted in future clinical trials.	[Gao, Jie; Liu, Suqing; Buonamici, Silvia; Aifantis, Iannis] NYU, Sch Med, Dept Pathol, New York, NY 10016 USA; [Gao, Jie; Liu, Suqing; Buonamici, Silvia; Aifantis, Iannis] NYU, Sch Med, Inst Canc, New York, NY 10016 USA; [Gao, Jie; Liu, Suqing; Buonamici, Silvia; Aifantis, Iannis] NYU, Sch Med, Helen & Martin S Kimmel Stem Cell Ctr, New York, NY 10016 USA; [Graves, Stephanie; Kee, Barbara L.] Univ Chicago, Dept Pathol, Chicago, IL 60637 USA; [Koch, Ute; Radtke, Freddy] Swiss Inst Expt Canc Res, Ecole Polytech Fed Lausanne, CH-1066 Epalinges, Switzerland; [Jankovic, Vladimir; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, Sloan Kettering Inst, New York, NY 10021 USA; [El Andaloussi, Abdeljabar] Univ Sherbrooke, Fac Med, Sherbrooke, PQ J1K 2R1, Canada; [Taichman, Russell] Univ Michigan, Dept Periodont & Oral Med, Sch Dent, Ann Arbor, MI 48109 USA	New York University; New York University; New York University; University of Chicago; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Memorial Sloan Kettering Cancer Center; University of Sherbrooke; University of Michigan System; University of Michigan	Aifantis, I (corresponding author), NYU, Sch Med, Dept Pathol, New York, NY 10016 USA.	iannis.aifantis@nyumc.org	Gao, Jie/C-2159-2011	Taichman, Russell S./0000-0002-7890-0020; Koch, Ute/0000-0001-7914-7061	Helen L. and Martin S. Kimmel Stem Cell Center; National Institutes of Health (NIH) [R56AI070310, RO1CA105129, RO1CA133379, RO1 DK52208, CA099978]; American Cancer Society [RSG0806801]; Leukemia and Lymphoma Society; New York State Department of Health [CO23058]; Irma T. Hirchl Trust; E. Mallinckrodt Foundation; Swiss National Science Foundation [F3100A0-119725]; Swiss Cancer League [KLS-01840-02-2006]; Medical Student Training Program (MSTP); NATIONAL CANCER INSTITUTE [R01CA105129, R01CA133379, R01CA099978] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI070310] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052208] Funding Source: NIH RePORTER	Helen L. and Martin S. Kimmel Stem Cell Center; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); New York State Department of Health; Irma T. Hirchl Trust; E. Mallinckrodt Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; Medical Student Training Program (MSTP); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Dr. A. McMahon for the Smo<SUP>F/F</SUP> animals, Dr. A. Joyner for Gli1<SUP>lacZ</SUP> animals, Jiri Zavadil for advice on microarray analysis, Peter Lopez for excellent cell-sorting support, Drs. T. Reya and G. Gilliland for sharing unpublished observations, and C.W. Brains for constructive discussions. The Aifantis laboratory is supported by a generous donation from the Helen L. and Martin S. Kimmel Stem Cell Center, the National Institutes of Health (NIH) (R56AI070310, RO1CA105129, and RO1CA133379 to I.A. RO1 DK52208 to S.D.N.; and CA099978 to B.L.K.), the American Cancer Society (RSG0806801 to I.A.), the Leukemia and Lymphoma Society (Scholar Award to I.A. and a SCOR Award to S.D.N.), the New York State Department of Health (CO23058), the Irma T. Hirchl Trust, and the E. Mallinckrodt Foundation (to I.A.). F.R. is supported by the Swiss National Science Foundation (F3100A0-119725) and the Swiss Cancer League (KLS-01840-02-2006). S.G. is supported by the Medical Student Training Program (MSTP) program of the University of Chicago.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Aifantis I, 1999, J EXP MED, V190, P141, DOI 10.1084/jem.190.1.141; Bai CB, 2002, DEVELOPMENT, V129, P4753; BERARDI AC, 1995, SCIENCE, V267, P104, DOI 10.1126/science.7528940; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; El Abdaloussi E, 2006, NAT IMMUNOL, V7, P418, DOI 10.1038/ni1313; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; GU H, 1994, SCIENCE, V265, P103, DOI 10.1126/science.8016642; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Hammerschmidt M, 1997, TRENDS GENET, V13, P14, DOI 10.1016/S0168-9525(96)10051-2; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; Mak KK, 2006, DEVELOPMENT, V133, P3695, DOI 10.1242/dev.02546; Lessard J, 2004, ONCOGENE, V23, P7199, DOI 10.1038/sj.onc.1207940; Long FX, 2001, DEVELOPMENT, V128, P5099; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Stadtfeld M, 2005, DEVELOPMENT, V132, P203, DOI 10.1242/dev.01558; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Tanigaki K, 2004, IMMUNITY, V20, P611, DOI 10.1016/S1074-7613(04)00109-8; Terskikh AV, 2003, BLOOD, V102, P94, DOI 10.1182/blood-2002-08-2509; Thompson BJ, 2008, J EXP MED, V205, P1395, DOI 10.1084/jem.20080277; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Vilimas T, 2007, NAT MED, V13, P70, DOI 10.1038/nm1524; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; YANG YZ, 1995, CELL, V80, P939, DOI 10.1016/0092-8674(95)90297-X; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	45	150	158	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					548	558		10.1016/j.stem.2009.03.015	http://dx.doi.org/10.1016/j.stem.2009.03.015			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497283	Green Accepted, Bronze			2022-12-28	WOS:000266793600017
J	Subramanian, V; Klattenhoff, CA; Boyer, LA				Subramanian, Vidya; Klattenhoff, Carla A.; Boyer, Laurie A.			Screening for Novel Regulators of Embryonic Stem Cell Identity	CELL STEM CELL			English	Editorial Material							RNAI SCREEN; MESSENGER-RNA; COMPLEX	Two recent studies, including one in this issue of Cell Stem Cell, have identified novel regulators of embryonic stem cell (ESC) self-renewal using genome-wide RNAi screens in mouse ESCs (Ding et al., 2009; Hu et al., 2009) and have further expanded the repertoire of factors that regulate ESC identity.	[Subramanian, Vidya; Klattenhoff, Carla A.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu						Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; BENPORATH I, 2008, GENE DEV, V4, P499; Collart MA, 2004, PROG NUCLEIC ACID RE, V77, P289, DOI 10.1016/S0079-6603(04)77008-7; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Mulder KW, 2007, NUCLEIC ACIDS RES, V35, P2428, DOI 10.1093/nar/gkm175; Rosonina E, 2005, MOL CELL, V20, P167, DOI 10.1016/j.molcel.2005.10.004; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009	12	8	9	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					377	378		10.1016/j.stem.2009.04.006	http://dx.doi.org/10.1016/j.stem.2009.04.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427287	Bronze, Green Published			2022-12-28	WOS:000266071100004
J	Somervaille, TCP; Matheny, CJ; Spencer, GJ; Iwasaki, M; Rinn, JL; Witten, DM; Chang, HY; Shurtleff, SA; Downing, JR; Cleary, ML				Somervaille, Tim C. P.; Matheny, Christina J.; Spencer, Gary J.; Iwasaki, Masayuki; Rinn, John L.; Witten, Daniela M.; Chang, Howard Y.; Shurtleff, Sheila A.; Downing, James R.; Cleary, Michael L.			Hierarchical Maintenance of MLL Myeloid Leukemia Stem Cells Employs a Transcriptional Program Shared with Embryonic Rather Than Adult Stem Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION SIGNATURE; HEMATOPOIETIC PROGENITORS; TRANSFORMATION; MICE; DIFFERENTIATION; IDENTIFICATION; HETEROGENEITY; MLL-GAS7; MLL-AF9; TUMORS	The genetic programs that promote retention of self-renewing leukemia stem cells (LSCs) at the apex of cellular hierarchies in acute myeloid leukemia (AML) are not known. In a mouse model of human AML, LSCs exhibit variable frequencies that correlate with the initiating MLL oncogene and are maintained in a self-renewing state by a transcriptional subprogram more akin to that of embryonic stem cells (ESCs) than to that of adult stem cells. The transcription/chromatin regulatory factors Myb, Hmgb3, and Cbx5 are critical components of the program and suffice for Hoxa/Meis-independent immortalization of myeloid progenitors when coexpressed, establishing the cooperative and essential role of an ESC-like LSC maintenance program ancillary to the leukemia-initiating MLL/Hox/Meis program. Enriched expression of LSC maintenance and ESC-like program genes in normal myeloid progenitors and poor-prognosis human malignancies links the frequency of aberrantly self-renewing progenitor-like cancer stem cells (CSCs) to prognosis in human cancer.	[Somervaille, Tim C. P.; Matheny, Christina J.; Iwasaki, Masayuki; Cleary, Michael L.] Stanford Univ, Dept Pathol, Stanford, CA 94305 USA; [Rinn, John L.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Witten, Daniela M.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA; [Somervaille, Tim C. P.; Spencer, Gary J.] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Leukaemia Biol Grp, Manchester M20 4BX, Lancs, England; [Shurtleff, Sheila A.; Downing, James R.] St Jude Childrens Hosp, Dept Pathol, Memphis, TN 38105 USA	Stanford University; Stanford University; Stanford University; Paterson Institute for Cancer Research; University of Manchester; St Jude Children's Research Hospital	Cleary, ML (corresponding author), Stanford Univ, Dept Pathol, Stanford, CA 94305 USA.	mcleary@stanford.edu	Downing, James R./N-8102-2018	Somervaille, Tim/0000-0002-9188-4379; Rinn, John/0000-0002-7231-7539	Leikaemia Research Fund (UK); Cancer Research UK [C147/A6058]; National Cancer Institute, Department of Health and Human Services [T32 CA09151]; American Cancer Society; Children's Health Initiative of the Packard Foundation [CA55029, CA116606]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA116606, R01CA055029] Funding Source: NIH RePORTER	Leikaemia Research Fund (UK); Cancer Research UK(Cancer Research UK); National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Children's Health Initiative of the Packard Foundation; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Maria Ambus, Cite Nicholas, Jude Aldaco, and Letha Phillips for technical support; Scott Kogan for consultation on leukemia classifications; Bill Wong for MLL-ENL-ER cells; Robert Tibshirani, Francesca Ficara, and Crispin Miller for helpful discussions; and Julien Sage and Patrick Vlatour for the mCherry construct. T.C.P.S. was supported by a Leikaemia Research Fund (UK) Senior Clinical Fellowship and by Cancer Research UK grant number C147/A6058. C.J.M. was supported by Public Health Service grant T32 CA09151 awarded by the National Cancer Institute, Department of Health and Human Services. J.L.R. is a Fellow and H.Y.C. is the Kenneth G. and Elaine A. Langone Scholar of the Damon Runyon Cancer Research Foundation. We acknowledge support from the American Cancer Society (H.Y.C.), Children's Health Initiative of the Packard Foundation, PHS grants CA55029 and CA116606, and the Leukemia and Lymphoma Society.	Adams JM, 2007, SCIENCE, V318, DOI 10.1126/science.1149672; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; BUICK RN, 1977, LANCET, V1, P862; Cano F, 2008, ONCOGENE, V27, P1945, DOI 10.1038/sj.onc.1210818; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; DiMartino JF, 2002, BLOOD, V99, P3780, DOI 10.1182/blood.V99.10.3780; FEARON ER, 1986, NEW ENGL J MED, V315, P15, DOI 10.1056/NEJM198607033150103; Hess JL, 2006, BLOOD, V108, P297, DOI 10.1182/blood-2005-12-5014; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kennedy James A, 2007, Science, V318, P1722; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Lavau C, 2000, P NATL ACAD SCI USA, V97, P10984, DOI 10.1073/pnas.190167297; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; So CW, 2004, BLOOD, V103, P3192, DOI 10.1182/blood-2003-10-3722; So CW, 2003, CANCER CELL, V4, P99, DOI 10.1016/S1535-6108(03)00188-0; So CW, 2003, CANCER CELL, V3, P161, DOI 10.1016/S1535-6108(03)00019-9; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Steidl U, 2006, NAT GENET, V38, P1269, DOI 10.1038/ng1898; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wong P, 2007, GENE DEV, V21, P2762, DOI 10.1101/gad.1602107; Yagi T, 2003, BLOOD, V102, P1849, DOI 10.1182/blood-2003-02-0578	41	273	275	2	18	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					129	140		10.1016/j.stem.2008.11.015	http://dx.doi.org/10.1016/j.stem.2008.11.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200802	Bronze, Green Accepted			2022-12-28	WOS:000263213400010
J	Kanatsu-Shinohara, M; Takehashi, M; Takashima, S; Lee, J; Morimoto, H; Chuma, S; Raducanu, A; Nakatsuji, N; Faassler, R; Shinohara, T				Kanatsu-Shinohara, Mito; Takehashi, Masanori; Takashima, Seiji; Lee, Jiyoung; Morimoto, Hiroko; Chuma, Shinichiro; Raducanu, Aurelia; Nakatsuji, Norio; Faessler, Reinhard; Shinohara, Takashi			Homing of Mouse Spermatogonial Stem Cells to Germline Niche Depends on beta 1-integrin	CELL STEM CELL			English	Article							MEDIATED GENE DELIVERY; E-CADHERIN; UNDIFFERENTIATED SPERMATOGONIA; IN-VITRO; SPERMATOGENESIS; DIFFERENTIATION; PROLIFERATION; EXPRESSION; MIGRATION; SURVIVAL	Spermatogonial stem cells (SSCs) provide the foundation for spermatogenesis. In a manner comparable to hematopoietic stem cell transplantation, SSCs colonize the niche of recipient testes and reinitiate spermatogenesis following microinjection into the seminiferous tubules. However, little is known about the homing mechanism of SSCs. Here we examine the role of adhesion molecules in SSC homing. SSCs isolated from mice carrying loxP-tagged beta 1-integrin alleles were ablated for beta 1-integrin expression by in vitro adenoviral cre transduction. The beta 1-integrin mutant SSCs showed significantly reduced ability to recolonize recipient testes in vivo and to attach to laminin molecules in vitro. In contrast, genetic ablation of E-cadherin did not impair homing, and E-cadherin mutant SSCs completed normal spermatogenesis. In addition, the deletion of beta 1-integrin on Sertoli cells reduced SSC homing. These results identify beta 1-integrin as an essential adhesion receptor for SSC homing and its association with laminin is critical in multiple steps of SSC homing.	[Kanatsu-Shinohara, Mito; Takehashi, Masanori; Takashima, Seiji; Lee, Jiyoung; Morimoto, Hiroko; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Chuma, Shinichiro; Nakatsuji, Norio] Kyoto Univ, Inst Frontier Med Sci, Dept Dev & Differentiat, Kyoto 6068507, Japan; [Raducanu, Aurelia; Faessler, Reinhard] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Shinohara, Takashi] CREST, Japan Sci & Technol Agcy, Kyoto 6068501, Japan	Kyoto University; Kyoto University; Max Planck Society; Japan Science & Technology Agency (JST)	Kanatsu-Shinohara, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	mshinoha@virus.kyoto-u.ac.jp	Takashima, Seiji/I-4993-2019	Takashima, Seiji/0000-0002-9176-3139	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kanae Foundation, Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Genome Network Project; Japan Science and Technology Agency (CREST)	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kanae Foundation, Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO)(National Institute of Biomedical Innovation); Genome Network Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	We thank Mr. H. Sal and Ms. Y. Ogata for technical assistance and Dr. Y. Matsui (Tohoku University) for EG cells. Financial support for this research was provided by the Ministry of Education, Culture, Sports, Science, and Technology of Japan. This work was also supported by Kanae Foundation, Program for Promotion of Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO), Genome Network Project, and Japan Science and Technology Agency (CREST).	Anderson R, 1999, DEVELOPMENT, V126, P1655; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Bendel-Stenzel MR, 2000, MECH DEVELOP, V91, P143, DOI 10.1016/S0925-4773(99)00287-7; Boussadia O, 2002, MECH DEVELOP, V115, P53, DOI 10.1016/S0925-4773(02)00090-4; Brakebusch C, 2002, IMMUNITY, V16, P465, DOI 10.1016/S1074-7613(02)00281-9; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Campos LS, 2004, DEVELOPMENT, V131, P3433, DOI 10.1242/dev.01199; Chuma S, 2001, DEV BIOL, V229, P468, DOI 10.1006/dbio.2000.9989; De Rooij DG, 2000, J ANDROL, V21, P776; Di Carlo A, 2000, DEV BIOL, V226, P209, DOI 10.1006/dbio.2000.9861; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; Hirsch E, 1996, NATURE, V380, P171, DOI 10.1038/380171a0; Kanatsu-Shinohara M, 2006, BIOL REPROD, V74, P522, DOI 10.1095/biolreprod.105.046441; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2005, BIOL REPROD, V72, P985, DOI 10.1095/biolreprod.104.036400; Kanatsu-Shinohara M, 2002, P NATL ACAD SCI USA, V99, P1383, DOI 10.1073/pnas.022646399; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Leone DP, 2005, J CELL SCI, V118, P2589, DOI 10.1242/jcs.02396; Levy L, 2000, MOL BIOL CELL, V11, P453, DOI 10.1091/mbc.11.2.453; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Molyneaux K, 2004, INT J DEV BIOL, V48, P537, DOI 10.1387/ijdb.041833km; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Okamura D, 2003, DEVELOPMENT, V130, P6423, DOI 10.1242/dev.00870; Parreira GG, 1998, BIOL REPROD, V59, P1360, DOI 10.1095/biolreprod59.6.1360; Potocnik AJ, 2000, IMMUNITY, V12, P653, DOI 10.1016/S1074-7613(00)80216-2; Raz E, 2004, CURR OPIN CELL BIOL, V16, P169, DOI 10.1016/j.ceb.2004.01.004; Russell LD, 1996, J ANDROL, V17, P603; SALANOVA M, 1995, BIOL REPROD, V52, P79, DOI 10.1095/biolreprod52.1.79; Shinohara T, 2001, P NATL ACAD SCI USA, V98, P6186, DOI 10.1073/pnas.111158198; Shinohara T, 1999, P NATL ACAD SCI USA, V96, P5504, DOI 10.1073/pnas.96.10.5504; Song XQ, 2002, SCIENCE, V296, P1855, DOI 10.1126/science.1069871; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Takehashi M, 2007, P NATL ACAD SCI USA, V104, P2596, DOI 10.1073/pnas.0609282104; Tokuda M, 2007, BIOL REPROD, V76, P130, DOI 10.1095/biolreprod.106.053181; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; WU JC, 1993, BIOL REPROD, V49, P1353, DOI 10.1095/biolreprod49.6.1353; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513	40	135	142	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					533	542		10.1016/j.stem.2008.08.002	http://dx.doi.org/10.1016/j.stem.2008.08.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983968	Bronze			2022-12-28	WOS:000260895100012
J	Viatour, P; Somervaille, TC; Venkatasubrahmanyam, S; Kogan, S; McLaughlin, ME; Weissman, IL; Butte, AJ; Passegue, E; Sage, J				Viatour, Patrick; Somervaille, Tim C.; Venkatasubrahmanyam, Shivkumar; Kogan, Scott; McLaughlin, Margaret E.; Weissman, Irving L.; Butte, Atul J.; Passegue, Emmanuelle; Sage, Julien			Hematopoietic Stem Cell Quiescence Is Maintained by Compound Contributions of the Retinoblastoma Gene Family	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR; SELF-RENEWAL; CYCLE; RB; BMI-1; ERYTHROPOIESIS; PROLIFERATION; MAINTENANCE; SUFFICIENT; EXPRESSION	Individual members of the retinoblastoma (Rb) tumor suppressor gene family serve critical roles in the control of cellular proliferation and differentiation, but the extent of their contributions is masked by redundant and compensatory mechanisms. Here we employed a conditional knockout strategy to simultaneously inactivate all three members, Rb, p107, and p130, in adult hematopoietic stem cells (HSCs). Rb family triple knockout (TKO) mice develop a cell-intrinsic myeloproliferation that originates from hyperproliferative early hematopoietic progenitors and is accompanied by increased apoptosis in lymphoid progenitor populations. Loss of quiescence in the TKO HSC pool is associated with an expansion of these mutant stem cells but also with an enhanced mobilization and an impaired reconstitution potential upon transplantation. The presence of a single p107 allele Is sufficient to largely rescue these defects. Thus, Rb family members collectively maintain HSC quiescence and the balance between lymphoid and myeloid cell fates in the hematopoietic system.	[Viatour, Patrick; Venkatasubrahmanyam, Shivkumar; Butte, Atul J.; Sage, Julien] Stanford Med Sch, Dept Pediat, Stanford, CA 94305 USA; [Viatour, Patrick; Sage, Julien] Stanford Med Sch, Dept Genet, Stanford, CA 94305 USA; [Somervaille, Tim C.; Weissman, Irving L.] Stanford Med Sch, Dept Pathol, Stanford, CA 94305 USA; [Venkatasubrahmanyam, Shivkumar; Butte, Atul J.] Stanford Med Sch, Dept Med, Stanford, CA 94305 USA; [McLaughlin, Margaret E.] Massachusetts Eye & Ear Infirm, Dept Ophthalmol, Boston, MA 02114 USA; [Kogan, Scott] Univ Calif San Francisco, Ctr Comprehens Canc, Dept Lab Med, San Francisco, CA 94143 USA; [Passegue, Emmanuelle] Univ Calif San Francisco, Ctr Comprehens Canc, Inst Regenerat Med, San Francisco, CA 94143 USA; [Viatour, Patrick] Univ Liege, Dept Med Chem, B-4000 Liege, Belgium	Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Massachusetts Eye & Ear Infirmary; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; University of Liege	Sage, J (corresponding author), Stanford Med Sch, Dept Pediat, Stanford, CA 94305 USA.	julsage@stanford.edu		Kogan, Scott/0000-0002-2395-8479; Somervaille, Tim/0000-0002-9188-4379; Passegue, Emmanuelle/0000-0002-3516-297X	Lucile Packard Foundation for Children's Health; Damon Runyon Cancer Research Foundation; NIH-NCI [RO1 CA114102, PO1 CA049605]; Human Frontier Science Program; European Molecular Biology Organization; Fonds de la Recherche Scientifique; Leon Fredericq Foundation; California Institute for Regenerative Medicine; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [T32CA009151, R01CA114102, P01CA049605] Funding Source: NIH RePORTER	Lucile Packard Foundation for Children's Health; Damon Runyon Cancer Research Foundation; NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Human Frontier Science Program(Human Frontier Science Program); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Fonds de la Recherche Scientifique(Fonds de la Recherche Scientifique - FNRS); Leon Fredericq Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Tom Serwold, Anne Brunet, and Steven Artandi for critical reading of the manuscript; Jinkuk Choi for his help with the initial microarray analysis; Michael Cleary for his support and helpful discussions; and Tyler Jacks for the generous provision of mutant mice generated in his laboratory. This work was supported by the Lucile Packard Foundation for Children's Health (J.S. and A.J.B.); the Damon Runyon Cancer Research Foundation and NIH-NCI RO1 CA114102 (J.S.); fellowships from the Human Frontier Science Program, the European Molecular Biology Organization, the Fonds de la Recherche Scientifique, and the Leon Fredericq Foundation (P.V.); and the California Institute for Regenerative Medicine and NIH-NCI PO1 CA049605 (A.J.B.). S.K. is a Leukemia and Lymphoma Society scholar.	Barista I, 2001, LANCET ONCOL, V2, P141, DOI 10.1016/S1470-2045(00)00255-2; CHEN JZ, 1993, CURR BIOL, V3, P405, DOI 10.1016/0960-9822(93)90347-Q; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; COBRINIK D, 2007, GENE DEV, V10, P1633; Daria D, 2008, BLOOD, V111, P1894, DOI 10.1182/blood-2007-02-071746; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; FLEMING WH, 1993, J CELL BIOL, V122, P897, DOI 10.1083/jcb.122.4.897; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Iavarone A, 2004, NATURE, V432, P1040, DOI 10.1038/nature03068; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LeCouter JE, 1998, MOL CELL BIOL, V18, P7455, DOI 10.1128/MCB.18.12.7455; Lee MH, 1996, GENE DEV, V10, P1621, DOI 10.1101/gad.10.13.1621; Leoncini L, 2006, ONCOGENE, V25, P5309, DOI 10.1038/sj.onc.1209619; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Maru Y, 2001, INT J HEMATOL, V73, P308, DOI 10.1007/BF02981955; Metcalf D, 2007, IMMUNITY, V26, P669, DOI 10.1016/j.immuni.2007.05.012; Mihara K, 2006, BLOOD, V107, P305, DOI 10.1182/blood-2005-06-2393; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sankaran VG, 2008, GENE DEV, V22, P463, DOI 10.1101/gad.1627208; Santamaria D, 2007, NATURE, V448, P811, DOI 10.1038/nature06046; Spike BT, 2005, CELL CYCLE, V4, P42, DOI 10.4161/cc.4.1.1337; Spike BT, 2004, EMBO J, V23, P4319, DOI 10.1038/sj.emboj.7600432; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103; Wikenheiser-Brokamp KA, 2006, CELL MOL LIFE SCI, V63, P767, DOI 10.1007/s00018-005-5487-3; Ye M, 2003, IMMUNITY, V19, P689, DOI 10.1016/S1074-7613(03)00299-1; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yu H, 2006, BLOOD, V107, P1200, DOI 10.1182/blood-2005-02-0685; Yuan YZ, 2006, CANCER RES, V66, P343, DOI 10.1158/0008-5472.CAN-05-2945; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	44	122	124	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					416	428		10.1016/j.stem.2008.07.009	http://dx.doi.org/10.1016/j.stem.2008.07.009			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940733	Green Accepted, Bronze			2022-12-28	WOS:000260149800012
J	Vunjak-Novakovic, G				Vunjak-Novakovic, Gordana			Patterning Stem Cell Differentiation	CELL STEM CELL			English	Editorial Material							SHAPE	Regulation of cell differentiation and assembly remains a fundamental question in developmental biology. Now, a report from the Chen laboratory (Ruiz and Chen, 2008) describes an approach that represents a major step toward a more profound understanding of the geometric-force control of stem cell differentiation.	Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA	Columbia University	Vunjak-Novakovic, G (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,1210 Amsterdam Ave,Mail Code 890, New York, NY 10027 USA.	gv2131@columbia.edu	vunjak-novakovic, gordana/J-9279-2012	Vunjak-Novakovic, Gordana/0000-0002-9382-1574	NHLBI NIH HHS [R01 HL076485-05, R01 HL076485] Funding Source: Medline; NIBIB NIH HHS [P41 EB002520, P41 EB002520-059002] Funding Source: Medline; NIDCR NIH HHS [R01 DE016525, R01 DE016525-04] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL076485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB002520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016525] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Burdick JA, 2009, TISSUE ENG PT A, V15, P205, DOI 10.1089/ten.tea.2008.0131; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Krieg M, 2008, NAT CELL BIOL, V10, P429, DOI 10.1038/ncb1705; Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; Nelson CM, 2005, P NATL ACAD SCI USA, V102, P11594, DOI 10.1073/pnas.0502575102; Ruiz SA, 2008, STEM CELLS, V26, P2921, DOI 10.1634/stemcells.2008-0432	7	11	11	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					362	363		10.1016/j.stem.2008.09.007	http://dx.doi.org/10.1016/j.stem.2008.09.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940727	Green Accepted, Bronze			2022-12-28	WOS:000260149800005
J	Goldman, SA; Natesan, S				Goldman, Steven A.; Natesan, Sridaran			A niche-defying feat: Induced oligoneogenesis in the adult dentate gyrus	CELL STEM CELL			English	Editorial Material							PROGENITOR CELLS; STEM-CELLS; MULTIPOTENT	In a recent paper in Nature Neuroscience, Jessberger et al. (2008) report that overexpression of ASCL1 (mash1) directs adult hippocampal progenitors to adopt an oligodendrocytic fate. The effect is specific to the hippocampal niche in vivo, indicating that cell-autonomous and niche-defined factors collaborate to instruct cell fate choices.	[Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14580 USA; [Goldman, Steven A.] Univ Rochester, Med Ctr, Dept Neurosurg, Rochester, NY 14580 USA; [Goldman, Steven A.] Univ Rochester, Med Ctr, Ctr Translat Neuromed, Rochester, NY 14580 USA; [Natesan, Sridaran] Cambridge Res Ctr, Dept Biol Sci, Cambridge, MA 02139 USA	University of Rochester; University of Rochester; University of Rochester	Goldman, SA (corresponding author), Univ Rochester, Med Ctr, Dept Neurol, Rochester, NY 14580 USA.	steven_goldman@urmc.rochester.edu		Goldman, Steven/0000-0002-5498-4303				Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Roy NS, 2000, NAT MED, V6, P271; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	10	4	4	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					125	126		10.1016/j.stem.2008.07.006	http://dx.doi.org/10.1016/j.stem.2008.07.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682232	Bronze			2022-12-28	WOS:000258523300003
J	Misteli, T				Misteli, Tom			HGPS-Derived iPSCs For The Ages	CELL STEM CELL			English	Editorial Material							PROGERIA-SYNDROME	In this issue of Cell Stem Cell, Zhang et al. (2011) generate patient-derived iPSCs for one of the major premature aging diseases, Hutchinson-Gilford Progeria Syndrome (HGPS). These cells are a much-needed new tool to study HGPS, and their use may lead to novel insights into mechanisms of aging.	NCI, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov			Intramural NIH HHS [ZIA BC010309-12] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Worman HJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000760; ZHANG JL, 2011, CELL STEM CELL, V8	7	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					4	6		10.1016/j.stem.2010.12.014	http://dx.doi.org/10.1016/j.stem.2010.12.014			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211775	Green Accepted, Bronze			2022-12-28	WOS:000286786200003
J	Moore, K				Moore, Kateri			A Roundabout Way to the Niche	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM; CELL NICHES; BONE	A new player in hematopoietic stem cell (HSC)-niche interactions is introduced in this issue of Cell Stem Cell. Smith-Berdan et al. (2010) demonstrate that Robo4 is involved in HSC engraftment and mobilization and does so in cooperation with Cxcr4 to guide stem cells to and secure them in the niche.	[Moore, Kateri] Mt Sinai Sch Med, Dept Gene, New York, NY 10029 USA; [Moore, Kateri] Mt Sinai Sch Med, Dept Cell Med, New York, NY 10029 USA; [Moore, Kateri] Mt Sinai Sch Med, Dept Dev & Regenerat Biol, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Moore, K (corresponding author), Mt Sinai Sch Med, Dept Gene, New York, NY 10029 USA.	kateri.moore@mssm.edu						Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; SMITHBERDAN S, 2010, CELL STEM CELL, V8; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016	10	0	0	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					6	7		10.1016/j.stem.2010.12.011	http://dx.doi.org/10.1016/j.stem.2010.12.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211776	Bronze			2022-12-28	WOS:000286786200004
J	Barker, N; Bartfeld, S; Clevers, H				Barker, Nick; Bartfeld, Sina; Clevers, Hans			Tissue-Resident Adult Stem Cell Populations of Rapidly Self-Renewing Organs	CELL STEM CELL			English	Review							SMALL INTESTINAL EPITHELIUM; LABEL-RETAINING CELLS; HAIR FOLLICLE BULGE; MOUSE STOMACH; CLONAL ANALYSIS; ANTRAL EPITHELIUM; DYNAMIC HISTOLOGY; GASTRIC-MUCOSA; PANETH CELLS; MIGRATION	The epithelial lining of the intestine, stomach, and skin is continuously exposed to environmental assault, imposing a requirement for regular self-renewal. Resident adult stem cell populations drive this renewal, and much effort has been invested in revealing their identity. Reliable adult stem cell biomarkers would accelerate our understanding of stem cell roles in tissue homeostasis and cancer. Membrane-expressed markers would also facilitate isolation of these adult stem cell populations for exploitation of their regenerative potential. Here, we review recent advances in adult stem cell biology, highlighting the promise and pitfalls of the candidate biomarkers of the various stem cell populations.	[Barker, Nick; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Bartfeld, Sina] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Barker, Nick; Clevers, Hans] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands	Utrecht University; Utrecht University Medical Center; Max Planck Society; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Barker, N (corresponding author), Inst Med Biol, 8A Biomed Grove,Immunos 06-06, Singapore 138648, Singapore.	nicholas.barker@imb.a-star.edu.sg	Barker, Nick/AAE-9833-2021; Barker, Nick/AAS-2774-2020; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Bartfeld, Sina/0000-0003-2493-8282				ARGYRIS TS, 1956, ARCH PATHOL, V61, P31; Barker N, 2007, GASTROENTEROLOGY, V133, P1755, DOI 10.1053/j.gastro.2007.10.029; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, GASTROENTEROLOGY, V138, P1681, DOI 10.1053/j.gastro.2010.03.002; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bezencon C, 2008, J COMP NEUROL, V509, P514, DOI 10.1002/cne.21768; BJERKNES M, 1981, AM J ANAT, V160, P51, DOI 10.1002/aja.1001600105; BJERKNES M, 1981, AM J ANAT, V160, P77, DOI 10.1002/aja.1001600107; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Bjerknes M, 1999, GASTROENTEROLOGY, V116, P7, DOI 10.1016/S0016-5085(99)70222-2; Bjerknes M, 2005, NAT GENET, V37, P1016, DOI 10.1038/ng1005-1016; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Blanpain C, 2010, NATURE, V464, P686, DOI 10.1038/464686a; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Breault DT, 2008, P NATL ACAD SCI USA, V105, P10420, DOI 10.1073/pnas.0804800105; CAIRNIE AB, 1965, EXP CELL RES, V39, P528, DOI 10.1016/0014-4827(65)90055-8; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; CHENG H, 1974, AM J ANAT, V141, P537, DOI 10.1002/aja.1001410407; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Formeister EJ, 2009, AM J PHYSIOL-GASTR L, V296, pG1108, DOI 10.1152/ajpgi.00004.2009; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; FUKAMACHI H, 1979, ANAT EMBRYOL, V157, P151, DOI 10.1007/BF00305155; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; Gerbe F, 2009, GASTROENTEROLOGY, V137, P2179, DOI 10.1053/j.gastro.2009.06.072; GHADIALLY FN, 1958, NATURE, V181, P993, DOI 10.1038/181993a0; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Giannakis M, 2006, J BIOL CHEM, V281, P11292, DOI 10.1074/jbc.M512118200; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; Gregorieff A, 2005, GENE DEV, V19, P877, DOI 10.1101/gad.1295405; GRIFFITHS DFR, 1988, NATURE, V333, P461, DOI 10.1038/333461a0; HATTORI T, 1976, CELL TISSUE RES, V175, P49; HATTORI T, 1976, CELL TISSUE RES, V172, P171; He XC, 2004, NAT GENET, V36, P1117, DOI 10.1038/ng1430; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; HERMISTON ML, 1993, P NATL ACAD SCI USA, V90, P8866, DOI 10.1073/pnas.90.19.8866; Hoffmann W, 2008, CURR MED CHEM, V15, P3133, DOI 10.2174/092986708786848587; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2008, J INVEST DERMATOL, V128, P1059, DOI 10.1038/jid.2008.86; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jaks V, 2010, EXP CELL RES, V316, P1422, DOI 10.1016/j.yexcr.2010.03.014; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Karam Sherif M., 1999, Frontiers in Bioscience, V4, pD286, DOI 10.2741/Karam; KARAM SM, 1993, ANAT RECORD, V236, P280, DOI 10.1002/ar.1092360203; KARAM SM, 1993, ANAT REC, V236, P314, DOI 10.1002/ar.1092360205; KARAM SM, 1993, ANAT REC, V236, P333, DOI 10.1002/ar.1092360206; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1992, ANAT RECORD, V232, P231, DOI 10.1002/ar.1092320208; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Karam SM, 1997, AM J PHYSIOL-GASTR L, V272, pG1209, DOI 10.1152/ajpgi.1997.272.5.G1209; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; LEBLOND CP, 1948, ANAT REC, V100, P357, DOI 10.1002/ar.1091000306; LEE ER, 1985, AM J ANAT, V172, P205, DOI 10.1002/aja.1001720304; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; LEE ER, 1985, AM J ANAT, V172, P241, DOI 10.1002/aja.1001720306; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Li X, 2009, DEV DYNAM, V238, P3205, DOI 10.1002/dvdy.22134; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; May R, 2008, STEM CELLS, V26, P630, DOI 10.1634/stemcells.2007-0621; May R, 2009, STEM CELLS, V27, P2571, DOI 10.1002/stem.193; Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035; Morasso MI, 2005, BIOL CELL, V97, P173; Mori-Akiyama Y, 2007, GASTROENTEROLOGY, V133, P539, DOI 10.1053/j.gastro.2007.05.020; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nomura S, 1996, BIOCHEM BIOPH RES CO, V226, P385, DOI 10.1006/bbrc.1996.1365; Nomura S, 1998, DEV BIOL, V204, P124, DOI 10.1006/dbio.1998.9055; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; Potten CS, 2003, DIFFERENTIATION, V71, P28, DOI 10.1046/j.1432-0436.2003.700603.x; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; ROCHAT A, 1994, CELL, V76, P1063, DOI 10.1016/0092-8674(94)90383-2; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; SATO T, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09637; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; Snippert HJ, 2010, SCIENCE, V327, P1385, DOI 10.1126/science.1184733; Snippert HJ, 2009, GASTROENTEROLOGY, V136, P2187, DOI 10.1053/j.gastro.2009.03.002; Sotiropoulou PA, 2008, STEM CELLS, V26, P2964, DOI 10.1634/stemcells.2008-0634; TATEMATSU M, 1994, CANCER LETT, V83, P37, DOI 10.1016/0304-3835(94)90296-8; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; VANDERFLIER LG, 2009, CELL IN PRESS; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; WINTON DJ, 1990, CANCER RES, V50, P7992; WINTON DJ, 1990, P ROY SOC B-BIOL SCI, V241, P13, DOI 10.1098/rspb.1990.0059; Zawacki B E, 1967, Br J Plast Surg, V20, P347, DOI 10.1016/S0007-1226(67)80065-1; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004; ZHANG YV, 2010, CELL CYCLE IN PRESS, V9; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	109	255	273	1	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					656	670		10.1016/j.stem.2010.11.016	http://dx.doi.org/10.1016/j.stem.2010.11.016			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112561	Bronze			2022-12-28	WOS:000285537700008
J	Neveu, P; Kye, MJ; Qi, SP; Buchholz, DE; Clegg, DO; Sahin, M; Park, IH; Kim, KS; Daley, GQ; Kornblum, HI; Shraiman, BI; Kosik, KS				Neveu, Pierre; Kye, Min Jeong; Qi, Shuping; Buchholz, David E.; Clegg, Dennis O.; Sahin, Mustafa; Park, In-Hyun; Kim, Kwang-Soo; Daley, George Q.; Kornblum, Harley I.; Shraiman, Boris I.; Kosik, Kenneth S.			MicroRNA Profiling Reveals Two Distinct p53-Related Human Pluripotent Stem Cell States	CELL STEM CELL			English	Article							IPS CELLS; GENERATION; PATHWAYS; GENES; MICE	Reprogramming methodologies have provided multiple routes for achieving pluripotency. However, pluripotency is generally considered to be an almost singular state, with subtle differences described between induced pluripotent stem cells (iPSCs) and embryonic stem cells (ESCs). We profiled miRNA expression levels across 49 human cell lines, including ESCs, iPSCs, differentiated cells, and cancer cell lines. We found that the resulting miRNA profiles divided the iPSCs and hESCs examined into two distinct categories irrespective of the cell line origin. The miRNAs that defined these two pluripotency categories also distinguished cancer cells from differentiated cells. Transcriptome analysis suggested that several gene sets related to p53 distinguished these categories, and overexpression of the p53-targeting miRNAs miR-92 and miR-141 in iPSCs was sufficient to change their classification status. Thus, our results suggest a subdivision of pluripotent stem cell states that is independent of their origin but related to p53 network status.	[Neveu, Pierre; Kye, Min Jeong; Buchholz, David E.; Clegg, Dennis O.; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Neveu, Pierre; Shraiman, Boris I.] Univ Calif Santa Barbara, Kavli Inst Theoret Phys, Santa Barbara, CA 93106 USA; [Kye, Min Jeong; Buchholz, David E.; Clegg, Dennis O.; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Kye, Min Jeong; Buchholz, David E.; Clegg, Dennis O.; Kosik, Kenneth S.] Univ Calif Santa Barbara, Ctr Stem Cell Biol & Engn, Santa Barbara, CA 93106 USA; [Shraiman, Boris I.] Univ Calif Santa Barbara, Dept Phys, Santa Barbara, CA 93106 USA; [Kye, Min Jeong; Sahin, Mustafa] Harvard Univ, Sch Med, Dept Neurol, FM Kirby Neurobiol Ctr,Childrens Hosp Boston, Boston, MA 02115 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, Dept Psychiat, Semel Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Semel Inst, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Qi, Shuping; Kornblum, Harley I.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Park, In-Hyun; Daley, George Q.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Div Pediat Hematol Oncol,Childrens Hosp Boston, Boston, MA 02115 USA; [Park, In-Hyun; Daley, George Q.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Howard Hughes Med Inst, Boston, MA 02115 USA; [Park, In-Hyun] Yale Univ, Sch Med, Dept Genet, Yale Stem Cell Ctr, New Haven, CT 06520 USA; [Kim, Kwang-Soo] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Mol Neurobiol Lab,Dept Psychiat, Belmont, MA 02478 USA; [Kim, Kwang-Soo] Harvard Univ, Sch Med, Harvard Stem Cell Inst, McLean Hosp, Belmont, MA 02478 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Harvard University; Boston Children's Hospital; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Yale University; Harvard University; Harvard University; McLean Hospital	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu	SAHIN, MUSTAFA/I-8653-2019; Kye, Min Jeong/ABC-3439-2020; Neveu, Pierre/C-1170-2009	SAHIN, MUSTAFA/0000-0001-7044-2953; Kye, Min Jeong/0000-0002-1323-7256; Neveu, Pierre/0000-0003-4939-3418	National Science Foundation [PHY05-51164]; A.W.M. Keck Foundation	National Science Foundation(National Science Foundation (NSF)); A.W.M. Keck Foundation	We thank E. Domany, M. Elowitz, R. Neher, T. Papagiannakopoulos, and members of the K.S.K. lab for helpful discussions; J. Thomson for the gift of virus- and episome-induced iPSC lines and reagents; K. Lao for technical support and gift of reagents; D. Kwiatkowski for the gift of p53<SUP>-/-</SUP> and p53<SUP>-/-</SUP>T-sc2<SUP>-/-</SUP> MEFs; K. Abu-Elneel for sharing miRNA profiles of fetal brain (samples were kindly provided by the Harvard Brain Tissue Resource Center); S. Ratanasirintrawoot for RNA of partially reprogrammed cells; and S. Hikita and the California Institute for Regenerative Medicine-funded Laboratory for Stem Cell Biology and Engineering. P.N. and B.I.S. research is supported in part by the National Science Foundation under Grant No. PHY05-51164. M.J.K. and D.E.B. are CIRM scholars. A.W.M. Keck Foundation grant to K.S.K. supported the studies. K.S.K. owns stock in and serves on the board of Minerva Biotechnologies corporation. G.Q.D. is a member of the scientific advisory boards and holds equity in the following companies: Epizyme, iPierian, Solasia KK, and MPM Capital, LLP.	Aboobaker AA, 2005, P NATL ACAD SCI USA, V102, P18017, DOI 10.1073/pnas.0508823102; Ach RA, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-69; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lee DD, 1999, NATURE, V401, P788, DOI 10.1038/44565; Lin CJ, 2007, NEURAL COMPUT, V19, P2756, DOI 10.1162/neco.2007.19.10.2756; Liu TL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000804; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Luo J, 2003, CANCER CELL, V4, P257, DOI 10.1016/S1535-6108(03)00248-4; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Migliore C, 2008, CANCER RES, V68, P10128, DOI 10.1158/0008-5472.CAN-08-2148; Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Segal E, 2004, NAT GENET, V36, P1090, DOI 10.1038/ng1434; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadler B, 2010, STEM CELLS DEV, V19, P935, DOI 10.1089/scd.2009.0426; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zito Tiziano, 2008, Front Neuroinform, V2, P8, DOI 10.3389/neuro.11.008.2008	52	75	80	0	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					671	681		10.1016/j.stem.2010.11.012	http://dx.doi.org/10.1016/j.stem.2010.11.012			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112562	Bronze			2022-12-28	WOS:000285537700009
J	Chen, GK; Hou, ZG; Gulbranson, DR; Thomson, JA				Chen, Guokai; Hou, Zhonggang; Gulbranson, Daniel R.; Thomson, James A.			Actin-Myosin Contractility Is Responsible for the Reduced Viability of Dissociated Human Embryonic Stem Cells	CELL STEM CELL			English	Article							ROCK INHIBITOR; DISTINCT ROLES; PHOSPHORYLATION; TRANSCRIPTION; BLEBBISTATIN; CYTOKINESIS; SPECIFICITY; SUBSTRATE; MOTILITY; CULTURE	Human ESCs are the pluripotent precursor of the three embryonic germ layers. Human ESCs exhibit basal-apical polarity, junctional complexes, integrin-dependent matrix adhesion, and E-cadherin-dependent cell-cell adhesion, all characteristics shared by the epiblast epithelium of the intact mammalian embryo. After disruption of epithelial structures, programmed cell death is commonly observed. If individualized human ESCs are prevented from reattaching and forming colonies, their viability is significantly reduced. Here, we show that actin-myosin contraction is a critical effector of the cell death response to human ESC dissociation. Inhibition of myosin heavy chain ATPase, downregulation of myosin heavy chain, and downregulation of myosin light chain all increase survival and cloning efficiency of individualized human ESCs. ROCK inhibition decreases phosphorylation of myosin light chain, suggesting that inhibition of actin-myosin contraction is also the mechanism through which ROCK inhibitors increase cloning efficiency of human ESCs.	[Chen, Guokai; Hou, Zhonggang; Gulbranson, Daniel R.; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Chen, Guokai; Hou, Zhonggang; Gulbranson, Daniel R.; Thomson, James A.] Univ Wisconsin, Genome Ctr Wisconsin, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Thomson, JA (corresponding author), Morgridge Inst Res, Madison, WI 53707 USA.	thomson@primate.wisc.edu	Gulbranson, Daniel/AAE-4807-2020; Gulbranson, Daniel/AAE-4338-2020		Charlotte Geyer Foundation; Morgridge Institute for Research; NIH [UO1ES017166, RR-05-19]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	Charlotte Geyer Foundation; Morgridge Institute for Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Charlotte Geyer Foundation, the Morgridge Institute for Research, NIH grant UO1ES017166 (to J.A.T.) and NIH contract RR-05-19 (to J.A.T.). We thank Dr. William Bement and Dr. Ivan Rayment for their discussion and suggestions. We thank Ron Stewart for his help on statistic analysis. We also thank Clay Glennon for assistance with confocal images and videos and Deborah Faupel and Krista Eastman for editorial assistance. J.A.T. is a founder, stock owner, consultant, and board member of Cellular Dynamics International (CDI). He also serves as scientific advisor to and has financial interests in Tactics II Stem Cell Ventures.	Allingham JS, 2005, NAT STRUCT MOL BIOL, V12, P378, DOI 10.1038/nsmb908; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Croft DR, 2005, J CELL BIOL, V168, P245, DOI 10.1083/jcb.200409049; Ellerstrom C, 2007, STEM CELLS, V25, P1690, DOI 10.1634/stemcells.2006-0607; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Frey MT, 2006, BIOPHYS J, V90, P3774, DOI 10.1529/biophysj.105.074526; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Kanada M, 2005, MOL BIOL CELL, V16, P3865, DOI 10.1091/mbc.E05-03-0233; Kang JH, 2007, BIOCHIMIE, V89, P39, DOI 10.1016/j.biochi.2006.08.003; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Limouze J, 2004, J MUSCLE RES CELL M, V25, P337, DOI 10.1007/s10974-004-6060-7; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Ndozangue-Touriguine O, 2008, BIOCHEM PHARMACOL, V76, P11, DOI 10.1016/j.bcp.2008.03.016; Okeyo KO, 2009, J BIOMECH, V42, P2540, DOI 10.1016/j.jbiomech.2009.07.002; Quintin S, 2008, TRENDS GENET, V24, P221, DOI 10.1016/j.tig.2008.02.005; Sathananthan Henry, 2002, Reprod Biomed Online, V4, P56; Simpson CD, 2008, CANCER LETT, V272, P177, DOI 10.1016/j.canlet.2008.05.029; Straight AF, 2003, SCIENCE, V299, P1743, DOI 10.1126/science.1081412; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Totsukawa G, 2004, J CELL BIOL, V164, P427, DOI 10.1083/jcb.200306172; Totsukawa G, 2000, J CELL BIOL, V150, P797, DOI 10.1083/jcb.150.4.797; Ullmann U, 2007, MOL HUM REPROD, V13, P21, DOI 10.1093/molehr/gal091; von Dassow G, 2009, TRENDS CELL BIOL, V19, P165, DOI 10.1016/j.tcb.2009.01.008; Wang PB, 2003, J BIOL CHEM, V278, P19917, DOI 10.1074/jbc.M210337200; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wong RCB, 2004, STEM CELLS, V22, P883, DOI 10.1634/stemcells.22-6-883; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x	42	201	213	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					240	248		10.1016/j.stem.2010.06.017	http://dx.doi.org/10.1016/j.stem.2010.06.017			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682449	Bronze, Green Accepted			2022-12-28	WOS:000281107400015
J	Pajcini, KV; Corbel, SY; Sage, J; Pomerantz, JH; Blau, HM				Pajcini, Kostandin V.; Corbel, Stephane Y.; Sage, Julien; Pomerantz, Jason H.; Blau, Helen M.			Transient Inactivation of Rb and ARF Yields Regenerative Cells from Postmitotic Mammalian Muscle	CELL STEM CELL			English	Article							RETINOBLASTOMA GENE FAMILY; LIMB REGENERATION; TUMOR SUPPRESSION; SELF-RENEWAL; STEM-CELLS; MYOGENIC DIFFERENTIATION; NEWT TRITURUS; INK4A LOCUS; CYCLE EXIT; IN-VIVO	An outstanding biological question is why tissue regeneration in mammals is limited, whereas urodele amphibians and teleost fish regenerate major structures, largely by cell cycle reentry. Upon inactivation of Rb, proliferation of postmitotic urodele skeletal muscle is induced, whereas in mammalian muscle this mechanism does not exist. We postulated that a tumor suppressor present in mammals but absent in regenerative vertebrates, the Ink4a product ARF (alternative reading frame), is a regeneration suppressor. Concomitant inactivation of Ad and Rb led to mammalian muscle cell cycle reentry, loss of differentiation properties, and upregulation of cytokinetic machinery. Single postmitotic myocytes were isolated by laser micro-dissection-catapulting, and transient suppression of Art and Rb yielded myoblast colonies that retained the ability to differentiate and fuse into myofibers upon transplantation in vivo. These results show that differentiation of mammalian cells is reversed by inactivation of Ad and Rb and support the hypothesis that Ad evolved at the expense of regeneration.	[Pajcini, Kostandin V.; Corbel, Stephane Y.; Pomerantz, Jason H.; Blau, Helen M.] Stanford Univ, Inst Stem Cell Biol & Regenerat Med, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol,Sch Med, Stanford, CA 94305 USA; [Sage, Julien] Stanford Univ, Dept Pediat, Sch Med, Stanford, CA 94305 USA; [Sage, Julien] Stanford Univ, Dept Genet, Sch Med, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Pomerantz, JH (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Craniofacial & Mesenchymal Biol, Dept Surg,Div Plast & Reconstruct Surg, San Francisco, CA 94143 USA.	jason.pomerantz@ucsfmedctr.org; hblau@stanford.edu			The Developmental and Neonatal Biology Program [2T32 HD007249]; NIH [5T32 AI07328, 5T32 HD007249, F32 AR051678-01, AG009521, AG020961, HL096113]; MDA [4320]; LLS [TR6025-09]; JDRF [34-2008-623]; CIRM [RT1-01001]; Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007249] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096113, U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR051678] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521, R01AG020961] Funding Source: NIH RePORTER	The Developmental and Neonatal Biology Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MDA(Muscular Dystrophy Association); LLS; JDRF(Juvenile Diabetes Research Foundation); CIRM(California Institute for Regenerative Medicine); Baxter Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We gratefully acknowledge grants 2T32 HD007249 of The Developmental and Neonatal Biology Program and NIH training grants 5T32 AI07328 and 5T32 HD007249 to K.V.P.; grant F32 AR051678-01 to J.H.P.; and NIH grants AG009521, AG020961, HL096113, MDA grant 4320, LLS grant TR6025-09, JDRF grant 34-2008-623, CIRM grant RT1-01001, and the Baxter Foundation to H.M.B.	Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Bersell K, 2009, CELL, V138, P257, DOI 10.1016/j.cell.2009.04.060; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Brockes JR, 2008, ANNU REV CELL DEV BI, V24, P525, DOI 10.1146/annurev.cellbio.24.110707.175336; Brooke S, 2004, EXP CELL RES, V298, P549, DOI 10.1016/j.yexcr.2004.04.035; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Caldas H, 2005, ONCOGENE, V24, P1994, DOI 10.1038/sj.onc.1208350; Camarda G, 2004, J CELL BIOL, V167, P417, DOI 10.1083/jcb.200408164; Carlson BM, 2003, DEV DYNAM, V226, P167, DOI 10.1002/dvdy.10223; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL CYCLE, V4, P1338, DOI 10.4161/cc.4.10.2114; CRESCENZI M, 1995, ANN NY ACAD SCI, V752, P9, DOI 10.1111/j.1749-6632.1995.tb17402.x; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Duckmanton A, 2005, CHEM BIOL, V12, P1117, DOI 10.1016/j.chembiol.2005.07.011; Echeverri K, 2001, DEV BIOL, V236, P151, DOI 10.1006/dbio.2001.0312; Gardiner DM, 1996, INT J DEV BIOL, V40, P797; Gilley J, 2001, ONCOGENE, V20, P7447, DOI 10.1038/sj.onc.1204933; GU W, 1993, CELL, V72, P309, DOI 10.1016/0092-8674(93)90110-C; HAY ED, 1961, DEV BIOL, V3, P26, DOI 10.1016/0012-1606(61)90009-4; Hickson GRX, 2008, BIOCHEM SOC T, V36, P439, DOI 10.1042/BST0360439; Hjiantoniou E, 2008, DIFFERENTIATION, V76, P182, DOI 10.1111/j.1432-0436.2007.00195.x; Hub MS, 2004, J CELL BIOL, V166, P865, DOI 10.1083/jcb.200403004; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Kazianis S, 1999, ONCOGENE, V18, P5088, DOI 10.1038/sj.onc.1202884; Kim SH, 2003, P NATL ACAD SCI USA, V100, P211, DOI 10.1073/pnas.0135557100; KINTNER CR, 1984, NATURE, V308, P67, DOI 10.1038/308067a0; Kobayashi K, 1999, P NATL ACAD SCI USA, V96, P1457, DOI 10.1073/pnas.96.4.1457; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; LASSAR A, 1994, CURR OPIN CELL BIOL, V6, P432, DOI 10.1016/0955-0674(94)90037-X; LENTZ TL, 1969, AM J ANAT, V124, P447, DOI 10.1002/aja.1001240404; Levi BP, 2008, COLD SH Q B, V73, P539, DOI 10.1101/sqb.2008.73.049; Li FZ, 1999, BIOCHEM J, V344, P305, DOI 10.1042/0264-6021:3440305; Lipinski MM, 1999, ONCOGENE, V18, P7873, DOI 10.1038/sj.onc.1203244; LO DC, 1993, P NATL ACAD SCI USA, V90, P7230, DOI 10.1073/pnas.90.15.7230; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Molkentin JD, 1996, CURR OPIN GENET DEV, V6, P445, DOI 10.1016/S0959-437X(96)80066-9; Novitch BG, 1996, J CELL BIOL, V135, P441, DOI 10.1083/jcb.135.2.441; Odelberg SJ, 2000, CELL, V103, P1099, DOI 10.1016/S0092-8674(00)00212-9; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Perez OD, 2002, CHEM BIOL, V9, P475, DOI 10.1016/S1074-5521(02)00131-X; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Puri PL, 2001, MOL CELL, V8, P885, DOI 10.1016/S1097-2765(01)00373-2; RANDO TA, 1994, J CELL BIOL, V125, P1275, DOI 10.1083/jcb.125.6.1275; Reimann JDR, 2001, CELL, V105, P645, DOI 10.1016/S0092-8674(01)00361-0; Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257; Sacco A, 2003, ONCOGENE, V22, P4027, DOI 10.1038/sj.onc.1206353; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; SAWIN KE, 1995, P NATL ACAD SCI USA, V92, P4289, DOI 10.1073/pnas.92.10.4289; SCHNEIDER JW, 1994, SCIENCE, V264, P1467, DOI 10.1126/science.8197461; Schutze K, 2007, METHOD CELL BIOL, V82, P649, DOI 10.1016/S0091-679X(06)82023-6; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 1999, CURR OPIN GENET DEV, V9, P22, DOI 10.1016/S0959-437X(99)80004-5; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Shen X, 2003, DEV DYNAM, V226, P128, DOI 10.1002/dvdy.10200; Sherr CJ, 2005, COLD SH Q B, V70, P129, DOI 10.1101/sqb.2005.70.004; Sherr CJ, 2000, CELL, V102, P407, DOI 10.1016/S0092-8674(00)00046-5; Sobkow L, 2006, DEV BIOL, V290, P386, DOI 10.1016/j.ydbio.2005.11.037; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stich M, 2003, PATHOL RES PRACT, V199, P405, DOI 10.1078/0344-0338-00437; Takahashi C, 2003, MOL CELL BIOL, V23, P5256, DOI 10.1128/MCB.23.15.5256-5268.2003; Tanaka EM, 2008, GENE DEV, V22, P700, DOI 10.1101/gad.1660508; Tanaka EM, 1997, J CELL BIOL, V136, P155, DOI 10.1083/jcb.136.1.155; Velloso CP, 2001, CURR BIOL, V11, P855, DOI 10.1016/S0960-9822(01)00234-2; Velloso CP, 2000, DIFFERENTIATION, V66, P239, DOI 10.1046/j.1432-0436.2000.660410.x; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Walsh K, 1997, CURR OPIN GENET DEV, V7, P597, DOI 10.1016/S0959-437X(97)80005-6; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zacksenhaus E, 1996, GENE DEV, V10, P3051, DOI 10.1101/gad.10.23.3051	73	139	144	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					198	213		10.1016/j.stem.2010.05.022	http://dx.doi.org/10.1016/j.stem.2010.05.022			16	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682446	Bronze, Green Accepted			2022-12-28	WOS:000281107400012
J	Siegenthaler, JA; Pleasure, SJ				Siegenthaler, Julie A.; Pleasure, Samuel J.			There's No Place Like Home for a Neural Stem Cell	CELL STEM CELL			English	Editorial Material							VASCULAR NICHE		[Pleasure, Samuel J.] Univ Calif San Francisco, Dept Neurol, Inst Regenerat Med, Program Neurosci, San Francisco, CA 94158 USA; Univ Calif San Francisco, Dept Neurol, Inst Regenerat Med, Program Dev Biol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pleasure, SJ (corresponding author), Univ Calif San Francisco, Dept Neurol, Inst Regenerat Med, Program Neurosci, San Francisco, CA 94158 USA.	sam.pleasure@ucsf.edu	abelmadani, abdel/D-7856-2012	, Julie/0000-0003-3700-6441	NINDS NIH HHS [K99 NS070920] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K99NS070920] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Javaherian A, 2009, CEREB CORTEX, V19, pI70, DOI 10.1093/cercor/bhp029; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kokovay E, 2010, CELL STEM CELL, V7, P163, DOI 10.1016/j.stem.2010.05.019; Li GN, 2009, DEVELOPMENT, V136, P327, DOI 10.1242/dev.025742; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Stubbs D, 2009, CEREB CORTEX, V19, pI32, DOI 10.1093/cercor/bhp040; Zhu Y, 2002, NAT NEUROSCI, V5, P719, DOI 10.1038/nn881	10	5	5	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					141	143		10.1016/j.stem.2010.07.001	http://dx.doi.org/10.1016/j.stem.2010.07.001			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682440	Bronze			2022-12-28	WOS:000281107400004
J	Hope, KJ; Cellot, S; Ting, SB; MacRae, T; Mayotte, N; Iscove, NN; Sauvageau, G				Hope, Kristin J.; Cellot, Sonia; Ting, Stephen B.; MacRae, Tara; Mayotte, Nadine; Iscove, Norman N.; Sauvageau, Guy			An RNAi Screen Identifies Msi2 and Prox1 as Having Opposite Roles in the Regulation of Hematopoietic Stem Cell Activity	CELL STEM CELL			English	Article							BINDING PROTEIN MUSASHI; SELF-RENEWAL; ASYMMETRIC SEGREGATION; PROGENITOR CELLS; DIVISION; DIFFERENTIATION; DROSOPHILA; RECEPTORS; POLARITY; FAMILY	In this study, we describe an in vivo RNA interference functional genetics approach to evaluate the role of 20 different conserved polarity factors and fate determinants in mouse hematopoietic stem cell (HSC) activity. In total, this screen revealed three enhancers and one suppressor of HSC-derived reconstitution. Pard6a, Prkcz, and Msi2 shRNA-mediated depletion significantly impaired HSC repopulation. An in vitro promotion of differentiation was observed after the silencing of these genes, consistent with their function in regulating HSC self-renewal. Conversely, Prox1 knockdown led to in vivo accumulation of primitive and differentiated cells. HSC activity was also enhanced in vitro when Prox1 levels were experimentally reduced, identifying it as a potential antagonist of self-renewal. HSC engineered to overexpress Msi2 or Prox1 showed the reverse phenotype to those transduced with corresponding shRNA vectors. Gene expression profiling studies identified a number of known HSC and cell cycle regulators as potential downstream targets to Msi2 and Prox1	[Hope, Kristin J.; Cellot, Sonia; Ting, Stephen B.; MacRae, Tara; Mayotte, Nadine; Sauvageau, Guy] Univ Montreal, IRIC, Mol Genet Stem Cells Lab, Montreal, PQ H3C 3J7, Canada; [Iscove, Norman N.] Univ Toronto, Univ Hlth Network, Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada	Universite de Montreal; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Sauvageau, G (corresponding author), Univ Montreal, IRIC, Mol Genet Stem Cells Lab, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca		Hope, Kristin/0000-0003-1449-4948; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institute of Health Research (CIHR) [154290]; National Health Medical Research Council; Royal Australian College of Physicians; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI); Fonds de Recherche en Sante du Quebec (FRSQ)	Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); National Health Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Royal Australian College of Physicians; Canadian Center of Excellence in Commercialization and Research (CECR); Canada Foundation for Innovation (CFI)(Canada Foundation for Innovation); Fonds de Recherche en Sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec)	We thank M. Frechette and A. Fournier for technical assistance with mouse transplantations, D. Gagne from the IRIC flow cytometry platform, R. Lambert from the IRIC genomic platform for help with quantitative RT-PCR, and J. Landry for technical assistance with microarray experiments. The authors also thank J. Krosl for discussions and critical comments about the manuscript. This work was supported by the Canadian Institute of Health Research (CIHR) Team Grant in Hematopoietic Stem Cell Self-Renewal: From Genes to Bedside (Grant number 154290). G.S. holds a Canada Research Chair on molecular genetics of stem cells; K.J.H. and S.C. are recipients of a CIHR Post-doctoral fellowship and Clinician Scientist award, respectively; S.B.T. is the recipient of National Health Medical Research Council, Royal Australian College of Physicians, and CIHR Post-doctoral fellowships. IRIC is supported in part by the Canadian Center of Excellence in Commercialization and Research (CECR), the Canada Foundation for Innovation (CFI), and the Fonds de Recherche en Sante du Quebec (FRSQ).	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Barbouti A, 2003, CANCER RES, V63, P1202; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Brummendorf TH, 1998, J EXP MED, V188, P1117, DOI 10.1084/jem.188.6.1117; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Clarke RB, 2005, DEV BIOL, V277, P443, DOI 10.1016/j.ydbio.2004.07.044; De Weer A, 2008, HAEMATOL-HEMATOL J, V93, P1903, DOI 10.3324/haematol.13192; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Dyer MA, 2003, CELL CYCLE, V2, P350, DOI 10.4161/cc.2.4.429; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Ema H, 2000, BLOOD, V95, P2284, DOI 10.1182/blood.V95.7.2284.007k14_2284_2288; Faubert A, 2004, ONCOGENE, V23, P7247, DOI 10.1038/sj.onc.1207944; Gu Y, 2005, CELL CYCLE, V4, P201; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; INADA S, 1983, P NATL ACAD SCI-BIOL, V80, P2351, DOI 10.1073/pnas.80.8.2351; IRNAI T, 2001, MOL CELL BIOL, V21, P3888; Joberty G, 2000, NAT CELL BIOL, V2, P531, DOI 10.1038/35019573; Kayahara T, 2003, FEBS LETT, V535, P131, DOI 10.1016/S0014-5793(02)03896-6; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; KRIEGER M, 1993, J BIOL CHEM, V268, P4569; Krosl J, 2003, IMMUNITY, V18, P561, DOI 10.1016/S1074-7613(03)00090-6; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lin D, 2000, NAT CELL BIOL, V2, P540, DOI 10.1038/35019582; Nagai H, 2003, GENE CHROMOSOME CANC, V38, P13, DOI 10.1002/gcc.10248; NAKAMURA M, 1994, NEURON, V13, P67, DOI 10.1016/0896-6273(94)90460-X; Okano H, 2002, J CELL SCI, V115, P1355; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Palmqvist L, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000768; POLLEN CS, 2003, DIFFERENTIATION, V71, P28; Punzel M, 2002, EXP HEMATOL, V30, P464, DOI 10.1016/S0301-472X(02)00781-6; Risebro CA, 2009, DEVELOPMENT, V136, P495, DOI 10.1242/dev.030007; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Watts JL, 1996, DEVELOPMENT, V122, P3133; Wigle JT, 1999, NAT GENET, V21, P318, DOI 10.1038/6844; Wigle JT, 2002, EMBO J, V21, P1505, DOI 10.1093/emboj/21.7.1505; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yokota T, 2009, BLOOD, V113, P2914, DOI 10.1182/blood-2008-07-167106; Zhao Y, 2000, BLOOD, V96, P3016	51	110	118	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					101	113		10.1016/j.stem.2010.06.007	http://dx.doi.org/10.1016/j.stem.2010.06.007			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621054	Bronze			2022-12-28	WOS:000280222300017
J	Buecker, C; Chen, HH; Polo, JM; Daheron, L; Bu, L; Barakat, TS; Okwieka, P; Porter, A; Gribnau, J; Hochedlinger, K; Geijsen, N				Buecker, Christa; Chen, Hsu-Hsin; Polo, Jose Maria; Daheron, Laurence; Bu, Lei; Barakat, Tahsin Stefan; Okwieka, Patricia; Porter, Andrew; Gribnau, Joost; Hochedlinger, Konrad; Geijsen, Niels			A Murine ESC-like State Facilitates Transgenesis and Homologous Recombination in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							HUMAN BLASTOCYSTS; MOUSE EMBRYOS; GROUND-STATE; SELF-RENEWAL; METHYLATION; CHROMATIN; EPIBLAST; LINES; DIFFERENTIATION; GENERATION	Murine pluripotent stem cells can exist in two functionally distinct states, LIF-dependent embryonic stem cells (ESCs) and bFGF-dependent epiblast stem cells (EpiSCs). However, human pluripotent cells so far seemed to assume only an epiblast-like state. Here we demonstrate that human iPSC reprogramming in the presence of LIF yields human stem cells that display morphological, molecular, and functional properties of murine ESCs. We termed these hLR5 iPSCs because they require the expression of five ectopic reprogramming factors, Oct4, Sox2, Klf4, cMyc, and Nanog, to maintain this more naive state. The cells are "metastable" and upon ectopic factor withdrawal they revert to standard human iPSCs. Finally, we demonstrate that the hLR5 state facilitates gene targeting, and as such provides a powerful tool for the generation of recombinant human pluripotent stem cell lines.	[Buecker, Christa; Chen, Hsu-Hsin; Polo, Jose Maria; Daheron, Laurence; Okwieka, Patricia; Hochedlinger, Konrad; Geijsen, Niels] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose Maria; Hochedlinger, Konrad] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc, Boston, MA 02114 USA; [Bu, Lei] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Buecker, Christa; Chen, Hsu-Hsin; Polo, Jose Maria; Daheron, Laurence; Bu, Lei; Hochedlinger, Konrad; Geijsen, Niels] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Barakat, Tahsin Stefan; Gribnau, Joost] Univ Med Ctr, Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands; [Porter, Andrew] Univ London Imperial Coll Sci Technol & Med, Gene Therapy Grp, Dept Haematol, London W12 0NN, England; [Geijsen, Niels] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Erasmus University Rotterdam; Erasmus MC; Imperial College London; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW)	Geijsen, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA.	ngeijsen@mgh.harvard.edu	Bu, Lei/F-4461-2011; Barakat, Stefan/X-8234-2019	Barakat, Stefan/0000-0003-1231-1562; Polo, Jose M/0000-0002-2531-778X; Buecker, Christa/0000-0003-3055-2642; BU, LEI/0000-0003-4476-2157	NIH; Dutch Science Organization (NWO); Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch Science Organization (NWO)(Netherlands Organization for Scientific Research (NWO)); Gottlieb Daimler- and Karl Benz-Foundation; National Science Council (Taiwan, ROC)(Ministry of Science and Technology, Taiwan); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Tim Ahfeldt, Nimet Maherali, and Chad Cowan for providing human iPSCs, Laura Prickett-Rice and Kat Folz-Donahue at the HSCI/MGH Flow Cytometry Core facility cell sorting; and Jason West and Meredith Bryden for technical support. This work was supported by grants from the NIH and a grant from the Dutch Science Organization (NWO). C.B. was supported by the Gottlieb Daimler- and Karl Benz-Foundation. H.-H.C. was supported by the National Science Council (Taiwan, ROC).	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Pray-Grant MG, 2005, NATURE, V433, P434, DOI 10.1038/nature03242; Ptaszek LM, 2007, CELL STEM CELL, V1, P600, DOI 10.1016/j.stem.2007.11.004; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Sims RJ, 2005, J BIOL CHEM, V280, P41789, DOI 10.1074/jbc.C500395200; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Song H, 2010, CELL STEM CELL, V6, P80, DOI 10.1016/j.stem.2009.11.016; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, CURR TOP DEV BIOL, V38, P133; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	36	165	174	0	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					535	546		10.1016/j.stem.2010.05.003	http://dx.doi.org/10.1016/j.stem.2010.05.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569691	Bronze, Green Accepted			2022-12-28	WOS:000278840700014
J	Zeng, YA; Nusse, R				Zeng, Yi Arial; Nusse, Roel			Wnt Proteins Are Self-Renewal Factors for Mammary Stem Cells and Promote Their Long-Term Expansion in Culture	CELL STEM CELL			English	Article							GENE-EXPRESSION; GLAND; CANCER; TUMORS; IDENTIFICATION; TRANSCRIPTION; REGULATOR; RECEPTOR; FAMILY; GATA-3	Adult stem cells have the ability to self-renew and to generate specialized cells. Self-renewal is dependent on extrinsic niche factors but few of those signals have been identified. In addition, stem cells tend to differentiate in the absence of the proper signals and are therefore difficult to maintain in cell culture. The mammary gland provides an excellent system to study self-renewal signals, because the organ develops postnatally, arises from stem cells, and is readily generated from transplanted cells. We show here that adult mammary glands contain a Wnt-responsive cell population that is enriched for stem cells. In addition, stem cells mutant for the negative-feedback regulator Axin2 and therefore sensitized to Wnt signals have a competitive advantage in mammary gland reconstitution assays. In cell culture experiments, exposure to purified Wnt protein clonally expands mammary stem cells for many generations and maintains their ability to generate functional glands in transplantation assays. We conclude that Wnt proteins serve as rate-limiting self-renewal signals acting directly on mammary stem cells.	[Zeng, Yi Arial; Nusse, Roel] Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Sch Med,Beckman Ctr, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Nusse, R (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Dev Biol, Sch Med,Beckman Ctr, B271,279 Campus Dr, Stanford, CA 94305 USA.	rnusse@stanford.edu			Howard Hughes Medical Institute; California Institute of Regenerative Medicine; Morton Family Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); Morton Family Foundation	We thank various colleagues, in particular Renee van Amerongen, Angela Bowman, Margaret Fuller, Esther Verheyen, Jill Helms, and Mike Clarke for comments and discussions. Matt van de Rijn kindly provided advice on histology. Priya Rajaraman and Steve Artandi helped in cleared fat pad assays. We thank Christophe Fuerer for providing the 7XTcf-FFluc//SV40 construct and Walter Birchmeier for the Axin2<SUP>lacz</SUP> mouse strain. This work was supported by the Howard Hughes Medical Institute, a fellowship from the California Institute of Regenerative Medicine, and the Morton Family Foundation.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Baker R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008854; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Boras-Granic K, 2006, DEV BIOL, V295, P219, DOI 10.1016/j.ydbio.2006.03.030; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brisken C, 2000, GENE DEV, V14, P650; BUHLER TA, 1993, DEV BIOL, V155, P87, DOI 10.1006/dbio.1993.1009; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; DEOME KB, 1959, CANCER RES, V19, P515; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; GAVIN BJ, 1992, MOL CELL BIOL, V12, P2418, DOI 10.1128/MCB.12.5.2418; HUGUET EL, 1994, CANCER RES, V54, P2615; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Kalani MYS, 2008, P NATL ACAD SCI USA, V105, P16970, DOI 10.1073/pnas.0808616105; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kordon EC, 1998, DEVELOPMENT, V125, P1921; Kouros-Mehr H, 2006, CELL, V127, P1041, DOI 10.1016/j.cell.2006.09.048; Lane TF, 1997, ONCOGENE, V15, P2133, DOI 10.1038/sj.onc.1201593; Leung JY, 2002, J BIOL CHEM, V277, P21657, DOI 10.1074/jbc.M200139200; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; OLSON DJ, 1994, CELL GROWTH DIFFER, V5, P197; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; ROELINK H, 1990, P NATL ACAD SCI USA, V87, P4519, DOI 10.1073/pnas.87.12.4519; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Teissedre B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004537; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2006, CANCER RES, V66, P9798, DOI 10.1158/0008-5472.CAN-06-2254; WEBERHALL SJ, 1994, DIFFERENTIATION, V57, P205, DOI 10.1046/j.1432-0436.1994.5730205.x; Welm B, 2003, CELL PROLIFERAT, V36, P17, DOI 10.1046/j.1365-2184.36.s.1.3.x; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Woodward WA, 2005, J CELL SCI, V118, P3585, DOI 10.1242/jcs.02532; YOUNG LJT, 1971, EXP GERONTOL, V6, P49, DOI 10.1016/0531-5565(71)90048-9	44	306	316	0	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					568	577		10.1016/j.stem.2010.03.020	http://dx.doi.org/10.1016/j.stem.2010.03.020			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569694	Green Accepted, Bronze			2022-12-28	WOS:000278840700017
J	Marks, H; Veenstra, GJC; Stunnenberg, HG				Marks, Hendrik; Veenstra, Gert Jan C.; Stunnenberg, Hendrik G.			Insightful Tales from Single Embryonic Cells	CELL STEM CELL			English	Editorial Material							STEM-CELLS; PLURIPOTENCY; BLASTOCYST; MOUSE	Two studies by Guo et al. (2010) and Tang et al. (2010) use comprehensive and systematic single-cell RNA profiling to address pivotal questions in mouse embryonic biology: when initial asymmetries become apparent during development and how cells adapt to an in vitro environment to become embryonic stem cells.	[Marks, Hendrik; Veenstra, Gert Jan C.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NCMLS, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Fac Sci, NCMLS, POB 9101, NL-6500 HB Nijmegen, Netherlands.	h.stunnenberg@ncmls.ru.nl	Marks, Hendrik/E-2801-2012; Stunnenberg, Hendrik G./D-6875-2012; Veenstra, Gert Jan C./D-4963-2012	Marks, Hendrik/0000-0002-4198-3731; Stunnenberg, Hendrik G./0000-0002-0066-1576; Veenstra, Gert Jan C./0000-0002-7787-4940				Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Guo GJ, 2010, DEV CELL, V18, P675, DOI 10.1016/j.devcel.2010.02.012; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	9	4	5	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					397	398		10.1016/j.stem.2010.04.008	http://dx.doi.org/10.1016/j.stem.2010.04.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452308	Bronze			2022-12-28	WOS:000277844800001
J	Chung, S; Leung, A; Han, BS; Chang, MY; Moon, JI; Kim, CH; Hong, S; Pruszak, J; Isacson, O; Kim, KS				Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Pruszak, Jan; Isacson, Ole; Kim, Kwang-Soo			Wnt1-Imx1a Forms a Novel Autoregulatory Loop and Controls Midbrain Dopaminergic Differentiation Synergistically with the SHH-FoxA2 Pathway	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; FLOOR PLATE; PARKINSONS-DISEASE; NEURON DEVELOPMENT; ISTHMIC ORGANIZER; SONIC HEDGEHOG; BETA-CATENIN; FGF8; HINDBRAIN; GROWTH	Selective degeneration of midbrain dopaminergic (mDA) neurons is associated with Parkinson's disease (PD), and thus an in-depth understanding of molecular pathways underlying mDA development will be crucial for optimal bioassays and cell replacement therapy for PD. In this study, we identified a novel Wnt1-Lmx1a autoregulatory loop during mDA differentiation of ESCs and confirmed its in vivo presence during embryonic development. We found that the Wnt1-Lmx1a autoregulatory loop directly regulates Otx2 through the beta-catenin complex and Nurr1 and Pitx3 through Lmx1a. We also found that Lmx1a and Lmx1b cooperatively regulate mDA differentiation with overlapping and cross-regulatory functions. Furthermore, coactivation of both Wnt1 and SHH pathways by exogenous expression of Lmx1a, Otx2, and FoxA2 synergistically enhanced the differentiation of ESCs to mDA neurons. Together with previous works, this study shows that two regulatory loops (Wnt1-Lmx1a and SHH-FoxA2) critically link extrinsic signals to cell-intrinsic factors and cooperatively regulate mDA neuron development.	[Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat,Mol Neurobiol Lab, Belmont, MA 02478 USA; [Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Program Neurosci, Belmont, MA 02478 USA; [Chung, Sangmi; Leung, Amanda; Han, Baek-Soo; Chang, Mi-Yoon; Moon, Jung-Il; Kim, Chun-Hyung; Hong, Sunghoi; Pruszak, Jan; Isacson, Ole; Kim, Kwang-Soo] Harvard Univ, McLean Hosp, Sch Med, Harvard Stem Cell Inst, Belmont, MA 02478 USA; [Pruszak, Jan; Isacson, Ole] Harvard Univ, McLean Hosp, Sch Med, Neurogenerat Labs, Belmont, MA 02478 USA	Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital; Harvard University; McLean Hospital	Kim, KS (corresponding author), Harvard Univ, McLean Hosp, Sch Med, Dept Psychiat,Mol Neurobiol Lab, Belmont, MA 02478 USA.	kskim@mclean.harvard.edu	Pruszak, Jan/G-6972-2015	Pruszak, Jan/0000-0003-4297-4009; Isacson, Ole/0000-0001-8091-8302	NIH [P50 NS39793, MH48866]; Korean Brain Research Center; Dongyang Corporation Co. in Korea; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH048866, R29MH048866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039793] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean Brain Research Center; Dongyang Corporation Co. in Korea; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants P50 NS39793 and MH48866 and international grants from the Korean Brain Research Center and Dongyang Corporation Co. in Korea. The authors also thank Dr. Siew-Lan Ang at MRC, UK, for sharing her unpublished work as a personal communication. We appreciate Dr. German at UCSF, Dr. Birchmeier at Max Delbruck Center for Molecular Medicine, Dr. Morgan at NIGH, and Dr. Duester at Burnham Institute for kindly providing us with valuable antibodies.	Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Ang SL, 2006, DEVELOPMENT, V133, P3499, DOI 10.1242/dev.02501; Arenas E, 2008, CELL STEM CELL, V2, P110, DOI 10.1016/j.stem.2008.01.012; BJORKLUND A, 1984, HDB CHEM NEUROANATOM; Castelo-Branco G, 2004, J CELL SCI, V117, P5731, DOI 10.1242/jcs.01505; Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487; Chung S, 2002, EUR J NEUROSCI, V16, P1829, DOI 10.1046/j.1460-9568.2002.02255.x; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Guo C, 2007, DEVELOPMENT, V134, P317, DOI 10.1242/dev.02745; Hobert O, 2000, TRENDS GENET, V16, P75, DOI 10.1016/S0168-9525(99)01883-1; Jeong Y, 2003, DEVELOPMENT, V130, P3891, DOI 10.1242/dev.00590; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kim JH, 2002, NATURE, V418, P50, DOI 10.1038/nature00900; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Lang AE, 1998, NEW ENGL J MED, V339, P1044, DOI 10.1056/NEJM199810083391506; Lee SMK, 1997, DEVELOPMENT, V124, P959; Liu AM, 2001, DEVELOPMENT, V128, P181; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; MCMAHON AP, 1990, CELL, V62, P1073, DOI 10.1016/0092-8674(90)90385-R; Megason SG, 2002, DEVELOPMENT, V129, P2087; Millonig JH, 2000, NATURE, V403, P764, DOI 10.1038/35001573; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Pabst O, 2000, DEV GENES EVOL, V210, P47, DOI 10.1007/PL00008188; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Pruszak J, 2007, STEM CELLS, V25, P2257, DOI 10.1634/stemcells.2006-0744; Saarimaki-Vire J, 2007, J NEUROSCI, V27, P8581, DOI 10.1523/JNEUROSCI.0192-07.2007; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Smidt MP, 2007, NAT REV NEUROSCI, V8, P21, DOI 10.1038/nrn2039; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Tang MZ, 2009, DEVELOPMENT, V136, P2027, DOI 10.1242/dev.034330; Vernay B, 2005, J NEUROSCI, V25, P4856, DOI 10.1523/JNEUROSCI.5158-04.2005; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Yochum GS, 2007, P NATL ACAD SCI USA, V104, P3324, DOI 10.1073/pnas.0611576104	38	142	147	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					646	658		10.1016/j.stem.2009.09.015	http://dx.doi.org/10.1016/j.stem.2009.09.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951692	Bronze, Green Accepted			2022-12-28	WOS:000273616700012
J	Schinder, AF; Morgenstern, NA				Schinder, Alejandro F.; Morgenstern, Nicolas A.			Adult Neurogenesis Is Altered by GABAergic Imbalance in Models of Alzheimer's Disease	CELL STEM CELL			English	Editorial Material							APOLIPOPROTEIN-E; INTEGRATION; BRAIN		[Schinder, Alejandro F.; Morgenstern, Nicolas A.] Consejo Nacl Invest Cient & Tecn, Leloir Inst, Lab Neuronal Plast, RA-1033 Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Schinder, AF (corresponding author), Consejo Nacl Invest Cient & Tecn, Leloir Inst, Lab Neuronal Plast, C1405BWE, RA-1033 Buenos Aires, DF, Argentina.	aschinder@leloir.org.ar		Schinder, Alejandro/0000-0003-4863-8348; Morgenstern, Nicolas A./0000-0003-4733-3286				Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Kim J, 2009, NEURON, V63, P287, DOI 10.1016/j.neuron.2009.06.026; LaFerla FM, 2005, TRENDS MOL MED, V11, P170, DOI 10.1016/j.molmed.2005.02.009; Li G, 2009, CELL STEM CELL, V5, P634, DOI 10.1016/j.stem.2009.10.015; Overstreet-Wadiche LS, 2006, J NEUROSCI, V26, P4095, DOI 10.1523/JNEUROSCI.5508-05.2006; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Sun BG, 2009, CELL STEM CELL, V5, P624, DOI 10.1016/j.stem.2009.10.003; Wang YX, 2005, NEUROBIOL AGING, V26, P309, DOI 10.1016/j.neurobiolaging.2004.06.018; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	11	9	9	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					573	574		10.1016/j.stem.2009.11.007	http://dx.doi.org/10.1016/j.stem.2009.11.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951683	Bronze, Green Published			2022-12-28	WOS:000273616700003
J	Zovein, AC; Iruela-Arispe, ML				Zovein, Ann C.; Iruela-Arispe, M. Luisa			Time to Cut the Cord: Placental HSCs Grow Up	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; ORIGIN; ORGAN	In this issue of Cell Stem Cell, Robin et al. (2009) demonstrate the robust hematopoietic stem cell capacity of the human placenta. The study investigates components of the placental niche and paves the way for clinical applications of blood production.	[Zovein, Ann C.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA; [Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Iruela-Arispe, ML (corresponding author), Univ Calif Los Angeles, Dept Mol Cellular & Dev Biol, Los Angeles, CA 90095 USA.	arispe@mcdb.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020; Zovein, Ann/L-8520-2013	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Zovein, Ann/0000-0003-3298-7308	NHLBI NIH HHS [R01 HL074455] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074455] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Barcena A, 2009, DEV BIOL, V327, P24, DOI 10.1016/j.ydbio.2008.11.017; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Ohlsson R, 1999, DEV BIOL, V212, P124, DOI 10.1006/dbio.1999.9306; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Robin C, 2009, CELL STEM CELL, V5, P385, DOI 10.1016/j.stem.2009.08.020; Serikov V, 2009, EXP BIOL MED, V234, P813, DOI 10.3181/0809-BC-262; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958	10	2	2	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					351	352		10.1016/j.stem.2009.09.003	http://dx.doi.org/10.1016/j.stem.2009.09.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796613	Bronze			2022-12-28	WOS:000271401900005
J	Wood, KC; Sabatini, DM				Wood, Kris C.; Sabatini, David M.			Growth Signaling at the Nexus of Stem Cell Life and Death	CELL STEM CELL			English	Editorial Material							STRESS; SPAN		[Wood, Kris C.; Sabatini, David M.] Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Wood, Kris C.; Sabatini, David M.] Seven Cambridge Ctr, Broad Inst, Cambridge, MA 02142 USA; [Wood, Kris C.; Sabatini, David M.] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02139 USA; [Sabatini, David M.] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Sabatini, DM (corresponding author), Nine Cambridge Ctr, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	sabatini@wi.mit.edu		/0000-0002-1446-7256	NCI NIH HHS [R01 CA103866] Funding Source: Medline; NIAID NIH HHS [R01 AI047389] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047389] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	11	6	6	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					232	234		10.1016/j.stem.2009.08.008	http://dx.doi.org/10.1016/j.stem.2009.08.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733530	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000272545700004
J	Adams, GB				Adams, Gregor B.			Myeloproliferative Disorder by TKO	CELL STEM CELL			English	Editorial Material							SELF-RENEWAL	In this issue of Cell Stem Cell, Viatour et al. (2008) delete all three members of the retinoblastoma tumor suppressor gene family in hematopoietic stem cells, resulting in a myeloproliferative disorder. The disease was cell autonomous and resulted from alterations in the primitive hematopoietic cells.	Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California	Adams, GB (corresponding author), Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 1450 Biggy St NRT 4507, Los Angeles, CA 90033 USA.	gregor.adams@keck.usc.edu						Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; METCALF D, 1993, BLOOD, V82, P3515; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Viatour P, 2008, CELL STEM CELL, V3, P416, DOI 10.1016/j.stem.2008.07.009; Walkley CR, 2006, P NATL ACAD SCI USA, V103, P9057, DOI 10.1073/pnas.0603389103	5	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					361	362		10.1016/j.stem.2008.09.008	http://dx.doi.org/10.1016/j.stem.2008.09.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940726	Bronze			2022-12-28	WOS:000260149800004
J	Bilousova, G; Roop, DR				Bilousova, Ganna; Roop, Dennis R.			Altering Cell Fate: From Thymus Epithelium to Skin Stem Cells	CELL STEM CELL			English	Editorial Material							DEFINED FACTORS; FIBROBLASTS		[Bilousova, Ganna; Roop, Dennis R.] Univ Colorado Denver, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO 80045 USA; [Bilousova, Ganna; Roop, Dennis R.] Univ Colorado Denver, Dept Dermatol, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Roop, DR (corresponding author), Univ Colorado Denver, Charles C Gates Ctr Regenerat Med & Stem Cell Bio, Aurora, CO 80045 USA.	dennis.roop@ucdenver.edu						Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; Bonfanti P, 2010, NATURE, V466, P978, DOI 10.1038/nature09269; Ieda M, 2010, CELL, V142, P375, DOI 10.1016/j.cell.2010.07.002; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kyewski B, 2004, NAT REV IMMUNOL, V4, P688, DOI 10.1038/nri1436; LASTER AJ, 1986, DIFFERENTIATION, V31, P67, DOI 10.1111/j.1432-0436.1986.tb00385.x; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	10	2	3	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					419	420		10.1016/j.stem.2010.09.007	http://dx.doi.org/10.1016/j.stem.2010.09.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887943	Bronze			2022-12-28	WOS:000283270600001
J	Molyneux, G; Geyer, FC; Magnay, FA; McCarthy, A; Kendrick, H; Natrajan, R; MacKay, A; Grigoriadis, A; Tutt, A; Ashworth, A; Reis, JS; Smalley, MJ				Molyneux, Gemma; Geyer, Felipe C.; Magnay, Fiona-Ann; McCarthy, Afshan; Kendrick, Howard; Natrajan, Rachael; MacKay, Alan; Grigoriadis, Anita; Tutt, Andrew; Ashworth, Alan; Reis-Filho, Jorge S.; Smalley, Matthew J.			BRCA1 Basal-like Breast Cancers Originate from Luminal Epithelial Progenitors and Not from Basal Stem Cells	CELL STEM CELL			English	Article							ESTROGEN-RECEPTOR-ALPHA; MAMMARY-GLAND; GENE-EXPRESSION; MOUSE MODEL; TUMORS; SUBTYPES; FATE; P53; BETA-1-INTEGRIN; MORPHOGENESIS	Breast cancers in BRCA1 mutation carriers frequently have a distinctive basal-like phenotype. It has been suggested that this results from an origin in basal breast epithelial stem cells. Here, we demonstrate that deleting Brca1 in mouse mammary epithelial luminal progenitors produces tumors that phenocopy human BRCA1 breast cancers. They also resemble the majority of sporadic basal-like breast tumors. However, directing Brca1 deficiency to basal cells generates tumors that express molecular markers of basal breast cancers but do not histologically resemble either human BRCA1 or the majority of sporadic basal-like breast tumors. These findings support a derivation of the majority of human BRCA1-associated and sporadic basal-like tumors from luminal progenitors rather than from basal stem cells. They also demonstrate that when target cent for transformation have the potential for phenotypic plasticity, tumor phenotypes may not directly reflect histogenesis. This has important implications for cancer prevention strategies.	[Molyneux, Gemma; Geyer, Felipe C.; Magnay, Fiona-Ann; McCarthy, Afshan; Kendrick, Howard; Natrajan, Rachael; MacKay, Alan; Ashworth, Alan; Reis-Filho, Jorge S.; Smalley, Matthew J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Grigoriadis, Anita; Tutt, Andrew] Kings Hlth Partners AHSC, Guys Hosp, Breakthrough Breast Canc Res Unit, London SE1 9RT, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Guy's & St Thomas' NHS Foundation Trust; King's Health Partners; University of London; King's College London	Smalley, MJ (corresponding author), Inst Canc Res, Breakthrough Breast Canc Res Ctr, 237 Fulham Rd, London SW3 6JB, England.	matthew.smalley@icr.ac.uk	Smalley, Matthew J/M-7000-2015	Smalley, Matthew J/0000-0001-9540-1146; Tutt, Andrew/0000-0001-8715-2901; Grigoriadis, Anita/0000-0003-3434-201X; Natrajan, Rachael/0000-0002-9987-2946	Breakthrough Breast Cancer; NHS	Breakthrough Breast Cancer; NHS	We thank the Breakthrough Histopathology Facility for their assistance with processing tumor tissues, Fredrik Wallberg for help with flow cytometry analysis, and Britta Weigelt for providing the centroids for human breast cancer molecular subtype assignment. This work was funded by Breakthrough Breast Cancer. We acknowledge NHS funding to the NIHR Biomedical Research Centre.	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Barbera M, 2009, SURG ONCOL CLIN N AM, V18, P393, DOI 10.1016/j.soc.2009.03.001; Booth BW, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1538; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dontu G, 2003, CELL PROLIFERAT, V36, P59, DOI 10.1046/j.1365-2184.36.s.1.6.x; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Geyer FC, 2010, J PATHOL, V220, P562, DOI 10.1002/path.2675; Gorski JJ, 2010, BREAST CANCER RES TR, V122, P721, DOI 10.1007/s10549-009-0565-0; Gusterson BA, 2005, BREAST CANCER RES, V7, P143, DOI 10.1186/bcr1041; Gusterson B, 2009, NAT REV CANCER, V9, P128, DOI 10.1038/nrc2571; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kendrick H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-591; Lakhani SR, 2005, CLIN CANCER RES, V11, P5175, DOI 10.1158/1078-0432.CCR-04-2424; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103; Marusyk A, 2010, BBA-REV CANCER, V1805, P105, DOI 10.1016/j.bbcan.2009.11.002; McCarthy A, 2007, J PATHOL, V211, P389, DOI 10.1002/path.2124; Melchor L, 2008, CARCINOGENESIS, V29, P1475, DOI 10.1093/carcin/bgn157; Mesquita Patricia, 2006, Critical Reviews in Oncogenesis, V12, P3; Natrajan R, 2010, BREAST CANCER RES TR, V121, P575, DOI 10.1007/s10549-009-0501-3; Naylor MJ, 2005, J CELL BIOL, V171, P717, DOI 10.1083/jcb.200503144; Nielsen TO, 2004, CLIN CANCER RES, V10, P5367, DOI 10.1158/1078-0432.CCR-04-0220; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Palacios J, 2005, BREAST CANCER RES TR, V90, P5, DOI 10.1007/s10549-004-1536-0; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rebbeck TR, 2002, NEW ENGL J MED, V346, P1616, DOI 10.1056/NEJMoa012158; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2007, J CELL BIOL, V176, P19, DOI 10.1083/jcb.200604065; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; Smalley M, 2003, NAT REV CANCER, V3, P832, DOI 10.1038/nrc1212; Smart CE, 2008, BREAST CANCER RES TR, V112, P237, DOI 10.1007/s10549-007-9859-2; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Taddei I, 2008, NAT CELL BIOL, V10, P716, DOI 10.1038/ncb1734; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; Vassilopoulos A, 2008, INT J BIOL SCI, V4, P133, DOI 10.7150/ijbs.4.133; Weigelt B, 2010, LANCET ONCOL, V11, P339, DOI 10.1016/S1470-2045(10)70008-5	47	492	509	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					403	417		10.1016/j.stem.2010.07.010	http://dx.doi.org/10.1016/j.stem.2010.07.010			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804975	Bronze			2022-12-28	WOS:000282037800016
J	Martinez, NJ; Gregory, RI				Martinez, Natalia J.; Gregory, Richard I.			MicroRNA Gene Regulatory Pathways in the Establishment and Maintenance of ESC Identity	CELL STEM CELL			English	Review							STEM; BIOGENESIS; OCT4; SOX2	Understanding the molecular foundations of embryonic stem cell (ESC) self-renewal and pluripotency will facilitate therapeutic exploitation of these remarkable cells. Here we discuss the emerging roles of microRNAs in the establishment and maintenance of ESC identity and summarize our current understanding of the mechanisms controlling microRNA expression and function in ESCs.	[Martinez, Natalia J.; Gregory, Richard I.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol,Stem Cell Program, Harvard Stem Cell Inst,Childrens Hosp Boston, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Gregory, RI (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol,Stem Cell Program, Harvard Stem Cell Inst,Childrens Hosp Boston, Boston, MA 02115 USA.	rgregory@enders.tch.harvard.edu			Children's Hospital Boston; NIH-NIGMS [1R01GM086386-01A1]; Harvard Stem Cell Institute; Emerald Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086386] Funding Source: NIH RePORTER	Children's Hospital Boston; NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Harvard Stem Cell Institute; Emerald Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	R.I.G. is supported by lab start-up funds from The Children's Hospital Boston and grants from the NIH-NIGMS (1R01GM086386-01A1), the Harvard Stem Cell Institute, and the Emerald Foundation. R.I.G. is a Pew Research Scholar.	Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Ivey KN, 2010, CELL STEM CELL, V7, P36, DOI 10.1016/j.stem.2010.06.012; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Qi JL, 2009, CELL CYCLE, V8, P3729, DOI 10.4161/cc.8.22.10033; Sengupta S, 2009, STEM CELLS, V27, P1524, DOI 10.1002/stem.84; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	21	96	107	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					31	35		10.1016/j.stem.2010.06.011	http://dx.doi.org/10.1016/j.stem.2010.06.011			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621047	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000280222300010
J	Hasegawa, K; Pomeroy, JE; Pera, MF				Hasegawa, Kouichi; Pomeroy, Jordan E.; Pera, Martin F.			Current Technology for the Derivation of Pluripotent Stem Cell Lines from Human Embryos	CELL STEM CELL			English	Review							DEFINED CULTURE-CONDITIONS; FIBROBLAST-GROWTH-FACTOR; IN-VITRO FERTILIZATION; SELF-RENEWAL; HUMAN BLASTOCYSTS; CRYOPRESERVATION METHOD; ROCK INHIBITOR; SERUM-FREE; UNDIFFERENTIATED GROWTH; MAINTAIN PLURIPOTENCY	Technology for the derivation, propagation, and characterization of pluripotent stem cell lines from the human embryo has undergone considerable refinement and improvement since the first published description of human embryonic stem cells in 1998. In particular, there has been extensive effort to optimize protocols and develop defined culture systems with a view toward future clinical applications of embryonic stem cell-derived products. Here, we review the current status of methodology for human embryonic stem cell derivation and culture, and we highlight the challenges that remain for workers in the field.	[Hasegawa, Kouichi; Pomeroy, Jordan E.; Pera, Martin F.] Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90033 USA	University of Southern California	Pera, MF (corresponding author), Univ So Calif, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Keck Sch Med, Los Angeles, CA 90033 USA.	pera@usc.edu	Hasegawa, Kouichi/Y-9349-2019; PERA, MARTIN/A-9812-2012	Hasegawa, Kouichi/0000-0001-5947-5471; PERA, MARTIN/0000-0001-6239-0428; Pomeroy, Jordan/0000-0003-2640-7960				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; AKOPIAN V, 2010, CELL DEV BIOL ANIM, V46, P247; Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Biggers JD, 2008, FERTIL STERIL, V90, P473, DOI 10.1016/j.fertnstert.2008.08.010; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; BONGSO A, 1994, HUM REPROD, V9, P2110, DOI 10.1093/oxfordjournals.humrep.a138401; Bongso A, 2005, STEM CELL REV, V1, P87, DOI 10.1385/SCR:1:2:087; Botros L, 2008, MOL HUM REPROD, V14, P679, DOI 10.1093/molehr/gan066; Braam SR, 2008, STEM CELLS, V26, P2257, DOI 10.1634/stemcells.2008-0291; Catalina P, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-76; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Choudhary M, 2007, STEM CELLS, V25, P3045, DOI 10.1634/stemcells.2007-0296; Chung Y, 2006, NATURE, V439, P216, DOI 10.1038/nature04277; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Cooke MJ, 2006, STEM CELLS DEV, V15, P254, DOI 10.1089/scd.2006.15.254; COOPER S, 1988, DEVELOPMENT, V104, P565; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Crook JM, 2007, CELL STEM CELL, V1, P490, DOI 10.1016/j.stem.2007.10.004; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Damoiseaux R, 2009, STEM CELLS, V27, P533, DOI 10.1634/stemcells.2008-0596; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Ellerstrom C, 2006, STEM CELLS, V24, P2170, DOI 10.1634/stemcells.2006-0130; Ellerstrom C, 2010, METHODS MOL BIOL, V584, P121, DOI 10.1007/978-1-60761-369-5_7; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Escobedo-Lucea C, 2010, METHODS MOL BIOL, V584, P55, DOI 10.1007/978-1-60761-369-5_3; Evseenko D, 2009, STEM CELLS DEV, V18, P919, DOI 10.1089/scd.2008.0293; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fletcher JM, 2006, CLONING STEM CELLS, V8, P319, DOI 10.1089/clo.2006.8.319; Fong WJ, 2005, BIOPROC BIOSYST ENG, V27, P381, DOI 10.1007/s00449-005-0421-5; Forsyth NR, 2006, CLONING STEM CELLS, V8, P16, DOI 10.1089/clo.2006.8.16; Fujioka T, 2004, INT J DEV BIOL, V48, P1149, DOI 10.1387/ijdb.041852tf; Gauthaman K, 2009, BRIT J PHARMACOL, V157, P962, DOI 10.1111/j.1476-5381.2009.00241.x; Geens M, 2009, HUM REPROD, V24, P2709, DOI 10.1093/humrep/dep262; Gerecht S, 2007, P NATL ACAD SCI USA, V104, P11298, DOI 10.1073/pnas.0703723104; Gertow K, 2007, CURR PROTOC STEM CEL; Gonzalez R, 2010, P NATL ACAD SCI USA, V107, P3552, DOI 10.1073/pnas.0914019107; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; Heng BC, 2007, BIOSCIENCE REP, V27, P257, DOI 10.1007/s10540-007-9051-2; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Hunt Charles J, 2007, Methods Mol Biol, V368, P261; Hyun I, 2007, CELL STEM CELL, V1, P367, DOI 10.1016/j.stem.2007.09.006; Ilic D., 2007, CURR PROTOC STEM CEL; Ilic D, 2009, STEM CELLS DEV, V18, P1343, DOI 10.1089/scd.2008.0416; Kattal N, 2008, FERTIL STERIL, V90, P1069, DOI 10.1016/j.fertnstert.2007.07.1349; Katz-Jaffe MG, 2009, MOL HUM REPROD, V15, P271, DOI 10.1093/molehr/gap012; Kim DS, 2010, STEM CELL REV REP, V6, P270, DOI 10.1007/s12015-010-9138-1; Kim HS, 2005, STEM CELLS, V23, P1228, DOI 10.1634/stemcells.2004-0296; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Krawetz R, 2010, TISSUE ENG PART C-ME, V16, P573, DOI [10.1089/ten.tec.2009.0228, 10.1089/ten.TEC.2009.0228]; Kulkeaw K, 2010, STEM CELL REV REP, V6, P381, DOI 10.1007/s12015-010-9150-5; Laurent LC, 2010, NAT METHODS, V7, P6, DOI 10.1038/nmeth0110-06; Lee H, 2009, REGEN MED, V4, P759, DOI [10.2217/rme.09.46, 10.2217/RME.09.46]; Lee JY, 2010, FERTIL STERIL, V93, P976, DOI 10.1016/j.fertnstert.2008.10.017; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Levenstein ME, 2008, STEM CELLS, V26, P3099, DOI 10.1634/stemcells.2007-1056; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Liu YX, 2006, BIOCHEM BIOPH RES CO, V346, P131, DOI 10.1016/j.bbrc.2006.05.086; Loser P, 2010, STEM CELLS, V28, P240, DOI 10.1002/stem.286; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig Tenneille, 2007, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01c02s2; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Manton KJ, 2010, STEM CELLS DEV, V19, P1297, DOI 10.1089/scd.2009.0504; Martin-Ibanez R, 2008, HUM REPROD, V23, P2744, DOI 10.1093/humrep/den316; McCormick JB, 2009, CELL STEM CELL, V4, P107, DOI 10.1016/j.stem.2009.01.002; Meng GL, 2010, STEM CELLS DEV, V19, P547, DOI 10.1089/scd.2009.0303; Meng Y, 2010, FASEB J, V24, P1056, DOI 10.1096/fj.08-126821; Mercader A, 2006, METHOD ENZYMOL, V420, P3, DOI 10.1016/S0076-6879(06)20001-6; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; Miyazaki T, 2008, BIOCHEM BIOPH RES CO, V375, P27, DOI 10.1016/j.bbrc.2008.07.111; Morris GJ, 2006, REPROD BIOMED ONLINE, V13, P421, DOI 10.1016/S1472-6483(10)61448-4; Mosher JT, 2010, NEW ENGL J MED, V362, P183, DOI 10.1056/NEJMc0910371; Muller FJ, 2010, CELL STEM CELL, V6, P412, DOI 10.1016/j.stem.2010.04.009; Narva E, 2010, NAT BIOTECHNOL, V28, P371, DOI 10.1038/nbt.1615; Ng ES, 2005, BLOOD, V106, P1601, DOI 10.1182/blood-2005-03-0987; Nie Y, 2009, BIOTECHNOL PROGR, V25, P20, DOI 10.1002/btpr.110; Oh SKW, 2009, STEM CELL RES, V2, P219, DOI 10.1016/j.scr.2009.02.005; Peiffer I, 2010, METHODS MOL BIOL, V584, P97, DOI 10.1007/978-1-60761-369-5_5; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Phillips BW, 2008, J BIOTECHNOL, V138, P24, DOI 10.1016/j.jbiotec.2008.07.1997; Prokhorova TA, 2009, STEM CELLS DEV, V18, P47, DOI 10.1089/scd.2007.0266; Przyborski SA, 2005, STEM CELLS, V23, P1242, DOI 10.1634/stemcells.2005-0014; Rajala K, 2007, HUM REPROD, V22, P1231, DOI 10.1093/humrep/del523; Reubinoff BE, 2001, HUM REPROD, V16, P2187, DOI 10.1093/humrep/16.10.2187; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Richards M, 2004, STEM CELLS, V22, P779, DOI 10.1634/stemcells.22-5-779; Rowland TJ, 2010, STEM CELLS DEV, V19, P1231, DOI 10.1089/scd.2009.0328; Sathananthan AH, 2010, METHODS MOL BIOL, V584, P1, DOI 10.1007/978-1-60761-369-5_1; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Scott CT, 2009, NAT BIOTECHNOL, V27, P696, DOI 10.1038/nbt0809-696; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Soh BS, 2007, STEM CELLS, V25, P3029, DOI 10.1634/stemcells.2007-0372; SOLTER D, 1975, P NATL ACAD SCI USA, V72, P5099, DOI 10.1073/pnas.72.12.5099; Steiner D, 2010, NAT BIOTECHNOL, V28, P361, DOI 10.1038/nbt.1616; Stojkovic P, 2005, STEM CELLS, V23, P306, DOI 10.1634/stemcells.2004-0137; Strom S, 2007, HUM REPROD, V22, P3051, DOI 10.1093/humrep/dem335; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Swistowski A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006233; Terstegge S, 2007, BIOTECHNOL BIOENG, V96, P195, DOI 10.1002/bit.21061; Terstegge S, 2009, J BIOTECHNOL, V143, P224, DOI 10.1016/j.jbiotec.2009.07.002; Thomas RJ, 2009, BIOTECHNOL BIOENG, V102, P1636, DOI 10.1002/bit.22187; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Turetsky T, 2008, HUM REPROD, V23, P46, DOI 10.1093/humrep/dem351; Unger C, 2008, HUM MOL GENET, V17, pR48, DOI 10.1093/hmg/ddn079; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wagner KE, 2010, METHODS MOL BIOL, V584, P109, DOI 10.1007/978-1-60761-369-5_6; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Ware Carol B., 2007, V407, P43, DOI 10.1007/978-1-59745-536-7_4; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Werbowetski-Ogilvie TE, 2009, NAT BIOTECHNOL, V27, P91, DOI 10.1038/nbt.1516; Wong RCB, 2007, STEM CELLS DEV, V16, P989, DOI 10.1089/scd.2007.0057; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Xu Y, 2010, P NATL ACAD SCI USA, V107, P8129, DOI 10.1073/pnas.1002024107; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu PB, 2008, NAT MED, V14, P1363, DOI 10.1038/nm.1888	133	25	25	2	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					521	531		10.1016/j.stem.2010.05.010	http://dx.doi.org/10.1016/j.stem.2010.05.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569689	Bronze			2022-12-28	WOS:000278840700012
J	Tang, FC; Barbacioru, C; Bao, SQ; Lee, C; Nordman, E; Wang, XH; Lao, KQ; Surani, MA				Tang, Fuchou; Barbacioru, Catalin; Bao, Siqin; Lee, Caroline; Nordman, Ellen; Wang, Xiaohui; Lao, Kaiqin; Surani, M. Azim			Tracing the Derivation of Embryonic Stem Cells from the Inner Cell Mass by Single-Cell RNA-Seq Analysis	CELL STEM CELL			English	Article							SELF-RENEWAL; PLURIPOTENCY; DIFFERENTIATION; NANOG; EXPRESSION; GENES; DICER; ESTABLISHMENT; DOWNSTREAM; COMPONENT	During the transition from the inner cell mass (ICM) cells of blastocysts to pluripotent embryonic stem cells (ESCs) in vitro, a normal developmental program is replaced in cells that acquire a capacity for infinite self-renewal and pluripotency. We explored the underlying mechanism of this switch by using RNA-Seq transcriptome analysis at the resolution of single cells. We detected significant molecular transitions and major changes in transcript variants, which include genes for general metabolism. Furthermore, the expression of repressive epigenetic regulators increased with a concomitant decrease in gene activators that might be necessary to sustain the inherent plasticity of ESCs. Furthermore, we detected changes in microRNAs (miRNAs), with one set that targets early differentiation genes while another set targets pluripotency genes to maintain the unique ESC epigenotype. Such genetic and epigenetic events may contribute to a switch from a normal developmental program in adult cells during the formation of diseased tissues, including cancers.	[Barbacioru, Catalin; Nordman, Ellen; Wang, Xiaohui; Lao, Kaiqin] Appl Biosyst Inc, Genet Syst, Foster City, CA 94404 USA; [Tang, Fuchou; Bao, Siqin; Lee, Caroline; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst Canc & Dev, Cambridge CB2 1QN, England	Thermo Fisher Scientific; Applied Biosystems; University of Cambridge	Lao, KQ (corresponding author), Appl Biosyst Inc, Genet Syst, 850 Lincoln Ctr Dr, Foster City, CA 94404 USA.	kai.lao@lifetech.com; a.surani@gurdon.cam.ac.uk		Surani, Azim/0000-0002-8640-4318	Wellcome Trust; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank J. Bodeau, E. Dimalanta, S. Dadi, E. Langit, P. Brzoska, J. Au-Young, and J. Sherlock for performing sequencing runs, design, and preparation of real-time PCR assays. We would also like to thank K. Hayashi, S. Jeffery, and W. Mifsud for insightful discussions. The work was supported by a grant from the Wellcome Trust to M.A.S.	Aksoy I, 2007, STEM CELLS, V25, P2996, DOI 10.1634/stemcells.2007-0066; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen M, 2009, NAT REV MOL CELL BIO, V10, P741, DOI 10.1038/nrm2777; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson BV, 2006, CURR OPIN GENET DEV, V16, P447, DOI 10.1016/j.gde.2006.08.012; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ogawa K, 2007, J CELL SCI, V120, P55, DOI 10.1242/jcs.03296; Ralston A, 2008, DEV BIOL, V313, P614, DOI 10.1016/j.ydbio.2007.10.054; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Smith A, 2006, NATURE, V441, P1060, DOI 10.1038/nature04954; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang FC, 2006, NAT PROTOC, V1, P1154, DOI 10.1038/nprot.2006.161; Tang FC, 2010, NAT PROTOC, V5, P516, DOI 10.1038/nprot.2009.236; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Tsuneyoshi N, 2008, BIOCHEM BIOPH RES CO, V367, P899, DOI 10.1016/j.bbrc.2007.12.189; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	53	376	391	2	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					468	478		10.1016/j.stem.2010.03.015	http://dx.doi.org/10.1016/j.stem.2010.03.015			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452321	Green Published, hybrid			2022-12-28	WOS:000277844800014
J	Li, PL; Zon, LI				Li, Pulin; Zon, Leonard I.			Resolving the controversy about N-cadherin and hematopoietic stem cells	CELL STEM CELL			English	Editorial Material							NICHE; ADHESION; EXPRESSION; DEPEND		[Li, Pulin; Zon, Leonard I.] Howard Hughes Med Inst, Stem Cell Program, Hematol Oncol, Childrens Hosp,Harvard Med Sch, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Zon, LI (corresponding author), Howard Hughes Med Inst, Stem Cell Program, Hematol Oncol, Childrens Hosp,Harvard Med Sch, Boston, MA 02115 USA.			Li, Pulin/0000-0002-8525-4936	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hosokawa K, 2007, BIOCHEM BIOPH RES CO, V363, P578, DOI 10.1016/j.bbrc.2007.09.014; Hosokawa K, 2010, CELL STEM CELL, V6, P194, DOI 10.1016/j.stem.2009.04.013; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	15	39	39	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					199	202		10.1016/j.stem.2010.02.007	http://dx.doi.org/10.1016/j.stem.2010.02.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207222	Bronze			2022-12-28	WOS:000276254600015
J	Nishimura, EK; Suzuki, M; Igras, V; Du, JY; Lonning, S; Miyachi, Y; Roes, J; Beermann, F; Fisher, DE				Nishimura, Emi K.; Suzuki, Misa; Igras, Vivien; Du, Jinyan; Lonning, Scott; Miyachi, Yoshiki; Roes, Juergen; Beermann, Friedrich; Fisher, David E.			Key Roles for Transforming Growth Factor beta in Melanocyte Stem Cell Maintenance	CELL STEM CELL			English	Article							TGF-BETA; IN-VIVO; DOPACHROME TAUTOMERASE; MASTER REGULATOR; SELF-RENEWAL; HAIR CYCLE; NICHE; SKIN; DIFFERENTIATION; ACTIVATION	Melanocyte stem cells in the bulge area of hair follicles are responsible for hair pigmentation, and defects in them cause hair graying. Here we describe the process of melanocyte stem cell entry into the quiescent state and show that niche-derived transforming growth factor beta (TGF-beta) signaling plays important roles in this process. In vitro, TGF-beta not only induces reversible cell cycle arrest, but also promotes melanocyte immaturity by clownregulating MITF, the master transcriptional regulator of melanocyte differentiation, and its downstream melanogenic genes. In vivo, TGF-beta signaling is activated in melanocyte stem cells when they reenter the quiescent noncycling state during the hair cycle and this process requires Bcl2 for cell survival. Furthermore, targeted TGF-beta type II receptor (TGFbRII) deficiency in the melanocyte lineage causes incomplete maintenance of melanocyte stem cell immaturity and results in mild hair graying. These data demonstrate that the TGF-beta signaling pathway is one of the key niche factors that regulate melanocyte stem cell immaturity and quiescence.	[Nishimura, Emi K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan; [Nishimura, Emi K.; Suzuki, Misa] Kanazawa Univ, Div Stem Cell Med, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Igras, Vivien; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Dermatol, Boston, MA 02114 USA; [Igras, Vivien; Fisher, David E.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Melanoma Program Med Oncol, Boston, MA 02114 USA; [Du, Jinyan] Broad Inst Biomed Res, Boston, MA 02115 USA; [Du, Jinyan] Dana Farber Canc Inst, Boston, MA 02115 USA; [Lonning, Scott] Genzyme Corp, Cambridge, MA 01701 USA; [Miyachi, Yoshiki] Kyoto Univ, Grad Sch Med, Dept Dermatol, Sakyo Ku, Kyoto 6068507, Japan; [Roes, Juergen] UCL, Windeyer Inst Med Sci, Dept Med, London W1P 6DB, England; [Beermann, Friedrich] Ecole Polytech Fed Lausanne, Sch Life Sci, Swiss Inst Expt Canc Res ISREC, CH-1015 Lausanne, Switzerland	Tokyo Medical & Dental University (TMDU); Kanazawa University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Dana-Farber Cancer Institute; Sanofi-Aventis; Genzyme Corporation; Kyoto University; University of London; University College London; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research	Nishimura, EK (corresponding author), Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Chiyoda Ku, 2-3-10 Kandasurugadai, Tokyo 1010062, Japan.	nishscm@tmd.ac.jp		Roes, Jurgen/0000-0003-3235-2345	Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; NIH; Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR043369] Funding Source: NIH RePORTER	Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Melanoma Research Alliance; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Tetsuo Watabe, Dr. Kohei Miyazono, Dr. Elaine Fuchs, Dr. Vincent Hearing, and Dr. Elizabeth Hearing for antibodies, Dr. Ian Jackson for the Dct-LacZ transgenic mice, and Dr. Hans Widlund for discussion. The research was funded by grants from the Uehara Memorial Foundation, the Kato Memorial Bioscience Foundation (to E.K.N.), and grants from the NIH and the Melanoma Research Alliance (to D.E.F., who is also a Distinguished Clinical Scholar of the Doris Duke Medical Foundation).	Batard P, 2000, J CELL SCI, V113, P383; Boyer R.F, 1993, MODERN EXPT BIOCH; Bruckheimer EM, 2002, PROSTATE, V53, P133, DOI 10.1002/pros.10143; Busca R, 2000, PIGM CELL RES, V13, P60, DOI 10.1034/j.1600-0749.2000.130203.x; Cazac BB, 2000, IMMUNITY, V13, P443, DOI 10.1016/S1074-7613(00)00044-3; Chin L, 2006, GENE DEV, V20, P2149, DOI 10.1101/gad.1437206; Chu W, 2000, ONCOGENE, V19, P395, DOI 10.1038/sj.onc.1203315; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; DASCH JR, 1989, J IMMUNOL, V142, P1536; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Delmas V, 2003, GENESIS, V36, P73, DOI 10.1002/gene.10197; Falk S, 2008, CELL STEM CELL, V2, P472, DOI 10.1016/j.stem.2008.03.006; Foitzik K, 2000, FASEB J, V14, P752, DOI 10.1096/fasebj.14.5.752; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Guyonneau L, 2004, MOL CELL BIOL, V24, P3396, DOI 10.1128/MCB.24.8.3396-3403.2004; Huang YL, 1998, J BIOMED SCI, V5, P185; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Karlsson G, 2007, J EXP MED, V204, P467, DOI 10.1084/jem.20060465; Kim DS, 2004, INT J BIOCHEM CELL B, V36, P1482, DOI 10.1016/j.biocel.2003.10.023; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Levy C, 2006, TRENDS MOL MED, V12, P406, DOI 10.1016/j.molmed.2006.07.008; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Ling H, 2003, J AM SOC NEPHROL, V14, P377, DOI 10.1097/01.ASN.0000042168.43665.9B; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Michard Q, 2008, FREE RADICAL BIO MED, V44, P1023, DOI 10.1016/j.freeradbiomed.2007.11.021; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishioka E, 1999, MELANOMA RES, V9, P433, DOI 10.1097/00008390-199910000-00002; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Salm SN, 2005, J CELL BIOL, V170, P81, DOI 10.1083/jcb.200412015; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Siegel PM, 2003, NAT REV CANCER, V3, P807, DOI 10.1038/nrc1208; Soma T, 2003, J INVEST DERMATOL, V121, P969, DOI 10.1046/j.1523-1747.2003.12516.x; Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Suzuki I, 1997, J INVEST DERMATOL, V108, P838, DOI 10.1111/1523-1747.ep12292572; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vance KW, 2004, PIGM CELL RES, V17, P318, DOI 10.1111/j.1600-0749.2004.00164.x; VANTVEER LJ, 1989, MOL CELL BIOL, V9, P3114, DOI 10.1128/MCB.9.7.3114; Watabe T, 2009, CELL RES, V19, P103, DOI 10.1038/cr.2008.323; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427; Yamazaki S, 2007, ANN NY ACAD SCI, V1106, P54, DOI 10.1196/annals.1392.017; YANG L, 2005, CANCER RES, V1, P8671; Yang LL, 2009, MOL BIOL CELL, V20, P882, DOI 10.1091/mbc.E08-07-0731	53	159	175	0	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					130	140		10.1016/j.stem.2009.12.010	http://dx.doi.org/10.1016/j.stem.2009.12.010			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144786	Green Accepted, Bronze			2022-12-28	WOS:000274520800008
J	Brack, A				Brack, Andrew			Adult Muscle Stem Cells Avoid Death and Paxes	CELL STEM CELL			English	Editorial Material							POPULATION; RENEWAL	In a recent Nature publication, Lepper et al. (2009) use cell-specific lineage tracing and temporally controllable gene deletion approaches to study muscle stem cell function and reveal age-dependent requirements for Pax gene expression.	Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Brack, A (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St,MGH Charles River Plaza N,Room 4, Boston, MA 02114 USA.	brack.andrew@mgh.harvard.edu						Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Kassar-Duchossoy L, 2005, GENE DEV, V19, P1426, DOI 10.1101/gad.345505; LEPPER C, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08209; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					132	134		10.1016/j.stem.2009.07.005	http://dx.doi.org/10.1016/j.stem.2009.07.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664985	Bronze			2022-12-28	WOS:000269511900005
J	Singh, AM; Dalton, S				Singh, Amar M.; Dalton, Stephen			The Cell Cycle and Myc Intersect with Mechanisms that Regulate Pluripotency and Reprogramming	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; SELF-RENEWAL; C-MYC; N-MYC; GENE-EXPRESSION; G(1) CONTROL; MOUSE; DIFFERENTIATION; GROWTH; PROGRESSION	Pluripotent stem cells have long-term proliferative capacity and an unusual mode of cell-cycle regulation and can divide independently of extrinsic mitogenic signals. The last few years has seen evidence emerge that links cell-cycle regulation to the maintenance and establishment of pluripotency. Myc transcription factors appear to be central to this regulation. This review addresses these links and discusses how cell-cycle controls and Myc impact on the maintenance and establishment of pluripotency.	[Singh, Amar M.; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Dalton, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, 500 DW Brooks Dr, Athens, GA 30602 USA.	sdalton@uga.edu		Dalton, Stephen/0000-0002-3450-1263	National Institute of Child Health and Human Development [HD049647]; National Institute for General Medical Sciences [GM75334]; Juvenile Diabetes Research Foundation (JDRF); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to S.D. from the National Institute of Child Health and Human Development (HD049647), the National Institute for General Medical Sciences (GM75334), and the Juvenile Diabetes Research Foundation (JDRF). We thank members of the Dalton laboratory, past and present, for many insightful discussions over the years.	Alvarez B, 2003, J BIOL CHEM, V278, P26466, DOI 10.1074/jbc.M300663200; Amati Bruno, 1998, Frontiers in Bioscience, V3, pD250; Baserga R, 2007, CELL CYCLE, V6, P814, DOI 10.4161/cc.6.7.4049; Becker KA, 2006, J CELL PHYSIOL, V209, P883, DOI 10.1002/jcp.20776; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Brimble SN, 2004, STEM CELLS DEV, V13, P585, DOI 10.1089/scd.2004.13.585; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Dalton Stephen, 2009, P3, DOI 10.1007/978-1-60327-227-8_1; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Edgar BA, 1996, SCIENCE, V274, P1646, DOI 10.1126/science.274.5293.1646; Egli D, 2008, NAT REV MOL CELL BIO, V9, P505, DOI 10.1038/nrm2439; Faast R, 2004, ONCOGENE, V23, P491, DOI 10.1038/sj.onc.1207133; Fernandez PC, 2003, GENE DEV, V17, P1115, DOI 10.1101/gad.1067003; Filipczyk AA, 2007, STEM CELL RES, V1, P45, DOI 10.1016/j.scr.2007.09.002; Fingar DC, 2004, MOL CELL BIOL, V24, P200, DOI 10.1128/MCB.24.1.200-216.2004; Fluckiger AC, 2006, STEM CELLS, V24, P547, DOI 10.1634/stemcells.2005-0194; Ghule PN, 2007, J CELL PHYSIOL, V213, P9, DOI 10.1002/jcp.21119; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Han DW, 2008, STEM CELLS, V26, P445, DOI 10.1634/stemcells.2007-0553; Hanna J, 2009, CELL STEM CELL, V5, P124, DOI 10.1016/j.stem.2009.06.007; Herrera RE, 1996, P NATL ACAD SCI USA, V93, P11510, DOI 10.1073/pnas.93.21.11510; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; JONK LJC, 1992, MECH DEVELOP, V36, P165, DOI 10.1016/0925-4773(92)90067-T; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kameda T, 2005, STEM CELLS, V23, P1535, DOI 10.1634/stemcells.2005-0054; Kenney AM, 2004, DEVELOPMENT, V131, P217, DOI 10.1242/dev.00891; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; LAWSON KA, 1991, DEVELOPMENT, V113, P891; Lee NS, 2008, BIOCHEM BIOPH RES CO, V377, P434, DOI 10.1016/j.bbrc.2008.09.159; Macaluso M, 2006, ONCOGENE, V25, P5263, DOI 10.1038/sj.onc.1209680; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Malynn BA, 2000, GENE DEV, V14, P1390; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitalipova MM, 2005, NAT BIOTECHNOL, V23, P19, DOI 10.1038/nbt0105-19; MUMMERY CL, 1987, CELL DIFFER DEV, V20, P153, DOI 10.1016/0045-6039(87)90429-5; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; Neganova I, 2009, ONCOGENE, V28, P20, DOI 10.1038/onc.2008.358; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; Okubo T, 2005, DEVELOPMENT, V132, P1363, DOI 10.1242/dev.01678; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; PARDEE AB, 1974, P NATL ACAD SCI USA, V71, P1286, DOI 10.1073/pnas.71.4.1286; Ryan KM, 1996, BIOCHEM J, V314, P713, DOI 10.1042/bj3140713; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Satoh Y, 2004, J BIOL CHEM, V279, P24986, DOI 10.1074/jbc.M400407200; Saucedo LJ, 2002, CURR OPIN GENET DEV, V12, P565, DOI 10.1016/S0959-437X(02)00341-6; Savatier P, 1996, ONCOGENE, V12, P309; SAVATIER P, 1994, ONCOGENE, V9, P809; Schratt G, 2001, MOL CELL BIOL, V21, P2933, DOI 10.1128/MCB.21.8.2933-2943.2001; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Sun H, 1999, P NATL ACAD SCI USA, V96, P6199, DOI 10.1073/pnas.96.11.6199; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Watt FM, 2008, NAT REV CANCER, V8, P234, DOI 10.1038/nrc2328; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yarden A, 1996, DEV DYNAM, V206, P1; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zhang X, 2009, J CELL BIOL, V184, P67, DOI 10.1083/jcb.200801009; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zindy F, 1997, ONCOGENE, V15, P203, DOI 10.1038/sj.onc.1201178; Zwaka TP, 2005, STEM CELLS, V23, P146, DOI 10.1634/stemcells.2004-0248	84	204	212	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					141	149		10.1016/j.stem.2009.07.003	http://dx.doi.org/10.1016/j.stem.2009.07.003			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664987	Green Accepted, Bronze			2022-12-28	WOS:000269511900008
J	Schindler, JW; Van Buren, D; Foudi, A; Krejci, O; Qin, JZ; Orkin, SH; Hock, H				Schindler, Jeffrey W.; Van Buren, Denille; Foudi, Adlen; Krejci, Ondrej; Qin, Jinzhong; Orkin, Stuart H.; Hock, Hanno			TEL-AML1 Corrupts Hematopoietic Stem Cells to Persist in the Bone Marrow and Initiate Leukemia	CELL STEM CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T(12/21) TRANSLOCATION; ADULT HEMATOPOIESIS; FUSION GENE; MICE; DIFFERENTIATION; TRANSFORMATION; TEL/AML1; RUNX1; FETAL	The initial steps in the pathogenesis of acute leukemia remain incompletely understood. The TEL-AML1 gene fusion, the hallmark translocation in Childhood Acute Lymphoblastic Leukemia and the first hit, occurs years before the clinical disease, most often in utero. We have generated mice in which TEL-AML1 expression is driven from the endogenous promoter and can be targeted to specific populations. TEL-AML1 renders mice prone to malignancy after chemical mutagenesis when expressed in hematopoietic stem cells (HSCs), but not in early lymphoid progenitors. We reveal that TEL-AML1 markedly increases the number of HSCs and predominantly maintains them in the quiescent (Go) stage of the cell cycle. TEL-AML1(+) HSCs retain self-renewal properties and contribute to hematopoiesis, but fail to out-compete normal HSCs. Our work shows that stem cells are susceptible to subversion by weak oncogenes that can subtly alter their molecular program to provide a latent reservoir for the accumulation of further mutations.	[Schindler, Jeffrey W.; Van Buren, Denille; Foudi, Adlen; Krejci, Ondrej; Qin, Jinzhong; Hock, Hanno] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Schindler, Jeffrey W.; Van Buren, Denille; Foudi, Adlen; Krejci, Ondrej; Qin, Jinzhong; Hock, Hanno] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Orkin, Stuart H.; Hock, Hanno] Harvard Stem Cell Inst, Boston, MA 02111 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02111 USA; [Orkin, Stuart H.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02111 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02111 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute	Hock, H (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	hock.hanno@mgh.harvard.edu	Foudi, Adlen/L-7251-2018	Foudi, Adlen/0000-0001-5002-5490	NCI NIH HHS [P01 CA68486] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Andreasson P, 2001, CANCER GENET CYTOGEN, V130, P93, DOI 10.1016/S0165-4608(01)00518-0; Bernardin F, 2002, CANCER RES, V62, P3904; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Castilla LH, 1996, CELL, V87, P687, DOI 10.1016/S0092-8674(00)81388-4; Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chen W, 2008, CANCER CELL, V13, P432, DOI 10.1016/j.ccr.2008.03.005; Cox CV, 2004, BLOOD, V104, P2919, DOI 10.1182/blood-2004-03-0901; Eguchi-Ishimae M, 2001, BLOOD, V97, P737, DOI 10.1182/blood.V97.3.737; Fischer M, 2005, ONCOGENE, V24, P7579, DOI 10.1038/sj.onc.1208931; Ford AM, 1998, P NATL ACAD SCI USA, V95, P4584, DOI 10.1073/pnas.95.8.4584; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Greaves Mel, 2003, Rev Clin Exp Hematol, V7, P233; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Gunji H, 2004, BIOCHEM BIOPH RES CO, V322, P623, DOI 10.1016/j.bbrc.2004.07.169; Hiebert SW, 1996, MOL CELL BIOL, V16, P1349; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hock H, 2003, IMMUNITY, V18, P109, DOI 10.1016/S1074-7613(02)00501-0; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Hotfilder M, 2002, BLOOD, V100, P640, DOI 10.1182/blood.V100.2.640; Ichikawa M, 2004, NAT MED, V10, P299, DOI 10.1038/nm997; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kundu M, 2005, BLOOD, V106, P3621, DOI 10.1182/blood-2005-04-1447; Mori H, 2002, P NATL ACAD SCI USA, V99, P8242, DOI 10.1073/pnas.112218799; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Morrow M, 2004, BLOOD, V103, P3890, DOI 10.1182/blood-2003-10-3695; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Olsen M, 2006, J PEDIAT HEMATOL ONC, V28, P734, DOI 10.1097/01.mph.0000243652.33561.0f; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Panzer-Grumayer ER, 2005, CLIN CANCER RES, V11, P7720, DOI 10.1158/1078-0432.CCR-05-1239; Pine SR, 2003, LEUKEMIA RES, V27, P155, DOI 10.1016/S0145-2126(02)00183-2; Pui CH, 2008, LANCET, V371, P1030, DOI 10.1016/S0140-6736(08)60457-2; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sabaawy HE, 2006, P NATL ACAD SCI USA, V103, P15166, DOI 10.1073/pnas.0603349103; Song WJ, 1999, NAT GENET, V23, P166, DOI 10.1038/13793; Speck NA, 2002, NAT REV CANCER, V2, P502, DOI 10.1038/nrc840; Tsai AG, 2008, CELL, V135, P1130, DOI 10.1016/j.cell.2008.10.035; Tsuzuki S, 2004, P NATL ACAD SCI USA, V101, P8443, DOI 10.1073/pnas.0402063101; Wang LC, 1997, EMBO J, V16, P4374, DOI 10.1093/emboj/16.14.4374; Weston VJ, 2001, CANCER RES, V61, P8547; Yergeau DA, 1997, NAT GENET, V15, P303, DOI 10.1038/ng0397-303	43	77	78	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					43	53		10.1016/j.stem.2009.04.019	http://dx.doi.org/10.1016/j.stem.2009.04.019			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570513	Bronze			2022-12-28	WOS:000267879200009
J	Taylor, PL				Taylor, Patrick L.			Retroactive Ethics in Rapidly Developing Scientific Fields	CELL STEM CELL			English	Editorial Material							STEM-CELL LINES	Science often progresses faster than regulation, and retroactive ethically linked rules have been a persistent issue in stem cell research. Proposed NIH funding rules are retroactive. Legal history and ethical analysis show why there should be a strong presumption that such new rules should be only prospective, in any area of scientific research.	[Taylor, Patrick L.] Childrens Hosp, Off Gen Counsel, Boston, MA 02115 USA; [Taylor, Patrick L.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Taylor, PL (corresponding author), Childrens Hosp, Off Gen Counsel, 300 Longwood Ave, Boston, MA 02115 USA.	patrick.taylor@childrens.harvard.edu						Aalto-Setala K, 2009, PLOS BIOL, V7, P204, DOI 10.1371/journal.pbio.1000042; BAKER M, 2008, NATURE NEWS, DOI DOI 10.1038/454556A; EMANUEL EJ, 2005, PROTECTING COMMUNITI; Fuller Lon L., 1969, STORRS LECT SERIES; *HUM EMBR STEM CEL, 2006, GUID HUM EMBR STEM C; Lo B, 2004, FERTIL STERIL, V82, P559, DOI 10.1016/j.fertnstert.2004.01.040; Lo B, 2009, CELL STEM CELL, V4, P115, DOI 10.1016/j.stem.2009.01.013; Marchant GE, 2009, SCI ENG ETHICS, V15, P375, DOI 10.1007/s11948-009-9130-9; *NAT RES COUNC COM, 2005, GUID HUM EMBR STEM C; Rugg-Gunn PJ, 2009, CELL STEM CELL, V4, P285, DOI 10.1016/j.stem.2009.03.004; Sugarman J, 2008, CELL STEM CELL, V3, P238, DOI 10.1016/j.stem.2008.08.012; Taylor PL, 2007, NATURE, V450, P163, DOI 10.1038/450163a	12	5	5	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					479	482		10.1016/j.stem.2009.05.002	http://dx.doi.org/10.1016/j.stem.2009.05.002			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19446517	Bronze			2022-12-28	WOS:000266793600007
J	Jensen, KB; Collins, CA; Nascimento, E; Tan, DW; Frye, M; Itami, S; Watt, FM				Jensen, Kim B.; Collins, Charlotte A.; Nascimento, Elisabete; Tan, David W.; Frye, Michaela; Itami, Satoshi; Watt, Fiona M.			Lrig1 Expression Defines a Distinct Multipotent Stem Cell Population in Mammalian Epidermis	CELL STEM CELL			English	Article							HAIR FOLLICLE BULGE; LABEL-RETAINING CELLS; BETA-CATENIN; C-MYC; MOUSE EPIDERMIS; PROGENITOR-CELL; SEBACEOUS GLAND; ADULT EPIDERMIS; SKIN; SURFACE	Lrig1 is a marker of human interfollicular epidermal stem cells and helps maintain stem cell quiescence. We show that, in mouse epidermis, Lrig1 defines the hair follicle junctional zone adjacent to the sebaceous glands and infundibulum. Lrig1 is a Myc target gene; loss of Lrig1 increases the proliferative capacity of stem cells in culture and results in epidermal hyper-proliferation in vivo. Lrig1-expressing cells can give rise to all of the adult epidermal lineages in skin reconstitution assays. However, during homeostasis and on retinoic acid stimulation, they are bipotent, contributing to the sebaceous gland and interfollicular epidermis. beta-catenin activation increases the size of the junctional zone compartment, and loss of Lrig1 causes a selective increase in beta-catenin-induced ectopic hair follicle formation in the interfollicular epidermis. Our results suggest that Lrig1-positive cells constitute a previously unidentified reservoir of adult mouse interfollicular epidermal stem cells.	[Jensen, Kim B.; Collins, Charlotte A.; Tan, David W.; Watt, Fiona M.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Lab Epidermal Stem Cell Biol, Cambridge CB2 1QR, England; [Nascimento, Elisabete; Frye, Michaela] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Lab Epithelial Stem Cell Homeostasis & Canc, Cambridge CB2 1QR, England; [Itami, Satoshi] Osaka Univ, Grad Sch Med, Dept Regenerat Dermatol, Suita, Osaka 5650871, Japan; [Watt, Fiona M.] Li Ka Shing Ctr, Canc Res UK Cambridge Res Inst, Epithelial Cell Biol Lab, Cambridge CB2 0RE, England	University of Cambridge; University of Cambridge; Osaka University; Cancer Research UK; CRUK Cambridge Institute	Watt, FM (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Lab Epidermal Stem Cell Biol, Cambridge CB2 1QR, England.	fiona.watt@cancer.org.uk	Jensen, Kim/F-5333-2014; Watt, Fiona/AHB-0226-2022	Watt, Fiona/0000-0001-9151-5154; Collins, Charlotte/0000-0002-8715-9035; Jensen, Kim/0000-0001-6569-1664; Frye, Michaela/0000-0002-5636-6840	Cancer Research UK; Medical Research Council; Wellcome Trust; EuroStemCell; University of Cambridge and Hutchison Whampoa Ltd.; A STAR, Singapore; MRC [G0300723, G0801904, G0800784] Funding Source: UKRI; Medical Research Council [G0800784, G0801904, G0800784B, G0300723] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); EuroStemCell(European Commission); University of Cambridge and Hutchison Whampoa Ltd.; A STAR, Singapore(Agency for Science Technology & Research (A*STAR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Angela Mowbray, Peter Humphreys, Rachael Walker, and Margaret MacLeish for expert technical assistance. We are grateful to Duncan Odom, David Owens, David Doupe, Phil Jones, Ryan Driskell, Adam Giangreco, Hironobu Fujiwara, Esther Arwert, and the entire Watt lab for suggestions and advice. This work was supported by Cancer Research UK, the Medical Research Council, the Wellcome Trust, and EuroStemCell. We are also grateful for support from the University of Cambridge and Hutchison Whampoa Ltd. K.B.J. is a Carlsberg Fellow. C.A.C. is a Herchel Smith postdoctoral fellow and the recipient of an Evans-Freke Next Generation Junior Research Fellowship. D.W.T. is supported by A STAR, Singapore.	Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Bleul CC, 2006, NATURE, V441, P992, DOI 10.1038/nature04850; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Chuong CM, 2007, NATURE, V447, P265, DOI 10.1038/447265a; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Collins CA, 2008, DEV BIOL, V324, P55, DOI 10.1016/j.ydbio.2008.08.034; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Estrach S, 2006, DEVELOPMENT, V133, P4427, DOI 10.1242/dev.02644; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gambardella L, 2003, CURR OPIN CELL BIOL, V15, P771, DOI 10.1016/j.ceb.2003.10.011; Gu LH, 2007, J INVEST DERMATOL, V127, P1061, DOI 10.1038/sj.jid.5700673; Gur G, 2004, EMBO J, V23, P3270, DOI 10.1038/sj.emboj.7600342; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu SY, 2000, MOL ENDOCRINOL, V14, P1257, DOI 10.1210/me.14.8.1257; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2006, P NATL ACAD SCI USA, V103, P11958, DOI 10.1073/pnas.0601886103; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Laederich MB, 2004, J BIOL CHEM, V279, P47050, DOI 10.1074/jbc.M409703200; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lo Celso C, 2008, STEM CELLS, V26, P1241, DOI 10.1634/stemcells.2007-0651; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Lyle S, 1998, J CELL SCI, V111, P3179; Majo F, 2008, NATURE, V456, P250, DOI 10.1038/nature07406; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Silva-Vargas V, 2005, DEV CELL, V9, P121, DOI 10.1016/j.devcel.2005.04.013; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Suzuki Y, 2002, FEBS LETT, V521, P67, DOI 10.1016/S0014-5793(02)02824-7; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; WALZER C, 1989, J INVEST DERMATOL, V92, P78, DOI 10.1111/1523-1747.ep13071253; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Watt FM, 2000, SCIENCE, V287, P1427, DOI 10.1126/science.287.5457.1427	47	376	386	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					427	439		10.1016/j.stem.2009.04.014	http://dx.doi.org/10.1016/j.stem.2009.04.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427292	Green Published, hybrid			2022-12-28	WOS:000266071100011
J	Biteau, B; Hochmuth, CE; Jasper, H				Biteau, Benoit; Hochmuth, Christine E.; Jasper, Heinrich			JNK Activity in Somatic Stem Cells Causes Loss of Tissue Homeostasis in the Aging Drosophila Gut	CELL STEM CELL			English	Article							EXTENDS LIFE-SPAN; OXIDATIVE STRESS; SELF-RENEWAL; CANCER; AGE; MIDGUT; KINASE; JUN; ENCODES; PATHWAY	Metazoans employ cytoprotective and regenerative strategies to maintain tissue homeostasis. Understanding the coordination of these strategies is critical to developing accurate models for aging and associated diseases. Here we show that cytoprotective Jun N-terminal kinase (JNK) signaling influences regeneration in the Drosophila gut by directing proliferation of intestinal stem cells (ISCs). Interestingly, this function of JNK contributes to the loss of tissue homeostasis in old and stressed intestines by promoting the accumulation of misdifferentiated ISC daughter cells. Ectopic Delta/Notch signaling in these cells causes their abnormal differentiation but also limits JNK-induced proliferation. Protective JNK signaling and control of cell proliferation and differentiation by Delta/Notch signaling thus have to be carefully balanced to ensure tissue homeostasis. Our findings suggest that this balance is lost in old animals, increasing the potential for neoplastic transformation.	[Biteau, Benoit; Hochmuth, Christine E.; Jasper, Heinrich] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	University of Rochester	Jasper, H (corresponding author), Univ Rochester, Dept Biol, River Campus Box 270211, Rochester, NY 14627 USA.	henri_jasper@urmc.rochester.edu			National Institute on Aging [RO1 AG028127]; French Cancer Research Association; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024577] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); French Cancer Research Association(Fondation ARC pour la Recherche sur le Cancer); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dirk Bohmann and Julie Hull-Thompson for comments and Karen Bentley at the University of Rochester Medical Center Electron Microscopy Core Facility for technical assistance. This work was funded in part by the National Institute on Aging (RO1 AG028127) and the French Cancer Research Association (fellowship to B.B.).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beckman KB, 1998, PHYSIOL REV, V78, P547, DOI 10.1152/physrev.1998.78.2.547; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Finkel T, 2000, NATURE, V408, P239, DOI 10.1038/35041687; Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; Jasper H, 2001, DEV CELL, V1, P579, DOI 10.1016/S1534-5807(01)00045-4; Kennedy NJ, 2003, CELL CYCLE, V2, P199, DOI 10.4161/cc.2.3.388; Kockel L, 2001, ONCOGENE, V20, P2347, DOI 10.1038/sj.onc.1204300; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Manning AM, 2003, NAT REV DRUG DISCOV, V2, P554, DOI 10.1038/nrd1132; Martin K, 1998, J CELL SCI, V111, P2297; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Micchelli CA, 2002, FASEB J, V16, P79, DOI 10.1096/fj.02-0394fje; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rando TA, 2006, NATURE, V441, P1080, DOI 10.1038/nature04958; RiesgoEscovar JR, 1996, GENE DEV, V10, P2759, DOI 10.1101/gad.10.21.2759; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Spradling AC, 1999, GENETICS, V153, P135; Stadtman ER, 2001, ANN NY ACAD SCI, V928, P22; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Weber U, 2000, DEVELOPMENT, V127, P3619; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Whitmarsh AJ, 2007, ONCOGENE, V26, P3172, DOI 10.1038/sj.onc.1210410; Wong MD, 2005, ANNU REV GENET, V39, P173, DOI 10.1146/annurev.genet.39.073003.105855; Yagi Y, 1997, GENES CELLS, V2, P41, DOI 10.1046/j.1365-2443.1997.d01-282.x	46	384	393	3	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					442	455		10.1016/j.stem.2008.07.024	http://dx.doi.org/10.1016/j.stem.2008.07.024			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940735	Bronze, Green Accepted			2022-12-28	WOS:000260149800014
J	Caplan, AI				Caplan, Arnold I.			All MSCs are pericytes?	CELL STEM CELL			English	Editorial Material							MESENCHYMAL STEM-CELLS	In this issue of Cell Stem Cell, Crisan et al. (2008) document a subpopulation of human perivascular cells that express both pericyte and mesenchymal stem cell (MSC) markers in situ. The isolated population can expand and is clonally multipotent in culture, establishing that MSCs found throughout fetal and adult tissues are members of the pericyte family of cells.	Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA	Case Western Reserve University	Caplan, AI (corresponding author), Case Western Reserve Univ, Dept Biol, Skeletal Res Ctr, Cleveland, OH 44106 USA.	arnold.caplan@case.edu		Caplan, Arnold/0000-0002-8677-6621				BRIGHTON CT, 1992, CLIN ORTHOP RELAT R, P287; CAPLAN AI, 1990, CLIN ORTHOP RELAT R, P257; Caplan AI, 1987, BONE MINERAL RES, P117; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dennis JE, 1996, CONNECT TISSUE RES, V35, P93, DOI 10.3109/03008209609029179; Estes BT, 2006, ARTHRITIS RHEUM-US, V54, P1222, DOI 10.1002/art.21779; Hirschi KK, 1996, CARDIOVASC RES, V32, P687, DOI 10.1016/S0008-6363(96)00063-6; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122	10	495	511	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					229	230		10.1016/j.stem.2008.08.008	http://dx.doi.org/10.1016/j.stem.2008.08.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786406	Bronze			2022-12-28	WOS:000259665000001
J	Quaggin, SE				Quaggin, Susan E.			Uncapping the potential of renal stem cells	CELL STEM CELL			English	Editorial Material							KIDNEY DEVELOPMENT; MESENCHYME; SIX2	In this issue of Cell Stem Cell, McMahon and coworkers (Kobayashi et al., 2008) characterize a subset of progenitor cells in the developing kidney. six2-expressing mesenchymal cells exhibit hallmark stem cell traits, in that they appear to self-renew and are clonally multipotent for a range of nephron epithelial cell types.	[Quaggin, Susan E.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Quaggin, Susan E.] Univ Toronto, Div Nephrol, St Michaels Hosp, Toronto, ON M5B 1W8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto	Quaggin, SE (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 881-600 Univ Ave, Toronto, ON M5G 1X5, Canada.	quaggin@mshri.on.ca						Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cui SY, 2003, DEV DYNAM, V226, P512, DOI 10.1002/dvdy.10244; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; Hatini V, 1996, GENE DEV, V10, P1467, DOI 10.1101/gad.10.12.1467; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Levinson R, 2003, SEMIN CELL DEV BIOL, V14, P225, DOI 10.1016/S1084-9521(03)00025-9; QUAGGIN SE, 2008, BRENNER RECTORS KIDN, P1; Saxen L., 1987, ORGANOGENESIS KIDNEY; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381	10	1	1	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					123	124		10.1016/j.stem.2008.07.019	http://dx.doi.org/10.1016/j.stem.2008.07.019			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682231	Bronze			2022-12-28	WOS:000258523300002
J	Boyerinas, B; Sipkins, DA				Boyerinas, Benjamin; Sipkins, Dorothy A.			HSPCs in the Balance: The Vascular Niche	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; ENDOTHELIAL-CELLS; SELF-RENEWAL	Recently, in Nature Cell Biology, Kobayashi et al. (2010) report that Akt-activated sinusoidal endothelial cells within the bone marrow modulate the self-renewal and differentiation of hematopoietic stem cells. This finding demonstrates a mechanistic role for endothelial cells in regulating the hematopoietic stem and progenitor cells' pool during homeostasis and in response to myeloablative stress.	[Boyerinas, Benjamin; Sipkins, Dorothy A.] Univ Chicago, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA	University of Chicago	Sipkins, DA (corresponding author), Univ Chicago, Dept Med, Hematol Oncol Sect, KCBD 9140,900 E 57th St, Chicago, IL 60637 USA.	dsipkins@medicine.bsd.uchicago.edu						Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kobayashi H, 2010, NAT CELL BIOL, V12, P1046, DOI 10.1038/ncb2108; Kwon KR, 2010, STEM CELLS, V28, P268, DOI 10.1002/stem.285; Phung TL, 2006, CANCER CELL, V10, P159, DOI 10.1016/j.ccr.2006.07.003; Sun JF, 2005, P NATL ACAD SCI USA, V102, P128, DOI 10.1073/pnas.0403198102; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	10	6	6	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					645	646		10.1016/j.stem.2010.11.021	http://dx.doi.org/10.1016/j.stem.2010.11.021			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112557	Bronze			2022-12-28	WOS:000285537700004
J	Kikushige, Y; Shima, T; Takayanagi, S; Urata, S; Miyamoto, T; Iwasaki, H; Takenaka, K; Teshima, T; Tanaka, T; Inagaki, Y; Akashi, K				Kikushige, Yoshikane; Shima, Takahiro; Takayanagi, Shin-ichiro; Urata, Shingo; Miyamoto, Toshihiro; Iwasaki, Hiromi; Takenaka, Katsuto; Teshima, Takanori; Tanaka, Toshiyuki; Inagaki, Yoshimasa; Akashi, Koichi			TIM-3 Is a Promising Target to Selectively Kill Acute Myeloid Leukemia Stem Cells	CELL STEM CELL			English	Article							MONOCLONAL-ANTIBODY; INITIATING CELLS; MICE; CHAIN; PHAGOCYTOSIS; PROGENITORS; ENGRAFTMENT; ACTIVATION; AUTOIMMUNE; EXPRESSION	Acute myeloid leukemia (AML) originates from self-renewing leukemic stem cells (LSCs), an ultimate therapeutic target for AML. Here we identified T cell immunoglobulin mucin-3 (TIM-3) as a surface molecule expressed on LSCs in most types of AML except for acute promyelocytic leukemia, but not on normal hematopoietic stem cells (HSCs). TIM-3(+) but not TIM-3(-) AML cells reconstituted human AML in immunodeficient mice, suggesting that the TIM-3(+) population contains most, if not all, of functional LSCs. We established an anti-human TIM-3 mouse IgG2a antibody having complement-dependent and antibody-dependent cellular cytotoxic activities. This antibody did not harm reconstitution of normal human HSCs, but blocked engraftment of AML after xenotransplantation. Furthermore, when it is administered into mice grafted with human AML, this treatment dramatically diminished their leukemic burden and eliminated LSCs capable of reconstituting human AML in secondary recipients. These data suggest that TIM-3 is one of the promising targets to eradicate AML LSCs.	[Kikushige, Yoshikane; Shima, Takahiro; Urata, Shingo; Miyamoto, Toshihiro; Iwasaki, Hiromi; Takenaka, Katsuto; Teshima, Takanori; Akashi, Koichi] Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan; [Takayanagi, Shin-ichiro; Inagaki, Yoshimasa] Kyowa Hakko Kirin Co Ltd, Innovat Drug Res Labs, Tokyo 1948538, Japan; [Tanaka, Toshiyuki] Hyogo Univ Hlth Sci, Sch Pharm, Kobe, Hyogo 6508530, Japan	Kyushu University; Kyowa Kirin Ltd	Akashi, K (corresponding author), Kyushu Univ, Grad Sch Med, Dept Med & Biosyst Sci, Fukuoka 8128582, Japan.	akashi@med.kyushu-u.ac.jp	teshima, takanori/G-1671-2012	teshima, takanori/0000-0002-0941-271X	Ministry of Education, Culture, Sports, Science and Technology in Japan; Grants-in-Aid for Scientific Research [21390295] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology in Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology in Japan. S.-i.T. and Y.I. are employees of Kyowa Hakko Kirin Co., Ltd.	Aikawa Y, 2010, NAT MED, V16, P580, DOI 10.1038/nm.2122; Anderson AC, 2007, SCIENCE, V318, P1141, DOI 10.1126/science.1148536; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Doenecke A, 1997, LEUKEMIA, V11, P1787, DOI 10.1038/sj.leu.2400781; Florian S, 2006, LEUKEMIA LYMPHOMA, V47, P207, DOI 10.1080/10428190500272507; Hauswirth AW, 2007, EUR J CLIN INVEST, V37, P73, DOI 10.1111/j.1365-2362.2007.01746.x; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Hosen N, 2007, P NATL ACAD SCI USA, V104, P11008, DOI 10.1073/pnas.0704271104; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Kikushige Y, 2008, J IMMUNOL, V180, P7358, DOI 10.4049/jimmunol.180.11.7358; Krause DS, 2007, TRENDS MOL MED, V13, P470, DOI 10.1016/j.molmed.2007.09.003; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Majeti R, 2009, CELL, V138, P286, DOI 10.1016/j.cell.2009.05.045; Manz MG, 2002, P NATL ACAD SCI USA, V99, P11872, DOI 10.1073/pnas.172384399; MARTELLI MP, 2010, BLOOD PRESSURE, DOI DOI 10.1182/BLOOD-2009-08-238899; Monney L, 2002, NATURE, V415, P536, DOI 10.1038/415536a; Nakae S, 2007, BLOOD, V110, P2565, DOI 10.1182/blood-2006-11-058800; Nakayama M, 2009, BLOOD, V113, P3821, DOI 10.1182/blood-2008-10-185884; Nimmerjahn F, 2005, SCIENCE, V310, P1510, DOI 10.1126/science.1118948; Nimmerjahn F, 2007, CURR OPIN IMMUNOL, V19, P239, DOI 10.1016/j.coi.2007.01.005; Pearson T, 2008, CLIN EXP IMMUNOL, V154, P270, DOI 10.1111/j.1365-2249.2008.03753.x; Sabatos CA, 2003, NAT IMMUNOL, V4, P1102, DOI 10.1038/ni988; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Sanchez-Fueyo A, 2003, NAT IMMUNOL, V4, P1093, DOI 10.1038/ni987; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Takenaka K, 2007, NAT IMMUNOL, V8, P1313, DOI 10.1038/ni1527; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Taussig DC, 2010, BLOOD, V115, P1976, DOI 10.1182/blood-2009-02-206565; Taussig DC, 2005, BLOOD, V106, P4086, DOI 10.1182/blood-2005-03-1072; Tawara T, 2008, J IMMUNOL, V180, P2294, DOI 10.4049/jimmunol.180.4.2294; Uchida JJ, 2004, J EXP MED, V199, P1659, DOI 10.1084/jem.20040119; van Rhenen A, 2007, BLOOD, V110, P2659, DOI 10.1182/blood-2007-03-083048; Yalcintepe L, 2006, BLOOD, V108, P3530, DOI 10.1182/blood-2006-04-013813; Yoshimoto G, 2009, BLOOD, V114, P5034, DOI 10.1182/blood-2008-12-196055	40	288	321	1	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					708	717		10.1016/j.stem.2010.11.014	http://dx.doi.org/10.1016/j.stem.2010.11.014			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112565	Bronze			2022-12-28	WOS:000285537700012
J	Li, F; He, ZM; Shen, JP; Huang, QA; Li, WR; Liu, XJ; He, YJ; Wolf, F; Li, CY				Li, Fang; He, Zhimin; Shen, Jingping; Huang, Qian; Li, Wenrong; Liu, Xinjian; He, Yujun; Wolf, Frank; Li, Chuan-Yuan			Apoptotic Caspases Regulate Induction of iPSCs from Human Fibroblasts	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; RETINOBLASTOMA PROTEIN; C-FLIP; MOUSE; GENERATION; RB; DEATH; MYC; P53; PATHWAY	The molecular mechanisms involved in the derivation of induced pluripotent stem cells (iPSCs) from differentiated cells are poorly understood. Here we report that caspases 3 and 8, two proteases associated with apoptotic cell death, play critical roles in induction of iPSCs from human fibroblasts. Activation of caspases 3 and 8 occurs soon after transduction of iPSC-inducing transcription factors. Oct-4, a key iPSC transcription factor, is responsible for the activation. Inhibition of caspase 3 or 8 in human fibroblast cells partially or completely (respectively) prevents the induction of iPSCs. Furthermore, retinoblastoma susceptibility (Rb) protein appears to be one of the factors that act downstream of the caspases. We propose that caspases are key facilitators of nuclear reprogramming in iPSC induction.	[Li, Fang; He, Zhimin; Shen, Jingping; Huang, Qian; Li, Wenrong; Liu, Xinjian; He, Yujun; Wolf, Frank; Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA; [Li, Chuan-Yuan] Univ Colorado, Sch Med, Dept Pharmacol, Aurora, CO 80045 USA; [He, Zhimin] Cent S Univ, Canc Res Inst, Changsha 410078, Hunan, Peoples R China; [Huang, Qian] Shanghai Jiao Tong Univ, Sch Med, Peoples Hosp 1, Shanghai 200080, Peoples R China	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; Central South University; Shanghai Jiao Tong University	Li, CY (corresponding author), Univ Colorado, Sch Med, Dept Radiat Oncol, Aurora, CO 80045 USA.	chuan.li@ucdenver.edu	Li, Chuan-Yuan/H-4148-2013		US National Cancer Institute [CA131408, CA136748]; NCI; NASA [NNX09AH19G]; National Basic Research Project of China [2010CB529900]; China National Natural Science Foundation [30325043, 30428015]; NATIONAL CANCER INSTITUTE [R01CA131408, R01CA136748] Funding Source: NIH RePORTER	US National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NASA(National Aeronautics & Space Administration (NASA)); National Basic Research Project of China(National Basic Research Program of China); China National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the various investigators who have deposited many of the plasmids used in this study at Addgene (Cambridge, MA). These include the iPSC factors deposited by Drs. Thomson (U. of Wisconsin) and Yamanaka (Kyoto University) and the dominant/negative caspase plasmids deposited by Dr. Salvesen (Burnham Institute). We also want to thank Drs. Hochedlingder and Mahereli (Harvard Medical School) for their gift of the doxycycline-inducible secondary reprogramming mouse fibroblast cells. This study was supported in part by grants CA131408 and CA136748 from the US National Cancer Institute (to C.-Y.L.), an NCI SPORE developmental grant in lung cancer research (to C.-Y.L.), and grant NNX09AH19G (to C.-Y.L.) from the NASA Space Radiation Biology Research Program. Q.H. was supported by grant 2010CB529900 from the National Basic Research Project of China and Outstanding Young Scientist grants 30325043 and 30428015 from the China National Natural Science Foundation. We thank Melissa Stauffer, PhD, of Scientific Editing Solutions, for editing the manuscript.	An B, 1996, CANCER RES, V56, P438; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BARBOSA MS, 1990, EMBO J, V9, P153, DOI 10.1002/j.1460-2075.1990.tb08091.x; Bhutani N, 2010, NATURE, V463, P1042, DOI 10.1038/nature08752; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dejosez M, 2008, CELL, V133, P1162, DOI 10.1016/j.cell.2008.05.047; Dou QP, 1997, J CELL BIOCHEM, V64, P586; DYSON N, 1989, SCIENCE, V243, P934, DOI 10.1126/science.2537532; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; EVAN G, 1994, PHILOS T R SOC B, V345, P269, DOI 10.1098/rstb.1994.0105; EVAN GI, 1992, CELL, V69, P119, DOI 10.1016/0092-8674(92)90123-T; Ferrari R, 2008, SCIENCE, V321, P1086, DOI 10.1126/science.1155546; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; GAGE JR, 1990, J VIROL, V64, P723, DOI 10.1128/JVI.64.2.723-730.1990; GAGLIARDINI V, 1994, SCIENCE, V263, P826, DOI 10.1126/science.8303301; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hemberger M, 2009, NAT REV MOL CELL BIO, V10, P526, DOI 10.1038/nrm2727; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Hsieh JK, 1999, MOL CELL, V3, P181, DOI 10.1016/S1097-2765(00)80309-3; Hueber AO, 1997, SCIENCE, V278, P1305, DOI 10.1126/science.278.5341.1305; Janicke RU, 1996, EMBO J, V15, P6969, DOI 10.1002/j.1460-2075.1996.tb01089.x; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Jones DL, 1997, VIROLOGY, V239, P97, DOI 10.1006/viro.1997.8851; Jori FP, 2007, MOL CELL NEUROSCI, V34, P299, DOI 10.1016/j.mcn.2006.11.009; Kang TB, 2004, J IMMUNOL, V173, P2976, DOI 10.4049/jimmunol.173.5.2976; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; RAY CA, 1992, CELL, V69, P597, DOI 10.1016/0092-8674(92)90223-Y; SAVATIER P, 1994, ONCOGENE, V9, P809; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, NAT METHODS, V7, P53, DOI [10.1038/NMETH.1409, 10.1038/nmeth.1409]; Stennicke HR, 1997, J BIOL CHEM, V272, P25719, DOI 10.1074/jbc.272.41.25719; Szymczyk KH, 2006, J CELL PHYSIOL, V209, P836, DOI 10.1002/jcp.20770; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan XQ, 1997, J BIOL CHEM, V272, P9613; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WHITE AE, 1994, GENE DEV, V8, P666, DOI 10.1101/gad.8.6.666; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang YP, 1998, CELL, V92, P725, DOI 10.1016/S0092-8674(00)81401-4; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	69	84	90	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					508	520		10.1016/j.stem.2010.09.003	http://dx.doi.org/10.1016/j.stem.2010.09.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887956	Green Accepted, Bronze			2022-12-28	WOS:000283270600012
J	Sierra, A; Encinas, JM; Deudero, JJP; Chancey, JH; Enikolopov, G; Overstreet-Wadiche, LS; Tsirka, SE; Maletic-Savatic, M				Sierra, Amanda; Encinas, Juan M.; Deudero, Juan J. P.; Chancey, Jessica H.; Enikolopov, Grigori; Overstreet-Wadiche, Linda S.; Tsirka, Stella E.; Maletic-Savatic, Mirjana			Microglia Shape Adult Hippocampal Neurogenesis through Apoptosis-Coupled Phagocytosis	CELL STEM CELL			English	Article							GREEN FLUORESCENT PROTEIN; PROGRAMMED CELL-DEATH; DENTATE GYRUS; PROGENITOR CELLS; STATUS EPILEPTICUS; OLFACTORY-BULB; TERM SURVIVAL; GRANULE CELLS; NEURAL STEM; NEURONS	In the adult hippocampus, neuroprogenitor cells in the subgranular zone (SGZ) of the dentate gyrus give rise to newborn neuroblasts. However, only a small subset of these cells integrates into the hippocampal circuitry as mature neurons at the end of a 4 week period. Here, we show that the majority of the newborn cells undergo death by apoptosis in the first 1 to 4 days of their life, during the transition from amplifying neuroprogenitors to neuroblasts. These apoptotic newborn cells are rapidly cleared out through phagocytosis by unchallenged microglia present in the adult SGZ niche. Phagocytosis by the microglia is efficient and undeterred by increased age or inflammatory challenge. Our results suggest that the main critical period of newborn cell survival occurs within a few days of birth and reveal a new role for microglia in maintaining the homeostasis of the baseline neurogenic cascade.	[Sierra, Amanda; Encinas, Juan M.; Deudero, Juan J. P.; Maletic-Savatic, Mirjana] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Encinas, Juan M.; Enikolopov, Grigori] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Chancey, Jessica H.; Overstreet-Wadiche, Linda S.] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Tsirka, Stella E.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11733 USA	Baylor College of Medicine; Cold Spring Harbor Laboratory; University of Alabama System; University of Alabama Birmingham; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Sierra, A (corresponding author), Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA.	amanda.sierrasaavedra@gmail.com; maletics@bcm.edu	Encinas, Juan M/E-3625-2010; Tsirka, Stella/AAD-4018-2019; Sierra, Amanda/E-3305-2010; Encinas, Juan Manuel/ABB-5304-2020; Encinas, Juan Manuel/N-5906-2014; Enikolopov, Grigori/P-5731-2019	Sierra, Amanda/0000-0001-8415-096X; Encinas, Juan Manuel/0000-0002-0402-972X; Encinas, Juan Manuel/0000-0002-0402-972X; Enikolopov, Grigori/0000-0001-8178-8917; Wadiche, Linda/0000-0001-7367-5998; Pena Deudero, Juan Jose/0000-0002-0203-2247; Maletic-Savatic, Mirjana/0000-0002-6548-4662; Chancey, Jessica/0000-0002-8807-3938	National Institute of Neurological Disorders and Stroke [R21NS05875-1, K08NS0044276]; Child Neurology Society; U.S. Army [DAMD170110754]; NIH [P30HD024064]; Farish foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053875, K08NS044276, R01NS042168, R01NS064025] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Child Neurology Society; U.S. Army; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Farish foundation; National Alliance for Research on Schizophrenia and Depression Young Investigator Award(NARSAD); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank all the members of the M.M.-S. lab for discussion and Fuguo Zhou for technical assistance. We would like to thank Drs. Huda Zoghbi, Juan Botas, Thomas Zwaka, Zhou Zhang, John Swan, Katrina Gwinn, and Vicky Brandt for their critical comments. This work was supported by the National Institute of Neurological Disorders and Stroke (R21NS05875-1 and K08NS0044276); Phillip R. Dodge Young Investigator Award (Child Neurology Society); U.S. Army Medical Research Grant (DAMD170110754): NIH Intellectual and Developmental Disabilities Research Grant (P30HD024064); and the Farish foundation (M.M.-S.). J.M.E. is the recipient of a National Alliance for Research on Schizophrenia and Depression Young Investigator Award. A.S. designed and performed the experiments, analyzed the data, and wrote the paper. J.M.E., J.J.P.D., and J.H.C. performed experiments. L.S.O.-W. provided the POMC-EGFP mice and critically reviewed the paper. G.E. provided the nestin-GFP and the nestin-CFPNuc mice and critically reviewed the paper. S.E.T. provided the fms-EGFP mice and critically reviewed the paper. M.M.-S. designed and supervised all the experiments and wrote the paper.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Aldskogius H, 1999, J NEUROSCI RES, V58, P33, DOI 10.1002/(SICI)1097-4547(19991001)58:1<33::AID-JNR5>3.3.CO;2-D; ALOISI F, 2005, NEUROGLIA, P285; BARRES BA, 1992, CELL, V70, P31, DOI 10.1016/0092-8674(92)90531-G; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Dayer AG, 2003, J COMP NEUROL, V460, P563, DOI 10.1002/cne.10675; de la Rosa EJ, 2000, TRENDS NEUROSCI, V23, P454, DOI 10.1016/S0166-2236(00)01628-3; Eid T, 2008, EPILEPSIA, V49, P42, DOI 10.1111/j.1528-1167.2008.01492.x; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2002, EUR J NEUROSCI, V16, P1463, DOI 10.1046/j.1460-9568.2002.02202.x; Ekdahl CT, 2003, NEUROBIOL DIS, V14, P513, DOI 10.1016/j.nbd.2003.08.022; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Ekdahl CT, 2001, EUR J NEUROSCI, V14, P937, DOI 10.1046/j.0953-816x.2001.01713.x; Encinas JM, 2006, P NATL ACAD SCI USA, V103, P8233, DOI 10.1073/pnas.0601992103; Encinas JM, 2008, METHOD CELL BIOL, V85, P243, DOI 10.1016/S0091-679X(08)85011-X; Hatzold J, 2008, PLOS BIOL, V6, P771, DOI 10.1371/journal.pbio.0060084; Hayes NL, 2002, DEV BRAIN RES, V134, P77, DOI 10.1016/S0165-3806(01)00324-8; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kettenmann H, 2007, NATURE, V446, P987, DOI 10.1038/nature05713; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lagace DC, 2007, J NEUROSCI, V27, P12623, DOI 10.1523/JNEUROSCI.3812-07.2007; Ma DKK, 2009, ANN NY ACAD SCI, V1170, P664, DOI 10.1111/j.1749-6632.2009.04373.x; Mallat M, 2005, CURR OPIN NEUROBIOL, V15, P101, DOI 10.1016/j.conb.2005.01.006; Mandyam CD, 2007, NEUROSCIENCE, V146, P108, DOI 10.1016/j.neuroscience.2006.12.064; Marin-Teva JL, 2004, NEURON, V41, P535, DOI 10.1016/S0896-6273(04)00069-8; Mignone JL, 2004, J COMP NEUROL, V469, P311, DOI 10.1002/cne.10964; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; NICHOLSON DW, 1995, NATURE, V376, P37, DOI 10.1038/376037a0; Olah M, 2009, GLIA, V57, P1046, DOI 10.1002/glia.20828; Overstreet LS, 2004, J NEUROSCI, V24, P3251, DOI 10.1523/JNEUROSCI.5173-03.2004; Petersen MA, 2004, GLIA, V46, P195, DOI 10.1002/glia.10362; Petreanu L, 2002, J NEUROSCI, V22, P6106; Sasmono RT, 2003, BLOOD, V101, P1155, DOI 10.1182/blood-2002-02-0569; Savill J, 2002, NAT REV IMMUNOL, V2, P965, DOI 10.1038/nri957; Savill J, 1997, BRIT MED BULL, V53, P491; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sun W, 2004, J NEUROSCI, V24, P11205, DOI 10.1523/JNEUROSCI.1436-04.2004; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Thomaidou D, 1997, J NEUROSCI, V17, P1075, DOI 10.1523/jneurosci.17-03-01075.1997; Weise J, 2005, NEUROBIOL DIS, V18, P582, DOI 10.1016/j.nbd.2004.10.025; Yang FS, 1998, AM J PATHOL, V152, P379; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	51	970	992	3	78	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					483	495		10.1016/j.stem.2010.08.014	http://dx.doi.org/10.1016/j.stem.2010.08.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887954	Green Accepted, Bronze			2022-12-28	WOS:000283270600010
J	Freeman, SN; Burke, KA; Imoisili, MA; Cote, TR				Freeman, Scott N.; Burke, Kathryn A.; Imoisili, Menfo A.; Cote, Timothy R.			The Orphan Drug Act and the Development of Stem Cell-Based Products for Rare Diseases	CELL STEM CELL			English	Editorial Material							FDA REGULATION; THERAPIES	The Orphan Drug Act encourages the development of products for rare diseases and conditions. Many conditions that stand to benefit from stem cell-based products are rare diseases. We address the Orphan Drug Act in relation to the development of stem cell-based products.	[Freeman, Scott N.; Burke, Kathryn A.; Imoisili, Menfo A.; Cote, Timothy R.] US FDA, Off Orphan Prod Dev, Off Special Med Programs, Off Commissioner, Silver Spring, MD 20993 USA	US Food & Drug Administration (FDA)	Cote, TR (corresponding author), US FDA, Off Orphan Prod Dev, Off Special Med Programs, Off Commissioner, Silver Spring, MD 20993 USA.	timothy.cote@fda.hhs.gov		Freeman, Scott/0000-0003-2676-3236				Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Cote T, 2010, NAT REV DRUG DISCOV, V9, P84, DOI 10.1038/nrd2546-c1; Fink DW, 2009, SCIENCE, V324, P1662, DOI 10.1126/science.1173712; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; *US FDA, 2010, ORPH PROD DAT INT; *US FDA, 2010, INT COLL FDA EUR MED; *US FDA, 2010, BIOL INV REL APPL SY; *US FDA, 2010, ORPHANDRUG PROD DES	9	7	7	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					283	287		10.1016/j.stem.2010.08.003	http://dx.doi.org/10.1016/j.stem.2010.08.003			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804965	Bronze			2022-12-28	WOS:000282037800006
J	Azarin, SM; Palecek, SP				Azarin, Samira M.; Palecek, Sean P.			Matrix Revolutions: A Trinity of Defined Substrates for Long-Term Expansion of Human ESCs	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; SELF-RENEWAL; DERIVATION; GROWTH; LINES	Recently in Nature Biotechnology, Rodin et al. (2010), Melkoumian et al. (2010), and Villa-Diaz et al. (2010) described defined, nonxenogenic substrates that support long-term self-renewal of human embryonic stem cells (hESCs). Used in conjunction with defined media, these substrates will facilitate expansion of hESCs for therapeutic applications.	[Azarin, Samira M.; Palecek, Sean P.] Univ Wisconsin, Dept Chem & Biol Engn, Madison, WI 53706 USA; [Azarin, Samira M.; Palecek, Sean P.] WiCell Res Inst, Madison, WI 53707 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute	Palecek, SP (corresponding author), Univ Wisconsin, Dept Chem & Biol Engn, 1415 Engn Dr, Madison, WI 53706 USA.	palecek@engr.wisc.edu						Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Hasegawa K, 2010, CELL STEM CELL, V6, P521, DOI 10.1016/j.stem.2010.05.010; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Melkoumian Z, 2010, NAT BIOTECHNOL, V28, P606, DOI 10.1038/nbt.1629; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Villa-Diaz LG, 2010, NAT BIOTECHNOL, V28, P581, DOI 10.1038/nbt.1631; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586	8	13	13	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					7	8		10.1016/j.stem.2010.06.008	http://dx.doi.org/10.1016/j.stem.2010.06.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621041	Bronze			2022-12-28	WOS:000280222300004
J	Bubela, T; Strotmann, A; Adams, R; Morrison, S				Bubela, Tania; Strotmann, Andreas; Adams, Rhiannon; Morrison, Shawn			Commercialization and Collaboration: Competing Policies in Publicly Funded Stem Cell Research?	CELL STEM CELL			English	Editorial Material							PATENTS	Advances in bibliometrics present new methods for analyzing emerging collaborative innovation models. These methods are illustrated by the Canadian Stem Cell Network, which fosters high-profile multidisciplinary, collaborative, international research. However, patenting negatively impacts collaboration patterns in published research. Policies directed at collaboration and commercialization may be in conflict, depending on the degree to which one activity is emphasized over the other.	[Bubela, Tania; Strotmann, Andreas] Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada; [Adams, Rhiannon] Univ Alberta, Fac Law, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Morrison, Shawn] Dryas Res Ltd, Edmonton, AB T6C 2R6, Canada	University of Alberta; University of Alberta	Bubela, T (corresponding author), Univ Alberta, Sch Publ Hlth, Dept Publ Hlth Sci, Edmonton, AB T6G 2G3, Canada.	tbubela@ualberta.ca	Morrison, Shawn/F-3953-2010; Strotmann, Andreas/P-5891-2017; Bubela, Tania/F-4860-2014	Strotmann, Andreas/0000-0002-0679-6498; Bubela, Tania/0000-0002-0807-2899; Morrison, Shawn/0000-0003-3674-5955	Stem Cell Network; Genome Canada	Stem Cell Network; Genome Canada(Genome Canada)	Funding for this project was provided by a Catalyst Grant from the Stem Cell Network to T.B., a Genome Canada Grant to Geoff Hicks, Manitoba Institute of Cell Biology, and Janet Rossant, Hospital for Sick Children, at which T.B. is a coinvestigator; and a SSHRC INE grant to E. Richard Gold in whose lab T.B. was a coinvestigator. These grants have provided postdoctoral fellow salary support to A.S. Dangzhi Zhao provided great assistance and expertise in all aspects of the bibliometric analyses, and Logan McLeod and Gian Jhangri provided additional assistance with regression models. Helpful comments were provided on earlier drafts of the manuscript by Timothy Caulfield, Richard Gold, David Castle, and David Hik.	ATKINSONGROSJEA.A, 2005, PUBLIC SCI PRIVATE I; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Caulfield T, 2008, REGEN MED, V3, P483, DOI 10.2217/17460751.3.4.483; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Giebel LB, 2005, NAT BIOTECHNOL, V23, P798, DOI 10.1038/nbt0705-798; Herder M, 2008, J BUS ETHICS, V77, P73, DOI 10.1007/s10551-006-9294-z; Hong W, 2009, SOCIOL QUART, V50, P145, DOI 10.1111/j.1533-8525.2008.01136.x; Huang KG, 2009, ACAD MANAGE J, V52, P1193, DOI 10.5465/AMJ.2009.47084665; Katz JS, 1997, RES POLICY, V26, P1, DOI 10.1016/S0048-7333(96)00917-1; Lee S, 2005, SOC STUD SCI, V35, P673, DOI 10.1177/0306312705052359; Little M, 2006, EMBO REP, V7, P1188, DOI 10.1038/sj.embor.7400861; Moed HF., 2005, CITATION ANAL RES EV; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; PLAGNOL AC, 2009, FUTURE MED, V4, P549; Schofield PN, 2009, NATURE, V461, P171, DOI 10.1038/461171a; Strandburg Katherine J., 2006, BERKELEY TECH LJ, V21, P1293, DOI DOI 10.2139/SSRN.926354; Walsh JP, 2005, SCIENCE, V309, P2002, DOI 10.1126/science.1115813; Winickoff DE, 2009, YALE J HLTH POLICY L, V9, P54	18	25	25	1	16	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					25	30		10.1016/j.stem.2010.06.010	http://dx.doi.org/10.1016/j.stem.2010.06.010			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Cell Biology	629TJ	20621046	Bronze			2022-12-28	WOS:000280222300009
J	Liber, D; Domaschenz, R; Holmqvist, PH; Mazzarella, L; Georgiou, A; Leleu, M; Fisher, AG; Labosky, PA; Dillon, N				Liber, Daniel; Domaschenz, Renae; Holmqvist, Per-Henrik; Mazzarella, Luca; Georgiou, Andrew; Leleu, Marion; Fisher, Amanda G.; Labosky, Patricia A.; Dillon, Niall			Epigenetic Priming of a Pre-B Cell-Specific Enhancer through Binding of Sox2 and Foxd3 at the ESC Stage	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TISSUE-SPECIFIC ENHANCERS; TRANSCRIPTION FACTORS; CHROMATIN-STRUCTURE; SELF-RENEWAL; PLURIPOTENT; MOUSE; GENES; DIFFERENTIATION; SIGNATURES	Modifications to the core histones are thought to contribute to ESC pluripotency by priming tissue-specific promoters and enhancers for later activation. However, it is unclear how these marks are targeted in ESCs and maintained during differentiation. Here, we show that the ESC factor Sox2 targets H3K4 methylation to monovalent and bivalent domains. In ESCs, Sox2 contributes to the formation of a monovalent mark at an enhancer in the pro/pre-B cell-specific lambda 5-VpreB1 locus. Binding of Foxd3 suppresses intergenic transcription of the enhancer and surrounding sequences. In pro-B cells, enhancer activity is dependent on the Sox and Fox binding sites, and the enhancer is bound by Sox4, which is required for efficient expression of lambda 5. Our results lead us to propose a factor relay model whereby ESC factors establish active epigenetic marks at tissue specific elements before being replaced by cell type-specific factors as cells differentiate.	[Liber, Daniel; Domaschenz, Renae; Holmqvist, Per-Henrik; Georgiou, Andrew; Leleu, Marion; Dillon, Niall] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, London W12 0NN, England; [Mazzarella, Luca; Fisher, Amanda G.] Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Labosky, Patricia A.] Vanderbilt Univ, Sch Med, Ctr Stem Cell Biol, Dept Cell & Dev Biol, Nashville, TN 37232 USA	Imperial College London; Imperial College London; Vanderbilt University	Dillon, N (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, MRC Clin Sci Ctr, Gene Regulat & Chromatin Grp, Hammersmith Campus,Du Cane Rd, London W12 0NN, England.	niall.dillon@csc.mrc.ac.uk	mazzarella, luca/AAC-2391-2019; Holmqvist, Per-Henrik/A-2804-2016	mazzarella, luca/0000-0002-4043-3279; Holmqvist, Per-Henrik/0000-0001-8074-2749; Labosky, Patricia/0000-0001-5880-2194; Domaschenz, Renae/0000-0002-8128-138X	Medical Research Council UK; Leukaemia and Lymphoma Research; EU [HPRN-CT 00504228]; NIH [HD36720]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD036720] Funding Source: NIH RePORTER; Medical Research Council [MC_U120036884, MC_U120027516] Funding Source: researchfish; MRC [MC_U120036884, MC_U120027516] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia and Lymphoma Research; EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Constanz Bonifer for advice on in vivo footprinting, Rudolf Grosschedl for the E47 forced dimer construct, Pierangela Sabbattini for helpful discussions and comments on the manuscript, and Svetlana Nikic for helpful discussions. This research was funded by the Medical Research Council UK and by Leukaemia and Lymphoma Research. D.L. was funded by an EU Marie Curie Research Training Fellowship (HPRN-CT 00504228). P.A.L.'s research is funded by NIH Grant HD36720.	ALT FW, 1992, ANN NY ACAD SCI, V651, P277; Araki Y, 2009, IMMUNITY, V30, P912, DOI 10.1016/j.immuni.2009.05.006; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Efroni S, 2009, CELL CYCLE, V8, P43, DOI 10.4161/cc.8.1.7216; Fehling HJ, 2003, DEVELOPMENT, V130, P4217, DOI 10.1242/dev.00589; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Hannenhalli S, 2009, NAT REV GENET, V10, P233, DOI 10.1038/nrg2523; Hu H, 2006, NAT IMMUNOL, V7, P819, DOI 10.1038/ni1358; Inoue M, 2007, GENES CELLS, V12, P1049, DOI 10.1111/j.1365-2443.2007.01114.x; Ji HK, 2005, BIOINFORMATICS, V21, P3629, DOI 10.1093/bioinformatics/bti593; Kaufman PD, 2010, CURR OPIN CELL BIOL, V22, P284, DOI 10.1016/j.ceb.2010.02.002; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lang RA, 2004, INT J DEV BIOL, V48, P783, DOI 10.1387/ijdb.041903rl; Lefebvre V, 2007, INT J BIOCHEM CELL B, V39, P2195, DOI 10.1016/j.biocel.2007.05.019; Litt MD, 2001, EMBO J, V20, P2224, DOI 10.1093/emboj/20.9.2224; Liu Y, 2008, STEM CELLS, V26, P2475, DOI 10.1634/stemcells.2008-0269; Margueron R, 2010, NAT REV GENET, V11, P285, DOI 10.1038/nrg2752; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Minaee S, 2005, MOL IMMUNOL, V42, P1283, DOI 10.1016/j.molimm.2005.01.003; Pan GJ, 2007, CELL RES, V17, P42, DOI 10.1038/sj.cr.7310125; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Schilham MW, 1996, NATURE, V380, P711, DOI 10.1038/380711a0; Sigvardsson M, 1997, IMMUNITY, V7, P25, DOI 10.1016/S1074-7613(00)80507-5; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Steiner AB, 2006, DEVELOPMENT, V133, P4827, DOI 10.1242/dev.02663; Szutorisz H, 2005, BIOESSAYS, V27, P1286, DOI 10.1002/bies.20330; Szutorisz H, 2005, MOL CELL BIOL, V25, P1804, DOI 10.1128/MCB.25.5.1804-1820.2005; Szutorisz H, 2006, CELL, V127, P1375, DOI 10.1016/j.cell.2006.10.045; Tagoh H, 2006, METH MOL B, V325, P285; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	41	65	65	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					114	126		10.1016/j.stem.2010.05.020	http://dx.doi.org/10.1016/j.stem.2010.05.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621055	Bronze			2022-12-28	WOS:000280222300018
J	Verheyen, EM; Clevers, H				Verheyen, Esther M.; Clevers, Hans			Wnts as Self-Renewal Factors: Mammary Stem Cells and Beyond	CELL STEM CELL			English	Editorial Material								Adult stem cells hold great promise for regenerative medicine, yet it is difficult to expand such cells. In this issue of Cell Stem Cell, Zeng and Nusse (2010) demonstrate that Wnt3A keeps mammary stem cells multipotent over multiple passages in vitro.	[Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Verheyen, Esther M.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Simon Fraser University	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu		Verheyen, Esther/0000-0002-9795-5094				Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Polakis P, 2007, CURR OPIN GENET DEV, V17, P45, DOI 10.1016/j.gde.2006.12.007; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020	9	1	1	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					494	495		10.1016/j.stem.2010.05.004	http://dx.doi.org/10.1016/j.stem.2010.05.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569681	Bronze			2022-12-28	WOS:000278840700002
J	Corsini, NS; Martin-Villalba, A				Corsini, Nina S.; Martin-Villalba, Ana			Integrin Alpha 6: Anchors Away for Glioma Stem Cells	CELL STEM CELL			English	Editorial Material							VASCULAR NICHE; CD133	The laminin receptor Integrin alpha 6 beta 1 anchors adult neural stem cells to the niche vasculature. In this issue of Cell Stem Cell, Lathia et al. (2010) show that glioblastoma stem cells highly express integrin alpha 6 and that their interaction with laminin on endothelial cells directly regulates their tumorigenic capacity.	[Corsini, Nina S.; Martin-Villalba, Ana] German Canc Res Ctr, Dept Mol Neurobiol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ)	Martin-Villalba, A (corresponding author), German Canc Res Ctr, Dept Mol Neurobiol, D-69120 Heidelberg, Germany.	a.martin-villalba@dkfz.de		Corsini, Nina/0000-0001-6731-3544; Martin-Villalba, Ana/0000-0002-9405-8910				Fortunel NO, 2003, SCIENCE, V302, P393; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; PANAYOTOU G, 1989, CELL, V56, P93, DOI 10.1016/0092-8674(89)90987-2; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130	10	15	16	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					403	404		10.1016/j.stem.2010.04.003	http://dx.doi.org/10.1016/j.stem.2010.04.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452311	Bronze			2022-12-28	WOS:000277844800004
J	Challen, GA; Boles, NC; Chambers, SM; Goodell, MA				Challen, Grant A.; Boles, Nathan C.; Chambers, Stuart M.; Goodell, Margaret A.			Distinct Hematopoietic Stem Cell Subtypes Are Differentially Regulated by TGF-beta 1	CELL STEM CELL			English	Article							SELF-RENEWAL CAPACITY; TGF-BETA; IN-VITRO; IDENTIFICATION; PROGENITOR; MECHANISM; QUANTIFICATION; HETEROGENEITY; REPOPULATION; COMPARTMENT	The traditional view of hematopoiesis has been that all the cells of the peripheral blood are the progeny of a unitary homogeneous pool of hematopoietic stem cells (HSCs). Recent evidence suggests that the hematopoietic system is actually maintained by a consortium of HSC subtypes with distinct functional characteristics. We show here that myeloid-biased HSCs (My-HSCs) and lymphoid-biased HSCs (Ly-HSCs) can be purified according to their capacity for Hoechst dye efflux in combination with canonical HSC markers. These phenotypes are stable under natural (aging) or artificial (serial transplantation) stress and are exacerbated in the presence of competing HSCs. My- and Ly-HSCs' respond differently to TGF-beta 1, presenting a possible mechanism for differential regulation of HSC subtype activation. This study demonstrates definitive isolation of lineage-biased HSC subtypes and contributes to the fundamental change in view that the hematopoietic system is maintained by a continuum of HSC subtypes, rather than a functionally uniform pool.	[Challen, Grant A.; Boles, Nathan C.; Chambers, Stuart M.; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Challen, Grant A.; Boles, Nathan C.; Chambers, Stuart M.; Goodell, Margaret A.] Baylor Coll Med, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Goodell, Margaret A.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Challen, Grant A.] Monash Univ, Dept Anat & Cell Biol, Clayton, Vic 3800, Australia	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Monash University	Goodell, MA (corresponding author), Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA.	goodell@bcm.edu		Goodell, Margaret A./0000-0003-1111-2932	Australian National Health and Medical Research Council (NHMRC) [384369]; NIH [HL081007, EB005173, DK58192]; Ellison foundation [AGSS178706]; American Heart Association [0740020N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007, R01HL096360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG034451] Funding Source: NIH RePORTER	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison foundation(Lawrence Ellison Foundation); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors have no financial conflicts of interest to disclose. The authors would like to thank all members of the Goodell lab for scientific advice, Jonathan Berg and Katherine King for manuscript review, and Chris Threeton for flow cytometric sorting and analysis. G.A.C. was supported by an Australian National Health and Medical Research Council (NHMRC) CJ Martin Fellowship (384369). This work was also supported by NIH grants HL081007, EB005173, and DK58192, the Ellison foundation (AGSS178706), and the American Heart Association (0740020N).	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Buonamici S, 2003, BLOOD CELL MOL DIS, V31, P206, DOI 10.1016/S1079-9796(03)00159-1; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Chabanon A, 2008, STEM CELLS, V26, P3150, DOI 10.1634/stemcells.2008-0219; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Cho RH, 2008, BLOOD, V111, P5553, DOI 10.1182/blood-2007-11-123547; COSENZA SC, 1994, J CELL BIOCHEM, V55, P503, DOI 10.1002/jcb.240550410; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Fortunel N, 2000, STEM CELLS, V18, P102, DOI 10.1634/stemcells.18-2-102; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; GRZEGORZEWSKI K, 1994, J EXP MED, V180, P1047, DOI 10.1084/jem.180.3.1047; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; Kale VP, 2004, STEM CELLS DEV, V13, P536, DOI 10.1089/1547328042417390; Kale VP, 2004, STEM CELLS DEV, V13, P27, DOI 10.1089/154732804773099236; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim M, 2003, ANN NY ACAD SCI, V996, P195, DOI 10.1111/j.1749-6632.2003.tb03247.x; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Larsson J, 2005, EXP HEMATOL, V33, P592, DOI 10.1016/j.exphem.2005.02.003; Lemieux ME, 1996, BLOOD, V88, P1639; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; Matsuzaki Y, 2004, IMMUNITY, V20, P87, DOI 10.1016/S1074-7613(03)00354-6; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ramalho-Santos Miguel, 2007, Cell Stem Cell, V1, P35, DOI 10.1016/j.stem.2007.05.013; Roeder I, 2008, BLOOD, V112, P4874, DOI 10.1182/blood-2008-05-155374; Rossi DJ, 2007, EXP GERONTOL, V42, P385, DOI 10.1016/j.exger.2006.11.019; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; SMITH LG, 1991, P NATL ACAD SCI USA, V88, P2788, DOI 10.1073/pnas.88.7.2788; SPANGRUDE GJ, 1995, BLOOD, V85, P1006, DOI 10.1182/blood.V85.4.1006.bloodjournal8541006; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; SZILVASSY SJ, 1990, P NATL ACAD SCI USA, V87, P8736, DOI 10.1073/pnas.87.22.8736; Takano H, 2004, J EXP MED, V199, P295, DOI 10.1084/jem.20030929; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Weksberg DC, 2008, BLOOD, V111, P2444, DOI 10.1182/blood-2007-09-115006; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wineman J, 1996, BLOOD, V87, P4082, DOI 10.1182/blood.V87.10.4082.bloodjournal87104082; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	51	394	401	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					265	278		10.1016/j.stem.2010.02.002	http://dx.doi.org/10.1016/j.stem.2010.02.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207229	Green Accepted, Bronze			2022-12-28	WOS:000276254600013
J	North, TE; Goessling, W				North, Trista E.; Goessling, Wolfram			NOTCHing an Arrow at Cord Blood: Translating Stem Cell Knowledge into Clinical Practice	CELL STEM CELL			English	Editorial Material							TRANSPLANTATION; EXPANSION	Umbilical cord transplants have emerged as an important therapeutic option for patients with leukemia and lymphoma. A recent study in Nature Medicine highlights the potential and challenges of translating cell-based therapies to the clinic.	[North, Trista E.] Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA; [North, Trista E.; Goessling, Wolfram] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Div Genet,Med Sch, Boston, MA 02115 USA; [North, Trista E.; Goessling, Wolfram] Harvard Univ, Brigham & Womens Hosp, Dana Farber Canc Inst, Div Gastroenterol,Med Sch, Boston, MA 02115 USA; [Goessling, Wolfram] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University	North, TE (corresponding author), Harvard Univ, Sch Med, Dept Pathol, Beth Israel Deaconess Med Ctr, Boston, MA 02115 USA.	tnorth@bidmc.harvard.edu; wgoessling@partners.org	North, Trista/ABG-4789-2020	North, Trista/0000-0003-1249-563X; Goessling, Wolfram/0000-0001-9972-1569				Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Ballen KK, 2007, BIOL BLOOD MARROW TR, V13, P82, DOI 10.1016/j.bbmt.2006.08.041; Broxmeyer HE, 2009, BONE MARROW TRANSPL, V44, P627, DOI 10.1038/bmt.2009.285; Butler JM, 2010, CELL STEM CELL, V6, P251, DOI 10.1016/j.stem.2010.02.001; Campbell TB, 2007, STEM CELLS DEV, V16, P347, DOI 10.1089/scd.2007.9995; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; MILNER LA, 1994, BLOOD, V83, P2057; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	10	5	5	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					186	187		10.1016/j.stem.2010.02.009	http://dx.doi.org/10.1016/j.stem.2010.02.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207217	Bronze			2022-12-28	WOS:000276254600003
J	Noseda, M; Schneider, MD				Noseda, Michela; Schneider, Michael D.			Unleashing Cardiopoiesis: A Novel Role for G-CSF	CELL STEM CELL			English	Editorial Material							COLONY-STIMULATING FACTOR; MYOCARDIAL-INFARCTION; STEM-CELLS; INHIBITION; DISEASE	Identifying pathways for cardiac muscle creation is a paramount objective of cardiac stem cell biology. In this issue of Cell Stem Cell, Shimoji and colleagues (2010) report the unforeseen ability of granulocyte colony-stimulating factor (G-CSF) to drive cardiopoiesis in mouse, primate, and human pluripotent cells.	[Noseda, Michela; Schneider, Michael D.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Ctr Res Excellence, British Heart Fdn, London SW7 2AZ, England	Imperial College London; University of London; University College London	Schneider, MD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Ctr Res Excellence, British Heart Fdn, London SW7 2AZ, England.	m.d.schneider@imperial.ac.uk		Schneider, Michael/0000-0001-9645-1938; Noseda, Michela/0000-0002-9553-5029				Brunner S, 2008, EXP HEMATOL, V36, P695, DOI 10.1016/j.exphem.2008.01.011; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Liu FL, 1996, IMMUNITY, V5, P491, DOI 10.1016/S1074-7613(00)80504-X; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Sadek H, 2008, P NATL ACAD SCI USA, V105, P6063, DOI 10.1073/pnas.0711507105; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shimoji K, 2010, CELL STEM CELL, V6, P227, DOI 10.1016/j.stem.2010.01.002; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	10	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					188	189		10.1016/j.stem.2010.02.005	http://dx.doi.org/10.1016/j.stem.2010.02.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207218	Bronze			2022-12-28	WOS:000276254600004
J	Charles, N; Ozawa, T; Squatrito, M; Bleau, AM; Brennan, CW; Hambardzumyan, D; Holland, EC				Charles, Nikki; Ozawa, Tatsuya; Squatrito, Massimo; Bleau, Anne-Marie; Brennan, Cameron W.; Hambardzumyan, Dolores; Holland, Eric C.			Perivascular Nitric Oxide Activates Notch Signaling and Promotes Stem-like Character in PDGF-Induced Glioma Cells	CELL STEM CELL			English	Article							SIDE POPULATION; SELF-RENEWAL; BRAIN; EXPRESSION; NICHE; SYNTHASE; GROWTH; NEUROGENESIS; INHIBITION; SUBCLASSES	eNOS expression is elevated in human glioblastomas and correlated with increased tumor growth and aggressive character. We investigated the potential role of nitric oxide (NO) activity in the perivascular niche (PVN) using a genetic engineered mouse model of PDGF-induced gliomas. eNOS expression is highly elevated in tumor vascular endothelium adjacent to perivascular glioma cells expressing Nestin, Notch, and the NO receptor, sGC. In addition, the NO/cGMP/PKG pathway drives Notch signaling in PIDGF-induced gliomas in vitro, and induces the side population phenotype in primary glioma cell cultures. NO also increases neurosphere forming capacity of PDGF-driven glioma primary cultures, and enhances their tumorigenic capacity in vivo. Loss of NO activity in these tumors suppresses Notch signaling in vivo and prolongs survival of mice. This mechanism is conserved in human PDGFR amplified gliomas. The NO/cGMP/PKG pathway's promotion of stem cell-like character in the tumor PVN may identify therapeutic targets for this subset of gliomas.	[Charles, Nikki; Ozawa, Tatsuya; Squatrito, Massimo; Bleau, Anne-Marie; Hambardzumyan, Dolores; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Charles, Nikki; Ozawa, Tatsuya; Squatrito, Massimo; Bleau, Anne-Marie; Brennan, Cameron W.; Hambardzumyan, Dolores; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg & Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, EC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	hollande@mskcc.org	Squatrito, Massimo/F-4149-2016; Brennan, Cameron/R-7082-2019	Squatrito, Massimo/0000-0002-4593-3790; Brennan, Cameron/0000-0003-4064-8891	NIH [U54 CA126518, U54 CA143798]; Litwin Foundation; Leon Levy Foundation; NATIONAL CANCER INSTITUTE [U54CA143798, R01CA100688, U54CA126518] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Litwin Foundation; Leon Levy Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Finney and Q. Zhang for technical assistance and A. Pedraza-Fernandez for providing human tumor neurospheres for analyses. We extend thanks to R. Bish for critical reading and feedback of this manuscript. Sincere thanks to the flow cytometry core facility for acquisition of flow cytometry data. This work was supported by NIH grant U54 CA126518, NIH grant U54 CA143798, and the Litwin Foundation. D.H. is supported by the Leon Levy Foundation.	Bakshi A, 1998, J NEUROL SCI, V155, P196, DOI 10.1016/S0022-510X(97)00315-8; Becher OJ, 2008, CANCER RES, V68, P2241, DOI 10.1158/0008-5472.CAN-07-6350; Bender AT, 2006, PHARMACOL REV, V58, P488, DOI 10.1124/pr.58.3.5; Blaise GA, 2005, TOXICOLOGY, V208, P177, DOI 10.1016/j.tox.2004.11.032; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Broholm H, 2003, CLIN NEUROPATHOL, V22, P273; Butt Elke, 2009, V191, P409, DOI 10.1007/978-3-540-68964-5_17; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chen JL, 2005, J NEUROSCI, V25, P2366, DOI 10.1523/JNEUROSCI.5071-04.2005; Chua C, 2008, J NEUROSURG, V109, P856, DOI 10.3171/JNS/2008/109/11/0856; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; COBBS CS, 1995, CANCER RES, V55, P727; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Folkins C, 2007, CANCER RES, V67, P3560, DOI 10.1158/0008-5472.CAN-06-4238; Franklin K., 2007, MOUSE BRAIN STEREOTA; Fukumura D, 2006, NAT REV CANCER, V6, P521, DOI 10.1038/nrc1910; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hambardzumyan D, 2008, CELL CYCLE, V7, P1371, DOI 10.4161/cc.7.10.5954; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Holland EC, 2004, MOUSE MODELS HUMAN C; Iwata S, 1999, NEUROSURGERY, V45, P24, DOI 10.1097/00006123-199907000-00006; Jin Y, 2009, J CANCER RES CLIN, V135, P1369, DOI 10.1007/s00432-009-0578-4; KLEIHUES P, 1995, GLIA, V15, P211, DOI 10.1002/glia.440150303; Legler JM, 1999, JNCI-J NATL CANCER I, V91, P1382, DOI 10.1093/jnci/91.16.1382; Lewis HD, 2007, CHEM BIOL, V14, P209, DOI 10.1016/j.chembiol.2006.12.010; Lim KH, 2008, NATURE, V452, P646, DOI 10.1038/nature06778; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Madhusoodanan KS, 2007, NEUROCHEM RES, V32, P681, DOI 10.1007/s11064-006-9167-y; OESTERHELD J, 2009, SOME ABC DRUG TRANSP; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Singh SK, 2003, CANCER RES, V63, P5821; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Uhrbom L, 2005, CANCER RES, V65, P2065, DOI 10.1158/0008-5472.CAN-04-3588	45	303	319	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					141	152		10.1016/j.stem.2010.01.001	http://dx.doi.org/10.1016/j.stem.2010.01.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144787	Green Accepted, Bronze			2022-12-28	WOS:000274520800009
J	Seoane, J				Seoane, Joan			NO Signals from the Cancer Stem Cell Niche	CELL STEM CELL			English	Editorial Material							INITIATING CELLS; NEUROGENESIS; BRAIN	Characterization of signaling pathways that control cancer stem cells may lead to more effective treatments against cancer. In this issue of Cell Stem Cell, a study by Charles et al. (2010) identifies the NO and Notch pathways as important regulators of the perivascular niche of cancer stem cells in glioma.	Autonomous Univ Barcelona, ICREA, Vall dHebron Inst Oncol, Vall dHebron Univ Hosp, E-08035 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; ICREA; Vall d'Hebron Institut d'Oncologia (VHIO)	Seoane, J (corresponding author), Autonomous Univ Barcelona, ICREA, Vall dHebron Inst Oncol, Vall dHebron Univ Hosp, Psg Vall dHebron 119-129, E-08035 Barcelona, Spain.	jseoane@vhio.net	Seoane, Joan/AAG-9173-2019	Seoane, Joan/0000-0002-6541-5974	ICREA Funding Source: Custom	ICREA(ICREA)		Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Zhou BBS, 2009, NAT REV DRUG DISCOV, V8, P806, DOI 10.1038/nrd2137	10	1	5	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					97	98		10.1016/j.stem.2010.01.007	http://dx.doi.org/10.1016/j.stem.2010.01.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144782	Bronze			2022-12-28	WOS:000274520800004
J	Charles, NA; Holland, EC				Charles, Nikki A.; Holland, Eric C.			TRRAP and the Maintenance of Stemness in Gliomas	CELL STEM CELL			English	Editorial Material							TUMOR-INITIATING CELLS		[Charles, Nikki A.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Holland, EC (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10065 USA.	hollande@mskcc.org			NATIONAL CANCER INSTITUTE [U54CA126518] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA126518] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BARRETT JF, 1995, J BIOL CHEM, V270, P15923, DOI 10.1074/jbc.270.27.15923; Brennan C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007752; Chen J, 2009, NEUROSCI LETT, V453, P166, DOI 10.1016/j.neulet.2009.02.019; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Wang ZG, 1998, SCIENCE, V279, P1547; Wurdak H, 2010, CELL STEM CELL, V6, P37, DOI 10.1016/j.stem.2009.11.002	10	71	71	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					6	7		10.1016/j.stem.2009.12.005	http://dx.doi.org/10.1016/j.stem.2009.12.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085736	Bronze			2022-12-28	WOS:000274029700004
J	Pellegrini, G; De Luca, M				Pellegrini, Graziella; De Luca, Michele			Human Embryonic Stem Cell-Derived Keratinocytes: How Close to Clinics?	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION; TRANSPLANTATION; PROGENY		[Pellegrini, Graziella; De Luca, Michele] Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, I-41100 Modena, Italy	Universita di Modena e Reggio Emilia	De Luca, M (corresponding author), Univ Modena & Reggio Emilia, Ctr Regenerat Med Stefano Ferrari, I-41100 Modena, Italy.	michele.deluca@unimore.it	Pellegrini, Graziella/E-1189-2015; De Luca, Michele/N-5883-2014	Pellegrini, Graziella/0000-0001-9861-0736; De Luca, Michele/0000-0002-0850-8445				Blanpain C, 2007, NAT CELL BIOL, V9, P731, DOI 10.1038/ncb0707-731; Dabelsteen S, 2009, STEM CELLS, V27, P1388, DOI 10.1002/stem.64; De Luca M, 2006, REGEN MED, V1, P45, DOI 10.2217/17460751.1.1.45; Green H, 2003, P NATL ACAD SCI USA, V100, P15625, DOI 10.1073/pnas.0307226100; Guenou H, 2009, LANCET, V374, P1745, DOI 10.1016/S0140-6736(09)61496-3; Iuchi S, 2006, P NATL ACAD SCI USA, V103, P1792, DOI 10.1073/pnas.0510953103; Kiuru M, 2009, CELL STEM CELL, V4, P289, DOI 10.1016/j.stem.2009.03.010; Mavilio F, 2006, NAT MED, V12, P1397, DOI 10.1038/nm1504; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pellegrini G, 1999, J CELL BIOL, V145, P769, DOI 10.1083/jcb.145.4.769	10	10	10	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					8	9		10.1016/j.stem.2009.12.002	http://dx.doi.org/10.1016/j.stem.2009.12.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085737	Bronze			2022-12-28	WOS:000274029700005
J	Li, G; Bien-Ly, N; Andrews-Zwilling, Y; Xu, Q; Bernardo, A; Ring, K; Halabisky, B; Deng, CH; Mahley, RW; Huang, YD				Li, Gang; Bien-Ly, Nga; Andrews-Zwilling, Yaisa; Xu, Qin; Bernardo, Aubrey; Ring, Karen; Halabisky, Brian; Deng, Changhui; Mahley, Robert W.; Huang, Yadong			GABAergic Interneuron Dysfunction Impairs Hippocampal Neurogenesis in Adult Apolipoprotein E4 Knockin Mice	CELL STEM CELL			English	Article							POSTNATAL SUBVENTRICULAR ZONE; TARGETED-REPLACEMENT MICE; NEWLY GENERATED NEURONS; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; ALZHEIMERS-DISEASE; TRANSGENIC MICE; HUMAN BRAIN; OLFACTORY-BULB; DENTATE GYRUS	Apolipoprotein (apo) E, a polymorphic protein with three isoforms (apoE2, apoE3, and apoE4), is essential for lipid homeostasis. Carriers of apoE4 are at higher risk for developing Alzheimer's disease. We have investigated adult neurogenesis in mice with knockout (KO) for apoE or with knockin (KI) alleles for human apoE3 or apoE4, and we report that neurogenesis is reduced in both apoE-KO and apoE4-KI mice. In apoE-KO mice, increased BMP signaling promoted glial differentiation at the expense of neurogenesis. In contrast, in apoE4-KI mice, presynaptic GABAergic input-mediated maturation of newborn neurons was diminished. Tau phosphorylation, an Alzheimer's disease characteristic, and levels of neurotoxic apoE fragments were both elevated in apoE4-KI hippocampal neurons concomitant with decreased GABAergic interneuron survival. Potentiating GABAergic signaling restored neuronal maturation and neurogenesis in apoE4-KI mice to normal levels. These findings suggest that GABAergic signaling can be targeted to mitigate the deleterious effects of apoE4 on neurogenesis.	[Li, Gang; Bien-Ly, Nga; Andrews-Zwilling, Yaisa; Xu, Qin; Bernardo, Aubrey; Ring, Karen; Halabisky, Brian; Mahley, Robert W.; Huang, Yadong] Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Li, Gang; Andrews-Zwilling, Yaisa; Huang, Yadong] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Bien-Ly, Nga; Ring, Karen; Huang, Yadong] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Deng, Changhui] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA; [Mahley, Robert W.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Mahley, Robert W.; Huang, Yadong] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA; [Mahley, Robert W.; Huang, Yadong] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Huang, YD (corresponding author), Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	yhuang@gladstone.ucsf.edu	Deng, Changhui/A-1010-2012	Li, Gang/0000-0002-1933-484X	California Institute of Regenerative Medicine [T2-00003, RN2-00952-1]; National Institutes of Health [P01 AG022074]; NATIONAL INSTITUTE ON AGING [P01AG022074] Funding Source: NIH RePORTER	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the J. David Gladstone Institutes, grants T2-00003 and RN2-00952-1 from the California Institute of Regenerative Medicine, and grant P01 AG022074 from the National Institutes of Health. The retroviral construct encoding GFP was a generous gift of Dr. Fred H. Gage (Salk Institute for Biological Studies, La Jolla, CA). We thank John Carroll and Alisha Wilson for graphics, Linda Turney for manuscript preparation, and Stephen Ordway and Gary Howard for editorial assistance.	Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Aoki K, 2003, STROKE, V34, P875, DOI 10.1161/01.STR.0000064320.73388.C6; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bour A, 2008, BEHAV BRAIN RES, V193, P174, DOI 10.1016/j.bbr.2008.05.008; Brecht WJ, 2004, J NEUROSCI, V24, P2527, DOI 10.1523/JNEUROSCI.4315-03.2004; Brewer GJ, 2007, NAT PROTOC, V2, P1490, DOI 10.1038/nprot.2007.207; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Caselli RJ, 2009, NEW ENGL J MED, V361, P255, DOI 10.1056/NEJMoa0809437; Chang SJ, 2005, P NATL ACAD SCI USA, V102, P18694, DOI 10.1073/pnas.0508254102; Chen J, 2005, J BIOL CHEM, V280, P40364, DOI 10.1074/jbc.M509329200; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Cohen RM, 2001, NEUROLOGY, V57, P2223, DOI 10.1212/WNL.57.12.2223; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Earnheart JC, 2007, J NEUROSCI, V27, P3845, DOI 10.1523/JNEUROSCI.3609-06.2007; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fan XT, 2003, DEV BRAIN RES, V146, P51, DOI 10.1016/j.devbrainres.2003.09.007; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2007, TRENDS NEUROSCI, V30, P1, DOI 10.1016/j.tins.2006.11.001; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; GOTZ J, 1995, EMBO J, V14, P1304, DOI 10.1002/j.1460-2075.1995.tb07116.x; Grootendorst J, 2005, BEHAV BRAIN RES, V159, P1, DOI 10.1016/j.bbr.2004.09.019; Harris FM, 2004, J BIOL CHEM, V279, P3862, DOI 10.1074/jbc.M309475200; Harris FM, 2003, P NATL ACAD SCI USA, V100, P10966, DOI 10.1073/pnas.1434398100; Huang Y, 2006, CURR OPIN DRUG DISC, V9, P627; Huang YD, 2004, J MOL NEUROSCI, V23, P189, DOI 10.1385/JMN:23:3:189; Huang YD, 2006, NEUROLOGY, V66, pS79, DOI 10.1212/01.wnl.0000192102.41141.9e; Huang YD, 2001, P NATL ACAD SCI USA, V98, P8838, DOI 10.1073/pnas.151254698; Ishihara T, 1999, NEURON, V24, P751, DOI 10.1016/S0896-6273(00)81127-7; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; KAPLAN MS, 1984, J NEUROSCI, V4, P1429; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu XX, 2005, NAT NEUROSCI, V8, P1179, DOI 10.1038/nn1522; Liu ZP, 2006, SCIENCE, V314, P1610, DOI 10.1126/science.1134246; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Moffat SD, 2000, NEUROLOGY, V55, P134, DOI 10.1212/WNL.55.1.134; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Raber J, 1998, P NATL ACAD SCI USA, V95, P10914, DOI 10.1073/pnas.95.18.10914; Raber J, 2000, NATURE, V404, P352, DOI 10.1038/35006165; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; SAUNDERS AM, 1993, NEUROLOGY, V43, P1467, DOI 10.1212/WNL.43.8.1467; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Suh H, 2009, ANNU REV CELL DEV BI, V25, P253, DOI 10.1146/annurev.cellbio.042308.113256; Sullivan PM, 2004, NEUROSCIENCE, V124, P725, DOI 10.1016/j.neuroscience.2003.10.011; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Tanzi RE, 2001, NEURON, V32, P181, DOI 10.1016/S0896-6273(01)00476-7; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Villasana L, 2006, RADIAT RES, V166, P883, DOI 10.1667/RR0642.1; Xu PT, 1999, AM J PATHOL, V154, P601, DOI 10.1016/S0002-9440(10)65305-9; Xu Q, 2008, J NEUROSCI, V28, P1452, DOI 10.1523/JNEUROSCI.3253-07.2008; Xu Q, 2006, J NEUROSCI, V26, P4985, DOI 10.1523/JNEUROSCI.5476-05.2006; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	69	174	177	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					634	645		10.1016/j.stem.2009.10.015	http://dx.doi.org/10.1016/j.stem.2009.10.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951691	Green Accepted, Bronze			2022-12-28	WOS:000273616700011
J	Ma, DKK; Ming, GL; Song, HJ				Ma, Dengke K.; Ming, Guo-li; Song, Hongjun			Oxysterols Drive Dopaminergic Neurogenesis from Stem Cells	CELL STEM CELL			English	Editorial Material							LIVER-X RECEPTOR; DISEASE	Stem cell therapy for Parkinson's disease requires effective production of dopaminergic neurons. In this issue of Cell Stem Cell, Sacchetti et al. (2009) report an unexpected role of liver X receptors and their ligand, oxysterols, in regulating dopaminergic neurogenesis.	[Ma, Dengke K.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21209 USA; [Ma, Dengke K.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21209 USA; [Ma, Dengke K.; Ming, Guo-li; Song, Hongjun] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21209 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Song, HJ (corresponding author), Johns Hopkins Univ, Sch Med, Inst Cell Engn, Baltimore, MD 21209 USA.	shongju1@jhmi.edu	Ming, Guo-li/J-7880-2013; Ma, Nan/L-1282-2013	Ma, Nan/0000-0003-4006-1003; Ming, Guo-li/0000-0002-2517-6075	NICHD NIH HHS [R01 HD069184] Funding Source: Medline; NINDS NIH HHS [R21 NS095348, R01 NS048271] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069184] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS095348, R01NS048271] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Gale E, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-8; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P2094, DOI 10.1073/pnas.0711599105; Kim SU, 2009, J NEUROSCI RES, V87, P2183, DOI 10.1002/jnr.22054; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; McKay RD, 2004, PHILOS T R SOC B, V359, P851, DOI 10.1098/rstb.2004.1472; Sacchetti P, 2009, CELL STEM CELL, V5, P409, DOI 10.1016/j.stem.2009.08.019; Vedin LL, 2009, CARCINOGENESIS, V30, P575, DOI 10.1093/carcin/bgp029; Volle DH, 2007, MOL ENDOCRINOL, V21, P1014, DOI 10.1210/me.2006-0277	10	5	5	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					343	344		10.1016/j.stem.2009.09.001	http://dx.doi.org/10.1016/j.stem.2009.09.001			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796609	Bronze, Green Accepted			2022-12-28	WOS:000271401900001
J	Zhang, YV; Cheong, J; Ciapurin, N; McDermitt, DJ; Tumbar, T				Zhang, Ying V.; Cheong, Janice; Ciapurin, Nichita; McDermitt, David J.; Tumbar, Tudorita			Distinct Self-Renewal and Differentiation Phases in the Niche of Infrequently Dividing Hair Follicle Stem Cells	CELL STEM CELL			English	Article							ACTIVATION; SKIN; KERATINOCYTES; REGENERATION; EXPRESSION; EPIDERMIS; DEFECTS; LGR5	In homeostasis of adult vertebrate tissues, stem cells are thought to self-renew by infrequent and asymmetric divisions that generate another stem cell daughter and a progenitor daughter cell committed to differentiate. This model is based largely on in vivo invertebrate or in vitro mammal studies. Here, we examine the dynamic behavior of adult hair follicle stem cells in their normal setting by employing mice with repressible H2B-GFP expression to track cell divisions and Cre-inducible mice to perform long-term single-cell lineage tracing. We provide direct evidence for the infrequent stem cell division model in intact tissue. Moreover, we find that differentiation of progenitor cells occurs at different times and tissue locations than self-renewal of stem cells. Distinct fates of differentiation or self-renewal are assigned to individual cells in a temporal-spatial manner. We propose that large clusters of tissue stem cells behave as populations whose maintenance involves unidirectional daughter-cell-fate decisions.	[Zhang, Ying V.; Cheong, Janice; Ciapurin, Nichita; McDermitt, David J.; Tumbar, Tudorita] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Cornell University	Tumbar, T (corresponding author), Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA.	tt252@cornell.edu	; Tumbar, Tudorita/A-1916-2014	Chapurin, Nikita/0000-0002-3744-0451; Tumbar, Tudorita/0000-0002-2273-1889	NIH/NIAMS [AR053201]; NYSTEM; Cornell Vertebrate Genomics Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R56AR053201, R01AR053201] Funding Source: NIH RePORTER	NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NYSTEM; Cornell Vertebrate Genomics Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Dr. Jim Smith and Jie Zhao for help with FACS and microarray data generation and Dr. Wei Wang and Dr. Jeff Pleiss for help with microarray data analysis. We thank our colleagues for critical reading of the manuscript. Funding was provided by NIH/NIAMS AR053201 and NYSTEM (2008 Award) grants to T. T and a Cornell Vertebrate Genomics Institute fellowship to Y.V.Z.	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jones CL, 1997, ARCH BIOCHEM BIOPHYS, V347, P163, DOI 10.1006/abbi.1997.0350; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Luong MX, 2002, MOL CELL BIOL, V22, P1424, DOI 10.1128/MCB.22.5.1424-1437.2002; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Osorio KM, 2008, DEVELOPMENT, V135, P1059, DOI 10.1242/dev.012799; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; RIEGER E, 1994, J INVEST DERMATOL, V103, P341, DOI 10.1111/1523-1747.ep12394888; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Sur I, 2006, J CELL SCI, V119, P3593, DOI 10.1242/jcs.03070; Tanahashi H, 2000, ANAL BIOCHEM, V279, P122, DOI 10.1006/abio.1999.4444; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Vasioukhin V, 1999, P NATL ACAD SCI USA, V96, P8551, DOI 10.1073/pnas.96.15.8551; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72	24	156	160	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					267	278		10.1016/j.stem.2009.06.004	http://dx.doi.org/10.1016/j.stem.2009.06.004			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19664980	Green Accepted, Bronze			2022-12-28	WOS:000272545700013
J	Hutchins, AP; Robson, P				Hutchins, Andrew P.; Robson, Paul			Unraveling the Human Embryonic Stem Cell Phosphoproteome	CELL STEM CELL			English	Editorial Material							TANDEM MASS-SPECTROMETRY; DIFFERENTIATION	The human embryonic stem cell (hESC) transcriptome is well described, but minimal proteome characterization is available. In this issue of Cell Stem Cell, Brill et al. (2009) and Van Hoof et al. (2009) describe the hESC phosphoproteome and its changes upon differentiation.	[Hutchins, Andrew P.; Robson, Paul] Genome Inst Singapore, Singapore 138672, Singapore; [Robson, Paul] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Robson, P (corresponding author), Genome Inst Singapore, Singapore 138672, Singapore.	robsonp@gis.a-star.edu.sg	Robson, Paul/A-3464-2009; Hutchins, Andrew/G-5496-2011; Hutchins, Andrew/O-5708-2018	Robson, Paul/0000-0002-0191-3958; Hutchins, Andrew/0000-0001-7784-2255				Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Swaney DL, 2008, NAT METHODS, V5, P959, DOI 10.1038/nmeth.1260; Swaney DL, 2009, P NATL ACAD SCI USA, V106, P995, DOI 10.1073/pnas.0811964106; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761	10	10	12	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					126	128		10.1016/j.stem.2009.07.007	http://dx.doi.org/10.1016/j.stem.2009.07.007			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664982	Bronze			2022-12-28	WOS:000269511900002
J	Ko, K; Tapia, N; Wu, GM; Kim, JB; Arauzo-Bravo, MJ; Sasse, P; Glaser, T; Ruau, D; Han, DW; Greber, B; Hausdorfer, K; Sebastiano, V; Stehling, M; Fleischmann, BK; Brustle, O; Zenke, M; Scholer, HR				Ko, Kinarm; Tapia, Natalia; Wu, Guangming; Kim, Jeong Beom; Arauzo-Bravo, Marcos J.; Sasse, Philipp; Glaser, Tamara; Ruau, David; Han, Dong Wook; Greber, Boris; Hausdoerfer, Kirsten; Sebastiano, Vittorio; Stehling, Martin; Fleischmann, Bernd K.; Bruestle, Oliver; Zenke, Martin; Schoeler, Hans R.			Induction of Pluripotency in Adult Unipotent Germline Stem Cells	CELL STEM CELL			English	Article							LONG-TERM PROLIFERATION; MYELIN-DEFICIENT RAT; MOUSE TESTIS; RETINOIC ACID; SELF-RENEWAL; GENERATION; CULTURE; SPERMATOGENESIS; ESTABLISHMENT; METHYLATION	Mouse and human stem cells with features similar to those of embryonic stem cells have been derived from testicular cells. Although pluripotent stem cells have been obtained from defined germline stem cells (GSCs) of mouse neonatal testis, only multipotent stem cells have been obtained so far from defined cells of mouse adult testis. In this study we describe a robust and reproducible protocol for obtaining germ line-derived pluripotent stem (gPS) cells from adult unipotent GSCs. Pluripotency of gPS cells was confirmed by in vitro and in vivo differentiation, including germ cell contribution and transmission. As determined by clonal analyses, gPS cells indeed originate from unipotent GSCs. We propose that the conversion process requires a GSC culture microenvironment that depends on the initial number of plated GSCs and the length of culture time.	[Ko, Kinarm; Tapia, Natalia; Wu, Guangming; Kim, Jeong Beom; Arauzo-Bravo, Marcos J.; Han, Dong Wook; Greber, Boris; Sebastiano, Vittorio; Stehling, Martin; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Sasse, Philipp; Fleischmann, Bernd K.] Univ Bonn, Life & Brain Ctr, Inst Physiol 1, D-53105 Bonn, Germany; [Glaser, Tamara; Hausdoerfer, Kirsten; Bruestle, Oliver] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53105 Bonn, Germany; [Glaser, Tamara; Hausdoerfer, Kirsten; Bruestle, Oliver] Hertie Fdn, D-53105 Bonn, Germany; [Ruau, David; Zenke, Martin] Rhein Westfal TH Aachen, Sch Med, Dept Cell Biol, Inst Biomed Engn, D-52074 Aachen, Germany; [Ruau, David; Zenke, Martin] Rhein Westfal TH Aachen, Helmholtz Inst Biomed Engn, D-52074 Aachen, Germany	Max Planck Society; University of Bonn; University of Bonn; RWTH Aachen University; Helmholtz Association; RWTH Aachen University	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Han, Dong Wook/D-6041-2011; , HS/AAB-4434-2019; Marcos, Arauzo-Bravo/A-1706-2011; Sasse, Philipp/G-9866-2013; Tapia, Natalia/H-5500-2012	, HS/0000-0003-2643-5136; Marcos, Arauzo-Bravo/0000-0002-3264-464X; Sasse, Philipp/0000-0002-8502-9472; Greber, Boris/0000-0002-9404-7293; Tapia, Natalia/0000-0003-0226-1952; Kim, Jeong Beom/0000-0001-6230-8826; Wu, Guangming/0000-0003-1923-7609	Max Planck Society; DFG [SPP 1356, SCHO 340/5-1, ZE 432/5-1]; BMBF grant [FKZ 01GN0811]	Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); BMBF grant(Federal Ministry of Education & Research (BMBF))	We thank Jeanine MOller-Keuker for critically reviewing and Areti Malapetsas and Susanne Kolsch for editing the manuscript, as well as Anna Niehues and Martina Bleidissel for providing technical assistance with the experiments. We also thank Dr. Takashi Shinohara of Kyoto University for providing ESC-like cells from PND 0-2 testes and Dr. Kaomei Guan of Georg-August-University (Gottingen) for multipotent GSCs. This work was supported by the Max Planck Society and the DFG grants SPP 1356 "Pluripotency and Cellular Reprogramming" (SCHO 340/5-1 and ZE 432/5-1), as well as the BMBF grant "Diseasespecific iPS cells" (FKZ 01GN0811).	Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; BOISON D, 1989, EMBO J, V8, P3295, DOI 10.1002/j.1460-2075.1989.tb08490.x; Brustle O, 1999, SCIENCE, V285, P754, DOI 10.1126/science.285.5428.754; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Dann CT, 2008, STEM CELLS, V26, P2928, DOI 10.1634/stemcells.2008-0134; Duncan ID, 1997, MOL MED TODAY, V3, P554, DOI 10.1016/S1357-4310(97)01162-3; FEIL R, 1994, DEVELOPMENT, V120, P2933; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Igelmund P, 1999, PFLUG ARCH EUR J PHY, V437, P669, DOI 10.1007/s004240050831; Izadyar F, 2008, REPRODUCTION, V135, P771, DOI 10.1530/REP-07-0479; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Kehler J, 2004, EMBO REP, V5, P1078, DOI 10.1038/sj.embor.7400279; Kerjean A, 2000, HUM MOL GENET, V9, P2183, DOI 10.1093/hmg/9.14.2183; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; KOEPPEN AH, 1988, J NEUROL SCI, V84, P315, DOI 10.1016/0022-510X(88)90135-9; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Looijenga LHJ, 2007, ANN NY ACAD SCI, V1120, P187, DOI 10.1196/annals.1411.000; Looijenga LHJ, 2003, CANCER RES, V63, P2244; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Narasimha M, 1997, CURR BIOL, V7, P881, DOI 10.1016/S0960-9822(06)00377-0; Ogawa T, 1997, INT J DEV BIOL, V41, P111; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; WOOD SA, 1993, NATURE, V365, P87, DOI 10.1038/365025a0; Yeh JR, 2007, BIOL REPROD, V77, P897, DOI 10.1095/biolreprod.107.063057	34	190	197	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					87	96		10.1016/j.stem.2009.05.025	http://dx.doi.org/10.1016/j.stem.2009.05.025			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570517	Bronze			2022-12-28	WOS:000267879200013
J	Sweet, D				Sweet, Deborah			Enjoying the Ride-(sic)Vivan las celulas madre!	CELL STEM CELL			English	Editorial Material																		Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Park Alice, 2009, Time, V173, P38; Rugg-Gunn PJ, 2009, CELL STEM CELL, V4, P285, DOI 10.1016/j.stem.2009.03.004	5	0	0	1	14	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					465	465		10.1016/j.stem.2009.05.018	http://dx.doi.org/10.1016/j.stem.2009.05.018			1	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497270	Bronze			2022-12-28	WOS:000266793600001
J	Semb, H				Semb, Henrik			Expandable Endodermal Progenitors: New Tools to Explore Endoderm and Its Derivatives	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; FGF; DIFFERENTIATION; ZEBRAFISH; INDUCTION; MESODERM	In the two recent issues of Cell Stem Cell, Rossant and colleagues (Seguin et al., 2008) produced expandable endoderm from hESCs by constitutive expression of Sox transcription factors, while Brickman and associates (Morrison et al., 2008) used a reporter gene strategy to isolate replicating anterior definitive endoderm from mESCs.	Lund Univ, Stem Cell Ctr, S-22184 Lund, Sweden	Lund University	Semb, H (corresponding author), Lund Univ, Stem Cell Ctr, BMC B10, S-22184 Lund, Sweden.	henrik.semb@med.lu.se		Semb, Henrik/0000-0002-6747-787X				Cai J, 2007, HEPATOLOGY, V45, P1229, DOI 10.1002/hep.21582; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Deutsch G, 2001, DEVELOPMENT, V128, P871; Mizoguchi T, 2006, DEV BIOL, V300, P612, DOI 10.1016/j.ydbio.2006.08.073; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Seguin CA, 2008, CELL STEM CELL, V3, P182, DOI 10.1016/j.stem.2008.06.018	9	4	6	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					355	356		10.1016/j.stem.2008.09.010	http://dx.doi.org/10.1016/j.stem.2008.09.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940723	Bronze			2022-12-28	WOS:000260149800001
J	Tlsty, TD				Tlsty, Thea D.			A Twist of Cell Fate	CELL STEM CELL			English	Editorial Material							MAMMARY EPITHELIAL-CELLS; BRCA1; DIFFERENTIATION	Individuals carrying deleterious BRCA1 mutations typically develop basal-like rather than luminal breast cancers. In this issue of Cell Stem Cell, Proia et al. (2011) study breast tissue from women with heterozygous BRCA1 mutations and identify molecular mechanisms that regulate mammary progenitor cell differentiation and bias toward subsequent basal-like tumor formation.	Univ Calif San Francisco, San Francisco, CA 94143 USA	University of California System; University of California San Francisco	Tlsty, TD (corresponding author), Univ Calif San Francisco, Box 0506, San Francisco, CA 94143 USA.	thea.tlsty@ucsf.edu						Boulton SJ, 2006, BIOCHEM SOC T, V34, P633, DOI 10.1042/BST0340633; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Hakem R, 1998, J MAMMARY GLAND BIOL, V3, P431, DOI 10.1023/A:1018792200700; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Lord CJ, 2008, CURR OPIN PHARMACOL, V8, P363, DOI 10.1016/j.coph.2008.06.016; OSTERMEYER EA, 1994, COLD SPRING HARB SYM, V59, P523, DOI 10.1101/SQB.1994.059.01.058; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007	9	2	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					126	127		10.1016/j.stem.2011.01.004	http://dx.doi.org/10.1016/j.stem.2011.01.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295267	Bronze			2022-12-28	WOS:000287633400004
J	Gottweis, H				Gottweis, Herbert			The Endless hESC Controversy in the United States: History, Context, and Prospects	CELL STEM CELL			English	Editorial Material							EMBRYO RESEARCH; POLICY	Human embryonic stem cell research has faced a long, tough political battle in the United States. The article explores the history of this controversy and the motives behind it, leading up to the August 23, 2010 district court injunction temporarily stopping all U.S. federal funding for research with human ESCs.	[Gottweis, Herbert] Univ Vienna, A-1014 Vienna, Austria; [Gottweis, Herbert] United Nations Univ, Shibuya Ku, Tokyo 1508925, Japan	University of Vienna; United Nations University	Gottweis, H (corresponding author), Univ Vienna, Univ Str 7, A-1014 Vienna, Austria.	herbert.gottweis@univie.ac.at						Annas GJ, 1999, NAT MED, V5, P1339, DOI 10.1038/70900; CHAMBERLAIN P, 2010, POLISHED LENSES FOCU; Gottweis H, 2009, HEALTH TECHNOL SOC, P1, DOI 10.1057/9780230594364; Khushf G, 1997, J MED PHILOS, V22, P495; KINNER JK, 2000, ETHICAL ISSUES HUMAN, V2, pG1; RABB H, 1999, FEDERAL FUNDING RES; Tauer CA, 1997, J MED PHILOS, V22, P423; VAWTER DE, 1993, POLIT LIFE SCI, V12, P79, DOI 10.1017/S0730938400011278	8	14	15	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					555	558		10.1016/j.stem.2010.10.008	http://dx.doi.org/10.1016/j.stem.2010.10.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040896	Bronze			2022-12-28	WOS:000284390500006
J	Bondar, T; Medzhitov, R				Bondar, Tanya; Medzhitov, Ruslan			p53-Mediated Hematopoietic Stem and Progenitor Cell Competition	CELL STEM CELL			English	Article							WILD-TYPE P53; DNA-DAMAGE; RADIATION SENSITIVITY; NICHE OCCUPANCY; B-LYMPHOCYTES; MICE; REPAIR; SELECTION; RADIOSENSITIVITY; COMPARTMENTS	Cell competition was originally described in Drosophila as a process for selection of the fittest cells. It is likely to play an important role in tissue homeostasis in all metazoans, but little is known about its role and regulation in mammals. By using genetic mosaic mouse models and bone marrow chimeras, we describe here a form of cell competition that selects for the least damaged cells. This competition is controlled by p53 but is distinct from the classical p53-mediated DNA damage response: it persists for months, is specific to the hematopoietic stem and progenitor cells, and depends on the relative rather than absolute level of p53 in competing cells. The competition appears to be mediated by a non-cell-autonomous induction of growth arrest and senescence-related gene expression in outcompeted cells with higher p53 activity, p53-mediated cell competition of this type could potentially contribute to the clonal expansion of incipient cancer cells.	[Bondar, Tanya; Medzhitov, Ruslan] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Bondar, Tanya; Medzhitov, Ruslan] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06510 USA	Howard Hughes Medical Institute; Yale University; Yale University	Medzhitov, R (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA.		Bondar, Tanya/T-5576-2017	Bondar, Tanya/0000-0003-4765-8910	Leukemia and Lymphoma Society; the Howard Hughes Medical Institute; Yale Center of Excellence in Molecular Hematology [P30 DK072442]; NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI046688, R01AI055502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK072442, R01DK071754] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); the Howard Hughes Medical Institute(Howard Hughes Medical Institute); Yale Center of Excellence in Molecular Hematology; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Dr Klaus Rajewsky for Rosa26 targeting vector and Bruce4 ESCs, Dr Frank Costantini for providing Rosa26-LSL-eYFP mice, Dr Irving Weissman for providing H<SUP>k</SUP>-Bcl2 mice, Dr Jean-Chnstophe Marine for providing Mdm2<SUP>+/-</SUP> mice, Timothy Nottoli for technical assistance in generating R26-mp53 knockin mice, Charles Anicelli and Sophie Cronin for expert mouse work, Gouzel Tokmulina, Tom Taylor, and Xiao Xiao for FACS sorting, Bohwoo Kim and Sasha Stone for technical assistance. all R M lab members for insightful discussions, and Maya Kotas, Oscar Colegio, Arun Unni, and Dan Stetson for critical reading of the manuscript T B is supported by Leukemia and Lymphoma Society postdoctoral fellowship Supported by the Howard Hughes Medical Institute, Yale Center of Excellence in Molecular Hematology Award P30 DK072442, and grants from NIH	Adachi-Yamada T, 2004, J BIOCHEM, V136, P13, DOI 10.1093/jb/mvh099; ANDERSON RE, 1977, J IMMUNOL, V118, P1191; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Badea TC, 2003, J NEUROSCI, V23, P2314; Bahar R, 2006, NATURE, V441, P1011, DOI 10.1038/nature04844; Baker NE, 2008, CANCER RES, V68, P5505, DOI 10.1158/0008-5472.CAN-07-6348; Bar J, 2010, SEMIN CELL DEV BIOL, V21, P47, DOI 10.1016/j.semcdb.2009.11.006; Betz UAK, 1996, CURR BIOL, V6, P1307, DOI 10.1016/S0960-9822(02)70717-3; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chambers SM, 2007, PLOS BIOL, V5, P1750, DOI 10.1371/journal.pbio.0050201; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Christophorou MA, 2005, NAT GENET, V37, P718, DOI 10.1038/ng1572; Chumakov PM, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1399, DOI 10.1134/S0006297907130019; de la Cova C, 2004, CELL, V117, P107, DOI 10.1016/S0092-8674(04)00214-4; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; Fitzpatrick MJ, 2007, NATURE, V447, P210, DOI 10.1038/nature05764; Fujikawa K, 2000, J RADIAT RES, V41, P113, DOI 10.1269/jrr.41.113; HODGSON GS, 1984, EXP HEMATOL, V12, P683; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Itahana K, 2001, EUR J BIOCHEM, V268, P2784, DOI 10.1046/j.1432-1327.2001.02228.x; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; KATAOKA Y, 1975, IMMUNOLOGY, V29, P121; Khare A, 2006, NAT REV GENET, V7, P577, DOI 10.1038/nrg1875; Kortlever RM, 2006, NAT CELL BIOL, V8, P877, DOI 10.1038/ncb1448; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Levine AJ, 2006, CELL DEATH DIFFER, V13, P1027, DOI 10.1038/sj.cdd.4401910; Levine AJ, 2009, NAT REV CANCER, V9, P749, DOI 10.1038/nrc2723; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Marusyk A, 2008, BBA-REV CANCER, V1785, P1, DOI 10.1016/j.bbcan.2007.09.001; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; MORATA G, 1975, DEV BIOL, V42, P211, DOI 10.1016/0012-1606(75)90330-9; Morata G, 2007, DEV CELL, V13, P1, DOI 10.1016/j.devcel.2007.06.002; Moreno E, 2004, CELL, V117, P117, DOI 10.1016/S0092-8674(04)00262-4; Moreno E, 2008, NAT REV CANCER, V8, P141, DOI 10.1038/nrc2252; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Oertel M, 2006, GASTROENTEROLOGY, V130, P507, DOI 10.1053/j.gastro.2005.10.049; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; PLOEMACHER RE, 1992, INT J RADIAT BIOL, V61, P489, DOI 10.1080/09553009214551251; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rhiner C, 2009, DEVELOPMENT, V136, P995, DOI 10.1242/dev.033340; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Santorelli LA, 2008, NATURE, V451, P1107, DOI 10.1038/nature06558; Sasaki Y, 2006, IMMUNITY, V24, P729, DOI 10.1016/j.immuni.2006.04.005; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; SIMPSON P, 1981, DEV BIOL, V85, P299, DOI 10.1016/0012-1606(81)90261-X; Spencer SL, 2009, NATURE, V459, P428, DOI 10.1038/nature08012; SPRENT J, 1991, J EXP MED, V174, P717, DOI 10.1084/jem.174.3.717; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Stirewalt DL, 2009, LEUKEMIA, V23, P391, DOI 10.1038/leu.2008.176; TANG X, 2002, ONCOGENE, V23, P5759; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Tyler DM, 2007, GENETICS, V175, P643, DOI 10.1534/genetics.106.061929; VANBEKKUM DW, 1991, RADIAT RES, V128, pS4, DOI 10.2307/3577994; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Weisz L, 2007, ONCOGENE, V26, P2202, DOI 10.1038/sj.onc.1210294; Willis A, 2004, ONCOGENE, V23, P2330, DOI 10.1038/sj.onc.1207396; Wlodarski P, 1998, BLOOD, V91, P2998, DOI 10.1182/blood.V91.8.2998.2998_2998_3006; Zhao HQ, 2001, CELL, V104, P651, DOI 10.1016/S0092-8674(02)01107-8	81	228	234	2	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					309	322		10.1016/j.stem.2010.03.002	http://dx.doi.org/10.1016/j.stem.2010.03.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362536	Bronze, Green Accepted			2022-12-28	WOS:000276823300010
J	Braun, SMG; Jessberger, S				Braun, Simon M. G.; Jessberger, Sebastian			Crossing Boundaries: Direct Programming of Fibroblasts into Neurons	CELL STEM CELL			English	Editorial Material							CELLS	In a recent paper in Nature, Vierbuchen et al. (2010) show that fibroblasts can be directly converted into functional neurons by defined factors. This finding sheds new light on the biology underlying cell-fate restrictions and might offer a new avenue for studying neurological diseases.	[Braun, Simon M. G.; Jessberger, Sebastian] Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland	ETH Zurich	Jessberger, S (corresponding author), Swiss Fed Inst Technol, Inst Cell Biol, Dept Biol, Schafmattstr 18, CH-8093 Zurich, Switzerland.	jessberger@cell.biol.ethz.ch	Jessberger, Sebastian/AAJ-4032-2020	Jessberger, Sebastian/0000-0002-0056-8275; Braun, Simon/0000-0003-2622-9914				Casarosa S, 1999, DEVELOPMENT, V126, P525; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jessberger S, 2008, NAT NEUROSCI, V11, P888, DOI 10.1038/nn.2148; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; VIERBUCHEN T, 2010, NATURE IN PRESS 0127, DOI DOI 10.1038/NATURE08797; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	10	3	3	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					189	191		10.1016/j.stem.2010.02.004	http://dx.doi.org/10.1016/j.stem.2010.02.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207219	Bronze			2022-12-28	WOS:000276254600005
J	Ikushima, H; Todo, T; Ino, Y; Takahashi, M; Miyazawa, K; Miyazono, K				Ikushima, Hiroaki; Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi; Miyazawa, Keiji; Miyazono, Kohei			Autocrine TGF-beta Signaling Maintains Tumorigenicity of Glioma-Initiating Cells through Sry-Related HMG-Box Factors	CELL STEM CELL			English	Article							GROWTH-FACTOR-BETA; SEX-DETERMINING REGION; EMBRYONIC STEM-CELLS; MESENCHYMAL TRANSITION; GENE-EXPRESSION; SOX4 EXPRESSION; SELF-RENEWAL; CANCER; IDENTIFICATION; GLIOBLASTOMA	Despite aggressive surgery, radiotherapy, and chemotherapy, treatment of malignant glioma remains formidable. Although the concept of cancer stem cells reveals a new framework of cancer therapeutic strategies against malignant glioma, it remains unclear how glioma stem cells could be eradicated. Here, we demonstrate that autocrine TGF-beta signaling plays an essential role in retention of sternness of glioma-initiating cells (GICs) and describe the underlying mechanism for it. TGF-beta-induced expression of Sox2, a stemness gene, and this induction was mediated by Sox4, a direct TGF-beta target gene. Inhibitors of TGF-beta signaling drastically deprived tumorigenicity of GICs by promoting their differentiation, and these effects were attenuated in GICs transduced with Sox2 or Sox4. Furthermore, GICs pretreated with TGF-beta signaling inhibitor exhibited less lethal potency in intracranial transplantation assay. These results identify an essential pathway for GICs, the TGF-beta-Sox4-Sox2 pathway, whose disruption would be a therapeutic strategy against gliomas.	[Ikushima, Hiroaki; Miyazawa, Keiji; Miyazono, Kohei] Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi; Takahashi, Masamichi] Univ Tokyo, Grad Sch Med, Dept Neurosurg, Tokyo 1130033, Japan; [Todo, Tomoki; Ino, Yasushi] Univ Tokyo, Grad Sch Med, Translat Res Ctr, Tokyo 1130033, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Miyazono, K (corresponding author), Univ Tokyo, Grad Sch Med, Dept Mol Pathol, Tokyo 1130033, Japan.	miyazono@m.u-tokyo.ac.jp	MIYAZAWA, KEIJI/I-9713-2014; Takahashi, Masamichi/GRJ-2866-2022	Todo, Tomoki/0000-0003-0523-8010; Takahashi, Masamichi/0000-0001-8792-1993	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for the Promotion of Science for Young Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We are grateful to Yasuyuki Morishita, Daisuke Itoh, Hiroshi Yoshida, and Chihana Fujita for skilled technical assistance. This work was supported by KAKENHI (Grant-in-aid for Scientific Research) and Global COE Program (integrative Life Science Based on the Study of Biosignaling Mechanisms) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. H.I. has been supported by a Tetsumon-scholarship for the Ph.D.-M.D. program of the University of Tokyo and by a research fellowship of the Japan Society for the Promotion of Science for Young Scientists.	Aaboe M, 2006, CANCER RES, V66, P3434, DOI 10.1158/0008-5472.CAN-05-3456; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Cheung M, 2000, MOL BRAIN RES, V79, P180, DOI 10.1016/S0169-328X(00)00109-1; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ehata S, 2007, CANCER RES, V67, P9694, DOI 10.1158/0008-5472.CAN-07-1522; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Golestaneh N, 2005, ONCOGENE, V24, P5722, DOI 10.1038/sj.onc.1208925; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ikushima H, 2008, EMBO J, V27, P2955, DOI 10.1038/emboj.2008.218; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kamachi Y, 2000, TRENDS GENET, V16, P182, DOI 10.1016/S0168-9525(99)01955-1; Koinuma D, 2009, MOL CELL BIOL, V29, P172, DOI 10.1128/MCB.01038-08; Kondo T, 2004, P NATL ACAD SCI USA, V101, P781, DOI 10.1073/pnas.0307618100; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Matsuyama S, 2003, CANCER RES, V63, P7791; Miyazawa K, 2002, GENES CELLS, V7, P1191, DOI 10.1046/j.1365-2443.2002.00599.x; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Penuelas S, 2009, CANCER CELL, V15, P315, DOI 10.1016/j.ccr.2009.02.011; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pramoonjago P, 2006, ONCOGENE, V25, P5626, DOI 10.1038/sj.onc.1209566; Sanchez-Capelo A, 2005, CYTOKINE GROWTH F R, V16, P15, DOI 10.1016/j.cytogfr.2004.11.002; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Schlingensiepen KH, 2006, CYTOKINE GROWTH F R, V17, P129, DOI 10.1016/j.cytogfr.2005.09.002; Schmitz M, 2007, BRIT J CANCER, V96, P1293, DOI 10.1038/sj.bjc.6603696; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Surawicz TS, 1998, J NEURO-ONCOL, V40, P151, DOI 10.1023/A:1006091608586; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Tomioka M, 2002, NUCLEIC ACIDS RES, V30, P3202, DOI 10.1093/nar/gkf435; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yokota N, 2004, ONCOGENE, V23, P3444, DOI 10.1038/sj.onc.1207475	49	409	424	5	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					504	514		10.1016/j.stem.2009.08.018	http://dx.doi.org/10.1016/j.stem.2009.08.018			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896441	Bronze			2022-12-28	WOS:000272019500012
J	Haase, A; Olmer, R; Schwanke, K; Wunderlich, S; Merkert, S; Hess, C; Zweigerdt, R; Gruh, I; Meyer, J; Wagner, S; Maier, LS; Han, DW; Glage, S; Miller, K; Fischer, P; Scholer, HR; Martin, U				Haase, Alexandra; Olmer, Ruth; Schwanke, Kristin; Wunderlich, Stephanie; Merkert, Sylvia; Hess, Christian; Zweigerdt, Robert; Gruh, Ina; Meyer, Johann; Wagner, Stefan; Maier, Lars S.; Han, Dong Wook; Glage, Silke; Miller, Konstantin; Fischer, Philipp; Schoeler, Hans R.; Martin, Ulrich			Generation of Induced Pluripotent Stem Cells from Human Cord Blood	CELL STEM CELL			English	Article								Induced pluripotent stem cells (iPSCs) may represent an ideal cell source for future regenerative therapies. A critical issue concerning the clinical use of patient-specific iPSCs is the accumulation of mutations in somatic (stem) cells over an organism's lifetime. Acquired somatic mutations are passed onto iPSCs during reprogramming and may be associated with loss of cellular functions and cancer formation. Here we report the generation of human iPSCs from cord blood (CB) as a juvenescent cell source. CBiPSCs show characteristics typical of embryonic stem cells and can be differentiated into derivatives of all three germ layers, including functional cardiomyocytes. For future therapeutic production of autologous and allogeneic iPSC derivatives, CB could be routinely harvested for public and commercial CB banks without any donor risk. CB could readily become available for pediatric patients and, in particular, for newborns with genetic diseases or congenital malformations.	[Haase, Alexandra; Olmer, Ruth; Schwanke, Kristin; Wunderlich, Stephanie; Merkert, Sylvia; Hess, Christian; Zweigerdt, Robert; Gruh, Ina; Martin, Ulrich] Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, Leibniz Res Labs Biotechnol & Artificial Organs, D-30625 Hannover, Germany; [Meyer, Johann] Hannover Med Sch, Dept Expt Hematol, D-30625 Hannover, Germany; [Glage, Silke] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany; [Miller, Konstantin] Hannover Med Sch, Dept Human Genet, D-30625 Hannover, Germany; [Fischer, Philipp] Hannover Med Sch, Dept Cardiol & Angiol, D-30625 Hannover, Germany; [Han, Dong Wook; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Wagner, Stefan; Maier, Lars S.] Univ Gottingen, Dept Cardiol & Pneumol, D-37075 Gottingen, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Max Planck Society; University of Gottingen	Martin, U (corresponding author), Hannover Med Sch, Dept Cardiac Thorac Transplantat & Vasc Surg, Leibniz Res Labs Biotechnol & Artificial Organs, D-30625 Hannover, Germany.	martin.ulrich@mh-hannover.de	, HS/AAB-4434-2019; Wagner, Stefan/AAE-3721-2021; Martin, Ulrich/F-4888-2017; Maier, Lars/AAQ-8313-2021; Han, Dong Wook/D-6041-2011	, HS/0000-0003-2643-5136; Wagner, Stefan/0000-0002-9471-1166; Martin, Ulrich/0000-0003-1058-4540; Maier, Lars/0000-0001-9915-4429; Haase, Alexandra/0000-0003-2666-4297; Merkert, Sylvia/0000-0001-7275-4205	Nordcleutsches Knochenmarks- und Stammzellspender-Register (NKR); German Federal Ministry of Education and Research [01GN0522, 0313926A, 01GN0816]; Excellence Cluster REBIRTH	Nordcleutsches Knochenmarks- und Stammzellspender-Register (NKR); German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Excellence Cluster REBIRTH	The authors are grateful to S. Dorfman for revising the manuscript, C. Mauritz, T. Schnick, J. Beier, S. Schubert, and S.L. Weber for providing technical assistance, and J. Thomson for providing the reprogramming plasmids via Addgene. We thank the Nordcleutsches Knochenmarks- und Stammzellspender-Register (NKR) for providing cord blood samples. This work has been supported by the German Federal Ministry of Education and Research (01GN0522; 0313926A; 01GN0816) as well as by the Excellence Cluster REBIRTH.	Cashen AF, 2007, BONE MARROW TRANSPL, V39, P577, DOI 10.1038/sj.bmt.1705616; Guan K, 2007, CIRC RES, V100, P1615, DOI 10.1161/01.RES.0000269182.22798.d9; Hofmeister CC, 2007, BONE MARROW TRANSPL, V39, P11, DOI 10.1038/sj.bmt.1705538; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Murohara T, 2000, J CLIN INVEST, V105, P1527, DOI 10.1172/JCI8296; Ono T, 2002, MECH AGEING DEV, V123, P1543, DOI 10.1016/S0047-6374(02)00090-8; Rohde E, 2007, STEM CELLS, V25, P1746, DOI 10.1634/stemcells.2006-0833; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trifunovic A, 2008, J INTERN MED, V263, P167, DOI 10.1111/j.1365-2796.2007.01905.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	14	354	384	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					434	441		10.1016/j.stem.2009.08.021	http://dx.doi.org/10.1016/j.stem.2009.08.021			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796623	Bronze			2022-12-28	WOS:000271401900014
J	Geijsen, N; Hochedlinger, K				Geijsen, Niels; Hochedlinger, Konrad			gPS Navigates Germ Cells to Pluripotency	CELL STEM CELL			English	Editorial Material							STEM-CELLS; GENERATION	The establishment of pluripotent stem cell lines from explanted testes has been hampered by a poor understanding of their cellular origin. In this issue of Cell Stem Cell, Ko et al. (2009) reproducibly generate pluripotent cell lines from murine testes and unequivocally demonstrate their origin from spermatogonial stem cells.	[Geijsen, Niels; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Geijsen, Niels; Hochedlinger, Konrad] Harvard Stem Cell Inst, Ctr Canc, Boston, MA 02114 USA; [Geijsen, Niels] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Harvard University	Geijsen, N (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	ngeijsen@mgh.harvard.edu; khochedlinger@helix.mgh.harvard.edu			EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD048769] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P681, DOI 10.1095/biolreprod.107.066068; Ko K, 2009, CELL STEM CELL, V5, P87, DOI 10.1016/j.stem.2009.05.025; Kossack N, 2009, STEM CELLS, V27, P138, DOI 10.1634/stemcells.2008-0439; Lovell-Badge R, 2007, NAT BIOTECHNOL, V25, P1114, DOI 10.1038/nbt1007-1114; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129	11	13	14	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					3	4		10.1016/j.stem.2009.06.012	http://dx.doi.org/10.1016/j.stem.2009.06.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570505	Green Accepted, Bronze			2022-12-28	WOS:000267879200002
J	Sloma, I; Eaves, CJ				Sloma, Ivan; Eaves, Connie J.			TEL Me ALL	CELL STEM CELL			English	Editorial Material							CHILDHOOD LEUKEMIA	Genetically engineered mouse models are powerful systems for dissecting the process of human leukemo-genesis. In this issue of Cell Stem Cell, Schindler et al. (2009) describe the elegant use of this approach to dissect, but not completely replicate, the multistep pathogenesis of TEL-AML1(+) leukemia.	[Sloma, Ivan; Eaves, Connie J.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency	Eaves, CJ (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	ceaves@bccrc.ca		Eaves, Connie/0000-0002-3452-1926; Sloma, Ivan/0000-0001-8585-0861				Castor A, 2005, NAT MED, V11, P630, DOI 10.1038/nm1253; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Greaves MF, 2003, NAT REV CANCER, V3, P639, DOI 10.1038/nrc1164; Hong DL, 2008, SCIENCE, V319, P336, DOI 10.1126/science.1150648; Schindler JW, 2009, CELL STEM CELL, V5, P43, DOI 10.1016/j.stem.2009.04.019	5	2	2	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					5	6		10.1016/j.stem.2009.06.011	http://dx.doi.org/10.1016/j.stem.2009.06.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570506	Bronze			2022-12-28	WOS:000267879200003
J	Nichols, J; Smith, A				Nichols, Jennifer; Smith, Austin			Naive and Primed Pluripotent States	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; PRIMORDIAL GERM-CELLS; SELF-RENEWAL; TRANSCRIPTION FACTOR; PRIMITIVE ENDODERM; MOUSE EPIBLAST; GROUND-STATE; NANOG; EXPRESSION; DERIVATION	After maternal predetermination gives way to zygotic regulation, a ground state is established within the mammalian embryo. This tabula rasa for embryogenesis is present only transiently in the preimplantation epiblast. Here, we consider how unrestricted cells are first generated and then prepared for lineage commitment. We propose that two phases of pluripotency can be defined: naive and primed. This distinction extends to pluripotent stem cells derived from embryos or by molecular reprogramming ex vivo.	[Nichols, Jennifer; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Nichols, Jennifer] Univ Cambridge, Dept Psychiat Dev & Neurosci, Cambridge CB2 1QR, England; [Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge; University of Cambridge	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk		Nichols, Jennifer/0000-0002-8650-1388; Smith, Austin/0000-0002-3029-4682	Medical Research Council [G19/38] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Beddington RSP, 1999, CELL, V96, P195, DOI 10.1016/S0092-8674(00)80560-7; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Coucouvanis E, 1999, DEVELOPMENT, V126, P535; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gardner RL, 1997, INT J DEV BIOL, V41, P235; GARDNER RL, 1983, INT REV EXP PATHOL, V24, P63; Gardner RL, 1998, BIOESSAYS, V20, P168, DOI 10.1002/(SICI)1521-1878(199802)20:2&lt;168::AID-BIES9&gt;3.0.CO;2-P; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Heard E, 2004, CURR OPIN CELL BIOL, V16, P247, DOI 10.1016/j.ceb.2004.03.005; HILLMAN N, 1972, J EMBRYOL EXP MORPH, V28, P263; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Kaufman M.H., 1992, ATLAS MOUSE DEV; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1980, SCIENCE, V209, P768, DOI 10.1126/science.6250214; MATSUI Y, 1992, CELL, V70, P841, DOI 10.1016/0092-8674(92)90317-6; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; PALMIERI SL, 1994, DEV BIOL, V166, P259, DOI 10.1006/dbio.1994.1312; Plusa B, 2008, DEVELOPMENT, V135, P3081, DOI 10.1242/dev.021519; RESNICK JL, 1992, NATURE, V359, P550, DOI 10.1038/359550a0; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Selwood L, 2006, BIOESSAYS, V28, P128, DOI 10.1002/bies.20360; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith A, 2001, COLD SPRING HARBOR M, P205; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; TARKOWSKI AK, 1967, J EMBRYOL EXP MORPH, V18, P155; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; ZIOMEK CA, 1980, CELL, V21, P935, DOI 10.1016/0092-8674(80)90457-2	53	1187	1242	2	145	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					487	492		10.1016/j.stem.2009.05.015	http://dx.doi.org/10.1016/j.stem.2009.05.015			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497275	Bronze			2022-12-28	WOS:000266793600009
J	Ding, L; Paszkowski-Rogacz, M; Nitzsche, A; Slabicki, MM; Heninger, AK; de Vries, I; Kittler, R; Junqueira, M; Shevchenko, A; Schulz, H; Hubner, N; Doss, MX; Sachinidis, A; Hescheler, J; Iacone, R; Anastassiadis, K; Stewart, AF; Pisabarro, MT; Caldarelli, A; Poser, I; Theis, M; Buchholz, F				Ding, Li; Paszkowski-Rogacz, Maciej; Nitzsche, Anja; Slabicki, Mikolaj Michal; Heninger, Anne-Kristin; de Vries, Ingrid; Kittler, Ralf; Junqueira, Magno; Shevchenko, Andrej; Schulz, Herbert; Hubner, Norbert; Doss, Michael Xavier; Sachinidis, Agapios; Hescheler, Juergen; Iacone, Roberto; Anastassiadis, Konstantinos; Stewart, A. Francis; Pisabarro, M. Teresa; Caldarelli, Antonio; Poser, Ina; Theis, Mirko; Buchholz, Frank			A Genome-Scale RNAi Screen for Oct4 Modulators Defines a Role of the Paf1 Complex for Embryonic Stem Cell Identity	CELL STEM CELL			English	Article							SHORT INTERFERING RNAS; SELF-RENEWAL; TRANSCRIPTIONAL ELONGATION; CHROMATIN-STRUCTURE; BINDING PROTEIN; DIFFERENTIATION; RTF1; METHYLATION; EXPRESSION; PLURIPOTENCY	Pluripotent embryonic stem cells (ESCs) maintain self-renewal while ensuring a rapid response to differentiation cues. The identification of genes maintaining ESC identity is important to develop these cells for their potential therapeutic use. Here we report a genome-scale RNAi screen for a global survey of genes affecting ESC identity via alteration of Oct4 expression. Factors with the strongest effect on Oct4 expression included components of the Paf1 complex, a protein complex associated with RNA polymerase II. Using a combination of proteomics, expression profiling, and chromatin immunoprecipitation, we demonstrate that the Paf1C binds to promoters of key pluripotency genes, where it is required to maintain a transcriptionally active chromatin structure. The Paf1C is developmentally regulated and blocks ESC differentiation upon overexpression, and the knockdown in ESCs causes expression changes similar to Oct4 or Nanog depletions. We propose that the Paf1C plays an important role in maintaining ESC identity.	[Ding, Li; Paszkowski-Rogacz, Maciej; Nitzsche, Anja; Slabicki, Mikolaj Michal; Heninger, Anne-Kristin; de Vries, Ingrid; Kittler, Ralf; Junqueira, Magno; Shevchenko, Andrej; Caldarelli, Antonio; Poser, Ina; Theis, Mirko; Buchholz, Frank] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Iacone, Roberto; Anastassiadis, Konstantinos; Stewart, A. Francis; Pisabarro, M. Teresa] BIOTEC TU Dresden, D-01307 Dresden, Germany; [Schulz, Herbert; Hubner, Norbert] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Doss, Michael Xavier; Sachinidis, Agapios; Hescheler, Juergen] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Doss, Michael Xavier; Sachinidis, Agapios; Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Ctr Physiol & Pathophysiol, D-50931 Cologne, Germany	Max Planck Society; Technische Universitat Dresden; Helmholtz Association; Max Delbruck Center for Molecular Medicine; University of Cologne; University of Cologne	Buchholz, F (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	buchholz@mpi-cbg.de	Pisabarro, M. Teresa/D-4270-2012; Sachinidis, Agapios/AAD-4178-2020; Buchholz, Frank/B-4700-2017; Kittler, Ralf/I-4662-2013; Stewart, A. Francis/E-7789-2010; Kittler, Ralf/AAD-4258-2020; Junqueira, Magno/A-7495-2012; Sachinidis, Agapios/AAM-7988-2020; Anastassiadis, Konstantinos/A-8944-2010; Kumar, Rajesh/E-7957-2010; Jesudoss, Michael Xavier Doss/D-1983-2015	Buchholz, Frank/0000-0002-4577-3344; Kittler, Ralf/0000-0002-0098-6792; Kittler, Ralf/0000-0002-0098-6792; Junqueira, Magno/0000-0002-7036-0728; Anastassiadis, Konstantinos/0000-0002-9814-0559; Heninger, Anne-Kristin/0000-0003-3151-826X; Jesudoss, Michael Xavier Doss/0000-0001-6339-9782	EU [LSHG-CT-2003-503494]; BMBF [0315105]; Deutsche Krebshilfe [106685]; DFG [SPP1356 BU1400/3-1]	EU(European Commission); BMBF(Federal Ministry of Education & Research (BMBF)); Deutsche Krebshilfe(Deutsche Krebshilfe); DFG(German Research Foundation (DFG))	We would like to thank Ina Nusslein for help with FACS assays, Julia Jarrells for help analyzing ChIP-chip data, and Ian Chambers and Austin Smith for providing the Oct4-Gip and Sox1-GFP cell lines. This work was supported by the EU grant "FunGenES" (LSHG-CT-2003-503494), the BMBF grant GO-Bio (0315105), the Deutsche Krebshilfe grant (106685), and the DFG grant SPP1356 BU1400/3-1.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Akanuma T, 2007, EMBO REP, V8, P858, DOI 10.1038/sj.embor.7401045; Anastassiadis K, 2002, GENE, V298, P159, DOI 10.1016/S0378-1119(02)00979-4; Aubert J, 2003, P NATL ACAD SCI USA, V100, P11836, DOI 10.1073/pnas.1734197100; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Carpenter L, 2004, GENESIS, V40, P157, DOI 10.1002/gene.20078; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; CHEESEMAN IM, 2005, SCI STKE, pPL1, DOI DOI 10.1126/STKE.2662005PL1; Costa PJ, 2000, GENETICS, V156, P535; Diogo MM, 2008, BIOTECHNOL APPL BIOC, V49, P105, DOI 10.1042/BA20070011; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kittler R, 2005, NAT METHODS, V2, P779, DOI 10.1038/nmeth1005-779; Kittler R, 2005, P NATL ACAD SCI USA, V102, P2396, DOI 10.1073/pnas.0409861102; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Lee JH, 2005, J BIOL CHEM, V280, P41725, DOI 10.1074/jbc.M508312200; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Myers LC, 2000, ANNU REV BIOCHEM, V69, P729, DOI 10.1146/annurev.biochem.69.1.729; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Shea KS, 2004, BIOL REPROD, V71, P1755, DOI 10.1095/biolreprod.104.028100; Penheiter KL, 2005, MOL CELL, V20, P213, DOI 10.1016/j.molcel.2005.08.023; Pesce M, 2001, STEM CELLS, V19, P271, DOI 10.1634/stemcells.19-4-271; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Takahashi K, 2005, BIOCHEM SOC T, V33, P1522, DOI 10.1042/BST0331522; Tenney K, 2006, P NATL ACAD SCI USA, V103, P11970, DOI 10.1073/pnas.0603620103; TURKSEN K, 2001, EMBRYONIC STEM CELLS; Wang PF, 2008, MOL CELL BIOL, V28, P2930, DOI 10.1128/MCB.00654-07; Yamazaki K, 2003, J BIOL CHEM, V278, P13585, DOI 10.1074/jbc.C300047200; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2002, NATURE, V416, P545, DOI 10.1038/nature729; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	49	200	214	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					403	415		10.1016/j.stem.2009.03.009	http://dx.doi.org/10.1016/j.stem.2009.03.009			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19345177	Bronze			2022-12-28	WOS:000266071100009
J	Souroullas, GP; Salmon, JM; Sablitzky, F; Curtis, DJ; Goodell, MA				Souroullas, George P.; Salmon, Jessica M.; Sablitzky, Fred; Curtis, David J.; Goodell, Margaret A.			Adult Hematopoietic Stem and Progenitor Cells Require Either Lyl1 or Scl for Survival	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR SCL; MICE LACKING; HUMAN CANCER; DNA-BINDING; YOLK-SAC; GENE; LEUKEMIA; PROTEINS; BHLH; DIFFERENTIATION	Scl and Lyl1 encode two related basic-helix-loop-helix transcription factors implicated in T cell acute lymphoblastic leukemia. Previous studies showed that Scl is essential for embryonic and adult erythropoiesis, while Lyl1 is important for B cell development. Single-knockout mice have not revealed an essential function for Scl or Lyl1 in adult hematopoietic stem cells (HSCs). To determine if maintenance of HSCs in single-knockout mice is due to functional redundancy, we generated Lyl1;Scl-conditional double-knockout mice. Here, we report a striking genetic interaction between the two genes, with a clear dose dependence for the presence of Scl or Lyl1 alleles for HSC function. Bone marrow repopulation assays and analyses demonstrated rapid loss of hematopoietic progenitors due to apoptosis. The function of HSCs could be rescued by a single allele of Lyl1 but not Scl. These results show that expression of at least one of these factors is essential for maintenance of adult HSC function.	[Salmon, Jessica M.; Curtis, David J.] Royal Melbourne Hosp, Rotary Bone Marrow Res Labs, Melbourne, Vic 3050, Australia; [Souroullas, George P.; Goodell, Margaret A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Souroullas, George P.; Goodell, Margaret A.] Baylor Coll Med, Stem Cells & Regenerat Med Ctr, Houston, TX 77030 USA; [Salmon, Jessica M.; Curtis, David J.] Univ Melbourne, Dept Med, Melbourne, Vic 3010, Australia; [Sablitzky, Fred] Univ Nottingham, Queens Med Ctr, Inst Genet, Sch Biol, Nottingham NG7 2UH, England	Royal Melbourne Hospital; Baylor College of Medicine; Baylor College of Medicine; University of Melbourne; University of Nottingham	Curtis, DJ (corresponding author), Royal Melbourne Hosp, Rotary Bone Marrow Res Labs, Grattan St, Melbourne, Vic 3050, Australia.	dcurtis@wehi.edu.au; goodell@bcm.edu	Sablitzky, Fred/A-2276-2011; Curtis, David/H-4996-2014	Sablitzky, Fred/0000-0001-9718-1546; Curtis, David/0000-0001-9497-0996; Salmon, Jessica/0000-0003-0307-3574; Souroullas, George P./0000-0003-2196-8662; Goodell, Margaret A./0000-0003-1111-2932	National Health & Medical Research Council (NHMRC) [332502, 382904]; NIH [DK58192, EB005173, HL081C0]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081007, R01HL096360] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB005173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058192] Funding Source: NIH RePORTER	National Health & Medical Research Council (NHMRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)National Health and Medical Research Council (NHMRC) of Australia); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Corinne Sonnet for assistance with mice; Dean Hewish for cell sorting; Jason Corbin for blood counts; and Lan Ta, Rebecca Bowyer, and Jenny Davis for animal husbandry. We also thank Fernando Camargo (MIT) for discussions that led to this study. This work was supported by National Health & Medical Research Council (NHMRC) project grant 332502. D.J.C. is supported by a NHMRC RD Wright Fellowship 382904. This work was also supported by NIH grants DK58192, EB005173, and HL081C0.	Capron C, 2006, BLOOD, V107, P4678, DOI 10.1182/blood-2005-08-3145; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chan WYI, 2007, BLOOD, V109, P1908, DOI 10.1182/blood-2006-05-023226; Cochrane SW, 2009, BLOOD, V113, P1016, DOI 10.1182/blood-2008-06-164996; Curtis DJ, 2004, BLOOD, V103, P3342, DOI 10.1182/blood-2003-09-3202; Elefanty AG, 1998, P NATL ACAD SCI USA, V95, P11897, DOI 10.1073/pnas.95.20.11897; Engel I, 2001, NAT REV IMMUNOL, V1, P193, DOI 10.1038/35105060; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Giroux S, 2007, GENE EXPR PATTERNS, V7, P215, DOI 10.1016/j.modgep.2006.10.004; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Ji M, 2008, BLOOD, V112, P1068, DOI 10.1182/blood-2008-01-133504; Krosl G, 1998, J EXP MED, V188, P439, DOI 10.1084/jem.188.3.439; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; METCALF D, 1984, HAEMOPOIETIC COLONY; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Miyamoto A, 1996, MOL CELL BIOL, V16, P2394; Murre C, 2000, NAT IMMUNOL, V1, P97, DOI 10.1038/77881; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Porcher C, 1999, DEVELOPMENT, V126, P4603; RABBITTS TH, 1994, NATURE, V372, P143, DOI 10.1038/372143a0; Rawls A, 1998, DEVELOPMENT, V125, P2349; ROBB L, 1995, P NATL ACAD SCI USA, V92, P7075, DOI 10.1073/pnas.92.15.7075; Salmon JM, 2007, BLOOD, V110, P3573, DOI 10.1182/blood-2006-10-053124; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; Shivdasani RA, 1996, BLOOD, V87, P4025, DOI 10.1182/blood.V87.10.4025.bloodjournal87104025; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; WADMAN I, 1994, EMBO J, V13, P4831, DOI 10.1002/j.1460-2075.1994.tb06809.x	29	103	103	3	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					180	186		10.1016/j.stem.2009.01.001	http://dx.doi.org/10.1016/j.stem.2009.01.001			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200805	Bronze, Green Accepted			2022-12-28	WOS:000263213400014
J	Shi, Y; Desponts, C; Do, JT; Hahm, HS; Scholer, HR; Ding, S				Shi, Yan; Desponts, Caroline; Do, Jeong Tae; Hahm, Heung Sik; Schoeler, Hans R.; Ding, Sheng			Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds	CELL STEM CELL			English	Article							GENERATION; INHIBITOR; G9A	Somatic cells can be induced into pluripotent stem cells (iPSCs) with a combination of four transcription factors, Oct4/Sox2/Klf4/c-Myc or Oct4/Sox2/Nanog/LIN28. This provides an enabling platform to obtain patient-specific cells for various therapeutic and research applications. However, several problems remain for this approach to be therapeutically relevant due to drawbacks associated with efficiency and viral genome integration. Recently, it was shown that neural progenitor cells (NPCs) transduced with 0ct4/Klf4 can be reprogrammed into iPSCs. However, NPCs express Sox2 endogenously, possibly facilitating reprogramming in the absence of exogenous Sox2. In this study, we identified a small-molecule combination, BIX-01294 and BayK8644, that enables reprogramming of Oct4/Klf4-transduced mouse embryonic fibroblasts, which do not endogenously express the factors essential for reprogramming. This study demonstrates that small molecules identified through a phenotypic screen can compensate for viral transduction of critical factors, such as Sox2, and improve reprogramming efficiency.	[Shi, Yan; Desponts, Caroline; Hahm, Heung Sik; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Do, Jeong Tae; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany	Scripps Research Institute; Max Planck Society	Ding, S (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sding@scripps.edu	Hahm, Heung Sik/A-8809-2014; , HS/AAB-4434-2019	Hahm, Heung Sik/0000-0003-2326-7923; , HS/0000-0003-2643-5136; Do, Jeong Tae/0000-0001-6721-1441				Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Brueckner B, 2005, CANCER RES, V65, P6305, DOI 10.1158/0008-5472.CAN-04-2957; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Heo JS, 2006, AM J PHYSIOL-CELL PH, V290, pC123, DOI 10.1152/ajpcell.00142.2005; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; SCHRAMM M, 1983, NATURE, V303, P535, DOI 10.1038/303535a0; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tosti E, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-26; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	19	662	773	1	109	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					568	574		10.1016/j.stem.2008.10.004	http://dx.doi.org/10.1016/j.stem.2008.10.004			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983970	Bronze			2022-12-28	WOS:000260895100015
J	Cantone, I; Fisher, AG				Cantone, Irene; Fisher, Amanda G.			Unraveling Epigenetic Landscapes: The Enigma of Enhancers	CELL STEM CELL			English	Editorial Material							CHROMATIN SIGNATURES; GENES	In recent publications in Nature and PNAS, Rada-Iglesias et al. (2010) and Creyghton et al. (2010) have uncovered unique chromatin signatures of developmental enhancers marking active, primed, or silent genes in human and mouse embryonic stem cells.	[Cantone, Irene; Fisher, Amanda G.] Imperial Coll Sch Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England	Imperial College London	Fisher, AG (corresponding author), Imperial Coll Sch Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Hammersmith Hosp Campus,Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk	Cantone, Irene/AAB-1071-2020	Cantone, Irene/0000-0002-8156-7126	Medical Research Council [MC_U120027516] Funding Source: Medline; MRC [MC_U120027516] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, CURR OPIN GENET DEV, V19, P541, DOI 10.1016/j.gde.2009.09.006; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; RADAIGLESIAS A, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09692; Schmitz KM, 2010, GENE DEV, V24, P2264, DOI 10.1101/gad.590910; Visel A, 2009, NATURE, V457, P854, DOI 10.1038/nature07730	10	2	2	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					128	129		10.1016/j.stem.2011.01.005	http://dx.doi.org/10.1016/j.stem.2011.01.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295268	Bronze			2022-12-28	WOS:000287633400005
J	Kamp, TJ				Kamp, Timothy J.			An Electrifying iPSC Disease Model: Long QT Syndrome Type 2 and Heart Cells in a Dish	CELL STEM CELL			English	Editorial Material								In a recent Nature paper, Itzhaki et al. (2011) generate induced pluripotent stem cells (iPSCs) from patients with a potentially fatal inherited arrhythmia, long QT syndrome type 2. Cardiomyocytes differentiated from the patient-derived iPSCs exhibit the hallmark cardiac electrical signatures of the disease, which can be reversed by pharmacological intervention.	Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Clin Sci Ctr H6 370, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison	Kamp, TJ (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, Dept Med, Clin Sci Ctr H6 370, MC 3248,600 Highland Ave, Madison, WI 53792 USA.	tjk@medicine.wisc.edu	Kamp, Timothy/ABD-1343-2020	Kamp, Timothy/0000-0003-2103-7876	NHLBI NIH HHS [U01 HL099773, R01 HL084615] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL084615, U01HL099773] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Carvajal-Vergara X, 2010, NATURE, V465, P808, DOI 10.1038/nature09005; Delisle BP, 2004, CIRC RES, V94, P1418, DOI 10.1161/01.RES.0000128561.28701.ea; Eschenhagen T, 2005, CIRC RES, V97, P1220, DOI 10.1161/01.RES.0000196562.73231.7d; Itzhaki I, 2011, NATURE, V471, P225, DOI 10.1038/nature09747; Moretti A, 2010, NEW ENGL J MED, V363, P1397, DOI 10.1056/NEJMoa0908679; Nakajima T, 1998, CIRC RES, V83, P415, DOI 10.1161/01.RES.83.4.415; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	7	11	11	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					130	131		10.1016/j.stem.2011.01.010	http://dx.doi.org/10.1016/j.stem.2011.01.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295269	Bronze			2022-12-28	WOS:000287633400006
J	Koh, KP; Yabuuchi, A; Rao, S; Huang, Y; Cunniff, K; Nardone, J; Laiho, A; Tahiliani, M; Sommer, CA; Mostoslavsky, G; Lahesmaa, R; Orkin, SH; Rodig, SJ; Daley, GQ; Rao, A				Koh, Kian Peng; Yabuuchi, Akiko; Rao, Sridhar; Huang, Yun; Cunniff, Kerrianne; Nardone, Julie; Laiho, Asta; Tahiliani, Mamta; Sommer, Cesar A.; Mostoslavsky, Gustavo; Lahesmaa, Riitta; Orkin, Stuart H.; Rodig, Scott J.; Daley, George Q.; Rao, Anjana			Tet1 and Tet2 Regulate 5-Hydroxymethylcytosine Production and Cell Lineage Specification in Mouse Embryonic Stem Cells	CELL STEM CELL			English	Article							DNA METHYLATION; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; MYELOID CANCERS; GENOMIC DNA; 5-METHYLCYTOSINE; PLURIPOTENCY; CONVERSION; PROTEINS; ROLES	TET family enzymes convert 5-methylcytosine (5mC) to 5-hydroxymethylcytosine (5hmC) in DNA. Here, we show that Tet1 and Tet2 are Oct4-regulated enzymes that together sustain 5hmC in mouse embryonic stem cells (ESCs) and are induced concomitantly with 5hmC during reprogramming of fibroblasts to induced pluripotent stem cells. ESCs depleted of Tet1 by RNAi show diminished expression of the Nodal antagonist Lefty1 and display hyperactive Nodal signaling and skewed differentiation into the endoderm-mesoderm lineage in embryoid bodies in vitro. In Fgf4- and heparin-supplemented culture conditions, Tet1-depleted ESCs activate the trophoblast stem cell lineage determinant Elf5 and can colonize the placenta in midgestation embryo chimeras. Consistent with these findings, Tet1-depleted ESCs form aggressive hemorrhagic teratomas with increased endoderm, reduced neuroectoderm, and ectopic appearance of trophoblastic giant cells. Thus, 5hmC is an epigenetic modification associated with the pluripotent state, and Tet1 functions to regulate the lineage differentiation potential of ESCs.	[Koh, Kian Peng; Huang, Yun; Tahiliani, Mamta; Lahesmaa, Riitta; Rao, Anjana] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Yabuuchi, Akiko; Rao, Sridhar; Cunniff, Kerrianne; Orkin, Stuart H.; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Yabuuchi, Akiko; Rao, Sridhar; Cunniff, Kerrianne; Orkin, Stuart H.; Daley, George Q.] Harvard Stem Cell Inst, Dana Faber Canc Inst, Boston, MA 02115 USA; [Nardone, Julie] Cell Signaling Technol, Bioinformat, Danvers, MA 01923 USA; [Laiho, Asta; Lahesmaa, Riitta] Univ Turku, Turku Ctr Biotechnol, FI-20520 Turku, Finland; [Laiho, Asta; Lahesmaa, Riitta] Abo Akad Univ, FI-20520 Turku, Finland; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, Boston, MA 02118 USA; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med, Boston, MA 02118 USA; [Orkin, Stuart H.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Rodig, Scott J.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Daley, George Q.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Koh, Kian Peng; Huang, Yun; Tahiliani, Mamta; Lahesmaa, Riitta; Rao, Anjana] Childrens Hosp, Immune Dis Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; University of Turku; Abo Akademi University; Boston University; Boston University; Howard Hughes Medical Institute; Harvard University; Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Rao, A (corresponding author), La Jolla Inst Allergy & Immunol, La Jolla, CA 92037 USA.	arao@idi.harvard.edu	Sommer, Cesar A/H-9187-2013; Koh, Kian Peng/S-6279-2016; Rodig, Scott/Y-3889-2019; Sommer, Cesar A/H-7062-2012	Koh, Kian Peng/0000-0003-2523-5175; Mostoslavsky, Gustavo/0000-0002-0784-2169; Huang, Yun/0000-0001-5950-9168	NIH [AI44432, CA42471, RC1-DA028422, RO1-DK70055, RO1-DK59279, UO1-HL100001]; ARRA [RC2-HL102815]; Roche Foundation for Anemia Research; Alex's Lemonade Stand; Harvard Stem Cell Institute; American Heart Association; Academy of Finland; Sigrid Juselius Foundation; Burroughs Wellcome Fund; Leukemia and Lymphoma Society; Johnson Johnson; Verastem; Epizyme; iPierian; Solasia KK; MPM Capital, L.L.P.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD065812] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R37CA042471, R01CA042471] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, RC2HL102815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044432] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055, R01DK059279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [RC1DA028422] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ARRA; Roche Foundation for Anemia Research; Alex's Lemonade Stand; Harvard Stem Cell Institute; American Heart Association(American Heart Association); Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Verastem; Epizyme; iPierian; Solasia KK; MPM Capital, L.L.P.; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank P. Gadue and G. Keller for CD4-Foxa2/GFP-Bry ESCs, C. Unitt and staff at the Specialized Rodent Histopathology Services, Brigham and Women's Hospital for mouse histology and GFP staining, P. Junni at the Finnish Microarray and Sequencing Centre, Turku Centre for Biotechnology for sample processing and array hybridization, and K. E. Waraska at the Biopolymers facility, Harvard Medical School, for low-density array-based q-PCR. This work was funded by NIH grants AI44432, CA42471, and RC1-DA028422 (to A.R.); RO1-DK70055, RO1-DK59279, UO1-HL100001, and special funds from the ARRA stimulus package RC2-HL102815 (to GOD); the Roche Foundation for Anemia Research, Alex's Lemonade Stand, and the Harvard Stem Cell Institute (to GOD); an American Heart Association postdoctoral fellowship (to K.P.K); and grants from The Academy of Finland and The Sigrid Juselius Foundation (to R.L.). G.Q.D. is an affiliate member of the Broad Institute, a recipient of Clinical Scientist Awards in Translational Research from the Burroughs Wellcome Fund and the Leukemia and Lymphoma Society, and an investigator of the Howard Hughes Medical Institute and the Manton Center for Orphan Disease Research. G.Q.D. is a member of the scientific advisory boards and holds stock in or receives consulting fees from the following companies: Johnson & Johnson, Verastem, Epizyme, iPierian, Solasia KK, and MPM Capital, L.L.P..	Arnold SJ, 2008, DEVELOPMENT, V135, P501, DOI 10.1242/dev.014357; BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brennan J, 2001, NATURE, V411, P965, DOI 10.1038/35082103; Chen CH, 2004, CURR BIOL, V14, P618, DOI 10.1016/j.cub.2004.02.042; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Feng SH, 2010, SCIENCE, V330, P622, DOI 10.1126/science.1190614; Feng SH, 2010, P NATL ACAD SCI USA, V107, P8689, DOI 10.1073/pnas.1002720107; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gal-Yam EN, 2008, ANNU REV MED, V59, P267, DOI 10.1146/annurev.med.59.061606.095816; Goll MG, 2005, ANNU REV BIOCHEM, V74, P481, DOI 10.1146/annurev.biochem.74.010904.153721; Huang Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008888; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Iyer LM, 2009, CELL CYCLE, V8, P1698, DOI 10.4161/cc.8.11.8580; Jackson M, 2004, MOL CELL BIOL, V24, P8862, DOI 10.1128/MCB.24.20.8862-8871.2004; Jin SG, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq223; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Ng RK, 2008, NAT CELL BIOL, V10, P1280, DOI 10.1038/ncb1786; Ooi SKT, 2009, J CELL SCI, V122, P2787, DOI 10.1242/jcs.015123; Ramsahoye BH, 2000, P NATL ACAD SCI USA, V97, P5237, DOI 10.1073/pnas.97.10.5237; Rao S, 2010, MOL CELL BIOL, V30, P5364, DOI 10.1128/MCB.00419-10; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Saijoh Y, 2000, MOL CELL, V5, P35, DOI 10.1016/S1097-2765(00)80401-3; Schier AF, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a003459; Shen MM, 2007, DEVELOPMENT, V134, P1023, DOI 10.1242/dev.000166; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam PPL, 2007, NAT REV GENET, V8, P368, DOI 10.1038/nrg2084; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zemach A, 2010, SCIENCE, V328, P916, DOI 10.1126/science.1186366	48	561	606	0	112	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					200	213		10.1016/j.stem.2011.01.008	http://dx.doi.org/10.1016/j.stem.2011.01.008			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295276	Bronze, Green Accepted			2022-12-28	WOS:000287633400013
J	de Jesus, BB; Blasco, MA				Bernardes de Jesus, Bruno; Blasco, Maria A.			Aging by Telomere Loss Can Be Reversed	CELL STEM CELL			English	Editorial Material							MICE	Recently in Nature, Jaskelioff et al. (2010) demonstrated that multiple aging phenotypes in a mouse model of accelerated telomere loss can be reversed within 4 weeks of reactivating telomerase. This raises the major question of whether physiological aging, likely caused by a combination of molecular defects, may also be reversible.	[Bernardes de Jesus, Bruno; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Blasco, Maria A./M-1694-2014; Bernardes de Jesus, Bruno/GLQ-7625-2022	Blasco, Maria A./0000-0002-4211-233X; Bernardes de Jesus, Bruno/0000-0002-6407-3466; Nobrega-Pereira, Sandrina/0000-0002-9652-1382				Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Garcia-Cao I, 2006, EMBO REP, V7, P546, DOI 10.1038/sj.embor.7400667; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 2010, REJUVENATIO IN PRESS, V14, DOI DOI 10.1089/REJ.2010.1085; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Siegl-Cachedenier I, 2007, J CELL BIOL, V179, P277, DOI 10.1083/jcb.200704141; Tomas-Loba A, 2008, CELL, V135, P609, DOI 10.1016/j.cell.2008.09.034	10	14	14	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					3	4		10.1016/j.stem.2010.12.013	http://dx.doi.org/10.1016/j.stem.2010.12.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211774	Bronze			2022-12-28	WOS:000286786200002
J	Koche, RP; Smith, ZD; Adli, M; Gu, HC; Ku, MC; Gnirke, A; Bernstein, BE; Meissner, A				Koche, Richard P.; Smith, Zachary D.; Adli, Mazhar; Gu, Hongcang; Ku, Manching; Gnirke, Andreas; Bernstein, Bradley E.; Meissner, Alexander			Reprogramming Factor Expression Initiates Widespread Targeted Chromatin Remodeling	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DIFFERENTIATED CELLS; PLURIPOTENT; GENOME; MAPS; TRANSCRIPTION; CIRCUITRY; ENHANCERS; GENES	Despite rapid progress in characterizing transcription factor-driven reprogramming of somatic cells to an induced pluripotent stem cell (iPSC) state, many mechanistic questions still remain. To gain insight into the earliest events in the reprogramming process, we systematically analyzed the transcriptional and epigenetic changes that occur during early factor induction after discrete numbers of divisions. We observed rapid, genome-wide changes in the euchromatic histone modification, H3K4me2, at more than a thousand loci including large subsets of pluripotency-related or developmentally regulated gene promoters and enhancers. In contrast, patterns of the repressive H3K27me3 modification remained largely unchanged except for focused depletion specifically at positions where H3K4 methylation is gained. These chromatin regulatory events precede transcriptional changes within the corresponding loci. Our data provide evidence for an early, organized, and population-wide epigenetic response to ectopic reprogramming factors that clarify the temporal order through which somatic identity is reset during reprogramming.	[Koche, Richard P.; Smith, Zachary D.; Adli, Mazhar; Gu, Hongcang; Ku, Manching; Gnirke, Andreas; Bernstein, Bradley E.; Meissner, Alexander] Broad Inst, Cambridge, MA 02142 USA; [Koche, Richard P.; Adli, Mazhar; Ku, Manching; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Koche, Richard P.; Adli, Mazhar; Ku, Manching; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Koche, Richard P.] MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Smith, Zachary D.; Meissner, Alexander] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Smith, Zachary D.; Bernstein, Bradley E.; Meissner, Alexander] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Bernstein, Bradley E.] Howard Hughes Med Inst, Boston, MA 02114 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT); Harvard University; Harvard University; Howard Hughes Medical Institute	Meissner, A (corresponding author), Broad Inst, Cambridge, MA 02142 USA.	alexander_meissner@harvard.edu		Gu, Hongcang/0000-0002-1439-7606; Koche, Richard/0000-0002-6820-5083	MLSC; Pew Charitable Trusts; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002295] Funding Source: NIH RePORTER	MLSC; Pew Charitable Trusts; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We would like to thank Tarjei Mikkelsen for critical reading of the manuscript. We would like to apologize to authors whose primary work we didn't cite because of space restrictions. B.E.B. is an early career scientist of the HHMI. A.M. is a New Investigator of the Massachusetts Life Science Center (MLSC) and Pew Scholar. This work was funded by the MLSC and Pew Charitable Trusts.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Graf T, 2009, NATURE, V462, P587, DOI 10.1038/nature08533; Gu H, 2010, NAT METHODS, V7, P133, DOI 10.1038/nmeth.1414; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna JH, 2010, CELL, V143, P508, DOI 10.1016/j.cell.2010.10.008; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Pereira CF, 2010, CELL STEM CELL, V6, P547, DOI 10.1016/j.stem.2010.04.013; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xu J, 2009, GENE DEV, V23, P2824, DOI 10.1101/gad.1861209; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180	23	283	290	2	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					96	105		10.1016/j.stem.2010.12.001	http://dx.doi.org/10.1016/j.stem.2010.12.001			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211784	Green Accepted, Bronze			2022-12-28	WOS:000286786200014
J	Zhang, JQ; Lian, QZ; Zhu, GL; Zhou, F; Sui, L; Tan, C; Mutalif, RA; Navasankari, R; Zhang, YL; Tse, HF; Stewart, CL; Colman, A				Zhang, Jinqiu; Lian, Qizhou; Zhu, Guili; Zhou, Fan; Sui, Lin; Tan, Cindy; Mutalif, Rafidah Abdul; Navasankari, Raju; Zhang, Yuelin; Tse, Hung-Fat; Stewart, Colin L.; Colman, Alan			A Human iPSC Model of Hutchinson Gilford Progeria Reveals Vascular Smooth Muscle and Mesenchymal Stem Cell Defects	CELL STEM CELL			English	Article							ELECTRICAL-STIMULATION; LAMINOPATHIES; FIBROBLASTS; EXPRESSION; PHENOTYPES; MOUSE; PROLIFERATION; MISREGULATION; ARCHITECTURE; RESPONSES	The segmental premature aging disease Hutchinson-Gilford Progeria syndrome (HGPS) is caused by a truncated and farnesylated form of Lamin A called progerin. HGPS affects mesenchymal lineages, including the skeletal system, dermis, and vascular smooth muscle (VSMC). To understand the underlying molecular pathology of HGPS, we derived induced pluripotent stem cells (iPSCs) from HGPS dermal fibroblasts. The iPSCs mere differentiated into neural progenitors, endothelial cells, fibroblasts, VSMCs, and mesenchymal stem cells (MSCs). Progerin levels were highest in MSCs, VSMCs, and fibroblasts, in that order, with these lineages displaying increased DNA damage, nuclear abnormalities, and HGPS-VSMC accumulating numerous calponin-staining inclusion bodies. Both HGPS-MSC and -VSMC viability was compromised by stress and hypoxia in vitro and in vivo (MSC). Because MSCs reside in low oxygen niches in vivo, we propose that, in HGPS, this causes additional depletion of the MSC pool responsible for replacing differentiated cells lost to progerin toxicity.	[Zhang, Jinqiu; Zhu, Guili; Zhou, Fan; Sui, Lin; Tan, Cindy; Mutalif, Rafidah Abdul; Navasankari, Raju; Stewart, Colin L.; Colman, Alan] A STAR Inst Med Biol, Singapore 138648, Singapore; [Lian, Qizhou; Zhang, Yuelin; Tse, Hung-Fat] Univ Hong Kong, Div Cardiol, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Lian, Qizhou] Univ Hong Kong, Li Ka Shing Fac Med, Inst Eye, Pokfulam, Hong Kong, Peoples R China	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of Hong Kong; University of Hong Kong	Stewart, CL (corresponding author), A STAR Inst Med Biol, Singapore 138648, Singapore.	colin.stewart@imb.a-star.edu.sg; alan.colman@imb.a-star.edu.sg	Tse, Hung-Fat/C-4426-2009; Zhang, Yuelin/C-4569-2009; Lian, Qizhou/Y-1613-2019	Tse, Hung-Fat/0000-0002-9578-7808; Lian, Qizhou/0000-0001-8189-7160	Singapore Biomedical Research Council; Singapore Agency for Science, Technology and Research (A*STAR); Hong Kong Research Grant Council [HKU 8/CRF/09]	Singapore Biomedical Research Council(Agency for Science Technology & Research (A*STAR)); Singapore Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); Hong Kong Research Grant Council(Hong Kong Research Grants Council)	We thank the Singapore Biomedical Research Council and the Singapore Agency for Science, Technology and Research (A*STAR) for funding this work. The animal work was supported by Hong Kong Research Grant Council (HKU 8/CRF/09). We also thank M. Costa for helpful advice.	Ackerman J, 2002, PEDIATR PATHOL MOL M, V21, P1, DOI 10.1080/15227950252774110; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Bridger JM, 2004, EXP GERONTOL, V39, P717, DOI 10.1016/j.exger.2004.02.002; Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104; Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906; Colman A, 2009, CELL STEM CELL, V5, P244, DOI 10.1016/j.stem.2009.08.010; Constantinescu D, 2006, STEM CELLS, V24, P474, DOI 10.1634/stemcells.2006-erratum.2; Csoka AB, 2004, AGING CELL, V3, P235, DOI 10.1111/j.1474-9728.2004.00105.x; De Sandre-Giovannoli A, 2003, SCIENCE, V300, P2055, DOI 10.1126/science.1084125; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dos Santos F, 2010, J CELL PHYSIOL, V223, P27, DOI 10.1002/jcp.21987; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Fong LG, 2004, P NATL ACAD SCI USA, V101, P18111, DOI 10.1073/pnas.0408558102; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gordon LB, 2007, PEDIATRICS, V120, P824, DOI 10.1542/peds.2007-1357; Halaschek-Wiener J, 2007, J GERONTOL A-BIOL, V62, P3, DOI 10.1093/gerona/62.1.3; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hennekam RCM, 2006, AM J MED GENET A, V140A, P2603, DOI 10.1002/ajmg.a.31346; Hernandez L, 2010, DEV CELL, V19, P413, DOI 10.1016/j.devcel.2010.08.013; Horwitz EM, 2009, ISR MED ASSOC J, V11, P209; Huang SR, 2005, HUM GENET, V118, P444, DOI 10.1007/s00439-005-0051-7; Jeon ES, 2006, J CELL SCI, V119, P4994, DOI 10.1242/jcs.03281; Lee G, 2009, NATURE, V461, P402, DOI 10.1038/nature08320; Leskela HV, 2006, BONE, V39, P1026, DOI 10.1016/j.bone.2006.05.003; Li QA, 2011, J SURG RES, V166, P162, DOI 10.1016/j.jss.2009.08.031; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; McClintock D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001269; Merideth MA, 2008, NEW ENGL J MED, V358, P592, DOI 10.1056/NEJMoa0706898; Meshorer E, 2008, J CELL BIOL, V181, P9, DOI 10.1083/jcb.200802155; Mounkes LC, 2004, CURR OPIN CELL BIOL, V16, P322, DOI 10.1016/j.ceb.2004.03.009; Mounkes LC, 2003, NATURE, V423, P298, DOI 10.1038/nature01631; Musich PR, 2009, AGING-US, V1, P28, DOI 10.18632/aging.100012; Olive M, 2010, ARTERIOSCL THROM VAS, V30, P2301, DOI 10.1161/ATVBAHA.110.209460; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Sagelius H, 2008, J CELL SCI, V121, P969, DOI 10.1242/jcs.022913; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Scaffidi P, 2008, NAT CELL BIOL, V10, P452, DOI 10.1038/ncb1708; Stehbens WE, 2001, CARDIOVASC PATHOL, V10, P133, DOI 10.1016/S1054-8807(01)00069-2; Takahashi K, 2003, ADV BIOPHYS, V37, P91, DOI 10.1016/S0065-227X(03)80004-7; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Varga R, 2006, P NATL ACAD SCI USA, V103, P3250, DOI 10.1073/pnas.0600012103; Verstraeten VLRM, 2008, AGING CELL, V7, P383, DOI 10.1111/j.1474-9726.2008.00382.x; Weil BR, 2009, SURGERY, V146, P190, DOI 10.1016/j.surg.2009.03.031; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Yang SH, 2005, P NATL ACAD SCI USA, V102, P10291, DOI 10.1073/pnas.0504641102; Yang SH, 2008, J CLIN INVEST, V118, P3291, DOI 10.1172/JCI35876; Zhao M, 2004, J CELL SCI, V117, P397, DOI 10.1242/jcs.00868	50	345	353	2	72	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					31	45		10.1016/j.stem.2010.12.002	http://dx.doi.org/10.1016/j.stem.2010.12.002			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21185252	Bronze			2022-12-28	WOS:000286786200009
J	Sullivan, JP; Minna, JD				Sullivan, James P.; Minna, John D.			Tumor Oncogenotypes and Lung Cancer Stem Cell Identity	CELL STEM CELL			English	Editorial Material							IDENTIFICATION	In this issue of Cell Stem Cell, Curtis et. al. (2010) reveal that the identities of lung cancer stem cell populations differ depending on the specific tumor oncogenotype in three murine lung adenocarcinoma models. These findings highlight the importance of determining the cancer stem cell oncogenotype for genotypically diverse malignancies.	[Sullivan, James P.; Minna, John D.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Minna, JD (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	john.minna@utsw.edu			NCI NIH HHS [P50 CA070907] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bass AJ, 2009, NAT GENET, V41, P1238, DOI 10.1038/ng.465; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kwei KA, 2008, ONCOGENE, V27, P3635, DOI 10.1038/sj.onc.1211012; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; Sullivan JP, 2010, CANCER METAST REV, V29, P61, DOI 10.1007/s10555-010-9216-5; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190	10	15	15	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					2	4		10.1016/j.stem.2010.06.005	http://dx.doi.org/10.1016/j.stem.2010.06.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621039	Green Accepted, Bronze			2022-12-28	WOS:000280222300002
J	Davison, AC				Davison, Anna C.			Brave Pioneers or Clinical Cowboys?	CELL STEM CELL			English	Editorial Material																			0	6	6	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					504	505		10.1016/j.stem.2010.05.011	http://dx.doi.org/10.1016/j.stem.2010.05.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20578343	Bronze			2022-12-28	WOS:000278840700007
J	McKnight, KD; Wang, P; Kim, SK				McKnight, Kristen D.; Wang, Pei; Kim, Seung K.			Deconstructing Pancreas Development to Reconstruct Human Islets from Pluripotent Stem Cells	CELL STEM CELL			English	Article							MULTIPLE ENDOCRINE NEOPLASIA; CONGENITAL MALABSORPTIVE DIARRHEA; NEONATAL DIABETES-MELLITUS; ADULT-MOUSE PANCREAS; BETA-CELL; PROGENITOR CELLS; HUMAN FETAL; ES CELLS; MUTANT NEUROGENIN-3; EXPRESSION ANALYSIS	There is considerable excitement about harnessing the potential of human stem cells to replace pancreatic islets that are destroyed in type 1 diabetes mellitus. However, our current understanding of the mechanisms underlying pancreas and islet ontogeny has come largely from the powerful genetic, developmental, and embryological approaches available in nonhuman organisms. Successful islet reconstruction from human pluripotent cells will require greater attention to "deconstructing" human pancreas and islet developmental biology and consistent application of conditional genetics, lineage tracing, and cell purification to stem cell biology.	[McKnight, Kristen D.; Wang, Pei; Kim, Seung K.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Dept Med, Div Oncol, Stanford, CA 94305 USA; [Kim, Seung K.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Kim, SK (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.			Wang, Pei/0000-0003-2373-7315; Kim, Seung/0000-0001-6135-7810	Juvenile Diabetes Research Foundation (JDRF); Larry L Hillblom Foundation (LLHF); Mead Foundation; Snyder Foundation; Stinehart Foundation; Harry and Leona Helmsley Foundation; JDRF; LLHF; California Institute of Regenerative Medicine; U S National Institutes of Health; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK075919] Funding Source: NIH RePORTER	Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Larry L Hillblom Foundation (LLHF); Mead Foundation; Snyder Foundation; Stinehart Foundation; Harry and Leona Helmsley Foundation; JDRF(Juvenile Diabetes Research Foundation); LLHF; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); U S National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank members of the S K K group for advice and assistance K D M is supported by a Juvenile Diabetes Research Foundation (JDRF) fellowship and P W was supported by a Larry L Hillblom Foundation (LLHF) fellowship The S K K group was supported by the Mead Foundation, Snyder Foundation, Stinehart Foundation, Harry and Leona Helmsley Foundation, JDRF, LLHF, California Institute of Regenerative Medicine, the U S National Institutes of Health, and the Howard Hughes Medical Institute (HHMI) S K K is an Investigator of the HHMI We apologize to colleagues whose work we could not cite because of space constraints	Agarwal SK, 2009, J CLIN ENDOCR METAB, V94, P1826, DOI 10.1210/jc.2008-2083; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Bouwens L, 2006, CURR DIABETES REV, V2, P3, DOI 10.2174/157339906775473644; Bu L, 2009, NATURE, V460, P113, DOI 10.1038/nature08191; Cabrera O, 2006, P NATL ACAD SCI USA, V103, P2334, DOI 10.1073/pnas.0510790103; Castaing M, 2005, DEV DYNAM, V234, P339, DOI 10.1002/dvdy.20547; Cernea S, 2008, DIABETIC MED, V25, P1259, DOI 10.1111/j.1464-5491.2008.02556.x; Chandrasekharappa SC, 1997, SCIENCE, V276, P404, DOI 10.1126/science.276.5311.404; Chen HA, 2009, GENE DEV, V23, P975, DOI 10.1101/gad.1742509; Cirulli V, 1998, J CELL BIOL, V140, P1519, DOI 10.1083/jcb.140.6.1519; CIRULLI V, 1994, J CELL SCI, V107, P1429; Cirulli V, 1995, TRANSPLANT P, V27, P3335; Cirulli V, 2000, J CELL BIOL, V150, P1445, DOI 10.1083/jcb.150.6.1445; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Collombat P, 2009, CELL CYCLE, V8, P3450, DOI 10.4161/cc.8.21.9791; Cozar-Castellano I, 2006, ENDOCR REV, V27, P356, DOI 10.1210/er.2006-0004; Crabtree JS, 2001, P NATL ACAD SCI USA, V98, P1118, DOI 10.1073/pnas.98.3.1118; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Desgraz R, 2009, DEVELOPMENT, V136, P3567, DOI 10.1242/dev.039214; Deutsch G, 2001, DEVELOPMENT, V128, P871; Dhawan S, 2009, GENE DEV, V23, P906, DOI 10.1101/gad.1742609; Dorrell C, 2008, STEM CELL RES, V1, P183, DOI 10.1016/j.scr.2008.04.001; Dufour JM, 2005, TISSUE ENG, V11, P1323, DOI 10.1089/ten.2005.11.1323; Dugas JC, 2008, J NEUROSCI, V28, P8294, DOI 10.1523/JNEUROSCI.2010-08.2008; Eizirik DL, 2009, NAT REV ENDOCRINOL, V5, P219, DOI 10.1038/nrendo.2009.21; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; Fajans SS, 2001, NEW ENGL J MED, V345, P971, DOI 10.1056/NEJMra002168; FOSTER JW, 1994, NATURE, V372, P525, DOI 10.1038/372525a0; Gadue P, 2009, STEM CELLS, V27, P2103, DOI 10.1002/stem.147; Gittes GK, 2009, DEV BIOL, V326, P4, DOI 10.1016/j.ydbio.2008.10.024; Gloyn AL, 2004, NEW ENGL J MED, V350, P1838, DOI 10.1056/NEJMoa032922; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2004, DEVELOPMENT, V131, P165, DOI 10.1242/dev.00921; Gu GQ, 2002, DEVELOPMENT, V129, P2447; HAYEK A, 1992, METABOLISM, V41, P1367, DOI 10.1016/0026-0495(92)90109-N; Hayek A, 1997, J CLIN ENDOCR METAB, V82, P2471, DOI 10.1210/jc.82.8.2471; Heit JJ, 2006, ANNU REV CELL DEV BI, V22, P311, DOI 10.1146/annurev.cellbio.22.010305.104425; Horikawa Y, 1997, NAT GENET, V17, P384, DOI 10.1038/ng1297-384; Huppert SS, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.283pe50; Jensen J, 2000, NAT GENET, V24, P36, DOI 10.1038/71657; Jensen JN, 2007, NEW ENGL J MED, V356, P1781; Jeon J, 2009, J HISTOCHEM CYTOCHEM, V57, P811, DOI 10.1369/jhc.2009.953307; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kania G, 2005, STEM CELLS, V23, P791, DOI 10.1634/stemcells.2004-0232; Kawaguchi J, 2010, DEVELOPMENT, V137, P693, DOI 10.1242/dev.046896; Kawaguchi Y, 2002, NAT GENET, V32, P128, DOI 10.1038/ng959; Kawasaki H, 2000, NEURON, V28, P31, DOI 10.1016/S0896-6273(00)00083-0; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; Krapp A, 1998, GENE DEV, V12, P3752, DOI 10.1101/gad.12.23.3752; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kutlu B, 2009, BMC MED GENOMICS, V2, DOI 10.1186/1755-8794-2-3; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Lutolf MP, 2009, INTEGR BIOL, V1, P59, DOI 10.1039/b815718a; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; Malecki MT, 1999, NAT GENET, V23, P323, DOI 10.1038/15500; Mayhew CN, 2010, CURR OPIN ORGAN TRAN, V15, P54, DOI 10.1097/MOT.0b013e3283337e1c; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Mutskov V, 2009, P NATL ACAD SCI USA, V106, P17419, DOI 10.1073/pnas.0909288106; Njolstad PR, 2001, NEW ENGL J MED, V344, P1588, DOI 10.1056/NEJM200105243442104; Oliver-Krasinski JM, 2008, GENE DEV, V22, P1998, DOI 10.1101/gad.1670808; OUTZEN HC, 1981, TRANSPLANTATION, V32, P101, DOI 10.1097/00007890-198108000-00004; Pellegata NS, 2006, P NATL ACAD SCI USA, V103, P15558, DOI 10.1073/pnas.0603877103; Piper K, 2004, J ENDOCRINOL, V181, P11, DOI 10.1677/joe.0.1810011; Plengvidhya N, 2007, J CLIN ENDOCR METAB, V92, P2821, DOI 10.1210/jc.2006-1927; Polak M, 2000, DIABETES, V49, P225, DOI 10.2337/diabetes.49.2.225; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Puri S, 2010, DEV CELL, V18, P342, DOI 10.1016/j.devcel.2010.02.005; Robbins RD, 2010, CURR OPIN ORGAN TRAN, V15, P61, DOI 10.1097/MOT.0b013e3283337196; Sarkar SA, 2008, DIABETOLOGIA, V51, P285, DOI 10.1007/s00125-007-0880-0; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Sellick GS, 2004, NAT GENET, V36, P1301, DOI 10.1038/ng1475; Senee V, 2006, NAT GENET, V38, P682, DOI 10.1038/ng1802; Seymour PA, 2008, DEV BIOL, V323, P19, DOI 10.1016/j.ydbio.2008.07.034; Seymour PA, 2007, P NATL ACAD SCI USA, V104, P1865, DOI 10.1073/pnas.0609217104; Smith SB, 2010, NATURE, V463, P775, DOI 10.1038/nature08748; Sosa-Pineda B, 2004, MOL CELLS, V18, P289; Stoffers DA, 1997, NAT GENET, V15, P106, DOI 10.1038/ng0197-106; Stoffers DA, 1997, NAT GENET, V17, P138, DOI 10.1038/ng1097-138; Sugiyama T, 2007, P NATL ACAD SCI USA, V104, P175, DOI 10.1073/pnas.0609490104; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomas P, 1996, HUM MOL GENET, V5, P1809, DOI 10.1093/hmg/5.11.1809; Van Hoof D, 2009, STEM CELL RES, V3, P73, DOI 10.1016/j.scr.2009.08.003; VIONNET N, 1992, NATURE, V356, P721, DOI 10.1038/356721a0; Wandzioch E, 2009, SCIENCE, V324, P1707, DOI 10.1126/science.1174497; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang S, 2009, P NATL ACAD SCI USA, V106, P9715, DOI 10.1073/pnas.0904247106; White P, 2008, DIABETES, V57, P654, DOI 10.2337/db07-1362; White P, 2009, METHODS MOL BIOL, V560, P239, DOI 10.1007/978-1-59745-448-3_16; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yoshitomi H, 2004, DEVELOPMENT, V131, P807, DOI 10.1242/dev.00960; Zhang DH, 2009, CELL RES, V19, P429, DOI 10.1038/cr.2009.28; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	103	51	54	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					300	308		10.1016/j.stem.2010.03.003	http://dx.doi.org/10.1016/j.stem.2010.03.003			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362535	Bronze, Green Accepted			2022-12-28	WOS:000276823300009
J	Ichida, JK; Blanchard, J; Lam, K; Son, EY; Chung, JE; Egli, D; Loh, KM; Carter, AC; Di Giorgio, FP; Koszka, K; Huangfu, DW; Akutsu, H; Liu, DR; Rubin, LL; Eggan, K				Ichida, Justin K.; Blanchard, Joel; Lam, Kelvin; Son, Esther Y.; Chung, Julia E.; Egli, Dieter; Loh, Kyle M.; Carter, Ava C.; Di Giorgio, Francesco P.; Koszka, Kathryn; Huangfu, Danwei; Akutsu, Hidenori; Liu, David R.; Rubin, Lee L.; Eggan, Kevin			A Small-Molecule Inhibitor of Tgf-beta Signaling Replaces Sox2 in Reprogramming by Inducing Nanog	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; HUMAN FIBROBLASTS; INDUCTION; GENERATION; MOUSE; POTENT; DIFFERENTIATION; OCT4	The combined activity of three transcription factors can reprogram adult cells into induced pluripotent stem cells (iPSCs). However, the transgenic methods used for delivering reprogramming factors have raised concerns regarding the future utility of the resulting stem cells. These uncertainties could be overcome if each transgenic factor were replaced with a small molecule that either directly activated its expression from the somatic genome or in some way compensated for its activity. To this end, we have used high-content chemical screening to identify small molecules that can replace Sox2 in reprogramming. We show that one of these molecules functions in reprogramming by inhibiting Tgf-beta signaling in a stable and trapped intermediate cell type that forms during the process. We find that this inhibition promotes the completion of reprogramming through induction of the transcription factor Nanog.	[Ichida, Justin K.; Blanchard, Joel; Lam, Kelvin; Son, Esther Y.; Chung, Julia E.; Egli, Dieter; Loh, Kyle M.; Carter, Ava C.; Di Giorgio, Francesco P.; Koszka, Kathryn; Huangfu, Danwei; Rubin, Lee L.; Eggan, Kevin] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Son, Esther Y.; Chung, Julia E.; Eggan, Kevin] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ichida, Justin K.; Son, Esther Y.; Chung, Julia E.; Egli, Dieter; Carter, Ava C.; Di Giorgio, Francesco P.; Koszka, Kathryn; Eggan, Kevin] Stowers Med Inst, Kansas City, MO 64110 USA; [Akutsu, Hidenori] Natl Res Inst Child Hlth & Dev, Dept Reprod Biol, Setagaya Ku, Tokyo 1578535, Japan; [Son, Esther Y.; Liu, David R.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Son, Esther Y.; Liu, David R.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA	Harvard University; Harvard University; Stowers Institute for Medical Research; National Center for Child Health & Development - Japan; Harvard University; Howard Hughes Medical Institute; Harvard University	Rubin, LL (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	lee_rubin@harvard.edu; eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018; TCW, Julia/AED-4001-2022	TCW, Julia/0000-0002-3054-9374; Loh, Kyle/0000-0002-8042-0149; Carter, Ava/0000-0002-1892-8742; Huangfu, Danwei/0000-0002-1145-6199	Harvard Stem Cell Institute; NIH [R01 HD046732-01A1, GM065400]; NYSCF; Howard Hughes Medical Institute; Sankyo Foundation of Life Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD046732] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065400] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSCF; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Sankyo Foundation of Life Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Noggle, E. Kiskinis, A. Arvanites, S. Bobrowicz, L. Weisenthal, R. Maehr, A. Kweudjeu, R. Gali, M. Yamaki, E. Massassa, R. Martinez, and K. Rosowski for technical assistance and S. Sullivan, K. Niakan, K. Rodolfa, S. Mekhoubad, I. Tabansky, C. Sasaki, D. Melton, and S. Chen for helpful discussions. This work was made possible by support provided by the Harvard Stem Cell Institute to L.R. and K.E., by support from the NIH grant R01 HD046732-01A1 to K.E., and by an innovation grant from the NYSCF to L.R. E.S. and D.L. acknowledge support from the NIH (GM065400) and from the Howard Hughes Medical Institute. J.K.I. and F.P.D. are New York Stem Cell Foundation postdoctoral fellows. D.H. is a Helen Hay Whitney postdoctoral fellow. K.E. is a fellow of the John D. and Catherine T. MacArthur Foundation. H.A. was funded by the Sankyo Foundation of Life Science. The authors are filing a patent based on the results reported in this paper. L.L.R. is a founder of iPierian and a member of its scientific advisory board. K.E. is a member of the iPierian scientific advisory board.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Boiani M, 2004, METH MOL B, V254, P1; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Gellibert FO, 2004, J MED CHEM, V47, P4494, DOI 10.1021/jm0400247; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hanke JH, 1996, J BIOL CHEM, V271, P695, DOI 10.1074/jbc.271.2.695; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; THRASHER A, 2007, SEVERE ADVERSE EVENT; Utikal J, 2009, J CELL SCI, V122, P3502, DOI 10.1242/jcs.054783; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	40	593	678	1	83	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					491	503		10.1016/j.stem.2009.09.012	http://dx.doi.org/10.1016/j.stem.2009.09.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19818703	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000272019500011
J	Ware, CB; Wang, LL; Mecham, BH; Shen, LL; Nelson, AM; Bar, M; Lamba, DA; Dauphin, DS; Buckingham, B; Askari, B; Lim, R; Tewari, M; Gartler, SM; Issa, JP; Pavlidis, P; Duan, ZJ; Blau, CA				Ware, Carol B.; Wang, Linlin; Mecham, Brigham H.; Shen, Lanlan; Nelson, Angelique M.; Bar, Merav; Lamba, Deepak A.; Dauphin, Derek S.; Buckingham, Brian; Askari, Bardia; Lim, Raymond; Tewari, Muneesh; Gartler, Stanley M.; Issa, Jean-Pierre; Pavlidis, Paul; Duan, Zhijun; Blau, C. Anthony			Histone Deacetylase Inhibition Elicits an Evolutionarily Conserved Self-Renewal Program in Embryonic Stem Cells	CELL STEM CELL			English	Article							FIBROBLAST-GROWTH-FACTOR; GENE-EXPRESSION; TARGET GENES; MOUSE; LINES; TRANSCRIPTION; CHROMATIN; PATHWAYS; PLURIPOTENCY; DOWNSTREAM	Recent evidence indicates that mouse and human embryonic stem cells (ESCs) are fixed at different developmental stages, with the former positioned earlier. We show that a narrow concentration of the naturally occurring short-chain fatty acid, sodium butyrate, supports the extensive self-renewal of mouse and human ESCs, while promoting their convergence toward an intermediate stem cell state. In response to butyrate, human ESCs regress to an earlier developmental stage characterized by a gene expression profile resembling that of mouse ESCs, preventing precocious Xist expression while retaining the ability to form complex teratomas in vivo. Other histone deacetylase inhibitors (HDACi) also support human ESC self-renewal. Our results indicate that HDACi can promote ESC self-renewal across species, and demonstrate that ESCs can toggle between alternative states in response to environmental factors.	[Ware, Carol B.; Wang, Linlin; Nelson, Angelique M.; Lamba, Deepak A.; Tewari, Muneesh; Duan, Zhijun; Blau, C. Anthony] Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA; [Ware, Carol B.; Nelson, Angelique M.] Univ Washington, Dept Comparat Med, Seattle, WA 98195 USA; [Wang, Linlin; Dauphin, Derek S.; Duan, Zhijun; Blau, C. Anthony] Univ Washington, Dept Med Hematol, Seattle, WA 98195 USA; [Buckingham, Brian] Univ Washington, Med Scientist Training Program, Seattle, WA 98195 USA; [Gartler, Stanley M.] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA; [Lamba, Deepak A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA; [Mecham, Brigham H.; Gartler, Stanley M.; Blau, C. Anthony] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Askari, Bardia] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Bar, Merav; Tewari, Muneesh] Fred Hutchinson Canc Res Ctr, Seattle, WA 98109 USA; [Lim, Raymond; Pavlidis, Paul] Univ British Columbia, Dept Psychiat, Vancouver, BC V6T 1Z4, Canada; [Lim, Raymond; Pavlidis, Paul] Univ British Columbia, Ctr High Throughput Biol, Vancouver, BC V6T 1Z4, Canada; [Shen, Lanlan; Issa, Jean-Pierre] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; University of British Columbia; University of British Columbia; University of Texas System; UTMD Anderson Cancer Center	Ware, CB (corresponding author), Univ Washington, Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA.	cware@u.washington.edu; tblau@u.washington.edu	Pavlidis, Paul/H-8406-2013	Pavlidis, Paul/0000-0002-0426-5028; Issa, Jean-Pierre/0000-0003-2258-5030; Lim, Raymond/0000-0001-8772-3882	NIH [1 P01 dM081619]; University of Washington; Michael Smith Foundation [GM076990]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069983, R01GM076990, P01GM081619] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Washington(University of Washington); Michael Smith Foundation(Michael Smith Foundation for Health Research); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Daniel G. Miller, William Noble, Richard Young, Matt Guenther, Paul Tesar, Ron McKay, Piper Treuting, Edith Wang, and Julian Simon for useful discussions. We thank Austin Smith for LIFR-'- mESCs and Ian Chambers for gpl 30-1- mESCs; Paul Tesar and Ron McKay for mEpiSCs; Samuel Sun for assistance with data analysis; and Jeff Okada, Jennifer Potter, Chris Cavanaugh, and Jennifer Hesson for technical support. We also thank Robert Hall at the University of Washington Center for Array Technologies and William Howald at the Mass Spectrometry Center for their expertise and assistance. This work was supported by NIH grant 1 P01 dM081619 and through the Institute for Stem Cell and Regenerative Medicine (ISCRM) of the University of Washington. P.P. is supported by a Michael Smith Foundation for Health Research Career Investigator Award and NIH grant GM076990. C.B.W. made the initial observation regarding butyrate's activity in culture, designed and performed experiments, interpreted findings, prepared figures, and helped to draft and revise the manuscript; L.W. performed all experiments pertaining to flow cytome" and assisted with many of the qPCR studies; B.M., R.L., and P.P. analyzed data from expression arrays of mESCs and hESCs and compared them to published expression arrays; R.F. designed and performed chromatin immunoprecipitation analyses; A.M.N. assisted C.B.W. in many of the culture studies of mESC and hESC, as well as in generating mESC lines in the presence of butyrate; D.D. and B.B. designed and performed a number of qPCR experiments; M.B. and M.T. performed qPCR for microRNAs; S.M.G. performed studies of Xist expression and critically reviewed the manuscript; L.S. and J.-P.I. performed promoter methylation analysis; B.A. explored metabolic fate of cells grown in butyrate; D.L. tested directed differentiation to a neuroretinal fate; Z-J.D. performed telomerase assays and assisted in study design and in revising the manuscript; and C.A.B. assisted in designing experiments, interpreting results, preparing figures, and writing the manuscript.	ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Andang M, 2008, NATURE, V451, P460, DOI 10.1038/nature06488; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Becker KA, 2007, J CELL PHYSIOL, V210, P517, DOI 10.1002/jcp.20903; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BOFFA LC, 1978, J BIOL CHEM, V253, P3364; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buszczak M, 2006, CELL, V125, P233, DOI 10.1016/j.cell.2006.04.004; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; Denning C, 2006, INT J DEV BIOL, V50, P27, DOI 10.1387/ijdb.052107cd; Dreesen O, 2007, STEM CELL REV, V3, P7, DOI 10.1007/s12015-007-0004-8; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Eiselleova L, 2008, INT J DEV BIOL, V52, P353, DOI 10.1387/ijdb.082590le; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nelson JD, 2006, NAT PROTOC, V1, P179, DOI 10.1038/nprot.2006.27; PARK IH, 2007, NATURE, V451, P135; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Rada-Iglesias A, 2007, GENOME RES, V17, P708, DOI 10.1101/gr.5540007; Rathjen J, 1999, J CELL SCI, V112, P601; SAVATIER P, 1994, ONCOGENE, V9, P809; Shen L, 2007, PLOS GENET, V3, P2023, DOI 10.1371/journal.pgen.0030181; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; STEWART CL, 1992, NATURE, V359, P76, DOI 10.1038/359076a0; Tabibzadeh S, 2006, STEM CELLS, V24, P1998, DOI 10.1634/stemcells.2006-0075; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Ware CB, 2006, STEM CELLS, V24, P2677, DOI 10.1634/stemcells.2005-0452; WARE CB, 1995, DEVELOPMENT, V121, P1283; Weidinger G, 2005, CURR BIOL, V15, P489, DOI 10.1016/j.cub.2005.01.041; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620; Yao HHC, 2004, DEV DYNAM, V230, P210, DOI 10.1002/dvdy.20042; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zirn B, 2006, GENE CHROMOSOME CANC, V45, P565, DOI 10.1002/gcc.20319	54	117	121	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					359	369		10.1016/j.stem.2009.03.001	http://dx.doi.org/10.1016/j.stem.2009.03.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341625	Green Accepted, Bronze			2022-12-28	WOS:000265162700012
J	Casali, A; Batlle, E				Casali, Andreu; Batlle, Eduard			Intestinal Stem Cells in Mammals and Drosophila	CELL STEM CELL			English	Review							PROGENITOR CELLS; MIDGUT; DELETION; CRYPTS; LGR5; MYC	In the last few years, our knowledge of intestinal stem cell biology has flourished. Here we review recent developments in this exciting field, paying special attention to the characterization of Drosophila and mammalian intestinal stem cells.	[Casali, Andreu; Batlle, Eduard] IRB Barcelona, Barcelona 08028, Spain; [Casali, Andreu] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain; [Batlle, Eduard] ICREA, Barcelona 08010, Spain	Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); ICREA	Batlle, E (corresponding author), IRB Barcelona, Baldiri Reixac 10, Barcelona 08028, Spain.	eduard.batlle@irbbarcelona.org	Casali, Andreu/Z-5620-2019; Batlle, Eduard/K-8080-2014; Casali, Andreu/ABD-5226-2021	Batlle, Eduard/0000-0003-2422-0326; Casali, Andreu/0000-0003-1738-869X	ICREA Funding Source: Custom	ICREA(ICREA)		Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Fre S, 2005, NATURE, V435, P964, DOI 10.1038/nature03589; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Muncan V, 2006, MOL CELL BIOL, V26, P8418, DOI 10.1128/MCB.00821-06; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Riccio O, 2008, EMBO REP, V9, P377, DOI 10.1038/embor.2008.7; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sansom OJ, 2007, NATURE, V446, P676, DOI 10.1038/nature05674; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	23	132	138	1	24	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					124	127		10.1016/j.stem.2009.01.009	http://dx.doi.org/10.1016/j.stem.2009.01.009			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200801	Bronze			2022-12-28	WOS:000263213400009
J	Chuong, CM; Widelitz, RB				Chuong, Cheng-Ming; Widelitz, Randall Bruce			The River of Stem Cells	CELL STEM CELL			English	Editorial Material									[Chuong, Cheng-Ming; Widelitz, Randall Bruce] Univ So Calif, Keck Sch Med, Dept Pathol, Los Angeles, CA 90033 USA	University of Southern California	Chuong, CM (corresponding author), Univ So Calif, Keck Sch Med, Dept Pathol, 2011 Zonal Ave,HMR 305D, Los Angeles, CA 90033 USA.	cmchuong@usc.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR042177, R01AR047364] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR042177-14, R01 AR047364, R01 AR047364-07, R01 AR042177] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; DRY FW, 1926, J GENET, V16, P288; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Lander AD, 2009, PLOS BIOL, V7, P84, DOI 10.1371/journal.pbio.1000015; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Potten C S, 1981, Int Rev Cytol, V69, P271; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475	10	9	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					100	102		10.1016/j.stem.2009.01.003	http://dx.doi.org/10.1016/j.stem.2009.01.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200797	Green Accepted, Bronze			2022-12-28	WOS:000263213400004
J	Maherali, N; Hochedlinger, K				Maherali, Nimet; Hochedlinger, Konrad			Guidelines and Techniques for the Generation of Induced Pluripotent Stem Cells	CELL STEM CELL			English	Review							HUMAN SOMATIC-CELLS; HUMAN FIBROBLASTS; SERUM-FREE; MOUSE; INDUCTION; EXPRESSION; DIFFERENTIATION; SYSTEM; OCT4; TRANSDUCTION	Direct reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) provides an invaluable resource for regenerative medicine, enabling the generation of patient-specific cells of any lineage without the use of embryonic material. A variety of methods exist for iPSC derivation, all reliant upon manipulation of a select group of transcription factors. We compare the currently reported protocols, identify essential steps common to these methods, and suggest minimal criteria for defining fully reprogrammed cells. In addition, specific procedures aimed to optimize reproducible iPSC derivation are presented, with an emphasis on standardization of certain parameters for accurate comparison between independent experiments.	[Maherali, Nimet; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Maherali, Nimet; Hochedlinger, Konrad] Harvard Stem Cell Inst, Ctr Canc, Dept Stem Cell & Regenerat Biol, Boston, MA 02114 USA; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu			Natural Sciences and Engineering Research Council of Canada; Alberta Scholarship Programs; NIH Director's Innovator Award; Harvard Stem Cell Institute; Kimmel Foundation; V Foundation	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Scholarship Programs; NIH Director's Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; Kimmel Foundation; V Foundation	We thank Todd Meyerrose, Jose Polo, Matthias Stadtfeld, and Jochen Utikal for discussion and critical reading of the manuscript, and Tom DeCesare for figure contributions. N.M. is supported by the Natural Sciences and Engineering Research Council of Canada and Alberta Scholarship Programs. K.H. is supported by an NIH Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation, and the V Foundation.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Akutsu H, 2006, METHOD ENZYMOL, V418, P78, DOI 10.1016/S0076-6879(06)18005-2; Amit M, 2006, METH MOL B, V331, P105; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Bosnali M, 2008, BIOL CHEM, V389, P851, DOI 10.1515/BC.2008.106; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cheng J, 2004, GENESIS, V39, P100, DOI 10.1002/gene.20031; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Gaudet F, 2003, SCIENCE, V300, P489, DOI 10.1126/science.1083558; Gertow K, 2007, CURR PROTOC STEM CEL; Gump JM, 2007, TRENDS MOL MED, V13, P443, DOI 10.1016/j.molmed.2007.08.002; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; JacksonGrusby L, 1997, P NATL ACAD SCI USA, V94, P4681, DOI 10.1073/pnas.94.9.4681; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Lee H, 2007, STEM CELLS, V25, P1931, DOI 10.1634/stemcells.2007-0097; Lei H, 1996, DEVELOPMENT, V122, P3195; Lerou PH, 2008, NAT PROTOC, V3, P923, DOI 10.1038/nprot.2008.60; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Nagy A., 2003, MANIPULATING MOUSE E, P764; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Ramezani A., 2002, CURR PROTOC MOL BIOL; Rideout WM, 2001, SCIENCE, V293, P1093, DOI 10.1126/science.1063206; ROSENZWEIG A, 2007, CURR PROTOC HUM GENE, pCH12; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tiscornia G, 2006, NAT PROTOC, V1, P241, DOI 10.1038/nprot.2006.37; VARAS F, 2008, STEM CELLS, DOI DOI 10.1634/STEM-CELLS.2008-0696; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	76	369	435	2	113	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					595	605		10.1016/j.stem.2008.11.008	http://dx.doi.org/10.1016/j.stem.2008.11.008			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041776	Bronze			2022-12-28	WOS:000261670900008
J	Goyama, S; Yamamoto, G; Shimabe, M; Sato, T; Ichikawa, M; Ogawa, S; Chiba, S; Kurokawa, M				Goyama, Susumu; Yamamoto, Go; Shimabe, Munetake; Sato, Tomohiko; Ichikawa, Motoshi; Ogawa, Seishi; Chiba, Shigeru; Kurokawa, Mineo			Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; ZINC-FINGER GENE; MYELODYSPLASTIC SYNDROME; EXPRESSION; DOMAIN; IDENTIFICATION; PROTOONCOGENE; PROGENITORS; INTEGRATION; ACTIVATION	Evi-1 has been recognized as one of the dominant oncogenes associated with murine and human myeloid leukemia. Here, we show that hematopoietic stem cells (HSCs) in Evi-1-deficient embryos are severely reduced in number with defective proliferative and repopulating capacity. Selective ablation of EVIL 1 in Tie2(+) cells mimics Evi-1 deficiency, suggesting that Evi-1 function is required in Tie2(+) hemtopoietic stem/progenitors. Conditional deletion of Evi-1 in the adult hematopoietic system revealed that Evi-1-deficient bone marrow HSCs cannot maintain hematopoiesis and lose their repopulating ability. In contrast, Evi-1 is dispensable for blood cell lineage commitment. Evi-1(+/-) mice exhibit the intermediate phenotype for HSC activity, suggesting a gene dosage requirement for Evi-1. We further demonstrate that disruption of Evi-1 in transformed leukemic cells leads to significant loss of their proliferative activity both in vitro and in vivo. Thus, Evi-1 is a common and critical regulator essential for proliferation of embryonic/adult HSCs and transformed leukemic cells.	[Goyama, Susumu; Yamamoto, Go; Shimabe, Munetake; Sato, Tomohiko; Ichikawa, Motoshi; Ogawa, Seishi; Chiba, Shigeru; Kurokawa, Mineo] Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Hermatol & Oncol,Bunkyo Ku, Tokyo 1138655, Japan; [Ogawa, Seishi; Chiba, Shigeru] Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Cell Therapy & Transplantat Med,Bunkyo Ku, Tokyo 1138655, Japan; [Ogawa, Seishi] Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Regenerat Med Hematopoiesis,Bunkyo Ku, Tokyo 1138655, Japan	University of Tokyo; University of Tokyo; University of Tokyo	Kurokawa, M (corresponding author), Univ Tokyo, Tokyo Univ Hosp, Grad Sch Med, Dept Hermatol & Oncol,Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	kurokawa-tky@umin.ac.jp	Ogawa, Seishi/AAE-7088-2019	Sato, Tomohiko/0000-0002-8244-075X; Ichikawa, Motoshi/0000-0001-6497-0848	Japan Society for the Promotion of Science; Ministry of Health, Labour and Welfare; Grants-in-Aid for Scientific Research [19679004] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura for Plat-E packaging cells and pMXs retroviral vector; H. Nakauchi and M. Onodera for pGCDNsam-eGFP retroviral vector; T. Nakano for OP9 stromal cells; R. Ono and T. Nosaka for MLL/ENL cDNA; T. Inaba for E2A/HLF cDNA; R. Sprengel for iCre cDNA; M.H. Tomasson for cMyc-bcl2 cDNA; N. Watanabe, Y. Kato, and A. Iwama for technical advice; R. Takizawa for help with the generation of Evi-1 mutant mice; Y. Shimamura and Y. Sawamoto for expert technical assistance; and Kirin Brewery Pharmaceutical Research Laboratory for cytokines. This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and by Health and Labour Sciences Research grants from the Ministry of Health, Labour and Welfare.	Ayton PM, 2003, GENE DEV, V17, P2298, DOI 10.1101/gad.1111603; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BORDEREAUX D, 1990, ONCOGENE, V5, P925; Buonamici S, 2004, J CLIN INVEST, V114, P713, DOI 10.1172/JCI200421716; Calmels B, 2005, BLOOD, V106, P2530, DOI 10.1182/blood-2005-03-1115; DELWEL R, 1993, MOL CELL BIOL, V13, P4291, DOI 10.1128/MCB.13.7.4291; Fears S, 1996, P NATL ACAD SCI USA, V93, P1642, DOI 10.1073/pnas.93.4.1642; Goyama S, 2004, BLOOD, V104, P3558, DOI 10.1182/blood-2004-04-1535; Hirai H, 1999, INT J BIOCHEM CELL B, V31, P1367, DOI 10.1016/S1357-2725(99)00064-3; Hoyt PR, 1997, MECH DEVELOP, V65, P55, DOI 10.1016/S0925-4773(97)00057-9; Huntly BJP, 2005, NAT REV CANCER, V5, P311, DOI 10.1038/nrc1592; Izutsu K, 2001, BLOOD, V97, P2815, DOI 10.1182/blood.V97.9.2815; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Kurokawa M, 1998, NATURE, V394, P92, DOI 10.1038/27945; Kurokawa M, 2000, EMBO J, V19, P2958, DOI 10.1093/emboj/19.12.2958; Kustikova O, 2005, SCIENCE, V308, P1171, DOI 10.1126/science.1105063; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Luo H, 2005, BLOOD, V106, P2452, DOI 10.1182/blood-2005-02-0734; MORISHITA K, 1992, MOL CELL BIOL, V12, P183, DOI 10.1128/MCB.12.1.183; MORISHITA K, 1990, ONCOGENE, V5, P1419; MUCENSKI ML, 1988, MOL CELL BIOL, V8, P301, DOI 10.1128/MCB.8.1.301; Nitta E, 2005, ONCOGENE, V24, P6165, DOI 10.1038/sj.onc.1208754; Ogawa S, 1996, Hum Cell, V9, P323; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; PERKINS AS, 1991, MOL CELL BIOL, V11, P2665, DOI 10.1128/MCB.11.5.2665; PINTADO T, 1985, CANCER, V55, P535, DOI 10.1002/1097-0142(19850201)55:3<535::AID-CNCR2820550311>3.0.CO;2-4; Smith KS, 2002, MOL CELL BIOL, V22, P7678, DOI 10.1128/MCB.22.21.7678-7688.2002; Sood R, 1999, LEUKEMIA, V13, P348, DOI 10.1038/sj.leu.2401360; Sugita M, 2000, CANCER GENET CYTOGEN, V117, P9, DOI 10.1016/S0165-4608(99)00135-1; SUZUKAWA K, 1994, BLOOD, V84, P2681; TANAKA T, 1994, J BIOL CHEM, V269, P24020; Valk PJM, 2004, NEW ENGL J MED, V350, P1617, DOI 10.1056/NEJMoa040465; van Doorn-Khosrovani SBV, 2003, BLOOD, V101, P837, DOI 10.1182/blood-2002-05-1459; Yuasa H, 2005, EMBO J, V24, P1976, DOI 10.1038/sj.emboj.7600679; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418	38	208	215	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					207	220		10.1016/j.stem.2008.06.002	http://dx.doi.org/10.1016/j.stem.2008.06.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682242	Bronze			2022-12-28	WOS:000258523300015
J	Tanimura, S; Tadokoro, Y; Inomata, K; Nguyen, TB; Nishie, W; Yamazaki, S; Nakauchi, H; Tanaka, Y; McMillan, JR; Sawamura, D; Yancey, K; Shimizu, H; Nishimura, EK				Tanimura, Shintaro; Tadokoro, Yuko; Inomata, Ken; Nguyen Thanh Binh; Nishie, Wataru; Yamazaki, Satoshi; Nakauchi, Hiromitsu; Tanaka, Yoshio; McMillan, James R.; Sawamura, Daisuke; Yancey, Kim; Shimizu, Hiroshi; Nishimura, Emi K.			Hair Follicle Stem Cells Provide a Functional Niche for Melanocyte Stem Cells	CELL STEM CELL			English	Article							BENIGN EPIDERMOLYSIS-BULLOSA; EPIDERMAL BASEMENT-MEMBRANE; PEMPHIGOID ANTIGEN; SELF-RENEWAL; SKIN; BETA; DIFFERENTIATION; MORPHOGENESIS; ACTIVATION; INTEGRIN	In most stem cell systems, the organization of the stem cell niche and the anchoring matrix required for stem cell maintenance are largely unknown. We report here that collagen XVII (COL17A1/BP180/BPAG2), a hemidesmosomal transmembrane collagen, is highly expressed in hair follicle stem cells (HFSCs) and is required for the maintenance not only of HFSCs but also of melanocyte stem cells (MSCs), which do not express Col17a1 but directly adhere to HFSCs. Mice lacking Col17a1 show premature hair graying and hair loss. Analysis of Col17a1-null mice revealed that COL17A1 is critical for the self-renewal of HFSCs through maintaining their quiescence and immaturity, potentially explaining the mechanism underlying hair loss in human COL17A1 deficiency. Moreover, forced expression of COL17A1 in basal keratinocytes, including HFSCs, in Col17a1-null mice rescues MSCs from premature differentiation and restores TGF-8 signaling, demonstrating that HFSCs function as a critical regulatory component of the MSC niche.	[Tanimura, Shintaro; Tadokoro, Yuko; Inomata, Ken; Nguyen Thanh Binh; Tanaka, Yoshio; Nishimura, Emi K.] Kanazawa Univ, Canc Res Inst, Dept Stem Cell Med, Kanazawa, Ishikawa 9200934, Japan; [Tanimura, Shintaro; Nishie, Wataru; McMillan, James R.; Shimizu, Hiroshi; Nishimura, Emi K.] Hokkaido Univ, Grad Sch Med, Dept Dermatol, Sapporo, Hokkaido 0608638, Japan; [Inomata, Ken] KOSE Corp, Fundamental Res Labs, Itabashi Ku, Tokyo 1740051, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] ERATO, Japan Sci & Technol Agcy JST, Chiyoda Ku, Tokyo 1020075, Japan; [Yamazaki, Satoshi; Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Therapy,Minato Ku, Tokyo 1088639, Japan; [Sawamura, Daisuke] Hirosaki Univ, Dept Dermatol, Sch Med, Aomori 0368562, Japan; [Yancey, Kim] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Nguyen Thanh Binh; Nishimura, Emi K.] Tokyo Med & Dent Univ, Med Res Inst, Dept Stem Cell Biol, Chiyoda Ku, Tokyo 1010062, Japan	Kanazawa University; Hokkaido University; Japan Science & Technology Agency (JST); University of Tokyo; Hirosaki University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tokyo Medical & Dental University (TMDU)	Nishimura, EK (corresponding author), Kanazawa Univ, Canc Res Inst, Dept Stem Cell Med, Kanazawa, Ishikawa 9200934, Japan.	nishscm@tmd.ac.jp	McMillan, James R/C-6657-2009; Shimizu, Hiroshi/A-5193-2012; Nishie, Wataru/A-5236-2012	Inomata, Ken/0000-0002-3556-1380	Japanese Ministry of Education, Culture, Sports, Science, and Technology [17689033, 19390293]; Uehara Memorial Foundation; Kato Memorial Bioscience Foundation; Takeda Science Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Kato Memorial Bioscience Foundation; Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr. Makoto Taketo for Tgfbr2 knockout mice; Dr. Hideki Nakamura, Dr. Tomohiko Wakayama, and Dr. Shoichi Iseki for their technical advice concerning electron microscopic analysis; Dr. Hiroyuki Nishimura for critical reading of the manuscript; Dr. Masashi Akiyama for discussion; Dr. Atsushi Hirao and Dr. Masako Ohmura for the use of the flow cytometer; Dr. Ken Natsuga and Ms. Kaori Sakai for sample identification; and Ms. Miss Suzuki, Ms. Megumi Sato, and Ms. Yuika Osaki for technical assistance. This study was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science, and Technology (17689033, 19390293), the Uehara Memorial Foundation, the Kato Memorial Bioscience Foundation, and the Takeda Science Foundation to E.K.N.	Arnold I, 2001, CURR BIOL, V11, P558, DOI 10.1016/S0960-9822(01)00154-3; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Darling T N, 1997, Adv Dermatol, V13, P87; Dowling J, 1996, J CELL BIOL, V134, P559, DOI 10.1083/jcb.134.2.559; GeorgesLabouesse E, 1996, NAT GENET, V13, P370, DOI 10.1038/ng0796-370; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; GREEN H, 1977, CELL, V11, P405, DOI 10.1016/0092-8674(77)90058-7; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; HINTNER H, 1982, ARCH DERMATOL, V118, P375, DOI 10.1001/archderm.118.6.375; HOJIRO O, 1972, J ELECTRON MICROSC, V21, P127; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Iwata H, 2009, J INVEST DERMATOL, V129, P919, DOI 10.1038/jid.2008.305; Leatherman JL, 2010, NAT CELL BIOL, V12, P806, DOI 10.1038/ncb2086; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; MacKenzie MAF, 1997, DEV BIOL, V192, P99, DOI 10.1006/dbio.1997.8738; Masunaga T, 1997, J INVEST DERMATOL, V109, P200, DOI 10.1111/1523-1747.ep12319337; MCGRATH JA, 1995, NAT GENET, V11, P83, DOI 10.1038/ng0995-83; McMillan JR, 2003, J DERMATOL SCI, V31, P169, DOI 10.1016/S0923-1811(03)00045-8; Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nishie W, 2007, NAT MED, V13, P378, DOI 10.1038/nm1496; Nishimura EK, 1999, DEV BIOL, V215, P155, DOI 10.1006/dbio.1999.9478; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; NISHIZAWA Y, 1993, J BIOCHEM-TOKYO, V113, P493, DOI 10.1093/oxfordjournals.jbchem.a124072; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Olasz EB, 2007, J INVEST DERMATOL, V127, P2807, DOI 10.1038/sj.jid.5700970; Omatsu Y, 2010, IMMUNITY, V33, P387, DOI 10.1016/j.immuni.2010.08.017; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Oshima M, 1996, DEV BIOL, V179, P297, DOI 10.1006/dbio.1996.0259; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Paus R, 1999, NEW ENGL J MED, V341, P491, DOI 10.1056/NEJM199908123410706; Powell AM, 2005, CLIN EXP DERMATOL, V30, P682, DOI 10.1111/j.1365-2230.2005.01937.x; Qiao W, 2006, ONCOGENE, V25, P207, DOI 10.1038/sj.onc.1209029; Raghavan S, 2000, J CELL BIOL, V150, P1149, DOI 10.1083/jcb.150.5.1149; Raymond K, 2009, CURR OPIN CELL BIOL, V21, P623, DOI 10.1016/j.ceb.2009.05.004; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; vanderNeut R, 1996, NAT GENET, V13, P366, DOI 10.1038/ng0796-366; Waikel RL, 2001, NAT GENET, V28, P165, DOI 10.1038/88889; Watt FM, 2002, EMBO J, V21, P3919, DOI 10.1093/emboj/cdf399; Yang LL, 2009, MOL BIOL CELL, V20, P882, DOI 10.1091/mbc.E08-07-0731; Yang LL, 2005, CANCER RES, V65, P8671, DOI 10.1158/0008-5472.CAN-05-0800; Zanet J, 2005, J CELL SCI, V118, P1693, DOI 10.1242/jcs.02298	50	184	195	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					177	187		10.1016/j.stem.2010.11.029	http://dx.doi.org/10.1016/j.stem.2010.11.029			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295274	Bronze			2022-12-28	WOS:000287633400011
J	Takubo, K; Goda, N; Yamada, W; Iriuchishima, H; Ikeda, E; Kubota, Y; Shima, H; Johnson, RS; Hirao, A; Suematsu, M; Suda, T				Takubo, Keiyo; Goda, Nobuhito; Yamada, Wakako; Iriuchishima, Hirono; Ikeda, Eiji; Kubota, Yoshiaki; Shima, Haruko; Johnson, Randall S.; Hirao, Atsushi; Suematsu, Makoto; Suda, Toshio			Regulation of the HIF-1 alpha Level Is Essential for Hematopoietic Stem Cells	CELL STEM CELL			English	Article							BONE-MARROW; PROGENITOR CELLS; MAINTENANCE; NICHE; QUIESCENCE; EXPRESSION; HYPOXIA; RESIDE	Hematopoietic stem cells (HSCs) are sustained in a specific microenvironment known as the stem cell niche. Mammalian HSCs are kept quiescent in the endosteal niche, a hypoxic zone of the bone marrow (BM). In this study, we show that normal HSCs maintain intracellular hypoxia and stabilize hypoxia-inducible factor-1 alpha (HIF-1 alpha) protein. In HIF-1 alpha-deficient mice, the HSCs lost their cell cycle quiescence and HSC numbers decreased during various stress settings including bone marrow transplantation, myelosuppression, or aging, in a p16(Ink4a)/p19(Arf)-dependent manner. Overstabilization of HIF-1 alpha by biallelic loss of an E3 ubiquitin ligase for HIF-1 alpha (VHL) induced cell cycle quiescence in HSCs and their progenitors but resulted in an impairment in transplantation capacity. In contrast, monoallelic loss of VHL induced cell cycle quiescence and improved BM engraftment during bone marrow transplantation. These data indicate that HSCs maintain cell cycle quiescence through the precise regulation of HIF-1 alpha levels.	[Takubo, Keiyo; Yamada, Wakako; Iriuchishima, Hirono; Kubota, Yoshiaki; Shima, Haruko; Suda, Toshio] Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, Tokyo 1608582, Japan; [Suematsu, Makoto] Keio Univ, Sch Med, Dept Biochem, Tokyo 1608582, Japan; [Suematsu, Makoto] Suematsu Gas Biol Project, JST ERATO, Shinjuku Ku, Tokyo 1608582, Japan; [Goda, Nobuhito] Waseda Univ, Dept Life Sci & Med Biosci, Sch Adv Sci & Engn, Shinjuku Ku, Tokyo 1628480, Japan; [Ikeda, Eiji] Yamaguchi Univ, Grad Sch Med, Dept Pathol, Yamaguchi 7558505, Japan; [Johnson, Randall S.] Univ Calif San Diego, Mol Biol Sect, Div Biol Sci, La Jolla, CA 92093 USA; [Goda, Nobuhito; Hirao, Atsushi] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020075, Japan; [Hirao, Atsushi] Kanazawa Univ, Div Mol Genet, Canc Res Inst, Kanazawa, Ishikawa 9201192, Japan	Keio University; Keio University; Waseda University; Yamaguchi University; University of California System; University of California San Diego; Japan Science & Technology Agency (JST); Kanazawa University	Takubo, K (corresponding author), Keio Univ, Sch Med, Dept Cell Differentiat, Sakaguchi Lab Dev Biol,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	keiyot@gmail.com; sudato@sc.itc.keio.ac.jp	Takubo, Keiyo/AAX-5546-2020; Suematsu, Makoto/I-8135-2013; Suda, Toshio/H-6761-2013; Kubota, Yoshiaki/L-2231-2013; Goda, Nobuhito/W-2468-2019; Suematsu, Makoto/O-5762-2018; Johnson, Randall/AAM-1189-2021	Takubo, Keiyo/0000-0002-1736-7592; Suematsu, Makoto/0000-0002-7165-6336; Suda, Toshio/0000-0001-7540-1771; Suematsu, Makoto/0000-0002-7165-6336; Johnson, Randall/0000-0002-4084-6639; Goda, Nobuhito/0000-0003-0295-4257	JSPS; MEXT [17GS0419]; JST; Grants-in-Aid for Scientific Research [21390290] Funding Source: KAKEN	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JST(Japan Science & Technology Agency (JST)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank T. Kitamura for providing Plat E packaging cells; A. Iwama for providing Bmi1 retroviral vector; K. Rajewsky for providing Mx1-Cre mice; V. Haase for providing VHL<SUP>flox/flox</SUP> mice; H. Saya and M.C. Simon for fruitful suggestions; T. Muraki, A. Kumakubo, and T. Hirose for essential support; and F. Arai, T. Naito, N. Tago, and A. Ono for FAGS operation. K.T. was a research fellow of JSPS supported by the Global COE Programs for Human Metabolomic Systems Biology and for Stem Cell Medicine and also in part by a MEXT Grant-in-Aid for Young Scientists (B) and a Grant-in-Aid for Scientific Research on Priority Areas. A.H. and M.S. were supported in part by a MEXT Grant-in-Aid for Creative Scientific Research 17GS0419. M.S. supported FACS analysis as the Leader of ERATO, JST, Suematsu Gas Biology Project. T.S. was supported by a MEXT Grant-in-Aid for Specially Promoted Research.	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Haase VH, 2001, P NATL ACAD SCI USA, V98, P1583, DOI 10.1073/pnas.98.4.1583; Hackney JA, 2004, METH MOLEC MED, V105, P439; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim MJ, 1998, BLOOD, V91, P4106, DOI 10.1182/blood.V91.11.4106.411k40_4106_4117; Kirito K, 2005, BLOOD, V105, P4258, DOI 10.1182/blood-2004-07-2712; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Levesque JP, 2007, STEM CELLS, V25, P1954, DOI 10.1634/stemcells.2006-0688; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Pedersen M, 2008, BIOCHEM BIOPH RES CO, V377, P98, DOI 10.1016/j.bbrc.2008.09.102; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Tanaka T, 2009, BIOCHEM J, V424, P143, DOI 10.1042/BJ20090120; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020	38	629	650	2	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					391	402		10.1016/j.stem.2010.06.020	http://dx.doi.org/10.1016/j.stem.2010.06.020			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804974	Bronze			2022-12-28	WOS:000282037800015
J	Loh, KM; Lim, B				Loh, Kyle M.; Lim, Bing			Recreating Pluripotency?	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS		[Loh, Kyle M.; Lim, Bing] Genome Inst Singapore, Singapore 138672, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Lim, Bing] Beth Israel Deaconess Med Ctr, Div Hematol Oncol, Boston, MA 02115 USA	Agency for Science Technology & Research (ASTAR); A*STAR - Genome Institute of Singapore (GIS); Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center	Lim, B (corresponding author), Genome Inst Singapore, Singapore 138672, Singapore.	limb1@gis.a-star.edu.sg		Loh, Kyle/0000-0002-8042-0149				Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; KIM K, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09342; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yamanaka S, 2010, NATURE, V465, P704, DOI 10.1038/nature09229; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	13	10	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					137	139		10.1016/j.stem.2010.07.005	http://dx.doi.org/10.1016/j.stem.2010.07.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682438	Bronze			2022-12-28	WOS:000281107400002
J	Samuel, MS; Olson, MF				Samuel, Michael S.; Olson, Michael F.			Dying Alone: A Tale of Rho	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; ROCK INHIBITOR; APOPTOSIS		[Samuel, Michael S.; Olson, Michael F.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	Beatson Institute	Olson, MF (corresponding author), Beatson Inst Canc Res, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	m.olson@beatson.gla.ac.uk	Olson, Michael/ABA-4240-2021; Samuel, Michael/D-2706-2011; Olson, Michael F/A-3240-2011	Olson, Michael/0000-0003-3428-3507; Samuel, Michael/0000-0001-7880-6379; 				Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Olson MF, 2008, CURR OPIN CELL BIOL, V20, P242, DOI 10.1016/j.ceb.2008.01.002; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310	10	6	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					135	136		10.1016/j.stem.2010.07.002	http://dx.doi.org/10.1016/j.stem.2010.07.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682437	Bronze			2022-12-28	WOS:000281107400001
J	Goff, D; Jamieson, C				Goff, Daniel; Jamieson, Catriona			Cycling toward Elimination of Leukemic Stem Cells	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM; MODEL	In two recent articles in Science Translational Medicine and Nature Biotechnology, Saito et al. (2010) identify a molecular signature of acute myeloid leukemia (AML) stem cells and demonstrate that quiescent AML stem cells become sensitized to chemotherapy after G-CSF stimulation.	[Goff, Daniel; Jamieson, Catriona] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Goff, Daniel; Jamieson, Catriona] Univ Calif San Diego, Moores Canc Ctr, San Diego, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Jamieson, C (corresponding author), Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA.			Goff, Daniel/0000-0003-2109-1696				Abrahamsson AE, 2009, P NATL ACAD SCI USA, V106, P3925, DOI 10.1073/pnas.0900189106; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Geron I, 2008, CANCER CELL, V13, P321, DOI 10.1016/j.ccr.2008.02.017; Hosen N, 2007, LEUKEMIA, V21, P1783, DOI 10.1038/sj.leu.2404752; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Saito Y, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000349; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Werning G, 2008, CANCER CELL, V13, P311, DOI 10.1016/j.ccr.2008.02.009	10	5	5	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					296	297		10.1016/j.stem.2010.03.008	http://dx.doi.org/10.1016/j.stem.2010.03.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362532	Bronze			2022-12-28	WOS:000276823300006
J	Hall, J; Guo, G; Wray, J; Eyres, I; Nichols, J; Grotewold, L; Morfopoulou, S; Humphreys, P; Mansfield, W; Walker, R; Tomlinson, S; Smith, A				Hall, John; Guo, Ge; Wray, Jason; Eyres, Isobel; Nichols, Jennifer; Grotewold, Lars; Morfopoulou, Sofia; Humphreys, Peter; Mansfield, William; Walker, Rachael; Tomlinson, Simon; Smith, Austin			Oct4 and LIF/Stat3 Additively Induce Kruppel Factors to Sustain Embryonic Stem Cell Self-Renewal	CELL STEM CELL			English	Article							TRANSCRIPTIONAL NETWORK; SIGNALING PATHWAYS; GROUND-STATE; DIFFERENTIATION; PLURIPOTENCY; MOUSE; NANOG; ACTIVATION; EXPRESSION; GENE	Embryonic stem cell (ESC) pluripotency is dependent on an intrinsic gene regulatory network centered on Oct4. Propagation of the pluripotent state is stimulated by the cytokine leukemia inhibitory factor (LIF) acting through the transcriptional regulator Stat3. Here, we show that this extrinsic stimulus converges with the intrinsic circuitry in Kruppel-factor activation. Oct4 primarily induces Klf2 while LIF/Stat3 selectively enhances Klf4 expression. Overexpression of either factor reduces LIF dependence, but with quantitative and qualitative differences. Unlike Klf4, Klf2 increases ESC clonogenicity, maintains undifferentiated ESCs in the genetic absence of Stat3, and confers resistance to BMP-induced differentiation. ESCs expanded with Klf2 remain capable of contributing to adult chimeras. Postimplantation-embryo-derived EpiSCs lack both Klf2 and KIN and expression of either can reinstate naive pluripotency. These findings indicate that Oct4 and Stat3 intersect in directing expression of Klf transcriptional regulators with overlapping properties that additively reinforce ground-state ESC pluripotency, identity, and self-renewal.	[Grotewold, Lars; Morfopoulou, Sofia; Tomlinson, Simon] Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Hall, John; Guo, Ge; Wray, Jason; Eyres, Isobel; Nichols, Jennifer; Humphreys, Peter; Mansfield, William; Walker, Rachael; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Hall, John; Guo, Ge; Wray, Jason; Eyres, Isobel; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Nichols, Jennifer] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 1QR, England	University of Edinburgh; University of Cambridge; University of Cambridge; University of Cambridge	Tomlinson, S (corresponding author), Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	simon.tomlinson@ed.ac.uk; austin.smith@cscr.cam.ac.uk	Kumar, Rajesh/E-7957-2010	Smith, Austin/0000-0002-3029-4682; Morfopoulou, Sofia/0000-0001-8181-4548; Nichols, Jennifer/0000-0002-8650-1388	Biotechnology and Biological Sciences Research Council; European Commission; Medical Research Council; Wellcome Trust; Pfizer; Human Frontier Sciences Program Fellow; Medical Research Council Stem Cell Fellow; Medical Research Council [G9806702, G0700665, G0300723B, G0700711B] Funding Source: researchfish; MRC [G0700665, G9806702] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Pfizer(Pfizer); Human Frontier Sciences Program Fellow(Human Frontier Science Program); Medical Research Council Stem Cell Fellow(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Nigel Miller for flow cytometry, Douglas Colby, and Sameera Patel for ESC culture, and Marko Hyvonen for recombinant proteins. This research was supported by the Biotechnology and Biological Sciences Research Council, the European Commission Framework 7 integrated project "EuroSystem," the Medical Research Council and the Wellcome Trust. In initial stages of this work, J.H. was supported by a collaborative PhD studentship sponsored by Pfizer. LG was a Human Frontier Sciences Program Fellow, G.G. is a Medical Research Council Stem Cell Fellow and A.S. is a Medical Research Council Professor. J.H. performed, analyzed and interpreted experiments, G.G. reprogrammed EpiSCs, J.W. generated Stat3 null ESC and luciferase data, I.E. provided real-time PCR and ChIP data, J.N. derived EpiSCs, L.G. contributed to ZHBTc4 and RCN studies, S.M. analyzed public datasets, B.M. generated chimaeras and with R.W. carried out Cre excision, P.H. designed image analysis software, S.T. supervised bioinformatics analyses, and A.S. supervised the experimental studies and wrote the paper with J.H. Please contact S.T. for bioinformatics and A.S. for other matters.	Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Bruce SJ, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-365; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Dani C, 1998, DEV BIOL, V203, P149, DOI 10.1006/dbio.1998.9026; Ema M, 2008, CELL STEM CELL, V3, P555, DOI 10.1016/j.stem.2008.09.003; Fisher CL, 1997, BIOTECHNIQUES, V23, P570, DOI 10.2144/97234bm01; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kawai-Kowase K, 1999, CIRC RES, V85, P787, DOI 10.1161/01.RES.85.9.787; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Kuo CT, 1997, SCIENCE, V277, P1986, DOI 10.1126/science.277.5334.1986; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Ovcharenko I, 2004, NUCLEIC ACIDS RES, V32, pW280, DOI 10.1093/nar/gkh355; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; RATHJEN PD, 1990, GENE DEV, V4, P2308, DOI 10.1101/gad.4.12b.2308; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; SCHUH R, 1986, CELL, V47, P1025, DOI 10.1016/0092-8674(86)90817-2; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Smith A, 2001, COLD SPRING HARBOR M, P205; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Smith AG., 1991, J TISSUE CULT METHOD, V13, P89, DOI [10.1007/BF01666137, DOI 10.1007/BF01666137, 10.1007/bf01666137]; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YOSHIDA K, 1994, MECH DEVELOP, V45, P163, DOI 10.1016/0925-4773(94)90030-2	54	272	278	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					597	609		10.1016/j.stem.2009.11.003	http://dx.doi.org/10.1016/j.stem.2009.11.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951688	Bronze			2022-12-28	WOS:000273616700008
J	Hansson, EM; Lindsay, ME; Chien, KR				Hansson, Emil M.; Lindsay, Mark E.; Chien, Kenneth R.			Regeneration Next: Toward Heart Stem Cell Therapeutics	CELL STEM CELL			English	Review							BONE-MARROW-CELLS; PROGENITOR CELLS; MYOCARDIAL-INFARCTION; MYOBLAST TRANSPLANTATION; ISCHEMIC-HEART; SMOOTH-MUSCLE; GENE-THERAPY; CARDIOMYOCYTES; TISSUE; DIFFERENTIATION	Stem cell biology holds great promise for a new era of cell-based therapy, sparking considerable interest among scientists, clinicians, and their patients. However, the translational arm of stem cell science is in a relatively primitive state. Although a number of clinical studies have been initiated, the early returns point to several inherent problems. In this regard, the clinical potential of stem cells can only be fully realized by the identification of the key barriers to clinical implementation. Here, we examine experimental paradigms to address the critical steps in the transition from stem cell biology to regenerative medicine, utilizing cardiovascular disease as a case study.	[Hansson, Emil M.; Lindsay, Mark E.; Chien, Kenneth R.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Boston, MA 02114 USA; [Chien, Kenneth R.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Lindsay, Mark E.] Johns Hopkins Univ Hosp, Dept Pediat, Div Pediat Cardiol, Baltimore, MD 21205 USA	Harvard University; Massachusetts General Hospital; Harvard University; Johns Hopkins University; Johns Hopkins Medicine	Chien, KR (corresponding author), Massachusetts Gen Hosp, Cardiovasc Res Ctr, Charles River Plaza,CPZN 3200,185 Cambridge St, Boston, MA 02114 USA.	krchien@partners.org			NIH; LeDucq Foundation; Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100408] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); LeDucq Foundation(Leducq Foundation); Harvard Stem Cell Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We apologize to our colleagues whose work could not be cited due to space constraints. We thank Goran K. Hansson and B. Alexander Yi for helpful comments on the manuscript and Mattias Karlen for help with the artwork. E.M.H. is a Wenner-Gren Foundations fellow. M.E.L. is supported by a HHMI postdoctoral fellowship in the laboratory of H.C. Dietz. K.R.C. is supported by NIH, the LeDucq Foundation, and the Harvard Stem Cell Institute.	Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; BILLINGHAM RE, 1957, TRANSPLAN B, V4, P58; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; BU L, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08191; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Cai CL, 2008, NATURE, V454, P104, DOI 10.1038/nature06969; Cai CL, 2003, DEV CELL, V5, P877, DOI 10.1016/S1534-5807(03)00363-0; Chen SL, 2004, AM J CARDIOL, V94, P92, DOI 10.1016/j.amjcard.2004.03.034; Chien KR, 2008, SCIENCE, V322, P1494, DOI 10.1126/science.1163267; Chien KR, 2008, NATURE, V453, P302, DOI 10.1038/nature07037; Chien KR, 2004, NATURE, V428, P607, DOI 10.1038/nature02500; Conway SJ, 1997, DEVELOPMENT, V124, P505; Couzin J, 2009, SCIENCE, V323, P568, DOI 10.1126/science.323.5914.568; David R, 2008, NAT CELL BIOL, V10, P338, DOI 10.1038/ncb1696; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Deb A, 2003, CIRCULATION, V107, P1247, DOI 10.1161/01.CIR.0000061910.39145.F0; Dixon JA, 2009, CIRC-HEART FAIL, V2, P262, DOI 10.1161/CIRCHEARTFAILURE.108.814459; Drenckhahn JD, 2008, DEV CELL, V15, P521, DOI 10.1016/j.devcel.2008.09.005; Feinberg AW, 2007, SCIENCE, V317, P1366, DOI 10.1126/science.1146885; GATTI RA, 1968, LANCET, V2, P1366; Ghostine S, 2002, CIRCULATION, V106, pI131, DOI 10.1161/01.cir.0000032889.55215.f1; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hoerstrup SP, 2002, ANN THORAC SURG, V74, P46, DOI 10.1016/S0003-4975(02)03649-4; Hsieh PCH, 2007, NAT MED, V13, P970, DOI 10.1038/nm1618; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Janssens S, 2006, LANCET, V367, P113, DOI 10.1016/S0140-6736(05)67861-0; Jessup M, 2003, NEW ENGL J MED, V348, P2007, DOI 10.1056/NEJMra021498; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kang HJ, 2006, CIRCULATION, V114, pI145, DOI 10.1161/CIRCULATIONAHA.105.001107; Kehat I, 2001, J CLIN INVEST, V108, P407, DOI 10.1172/JCI12131; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kirouac DC, 2008, CELL STEM CELL, V3, P369, DOI 10.1016/j.stem.2008.09.001; Kiuru M, 2009, CELL STEM CELL, V4, P289, DOI 10.1016/j.stem.2009.03.010; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Lepilina A, 2006, CELL, V127, P607, DOI 10.1016/j.cell.2006.08.052; Li BG, 2007, CORONARY ARTERY DIS, V18, P221, DOI 10.1097/MCA.0b013e32801235da; Li J, 1999, DEVELOPMENT, V126, P2495; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Lunde K, 2006, NEW ENGL J MED, V355, P1199, DOI 10.1056/NEJMoa055706; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Martin CM, 2004, DEV BIOL, V265, P262, DOI 10.1016/j.ydbio.2003.09.028; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; MARX JL, 1980, SCIENCE, V210, P621, DOI 10.1126/science.7001625; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meluzin J, 2008, INT J CARDIOL, V128, P185, DOI 10.1016/j.ijcard.2007.04.098; Menasche P, 2003, J AM COLL CARDIOL, V41, P1078, DOI 10.1016/S0735-1097(03)00092-5; Menasche P, 2001, LANCET, V357, P279, DOI 10.1016/S0140-6736(00)03617-5; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Mettler BA, 2008, ANN THORAC SURG, V86, P132, DOI 10.1016/j.athoracsur.2008.02.074; Min JY, 2002, J APPL PHYSIOL, V92, P288, DOI 10.1152/jappl.2002.92.1.288; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Muller-Ehmsen J, 2002, J MOL CELL CARDIOL, V34, P107, DOI 10.1006/jmcc.2001.1491; Mummery C, 2003, CIRCULATION, V107, P2733, DOI 10.1161/01.CIR.0000068356.38592.68; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Nygren JM, 2004, NAT MED, V10, P494, DOI 10.1038/nm1040; OBERPRILLER JO, 1974, J EXP ZOOL, V187, P249, DOI 10.1002/jez.1401870208; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Passier R, 2006, HANDB EXP PHARM, V174, P101; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Qyang Y, 2007, CELL STEM CELL, V1, P165, DOI 10.1016/j.stem.2007.05.018; Reinecke H, 2002, J MOL CELL CARDIOL, V34, P241, DOI 10.1006/jmcc.2001.1507; Rubart M, 2004, J CLIN INVEST, V114, P775, DOI 10.1172/JCI200421589; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; Schachinger V, 2006, NEW ENGL J MED, V355, P1210, DOI 10.1056/NEJMoa060186; Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002; Shinoka T, 1998, J THORAC CARDIOV SUR, V115, P536, DOI 10.1016/S0022-5223(98)70315-0; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; Stoller JZ, 2005, SEMIN CELL DEV BIOL, V16, P704, DOI 10.1016/j.semcdb.2005.06.004; Strauer BE, 2002, CIRCULATION, V106, P1913, DOI 10.1161/01.CIR.0000034046.87607.1C; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Taylor DA, 1998, NAT MED, V4, P929, DOI 10.1038/nm0898-929; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; THOMAS ED, 1959, J CLIN INVEST, V38, P1709, DOI 10.1172/JCI103949; THOMAS ED, 1975, NEW ENGL J MED, V292, P895, DOI 10.1056/NEJM197504242921706; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; van Ramshorst J, 2009, JAMA-J AM MED ASSOC, V301, P1997, DOI 10.1001/jama.2009.685; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu SM, 2006, CELL, V127, P1137, DOI 10.1016/j.cell.2006.10.028; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394	110	134	145	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					364	377		10.1016/j.stem.2009.09.004	http://dx.doi.org/10.1016/j.stem.2009.09.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796617	Bronze			2022-12-28	WOS:000271401900009
J	Abou-Khalil, R; Le Grand, F; Pallafacchina, G; Valable, S; Authier, FJ; Rudnicki, MA; Gherardi, RK; Germain, S; Chretien, F; Sotiropoulos, A; Lafuste, P; Montarras, D; Chazaud, B				Abou-Khalil, Rana; Le Grand, Fabien; Pallafacchina, Giorgia; Valable, Samuel; Authier, Francois-Jerome; Rudnicki, Michael A.; Gherardi, Romain K.; Germain, Stephane; Chretien, Fabrice; Sotiropoulos, Athanassia; Lafuste, Peggy; Montarras, Didier; Chazaud, Benedicte			Autocrine and Paracrine Angiopoietin 1/Tie-2 Signaling Promotes Muscle Satellite Cell Self-Renewal	CELL STEM CELL			English	Article							STEM-CELL; POTENTIAL MECHANISM; M-CADHERIN; EXPRESSION; TIE2; ROLES; NOTCH; MYOD	Mechanisms governing muscle satellite cell withdrawal from cell cycle to enter into quiescence remain poorly understood. We studied the role of angiopoietin 1 (Ang1) and its receptor Tie-2 in the regulation of myogenic precursor cell (mpc) fate. In human and mouse, Tie-2 was preferentially expressed by quiescent satellite cells in vivo and reserve cells (RCs) in vitro. Ang1/Tie-2 signaling, through ERK1/2 pathway, decreased mpc proliferation and differentiation, increased the number of cells in G0, increased expression of RC-associated markers (p130, Pax7, Myf-5, M-cadherin), and downregulated expression of differentiation-associated markers. Silencing Tie-2 had opposite effects. Cells located in the satellite cell neighborhood (smooth muscle cells, fibroblasts) upregulated RC-associated markers by secreting Ang1 in vitro. In vivo, Tie-2 blockade and Ang1 overexpression increased the number of cycling and quiescent satellite cells, respectively. We propose that Ang1/Tie-2 signaling regulates mpc self-renewal by controlling the return to quiescence of a subset of satellite cells.	[Chazaud, Benedicte] Univ Paris 05, CNRS, INSERM, Inst COCHIN,Dept Genet & Dev,U567,UMR8104, F-75014 Paris, France; [Abou-Khalil, Rana; Authier, Francois-Jerome; Gherardi, Romain K.; Chretien, Fabrice; Lafuste, Peggy; Chazaud, Benedicte] Univ Paris 12, F-94000 Creteil, France; [Le Grand, Fabien; Rudnicki, Michael A.] Sprott Ctr Stem Cell Res, Ottawa Hlth Res Inst, Ottawa, ON K1H 8L6, Canada; [Pallafacchina, Giorgia; Montarras, Didier] Inst Pasteur, CNRS, URA 2578, F-75015 Paris, France; [Valable, Samuel] CYCERON, CNRS, UMR6185, F-14074 Caen, France; [Germain, Stephane] INSERM, U833, F-75005 Paris, France; [Sotiropoulos, Athanassia] Coll France, F-75005 Paris, France; [Abou-Khalil, Rana; Authier, Francois-Jerome; Gherardi, Romain K.; Chretien, Fabrice; Lafuste, Peggy; Chazaud, Benedicte] INSERM, U955, F-94000 Creteil, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Universite Paris-Est-Creteil-Val-de-Marne (UPEC); University of Ottawa; Ottawa Hospital Research Institute; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Universite de Caen Normandie; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Chazaud, B (corresponding author), Univ Paris 05, CNRS, INSERM, Inst COCHIN,Dept Genet & Dev,U567,UMR8104, 24 Rue Faubourg St Jacques, F-75014 Paris, France.	benedicte.chazaud@inserm.fr	Chretien, fabrice B/D-4035-2018; valable, samuel/B-7578-2008; Le Grand, Fabien/D-8803-2019; Chazaud, Benedicte/N-9291-2017; Sotiropoulos, Athanassia/P-4269-2017; Germain, Stephane/E-2301-2016; Pallafacchina, Giorgia/K-4056-2016	Chretien, fabrice B/0000-0002-2794-1383; valable, samuel/0000-0003-0355-0270; Le Grand, Fabien/0000-0002-7843-3899; Chazaud, Benedicte/0000-0002-1262-502X; Germain, Stephane/0000-0001-5992-1275; Pallafacchina, Giorgia/0000-0001-9766-5970; AUTHIER, Francois Jerome/0000-0002-0182-2052; Lafuste, Peggy/0000-0001-8239-3482; Rudnicki, Michael/0000-0002-3866-5249; Sotiropoulos, Athanassia/0000-0002-7265-1473	AFM; ANR; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	AFM(Association Francaise contre les Myopathies); ANR(French National Research Agency (ANR)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank G. Bassez, R. Mounier, E. Petit, S. Tajbakhsh, and C. Torre for their precious help. Cell sorting was performed on cytometry facility of Institut Jacques Monod, CNRS, Paris, France, and IM3, IMRB, INSERM, Creteil, France. This work was supported by AFM and ANR.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; Black EJ, 2000, CURR BIOL, V10, P1119, DOI 10.1016/S0960-9822(00)00699-0; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brown C, 2004, J BIOL CHEM, V279, P12794, DOI 10.1074/jbc.M308593200; Carnac G, 2000, CURR BIOL, V10, P543, DOI 10.1016/S0960-9822(00)00471-1; Charrasse S, 2006, MOL BIOL CELL, V17, P749, DOI 10.1091/mbc.E05-04-0284; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Christensen RA, 2002, J CELL BIOCHEM, V85, P505, DOI 10.1002/jcb.10148; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Dallabrida SM, 2005, CIRC RES, V96, DOI 10.1161/01.RES.0000158285.57191.60; Fiedler U, 2006, TRENDS IMMUNOL, V27, P552, DOI 10.1016/j.it.2006.10.004; Foulstone EJ, 2004, EXP CELL RES, V294, P223, DOI 10.1016/j.yexcr.2003.10.034; Friday BB, 2001, J CELL SCI, V114, P303; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Fukuhara S, 2008, NAT CELL BIOL, V10, P513, DOI 10.1038/ncb1714; Harfouche R, 2005, FASEB J, V19, P1728, DOI 10.1096/fj.04-3621fje; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; ILLA I, 1992, ANN NEUROL, V31, P46, DOI 10.1002/ana.410310109; IRINTCHEV A, 1994, DEV DYNAM, V199, P326, DOI 10.1002/aja.1001990407; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kitzmann M, 2006, J CELL PHYSIOL, V208, P538, DOI 10.1002/jcp.20688; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Perez-Ruiz A, 2007, CELL SIGNAL, V19, P1671, DOI 10.1016/j.cellsig.2007.03.003; Reed SA, 2007, J CELL BIOCHEM, V101, P1394, DOI 10.1002/jcb.21256; Reynaud EG, 2000, J BIOL CHEM, V275, P18767, DOI 10.1074/jbc.M907412199; Saharinen P, 2008, NAT CELL BIOL, V10, P527, DOI 10.1038/ncb1715; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shim WSN, 2007, MOL CANCER RES, V5, P655, DOI 10.1158/1541-7786.MCR-07-0072; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	39	154	157	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					298	309		10.1016/j.stem.2009.06.001	http://dx.doi.org/10.1016/j.stem.2009.06.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733541	Bronze, Green Accepted			2022-12-28	WOS:000272545700016
J	Colman, A; Dreesen, O				Colman, Alan; Dreesen, Oliver			Pluripotent Stem Cells and Disease Modeling	CELL STEM CELL			English	Editorial Material							MOTOR-NEURONS; ALS		[Colman, Alan; Dreesen, Oliver] Inst Med Biol, Singapore 138648, Singapore; [Colman, Alan] Kings Coll London, London SE1 1UL, England	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); University of London; King's College London	Colman, A (corresponding author), Inst Med Biol, Singapore 138648, Singapore.	alan.colman@imb.a-star.edu.sg; oliver.dreesen@imb.a-star.edu.sg	Dreesen, Oliver/AAJ-2132-2020					Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; LEE G, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08320; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; ZHAO Y, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08267; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023	20	73	76	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					244	247		10.1016/j.stem.2009.08.010	http://dx.doi.org/10.1016/j.stem.2009.08.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733533	Bronze			2022-12-28	WOS:000272545700008
J	Au, E; Fishell, G				Au, Edmund; Fishell, Gord			Cortex Shatters the Glass Ceiling	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; GENERATION; PRECURSORS; NEURONS; MOUSE	Recreating developmental structures in vitro has been a primary challenge for stem cell biologists. Recent studies in Cell Stem Cell (Eiraku et al., 2008) and Nature (Gaspard et al., 2008) demonstrate that embryonic stem cells can recapitulate early cortical development, enabling them to generate specific cortical subtypes.	[Au, Edmund; Fishell, Gord] NYU, Langone Med Ctr, Dept Cell Biol, Smilow Neurosci Program, New York, NY 10016 USA	New York University; NYU Langone Medical Center	Fishell, G (corresponding author), NYU, Langone Med Ctr, Dept Cell Biol, Smilow Neurosci Program, 522 1st Ave, New York, NY 10016 USA.	fisheg0l@nyumc.org		Au, Edmund/0000-0003-3190-9711; Fishell, Gordon/0000-0002-9640-9278				Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Haydar TF, 2000, J NEUROSCI, V20, P5764, DOI 10.1523/JNEUROSCI.20-15-05764.2000; Lee SH, 2000, NAT BIOTECHNOL, V18, P675, DOI 10.1038/76536; Leone DP, 2008, CURR OPIN NEUROBIOL, V18, P28, DOI 10.1016/j.conb.2008.05.006; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Tarabykin V, 2001, DEVELOPMENT, V128, P1983; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780	11	7	7	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					472	474		10.1016/j.stem.2008.10.013	http://dx.doi.org/10.1016/j.stem.2008.10.013			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983961	Bronze			2022-12-28	WOS:000260895100005
J	Zhou, Q; Melton, DA				Zhou, Qiao; Melton, Douglas A.			Extreme Makeover: Converting One Cell into Another	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; PANCREATIC BETA-CELLS; NUCLEAR TRANSFER; B-CELLS; ADULT; DIFFERENTIATION; PLASTICITY; FIBROBLASTS; EXPRESSION; PHENOTYPES	Cells of adult mammals can be converted (reprogrammed) to new cells. In one approach, adult cells are converted to pluripotent stem cells, followed by differentiation to regenerate new cell types. Alternatively, adult cells may be directly converted into other mature cells or progenitors. We discuss and compare these two approaches with particular emphasis on the latter and its relevance for regenerative medicine.	[Zhou, Qiao; Melton, Douglas A.] Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, HHMI, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute	Melton, DA (corresponding author), Harvard Univ, Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, HHMI, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Zhou, Qiao/0000-0002-0099-3909	Damon-Runyon Cancer Research Foundation; National Institute of Health; Harvard Stem Cell Institute; HHMI; JDRF	Damon-Runyon Cancer Research Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Stem Cell Institute; HHMI(Howard Hughes Medical Institute); JDRF(Juvenile Diabetes Research Foundation)	We thank many members of our laboratory for stimulating discussions. We apologize to colleagues whose work we could not cite due to space limitations. We thank Drs. Justin Annes, William Anderson, and Jay Rajagopal for critical readings of this manuscript. Q.Z. was supported by a Damon-Runyon Cancer Research Foundation Postdoctoral Fellowship and a Pathway to Independence (PI) Award from the National Institute of Health. D.A.M. is an HHMI investigator. Work in our laboratory is supported by the Harvard Stem Cell Institute, HHMI, JDRF, and the NIH.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Blelloch R, 2006, STEM CELLS, V24, P2007, DOI 10.1634/stemcells.2006-0050; Brazelton TR, 2000, SCIENCE, V290, P1775, DOI 10.1126/science.290.5497.1775; Brockes JR, 2002, NAT REV MOL CELL BIO, V3, P566, DOI 10.1038/nrm881; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; EGUCHI G, 1973, P NATL ACAD SCI USA, V70, P1495, DOI 10.1073/pnas.70.5.1495; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gurdon JB, 2006, ANNU REV CELL DEV BI, V22, P1, DOI 10.1146/annurev.cellbio.22.090805.140144; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; HADORN E, 1968, SCI AM, V219, P110, DOI 10.1038/scientificamerican1168-110; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Iovine MK, 2007, NAT CHEM BIOL, V3, P613, DOI 10.1038/nchembio.2007.36; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Klebes A, 2005, DEVELOPMENT, V132, P3753, DOI 10.1242/dev.01927; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Lagasse E, 2000, NAT MED, V6, P1229, DOI 10.1038/81326; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; MESSIER B, 1960, AM J ANAT, V106, P247, DOI 10.1002/aja.1001060305; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Olson EN, 2004, NAT MED, V10, P467, DOI 10.1038/nm0504-467; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Slack JMW, 2008, CELL MOL LIFE SCI, V65, P54, DOI 10.1007/s00018-007-7431-1; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka EM, 2003, CURR OPIN GENET DEV, V13, P497, DOI 10.1016/j.gde.2003.08.003; TSUBOUCHI S, 1987, ANAT REC, V218, P111, DOI 10.1002/ar.1092180203; Waddington C., 1957, STRATEGY GENES; Wagers AJ, 2004, CELL, V116, P639, DOI 10.1016/S0092-8674(04)00208-9; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; ZHOU Q, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07314; Zhou Q, 2007, DEV CELL, V13, P103, DOI 10.1016/j.devcel.2007.06.001	47	188	202	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					382	388		10.1016/j.stem.2008.09.015	http://dx.doi.org/10.1016/j.stem.2008.09.015			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940730	Bronze			2022-12-28	WOS:000260149800009
J	Willems, E; Mercola, M				Willems, Erik; Mercola, Mark			What Your Heart Doth Know	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; DIFFERENTIATION; MOUSE	Combining embryological insight with careful analysis of early stage cardiomyocyte differentiation, Kattman et al. (2011) in this issue of Cell Stem Cell have defined minimal culture conditions to efficiently produce cardiomyocytes from hESCs and hiPSCs. The lessons learned are applicable to the derivation of other organotypic cell types.	[Willems, Erik; Mercola, Mark] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Mercola, M (corresponding author), Sanford Burnham Med Res Inst, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	mmercola@burnham.org		Willems, Erik/0000-0002-2735-8382	NHLBI NIH HHS [R37 HL059502, R01 HL083463-05, R33 HL088266, R33 HL088266-03, R01 HL083463, R37 HL059502-14] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R33HL088266, R01HL083463, R37HL059502] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Blin G, 2010, J CLIN INVEST, V120, P1125, DOI 10.1172/JCI40120; Domian IJ, 2009, SCIENCE, V326, P426, DOI 10.1126/science.1177350; Freeman M, 2002, ANNU REV CELL DEV BI, V18, P515, DOI 10.1146/annurev.cellbio.18.012502.083458; GREEN JBA, 1992, CELL, V71, P731, DOI 10.1016/0092-8674(92)90550-V; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Mercola M, 2011, GENE DEV, V25, P299, DOI 10.1101/gad.2018411; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Stadtfeld M, 2010, GENE DEV, V24, P2239, DOI 10.1101/gad.1963910; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8	10	1	1	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					124	126		10.1016/j.stem.2011.01.003	http://dx.doi.org/10.1016/j.stem.2011.01.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295266	Green Accepted, Bronze			2022-12-28	WOS:000287633400003
J	Beckervordersandforth, R; Tripathi, P; Ninkovic, J; Bayam, E; Lepier, A; Stempfhuber, B; Kirchhoff, F; Hirrlinger, J; Haslinger, A; Lie, DC; Beckers, J; Yoder, B; Irmler, M; Gotz, M				Beckervordersandforth, Ruth; Tripathi, Pratibha; Ninkovic, Jovica; Bayam, Efil; Lepier, Alexandra; Stempfhuber, Barbara; Kirchhoff, Frank; Hirrlinger, Johannes; Haslinger, Anja; Lie, D. Chichung; Beckers, Johannes; Yoder, Bradley; Irmler, Martin; Goetz, Magdalena			In Vivo Fate Mapping and Expression Analysis Reveals Molecular Hallmarks of Prospectively Isolated Adult Neural Stem Cells	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE ASTROCYTES; EPENDYMAL CELLS; PRIMARY CILIA; RADIAL GLIA; GENE; MICE; DIFFERENTIATION; TRANSCRIPTOME; PROLIFERATION; SPECIFICATION	Until now, limitations in the ability to enrich adult NSCs (aNSCs) have hampered meaningful analysis of these cells at the transcriptome level. Here we show via a split-Cre technology that coincident activity of the hGFAP and promininl promoters is a hallmark of aNSCs in vivo. Sorting of cells from the adult mouse subependymal zone (SEZ) based on their expression of GFAP and promininl isolates all self-renewing, multipotent stem cells at high purity. Comparison of the transcriptome of these purified aNSCs to parenchymal nonneurogenic astrocytes and other SEZ cells reveals aNSC hallmarks, including neuronal lineage priming and the importance of cilia- and Ca-dependent signaling pathways. Inducible deletion of the ciliary protein IFT88 in aNSCs validates the role of ciliary function in aNSCs. Our work reveals candidate molecular regulators for unique features of aNSCs and facilitates future selective analysis of aNSCs in other functional contexts, such as aging and injury.	[Beckervordersandforth, Ruth; Tripathi, Pratibha; Ninkovic, Jovica; Bayam, Efil; Stempfhuber, Barbara; Goetz, Magdalena] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Neuherberg, Germany; [Haslinger, Anja; Lie, D. Chichung] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Res Grp Adult Neural Stem Cells & Neurogenesis, Inst Dev Genet, D-85764 Neuherberg, Germany; [Beckers, Johannes; Irmler, Martin] German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Expt Genet, D-85764 Neuherberg, Germany; [Ninkovic, Jovica; Lepier, Alexandra; Goetz, Magdalena] Univ Munich, Fac Med, D-80633 Munich, Germany; [Kirchhoff, Frank] Max Planck Inst Expt Med, Dept Neurogenet, D-37075 Gottingen, Germany; [Kirchhoff, Frank] DFG Res Ctr Mol Physiol Brain, D-37075 Gottingen, Germany; [Hirrlinger, Johannes] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol & Neural Plast N05, D-04103 Leipzig, Germany; [Beckers, Johannes] Tech Univ Munich, Ctr Life & Food Sci Weihenstephan, D-85354 Freising Weihenstephan, Germany; [Yoder, Bradley] Univ Birmingham, Birmingham, AL 35294 USA	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Max Planck Society; German Research Foundation (DFG); Leipzig University; Technical University of Munich	Gotz, M (corresponding author), German Res Ctr Environm Hlth GmbH, Helmholtz Ctr Munich, Inst Stem Cell Res, Ingolstadter Landstr 1, D-85764 Neuherberg, Germany.	magdalena.goetz@helmholtz-muenchen.de	Irmler, Martin/B-3317-2013; Ninkovic, Jovica/AAH-5220-2019; Beckers, Johannes/K-7237-2012; Lie, Dieter Chichung/AAS-8604-2020; Kirchhoff, Frank/B-9335-2008; Hirrlinger, Johannes/F-5984-2010; Lie, Dieter Chichung/S-7914-2017	Irmler, Martin/0000-0003-3169-479X; Ninkovic, Jovica/0000-0002-4381-0041; Beckers, Johannes/0000-0001-7874-3822; Lie, Dieter Chichung/0000-0002-6035-6442; Kirchhoff, Frank/0000-0002-2324-2761; Lie, Dieter Chichung/0000-0002-6035-6442; BAYAM, EFIL/0000-0001-9776-5234	DFG [SFB596, 870]; Hans and Ilse Breuer Price; BMBF; EUTRACC; HELMA; CoReNe as well as the UAB Hepato/Renal Fibrocystic Diseases Core Center [DK074038]	DFG(German Research Foundation (DFG)); Hans and Ilse Breuer Price; BMBF(Federal Ministry of Education & Research (BMBF)); EUTRACC; HELMA; CoReNe as well as the UAB Hepato/Renal Fibrocystic Diseases Core Center	We particularly would like to thank Timothy McClintock and Frank Zaucke for probes and antibodies; Jochen Graw for human DNA; and Andrea Steiner-Mezzadri, Christiane Lach, and Timucin Ozturk for excellent technical help. We are also particularly grateful to Armen Saghatelyan, Benedikt Berninger, Emily Violette, Filippo Calzolari, Pia Johansson, Troy Ghashghaei, and Yves Barde for excellent comments on the manuscript. This work is supported by the DFG including the SFB596, 870, the Hans and Ilse Breuer Price, BMBF, EUTRACC, HELMA, and CoReNe as well as the UAB Hepato/Renal Fibrocystic Diseases Core Center (UAB HRFDCC) DK074038.	Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Bergsland M, 2006, GENE DEV, V20, P3475, DOI 10.1101/gad.403406; Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Brill MS, 2008, J NEUROSCI, V28, P6439, DOI 10.1523/JNEUROSCI.0700-08.2008; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chitaev NA, 1997, J CELL BIOL, V138, P193, DOI 10.1083/jcb.138.1.193; Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Eggenschwiler JT, 2007, ANNU REV CELL DEV BI, V23, P345, DOI 10.1146/annurev.cellbio.23.090506.123249; Eiraku M, 2005, NAT NEUROSCI, V8, P873, DOI 10.1038/nn1492; Gabay L, 2003, NEURON, V40, P485, DOI 10.1016/S0896-6273(03)00637-8; Hack MA, 2005, NAT NEUROSCI, V8, P865, DOI 10.1038/nn1479; Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Haycraft CJ, 2007, DEVELOPMENT, V134, P307, DOI 10.1242/dev.02732; Hirrlinger J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004286; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Jacquet BV, 2009, DEVELOPMENT, V136, P4021, DOI 10.1242/dev.041129; Karmakar S, 2005, J BIOL CHEM, V280, P28623, DOI 10.1074/jbc.M414140200; Kawaguchi A, 2001, MOL CELL NEUROSCI, V17, P259, DOI 10.1006/mcne.2000.0925; Lim DA, 2006, MOL CELL NEUROSCI, V31, P131, DOI 10.1016/j.mcn.2005.10.005; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lovatt D, 2007, J NEUROSCI, V27, P12255, DOI 10.1523/JNEUROSCI.3404-07.2007; Lyons PJ, 2006, PROTEINS, V63, P1069, DOI 10.1002/prot.20946; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Mori T, 2006, GLIA, V54, P21, DOI 10.1002/glia.20350; Nakamura T, 2006, METHOD ENZYMOL, V406, P315, DOI 10.1016/S0076-6879(06)06023-X; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Nolte C, 2001, GLIA, V33, P72; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Pinto L, 2008, MOL CELL NEUROSCI, V38, P15, DOI 10.1016/j.mcn.2008.01.012; Platel JC, 2010, NEURON, V65, P859, DOI 10.1016/j.neuron.2010.03.009; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; RICHARDS LJ, 1992, P NATL ACAD SCI USA, V89, P8591, DOI 10.1073/pnas.89.18.8591; Rietze RL, 2001, NATURE, V412, P736, DOI 10.1038/35089085; Rottach A, 2010, NUCLEIC ACIDS RES, V38, P1796, DOI 10.1093/nar/gkp1152; Sakaguchi M, 2007, CELL MOL LIFE SCI, V64, P1254, DOI 10.1007/s00018-007-6476-5; Shepherd MC, 2007, AM J RESP CELL MOL, V37, P525, DOI 10.1165/rcmb.2006-0358OC; Sun LQ, 2004, GENE DEV, V18, P1035, DOI 10.1101/gad.1176104; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Warnecke M, 2005, GENE DEV, V19, P614, DOI 10.1101/gad.317905; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425	52	240	249	1	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					744	758		10.1016/j.stem.2010.11.017	http://dx.doi.org/10.1016/j.stem.2010.11.017			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112568	Bronze			2022-12-28	WOS:000285537700015
J	Ouyang, ZQ; Zheng, GXY; Chang, HY				Ouyang, Zhengqing; Zheng, Grace X. Y.; Chang, Howard Y.			Noncoding RNA Landmarks of Pluripotency and Reprogramming	CELL STEM CELL			English	Editorial Material							STEM-CELLS	Noncoding RNAs have emerged as important determinants of pluripotency and reprogramming. In this issue of Cell Stem Cell, Kosik and colleagues now provide a detailed map of microRNA expression patterns to infer the biological states of embryonic and induced pluripotent stem cells.	[Ouyang, Zhengqing; Zheng, Grace X. Y.; Chang, Howard Y.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Ouyang, Zhengqing; Zheng, Grace X. Y.; Chang, Howard Y.] Stanford Univ, Program Epithelial Biol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Chang, HY (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	howchang@stanford.edu			NHGRI NIH HHS [R01 HG004361, R01 HG004361-03] Funding Source: Medline; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004361] Funding Source: NIH RePORTER	NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Deng WB, 2009, TRENDS GENET, V25, P425, DOI 10.1016/j.tig.2009.09.004; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Loh KM, 2010, CELL STEM CELL, V7, P137, DOI 10.1016/j.stem.2010.07.005; Neveu P, 2010, CELL STEM CELL, V7, P671, DOI 10.1016/j.stem.2010.11.012; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017	9	3	3	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					649	650		10.1016/j.stem.2010.11.018	http://dx.doi.org/10.1016/j.stem.2010.11.018			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112559	Green Accepted, Bronze			2022-12-28	WOS:000285537700006
J	Abbas, HA; Maccio, DR; Coskun, S; Jackson, JG; Hazen, AL; Sills, TM; You, MJ; Hirschi, KK; Lozano, G				Abbas, Hussein A.; Maccio, Daniela R.; Coskun, Suleyman; Jackson, James G.; Hazen, Amy L.; Sills, Tiffany M.; You, M. James; Hirschi, Karen K.; Lozano, Guillermina			Mdm2 Is Required for Survival of Hematopoietic Stem Cells/Progenitors via Dampening of ROS-Induced p53 Activity	CELL STEM CELL			English	Article							SLAM FAMILY RECEPTORS; EMBRYONIC LETHALITY; MDM2-DEFICIENT MICE; CELL QUIESCENCE; DNA-DAMAGE; YOLK-SAC; IN-VIVO; B-CELL; SENESCENCE; TUMORIGENESIS	Mdm2 is an E3 ubiquitin ligase that targets p53 for degradation. p53(515C) (encoding p53R172P) is a hypomorphic allele of p53 that rescues the embryonic lethality of Mdm2(-/-) mice. Mdin2(-/-) p53(515C/515C) mice, however, die by postnatal day 13 resulting from hematopoietic failure. Hematopoietic stem cells and progenitors of Mdm2(-/-) p53(515C/515C) mice were normal in fetal livers but were depleted in postnatal bone marrows. After birth, these mice had elevated reactive oxygen species (ROS) thus activating p53R172P. In the absence of Mdm2, stable p53R172P induced ROS and cell cycle arrest, senescence, and cell death in the hematopoietic compartment. This phenotype was partially rescued with antioxidant treatment and upon culturing of hematopoietic cells in methycellulose at 3% oxygen. p16 was also stabilized because of ROS, and its loss increased cell cycling and partially rescued hematopoiesis and survival. Thus, Mdm2 is required to control ROS-induced p53 levels for sustainable hematopoiesis.	[Abbas, Hussein A.; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Abbas, Hussein A.; Maccio, Daniela R.; Jackson, James G.; Lozano, Guillermina] Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA; [Hazen, Amy L.] Univ Texas MD Anderson Canc Ctr, Dept Stem Cell Transplant & Cellular Therapy, Houston, TX 77030 USA; [You, M. James] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA; [Coskun, Suleyman; Sills, Tiffany M.; Hirschi, Karen K.] Baylor Coll Med, Dept Pediat & Mol & Cellular Biol, Ctr Cell & Gene Therapy, Houston, TX 77030 USA; [Sills, Tiffany M.] Baylor Coll Med, Interdept Program Cell & Mol Biol Program, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; Baylor College of Medicine; Baylor College of Medicine	Lozano, G (corresponding author), Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Grad Sch Biomed Sci, Houston, TX 77030 USA.	gglozano@mdanderson.org		Coskun, Suleyman/0000-0002-4830-0606; Jackson, James Griffith/0000-0002-2640-6442	NIH [CA82577]; Cancer Center; American Cancer Society; Ladies Leukemia League; Institutional Research Grant; University of Texas; NATIONAL CANCER INSTITUTE [R01CA082577] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center; American Cancer Society(American Cancer Society); Ladies Leukemia League; Institutional Research Grant; University of Texas; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH grant CA82577 to G.L. and the Cancer Center Support Grant to MDACC. We gratefully acknowledge Dr. Sean M. Post and Colby Suire for thoughtful discussions during the progress of this work and comments on the manuscript, and Emmanuelle Passegue for inspiring us to pursue this study. We would also like to thank Wendy Schober for technical assistance with flow cytometric analysis. M.J.Y. is supported by American Cancer Society Institutional Research Grant, Ladies Leukemia League, Institutional Research Grant, and Physician Scientist Award of the University of Texas M.D. Anderson Cancer.	Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Collado M, 2005, NATURE, V436, P642, DOI 10.1038/436642a; Collado M, 2006, NAT REV CANCER, V6, P472, DOI 10.1038/nrc1884; Cosme-Blanco W, 2007, EMBO REP, V8, P497, DOI 10.1038/sj.embor.7400937; Donald SP, 2001, CANCER RES, V61, P1810; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jackson JG, 2006, CANCER RES, V66, P8356, DOI 10.1158/0008-5472.CAN-06-1752; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; JONES SN, 1995, NATURE, V378, P206, DOI 10.1038/378206a0; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Lee SH, 1999, BBA-GENE STRUCT EXPR, V1446, P389, DOI 10.1016/S0167-4781(99)00112-8; Lehar SM, 1996, ONCOGENE, V12, P1181; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liu G, 2007, J PATHOL, V213, P360, DOI 10.1002/path.2238; Liu G, 2004, NAT GENET, V36, P63, DOI 10.1038/ng1282; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Ludwig RL, 1996, MOL CELL BIOL, V16, P4952; LUNA RMD, 1995, NATURE, V378, P203; Marine JC, 2006, CELL DEATH DIFFER, V13, P927, DOI 10.1038/sj.cdd.4401912; McDonnell TJ, 1999, J PATHOL, V188, P322, DOI 10.1002/(SICI)1096-9896(199907)188:3<322::AID-PATH372>3.0.CO;2-F; Mendrysa SM, 2003, MOL CELL BIOL, V23, P462, DOI 10.1128/MCB.23.2.462-473.2003; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; Naka K, 2008, ANTIOXID REDOX SIGN, V10, P1883, DOI 10.1089/ars.2008.2114; O'Leary KA, 2004, MOL CELL BIOL, V24, P186, DOI 10.1128/MCB.24.1.186-191.2004; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Palis J, 1999, DEVELOPMENT, V126, P5073; PALIS J, 1995, BLOOD, V86, P156, DOI 10.1182/blood.V86.1.156.bloodjournal861156; Passegue E, 2003, P NATL ACAD SCI USA, V100, P11842, DOI 10.1073/pnas.2034201100; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Post SM, 2010, ONCOGENE, V29, P1260, DOI 10.1038/onc.2009.423; Ringshausen I, 2006, CANCER CELL, V10, P501, DOI 10.1016/j.ccr.2006.10.010; Rowan S, 1996, EMBO J, V15, P827, DOI 10.1002/j.1460-2075.1996.tb00418.x; Sharpless NE, 2001, NATURE, V413, P86, DOI 10.1038/35092592; Terzian T, 2007, MOL CELL BIOL, V27, P5479, DOI 10.1128/MCB.00555-06; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Weissman IL, 2008, BLOOD, V112, P3543, DOI 10.1182/blood-2008-08-078220; YAMAOKA A, 1995, J IMMUNOL, V154, P3479; Zafon C, 2007, MED HYPOTHESES, V68, P1371, DOI 10.1016/j.mehy.2006.10.043	48	106	119	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					606	617		10.1016/j.stem.2010.09.013	http://dx.doi.org/10.1016/j.stem.2010.09.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040902	Green Accepted, Bronze			2022-12-28	WOS:000284390500012
J	Hanna, JH				Hanna, Jacob H.			The STATs on Naive iPSC Reprogramming	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; PLURIPOTENCY	Pluripotency can be induced in somatic cells via ectopic expression of defined transcription factors. In this issue of Cell Stem Cell, Yang et al. (2010) demonstrate that Lif/Stat3 signaling directly contributes to the in vitro induction of murine naive pluripotency.	[Hanna, Jacob H.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Hanna, Jacob H.] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Hanna, Jacob H.] Weizmann Inst Sci, Helen & Martin Kimmel Inst Stem Cell Res, IL-76100 Rehovot, Israel	Massachusetts Institute of Technology (MIT); Whitehead Institute; Weizmann Institute of Science; Weizmann Institute of Science	Hanna, JH (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	hanna@wi.mit.edu	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974				Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Silva N, 2008, REVSTAT-STAT J, V6, P253; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022	10	3	5	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					274	276		10.1016/j.stem.2010.08.005	http://dx.doi.org/10.1016/j.stem.2010.08.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804962	Bronze			2022-12-28	WOS:000282037800003
J	Barker, RA; Kuan, WL				Barker, Roger A.; Kuan, Wei-Li			Graft-Induced Dyskinesias in Parkinson's Disease: What Is It All About?	CELL STEM CELL			English	Editorial Material							DOPAMINE; PATHOLOGY; STRIATUM; NEURONS		[Barker, Roger A.; Kuan, Wei-Li] Univ Cambridge, Brain Repair Ctr, Cambridge CB2 0PY, England; [Barker, Roger A.; Kuan, Wei-Li] Univ Cambridge, Dept Neurol, Cambridge CB2 0PY, England	University of Cambridge; University of Cambridge	Barker, RA (corresponding author), Univ Cambridge, Brain Repair Ctr, Cambridge CB2 0PY, England.	rab46@cam.ac.uk	Kuan, Wei-Li/ABD-7860-2020	Kuan, Wei-Li/0000-0002-0273-1320; Barker, Roger Alistair/0000-0001-8843-7730				Braak H, 2006, MOVEMENT DISORD, V21, P2042, DOI 10.1002/mds.21065; Carlsson T, 2006, NEUROBIOL DIS, V21, P657, DOI 10.1016/j.nbd.2005.09.008; Carta M, 2007, BRAIN, V130, P1819, DOI 10.1093/brain/awm082; Goy RL, 2007, EXPERT OPIN BIOL TH, V7, P1487, DOI 10.1517/14712598.7.10.1487; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Ma YL, 2002, ANN NEUROL, V52, P628, DOI 10.1002/ana.10359; Mendez I, 2008, NAT MED, V14, P507, DOI 10.1038/nm1752; Munoz A, 2008, BRAIN, V131, P3380, DOI 10.1093/brain/awn235; Politis M, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000976; Tanaka H, 1999, NEUROREPORT, V10, P631, DOI 10.1097/00001756-199902250-00034	10	23	23	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					148	149		10.1016/j.stem.2010.07.003	http://dx.doi.org/10.1016/j.stem.2010.07.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682443	Bronze			2022-12-28	WOS:000281107400007
J	Iglesias-Bartolome, R; Gutkind, JS				Iglesias-Bartolome, Ramiro; Gutkind, J. Silvio			Keeping the Epidermal Stem Cell Niche in Shape	CELL STEM CELL			English	Editorial Material							SERUM RESPONSE FACTOR; ACTIN		[Iglesias-Bartolome, Ramiro; Gutkind, J. Silvio] NIDR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR)	Gutkind, JS (corresponding author), NIDR, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Iglesias-Bartolome, Ramiro/H-4460-2014; Gutkind, J. Silvio/A-1053-2009; Gutkind, J. Silvio/J-1201-2016	Iglesias-Bartolome, Ramiro/0000-0002-0792-1254; Gutkind, J. Silvio/0000-0002-5150-4482	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000551] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))		Bar-Sagi D, 2000, CELL, V103, P227, DOI 10.1016/S0092-8674(00)00115-X; Castilho RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010503; Castilho RM, 2009, CELL STEM CELL, V5, P279, DOI 10.1016/j.stem.2009.06.017; Connelly JT, 2010, NAT CELL BIOL, V12, P711, DOI 10.1038/ncb2074; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Samuel MS, 2010, CELL STEM CELL, V7, P135, DOI 10.1016/j.stem.2010.07.002	10	7	7	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					143	145		10.1016/j.stem.2010.07.008	http://dx.doi.org/10.1016/j.stem.2010.07.008			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682441	Bronze			2022-12-28	WOS:000281107400005
J	Breunig, JJ; Rakic, P				Breunig, Joshua J.; Rakic, Pasko			Profiling Identifies Precursor Suspects: Notch Family Again!	CELL STEM CELL			English	Editorial Material							NEURAL STEM-CELLS; ADULT HIPPOCAMPUS; NEUROGENESIS; NEURONS; FATE	Newborn neurons in the adult dentate gyrus pass through several distinct precursor and progenitor classes prior to differentiation. In this issue of Cell Stem Cell, Lugert et al. (2010) characterized their strikingly different proliferative behaviors after neurogenic stimuli or aging.	[Breunig, Joshua J.; Rakic, Pasko] Yale Univ, Sch Med, Dept Neurobiol, New Haven, CT 06510 USA; [Breunig, Joshua J.; Rakic, Pasko] Yale Univ, Sch Med, Kavli Inst Neurosci, New Haven, CT 06510 USA	Yale University; Yale University	Rakic, P (corresponding author), Yale Univ, Sch Med, Dept Neurobiol, 333 Cedar St, New Haven, CT 06510 USA.	pasko.rakic@yale.edu	Breunig, Joshua/F-8490-2012	Breunig, Joshua/0000-0002-3735-3390	NINDS NIH HHS [R01 NS014841, R01 NS014841-31] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS014841] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Breunig JJ, 2008, P NATL ACAD SCI USA, V105, P13127, DOI 10.1073/pnas.0804558105; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					401	402		10.1016/j.stem.2010.04.006	http://dx.doi.org/10.1016/j.stem.2010.04.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452310	Green Accepted, Bronze			2022-12-28	WOS:000277844800003
J	Golding, MC; Zhang, LY; Mann, MRW				Golding, Michael C.; Zhang, Liyue; Mann, Mellissa R. W.			Multiple Epigenetic Modifiers Induce Aggressive Viral Extinction in Extraembryonic Endoderm Stem Cells	CELL STEM CELL			English	Article							EMBRYONAL CARCINOMA-CELLS; DNA METHYLATION; RETROVIRAL GENOMES; GENE-EXPRESSION; MOUSE OOCYTES; SMALL RNAS; PROTEIN; VIRUS; CHROMATIN; IDENTIFICATION	To prevent insertional mutagenesis arising from retroviral reactivation, cells of embryonic origin possess a unique capacity to silence retroviruses. Given the distinct modes of X chromosome inactivation between embryonic and extraembryonic lineages, we investigated paradigms of viral extinction. We show that trophectoderm stem cells do not silence retroviral transcription, whereas extraembryonic endoderm stem cells aggressively extinguish proviral transcription, even more rapidly than do embryonic stem cells. By using a short hairpin RNA library, we identified epigenetic modifiers of retroviral extinction in extraembryonic endoderm stem cells. Multiple chromatin remodeling and polycomb repressor complex proteins act to modulate integrated, as well as endogenous, retroviral element silencing, with a subset of factors displaying differential effects between stem cell types. Furthermore, our data suggest that small RNAs play a role in this process through interactions with the Argonaute family. Our results further the understanding of mechanisms regulating retroviral transcription in different stem cell lineages.	[Golding, Michael C.; Mann, Mellissa R. W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Obstet & Gynecol, London, ON N6A 4V2, Canada; [Golding, Michael C.; Mann, Mellissa R. W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Biochem, London, ON N6A 4V2, Canada; [Golding, Michael C.; Zhang, Liyue; Mann, Mellissa R. W.] Childrens Hlth Res Inst, London, ON N6C 2V5, Canada; [Golding, Michael C.] Texas A&M Univ, Coll Vet Med, Dept Vet Physiol, College Stn, TX 77843 USA; [Zhang, Liyue; Mann, Mellissa R. W.] Lawson Hlth Res Inst, London, ON N6C 2V5, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Texas A&M University System; Texas A&M University College Station; Western University (University of Western Ontario)	Mann, MRW (corresponding author), Univ Western Ontario, Schulich Sch Med & Dent, Dept Obstet & Gynecol, London, ON N6A 4V2, Canada.	mmann22@uwo.ca	Mann, Mellissa/L-9006-2015	Mann, Mellissa/0000-0002-8075-3824; GOLDING, MICHAEL/0000-0003-1631-2175	Canadian Institute of Health Research [MOP-81167]; Lawson Health Research Institute; Department of Obstetrics and Gynecology; University of Western Ontario; Ontario Women's Health Council/CIHR Institute of Gender and Health New Investigator; Ontario Women's Health Council/CIHR Institute of Gender and Health	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Lawson Health Research Institute; Department of Obstetrics and Gynecology; University of Western Ontario; Ontario Women's Health Council/CIHR Institute of Gender and Health New Investigator(Canadian Institutes of Health Research (CIHR)); Ontario Women's Health Council/CIHR Institute of Gender and Health(Canadian Institutes of Health Research (CIHR))	The authors thank Joe Mymryk and Peter Pelka for critical review of the manuscript and Morgan McWilliam, Michelle Gabriel, and Fatima Bab'bad for technical assistance. Authors would also like to thank G.J. Hannon for reagents. This work was supported by Research Grant MOP-81167 from the Canadian Institute of Health Research and grants from Lawson Health Research Institute and Department of Obstetrics and Gynecology, University of Western Ontario. M.R.W.M. was supported by the Ontario Women's Health Council/CIHR Institute of Gender and Health New Investigator Award. M.C.G. was supported by the Ontario Women's Health Council/CIHR Institute of Gender and Health Fellowship Award and the Dr. David Whaley Postdoctoral Fellowship in Maternal/Fetal and Neonatal Research.	Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Best S, 1996, NATURE, V382, P826, DOI 10.1038/382826a0; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102; Cherry SR, 2000, MOL CELL BIOL, V20, P7419, DOI 10.1128/MCB.20.20.7419-7426.2000; Chong SY, 2007, NAT GENET, V39, P614, DOI 10.1038/ng2031; Cohen CJ, 2009, GENE, V448, P105, DOI 10.1016/j.gene.2009.06.020; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Gao GX, 2002, SCIENCE, V297, P1703, DOI 10.1126/science.1074276; GREZ M, 1990, P NATL ACAD SCI USA, V87, P9202, DOI 10.1073/pnas.87.23.9202; GROSS L, 1975, P NATL ACAD SCI USA, V72, P3240, DOI 10.1073/pnas.72.8.3240; HARBERS K, 1981, P NATL ACAD SCI-BIOL, V78, P7609, DOI 10.1073/pnas.78.12.7609; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kaiser SM, 2007, SCIENCE, V316, P1756, DOI 10.1126/science.1140579; KALTER SS, 1973, SCIENCE, V179, P1332, DOI 10.1126/science.179.4080.1332; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kazazian HH, 2002, CELL, V110, P277, DOI 10.1016/S0092-8674(02)00868-1; Keedy KS, 2009, J VIROL, V83, P4749, DOI 10.1128/JVI.02585-08; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kondo Y, 2004, P NATL ACAD SCI USA, V101, P7398, DOI 10.1073/pnas.0306641101; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Laker C, 1998, J VIROL, V72, P339, DOI 10.1128/JVI.72.1.339-348.1998; Lee MG, 2007, CELL, V128, P877, DOI 10.1016/j.cell.2007.02.004; LOH TP, 1990, MOL CELL BIOL, V10, P4045, DOI 10.1128/MCB.10.8.4045; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Mandal PK, 2008, CELL, V135, DOI 10.1016/j.cell.2008.09.028; Market-Velker BA, 2010, HUM MOL GENET, V19, P36, DOI 10.1093/hmg/ddp465; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MATSUI T, 2010, NATURE IN PRESS, V17, DOI DOI 10.1038/NATURE08858; MCCLINTOCK B, 1956, COLD SPRING HARB SYM, V21, P197, DOI 10.1101/SQB.1956.021.01.017; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Mukhopadhyay A, 2008, NAT PROTOC, V3, P698, DOI 10.1038/nprot.2008.38; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; Pannell D, 2000, EMBO J, V19, P5884, DOI 10.1093/emboj/19.21.5884; Poleshko A, 2008, J VIROL, V82, P2313, DOI 10.1128/JVI.01882-07; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Roberts CWM, 2004, NAT REV CANCER, V4, P133, DOI 10.1038/nrc1273; Rowe HM, 2010, NATURE, V463, P237, DOI 10.1038/nature08674; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Sewalt RGAB, 2002, MOL CELL BIOL, V22, P5539, DOI 10.1128/MCB.22.15.5539-5553.2002; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; STEWART CL, 1982, P NATL ACAD SCI-BIOL, V79, P4098, DOI 10.1073/pnas.79.13.4098; TAKAGI N, 1975, NATURE, V256, P640, DOI 10.1038/256640a0; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Turelli P, 2001, MOL CELL, V7, P1245, DOI 10.1016/S1097-2765(01)00255-6; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3	60	30	31	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					457	467		10.1016/j.stem.2010.03.014	http://dx.doi.org/10.1016/j.stem.2010.03.014			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452320	Bronze			2022-12-28	WOS:000277844800013
J	Pardo, M; Lang, B; Yu, L; Prosser, H; Bradley, A; Babu, MM; Choudhary, J				Pardo, Mercedes; Lang, Benjamin; Yu, Lu; Prosser, Haydn; Bradley, Allan; Babu, M. Madan; Choudhary, Jyoti			An Expanded Oct4 Interaction Network: Implications for Stem Cell Biology, Development, and Disease	CELL STEM CELL			English	Article							TRANSCRIPTION FACTORS; SELF-RENEWAL; EARLY DIFFERENTIATION; GENOMIC ANALYSIS; O-GLYCOSYLATION; RNAI SCREEN; ES CELLS; PLURIPOTENCY; EXPRESSION; FIBROBLASTS	The transcription factor Oct4 is key in embryonic stem cell identity and reprogramming. Insight into its partners should illuminate how the pluripotent state is established and regulated. Here, we identify a considerably expanded set of Oct4-binding proteins in mouse embryonic stem cells. We find that Oct4 associates with a varied set of proteins including regulators of gene expression and modulators of Oct4 function. Half of its partners are transcriptionally regulated by Oct4 itself or other stem cell transcription factors, whereas one-third display a significant change in expression upon cell differentiation. The majority of Oct4-associated proteins studied to date show an early lethal phenotype when mutated. A fraction of the human orthologs is associated with inherited developmental disorders or causative of cancer. The Oct4 interactome provides a resource for dissecting mechanisms of Oct4 function, enlightening the basis of pluripotency and development, and identifying potential additional reprogramming factors.	[Pardo, Mercedes; Yu, Lu; Prosser, Haydn; Bradley, Allan; Choudhary, Jyoti] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Lang, Benjamin; Babu, M. Madan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Wellcome Trust Sanger Institute; MRC Laboratory Molecular Biology	Pardo, M (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England.		Lang, Benjamin/C-5036-2009; Mohan, Babu P./I-7362-2019; Choudhary, Jyoti/S-1232-2017	Lang, Benjamin/0000-0001-6358-8380; Choudhary, Jyoti/0000-0003-0881-5477; Bradley, Allan/0000-0002-2349-8839; Pardo, Mercedes/0000-0002-3477-9695	Wellcome Trust; Herchel Smith Research Studentship Fund; Medical Research Council [MC_U105185859] Funding Source: researchfish; MRC [MC_U105185859] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Herchel Smith Research Studentship Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank Frances Law and Alastair Beasley for technical assistance and Sajani Swamy and Parthiban Vijayarangakannan for informatics support The work described here was supported by the Wellcome Trust and the Herchel Smith Research Studentship Fund (B L)	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Apweiler R, 2010, NUCLEIC ACIDS RES, V38, pD142, DOI 10.1093/nar/gkp846; Araki K, 1997, J BIOCHEM, V122, P977, DOI 10.1093/oxfordjournals.jbchem.a021860; Babaie Y, 2007, STEM CELLS, V25, P500, DOI 10.1634/stemcells.2006-0426; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Barsnes H, 2009, NAT BIOTECHNOL, V27, P598, DOI 10.1038/nbt0709-598; Blake JA, 2009, NUCLEIC ACIDS RES, V37, pD712, DOI 10.1093/nar/gkn886; Bourc'his D, 2001, SCIENCE, V294, P2536, DOI 10.1126/science.1065848; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brill LM, 2009, CELL STEM CELL, V5, P204, DOI 10.1016/j.stem.2009.06.002; Campbell PA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000553; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; de Boer E, 2003, P NATL ACAD SCI USA, V100, P7480, DOI 10.1073/pnas.1332608100; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Donohoe ME, 2009, NATURE, V460, P128, DOI 10.1038/nature08098; Doyon Y, 2006, MOL CELL, V21, P51, DOI 10.1016/j.molcel.2005.12.007; Fernandez E, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.27; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gao FR, 2009, J BIOL CHEM, V284, P22263, DOI 10.1074/jbc.M109.033118; Gowher H, 2005, J BIOL CHEM, V280, P13341, DOI 10.1074/jbc.M413412200; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; JACKSON SP, 1988, CELL, V55, P125, DOI 10.1016/0092-8674(88)90015-3; Jothi R, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.52; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kamemura K, 2003, PROG NUCLEIC ACID RE, V73, P107, DOI 10.1016/S0079-6603(03)01004-3; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lauberth SM, 2006, J BIOL CHEM, V281, P23922, DOI 10.1074/jbc.M513461200; Li XQ, 2008, J GENET GENOMICS, V35, P723, DOI 10.1016/S1673-8527(08)60227-1; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Martens L, 2005, PROTEOMICS, V5, P3537, DOI 10.1002/pmic.200401303; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199; Prosser HM, 2008, MOL CELL BIOL, V28, P1702, DOI 10.1128/MCB.01282-07; RAMIREZSOLIS R, 1993, CELL, V73, P279, DOI 10.1016/0092-8674(93)90229-J; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Rhodes DR, 2007, NEOPLASIA, V9, P166, DOI 10.1593/neo.07112; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rowley A, 2000, METHODS, V20, P383, DOI 10.1006/meth.2000.0951; Sandie Reatha, 2009, BMC Res Notes, V2, P39, DOI 10.1186/1756-0500-2-39; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schaft J, 2001, GENESIS, V31, P6, DOI 10.1002/gene.1076; Shimozaki K, 2003, DEVELOPMENT, V130, P2505, DOI 10.1242/dev.00476; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sun CH, 2009, MOL CELL BIOL, V29, P4574, DOI 10.1128/MCB.01863-08; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Van Hoof D, 2009, CELL STEM CELL, V5, P214, DOI 10.1016/j.stem.2009.05.021; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang ZX, 2008, STEM CELLS, V26, P2791, DOI 10.1634/stemcells.2008-0443; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Xu HM, 2009, CELL RES, V19, P561, DOI 10.1038/cr.2009.31; Yu HB, 2009, J BIOL CHEM, V284, P31327, DOI 10.1074/jbc.M109.016162; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zeghouf M, 2004, J PROTEOME RES, V3, P463, DOI 10.1021/pr034084x	78	285	297	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					382	395		10.1016/j.stem.2010.03.004	http://dx.doi.org/10.1016/j.stem.2010.03.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362542	Green Published, hybrid			2022-12-28	WOS:000276823300016
J	Borowiak, M; Maehr, R; Chen, SB; Chen, AE; Tang, WP; Fox, JL; Schreiber, SL; Melton, DA				Borowiak, Malgorzata; Maehr, Rene; Chen, Shuibing; Chen, Alice E.; Tang, Weiping; Fox, Julia L.; Schreiber, Stuart L.; Melton, Douglas A.			Small Molecules Efficiently Direct Endodermal Differentiation of Mouse and Human Embryonic Stem Cells	CELL STEM CELL			English	Article							DEFINITIVE ENDODERM; TRANSCRIPTION FACTOR; PANCREAS DEVELOPMENT; VISCERAL ENDODERM; GENE-EXPRESSION; SELF-RENEWAL; MESODERM; SOX17; INDUCTION; SIGNALS	An essential step for therapeutic and research applications of stem cells is the ability to differentiate them into specific cell types. Endodermal cell derivatives, including lung, liver, and pancreas, are of interest for regenerative medicine, but efforts to produce these cells have been met with only modest success. In a screen of 4000 compounds, two cell-permeable small molecules were indentified that direct differentiation of ESCs into the endodermal lineage. These compounds induce nearly 80% of ESCs to form definitive endoderm, a higher efficiency than that achieved by Activin A or Nodal, commonly used protein inducers of endoderm. The chemically induced endoderm expresses multiple endodermal markers, can participate in normal development when injected into developing embryos, and can form pancreatic progenitors. The application of small molecules to differentiate mouse and human ESCs into endoderm represents a step toward achieving a reproducible and efficient production of desired ESC derivatives.	[Borowiak, Malgorzata; Maehr, Rene; Chen, Shuibing; Chen, Alice E.; Fox, Julia L.; Melton, Douglas A.] Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Borowiak, Malgorzata; Maehr, Rene; Chen, Shuibing; Chen, Alice E.; Schreiber, Stuart L.; Melton, Douglas A.] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Schreiber, Stuart L.] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Tang, Weiping; Schreiber, Stuart L.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA	Harvard University; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Melton, DA (corresponding author), Harvard Stem Cell Inst, Dept Stem Cell & Regenerat Biol, 7 Divin Ave, Cambridge, MA 02138 USA.	dmelton@harvard.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Borowiak, Malgorzata/0000-0002-5829-1213	BCBC CBP; HSCl Heffron; Broad Institute SPARC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072505] Funding Source: NIH RePORTER	BCBC CBP; HSCl Heffron; Broad Institute SPARC; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	D.A.M. and S.L.S. are investigators of the Howard Hughes Medical Institute. Edouard G. Stanley (Pdx1-GFP), Andreas Nagy, and Kat Hadjantonakis (EYFP) kindly provided the mouse ESCs. We also thank Anastasie Kweudjeu, Calvin Balatbat, and Brian Tilton for their excellent technical support; Renate Hellmiss for her expertise in figure design; and Qiao Zhou and Peter Carolan for valuable comments. This work was supported by: BCBC CBP (to D.A.M. and S.L.S.), HSCl Heffron funds (to D.A.M.), and Broad Institute SPARC funds (to J.L.F. and S.L.S.). The authors have filed a patent on the IDE molecules described in this paper.	Agius E, 2000, DEVELOPMENT, V127, P1173; Anderson WJ, 2008, DEV DYNAM, V237, P504, DOI 10.1002/dvdy.21437; ANG SL, 1993, DEVELOPMENT, V119, P1301; Bhushan A, 2001, DEVELOPMENT, V128, P5109; Burridge PW, 2007, STEM CELLS, V25, P929, DOI 10.1634/stemcells.2006-0598; CHEN S, 2009, NAT CHEM BI IN PRESS, DOI DOI 10.1038/NCHEMBIO154; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Desbordes SC, 2008, CELL STEM CELL, V2, P602, DOI 10.1016/j.stem.2008.05.010; Deutsch G, 2001, DEVELOPMENT, V128, P871; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; DZIADEK M, 1979, J EMBRYOL EXP MORPH, V53, P367; GOLOSOW N, 1962, DEV BIOL, V4, P242, DOI 10.1016/0012-1606(62)90042-8; Gu GQ, 2003, MECH DEVELOP, V120, P35, DOI 10.1016/S0925-4773(02)00330-1; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Horb ME, 2001, DEV BIOL, V236, P330, DOI 10.1006/dbio.2001.0347; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Lammert E, 2001, SCIENCE, V294, P564, DOI 10.1126/science.1064344; Lau J, 2006, CELL MOL LIFE SCI, V63, P642, DOI 10.1007/s00018-005-5357-z; Lewis SL, 2006, DEV DYNAM, V235, P2315, DOI 10.1002/dvdy.20846; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; MASON IJ, 1986, EMBO J, V5, P1831, DOI 10.1002/j.1460-2075.1986.tb04434.x; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; MONAGHAN AP, 1993, DEVELOPMENT, V119, P567; Morrisey EE, 1996, DEV BIOL, V177, P309, DOI 10.1006/dbio.1996.0165; Offield MF, 1996, DEVELOPMENT, V122, P983; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park KS, 2006, DEV BIOL, V294, P192, DOI 10.1016/j.ydbio.2006.02.038; Pogoda HM, 2000, CURR BIOL, V10, P1041, DOI 10.1016/S0960-9822(00)00669-2; SASAKI H, 1993, DEVELOPMENT, V118, P47; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sherwood RI, 2007, DEV BIOL, V304, P541, DOI 10.1016/j.ydbio.2007.01.011; Stafford D, 2002, CURR BIOL, V12, P1215, DOI 10.1016/S0960-9822(02)00929-6; Wells JM, 2000, DEVELOPMENT, V127, P1563; Wells JM, 1999, ANNU REV CELL DEV BI, V15, P393, DOI 10.1146/annurev.cellbio.15.1.393; Whitman M, 1998, GENE DEV, V12, P2445, DOI 10.1101/gad.12.16.2445; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167	48	312	338	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					348	358		10.1016/j.stem.2009.01.014	http://dx.doi.org/10.1016/j.stem.2009.01.014			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341624	Green Accepted, Bronze			2022-12-28	WOS:000265162700011
J	Karp, JM; Teol, GSL				Karp, Jeffrey M.; Teol, Grace Sock Leng			Mesenchymal Stem Cell Homing: The Devil Is in the Details	CELL STEM CELL			English	Review							MARROW STROMAL CELLS; IMPROVES CARDIAC-PERFORMANCE; HUMAN BONE-MARROW; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; ENDOTHELIAL-CELLS; P-SELECTIN; IN-VITRO; PROMOTING MIGRATION; MAGNETIC-RESONANCE	The study of MSC trafficking is clinically relevant for minimally invasive cell therapy to promote regeneration of damaged tissue, to treat inflammation, and to promote angiogenesis. However, these studies are complicated by the diverse methods used to culture, characterize, and deliver MSCs and by the variety of methods used to assess homing events. This review provides a critical analysis of the methods used to track homing of exogenously infused MSCs and discusses strategies for enhancing their trafficking to particular tissues.	[Karp, Jeffrey M.; Teol, Grace Sock Leng] MIT, Harvard Mit Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Karp, Jeffrey M.; Teol, Grace Sock Leng] Brigham & Womens Hosp, Dept Med, HST Ctr Biomed Engn, Cambridge, MA 02139 USA; [Karp, Jeffrey M.; Teol, Grace Sock Leng] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Teol, Grace Sock Leng] Nanyang Technol Univ, Sch Chem & Biomed Engn, Singapore 639798, Singapore	Harvard University; Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Karp, JM (corresponding author), MIT, Harvard Mit Div Hlth Sci & Technol, 77 Massachusetts Ave,E25-519, Cambridge, MA 02139 USA.	jkarp@rics.bwh.harvard.edu		Katzschmann, Grace/0000-0001-6205-4125	American Heart Association [0970178N]	American Heart Association(American Heart Association)	The authors would like to thank Christopher V. Carman, Ulrich H. von Andrian, and Charles P. Lin for helpful discussions. This work was supported by the American Heart Association grant #0970178N to J.M.K.	ALON R, 1995, J CELL BIOL, V128, P1243, DOI 10.1083/jcb.128.6.1243; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; Bantubungi K, 2008, MOL CELL NEUROSCI, V37, P454, DOI 10.1016/j.mcn.2007.11.001; Barbash IM, 2003, CIRCULATION, V108, P863, DOI 10.1161/01.CIR.0000084828.50310.6A; Beggs KJ, 2006, CELL TRANSPLANT, V15, P711, DOI 10.3727/000000006783981503; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bensidhoum M, 2004, BLOOD, V103, P3313, DOI 10.1182/blood-2003-04-1121; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Brenner S, 2004, STEM CELLS, V22, P1128, DOI 10.1634/stemcells.2003-0196; BUTCHER EC, 1991, CELL, V67, P1033, DOI 10.1016/0092-8674(91)90279-8; Chan J, 2007, STEM CELLS, V25, P875, DOI 10.1634/stemcells.2006-0694; CHAVAKIS E, 2008, J MOL CELL IN PRESS; Chen JL, 2001, STROKE, V32, P1005, DOI 10.1161/01.STR.32.4.1005; Cheng ZK, 2008, MOL THER, V16, P571, DOI 10.1038/sj.mt.6300374; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Cilloni D, 2000, BLOOD, V96, P3637; CRISAN M, 2008, CELL STEM C IN PRESS; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; De Becker A, 2007, HAEMATOLOGICA, V92, P440, DOI 10.3324/haematol.10475; Dennis JE, 2004, J ORTHOPAED RES, V22, P735, DOI 10.1016/j.orthres.2003.12.002; Devine SM, 2001, EXP HEMATOL, V29, P244, DOI 10.1016/S0301-472X(00)00635-4; Devine SM, 2003, BLOOD, V101, P2999, DOI 10.1182/blood-2002-06-1830; Diacovo TG, 1996, BLOOD, V88, P146; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eder V, 2004, INT J RADIAT ONCOL, V60, P1530, DOI 10.1016/j.ijrobp.2004.07.698; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; FREAS W, 1989, AM J PHYSIOL, V256, pH655, DOI 10.1152/ajpheart.1989.256.3.H655; Freyman T, 2006, EUR HEART J, V27, P1114, DOI 10.1093/eurheartj/ehi818; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; GOETZ DJ, 1994, BIOPHYS J, V66, P2202, DOI 10.1016/S0006-3495(94)81016-1; He QL, 2007, STEM CELLS, V25, P69, DOI 10.1634/stemcells.2006-0335; Hong S, 2007, LANGMUIR, V23, P12261, DOI 10.1021/la7014397; Hordijk PL, 2003, CELL BIOCHEM BIOPHYS, V38, P305, DOI 10.1385/CBB:38:3:305; Hsiao JK, 2007, MAGN RESON MED, V58, P717, DOI 10.1002/mrm.21377; Ip JE, 2007, MOL BIOL CELL, V18, P2873, DOI 10.1091/mbc.E07-02-0166; Jiang WH, 2006, TRANSPL INT, V19, P570, DOI 10.1111/j.1432-2277.2006.00307.x; Jones EA, 2002, ARTHRITIS RHEUM-US, V46, P3349, DOI 10.1002/art.10696; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; KEATING A, 1982, NATURE, V298, P280, DOI 10.1038/298280a0; Kim DH, 2007, CELL TRANSPLANT, V16, P1007, DOI 10.3727/000000007783472381; Koc ON, 2001, BONE MARROW TRANSPL, V27, P235, DOI 10.1038/sj.bmt.1702791; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Kumar S, 2007, FASEB J, V21, P3917, DOI 10.1096/fj.07-8275com; Kuznetsov SA, 2001, J CELL BIOL, V153, P1133, DOI 10.1083/jcb.153.5.1133; Lee PH, 2008, CLIN PHARMACOL THER, V83, P723, DOI 10.1038/sj.clpt.6100386; Lee RJ, 2007, STEM CELLS, V25, P712, DOI 10.1634/stemcells.2005-0602; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Ponte AL, 2007, STEM CELLS, V25, P1737, DOI 10.1634/stemcells.2007-0054; Martens Timothy P, 2006, Nat Clin Pract Cardiovasc Med, V3 Suppl 1, pS18, DOI 10.1038/ncpcardio0404; Mazo IB, 2002, BLOOD, V99, P4182, DOI 10.1182/blood.V99.11.4182; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Nauta AJ, 2007, BLOOD, V110, P3499, DOI 10.1182/blood-2007-02-069716; *NIH, 2008, EV PROCHYMAL AD HUM; Omori Y, 2008, BRAIN RES, V1236, P30, DOI 10.1016/j.brainres.2008.07.116; Ortiz LA, 2003, P NATL ACAD SCI USA, V100, P8407, DOI 10.1073/pnas.1432929100; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Petite H, 2000, NAT BIOTECHNOL, V18, P959, DOI 10.1038/79449; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; Potapova IA, 2008, J BIOL CHEM, V283, P13100, DOI 10.1074/jbc.M800184200; Ries C, 2007, BLOOD, V109, P4055, DOI 10.1182/blood-2006-10-051060; Rochefort GY, 2006, STEM CELLS, V24, P2202, DOI 10.1634/stemcells.2006-0164; Rombouts WJC, 2003, LEUKEMIA, V17, P160, DOI 10.1038/sj.leu.2402763; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Ruster B, 2006, BLOOD, V108, P3938, DOI 10.1182/blood-2006-05-025098; Sackstein R, 2008, NAT MED, V14, P181, DOI 10.1038/nm1703; Salas A, 2002, J BIOL CHEM, V277, P50255, DOI 10.1074/jbc.M209822200; Sarkar D, 2008, BIOCONJUGATE CHEM, V19, P2105, DOI 10.1021/bc800345q; Sasaki M, 2008, J IMMUNOL, V180, P2581, DOI 10.4049/jimmunol.180.4.2581; Schenk S, 2007, STEM CELLS, V25, P245, DOI 10.1634/stemcells.2006-0293; Segers VFM, 2006, AM J PHYSIOL-HEART C, V290, pH1370, DOI 10.1152/ajpheart.00523.2005; Shah LS, 2007, NANO LETT, V7, P3071, DOI 10.1021/nl071547f; Shi MX, 2007, HAEMATOLOGICA, V92, P897, DOI 10.3324/haematol.10669; Sigal A, 2000, J IMMUNOL, V165, P442, DOI 10.4049/jimmunol.165.1.442; SIMMONS PJ, 1991, BLOOD, V78, P55; SIMMONS PJ, 1987, NATURE, V328, P429, DOI 10.1038/328429a0; Song YS, 2007, NEUROUROL URODYNAM, V26, P584, DOI 10.1002/nau.20351; Sordi V, 2005, BLOOD, V106, P419, DOI 10.1182/blood-2004-09-3507; Spees JL, 2003, P NATL ACAD SCI USA, V100, P2397, DOI 10.1073/pnas.0437997100; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; STEINGEN C, 2008, J MOL CELL IN PRESS; Svennilson J, 2005, BONE MARROW TRANSPL, V35, pS65, DOI 10.1038/sj.bmt.1704850; TANAKA J, 1994, BRIT J HAEMATOL, V86, P436, DOI 10.1111/j.1365-2141.1994.tb04764.x; Toma C, 2002, CIRCULATION, V105, P93, DOI 10.1161/hc0102.101442; Tondreau T, 2005, STEM CELLS, V23, P1105, DOI 10.1634/stemcells.2004-0330; Vajkoczy P, 2003, J EXP MED, V197, P1755, DOI 10.1084/jem.20021659; vonAndrian UH, 1997, P NATL ACAD SCI USA, V94, P4825, DOI 10.1073/pnas.94.10.4825; Walczak P, 2008, STROKE, V39, P1569, DOI 10.1161/STROKEAHA.107.502047; Wang CH, 2008, ARTERIOSCL THROM VAS, V28, P54, DOI 10.1161/ATVBAHA.107.147256; Wang JA, 2009, INT J CARDIOL, V133, P410, DOI 10.1016/j.ijcard.2007.11.096; Wu GD, 2003, TRANSPLANTATION, V75, P679, DOI 10.1097/01.TP.0000048488.35010.95; Wynn RF, 2004, BLOOD, V104, P2643, DOI 10.1182/blood-2004-02-0526; Xia LJ, 2004, BLOOD, V104, P3091, DOI 10.1182/blood-2004-02-0650; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Zhang J, 2008, J BIOMED SCI, V15, P585, DOI 10.1007/s11373-008-9256-9; Zhang M, 2007, FASEB J, V21, P3197, DOI 10.1096/fj.06-6558com	96	1037	1107	7	195	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					206	216		10.1016/j.stem.2009.02.001	http://dx.doi.org/10.1016/j.stem.2009.02.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265660	Bronze			2022-12-28	WOS:000264369300011
J	Persson, AI; Weiss, WA				Persson, Anders I.; Weiss, William A.			The Side Story of Stem-like Glioma Cells	CELL STEM CELL			English	Editorial Material							CANCER; POPULATION; PATHWAY	In this issue of Cel/Stem Stell, Bleau et al. report that activity of the drug transporter ABCG2 defines a tumorigenic stem-like side population (SP) isolated from glioma. Surprisingly, temozolomide, the first-line chemotherapeutic used for treatment of glioma, increased this side population, and even more so when PTEN was deleted.	[Persson, Anders I.; Weiss, William A.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Brain Tumor Res Ctr, San Francisco, CA 94143 USA; [Weiss, William A.] Univ Calif San Francisco, Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center	Persson, AI (corresponding author), Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA.	anders.persson@ucsf.edu; weiss@cgl.ucsf.edu		Persson, Anders/0000-0003-3868-0577; Weiss, William/0000-0003-2230-9132				Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Takada T, 2005, DRUG METAB DISPOS, V33, P905, DOI 10.1124/dmd.104.003228; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	10	6	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					191	192		10.1016/j.stem.2009.02.004	http://dx.doi.org/10.1016/j.stem.2009.02.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265652	Bronze			2022-12-28	WOS:000264369300003
J	Vijayaragavan, K; Szabo, E; Bosse, M; Ramos-Mejia, V; Moon, RT; Bhatia, M				Vijayaragavan, Kausalia; Szabo, Eva; Bosse, Marc; Ramos-Mejia, Veronica; Moon, Randall T.; Bhatia, Mickie			Noncanonical Wnt Signaling Orchestrates Early Developmental Events toward Hematopoietic Cell Fate from Human Embryonic Stem Cells	CELL STEM CELL			English	Article							AXIS FORMATION; DIFFERENTIAL EXPRESSION; CONVERGENT EXTENSION; PRIMITIVE STREAK; SELF-RENEWAL; MESODERM; PATHWAY; XENOPUS; SPECIFICATION; GASTRULATION	During human development, signals that govern lineage specification versus expansion of cells committed to a cell fate are poorly understood. We demonstrate that activation of canonical Wnt signaling by Wnt3a. promotes proliferation of human embryonic stem cells (hESCs)-precursors already committed to the hematopoietic lineage. In contrast, noncanonical Wnt signals, activated by Wnt11, control exit from the pluripotent state and entry toward mesoderm specification. Unique to embryoid body (EB) formation of hESCs, Wnt11 induces development and arrangement of cells expressing Brachyury that coexpress E-cadherin and Frizzled-7 (Fzd7). Knockdown of Fzd7 expression blocks Wnt11-dependent specification. Our study reveals an unappreciated role for noncanonical Wnt signaling in hESC specification that involves development of unique mesoderm precursors via morphogenic organization within human EBs.	[Vijayaragavan, Kausalia; Szabo, Eva; Bosse, Marc; Ramos-Mejia, Veronica; Bhatia, Mickie] McMaster Univ, Stem Cell & Canc Res Inst, Michael G DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada; [Vijayaragavan, Kausalia; Bosse, Marc; Ramos-Mejia, Veronica; Bhatia, Mickie] McMaster Univ, Dept Biochem, Hamilton, ON L8N 3Z5, Canada; [Moon, Randall T.] Univ Washington, Sch Med, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Moon, Randall T.] Univ Washington, Sch Med, Dept Pharmacol, Seattle, WA 98195 USA; [Moon, Randall T.] Univ Washington, Sch Med, Randall T Moon Inst Stem Cell & Regenerat Med, Seattle, WA 98195 USA	McMaster University; McMaster University; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Bhatia, M (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Michael G DeGroote Sch Med, Hamilton, ON L8N 3Z5, Canada.	mbhatia@mcmaster.ca	Vijayaragavan, Kausalia/AAM-8590-2021; Moon, Randall/M-5605-2019; Ramos-Mejia, Veronica/C-4338-2017; Bosse, Marc/AAM-8593-2021; Moon, Randall T/B-1743-2014	Moon, Randall/0000-0002-9352-1408; Ramos-Mejia, Veronica/0000-0002-8013-4273; Moon, Randall T/0000-0002-9352-1408	Canadian Chair Program; Howard Hughes Medical Institute (HHMI); Canadian Institutes of Health Research (CIHR); Canadian Cancer Society (CCS); Stem Cell Network (Canada)	Canadian Chair Program; Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society (CCS)(Canadian Cancer Society (CCS)); Stem Cell Network (Canada)	M.B. was supported by the Canadian Chair Program who holds the Canada Research Chair in human stem cell biology, and R.T.M. was supported by the Howard Hughes Medical Institute (HHMI). This work was supported by grants from the Canadian Institutes of Health Research (CIHR), the Canadian Cancer Society (CCS), and the Stem Cell Network (Canada) to M.B. We also are grateful to Aimee Kohn, Rhoda Mondeh, and Jiabi Yang for their technical assistance and to Morag Stewart, Tamra Werbowetski-Ogilvie, Jennifer Trowbridge, and Chantal Cerclan for useful suggestions.	Ang SJ, 2004, GENE EXPR PATTERNS, V4, P289, DOI 10.1016/j.modgep.2003.11.002; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandon C, 2000, BLOOD, V96, P4132, DOI 10.1182/blood.V96.13.4132.h8004132_4132_4141; BURDSAL CA, 1993, DEVELOPMENT, V118, P829; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220; Djiane A, 2000, DEVELOPMENT, V127, P3091; Duprat AM, 1996, INT J DEV BIOL, V40, P745; Eisenberg CA, 1999, DEV DYNAM, V216, P45, DOI 10.1002/(SICI)1097-0177(199909)216:1<45::AID-DVDY7>3.0.CO;2-L; Eisenberg CA, 1997, DEVELOPMENT, V124, P525; GURDON JB, 1993, CELL, V75, P831, DOI 10.1016/0092-8674(93)90526-V; Hart AH, 2002, DEVELOPMENT, V129, P3597; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; KATO K, 1993, P NATL ACAD SCI USA, V90, P1310, DOI 10.1073/pnas.90.4.1310; Kim DJ, 2008, CELL BIOCHEM FUNCT, V26, P24, DOI 10.1002/cbf.1391; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Kuhl M, 2000, J BIOL CHEM, V275, P12701, DOI 10.1074/jbc.275.17.12701; Kuhl M, 2002, SEMIN CELL DEV BIOL, V13, P243, DOI 10.1016/S1084-9521(02)00050-2; Kwan KM, 2003, DEVELOPMENT, V130, P1961, DOI 10.1242/dev.00412; Lengerke C, 2008, CELL STEM CELL, V2, P72, DOI 10.1016/j.stem.2007.10.022; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Maduro MF, 2005, DEV BIOL, V285, P510, DOI 10.1016/j.ydbio.2005.06.022; Martin BL, 2008, DEV CELL, V15, P121, DOI 10.1016/j.devcel.2008.04.013; McLean AB, 2007, STEM CELLS, V25, P29, DOI 10.1634/stemcells.2006-0219; Moon Randall T, 2005, Sci STKE, V2005, pcm1; MOON RT, 1993, DEVELOPMENT, V119, P97; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Na J, 2007, DEV BIOL, V302, P40, DOI 10.1016/j.ydbio.2006.08.036; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; Nateri AS, 2005, NATURE, V437, P281, DOI 10.1038/nature03914; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Nohno T, 1999, CELL MOL BIOL, V45, P653; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Ogawa M, 2001, Int Rev Immunol, V20, P21, DOI 10.3109/08830180109056721; Pandur P, 2002, NATURE, V418, P636, DOI 10.1038/nature00921; Poon E, 2006, J CELL SCI, V119, P759, DOI 10.1242/jcs.02788; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2000, IMMUNITY, V13, P15, DOI 10.1016/S1074-7613(00)00004-2; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; SHIVDASANI RA, 1995, NATURE, V373, P432, DOI 10.1038/373432a0; SKERJANC IS, 1994, MOL CELL BIOL, V14, P8451, DOI 10.1128/MCB.14.12.8451; Solnica-Krezel L, 2006, CURR OPIN GENET DEV, V16, P433, DOI 10.1016/j.gde.2006.06.009; Tavian M, 2005, INT J DEV BIOL, V49, P243, DOI 10.1387/ijdb.041957mt; ten Berge D, 2008, CELL STEM CELL, V3, P508, DOI 10.1016/j.stem.2008.09.013; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Toyofuku T, 2000, J CELL BIOL, V150, P225, DOI 10.1083/jcb.150.1.225; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wei F, 2007, J BIOL CHEM, V282, P21551, DOI 10.1074/jbc.M611041200; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Winklbauer R, 2001, NATURE, V413, P856, DOI 10.1038/35101621; Witzel S, 2006, J CELL BIOL, V175, P791, DOI 10.1083/jcb.200606017; Woll PS, 2008, BLOOD, V111, P122, DOI 10.1182/blood-2007-04-084186; Wu CH, 2002, J BIOL CHEM, V277, P41762, DOI 10.1074/jbc.M207850200; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Yamanaka H, 2007, GENES CELLS, V12, P961, DOI 10.1111/j.1365-2443.2007.01106.x; Zeineddine D, 2006, DEV CELL, V11, P535, DOI 10.1016/j.devcel.2006.07.013	70	69	80	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					248	262		10.1016/j.stem.2008.12.011	http://dx.doi.org/10.1016/j.stem.2008.12.011			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265664	Bronze, Green Accepted			2022-12-28	WOS:000264369300015
J	Warren, ST				Warren, Stephen T.			The epigenetics of fragile X syndrome	CELL STEM CELL			English	Editorial Material							HISTONE MODIFICATIONS; RNA	In this issue of Cell Stem Cell, Eiges et al (2007) generate a human ES cell line from an embryo identified by preimplantation genetic diagnosis, and shed light on the molecular pathology of fragile X syndrome. The discovery that, upon differentiation, epigenetic modifications likely trigger silencing of the FMR1 gene sets the stage for further studies.	Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Warren, ST (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	swarren@emory.edu	Warren, Stephen T/A-2498-2012					Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Gheldof N, 2006, P NATL ACAD SCI USA, V103, P12463, DOI 10.1073/pnas.0605343103; Handa V, 2003, NUCLEIC ACIDS RES, V31, P6243, DOI 10.1093/nar/gkg818; Jin P, 2004, NAT CELL BIOL, V6, P1048, DOI 10.1038/ncb1104-1048; Malter HE, 1997, NAT GENET, V15, P165, DOI 10.1038/ng0297-165; Penagarikano O, 2007, ANNU REV GENOM HUM G, V8, P109, DOI 10.1146/annurev.genom.8.080706.092249; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686	10	16	20	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					488	489		10.1016/j.stem.2007.10.017	http://dx.doi.org/10.1016/j.stem.2007.10.017			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18938744	Bronze			2022-12-28	WOS:000251276500005
J	Gearhart, J; Coutifaris, C				Gearhart, John; Coutifaris, Christos			In Vitro Fertilization, the Nobel Prize, and Human Embryonic Stem Cells	CELL STEM CELL			English	Editorial Material							HUMAN OOCYTES; INVITRO; IVF	Robert Edwards was awarded the 2010 Nobel Prize in Physiology or Medicine for the development of human in vitro fertilization. His work not only provided the means to overcome many forms of infertility, but it also enabled research on early stages of human embryos and the derivation of human embryonic stem cells.	[Gearhart, John] Univ Penn, Inst Regenerat Med, Philadelphia, PA 19104 USA; [Coutifaris, Christos] Univ Penn, Sch Med, Div Reprod Endocrinol & Infertil, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania	Gearhart, J (corresponding author), Univ Penn, Inst Regenerat Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.	gearhart@upenn.edu; ccoutifaris@obgyn.upenn.edu						BIGGERS JD, 1981, NEW ENGL J MED, V304, P336, DOI 10.1056/NEJM198102053040607; CHANG MC, 1959, NATURE, V184, P466, DOI 10.1038/184466a0; Cohen J, 2005, HUM REPROD UPDATE, V11, P439, DOI 10.1093/humupd/dmi016; EDWARDS RG, 1970, NATURE, V227, P1307, DOI 10.1038/2271307a0; EDWARDS RG, 1969, NATURE, V221, P632, DOI 10.1038/221632a0; EDWARDS RG, 1974, Q REV BIOL, V49, P3, DOI 10.1086/407901; EDWARDS RG, 1982, HUMAN CONCEPTION IN, P371; HANDYSIDE AH, 1990, NATURE, V344, P768, DOI 10.1038/344768a0; Heape W., 1890, P R SOC LONDON, V48, P457; Johnson MH, 2010, HUM REPROD, V25, P2157, DOI 10.1093/humrep/deq155; STEPTOE PC, 1978, LANCET, V2, P366; WOLF DP, 1984, HUMAN IN VITRO FERTI, P1; Wolpert L, 2001, NATURE, V413, P107, DOI 10.1038/35093269	13	13	18	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					12	15		10.1016/j.stem.2010.12.015	http://dx.doi.org/10.1016/j.stem.2010.12.015			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211779	Bronze			2022-12-28	WOS:000286786200007
J	Barrero, MJ; Boue, S; Belmonte, JCI				Barrero, Maria J.; Boue, Stephanie; Izpisua Belmonte, Juan Carlos			Epigenetic Mechanisms that Regulate Cell Identity	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; DEVELOPMENTAL REGULATORS; CHROMATIN SIGNATURES; INTERACTION NETWORK; GENE-REGULATION; PLURIPOTENT; METHYLATION; POLYCOMB; COMPLEX; CANCER	Individual cell fate decisions can vary according to changes in gene expression in response to environmental, developmental, or metabolic cues. This plasticity is tightly regulated during embryonic development and mediated by the exquisitely coordinated activation and repression of groups of genes. Genes that become repressed are immersed in a condensed chromatin environment that renders them refractory to stimulation. This mechanism is responsible for both the loss of cell plasticity during differentiation and the preservation of cell identity. Understanding the molecular events involved in the establishment and maintenance of these restrictive domains will benefit the design of strategies for cellular reprogramming, differentiation, and cancer treatment.	[Barrero, Maria J.; Boue, Stephanie; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	belmonte@salk.edu	Barrero, Maria J./Q-1785-2017	Barrero, Maria J./0000-0002-5990-7040; Boue, Stephanie/0000-0003-0680-4168	Ministerio de Ciencia e Innovacion of Spain [RYC-2007-01510, SAF2009-08588]; G. Harold and Leila Y. Mathers Charitable G. Harold and Leila Y. Mathers Charitable and Cellex Foundation; Cellex Foundation; Sanofi-Aventis; MICINN	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); G. Harold and Leila Y. Mathers Charitable G. Harold and Leila Y. Mathers Charitable and Cellex Foundation(Foundation CELLEX); Cellex Foundation(Foundation CELLEX); Sanofi-Aventis(Sanofi-Aventis); MICINN(Ministry of Science and Innovation, Spain (MICINN)Spanish GovernmentEuropean Commission)	We apologize for those authors whose work could not be cited because of space limitation. We would like to thank all the members of the J.C.I.B. lab at The Salk Institute for Biological Studies and the CMRB for their insightful comments and input. This work was partially supported by grants RYC-2007-01510 and SAF2009-08588 from the Ministerio de Ciencia e Innovacion of Spain to M.J.B. and grants from the G. Harold and Leila Y. Mathers Charitable and Cellex Foundations, Sanofi-Aventis, and MICINN to J.C.I.B.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boue S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012664; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brykczynska U, 2010, NAT STRUCT MOL BIOL, V17, P679, DOI 10.1038/nsmb.1821; Burgold T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003034; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Gargiulo G, 2009, DEV CELL, V16, P466, DOI 10.1016/j.devcel.2009.02.002; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kim K, 2010, NATURE, V467, P285, DOI 10.1038/nature09342; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li L, 2003, CANCER RES, V63, P2733; Liu JH, 2008, MOL REPROD DEV, V75, P598, DOI 10.1002/mrd.20803; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Polo JM, 2010, NAT BIOTECHNOL, V28, P848, DOI 10.1038/nbt.1667; Rodriguez J, 2008, P NATL ACAD SCI USA, V105, P19809, DOI 10.1073/pnas.0810133105; Ron-Bigger S, 2010, STEM CELLS, V28, P1349, DOI 10.1002/stem.468; Singhal N, 2010, CELL, V141, P943, DOI 10.1016/j.cell.2010.04.037; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	51	76	79	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					565	570		10.1016/j.stem.2010.10.009	http://dx.doi.org/10.1016/j.stem.2010.10.009			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040898	Bronze			2022-12-28	WOS:000284390500008
J	Rosa, A; Brivanlou, AH				Rosa, Alessandro; Brivanlou, Ali H.			Synthetic mRNAs: Powerful Tools for Reprogramming and Differentiation of Human Cells	CELL STEM CELL			English	Editorial Material							FIBROBLASTS; INDUCTION	In this issue of Cell Stem Cell, Warren et al. (2010) describe a new methodology, using synthetic mRNA, for efficiently generating iPSCs without compromising genomic integrity. This powerful approach can also be used for directed differentiation of iPSCs, or even for trans-differentiation to generate clinically relevant differentiated cell types.	[Rosa, Alessandro; Brivanlou, Ali H.] Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10065 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Lab Mol Vertebrate Embryol, New York, NY 10065 USA.	brvnlou@rockefeller.edu	Alessandro, Rosa/A-3860-2012	Alessandro, Rosa/0000-0001-9999-7223				Angel M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011756; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; VIZE PD, 1991, METHOD CELL BIOL, V36, P367; Warren L, 2010, CELL STEM CELL, V7, P618, DOI 10.1016/j.stem.2010.08.012; Yakubov E, 2010, BIOCHEM BIOPH RES CO, V394, P189, DOI 10.1016/j.bbrc.2010.02.150; YISRAELI JK, 1989, DEVELOPMENT, V107, P31; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	10	16	44	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					549	550		10.1016/j.stem.2010.10.002	http://dx.doi.org/10.1016/j.stem.2010.10.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040893	Bronze			2022-12-28	WOS:000284390500003
J	Chin, MH; Pellegrini, M; Plath, K; Lowry, WE				Chin, Mark H.; Pellegrini, Matteo; Plath, Kathrin; Lowry, William E.			Molecular Analyses of Human Induced Pluripotent Stem Cells and Embryonic Stem Cells	CELL STEM CELL			English	Article							DIFFERENTIALLY EXPRESSED GENES; FALSE DISCOVERY RATES; GENERATION; METHYLATION	Recent work from our group and others has argued that human induced pluripotent stem cells (hiPSCs) generated by the introduction of four viruses bearing reprogramming factors differ from human embryonic stem cells (hESCs) at the level of gene expression (Chin et al., 2009). Many of the differences seen were common across independent labs and, at least to some extent, are thought to be a result of residual expression of donor cell-specific genes (Chin et al., 2009; Ghosh et al., 2010; Marchetto et al., 2009). Two new reports reanalyze similar expression data sets as those used in Chin et al. (2009) and come to different conclusions (Newman and Cooper, 2010; Guenther et al., 2010). We compare various approaches to perform gene expression meta-analysis that all support our original conclusions and present new data to demonstrate that polycistronic delivery of the reprogramming factors and extended culture brings hiPSCs transcriptionally closer to hESCs.	[Chin, Mark H.; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Pellegrini, Matteo; Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu; blowry@ucla.edu	liang, yan/H-3894-2011	Pellegrini, Matteo/0000-0001-9355-9564; Plath, Kathrin/0000-0001-7796-3372	NRSA [T32CA009056]; NIH [DP2OD001686]; CIRM [RN1-00564]; The March of Dimes; NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); The March of Dimes(March of Dimes); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We would like to thank David Casero for his statistical advice and assistance with implementation. M.H.C. is supported by a Ruth L. Kirschstein Institutional Training Grant (NRSA # T32CA009056), and K.P. was supported by the NIH Director's Young Innovator Award (DP2OD001686) and a CIRM Young Investigator Award (RN1-00564). This work was also supported by the CIRM New Cell Line grant (Jerome Zack, PI). W.E.L. holds the Maria Rowena Ross Chair in Cell Biology and Biochemistry and is supported by The March of Dimes.	Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Carey BW, 2009, P NATL ACAD SCI USA, V106, P157, DOI 10.1073/pnas.0811426106; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; Chen J, 2006, STAT MED, V25, P3174, DOI 10.1002/sim.2422; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Deng J, 2009, NAT BIOTECHNOL, V27, P353, DOI 10.1038/nbt.1530; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Gonzalez F, 2009, P NATL ACAD SCI USA, V106, P8918, DOI 10.1073/pnas.0901471106; Grant GR, 2005, BIOINFORMATICS, V21, P2684, DOI 10.1093/bioinformatics/bti407; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Liu L, 2010, J BIOL CHEM, V285, P19483, DOI 10.1074/jbc.M110.131995; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Shao LJ, 2009, CELL RES, V19, P296, DOI 10.1038/cr.2009.20; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Shedden K, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-26; Shi LM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S9-S10; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; TCHIEU J, 2010, CELL STEM C IN PRESS, V7; Tsai CA, 2003, BIOMETRICS, V59, P1071, DOI 10.1111/j.0006-341X.2003.00123.x; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	35	116	127	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					263	269		10.1016/j.stem.2010.06.019	http://dx.doi.org/10.1016/j.stem.2010.06.019			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682452	Green Accepted, Bronze			2022-12-28	WOS:000281107400018
J	Ohgushi, M; Matsumura, M; Eiraku, M; Murakami, K; Aramaki, T; Nishiyama, A; Muguruma, K; Nakano, T; Suga, H; Ueno, M; Ishizaki, T; Suemori, H; Narumiya, S; Niwa, H; Sasai, Y				Ohgushi, Masatoshi; Matsumura, Michiru; Eiraku, Mototsugu; Murakami, Kazuhiro; Aramaki, Toshihiro; Nishiyama, Ayaka; Muguruma, Keiko; Nakano, Tokushige; Suga, Hidetaka; Ueno, Mono; Ishizaki, Toshimasa; Suemori, Hirofumi; Narumiya, Shuh; Niwa, Hitoshi; Sasai, Yoshiki			Molecular Pathway and Cell State Responsible for Dissociation-Induced Apoptosis in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							PROTEIN FAMILY; ROCK INHIBITOR; RHO GTPASES; ACTIVATION; MOUSE; RAC; MEMBRANE; ABR; SURVIVAL; PROBES	Human embryonic stem cells (hESCs), unlike mouse ones (mESCs), are vulnerable to apoptosis upon dissociation. Here, we show that the apoptosis, which is of a nonanoikis type, is caused by ROCK-dependent hyperactivation of actomyosin and efficiently suppressed by the myosin inhibitor Blebbistatin. The actomyosin hyperactivation is triggered by the loss of E-cadherin-dependent intercellular contact and also observed in dissociated mouse epiblast-derived pluripotent cells but not in mESCs. We reveal that Abr, a unique Rho-GEF family factor containing a functional Rac-GAP domain, is an indispensable upstream regulator of the apoptosis and ROCK/myosin hyperactivation. Rho activation coupled with Rac inhibition is induced in hESCs upon dissociation, but not in Abr-depleted hESCs or mESCs. Furthermore, artificial Rho or ROCK activation with Rac inhibition restores the vulnerability of Abr-depleted hESCs to dissociation-induced apoptosis. Thus, the Abr-dependent "Rho-high/Rac-low" state plays a decisive role in initiating the dissociation-induced actomyosin hyperactivation and apoptosis in hESCs.	[Ohgushi, Masatoshi; Matsumura, Michiru; Eiraku, Mototsugu; Aramaki, Toshihiro; Nishiyama, Ayaka; Muguruma, Keiko; Nakano, Tokushige; Suga, Hidetaka; Ueno, Mono; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Ohgushi, Masatoshi; Matsumura, Michiru; Sasai, Yoshiki] RIKEN, Ctr Dev Biol, Div Human Stem Cell Technol, Kobe, Hyogo 6500047, Japan; [Murakami, Kazuhiro; Niwa, Hitoshi] RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Kobe, Hyogo 6500047, Japan; [Ishizaki, Toshimasa; Narumiya, Shuh] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto 6068315, Japan; [Suemori, Hirofumi] Kyoto Univ, Inst Frontier Med Sci, Kyoto 6068315, Japan	RIKEN; RIKEN; RIKEN; Kyoto University; Kyoto University	Sasai, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Murakami, Kazuhiro/AAC-4569-2019; SUGA, HIDETAKA/I-7452-2014	Eiraku, Mototsugu/0000-0002-9433-9085; Suga, Hidetaka/0000-0003-1924-7639; Muguruma, Keiko/0000-0002-3149-4408; Murakami, Kazuhiro/0000-0003-1759-9542	MEXT; Kobe Cluster Project; Leading Project for Realization of Regenerative Medicine	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project for Realization of Regenerative Medicine	We are grateful to Drs. M. Matsuda and E. Kiyokawa for the Rho and Rac FRET probes and stimulating discussion, to Drs. G. Sheng, H. Enomoto, and N. Takata for invaluable comments, to Drs. M. Takeichi, M. Wenxiang, and T. Nishimura for advice on cell-adhesion and Abr analyses, to Dr. P. Tesar for mEpiSCs, to Drs. M. Miura and E. Kuranaga for FRET probes of Capases, to Dr. Y. Gotoh for caAkt, and to members of the Sasai lab for discussion and advice. This work was supported by grants-in-aid from MEXT, the Kobe Cluster Project, and the Leading Project for Realization of Regenerative Medicine (Y.S.).	Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Charras GT, 2005, NATURE, V435, P365, DOI 10.1038/nature03550; Charras G, 2008, NAT REV MOL CELL BIO, V9, P730, DOI 10.1038/nrm2453; Charras GT, 2006, J CELL BIOL, V175, P477, DOI 10.1083/jcb.200602085; Cho YJ, 2007, MOL CELL BIOL, V27, P899, DOI 10.1128/MCB.00756-06; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; Coleman ML, 2001, NAT CELL BIOL, V3, P339, DOI 10.1038/35070009; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Harb N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003001; Hasegawa K, 2006, STEM CELLS, V24, P2649, DOI 10.1634/stemcells.2005-0657; HEISTERKAMP N, 1993, J BIOL CHEM, V268, P16903; Itoh RE, 2002, MOL CELL BIOL, V22, P6582, DOI 10.1128/MCB.22.18.6582-6591.2002; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; JOHNSON KE, 1976, J CELL SCI, V22, P575; Kameda T, 2005, STEM CELLS, V23, P1535, DOI 10.1634/stemcells.2005-0054; Krawetz RJ, 2009, BIOESSAYS, V31, P336, DOI 10.1002/bies.200800157; Krtolica A, 2007, STEM CELLS, V25, P2215, DOI 10.1634/stemcells.2007-0230; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Sebbagh M, 2001, NAT CELL BIOL, V3, P346, DOI 10.1038/35070019; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takemoto K, 2003, J CELL BIOL, V160, P235, DOI 10.1083/jcb.200207111; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yoshizaki H, 2003, J CELL BIOL, V162, P223, DOI 10.1083/jcb.200212049; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308	36	305	317	0	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					225	239		10.1016/j.stem.2010.06.018	http://dx.doi.org/10.1016/j.stem.2010.06.018			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682448	Bronze			2022-12-28	WOS:000281107400014
J	Li, RH; Liang, JL; Ni, S; Zhou, T; Qing, XB; Li, HP; He, WZ; Chen, JK; Li, F; Zhuang, QA; Qin, BM; Xu, JY; Li, W; Yang, JY; Gan, Y; Qin, DJ; Feng, SP; Song, H; Yang, DS; Zhang, BL; Zeng, LW; Lai, LX; Esteban, MA; Pei, DQ				Li, Ronghui; Liang, Jialiang; Ni, Su; Zhou, Ting; Qing, Xiaobing; Li, Huapeng; He, Wenzhi; Chen, Jiekai; Li, Feng; Zhuang, Qiang; Qin, Baoming; Xu, Jianyong; Li, Wen; Yang, Jiayin; Gan, Yi; Qin, Dajiang; Feng, Shipeng; Song, Hong; Yang, Dongshan; Zhang, Biliang; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel Angel; Pei, Duanqing			A Mesenchymal-to-Epithelial Transition Initiates and Is Required for the Nuclear Reprogramming of Mouse Fibroblasts	CELL STEM CELL			English	Article							TRANSCRIPTION FACTOR SNAIL; PLURIPOTENT STEM-CELLS; HUMAN EMBRYONIC STEM; GROWTH-FACTOR-BETA; E-CADHERIN; SELF-RENEWAL; MIR-200 FAMILY; GROUND-STATE; IN-VIVO; GENERATION	Epithelial-to-mesenchymal transition (EMT) is a developmental process important for cell fate determination. Fibroblasts, a product of EMT, can be reset into induced pluripotent stem cells (iPSCs) via exogenous transcription factors but the underlying mechanism is unclear. Here we show that the generation of iPSCs from mouse fibroblasts requires a mesenchymal-to-epithelial transition (MET) orchestrated by suppressing pro-EMT signals from the culture medium and activating an epithelial program inside the cells. At the transcriptional level, Sox2/Oct4 suppress the EMT mediator Snail, c-Myc downregulates TGF-beta 1 and TGF-beta receptor 2, and Klf4 induces epithelial genes including E-cadherin. Blocking MET impairs the reprogramming of fibroblasts whereas preventing EMT in epithelial cells cultured with serum can produce iPSCs without Klf4 and c-Myc. Our work not only establishes MET as a key cellular mechanism toward induced pluripotency, but also demonstrates iPSC generation as a cooperative process between the defined factors and the extracellular milieu.	[Li, Ronghui; Liang, Jialiang; Ni, Su; Zhou, Ting; Qing, Xiaobing; Li, Huapeng; He, Wenzhi; Chen, Jiekai; Li, Feng; Zhuang, Qiang; Qin, Baoming; Xu, Jianyong; Li, Wen; Yang, Jiayin; Gan, Yi; Qin, Dajiang; Feng, Shipeng; Song, Hong; Yang, Dongshan; Zhang, Biliang; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510530, Guangdong, Peoples R China; [Li, Ronghui; Liang, Jialiang; Ni, Su; Zhou, Ting; Qing, Xiaobing; Li, Huapeng; He, Wenzhi; Chen, Jiekai; Li, Feng; Zhuang, Qiang; Qin, Baoming; Xu, Jianyong; Li, Wen; Yang, Jiayin; Gan, Yi; Qin, Dajiang; Feng, Shipeng; Song, Hong; Yang, Dongshan; Zhang, Biliang; Zeng, Lingwen; Lai, Liangxue; Esteban, Miguel Angel; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Hlth, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510530, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences	Esteban, MA (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol,Stem Cell & Canc Biol Grp, Guangzhou 510530, Guangdong, Peoples R China.	esteban@gibh.org; pei_duanqing@gibh.ac.cn	Yang, Dongshan/N-3333-2014; Li, Ronghui/AAB-4545-2019; Lai, Liangxue/H-4545-2011; Qin, Baoming/G-1553-2015; NI, Su/AAH-8267-2020; Qing, Xiaobing/ABF-5539-2020	Yang, Dongshan/0000-0003-2449-8651; Li, Ronghui/0000-0001-6329-5895; Qin, Baoming/0000-0001-7652-161X; Chen, Jiekai/0000-0001-5168-7074; Ni, Su/0000-0003-2883-574X; Feng, Shipeng/0000-0002-3365-9990	Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX2-YW-R-221, KSCX2-YW-R-244]; National Natural Science Foundation of China [30725012, 230725012, 90813033, 30630039]; Ministry of Science and Technology [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800, 2010DFB30430]; National High Technology Research and Development Program of China [2006AA02A103, 2007G-P034, 2007Z3-C7031]; Bureau of Science and Technology of Guangzhou Municipality [2008A1-E4011]	Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Bureau of Science and Technology of Guangzhou Municipality	This work is supported by the Knowledge Innovation Program of the Chinese Academy of Sciences (KSCX2-YW-R-48, KSCX2-YW-R-221), Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams, Chinese Academy of Sciences (KSCX2-YW-R-48, KSCX2-YW-R-244), National Natural Science Foundation of China (30725012, 230725012, 90813033, 30630039), Ministry of Science and Technology 973 program (2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2007CB947900, 2009CB941102, 2009CB940902, 2010CB944800), Ministry of Science and Technology International Technology Cooperation Program (2010DFB30430), National High Technology Research and Development Program of China (2006AA02A103, 2007G-P034, 2007Z3-C7031), and Bureau of Science and Technology of Guangzhou Municipality (2008A1-E4011).	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Amicone L, 2002, ONCOGENE, V21, P1335, DOI 10.1038/sj.onc.1205199; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Batlle E, 2000, NAT CELL BIOL, V2, P84, DOI 10.1038/35000034; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carver EA, 2001, MOL CELL BIOL, V21, P8184, DOI 10.1128/MCB.21.23.8184-8188.2001; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Come C, 2006, CLIN CANCER RES, V12, P5395, DOI 10.1158/1078-0432.CCR-06-0478; De Craene B, 2005, CANCER RES, V65, P6237, DOI 10.1158/0008-5472.CAN-04-3545; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Factor VM, 1997, CANCER RES, V57, P2089; Furuse M, 2009, BBA-BIOMEMBRANES, V1788, P813, DOI 10.1016/j.bbamem.2008.07.017; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Houghton FD, 2005, REPRODUCTION, V129, P129, DOI 10.1530/rep.1.00277; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; LARUE L, 1994, P NATL ACAD SCI USA, V91, P8263, DOI 10.1073/pnas.91.17.8263; Li L, 2010, STEM CELLS, V28, P247, DOI 10.1002/stem.289; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lin YF, 2008, SCIENCE, V322, P1685, DOI 10.1126/science.1166340; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Murray SA, 2006, CELL CYCLE, V5, P2566, DOI 10.4161/cc.5.22.3502; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Nieto MA, 2002, NAT REV MOL CELL BIO, V3, P155, DOI 10.1038/nrm757; PARK SM, 2002, GENE DEV, V22, P894; Peinado H, 2003, J BIOL CHEM, V278, P21113, DOI 10.1074/jbc.M211304200; Qin DJ, 2007, CELL RES, V17, P959, DOI 10.1038/cr.2007.92; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soncin F, 2009, STEM CELLS, V27, P2069, DOI 10.1002/stem.134; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; WIESER R, 1995, EMBO J, V14, P2199, DOI 10.1002/j.1460-2075.1995.tb07214.x; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Zavadil J, 2001, P NATL ACAD SCI USA, V98, P6686, DOI 10.1073/pnas.111614398; Zhou BHP, 2004, NAT CELL BIOL, V6, P931, DOI 10.1038/ncb1173	55	862	907	1	215	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					51	63		10.1016/j.stem.2010.04.014	http://dx.doi.org/10.1016/j.stem.2010.04.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621050	Bronze			2022-12-28	WOS:000280222300013
J	Muller, FJ; Goldmann, J; Loser, P; Loring, JF				Mueller, Franz-Josef; Goldmann, Johanna; Loeser, Peter; Loring, Jeanne F.			A Call to Standardize Teratoma Assays Used to Define Human Pluripotent Cell Lines	CELL STEM CELL			English	Editorial Material							TERATOCARCINOMA	The teratoma assay is the gold standard for documenting pluripotency of human stem cells. However, reports of new human ESC and iPSC lines vary widely in both methods and analysis of teratoma data. We call for consensus standards to be established to make this assay worthy of its "golden" status.	[Mueller, Franz-Josef; Goldmann, Johanna; Loring, Jeanne F.] Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA; [Mueller, Franz-Josef] Zentrum Integrat Psychiat, D-24105 Kiel, Germany; [Loeser, Peter] Robert Koch Inst, D-13353 Berlin, Germany	Scripps Research Institute; Robert Koch Institute	Muller, FJ (corresponding author), Scripps Res Inst, Dept Physiol Chem, Ctr Regenerat Med, La Jolla, CA 92037 USA.	fj.mueller@zip.kiel.de; jloring@scripps.edu	Müller, Franz-Josef/E-3336-2010; Loring, Jeanne F/A-1620-2011	Müller, Franz-Josef/0000-0001-9478-8430; Loring, Jeanne F/0000-0001-6226-9767	Else Kroner-Fresenius-Stiftung; California Institute of Regenerative Medicine; NIH; Bill and Melinda Gates Foundation; O'Keeffe Foundation	Else Kroner-Fresenius-Stiftung; California Institute of Regenerative Medicine(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); O'Keeffe Foundation	F.-J.M. is supported by an Else Kroner-Fresenius-Stiftung fellowship, and J.F.L. by grants from the California Institute of Regenerative Medicine, the NIH, The Bill and Melinda Gates Foundation, and the O'Keeffe Foundation. We are in debt to Jacqueline Schirm and Steven Posselt for their help with database searches. Dr. Mana Parast helped us with expert advice on the histopathological assessment of teratoma tissue. We would also like to thank Anja Fritz and David Barker for helpful discussions. The authors are grateful to Louise Laurent, Suzanne Peterson, and Ha Tran for their intellectual input in the early planning of this manuscript.	BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Damjanov I, 2005, STEM CELL REV, V1, P273, DOI 10.1385/SCR:1:3:273; Ellis J, 2009, CELL STEM CELL, V4, P198, DOI 10.1016/j.stem.2009.02.010; Gertow K, 2007, CURR PROTOC STEM CEL; Loring JF, 2006, NEUROBIOL AGING, V27, P1084, DOI 10.1016/j.neurobiolaging.2005.06.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008	9	96	96	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					412	414		10.1016/j.stem.2010.04.009	http://dx.doi.org/10.1016/j.stem.2010.04.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452314	Bronze			2022-12-28	WOS:000277844800007
J	Heng, JCD; Feng, B; Han, JY; Jiang, JM; Kraus, P; Ng, JH; Orlov, YL; Huss, M; Yang, L; Lufkin, T; Lim, B; Ng, HH				Heng, Jian-Chien Dominic; Feng, Bo; Han, Jianyong; Jiang, Jianming; Kraus, Petra; Ng, Jia-Hui; Orlov, Yuriy L.; Huss, Mikael; Yang, Lin; Lufkin, Thomas; Lim, Bing; Ng, Huck-Hui			The Nuclear Receptor Nr5a2 Can Replace Oct4 in the Reprogramming of Murine Somatic Cells to Pluripotent Cells	CELL STEM CELL			English	Article							STEM-CELLS; DOMAIN; LRH-1; MOUSE; MYC	Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSGs) with the introduction of Oct4, Sox2, Klf4, and c-Myc. Among these four factors, Oct4 is critical in inducing pluripotency because no transcription factor can substitute for Oct4, whereas Sox2, Klf4, and c-Myc can be replaced by other factors. Here we show that the orphan nuclear receptor Nr5a2 (also known as Lrh-1) can replace Oct4 in the derivation of iPSCs from mouse somatic cells, and it can also enhance reprogramming efficiency. Sumoylation mutants of Nr5a2 with enhanced transcriptional activity can further increase reprogramming efficiency. Genome-wide location analysis reveals that Nr5a2 shares many common gene targets with Sox2 and Klf4, which suggests that the transcription factor trio works in concert to mediate reprogramming. We also show that Nr5a2 works in part through activating Nanog. Together, we show that unrelated transcription factors can replace Oct4 and uncovers an exogenous Oct4-free reprogramming code.	[Heng, Jian-Chien Dominic; Feng, Bo; Jiang, Jianming; Ng, Jia-Hui; Yang, Lin; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Orlov, Yuriy L.; Huss, Mikael] Genome Inst Singapore, Computat & Syst Biol Grp, Singapore 138672, Singapore; [Heng, Jian-Chien Dominic; Ng, Jia-Hui; Ng, Huck-Hui] NUS, Grad Sch Integrat Sci & Engn, Singapore 117597, Singapore; [Lufkin, Thomas; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Ctr Life Sci, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore; Harvard University; Harvard Medical School	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Feng, Bo/D-7831-2014; Lufkin, Thomas/B-5352-2011; Orlov, Yuriy L/F-1520-2013; Ng, Huck Hui/A-1135-2009; Lufkin, Thomas/AAG-7476-2019; Kraus, Petra/I-5849-2014; jiang, jianming/B-3421-2012	Feng, Bo/0000-0002-4018-3257; Lufkin, Thomas/0000-0002-7902-4771; Orlov, Yuriy L/0000-0003-0587-1609; Lufkin, Thomas/0000-0002-7902-4771; Kraus, Petra/0000-0002-6716-5550; jiang, jianming/0000-0003-3251-2716; Huss, Mikael/0000-0003-0839-2451	Biomedical Research Council, Agency for Science, Technology and Research and Singapore Stem Cell Consortium; NUS Graduate School for Integrative Sciences and Engineering; A STAR	Biomedical Research Council, Agency for Science, Technology and Research and Singapore Stem Cell Consortium(Agency for Science Technology & Research (A*STAR)); NUS Graduate School for Integrative Sciences and Engineering(National University of Singapore); A STAR(Agency for Science Technology & Research (A*STAR))	We are grateful to the Biomedical Research Council, Agency for Science, Technology and Research and Singapore Stem Cell Consortium for funding. J.H. is supported by the NUS Graduate School for Integrative Sciences and Engineering Scholarship. J.-H.N. is supported by the A STAR graduate scholarship. We thank Xiangling Ng and Kuee-Theng Kuay for technical support and Meng-Chun Hu for plasmids. We acknowledge Valere Cacheux-Rataboul for karyotype analysis and GTB group for sequencing. We thank Andrew Hutchins and Felicia Huimei Hong for comments to the manuscript.	Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gu PL, 2005, MOL CELL BIOL, V25, P3492, DOI 10.1128/MCB.25.9.3492-3505.2005; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pare JF, 2004, J BIOL CHEM, V279, P21206, DOI 10.1074/jbc.M401523200; Sablin EP, 2003, MOL CELL, V11, P1575, DOI 10.1016/S1097-2765(03)00236-3; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Solomon IH, 2005, J MOL BIOL, V354, P1091, DOI 10.1016/j.jmb.2005.10.009; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Yang FM, 2009, FEBS J, V276, P425, DOI 10.1111/j.1742-4658.2008.06785.x; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	19	339	378	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					167	174		10.1016/j.stem.2009.12.009	http://dx.doi.org/10.1016/j.stem.2009.12.009			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20096661	Bronze			2022-12-28	WOS:000274520800011
J	Beier, CP; Schulz, JB				Beier, Christoph P.; Schulz, Joerg B.			CD95/Fas in the Brain-Not Just a Killer	CELL STEM CELL			English	Editorial Material							NEURONS	Although CD95 (Fas/Apo-1) has long been known to be broadly expressed in the brain, its function has remained enigmatic. In this issue of Cell Stem Cell, Corsini et al. (2009) now show that CD95 serves as a potent activator of neurogenesis in both the healthy and injured brain.	[Beier, Christoph P.; Schulz, Joerg B.] Univ Hosp RWTH Aachen, Dept Neurol, D-52074 Aachen, Germany	RWTH Aachen University; RWTH Aachen University Hospital	Schulz, JB (corresponding author), Univ Hosp RWTH Aachen, Dept Neurol, Pauwelsstr 30, D-52074 Aachen, Germany.	jschulz@ukaachen.de	Beier, Christoph Patrick/ABF-8791-2021; Schulz, Jörg B/D-9786-2012	Beier, Christoph Patrick/0000-0001-8268-1492; Schulz, Jörg B/0000-0002-8903-0593				Beier CP, 2005, J NEUROSCI, V25, P6765, DOI 10.1523/JNEUROSCI.1700-05.2005; Corsini NS, 2009, CELL STEM CELL, V5, P178, DOI 10.1016/j.stem.2009.05.004; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186; Reich A, 2008, TRENDS NEUROSCI, V31, P478, DOI 10.1016/j.tins.2008.06.007; Sakic B, 1997, NEUROSCI BIOBEHAV R, V21, P327; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	10	10	10	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					128	130		10.1016/j.stem.2009.07.008	http://dx.doi.org/10.1016/j.stem.2009.07.008			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664983	Bronze			2022-12-28	WOS:000269511900003
J	Sheng, XR; Brawley, CM; Matunis, EL				Sheng, X. Rebecca; Brawley, Crista M.; Matunis, Erika L.			Dedifferentiating Spermatogonia Outcompete Somatic Stem Cells for Niche Occupancy in the Drosophila Testis	CELL STEM CELL			English	Article							BAG-OF-MARBLES; MALE GERM-LINE; SELF-RENEWAL; UNDIFFERENTIATED SPERMATOGONIA; CONTRACTILE RING; CYST FORMATION; IN-VIVO; PROLIFERATION; PROTEIN; SPERMATOGENESIS	Differentiating cells can dedifferentiate to replace stem cells in aged or damaged tissues, but the underlying mechanisms are unknown. In the Drosophila testis, a cluster of stromal cells called the hub creates a niche by locally activating Janus kinase-signal transducer and activator of transcription (Jak-STAT) signaling in adjacent germline and somatic stem cells. Here, we establish a system to study spermatogonial dedifferentiation. Ectopically expressing the differentiation factor bag-of-marbles (Bam) removes germline stem cells from the niche. However, withdrawing ectopic Bam causes interconnected spermatogonia. to fragment, move into the niche, exchange positions with resident somatic stem cells, and establish contact with the hub. Concomitantly, actin-based protrusions appear on subsets of spermatogonia, suggesting acquired motility. Furthermore, global downregulation of Jak-STAT signaling inhibits dedifferentiation, indicating that normal levels of pathway activation are required to promote movement of spermatogonia into the niche during dedifferentiation, where they outcompete somatic stem cells for niche occupancy.	[Sheng, X. Rebecca; Brawley, Crista M.; Matunis, Erika L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, EL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	matunis@jhmi.edu			NIH [HD052937, HD040307-07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD052937, R01HD040307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank our colleagues who have supplied us with stocks, technical assistance, suggestions, and insightful comments during the course of this work. We thank Dr. M. de Cuevas and anonymous reviewers for comments and the Andrew lab for use of their Zeiss Axiophot. This work was supported by NIH grants HD052937 and HD040307-07 (to E.L.M.).	Arbouzova NI, 2006, DEVELOPMENT, V133, P2605, DOI 10.1242/dev.02411; BARROCA V, 2008, NAT CELL BIOL, V11, P118; Bhattacharya D, 2008, EUR J IMMUNOL, V38, P2060, DOI 10.1002/eji.200838383; Bloor JW, 2001, DEV BIOL, V239, P215, DOI 10.1006/dbio.2001.0452; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Brown S, 2006, DEV DYNAM, V235, P958, DOI 10.1002/dvdy.20709; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; de Cuevas M, 1997, ANNU REV GENET, V31, P405, DOI 10.1146/annurev.genet.31.1.405; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Dutta D, 2002, GENESIS, V34, P146, DOI 10.1002/gene.10113; Fabrizio JJ, 2003, DEV BIOL, V258, P117, DOI 10.1016/S0012-1606(03)00127-1; FIELD CM, 1995, J CELL BIOL, V131, P165, DOI 10.1083/jcb.131.1.165; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fuller MT, 1998, SEMIN CELL DEV BIOL, V9, P433, DOI 10.1006/scdb.1998.0227; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Gonczy P, 1997, DEVELOPMENT, V124, P4361; HARDY RW, 1979, J ULTRA MOL STRUCT R, V69, P180, DOI 10.1016/S0022-5320(79)90108-4; Hime GR, 1996, J CELL SCI, V109, P2779; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kunwar PS, 2006, ANNU REV CELL DEV BI, V22, P237, DOI 10.1146/annurev.cellbio.22.010305.103337; LAI ZC, 1991, MECH DEVELOP, V34, P123, DOI 10.1016/0925-4773(91)90049-C; LASKO PF, 1990, GENE DEV, V4, P905, DOI 10.1101/gad.4.6.905; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Li JH, 2003, DEV CELL, V5, P787, DOI 10.1016/S1534-5807(03)00328-9; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li WX, 2004, CELL CYCLE, V3, P249; LIN HF, 1994, DEVELOPMENT, V120, P947; Matunis E, 1997, DEVELOPMENT, V124, P4383; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Neufeld TP, 1998, CELL, V93, P1183, DOI 10.1016/S0092-8674(00)81462-2; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Ohlstein B, 1997, DEVELOPMENT, V124, P3651; Pignoni F, 1997, DEVELOPMENT, V124, P271; Raff M, 2003, ANNU REV CELL DEV BI, V19, P1, DOI 10.1146/annurev.cellbio.19.111301.143037; Schulz C, 2004, GENETICS, V167, P707, DOI 10.1534/genetics.103.023184; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; Straube WL, 2006, ARTIF ORGANS, V30, P743, DOI 10.1111/j.1525-1594.2006.00296.x; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Wallenfang MR, 2006, AGING CELL, V5, P297, DOI 10.1111/j.1474-9726.2006.00221.x; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	59	105	105	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					191	203		10.1016/j.stem.2009.05.024	http://dx.doi.org/10.1016/j.stem.2009.05.024			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664993	Green Accepted, Bronze			2022-12-28	WOS:000269511900012
J	Fuchs, E				Fuchs, Elaine			Finding One's Niche in the Skin	CELL STEM CELL			English	Review							STEM-CELLS; NEGATIVE REGULATOR; DIFFERENTIATION; STRATIFICATION; HOMEOSTASIS; EXPRESSION; TISSUE; NOTCH; P63; ACT	Skin epithelia must rejuvenate constantly during normal homeostasis and repair damage after wounding. Fulfilling these roles necessitates reservoirs of stem cells that persist for life. This review focuses on the elusive stem cell niche of the epidermis, long thought to reside within the basal layer that is sandwiched between the basement membrane and the suprabasal interface.	Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Lab Mammalian Cell Biol & Dev, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@mail.rockefeller.edu	Fuchs, Elaine/G-1565-2016		Howard Hughes Medical Institute Funding Source: Medline; NIAMS NIH HHS [R01 AR031737-27, R01 AR050452-05, R01 AR031737, R01 AR050452, R01 AR027883-25] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR027883, R01AR050452, R01AR031737] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Ferby I, 2006, NAT MED, V12, P568, DOI 10.1038/nm1401; Frye M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000763; Green H, 2008, BIOESSAYS, V30, P897, DOI 10.1002/bies.20797; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kolev V, 2008, NAT CELL BIOL, V10, DOI 10.1038/ncb1750; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Langton AK, 2008, J INVEST DERMATOL, V128, P1311, DOI 10.1038/sj.jid.5701178; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Moriyama M, 2008, DEV CELL, V14, P594, DOI 10.1016/j.devcel.2008.01.017; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Owens DM, 2003, NAT REV CANCER, V3, P444, DOI 10.1038/nrc1096; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Truong AB, 2007, CELL CYCLE, V6, P295, DOI 10.4161/cc.6.3.3753; Wang X, 2008, J CELL BIOL, V183, P37, DOI 10.1083/jcb.200804030; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Zenz R, 2006, INT J BIOCHEM CELL B, V38, P1043, DOI 10.1016/j.biocel.2005.11.011	25	123	134	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					499	502		10.1016/j.stem.2009.05.001	http://dx.doi.org/10.1016/j.stem.2009.05.001			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497277	Green Accepted, Bronze			2022-12-28	WOS:000266793600011
J	Rawlins, EL; Okubo, T; Xue, Y; Brass, DM; Auten, RL; Hasegawa, H; Wang, F; Hogan, BLM				Rawlins, Emma L.; Okubo, Tadashi; Xue, Yan; Brass, David M.; Auten, Richard L.; Hasegawa, Hiroshi; Wang, Fan; Hogan, Brigid L. M.			The Role of Scgb1a1(+) Clara Cells in the Long-Term Maintenance and Repair of Lung Airway, but Not Alveolar, Epithelium	CELL STEM CELL			English	Article							BRONCHIOALVEOLAR STEM-CELLS; SECRETORY PROTEIN; POSTNATAL-GROWTH; TYPE-2 CELLS; RAT; RENEWAL; PROLIFERATION; DIFFERENTIATION; IDENTIFICATION; RECOMBINATION	To directly test the contribution of Scgb1a1(+) Clara cells to postnatal growth, homeostasis, and repair of lung epithelium, we generated a Scgb1a1-CreER (TM) "knockin" mouse for lineage-tracing these cells. Under all conditions tested, the majority of Clara cells in the bronchioles both self-renews and generates ciliated cells. In the trachea, Clara cells give rise to ciliated cells but do not self-renew extensively. Nevertheless, they can contribute to tracheal repair. In the postnatal mouse lung, it has been proposed that bronchioalveolar stem cells (BASCs) which coexpress Scgb1a1 (Secretoglobin1a1) and SftpC (Surfactant Protein C), contribute descendants to both bronchioles and alveoli. The putative BASCs were lineage labeled in our studies. However, we find no evidence for the function of a special BASC population during postnatal growth, adult homeostasis, or repair. Rather, our results support a model in which the trachea, bronchioles, and alveoli are maintained by distinct populations of epithelial progenitor cells.	[Rawlins, Emma L.; Okubo, Tadashi; Xue, Yan; Hasegawa, Hiroshi; Wang, Fan; Hogan, Brigid L. M.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Brass, David M.; Auten, Richard L.] Duke Univ, Med Ctr, Dept Pediat, Durham, NC 27710 USA	Duke University; Duke University	Hogan, BLM (corresponding author), Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA.	b.hogan@cellbio.duke.edu		Okubo, Tadashi/0000-0001-7341-443X; Rawlins, Emma Louise/0000-0001-7426-3792	Ben Arenkiel; Claude Piantadosi; Lauren Thie; Terry Lechler; Scott Randell; Barry Stripp; NIH [HL071303]; Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071303, R37HL071303] Funding Source: NIH RePORTER	Ben Arenkiel; Claude Piantadosi; Lauren Thie; Terry Lechler; Scott Randell; Barry Stripp; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Parker B. Francis Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Ben Arenkiel, Claude Piantadosi, Lauren Thie, Terry Lechler, Scott Randell, and Barry Stripp for generous support, advice, and assistance. This work was supported by NIH grant HL071303 to B.L.M.H. and a Parker B. Francis Fellowship to E.L.R.	ADAMSON IYR, 1975, LAB INVEST, V32, P736; Ahmed MN, 2003, AM J RESP CRIT CARE, V167, P400, DOI 10.1164/rccm.200202-108OC; CRAPO JD, 1986, ANNU REV PHYSIOL, V48, P721; DODGE DE, 1993, J HISTOCHEM CYTOCHEM, V41, P1171, DOI 10.1177/41.8.8331282; EVANS MJ, 1978, LAB INVEST, V38, P648; EVANS MJ, 1975, EXP MOL PATHOL, V22, P142, DOI 10.1016/0014-4800(75)90059-3; EVANS MJ, 1986, AM J PATHOL, V123, P126; EVANS MJ, 1973, AM J PATHOL, V70, P175; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; FARR A, 1992, J HISTOCHEM CYTOCHEM, V40, P651, DOI 10.1177/40.5.1374092; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hong KU, 2004, AM J PHYSIOL-LUNG C, V286, pL643, DOI 10.1152/ajplung.00155.2003; Hong KU, 2001, AM J RESP CELL MOL, V24, P671, DOI 10.1165/ajrcmb.24.6.4498; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kauffman S L, 1980, Int Rev Exp Pathol, V22, P131; KAUFFMAN SL, 1974, ANAT RECORD, V180, P63, DOI 10.1002/ar.1091800108; Kim CF, 2007, AM J PHYSIOL-LUNG C, V293, pL1092, DOI 10.1152/ajplung.00015.2007; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; LIU JY, 1994, AM J PHYSIOL, V266, pL296, DOI 10.1152/ajplung.1994.266.3.L296; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Neuringer I P, 2006, Monaldi Arch Chest Dis, V65, P47; PATTON SE, 1991, ENVIRON HEALTH PERSP, V93, P225, DOI 10.2307/3431193; Perl AKT, 2005, AM J RESP CELL MOL, V33, P455, DOI 10.1165/rcmb.2005-0180OC; RANDELL SH, 1989, AM J ANAT, V186, P55, DOI 10.1002/aja.1001860105; Rawlins EL, 2008, AM J PHYSIOL-LUNG C, V295, pL231, DOI 10.1152/ajplung.90209.2008; Rawlins EL, 2007, P NATL ACAD SCI USA, V104, P410, DOI 10.1073/pnas.0610770104; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Reynolds SD, 2000, AM J PATHOL, V156, P269, DOI 10.1016/S0002-9440(10)64727-X; Reynolds SD, 2000, AM J PHYSIOL-LUNG C, V278, pL1256, DOI 10.1152/ajplung.2000.278.6.L1256; STRUM JM, 1992, TISSUE CELL, V24, P461, DOI 10.1016/0040-8166(92)90062-C; TRYKA AF, 1986, AM REV RESPIR DIS, V133, P1055; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Whitehead GS, 2006, IMMUNOGENETICS, V58, P793, DOI 10.1007/s00251-006-0147-9; Wuenschell CW, 1996, J HISTOCHEM CYTOCHEM, V44, P113, DOI 10.1177/44.2.8609367; Yang Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002220	36	545	561	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					525	534		10.1016/j.stem.2009.04.002	http://dx.doi.org/10.1016/j.stem.2009.04.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497281	Green Accepted, Bronze			2022-12-28	WOS:000266793600015
J	Morris, ZS; McClatchey, AI				Morris, Zachary S.; McClatchey, Andrea I.			The Neurofibroma Cell of Origin: SKPs Expand the Playing Field	CELL STEM CELL			English	Editorial Material							NF1; TYPE-1	Mounting evidence suggests that stem/progenitor cells maybe the cells of origin for many tumor types. In this issue of Cell Stem Cell, Le et al. (2009) demonstrate that skin-derived precursors (SKPs) can initiate dermal neurofibromas and highlight the importance of the microenvironment in the formation of this complex tumor.	[Morris, Zachary S.; McClatchey, Andrea I.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc Res, Charlestown, MA 02129 USA; [Morris, Zachary S.; McClatchey, Andrea I.] Harvard Univ, Sch Med, Dept Pathol, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital; Harvard University	McClatchey, AI (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Canc Res, 149 13th St, Charlestown, MA 02129 USA.	mcclatch@helix.mgh.harvard.edu		Morris, Zachary/0000-0001-5558-3547				Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; JACKS T, 1994, NAT GENET, V7, P353, DOI 10.1038/ng0794-353; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Le LQ, 2009, CELL STEM CELL, V4, P453, DOI 10.1016/j.stem.2009.03.017; Roth TM, 2008, AM J MED GENET A, V146A, P1624, DOI 10.1002/ajmg.a.32301; Rubin JB, 2005, NAT REV CANCER, V5, P557, DOI 10.1038/nrc1653; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	10	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					371	372		10.1016/j.stem.2009.04.010	http://dx.doi.org/10.1016/j.stem.2009.04.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427284	Bronze			2022-12-28	WOS:000266071100001
J	Zhou, HY; Wu, SL; Joo, JY; Zhu, SY; Han, DW; Lin, TX; Trauger, S; Bien, G; Yao, S; Zhu, Y; Siuzdak, G; Scholer, HR; Duan, LX; Ding, S				Zhou, Hongyan; Wu, Shili; Joo, Jin Young; Zhu, Saiyong; Han, Dong Wook; Lin, Tongxiang; Trauger, Sunia; Bien, Geoffery; Yao, Susan; Zhu, Yong; Siuzdak, Gary; Schoeler, Hans R.; Duan, Lingxun; Ding, Sheng			Generation of Induced Pluripotent Stem Cells Using Recombinant Proteins	CELL STEM CELL			English	Article							HUMAN FIBROBLASTS; INDUCTION; P53; OCT4		[Zhou, Hongyan; Zhu, Saiyong; Lin, Tongxiang; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Trauger, Sunia; Siuzdak, Gary] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Trauger, Sunia; Siuzdak, Gary] Scripps Res Inst, Ctr Mass Spectrometry, La Jolla, CA 92037 USA; [Duan, Lingxun] LD Biopharma Inc, San Diego, CA 92130 USA; [Wu, Shili; Bien, Geoffery; Yao, Susan; Zhu, Yong] ProteomTech Inc, Costa Mesa, CA 92626 USA; [Joo, Jin Young; Han, Dong Wook; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Max Planck Society	Ding, S (corresponding author), Scripps Res Inst, Dept Chem, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	sding@scripps.edu	, HS/AAB-4434-2019; zhou, hongyan/B-3689-2011; Han, Dong Wook/D-6041-2011; Zhou, Monica/E-4378-2011; Lin, Tongxiang/I-4695-2013	, HS/0000-0003-2643-5136; zhou, hongyan/0000-0001-5919-7715; Zhou, Monica/0000-0001-5919-7715; Lin, Tongxiang/0000-0001-7033-6982; Trauger, Sunia/0000-0002-1678-8715; Zhu, Yong/0000-0002-7468-8798; Siuzdak, Gary/0000-0002-4749-0014	NICHD NIH HHS [R01 HD064610] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD064610] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Inoue M, 2006, EUR UROL, V49, P161, DOI 10.1016/j.eururo.2005.08.019; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; LaFevre-Bernt M, 2008, MOL CANCER THER, V7, P1420, DOI 10.1158/1535-7163.MCT-08-0078; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Michiue H, 2005, J BIOL CHEM, V280, P8285, DOI 10.1074/jbc.M412430200; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wadia JS, 2002, CURR OPIN BIOTECH, V13, P52, DOI 10.1016/S0958-1669(02)00284-7; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	21	1298	1596	2	246	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					381	384		10.1016/j.stem.2009.04.005	http://dx.doi.org/10.1016/j.stem.2009.04.005			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19398399	Bronze			2022-12-28	WOS:000266071100006
J	Pitchford, SC; Furze, RC; Jones, CP; Wengner, AM; Rankin, SM				Pitchford, Simon C.; Furze, Rebecca C.; Jones, Carla P.; Wengner, Antje M.; Rankin, Sara M.			Differential Mobilization of Subsets of Progenitor Cells from the Bone Marrow	CELL STEM CELL			English	Article							COLONY-STIMULATING FACTOR; ENDOTHELIAL GROWTH-FACTOR; HEMATOPOIETIC STEM-CELLS; ACUTE MYOCARDIAL-INFARCTION; G-CSF; IN-VIVO; AMD3100; BLOOD; NEOVASCULARIZATION; EXPRESSION	G-CSF stimulates mobilization of hematopoietic progenitor cells (HPCs) from bone marrow by disrupting the CXCR4/SDF-1 alpha retention axis. We show here that distinct factors and mechanisms regulate the mobilization of endothelial (EPCs) and stromal progenitor cells (SPCs). Pretreatment of mice with VEGF did not disrupt the CXCR4/SDF-1 alpha chemokine axis but stimulated entry of HPCs into the cell cycle via VEGFR1, reducing their migratory capacity in vitro and suppressing their mobilization in vivo. In contrast, VEGF pretreatment enhanced EPC mobilization via VEGFIR2 in response to CXCR4 antagonism. Furthermore, SPC mobilization was detected when the CXCR4 antagonist was administered to mice pretreated with VEGF, but not G-CSF. Thus, differential mobilization of progenitor cell subsets is dependent upon the cytokine milieu that regulates cell retention and proliferation. These findings may inform studies investigating mechanisms that regulate progenitor cell recruitment in disease and can be exploited to provide efficacious stem cell therapy for tissue regeneration.	[Pitchford, Simon C.; Furze, Rebecca C.; Jones, Carla P.; Wengner, Antje M.; Rankin, Sara M.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London SW7 2AZ, England	Imperial College London	Rankin, SM (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Leukocyte Biol Sect, London SW7 2AZ, England.	s.rankin@imperial.ac.uk		Jones, Carla P/0000-0002-4329-3267; Pitchford, Simon/0000-0003-3961-0407	British Heart Foundation [PGO5092]; European Community INNOCHEM [LSHB-CT-2005-518167]; Wellcome Trust [073677/Z/03/Z]; CNPq (Brazil)	British Heart Foundation(British Heart Foundation); European Community INNOCHEM(European Commission); Wellcome Trust(Wellcome TrustEuropean Commission); CNPq (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was funded by the British Heart Foundation (project grant no. PGO5092), The European Community INNOCHEM (LSHB-CT-2005-518167), The Wellcome Trust (project grant no. 073677/Z/03/Z), and CNPq (Brazil). The authors wish to thank Ms. Anne Dewar for processing the bone marrow samples for histology and Ms. Gill Martin for assistance with the FACS Aria.	Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Bielby R, 2007, INJURY, V38, pS26, DOI 10.1016/j.injury.2007.02.007; Bowie MB, 2006, J CLIN INVEST, V116, P2808, DOI 10.1172/JCI28310; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Calandra G, 2008, BONE MARROW TRANSPL, V41, P331, DOI 10.1038/sj.bmt.1705908; Capoccia BJ, 2006, BLOOD, V108, P2438, DOI 10.1182/blood-2006-04-013755; Cashen Amanda F, 2004, Curr Hematol Rep, V3, P406; Colvin GA, 2007, EXP HEMATOL, V35, P96, DOI 10.1016/j.exphem.2006.09.005; Ellis SG, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.09.003; Forster R, 1998, J IMMUNOL, V160, P1522; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gerber HP, 1998, J BIOL CHEM, V273, P30336, DOI 10.1074/jbc.273.46.30336; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Hess DC, 2008, CELL PROLIFERAT, V41, P94, DOI 10.1111/j.1365-2184.2008.00486.x; Hill JM, 2005, J AM COLL CARDIOL, V46, P1643, DOI 10.1016/j.jacc.2005.01.067; Ince H, 2005, CIRCULATION, V112, P3097, DOI 10.1161/CIRCULATIONAHA.105.541433; Kocher AA, 2001, NAT MED, V7, P430, DOI 10.1038/86498; Le Blanc K, 2007, J INTERN MED, V262, P509, DOI 10.1111/j.1365-2796.2007.01844.x; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; LORD BI, 1989, P NATL ACAD SCI USA, V86, P9499, DOI 10.1073/pnas.86.23.9499; Martin C, 2003, IMMUNITY, V19, P583, DOI 10.1016/S1074-7613(03)00263-2; Martin C, 2006, BRIT J HAEMATOL, V134, P326, DOI 10.1111/j.1365-2141.2006.06181.x; McKinstry WJ, 1997, BLOOD, V89, P65, DOI 10.1182/blood.V89.1.65.65_65_71; Meirelles LD, 2003, BRIT J HAEMATOL, V123, P702, DOI 10.1046/j.1365-2141.2003.04669.x; Moore MAS, 2001, ANN NY ACAD SCI, V938, P36; Nolan DJ, 2007, GENE DEV, V21, P1546, DOI 10.1101/gad.436307; Ohki Y, 2005, FASEB J, V19, P2005, DOI 10.1096/fj.04-3496fje; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Palframan RT, 1998, J EXP MED, V188, P1621, DOI 10.1084/jem.188.9.1621; Phinney DG, 1999, J CELL BIOCHEM, V72, P570; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; RANKIN SM, 2008, CURR OPIN PHARMACOL, V8, P1; Ripa RS, 2006, CIRCULATION, V113, P1983, DOI 10.1161/CIRCULATIONAHA.105.610469; ROBERTS AW, 1995, BLOOD, V86, P1600, DOI 10.1182/blood.V86.4.1600.bloodjournal8641600; Shepherd RM, 2006, BLOOD, V108, P3662, DOI 10.1182/blood-2006-06-030577; Takahashi T, 1999, NAT MED, V5, P434, DOI 10.1038/7434; Uchida N, 1997, BLOOD, V89, P465, DOI 10.1182/blood.V89.2.465; Wengner AM, 2008, BLOOD, V111, P42, DOI 10.1182/blood-2007-07-099648; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yoon CH, 2005, CIRCULATION, V112, P1618, DOI 10.1161/CIRCULATIONAHA.104.503433; ZOHINHOFER D, 2006, JAMA-J AM MED ASSOC, V295, P1003	43	231	250	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					62	72		10.1016/j.stem.2008.10.017	http://dx.doi.org/10.1016/j.stem.2008.10.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128793	Green Submitted, Bronze			2022-12-28	WOS:000262559500012
J	Shors, TJ				Shors, Tracey J.			From stem cells to grandmother cells: How neurogenesis relates to learning and memory	CELL STEM CELL			English	Article							ADULT NEUROGENESIS; HIPPOCAMPAL NEUROGENESIS; DENTATE GYRUS; NEURONS; SURVIVAL; TIME; DIFFERENTIATION; PROLIFERATION; INHIBITION; MATURATION	Neurogenesis contributes thousands of new neurons each day to the hippocampus of the adult brain. Their production is influenced by numerous internal and external environmental factors, but their survival is especially sensitive to processes of learning. This commentary considers how learning enhances the survival of neural stem/progenitor cell progeny and what these new neurons might do once they are rescued from death.	[Shors, Tracey J.] Rutgers State Univ, Dept Psychol, Piscataway, NJ 08854 USA; [Shors, Tracey J.] Rutgers State Univ, Ctr Collaborat Neurosci, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University New Brunswick	Shors, TJ (corresponding author), Rutgers State Univ, Dept Psychol, 152 Frelinghuysen Rd, Piscataway, NJ 08854 USA.	shors@rutgers.edu			National Science Foundation [IOB-0444364]; National Institutes of Health-National Institutes of Mental Health [MH59970]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059970] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health-National Institutes of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Work in the author's laboratory is supported by the National Science Foundation (IOB-0444364) and the National Institutes of Health-National Institutes of Mental Health (MH59970).	Bangasser DA, 2006, J NEUROSCI, V26, P8702, DOI 10.1523/JNEUROSCI.1742-06.2006; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bird CM, 2008, NAT REV NEUROSCI, V9, P182, DOI 10.1038/nrn2335; Cameron HA, 1999, NAT NEUROSCI, V2, P894, DOI 10.1038/13197; CAMERON HA, 1993, NEUROSCIENCE, V56, P337, DOI 10.1016/0306-4522(93)90335-D; COHEN NJ, 1980, SCIENCE, V210, P207, DOI 10.1126/science.7414331; Dalla C, 2007, NEUROBIOL LEARN MEM, V88, P143, DOI 10.1016/j.nlm.2007.02.003; Drapeau E, 2007, J NEUROSCI, V27, P6037, DOI 10.1523/JNEUROSCI.1031-07.2007; Epp JR, 2007, NEUROSCIENCE, V149, P273, DOI 10.1016/j.neuroscience.2007.07.046; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fortin NJ, 2002, NAT NEUROSCI, V5, P458, DOI 10.1038/nn834; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; Kee N, 2007, NAT NEUROSCI, V10, P355, DOI 10.1038/nn1847; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; KEMPERMANN G, 2005, ADULT NEUROGENESIS S; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kozorovitskiy Y, 2004, J NEUROSCI, V24, P6755, DOI 10.1523/JNEUROSCI.0345-04.2004; LASHLEY KS, 1950, SYM SOC EXP BIOL, V4, P454; Leuner B, 2004, J NEUROSCI, V24, P7477, DOI 10.1523/JNEUROSCI.0204-04.2004; Leuner B, 2006, J NEUROSCI, V26, P13437, DOI 10.1523/JNEUROSCI.2781-06.2006; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Mak GK, 2007, NAT NEUROSCI, V10, P1003, DOI 10.1038/nn1928; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Nottebohm F, 2002, BRAIN RES BULL, V57, P737, DOI 10.1016/S0361-9230(02)00750-5; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Piatti VC, 2006, NEUROSCIENTIST, V12, P463, DOI 10.1177/1073858406293538; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Riedel G, 1999, NAT NEUROSCI, V2, P898, DOI 10.1038/13202; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; SHORS TJ, 2003, SCI AGING KNOWLEDGE, V49, P35; SHORS TJ, 2007, 37 ANN M SOC NEUR SA; Shors TJ, 2007, BIOL PSYCHIAT, V62, P487, DOI 10.1016/j.biopsych.2006.10.033; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; SOLOMON PR, 1975, J COMP PHYSIOL PSYCH, V89, P1192, DOI 10.1037/h0077183; Takehara K, 2002, BRAIN RES, V951, P183, DOI 10.1016/S0006-8993(02)03159-1; Tanapat P, 2001, J COMP NEUROL, V437, P496, DOI 10.1002/cne.1297; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Waddell J, 2008, EUR J NEUROSCI, V27, P3020, DOI 10.1111/j.1460-9568.2008.06222.x; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	50	57	58	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					253	258		10.1016/j.stem.2008.08.010	http://dx.doi.org/10.1016/j.stem.2008.08.010			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786413	Bronze			2022-12-28	WOS:000259665000009
J	Zhang, XQ; Huang, CT; Chen, J; Pankratz, MT; Xi, JJ; Li, J; Yang, Y; LaVaute, TM; Li, XJ; Ayala, M; Bondarenko, GI; Du, ZW; Jin, Y; Golos, TG; Zhang, SC				Zhang, Xiaoqing; Huang, Cindy T.; Chen, Jing; Pankratz, Matthew T.; Xi, Jiajie; Li, Jin; Yang, Ying; LaVaute, Timothy M.; Li, Xue-Jun; Ayala, Melvin; Bondarenko, Gennadiy I.; Du, Zhong-Wei; Jin, Ying; Golos, Thaddeus G.; Zhang, Su-Chun			Pax6 Is a Human Neuroectoderm Cell Fate Determinant	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; NEURAL DIFFERENTIATION; DIRECTED DIFFERENTIATION; RNA INTERFERENCE; PAIRED DOMAIN; SELF-RENEWAL; EXPRESSION; MOUSE; GENES; SOX2	The transcriptional regulation of neuroectoderm (NE) specification is unknown. Here we show that Pax6 is uniformly expressed in early NE cells of human fetuses and those differentiated from human embryonic stem cells (hESCs). This is in contrast to the later expression of Pax6 in restricted mouse brain regions. Knockdown of Pax6 blocks NE specification from hESCs. Overexpression of either Pax6a or Pax6b, but not Pax6 Delta PD, triggers hESC differentiation. However, only Pax6a converts hESCs to NE. In contrast, neither loss nor gain of function of Pax6 affects mouse NE specification. Both Pax6a and Pax6b bind to pluripotent gene promoters but only Pax6a binds to NE genes during human NE specification. These findings indicate that Pax6 is a transcriptional determinant of the human NE and suggest that Pax6a and Pax6b coordinate with each other in determining the transition from pluripotency to the NE fate in human by differentially targeting pluripotent and NE genes.	[Zhang, Xiaoqing; Huang, Cindy T.; Pankratz, Matthew T.; LaVaute, Timothy M.; Li, Xue-Jun; Ayala, Melvin; Du, Zhong-Wei; Zhang, Su-Chun] Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA; [Zhang, Xiaoqing; Huang, Cindy T.; Pankratz, Matthew T.; LaVaute, Timothy M.; Li, Xue-Jun; Ayala, Melvin; Du, Zhong-Wei; Zhang, Su-Chun] WiCell Inst, Madison, WI 53705 USA; [Chen, Jing; Xi, Jiajie; Li, Jin] Fudan Univ, Inst Stem Cells & Regenerat Med, Shanghai Med Sch, Dept Anat & Embryol, Shanghai 200032, Peoples R China; [Yang, Ying; Jin, Ying] Chinese Acad Sci, Shanghai Inst Biol Sci, Shanghai 200031, Peoples R China; [Bondarenko, Gennadiy I.; Golos, Thaddeus G.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53715 USA; [Golos, Thaddeus G.] Univ Wisconsin, Sch Med & Publ Hlth, Sch Vet Med & Obstet & Gynecol, Dept Comparat Biosci, Madison, WI 53715 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anat, Madison, WI 53705 USA; [Zhang, Su-Chun] Univ Wisconsin, Sch Med & Publ Hlth, Dept Neurol, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Zhang, SC (corresponding author), Univ Wisconsin, Waisman Ctr, Madison, WI 53705 USA.	zhang@waisman.wisc.edu	Zhang, Xiaoqing/O-3424-2017	Zhang, Xiaoqing/0000-0002-7405-1893; LI, XUEJUN/0000-0003-1899-9134; Ayala, Melvin/0000-0002-8669-1046; Pankratz, Matthew/0000-0002-7397-6755	National Institutes of Neurological Diseases and Stroke [NS045926]; National Institute of Child Health and Human Development [P30 HD03352]; Ministry of Science and Technology, China [2006CB94700, 2006AA02A101]; Shanghai Municipality [06dj14001]; NIH [RR00167, RR15459, RR020141]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD003352] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015459, C06RR020141, P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045926, R21NS061243] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P51OD011106] Funding Source: NIH RePORTER	National Institutes of Neurological Diseases and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Ministry of Science and Technology, China(Ministry of Science and Technology, China); Shanghai Municipality; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	`We thank Qilong Ying and Austin Smith for the Sox1 reporter mouse ESCs and Y. Sassai for the FoxG1 antibody. We also thank Elizabeth E. Capowski for reading our manuscript and helpful discussion. This study was supported by the National Institutes of Neurological Diseases and Stroke (NS045926 to S.-C.Z.), partly by a core grant to the Waisman Center from the National Institute of Child Health and Human Development (P30 HD03352), Ministry of Science and Technology, China (2006CB94700, 2006AA02A101), and Shanghai Municipality (06dj14001). The Wisconsin National Primate Research Center is supported by NIH grant RR00167, with support from Research Facilities Improvement Progress grant RR15459 and RR020141. The authors state that they have no competing financial interests.	Aiba K, 2006, STEM CELLS, V24, P889, DOI 10.1634/stemcells.2005-0332; AMIRTHALINGAM K, 1995, BIOCHEM BIOPH RES CO, V215, P122, DOI 10.1006/bbrc.1995.2441; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Bondarenko GI, 2007, J IMMUNOL, V179, P8042, DOI 10.4049/jimmunol.179.12.8042; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Chi N, 2002, TRENDS GENET, V18, P41, DOI 10.1016/S0168-9525(01)02594-X; Dorus S, 2004, CELL, V119, P1027, DOI 10.1016/j.cell.2004.11.040; EPSTEIN JA, 1994, GENE DEV, V8, P2022, DOI 10.1101/gad.8.17.2022; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gerrard L, 2005, STEM CELLS, V23, P1234, DOI 10.1634/stemcells.2005-0110; GOULDING MD, 1993, DEVELOPMENT, V117, P1001; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; Jedrusik A, 2008, GENE DEV, V22, P2692, DOI 10.1101/gad.486108; Kaas JH, 2006, CURR BIOL, V16, pR910, DOI 10.1016/j.cub.2006.09.057; Kim J, 2006, DEV BIOL, V292, P486, DOI 10.1016/j.ydbio.2005.12.041; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kozmik Z, 1997, EMBO J, V16, P6793, DOI 10.1093/emboj/16.22.6793; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Levine AJ, 2007, DEV BIOL, V308, P247, DOI 10.1016/j.ydbio.2007.05.036; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Li XJ, 2009, DEVELOPMENT, V136, P4055, DOI 10.1242/dev.036624; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Meyer JS, 2009, P NATL ACAD SCI USA, V106, P16698, DOI 10.1073/pnas.0905245106; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mizuseki K, 1998, DEVELOPMENT, V125, P579; Munoz-Sanjuan I, 2002, NAT REV NEUROSCI, V3, P271, DOI 10.1038/nrn786; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakata K, 1997, P NATL ACAD SCI USA, V94, P11980, DOI 10.1073/pnas.94.22.11980; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nishiguchi S, 1998, GENE DEV, V12, P776, DOI 10.1101/gad.12.6.776; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Pevny LH, 1998, DEVELOPMENT, V125, P1967; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Rex M, 1997, DEV DYNAM, V209, P323, DOI 10.1002/(SICI)1097-0177(199707)209:3<323::AID-AJA7>3.3.CO;2-B; Schlosser G, 2004, DEV BIOL, V271, P439, DOI 10.1016/j.ydbio.2004.04.013; SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; SIMEONE A, 1993, EMBO J, V12, P2735, DOI 10.1002/j.1460-2075.1993.tb05935.x; Stern CD, 2005, DEVELOPMENT, V132, P2007, DOI 10.1242/dev.01794; Stern CD, 2006, CURR OPIN CELL BIOL, V18, P692, DOI 10.1016/j.ceb.2006.09.002; Suter DM, 2009, STEM CELLS, V27, P49, DOI 10.1634/stemcells.2008-0319; WALTHER C, 1991, DEVELOPMENT, V113, P1435; Wu JQ, 2010, P NATL ACAD SCI USA, V107, P5254, DOI 10.1073/pnas.0914114107; Xia X, 2008, STEM CELLS, V26, P525, DOI 10.1634/stemcells.2007-0710; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yan YP, 2005, STEM CELLS, V23, P781, DOI 10.1634/stemcells.2004-0365; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang SC, 2006, BRAIN PATHOL, V16, P132, DOI 10.1111/j.1750-3639.2006.00008.x; Zhang XQ, 2010, METHODS MOL BIOL, V584, P355, DOI 10.1007/978-1-60761-369-5_19	60	299	310	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					90	100		10.1016/j.stem.2010.04.017	http://dx.doi.org/10.1016/j.stem.2010.04.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621053	Green Accepted, Bronze			2022-12-28	WOS:000280222300016
J	Trounson, A; Baum, E; Gibbons, D; Tekamp-Olson, P				Trounson, Alan; Baum, Elona; Gibbons, Don; Tekamp-Olson, Patricia			Developing a Case Study Model for Successful Translation of Stem Cell Therapies	CELL STEM CELL			English	Editorial Material								Cell therapies derived from pluripotent stem cells are entering the preclinical and early clinical development phase, but eventual translation faces many challenges. We describe a new approach by California to form global public-private "disease team" partnerships to enable new clinical opportunities to be evaluated in the complex regulatory environment.	[Trounson, Alan; Baum, Elona; Gibbons, Don; Tekamp-Olson, Patricia] Calif Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), Calif Inst Regenerat Med, 210 King St, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				*BRAINL INC, 2010, WHIT PAP SEAML LIF S; *CAMBR HLTH I, 2010, C 2 ANN COLL INN BIO; Cuende N, 2010, CELL STEM CELL, V6, P508, DOI 10.1016/j.stem.2010.05.005; Health Economics Research Group Office of Health Economics RAND Europe, 2008, MED RES WHATS IT WOR; KLEIN RN, 2010, DELIVERY RE IN PRESS; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Munos B, 2009, NAT REV DRUG DISCOV, V8, P959, DOI 10.1038/nrd2961; Murphy KM, 2003, MEASURING THE GAINS FROM MEDICAL RESEARCH, P41; Plagnol AC, 2009, REGEN MED, V4, P549, DOI 10.2217/RME.09.21	9	20	20	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					513	516		10.1016/j.stem.2010.05.008	http://dx.doi.org/10.1016/j.stem.2010.05.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569687	Bronze			2022-12-28	WOS:000278840700010
J	Lim, CY; Tam, WL; Zhang, J; Ang, HS; Jia, H; Lipovich, L; Ng, HH; Wei, CL; Sung, WK; Robson, P; Yang, H; Lim, B				Lim, Chin Yan; Tam, Wai-Leong; Zhang, Jinqiu; Ang, Haw Siang; Jia, Hui; Lipovich, Leonard; Ng, Huck-Hui; Wei, Chia-Lin; Sung, Wing Kin; Robson, Paul; Yang, Henry; Lim, Bing			Sall4 Regulates Distinct Transcription Circuitries in Different Blastocyst-Derived Stem Cell Lineages	CELL STEM CELL			English	Article							SELF-RENEWAL; VISCERAL ENDODERM; MOUSE; PLURIPOTENCY; GENE; NANOG; NETWORK; PROLIFERATION; MAINTENANCE; EPIBLAST	Stem cells self-renew or differentiate under the governance of a stem-cell-specific transcriptional program, with each transcription factor orchestrating the activities of a particular set of genes. Here we demonstrate that a single transcription factor is able to regulate distinct core circuitries in two different blastocyst-derived stem cell lines, embryonic stem cells (ESCs) and extraembryonic endoderm (XEN) cells. The transcription factor Sall4 is required for early embryonic development and for ESC pluripotency. Sall4 is also expressed in XEN cells, and depletion of Sall4 disrupts self-renewal and induces differentiation. Genome-wide analysis reveals that Sall4 is regulating different gene sets in ESCs and XEN cells, and depletion of Sall4 targets in the respective cell types induces differentiation. With Oct4, Sox2, and Nanog, Sall4 forms a crucial interconnected autoregulatory network in ESCs. In XEN cells, Sall4 regulates the key XEN lineage-associated genes Gata4, Gata6, Sox7, and Sox17. Our findings demonstrate how Sall4 functions as an essential sternness factor for two different stem cell lines.	[Tam, Wai-Leong; Jia, Hui; Lipovich, Leonard; Sung, Wing Kin] Genome Inst Singapore, Informat & Math Sci Grp, Singapore 138672, Singapore; [Wei, Chia-Lin] Genome Inst Singapore, Genome Technol & Biol Grp, Singapore 138672, Singapore; [Ang, Haw Siang; Yang, Henry] Bioinformat Inst, Singapore 138671, Singapore; [Ng, Huck-Hui; Robson, Paul] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lim, Bing] Harvard Univ, Sch Med, Harvard Inst Med, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); National University of Singapore; Harvard University; Harvard Medical School	Tam, WL (corresponding author), Genome Inst Singapore, Informat & Math Sci Grp, Singapore 138672, Singapore.	tamwl@gis.a-star.edu.sg; limb1@gis.a-star.edu.sg	Lipovich, Leonard/B-2355-2019; Ng, Huck Hui/A-1135-2009; Robson, Paul/A-3464-2009; Tam, Wai Leong/P-1497-2019	Lipovich, Leonard/0000-0002-0531-3570; Robson, Paul/0000-0002-0191-3958; Tam, Wai Leong/0000-0003-2365-5264; NG, HUCK HUI/0000-0001-6352-8417; Lim, Chin Yan/0000-0002-1585-002X; Sung, Wing-Kin/0000-0001-7806-7086	Agency for Science, Technology and Research (Singapore); Singapore Stem Cell Consortium [SSCC-06-003, SSCC-06-007]; National Institutes of Health (NIH) [DK47636, A154973]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Leah Vardy for critical reading of the manuscript. We are grateful to colleagues in the Genome Institute of Singapore for helpful discussions and technical assistance. This work is supported by the Agency for Science, Technology and Research (Singapore) and Singapore Stem Cell Consortium grants (SSCC-06-003 and SSCC-06-007). The work is also partially supported by National Institutes of Health (NIH) grants to B.L. (DK47636 and A154973).	BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fortunel NO, 2003, SCIENCE, V302, P393; FREI E, 1988, EMBO J, V7, P197, DOI 10.1002/j.1460-2075.1988.tb02800.x; Guccione E, 2006, NAT CELL BIOL, V8, P764, DOI 10.1038/ncb1434; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hirst CE, 2006, DEV BIOL, V293, P90, DOI 10.1016/j.ydbio.2006.01.023; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ji XW, 2006, NUCLEIC ACIDS RES, V34, pW551, DOI 10.1093/nar/gkl322; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x; Kunath T, 2005, DEVELOPMENT, V132, P1649, DOI 10.1242/dev.01715; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lupien M, 2008, CELL, V132, P958, DOI 10.1016/j.cell.2008.01.018; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Palmqvist L, 2005, STEM CELLS, V23, P663, DOI 10.1634/stemcells.2004-0157; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Ralston A, 2005, CLIN GENET, V68, P106, DOI 10.1111/j.1399-0004.2005.00478.x; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Sakaki-Yumoto M, 2006, DEVELOPMENT, V133, P3005, DOI 10.1242/dev.02457; Shimosato D, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-80; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	42	168	174	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					543	554		10.1016/j.stem.2008.08.004	http://dx.doi.org/10.1016/j.stem.2008.08.004			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18804426	Bronze			2022-12-28	WOS:000260895100013
J	Tzatsos, A; Bardeesy, N				Tzatsos, Alexandros; Bardeesy, Nabeel			Ink4a/Arf Regulation by let-7b and Hmga2: A Genetic Pathway Governing Stem Cell Aging	CELL STEM CELL			English	Editorial Material							EPITHELIAL-MESENCHYMAL TRANSITION; CANCER; P16(INK4A); OLD	Stem cell self-renewal capacity declines with age. In a recent issue of Cell, Nishino and colleagues (2008) show that Hmga2 maintains neural stem cell (NSC) function in young mice through repression of the Ink4a/Arf locus; in contrast, during aging, elevated let-7b blocks Hmga2 and contributes to declining NSC function.	[Tzatsos, Alexandros; Bardeesy, Nabeel] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Bardeesy, N (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	bardeesy.nabeel@mgh.harvard.edu						Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110	10	30	30	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					469	470		10.1016/j.stem.2008.10.008	http://dx.doi.org/10.1016/j.stem.2008.10.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983959	Bronze			2022-12-28	WOS:000260895100003
J	Levine, AD				Levine, Aaron D.			Policy Uncertainty and the Conduct of Stem Cell Research	CELL STEM CELL			English	Editorial Material								A survey of U.S. stem cell scientists shows that uncertainty following the legal challenge to the Obama Administration's hESC research policy has negative scientific and economic impacts and affects a range of stem cell scientists, not just those working with hESCs. The international implications of these results are also discussed.	[Levine, Aaron D.] Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA; [Levine, Aaron D.] Georgia Inst Technol, Inst Bioengn & Biosci, Atlanta, GA 30332 USA	University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology	Levine, AD (corresponding author), Georgia Inst Technol, Sch Publ Policy, Atlanta, GA 30332 USA.	aaron.levine@pubpolicy.gatech.edu						Caulfield T, 2009, STEM CELL REV REP, V5, P82, DOI 10.1007/s12015-009-9071-3; Gottweis H, 2009, HEALTH TECHNOL SOC, P1, DOI 10.1057/9780230594364; Gottweis H, 2010, CELL STEM CELL, V7, P555, DOI 10.1016/j.stem.2010.10.008; HARMON A, 2010, NY TIMES, pA14; Harvey O, 2009, POLITICS POLICY, V37, P51, DOI 10.1111/j.1747-1346.2008.00161.x; Karmali RN, 2010, NAT BIOTECHNOL, V28, P1246, DOI 10.1038/nbt1210-1246; Mathews DJH, 2006, SCIENCE, V313, P921, DOI 10.1126/science.1127990; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	8	23	23	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					132	135		10.1016/j.stem.2011.01.002	http://dx.doi.org/10.1016/j.stem.2011.01.002			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295270	Bronze			2022-12-28	WOS:000287633400007
J	Laffin, B; Tang, DG				Laffin, Brian; Tang, Dean G.			An Old Player on a New Playground: Bmi-1 as a Regulator of Prostate Stem Cells	CELL STEM CELL			English	Editorial Material							SUBPOPULATION; P63	The polycomb group transcriptional repressor Bmi-1 regulates both normal and cancer stem cells in multiple tissues. In this issue of Cell Stem Cell, Lukacs et al. (2010) report that Bmi-1 also regulates the self-renewal of at least one prostate stem cell population and is involved in prostate cancer initiation and progression.	[Laffin, Brian; Tang, Dean G.] Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Smithville, TX 78957 USA; [Tang, Dean G.] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Program Mol Carcinogenesis, Houston, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston	Tang, DG (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol Carcinogenesis, Sci Pk, Smithville, TX 78957 USA.	dtang@mdanderson.org	Tang, Dean/AAI-3457-2020	Tang, Dean/0000-0001-5029-1174				Burger PE, 2005, P NATL ACAD SCI USA, V102, P7180, DOI 10.1073/pnas.0502761102; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Lukacs RU, 2010, CELL STEM CELL, V7, P682, DOI 10.1016/j.stem.2010.11.013; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Xin L, 2005, P NATL ACAD SCI USA, V102, P6942, DOI 10.1073/pnas.0502320102	10	8	8	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					639	640		10.1016/j.stem.2010.11.019	http://dx.doi.org/10.1016/j.stem.2010.11.019			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112554	Bronze			2022-12-28	WOS:000285537700001
J	Mirkin, SM				Mirkin, Sergei M.			Getting to the Core of Repeat Expansions by Cell Reprogramming	CELL STEM CELL			English	Editorial Material							FRIEDREICHS-ATAXIA; DISEASE	In this issue of Cell Stem Cell, Ku et al. (2010) demonstrate that iPSCS derived from Friedreich's ataxia patients exhibit expansion of the causative (GAA)(n) repeat, consistent with the repeat instability observed during intergenerational transmissions in humans. Furthermore, the epigenetic signature of the disease remains intact in Friedreich's ataxia iPSCs.	Tufts Univ, Dept Biol, Medford, MA 02155 USA	Tufts University	Mirkin, SM (corresponding author), Tufts Univ, Dept Biol, Medford, MA 02155 USA.	sergei.mirkin@tufts.edu	Mirkin, Sergei/AAR-7226-2020; Mirkin, Sergei/A-7310-2010	Mirkin, Sergei/0000-0003-4576-7582; 	NIGMS NIH HHS [R01 GM060987] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060987] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; CHANDOK GS, 2010, NUCL ACIDS IN PRESS; De Michele G, 1998, HUM MOL GENET, V7, P1901, DOI 10.1093/hmg/7.12.1901; Ditch S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000704; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Ku S, 2010, CELL STEM CELL, V7, P631, DOI 10.1016/j.stem.2010.09.014; Kumari D, 2009, J BIOL CHEM, V284, P7413, DOI 10.1074/jbc.R800026200; McMurray CT, 2008, DNA REPAIR, V7, P1121, DOI 10.1016/j.dnarep.2008.03.013; SERIOLA A, 2010, HUM MOL GEN IN PRESS; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005	10	3	3	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					545	546		10.1016/j.stem.2010.10.005	http://dx.doi.org/10.1016/j.stem.2010.10.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040891	Bronze, Green Accepted			2022-12-28	WOS:000284390500001
J	Ferron, SR; Pozo, N; Laguna, A; Aranda, S; Porlan, E; Moreno, M; Fillat, C; de la Luna, S; Sanchez, P; Arbones, ML; Farinas, I				Ferron, Sacri R.; Pozo, Natividad; Laguna, Ariadna; Aranda, Sergi; Porlan, Eva; Moreno, Mireia; Fillat, Cristina; de la Luna, Susana; Sanchez, Pilar; Arbones, Maria L.; Farinas, Isabel			Regulated Segregation of Kinase Dyrk1A during Asymmetric Neural Stem Cell Division Is Critical for EGFR-Mediated Biased Signaling	CELL STEM CELL			English	Article							EPIDERMAL-GROWTH-FACTOR; PROTEIN-KINASE; PROGENITOR CELLS; DOWN-SYNDROME; NEURONAL DIFFERENTIATION; FACTOR RECEPTOR; ADULT BRAIN; MOUSE-BRAIN; NEUROGENESIS; MECHANISMS	Stem cell division can result in two sibling cells exhibiting differential mitogenic and self-renewing potential. Here, we present evidence that the dual-specificity kinase Dyrk1A is part of a molecular pathway involved in the regulation of biased epidermal growth factor receptor (EGFR) signaling in the progeny of dividing neural stem cells (NSC) of the adult subependymal zone (SEZ). We show that EGFR asymmetry requires regulated sorting and that a normal Dyrk1a dosage is required to sustain EGFR in the two daughters of a symmetrically dividing progenitor. Dyrk1A is symmetrically or asymmetrically distributed during mitosis, and biochemical analyses indicate that it prevents endocytosis-mediated degradation of EGFR by a mechanism that requires phosphorylation of the EGFR signaling modulator Sprouty2. Finally, Dyrk1a heterozygous NSCs exhibit defects in self-renewal, EGF-dependent cell-fate decisions, and long-term persistence in vivo, suggesting that symmetrical divisions play a role in the maintenance of the SEZ reservoir.	[Laguna, Ariadna; Aranda, Sergi; Fillat, Cristina; de la Luna, Susana; Arbones, Maria L.] UPF, CRG, Barcelona 08003, Spain; [Laguna, Ariadna; Aranda, Sergi; Fillat, Cristina; de la Luna, Susana; Arbones, Maria L.] CIBERER, Barcelona 08003, Spain; [Ferron, Sacri R.; Pozo, Natividad; Porlan, Eva; Moreno, Mireia; Sanchez, Pilar; Farinas, Isabel] Univ Valencia, Dept Biol Celular, E-46100 Burjassot, Spain; [Ferron, Sacri R.; Pozo, Natividad; Porlan, Eva; Moreno, Mireia; Sanchez, Pilar; Farinas, Isabel] Univ Valencia, Ctr Invest Biomed Red Enfermedades Neurodegenerat, E-46100 Burjassot, Spain; [de la Luna, Susana] ICREA, Barcelona 08003, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; University of Valencia; CIBERNED; University of Valencia; ICREA	Arbones, ML (corresponding author), UPF, CRG, Barcelona 08003, Spain.	mariona.arbones@crg.es; isabel.farinas@uv.es	Aranda, Sergi/X-9658-2019; porlan, Eva/AAE-6561-2022; de la Luna, Susana/E-9553-2015; Ferrón, Sacri R./I-2958-2015; Laguna, Ariadna/F-9561-2016; Arbones, Maria/D-4668-2016; Fillat, Cristina/ABH-1674-2020; Aranda, Sergi/K-1211-2015; Estelles, Mireia Moreno/H-2859-2017; Sánchez-Gómez, Pilar/K-8256-2014; Farinas, Isabel/L-7118-2014	Aranda, Sergi/0000-0003-3853-430X; porlan, Eva/0000-0003-0934-9711; de la Luna, Susana/0000-0001-7765-916X; Ferrón, Sacri R./0000-0003-0854-8575; Laguna, Ariadna/0000-0002-9732-6677; Arbones, Maria/0000-0002-6035-0235; Aranda, Sergi/0000-0003-3853-430X; Estelles, Mireia Moreno/0000-0001-8759-8794; Sánchez-Gómez, Pilar/0000-0002-0709-4973; Farinas, Isabel/0000-0003-2903-4960; Fillat, Cristina/0000-0002-0801-3338	Ministerio de Ciencia e Innovacion; Ministerio de Sanidad y Consumo [FIS04/1559]; Generalitat Valenciana; Fundacion "la Caixa"; Jerome Lejeune Foundation; EU; ICREA Funding Source: Custom	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Generalitat Valenciana(Center for Forestry Research & Experimentation (CIEF)European Commission); Fundacion "la Caixa"(La Caixa Foundation); Jerome Lejeune Foundation; EU(European Commission); ICREA(ICREA)	We thank M.P. Rubio, U. Brandt-Bohne, and S. Twit!) for help with constructs, viral production, and immunoblotting; M.J. Palop and E. Ramirez for help with the mouse colonies; and S. Bartlett for English editorial work. This work was supported by grants from Ministerio de Ciencia e Innovacion to IF., M.L.A., P.S., and S.L.; from Ministerio de Sanidad y Consumo (CIBERNED and Red Tercel to I.F. and CIBERER and FIS04/1559 to C.F.); Generalitat Valenciana (Programs Prometeo) and Fundacion "la Caixa" to IF.; and the Jerome Lejeune Foundation and the EU grant AnEUploidy to M.L.A. A.L. and S.A. were Fl predoctoral fellows (DuRsl, Generalitat de Catalunya).	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Alvarez M, 2003, J CELL SCI, V116, P3099, DOI 10.1242/jcs.00618; Andreu-Agullo C, 2009, NAT NEUROSCI, V12, P1514, DOI 10.1038/nn.2437; Aranda S, 2008, MOL CELL BIOL, V28, P5899, DOI 10.1128/MCB.00394-08; Bahler J, 2001, EMBO J, V20, P1064, DOI 10.1093/emboj/20.5.1064; Bettencourt-Dias M, 2004, NATURE, V432, P980, DOI 10.1038/nature03160; Ciccolini F, 2005, DEV BIOL, V284, P112, DOI 10.1016/j.ydbio.2005.05.007; Cournailleau F, 2008, CURR OPIN CELL BIOL, V20, P462, DOI 10.1016/j.ceb.2008.03.007; Craig CG, 1996, J NEUROSCI, V16, P2649; Di Marcotullio L, 2006, NAT CELL BIOL, V8, P1415, DOI 10.1038/ncb1510; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Enwere E, 2004, J NEUROSCI, V24, P8354, DOI 10.1523/JNEUROSCI.2751-04.2004; Fernandez-Martinez J, 2009, J CELL SCI, V122, P1574, DOI 10.1242/jcs.044354; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Fotaki V, 2002, MOL CELL BIOL, V22, P6636, DOI 10.1128/MCB.22.18.6636-6647.2002; Galceran J, 2003, J NEURAL TRANSM-SUPP, P139; Hammerle B, 2002, DEV BIOL, V246, P259, DOI 10.1006/dbio.2002.0675; Hammerle B, 2008, EUR J NEUROSCI, V27, P1061, DOI 10.1111/j.1460-9568.2008.06092.x; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kim HJ, 2007, CURR BIOL, V17, P455, DOI 10.1016/j.cub.2007.01.059; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Kuhn HG, 1997, J NEUROSCI, V17, P5820; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Levkowitz G, 1998, GENE DEV, V12, P3663, DOI 10.1101/gad.12.23.3663; Liu T, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r26; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marti E, 2003, BRAIN RES, V964, P250, DOI 10.1016/S0006-8993(02)04069-6; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Molofsky AV, 2004, CURR OPIN CELL BIOL, V16, P700, DOI 10.1016/j.ceb.2004.09.004; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Morshead CM, 2004, CURR OPIN NEUROBIOL, V14, P125, DOI 10.1016/j.conb.2004.01.008; Murakami Noriko, 2009, Biochemistry, V48, P9297, DOI 10.1021/bi9010557; Ortiz-Abalia J, 2008, AM J HUM GENET, V83, P479, DOI 10.1016/j.ajhg.2008.09.010; Pang KM, 2004, DEV BIOL, V265, P127, DOI 10.1016/j.ydbio.2003.09.024; Park J, 2009, CELL MOL LIFE SCI, V66, P3235, DOI 10.1007/s00018-009-0123-2; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Raponi E, 2007, GLIA, V55, P165, DOI 10.1002/glia.20445; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; SNYDER EY, 1992, CELL, V68, P33, DOI 10.1016/0092-8674(92)90204-P; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Stitzel ML, 2006, CURR BIOL, V16, P56, DOI 10.1016/j.cub.2005.11.063; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Zhang RL, 2004, J NEUROSCI, V24, P5810, DOI 10.1523/JNEUROSCI.1109-04.2004; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002	50	52	53	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					367	379		10.1016/j.stem.2010.06.021	http://dx.doi.org/10.1016/j.stem.2010.06.021			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804972	Bronze			2022-12-28	WOS:000282037800013
J	Diehn, M; Majeti, R				Diehn, Maximilian; Majeti, Ravindra			Metastatic Cancer Stem Cells: An Opportunity for Improving Cancer Treatment?	CELL STEM CELL			English	Editorial Material							POPULATIONS	Many human cancers are driven by cancer stem cells (CSCs) whose connection to metastatic spread remains incompletely understood. In this issue of Cell Stem Cell, Pang et al. (2010) isolate a subpopulation of human colorectal CSCs that uniquely possesses metastatic potential.	[Diehn, Maximilian; Majeti, Ravindra] Stanford Univ, Sch Med, Ctr Canc, Stanford, CA 94305 USA; [Diehn, Maximilian; Majeti, Ravindra] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Diehn, Maximilian] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Majeti, Ravindra] Stanford Univ, Sch Med, Dept Internal Med, Div Hematol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University	Majeti, R (corresponding author), Stanford Univ, Sch Med, Ctr Canc, Stanford, CA 94305 USA.	diehn@stanford.edu; rmajeti@stanford.edu		Diehn, Maximilian/0000-0003-2032-0581; Majeti, Ravindra/0000-0002-5814-0984				Brabletz T, 2005, NAT REV CANCER, V5, P744, DOI 10.1038/nrc1694; Cunningham D, 2010, LANCET, V375, P1030, DOI 10.1016/S0140-6736(10)60353-4; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Gill S, 2004, J CLIN ONCOL, V22, P1797, DOI 10.1200/JCO.2004.09.059; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Nagrath S, 2007, NATURE, V450, P1235, DOI 10.1038/nature06385; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Talasaz AH, 2009, P NATL ACAD SCI USA, V106, P3970, DOI 10.1073/pnas.0813188106	9	18	20	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					502	503		10.1016/j.stem.2010.05.001	http://dx.doi.org/10.1016/j.stem.2010.05.001			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569685	Bronze			2022-12-28	WOS:000278840700006
J	Nam, HS; Benezra, R				Nam, Hyung-song; Benezra, Robert			High Levels of Id1 Expression Define B1 Type Adult Neural Stem Cells	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE; PROGENITOR CELLS; MAMMALIAN FOREBRAIN; HEMATOPOIETIC STEM; GRANULE NEURONS; EPENDYMAL CELLS; VASCULAR NICHE; MIGRATION; DIFFERENTIATION; NEUROGENESIS	Defining the molecular identity of stem cells may be critical for formulating a rational strategy for the therapeutic intervention of stem cell dysfunction. We find that high expression of Id1, a dominant-negative helix-loop-helix transcriptional regulator, identifies a rare population of GFAP(+) astrocytes with stem cell attributes among the subventricular astrocytes in the adult brain. The rare, long-lived, and relatively quiescent Id1(high) astrocytes with morphology characteristic of B1 type astrocytes self-renew and generate migratory neuroblasts that differentiate into olfactory bulb interneurons. Cultured Id1(high) neural stem cells can self-renew asymmetrically and generate a stem and a differentiated cell expressing progressively lower levels of Id1, revealing an Id1 gradient in unperturbed cells of subventricular neurogenic lineages. Moreover, Id genes are necessary to confer self-renewal capacity, a characteristic of stem cell identity. We suggest that high expression of a single transcriptional regulator, Id1, molecularly defines the long-sought-after B1 type adult neural stem cells.	[Nam, Hyung-song; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Nam, HS (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, 1275 York Ave, New York, NY 10065 USA.	hyn2001@med.cornell.edu; r-benezra@ski.mskcc.org	Wilson, Matthew H/K-3193-2013	, namhyeongsong/0000-0002-0429-5446	NIGMS MSTP [T32GM07739]; NIDCD [F30DC008707]; MSKCC; NIH; Starr Foundation Tri-Institutional Stem Cell Initiative; NATIONAL CANCER INSTITUTE [R01CA107429] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [F30DC008707] Funding Source: NIH RePORTER	NIGMS MSTP(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); MSKCC; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Foundation Tri-Institutional Stem Cell Initiative; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank K. Anderson, F. Doetsch, P. Mombaerts, and L. Studer for helpful discussions; M. Khan for assistance with the generation of the Id1<SUP>IRES-creERT2</SUP> allele; S. Anderson for critical review of the manuscript; S. Arber, M. Barbacid, A. Chenn, N. Copeland, R. DePinho, K. Hadjantonakis, and A. Joyner for reagents; C. Yang at the RU Gene Targeting Core; W. Mark at the Mouse Genetics Core; J. Hendrikx at the Flow Cytometry Core; and A. Viale at the Genomics Core. H.-S.N. designed and characterized the mice and performed the experiments. H.-S.N. and R.B. designed the experiments, interpreted the results, and wrote the manuscript. H.-S.N. and R.B. are coinventors on a US patent application entitled "Identification and Isolation of Adult Stem Cells and Related Methods of Use." H.-S.N. is an NIGMS MSTP (T32GM07739), NIDCD Ruth L. Kirschstein (F30DC008707), and MSKCC Geoffrey Beene Fellow. Grants from the NIH (R.B.) and the Starr Foundation Tri-Institutional Stem Cell Initiative (H.-S.N. and R.B.) supported this work.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; ALTMAN J, 1969, J COMP NEUROL, V137, P433, DOI 10.1002/cne.901370404; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Carleton A, 2003, NAT NEUROSCI, V6, P507, DOI 10.1038/nn1048; Casper KB, 2006, MOL CELL NEUROSCI, V31, P676, DOI 10.1016/j.mcn.2005.12.006; Chiasson BJ, 1999, J NEUROSCI, V19, P4462; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; GOLDMAN SA, 1983, P NATL ACAD SCI-BIOL, V80, P2390, DOI 10.1073/pnas.80.8.2390; Golmohammadi MG, 2008, STEM CELLS, V26, P979, DOI 10.1634/stemcells.2007-0919; Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159; Ihrie RA, 2008, CELL TISSUE RES, V331, P179, DOI 10.1007/s00441-007-0461-z; Jeon HM, 2008, GENE DEV, V22, P2028, DOI 10.1101/gad.1668708; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; KAPLAN MS, 1985, J COMP NEUROL, V239, P117, DOI 10.1002/cne.902390110; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kornack DR, 2001, P NATL ACAD SCI USA, V98, P4752, DOI 10.1073/pnas.081074998; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Liu HK, 2008, GENE DEV, V22, P2473, DOI 10.1101/gad.479308; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Maslov AY, 2004, J NEUROSCI, V24, P1726, DOI 10.1523/JNEUROSCI.4608-03.2004; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Morshead CM, 1998, DEVELOPMENT, V125, P2251; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Nacher J, 2001, EUR J NEUROSCI, V14, P629, DOI 10.1046/j.0953-816x.2001.01683.x; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; PATON JA, 1984, SCIENCE, V225, P1046, DOI 10.1126/science.6474166; Perk J, 2005, NAT REV CANCER, V5, P603, DOI 10.1038/nrc1673; Perk J, 2006, CANCER RES, V66, P10870, DOI 10.1158/0008-5472.CAN-06-2643; Petreanu L, 2002, J NEUROSCI, V22, P6106; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Reumers V, 2008, STEM CELLS, V26, P2382, DOI 10.1634/stemcells.2007-1062; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	51	189	195	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					515	526		10.1016/j.stem.2009.08.017	http://dx.doi.org/10.1016/j.stem.2009.08.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896442	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000272019500013
J	Xie, T				Xie, Ting			Stem Cell in the Adult Drosophila Hindgut: Just a Sleeping Beauty	CELL STEM CELL			English	Editorial Material							BETA-CELLS; MIDGUT; WNT; DIFFERENTIATION; HOMEOSTASIS; EPITHELIUM		[Xie, Ting] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Xie, Ting] Univ Kansas, Sch Med, Dept Anat & Cell Biol, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center	Xie, T (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	tgx@stowers.org						Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fox DT, 2009, CELL STEM CELL, V5, P290, DOI 10.1016/j.stem.2009.06.003; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Pinto D, 2003, GENE DEV, V17, P1709, DOI 10.1101/gad.267103; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; van den Brink GR, 2004, NAT GENET, V36, P277, DOI 10.1038/ng1304; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015	10	8	9	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					227	228		10.1016/j.stem.2009.08.013	http://dx.doi.org/10.1016/j.stem.2009.08.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733527	Bronze			2022-12-28	WOS:000272545700001
J	Zou, JZ; Maeder, ML; Mali, P; Pruett-Miller, SM; Thibodeau-Beganny, S; Chou, BK; Chen, GB; Ye, ZH; Park, IH; Daley, GQ; Porteus, MH; Joung, JK; Cheng, L				Zou, Jizhong; Maeder, Morgan L.; Mali, Prashant; Pruett-Miller, Shondra M.; Thibodeau-Beganny, Stacey; Chou, Bin-Kuan; Chen, Guibin; Ye, Zhaohui; Park, In-Hyun; Daley, George Q.; Porteus, Matthew H.; Joung, J. Keith; Cheng, Linzhao			Gene Targeting of a Disease-Related Gene in Human Induced Pluripotent Stem and Embryonic Stem Cells	CELL STEM CELL			English	Article							ZINC-FINGER NUCLEASES; DIFFERENTIATION; EXPRESSION; LOCUS; LINES; GENERATION; DERIVATION; EFFICIENCY; SURVIVAL; RENEWAL	We report here homologous recombination (HR)-mediated gene targeting of two different genes in human PS cells (hiPSCs) and human ES cells (hESCs). HR-mediated correction of a chromosomally integrated mutant GFP reporter gene reaches efficiencies of 0.14%-0.24% in both cell types transfected by donor DNA with plasmids expressing zinc finger nucleases (ZFNs). Engineered ZFNs that induce a sequence-specific double-strand break in the GFP gene enhanced HR-mediated correction by > 1400-fold without detectable alterations in stem cell karyotypes or pluripotency. Efficient HR-mediated insertional mutagenesis was also achieved at the endogenous PIG-A locus, with a > 200-fold enhancement by ZFNs targeted to that gene. Clonal PIG-A null hESCs and iPSCs with normal karyotypes were readily obtained. The phenotypic and biological defects were rescued by PIG-A transgene expression. Our study provides the first demonstration of HR-mediated gene targeting in hiPSCs and shows the power of ZFNs for inducing specific genetic modifications in hiPSCs, as well as hESCs.	[Pruett-Miller, Shondra M.; Porteus, Matthew H.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [Pruett-Miller, Shondra M.; Porteus, Matthew H.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Zou, Jizhong; Mali, Prashant; Chou, Bin-Kuan; Chen, Guibin; Ye, Zhaohui; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Inst Cell Engn, Stem Cell Program, Baltimore, MD 21205 USA; [Mali, Prashant] Johns Hopkins Univ, Sch Med, Grad Program Biomed Engn, Baltimore, MD 21205 USA; [Chou, Bin-Kuan; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Grad Program Cellular & Mol Med, Baltimore, MD 21205 USA; [Ye, Zhaohui; Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Grad Program Immunol, Baltimore, MD 21205 USA; [Cheng, Linzhao] Johns Hopkins Univ, Sch Med, Dept Gynecol & Obstet, Baltimore, MD 21205 USA; [Maeder, Morgan L.; Thibodeau-Beganny, Stacey; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Mol Pathol Unit, Charlestown, MA 02129 USA; [Maeder, Morgan L.; Thibodeau-Beganny, Stacey; Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Charlestown, MA 02129 USA; [Park, In-Hyun; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Park, In-Hyun; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Park, In-Hyun; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Porteus, MH (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA.	matthew.porteus@utsouthwestern.edu; jjoung@partners.org; lcheng@welch.jhu.edu	Zou, Jizhong/B-4902-2011; Pruett-Miller, Shondra M./M-9414-2018	Pruett-Miller, Shondra M./0000-0002-3793-585X; Zou, Jizhong/0000-0003-1021-0549; Ye, Zhaohui/0000-0001-5272-9168	Stem Cell Research Foundation [S2005-026]; Johns Hopkins Institute for Cell Engineering; NIH [R01 HL073781, R01GM069906, R21RR024189, R21HL091808, R01 HL079295]; Maryland Stem Cell Research Postdoctoral Fellowship Grant; Cystic Fibrosis Foundation; Burroughs-Wellcome Fund; NATIONAL CENTER FOR RESEARCH RESOURCES [R21RR024189] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079295, R21HL091808, R01HL073781] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069906] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER	Stem Cell Research Foundation; Johns Hopkins Institute for Cell Engineering; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Maryland Stem Cell Research Postdoctoral Fellowship Grant; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Sarah Dowey and the Johns Hopkins Hospital Prenatal Cytogenetics Laboratory for professional karyotyping. We also thank three anonymous reviewers for suggestions that helped us in revision. This work is funded in part by the Stem Cell Research Foundation (S2005-026), Johns Hopkins Institute for Cell Engineering, and the NIH grant R01 HL073781 to L.C. J.Z. is supported by a Maryland Stem Cell Research Postdoctoral Fellowship Grant. J.K.J.'s group is supported by the NIH (R01GM069906, R21RR024189, and R21HL091808), the Cystic Fibrosis Foundation, and the MGH Pathology Service. M.H.P.'s lab is supported by the state of Texas, NIH R01 HL079295, and by a Career Development Award from the Burroughs-Wellcome Fund. G.Q.D. is an Investigator of Howard Hughes Medical Institute.	Cai LH, 2007, CELL RES, V17, P62, DOI 10.1038/sj.cr.7310138; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Chen GB, 2008, CELL STEM CELL, V2, P345, DOI 10.1016/j.stem.2008.02.004; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Di Domenico AI, 2008, CLONING STEM CELLS, V10, P217, DOI 10.1089/clo.2008.0016; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Durai S, 2005, NUCLEIC ACIDS RES, V33, P5978, DOI 10.1093/nar/gki912; Foley JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004348; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hohenstein KA, 2008, STEM CELLS, V26, P1436, DOI 10.1634/stemcells.2007-0857; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Lombardo A, 2007, NAT BIOTECHNOL, V25, P1298, DOI 10.1038/nbt1353; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maeder ML, 2008, MOL CELL, V31, P294, DOI 10.1016/j.molcel.2008.06.016; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Nightingale SJ, 2006, MOL THER, V13, P1121, DOI 10.1016/j.ymthe.2006.01.008; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Porteus MH, 2006, MOL THER, V13, P438, DOI 10.1016/j.ymthe.2005.08.003; Porteus MH, 2005, NAT BIOTECHNOL, V23, P967, DOI 10.1038/nbt1125; Porteus MH, 2003, SCIENCE, V300, P763, DOI 10.1126/science.1078395; Pruett-Miller SM, 2008, MOL THER, V16, P707, DOI 10.1038/mt.2008.20; Pruett-Miller SM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000376; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Suzuki K, 2008, P NATL ACAD SCI USA, V105, P13781, DOI 10.1073/pnas.0806976105; Szczepek M, 2007, NAT BIOTECHNOL, V25, P786, DOI 10.1038/nbt1317; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu XB, 2008, CELL STEM CELL, V2, P461, DOI 10.1016/j.stem.2008.03.001; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	41	389	443	1	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					97	110		10.1016/j.stem.2009.05.023	http://dx.doi.org/10.1016/j.stem.2009.05.023			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19540188	Bronze, Green Accepted			2022-12-28	WOS:000267879200014
J	Fine, A				Fine, Alan			Breathing Life into the Lung Stem Cell Field	CELL STEM CELL			English	Editorial Material								In this issue of Cell Stem Cell, Rawlins et al. (2009) use an elegant lineage-tracing system to circumvent technical obstacles that have long limited advances in lung stem cell research and, as a result, definitively clarify the role of Clara cells in lung growth, homeostasis, and repair.	Boston Univ, Ctr Pulm, Sch Med, Boston, MA 02118 USA	Boston University	Fine, A (corresponding author), Boston Univ, Ctr Pulm, Sch Med, Boston, MA 02118 USA.	afine@bu.edu		Fine, Alan/0000-0001-9351-3048				BOWDEN DH, 1983, AM REV RESPIR DIS, V128, pS46; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Dovey JS, 2008, P NATL ACAD SCI USA, V105, P11857, DOI 10.1073/pnas.0803574105; Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kotton DN, 2008, CELL TISSUE RES, V331, P145, DOI 10.1007/s00441-007-0479-2; Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; THURLBECK WM, 1983, AM REV RESPIR DIS, V128, P965	9	6	6	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					468	469		10.1016/j.stem.2009.05.012	http://dx.doi.org/10.1016/j.stem.2009.05.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497272	Bronze			2022-12-28	WOS:000266793600003
J	Tanaka, KK; Hall, JK; Troy, AA; Cornelison, DDW; Majka, SM; Olwin, BB				Tanaka, Kathleen Kelly; Hall, John K.; Troy, Andrew A.; Cornelison, D. D. W.; Majka, Susan M.; Olwin, Bradley B.			Syndecan-4-Expressing Muscle Progenitor Cells in the SP Engraft as Satellite Cells during Muscle Regeneration	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE; POPULATION CELLS; SELF-RENEWAL; BONE-MARROW; SIDE; EXPRESSION; TRANSPLANTATION; SPECIFICATION; PROGRESSION	Skeletal muscle satellite cells, located between the basal lamina and plasma membrane of myofibers, are required for skeletal muscle regeneration. The capacity of satellite cells as well as other cell lineages including mesoangioblasts, mesenchymal stem cells, and side population (SP) cells to contribute to muscle regeneration has complicated the identification of a satellite stem cell. We have characterized a rare subset of the muscle SP that efficiently engrafts into the host satellite cell niche when transplanted into regenerating muscle, providing 75% of the satellite cell population and 30% of the myonuclear population, respectively. These cells are found in the satellite cell position, adhere to isolated myofibers, and spontaneously undergo myogenesis in culture. We propose that this subset of SP cells (satellite-SP cells), characterized by ABCG2, Syndecan-4, and Pax7 expression, constitutes a self-renewing muscle stem cell capable of generating both satellite cells and their myonuclear progeny in vivo.	[Tanaka, Kathleen Kelly; Hall, John K.; Troy, Andrew A.; Olwin, Bradley B.] Univ Colorado, MCD Biol, Boulder, CO 80309 USA; [Cornelison, D. D. W.] Univ Missouri, Biol Sci & Bond Life Sci Ctr, Columbia, MO 65211 USA; [Majka, Susan M.] Univ Colorado, Hlth Sci Ctr, Dept Med Cardiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Boulder; University of Missouri System; University of Missouri Columbia; University of Colorado System; University of Colorado Anschutz Medical Campus	Olwin, BB (corresponding author), Univ Colorado, MCD Biol, Boulder, CO 80309 USA.	bradley.olwin@colorado.edu	Olwin, Bradley B/A-1333-2014	Cornelison, DDW/0000-0003-4287-7524; Kelly, Kathleen/0000-0002-1102-6279	NIH [P30CA046934, AR39467, AR49446, AG28907, 5T32HLOO7851, GM066728, SDG0335032N]; NATIONAL CANCER INSTITUTE [P30CA046934] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR039467, R29AR039467, R01AR049446] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM066728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028907] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors would like to acknowledge Karen Helm at The University of Colorado Cancer Center Flow Cytometry Core (supported by NIH P30CA046934) for assistance with cell isolation and Helen Marshall at the University of Colorado, MCD-Biology Department DNA Array Analysis Facility for Affymetrix hybridization and scanning. This work was supported by NIH AR39467, AR49446, AG28907, and a grant from the Muscular Dystrophy Association to B.B.O.; NIH 5T32HLOO7851 to K.K.T.; Muscular Dystrophy Association Development Grant to D.D.W.C.; NIH GM066728-01 to J.K.H.; and APS Giles Filley Award and AHA-SDG0335032N to S.M.M.	Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Beauchamp JR, 1999, J CELL BIOL, V144, P1113, DOI 10.1083/jcb.144.6.1113; Bosnakovski D, 2008, STEM CELLS, V26, P3194, DOI 10.1634/stemcells.2007-1017; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; CALDWELL CJ, 1990, NEUROPATH APPL NEURO, V16, P225, DOI 10.1111/j.1365-2990.1990.tb01159.x; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; LaBarge MA, 2002, CELL, V111, P589, DOI 10.1016/S0092-8674(02)01078-4; Majka SM, 2005, STEM CELLS, V23, P1073, DOI 10.1634/stemcells.2005-0039; Majka SM, 2003, J CLIN INVEST, V111, P71, DOI 10.1172/JCI200316157; Meeson AP, 2004, STEM CELLS, V22, P1305, DOI 10.1634/stemcells.2004-0077; Mitchell PO, 2005, DEV BIOL, V283, P240, DOI 10.1016/j.ydbio.2005.04.016; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Muskiewicz KR, 2005, J HISTOCHEM CYTOCHEM, V53, P861, DOI 10.1369/jhc.4A6573.2005; Olguin HC, 2004, DEV BIOL, V275, P375, DOI 10.1016/j.ydbio.2004.08.015; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sampaolesi M, 2006, NATURE, V444, P574, DOI 10.1038/nature05282; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Schultz E, 1996, DEV BIOL, V175, P84, DOI 10.1006/dbio.1996.0097; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Shinin V, 2006, NAT CELL BIOL, V8, P677, DOI 10.1038/ncb1425; Tadjali M, 2006, STEM CELLS, V24, P1556, DOI 10.1634/stemcells.2005-0562; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	37	171	175	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					217	225		10.1016/j.stem.2009.01.016	http://dx.doi.org/10.1016/j.stem.2009.01.016			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265661	Bronze, Green Accepted			2022-12-28	WOS:000264369300012
J	Dalton, S				Dalton, Stephen			Exposing Hidden Dimensions of Embryonic Stem Cell Cycle Control	Cell Stem Cell			English	Editorial Material									Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Dalton, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, 500 DW Brooks Dr, Athens, GA 30602 USA.	sdalton@uga.edu		Dalton, Stephen/0000-0002-3450-1263	NICHD NIH HHS [R01 HD049647, R01 HD049647-02, R01 HD049647-03, R01 HD049647-01A1, R01 HD049647-04] Funding Source: Medline; NIGMS NIH HHS [P01 GM085354-01, P01 GM085354, P01 GM085354-010001] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Ohtsuka S, 2008, GENE THER, V15, P74, DOI 10.1038/sj.gt.3303065; SNOW MHL, 1977, J EMBRYOL EXP MORPH, V42, P293; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056	7	15	15	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					9	10		10.1016/j.stem.2008.12.003	http://dx.doi.org/10.1016/j.stem.2008.12.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128789	Bronze, Green Accepted			2022-12-28	WOS:000262559500005
J	Blanpain, C; Mohrin, M; Sotiropoulou, PA; Passegue, E				Blanpain, Cedric; Mohrin, Mary; Sotiropoulou, Panagiota A.; Passegue, Emmanuelle			DNA-Damage Response in Tissue-Specific and Cancer Stem Cells	CELL STEM CELL			English	Review							TUMOR-INITIATING CELLS; MEDIATES RADIATION-RESISTANCE; INDUCED APOPTOSIS; PROGENITOR CELLS; SMALL-INTESTINE; BREAST-CANCER; SELF-RENEWAL; MAMMARY-GLAND; GERM-LINE; IONIZING-RADIATION	Recent studies have shown that tissue-specific stem cells (SCs) found throughout the body respond differentially to DNA damage. In this review, we will discuss how different SC populations sense and functionally respond to DNA damage, identify various common and distinct mechanisms utilized by tissue-specific SCs to address DNA damage, and describe how these mechanisms can impact SC genomic integrity by potentially promoting aging, tissue atrophy, and/or cancer development. Finally, we will discuss how similar mechanisms operate in cancer stem cells (CSCs) and can mediate resistance to chemo- and radiotherapy.	[Blanpain, Cedric; Sotiropoulou, Panagiota A.] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium; [Mohrin, Mary; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA	Universite Libre de Bruxelles; University of California System; University of California San Francisco	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be; passeguee@stemcell.ucsf.edu	Blanpain, Cedric/ABD-8392-2021	Passegue, Emmanuelle/0000-0002-3516-297X	CIRM; CIBLES of the Wallonia Region; Fondation Contre le Cancer; fond Gaston Ithier; European Research Council (ERC); EMBO; Rita Allen Scholar Award	CIRM(California Institute for Regenerative Medicine); CIBLES of the Wallonia Region; Fondation Contre le Cancer; fond Gaston Ithier; European Research Council (ERC)(European Research Council (ERC)); EMBO(European Molecular Biology Organization (EMBO)); Rita Allen Scholar Award	We thank Drs. E. Pietras and M. Warr for their insightful comments. C.B. and P.A.S are chercheur qualifie of the Fonds de la Recherche Scientifique (F.R.S.)/Fonds National de la Recherche Scientifique (FNRS). M.M. is supported by a CIRM predoctoral training grant. This work was supported by the program CIBLES of the Wallonia Region, a research grant from the Fondation Contre le Cancer and the fond Gaston Ithier, a starting grant of the European Research Council (ERC) and the EMBO Young Investigator Program to CS., and a CIRM New Faculty Award and Rita Allen Scholar Award to E.P.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; ASAI T, 2010, J CELL PHYSL, DOI DOI 10.1002/JCP.22561; BAKER TG, 1971, MUTAT RES, V11, P9, DOI 10.1016/0027-5107(71)90028-5; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V7, P656, DOI 10.1016/j.stem.2010.11.016; Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Bender CF, 2002, GENE DEV, V16, P2237, DOI 10.1101/gad.1007902; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Botchkarev VA, 2000, CANCER RES, V60, P5002; Bradley A, 1998, J MAMMARY GLAND BIOL, V3, P363, DOI 10.1023/A:1018727813904; Brown EJ, 2000, GENE DEV, V14, P397; Burke BA, 2010, LEUKEMIA, V24, P1105, DOI 10.1038/leu.2010.67; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Chang TC, 2007, MOL CELL, V26, P745, DOI 10.1016/j.molcel.2007.05.010; Chen MS, 2007, J CELL SCI, V120, P468, DOI 10.1242/jcs.03348; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Deutsch E, 2001, BLOOD, V97, P2084, DOI 10.1182/blood.V97.7.2084; di Fagagna FD, 2008, NAT REV CANCER, V8, P512, DOI 10.1038/nrc2440; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Elrick LJ, 2005, BLOOD, V105, P1862, DOI 10.1182/blood-2004-08-3373; Finlan LE, 2006, CELL CYCLE, V5, P2489, DOI 10.4161/cc.5.21.3393; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Forand A, 2009, BIOL REPROD, V80, P860, DOI 10.1095/biolreprod.108.072884; Galetzka D, 2007, J CELL BIOCHEM, V100, P1232, DOI 10.1002/jcb.21113; Georges SA, 2008, CANCER RES, V68, P10105, DOI 10.1158/0008-5472.CAN-08-1846; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; GOLDSCHMIDT H, 1980, J AM ACAD DERMATOL, V3, P551, DOI 10.1016/S0190-9622(80)80067-3; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Guzman ML, 2009, CANCER CELL, V15, P252, DOI 10.1016/j.ccr.2009.03.008; Hajkova P, 2010, SCIENCE, V329, P78, DOI 10.1126/science.1187945; Hakem R, 2008, EMBO J, V27, P589, DOI 10.1038/emboj.2008.15; Harfouche G, 2010, STEM CELLS, V28, P1639, DOI 10.1002/stem.485; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P611, DOI 10.1080/09553008214551591; Hendry JH, 1997, RADIAT RES, V148, P254, DOI 10.2307/3579610; Hoeijmakers JHJ, 2009, NEW ENGL J MED, V361, P1475, DOI 10.1056/NEJMra0804615; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kemp CJ, 1999, CARCINOGENESIS, V20, P2051, DOI 10.1093/carcin/20.11.2051; Kenyon J, 2007, NUCLEIC ACIDS RES, V35, P7557, DOI 10.1093/nar/gkm1064; Kim DJ, 2009, MOL CARCINOGEN, V48, P873, DOI 10.1002/mc.20527; Koptyra M, 2006, BLOOD, V108, P319, DOI 10.1182/blood-2005-07-2815; Kujjo LL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009204; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Loft S, 2003, HUM REPROD, V18, P1265, DOI 10.1093/humrep/deg202; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; Lopes SMCD, 2010, DIFFERENTIATION, V79, P131, DOI 10.1016/j.diff.2009.11.003; Marshman E, 2002, BIOESSAYS, V24, P91, DOI 10.1002/bies.10028; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Menezo Y, 2007, J ASSIST REPROD GEN, V24, P513, DOI 10.1007/s10815-007-9167-0; MERRITT AJ, 1995, J CELL SCI, V108, P2261; MERRITT AJ, 1994, CANCER RES, V54, P614; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Moreno SG, 2001, BIOL REPROD, V64, P1422, DOI 10.1095/biolreprod64.5.1422; Nijhof JGW, 2007, CARCINOGENESIS, V28, P792, DOI 10.1093/carcin/bgl213; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Passegue E, 2005, CELL CYCLE, V4, P266; Perrotti D, 2010, J CLIN INVEST, V120, P2254, DOI 10.1172/JCI41246; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Potten CS, 2002, J CELL SCI, V115, P2381; Potten CS, 2004, RADIAT RES, V161, P123, DOI 10.1667/RR3104; Potten CS, 1998, BRIT J CANCER, V78, P993, DOI 10.1038/bjc.1998.618; Prados MD, 2000, SEMIN ONCOL, V27, pS1; Prasher JM, 2005, EMBO J, V24, P861, DOI 10.1038/sj.emboj.7600542; Pritchard DM, 2000, ONCOGENE, V19, P3955, DOI 10.1038/sj.onc.1203729; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Rachidi W, 2007, RADIOTHER ONCOL, V83, P267, DOI 10.1016/j.radonc.2007.05.007; Reese JS, 2003, BLOOD, V102, P1626, DOI 10.1182/blood-2002-10-3035; Rice KN, 2010, INT J HEMATOL, V91, P748, DOI 10.1007/s12185-010-0615-8; Richardson BE, 2010, NAT REV MOL CELL BIO, V11, P37, DOI 10.1038/nrm2815; Robinson KC, 2009, SEMIN CELL DEV BIOL, V20, P111, DOI 10.1016/j.semcdb.2008.11.016; Ropolo M, 2009, MOL CANCER RES, V7, P383, DOI 10.1158/1541-7786.MCR-08-0409; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Rottenberg S, 2008, P NATL ACAD SCI USA, V105, P17079, DOI 10.1073/pnas.0806092105; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sasaki M, 2010, NAT REV MOL CELL BIO, V11, P182, DOI 10.1038/nrm2849; Schafer M, 2010, GENE DEV, V24, P1045, DOI 10.1101/gad.568810; Seita J, 2010, CELL STEM CELL, V7, P145, DOI 10.1016/j.stem.2010.07.006; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shafee N, 2008, CANCER RES, V68, P3243, DOI 10.1158/0008-5472.CAN-07-5480; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slupianek A, 2006, DNA REPAIR, V5, P243, DOI 10.1016/j.dnarep.2005.10.005; Slupianek A, 2002, MOL CELL BIOL, V22, P4189, DOI 10.1128/MCB.22.12.4189-4201.2002; Song SY, 1999, AM J PATHOL, V155, P1121, DOI 10.1016/S0002-9440(10)65215-7; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; Squatrito M, 2010, CANCER CELL, V18, P619, DOI 10.1016/j.ccr.2010.10.034; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Tagscherer KE, 2008, ONCOGENE, V27, P6646, DOI 10.1038/onc.2008.259; Takubo K, 2008, CELL STEM CELL, V2, P170, DOI 10.1016/j.stem.2007.10.023; Tani H, 2000, P NATL ACAD SCI USA, V97, P10960, DOI 10.1073/pnas.97.20.10960; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Wilson JW, 1998, AM J PATHOL, V153, P899, DOI 10.1016/S0002-9440(10)65631-3; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Zhang M, 2008, CANCER RES, V68, P4674, DOI 10.1158/0008-5472.CAN-07-6353; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107	120	239	246	0	32	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					16	29		10.1016/j.stem.2010.12.012	http://dx.doi.org/10.1016/j.stem.2010.12.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211780	Bronze			2022-12-28	WOS:000286786200008
J	Teitelbaum, SL				Teitelbaum, Steven L.			Stem Cells and Osteoporosis Therapy	CELL STEM CELL			English	Editorial Material							PARATHYROID-HORMONE; ALENDRONATE	Skeletal remodeling requires recruitment of osteoblast precursors, in the form of MSCs, to the bone surface. In this issue of Cell Stem Cell, Wu et al. (2010) demonstrate that this event is mediated by osteoclastic mobilization of active transforming growth factor beta 1, which is inhibited by a common antiosteoporosis drug.	Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Teitelbaum, SL (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	teitelbs@wustl.edu		Teitelbaum, Steven/0000-0002-4054-6679				Allen MR, 2007, J BONE MINER RES, V22, P1759, DOI 10.1359/JBMR.070720; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Bone HG, 2004, NEW ENGL J MED, V350, P1189, DOI 10.1056/NEJMoa030897; Drake MT, 2008, MAYO CLIN PROC, V83, P1032, DOI 10.4065/83.9.1032; Eisman JA, 2011, J BONE MINER RES, V26, P242, DOI 10.1002/jbmr.212; McClung MR, 2006, NEW ENGL J MED, V354, P821, DOI 10.1056/NEJMoa044459; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Wu XW, 2010, CELL STEM CELL, V7, P571, DOI 10.1016/j.stem.2010.09.012	9	47	55	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					553	554		10.1016/j.stem.2010.10.004	http://dx.doi.org/10.1016/j.stem.2010.10.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040895	Bronze			2022-12-28	WOS:000284390500005
J	Chou, S; Chu, P; Hwang, W; Lodish, H				Chou, Song; Chu, Pat; Hwang, William; Lodish, Harvey			Expansion of Human Cord Blood Hematopoietic Stem Cells for Transplantation	CELL STEM CELL			English	Editorial Material									[Chou, Song; Lodish, Harvey] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Chu, Pat; Hwang, William] Singapore Gen Hosp, Dept Hematol, Singapore 168608, Singapore; [Chu, Pat; Hwang, William] Singapore Cord Blood Bank, Singapore 229899, Singapore; [Hwang, William] Duke NUS Grad Med Sch, Canc & Stem Cell Biol Program, Singapore 169857, Singapore; [Lodish, Harvey] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Singapore General Hospital; National University of Singapore; Massachusetts Institute of Technology (MIT)	Lodish, H (corresponding author), Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	lodish@wi.mit.edu	Hwang, William/AAT-3079-2021; Hwang, William/AAX-8452-2021	Hwang, William/0000-0003-0143-6263; 	NIDDK NIH HHS [R01 DK067356] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067356] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Delaney C, 2010, NAT MED, V16, P232, DOI 10.1038/nm.2080; Foeken LM, 2010, BONE MARROW TRANSPL, V45, P811, DOI 10.1038/bmt.2010.9; Himburg HA, 2010, NAT MED, V16, P475, DOI 10.1038/nm.2119; Hwang WYK, 2007, BIOL BLOOD MARROW TR, V13, P444, DOI 10.1016/j.bbmt.2006.11.005; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Robinson SN, 2006, BONE MARROW TRANSPL, V37, P359, DOI 10.1038/sj.bmt.1705258; Zhang CC, 2008, CURR OPIN HEMATOL, V15, P307, DOI 10.1097/MOH.0b013e3283007db5; Zhang CC, 2008, BLOOD, V111, P3415, DOI 10.1182/blood-2007-11-122119	10	40	41	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					427	428		10.1016/j.stem.2010.09.001	http://dx.doi.org/10.1016/j.stem.2010.09.001			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887947	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000283270600005
J	Mohrin, M; Bourke, E; Alexander, D; Warr, MR; Barry-Holson, K; Le Beau, MM; Morrison, CG; Passegue, E				Mohrin, Mary; Bourke, Emer; Alexander, David; Warr, Matthew R.; Barry-Holson, Keegan; Le Beau, Michelle M.; Morrison, Ciaran G.; Passegue, Emmanuelle			Hematopoietic Stem Cell Quiescence Promotes Error-Prone DNA Repair and Mutagenesis	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; SELF-RENEWAL; DAMAGE; MECHANISMS; PROGENITOR; PROLIFERATION; PATHWAYS	Most adult stem cells, including hematopoietic stem cells (HSCs), are maintained in a quiescent or resting state in vivo. Quiescence is widely considered to be an essential protective mechanism for stem cells that minimizes endogenous stress caused by cellular respiration and DNA replication. We demonstrate that HSC quiescence can also have detrimental effects. We found that HSCs have unique cell-intrinsic mechanisms ensuring their survival in response to ionizing irradiation (IR), which include enhanced prosurvival gene expression and strong activation of p53-mediated DNA damage response. We show that quiescent and proliferating HSCs are equally radioprotected but use different types of DNA repair mechanisms. We describe how nonhomologous end joining (NHEJ)-mediated DNA repair in quiescent HSCs is associated with acquisition of genomic rearrangements, which can persist in vivo and contribute to hematopoietic abnormalities. Our results demonstrate that quiescence is a double-edged sword that renders HSCs intrinsically vulnerable to mutagenesis following DNA damage.	[Mohrin, Mary; Warr, Matthew R.; Barry-Holson, Keegan; Passegue, Emmanuelle] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA; [Bourke, Emer; Morrison, Ciaran G.] Natl Univ Ireland Galway, Sch Nat Sci, Ctr Chromosome Biol, Galway, Ireland; [Alexander, David] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Le Beau, Michelle M.] Univ Chicago, Hematol Oncol Sect, Chicago, IL 60637 USA; [Le Beau, Michelle M.] Ctr Comprehens Canc, Chicago, IL 60637 USA	University of California System; University of California San Francisco; Ollscoil na Gaillimhe-University of Galway; University of California System; University of California Santa Cruz; University of Chicago; Robert H. Lurie Comprehensive Cancer Center	Passegue, E (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Dept Med, Div Hematol Oncol, San Francisco, CA 94143 USA.	passeguee@stemcell.ucsf.edu	Morrison, Ciaran/AAH-2034-2019; Morrison, Ciaran/B-6568-2008	Morrison, Ciaran/0000-0003-2401-7029; Morrison, Ciaran/0000-0003-2401-7029; Bourke, Emer/0000-0002-2218-3114; Passegue, Emmanuelle/0000-0002-3516-297X	CIRM; PHS [P01 CA40046]; Rita Allen Scholar Award; Science Foundation Ireland; NATIONAL CANCER INSTITUTE [P01CA040046] Funding Source: NIH RePORTER	CIRM(California Institute for Regenerative Medicine); PHS(United States Department of Health & Human ServicesUnited States Public Health Service); Rita Allen Scholar Award; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Drs. David Toczyski, Zhao-Qi Wang, and Martin Carroll for insights and suggestions, Elizabeth Davis for SKY analyses, Tara Rambaldo and Bill Hyun for management of the Flow Cytrometry core facility, Dr. Gordon Shore for anti-Bid antibody gift, Dr. William Weiss for Trp53<SUP>-/-</SUP> mice, Dr. Andrew Leavitt for mobilization reagents, and all members of the Passegue laboratory for comments and discussion. M.M. is supported by a CIRM pre-doctoral training grant. This work was supported by a PHS P01 CA40046 to M.M.L., a Science Foundation Ireland PI award to C.G.M. and a CIRM New Investigator Award and Rita Allen Scholar Award to E.P.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Allan JM, 2005, NAT REV CANCER, V5, P943, DOI 10.1038/nrc1749; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chambers SM, 2007, STEM CELL REV, V3, P201, DOI 10.1007/s12015-007-0027-1; Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393; Domen J, 2000, J EXP MED, V191, P253, DOI 10.1084/jem.191.2.253; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; Francis R, 2007, GENE DEV, V21, P1064, DOI 10.1101/gad.1522807; Geiger H, 2009, TRENDS IMMUNOL, V30, P360, DOI 10.1016/j.it.2009.03.010; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Holyoake T, 1999, BLOOD, V94, P2056, DOI 10.1182/blood.V94.6.2056; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Klaude M, 1996, MUTAT RES-DNA REPAIR, V363, P89, DOI 10.1016/0921-8777(95)00063-1; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Le Beau MM, 2002, BLOOD, V99, P2985, DOI 10.1182/blood.V99.8.2985; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Look AT, 1997, SCIENCE, V278, P1059, DOI 10.1126/science.278.5340.1059; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park Y, 2005, ANNU REV MED, V56, P495, DOI 10.1146/annurev.med.56.082103.104546; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Santaguida M, 2009, CANCER CELL, V15, P341, DOI 10.1016/j.ccr.2009.02.016; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang WD, 2007, NAT REV GENET, V8, P735, DOI 10.1038/nrg2159; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028	34	426	441	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					174	185		10.1016/j.stem.2010.06.014	http://dx.doi.org/10.1016/j.stem.2010.06.014			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20619762	Green Accepted, Bronze			2022-12-28	WOS:000281107400010
J	Melcer, S; Meshorer, E				Melcer, Shai; Meshorer, Eran			The Silence of the LADs: Dynamic Genome-Lamina Interactions during ESC Differentiation	CELL STEM CELL			English	Editorial Material							NUCLEAR LAMINA; ORGANIZATION; PLASTICITY; CELLS	In a recent issue of Molecular Cell, Peric-Hupkes et al. (2010) use DamID to map the interactions between chromatin and the nuclear lamina (NL) in differentiating embryonic stem cells. NL-mediated locking/unlocking of genomic regions during differentiation provides an additional facet of transcription regulation.	[Melcer, Shai; Meshorer, Eran] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Meshorer, E (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	meshorer@cc.huji.ac.il		Meshorer, Eran/0000-0003-4777-986X				Bhattacharya D, 2009, BIOPHYS J, V96, P3832, DOI 10.1016/j.bpj.2008.11.075; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; MATTOUT A, 2010, CURR OPIN CELL BIOL; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Peric-Hupkes D, 2010, MOL CELL, V38, P603, DOI 10.1016/j.molcel.2010.03.016; Prokocimer M, 2009, J CELL MOL MED, V13, P1059, DOI [10.1111/j.1582-4934.2009.00676.x, 10.1111/j.1582-4934.2008.00676.x]; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727	10	7	7	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					495	497		10.1016/j.stem.2010.05.006	http://dx.doi.org/10.1016/j.stem.2010.05.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569682	Bronze			2022-12-28	WOS:000278840700003
J	Cibelli, J				Cibelli, Jose			The Human Egg Is Back	CELL STEM CELL			English	Editorial Material								In a recent issue of Nature, Tachibana et al. (2009) conducted chromosomal transfer into recipient primate oocytes to yield live offspring or monkey ESCs with no contribution of donor mitochondria. The success of this technique may increase demand for human oocyte donation for research.	[Cibelli, Jose] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Cibelli, Jose] Michigan State Univ, Dept Physiol, E Lansing, MI 48824 USA; [Cibelli, Jose] Consejeria Salud, Programa Andaluz Terapia Celular & Med Regenerati, Seville 41092, Spain	Michigan State University; Michigan State University	Cibelli, J (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	cibelli@msu.edu		Cibelli, Jose/0000-0002-2176-3854				Cibelli J.B., 2001, J REGEN MED, V2, P25, DOI [10.1089/152489001753262168, DOI 10.1089/152489001753262168]; Rinaudo P, 2004, REPRODUCTION, V128, P301, DOI 10.1530/rep.1.00297; TACHIBANA M, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08368; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	6	3	3	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					345	346		10.1016/j.stem.2009.09.009	http://dx.doi.org/10.1016/j.stem.2009.09.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796610	Bronze			2022-12-28	WOS:000271401900002
J	Corneo, B; Temple, S				Corneo, Barbara; Temple, Sally			Sense and Serendipity Aid RPE Generation	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; TRANSPLANTATION; SPECIFICATION	Retinal pigment epithelium (RPE) is a valuable cell type for a number of blinding disorders. In this issue of Cell Stem Cell, Idelson et al. (2009) use Nicotinamide and Activin A to markedly improve RPE yield from human embryonic stem cells.	[Corneo, Barbara; Temple, Sally] New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA		Temple, S (corresponding author), New York Neural Stem Cell Inst, 1 Discovery Dr, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org		Corneo, Barbara/0000-0001-5189-6749				da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Del Priore LV, 2001, AM J OPHTHALMOL, V131, P472, DOI 10.1016/S0002-9394(00)00850-3; Idelson M, 2009, CELL STEM CELL, V5, P396, DOI 10.1016/j.stem.2009.07.002; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Osakada F, 2009, J CELL SCI, V122, P3169, DOI 10.1242/jcs.050393; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007; Zaghloul NA, 2005, BIOL CELL, V97, P321, DOI 10.1042/BC2004/0521; Zuber ME, 2003, DEVELOPMENT, V130, P5155, DOI 10.1242/dev.00723	10	7	8	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					347	348		10.1016/j.stem.2009.09.011	http://dx.doi.org/10.1016/j.stem.2009.09.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796611	Bronze			2022-12-28	WOS:000271401900003
J	Hayashi, K; Surani, MA				Hayashi, Katsuhiko; Surani, M. Azim			Resetting the Epigenome beyond Pluripotency in the Germline	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; X-CHROMOSOME; PREIMPLANTATION EMBRYOS; CLONED MICE; SMALL RNAS; XIST EXPRESSION; IMPRINTED GENE; SOMATIC NUCLEI; MOUSE EMBRYOS; IN-VITRO	Germ cells undergo comprehensive epigenetic reprogramming toward acquiring fitness for pluripotency and totipotency. Notably, the full extent of the epigenetic reprogramming experienced by germ cells remains unmatched by attempts to experimentally restore pluripotency in somatic cells. We propose that the defects present in experimentally generated cells are corrected upon differentiation into the germ cell lineage, as has been observed in cases of germline transmission. Unraveling the mechanisms responsible for germ cell-specific epigenetic reprogramming will likely have important implications for both basic and clinical stem cell research.	[Hayashi, Katsuhiko; Surani, M. Azim] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Henry Wellcome Bldg Canc & Dev Biol,Tennis Court, Cambridge CB2 1QN, England.	a.surani@gurdon.cam.ac.uk		Surani, Azim/0000-0002-8640-4318	Wellcome Trust [062801]; Department for Innovation, Universities and Skills [TP/4/BIO/6/1/22020]; CellCentric; Medical Research Council [G0800784, G0800784B] Funding Source: researchfish; MRC [G0800784] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Department for Innovation, Universities and Skills; CellCentric; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of our group for their contributions. We thank the Wellcome Trust (062801), the Technology Strategy Board sponsored by the Department for Innovation, Universities and Skills (ref: TP/4/BIO/6/1/22020), and CellCentric for support.	Ancelin K, 2006, NAT CELL BIOL, V8, P623, DOI 10.1038/ncb1413; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Bao SQ, 2005, EMBO REP, V6, P748, DOI 10.1038/sj.embor.7400461; Bortvin A, 2003, DEVELOPMENT, V130, P1673, DOI 10.1242/dev.00366; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Lopes SMCD, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040030; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Daggag H, 2008, BIOL REPROD, V79, P468, DOI 10.1095/biolreprod.107.067348; Daniels R, 1997, AM J HUM GENET, V61, P33, DOI 10.1086/513892; de Napoles M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000860; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; Enver T, 2009, CELL STEM CELL, V4, P387, DOI 10.1016/j.stem.2009.04.011; Farthing CR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000116; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; HOWLETT SK, 1991, DEVELOPMENT, V113, P119; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mak W, 2004, SCIENCE, V303, P666, DOI 10.1126/science.1092674; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; MONK M, 1991, DEVELOPMENT, V112, P189; Navarro P, 2008, SCIENCE, V321, P1693, DOI 10.1126/science.1160952; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okamoto I, 2004, SCIENCE, V303, P644, DOI 10.1126/science.1092727; Ono R, 2006, NAT GENET, V38, P101, DOI 10.1038/ng1699; Rawn SM, 2008, ANNU REV CELL DEV BI, V24, P159, DOI 10.1146/annurev.cellbio.24.110707.175418; Ray PF, 1997, HUM MOL GENET, V6, P1323, DOI 10.1093/hmg/6.8.1323; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Seki Y, 2005, DEV BIOL, V278, P440, DOI 10.1016/j.ydbio.2004.11.025; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; Shamblott MJ, 1998, P NATL ACAD SCI USA, V95, P13726, DOI 10.1073/pnas.95.23.13726; Sharova LV, 2007, DEV BIOL, V307, P446, DOI 10.1016/j.ydbio.2007.05.004; Shen JJ, 2007, MOL CARCINOGEN, V46, P331, DOI 10.1002/mc.20256; Shimozawa N, 2002, GENESIS, V34, P203, DOI 10.1002/gene.10143; Shovlin TC, 2008, DEV BIOL, V313, P674, DOI 10.1016/j.ydbio.2007.11.007; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Sugimoto M, 2007, PLOS GENET, V3, P1309, DOI 10.1371/journal.pgen.0030116; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; TAKAGI N, 1982, CHROMOSOMA, V85, P275, DOI 10.1007/BF00294971; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamashiro KLK, 2003, EXP BIOL MED, V228, P1193, DOI 10.1177/153537020322801015; Tamashiro KLK, 2002, NAT MED, V8, P262, DOI 10.1038/nm0302-262; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Ueno H, 2009, P NATL ACAD SCI USA, V106, P175, DOI 10.1073/pnas.0810325105; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Watanabe T, 2006, GENE DEV, V20, P1732, DOI 10.1101/gad.1425706; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xu J, 2007, P NATL ACAD SCI USA, V104, P12377, DOI 10.1073/pnas.0704579104; Yabuta Y, 2006, BIOL REPROD, V75, P705, DOI 10.1095/biolreprod.106.053686; Yamaguchi S, 2005, GENE EXPR PATTERNS, V5, P639, DOI 10.1016/j.modgep.2005.03.001; Yamaji M, 2008, NAT GENET, V40, P1016, DOI 10.1038/ng.186; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	67	69	74	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					493	498		10.1016/j.stem.2009.05.007	http://dx.doi.org/10.1016/j.stem.2009.05.007			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497276	Bronze			2022-12-28	WOS:000266793600010
J	Miller, FD; Gauthier-Fisher, A				Miller, Freda D.; Gauthier-Fisher, Andree			Home at Last: Neural Stem Cell Niches Defined	CELL STEM CELL			English	Review							SUBVENTRICULAR ZONE; ADULT NEUROGENESIS; OLFACTORY-BULB; VASCULAR NICHE; SELF-RENEWAL; BRAIN; NEUROBLASTS; HEDGEHOG; EXPAND; SVZ	Adult neural stem cells (NSCs) are involved in regulating mammalian behavior and are controlled by diverse external stimuli. Improved understanding of the physical location of NSCs and the microenvironmental cues that regulate their behavior, which combine to define the NSC "home," or niche, may reveal how to control their function.	[Miller, Freda D.; Gauthier-Fisher, Andree] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Grp, Toronto, ON M5G 1L7, Canada; [Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto	Miller, FD (corresponding author), Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Grp, Toronto, ON M5G 1L7, Canada.	fredam@sickkids.ca		Gauthier-Fisher, Andree/0000-0002-1932-4684	International Research	International Research	We would like to acknowledge those primary publications that we could not quote due to reference limitations. F.D.M. is a Canada Research Chair and an H.H.M.I. International Research Scholar. We would like to thank David Kaplan and Derek van der Kooy for their helpful input.	Angot E, 2008, STEM CELLS, V26, P2311, DOI 10.1634/stemcells.2008-0297; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Curtis MA, 2007, SCIENCE, V315, P1243, DOI 10.1126/science.1136281; Gould E, 2007, NAT REV NEUROSCI, V8, P481, DOI 10.1038/nrn2147; Han YG, 2008, NAT NEUROSCI, V11, P277, DOI 10.1038/nn2059; Hoglinger GU, 2004, NAT NEUROSCI, V7, P726, DOI 10.1038/nn1265; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kokovay E, 2008, NEURON, V60, P420, DOI 10.1016/j.neuron.2008.10.025; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Quinones-Hinojosa A, 2007, EXP NEUROL, V205, P313, DOI 10.1016/j.expneurol.2007.03.016; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	21	104	112	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					507	510		10.1016/j.stem.2009.05.008	http://dx.doi.org/10.1016/j.stem.2009.05.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497279	Bronze			2022-12-28	WOS:000266793600013
J	Zaret, KS				Zaret, Kenneth S.			Using Small Molecules to Great Effect in Stem Cell Differentiation	CELL STEM CELL			English	Editorial Material							PLURIPOTENCY; MOUSE; MICE	Several recent reports, including two Cell Stem Cell papers (Zhu et al., 2009 [this issue]; Borowiak et al., 2009), screened small molecule libraries for compounds that promote embryonic stem cell differentiation. Their combined success helps bypass challenges associated with using natural protein factors and has revealed insights into controlling stem cell differentiation.	Fox Chase Canc Ctr, Program Cell & Dev Biol, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Zaret, KS (corresponding author), Fox Chase Canc Ctr, Program Cell & Dev Biol, 333 Cottman Ave, Philadelphia, PA 19111 USA.	zaret@fccc.edu						Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; CONLON FL, 1994, DEVELOPMENT, V120, P1919; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirouac DC, 2008, CELL STEM CELL, V3, P369, DOI 10.1016/j.stem.2008.09.001; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001	11	23	24	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					373	374		10.1016/j.stem.2009.04.012	http://dx.doi.org/10.1016/j.stem.2009.04.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427285	Bronze			2022-12-28	WOS:000266071100002
J	Zaruba, MM; Theiss, HD; Vallaster, M; Mehl, U; Brunner, S; David, R; Fischer, R; Krieg, L; Hirsch, E; Huber, B; Nathan, P; Israel, L; Imhof, A; Herbach, N; Assmann, G; Wanke, R; Mueller-Hoecker, J; Steinbeck, G; Franz, WM				Zaruba, Marc-Michael; Theiss, Hans Diogenes; Vallaster, Markus; Mehl, Ursula; Brunner, Stefan; David, Robert; Fischer, Rebekka; Krieg, Lisa; Hirsch, Eva; Huber, Bruno; Nathan, Petra; Israel, Lars; Imhof, Axel; Herbach, Nadja; Assmann, Gerald; Wanke, Ruediger; Mueller-Hoecker, Josef; Steinbeck, Gerhard; Franz, Wolfgang-Michael			Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction	CELL STEM CELL			English	Article							STEM-CELL MOBILIZATION; COLONY-STIMULATING FACTOR; DIPEPTIDYL PEPTIDASE IV; BONE-MARROW; HEMATOPOIETIC STEM; PROGENITOR CELLS; CD34(+) CELLS; CD26; SDF-1; CXCL12	Ischemic cardiomyopathy is one of the main causes of death, which may be prevented by stem cell-based therapies. SDF-1 alpha is the major chemokine attracting stem cells to the heart. Since SDF-1 alpha is cleaved and inactivated by CD26/dipeptidylpeptidase IV (DPP-IV), we established a therapeutic conceptapplicable to ischemic disorders in general-by combining genetic and pharmacologic inhibition of DPP-IV with G-CSF-mediated stem cell mobilization after myocardial infarction in mice. This approach leads to (1) decreased myocardial DPP-IV activity, (2) increased myocardial homing of circulating CXCR-4(+) stem cells, (3) reduced cardiac remodeling, and (4) improved heart function and survival. Indeed, CD26 depletion promoted post-translational stabilization of active SDF-1 alpha in heart lysates and preserved the cardiac SDF-1-CXCR4 homing axis. Therefore, we propose pharmacological DPP-IV inhibition and G-CSF-based stem cell mobilization as a therapeutic concept for future stem cell trials after myocardial infarction.	[Zaruba, Marc-Michael; Theiss, Hans Diogenes; Vallaster, Markus; Mehl, Ursula; Brunner, Stefan; David, Robert; Fischer, Rebekka; Krieg, Lisa; Hirsch, Eva; Huber, Bruno; Nathan, Petra; Steinbeck, Gerhard; Franz, Wolfgang-Michael] Univ Munich, Klinikum Grosshadern, Dept Med 1, D-8000 Munich, Germany; [Israel, Lars; Imhof, Axel] Univ Munich, Munich Ctr Integrated Prot Sci, D-8000 Munich, Germany; [Israel, Lars; Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-8000 Munich, Germany; [Herbach, Nadja; Wanke, Ruediger] Univ Munich, Inst Vet Pathol, D-8000 Munich, Germany; [Assmann, Gerald; Mueller-Hoecker, Josef] Univ Munich, Inst Pathol, D-8000 Munich, Germany	University of Munich; University of Munich; University of Munich; University of Munich; University of Munich	Franz, WM (corresponding author), Univ Munich, Klinikum Grosshadern, Dept Med 1, D-8000 Munich, Germany.	wolfgang.franz@med.uni-muenchen.de	Imhof, Axel/AAU-5313-2021; Zaruba, Marc-Michael/AAI-8571-2020	Imhof, Axel/0000-0003-2993-8249; Zaruba, Marc-Michael/0000-0003-1074-5463; Wanke, Rudiger/0000-0002-0153-224X; Herbach, Nadja/0000-0001-5893-0356; Huber, Bruno/0000-0002-1032-7686	German Research Foundation [DFG TH1398/2-1]; Ludwig Maximilians University Munich; German Research Foundation	German Research Foundation(German Research Foundation (DFG)); Ludwig Maximilians University Munich; German Research Foundation(German Research Foundation (DFG))	A research agreement for the use of CD26 KO mice was arranged with approval from the Centre d'lmmunologie de Marseille Luminy-INSERM, France. We are grateful to Judith Arcifa, Kathrin Angermuller, and Barbara Markieton for their excellent technical assistance. This work was supported by the German Research Foundation (DFG TH1398/2-1) and the Fritz-Bender-Stiftung. U.M., M.V., L.K., and E.H. were funded by the FoFoLe program of the Ludwig Maximilians University Munich. R.F. was financed by the Fritz-Bender-Stiftung and the German Research Foundation. Additional financial support for flow cytometry was provided by the Dr. Helmut	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Askari AT, 2003, LANCET, V362, P697, DOI 10.1016/S0140-6736(03)14232-8; Balsam LB, 2004, NATURE, V428, P668, DOI 10.1038/nature02460; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Busso N, 2005, AM J PATHOL, V166, P433, DOI 10.1016/S0002-9440(10)62266-3; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Christopherson KW, 2006, EXP HEMATOL, V34, P1060, DOI 10.1016/j.exphem.2006.03.012; Christopherson KW, 2004, SCIENCE, V305, P1000, DOI 10.1126/science.1097071; Christopherson KW, 2002, J IMMUNOL, V169, P7000, DOI 10.4049/jimmunol.169.12.7000; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; Deindl E, 2006, FASEB J, V20, P956, DOI 10.1096/fj.05-4763fje; Dickstein K, 2008, EUR J HEART FAIL, V10, P933, DOI 10.1016/j.ejheart.2008.08.005; Durinx C, 2000, EUR J BIOCHEM, V267, P5608, DOI 10.1046/j.1432-1327.2000.01634.x; Engelmann MG, 2006, J AM COLL CARDIOL, V48, P1712, DOI 10.1016/j.jacc.2006.07.044; Fazel S, 2006, J CLIN INVEST, V116, P1865, DOI 10.1172/JCI27019; FRANZ WM, 2005, NAT MED, V11, P305; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Hofmann M, 2005, CIRCULATION, V111, P2198, DOI 10.1161/01.CIR.0000163546.27639.AA; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; Huhn J, 2000, IMMUNOL LETT, V72, P127, DOI 10.1016/S0165-2478(00)00170-X; Ince H, 2005, CIRCULATION, V112, pI73, DOI 10.1161/CIRCULATIONAHA.104.254827; Kahne T, 1999, INT J MOL MED, V4, P3; Levesque JP, 2004, BLOOD, V104, P65, DOI 10.1182/blood-2003-05-1589; Levesque JP, 2003, J CLIN INVEST, V111, P187, DOI 10.1172/JCI200315994; Majka M, 2001, BLOOD, V97, P3075, DOI 10.1182/blood.V97.10.3075; Marguet D, 2000, P NATL ACAD SCI USA, V97, P6874, DOI 10.1073/pnas.120069197; Murry CE, 2004, NATURE, V428, P664, DOI 10.1038/nature02446; Naiyer AJ, 1999, BLOOD, V94, P4011, DOI 10.1182/blood.V94.12.4011.424k10_4011_4019; Nervi B, 2006, J CELL BIOCHEM, V99, P690, DOI 10.1002/jcb.21043; Ohtsuka M, 2004, FASEB J, V18, P851, DOI 10.1096/fj.03-0637fje; Orlic D, 2001, P NATL ACAD SCI USA, V98, P10344, DOI 10.1073/pnas.181177898; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Ruiz P, 1998, ACTA HAEMATOL-BASEL, V100, P110, DOI 10.1159/000040880; Saxena A, 2008, CIRCULATION, V117, P2224, DOI 10.1161/CIRCULATIONAHA.107.694992; Schachinger V, 2004, J AM COLL CARDIOL, V44, P1690, DOI 10.1016/j.jacc.2004.08.014; SCHARPE S, 1988, CLIN CHEM, V34, P2299; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Valenzuela-Fernandez A, 2002, J BIOL CHEM, V277, P15677, DOI 10.1074/jbc.M111388200; VANHAM G, 1993, J ACQ IMMUN DEF SYND, V6, P749; Vergote D, 2006, P NATL ACAD SCI USA, V103, P19182, DOI 10.1073/pnas.0604678103; Wang Y, 2008, BRAIN RES, V1195, P104, DOI 10.1016/j.brainres.2007.11.068; Wollert KC, 2004, LANCET, V364, P141, DOI 10.1016/S0140-6736(04)16626-9; Zaruba MM, 2008, CARDIOVASC RES, V77, P722, DOI 10.1093/cvr/cvm080; Zhou YY, 2000, AM J PHYSIOL-HEART C, V279, pH429; Zohlnhofer D, 2008, J AM COLL CARDIOL, V51, P1429, DOI 10.1016/j.jacc.2007.11.073; Zohlnhofer D, 2006, JAMA-J AM MED ASSOC, V295, P1003, DOI 10.1001/jama.295.9.1003	50	272	281	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					313	323		10.1016/j.stem.2009.02.013	http://dx.doi.org/10.1016/j.stem.2009.02.013			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341621	Bronze			2022-12-28	WOS:000265162700008
J	Jordan, CT				Jordan, Craig T.			Cancer Stem Cells: Controversial or Just Misunderstood?	CELL STEM CELL			English	Editorial Material							ACUTE MYELOID-LEUKEMIA; PROGENITOR; MAINTAINS; SURVIVAL	While a broad range of expertise has recently come to bear on the intriguing topic of "cancer stem cells," the overall relevance of stem cells as they relate to cancer remains in dispute. In this commentary, underlying points of contention are described with the aim of defining focal points for discussion and future consideration.	Univ Rochester, James P Wilmot Canc Ctr, Rochester, NY 14642 USA	University of Rochester	Jordan, CT (corresponding author), Univ Rochester, James P Wilmot Canc Ctr, 601 Elmwood Ave,Box 704, Rochester, NY 14642 USA.	craig_jordan@urmc.rochester.edu	jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465	Leukemia and Lymphoma Society; NIH [R01-CA122206]; NATIONAL CANCER INSTITUTE [R01CA122206] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	I gratefully acknowledge excellent critical comments and review by Drs. Martin Carroll, Monica Guzman. Fay Young, and William Matsui. I apologize to the many investigators whose work I was unable to cite in this article due to editorial limitations. C.T.J. is supported by a Scholar Award from the Leukemia and Lymphoma Society and NIH R01-CA122206.	Adams JM, 2008, CANCER RES, V68, P4018, DOI 10.1158/0008-5472.CAN-07-6334; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Feller N, 2004, LEUKEMIA, V18, P1380, DOI 10.1038/sj.leu.2403405; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Viale A, 2009, NATURE, V457, P51, DOI 10.1038/nature07618; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005; Xu Q, 2003, BLOOD, V102, P972, DOI 10.1182/blood-2002-11-3429	14	120	125	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					203	205		10.1016/j.stem.2009.02.003	http://dx.doi.org/10.1016/j.stem.2009.02.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265659	Green Accepted, Bronze			2022-12-28	WOS:000264369300010
J	Ahrlund-Richter, L; De Luca, M; Marshak, DR; Munsie, M; Veiga, A; Rao, M				Ahrlund-Richter, Lars; De Luca, Michele; Marshak, Daniel R.; Munsie, Megan; Veiga, Anna; Rao, Mahendra			Isolation and Production of Cells Suitable for Human Therapy: Challenges Ahead	CELL STEM CELL			English	Article							UMBILICAL-CORD BLOOD; STEM-CELLS; LINES; TRANSPLANTATION		[Rao, Mahendra] Invitrogen, Frederick, MD 21704 USA; [Ahrlund-Richter, Lars] Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [De Luca, Michele] Univ Modena, Ctr Regenerat Med, Dept Biomed Sci, I-41100 Modena, Italy; [Marshak, Daniel R.] PerkinElmer Inc, Shanghai 201203, Peoples R China; [Munsie, Megan] Govt Affairs & Policy Australian Stem Cell Ctr, Clayton, Vic 3800, Australia; [Veiga, Anna] CMRB, Banc Linies Cellulars, Barcelona 08003, Spain	Thermo Fisher Scientific; Karolinska Institutet; Universita di Modena e Reggio Emilia; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona	Rao, M (corresponding author), Invitrogen, Frederick, MD 21704 USA.	mahendra.rao@invitrogen.com	Ahrlund-Richter, Lars/C-6226-2012; De Luca, Michele/N-5883-2014	De Luca, Michele/0000-0002-0850-8445; Munsie, Megan/0000-0003-3588-8321; Veiga, Anna/0000-0002-0943-9904				Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Astradsson A, 2008, NEUROSURG FOCUS, V24, DOI 10.3171/FOC/2008/24/3-4/E5; Catalina P, 2007, CELL BIOL INT, V31, P861, DOI 10.1016/j.cellbi.2007.03.012; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Fanning LR, 2008, LEUKEMIA, V22, P1786, DOI 10.1038/leu.2008.55; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; HARRIS DT, 2007, CURR STEM CELL RES T, V1, P301; Harris N, 2006, REGEN MED, V1, P705, DOI 10.2217/17460751.1.5.705; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Kirouac DC, 2008, CELL STEM CELL, V3, P369, DOI 10.1016/j.stem.2008.09.001; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Le Blanc K, 2006, CURR OPIN IMMUNOL, V18, P586, DOI 10.1016/j.coi.2006.07.004; Loring JF, 2006, STEM CELLS, V24, P145, DOI 10.1634/stemcells.2005-0432; Magnus T, 2008, PHILOS T R SOC B, V363, P9, DOI 10.1098/rstb.2006.2009; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Otonkoski T, 2005, ANN MED, V37, P513, DOI 10.1080/07853890500300279; Rao M, 2008, STEM CELLS DEV, V17, P1, DOI 10.1089/scd.2008.0013; Stephenson EL, 2006, REGEN MED, V1, P739, DOI 10.2217/17460751.1.6.739; Yu BD, 2008, HUM MOL GENET, V17, pR54, DOI 10.1093/hmg/ddn086	21	98	100	1	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					20	26		10.1016/j.stem.2008.11.012	http://dx.doi.org/10.1016/j.stem.2008.11.012			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19058776	Bronze			2022-12-28	WOS:000262559500008
J	Ho, L; Crabtree, GR				Ho, Lena; Crabtree, Gerald R.			An EZ Mark to Miss	CELL STEM CELL			English	Editorial Material							POLYCOMB; PLURIPOTENCY; COMPLEXES	Ezh2, the m ethyl transferase within Polycomb Repressive II Complexes, was thought to be essential for all H3K27me3 marks in embryonic stem cells (ESCs). Recently in Molecular Cell, Shen and colleagues (2008) revealed that EZH2 is dispensable for ESC derivation and self-renewal, and that EZH1 may unexpectedly compensate for its loss.	[Crabtree, Gerald R.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA; [Ho, Lena] Stanford Univ, Program Immunol, Sch Med, Stanford, CA 94305 USA	Howard Hughes Medical Institute; Stanford University; Stanford University	Crabtree, GR (corresponding author), Stanford Univ, Howard Hughes Med Inst, Sch Med, Stanford, CA 94305 USA.	crabtree@cmgm.stanford.edu	Hu, Ruogu/B-2203-2008	Ho, Lena/0000-0002-9358-621X	NINDS NIH HHS [R01 NS046789-02, R01 NS046789-04, R01 NS046789-05, R01 NS046789, R01 NS046789-03, R01 NS046789-06] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046789] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; FAUST C, 1995, DEVELOPMENT, V121, P273; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Wang WD, 1996, GENE DEV, V10, P2117, DOI 10.1101/gad.10.17.2117	10	14	14	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					577	578		10.1016/j.stem.2008.11.007	http://dx.doi.org/10.1016/j.stem.2008.11.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041770	Green Accepted, Bronze			2022-12-28	WOS:000261670900002
J	Eisenhoffer, GT; Kang, H; Alvarado, AS				Eisenhoffer, George T.; Kang, Hara; Alvarado, Alejandro Sanchez			Molecular analysis of stem cells and their descendants during cell turnover and regeneration in the planarian Schmidtea mediterranea	CELL STEM CELL			English	Article							TRANSCRIPTION FACTORS; GENE-EXPRESSION; SELF-RENEWAL; RIBONUCLEOTIDE REDUCTASE; DROSOPHILA NEUROBLASTS; TISSUE HOMEOSTASIS; CREATINE SYNTHESIS; TEMPORAL IDENTITY; LINEAGE; IDENTIFICATION	In adult planarians, the replacement of cells lost to physiological turnover or injury is sustained by the proliferation and differentiation of stem cells known as neoblasts. Neoblast lineage relationships and the molecular changes that take place during differentiation into the appropriate cell types are poorly understood. Here we report the identification and characterization of a cohort of genes specifically expressed in neoblasts and their descendants. We find that genes with severely downregulated expression after irradiation molecularly define at least three discrete subpopulations of cells. Simultaneous BrdU labeling and in situ hybridization experiments in intact and regenerating animals indicate that these cell subpopulations are related by lineage. Our data demonstrate not only the ability to measure and study the in vivo population dynamics of adult stem cells during tissue homeostasis and regeneration, but also the utility of studies in planarians to broadly inform stem cell biology in adult organisms.	[Eisenhoffer, George T.; Kang, Hara; Alvarado, Alejandro Sanchez] Univ Utah, Howard Hughes Med Inst, Dept Neurobiol & Anat, Sch Med, Salt Lake City, UT 84132 USA	Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah	Alvarado, AS (corresponding author), Univ Utah, Howard Hughes Med Inst, Dept Neurobiol & Anat, Sch Med, 401 MREB,20N 1900E, Salt Lake City, UT 84132 USA.	sanchez@neuro.utah.edu		Sanchez Alvarado, Alejandro/0000-0002-1966-6959	NIH-NIGMS [RO-1 GM57260]; Howard Hughes Medical Institute; NIH [5T32 HD07491]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD007491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057260] Funding Source: NIH RePORTER	NIH-NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Bret Pearson and members of the Sanchez Laboratory for scientific discussions, suggestions, and comments, and we thank Brian Daley for assistance with microarrays. This work was supported by NIH-NIGMS RO-1 GM57260 and the Howard Hughes Medical Institute to A.S.A. G.T.E. was supported by NIH Developmental Biology Training Grant 5T32 HD07491.	Alvarado AS, 2002, DEVELOPMENT, V129, P5659, DOI 10.1242/dev.00167; Anderson DJ, 2001, NAT MED, V7, P393, DOI 10.1038/86439; BAGUNA J, 1976, J EXP ZOOL, V195, P53, DOI 10.1002/jez.1401950106; Bardeen CR, 1904, J EXP ZOOL, V1, P191, DOI 10.1002/jez.1400010107; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2007, CELL, V128, P445, DOI 10.1016/j.cell.2007.01.014; Braissant O, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-9; DUBOIS F, 1949, CR HEBD ACAD SCI, V229, P747; Duxbury MS, 2004, ONCOGENE, V23, P1539, DOI 10.1038/sj.onc.1207272; ENGSTROM Y, 1985, J BIOL CHEM, V260, P9114; Grosskortenhaus R, 2005, DEV CELL, V8, P193, DOI 10.1016/j.devcel.2004.11.019; Guo TX, 2006, DEV CELL, V11, P159, DOI 10.1016/j.devcel.2006.06.004; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Hayashi T, 2006, DEV GROWTH DIFFER, V48, P371, DOI 10.1111/j.1440-169x.2006.00876.x; Hernandez J, 2007, J BIOL CHEM, V282, P37894, DOI 10.1074/jbc.M703616200; Higuchi S, 2007, DEV GROWTH DIFFER, V49, P571, DOI 10.1111/j.1440-169X.2007.00947.x; Hori I, 1997, J SUBMICR CYTOL PATH, V29, P91; HORI I, 1982, J ELECTRON MICROSC, V31, P63; HORI I, 1991, International Journal of Developmental Biology, V35, P101; Hyman LH, 1951, INVERTEBRATES PLATYH, VII; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kittler R, 2004, NATURE, V432, P1036, DOI 10.1038/nature03159; Kutney SN, 2004, J BIOL CHEM, V279, P30850, DOI 10.1074/jbc.M404969200; Lee H, 1998, BIOL REPROD, V58, P1437, DOI 10.1095/biolreprod58.6.1437; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; McClure WC, 2007, NEUROMUSCULAR DISORD, V17, P639, DOI 10.1016/j.nmd.2007.04.008; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Morgan TH, 1898, ARCH ENTW MECH ORG, V7, P364; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Morrison SJ, 2001, CURR BIOL, V11, pR7, DOI 10.1016/S0960-9822(00)00033-6; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Nakayama Y, 2004, AM J PATHOL, V164, P1773, DOI 10.1016/S0002-9440(10)63735-2; Newmark PA, 2000, DEV BIOL, V220, P142, DOI 10.1006/dbio.2000.9645; Newmark PA, 2003, P NATL ACAD SCI USA, V100, P11861, DOI 10.1073/pnas.1834205100; NUELL MJ, 1991, MOL CELL BIOL, V11, P1372, DOI 10.1128/MCB.11.3.1372; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Oviedo NJ, 2007, DEVELOPMENT, V134, P3121, DOI 10.1242/dev.006635; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Peters MA, 2002, DEV BIOL, V251, P59, DOI 10.1006/dbio.2002.0791; RANDOLPH H, 1892, J MORPHOL, V7, P317, DOI DOI 10.1002/JMOR.1050070304; Reddien PW, 2005, SCIENCE, V310, P1327, DOI 10.1126/science.1116110; Reddien PW, 2005, DEV CELL, V8, P635, DOI 10.1016/j.devcel.2005.02.014; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Robb SMC, 2002, GENESIS, V32, P293, DOI 10.1002/gene.10087; Romanko MJ, 2004, PROG NEUROBIOL, V74, P77, DOI 10.1016/j.pneurobio.2004.07.001; Rossi L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r62; Seo SB, 2002, J BIOL CHEM, V277, P14005, DOI 10.1074/jbc.M112455200; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Wagers AJ, 2002, SCIENCE, V297, P2256, DOI 10.1126/science.1074807; Wang JCC, 2005, DEV BIOL, V285, P101, DOI 10.1016/j.ydbio.2005.05.041; Wang S, 1999, ONCOGENE, V18, P3501, DOI 10.1038/sj.onc.1202684; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zayas RM, 2005, P NATL ACAD SCI USA, V102, P18491, DOI 10.1073/pnas.0509507102	59	289	297	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					327	339		10.1016/j.stem.2008.07.002	http://dx.doi.org/10.1016/j.stem.2008.07.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786419	Bronze, Green Accepted			2022-12-28	WOS:000259665000015
J	Kunath, T				Kunath, Tilo			Primed for Pluripotency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; SELF-RENEWAL; DERIVATION	To date, pluripotent epiblast stem cells (EpiSCs) had only been derived from postimplantation mouse embryos. In this issue of Cell Stem Cell, Najm et al. (2011) demonstrate that EpiSCs can be routinely derived from preimplantation embryos, showing that both human and mouse blastocysts can produce the same class of primed pluripotent cells.	Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH9 3JQ, Midlothian, Scotland	University of Edinburgh	Kunath, T (corresponding author), Univ Edinburgh, MRC Ctr Regenerat Med, Edinburgh EH9 3JQ, Midlothian, Scotland.	tilo.kunath@ed.ac.uk		Kunath, Tilo/0000-0002-8805-7356	Medical Research Council [G0700711B] Funding Source: researchfish; Parkinson&quot;s UK [F-0902] Funding Source: researchfish; Parkinson&apos;s UK [F-0902] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Parkinson&quot;s UK(Parkinson&apos;s UK); Parkinson&apos;s UK(Parkinson&apos;s UK)		Alberio R, 2010, STEM CELLS DEV, V19, P1627, DOI 10.1089/scd.2010.0012; Anderson PD, 2009, CANCER RES, V69, P9112, DOI 10.1158/0008-5472.CAN-09-3342; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Han DW, 2011, NAT CELL BIOL, V13, P66, DOI 10.1038/ncb2136; NAIM FJ, 2011, CELL STEM CELL, V8, P318; Nichols J, 2011, DEVELOPMENT, V138, P3, DOI 10.1242/dev.050831; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Tang FC, 2010, CELL STEM CELL, V6, P468, DOI 10.1016/j.stem.2010.03.015; Wang SF, 2008, J BIOL CHEM, V283, P35929, DOI 10.1074/jbc.M804091200; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	10	5	5	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					241	242		10.1016/j.stem.2011.02.009	http://dx.doi.org/10.1016/j.stem.2011.02.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362560	Bronze			2022-12-28	WOS:000288404400001
J	Walter, J				Walter, Joern			An Epigenetic Tet a Tet with Pluripotency	CELL STEM CELL			English	Editorial Material								DNA and chromatin-modifying enzymes establish an ESC/iPSC-specific epigenomic landscape that is linked to a network of pluripotency genes and influences differentiation potential. In this issue of Cell Stem Cell, Koh et al. (2011) highlight Tet1 and Tet2 as key players in this network of coordinated genetic and epigenetic control.	Univ Saarland, FR Biosci 8 3, Lab EpiGenet, D-66041 Saarbrucken, Germany	Saarland University	Walter, J (corresponding author), Univ Saarland, FR Biosci 8 3, Lab EpiGenet, Bldg A2-4,Postbox 151150, D-66041 Saarbrucken, Germany.	j.walter@mx.uni-saarland.de	Walter, Jörn/AFN-6428-2022	Walter, Jörn/0000-0003-0563-7417				Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Ito S, 2010, NATURE, V466, P1129, DOI 10.1038/nature09303; Ko M, 2010, NATURE, V468, P839, DOI 10.1038/nature09586; Koh KP, 2011, CELL STEM CELL, V8, P200, DOI 10.1016/j.stem.2011.01.008; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Szwagierczak A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq684	6	12	13	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					121	122		10.1016/j.stem.2011.01.009	http://dx.doi.org/10.1016/j.stem.2011.01.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295264	Bronze			2022-12-28	WOS:000287633400001
J	Buecker, C; Geijsen, N				Buecker, Christa; Geijsen, Niels			Different Flavors of Pluripotency, Molecular Mechanisms, and Practical Implications	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GROUND-STATE PLURIPOTENCY; GENE-EXPRESSION; MOUSE EPIBLAST; HOMOLOGOUS RECOMBINATION; MAINTAINS PLURIPOTENCY; SELF-RENEWAL; ES CELLS; NANOG; LINES	Pluripotent stem cells (PSCs) have been classified into two distinct states: a primitive, naive LIF-dependent state represented by murine ESCs, and a primed bFGF-dependent state observed in murine and rat epiblast stem cells (EpiSCs). The vast similarities between EpiSCs and human ESCs suggest that, despite their blastocyst origin, human ESCs exist in a primed pluripotent state. Recent findings demonstrate that the naive and primed pluripotent states are interconvertible, even in human cells, and hint that growth factor-mediated Nanog expression may be an important factor regulating the balance between them.	[Buecker, Christa; Geijsen, Niels] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Buecker, Christa; Geijsen, Niels] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Geijsen, Niels] Hubrecht Inst Dev Biol & Stem Cell Res, NL-3584 CT Utrecht, Netherlands; [Geijsen, Niels] Univ Utrecht, Sch Vet Med, Dept Clin Sci Compan Anim, NL-3584 CM Utrecht, Netherlands	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University	Geijsen, N (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, CPZN 4256,185 Cambridge St, Boston, MA 02114 USA.	n.geijsen@hubrecht.eu		Buecker, Christa/0000-0003-3055-2642	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD048769] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD048769] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Barrero MJ, 2010, CELL STEM CELL, V7, P565, DOI 10.1016/j.stem.2010.10.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V6, P535, DOI 10.1016/j.stem.2010.05.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen AE, 2009, CELL STEM CELL, V4, P103, DOI 10.1016/j.stem.2008.12.001; Chin MH, 2010, CELL STEM CELL, V7, P263, DOI 10.1016/j.stem.2010.06.019; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; Faherty S, 2007, IN VITRO CELL DEV-AN, V43, P37, DOI 10.1007/s11626-006-9001-5; Fischer Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012533; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guo G, 2010, DEVELOPMENT, V137, P3185, DOI 10.1242/dev.052753; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Kalmar T, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000149; Kobayashi T, 2010, CELL, V142, P787, DOI 10.1016/j.cell.2010.07.039; Kuijk EW, 2008, DEV DYNAM, V237, P918, DOI 10.1002/dvdy.21480; Layden BT, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009105; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pant D, 2009, CLONING STEM CELLS, V11, P355, DOI 10.1089/clo.2008.0078; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Solter D, 2010, CELL, V142, P676, DOI 10.1016/j.cell.2010.08.021; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tong C, 2010, NATURE, V467, P211, DOI 10.1038/nature09368; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wray J, 2010, BIOCHEM SOC T, V38, P1027, DOI 10.1042/BST0381027; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yang JA, 2010, CELL STEM CELL, V7, P319, DOI 10.1016/j.stem.2010.06.022; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhang PL, 2010, J BIOL CHEM, V285, P9180, DOI 10.1074/jbc.M109.077958	50	29	30	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					559	564		10.1016/j.stem.2010.10.007	http://dx.doi.org/10.1016/j.stem.2010.10.007			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040897	Bronze			2022-12-28	WOS:000284390500007
J	Wu, XW; Pang, LJ; Lei, WQ; Lu, W; Li, J; Li, ZY; Frassica, FJ; Chen, XL; Wan, M; Cao, X				Wu, Xiangwei; Pang, Lijuan; Lei, Weiqi; Lu, William; Li, Jun; Li, Zhaoyang; Frassica, Frank J.; Chen, Xueling; Wan, Mei; Cao, Xu			Inhibition of Sca-1-Positive Skeletal Stem Cell Recruitment by Alendronate Blunts the Anabolic Effects of Parathyroid Hormone on Bone Remodeling	CELL STEM CELL			English	Article							TGF-BETA; MINERAL DENSITY; MARROW; ANGIOGENESIS; OSTEOPOROSIS; RESORPTION; RECEPTOR; WOMEN; OSTEOGENESIS; PATHOGENESIS	The anabolic effects of parathyroid hormone (PTH) on bone formation are impaired by concurrent use of antiresorptive drugs. We found that the release of active transforming growth factor (TGF)-beta 1 during osteoclastic bone resorption is inhibited by alendronate. We showed that mouse Sca-1-positive (Sca-1(+)) bone marrow stromal cells are a skeletal stem cell subset, which are recruited to bone remodeling sites by active TGF-beta 1 in response to bone resorption. Alendronate inhibits the release of active TGF-beta 1 and the recruitment of Sca-1(+) skeletal stem cells for the bone formation. The observation was validated in a Tgfb1(-/-) mouse model, in which the anabolic effects of PTH on bone formation are diminished. The PTH-stimulated recruitment of injected mouse Sca-1(+) cells to the resorptive sites was inhibited by alendronate. Thus, inhibition of active TGF-beta 1 release by alendronate reduces the recruitment of Sca-1(+) skeletal stem cells and impairs the anabolic action of PTH in bone.	[Wu, Xiangwei; Pang, Lijuan; Lei, Weiqi; Li, Jun; Frassica, Frank J.; Chen, Xueling; Wan, Mei; Cao, Xu] Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA; [Wu, Xiangwei; Pang, Lijuan; Li, Jun] Huazhong Univ Sci & Technol, Tongji Med Sch, Tongji Hosp, Wuhan 430030, Hubei, Peoples R China; [Wu, Xiangwei; Pang, Lijuan; Li, Jun; Chen, Xueling] Shihezi Univ, Sch Med, Shihezi 832002, Xinjiang, Peoples R China; [Lu, William; Li, Zhaoyang] Univ Hong Kong, Dept Orthopaed & Traumatol, Hong Kong 999777, Hong Kong, Peoples R China	Johns Hopkins University; Huazhong University of Science & Technology; Shihezi University; University of Hong Kong	Cao, X (corresponding author), Johns Hopkins Univ, Sch Med, Dept Orthopaed Surg, Baltimore, MD 21205 USA.	xcao11@jhmi.edu	Sui, Yanwei/AAH-9928-2021; zhang, xu/GRX-9733-2022; zhang, xu/GYE-3558-2022		US National Institutes of Health [DK0080898, AR 053973]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080898, R01DK057501] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Elaine P. Henze (Editorial Services Department of Orthopaedic Surgery, Johns Hopkins University) for editing the manuscript and Dr. Brendan J. Canning (Asthma and Allergy Center, Johns Hopkins University) for providing guinea pig marrow cells. This research was supported by US National Institutes of Health grants DK0080898 and AR 053973 to X. Cao.	Atfi A, 2010, NAT CELL BIOL, V12, P205, DOI 10.1038/ncb0310-205; Beamer WG, 1996, BONE, V18, P397, DOI 10.1016/8756-3282(96)00047-6; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Black DM, 2003, NEW ENGL J MED, V349, P1207, DOI 10.1056/NEJMoa031975; Black DM, 2005, NEW ENGL J MED, V353, P555, DOI 10.1056/NEJMoa050336; Bonnick Sydney L, 2006, Clin Cornerstone, V8, P28, DOI 10.1016/S1098-3597(06)80063-3; Cao J, 2003, J BONE MINER RES, V18, P270, DOI 10.1359/jbmr.2003.18.2.270; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; Cranney A, 2002, ENDOCR REV, V23, P508, DOI 10.1210/er.2001-2002; Di Gregorio GB, 2001, J CLIN INVEST, V107, P803, DOI 10.1172/JCI11653; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; Finkelstein JS, 2010, J CLIN ENDOCR METAB, V95, P1838, DOI 10.1210/jc.2009-1703; Finkelstein JS, 2003, NEW ENGL J MED, V349, P1216, DOI 10.1056/NEJMoa035725; Hill P A, 1998, Br J Orthod, V25, P101; Iqbal MM, 2000, SOUTH MED J, V93, P2; Kurland ES, 2000, J CLIN ENDOCR METAB, V85, P3069, DOI 10.1210/jc.85.9.3069; Kuznetsov S, 1996, CALCIFIED TISSUE INT, V59, P265, DOI 10.1007/s002239900121; Kuznetsov SA, 1997, J BONE MINER RES, V12, P1335, DOI 10.1359/jbmr.1997.12.9.1335; Lagna G, 1996, NATURE, V383, P832, DOI 10.1038/383832a0; LIBERMAN UA, 1995, NEW ENGL J MED, V333, P1437, DOI 10.1056/NEJM199511303332201; MaciasSilva M, 1996, CELL, V87, P1215, DOI 10.1016/S0092-8674(00)81817-6; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Orwoll E, 2003, J BONE MINER RES, V18, P9, DOI 10.1359/jbmr.2003.18.1.9; PARFITT AM, 1982, METAB BONE DIS RELAT, V4, P1, DOI 10.1016/0221-8747(82)90002-9; Qiu T, 2010, NAT CELL BIOL, V12, P224, DOI 10.1038/ncb2022; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; RIGGS BL, 1991, WESTERN J MED, V154, P63; Rittmaster RS, 2000, J CLIN ENDOCR METAB, V85, P2129, DOI 10.1210/jc.85.6.2129; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Samadfam R, 2007, ENDOCRINOLOGY, V148, P2778, DOI 10.1210/en.2006-1475; Schipani E, 2009, J BONE MINER RES, V24, P1347, DOI [10.1359/JBMR.090602, 10.1359/jbmr.090602]; Street J, 2002, P NATL ACAD SCI USA, V99, P9656, DOI 10.1073/pnas.152324099; Tang Y, 2009, NAT MED, V15, P757, DOI 10.1038/nm.1979; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Towler DA, 2007, J CLIN INVEST, V117, P1477, DOI 10.1172/JCI32518; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Watanabe Ken, 2005, Molecular Aspects of Medicine, V26, P221, DOI 10.1016/j.mam.2005.01.006; Zaidi M, 2007, NAT MED, V13, P791, DOI 10.1038/nm1593; Zhang Y, 1996, NATURE, V383, P168, DOI 10.1038/383168a0; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	42	101	106	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					571	580		10.1016/j.stem.2010.09.012	http://dx.doi.org/10.1016/j.stem.2010.09.012			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040899	Bronze, Green Accepted			2022-12-28	WOS:000284390500009
J	Mattocks, M; Tropepe, V				Mattocks, Michael; Tropepe, Vincent			Waste Management and Adult Neurogenesis	CELL STEM CELL			English	Editorial Material							CELL-DEATH; BRAIN; INFLAMMATION; MICROGLIA		[Mattocks, Michael; Tropepe, Vincent] Univ Toronto, Ctr Anal Genome Evolut & Funct, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada	University of Toronto	Tropepe, V (corresponding author), Univ Toronto, Ctr Anal Genome Evolut & Funct, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada.	v.tropepe@utoronto.ca						Biebl M, 2000, NEUROSCI LETT, V291, P17, DOI 10.1016/S0304-3940(00)01368-9; Ekdahl CT, 2009, NEUROSCIENCE, V158, P1021, DOI 10.1016/j.neuroscience.2008.06.052; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Kuhn HG, 2005, EUR J NEUROSCI, V22, P1907, DOI 10.1111/j.1460-9568.2005.04377.x; MORSHEAD CM, 1992, J NEUROSCI, V12, P249; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Shruster A, 2010, APOPTOSIS, V15, P1415, DOI 10.1007/s10495-010-0491-y; Sierra A, 2010, CELL STEM CELL, V7, P483, DOI 10.1016/j.stem.2010.08.014; Ziv Y, 2006, NAT NEUROSCI, V9, P268, DOI 10.1038/nn1629	9	2	2	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					421	422		10.1016/j.stem.2010.09.008	http://dx.doi.org/10.1016/j.stem.2010.09.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887944	Bronze			2022-12-28	WOS:000283270600002
J	Yamanaka, S				Yamanaka, Shinya			Patient-Specific Pluripotent Stem Cells Become Even More Accessible	CELL STEM CELL			English	Editorial Material							GENERATION	In this issue of Cell Stem Cell, Staerk et al. (2010), Seki et al. (2010), and Loh et al. (2010) each describe the derivation of human iPSCs from peripheral blood. Although seemingly incremental, this advance brings the stem cell field an important step closer to eventual clinical use.	[Yamanaka, Shinya] Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yamanaka, S (corresponding author), Kyoto Univ, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	yamanaka@cira.kyoto-u.ac.jp						Loh YH, 2010, CELL STEM CELL, V7, P15, DOI 10.1016/j.stem.2010.06.004; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Seki T, 2010, CELL STEM CELL, V7, P11, DOI 10.1016/j.stem.2010.06.003; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Staerk J, 2010, CELL STEM CELL, V7, P20, DOI 10.1016/j.stem.2010.06.002; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	11	53	69	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					1	2		10.1016/j.stem.2010.06.009	http://dx.doi.org/10.1016/j.stem.2010.06.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621038	Bronze			2022-12-28	WOS:000280222300001
J	Pereira, CF; Piccolo, FM; Tsubouchi, T; Sauer, S; Ryan, NK; Bruno, L; Landeira, D; Santos, J; Banito, A; Gil, J; Koseki, H; Merkenschlager, M; Fisher, AG				Pereira, Carlos F.; Piccolo, Francesco M.; Tsubouchi, Tomomi; Sauer, Stephan; Ryan, Natalie K.; Bruno, Ludovica; Landeira, David; Santos, Joana; Banito, Ana; Gil, Jesus; Koseki, Haruhiko; Merkenschlager, Matthias; Fisher, Amanda G.			ESCs Require PRC2 to Direct the Successful Reprogramming of Differentiated Cells toward Pluripotency	CELL STEM CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; POLYCOMB GROUP PROTEINS; GENOME-WIDE ANALYSIS; STEM-CELLS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; CELLULAR MEMORY; GENE-EXPRESSION; METHYLATION	Embryonic stem cells (ESCs) are pluripotent, self-renewing, and have the ability to reprogram differentiated cell types to pluripotency upon cellular fusion. Polycomb-group (PcG) proteins are important for restraining the inappropriate expression of lineage-specifying factors in ESCs. To investigate whether PcG proteins are required for establishing, rather than maintaining, the pluripotent state, we compared the ability of wild-type, PRC1-, and PRC2-depleted ESCs to reprogram human lymphocytes. We show that ESCs lacking either PRC1 or PRC2 are unable to successfully reprogram B cells toward pluripotency. This defect is a direct consequence of the lack of PcG activity because it could be efficiently rescued by reconstituting PRC2 activity in PRC2-deficient ESCs. Surprisingly, the failure of PRC2-deficient ESCs to reprogram somatic cells is functionally dominant, demonstrating a critical requirement for PcG proteins in the chromatin-remodeling events required for the direct conversion of differentiated cells toward pluripotency.	[Pereira, Carlos F.; Piccolo, Francesco M.; Tsubouchi, Tomomi; Sauer, Stephan; Ryan, Natalie K.; Bruno, Ludovica; Landeira, David; Santos, Joana; Merkenschlager, Matthias; Fisher, Amanda G.] Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, London W12 0NN, England; [Banito, Ana; Gil, Jesus] Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Cell Proliferat Grp, London W12 0NN, England; [Koseki, Haruhiko] RIKEN Yokohama Inst, RIKEN Res Ctr Allergy & Immunol, Dept Dev Genet, Yokohama, Kanagawa, Japan	Imperial College London; Imperial College London; RIKEN	Fisher, AG (corresponding author), Hammersmith Hosp, Imperial Coll Sch Med, MRC Clin Sci Ctr, Lymphocyte Dev Grp, Du Cane Rd, London W12 0NN, England.	amanda.fisher@csc.mrc.ac.uk	Landeira, David/F-5001-2018; Pereira, Carlos-Filipe/B-8438-2013; Koseki, Haruhiko/I-3825-2014; Ryan, Natalie K/H-1539-2011; Landeira, David/ADY-5662-2022; Banito, Ana/P-6168-2017; Gil, Jesus/C-7739-2012	Landeira, David/0000-0002-3267-454X; Pereira, Carlos-Filipe/0000-0002-9724-1382; Koseki, Haruhiko/0000-0001-8424-5854; Gil, Jesus/0000-0002-4303-6260; Tsubouchi, Tomomi/0000-0001-9960-3888; Merkenschlager, Matthias/0000-0003-2889-3288; Banito, Ana/0000-0003-2188-0003	Medical Research Council [MC_U120027516, MC_U120085810] Funding Source: Medline; MRC [MC_U120085810, MC_U120027516] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chi AS, 2009, SCIENCE, V323, P220, DOI 10.1126/science.1166261; Cobb BS, 2005, J EXP MED, V201, P1367, DOI 10.1084/jem.20050572; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; Do JT, 2007, STEM CELLS, V25, P1013, DOI 10.1634/stemcells.2006-0691; Duncan SA, 1997, DEVELOPMENT, V124, P279; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; Jorgensen HF, 2006, CELL CYCLE, V5, P1411, DOI 10.4161/cc.5.13.2927; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; LANDEIRA D, 2010, NAT CELL BI IN PRESS; Lee N, 2005, NATURE, V438, P234, DOI 10.1038/nature04120; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; McClure KD, 2008, DEV BIOL, V319, P68, DOI 10.1016/j.ydbio.2008.04.004; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Murata K, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-4; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Pelton TA, 2002, J CELL SCI, V115, P329; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; PEREIRA CF, 2009, CURR PROTOC STEM CEL, pCH4; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Rossant J, 2009, DEVELOPMENT, V136, P701, DOI 10.1242/dev.017178; Santos J, 2010, EPIGENET CHROMATIN, V3, DOI 10.1186/1756-8935-3-1; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Scott IC, 2000, MOL CELL BIOL, V20, P530, DOI 10.1128/MCB.20.2.530-541.2000; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sinclair DAR, 2009, P NATL ACAD SCI USA, V106, P13427, DOI 10.1073/pnas.0904638106; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Su IH, 2003, NAT IMMUNOL, V4, P124, DOI 10.1038/ni876; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Tada T, 1998, DEV GENES EVOL, V207, P551, DOI 10.1007/s004270050146; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Terranova R, 2006, J CELL SCI, V119, P2065, DOI 10.1242/jcs.02945; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973	62	127	129	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					547	556		10.1016/j.stem.2010.04.013	http://dx.doi.org/10.1016/j.stem.2010.04.013			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569692	Bronze			2022-12-28	WOS:000278840700015
J	Sweet, DJ				Sweet, Deborah J.			Stepping Stones on Solid Ground	CELL STEM CELL			English	Editorial Material																		Cuende N, 2010, CELL STEM CELL, V6, P508, DOI 10.1016/j.stem.2010.05.005; Davison AC, 2010, CELL STEM CELL, V6, P504, DOI 10.1016/j.stem.2010.05.011; Kokovay E, 2010, CELL STEM CELL, V6, P533, DOI 10.1016/j.stem.2010.05.002; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Trounson A, 2010, CELL STEM CELL, V6, P513, DOI 10.1016/j.stem.2010.05.008; 2010, NAT MED, V16, P492	7	3	3	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					493	493		10.1016/j.stem.2010.05.015	http://dx.doi.org/10.1016/j.stem.2010.05.015			1	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569680	Bronze			2022-12-28	WOS:000278840700001
J	Fasano, CA; Chambers, SM; Lee, G; Tomishima, MJ; Studer, L				Fasano, Christopher A.; Chambers, Stuart M.; Lee, Gabsang; Tomishima, Mark J.; Studer, Lorenz			Efficient Derivation of Functional Floor Plate Tissue from Human Embryonic Stem Cells	CELL STEM CELL			English	Article							SONIC HEDGEHOG; DIRECTED DIFFERENTIATION; SELF-RENEWAL; DOPAMINE NEURONS; MOTOR-NEURONS; SPINAL-CORD; HUMAN ES; MOUSE; INDUCTION; SPECIFICATION	The floor plate (FP) is a critical signaling center during neural development located along the ventral midline of the embryo. Little is known about human FP development because of the lack of tissue accessibility. Here we report the efficient derivation of human embryonic stem cell (hESC)-derived FP tissue capable of secreting Netrin-1 and SHH and patterning primary and hESC derived tissues. FP induction in hESCs is dependent on early SHH exposure and occurs at the expense of anterior neurectoderm (AN). Global gene expression and functional studies identify SHH-mediated inhibition of Dkk-1 as key factor in FP versus AN specification. hESC-derived FP tissue is shown to be of anterior SIX6+ character but is responsive to caudalizing factors suppressing SIX6 expression and inducing a shift in usage of region-specific SHH enhancers. These data define the early signals that drive human FP versus AN specification and determine regional identity in hESC-derived FP.	[Fasano, Christopher A.; Chambers, Stuart M.; Lee, Gabsang; Studer, Lorenz] Sloan Kettering Inst, Dev Biol Program, New York, NY 10065 USA; [Tomishima, Mark J.] Sloan Kettering Inst, SKI Stem Cell Res Facil, New York, NY 10065 USA; [Studer, Lorenz] Sloan Kettering Inst, Dept Neurosurg, New York, NY 10065 USA; [Fasano, Christopher A.] New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Fasano, CA (corresponding author), Sloan Kettering Inst, Dev Biol Program, 1275 York Ave, New York, NY 10065 USA.		Studer, Lorenz/ABH-1491-2021	Studer, Lorenz/0000-0003-0741-7987	New York Stem Cell Foundation; NINDS/NIH [NS052671]; Starr Foundation; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052671] Funding Source: NIH RePORTER	New York Stem Cell Foundation; NINDS/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Starr Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Marysia Plazcek for advice on Floor Plate markers, Doug Epstein for providing the Sonic Enhancers, and Sally Temple for critical reading of the manuscript We also thank Agnete Kirkeby for providing data on Sonic C25II C A F is supported by the New York Stem Cell Foundation, S A C is Starr Stem Cell Scholar, M J T is supported in part by the Starr Foundation. and the work is supported in part through grant NS052671 from NINDS/NIH and grant support to L S from the Starr Foundation C A F designed and performed all experiments, interpreted the data, and wrote the manuscript S M C helped with design and experiments for the microarray study and performed all array analysis G L helped with floor plate functional studies M T was instrumental in the conception of the project and helped with experimental design and data interpretations L S supervised design and execution of the entire study, helped with data interpretations and analysis, and writing of manuscript	Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Briscoe J, 1999, SEMIN CELL DEV BIOL, V10, P353, DOI 10.1006/scdb.1999.0295; Burns CJ, 2008, DEV DYNAM, V237, P1614, DOI 10.1002/dvdy.21565; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Charrier JB, 2002, DEVELOPMENT, V129, P4785; Charron F, 2003, CELL, V113, P11, DOI 10.1016/S0092-8674(03)00199-5; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dale K, 1999, DEVELOPMENT, V126, P397; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Ericson J, 1996, CELL, V87, P661, DOI 10.1016/S0092-8674(00)81386-0; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fasano CA, 2009, GENE DEV, V23, P561, DOI 10.1101/gad.1743709; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; HUNTER K, 1991, P NATL ACAD SCI USA, V88, P3666, DOI 10.1073/pnas.88.9.3666; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jeong Y, 2003, DEVELOPMENT, V130, P3891, DOI 10.1242/dev.00590; Jeong Y, 2008, NAT GENET, V40, P1348, DOI 10.1038/ng.230; Jeong YS, 2006, DEVELOPMENT, V133, P761, DOI 10.1242/dev.02239; JESSELL TM, 1989, CIBA F SYMP, V144, P255; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; JESSELL TM, 1989, CIBA F SYMP, V144, P290; JESSELL TM, 1989, CIBA F SYMP, V144, P276; Joksimovic M, 2009, NAT NEUROSCI, V12, P125, DOI 10.1038/nn.2243; Kapsimali M, 2004, DEVELOPMENT, V131, P5923, DOI 10.1242/dev.01453; Kim AS, 2001, MECH DEVELOP, V103, P167, DOI 10.1016/S0925-4773(01)00342-2; Kimura-Yoshida C, 2007, P NATL ACAD SCI USA, V104, P5919, DOI 10.1073/pnas.0607779104; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Li XJ, 2008, STEM CELLS, V26, P886, DOI 10.1634/stemcells.2007-0620; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; LYUKSYUTOVA AI, 1998, DEVELOPMENT, V125, P2759; Matise MP, 1998, DEVELOPMENT, V125, P2759; Mizuseki K, 2003, P NATL ACAD SCI USA, V100, P5828, DOI 10.1073/pnas.1037282100; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Mullor JL, 2002, TRENDS CELL BIOL, V12, P562, DOI 10.1016/S0962-8924(02)02405-4; Ono Y, 2007, DEVELOPMENT, V134, P3213, DOI 10.1242/dev.02879; Patten I, 2003, DEVELOPMENT, V130, P4809, DOI 10.1242/dev.00694; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Placzek M, 2005, NAT REV NEUROSCI, V6, P230, DOI 10.1038/nrn1628; PLACZEK M, 1993, DEVELOPMENT, V117, P205; PLACZEK M, 1995, CURR OPIN GENET DEV, V5, P499, DOI 10.1016/0959-437X(95)90055-L; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; SHIRASAKI R, 1995, NEURON, V14, P961, DOI 10.1016/0896-6273(95)90334-8; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Zoltewicz JS, 1999, DEVELOPMENT, V126, P5085	49	167	181	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					336	347		10.1016/j.stem.2010.03.001	http://dx.doi.org/10.1016/j.stem.2010.03.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362538	Green Accepted, Bronze			2022-12-28	WOS:000276823300012
J	Benveniste, P; Frelin, C; Janmohamed, S; Barbara, M; Herrington, R; Hyam, D; Iscove, NN				Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.			Intermediate-Term Hematopoietic Stem Cells with Extended but Time-Limited Reconstitution Potential	CELL STEM CELL			English	Article							LONG-TERM; SELF-RENEWAL; IN-VIVO; PROGENITOR CELLS; EXPRESSION; IDENTIFICATION; DIFFERENTIATION; COMPARTMENT; EXPANSION; CULTURE	Sustained blood cell production depends on divisions by hematopoietic stem cells (HSCs) that yield both differentiating progeny as well as new HSCs via self-renewal. Differentiating progeny remain capable of self-renewal, but only HSCs sustain self-renewal through successive divisions securely enough to maintain clones that persist life-long. Until recently, the first identified next stage consisted of "short-term" reconstituting cells able to sustain clones of differentiating cells for only 4-6 weeks. Here we expand evidence for a numerically dominant "intermediate-term" multipotent HSC stage in mice whose clones persist for 6-8 months before becoming extinct and that are separable from both short-term as well as permanently reconstituting "long-term" HSCs. The findings suggest that the first step in stem cell differentiation consists not in loss of initial capacity for serial self-renewal divisions, but rather in loss of mechanisms that stabilize self-renewing behavior throughout successive future stem cell divisions.	[Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] Univ Toronto, Dept Med Biophys, Toronto, ON M5S 1A8, Canada; [Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] Univ Toronto, Dept Immunol, Toronto, ON M5S 1A8, Canada; [Benveniste, Patricia; Frelin, Catherine; Janmohamed, Salima; Barbara, Mary; Herrington, Robert; Hyam, Deborah; Iscove, Norman N.] McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto	Iscove, NN (corresponding author), Ontario Canc Inst, Toronto, ON M5G 2M9, Canada.	iscove@uhnresearch.ca		Benveniste, Patricia/0000-0002-5673-0542	Terry Fox Foundation [015005]; National Cancer Institute of Canada; Canadian Institutes of Health Research; Stem Cell Network; National Institutes of Health; McEwen Centre for Regenerative Medicine	Terry Fox Foundation; National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Stem Cell Network; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); McEwen Centre for Regenerative Medicine	We thank Giselle Knowles and Pier-Andree Penttila for assistance with flow cytometry and Maria-Fernanda Monroy for help with animal procedures. The work was funded by grants from the Terry Fox Foundation (#015005), the National Cancer Institute of Canada, Canadian Institutes of Health Research, the Stem Cell Network, and the National Institutes of Health, and additional support came from the McEwen Centre for Regenerative Medicine.	Adolfsson J, 2001, IMMUNITY, V15, P659, DOI 10.1016/S1074-7613(01)00220-5; Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Dai XM, 2002, BLOOD, V99, P111, DOI 10.1182/blood.V99.1.111; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ema H, 2005, DEV CELL, V8, P907, DOI 10.1016/j.devcel.2005.03.019; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; HARRISON DE, 1991, EXP HEMATOL, V19, P374; Hasumura M, 2003, EXP HEMATOL, V31, P1331, DOI 10.1016/j.exphem.2003.09.004; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Iscove NN, 1997, CURR BIOL, V7, P805, DOI 10.1016/S0960-9822(06)00341-1; Iscove NN, 2002, NAT BIOTECHNOL, V20, P940, DOI 10.1038/nbt729; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; LI CL, 1995, BLOOD, V85, P1472, DOI 10.1182/blood.V85.6.1472.bloodjournal8561472; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morshead CM, 2002, NAT MED, V8, P268, DOI 10.1038/nm0302-268; Muro EM, 2008, P NATL ACAD SCI USA, V105, P20286, DOI 10.1073/pnas.0807813105; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P57, DOI 10.1111/j.1749-6632.1999.tb08453.x; Nakauchi H, 1999, ANN NY ACAD SCI, V872, P66; Nibley WE, 1998, BONE MARROW TRANSPL, V21, P345, DOI 10.1038/sj.bmt.1701097; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pawliuk R, 1996, BLOOD, V88, P2852, DOI 10.1182/blood.V88.8.2852.bloodjournal8882852; Perez-Iratxeta C, 2005, FEBS LETT, V579, P1795, DOI 10.1016/j.febslet.2005.02.020; Porter Christopher J., 2007, V407, P137, DOI 10.1007/978-1-59745-536-7_11; Ramsfjell V, 1999, BLOOD, V94, P4093, DOI 10.1182/blood.V94.12.4093.424k09_4093_4102; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Trevisan M, 1996, BLOOD, V88, P4149, DOI 10.1182/blood.V88.11.4149.bloodjournal88114149; TREVISAN M, 1995, J EXP MED, V181, P93, DOI 10.1084/jem.181.1.93; Uchida N, 2003, EXP HEMATOL, V31, P1338, DOI 10.1016/j.exphem.2003.09.001; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9; Wagers AJ, 2006, STEM CELLS, V24, P1087, DOI 10.1634/stemcells.2005-0396; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yang LP, 2005, BLOOD, V105, P2717, DOI 10.1182/blood-2004-06-2159; Zhao Y, 2000, BLOOD, V96, P3016; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	41	131	135	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					48	58		10.1016/j.stem.2009.11.014	http://dx.doi.org/10.1016/j.stem.2009.11.014			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074534	Bronze			2022-12-28	WOS:000274029700011
J	Trowbridge, JJ; Snow, JW; Kim, J; Orkin, SH				Trowbridge, Jennifer J.; Snow, Jonathan W.; Kim, Jonghwan; Orkin, Stuart H.			DNA Methyltransferase 1 Is Essential for and Uniquely Regulates Hematopoietic Stem and Progenitor Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; METHYLATION; DIFFERENTIATION; MAINTENANCE; SURVIVAL; DNMT3B	DNA methylation is essential for development and in diverse biological processes. The DNA methyltransferase Dnmt1 maintains parental cell methylation patterns on daughter DNA strands in mitotic cells; however, the precise role of Dnmt1 in regulation of quiescent adult stem cells is not known. To examine the role of Dnmt1 in adult hematopoietic stem cells (HSCs), we conditionally disrupted Dnmt1 in the hematopoietic system. Defects were observed in Dnmt1 deficient HSC self-renewal, niche retention, and in the ability of Dnmt1-deficient HSCs to give rise to multilineage hematopoiesis. Loss of Dnmt1 also had specific impact on myeloid progenitor cells, causing enhanced cell cycling and inappropriate expression of mature lineage genes. Dnmt1 regulates distinct patterns of methylation and expression of discrete gene families in long-term HSCs and multipotent and lineage-restricted progenitors, suggesting that Dnmt1 differentially controls these populations. These findings establish a unique and critical role for Dnmt1 in the primitive hematopoietic compartment.	[Trowbridge, Jennifer J.; Snow, Jonathan W.; Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Dana Farber Canc Inst, Boston, MA 02115 USA; [Trowbridge, Jennifer J.; Snow, Jonathan W.; Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp Boston,Div Hematol Oncol, Harvard Stem Cell Inst,Dept Pediat Oncol, Boston, MA 02115 USA; [Kim, Jonghwan; Orkin, Stuart H.] Harvard Univ, Sch Med, Childrens Hosp Boston,Div Hematol Oncol, Harvard Stem Cell Inst,Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute	Orkin, SH (corresponding author), Harvard Univ, Sch Med, Dept Pediat Oncol, Dana Farber Canc Inst, Boston, MA 02115 USA.	orkin@bloodgroup.tch.harvard.edu	Kim, Jonghwan/AAR-2815-2021	Kim, Jonghwan/0000-0002-9919-9843	Fellows of the Leukemia & Lymphoma Society; HHMI Research Associate; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	Fellows of the Leukemia & Lymphoma Society; HHMI Research Associate(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. C.R. Walkley, L.E. Purton, J. Xu, D.A. Williams, G.C. Yuan, and M.D. Kiers for helpful discussion and critical comments; J. Chong for technical assistance; Children's Hospital Animal Facility Staff for care of experimental animals; and J. Daley and S. Lazo-Kallanian of the DFCI HemNeo Flow Facility for cell sorting. J.J.T. and J.W.S. are Fellows of the Leukemia & Lymphoma Society, J.K. is a HHMI Research Associate, and S.H.O. is an Investigator of the HHMI.	Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Fan GP, 2001, J NEUROSCI, V21, P788, DOI 10.1523/JNEUROSCI.21-03-00788.2001; Gaudet F, 2004, MOL CELL BIOL, V24, P1640, DOI 10.1128/MCB.24.4.1640-1648.2004; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jaenisch R, 1997, TRENDS GENET, V13, P323, DOI 10.1016/S0168-9525(97)01180-3; Jasinski M, 2001, BLOOD, V98, P2248, DOI 10.1182/blood.V98.7.2248; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Schadt EE, 2001, J CELL BIOCHEM, V84, P120, DOI 10.1002/jcb.10073; Tadokoro Y, 2007, J EXP MED, V204, P715, DOI 10.1084/jem.20060750; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; VILLEVAL JL, 1985, BLOOD, V66, P1162; Walkley CR, 2007, CELL, V129, P1081, DOI 10.1016/j.cell.2007.03.055	16	258	261	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					442	449		10.1016/j.stem.2009.08.016	http://dx.doi.org/10.1016/j.stem.2009.08.016			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796624	Green Accepted, Bronze			2022-12-28	WOS:000271401900015
J	Duguez, S; Partridge, T				Duguez, Stephanie; Partridge, Terry			Skeletal Muscle Sings a Choral Stem Cell Lullaby	CELL STEM CELL			English	Editorial Material							SATELLITE CELLS; SELF-RENEWAL; HETEROGENEITY; PROGENITORS; NICHE		[Duguez, Stephanie; Partridge, Terry] Childrens Natl Med Ctr, Ctr Genet Med, Washington, DC 20010 USA	Children's National Health System	Partridge, T (corresponding author), Childrens Natl Med Ctr, Ctr Genet Med, 111 Michigan Ave NW, Washington, DC 20010 USA.	tpartridge@cnmcresearch.org	Duguez, Stephanie/J-1904-2016	Duguez, Stephanie/0000-0001-6510-5426				Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; Chazaud B, 2003, J CELL BIOL, V163, P1133, DOI 10.1083/jcb.200212046; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	7	3	3	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					231	232		10.1016/j.stem.2009.08.012	http://dx.doi.org/10.1016/j.stem.2009.08.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733529	Bronze			2022-12-28	WOS:000272545700003
J	Van Hoof, D; Munoz, J; Braam, SR; Pinkse, MWH; Linding, R; Heck, AJR; Mummery, CL; Krijgsveld, J				Van Hoof, Dennis; Munoz, Javier; Braam, Stefan R.; Pinkse, Martijn W. H.; Linding, Rune; Heck, Albert J. R.; Mummery, Christine L.; Krijgsveld, Jeroen			Phosphorylation Dynamics during Early Differentiation of Human Embryonic Stem Cells	CELL STEM CELL			English	Article							TRANSCRIPTIONAL REGULATORY CIRCUITRY; SELF-RENEWAL; IN-VIVO; PLURIPOTENCY; PROTEIN; SOX2; NANOG; EXPRESSION; TARGET; METHYLATION	Pluripotent stem cells, self-renew indefinitely and possess characteristic protein-protein networks that remodel during differentiation. How this occurs is poorly understood. Using quantitative mass spectrometry, we analyzed the (phospho)proteome of human embryonic stem cells (hESCs) during differentiation induced by bone morphogenetic protein (BMP) and removal of hESC growth factors. Of 5222 proteins identified, 1399 were phosphorylated on 3067 residues. Approximately 50% of these phosphosites were regulated within 1 hr of differentiation induction, revealing a complex interplay of phosphorylation networks spanning different signaling pathways and kinase activities. Among the phosphorylated proteins was the pluripotency-associated protein SOX2, which was SUMOylated as a result of phosphorylation. Using the data to predict kinase-substrate relationships, we reconstructed the hESC kinome, CDK1/2 emerged as central in controlling se renewal and lineage specification. The findings provide new insights into how hESCs exit the pluripotent state and present the hESC (phospho)proteome resource as a complement to existing pluripotency network databases.	[Van Hoof, Dennis; Munoz, Javier; Pinkse, Martijn W. H.; Heck, Albert J. R.; Krijgsveld, Jeroen] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CH Utrecht, Netherlands; [Van Hoof, Dennis; Munoz, Javier; Pinkse, Martijn W. H.; Heck, Albert J. R.; Krijgsveld, Jeroen] Univ Utrecht, Utrecht Inst Pharmaceut Sci, NL-3584 CH Utrecht, Netherlands; [Van Hoof, Dennis; Braam, Stefan R.; Mummery, Christine L.] Hubrecht Inst, NL-3584 CT Utrecht, Netherlands; [Braam, Stefan R.; Mummery, Christine L.] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2333 ZC Leiden, Netherlands; [Linding, Rune] Inst Canc Res, Sect Cell & Mol Biol, Cellular & Mol Log Team, London SW3 6JB, England	Utrecht University; Utrecht University; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Heck, AJR (corresponding author), Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, Padualaan 8, NL-3584 CH Utrecht, Netherlands.	a.j.r.heck@uu.nl; c.l.mummery@lumc.nl; jeroen.krijgsveld@embl.de	Krijgsveld, Jeroen/F-5974-2011; Munoz, Javier/I-4891-2012; Heck, Albert/D-7098-2011	Munoz, Javier/0000-0003-3288-3496; Heck, Albert/0000-0002-2405-4404; Linding, Rune/0000-0003-0420-4839; Krijgsveld, Jeroen/0000-0001-7549-9326; Mummery, Christine/0000-0002-4549-6535	Bsik programmes "Dutch Platform for Tissue Engineering," Stem Cells in Development and Disease; Netherlands Proteomic Center; FP6 EU Programme Heart Development and Heart Repair; Netherlands Organisation for Scientific Research (NWO)	Bsik programmes "Dutch Platform for Tissue Engineering," Stem Cells in Development and Disease; Netherlands Proteomic Center; FP6 EU Programme Heart Development and Heart Repair; Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO))	We thank Dr. A.C.O. Vertegaal for the nickel-nitrilotriacetic acid-agarose bead purification experiments; Dr. D. Melton for HUES-7; Dr. N.A. Hanley for pcDNA3.1/Zeo-hSox2; Dr. C. Denning for pCAG-GFP-IRES-Puror; Dr. M.J. Goumans for p-GSK3 beta and p-4EIFEBP1 antibodies; S. Mohammed for mass spectrometry support; and J. Gouw, B. van Breukelen, and H. van den Toorn for in-house software development. This work was supported by the Bsik programmes "Dutch Platform for Tissue Engineering," Stem Cells in Development and Disease; by the Netherlands Proteomic Center; by the FP6 EU Programme Heart Development and Heart Repair; and by the Netherlands Organisation for Scientific Research (NWO).	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Binetruy B, 2007, STEM CELLS, V25, P1090, DOI 10.1634/stemcells.2006-0612; Botuyan MV, 2006, CELL, V127, P1361, DOI 10.1016/j.cell.2006.10.043; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen GQ, 2000, GENE, V249, P1, DOI 10.1016/S0378-1119(00)00161-X; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79; Eckert JJ, 2008, BBA-BIOMEMBRANES, V1778, P717, DOI 10.1016/j.bbamem.2007.09.031; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Freund C, 2008, STEM CELLS, V26, P724, DOI 10.1634/stemcells.2007-0617; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; GU Y, 1992, EMBO J, V11, P3995, DOI 10.1002/j.1460-2075.1992.tb05493.x; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Hietakangas V, 2006, P NATL ACAD SCI USA, V103, P45, DOI 10.1073/pnas.0503698102; Irvine K, 2004, INT J DEV BIOL, V48, P1065, DOI 10.1387/ijdb.041893ki; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jelier R, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-6-r96; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Masui S, 2007, NAT CELL BIOL, V9, P625, DOI 10.1038/ncb1589; Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Pinkse MWH, 2008, J PROTEOME RES, V7, P687, DOI 10.1021/pr700605z; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; Shao ZL, 2006, CIRC RES, V98, P111, DOI 10.1161/01.RES.0000197781.20524.b9; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tsuruzoe S, 2006, BIOCHEM BIOPH RES CO, V351, P920, DOI 10.1016/j.bbrc.2006.10.130; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; van den Boom V, 2007, J CELL BIOL, V178, P913, DOI 10.1083/jcb.200702058; Van Hoof D, 2007, NAT METHODS, V4, P677, DOI 10.1038/nmeth0907-677; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Van Hoof D, 2008, STEM CELLS, V26, P2777, DOI 10.1634/stemcells.2008-0365; Vertegaal ACO, 2004, J BIOL CHEM, V279, P33791, DOI 10.1074/jbc.M404201200; Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635	64	253	258	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					214	226		10.1016/j.stem.2009.05.021	http://dx.doi.org/10.1016/j.stem.2009.05.021			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664995	Bronze			2022-12-28	WOS:000269511900014
J	Chin, MH; Mason, MJ; Xie, W; Volinia, S; Singer, M; Peterson, C; Ambartsumyan, G; Aimiuwu, O; Richter, L; Zhang, J; Khvorostov, I; Ott, V; Grunstein, M; Lavon, N; Benvenisty, N; Croce, CM; Clark, AT; Baxter, T; Pyle, AD; Teitell, MA; Pelegrini, M; Plath, K; Lowry, WE				Chin, Mark H.; Mason, Mike J.; Xie, Wei; Volinia, Stefano; Singer, Mike; Peterson, Cory; Ambartsumyan, Gayane; Aimiuwu, Otaren; Richter, Laura; Zhang, Jin; Khvorostov, Ivan; Ott, Vanessa; Grunstein, Michael; Lavon, Neta; Benvenisty, Nissim; Croce, Carlo M.; Clark, Amander T.; Baxter, Tim; Pyle, April D.; Teitell, Mike A.; Pelegrini, Matteo; Plath, Kathrin; Lowry, William E.			Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression Signatures	CELL STEM CELL			English	Article							DIFFERENTIATION; FIBROBLASTS; GENERATION; INDUCTION; SKIN; DERIVATION	Induced pluripotent stem cells (iPSCs) outwardly appear to be indistinguishable from embryonic stem cells (ESCs). A study of gene expression profiles of mouse and human ESCs and iPSCs suggests that, while iPSCs are quite similar to their embryonic counterparts, a recurrent gene expression signature appears in iPSCs regardless of their origin or the method by which they were generated. Upon extended culture, hiPSCs adopt a gene expression profile more similar to hESCs; however, they still retain a gene expression signature unique from hESCs that extends to miRNA expression. Genome-wide data suggested that the iPSC signature gene expression differences are due to differential promoter binding by the reprogramming factors. High-resolution array profiling demonstrated that there is no common specific subkaryotypic alteration that is required for reprogramming and that reprogramming does not lead to genomic instability. Together, these data suggest that iPSCs should be considered a unique subtype of pluripotent cell.	[Chin, Mark H.; Mason, Mike J.; Xie, Wei; Grunstein, Michael; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA; [Ambartsumyan, Gayane; Aimiuwu, Otaren; Richter, Laura; Clark, Amander T.; Pelegrini, Matteo; Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Peterson, Cory; Pyle, April D.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Zhang, Jin; Khvorostov, Ivan; Teitell, Mike A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol, Los Angeles, CA 90095 USA; [Zhang, Jin; Khvorostov, Ivan; Teitell, Mike A.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Los Angeles, CA 90095 USA; [Clark, Amander T.; Pyle, April D.; Teitell, Mike A.; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Broad Stem Cell Ctr, Los Angeles, CA 90095 USA; [Clark, Amander T.; Pyle, April D.; Teitell, Mike A.; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Clark, Amander T.; Pyle, April D.; Teitell, Mike A.; Pelegrini, Matteo; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Mason, Mike J.] Univ Calif Los Angeles, Dept Stat, Los Angeles, CA 90095 USA; [Lavon, Neta; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, IL-91904 Jerusalem, Israel; [Volinia, Stefano; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Singer, Mike; Ott, Vanessa; Baxter, Tim] Roche NimbleGen Inc, Madison, WI 53719 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Hebrew University of Jerusalem; University System of Ohio; Ohio State University; Roche Holding	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA.	kplath@mednet.ucla.edu; blowry@ucla.edu	Xie, Wei/J-1380-2017; ZHANG, JIN/D-1435-2013; Young, Richard A/F-6495-2012; Volinia, Stefano/AAA-9264-2019; Volinia, Stefano/A-3029-2010	Xie, Wei/0000-0003-2126-3849; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Volinia, Stefano/0000-0003-0910-3893; Plath, Kathrin/0000-0001-7796-3372; Mason, Michael/0000-0002-5652-7739	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K12HD001281] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [T32CA009056, P01CA129242] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081621, R37GM023674, R01GM023674] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA129242, T32 CA009056, #T32 CA009056] Funding Source: Medline; NICHD NIH HHS [K12 HD001281, 5 K12 HD001281] Funding Source: Medline; NIGMS NIH HHS [P01 GM081621-01A1, R01 GM023674, P01 GM081621, R37 GM023674, GM23674] Funding Source: Medline; NIH HHS [DP2 OD001686-01, DP2 OD001686] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Card DAG, 2008, MOL CELL BIOL, V28, P6426, DOI 10.1128/MCB.00359-08; Choi KD, 2009, STEM CELLS, V27, P559, DOI 10.1634/stemcells.2008-0922; Gokhale PJ, 2006, SEMIN REPROD MED, V24, P289, DOI 10.1055/s-2006-952151; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Krutzfeldt J, 2006, NAT GENET, V38, pS14, DOI 10.1038/ng1799; Laurent LC, 2008, STEM CELLS, V26, P1506, DOI 10.1634/stemcells.2007-1081; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Ng RK, 2008, NAT CELL BIOL, V10, P102, DOI 10.1038/ncb1674; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Selzer RR, 2005, GENE CHROMOSOME CANC, V44, P305, DOI 10.1002/gcc.20243; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tang GL, 2005, TRENDS BIOCHEM SCI, V30, P106, DOI 10.1016/j.tibs.2004.12.007; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilson KD, 2009, STEM CELLS DEV, V18, P749, DOI 10.1089/scd.2008.0247; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744; Yi R, 2008, NATURE, V452, P225, DOI 10.1038/nature06642; Yi R, 2009, P NATL ACAD SCI USA, V106, P498, DOI 10.1073/pnas.0810766105; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105	41	758	827	0	130	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					111	123		10.1016/j.stem.2009.06.008	http://dx.doi.org/10.1016/j.stem.2009.06.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570518	Bronze, Green Accepted			2022-12-28	WOS:000267879200015
J	Lee, RH; Pulin, AA; Seo, MJ; Kota, DJ; Ylostalo, J; Larson, BL; Semprun-Prieto, L; Delafontaine, P; Prockop, DJ				Lee, Ryang Hwa; Pulin, Andrey A.; Seo, Min Jeong; Kota, Daniel J.; Ylostalo, Joni; Larson, Benjamin L.; Semprun-Prieto, Laura; Delafontaine, Patrice; Prockop, Darwin J.			Intravenous hMSCs Improve Myocardial Infarction in Mice because Cells Embolized in Lung Are Activated to Secrete the Anti-inflammatory Protein TSG-6	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; COLLAGEN-INDUCED ARTHRITIS; MULTIPOTENT STROMAL CELLS; INTER-ALPHA-INHIBITOR; BONE-MARROW; HEMATOPOIETIC STEM; IN-VIVO; STEM/PROGENITOR CELLS; VENTRICULAR-FUNCTION; CLINICAL-TRIALS	Quantitative assays for human DNA and mRNA were used to examine the paradox that intravenously (i.v.) infused human multipotent stromal cells (hMSCs) can enhance tissue repair without significant engraftment. After 2 x 106 hMSCs were i.v. infused into mice, most of the cells were trapped as emboli in lung. The cells in lung disappeared with a half-life of about 24 hr, but <1000 cells appeared in six other tissues. The hMSCs in lung upregulated expression of multiple genes, with a large increase in the anti-inflammatory protein TSG-6. After myocardial infarction, i.v. hMSCs, but not hMSCs transduced with TSG-6 siRNA, decreased inflammatory responses, reduced infarct size, and improved cardiac function. I.v. administration of recombinant TSG-6 also reduced inflammatory responses and reduced infarct size. The results suggest that improvements in animal models and patients after i.v. infusions of MSCs are at least in part explained by activation of MSCs to secrete TSG-6.	[Lee, Ryang Hwa; Pulin, Andrey A.; Seo, Min Jeong; Kota, Daniel J.; Ylostalo, Joni; Larson, Benjamin L.; Prockop, Darwin J.] Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70112 USA; [Lee, Ryang Hwa; Kota, Daniel J.; Ylostalo, Joni; Larson, Benjamin L.; Prockop, Darwin J.] Texas A&M Hlth Sci Ctr, Coll Med, Inst Regenerat Med Scott & White, Temple, TX 76502 USA; [Semprun-Prieto, Laura; Delafontaine, Patrice] Tulane Univ, Sch Med, Inst Heart & Vasc, New Orleans, LA 70112 USA	Tulane University; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Tulane University	Prockop, DJ (corresponding author), Tulane Univ, Hlth Sci Ctr, Ctr Gene Therapy, New Orleans, LA 70112 USA.	prockop@medicine.tamhsc.edu	Pulin, Andrey A/R-7105-2016; Ylostalo, Joni/AAH-9457-2019	Pulin, Andrey A/0000-0002-9499-4979; Ylostalo, Joni/0000-0001-9746-1994; Delafontaine, Patrice/0000-0003-3744-3617	NIH [HL073252, P40 RR 17447, P01 HL 075161, 1R01HL080682-01A2]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR017447] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL075161, R01HL073252, R01HL080682] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The work was supported in part by grants from the NIH (HL073252, P40 RR 17447, P01 HL 075161, and 1R01HL080682-01A2). We thank Nickolay Bazhanov and Ulf Krause for helping with mouse surgery.	Akiyama Y, 2002, GLIA, V39, P229, DOI 10.1002/glia.10102; Baddoo M, 2003, J CELL BIOCHEM, V89, P1235, DOI 10.1002/jcb.10594; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Bardos T, 2001, AM J PATHOL, V159, P1711, DOI 10.1016/S0002-9440(10)63018-0; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; BURTON K, 1956, BIOCHEM J, V62, P315, DOI 10.1042/bj0620315; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Carvalho RF, 2006, INT J EXP PATHOL, V87, P437, DOI 10.1111/j.1365-2613.2006.00497.x; Chapelle J P, 1998, Rev Med Liege, V53, P619; Choi MS, 2008, CELL TRANSPLANT, V17, P899, DOI 10.3727/096368908786576471; Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d; Colter DC, 2001, P NATL ACAD SCI USA, V98, P7841, DOI 10.1073/pnas.141221698; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Dooner M, 2004, BLOOD CELL MOL DIS, V32, P47, DOI 10.1016/j.bcmd.2003.09.014; Ezquer FE, 2008, BIOL BLOOD MARROW TR, V14, P631, DOI 10.1016/j.bbmt.2008.01.006; Forteza R, 2007, AM J RESP CELL MOL, V36, P20, DOI 10.1165/rcmb.2006-0018OC; Furlani D, 2009, MICROVASC RES, V77, P370, DOI 10.1016/j.mvr.2009.02.001; Gao JZ, 2001, CELLS TISSUES ORGANS, V169, P12, DOI 10.1159/000047856; Getting SJ, 2002, J BIOL CHEM, V277, P51068, DOI 10.1074/jbc.M205121200; Giordano A, 2007, J CELL PHYSIOL, V211, P27, DOI 10.1002/jcp.20959; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi Massimiliano, 2009, V482, P281, DOI 10.1007/978-1-59745-060-7_18; GONZALEZREY E, 2009, GUT; Griffin MO, 2005, MOL CELL BIOCHEM, V270, P1, DOI 10.1007/s11010-005-2540-3; Halkos ME, 2008, BASIC RES CARDIOL, V103, P525, DOI 10.1007/s00395-008-0741-0; Heng BC, 2008, J BIOL CHEM, V283, P32294, DOI 10.1074/jbc.M804155200; Heymans S, 1999, NAT MED, V5, P1135, DOI 10.1038/13459; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Hwang NS, 2008, P NATL ACAD SCI USA, V105, P20641, DOI 10.1073/pnas.0809680106; Iso Y, 2007, BIOCHEM BIOPH RES CO, V354, P700, DOI 10.1016/j.bbrc.2007.01.045; Jolicoeur EM, 2007, AM HEART J, V153, P732, DOI 10.1016/j.ahj.2007.02.028; Khanna C, 2004, NAT MED, V10, P182, DOI 10.1038/nm982; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Koc ON, 1999, EXP HEMATOL, V27, P1675, DOI 10.1016/S0301-472X(99)00101-0; Krause U, 2007, STEM CELLS DEV, V16, P31, DOI 10.1089/scd.2006.0089; Le Blanc K, 2007, LEUKEMIA, V21, P1733, DOI 10.1038/sj.leu.2404777; Le Blanc K, 2006, CURR OPIN IMMUNOL, V18, P586, DOI 10.1016/j.coi.2006.07.004; Lee RH, 2009, BLOOD, V113, P816, DOI 10.1182/blood-2007-12-128702; LEE TH, 1992, J CELL BIOL, V116, P545, DOI 10.1083/jcb.116.2.545; Lindsey M, 2001, CIRCULATION, V103, P2181; Lu F, 2007, J MOL CELL CARDIOL, V43, P535, DOI 10.1016/j.yjmcc.2007.06.011; Lu ZQ, 2009, J NEUROIMMUNOL, V206, P58, DOI 10.1016/j.jneuroim.2008.10.014; McBride C, 2003, CYTOTHERAPY, V5, P7, DOI 10.1080/14653240310000038; McCombe PA, 2008, INT J STROKE, V3, P254, DOI 10.1111/j.1747-4949.2008.00222.x; Milner CM, 2006, BIOCHEM SOC T, V34, P446, DOI 10.1042/BST0340446; Mindrescu C, 2002, ARTHRITIS RHEUM, V46, P2453, DOI 10.1002/art.10503; Mindrescu C, 2000, ARTHRITIS RHEUM, V43, P2668, DOI 10.1002/1529-0131(200012)43:12<2668::AID-ANR6>3.0.CO;2-E; Moshal KS, 2008, PHYSIOL RES, V57, P379, DOI 10.33549/physiolres.931221; Nishida Y, 2006, J PHARMACOL SCI, V101, P52, DOI 10.1254/jphs.FP0050881; Nomura T, 2005, NEUROSCIENCE, V136, P161, DOI 10.1016/j.neuroscience.2005.06.062; Ohtaki H, 2008, P NATL ACAD SCI USA, V105, P14638, DOI 10.1073/pnas.0803670105; Ovechkin AV, 2005, J APPL PHYSIOL, V99, P2398, DOI 10.1152/japplphysiol.00442.2005; OWEN M, 1988, CIBA F SYMP, V136, P42; Paolocci N, 2006, J PHARMACOL EXP THER, V317, P506, DOI 10.1124/jpet.105.099168; Parr AM, 2007, BONE MARROW TRANSPL, V40, P609, DOI 10.1038/sj.bmt.1705757; Peister A, 2004, BLOOD, V103, P1662, DOI 10.1182/blood-2003-09-3070; Pereira RF, 1998, P NATL ACAD SCI USA, V95, P1142, DOI 10.1073/pnas.95.3.1142; Pervaiz S, 1997, CLIN CARDIOL, V20, P269, DOI 10.1002/clc.4960200316; Prockop DJ, 2007, BLOOD, V109, P3147, DOI 10.1182/blood-2006-03-013433; Qian H, 2006, BLOOD, V107, P3503, DOI 10.1182/blood-2005-10-3932; Sasportas LS, 2009, P NATL ACAD SCI USA, V106, P4822, DOI 10.1073/pnas.0806647106; Schrepfer S, 2007, TRANSPL P, V39, P573, DOI 10.1016/j.transproceed.2006.12.019; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Sung JH, 2008, TRANSPL P, V40, P2649, DOI 10.1016/j.transproceed.2008.08.009; Szanto S, 2004, ARTHRITIS RHEUM-US, V50, P3012, DOI 10.1002/art.20655; Takagawa J, 2007, J APPL PHYSIOL, V102, P2104, DOI 10.1152/japplphysiol.00033.2007; Theuma P, 2004, METAB SYNDR RELAT D, V2, P105, DOI 10.1089/met.2004.2.105; Tolar J, 2007, STEM CELLS, V25, P371, DOI 10.1634/stemcells.2005-0620; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wisniewski HG, 2004, CYTOKINE GROWTH F R, V15, P129, DOI 10.1016/j.cytogfr.2004.01.005; Wolf D, 2007, J AM SOC ECHOCARDIOG, V20, P512, DOI 10.1016/j.echo.2006.11.008; Ylostalo J, 2008, EXP HEMATOL, V36, P1390, DOI 10.1016/j.exphem.2008.05.003	75	1302	1388	1	89	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					54	63		10.1016/j.stem.2009.05.003	http://dx.doi.org/10.1016/j.stem.2009.05.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570514	Green Accepted, Bronze			2022-12-28	WOS:000267879200010
J	Lau, D; Ogbogu, U; Taylor, B; Stafinski, T; Menon, D; Caulfield, T				Lau, Darren; Ogbogu, Ubaka; Taylor, Benjamin; Stafinski, Tania; Menon, Devidas; Caulfield, Timothy			Stem Cell Clinics Online: The Direct-to-Consumer Portrayal of Stem Cell Medicine	CELL STEM CELL			English	Editorial Material							SPINAL-CORD-INJURY; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; TRANSPLANTATION; THERAPIES; BIOLOGY; UPDATE		[Lau, Darren; Stafinski, Tania; Menon, Devidas; Caulfield, Timothy] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2H5, Canada; [Ogbogu, Ubaka; Taylor, Benjamin; Caulfield, Timothy] Univ Alberta, Fac Law, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada	University of Alberta; University of Alberta	Caulfield, T (corresponding author), Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB T6G 2H5, Canada.	tcaulfld@law.ualberta.ca		Lau, Darren/0000-0001-9923-7902; Ogbogu, Ubaka/0000-0001-7764-6799				Baker M, 2005, NAT BIOTECHNOL, V23, P1467, DOI 10.1038/nbt1205-1467; BODEEN C, 2008, UNPROVEN STEM CELL T; Bongso A, 2004, BEST PRACT RES CL OB, V18, P827, DOI 10.1016/j.bpobgyn.2004.09.002; Braak H, 2008, NAT MED, V14, P483, DOI 10.1038/nm0508-483; Braude P, 2005, BMJ-BRIT MED J, V330, P1159, DOI 10.1136/bmj.330.7501.1159; BURT RK, 2007, IMMUNE REGULATION IM, P409; *CLINICALTRIALS GO, 2008, EMBR DOMP CELL IMPL; Coutts M, 2008, EXP NEUROL, V209, P368, DOI 10.1016/j.expneurol.2007.09.002; Daley George Q, 2003, Hematology Am Soc Hematol Educ Program, P398; Dobkin BH, 2006, NEUROREHAB NEURAL RE, V20, P5, DOI 10.1177/1545968305284675; Enserink M, 2006, SCIENCE, V313, P160, DOI 10.1126/science.313.5784.160; Fox S., 2006, ONLINE HLTH SEARCH 2; FREED CR, 1990, ARCH NEUROL-CHICAGO, V47, P505, DOI 10.1001/archneur.1990.00530050021007; Guyatt G., 2008, USERS GUIDE MED LIT; Lang RJ, 2007, PHYS WORLD, V20, P30; Lassmann H, 2005, J NEUROL SCI, V233, P83, DOI 10.1016/j.jns.2005.03.007; McAllister LD, 1997, BONE MARROW TRANSPL, V19, P395, DOI 10.1038/sj.bmt.1700666; McCullough M., 2008, STEM CELL TOURISM TR; Mckay R, 2008, NEURON, V58, P659, DOI 10.1016/j.neuron.2008.05.016; Mimeault M, 2007, CLIN PHARMACOL THER, V82, P252, DOI 10.1038/sj.clpt.6100301; Olanow CW, 2003, ANN NEUROL, V54, P403, DOI 10.1002/ana.10720; Phillips B, 2001, OXFORD CTR EVIDENCE; Saccardi R, 2006, MULT SCLER, V12, P814, DOI 10.1177/1352458506071301; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; Snyder BJ, 2005, CURR OPIN NEUROL, V18, P376, DOI 10.1097/01.wco.0000174298.27765.91; Suchowersky O, 2008, NAT CLIN PRACT NEURO, V4, P465, DOI 10.1038/ncpneuro0898; Weare C, 2000, SOC SCI COMPUT REV, V18, P272, DOI 10.1177/089443930001800304; ZHANG J, 2005, THESIS TEXAS A M U T	28	244	246	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					591	594		10.1016/j.stem.2008.11.001	http://dx.doi.org/10.1016/j.stem.2008.11.001			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041775	Bronze			2022-12-28	WOS:000261670900007
J	Mirzadeh, Z; Merkle, FT; Soriano-Navarro, M; Garcia-Verdugo, JM; Alvarez-Buylla, A				Mirzadeh, Zaman; Merkle, Florian T.; Soriano-Navarro, Mario; Manuel Garcia-Verdugo, Jose; Alvarez-Buylla, Arturo			Neural stem cells confer unique pinwheel architecture to the ventricular surface in neurogenic regions of the adult brain	CELL STEM CELL			English	Article							RADIAL GLIAL-CELLS; CENTRIOLE FORMATION; BASEMENT-MEMBRANE; NERVOUS-SYSTEM; CEREBRAL WALL; NEURONS; ZONE; PROLIFERATION; MIGRATION; EXPRESSION	Neural stem cells (NSCs, B1 cells) are retained in the walls of the adult lateral ventricles but, unlike embryonic NSCs, are displaced from the ventricular zone (VZ) into the subventricular zone (SVZ) by ependymal cells. Apical and basal compartments, which in embryonic NSCs play essential roles in self-renewal and differentiation, are not evident in adult NSCs. Here we show that SVZ B1 cells in adult mice extend a minute apical ending to directly contact the ventricle and a long basal process ending on blood vessels. A closer look at the ventricular surface reveals a striking pinwheel organization specific to regions of adult neurogenesis. The pinwheel's core contains the apical endings of B1 cells and in its periphery two types of ependymal cells: multiciliated (E1) and a type (E2) characterized by only two cilia and extraordinarily complex basal bodies. These results reveal that adult NSCs retain fundamental epithelial properties, including apical and basal compartmentalization, significantly reshaping our understanding of this adult neurogenic niche.	[Mirzadeh, Zaman; Merkle, Florian T.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA; [Mirzadeh, Zaman; Merkle, Florian T.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dev & Stem Cell Biol Program, San Francisco, CA 94143 USA; [Soriano-Navarro, Mario; Manuel Garcia-Verdugo, Jose] CIBERNED, Lab Morfol Celular, Unidad Mixta CIPF UVEG, Valencia 46012, Spain	University of California System; University of California San Francisco; University of California System; University of California San Francisco; CIBERNED; Prince Felipe Research Center	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurosurg, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu	García-Verdugo, José Manuel/L-8421-2017; Merkle, Florian/A-2639-2011	García-Verdugo, José Manuel/0000-0001-9872-6499; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Soriano Navarro, Mario/0000-0002-7245-2095; Merkle, Florian/0000-0002-8513-2998	National Institutes of Health (NIH) [HD-32116]; Sandler Family Supporting Foundation; John G. Bowes Research Fund; Carlos Baldoceda Foundation; UCSF Krevans Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD032116] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD032116] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sandler Family Supporting Foundation; John G. Bowes Research Fund; Carlos Baldoceda Foundation; UCSF Krevans Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Work supported by National Institutes of Health (NIH) grant HD-32116, the Sandler Family Supporting Foundation, and the John G. Bowes Research Fund. Z.M. is supported by the Carlos Baldoceda Foundation and UCSF Krevans Fellowship. A.A.-B. holds the Heather and Melanie Muss Endowed Chair. We thank B. Barres for Aldh1 L-GFP mice and Y.-G. Han, S. Noctor, R. Ihrie, J. Reiter, W. Marshall, and A. Javaherian for discussion. We thank K. Thorn and the UCSF Nikon Imaging Center for confocal imaging help. We thank Kenneth Xavier Probst for preparing the illustration in Figure 8.	Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; ALVAREZBUYLLA A, 1988, NATURE, V335, P353, DOI 10.1038/335353a0; ALVAREZBUYLLA A, 1990, NEURON, V5, P101, DOI 10.1016/0896-6273(90)90038-H; Bittman K, 1997, J NEUROSCI, V17, P7037; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; BRUNI JE, 1985, BRAIN RES REV, V9, P1, DOI 10.1016/0165-0173(85)90016-5; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Cho SR, 2007, J CLIN INVEST, V117, P2889, DOI 10.1172/JCI31778; COHEN E, 1988, BIOL CELL, V62, P165, DOI 10.1016/0248-4900(88)90033-0; COMMITTEE TB, 1970, ANAT REC, V166, P257; Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; DELBRIO MA, 1991, J SUBMICR CYTOL PATH, V23, P147; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Dubreuil V, 2007, J CELL BIOL, V176, P483, DOI 10.1083/jcb.200608137; FLAMENTDURAND J, 1985, INT REV CYTOL, V96, P121, DOI 10.1016/S0074-7696(08)60596-3; Garcia-Verdugo JM, 2002, BRAIN RES BULL, V57, P765, DOI 10.1016/S0361-9230(01)00769-9; Gerdes JM, 2007, NAT GENET, V39, P1350, DOI 10.1038/ng.2007.12; Goldman SA, 1996, J NEUROBIOL, V30, P505, DOI 10.1002/(SICI)1097-4695(199608)30:4<505::AID-NEU6>3.0.CO;2-7; Gomez-Roldan MDC, 2008, J COMP NEUROL, V507, P1571, DOI 10.1002/cne.21618; Halfter W, 2002, J NEUROSCI, V22, P6029; Haubst N, 2006, DEVELOPMENT, V133, P3245, DOI 10.1242/dev.02486; Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061; Jackson EL, 2008, CELLS TISSUES ORGANS, V188, P212, DOI 10.1159/000114541; Jackson EL, 2006, NEURON, V51, P187, DOI 10.1016/j.neuron.2006.06.012; Jiang JW, 1998, J NEUROBIOL, V36, P1, DOI 10.1002/(SICI)1097-4695(199807)36:1<1::AID-NEU1>3.0.CO;2-6; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kosodo Y, 2004, EMBO J, V23, P2314, DOI 10.1038/sj.emboj.7600223; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Manabe N, 2002, DEV DYNAM, V225, P61, DOI 10.1002/dvdy.10139; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Merkle FT, 2007, SCIENCE, V317, P381, DOI 10.1126/science.1144914; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; MISSON JP, 1988, DEV BRAIN RES, V38, P183, DOI 10.1016/0165-3806(88)90043-0; Nadarajah B, 1997, J NEUROSCI, V17, P3096; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor Stephen C, 2007, Novartis Found Symp, V288, P59; Noctor SC, 2007, ARCH NEUROL-CHICAGO, V64, P639, DOI 10.1001/archneur.64.5.639; Novak A, 2000, GENESIS, V28, P147, DOI 10.1002/1526-968X(200011/12)28:3/4<147::AID-GENE90>3.0.CO;2-G; Ou Y, 2004, CELL MOTIL CYTOSKEL, V57, P1, DOI 10.1002/cm.10154; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Peretto P, 2004, NEUROSCIENCE, V128, P685, DOI 10.1016/j.neuroscience.2004.06.053; Peretto P, 1997, BRAIN RES BULL, V42, P9, DOI 10.1016/S0361-9230(96)00116-5; Pincus DW, 1998, ANN NEUROL, V43, P576, DOI 10.1002/ana.410430505; RAKIC P, 1972, J COMP NEUROL, V145, P61, DOI 10.1002/cne.901450105; Rasin MR, 2007, NAT NEUROSCI, V10, P819, DOI 10.1038/nn1924; Rohatgi R, 2007, SCIENCE, V317, P372, DOI 10.1126/science.1139740; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Scheffler B, 2005, P NATL ACAD SCI USA, V102, P9353, DOI 10.1073/pnas.0503965102; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shingo T, 2003, SCIENCE, V299, P117, DOI 10.1126/science.1076647; SOROKIN SP, 1968, J CELL SCI, V3, P207; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; VOIGT T, 1989, J COMP NEUROL, V289, P74, DOI 10.1002/cne.902890106; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Weissman TA, 2004, NEURON, V43, P647, DOI 10.1016/j.neuron.2004.08.015; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	70	695	712	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					265	278		10.1016/j.stem.2008.07.004	http://dx.doi.org/10.1016/j.stem.2008.07.004			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786414	Bronze, Green Accepted			2022-12-28	WOS:000259665000010
J	Proia, TA; Keller, PJ; Gupta, PB; Klebba, I; Jones, AD; Sedic, M; Gilmore, H; Tung, N; Naber, SP; Schnitt, S; Lander, ES; Kuperwasser, C				Proia, Theresa A.; Keller, Patricia J.; Gupta, Piyush B.; Klebba, Ina; Jones, Ainsley D.; Sedic, Maja; Gilmore, Hannah; Tung, Nadine; Naber, Stephen P.; Schnitt, Stuart; Lander, Eric S.; Kuperwasser, Charlotte			Genetic Predisposition Directs Breast Cancer Phenotype by Dictating Progenitor Cell Fate	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; BRCA1; MUTATION; DIFFERENTIATION; METASTASIS; TISSUES; RECONSTRUCTION; TRANSFORMATION; PROLIFERATION; OVARIAN	Women with inherited mutations in the BRCA1 gene have increased risk of developing breast cancer but also exhibit a predisposition for the development of aggressive basal-like breast tumors. We report here that breast epithelial cells derived from patients harboring deleterious mutations in BRCA1 (BRCA1(mut/+)) give rise to tumors with increased basal differentiation relative to cells from BRCA1(+/+) patients. Molecular analysis of disease-free breast tissues from BRCA1(mut/+) patients revealed defects in progenitor cell lineage commitment even before cancer incidence. Moreover, we discovered that the transcriptional repressor Slug is an important functional suppressor of human breast progenitor cell lineage commitment and differentiation and that it is aberrantly expressed in BRCA1(mut/+) tissues. Slug expression is necessary for increased basal-like phenotypes prior to and after neoplastic transformation. These findings demonstrate that the genetic background of patient populations, in addition to affecting incidence rates, significantly impacts progenitor cell fate commitment and, therefore, tumor phenotype.	[Proia, Theresa A.; Keller, Patricia J.; Klebba, Ina; Jones, Ainsley D.; Sedic, Maja; Kuperwasser, Charlotte] Tufts Univ, Sch Med, Sackler Sch Biomed Res, Dept Anat & Cellular Biol, Boston, MA 02111 USA; [Proia, Theresa A.; Keller, Patricia J.; Klebba, Ina; Jones, Ainsley D.; Sedic, Maja; Kuperwasser, Charlotte] Tufts Med Ctr, Mol Oncol Res Inst, Boston, MA 02111 USA; [Naber, Stephen P.] Tufts Med Ctr, Dept Pathol, Boston, MA 02111 USA; [Gupta, Piyush B.; Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA; [Gupta, Piyush B.; Lander, Eric S.] Broad Inst MIT & Harvard, Cambridge, MA 02139 USA; [Gilmore, Hannah; Schnitt, Stuart] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Gilmore, Hannah; Tung, Nadine; Schnitt, Stuart] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA 02115 USA; [Tung, Nadine] Harvard Univ, Sch Med, Beth Israel Deaconess Med Ctr, Dept Surg Oncol, Boston, MA 02115 USA; [Lander, Eric S.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Tufts University; Tufts Medical Center; Tufts Medical Center; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Kuperwasser, C (corresponding author), Tufts Univ, Sch Med, Sackler Sch Biomed Res, Dept Anat & Cellular Biol, 136 Harrison Ave, Boston, MA 02111 USA.	charlotte.kuperwasser@tufts.edu			American Cancer Society-New England Division-Broadway on Beachside Postdoctoral Fellowship; Raymond and Beverly Sackler Foundation; Breast Cancer Research Foundation; Department of Defense [BC073866]; NIH/NCI [CA125554]; NATIONAL CANCER INSTITUTE [R01CA125554] Funding Source: NIH RePORTER	American Cancer Society-New England Division-Broadway on Beachside Postdoctoral Fellowship; Raymond and Beverly Sackler Foundation; Breast Cancer Research Foundation; Department of Defense(United States Department of Defense); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Gerbug Wulf, Steve Come, and Susan Troyan at Beth Israel Deaconess Medical Center for assistance with BRCA1<SUP>mut/+</SUP> tissue procurement and Kai Tao and Lisa Arendt for technical assistance. We thank Myriad Genetic Laboratories for gene-specific BRACAnalysis. We thank Annette Shepard-Barry at Tufts Medical Center in the Histology-Special Procedures Lab for histological and immunohistochemical staining. We thank Stephen Kwok for assistance with cell sorting and Supriya Gupta for assistance with gene expression experiments and data collection. We thank Josh LaBaer at Harvard Medical School for generously providing us with human cyclin D1, ras, p53, and PI3K cDNAs. This work was supported by grants from the American Cancer Society-New England Division-Broadway on Beachside Postdoctoral Fellowship (P.J.K.), the Raymond and Beverly Sackler Foundation (P.J.K., C.K.), the Breast Cancer Research Foundation (C.K., T.P.), the Department of Defense Breast Cancer Research Program (BC073866) (P.J.K., T.P., C.K.), and the NIH/NCI (CA125554, CA125554) (C.K., I.K.). C.K. is a Raymond and Beverly Sackler Foundation Scholar.	Allinen M, 2004, CANCER CELL, V6, P17, DOI 10.1016/j.ccr.2004.06.010; Arnes JB, 2005, CLIN CANCER RES, V11, P4003, DOI 10.1158/1078-0432.CCR-04-2064; Burga LN, 2009, CANCER RES, V69, P1273, DOI 10.1158/0008-5472.CAN-08-2954; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Clarke CL, 2006, BRIT J CANCER, V95, P515, DOI 10.1038/sj.bjc.6603298; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Elenbaas B, 2001, GENE DEV, V15, P50, DOI 10.1101/gad.828901; Elstrodt F, 2006, CANCER RES, V66, P41, DOI 10.1158/0008-5472.CAN-05-2853; Foulkes WD, 2004, CANCER RES, V64, P830, DOI 10.1158/0008-5472.CAN-03-2970; Foulkes WD, 2004, J MED GENET, V41, P1, DOI 10.1136/jmg.2003.013805; Furuta S, 2005, P NATL ACAD SCI USA, V102, P9176, DOI 10.1073/pnas.0503793102; Gauthier ML, 2007, CANCER CELL, V12, P479, DOI 10.1016/j.ccr.2007.10.017; Gluz O, 2009, ANN ONCOL, V20, P1913, DOI 10.1093/annonc/mdp492; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ince TA, 2007, CANCER CELL, V12, P160, DOI 10.1016/j.ccr.2007.06.013; Keller PJ, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2755; Kubista M, 2002, ONCOGENE, V21, P4747, DOI 10.1038/sj.onc.1205580; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Loi S, 2009, J CLIN ONCOL, V27; Miyakis S, 1998, BIOCHEM BIOPH RES CO, V251, P609, DOI 10.1006/bbrc.1998.9527; Miyoshi H, 1998, J VIROL, V72, P8150, DOI 10.1128/JVI.72.10.8150-8157.1998; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Niessen K, 2008, J CELL BIOL, V182, P315, DOI 10.1083/jcb.200710067; Peppercorn J, 2008, CANCER INVEST, V26, P1, DOI 10.1080/07357900701784238; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Saal LH, 2005, CANCER RES, V65, P2554, DOI 10.1158/0008-5472-CAN-04-3913; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Stingl J, 2001, BREAST CANCER RES TR, V67, P93, DOI 10.1023/A:1010615124301; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Welcsh PL, 2001, HUM MOL GENET, V10, P705, DOI 10.1093/hmg/10.7.705; Wu M, 2009, P NATL ACAD SCI USA, V106, P7022, DOI 10.1073/pnas.0811785106; Ye QN, 2001, J CELL BIOL, V155, P911, DOI 10.1083/jcb.200108049; Zhao XS, 2010, P NATL ACAD SCI USA, V107, P14146, DOI 10.1073/pnas.1009030107	41	256	261	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					149	163		10.1016/j.stem.2010.12.007	http://dx.doi.org/10.1016/j.stem.2010.12.007			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295272	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000287633400009
J	Surface, LE; Thornton, SR; Boyer, LA				Surface, Lauren E.; Thornton, Seraphim R.; Boyer, Laurie A.			Polycomb Group Proteins Set the Stage for Early Lineage Commitment	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; TRANSCRIPTIONAL REGULATORY CIRCUITRY; HISTONE METHYLTRANSFERASE ACTIVITY; H3 LYSINE-27 METHYLATION; HOX GENE-EXPRESSION; LONG NONCODING RNAS; REPRESSIVE COMPLEX; TARGET GENES; DEVELOPMENTAL REGULATORS; DNA METHYLATION	Precise control of gene expression patterns is critical for the specification of cellular diversity during metazoan development. Polycomb group (PcG) proteins comprise a class of transcriptional modifiers that have dynamic and essential roles in regulating a number of key processes including lineage commitment. How this is accomplished during mammalian development is incompletely understood. Here, we discuss recent studies in embryonic stem cells (ESCs) that provide critical new insights into how PcG proteins may be targeted to genomic sites as well as the mechanisms by which these regulators influence gene expression and multilineage differentiation in mammals.	[Surface, Lauren E.; Thornton, Seraphim R.; Boyer, Laurie A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Boyer, LA (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	lboyer@mit.edu		Surface, Lauren/0000-0003-4055-0237	Massachusetts Life Sciences Center; Smith Family Foundation for Excellence in Biomedical Research	Massachusetts Life Sciences Center; Smith Family Foundation for Excellence in Biomedical Research	We are thankful to members of the Boyer lab, especially Vidya Subramanian, for helpful discussions and for critical comments on the manuscript. L.A.B. is a Pew Scholar in the Biomedical Sciences. This work was supported by the Massachusetts Life Sciences Center and Smith Family Foundation for Excellence in Biomedical Research.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Akasaka T, 2001, DEVELOPMENT, V128, P1587; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cole MF, 2008, COLD SH Q B, V73, P183, DOI 10.1101/sqb.2008.73.027; Core N, 1997, DEVELOPMENT, V124, P721; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Dellino GI, 2004, MOL CELL, V13, P887, DOI 10.1016/S1097-2765(04)00128-5; Dinger ME, 2008, GENOME RES, V18, P1433, DOI 10.1101/gr.078378.108; Donohoe ME, 1999, MOL CELL BIOL, V19, P7237; DUNCAN IM, 1982, GENETICS, V102, P49; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Eskeland R, 2010, MOL CELL, V38, P452, DOI 10.1016/j.molcel.2010.02.032; FAUST C, 1995, DEVELOPMENT, V121, P273; Faust C, 1998, DEVELOPMENT, V125, P4495; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Fisher CL, 2006, GENE, V369, P109, DOI 10.1016/j.gene.2005.10.033; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Francis NJ, 2001, MOL CELL, V8, P545, DOI 10.1016/S1097-2765(01)00316-1; Gieni RS, 2009, BIOCHEM CELL BIOL, V87, P711, DOI 10.1139/O09-057; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Joo HY, 2007, NATURE, V449, P1068, DOI 10.1038/nature06256; Jung HR, 2010, MOL CELL PROTEOMICS, V9, P838, DOI 10.1074/mcp.M900489-MCP200; Jung J, 2005, J BIOL CHEM, V280, P30916, DOI 10.1074/jbc.M414482200; JURGENS G, 1985, NATURE, V316, P153, DOI 10.1038/316153a0; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Koziol MJ, 2010, CURR OPIN GENET DEV, V20, P142, DOI 10.1016/j.gde.2010.03.003; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Leeb M, 2007, J CELL BIOL, V178, P219, DOI 10.1083/jcb.200612127; Leeb M, 2010, GENE DEV, V24, P265, DOI 10.1101/gad.544410; Levine SS, 2004, TRENDS BIOCHEM SCI, V29, P478, DOI 10.1016/j.tibs.2004.07.007; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Liu YC, 2010, GENOMICS, V96, P17, DOI 10.1016/j.ygeno.2010.03.012; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2008, CELL CYCLE, V7, P885, DOI 10.4161/cc.7.7.5636; Lorente MD, 2000, DEVELOPMENT, V127, P5093; MacArthur BD, 2009, NAT REV MOL CELL BIO, V10, P672, DOI 10.1038/nrm2766; Mallo M, 2010, DEV BIOL, V344, P7, DOI 10.1016/j.ydbio.2010.04.024; Mateos-Langerak J, 2008, ADV GENET, V61, P45, DOI 10.1016/S0065-2660(07)00002-8; Mattout A, 2010, CURR OPIN CELL BIOL, V22, P334, DOI 10.1016/j.ceb.2010.02.001; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Morey C, 2007, DEVELOPMENT, V134, P909, DOI 10.1242/dev.02779; Morris KV, 2009, EPIGENETICS-US, V4, P296, DOI 10.4161/epi.4.5.9282; Motoyama J, 1997, MECH DEVELOP, V66, P27, DOI 10.1016/S0925-4773(97)00082-8; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Muller J, 2009, CURR OPIN GENET DEV, V19, P150, DOI 10.1016/j.gde.2009.03.001; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Orkin SH, 2008, COLD SH Q B, V73, P195, DOI 10.1101/sqb.2008.72.001; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Soshnikova N, 2009, EPIGENETICS-US, V4, P537, DOI 10.4161/epi.4.8.10132; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takihara Y, 1997, DEVELOPMENT, V124, P3673; Tanay A, 2007, P NATL ACAD SCI USA, V104, P5521, DOI 10.1073/pnas.0609746104; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Tiwari VK, 2008, PLOS BIOL, V6, P2911, DOI 10.1371/journal.pbio.0060306; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009; Wang SS, 2007, DEV DYNAM, V236, P853, DOI 10.1002/dvdy.21070; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; White J, 2005, STEM CELL REV, V1, P131, DOI 10.1385/SCR:1:2:131; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Xiang Y, 2007, CELL RES, V17, P850, DOI 10.1038/cr.2007.83; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	132	188	195	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					288	298		10.1016/j.stem.2010.08.004	http://dx.doi.org/10.1016/j.stem.2010.08.004			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804966	Green Published, Bronze			2022-12-28	WOS:000282037800007
J	Butler, JM; Nolan, DJ; Vertes, EL; Varnum-Finney, B; Kobayashi, H; Hooper, AT; Seandel, M; Shido, K; White, IA; Kobayashi, M; Witte, L; May, C; Shawber, C; Kimura, Y; Kitajewski, J; Rosenwaks, Z; Bernstein, ID; Rafii, S				Butler, Jason M.; Nolan, Daniel J.; Vertes, Eva L.; Varnum-Finney, Barbara; Kobayashi, Hideki; Hooper, Andrea T.; Seandel, Marco; Shido, Koji; White, Ian A.; Kobayashi, Mariko; Witte, Larry; May, Chad; Shawber, Carrie; Kimura, Yuki; Kitajewski, Jan; Rosenwaks, Zev; Bernstein, Irwin D.; Rafii, Shahin			Endothelial Cells Are Essential for the Self-Renewal and Repopulation of Notch-Dependent Hematopoietic Stem Cells	CELL STEM CELL			English	Article							BONE-MARROW NICHE; PROGENITOR CELLS; VASCULAR NICHE; TUMOR-GROWTH; IN-VITRO; EX-VIVO; GENE; EXPANSION; SURVIVAL; ANGIOGENESIS	Bone marrow endothelial cells (ECs) are essential for reconstitution of hematopoiesis, but their role in self-renewal of long-term hematopoietic stem cells (LT-HSCs) is unknown. We have developed angiogenic models to demonstrate that EC-derived angiocrine growth factors support in vitro self-renewal and in vivo repopulation of authentic LT-HSCs. In serum/cytokine-free cocultures, ECs, through direct cellular contact, stimulated incremental expansion of repopulating CD34(-)F1t3(-)cKit(+)Lineage(-)Sca1(+) LT-HSCs, which retained their self-renewal ability, as determined by single-cell and serial transplantation assays. Angiocrine expression of Notch ligands by ECs promoted proliferation and prevented exhaustion of LT-HSCs derived from wild-type, but not Notch1/Notch2-deficient, mice. In transgenic notch-reporter (TNR.Gfp) mice, regenerating TNR.Gfp(+) LT-HSCs were detected in cellular contact with sinusoidal ECs. Interference with angiocrine, but not perfusion, function of SECs impaired repopulation of TNR.Gfp(+) LT-HSCs. ECs establish an instructive vascular niche for clinical-scale expansion of LT-HSCs and a cellular platform to identify stem cellactive trophogens.	[Butler, Jason M.; Nolan, Daniel J.; Vertes, Eva L.; Kobayashi, Hideki; Hooper, Andrea T.; Seandel, Marco; Shido, Koji; White, Ian A.; Kobayashi, Mariko; Kimura, Yuki; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, Howard Hughes Med Inst, New York, NY 10065 USA; [Butler, Jason M.; Nolan, Daniel J.; Vertes, Eva L.; Kobayashi, Hideki; Hooper, Andrea T.; Seandel, Marco; Shido, Koji; White, Ian A.; Kobayashi, Mariko; Kimura, Yuki; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10065 USA; [Seandel, Marco] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Varnum-Finney, Barbara; Rosenwaks, Zev] ImClone Syst Inc, New York, NY 10014 USA; [Witte, Larry; May, Chad] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA; [Shawber, Carrie; Kitajewski, Jan] Columbia Univ, Med Ctr, Dept OB GYN, New York, NY 10032 USA; [Kitajewski, Jan] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Bernstein, Irwin D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Eli Lilly; Columbia University; Columbia University; Fred Hutchinson Cancer Center	Rafii, S (corresponding author), Weill Cornell Med Coll, Dept Med Genet, Howard Hughes Med Inst, New York, NY 10065 USA.	srafii@med.cornell.edu		Hooper, Andrea/0000-0003-1131-1229	Starr Stem Cell; Kirschstein National Research Service; Howard Hughes Medical Institute; Ansary Stem Cell Institute; Anbinder and Newmans Own Foundation; National Heart Lung and Blood Institute [HL075234, HL097797]; Qatar National Priorities; Empire State Stem Cell Board; New York State Department of Health [NYS C024180]; NATIONAL CANCER INSTITUTE [R01CA136673] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL083222, P01HL067839, U01HL066952, R01HL075234, R01HL097797, P01HL084205, P50HL084936, P01HL059312] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI080309] Funding Source: NIH RePORTER	Starr Stem Cell; Kirschstein National Research Service(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Anbinder and Newmans Own Foundation; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Qatar National Priorities; Empire State Stem Cell Board; New York State Department of Health; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	J.M.B. is supported by Starr Stem Cell Scholars Fellowship and Ruth L. Kirschstein National Research Service Award Institutional Research Training Grant. M.S. is a Fiona and Stanley Druckenmiller Fellow of the New York Stem Cell Foundation. S.R. is supported by Howard Hughes Medical Institute, Ansary Stem Cell Institute, Anbinder and Newmans Own Foundation, National Heart Lung and Blood Institute grants HL075234 and HL097797, Qatar National Priorities Research Program, Empire State Stem Cell Board, and the New York State Department of Health grant NYS C024180.	Antonchuk J, 2002, CELL, V109, P39, DOI 10.1016/S0092-8674(02)00697-9; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Butler JM, 2010, NAT REV CANCER, V10, P138, DOI 10.1038/nrc2791; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fernandez L, 2008, EXP HEMATOL, V36, P545, DOI 10.1016/j.exphem.2007.12.012; Funahashi Y, 2008, CANCER RES, V68, P4727, DOI 10.1158/0008-5472.CAN-07-6499; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Hadland BK, 2004, BLOOD, V104, P3097, DOI 10.1182/blood-2004-03-1224; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Karanu FN, 2000, J EXP MED, V192, P1365, DOI 10.1084/jem.192.9.1365; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Miller CL, 1997, P NATL ACAD SCI USA, V94, P13648, DOI 10.1073/pnas.94.25.13648; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Ramalingam R, 1999, BLOOD, V93, P2936; Seandel M, 2008, P NATL ACAD SCI USA, V105, P19288, DOI 10.1073/pnas.0805980105; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Varnum-Finney B, 2000, NAT MED, V6, P1278, DOI 10.1038/81390; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wolfe MS, 1999, BIOCHEMISTRY-US, V38, P4720, DOI 10.1021/bi982562p; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Zhang CC, 2006, NAT MED, V12, P240, DOI 10.1038/nm1342; Zhang F, 2005, CIRC RES, V96, P950, DOI 10.1161/01.RES.0000165867.95291.7b; Zhang F, 2004, J BIOL CHEM, V279, P11760, DOI 10.1074/jbc.M312221200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	34	458	483	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					251	264		10.1016/j.stem.2010.02.001	http://dx.doi.org/10.1016/j.stem.2010.02.001			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207228	Green Accepted, Bronze			2022-12-28	WOS:000276254600012
J	Ginestier, C; Liu, SL; Wicha, MS				Ginestier, Christophe; Liu, Suling; Wicha, Max S.			Getting to the Root of BRCA1-Deficient Breast Cancer	CELL STEM CELL			English	Editorial Material							STEM-CELLS; BRCA1; MICE		[Liu, Suling; Wicha, Max S.] Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA; [Ginestier, Christophe] Inst J Paoli I Calmettes, Oncol Mol Lab, INSERM, Ctr Rech Cancerol Marseille,UMR891, F-13009 Marseille, France	University of Michigan System; University of Michigan; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UNICANCER; Institut Paoli-Calmette (IPC)	Wicha, MS (corresponding author), Univ Michigan, Dept Internal Med, Ctr Comprehens Canc, Ann Arbor, MI 48109 USA.	mwicha@med.umich.edu	Ginestier, Christophe/M-8828-2017; Wicha, Max/AAE-7268-2019; Liu, Suling/N-2796-2013; liu, suling/AAF-5249-2019	Ginestier, Christophe/0000-0002-7477-3837; Liu, Suling/0000-0002-0475-0242; liu, suling/0000-0002-0475-0242				Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; Liu S, 2008, P NATL ACAD SCI USA, V105, P1680, DOI 10.1073/pnas.0711613105; Liu X, 2007, P NATL ACAD SCI USA, V104, P12111, DOI 10.1073/pnas.0702969104; Narod SA, 2004, NAT REV CANCER, V4, P665, DOI 10.1038/nrc1431; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153	10	19	19	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					229	230		10.1016/j.stem.2009.08.007	http://dx.doi.org/10.1016/j.stem.2009.08.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733528	Bronze			2022-12-28	WOS:000272545700002
J	Raya, A; Belmonte, JCI				Raya, Angel; Izpisua Belmonte, Juan Carlos			Stem Cell Research in Spain: If Only They Were Windmills ...	CELL STEM CELL			English	Editorial Material								Regenerative medicine has been endorsed in Spain as a strategic, interdisciplinary topic to boost biomedical research. Special programs have been developed to promote collaborative research efforts among Spanish basic, applied, translational, and clinical researchers. Here, we present what we consider Spain's main current assets in this area.	[Raya, Angel; Izpisua Belmonte, Juan Carlos] Ctr Regenerat Med Barcelona, Barcelona 08003, Spain; [Raya, Angel] ICREA, Barcelona 08010, Spain; [Raya, Angel] Networking Ctr Biomed Res Bioengn Biomat & Nanome, CIBER BBN, Barcelona 08003, Spain; [Izpisua Belmonte, Juan Carlos] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; University of Barcelona; ICREA; CIBER - Centro de Investigacion Biomedica en Red; CIBERBBN; Salk Institute	Belmonte, JCI (corresponding author), Ctr Regenerat Med Barcelona, Dr Aiguader 88, Barcelona 08003, Spain.	izpisua@cmrb.eu	Raya, Angel/E-6205-2010	Raya, Angel/0000-0003-2189-9775	ICREA Funding Source: Custom	ICREA(ICREA)		Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Borstlap J, 2008, NAT BIOTECHNOL, V26, P859, DOI 10.1038/nbt0808-859; Fernandez-Aviles F, 2004, CIRC RES, V95, P742, DOI 10.1161/01.RES.0000144798.54040.ed; Garcia-Olmo D, 2005, DIS COLON RECTUM, V48, P1416, DOI 10.1007/s10350-005-0052-6; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Pardal R, 2007, CELL, V131, P364, DOI 10.1016/j.cell.2007.07.043; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; RAYA A, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08129; Rugg-Gunn PJ, 2009, CELL STEM CELL, V4, P285, DOI 10.1016/j.stem.2009.03.004; Varas F, 2009, STEM CELLS, V27, P300, DOI 10.1634/stemcells.2008-0696; Winston R M L, 2007, Cell Stem Cell, V1, P27, DOI 10.1016/j.stem.2007.05.006	12	6	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					483	486		10.1016/j.stem.2009.05.016	http://dx.doi.org/10.1016/j.stem.2009.05.016			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497274	Bronze			2022-12-28	WOS:000266793600008
J	Morrison, GM; Oikonomopoulou, I; Migueles, RP; Soneji, S; Livigni, A; Enver, T; Brickman, JM				Morrison, Gillian M.; Oikonomopoulou, Ifigenia; Migueles, Rosa Portero; Soneji, Shamit; Livigni, Alessandra; Enver, Tariq; Brickman, Joshua M.			Anterior Definitive Endoderm from ESCs Reveals a Role for FGF Signaling	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; TYROSINE KINASE DOMAIN; MOUSE EMBRYO; PRIMITIVE STREAK; MORPHOGENETIC MOVEMENT; NEURAL DIFFERENTIATION; VISCERAL ENDODERM; DIVERGING POINT; SELF-RENEWAL; BETA-CATENIN	The use of embryonic stem cell (ESC) differentiation to generate functional hepatic or pancreatic progenitors and as a tool for developmental biology is limited by an inability to isolate in vitro equivalents of regionally specified anterior definitive endoderm (ADE). To address this, we devised a strategy using a fluorescent reporter gene under the transcriptional control of the anterior endoderm marker Hex alongside the definitive mesendoderm marker Cxcr4. Isolation of Hex(+)Cxcr4(+) differentiating ESCs yielded a population expressing ADE markers that both can be expanded and is competent to undergo differentiation toward liver and pancreatic fates. Hex reporter ESCs were also used to define conditions for ADE specification in serum-free adherent culture and revealed an unexpected role for FGF signaling in the generation of ADE. Our findings in defined monolayer differentiation suggest FGF signaling is an important regulator of early anterior mesendoderm differentiation rather than merely a mediator of morphogenetic movement.	[Morrison, Gillian M.; Oikonomopoulou, Ifigenia; Migueles, Rosa Portero; Livigni, Alessandra; Brickman, Joshua M.] Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Edinburgh EH9 3JQ, Midlothian, Scotland; [Soneji, Shamit; Enver, Tariq] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England	University of Edinburgh; University of Oxford	Morrison, GM (corresponding author), Univ Edinburgh, Sch Biol Sci, MRC Ctr Regenerat Med, Inst Stem Cell Res, Kings Bldg,W Mains Rd, Edinburgh EH9 3JQ, Midlothian, Scotland.	gmm38@cscr.cam.ac.uk; josh.brickman@ed.ac.uk		Brickman, Joshua/0000-0003-1580-7491	BBSRC Japan [JPA1355]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/C506605/1, BBS/B/15597]; Juvenile Diabetes Research Foundation (JDRF); Scottish Funding Council; Medical Research Council (MRC); Biotechnology and Biological Sciences Research Council [BBS/B/15597, BB/C506605/1] Funding Source: researchfish; Medical Research Council [MC_U137973817, G0700711, G0700711B, G0701429] Funding Source: researchfish; MRC [G0701429, G0700711, MC_U137973817] Funding Source: UKRI	BBSRC Japan(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Juvenile Diabetes Research Foundation (JDRF)(Juvenile Diabetes Research Foundation); Scottish Funding Council; Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Jane Brennan, Austin Smith, Tristan Rodriguez, Shankar Shrinivas, Palle Serup, Bill Stanford, and Meng Li for the provision of materials; Shin-Ichi Nishikawa for initial supply of SF03, technical suggestions, and communication of unpublished results prior to publication; and Val Wilson, Tristan Rodriguez, and Steve Pollard for critical reading of the manuscript. Communication with Shin-Ichi Nishikawa was supported by a BBSRC Japan partnering award (JPA1355). This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/C506605/1 and BBS/B/15597), a Juvenile Diabetes Research Foundation (JDRF) pilot project, and the Scottish Funding Council. G.M.M. was a recognized researcher on BB/C506605/1. J.M.B. is supported by a senior nonclinical fellowship from the Medical Research Council (MRC).	Bagutti C, 1996, DEV BIOL, V179, P184, DOI 10.1006/dbio.1996.0250; Barbera JPM, 2000, DEVELOPMENT, V127, P2433; Bottcher RT, 2005, ENDOCR REV, V26, P63, DOI 10.1210/er.2003-0040; Brickman JM, 2000, DEVELOPMENT, V127, P2303; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Casey ES, 1998, DEVELOPMENT, V125, P3887; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Ciruna BG, 1997, DEVELOPMENT, V124, P2829; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; DENG CX, 1994, GENE DEV, V8, P3045, DOI 10.1101/gad.8.24.3045; Deutsch G, 2001, DEVELOPMENT, V128, P871; Di-Gregorio A, 2007, DEVELOPMENT, V134, P3359, DOI 10.1242/dev.005967; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hart AH, 2002, DEVELOPMENT, V129, P3597; Hebrok M, 1998, GENE DEV, V12, P1705, DOI 10.1101/gad.12.11.1705; Kanai-Azuma M, 2002, DEVELOPMENT, V129, P2367; Kennedy M, 2003, METHOD ENZYMOL, V365, P39; Knop M, 2002, BIOTECHNIQUES, V33, P592, DOI 10.2144/02333rr02_11819a; Kubo A, 2005, BLOOD, V105, P4590, DOI 10.1182/blood-2004-10-4137; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kumar M, 2003, DEV BIOL, V259, P109, DOI 10.1016/S0012-1606(03)00183-0; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; LI M, 1995, NATURE, V378, P724, DOI 10.1038/378724a0; Lickert H, 2002, DEV CELL, V3, P171, DOI 10.1016/S1534-5807(02)00206-X; Lu CC, 2001, CURR OPIN GENET DEV, V11, P384, DOI 10.1016/S0959-437X(00)00208-2; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Mizoguchi T, 2006, DEV BIOL, V300, P612, DOI 10.1016/j.ydbio.2006.08.073; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Mohammadi M, 1998, EMBO J, V17, P5896, DOI 10.1093/emboj/17.20.5896; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; Okabayashi K, 2003, CURR OPIN GENET DEV, V13, P502, DOI 10.1016/S0959-437X(03)00111-4; Poulain M, 2006, DEVELOPMENT, V133, P2189, DOI 10.1242/dev.02387; Rodaway A, 1999, DEVELOPMENT, V126, P3067; Rodriguez TA, 2001, DEV BIOL, V234, P304, DOI 10.1006/dbio.2001.0265; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Stavridis MP, 2007, DEVELOPMENT, V134, P2889, DOI 10.1242/dev.02858; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Thomas PQ, 1998, DEVELOPMENT, V125, P85; YAMAGUCHI TP, 1994, GENE DEV, V8, P3032, DOI 10.1101/gad.8.24.3032; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Yusuf F, 2005, ANAT EMBRYOL, V210, P35, DOI 10.1007/s00429-005-0013-9; Zamparini AL, 2006, DEVELOPMENT, V133, P3709, DOI 10.1242/dev.02516	46	95	106	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					402	415		10.1016/j.stem.2008.07.021	http://dx.doi.org/10.1016/j.stem.2008.07.021			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940732	Bronze			2022-12-28	WOS:000260149800011
J	Robinson, GW				Robinson, Gertraud W.			Using Notches to Track Mammary Epithelial Cell Homeostasis	CELL STEM CELL			English	Editorial Material							FATE DETERMINATION; BREAST-CANCER; STEM-CELLS	Notch signals mediate a wide range of activities in development and cancer. A report in this issue of Cell Stem Cell (Bouras et al., 2008) demonstrates that Notch serves as a switch that controls cell fate and tissue homeostasis in mammary epithelium.	NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Robinson, GW (corresponding author), NIDDK, Lab Genet & Physiol, NIH, Bethesda, MD 20892 USA.	gertraur@bdg10.niddk.nih.gov	Robinson, Gertraud/I-2136-2012		Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stylianou S, 2006, CANCER RES, V66, P1517, DOI 10.1158/0008-5472.CAN-05-3054; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Wu FT, 2007, FRONT BIOSCI-LANDMRK, V12, P4370, DOI 10.2741/2394; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2	10	7	7	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					359	360		10.1016/j.stem.2008.09.014	http://dx.doi.org/10.1016/j.stem.2008.09.014			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940725	Bronze			2022-12-28	WOS:000260149800003
J	Schroeder, T				Schroeder, Timm			Asymmetric cell division in normal and malignant hematopoietic precursor cells	CELL STEM CELL			English	Editorial Material							STEM-CELLS		GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich	Schroeder, T (corresponding author), GSF, Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, Ingolstaedter Landstr 1, D-85764 Munich, Germany.	timm.schroeder@gsf.de	Schroeder, Timm/F-8448-2010	Schroeder, Timm/0000-0001-9320-0252				Abramovich C, 2005, CURR OPIN HEMATOL, V12, P210, DOI 10.1097/01.moh.0000160737.52349.aa; Beckmann J, 2007, BLOOD, V109, P5494, DOI 10.1182/blood-2006-11-055921; Brummendorf TH, 1998, J EXP MED, V188, P1117, DOI 10.1084/jem.188.6.1117; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Ema H, 2000, J EXP MED, V192, P1281, DOI 10.1084/jem.192.9.1281; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Punzel M, 2003, EXP HEMATOL, V31, P339, DOI 10.1016/S0301-472X(03)00024-9; Wilson A, 2007, J IMMUNOL, V178, P6746, DOI 10.4049/jimmunol.178.11.6746; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009	10	26	30	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					479	481		10.1016/j.stem.2007.10.016	http://dx.doi.org/10.1016/j.stem.2007.10.016			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18938740	Bronze			2022-12-28	WOS:000251276500001
J	Kee, BL				Kee, Barbara L.			A Comprehensive Transcriptional Landscape of Human Hematopoiesis	CELL STEM CELL			English	Editorial Material							STEM-CELLS	Recently in Cell, Novershtern et al. (2011) reported a comprehensive transcriptome analysis of human hematopoiesis, combined with sophisticated bioinformatics analysis and high-throughput DNA binding data for multiple transcription factors. The resulting map of regulatory interactions controlling stem cell differentiation provides a valuable resource for identification of novel hematopoietic regulators.	[Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Canc Biol, Chicago, IL 60637 USA; [Kee, Barbara L.] Univ Chicago, Dept Pathol, Comm Dev Regenerat & Stem Cell Biol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago	Kee, BL (corresponding author), Univ Chicago, Dept Pathol, Comm Immunol, Chicago, IL 60637 USA.	bkee@bsd.uchicago.edu						Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2005, ANN NY ACAD SCI, V1044, P125, DOI 10.1196/annals.1349.016; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Laslo P, 2008, SEMIN IMMUNOL, V20, P228, DOI 10.1016/j.smim.2008.08.003; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; NOVERSHTERN N, 2011, CELL IN PRESS, V144; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Yoshida T, 2010, CURR OPIN IMMUNOL, V22, P154, DOI 10.1016/j.coi.2010.02.011	8	3	4	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					122	124		10.1016/j.stem.2011.01.006	http://dx.doi.org/10.1016/j.stem.2011.01.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295265	Bronze			2022-12-28	WOS:000287633400002
J	Lukacs, RU; Memarzadeh, S; Wu, H; Witte, ON				Lukacs, Rita U.; Memarzadeh, Sanaz; Wu, Hong; Witte, Owen N.			Bmi-1 Is a Crucial Regulator of Prostate Stem Cell Self-Renewal and Malignant Transformation	CELL STEM CELL			English	Article							MAMMARY STEM/PROGENITOR CELLS; MURINE PROSTATE; ANDROGEN RECEPTOR; SONIC HEDGEHOG; POOR-PROGNOSIS; BETA-CATENIN; NEURAL-TUBE; BASAL-CELLS; IN-VITRO; CANCER	The Polycomb group transcriptional repressor Bmi-1 is often upregulated in prostate cancer, but its functional roles in prostate stem cell maintenance and prostate cancer are unclear. Loss- and gain-of-function analysis in a prostate sphere assay indicates that Bmi-1 expression is required for self-renewal activity and maintenance of p63(+) stem cells. Loss of Bmi-1 blocks the self-renewal activity induced by heightened beta-catenin signaling, suggesting that Bmi-1 is required for full activity of another self-renewal pathway. In vivo, Bmi-1 expression is necessary for normal prostate tubule regeneration. Altered self-renewal and proliferation through Bmi-1 modulation diminishes the susceptibility of prostate cells to transformation. In an in vivo prostate regeneration system, Bmi-1 inhibition protects prostate cells from FGF10-driven hyperplasia and slows the growth of aggressive Pten-deletion-induced prostate cancer. We conclude that Bmi-1 is a crucial regulator of self-renewal in adult prostate cells and plays important roles in prostate cancer initiation and progression.	[Lukacs, Rita U.; Witte, Owen N.] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Memarzadeh, Sanaz] Univ Calif Los Angeles, David Geffen Sch Med, Dept Obstet & Gynecol, Los Angeles, CA 90095 USA; [Wu, Hong; Witte, Owen N.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Wu, Hong; Witte, Owen N.] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Witte, Owen N.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Witte, ON (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	owenwitte@mednet.ucla.edu			Prostate Cancer Foundation; California Institute for Regenerative Medicine [T1-00005, TG2-01169]; Ovarian Cancer Research Fund; Stewart and Lynda Resnik Prostate Cancer Foundation; Stein/Oppenheimer Clinical Transitional Seed Grant; DOD [PCO31130]; NCI [UO1 CA84128-06, RO1 CA107166]; NATIONAL CANCER INSTITUTE [R01CA107166, U01CA084128] Funding Source: NIH RePORTER	Prostate Cancer Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Ovarian Cancer Research Fund; Stewart and Lynda Resnik Prostate Cancer Foundation; Stein/Oppenheimer Clinical Transitional Seed Grant; DOD(United States Department of Defense); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Donghui Cheng, Mireille Riedinger, and Stephanie Wiltzius for assistance with sorting, FGF10 virus preparation, and Cre/shRNA cloning. We thank Andrew Goldstein, David Mulholland, Devon Lawson, Li Xin, Yang Zong, and Houjian Cai for helpful discussions about results and the manuscript. Funding sources: O.N.W. is an Investigator of the Howard Hughes Medical Institute and is supported by the Prostate Cancer Foundation Challenge Award for Defining Targets and Biomarkers in Prostate Cancer Stem Cells. R.U.L. is supported by the California Institute for Regenerative Medicine training grant (T1-00005 and TG2-01169). S.M. is supported by the Ovarian Cancer Research Fund, the Stewart and Lynda Resnik Prostate Cancer Foundation Grant at UCLA, and the Stein/Oppenheimer Clinical Transitional Seed Grant. H.W. is supported by the Prostate Cancer Foundation, DOD PCO31130, NCI UO1 CA84128-06, and RO1 CA107166.	Asselin-Labat ML, 2008, COLD SH Q B, V73, P469, DOI 10.1101/sqb.2008.73.020; Bisson I, 2009, CELL RES, V19, P683, DOI 10.1038/cr.2009.43; Carson Culley C 3rd, 2006, N C Med J, V67, P122; Cui HJ, 2007, AM J PATHOL, V170, P1370, DOI 10.2353/ajpath.2007.060754; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; ENGLISH HF, 1987, PROSTATE, V11, P229, DOI 10.1002/pros.2990110304; Fiaschi M, 2009, CANCER RES, V69, P4810, DOI 10.1158/0008-5472.CAN-08-3938; Gil J, 2005, DNA CELL BIOL, V24, P117, DOI 10.1089/dna.2005.24.117; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Goldstein AS, 2008, P NATL ACAD SCI USA, V105, P20882, DOI 10.1073/pnas.0811411106; Goto K, 2006, STEM CELLS, V24, P1859, DOI 10.1634/stemcells.2005-0585; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Hayry V, 2008, NEUROPATH APPL NEURO, V34, P555, DOI 10.1111/j.1365-2990.2008.00949.x; He SH, 2009, ANNU REV CELL DEV BI, V25, P377, DOI 10.1146/annurev.cellbio.042308.113248; Hosen N, 2007, STEM CELLS, V25, P1635, DOI 10.1634/stemcells.2006-0229; Huggins C, 1941, CANCER RES, V1, P293; Hurt EM, 2008, BRIT J CANCER, V98, P756, DOI 10.1038/sj.bjc.6604242; Isaacs J. T., 1987, CONTROL CELL PROLIFE; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Lawson DA, 2010, P NATL ACAD SCI USA, V107, P2610, DOI 10.1073/pnas.0913873107; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Litvinov IV, 2003, J CLIN ENDOCR METAB, V88, P2972, DOI 10.1210/jc.2002-022038; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lukacs RU, 2010, NAT PROTOC, V5, P702, DOI 10.1038/nprot.2010.11; Memarzadeh S, 2007, CANCER CELL, V12, P572, DOI 10.1016/j.ccr.2007.11.002; Michaelidis TM, 2008, CELL TISSUE RES, V331, P193, DOI 10.1007/s00441-007-0476-5; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Ontiveros CS, 2008, PROSTATE, V68, P1263, DOI 10.1002/pros.20770; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Patten I, 2000, CELL MOL LIFE SCI, V57, P1695, DOI 10.1007/PL00000652; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 1996, DEV BIOL, V175, P1, DOI 10.1006/dbio.1996.0090; Robinson EJ, 1998, PROSTATE, V37, P149, DOI 10.1002/(SICI)1097-0045(19981101)37:3<149::AID-PROS4>3.0.CO;2-E; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sangiorgi E, 2009, P NATL ACAD SCI USA, V106, P7101, DOI 10.1073/pnas.0902508106; Shaw GL, 2007, BJU INT, V99, P1056, DOI 10.1111/j.1464-410X.2007.06770.x; Signoretti S, 2000, AM J PATHOL, V157, P1769, DOI 10.1016/S0002-9440(10)64814-6; Tsujimura A, 2002, J CELL BIOL, V157, P1257, DOI 10.1083/jcb.200202067; van Leenders GJLH, 2007, EUR UROL, V52, P455, DOI 10.1016/j.eururo.2006.11.020; VANLOHUIZEN M, 1991, CELL, V65, P737, DOI 10.1016/0092-8674(91)90382-9; Wang SY, 2006, P NATL ACAD SCI USA, V103, P1480, DOI 10.1073/pnas.0510652103; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xin L, 2003, P NATL ACAD SCI USA, V100, P11896, DOI 10.1073/pnas.1734139100; Xin L, 2007, STEM CELLS, V25, P2760, DOI 10.1634/stemcells.2007-0355; Xin L, 2006, P NATL ACAD SCI USA, V103, P7789, DOI 10.1073/pnas.0602567103; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	54	214	228	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					682	693		10.1016/j.stem.2010.11.013	http://dx.doi.org/10.1016/j.stem.2010.11.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112563	Bronze, Green Accepted			2022-12-28	WOS:000285537700010
J	Warren, L; Manos, PD; Ahfeldt, T; Loh, YH; Li, H; Lau, F; Ebina, W; Mandal, PK; Smith, ZD; Meissner, A; Daley, GQ; Brack, AS; Collins, JJ; Cowan, C; Schlaeger, TM; Rossi, DJ				Warren, Luigi; Manos, Philip D.; Ahfeldt, Tim; Loh, Yuin-Han; Li, Hu; Lau, Frank; Ebina, Wataru; Mandal, Pankaj K.; Smith, Zachary D.; Meissner, Alexander; Daley, George Q.; Brack, Andrew S.; Collins, James J.; Cowan, Chad; Schlaeger, Thorsten M.; Rossi, Derrick J.			Highly Efficient Reprogramming to Pluripotency and Directed Differentiation of Human Cells with Synthetic Modified mRNA	CELL STEM CELL			English	Article							TOLL-LIKE RECEPTORS; STEM-CELLS; ANTIVIRAL RESPONSES; IN-VITRO; INDUCTION; VECTOR; FIBROBLASTS; GENERATION; ANTIGEN; VIRUS	Clinical application of induced pluripotent stem cells (iPSCs) is limited by the low efficiency of iPSC derivation and the fact that most protocols modify the genome to effect cellular reprogramming. Moreover, safe and effective means of directing the fate of patient-specific iPSCs toward clinically useful cell types are lacking. Here we describe a simple, nonintegrating strategy for reprogramming cell fate based on administration of synthetic mRNA modified to overcome innate antiviral responses. We show that this approach can reprogram multiple human cell types to pluripotency with efficiencies that greatly surpass established protocols. We further show that the same technology can be used to efficiently direct the differentiation of RNA-induced pluripotent stem cells (RiPSCs) into terminally differentiated myogenic cells. This technology represents a safe, efficient strategy for somatic cell reprogramming and directing cell fate that has broad applicability for basic research, disease modeling, and regenerative medicine.	[Warren, Luigi; Ebina, Wataru; Mandal, Pankaj K.; Rossi, Derrick J.] Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, Boston, MA 02115 USA; [Manos, Philip D.; Daley, George Q.; Schlaeger, Thorsten M.; Rossi, Derrick J.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Daley, George Q.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Manos, Philip D.; Ahfeldt, Tim; Lau, Frank; Meissner, Alexander; Daley, George Q.; Cowan, Chad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Meissner, Alexander; Daley, George Q.; Brack, Andrew S.; Cowan, Chad; Rossi, Derrick J.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ahfeldt, Tim; Brack, Andrew S.; Cowan, Chad] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany; [Loh, Yuin-Han; Daley, George Q.; Schlaeger, Thorsten M.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Loh, Yuin-Han; Daley, George Q.; Schlaeger, Thorsten M.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loh, Yuin-Han] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Lau, Frank; Cowan, Chad] Stowers Med Inst, Boston, MA 02114 USA; [Smith, Zachary D.; Meissner, Alexander] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Daley, George Q.; Collins, James J.] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol Oncol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard University; Massachusetts General Hospital; University of Hamburg; University Medical Center Hamburg-Eppendorf; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Boston University; Boston University; Harvard University; Stowers Institute for Medical Research; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Rossi, DJ (corresponding author), Childrens Hosp, Immune Dis Inst, Program Cellular & Mol Med, 300 Longwood Ave, Boston, MA 02115 USA.	rossi@idi.harvard.edu	mandal, pankaj/B-4885-2016; Ahfeldt, Tim/E-2935-2017; Loh, Yuin-Han/E-1096-2014	Loh, Yuin-Han/0000-0002-4715-6454; Mandal, Pankaj/0000-0003-1993-9918; Ahfeldt, Tim/0000-0001-6377-7376; Schlaeger, Thorsten/0000-0002-1599-9908	Harvard Stem Cell Institute; A*Star Institute of Medical Biology and Singapore stem cell consortium; Roberto and Allison Mignone Fund for Stem Cell Research; Howard Hughes Medical Institute; NIH [RL1DE019021]; SysCODE (Systems-based Consortium for Organ Design Engineering); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019021] Funding Source: NIH RePORTER	Harvard Stem Cell Institute; A*Star Institute of Medical Biology and Singapore stem cell consortium; Roberto and Allison Mignone Fund for Stem Cell Research; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SysCODE (Systems-based Consortium for Organ Design Engineering); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The authors wish to thank Sun Hur, Victor Li, Laurence Daheron, Odelya Hartung, Alys Peisley, Sutheera Ratanasirintrawoot, Brad Hamilton, Chenmei Luo, Jonathan Kagan, Julie Sahalie, Alejandro De Los Angeles, and Lior Zangi for help, insight, and suggestions. D.J.R., A.M., GOD, A.S.B, C.C., and T.M.S. were supported by grants from the Harvard Stem Cell Institute. Y.-H.L. is supported by the A*Star Institute of Medical Biology and Singapore stem cell consortium. T.A. was supported by the Roberto and Allison Mignone Fund for Stem Cell Research. J.J.C. is supported by Howard Hughes Medical Institute, SysCODE (Systems-based Consortium for Organ Design & Engineering), and NIH grant # RL1DE019021. D.J.R. recently founded a company, Mod-eRNA Therapeutics, dedicated to the clinical translation of this technology. G.Q.D. is a member of the scientific advisory boards and holds equity in the following companies: Epizyme, iPierian, Solasia KK, and MPM Capital, LLP. C.C. is on the SAB of lpierian. L.W. is a consultant for Stemgent.	Audouy S, 2001, MOL MEMBR BIOL, V18, P129, DOI 10.1080/713816122; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Chang CW, 2009, STEM CELLS, V27, P1042, DOI 10.1002/stem.39; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Diebold SS, 2004, SCIENCE, V303, P1529, DOI 10.1126/science.1093616; Elango N, 2005, BIOCHEM BIOPH RES CO, V330, P958, DOI 10.1016/j.bbrc.2005.03.067; Fusaki N, 2009, P JPN ACAD B-PHYS, V85, P348, DOI 10.2183/pjab.85.348; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Holtkamp S, 2006, BLOOD, V108, P4009, DOI 10.1182/blood-2006-04-015024; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jia FJ, 2010, NAT METHODS, V7, P197, DOI [10.1038/NMETH.1426, 10.1038/nmeth.1426]; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kariko K, 2005, IMMUNITY, V23, P165, DOI 10.1016/j.immuni.2005.06.008; Kariko K, 2008, MOL THER, V16, P1833, DOI 10.1038/mt.2008.200; Kariko K, 2007, CURR OPIN DRUG DISC, V10, P523; Kawai T, 2007, J BIOCHEM, V141, P137, DOI 10.1093/jb/mvm032; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li XQ, 1998, J BIOL CHEM, V273, P34970, DOI 10.1074/jbc.273.52.34970; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Miura K, 2009, NAT BIOTECHNOL, V27, P743, DOI 10.1038/nbt.1554; Nallagatla SR, 2008, RNA, V14, P1201, DOI 10.1261/rna.1007408; Nallagatla SR, 2008, RNA BIOL, V5, P140, DOI 10.4161/rna.5.3.6839; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Papapetrou EP, 2009, P NATL ACAD SCI USA, V106, P12759, DOI 10.1073/pnas.0904825106; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Rabinovich PM, 2006, HUM GENE THER, V17, P1027, DOI 10.1089/hum.2006.17.1027; Rabinovich PM, 2009, HUM GENE THER, V20, P51, DOI 10.1089/hum.2008.068; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Shea KL, 2010, CELL STEM CELL, V6, P117, DOI 10.1016/j.stem.2009.12.015; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Smith ZD, 2010, NAT BIOTECHNOL, V28, P521, DOI 10.1038/nbt.1632; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; SYMONS JA, 1995, CELL, V81, P551, DOI 10.1016/0092-8674(95)90076-4; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Uematsu S, 2007, J BIOL CHEM, V282, P15319, DOI 10.1074/jbc.R700009200; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Van den Bosch GA, 2006, J IMMUNOTHER, V29, P512, DOI 10.1097/01.cji.0000210385.48327.1e; Van Tendeloo VFI, 2001, BLOOD, V98, P49, DOI 10.1182/blood.V98.1.49; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Weissman D, 2000, J IMMUNOL, V165, P4710, DOI 10.4049/jimmunol.165.8.4710; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; YISRAELI JK, 1989, METHOD ENZYMOL, V180, P42; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	53	1792	2092	15	476	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					618	630		10.1016/j.stem.2010.08.012	http://dx.doi.org/10.1016/j.stem.2010.08.012			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	20888316	Green Accepted, Bronze			2022-12-28	WOS:000284390500013
J	Mayshar, Y; Ben-David, U; Lavon, N; Biancotti, JC; Yakir, B; Clark, AT; Plath, K; Lowry, WE; Benvenisty, N				Mayshar, Yoav; Ben-David, Uri; Lavon, Neta; Biancotti, Juan-Carlos; Yakir, Benjamin; Clark, Amander T.; Plath, Kathrin; Lowry, William E.; Benvenisty, Nissim			Identification and Classification of Chromosomal Aberrations in Human Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							COPY NUMBER VARIATION; COMPARATIVE GENOMIC HYBRIDIZATION; GENE-EXPRESSION; CULTURE; ANEUPLOIDY; ABNORMALITIES; LEUKEMIAS; IDENTIFY; PROGRAM; REGIONS	Because of their somatic cell origin, human induced pluripotent stem cells (HiPSCs) are assumed to carry a normal diploid genome, and adaptive chromosomal aberrations have not been fully evaluated. Here, we analyzed the chromosomal integrity of 66 HiPSC and 38 human embryonic si:em cell (HESC) samples from 18 different studies by global gene expression meta-analysis. We report identification of a substantial number of cell lines carrying full and partial chromosomal aberrations, half of which were validated at the DNA level. Several aberrations resulted from culture adaptation, and others are suspected to originate from the parent somatic cell. Our classification revealed a third type of aneuploidy already evident in early passage HiPSCs, suggesting considerable selective pressure during the reprogramming process. The analysis indicated high incidence of chromosome 12 duplications, resulting in significant enrichment for cell cycle-related genes. Such aneuploidy may limit the differentiation capacity and increase the tumorigenicity of HiPSCs.	[Mayshar, Yoav; Ben-David, Uri; Lavon, Neta; Benvenisty, Nissim] Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel; [Biancotti, Juan-Carlos] Cedars Sinai Med Ctr, Regenerat Med Inst, Los Angeles, CA 90048 USA; [Yakir, Benjamin] Hebrew Univ Jerusalem, Dept Stat, IL-91905 Jerusalem, Israel; [Clark, Amander T.; Lowry, William E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Clark, Amander T.; Plath, Kathrin; Lowry, William E.] Univ Calif Los Angeles, Broad Stem Cell Ctr, Los Angeles, CA 90095 USA; [Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Los Angeles, CA 90095 USA	Hebrew University of Jerusalem; Cedars Sinai Medical Center; Hebrew University of Jerusalem; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Benvenisty, N (corresponding author), Hebrew Univ Jerusalem, Silberman Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.	nissimb@cc.huji.ac.il	Ben-David, Uri/H-4119-2019	Ben-David, Uri/0000-0001-7098-2378; Mayshar, Yoav/0000-0002-5553-2472; Plath, Kathrin/0000-0001-7796-3372	European Community [018739]; Morasha-ISF [943/09]; Legacy Heritage Fund of New York	European Community(European Commission); Morasha-ISF; Legacy Heritage Fund of New York	We would like to thank Tamar Golan-Lev for excellent technical assistance, Dr. Danny Kitzberg for critically reading this manuscript and Dr. Sagiv Shifman for stimulating discussions. N.B. is the Herbert Cohn Chair in Cancer Research. This research was partially supported by funds from the European Community (ESTOOLS. Grant number 018739) and by funds from the Morasha-ISF (Grant number 943/09). We gratefully acknowledge support for this project provided by a grant from the Legacy Heritage Fund of New York.	Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Blum B, 2009, CELL CYCLE, V8, P3822, DOI 10.4161/cc.8.23.10067; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Crawley JJ, 2002, GENOME BIOL, V3; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Draper JS, 2004, STEM CELLS DEV, V13, P325, DOI 10.1089/1547328041797525; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; Furge KA, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-67; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Hertzberg L, 2007, GENE CHROMOSOME CANC, V46, P75, DOI 10.1002/gcc.20391; Hosack DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r70; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Kadaja M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000397; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lilljebjorn H, 2007, LEUKEMIA, V21, P2137, DOI 10.1038/sj.leu.2404879; Lingjaerde OC, 2005, BIOINFORMATICS, V21, P821, DOI 10.1093/bioinformatics/bti113; Looijenga LHJ, 2006, CANCER RES, V66, P290, DOI 10.1158/0008-5472.CAN-05-2936; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Masayesva BG, 2004, P NATL ACAD SCI USA, V101, P8715, DOI 10.1073/pnas.0400027101; McIntyre A, 2007, BRIT J CANCER, V97, P1707, DOI 10.1038/sj.bjc.6604079; Olariu V, 2010, STEM CELL RES, V4, P50, DOI 10.1016/j.scr.2009.09.001; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Phillips JL, 2001, CANCER RES, V61, P8143; Pollack JR, 2002, P NATL ACAD SCI USA, V99, P12963, DOI 10.1073/pnas.162471999; Reuter VE, 2005, MODERN PATHOL, V18, pS51, DOI 10.1038/modpathol.3800309; Schoch C, 2005, LEUKEMIA, V19, P1224, DOI 10.1038/sj.leu.2403810; Sharan R, 2003, BIOINFORMATICS, V19, P1787, DOI 10.1093/bioinformatics/btg232; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stransky N, 2006, NAT GENET, V38, P1386, DOI 10.1038/ng1923; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tsafrir D, 2006, CANCER RES, V66, P2129, DOI 10.1158/0008-5472.CAN-05-2569; Yang S, 2008, GENE CHROMOSOME CANC, V47, P665, DOI 10.1002/gcc.20574; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	38	546	576	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					521	531		10.1016/j.stem.2010.07.017	http://dx.doi.org/10.1016/j.stem.2010.07.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887957	Bronze			2022-12-28	WOS:000283270600013
J	Mohyeldin, A; Garzon-Muvdi, T; Quinones-Hinojosa, A				Mohyeldin, Ahmed; Garzon-Muvdi, Tomas; Quinones-Hinojosa, Alfredo			Oxygen in Stem Cell Biology: A Critical Component of the Stem Cell Niche	CELL STEM CELL			English	Review							HYPOXIA-INDUCIBLE FACTORS; MESENCHYMAL STROMAL CELLS; HUMAN BONE-MARROW; IN-VITRO; ENHANCES PROLIFERATION; STEM/PROGENITOR CELLS; SUBVENTRICULAR ZONE; DOPAMINERGIC DIFFERENTIATION; OSTEOGENIC DIFFERENTIATION; EMBRYONIC-DEVELOPMENT	The defining hallmark of stem cells is their ability to self-renew and maintain multipotency. This capacity depends on the balance of complex signals in their microenvironment. Low oxygen tensions (hypoxia) maintain undifferentiated states of embryonic, hematopoietic, mesenchymal, and neural stem cell phenotypes and also influence proliferation and cell-fate commitment. Recent evidence has identified a broader spectrum of stem cells influenced by hypoxia that includes cancer stem cells and induced pluripotent stem cells. These findings have important implications on our understanding of development, disease, and tissue-engineering practices and furthermore elucidate an added dimension of stem cell control within the niche.	[Mohyeldin, Ahmed; Garzon-Muvdi, Tomas; Quinones-Hinojosa, Alfredo] Johns Hopkins Sch Med, Brain Tumor Stem Cell Lab, Dept Neurosurg & Oncol, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Quinones-Hinojosa, A (corresponding author), Johns Hopkins Sch Med, Brain Tumor Stem Cell Lab, Dept Neurosurg & Oncol, Baltimore, MD 21231 USA.	aquinon2@jhmi.edu	Garzon-Muvdi, Tomas/A-9712-2011	Garzon-Muvdi, Tomas/0000-0002-2198-9757	National Institutes of Health (NIH) [K08NS055851]; Howard Hughes Medical Institute; Maryland Stem Cell Postdoctoral Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS055851] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Maryland Stem Cell Postdoctoral Research Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank three anonymous reviewers for comments on the manuscript, and we apologize to those colleagues whose work we could not reference directly due to space constraints. In addition, we would like to thank A. Yaktieen and A. Ibrahim for their graphic design technical input and A. Verma for his conceptual input for the cancer stem cell niche figure and for inspiring the concept behind the review. A.M. would like to thank S. Ashrafi and G. Vela for brainstorming and discussions on the stem cell niche. This work was supported by funds from the National Institutes of Health (NIH, KO8 Grant, no. K08NS055851) and the Howard Hughes Medical Institute. A. M. and T.G.M. were supported by the Maryland Stem Cell Postdoctoral Research Fellowship.	Adelman DM, 1999, GENE DEV, V13, P2478, DOI 10.1101/gad.13.19.2478; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Annabi B, 2003, STEM CELLS, V21, P337, DOI 10.1634/stemcells.21-3-337; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Berchner-Pfannschmidt U, 2007, J BIOL CHEM, V282, P1788, DOI 10.1074/jbc.M607065200; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Boiani M, 2002, GENE DEV, V16, P1209, DOI 10.1101/gad.966002; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brahimi-Horn MC, 2007, FEBS LETT, V581, P3582, DOI 10.1016/j.febslet.2007.06.018; Braun RD, 2001, AM J PHYSIOL-HEART C, V280, pH2533, DOI 10.1152/ajpheart.2001.280.6.H2533; BREZIS M, 1984, KIDNEY INT, V26, P375, DOI 10.1038/ki.1984.185; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Busuttil RA, 2003, AGING CELL, V2, P287, DOI 10.1046/j.1474-9728.2003.00066.x; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carrel A, 1912, J EXP MED, V15, P516, DOI 10.1084/jem.15.5.516; Ceradini DJ, 2005, TRENDS CARDIOVAS MED, V15, P57, DOI 10.1016/j.tcm.2005.02.002; Charles N, 2010, CELL STEM CELL, V6, P141, DOI 10.1016/j.stem.2010.01.001; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Chen X, 2010, NEUROSCIENCE, V165, P705, DOI 10.1016/j.neuroscience.2009.11.007; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; Chung DJ, 2009, J NEUROSCI RES, V87, P3554, DOI 10.1002/jnr.22162; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Clarke L, 2009, STEM CELLS, V27, P1879, DOI 10.1002/stem.96; Coulet F, 2003, J BIOL CHEM, V278, P46230, DOI 10.1074/jbc.M305420200; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cui X, 2007, STEM CELLS, V25, P2777, DOI 10.1634/stemcells.2007-0169; D'Ippolito G, 2006, BONE, V39, P513, DOI 10.1016/j.bone.2006.02.061; DELLOSBARBA P, 1987, EXP HEMATOL, V15, P137; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Dings J, 1998, NEUROSURGERY, V43, P1082, DOI 10.1097/00006123-199811000-00045; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; Erices A, 2000, BRIT J HAEMATOL, V109, P235, DOI 10.1046/j.1365-2141.2000.01986.x; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Fan X, 2010, STEM CELLS, V28, P5, DOI 10.1002/stem.254; Fehrer C, 2007, AGING CELL, V6, P745, DOI 10.1111/j.1474-9726.2007.00336.x; Folkman J, 2000, NAT REV MOL CELL BIO, V1, P76, DOI 10.1038/35036100; Forristal CE, 2010, REPRODUCTION, V139, P85, DOI 10.1530/REP-09-0300; Franovic A, 2009, P NATL ACAD SCI USA, V106, P21306, DOI 10.1073/pnas.0906432106; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gordan JD, 2007, CURR OPIN GENET DEV, V17, P71, DOI 10.1016/j.gde.2006.12.006; GRANT WC, 1947, AM J PHYSIOL, V150, P618, DOI 10.1152/ajplegacy.1947.150.4.618; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Gu YZ, 2000, ANNU REV PHARMACOL, V40, P519, DOI 10.1146/annurev.pharmtox.40.1.519; Gupta PB, 2009, NAT MED, V15, P1010, DOI 10.1038/nm0909-1010; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Harms KM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009767; Harrison JS, 2002, BLOOD, V99, P394, DOI 10.1182/blood.V99.1.394; Hata N, 2010, NEUROSURGERY, V66, P144, DOI 10.1227/01.NEU.0000363149.58885.2E; Heddleston JM, 2009, CELL CYCLE, V8, P3274, DOI 10.4161/cc.8.20.9701; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermitte F, 2006, STEM CELLS, V24, P65, DOI 10.1634/stemcells.2004-0351; Holzwarth C, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-11; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Hung SC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000416; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Ji L, 2009, J CELL PHYSIOL, V221, P54, DOI 10.1002/jcp.21826; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jones DL, 2008, NAT REV MOL CELL BIO, V9, P11, DOI 10.1038/nrm2319; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; KOFOED H, 1985, ACTA ORTHOP SCAND, V56, P400, DOI 10.3109/17453678508994357; Koshiji M, 2004, EMBO J, V23, P1949, DOI 10.1038/sj.emboj.7600196; Kosztowski T, 2009, EXPERT REV ANTICANC, V9, P597, DOI 10.1586/ERA.09.22; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; Kuhn NZ, 2010, J CELL PHYSIOL, V222, P268, DOI 10.1002/jcp.21940; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Laywell ED, 2007, NEUROSURG CLIN N AM, V18, P21, DOI 10.1016/j.nec.2006.10.003; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lee SH, 2010, AM J PHYSIOL-CELL PH, V298, pC847, DOI 10.1152/ajpcell.00418.2009; Lekli I, 2009, CAN J PHYSIOL PHARM, V87, P989, DOI 10.1139/Y09-102; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Lim DA, 2007, NEUROSURG CLIN N AM, V18, P81, DOI 10.1016/j.nec.2006.10.002; Liu LP, 2004, CANCER BIOL THER, V3, P492, DOI 10.4161/cbt.3.6.1010; Lopez-Barneo J, 2009, J NEURAL TRANSM, V116, P975, DOI 10.1007/s00702-009-0201-5; LORD BI, 1975, BLOOD, V46, P65; Lund P, 2009, CYTOTHERAPY, V11, P189, DOI 10.1080/14653240902736266; Malladi P, 2007, TISSUE ENG, V13, P1159, DOI 10.1089/ten.2006.0265; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Menon LG, 2009, STEM CELLS, V27, P2320, DOI 10.1002/stem.136; Miles DK, 2008, HIPPOCAMPUS, V18, P793, DOI 10.1002/hipo.20439; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; MITCHELL JA, 1968, ENDOCRINOLOGY, V83, P701, DOI 10.1210/endo-83-4-701; Miura M, 2003, P NATL ACAD SCI USA, V100, P5807, DOI 10.1073/pnas.0937635100; Moreno-Manzano V, 2010, J BIOL CHEM, V285, P1333, DOI 10.1074/jbc.M109.008326; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nilsson SK, 2001, BLOOD, V97, P2293, DOI 10.1182/blood.V97.8.2293; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oliver JA, 2004, J CLIN INVEST, V114, P795, DOI 10.1172/JCI200420921; Panchision DM, 2009, J CELL PHYSIOL, V220, P562, DOI 10.1002/jcp.21812; Pasarica M, 2009, DIABETES, V58, P718, DOI 10.2337/db08-1098; Pistollato F, 2007, MOL CELL NEUROSCI, V35, P424, DOI 10.1016/j.mcn.2007.04.003; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Potier E, 2007, BONE, V40, P1078, DOI 10.1016/j.bone.2006.11.024; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Quinones-Hinojosa A, 2006, J COMP NEUROL, V494, P415, DOI 10.1002/cne.20798; Rafii S, 2003, NAT MED, V9, P702, DOI 10.1038/nm0603-702; Ramirez-Bergeron DL, 2006, DEV CELL, V11, P81, DOI 10.1016/j.devcel.2006.04.018; Richardson SM, 2010, J CELL PHYSIOL, V222, P23, DOI 10.1002/jcp.21915; RODESCH F, 1992, OBSTET GYNECOL, V80, P283; Rodrigues CAV, 2010, BIOTECHNOL BIOENG, V106, P260, DOI 10.1002/bit.22648; Roitbak T, 2008, J CEREBR BLOOD F MET, V28, P1530, DOI 10.1038/jcbfm.2008.38; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sahlgren C, 2008, P NATL ACAD SCI USA, V105, P6392, DOI 10.1073/pnas.0802047105; Santilli G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008575; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Schindl M, 2002, CLIN CANCER RES, V8, P1831; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 1999, ANNU REV CELL DEV BI, V15, P551, DOI 10.1146/annurev.cellbio.15.1.551; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shi S, 2003, J BONE MINER RES, V18, P696, DOI 10.1359/jbmr.2003.18.4.696; Shima H, 2009, BIOCHEM BIOPH RES CO, V378, P467, DOI 10.1016/j.bbrc.2008.11.056; Shingo T, 2001, J NEUROSCI, V21, P9733, DOI 10.1523/JNEUROSCI.21-24-09733.2001; SHOOTER RA, 1952, BRIT J EXP PATHOL, V33, P98; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Silvan U, 2009, DIFFERENTIATION, V78, P159, DOI 10.1016/j.diff.2009.06.002; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Slavin S, 2008, CLIN NEUROL NEUROSUR, V110, P943, DOI 10.1016/j.clineuro.2008.01.014; Sonabend AM, 2008, STEM CELLS, V26, P831, DOI 10.1634/stemcells.2007-0758; Storch A, 2001, EXP NEUROL, V170, P317, DOI 10.1006/exnr.2001.7706; Studer L, 2000, J NEUROSCI, V20, P7377; Sun JQ, 2009, BRAIN DEV-JPN, V31, P331, DOI 10.1016/j.braindev.2008.06.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Torrente Y, 2008, CELL TRANSPLANT, V17, P1103, DOI 10.3727/096368908787236576; Undale AH, 2009, MAYO CLIN PROC, V84, P893, DOI 10.1016/S0025-6196(11)60506-5; Wang DW, 2005, J CELL PHYSIOL, V204, P184, DOI 10.1002/jcp.20324; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Westfall SD, 2008, STEM CELLS DEV, V17, P869, DOI 10.1089/scd.2007.0240; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xu Y, 2007, TISSUE ENG, V13, P2981, DOI 10.1089/ten.2007.0050; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; YOUSSOUFIAN H, 1993, BLOOD, V81, P2223; Yu DY, 2005, EXP EYE RES, V80, P745, DOI 10.1016/j.exer.2005.01.018; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zannettino ACW, 2008, J CELL PHYSIOL, V214, P413, DOI 10.1002/jcp.21210; Zhong H, 1999, CANCER RES, V59, P5830; Zhu WQ, 2006, STEM CELLS, V24, P416, DOI 10.1634/stemcells.2005-0121	165	1052	1097	7	265	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					150	161		10.1016/j.stem.2010.07.007	http://dx.doi.org/10.1016/j.stem.2010.07.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682444	Bronze			2022-12-28	WOS:000281107400008
J	Seita, J; Rossi, DJ; Weissman, IL				Seita, Jun; Rossi, Derrick J.; Weissman, Irving L.			Differential DNA Damage Response in Stem and Progenitor Cells	CELL STEM CELL			English	Editorial Material							RESISTANCE; BCL-2; MOUSE		[Seita, Jun; Weissman, Irving L.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA; [Rossi, Derrick J.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Rossi, Derrick J.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Rossi, Derrick J.] Immune Dis Inst, Boston, MA 02115 USA; [Rossi, Derrick J.] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA	Stanford University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	Seita, J (corresponding author), Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Sch Med, Stanford, CA 94305 USA.	jseita@stanford.edu	Seita, Jun/AAM-1478-2020	Seita, Jun/0000-0002-3008-3615				Domen J, 2003, EXP HEMATOL, V31, P631, DOI 10.1016/S0301-472X(03)00084-5; MEIJNE EIM, 1991, EXP HEMATOL, V19, P617; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sotiropoulou PA, 2010, NAT CELL BIOL, V12, P572, DOI 10.1038/ncb2059; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236	10	36	38	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					145	147		10.1016/j.stem.2010.07.006	http://dx.doi.org/10.1016/j.stem.2010.07.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682442	Bronze			2022-12-28	WOS:000281107400006
J	Taylor, PL; Barker, RA; Blume, KG; Cattaneo, E; Colman, A; Deng, H; Edgar, H; Fox, IJ; Gerstle, C; Goldstein, LSB; High, KA; Lyall, A; Parkman, R; Pitossi, FJ; Prentice, ED; Rooke, HM; Sipp, DA; Srivastava, A; Stayn, S; Steinberg, GK; Wagers, AJ; Weissman, IL				Taylor, Patrick L.; Barker, Roger A.; Blume, Karl G.; Cattaneo, Elena; Colman, Alan; Deng, Hongkui; Edgar, Harold; Fox, Ira J.; Gerstle, Claude; Goldstein, Lawrence S. B.; High, Katherine A.; Lyall, Andrew; Parkman, Robertson; Pitossi, Fernando J.; Prentice, Ernest D.; Rooke, Heather M.; Sipp, Douglas A.; Srivastava, Alok; Stayn, Susan; Steinberg, Gary K.; Wagers, Amy J.; Weissman, Irving L.			Patients Beware: Commercialized Stem Cell Treatments on the Web	CELL STEM CELL			English	News Item							ISSCR GUIDELINES	A report by the International Society for Stem Cell Research (ISSCR)'s Task Force on Unproven Stem Cell Treatments outlines development of resources for patients, their families, and physicians seeking information on stem cell treatments.	[Rooke, Heather M.] Int Soc Stem Cell Res, Boston, MA 02115 USA; [Taylor, Patrick L.] Childrens Hosp, Boston, MA 02115 USA; [Barker, Roger A.] Univ Cambridge, Dept Clin Neurosci, Cambridge Ctr Brain Repair, Cambridge CB2 2PY, England; [Blume, Karl G.] Stanford Univ, Sch Med, Stanford, CA 94305 USA; [Cattaneo, Elena] Univ Milan, I-20133 Milan, Italy; [Colman, Alan] ASTAR Singapore Stem Cell Consortium, Singapore 138648, Singapore; [Deng, Hongkui] Peking Univ, Beijing 100871, Peoples R China; [Edgar, Harold] Columbia Law Sch, New York, NY 10027 USA; [Fox, Ira J.] UPMC, Childrens Hosp Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15201 USA; [Goldstein, Lawrence S. B.] Univ Calif San Diego, La Jolla, CA 92093 USA; [High, Katherine A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Lyall, Andrew] Stem Cell Network, Ottawa, ON K1H 8L6, Canada; [Parkman, Robertson] Childrens Hosp Los Angeles, Los Angeles, CA 90027 USA; [Pitossi, Fernando J.] Fdn Inst Leloir IIBBA CONICET, RA-1405 Buenos Aires, DF, Argentina; [Prentice, Ernest D.] Univ Nebraska Med Ctr, Omaha, NE 68198 USA; [Sipp, Douglas A.] RIKEN, Ctr Dev Biol, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Srivastava, Alok] Christian Med Coll & Hosp, Vellore 632004, Tamil Nadu, India; [Wagers, Amy J.] Joslin Diabet Ctr, Boston, MA 02215 USA	Harvard University; Boston Children's Hospital; University of Cambridge; Stanford University; University of Milan; Agency for Science Technology & Research (A*STAR); Peking University; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California San Diego; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Children's Hospital Los Angeles; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute; University of Nebraska System; University of Nebraska Medical Center; RIKEN; Christian Medical College & Hospital (CMCH) Vellore; Harvard University; Joslin Diabetes Center, Inc.	Rooke, HM (corresponding author), Int Soc Stem Cell Res, Boston, MA 02115 USA.		Sipp, Doug/C-9218-2017; High, Katherine A./AAB-9322-2020	Sipp, Doug/0000-0002-5979-0938; Pitossi, Fernando/0000-0001-5104-9726; CATTANEO, ELENA/0000-0002-0755-4917; High, Katherine/0000-0002-0805-6223; Barker, Roger Alistair/0000-0001-8843-7730	Medical Research Council [G0300723B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		COHEN IG, 2010, IOWA L REV, V95; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; *ISSCR, 2008, GUID CLIN TRANSL STE; ISSCR, 2008, PAT HDB STEM CELL TH; *ISSCR, 2006, GUID COND HUM EMBR S; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Taylor PL, 2007, NAT BIOTECHNOL, V25, P398, DOI 10.1038/nbt0407-398; *US LIB MED, 2007, FACT SHEET MED J SEL; Weissman Irving, 2009, Cell Stem Cell, V5, P151, DOI 10.1016/j.stem.2009.07.013	10	38	39	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					43	49		10.1016/j.stem.2010.06.001	http://dx.doi.org/10.1016/j.stem.2010.06.001			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621049	Green Published, Bronze			2022-12-28	WOS:000280222300012
J	Hawkins, RD; Hon, GC; Lee, LK; Ngo, Q; Lister, R; Pelizzola, M; Edsall, LE; Kuan, S; Luu, Y; Klugman, S; Antosiewicz-Bourget, J; Ye, Z; Espinoza, C; Agarwahl, S; Shen, L; Ruotti, V; Wang, W; Stewart, R; Thomson, JA; Ecker, JR; Ren, B				Hawkins, R. David; Hon, Gary C.; Lee, Leonard K.; Ngo, QueMinh; Lister, Ryan; Pelizzola, Mattia; Edsall, Lee E.; Kuan, Samantha; Luu, Ying; Klugman, Sarit; Antosiewicz-Bourget, Jessica; Ye, Zhen; Espinoza, Celso; Agarwahl, Saurabh; Shen, Li; Ruotti, Victor; Wang, Wei; Stewart, Ron; Thomson, James A.; Ecker, Joseph R.; Ren, Bing			Distinct Epigenomic Landscapes of Pluripotent and Lineage-Committed Human Cells	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; H3K9ME2 CHROMATIN DOMAINS; DNA METHYLATION; HISTONE H3; LYSINE-9 METHYLATION; GENE-EXPRESSION; POLYCOMB; GENOME; FIBROBLASTS; SIGNATURES	Human embryonic stem cells (hESCs) share an identical genome with lineage-committed cells, yet possess the remarkable properties of self-renewal and pluripotency. The diverse cellular properties in different cells have been attributed to their distinct epigenomes, but how much epigenomes differ remains unclear. Here, we report that epigenomic landscapes in hESCs and lineage-committed cells are drastically different. By comparing the chromatin-modification profiles and DNA methylomes in hESCs and primary fibroblasts, we find that nearly one-third of the genome differs in chromatin structure. Most changes arise from dramatic redistributions of repressive H3K9me3 and H3K27me3 marks, which form blocks that significantly expand in fibroblasts. A large number of potential regulatory sequences also exhibit a high degree of dynamics in chromatin modifications and DNA methylation. Additionally, we observe novel, context-dependent relationships between DNA methylation and chromatin modifications. Our results provide new insights into epigenetic mechanisms underlying properties of pluripotency and cell fate commitment.	[Hawkins, R. David; Hon, Gary C.; Lee, Leonard K.; Ngo, QueMinh; Edsall, Lee E.; Kuan, Samantha; Luu, Ying; Klugman, Sarit; Ye, Zhen; Espinoza, Celso; Agarwahl, Saurabh; Ren, Bing] Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Lister, Ryan; Pelizzola, Mattia; Ecker, Joseph R.] Salk Inst Biol Studies, Genom Anal Lab, La Jolla, CA 92037 USA; [Antosiewicz-Bourget, Jessica; Ruotti, Victor; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Shen, Li; Wang, Wei] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Inst Genom Med, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Ren, Bing] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Ruotti, Victor; Stewart, Ron; Thomson, James A.] Genome Ctr Wisconsin, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Wisconsin Natl Primate Res Ctr, Madison, WI 53706 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53715 USA	Ludwig Institute for Cancer Research; Salk Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ren, B (corresponding author), Ludwig Inst Canc Res, La Jolla, CA 92093 USA.	biren@ucsd.edu	Ecker, Joseph R/B-9144-2008; Shen, Li/B-3562-2008; Lister, Ryan/B-5168-2012	Ecker, Joseph R/0000-0001-5799-5895; Shen, Li/0000-0002-5190-2851; Lister, Ryan/0000-0001-6637-7239; Pelizzola, Mattia/0000-0001-6672-9636; Edsall, Lee Elizabeth/0000-0002-0326-2829	American Cancer Society; Human Frontier Science; NIH; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U01ES017166] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Human Frontier Science(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We acknowledge Bradley Bernstein and the ENCODE Chromatin Group at Broad Institute and MGH for generating the H3K27me3 data sets for HUVEC, NHEK, GM, and K562 cell types. These data were used for validation during the revision and were under embargo until October 7, 2009. R.D.H. is supported by an American Cancer Society Postdoctoral Fellowship. R.L. is supported by a Human Frontier Science Program Long-term Fellowship. This work was supported by the following: NIH Epigenomics Roadmap Project (to B.R., J.A.T., J.R.E., and W.W.), the California Institute for Regenerative Medicine (B.R.), the Ludwig Institute for Cancer Research (B.R.), the Mary K. Chapman Foundation (J.R.E.), and the J.T.F. Morgridge Institute for Research (J.A.T.). This study was carried out as part of the NIH Roadmap Epigenomics Program (http://nihroadmap.nih.gov/epigenomics/referenceepigenomeconsortium.asp).	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barrand S, 2010, BIOCHEM BIOPH RES CO, V391, P762, DOI 10.1016/j.bbrc.2009.11.134; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BENSHUSHAN E, 1993, MOL CELL BIOL, V13, P891, DOI 10.1128/MCB.13.2.891; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bilodeau S, 2009, GENE DEV, V23, P2484, DOI 10.1101/gad.1837309; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Brunner AL, 2009, GENOME RES, V19, P1044, DOI 10.1101/gr.088773.108; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; Cedar H, 2009, NAT REV GENET, V10, P295, DOI 10.1038/nrg2540; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Deb-Rinker P, 2005, J BIOL CHEM, V280, P6257, DOI 10.1074/jbc.C400479200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; Faust C, 1998, DEVELOPMENT, V125, P4495; Filion GJ, 2010, NAT GENET, V42, P4, DOI 10.1038/ng0110-4; Fuks F, 2003, NUCLEIC ACIDS RES, V31, P2305, DOI 10.1093/nar/gkg332; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hon G, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000201; Humburg P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-343; Jackson JP, 2002, NATURE, V416, P556, DOI 10.1038/nature731; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Jones PA, 1999, TRENDS GENET, V15, P34, DOI 10.1016/S0168-9525(98)01636-9; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Lehnertz B, 2003, CURR BIOL, V13, P1192, DOI 10.1016/S0960-9822(03)00432-9; Li HW, 2006, J BIOL CHEM, V281, P19489, DOI 10.1074/jbc.M513249200; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Pilia G, 1996, NAT GENET, V12, P241, DOI 10.1038/ng0396-241; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ryan AK, 1997, GENE DEV, V11, P1207, DOI 10.1101/gad.11.10.1207; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341; Tachibana M, 2002, GENE DEV, V16, P1779, DOI 10.1101/gad.989402; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tamaru H, 2001, NATURE, V414, P277, DOI 10.1038/35104508; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Wen B, 2010, NAT GENET, V42, P5, DOI 10.1038/ng0110-5; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297; Wendt KS, 2008, NATURE, V451, P796, DOI 10.1038/nature06634; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	72	581	600	4	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					479	491		10.1016/j.stem.2010.03.018	http://dx.doi.org/10.1016/j.stem.2010.03.018			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452322	Green Accepted, Bronze			2022-12-28	WOS:000277844800015
J	Broxmeyer, HE				Broxmeyer, Hal E.			Will iPS Cells Enhance Therapeutic Applicability of Cord Blood Cells and Banking?	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; GENERATION; PROGENITOR		Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Broxmeyer, HE (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	hbroxmey@iupui.edu						Broxmeyer HE, 2003, P NATL ACAD SCI USA, V100, P645, DOI 10.1073/pnas.0237086100; BROXMEYER HE, 1989, P NATL ACAD SCI USA, V86, P3828, DOI 10.1073/pnas.86.10.3828; BROXMEYER HE, 2009, CORD BLOOD HEMATOPOI, P559; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; GLUCKMAN E, 1989, NEW ENGL J MED, V321, P1174, DOI 10.1056/NEJM198910263211707; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Kaimal AJ, 2009, OBSTET GYNECOL, V114, P848, DOI 10.1097/AOG.0b013e3181b8fc0d; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mantel C, 2007, BLOOD, V109, P4518, DOI 10.1182/blood-2006-10-054247; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; YE Z, 2009, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2009-04-217406; Yoder MI, 2009, CURR OPIN HEMATOL, V16, P269, DOI 10.1097/MOH.0b013e32832bbcab	15	31	33	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					21	24		10.1016/j.stem.2009.12.008	http://dx.doi.org/10.1016/j.stem.2009.12.008			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074533	Bronze			2022-12-28	WOS:000274029700008
J	Esteban, MA; Wang, T; Qin, BM; Yang, JY; Qin, DJ; Cai, JL; Li, W; Weng, ZH; Chen, JK; Ni, S; Chen, KS; Li, Y; Liu, XP; Xu, JY; Zhang, SQ; Li, F; He, WZ; Labuda, K; Song, YC; Peterbauer, A; Wolbank, S; Redl, H; Zhong, M; Cai, DZ; Zeng, LW; Pei, DQ				Esteban, Miguel Angel; Wang, Tao; Qin, Baoming; Yang, Jiayin; Qin, Dajiang; Cai, Jinglei; Li, Wen; Weng, Zhihui; Chen, Jiekai; Ni, Su; Chen, Keshi; Li, Yuan; Liu, Xiaopeng; Xu, Jianyong; Zhang, Shiqiang; Li, Feng; He, Wenzhi; Labuda, Krystyna; Song, Yancheng; Peterbauer, Anja; Wolbank, Susanne; Redl, Heinz; Zhong, Mei; Cai, Daozhang; Zeng, Lingwen; Pei, Duanqing			Vitamin C Enhances the Generation of Mouse and Human Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							DEMETHYLASES; FIBROBLASTS; EFFICIENCY; INDUCTION; LIMITS; MYC	Somatic cells can be reprogrammed into induced pluripotent stem cells (iPSCs) by defined factors. However, the low efficiency and slow kinetics of the reprogramming process have hampered progress with this technology. Here we report that a natural compound, vitamin C (Vc), enhances iPSC: generation from both mouse and human somatic cells. Vc acts at least in part by alleviating cell senescence, a recently identified roadblock for reprogramming. In addition, Vc accelerates gene expression changes and promotes the transition of pre-iPSC colonies to a fully reprogrammed state. Our results therefore highlight a straightforward method for improving the speed and efficiency of iPSC generation and provide additional insights into the mechanistic basis of the reprogramming process.	[Esteban, Miguel Angel; Wang, Tao; Qin, Baoming; Yang, Jiayin; Qin, Dajiang; Cai, Jinglei; Li, Wen; Weng, Zhihui; Chen, Jiekai; Ni, Su; Chen, Keshi; Li, Yuan; Liu, Xiaopeng; Xu, Jianyong; Zhang, Shiqiang; Li, Feng; He, Wenzhi; Zeng, Lingwen; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Esteban, Miguel Angel; Wang, Tao; Qin, Baoming; Yang, Jiayin; Qin, Dajiang; Cai, Jinglei; Li, Wen; Weng, Zhihui; Chen, Jiekai; Ni, Su; Chen, Keshi; Li, Yuan; Liu, Xiaopeng; Xu, Jianyong; Zhang, Shiqiang; Li, Feng; He, Wenzhi; Zeng, Lingwen; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Labuda, Krystyna; Wolbank, Susanne; Redl, Heinz] Ludwig Boltzmann Inst Clin & Expt Traumatol, A-1200 Vienna, Austria; [Song, Yancheng; Cai, Daozhang] Sun Yat Sen Univ, Affiliated Hosp 3, Guangzhou 510630, Guangdong, Peoples R China; [Peterbauer, Anja] Red Cross Blood Transfus Serv Upper Austria, A-4020 Linz, Austria; [Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Ludwig Boltzmann Institute; Sun Yat Sen University; Southern Medical University - China	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	NI, Su/AAH-8267-2020; Gabriel, Christian/A-1689-2014; Qin, Baoming/G-1553-2015; Redl, Heinz/AAD-8157-2019; Chen, Keshi/AAE-4600-2020; wang, tom/M-6808-2014; zhou, xingru/G-4442-2012	Gabriel, Christian/0000-0003-2043-9320; Qin, Baoming/0000-0001-7652-161X; Ni, Su/0000-0003-2883-574X; Yang, Jiayin/0000-0001-9134-1959; Chen, Jiekai/0000-0001-5168-7074; Wolbank, Susanne/0000-0002-1244-5854; Chen, Keshi/0000-0003-0402-4555	National Natural Science Foundation of China [30630039, 90813033]; National Science Fund for Distinguished Young Scholars [30725012]; Knowledge Innovation Project of The Chinese Academy of Sciences [KSCX2-YW-R-48, KSCX1-YW-02-1]; Bureau of Science and Technology of Guangzhou Municipality, China [2008A1-E4011]; Key Technologies R&D Program, 973 Program of China [2006CB701504, 2006CB943600, 2007CB948002, 2009CB941102, 2009CB940902]; EFBIC RED travel grant; Chinese Academy of Sciences/SAFEA International Partnership [230725012]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Knowledge Innovation Project of The Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Bureau of Science and Technology of Guangzhou Municipality, China; Key Technologies R&D Program, 973 Program of China(National Basic Research Program of ChinaNational Key Technology R&D Program); EFBIC RED travel grant; Chinese Academy of Sciences/SAFEA International Partnership(Chinese Academy of Sciences)	Supported by National Natural Science Foundation of China (grant numbers 30630039 and 90813033), National Science Fund for Distinguished Young Scholars (30725012), Knowledge Innovation Project of The Chinese Academy of Sciences (grant numbers KSCX2-YW-R-48, KSCX1-YW-02-1), Bureau of Science and Technology of Guangzhou Municipality, China (grant 2008A1-E4011), Key Technologies R&D Program, 973 Program of China (grant numbers 2006CB701504, 2006CB943600, 2007CB948002, 2009CB941102, 2009CB940902), an EFBIC RED travel grant, and the Chinese Academy of Sciences/SAFEA International Partnership Program for Creative Research Teams (grant number 230725012). We wish to thank members of our laboratories for their support.	Arrigoni O, 2002, BBA-GEN SUBJECTS, V1569, P1, DOI 10.1016/S0304-4165(01)00235-5; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Esteban MA, 2009, J BIOL CHEM, V284, P17634, DOI 10.1074/jbc.M109.008938; Garcia-Gonzalo FR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001384; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; Kawamura T, 2009, NATURE, V460, P1140, DOI 10.1038/nature08311; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Li H, 2009, NATURE, V460, P1136, DOI 10.1038/nature08290; Marion RM, 2009, NATURE, V460, P1149, DOI 10.1038/nature08287; MASSIP L, 2009, FASEB J; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Parrinello S, 2003, NAT CELL BIOL, V5, P741, DOI 10.1038/ncb1024; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Shi Y, 2007, NAT REV GENET, V8, P829, DOI 10.1038/nrg2218; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sun N, 2009, P NATL ACAD SCI USA, V106, P15720, DOI 10.1073/pnas.0908450106; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Utikal J, 2009, NATURE, V460, P1145, DOI 10.1038/nature08285; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	32	726	826	7	231	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					71	79		10.1016/j.stem.2009.12.001	http://dx.doi.org/10.1016/j.stem.2009.12.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20036631	Bronze			2022-12-28	WOS:000274029700013
J	Pollard, SM; Stricker, SH; Beck, S				Pollard, Steven M.; Stricker, Stefan H.; Beck, Stephan			A Shore Sign of Reprogramming	CELL STEM CELL			English	Editorial Material							STEM-CELLS		[Pollard, Steven M.; Stricker, Stefan H.] Univ Cambridge, Wellcome Trust Ctr Stem Cell Biol, Cambridge CB2 1QR, England; [Pollard, Steven M.; Stricker, Stefan H.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Pollard, Steven M.; Beck, Stephan] UCL, UCL Canc Inst, London WC1E 6BT, England	University of Cambridge; University of Cambridge; University of London; University College London	Pollard, SM (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Biol, Cambridge CB2 1QR, England.	steven.pollard@cscr.cam.ac.uk; shs35@cscr.cam.ac.uk; s.beck@ucl.ac.uk	Stricker, Stefan H/A-4930-2015; Stricker, Stefan/A-7410-2013; Pollard, Steven/B-7966-2010	Stricker, Stefan H/0000-0002-5488-8530; Pollard, Steven/0000-0001-6428-0492				Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Clarke J, 2009, NAT NANOTECHNOL, V4, P265, DOI [10.1038/NNANO.2009.12, 10.1038/nnano.2009.12]; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Irizarry RA, 2008, GENOME RES, V18, P780, DOI 10.1101/gr.7301508; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; LISTER R, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08514; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Suzuki MM, 2008, NAT REV GENET, V9, P465, DOI 10.1038/nrg2341	10	7	8	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					571	572		10.1016/j.stem.2009.11.006	http://dx.doi.org/10.1016/j.stem.2009.11.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951682	Bronze			2022-12-28	WOS:000273616700002
J	Jorgensen, HF; Fisher, AG				Jorgensen, Helle F.; Fisher, Amanda G.			LOCKing in Cellular Potential	CELL STEM CELL			English	Editorial Material							STEM-CELLS; CHROMATIN; METHYLATION; PLURIPOTENT	Recently in Nature Genetics, Wen et al. (2009) report that H3K9me2 modification is more abundant in differentiated cells than in embryonic stem cells and that it decorates chromatin in repressive blocks.	[Jorgensen, Helle F.; Fisher, Amanda G.] Imperial Coll Sch Med, MRC Clin Sci Ctr, London W12 0NN, England	Imperial College London	Jorgensen, HF (corresponding author), Imperial Coll Sch Med, MRC Clin Sci Ctr, Hammersmith Hosp Campus,Cane Rd, London W12 0NN, England.	helle.jorgensen@csc.mrc.ac.uk; amanda.fisher@csc.mrc.ac.uk		Jorgensen, Helle/0000-0002-7909-2977	MRC [MC_U120027516] Funding Source: UKRI; Medical Research Council [MC_U120027516] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Liu YF, 2004, P NATL ACAD SCI USA, V101, P1679, DOI 10.1073/pnas.0305421101; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; O'Neill LP, 2003, METHODS, V31, P76, DOI 10.1016/S1046-2023(03)00090-2; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Spemann H., 1938, EMBRYONIC DEV INDUCT; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Wen B, 2009, NAT GENET, V41, P246, DOI 10.1038/ng.297	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					192	194		10.1016/j.stem.2009.02.007	http://dx.doi.org/10.1016/j.stem.2009.02.007			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265653	Bronze			2022-12-28	WOS:000264369300004
J	Greco, V; Chen, T; Rendl, M; Schober, M; Pasolli, HA; Stokes, N; dela Cruz-Racelis, J; Fuchs, E				Greco, Valentina; Chen, Ting; Rendl, Michael; Schober, Markus; Pasolli, H. Amalia; Stokes, Nicole; dela Cruz-Racelis, June; Fuchs, Elaine			A Two-Step Mechanism for Stem Cell Activation during Hair Regeneration	CELL STEM CELL			English	Article							LABEL-RETAINING CELLS; BIOCHEMICALLY DISTINCT; FOLLICLE; DIFFERENTIATION; PROLIFERATION; MORPHOGENESIS; INDUCTION; CYCLE; KERATINOCYTE; POPULATIONS	Hair follicles (HFs) undergo cyclic bouts of degeneration, rest, and regeneration. During rest (telogen), the hair germ (HG) appears as a small cell cluster between the slow-cycling bulge and dermal papilla (DP). Here we show that HG cells are derived from bulge stem cells (SCs) but become responsive quicker to DP-promoting signals. In vitro, HG cells also proliferate sooner but display shorter-lived potential than bulge cells. Molecularly, they more closely resemble activated bulge rather than transit-amplifying (matrix) cells. Transcriptional profiling reveals precocious activity of both HG and DIP in late telogen, accompanied by Wilt signaling in HG and elevated FGFs and BMP inhibitors in DID. FGFs and BMP inhibitors participate with Wnts in exerting selective and potent stimuli to the HG both in vivo and in vitro. Our findings suggest a model where HG cells fuel initial steps in hair regeneration, while the bulge is the engine maintaining the process.	[Greco, Valentina; Chen, Ting; Rendl, Michael; Schober, Markus; Pasolli, H. Amalia; Stokes, Nicole; dela Cruz-Racelis, June; Fuchs, Elaine] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Fuchs, E (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10065 USA.	fuchslb@rockefeller.edu	Fuchs, Elaine/G-1565-2016	Rendl, Michael/0000-0001-6326-620X; Pasolli, Hilda Amalia/0000-0003-3899-3530	NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR031737, R01AR050452, R01AR063663] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	For technical assistance, we thank Andrew Levine (Fuchs Laboratory); Svetlana Mazel, Fan Xiaoxuan, and Chris Bare (Rockefeller FCRD Facility); and Agnes Vials (Genomics Core Facility, MSKI). For suggestions and advice, we thank Mima Perez-Moreno, Geraldine Guasch, Terry Lechler, and Tudorita Tumbar (Fuchs Laboratory); Sabrina Desbordes (MSKI); Wendy Lynn Havran (Scripps); and Richard Lifton, Hafan Lin, Diane Krause, and Natalia Ivanova (Yale Uuniversity). Randall Kramer (UCSF) provided the integrin alpha 7 antibody. Bruce Morgan (Harvard) provided the Shh Cre-ER mice. V.G was a Human Frontier Science Program fellow. T.C is a fellow of the New York Stem Cell Foundation and the recipient of an American Association of Cancer Research-Astellas Fellowship for Basic Cancer Research. E.F. is an Investigator of the Howard Hughes Medical Institute. This work was supported in part from a grant from the NIH (E.F.).	Alonso L, 2005, J CELL BIOL, V170, P559, DOI 10.1083/jcb.200504131; Andl T, 2004, DEVELOPMENT, V131, P2257, DOI 10.1242/dev.01125; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Botchkarev VA, 2001, FASEB J, V15, P2205, DOI 10.1096/fj.01-0207com; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Guo LF, 1996, GENE DEV, V10, P165, DOI 10.1101/gad.10.2.165; HEBERT JM, 1994, CELL, V78, P1017, DOI 10.1016/0092-8674(94)90276-3; Horsley V, 2008, CELL, V132, P299, DOI 10.1016/j.cell.2007.11.047; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lo Celso C, 2004, DEVELOPMENT, V131, P1787, DOI 10.1242/dev.01052; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Lyle S, 1999, J INVEST DERM SYMP P, V4, P296, DOI 10.1038/sj.jidsp.5640233; Merrill BJ, 2001, GENE DEV, V15, P1688, DOI 10.1101/gad.891401; Morris RJ, 1999, J INVEST DERMATOL, V112, P470, DOI 10.1046/j.1523-1747.1999.00537.x; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Muller-Rover S, 1999, EXP DERMATOL, V8, P237; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nguyen H, 2006, CELL, V127, P171, DOI 10.1016/j.cell.2006.07.036; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2001, J CELL SCI, V114, P3419; Petiot A, 2003, DEVELOPMENT, V130, P5493, DOI 10.1242/dev.00788; Plikus MV, 2008, NATURE, V451, P340, DOI 10.1038/nature06457; Rendl M, 2005, PLOS BIOL, V3, P1910, DOI 10.1371/journal.pbio.0030331; Rendl M, 2008, GENE DEV, V22, P543, DOI 10.1101/gad.1614408; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Schmidt-Ullrich R, 2005, BIOESSAYS, V27, P247, DOI 10.1002/bies.20184; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Suzuki Y, 2000, JPN J EDUC PSYCHOL, V48, P1; Taylor G, 2000, CELL, V102, P451, DOI 10.1016/S0092-8674(00)00050-7; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Van Mater D, 2003, GENE DEV, V17, P1219, DOI 10.1101/gad.1076103; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064; Waghmare SK, 2008, EMBO J, V27, P1309, DOI 10.1038/emboj.2008.72; WERNER S, 1994, SCIENCE, V266, P819, DOI 10.1126/science.7973639; Zhang Y, 2008, DEVELOPMENT, V135, P2161, DOI 10.1242/dev.017459	43	527	548	3	66	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					155	169		10.1016/j.stem.2008.12.009	http://dx.doi.org/10.1016/j.stem.2008.12.009			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200804	Green Accepted, Bronze			2022-12-28	WOS:000263213400012
J	Cui, KR; Zang, CZ; Roh, TY; Schones, DE; Childs, RW; Peng, WQ; Zhao, K				Cui, Kairong; Zang, Chongzhi; Roh, Tae-Young; Schones, Dustin E.; Childs, Richard W.; Peng, Weiqun; Zhao, Keji			Chromatin Signatures in Multipotent Human Hematopoietic Stem Cells Indicate the Fate of Bivalent Genes during Differentiation	CELL STEM CELL			English	Article							BETA-GLOBIN GENE; DNA METHYLATION; HISTONE MODIFICATIONS; PLURIPOTENT; EXPRESSION; BLOOD; MAPS; PROGENITORS; PROMOTERS; ENHANCERS	Histone modifications have been implicated in stem cell maintenance and differentiation. We have analyzed genome-wide changes in gene expression and histone modifications during differentiation of multipotent human primary hematopoietic stem cells/progenitor cells (HSCs/HPCs) into erythrocyte precursors. Our data indicate that H3K4me1, H3K9me1, and H3K27me1 associate with enhancers of differentiation genes prior to their activation and correlate with basal expression, suggesting that these monomethylations are involved in the maintenance of activation potential required for differentiation. In addition, although the majority of genes associated with both H3K4me3 and H3K27me3 in HSCs/HPCs become silent and lose H3K4me3 after differentiation, those that lose H3K27me3 and become activated after differentiation are associated with increased levels of H2A.Z, H3K4me1, H3K9me1, H4K20me1, and RNA polymerase 11 in HSCs/HPCs. Thus, our data suggest that gene expression changes during differentiation are programmed by chromatin modifications present at the HSC/HPC stage and provide a resource for enhancer and promoter identification.	[Cui, Kairong; Roh, Tae-Young; Schones, Dustin E.; Zhao, Keji] NHLBI, Lab Mol Immunol, NIH, Bethesda, MD 20892 USA; [Childs, Richard W.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA; [Zang, Chongzhi; Peng, Weiqun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); George Washington University	Zhao, K (corresponding author), NHLBI, Lab Mol Immunol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	zhaok@nhlbi.nih.gov	/AAI-2516-2019; Zang, Chongzhi/D-1445-2011	Zang, Chongzhi/0000-0003-4812-3627; Roh, Tae-Young/0000-0001-5833-0844; Peng, Weiqun/0000-0001-5521-9091	National Institutes of Health, National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345, ZIAHL005801, ZICHL006018, ZIAHL006090, ZIAHL006031] Funding Source: NIH RePORTER	National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Susan Wong for helpful discussions and Dr. Warren Leonard for critical reading of the manuscript. The gene expression analysis using the Affymetrix microarrays was performed by the Gene Expression Core Facility of the National Heart, Lung, and Blood Institute. This work was supported by the Intramural Research Program of the National Institutes of Health, National Heart, Lung, and Blood Institute.	Ansel KM, 2006, ANNU REV IMMUNOL, V24, P607, DOI 10.1146/annurev.immunol.23.021704.115821; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bitan M, 2005, EXP HEMATOL, V33, P713, DOI 10.1016/j.exphem.2005.03.004; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; de Laat W, 2008, CURR TOP DEV BIOL, V82, P117, DOI 10.1016/S0070-2153(07)00005-1; DONZE D, 1995, J BIOL CHEM, V270, P1955, DOI 10.1074/jbc.270.4.1955; Ford AM, 1996, P NATL ACAD SCI USA, V93, P10838, DOI 10.1073/pnas.93.20.10838; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Hu M, 1997, GENE DEV, V11, P774, DOI 10.1101/gad.11.6.774; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Lepikhov Konstantin, 2004, BMC Dev Biol, V4, P12, DOI 10.1186/1471-213X-4-12; Litt MD, 2001, SCIENCE, V293, P2453, DOI 10.1126/science.1064413; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Migliaccio G, 2002, BLOOD CELL MOL DIS, V28, P169, DOI 10.1006/bcmd.2002.0502; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Morrison SJ, 1995, ANNU REV CELL DEV BI, V11, P35, DOI 10.1146/annurev.cb.11.110195.000343; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Orford K, 2008, DEV CELL, V14, P798, DOI 10.1016/j.devcel.2008.04.002; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ramos CA, 2006, PLOS GENET, V2, P1487, DOI 10.1371/journal.pgen.0020159; Roh TY, 2007, GENOME RES, V17, P74, DOI 10.1101/gr.5767907; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roh TY, 2005, GENE DEV, V19, P542, DOI 10.1101/gad.1272505; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Sanyal M, 2007, BLOOD, V109, P4191, DOI 10.1182/blood-2006-10-054213; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Szilvassy SJ, 2003, ARCH MED RES, V34, P446, DOI 10.1016/j.arcmed.2003.06.004; Takahashi S, 1997, J BIOL CHEM, V272, P12611, DOI 10.1074/jbc.272.19.12611; Ting CN, 1996, NATURE, V384, P474, DOI 10.1038/384474a0; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Wong S, 2008, J VIROL, V82, P2470, DOI 10.1128/JVI.02247-07; Yin AH, 1997, BLOOD, V90, P5002, DOI 10.1182/blood.V90.12.5002.5002_5002_5012; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	46	463	474	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					80	93		10.1016/j.stem.2008.11.011	http://dx.doi.org/10.1016/j.stem.2008.11.011			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128795	Green Accepted, Bronze			2022-12-28	WOS:000262559500014
J	Lin, KK; Andersen, B				Lin, Kevin K.; Andersen, Bogi			Have Hair Follicle Stem Cells Shed Their Tranquil Image?	CELL STEM CELL			English	Editorial Material							SKIN; POPULATION; LGR5	In a recent issue of Nature Genetics, Jaks et al. (2008) demonstrate that hair follicle cells expressing the intestinal stem cell marker Lgr5 are hair follicle epithelial stem cells. In contrast to the established bulge stem cell population, Lrg5(+) cells are actively cycling and reside in part outside the bulge.	[Lin, Kevin K.; Andersen, Bogi] Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA; [Lin, Kevin K.; Andersen, Bogi] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Andersen, B (corresponding author), Univ Calif Irvine, Dept Med, Irvine, CA 92697 USA.	bogi@uci.edu	Lin, Kevin/C-1959-2009	Lin, Kevin/0000-0003-4305-8352				Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Cotsarelis G, 2006, J INVEST DERMATOL, V126, P1459, DOI 10.1038/sj.jid.5700376; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Kopan R, 2002, DEV BIOL, V242, P44, DOI 10.1006/dbio.2001.0516; Legue E, 2005, DEVELOPMENT, V132, P4143, DOI 10.1242/dev.01975; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436	10	5	5	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					581	582		10.1016/j.stem.2008.11.005	http://dx.doi.org/10.1016/j.stem.2008.11.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041772	Bronze			2022-12-28	WOS:000261670900004
J	de Rooij, DG; Repping, S; van Pelt, AMM				de Rooij, Dirk G.; Repping, S.; van Pelt, Ans M. M.			Role for Adhesion Molecules in the Spermatogonial Stem Cell Niche	CELL STEM CELL			English	Editorial Material							UNDIFFERENTIATED SPERMATOGONIA; MOUSE; TESTIS	In this issue of Cell Stem Cell, Kanatsu-Shinohara et al. (2008) show that beta 1-integrin participates in normal spermatogenesis and is required for spermatogonial stem cell (SSC) homing to the basal membrane niche. The methodology used provides a powerful tool to study the role of other factors in niche-SSC interactions.	[de Rooij, Dirk G.; Repping, S.; van Pelt, Ans M. M.] Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [de Rooij, Dirk G.] Univ Utrecht, Fac Sci, Dept Endocrinol & Metab, NL-3584 CH Utrecht, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University	de Rooij, DG (corresponding author), Univ Amsterdam, Acad Med Ctr, Ctr Reprod Med, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	d.g.derooij@uu.nl	de Rooij, D.G./AAW-1195-2021	de Rooij, Dirk/0000-0003-3932-4419; Repping, Sjoerd/0000-0002-6959-149X; van Pelt, Ans/0000-0001-9155-548X				Blanchard KT, 1997, BIOL REPROD, V56, P495, DOI 10.1095/biolreprod56.2.495; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Chiarini-Garcia H, 2001, BIOL REPROD, V65, P1179, DOI 10.1095/biolreprod65.4.1179; De Rooij DG, 2000, J ANDROL, V21, P776; Goriely A, 2005, P NATL ACAD SCI USA, V102, P6051, DOI 10.1073/pnas.0500267102; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kubota H, 2004, P NATL ACAD SCI USA, V101, P16489, DOI 10.1073/pnas.0407063101; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Takehashi M, 2007, DEV BIOL, V312, P344, DOI 10.1016/j.ydbio.2007.09.029; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	10	22	22	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					467	468		10.1016/j.stem.2008.10.010	http://dx.doi.org/10.1016/j.stem.2008.10.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983958	Bronze			2022-12-28	WOS:000260895100002
J	Mercher, T; Cornejo, MG; Sears, C; Kindler, T; Moore, SA; Maillard, I; Pear, WS; Aster, JC; Gilliland, DG				Mercher, Thomas; Cornejo, Melanie G.; Sears, Christopher; Kindler, Thomas; Moore, Sandra A.; Maillard, Ivan; Pear, Warren S.; Aster, Jon C.; Gilliland, D. Gary			Notch signaling specifies megakaryocyte development from hematopoietic stem cells	CELL STEM CELL			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; TRANSCRIPTION FACTOR GATA-1; ZINC-FINGER PROTEIN; T-CELL; BONE-MARROW; LINEAGE COMMITMENT; SELF-RENEWAL; IN-VITRO; B-CELL; DIFFERENTIATION	In the hematopoietic system, Notch signaling specifies T cell lineage fate, in part through negative regulation of B cell and myeloid lineage development. However, we unexpectedly observed the development of megakaryocytes when using heterotypic cocultures of hematopoetic stem cells with OP9 cells expressing Delta-like1, but not with parental OP9 cells. This effect was abrogated by inhibition of Notch signaling either with gamma-secretase inhibitors or by expression of the dominant-negative Mastermind-like1. The importance of Notch signaling for megakaryopoietic development in vivo was confirmed by using mutant alleles that either activate or inhibit Notch signaling. These findings indicate that Notch is a positive regulator of megakaryopoiesis and plays a more complex role in cell-fate decisions among myeloid progenitors than previously appreciated.	[Mercher, Thomas; Cornejo, Melanie G.; Kindler, Thomas; Moore, Sandra A.; Gilliland, D. Gary] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Hematol, Boston, MA 20115 USA; [Aster, Jon C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Dept Med,Div Pathol, Boston, MA 02115 USA; [Sears, Christopher] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Maillard, Ivan] Univ Michigan, Dept Med, Inst Life Sci, Ann Arbor, MI 48104 USA; [Maillard, Ivan] Univ Michigan, Div Hematol Oncol, Ctr Stem Cell Biol, Ann Arbor, MI 48104 USA; [Pear, Warren S.] Univ Penn, Dept Pathol & Lab Med, Div Hematol, Abramson Family Res Inst, Philadelphia, PA 19104 USA; [Gilliland, D. Gary] Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Pennsylvania; Pennsylvania Medicine; Howard Hughes Medical Institute	Mercher, T (corresponding author), Hop Necker Enfants Malad, INSERM, EMI0210, 149 Rue Sevres, F-75743 Paris 15, France.	tmercher@rics.bwh.harvard.edu; ggilliland@rics.bwh.harvard.edu	Mercher, Thomas/J-2446-2014; Kindler, Thomas/K-5995-2013	Mercher, Thomas/0000-0003-1552-087X; Cornejo, Melanie/0000-0001-6094-2719; Maillard, Ivan/0000-0003-1312-6748	National Institute of Health [AI047833, CA119070, DK50654, CA66996]; Leukemia and Lymphoma Society; NATIONAL CANCER INSTITUTE [P01CA066996, P01CA119070] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK050654] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We are very grateful to Dr. J.C. Zuniga-Pflucker for the OP9-GFP and OP9-DL1 cells; Dr. C. Lavau for the ICN1, Hesl, and Hes5 constructs; and Dr. J.D. Griffin and Dr. Lizi Wu for the dnMAML1 construct. We are very grateful to Dr. O. Shestova and Dr. M. Santos for help with dnMAML1 transgenics. We thank A. Fabian for technical assistance with cell sorting and Dr. J.L. Kutok and the Dana Farber Histopathology Core Facility for histology studies. T.M. is a recipient of a Leukemia and Lymphoma Society Special Fellow Award. D.G.G. is a Doris Duke Foundation Distinguished Clinical Scientist and a Howard Hughes Medical Institute investigator. This work was supported in part by National Institute of Health grants AI047833 (W.S.P.), CA119070 (J.C.A.), and DK50654 and CA66996 (D.G.G.) and by the Leukemia and Lymphoma Society to W.S.P., J.C.A., and D.G.G. The authors declare no competing financial interests.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Besseyrias V, 2007, J EXP MED, V204, P331, DOI 10.1084/jem.20061442; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chang AN, 2002, P NATL ACAD SCI USA, V99, P9237, DOI 10.1073/pnas.142302099; Dando JS, 2005, STEM CELLS, V23, P550, DOI 10.1634/stemcells.2004-0205; de Pooter RF, 2006, J IMMUNOL, V176, P5267, DOI 10.4049/jimmunol.176.9.5267; De Smedt M, 2005, BLOOD, V106, P3498, DOI 10.1182/blood-2005-02-0496; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Deng WM, 2001, DEVELOPMENT, V128, P4737; Deveaux S, 1996, BLOOD, V87, P4678, DOI 10.1182/blood.V87.11.4678.bloodjournal87114678; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Goldfarb AN, 2007, ONCOGENE, V26, P6795, DOI 10.1038/sj.onc.1210762; Hasserjian RP, 1996, BLOOD, V88, P970, DOI 10.1182/blood.V88.3.970.bloodjournal883970; Huang EY, 2003, J IMMUNOL, V171, P2296, DOI 10.4049/jimmunol.171.5.2296; Ishiko E, 2005, J BIOL CHEM, V280, P4929, DOI 10.1074/jbc.M406788200; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kumano K, 2001, BLOOD, V98, P3283, DOI 10.1182/blood.V98.12.3283; Lam LT, 2000, J BIOL CHEM, V275, P19676, DOI 10.1074/jbc.M002866200; Luc S, 2008, BLOOD, V111, P3424, DOI 10.1182/blood-2007-08-108324; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Mandal L, 2004, NAT GENET, V36, P1019, DOI 10.1038/ng1404; Mercher T, 2006, BLOOD, V108, P2770, DOI 10.1182/blood-2006-04-014712; Nam Y, 2006, CELL, V124, P973, DOI 10.1016/j.cell.2005.12.037; Nam YS, 2007, P NATL ACAD SCI USA, V104, P2103, DOI 10.1073/pnas.0611092104; Nerlov C, 2000, BLOOD, V95, P2543, DOI 10.1182/blood.V95.8.2543.008k19_2543_2551; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Radtke F, 2004, CURR OPIN IMMUNOL, V16, P174, DOI 10.1016/j.coi.2004.01.002; Radtke F, 2004, NAT IMMUNOL, V5, P247, DOI 10.1038/ni1045; Rekhtman N, 1999, GENE DEV, V13, P1398, DOI 10.1101/gad.13.11.1398; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shivdasani RA, 1997, EMBO J, V16, P3965, DOI 10.1093/emboj/16.13.3965; Stier S, 2002, BLOOD, V99, P2369, DOI 10.1182/blood.V99.7.2369; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tsang AP, 1997, CELL, V90, P109, DOI 10.1016/S0092-8674(00)80318-9; Tu LL, 2005, J EXP MED, V202, P1037, DOI 10.1084/jem.20050923; Visan I, 2006, IMMUNOL REV, V209, P76, DOI 10.1111/j.0105-2896.2006.00360.x; Weng AP, 2003, MOL CELL BIOL, V23, P655, DOI 10.1128/MCB.23.2.655-664.2003; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Zhang P, 1999, P NATL ACAD SCI USA, V96, P8705, DOI 10.1073/pnas.96.15.8705	50	105	108	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					314	326		10.1016/j.stem.2008.07.010	http://dx.doi.org/10.1016/j.stem.2008.07.010			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786418	Green Accepted, Bronze			2022-12-28	WOS:000259665000014
J	Larsson, J; Ohishi, M; Garrison, B; Aspling, M; Janzen, V; Adams, GB; Curto, M; McClatchey, AI; Schipani, E; Scadden, DT				Larsson, Jonas; Ohishi, Masanobu; Garrison, Brian; Aspling, Marie; Janzen, Viktor; Adams, Gregor B.; Curto, Marcello; McClatchey, Andrea I.; Schipani, Ernestina; Scadden, David T.			Nf2/merlin regulates hematopoietic stem cell behavior by altering microenvironmental architecture	CELL STEM CELL			English	Article							NF2 TUMOR-SUPPRESSOR; VASCULAR-PERMEABILITY FACTOR; PROGENITOR CELLS; MICE; ANGIOPOIETIN-1; ANGIOGENESIS; NICHE; TUMORIGENESIS; DEFICIENCY; MUTATION	Stem cell population size is highly regulated across species and tissue types, and alterations are associated with premature tissue failure or cancer. We assessed whether the tumor suppressor and mediator of cell contact inhibition Nf2/merlin plays a role in governing the hematopoietic stem cell pool by stem cell-autonomous or niche-determined processes. Hematopoietic stem cells in Nf2-deficient mice were increased in number and demonstrated a marked shift in location to the circulation. These changes were entirely dependent on changes in the microenvironment, with a marked increase in trabecular bone and marrow vascularity associated with increased VEGF, but without cell-autonomous alterations in stem cell characteristics. Nf2/merlin is critical for maintaining normal structure and function of the hematopoietic stem cell niche. It limits both bone and vascular components, and our model suggests that it thereby constrains stem cell number and position.	[Larsson, Jonas; Garrison, Brian; Aspling, Marie; Janzen, Viktor; Adams, Gregor B.; Scadden, David T.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Larsson, Jonas; Garrison, Brian; Janzen, Viktor; Adams, Gregor B.; Scadden, David T.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ohishi, Masanobu; Schipani, Ernestina] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Scadden, David T.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University	Scadden, DT (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	scadden.david@mgh.harvard.edu			National Institutes of Health [HL44851, HL081030, CA113733]; Department of Defense [W81XWH-05-1-0189]; EMBO; NATIONAL CANCER INSTITUTE [R01CA113733] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U54HL081030, R01HL044851] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense(United States Department of Defense); EMBO(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors would like to thank Marco Giovannini for providing the Nf2 floxed mice. This work was supported by National Institutes of Health Grants (HL44851, HL081030) to D.T.S. and (CA113733) to A.I.M., a Department of Defense Grant (W81XWH-05-1-0189) to A.I.M., and an EMBO postdoctoral grant to J.L.	Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chiusaroli R, 2003, ENDOCRINOLOGY, V144, P4106, DOI 10.1210/en.2003-0254; CONNOLLY DT, 1989, J CLIN INVEST, V84, P1470, DOI 10.1172/JCI114322; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gerber HP, 1999, NAT MED, V5, P623, DOI 10.1038/9467; Giovannini M, 2000, GENE DEV, V14, P1617; Hattori K, 2001, J EXP MED, V193, P1005, DOI 10.1084/jem.193.9.1005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Larsson J, 2003, BLOOD, V102, P3129, DOI 10.1182/blood-2003-04-1300; Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 1998, GENE DEV, V12, P1121, DOI 10.1101/gad.12.8.1121; McLaughlin ME, 2007, P NATL ACAD SCI USA, V104, P3261, DOI 10.1073/pnas.0700044104; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Suzuki T, 2007, BIOCHEM BIOPH RES CO, V362, P1019, DOI 10.1016/j.bbrc.2007.08.099; Thurston G, 1999, SCIENCE, V286, P2511, DOI 10.1126/science.286.5449.2511; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wang Y, 2007, J CLIN INVEST, V117, P1616, DOI 10.1172/JCI31581; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	23	37	40	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					221	227		10.1016/j.stem.2008.06.005	http://dx.doi.org/10.1016/j.stem.2008.06.005			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682243	Green Accepted, Bronze			2022-12-28	WOS:000258523300016
J	Cuylen, S; Haering, CH				Cuylen, Sara; Haering, Christian H.			A New Cohesive Team to Mediate DNA Looping	CELL STEM CELL			English	Editorial Material							GENE-EXPRESSION		[Cuylen, Sara; Haering, Christian H.] European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Haering, CH (corresponding author), European Mol Biol Lab, Cell Biol & Biophys Unit, D-69117 Heidelberg, Germany.	christian.haering@embl.de		Haering, Christian/0000-0001-8301-1722				Bose T, 2010, J CELL BIOL, V189, P201, DOI 10.1083/jcb.200912129; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Ebmeier CC, 2010, P NATL ACAD SCI USA, V107, P11283, DOI 10.1073/pnas.0914215107; Kagey MH, 2010, NATURE, V467, P430, DOI 10.1038/nature09380; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; Schmidt D, 2010, GENOME RES, V20, P578, DOI 10.1101/gr.100479.109; Wendt KS, 2009, CHROMOSOME RES, V17, P201, DOI 10.1007/s10577-008-9017-7	8	9	10	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					424	426		10.1016/j.stem.2010.09.006	http://dx.doi.org/10.1016/j.stem.2010.09.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887946	Bronze			2022-12-28	WOS:000283270600004
J	Ivey, KN; Srivastava, D				Ivey, Kathryn N.; Srivastava, Deepak			MicroRNAs as Regulators of Differentiation and Cell Fate Decisions	CELL STEM CELL			English	Review							MUSCLE-SPECIFIC MICRORNA; EMBRYONIC STEM-CELLS; SKELETAL-MUSCLE; TARGET; PROLIFERATION; CARDIOGENESIS; PROGRAM; HEART; CYCLE; MICE	Unique expression domains, targets, and gain- and loss-of-function phenotypes of particular microRNAs have important implications for directed differentiation of stem cell populations and suppression of undesired cell types. We discuss this emerging topic, in part using muscle differentiation as a paradigm, and highlight common themes and unique modalities by which microRNAs exert their lineage-promoting or differentiation effects on multiple tissues.	[Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94158 USA; [Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biochem, San Francisco, CA 94158 USA; [Ivey, Kathryn N.; Srivastava, Deepak] Univ Calif San Francisco, Dept Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Srivastava, D (corresponding author), Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, 1650 Owens St, San Francisco, CA 94158 USA.	dsrivastava@gladstone.ucsf.edu			NHLBI/NIH; California Institute for Regenerative Medicine	NHLBI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	We wish to acknowledge and apologize to the many contributors to this important field who we were not able to cite here due to formatting constraints and strict limits on references. D.S. is supported by grants from the NHLBI/NIH and the California Institute for Regenerative Medicine. D.S. is a member of the scientific advisory board of iPierian, Inc., and RegeneRx, Inc.	Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Garzon R, 2008, CURR OPIN HEMATOL, V15, P352, DOI 10.1097/MOH.0b013e328303e15d; Hwang HW, 2007, SCIENCE, V315, P97, DOI 10.1126/science.1136235; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Li H, 2009, J CLIN INVEST, V119, P3666, DOI 10.1172/JCI39832; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Martinez NJ, 2010, CELL STEM CELL, V7, P31, DOI 10.1016/j.stem.2010.06.011; Niu Z, 2008, P NATL ACAD SCI USA, V105, P17824, DOI 10.1073/pnas.0805491105; Rosa A, 2009, DEV CELL, V16, P517, DOI 10.1016/j.devcel.2009.02.007; Taulli R, 2009, J CLIN INVEST, V119, P2366, DOI 10.1172/JCI38075; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yan D, 2009, J BIOL CHEM, V284, P29596, DOI 10.1074/jbc.M109.020511; Zhang CX, 2009, CELL CYCLE, V8, P3469, DOI 10.4161/cc.8.21.9837; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	27	335	356	0	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					36	41		10.1016/j.stem.2010.06.012	http://dx.doi.org/10.1016/j.stem.2010.06.012			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621048	Bronze			2022-12-28	WOS:000280222300011
J	Loh, YH; Hartung, O; Li, H; Guo, CG; Sahalie, JM; Manos, PD; Urbach, A; Heffner, GC; Grskovic, M; Vigneault, F; Lensch, MW; Park, IH; Agarwal, S; Church, GM; Collins, JJ; Irion, S; Daley, GQ				Loh, Yuin-Han; Hartung, Odelya; Li, Hu; Guo, Chunguang; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Grskovic, Marica; Vigneault, Francois; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Church, George M.; Collins, James J.; Irion, Stefan; Daley, George Q.			Reprogramming of T Cells from Human Peripheral Blood	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; GENERATION; FIBROBLASTS; EXPRESSION; INDUCTION		[Grskovic, Marica; Irion, Stefan] iPierian Inc, San Francisco, CA 94080 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Stem Cell Transplantat Program, Boston, MA 02115 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Loh, Yuin-Han; Hartung, Odelya; Sahalie, Julie M.; Manos, Philip D.; Urbach, Achia; Heffner, Garrett C.; Lensch, M. William; Park, In-Hyun; Agarwal, Suneet; Daley, George Q.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Hu; Collins, James J.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Boston Univ, Ctr BioDynam, Boston, MA 02215 USA; [Li, Hu; Collins, James J.] Harvard Univ, Wyss Inst Biologically Inspired Engn, Boston, MA 02115 USA; [Guo, Chunguang; Lensch, M. William; Collins, James J.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Guo, Chunguang] Harvard Univ, Sch Med, Childrens Hosp Boston, Immune Dis Inst, Boston, MA 02115 USA; [Guo, Chunguang; Vigneault, Francois; Church, George M.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Boston University; Boston University; Harvard University; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Irion, S (corresponding author), iPierian Inc, San Francisco, CA 94080 USA.	stefanirion@ipierian.com; george.daley@childrens.harvard.edu	/GLR-9975-2022; Loh, Yuin-Han/E-1096-2014; Grskovic, Marica/AAJ-4080-2021	Loh, Yuin-Han/0000-0002-4715-6454; Urbach, Achia/0000-0001-9393-4504; church, george/0000-0001-6232-9969	National Institutes of Health (NIH) [RL1DE019021]; Howard Hughes Medical Institute; SysCODE (Systems-based Consortium for Organ Design Engineering); Agency of Science, Technology, and Research (A*Star); Institute of Medical Biology, Singapore; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100001, K08HL089150] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [RL1DE019021] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); SysCODE (Systems-based Consortium for Organ Design Engineering); Agency of Science, Technology, and Research (A*Star)(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology, Singapore; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was funded by grants from the National Institutes of Health (NIH) and the Howard Hughes Medical Institute to G.Q.D. J.J.C. is supported by SysCODE (Systems-based Consortium for Organ Design & Engineering), NIH grant # RL1DE019021. Y.-H.L. is supported by the overseas fellowship from Agency of Science, Technology, and Research (A*Star) and the Institute of Medical Biology, Singapore. We are grateful to Ann M. Mullally, Anupama Narla, Benjamin L. Ebert, Lars U.W. Muller, Axel Schambach, and Stelios Andreadis for technical assistances. We acknowledge Sabine Loewer for helpful discussions and critical comments on the manuscript. G.Q.D. is a member of the Scientific Advisory Board of iPierian, Inc. M.G. and S.I. are employed by iPierian, Inc., a biotechnology company using iPSCs for drug discovery.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Giorgetti A, 2009, CELL STEM CELL, V5, P353, DOI 10.1016/j.stem.2009.09.008; Haase A, 2009, CELL STEM CELL, V5, P434, DOI 10.1016/j.stem.2009.08.021; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Ikehata H, 2003, ENVIRON MOL MUTAGEN, V41, P280, DOI 10.1002/em.10153; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; MUELLER DL, 1994, J IMMUNOL, V153, P3014; Okabe M, 2009, BLOOD, V114, P1764, DOI 10.1182/blood-2009-02-203695; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Serwold T, 2007, J IMMUNOL, V179, P928, DOI 10.4049/jimmunol.179.2.928; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	22	214	241	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					15	19		10.1016/j.stem.2010.06.004	http://dx.doi.org/10.1016/j.stem.2010.06.004			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621044	Green Accepted, Bronze			2022-12-28	WOS:000280222300007
J	Mira, H; Andreu, Z; Suh, H; Lie, DC; Jessberger, S; Consiglio, A; San Emeterio, J; Hortiguela, R; Marques-Torrejon, MA; Nakashima, K; Colak, D; Gotz, M; Farinas, I; Gage, FH				Mira, Helena; Andreu, Zoraida; Suh, Hoonkyo; Lie, D. Chichung; Jessberger, Sebastian; Consiglio, Antonella; San Emeterio, Juana; Hortigueela, Rafael; Angeles Marques-Torrejon, Maria; Nakashima, Kinichi; Colak, Dilek; Goetz, Magdalena; Farinas, Isabel; Gage, Fred H.			Signaling through BMPR-IA Regulates Quiescence and Long-Term Activity of Neural Stem Cells in the Adult Hippocampus	CELL STEM CELL			English	Article							BONE MORPHOGENETIC PROTEIN; NERVOUS-SYSTEM; PROGENITOR CELLS; NEUROGENESIS; EXPRESSION; RECEPTOR; NOGGIN; SUBPOPULATIONS; MAINTENANCE; MECHANISMS	Neural stem cells (NSCs) in the adult hippocampus divide infrequently, and the molecules that modulate their quiescence are largely unknown. Here, we show that bone morphogenetic protein (BMP) signaling is active in hippocampal NSCs, downstream of BMPR-IA. BMPs reversibly diminish proliferation of cultured NSCs while maintaining their undifferentiated state. In vivo, acute blockade of BMP signaling in the hippocampus by intracerebral infusion of Noggin first recruits quiescent NSCs into the cycle and increases neurogenesis; subsequently, it leads to decreased stem cell division and depletion of precursors and newborn neurons. Consistently, selective ablation of Bmpr1a in hippocampal NSCs, or inactivation of BMP canonical signaling in conditional Smad4 knockout mice, transiently enhances proliferation but later leads to a reduced number of precursors, thereby limiting neuronal birth. BMPs are therefore required to balance NSC quiescence/proliferation and to prevent loss of the stem cell activity that supports continuous neurogenesis in the mature hippocampus.	[Mira, Helena; Suh, Hoonkyo; Jessberger, Sebastian; Consiglio, Antonella; Nakashima, Kinichi; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Mira, Helena; Andreu, Zoraida; San Emeterio, Juana; Hortigueela, Rafael] Inst Salud Carlos III, Ctr Nacl Microbiol, Area Biol Celular & Desarrollo, Madrid 28220, Spain; [Andreu, Zoraida; Angeles Marques-Torrejon, Maria; Farinas, Isabel] Univ Valencia, Dept Cellular Biol, Valencia 46100, Spain; [Suh, Hoonkyo] Cleveland Clin, Lerner Res Inst, Cleveland, OH 44195 USA; [Lie, D. Chichung] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Dev Genet, D-85764 Munich, Germany; [Jessberger, Sebastian] ETH, Dept Biol, Inst Cell Biol, CH-8092 Zurich, Switzerland; [Consiglio, Antonella] Ctr Med Regenerat Barcelona, Barcelona 08003, Spain; [Nakashima, Kinichi] Nara Inst Sci & Technol, Grad Sch Biol Sci, Lab Mol Neurosci, Ikoma 6300101, Japan; [Colak, Dilek; Goetz, Magdalena] German Res Ctr Environm Hlth, Helmholtz Ctr Munich, Inst Stem Cell Res, D-85764 Munich, Germany; [Andreu, Zoraida; Angeles Marques-Torrejon, Maria; Farinas, Isabel] CIBERNED, Valencia 46100, Spain	Salk Institute; Instituto de Salud Carlos III; Centro Nacional de Microbiologa (CNM); University of Valencia; Cleveland Clinic Foundation; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Centro de Medicina Regenerativa de Barcelona; Nara Institute of Science & Technology; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; CIBERNED	Mira, H (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	helena.mira@uv.es; gage@salk.edu	Lie, Dieter Chichung/AAS-8604-2020; Lie, Dieter Chichung/S-7914-2017; Andreu, Zoraida/AAB-3722-2019; consiglio, antonella/G-1815-2016; Marques, Maria Angeles/AAH-2720-2019; Jessberger, Sebastian/AAJ-4032-2020; consiglio, antonella/AAA-5864-2019; Farinas, Isabel/L-7118-2014	Lie, Dieter Chichung/0000-0002-6035-6442; Lie, Dieter Chichung/0000-0002-6035-6442; consiglio, antonella/0000-0002-3988-6254; consiglio, antonella/0000-0002-3988-6254; Jessberger, Sebastian/0000-0002-0056-8275; Mira, Helena/0000-0001-8574-9544; Farinas, Isabel/0000-0003-2903-4960; Suh, Hoonkyo/0000-0002-4227-2982; Hortiguela, Rafael/0000-0002-9621-6441	Deutsche Forschungsgemeirischaft; Spanish Ministerio de Educacion y Ciencia (MEC); Centro de Investigacion Principe Felipe; FPI/MEC; Helma; Ministerio de Sanidad y Consumo (MSC; Fondo de Investigacion Sanitaria) [PI06/0754, PI09/2254]; MEC [SAF2005-06325]; MSC; Fundacion "la Caixa"; Bavarian Network on Adult Neural Stem Cells "FORNEUROCELL";  [SFB 596]	Deutsche Forschungsgemeirischaft; Spanish Ministerio de Educacion y Ciencia (MEC)(Spanish Government); Centro de Investigacion Principe Felipe; FPI/MEC(Spanish Government); Helma; Ministerio de Sanidad y Consumo (MSC; Fondo de Investigacion Sanitaria)(Instituto de Salud Carlos III); MEC(European Commission); MSC; Fundacion "la Caixa"(La Caixa Foundation); Bavarian Network on Adult Neural Stem Cells "FORNEUROCELL"; 	The authors thank Dr.Yuji Mishina for Bmpr1a<SUP>flox/fllox</SUP> and Bmpr1a<SUP>wt/null</SUP> mice and Dr. C.X. Deng for the Smad4<SUP>flox/flox</SUP> mice. They also thank Mary Lynn Gage for editorial support, Dr. Pilar Sanchez-Gomez for helpful discussions and suggestions, Dr. Mari Paz Rubio, Maria Jose Palop, Andre Luis Carvalho, Mireia Moreno, Yolanda Noriega, and Mario Alia for technical assistance. S.J. was supported in part by the Deutsche Forschungsgemeirischaft; H.M. was supported by the Programa Ramon y Cajal from the Spanish Ministerio de Educacion y Ciencia (MEC); Z.A. was supported by the Centro de Investigacion Principe Felipe; and M.A.M-T. is a recipient of a pre-doctoral fellowship from the FPI/MEC. M.G. was funded by Helma and SFB 596. Additional support was provided by grants from Ministerio de Sanidad y Consumo (MSC; Fondo de Investigacion Sanitaria-PI06/0754 and PI09/2254) to H.M.; from MEC (SAF2005-06325), MSC (RETIC Tercel and CIBERNED) and Fundacion "la Caixa" to IF., and from the Bavarian Network on Adult Neural Stem Cells "FORNEUROCELL" to D.C.L.	AIZAWA K, 2009, AGING IN PRESS, DOI DOI 10.1016/J.NEUROBIO-LAGING.2008.12.011; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Charytoniuk DA, 2000, NEUROSCIENCE, V100, P33, DOI 10.1016/S0306-4522(00)00246-3; Chen HL, 2007, STEM CELLS, V25, P63, DOI 10.1634/stemcells.2006-0339; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Coskun V, 2001, INT J DEV NEUROSCI, V19, P219, DOI 10.1016/S0736-5748(00)00092-7; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Fukuda S, 2003, J NEUROSCI, V23, P9357; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Hall AK, 2004, J NEUROSCI RES, V76, P1, DOI 10.1002/jnr.20019; Hatakeyama J, 2004, DEVELOPMENT, V131, P5539, DOI 10.1242/dev.01436; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; ISHIBASHI M, 1994, EMBO J, V13, P1799, DOI 10.1002/j.1460-2075.1994.tb06448.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Miller FD, 2009, CELL STEM CELL, V4, P507, DOI 10.1016/j.stem.2009.05.008; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakashima K, 2001, P NATL ACAD SCI USA, V98, P5868, DOI 10.1073/pnas.101109698; Ninkovic J, 2007, J NEUROSCI, V27, P10906, DOI 10.1523/JNEUROSCI.2572-07.2007; Ohtsuka T, 2001, J BIOL CHEM, V276, P30467, DOI 10.1074/jbc.M102420200; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Pera EM, 2003, GENE DEV, V17, P3023, DOI 10.1101/gad.1153603; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Soderstrom S, 1996, CELL TISSUE RES, V286, P269, DOI 10.1007/s004410050697; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Tang J, 2009, BIOCHEM BIOPH RES CO, V385, P341, DOI 10.1016/j.bbrc.2009.05.067; Temple S, 1999, CURR OPIN NEUROBIOL, V9, P135, DOI 10.1016/S0959-4388(99)80017-8; TENDIJKE P, 1994, J BIOL CHEM, V269, P16985; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Voog J, 2010, CELL STEM CELL, V6, P103, DOI 10.1016/j.stem.2010.01.011; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	40	329	342	0	43	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					78	89		10.1016/j.stem.2010.04.016	http://dx.doi.org/10.1016/j.stem.2010.04.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621052	Bronze			2022-12-28	WOS:000280222300015
J	Shea, KL; Xiang, WY; LaPorta, VS; Licht, JD; Keller, C; Basson, MA; Brack, AS				Shea, Kelly L.; Xiang, Wanyi; LaPorta, Vincent S.; Licht, Jonathan D.; Keller, Charles; Basson, M. Albert; Brack, Andrew S.			Sprouty1 Regulates Reversible Quiescence of a Self-Renewing Adult Muscle Stem Cell Pool during Regeneration	CELL STEM CELL			English	Article							SATELLITE CELLS; GENE-EXPRESSION; PAX7; PROLIFERATION; DISTINCT; FGF; DIFFERENTIATION; HETEROGENEITY; PROGENITORS; COMMITMENT	Satellite cells are skeletal muscle stem cells capable of self-renewal and differentiation after transplantation, but whether they contribute to endogenous muscle fiber repair has been unclear. The transcription factor Pax7 marks satellite cells and is critical for establishing the adult satellite cell pool. By using a lineage tracing approach, we show that after injury, quiescent adult Pax7(+) cells enter the cell cycle; a subpopulation returns to quiescence to replenish the satellite cell compartment, while others contribute to muscle fiber formation. We demonstrate that Sprouty1 (Spry1), a receptor tyrosine kinase signaling inhibitor, is expressed in quiescent Pax7(+) satellite cells in uninjured muscle, downregulated in proliferating myogenic cells after injury, and reinduced as Pax7(+) cells re-enter quiescence. We show that Spry1 is required for the return to quiescence and homeostasis of the satellite cell pool during repair. Our results therefore define a role for Spry1 in adult muscle stem cell biology and tissue repair.	[Shea, Kelly L.; Xiang, Wanyi; LaPorta, Vincent S.; Brack, Andrew S.] Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA; [Xiang, Wanyi] Massachusetts Gen Hosp, Dept Orthoped Surg, Boston, MA 02114 USA; [Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Chicago, IL 60611 USA; [Keller, Charles] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Basson, M. Albert] Kings Coll London, Dept Craniofacial Dev, London SE1 9RT, England	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Feinberg School of Medicine; Robert H. Lurie Comprehensive Cancer Center; University of Texas System; University of Texas Health San Antonio; University of London; King's College London	Brack, AS (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.	brack.andrew@mgh.harvard.edu	Basson, M. Albert/C-5565-2009; Licht, Jonathan/L-4239-2019; Licht, Jonathan/AAL-9184-2020	Licht, Jonathan/0000-0002-3942-1369; Keller, Charles/0000-0003-2505-7487; Basson, M. Albert/0000-0001-9834-7528	MGH; Orthopedic Department (NIGH); Wellcome Trust [WT080470]; Medical Research Council [G0601104]; NIH [R01 CA059998]; NIH/NCI [1K08CA90438]; MRC [G0601104] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA059998, K08CA090438] Funding Source: NIH RePORTER	MGH; Orthopedic Department (NIGH); Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors would like to thank Brad Olwin (University of Colorado), Prajakta Ghatpande, Gail Martin (USCF), and Thomas Rando (Stanford University) for the generous provision of reagents. Supported by MGH start-up funds to A.S.B., Orthopedic Department (NIGH) to W.X., Wellcome Trust (WT080470) and Medical Research Council (G0601104) to M.A.B., NIH (R01 CA059998) to J.D.L., and NIH/NCI (1K08CA90438) to C.K.	Abou-Khalil R, 2009, CELL STEM CELL, V5, P298, DOI 10.1016/j.stem.2009.06.001; ALLEN RE, 1984, EXP CELL RES, V152, P154, DOI 10.1016/0014-4827(84)90239-8; Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004; Bockhold KJ, 1998, MUSCLE NERVE, V21, P173, DOI 10.1002/(SICI)1097-4598(199802)21:2<173::AID-MUS4>3.0.CO;2-8; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2009, DEV BIOL, V335, P93, DOI 10.1016/j.ydbio.2009.08.014; Casci T, 1999, CELL, V96, P655, DOI 10.1016/S0092-8674(00)80576-0; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; CLEGG CH, 1987, J CELL BIOL, V105, P949, DOI 10.1083/jcb.105.2.949; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Conboy MJ, 2007, PLOS BIOL, V5, P1120, DOI 10.1371/journal.pbio.0050102; Fedorov YV, 1998, MOL CELL BIOL, V18, P5780, DOI 10.1128/MCB.18.10.5780; Fukada SI, 2007, STEM CELLS, V25, P2448, DOI 10.1634/stemcells.2007-0019; Hanafusa H, 2002, NAT CELL BIOL, V4, P850, DOI 10.1038/ncb867; JOHNSON RL, 1994, CURR OPIN GENET DEV, V4, P535, DOI 10.1016/0959-437X(94)90069-F; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Jones NC, 2001, J CELL PHYSIOL, V186, P104, DOI 10.1002/1097-4652(200101)186:1<104::AID-JCP1015>3.0.CO;2-0; Kanisicak O, 2009, DEV BIOL, V332, P131, DOI 10.1016/j.ydbio.2009.05.554; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Kramer S, 1999, DEVELOPMENT, V126, P2515; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lagha M, 2008, GENE DEV, V22, P1828, DOI 10.1101/gad.477908; Laziz I, 2007, GROWTH FACTORS, V25, P151, DOI 10.1080/08977190701723166; Le Grand F, 2009, CELL STEM CELL, V4, P535, DOI 10.1016/j.stem.2009.03.013; Lee Y, 2005, DEVELOPMENT, V132, P5173, DOI 10.1242/dev.02101; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Mason JM, 2006, TRENDS CELL BIOL, V16, P45, DOI 10.1016/j.tcb.2005.11.004; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Nishijo K, 2009, FASEB J, V23, P2681, DOI 10.1096/fj.08-128116; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Perez-Ruiz A, 2007, CELL SIGNAL, V19, P1671, DOI 10.1016/j.cellsig.2007.03.003; Poss FD, 2000, DEV BIOL, V222, P347, DOI 10.1006/dbio.2000.9722; Reich A, 1999, DEVELOPMENT, V126, P4139; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Schienda J, 2006, P NATL ACAD SCI USA, V103, P945, DOI 10.1073/pnas.0510164103; Schuh K, 2009, BIOCHEM PHARMACOL, V77, P1827, DOI 10.1016/j.bcp.2009.03.012; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Sheehan SM, 1999, J CELL PHYSIOL, V181, P499, DOI 10.1002/(SICI)1097-4652(199912)181:3<499::AID-JCP14>3.0.CO;2-1; Shinin Vasily, 2009, V482, P295, DOI 10.1007/978-1-59745-060-7_19; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; Yablonka-Reuveni Z, 1999, J HISTOCHEM CYTOCHEM, V47, P23, DOI 10.1177/002215549904700104; Yoshida N, 1998, J CELL SCI, V111, P769; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	50	207	213	1	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					117	129		10.1016/j.stem.2009.12.015	http://dx.doi.org/10.1016/j.stem.2009.12.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144785	Green Submitted, Green Accepted, hybrid			2022-12-28	WOS:000274520800007
J	Paik, JH; Ding, ZH; Narurkar, R; Ramkissoon, S; Muller, F; Kamoun, WS; Chae, SS; Zheng, HW; Ying, HQ; Mahoney, J; Hiller, D; Jiang, S; Protopopov, A; Wong, WH; Chin, L; Ligon, KL; DePinho, RA				Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Ramkissoon, Shakti; Muller, Florian; Kamoun, Walid S.; Chae, Sung-Suk; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Hiller, David; Jiang, Shan; Protopopov, Alexei; Wong, Wing H.; Chin, Lynda; Ligon, Keith L.; DePinho, Ronald A.			FoxOs Cooperatively Regulate Diverse Pathways Governing Neural Stem Cell Homeostasis	CELL STEM CELL			English	Article							FORKHEAD TRANSCRIPTION FACTORS; SELF-RENEWAL; OXIDATIVE STRESS; DOWN-REGULATION; DIFFERENTIATION; PROLIFERATION; NEUROGENESIS; ASPM; EXPRESSION; FOREBRAIN	The PI3K-AKT-FoxO pathway is integral to lifespan regulation in lower organisms and essential for the stability of long-lived cells in mammals. Here, we report the impact of combined FoxO1, 3, and 4 deficiencies on mammalian brain physiology with a particular emphasis on the study of the neural stem/progenitor cell (NSC) pool. We show that the FoxO family plays a prominent role in NSC proliferation and renewal. FoxO-deficient mice show initial increased brain size and proliferation of neural progenitor cells during early postnatal life, followed by precocious significant decline in the NSC pool and accompanying neurogenesis in adult brains. Mechanistically, integrated transcriptomic, promoter, and functional analyses of FoxO-deficient NSC cultures identified direct gene targets with known links to the regulation of human brain size and the control of cellular proliferation, differentiation, and oxidative defense. Thus, the FoxO family coordinately regulates diverse genes and pathways to govern key aspects of NSC homeostasis in the mammalian brain.	[Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Muller, Florian; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Jiang, Shan; Protopopov, Alexei; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA; [Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Muller, Florian; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Jiang, Shan; Protopopov, Alexei; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med, Boston, MA 02115 USA; [Paik, Ji-hye; Ding, Zhihu; Narurkar, Rujuta; Muller, Florian; Zheng, Hongwu; Ying, Haoqiang; Mahoney, Jed; Jiang, Shan; Protopopov, Alexei; Chin, Lynda; DePinho, Ronald A.] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Genet, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Dana Farber Canc Inst, Dept Med Oncol, Ctr Mol Oncol Pathol, Boston, MA 02115 USA; [Ramkissoon, Shakti; Ligon, Keith L.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Kamoun, Walid S.; Chae, Sung-Suk] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Kamoun, Walid S.; Chae, Sung-Suk] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Hiller, David; Wong, Wing H.] Stanford Univ, Dept Stat, Stanford, CA 94305 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Stanford University	DePinho, RA (corresponding author), Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Dept Med Oncol, Boston, MA 02115 USA.	ron_depinho@dfci.harvard.edu	Ying, Haoqiang/AAK-4325-2020	DePinho, Ronald/0000-0002-5625-577X; Muller, Florian/0000-0001-7568-2948; Zheng, Hongwu/0000-0002-5823-4913	Damon Runyon Cancer Research Foundation [DRG 1900-06]; Claudia Adam Barr Foundation; ACS; ABTA; Ellison Medical Foundation; Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science;  [5P01CA95616]; NATIONAL CANCER INSTITUTE [P01CA095616] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; Claudia Adam Barr Foundation; ACS(American Cancer Society); ABTA; Ellison Medical Foundation(Lawrence Ellison Foundation); Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	J.-h.P. is Damon Runyon Fellow was supported by the Damon Runyon Cancer Research Foundation (DRG 1900-06). Grant support includes the Claudia Adam Barr Foundation (J.-h.P.), ACS fellowship (F.M.), ABTA fellowship (H.Y.), Ellison Medical Foundation (R.A.D.), and 5P01CA95616 (R.A.D., K.L.L., L.C.). R.A.D. is an American Cancer Society Research Professor and supported by the Robert A. and Renee E. Belfer Foundation Institute for Applied Cancer Science. We thank D. Pellman and S. Yoshida for the deconvolution microscope use and advice, R. Maser for MSCV-puro-v5 gateway vector, W. Hahn for shRNA constructs, and J. Ling for technical assistance.	Alvarez B, 2001, NATURE, V413, P744, DOI 10.1038/35099574; Battista D, 2006, EUR J NEUROSCI, V23, P83, DOI 10.1111/j.1460-9568.2005.04539.x; Birkenkamp KU, 2007, J BIOL CHEM, V282, P2211, DOI 10.1074/jbc.M606669200; Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Cheng T, 2000, NAT MED, V6, P1235, DOI 10.1038/81335; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Doetsch F, 2002, J NEUROSCI, V22, P2255, DOI 10.1523/JNEUROSCI.22-06-02255.2002; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Fish JL, 2006, P NATL ACAD SCI USA, V103, P10438, DOI 10.1073/pnas.0604066103; Gan B, 2008, P NATL ACAD SCI USA, V105, P19384, DOI 10.1073/pnas.0810584105; Gorczyca W, 2001, METHOD CELL BIOL, V64, P421; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hoekman MFM, 2006, GENE EXPR PATTERNS, V6, P134, DOI 10.1016/j.modgep.2005.07.003; Horvath S, 2006, P NATL ACAD SCI USA, V103, P17402, DOI 10.1073/pnas.0608396103; Hosaka T, 2004, P NATL ACAD SCI USA, V101, P2975, DOI 10.1073/pnas.0400093101; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jin KL, 2003, AGING CELL, V2, P175, DOI 10.1046/j.1474-9728.2003.00046.x; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kitamura T, 2007, J CLIN INVEST, V117, P2477, DOI 10.1172/JCI32054; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Krishnamurthy J, 2006, NATURE, V443, P453, DOI 10.1038/nature05092; Lim DA, 2009, NATURE, V458, P529, DOI 10.1038/nature07726; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; MORSHEAD CM, 1994, NEURON, V13, P1071, DOI 10.1016/0896-6273(94)90046-9; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paling NRD, 2004, J BIOL CHEM, V279, P48063, DOI 10.1074/jbc.M406467200; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yuan YZ, 2004, NAT CELL BIOL, V6, P436, DOI 10.1038/ncb1126; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	50	333	341	1	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					540	553		10.1016/j.stem.2009.09.013	http://dx.doi.org/10.1016/j.stem.2009.09.013			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896444	Bronze, Green Accepted			2022-12-28	WOS:000272019500015
J	Lacoste, A; Berenshteyn, F; Brivanlou, AH				Lacoste, Arnaud; Berenshteyn, Frada; Brivanlou, Ali H.			An Efficient and Reversible Transposable System for Gene Delivery and Lineage-Specific Differentiation in Human Embryonic Stem Cells	CELL STEM CELL			English	Article							STABLE TRANSGENE EXPRESSION; PIGGYBAC TRANSPOSON; BACULOVIRUS GENOME; LENTIVIRAL VECTORS; HUMAN BLASTOCYSTS; IN-VITRO; MOUSE; EXCISION; DNA; PLURIPOTENCY	Unraveling the therapeutic potential of human embryonic stem cells (hESC) requires tools to modify their genome. We have engineered the PiggyBac transposable element to create an efficient system for gene delivery in hESCs. This redesigned system, named "ePiggyBac," can deliver up to 18 Kb inserts, and transgene expression is observed in almost 90% of hES cells. ePiggyBac transposons can also carry insulators, inducible expression cassettes, and short hairpin RNAs for gain-and loss-of-function approaches. In hES cells, ePiggyBac's efficiency is superior to that of viral vectors and previously described transposons, including other PiggyBac-based systems. In addition, ePiggyBac transgenes can be removed from the hESC genome without leaving any mutation. We used this system to direct hESC differentiation toward a neuronal phenotype. We then removed the transposons to obtain transgene-free neuronal precursors and neurons. The ability to create fully reversible genetic modifications represents an important step toward clinical applications of hESCs.	[Lacoste, Arnaud; Berenshteyn, Frada; Brivanlou, Ali H.] Rockefeller Univ, Mol Embryol Lab, New York, NY 10021 USA	Rockefeller University	Brivanlou, AH (corresponding author), Rockefeller Univ, Mol Embryol Lab, 1230 York Ave, New York, NY 10021 USA.	brvnlou@rockefeller.edu	Wilson, Matthew H/K-3193-2013		Rockefeller University; Starr foundation; NIH [5RO1 GM073379]; Emerald Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073379] Funding Source: NIH RePORTER	Rockefeller University; Starr foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Emerald Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Scott A. Noggle for advice during the design of the experiments and Shalini Jaiswal for outstanding technical assistance. This work was supported by private funding from The Rockefeller University, The Starr foundation, NIH grant 5RO1 GM073379 (for work on hESC lines H1 and BGN1) to A. H. B., and by a grant from the Emerald Foundation to A. L.	Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Braam SR, 2008, NAT METHODS, V5, P389, DOI 10.1038/NMETH.1200; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cadinanos J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm446; CARY LC, 1989, VIROLOGY, V172, P156, DOI 10.1016/0042-6822(89)90117-7; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Elick TA, 1996, GENETICA, V98, P33, DOI 10.1007/BF00120216; FRASER MJ, 1995, VIROLOGY, V211, P397, DOI 10.1006/viro.1995.1422; Fraser MJ, 1996, INSECT MOL BIOL, V5, P141, DOI 10.1111/j.1365-2583.1996.tb00048.x; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; James D, 2006, DEV BIOL, V295, P90, DOI 10.1016/j.ydbio.2006.03.026; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Li X, 2005, INSECT MOL BIOL, V14, P17, DOI 10.1111/j.1365-2583.2004.00525.x; Maragathavally KJ, 2006, FASEB J, V20, P1880, DOI 10.1096/fj.05-5485fje; McCarty DM, 2004, ANNU REV GENET, V38, P819, DOI 10.1146/annurev.genet.37.110801.143717; Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001; Mitalipova M, 2003, STEM CELLS, V21, P521, DOI 10.1634/stemcells.21-5-521; Pfeifer A, 2002, P NATL ACAD SCI USA, V99, P2140, DOI 10.1073/pnas.251682798; Recillas-Targa F, 2002, P NATL ACAD SCI USA, V99, P6883, DOI 10.1073/pnas.102179399; Siemen H, 2005, STEM CELLS DEV, V14, P378, DOI 10.1089/scd.2005.14.378; Silva JM, 2005, NAT GENET, V37, P1281, DOI 10.1038/ng1650; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Thyagarajan B, 2008, STEM CELLS, V26, P119, DOI 10.1634/stemcells.2007-0283; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wilber A, 2007, STEM CELLS, V25, P2919, DOI 10.1634/stemcells.2007-0026; Wilson MH, 2007, MOL THER, V15, P139, DOI 10.1038/sj.mt.6300028; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yin B, 2007, BIOTECHNIQUES, V43, P79, DOI 10.2144/000112474; Yusa K, 2009, NAT METHODS, V6, P363, DOI [10.1038/NMETH.1323, 10.1038/nmeth.1323]; Zeng JM, 2007, STEM CELLS, V25, P1055, DOI 10.1634/stemcells.2006-0616; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	34	118	129	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					332	342		10.1016/j.stem.2009.07.011	http://dx.doi.org/10.1016/j.stem.2009.07.011			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733544	Bronze			2022-12-28	WOS:000272545700019
J	Su, XH; Paris, M; Gi, YJ; Tsai, KY; Cho, MS; Lin, YL; Biernaskie, JA; Sinha, S; Prives, C; Pevny, LH; Miller, FD; Flores, ER				Su, Xiaohua; Paris, Maryline; Gi, Young Jin; Tsai, Kenneth Y.; Cho, Min Soon; Lin, Yu-Li; Biernaskie, Jeffrey A.; Sinha, Satrajit; Prives, Carol; Pevny, Larysa H.; Miller, Freda D.; Flores, Elsa R.			TAp63 Prevents Premature Aging by Promoting Adult Stem Cell Maintenance	CELL STEM CELL			English	Article							P63 ISOFORMS; MOUSE MODEL; GERM-LINE; P53; MICE; AGE; EXPRESSION; MUTATIONS; PROTEIN; MUTANT	The cellular mechanisms that regulate the maintenance of adult tissue stem cells are still largely unknown. We show here that the p53 family member, TAp63, is essential for maintenance of epidermal and dermal precursors and that, in its absence, these precursors senesce and skin ages prematurely. Specifically, we have developed a TAp63 conditional knockout mouse and used it to ablate TAp63 in the germline (TAp63(-/-)) or in K14-expressing cells in the basal layer of the epidermis (TAp63(fl/fl) ;K14cre+). TAp63(-/-) mice age prematurely and develop blisters, skin ulcerations, senescence of hair follicle-associated dermal and epidermal cells, and decreased hair morphogenesis. These phenotypes are likely due to loss of TAp63 in dermal and epidermal precursors since both cell types show defective proliferation, early senescence, and genomic instability. These data indicate that TAp63 serves to maintain adult skin stem cells by regulating cellular senescence and genomic stability, thereby preventing premature tissue aging.	[Su, Xiaohua; Gi, Young Jin; Cho, Min Soon; Lin, Yu-Li; Flores, Elsa R.] Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Dept Mol & Cellular Oncol, Houston, TX 77030 USA; [Tsai, Kenneth Y.] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA; [Tsai, Kenneth Y.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Paris, Maryline; Biernaskie, Jeffrey A.; Miller, Freda D.] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Grp, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Paris, Maryline; Biernaskie, Jeffrey A.; Miller, Freda D.] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Grp, Dept Physiol, Toronto, ON M5G 1X5, Canada; [Sinha, Satrajit] SUNY Buffalo, Dept Biochem, Sch Med & Biomed Sci, Buffalo, NY 14214 USA; [Prives, Carol] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Pevny, Larysa H.] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Columbia University; University of North Carolina; University of North Carolina Chapel Hill	Flores, ER (corresponding author), Univ Texas MD Anderson Canc Ctr, Grad Sch Biomed Sci, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd, Houston, TX 77030 USA.	elsaflores@mdanderson.org		Tsai, Kenneth/0000-0001-5325-212X	American Cancer Society [RSG-07-082-01-MGO]; Susan G. Komen Foundation [BCTR600208]; Leukemia and Lymphoma Society/Hildegarde D. Becher Foundation; NCI Cancer Center [CA-16672]; Anderson Cancer Center; Canadian Institutes of Health Research [MOP-64211]; Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE [P30CA016672, R01CA160394] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); Leukemia and Lymphoma Society/Hildegarde D. Becher Foundation(Leukemia and Lymphoma Society); NCI Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Anderson Cancer Center; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Rita Allen Foundation; V Foundation for Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants to E.R.F. from the American Cancer Society (RSG-07-082-01-MGO), March of Dimes (Basil O'Connor Scholar), Susan G. Komen Foundation (BCTR600208), Leukemia and Lymphoma Society/Hildegarde D. Becher Foundation, and NCI Cancer Center Core Grant (CA-16672) (U.T. M.D. Anderson Cancer Center) and by grants to F.D.M. from the Canadian Institutes of Health Research (MOP-64211) and HHMI. E.R.F. is a scholar of the Rita Allen Foundation and the V Foundation for Cancer Research. F.D.M. is a Canada Research Chair and an HHMI International Research Scholar. We gratefully acknowledge the work of Jan Parker-Thornburg, the Genetically Engineered Mouse Facility, and the T.C. Hsu Molecular Cytogenetics Core at M.D. Anderson (funded by NCI no. CA16672). We would also like to acknowledge Wei Zhang for technical assistance, Paul Lambert and Denis Lee for J2-3T3 feeder cells, Dennis Roop for K14 antibody, Alea Mills for p63<SUP>-/-</SUP> mice, Elaine Fuchs for advice on wound-healing assays, and David Kaplan and Chi-chung Hui for advice and input with regard to the manuscript.	Ackerman AB., 1997, HISTOLOGIC DIAGNOSIS; BARRANDON Y, 1987, P NATL ACAD SCI USA, V84, P2302, DOI 10.1073/pnas.84.8.2302; Beretta C, 2005, CELL CYCLE, V4, P1625, DOI 10.4161/cc.4.11.2135; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Candi E, 2006, CELL DEATH DIFFER, V13, P1037, DOI 10.1038/sj.cdd.4401926; Celli J, 1999, CELL, V99, P143, DOI 10.1016/S0092-8674(00)81646-3; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Flores ER, 2007, CELL CYCLE, V6, P300, DOI 10.4161/cc.6.3.3793; Flores ER, 2002, NATURE, V416, P560, DOI 10.1038/416560a; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; Gu XL, 2006, J INVEST DERMATOL, V126, P137, DOI 10.1038/sj.jid.5700010; Hasty P, 2003, SCIENCE, V299, P1355, DOI 10.1126/science.1079161; Iwakuma T, 2005, CELL CYCLE, V4, P865, DOI 10.4161/cc.4.7.1800; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Jacobs WB, 2005, NEURON, V48, P743, DOI 10.1016/j.neuron.2005.10.027; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Koster MI, 2007, P NATL ACAD SCI USA, V104, P3255, DOI 10.1073/pnas.0611376104; Koster MI, 2004, GENE DEV, V18, P126, DOI 10.1101/gad.1165104; Kurita T, 2005, MECH DEVELOP, V122, P1043, DOI 10.1016/j.mod.2005.04.008; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Lewandoski M, 1997, CURR BIOL, V7, P148, DOI 10.1016/S0960-9822(06)00059-5; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maier B, 2004, GENE DEV, V18, P306, DOI 10.1101/gad.1162404; McGrath JA, 2001, HUM MOL GENET, V10, P221, DOI 10.1093/hmg/10.3.221; Mendrysa SM, 2006, GENE DEV, V20, P16, DOI 10.1101/gad.1378506; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; O'Gorman S, 1997, P NATL ACAD SCI USA, V94, P14602, DOI 10.1073/pnas.94.26.14602; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Senoo M, 2007, CELL, V129, P523, DOI 10.1016/j.cell.2007.02.045; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	37	182	183	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					64	75		10.1016/j.stem.2009.04.003	http://dx.doi.org/10.1016/j.stem.2009.04.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570515	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000267879200011
J	Le, LQ; Shipman, T; Burns, DK; Parada, LF				Le, Lu Q.; Shipman, Tracey; Burns, Dennis K.; Parada, Luis F.			Cell of Origin and Microenvironment Contribution for NF1-Associated Dermal Neurofibromas	CELL STEM CELL			English	Article							SKIN-DERIVED PRECURSORS; MYELINATING SCHWANN-CELLS; EMBRYONIC STEM-CELLS; TUMOR-SUPPRESSOR; SELF-RENEWAL; MOUSE MODELS; CANCER; NF1; PROGESTERONE; PROLIFERATION	The tumor predisposition disorder neurofibromatosis type I (NF1) is one of the most common genetic disorders of the nervous system. It is caused by mutations in the Nf1 tumor-suppressor gene, which encodes a GTPase-activating protein (GAP) that negatively regulates p21-RAS. Development of malignant nerve tumors and neurofibromas occurs frequently in NF1. However, little is known about the molecular mechanisms mediating the initiation and progression of these complex tumors, or the identity of the specific cell type that gives rise to dermal or cutaneous neurofibromas. In this study, we identify a population of stem/progenitor cells residing in the dermis termed skin-derived precursors (SKPs) that, through loss of Nf1, form neurofibromas. We propose that SKPs, or their derivatives, are the cell of origin of dermal neurofibroma. We also provide evidence that additional signals from nonneoplastic cells in the tumor microenvironment play essential roles in neurofibromagenesis.	[Le, Lu Q.; Shipman, Tracey; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Burns, Dennis K.] Univ Texas SW Med Ctr Dallas, Dept Pathol, Dallas, TX 75390 USA; [Le, Lu Q.] Univ Texas SW Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA; [Le, Lu Q.; Shipman, Tracey; Parada, Luis F.] Univ Texas SW Med Ctr Dallas, Kent Waldrep Fdn Ctr Basic Res Nerve Growth & Reg, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Parada, LF (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA.	luis.parada@utsouthwestern.edu	Parada, luis F/B-9400-2014	Le, Lu/0000-0003-2817-5382	National Institute of Neurological Disorders and Stroke (NINDS); Department of Defense (DOD) [DAMD 17-02-1-0638, DAMD 17-03-1-0216, ACS RP-04-084-01]; Dermatology Foundation and Galderma; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS052606] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Department of Defense (DOD)(United States Department of Defense); Dermatology Foundation and Galderma; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank members of the Parada lab for helpful suggestions and discussions, Chiachi Liu for technical help, and Renee McKay for assistance in the preparation of this manuscript. We also thank Dr. Ueli Suter for the PO-CreERT and the Plp-CreERT mice. L.Q.L. holds a Career Award for Medical Scientists from the Burroughs Wellcome Fund. L.F.P. is an American Cancer Society Research Professor. This work was partially supported by funding from the National Institute of Neurological Disorders and Stroke (NINDS), Department of Defense (DOD) Grant # DAMD 17-02-1-0638, and DAMD 17-03-1-0216, ACS RP-04-084-01 to L.F.P.; and by funding from the Dermatology Foundation and Galderma to L.Q.L.	Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947; Biernaskie J, 2007, J NEUROSCI, V27, P9545, DOI 10.1523/JNEUROSCI.1930-07.2007; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Cichowski K, 2001, CELL, V104, P593, DOI 10.1016/S0092-8674(01)00245-8; Cichowski K, 1999, SCIENCE, V286, P2172, DOI 10.1126/science.286.5447.2172; Dugoff L, 1996, AM J MED GENET, V66, P7, DOI 10.1002/(SICI)1096-8628(19961202)66:1<7::AID-AJMG2>3.0.CO;2-R; Fernandes KJL, 2008, PHILOS T R SOC B, V363, P185, DOI 10.1098/rstb.2006.2020; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Ferner RE, 2007, EUR J HUM GENET, V15, P131, DOI 10.1038/sj.ejhg.5201676; Gao JX, 2008, J CELL MOL MED, V12, P67, DOI 10.1111/j.1582-4934.2007.00170.x; Gardner D.G., 2011, GREENSPANS BASIC CLI, V9th; GRAY GD, 1993, CANCER RES, V53, P577; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; HUSON SM, 1988, BRAIN, V111, P1355, DOI 10.1093/brain/111.6.1355; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; JungTestas I, 1996, J STEROID BIOCHEM, V58, P77, DOI 10.1016/0960-0760(96)00009-X; Kwon CH, 2008, CANCER RES, V68, P3286, DOI 10.1158/0008-5472.CAN-07-6867; Lakkis MM, 2000, J NEUROSCI RES, V62, P755, DOI 10.1002/1097-4547(20001215)62:6<755::AID-JNR1>3.3.CO;2-N; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; McLaughlin ME, 2003, CANCER RES, V63, P752; Miller SJ, 2005, BBA-REV CANCER, V1756, P25, DOI 10.1016/j.bbcan.2005.07.003; Movaghar B, 2008, BRAIN RES, V1208, P17, DOI 10.1016/j.brainres.2008.02.071; NOWELL PC, 1960, JNCI-J NATL CANCER I, V25, P85; Nussbaum J, 2007, FASEB J, V21, P1345, DOI 10.1096/fj.06-6769com; Overdiek A, 2008, PEDIATR RES, V64, P40, DOI 10.1203/PDR.0b013e31817445b8; Prophet E. B., 1992, LAB METHODS HISTOTEC; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; RICCARDI VM, 1981, BIRTH DEFECTS-ORIG, V17, P129; Roth TM, 2008, DEV DYNAM, V237, P513, DOI 10.1002/dvdy.21430; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stemmer-Rachamimov AO, 2004, CANCER RES, V64, P3718, DOI 10.1158/0008-5472.CAN-03-4079; STENBACK F, 1981, BRIT J CANCER, V44, P1, DOI 10.1038/bjc.1981.141; Stindl R, 2008, MED HYPOTHESES, V71, P126, DOI 10.1016/j.mehy.2008.01.010; Szudek J, 2000, GENET EPIDEMIOL, V19, P429, DOI 10.1002/1098-2272(200012)19:4<429::AID-GEPI13>3.0.CO;2-N; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; Trovo-Marqui AB, 2006, CLIN GENET, V70, P1, DOI 10.1111/j.1399-0004.2006.00639.x; Vogel KS, 1999, SCIENCE, V286, P2176, DOI 10.1126/science.286.5447.2176; Ward BA, 2005, PEDIATR NEUROL, V32, P221, DOI 10.1016/j.pediatrneurol.2004.11.002; Wong S, 2004, ANNU REV IMMUNOL, V22, P247, DOI 10.1146/annurev.immunol.22.012703.104753; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Yang FC, 2003, J CLIN INVEST, V112, P1851, DOI 10.1172/JCI200319195; Yang FC, 2008, CELL, V135, P437, DOI 10.1016/j.cell.2008.08.041; Yang FC, 2006, HUM MOL GENET, V15, P2421, DOI 10.1093/hmg/ddl165; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452; Zhu Y, 2001, EXP CELL RES, V264, P19, DOI 10.1006/excr.2000.5138	50	114	115	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					453	463		10.1016/j.stem.2009.03.017	http://dx.doi.org/10.1016/j.stem.2009.03.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427294	Green Accepted, Bronze			2022-12-28	WOS:000266071100013
J	Sauvageau, G; Perreault, C				Sauvageau, Guy; Perreault, Claude			Killer Granzyme B Linked to N-myc- and c-myc-Dependent HSC Survival: Isn't That Comyc?	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM; DIFFERENTIATION; CELLS	c-myc is a key regulator of hemopoietic stem cell (HSC) activity. In this issue of Cell Stem Cell, Laurenti et al. (2008) show that c-myc and N-myc control HSC survival and link this finding to the regulation of granzyme B expression,	[Sauvageau, Guy] IRIC, Lab Mol Genet Stem Cells, Montreal, PQ H3C 3J7, Canada; [Perreault, Claude] IRIC, Immunobiol Lab, Montreal, PQ H3C 3J7, Canada; [Sauvageau, Guy; Perreault, Claude] Maisonneuve Rosemont Hosp, Dept Med, Montreal, PQ H1T 2M4, Canada; [Sauvageau, Guy; Perreault, Claude] Maisonneuve Rosemont Hosp, Div Hematol, Montreal, PQ H1T 2M4, Canada; [Sauvageau, Guy] Maisonneuve Rosemont Hosp, Leukemia Cell Bank Quebec, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), IRIC, Lab Mol Genet Stem Cells, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca	Perreault, Claude/A-7220-2008	Perreault, Claude/0000-0001-9453-7383; Sauvageau, Guy/0000-0002-4333-7266				Baena E, 2007, EXP HEMATOL, V35, P1333, DOI 10.1016/j.exphem.2007.05.015; Chang JT, 2007, SCIENCE, V315, P1687, DOI 10.1126/science.1139393; Cole MD, 2008, NAT REV MOL CELL BIO, V9, P810, DOI 10.1038/nrm2467; HEUSEL JW, 1994, CELL, V76, P977, DOI 10.1016/0092-8674(94)90376-X; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lord SJ, 2003, IMMUNOL REV, V193, P31, DOI 10.1034/j.1600-065X.2003.00044.x; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002	10	0	2	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					579	580		10.1016/j.stem.2008.11.003	http://dx.doi.org/10.1016/j.stem.2008.11.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041771	Bronze			2022-12-28	WOS:000261670900003
J	Bouras, T; Pal, B; Vaillant, F; Harburg, G; Asselin-Labat, ML; Oakes, SR; Lindeman, GJ; Visvader, JE				Bouras, Toula; Pal, Bhupinder; Vaillant, Francois; Harburg, Gwyndolen; Asselin-Labat, Marie-Liesse; Oakes, Samantha R.; Lindeman, Geoffrey J.; Visvader, Jane E.			Notch Signaling Regulates Mammary Stem Cell Function and Luminal Cell-Fate Commitment	CELL STEM CELL			English	Article							HUMAN BREAST; MESENCHYMAL TRANSITION; STEM/PROGENITOR CELLS; INTRACELLULAR DOMAIN; GLAND DEVELOPMENT; GATA3 EXPRESSION; DIFFERENTIATION; TUMORIGENESIS; SURVIVAL; CANCER	The recent identification of mouse mammary stem cells (MaSCs) and progenitor subpopulations has enhanced the prospect of investigating the genetic control of their lineage specification and differentiation. Here we have explored the role of the Notch pathway within the mammary epithelial hierarchy. We show that knockdown of the canonical Notch effector Cbf-1 in the MaSC-enriched population results in increased stem cell activity in vivo as well as the formation of aberrant end buds, implying a role for endogenous Notch signaling in restricting MaSC expansion. Conversely, Notch was found to be preferentially activated in the ductal luminal epithelium in vivo and promoted commitment of MaSCs exclusively along the luminal lineage. Notably, constitutive Notch signaling specifically targeted luminal progenitor cells for expansion, leading to hyperplasia and tumorigenesis. These findings reveal key roles for Notch signaling in MaSCs and luminal cell commitment and further suggest that inappropriate Notch activation promotes the self-renewal and transformation of luminal progenitor cells.	[Bouras, Toula; Pal, Bhupinder; Vaillant, Francois; Harburg, Gwyndolen; Asselin-Labat, Marie-Liesse; Oakes, Samantha R.; Lindeman, Geoffrey J.; Visvader, Jane E.] Walter & Eliza Hall Inst Med Res, VBCRC Lab, Parkville, Vic 3050, Australia; [Lindeman, Geoffrey J.] Royal Melbourne Hosp, Dept Med Oncol, Parkville, Vic 3050, Australia	Walter & Eliza Hall Institute; Royal Melbourne Hospital	Visvader, JE (corresponding author), Walter & Eliza Hall Inst Med Res, VBCRC Lab, Parkville, Vic 3050, Australia.	visvader@wehi.edu.au	Pal, Bhupinder/AAF-4011-2020	Pal, Bhupinder/0000-0002-3684-4331; Lindeman, Geoffrey/0000-0001-9386-2416; Oakes, Samantha/0000-0003-1838-2310	Victorian Breast Cancer Research Consortium; National Health and Medical Research Council (NHMRC, Australia); National Breast Cancer Foundation (Australia); NHMRC; Australian Research Council Fellowship	Victorian Breast Cancer Research Consortium; National Health and Medical Research Council (NHMRC, Australia)(National Health and Medical Research Council (NHMRC) of Australia); National Breast Cancer Foundation (Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council Fellowship(Australian Research Council)	We thank K. Field, K. Johnson, E. Lim, S. Holroyd, N. Forrest, S. Mihajlovic, E. Tsui, T. Ward, and C. Wells for expert assistance in FACS, animal husbandry, histology, and graphics. We are grateful to J. Adams for invaluable discussions and T. Reya, S. Lowe, R. Dickins, S. Pece, and D. Izon for DNA constructs. This work was supported by the Victorian Breast Cancer Research Consortium and the National Health and Medical Research Council (NHMRC, Australia). T.B. and S.R.O. are supported by National Breast Cancer Foundation (Australia) and NHMRC Fellowships and M.-L.A.-L. by an Australian Research Council Fellowship.	Amsen D, 2007, IMMUNITY, V27, P89, DOI 10.1016/j.immuni.2007.05.021; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Buono KD, 2006, DEV BIOL, V293, P565, DOI 10.1016/j.ydbio.2006.02.043; Chiba S, 2006, STEM CELLS, V24, P2437, DOI 10.1634/stemcells.2005-0661; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; DANIEL CW, 1987, CANCER RES, V47, P6052; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Dievart A, 1999, ONCOGENE, V18, P5973, DOI 10.1038/sj.onc.1202991; Dontu G, 2004, BREAST CANCER RES, V6, pR605, DOI 10.1186/bcr920; Fang TC, 2007, IMMUNITY, V27, P100, DOI 10.1016/j.immuni.2007.04.018; Farnie G, 2007, STEM CELL REV, V3, P169, DOI 10.1007/s12015-007-0023-5; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; GALLAHAN D, 1987, J VIROL, V61, P218, DOI 10.1128/JVI.61.1.218-220.1987; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Hennighausen L, 2001, DEV CELL, V1, P467, DOI 10.1016/S1534-5807(01)00064-8; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Kiaris H, 2004, AM J PATHOL, V165, P695, DOI 10.1016/S0002-9440(10)63333-0; Klinakis A, 2006, P NATL ACAD SCI USA, V103, P9262, DOI 10.1073/pnas.0603371103; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Morrison SJ, 2000, CELL, V101, P499, DOI 10.1016/S0092-8674(00)80860-0; Nguyen BC, 2006, GENE DEV, V20, P1028, DOI 10.1101/gad.1406006; Paddison PJ, 2004, NATURE, V428, P427, DOI 10.1038/nature02370; Pear WS, 2003, SEMIN IMMUNOL, V15, P69, DOI 10.1016/S1044-5323(03)00003-4; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Raafat A, 2004, ONCOGENE, V23, P9401, DOI 10.1038/sj.onc.1208187; Radtke F, 2003, NAT REV CANCER, V3, P756, DOI 10.1038/nrc1186; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Roy M, 2007, CURR OPIN GENET DEV, V17, P52, DOI 10.1016/j.gde.2006.12.001; Sansone P, 2007, STEM CELLS, V25, P807, DOI 10.1634/stemcells.2006-0442; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Sleeman KE, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1371; STANGER BZ, 2001, BREAST CANC RES TREA, V67, P93; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Timmerman LA, 2004, GENE DEV, V18, P99, DOI 10.1101/gad.276304; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; Welm Bryan E, 2008, Cell Stem Cell, V2, P90, DOI 10.1016/j.stem.2007.10.002; Yamamoto N, 2003, CURR BIOL, V13, P333, DOI 10.1016/S0960-9822(03)00081-2	44	331	344	2	20	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					429	441		10.1016/j.stem.2008.08.001	http://dx.doi.org/10.1016/j.stem.2008.08.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940734	Bronze			2022-12-28	WOS:000260149800013
J	Smith-Berdan, S; Nguyen, A; Hassanein, D; Zimmer, M; Ugarte, F; Ciriza, J; Li, D; Garcia-Ojeda, ME; Hinck, L; Forsberg, EC				Smith-Berdan, Stephanie; Nguyen, Andrew; Hassanein, Deena; Zimmer, Matthew; Ugarte, Fernando; Ciriza, Jesus; Li, Dean; Garcia-Ojeda, Marcos E.; Hinck, Lindsay; Forsberg, E. Camilla			Robo4 Cooperates with Cxcr4 to Specify Hematopoietic Stem Cell Localization to Bone Marrow Niches	CELL STEM CELL			English	Article							COLONY-STIMULATING FACTOR; PROGENITOR CELLS; CHEMOKINE RECEPTOR; HEPARAN-SULFATE; MAGIC ROUNDABOUT; REPELLENT SLIT; NOD/SCID MICE; MOBILIZATION; BLOOD; ANGIOGENESIS	Specific bone marrow (BM) niches are critical for hematopoietic stem cell (HSC) function during both normal hematopoiesis and in stem cell transplantation therapy. We demonstrate that the guidance molecule Robo4 functions to specifically anchor HSCs to BM niches. Robo4-deficient HSCs displayed poor localization to BM niches and drastically reduced long-term reconstitution capability while retaining multilineage potential. Cxcr4, a critical regulator of HSC location, is upregulated in Robo4(-/-) HSCs to compensate for Robo4 loss. Robo4 deletion led to altered HSC mobilization efficiency, revealing that inhibition of both Cxcr4- and Robo4-mediated niche interactions are necessary for efficient HSC mobilization. Surprisingly, we found that WT HSCs express very low levels of Cxcr4 and respond poorly to Cxcr4 manipulation relative to other hematopoietic cells. We conclude that Robo4 cooperates with Cxcr4 to endow HSCs with competitive access to limited stem cell niches, and we propose Robo4 as a therapeutic target in HSC transplantation therapy.	[Smith-Berdan, Stephanie; Nguyen, Andrew; Hassanein, Deena; Zimmer, Matthew; Ugarte, Fernando; Hinck, Lindsay; Forsberg, E. Camilla] Univ Calif Santa Cruz, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA; [Ciriza, Jesus; Garcia-Ojeda, Marcos E.] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA; [Li, Dean] Univ Utah, Dept Oncol Sci, Salt Lake City, UT 84112 USA	University of California System; University of California Santa Cruz; University of California System; University of California Merced; Utah System of Higher Education; University of Utah	Forsberg, EC (corresponding author), Univ Calif Santa Cruz, Inst Biol Stem Cells, Santa Cruz, CA 95064 USA.	cforsber@ucsc.edu	Ciriza, Jesus/M-3821-2018	Ciriza, Jesus/0000-0002-8666-622X; Hinck, Lindsay/0000-0002-4009-3913	University of California Santa Cruz; California Institute for Regenerative Medicine (CIRM); UCSC; Government of Navarra, Spain; University of California; DOD; AAF; JDRF; NIH [RO1 CA-128902]; NATIONAL CANCER INSTITUTE [R01CA128902] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077671] Funding Source: NIH RePORTER	University of California Santa Cruz(University of California System); California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); UCSC; Government of Navarra, Spain; University of California(University of California System); DOD(United States Department of Defense); AAF; JDRF(Juvenile Diabetes Research Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Andrew Leavitt for generously providing reagents. This work was funded by University of California Santa Cruz start-up funds (E.C.F.); California Institute for Regenerative Medicine (CIRM) Stem Cell Training Program Awards (AN., FU., and J.C.); a UCSC Minority Access to Research Careers Fellowship (D.H.); a postdoctoral fellowship from the Government of Navarra, Spain (J.C.); and University of California, Merced start-up funds (M.E.G.-O.). D.L. is supported by the DOD, AAF, JDRF, and NIH. L.H. was partially funded by NIH (RO1 CA-128902). E.C.F. is the recipient of a CIRM New Faculty Award. University of Utah has licensed intellectual property surrounding the Robo4 pathway to Navigen. Both the University of Utah and D.Y.L. have equity in Navigen.	Aiuti A, 1997, J EXP MED, V185, P111, DOI 10.1084/jem.185.1.111; Bonig H, 2009, EXP HEMATOL, V37, P402, DOI 10.1016/j.exphem.2008.10.017; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Dallol A, 2002, ONCOGENE, V21, P3020, DOI 10.1038/sj.onc.1205421; Flomenberg N, 2005, ACTA HAEMATOL-BASEL, V114, P198, DOI 10.1159/000088410; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Forsberg EC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008785; Forsberg EC, 2009, HAEMATOL-HEMATOL J, V94, P1477, DOI 10.3324/haematol.2009.013730; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Hu HY, 2001, NAT NEUROSCI, V4, P695, DOI 10.1038/89482; Huminiecki L, 2002, GENOMICS, V79, P547, DOI 10.1006/geno.2002.6745; Johnson KG, 2004, CURR BIOL, V14, P499, DOI 10.1016/j.cub.2004.02.005; Jones CA, 2008, NAT MED, V14, P448, DOI 10.1038/nm1742; Kaus S, 2006, J BIOL CHEM, V281, P11347, DOI 10.1074/jbc.M508853200; Kikuta T, 2000, EXP HEMATOL, V28, P311, DOI 10.1016/S0301-472X(99)00151-4; Lapidot T, 2001, ANN NY ACAD SCI, V938, P83, DOI 10.1111/j.1749-6632.2001.tb03577.x; Legg JA, 2008, ANGIOGENESIS, V11, P13, DOI 10.1007/s10456-008-9100-x; Liles WC, 2003, BLOOD, V102, P2728, DOI 10.1182/blood-2003-02-0663; London NR, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000678; Marlow R, 2008, CANCER RES, V68, P7819, DOI 10.1158/0008-5472.CAN-08-1357; Marlow R, 2010, P NATL ACAD SCI USA, V107, P10520, DOI 10.1073/pnas.1001896107; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nie YC, 2008, J EXP MED, V205, P777, DOI 10.1084/jem.20072513; Ooi AGL, 2009, STEM CELLS, V27, P653, DOI 10.1634/stemcells.2008-0824; Park KW, 2003, DEV BIOL, V261, P251, DOI 10.1016/S0012-1606(03)00258-6; Passegue E, 2004, CELL, V119, P431, DOI 10.1016/j.cell.2004.10.010; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Prasad A, 2007, J LEUKOCYTE BIOL, V82, P465, DOI 10.1189/jlb.1106678; Ross EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002338; Sasaki Y, 2009, INT J HEMATOL, V90, P553, DOI 10.1007/s12185-009-0451-x; Seth P, 2005, BIOCHEM BIOPH RES CO, V332, P533, DOI 10.1016/j.bbrc.2005.03.250; Sheldon H, 2009, FASEB J, V23, P513, DOI 10.1096/fj.07-098269; Shibata F, 2009, STEM CELLS, V27, P183, DOI 10.1634/stemcells.2008-0292; Steigemann P, 2004, CURR BIOL, V14, P225, DOI 10.1016/j.cub.2004.01.006; Suchting S, 2004, FASEB J, V18, P121, DOI 10.1096/fj.04-1991fje; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Watt SM, 2008, VOX SANG, V94, P18, DOI 10.1111/j.1423-0410.2007.00995.x; Wright DE, 2002, J EXP MED, V195, P1145, DOI 10.1084/jem.20011284; Wright DE, 2001, BLOOD, V97, P2278, DOI 10.1182/blood.V97.8.2278; Wu JY, 2001, NATURE, V410, P948, DOI 10.1038/35073616; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	44	99	103	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					72	83		10.1016/j.stem.2010.11.030	http://dx.doi.org/10.1016/j.stem.2010.11.030			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211783	Green Accepted, Bronze			2022-12-28	WOS:000286786200012
J	Barnabe-Heider, F; Goritz, C; Sabelstrom, H; Takebayashi, H; Pfrieger, FW; Meletis, K; Frisen, J				Barnabe-Heider, Fanie; Goritz, Christian; Sabelstrom, Hanna; Takebayashi, Hirohide; Pfrieger, Frank W.; Meletis, Konstantinos; Frisen, Jonas			Origin of New Glial Cells in Intact and Injured Adult Spinal Cord	CELL STEM CELL			English	Article							GRAY-MATTER ASTROCYTES; NEURAL STEM-CELL; REACTIVE ASTROCYTES; PROGENITOR CELLS; EPENDYMAL CELLS; GAP-JUNCTIONS; SCAR TISSUE; BETA-CELLS; BRAIN; OLIGODENDROCYTES	Several distinct cell types in the adult central nervous system have been suggested to act as stem or progenitor cells generating new cells under physiological or pathological conditions. We have assessed the origin of new cells in the adult mouse spinal cord by genetic fate mapping. Oligodendrocyte progenitors self-renew, give rise to new mature oligodendrocytes, and constitute the dominating proliferating cell population in the intact adult spinal cord. In contrast, astrocytes and ependymal cells, which are restricted to limited self-duplication in the intact spinal cord, generate the largest number of cells after spinal cord injury. Only ependymal cells generate progeny of multiple fates, and neural stem cell activity in the intact and injured adult spinal cord is confined to this cell population. We provide an integrated view of how several distinct cell types contribute in complementary ways to cell maintenance and the reaction to injury.	[Barnabe-Heider, Fanie; Goritz, Christian; Sabelstrom, Hanna; Meletis, Konstantinos; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Takebayashi, Hirohide] Kumamoto Univ, Grad Sch Med Sci, Dept Morphol Neural Sci, Kumamoto 8608556, Japan; [Pfrieger, Frank W.] Univ Strasbourg, Inst Cellular & Integrat Neurosci INCI, CNRS, UPR 3212, F-67084 Strasbourg, France	Karolinska Institutet; Kumamoto University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Pfrieger, Frank/AAX-3208-2020; Takebayashi, Hirohide/AAO-1693-2020; Meletis, Konstantinos/ABE-6777-2020; Göritz, Christian/AAK-5348-2021	Pfrieger, Frank/0000-0001-7085-1431; Göritz, Christian/0000-0003-0799-766X; Sabelstrom, Hanna/0000-0002-1736-7234; Meletis, Konstantinos/0000-0001-5665-4781	Swedish Research Council; Swedish Cancer Society; Swedish Agency for Innovation Systems; Karolinska Institute; Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse; Canadian Institutes of Health Research (CIHR); Christopher and Dana Reeve Foundation (CDRF)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Agency for Innovation Systems(Vinnova); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Christopher and Dana Reeve Foundation (CDRF)	We are indebted to the members of the J.F. lab for valuable discussions. We thank Drs. H. Okano, T. Edlund, and U. Lendahl for providing antibodies. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Swedish Agency for Innovation Systems, the Karolinska Institute, Tobias Stiftelsen, and Knut och Alice Wallenbergs Stiftelse. F.B.-H. was supported by postdoctoral fellowships from Canadian Institutes of Health Research (CIHR) and Christopher and Dana Reeve Foundation (CDRF).	Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Busch SA, 2007, CURR OPIN NEUROBIOL, V17, P120, DOI 10.1016/j.conb.2006.09.004; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Carlen M, 2006, EXP CELL RES, V312, P2851, DOI 10.1016/j.yexcr.2006.05.012; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Corti S, 2007, EXP NEUROL, V205, P547, DOI 10.1016/j.expneurol.2007.03.021; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Dor Y, 2008, CELL, V132, P183, DOI 10.1016/j.cell.2008.01.004; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; FRISEN J, 1993, INT J DEV NEUROSCI, V11, P461, DOI 10.1016/0736-5748(93)90020-E; Grossman SD, 2001, EXP NEUROL, V168, P273, DOI 10.1006/exnr.2001.7628; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Horky LL, 2006, J COMP NEUROL, V498, P525, DOI 10.1002/cne.21065; Horner PJ, 2000, J NEUROSCI, V20, P2218; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kunzelmann P, 1999, GLIA, V25, P111, DOI 10.1002/(SICI)1098-1136(19990115)25:2<111::AID-GLIA2>3.0.CO;2-I; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Lytle JM, 2007, EUR J NEUROSCI, V25, P1711, DOI 10.1111/j.1460-9568.2007.05390.x; Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; McDonald JW, 2006, J NEUROTRAUM, V23, P345, DOI 10.1089/neu.2006.23.345; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24; Nagy JI, 1999, NEUROSCIENCE, V88, P447, DOI 10.1016/S0306-4522(98)00191-2; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nashmi R, 2001, BRAIN RES REV, V38, P165, DOI 10.1016/S0165-0173(01)00134-5; Nishiyama A, 2009, NAT REV NEUROSCI, V10, P9, DOI 10.1038/nrn2495; Ohori Y, 2006, J NEUROSCI, V26, P11948, DOI 10.1523/JNEUROSCI.3127-06.2006; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Pompolo S, 2001, BRAIN RES, V906, P143, DOI 10.1016/S0006-8993(01)02574-4; Rash JE, 2001, CELL COMMUN ADHES, V8, P315, DOI 10.3109/15419060109080745; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Sellers DL, 2009, J NEUROSCI, V29, P6722, DOI 10.1523/JNEUROSCI.4538-08.2009; Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Takebayashi H, 2002, CURR BIOL, V12, P1157, DOI 10.1016/S0960-9822(02)00926-0; Weiss S, 1996, J NEUROSCI, V16, P7599; Wu D, 2005, J NEUROCYTOL, V34, P459, DOI 10.1007/s11068-006-8998-4; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Xu Y, 2006, NEUROSCI LETT, V397, P174, DOI 10.1016/j.neulet.2005.12.051; Yamamoto S, 2001, EXP NEUROL, V172, P115, DOI 10.1006/exnr.2001.7798; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895; Zhu XQ, 2008, NEURON GLIA BIOL, V4, P19, DOI 10.1017/S1740925X09000015	57	411	430	4	40	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					470	482		10.1016/j.stem.2010.07.014	http://dx.doi.org/10.1016/j.stem.2010.07.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887953	Bronze			2022-12-28	WOS:000283270600009
J	Palacios, D; Mozzetta, C; Consalvi, S; Caretti, G; Saccone, V; Proserpio, V; Marquez, VE; Valente, S; Mai, A; Forcales, SV; Sartorelli, V; Puri, PL				Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Caretti, Giuseppina; Saccone, Valentina; Proserpio, Valentina; Marquez, Victor E.; Valente, Sergio; Mai, Antonello; Forcales, Sonia V.; Sartorelli, Vittorio; Puri, Pier Lorenzo			TNF/p38 alpha/Polycomb Signaling to Pax7 Locus in Satellite Cells Links Inflammation to the Epigenetic Control of Muscle Regeneration	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR ACTIVITY; POLYCOMB GROUP PROTEINS; SKELETAL-MUSCLE; GENE-EXPRESSION; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; TARGET GENES; STEM-CELL; FATE; DIFFERENTIATION	How regeneration cues are converted into the epigenetic information that controls gene expression in adult stem cells is currently unknown. We identified an inflammation-activated signaling in muscle stem (satellite) cells, by which the polycomb repressive complex 2 (PRC2) represses Pax7 expression during muscle regeneration. TNF-activated p38 alpha kinase promotes the interaction between YY1 and PRC2, via threonine 372 phosphorylation of EZH2, the enzymatic subunit of the complex, leading to the formation of repressive chromatin on Pax7 promoter. TNF-alpha antibodies stimulate satellite cell proliferation in regenerating muscles of dystrophic or normal mice. Genetic knockdown or pharmacological inhibition of the enzymatic components of the p38/PRC2 signaling-p38 alpha and EZH2-invariably promote Pax7 expression and expansion of satellite cells that retain their differentiation potential upon signaling resumption. Genetic knockdown of Pax7 impaired satellite cell proliferation in response to p38 inhibition, thereby establishing the biological link between p38/PRC2 signaling to Pax7 and satellite cell decision to proliferate or differentiate.	[Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Saccone, Valentina; Puri, Pier Lorenzo] IRCCS Fdn Santa Lucia, DTI, I-00143 Rome, Italy; [Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Saccone, Valentina; Puri, Pier Lorenzo] European Brain Res Inst, I-00143 Rome, Italy; [Palacios, Daniela; Mozzetta, Chiara; Consalvi, Silvia; Saccone, Valentina; Puri, Pier Lorenzo] Sanford Burnham Inst Med Res, La Jolla, CA 92037 USA; [Caretti, Giuseppina; Proserpio, Valentina; Sartorelli, Vittorio] NIAMS, Lab Muscle Stem Cells & Gene Regulat, NIH, Bethesda, MD 20892 USA; [Caretti, Giuseppina; Proserpio, Valentina] Univ Milan, Dept Biomol Sci & Biotechnol, I-20133 Milan, Italy; [Marquez, Victor E.] NCI, Med Chem Lab, Frederick, MD 21720 USA; [Valente, Sergio; Mai, Antonello] Univ Roma La Sapienza, Dept Chem & Drug Technol, Inst Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy	IRCCS Santa Lucia; Sanford Burnham Prebys Medical Discovery Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); University of Milan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Fondazione Cenci Bolognetti; Sapienza University Rome	Puri, PL (corresponding author), IRCCS Fdn Santa Lucia, DTI, I-00143 Rome, Italy.	plpuri@dti.telethon.it	Palacios, Daniela/AAA-7608-2019; Consalvi, Silvia/K-5960-2016; Forcales, Sonia/AAU-8996-2020; Palacios, Daniela/K-4698-2016; Mozzetta, Chiara/K-9947-2018; Marquez, Victor/AAP-3549-2021; Mozzetta, Chiara/Q-2786-2019; Proserpio, Valentina/AAB-3630-2019; Forcales, Sonia-V./B-2157-2013; Valente, Sergio/K-2198-2016; Mai, Antonello/AAC-2144-2019	Palacios, Daniela/0000-0002-2207-2369; Forcales, Sonia/0000-0002-7111-4959; Palacios, Daniela/0000-0002-2207-2369; Mozzetta, Chiara/0000-0002-7147-7266; Mozzetta, Chiara/0000-0002-7147-7266; Proserpio, Valentina/0000-0003-2071-4206; Forcales, Sonia-V./0000-0002-7111-4959; Valente, Sergio/0000-0002-2241-607X; Puri, Pier Lorenzo/0000-0003-4964-0095; Mai, Antonello/0000-0001-9176-2382; Saccone, Valentina/0000-0002-0566-6384; Sartorelli, Vittorio/0000-0002-9284-3675	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD) [R01 AR053779]; European Community [241440]; Sanford Children's Health Research Center; Association Francaise contre les Myopathies (AFM) [14767]; Associazione Italiana Ricerca sul Cancro (AIRC); Parent Project Onlus; AIRC MFAG; Marie Curie Reintegration Grant; AFM; National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the NIH; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041126, R01AR052779] Funding Source: NIH RePORTER; Fondazione Telethon Funding Source: Custom	National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); European Community(European Commission); Sanford Children's Health Research Center; Association Francaise contre les Myopathies (AFM)(Association Francaise contre les Myopathies); Associazione Italiana Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Parent Project Onlus; AIRC MFAG(Fondazione AIRC per la ricerca sul cancro); Marie Curie Reintegration Grant(European Commission); AFM(Association Francaise contre les Myopathies); National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Fondazione Telethon(Fondazione Telethon)	P.L.P. is an Associate Telethon Scientist of the Dulbecco Telethon Institute (DTI) and Associate Investigator of Sanford Children's Health Research Center. This work has been supported by the following grants to P.L.P.: R01 AR053779 from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMSD); research funding from the European Community's Seventh Framework Programme in the project ENDOSTEM (Activation of vasculature associated stem cells and muscle stem cells for the repair and maintenance of muscle tissue; grant agreement number 241440); Sanford Children's Health Research Center grant; Association Francaise contre les Myopathies (AFM, Pharmacological treatment of muscular dystrophy: insight into deacetylase inhibitor-mediated regeneration and synergistic cooperation with anti-inflammatoryagents" code # 14767); Associazione Italiana Ricerca sul Cancro (AIRC); and Parent Project Onlus.; G.C. is supported by AIRC MFAG and Marie Curie Reintegration Grant. C.M. is a recipient of AFM fellowship. This work was also supported in part by the Intramural Program of the National Institute of Arthritis, Musculoskeletal, and Skin Diseases of the NIH to V.S.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Buckingham M, 2007, ANNU REV CELL DEV BI, V23, P645, DOI 10.1146/annurev.cellbio.23.090506.123438; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chen SE, 2007, AM J PHYSIOL-CELL PH, V292, pC1660, DOI 10.1152/ajpcell.00486.2006; Chow CW, 2006, CELL, V127, P887, DOI 10.1016/j.cell.2006.11.015; Classen AK, 2009, NAT GENET, V41, P1150, DOI 10.1038/ng.445; Collins CA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004475; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; de la Serna IL, 2006, NAT REV GENET, V7, P461, DOI 10.1038/nrg1882; de Nadal E, 2010, EMBO J, V29, P4, DOI 10.1038/emboj.2009.346; Dhawan J, 2005, TRENDS CELL BIOL, V15, P666, DOI 10.1016/j.tcb.2005.10.007; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Gillespie MA, 2009, J CELL BIOL, V187, P991, DOI 10.1083/jcb.200907037; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Guasconi V, 2009, TRENDS CELL BIOL, V19, P286, DOI 10.1016/j.tcb.2009.03.002; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Holterman CE, 2007, J CELL BIOL, V179, P911, DOI 10.1083/jcb.200709083; Hu P, 2008, DEV CELL, V15, P534, DOI 10.1016/j.devcel.2008.08.018; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Ito T, 2001, J BIOL CHEM, V276, P2852, DOI 10.1074/jbc.M009633200; Jones NC, 2005, J CELL BIOL, V169, P105, DOI 10.1083/jcb.200408066; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kumar D, 2009, MOL BIOL CELL, V20, P3170, DOI 10.1091/mbc.E08-12-1185; Lassar AB, 2009, J CELL BIOL, V187, P941, DOI 10.1083/jcb.200911123; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Lickert H, 2004, NATURE, V432, P107, DOI 10.1038/nature03071; Lluis F, 2005, EMBO J, V24, P974, DOI 10.1038/sj.emboj.7600528; Mai A, 2007, CHEMMEDCHEM, V2, P987, DOI 10.1002/cmdc.200700023; Martinez AM, 2009, NAT GENET, V41, P1076, DOI 10.1038/ng.414; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Merdes G, 2009, DEV CELL, V17, P440, DOI 10.1016/j.devcel.2009.10.001; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Mozzetta C, 2009, INT J BIOCHEM CELL B, V41, P701, DOI 10.1016/j.biocel.2008.08.033; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Olguin HC, 2007, J CELL BIOL, V177, P769, DOI 10.1083/jcb.200608122; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Panning B, 2010, CELL STEM CELL, V6, P3, DOI 10.1016/j.stem.2009.12.013; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Perdiguero E, 2007, EMBO J, V26, P1245, DOI 10.1038/sj.emboj.7601587; Perez-Ruiz A, 2008, J CELL SCI, V121, P1373, DOI 10.1242/jcs.024885; Peterson JM, 2008, INT REV IMMUNOL, V27, P375, DOI 10.1080/08830180802302389; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Radley HG, 2008, NEUROMUSCULAR DISORD, V18, P227, DOI 10.1016/j.nmd.2007.11.002; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Relaix F, 2005, NATURE, V435, P948, DOI 10.1038/nature03594; Relaix F, 2006, J CELL BIOL, V172, P91, DOI 10.1083/jcb.200508044; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Ruiz-Bonilla V, 2008, CELL CYCLE, V7, P2208, DOI 10.4161/cc.7.14.6273; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seale P, 2004, PLOS BIOL, V2, P664, DOI 10.1371/journal.pbio.0020130; Serra C, 2007, MOL CELL, V28, P200, DOI 10.1016/j.molcel.2007.08.021; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tan J, 2007, GENE DEV, V21, P1050, DOI 10.1101/gad.1524107; Wong ESM, 2009, DEV CELL, V17, P142, DOI 10.1016/j.devcel.2009.05.009; Woo CJ, 2010, CELL, V140, P99, DOI 10.1016/j.cell.2009.12.022; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; Zammit PS, 2006, J CELL SCI, V119, P1824, DOI 10.1242/jcs.02908	79	293	304	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					455	469		10.1016/j.stem.2010.08.013	http://dx.doi.org/10.1016/j.stem.2010.08.013			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887952	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000283270600008
J	Pollard, PJ; Kranc, KR				Pollard, Patrick J.; Kranc, Kamil R.			Hypoxia Signaling in Hematopoietic Stem Cells: A Double-Edged Sword	CELL STEM CELL			English	Editorial Material							BIOLOGY; OXYGEN	Although hematopoietic stem cells (HSCs) reside in hypoxic niches, the significance of hypoxia signaling in HSCs remains unclear. In this issue of Cell Stem Cell, Takubo et al. (2010) and Simsek et al. (2010) demonstrate that hypoxia regulates the metabolic state of HSCs and protects their integrity by controlling HIF-1 alpha.	[Kranc, Kamil R.] Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Coll Med, Vet & Life Sci,Inst Canc Sci, Glasgow G12 0XB, Lanark, Scotland; [Pollard, Patrick J.] Univ Oxford, Oxford OX3 7BN, England	University of Glasgow; University of Oxford	Kranc, KR (corresponding author), Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Coll Med, Vet & Life Sci,Inst Canc Sci, Glasgow G12 0XB, Lanark, Scotland.	kamil.kranc@glasgow.ac.uk	Pollard, Patrick/F-7516-2012	Pollard, Patrick/0000-0002-4459-4993	Wellcome Trust [091112] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Eliasson P, 2010, EXP HEMATOL, V38, P301, DOI 10.1016/j.exphem.2010.01.005; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Takubo K, 2010, CELL STEM CELL, V7, P391, DOI 10.1016/j.stem.2010.06.020	10	17	17	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					276	278		10.1016/j.stem.2010.08.006	http://dx.doi.org/10.1016/j.stem.2010.08.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804963	Bronze			2022-12-28	WOS:000282037800004
J	Polo, JM; Hochedlinger, K				Polo, Jose M.; Hochedlinger, Konrad			When Fibroblasts MET iPSCs	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; GENERATION	Two independent studies by Li et al. (2010) and Samavarchi-Tehrani et al. (2010) in this issue of Cell Stem Cell suggest that a mesenchymal-to-epithelial transition is a critical initiating event during the derivation of induced pluripotent stem cells (iPSCs) from fibroblasts, indicating remarkable similarities between cellular reprogramming, development, and cancer.	[Polo, Jose M.; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Howard Hughes Med Inst, Boston, MA 02114 USA; [Polo, Jose M.; Hochedlinger, Konrad] Ctr Regenerat Med, Boston, MA 02114 USA; [Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Polo, Jose M.; Hochedlinger, Konrad] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Polo, Jose M.; Hochedlinger, Konrad] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard University; Harvard University	Hochedlinger, K (corresponding author), Massachusetts Gen Hosp, Ctr Canc, Howard Hughes Med Inst, 185 Cambridge St, Boston, MA 02114 USA.	khochedlinger@helix.mgh.harvard.edu		Polo, Jose M/0000-0002-2531-778X				Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Samavarchi-Tehrani P, 2010, CELL STEM CELL, V7, P64, DOI 10.1016/j.stem.2010.04.015; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007	10	48	51	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					5	6		10.1016/j.stem.2010.05.018	http://dx.doi.org/10.1016/j.stem.2010.05.018			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621040	Bronze			2022-12-28	WOS:000280222300003
J	Lugert, S; Basak, O; Knuckles, P; Haussler, U; Fabel, K; Gotz, M; Haas, CA; Kempermann, G; Taylor, V; Giachino, C				Lugert, Sebastian; Basak, Onur; Knuckles, Philip; Haussler, Ute; Fabel, Klaus; Goetz, Magdalena; Haas, Carola A.; Kempermann, Gerd; Taylor, Verdon; Giachino, Claudio			Quiescent and Active Hippocampal Neural Stem Cells with Distinct Morphologies Respond Selectively to Physiological and Pathological Stimuli and Aging	CELL STEM CELL			English	Article							DENTATE GYRUS; STEM/PROGENITOR CELLS; INDUCED NEUROGENESIS; PHYSICAL-ACTIVITY; PRECURSOR CELLS; NEURONAL FATE; OLD-AGE; ADULT; PROLIFERATION; NOTCH1	New neurons are generated in the adult hippocampus throughout life by neural stem/progenitor cells (NSCs), and neurogenesis is a plastic process responsive to external stimuli. We show that canonical Notch signaling through RBP-J is required for hippocampal neurogenesis. Notch signaling distinguishes morphologically distinct Sox2(+) NSCs, and within these pools subpopulations can shuttle between mitotically active or quiescent. Radial and horizontal NSCs respond selectively to neurogenic stimuli. Physical exercise activates the quiescent radial population whereas epileptic seizures induce expansion of the horizontal NSC pool. Surprisingly, reduced neurogenesis correlates with a loss of active horizontal NSCs in aged mice rather than a total loss of stem cells, and the transition to a quiescent state is reversible to rejuvenate neurogenesis in the brain. The discovery of multiple NSC populations with Notch dependence but selective responses to stimuli and reversible quiescence has important implications for the mechanisms of adaptive learning and also for regenerative therapy.	[Lugert, Sebastian; Basak, Onur; Knuckles, Philip; Taylor, Verdon; Giachino, Claudio] Max Planck Inst Immunobiol, Dept Mol Embryol, D-79108 Freiburg, Germany; [Haussler, Ute; Haas, Carola A.] Univ Freiburg, Neuroctr, D-79106 Freiburg, Germany; [Fabel, Klaus; Kempermann, Gerd] Ctr Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Goetz, Magdalena] Helmholtz Zentrum Munchen, Inst Stem Cell Res, D-85764 Munich, Germany; [Goetz, Magdalena] Univ Munich, Inst Physiol, Dept Physiol Genom, D-80336 Munich, Germany; [Taylor, Verdon] Univ Sheffield, Dept Biomed Sci, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England	Max Planck Society; University of Freiburg; Technische Universitat Dresden; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; University of Sheffield	Taylor, V (corresponding author), Max Planck Inst Immunobiol, Dept Mol Embryol, Stubeweg 51, D-79108 Freiburg, Germany.	taylor@immunbio.mpg.de	Kempermann, Gerd/F-5416-2010; Basak, Onur/GLV-6113-2022; Häussler, Ute/GPF-8944-2022	Kempermann, Gerd/0000-0002-5304-4061; Basak, Onur/0000-0002-6864-3403; Knuckles, Philip/0000-0001-5254-8244; GIACHINO, Claudio/0000-0002-8332-0899; Haussler, Ute/0000-0001-5601-9833; Taylor, Verdon/0000-0003-3497-5976	Deutsche Forschungsgemeinschaft [SPP1109, TA-310-1, TA-310-2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank Drs. T. Honjo and P. Soriano for mice, S. Jessberger and J. Gilthorpe for comments on the manuscript, members of the Taylor lab for helpful discussions, and Frank Sager for excellent technical assistance. S.L. and P.K. are IMPRS-MCB PhD students of the Faculty of Biology, University of Freiburg, Germany. This work was supported by the Deutsche Forschungsgemeinschaft (SPP1109; TA-310-1; TA-310-2).	Amrein I, 2009, BIOL LETTERS, V5, P141, DOI 10.1098/rsbl.2008.0511; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Basak O, 2007, EUR J NEUROSCI, V25, P1006, DOI 10.1111/j.1460-9568.2007.05370.x; Ben Abdallah NMB, 2010, NEUROBIOL AGING, V31, P151, DOI 10.1016/j.neurobiolaging.2008.03.002; Breunig JJ, 2007, P NATL ACAD SCI USA, V104, P20558, DOI 10.1073/pnas.0710156104; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; delaPompa J, 1997, DEVELOPMENT, V124, P1139; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; Favaro R, 2009, NAT NEUROSCI, V12, P1248, DOI 10.1038/nn.2397; Filippov V, 2003, MOL CELL NEUROSCI, V23, P373, DOI 10.1016/S1044-7431(03)00060-5; Garthe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005464; Hattiangady B, 2008, AGING CELL, V7, P207, DOI 10.1111/j.1474-9726.2007.00363.x; Hattiangady B, 2008, NEUROBIOL AGING, V29, P129, DOI 10.1016/j.neurobiolaging.2006.09.015; Huttmann K, 2003, EUR J NEUROSCI, V18, P2769, DOI 10.1111/j.1460-9568.2003.03002.x; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2004, TRENDS NEUROSCI, V27, P447, DOI 10.1016/j.tins.2004.05.013; Kempermann G, 2002, ANN NEUROL, V52, P135, DOI 10.1002/ana.10262; Kim EJ, 2008, MOL CELL NEUROSCI, V38, P595, DOI 10.1016/j.mcn.2008.05.008; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Kuwabara T, 2009, NAT NEUROSCI, V12, P1097, DOI 10.1038/nn.2360; Leung CT, 2007, NAT NEUROSCI, V10, P720, DOI 10.1038/nn1882; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; LUMBAR T, 2004, SCIENCE, V303, P359; Lutolf S, 2002, DEVELOPMENT, V129, P373; Mizutani K, 2007, NATURE, V449, P351, DOI 10.1038/nature06090; Mumm JS, 2000, DEV BIOL, V228, P151, DOI 10.1006/dbio.2000.9960; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 2007, PROG BRAIN RES, V163, P529, DOI 10.1016/S0079-6123(07)63028-3; Petrus DS, 2009, EUR J NEUROSCI, V29, P244, DOI 10.1111/j.1460-9568.2008.06579.x; Rao MS, 2005, EUR J NEUROSCI, V21, P464, DOI 10.1111/j.1460-9568.2005.03853.x; Rao MS, 2008, HIPPOCAMPUS, V18, P931, DOI 10.1002/hipo.20449; Roybon L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004779; Scharfman HE, 2007, EPILEPSIA, V48, P33, DOI 10.1111/j.1528-1167.2007.01065.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Sestan N, 1999, SCIENCE, V286, P741, DOI 10.1126/science.286.5440.741; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Sibbe M, 2009, J NEUROSCI, V29, P8578, DOI 10.1523/JNEUROSCI.0958-09.2009; Steiner B, 2008, NEUROSCIENCE, V154, P521, DOI 10.1016/j.neuroscience.2008.04.023; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Stump G, 2002, MECH DEVELOP, V114, P153, DOI 10.1016/S0925-4773(02)00043-6; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	52	499	515	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					445	456		10.1016/j.stem.2010.03.017	http://dx.doi.org/10.1016/j.stem.2010.03.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452319	Bronze			2022-12-28	WOS:000277844800012
J	Shiozawa, Y; Taichman, RS				Shiozawa, Yusuke; Taichman, Russell S.			Dysfunctional Niches as a Root of Hematopoietic Malignancy	CELL STEM CELL			English	Editorial Material							STEM-CELL NICHE; BONE	Whether the bone marrow microenvironment can contribute to development of blood borne cancers is controversial. In a recent issue of Nature, Raaijmakers et al. (2010) show that deletion of Dicerl specifically in osteoprogenitors not only impaired their differentiation but also resulted in disrupted blood formation and secondary leukemia.	[Shiozawa, Yusuke; Taichman, Russell S.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Taichman, RS (corresponding author), Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA.	rtaich@umich.edu		Taichman, Russell S./0000-0002-7890-0020	NATIONAL CANCER INSTITUTE [P01CA093900, U54CA163124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046024] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA093900, U54 CA163124] Funding Source: Medline; NIAMS NIH HHS [P30 AR046024] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Burroughs L, 2009, HEMATOL ONCOL CLIN N, V23, P233, DOI 10.1016/j.hoc.2009.01.007; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Raaijmakers MHGP, 2010, NATURE, V464, P852, DOI 10.1038/nature08851; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	8	7	7	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					399	400		10.1016/j.stem.2010.04.004	http://dx.doi.org/10.1016/j.stem.2010.04.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452309	Bronze			2022-12-28	WOS:000277844800002
J	Lo, B; Parham, L; Alvarez-Buylla, A; Cedars, M; Conklin, B; Fisher, S; Gates, E; Giudice, L; Halme, DG; Hershon, W; Kriegstein, A; Kwok, PY; Wagner, R				Lo, Bernard; Parham, Lindsay; Alvarez-Buylla, Arturo; Cedars, Marcelle; Conklin, Bruce; Fisher, Susan; Gates, Elena; Giudice, Linda; Halme, Dina Gould; Hershon, William; Kriegstein, Arnold; Kwok, Pui-Yan; Wagner, Richard			Cloning Mice and Men: Prohibiting the Use of iPS Cells for Human Reproductive Cloning	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS		[Lo, Bernard; Parham, Lindsay] Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; [Lo, Bernard; Conklin, Bruce] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lo, Bernard; Alvarez-Buylla, Arturo; Cedars, Marcelle; Conklin, Bruce; Fisher, Susan; Gates, Elena; Giudice, Linda; Kriegstein, Arnold] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Cedars, Marcelle; Fisher, Susan; Gates, Elena; Giudice, Linda] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Halme, Dina Gould] Univ Calif San Francisco, Sch Med, Off Dean, San Francisco, CA 94143 USA; [Kriegstein, Arnold] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kwok, Pui-Yan] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Wagner, Richard] Univ Calif San Francisco, Human Res Protect Program, San Francisco, CA 94143 USA; [Conklin, Bruce] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Hershon, William] Disabil Rights Calif, Oakland, CA 94612 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu	Kwok, Pui-Yan/F-7725-2014; Conklin, Bruce/E-4738-2019	Kwok, Pui-Yan/0000-0002-5087-3059; Alvarez-Buylla, Arturo/0000-0003-4426-8925; Conklin, Bruce/0000-0003-1463-6061	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028478] Funding Source: NIH RePORTER; NCRR NIH HHS [1 UL1 RR024131-04, UL1 RR024131] Funding Source: Medline; NINDS NIH HHS [R01 NS028478] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Brock DW, 2002, SCIENCE, V296, P314, DOI 10.1126/science.1070371; DeChiara Thomas M., 2009, V530, P311, DOI 10.1007/978-1-59745-471-1_16; Denker HW, 2009, NATURE, V461, P341, DOI 10.1038/461341b; Denker HW, 2009, REPROD BIOMED ONLINE, V19, P34, DOI 10.1016/S1472-6483(10)60062-4; Greely H, 2002, HASTINGS LAW J, V53, P1085; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; National Bioethics Advisory Commission, 1997, CLON HUM BEINGS; National Bioethics Advisory Commission, 1999, ETH ISS HUM STEM CEL; National Research Council, 2002, SCI MED ASP HUM REPR; Poueymirou WT, 2007, NAT BIOTECHNOL, V25, P91, DOI 10.1038/nbt1263; Sunstein CR, 2002, HASTINGS LAW J, V53, P987; The President's Council on Bioethics, 2002, HUM CLON HUM DIGN ET; United Nations General Assembly, 2005, UN DECL HUM CLON; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	15	21	21	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					16	20		10.1016/j.stem.2009.12.004	http://dx.doi.org/10.1016/j.stem.2009.12.004			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085739	Bronze, Green Accepted			2022-12-28	WOS:000274029700007
J	Yoshida, Y; Takahashi, K; Okita, K; Ichisaka, T; Yamanaka, S				Yoshida, Yoshinori; Takahashi, Kazutoshi; Okita, Keisuke; Ichisaka, Tomoko; Yamanaka, Shinya			Hypoxia Enhances the Generation of Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							SMALL-MOLECULE COMPOUNDS; HUMAN FIBROBLASTS; DEFINED FACTORS; INDUCTION; MOUSE; DIFFERENTIATION		[Yoshida, Yoshinori; Takahashi, Kazutoshi; Okita, Keisuke; Yamanaka, Shinya] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan; [Ichisaka, Tomoko; Yamanaka, Shinya] Japan Sci & Technol Agcy, Yamanaka iPS Cell Special Project, Kawaguchi, Saitama 3320012, Japan; [Yamanaka, Shinya] Kyoto Univ, Inst Frontier Med Sci, Dept Stem Cell Biol, Kyoto 6068507, Japan; [Yamanaka, Shinya] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA	Kyoto University; Japan Science & Technology Agency (JST); Kyoto University; University of California System; University of California San Francisco; The J David Gladstone Institutes	Yoshida, Y (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat, Kyoto 6068507, Japan.	yoshinor@frontier.kyoto-u.ac.jp; yamanaka@frontier.kyoto-u.ac.jp	Yoshida, Yoshinori/AAY-6009-2020; Takahashi, Kazutoshi/ABE-5504-2020	Yoshida, Yoshinori/0000-0001-5511-9090; Takahashi, Kazutoshi/0000-0002-5329-8395; Okita, Keisuke/0000-0001-5806-1090				Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Morrison SJ, 2000, J NEUROSCI, V20, P7370; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863	17	564	638	4	68	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					237	241		10.1016/j.stem.2009.08.001	http://dx.doi.org/10.1016/j.stem.2009.08.001			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19716359	Bronze, Green Published			2022-12-28	WOS:000272545700006
J	Neppl, RL; Wang, DZ				Neppl, Ronald L.; Wang, Da-Zhi			Smooth(ing) Muscle Differentiation by MicroRNAs	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; GENE-EXPRESSION; MYOCARDIN	In a recent report in Nature, Cordes et al. (2009) demonstrate that miR-143 and miR-145 modulate smooth muscle cell (SMC) plasticity in part by regulating key transcription factors involved in SMC fate determination.	[Neppl, Ronald L.; Wang, Da-Zhi] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard Medical School	Wang, DZ (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Cardiol, Enders 1260,320 Longwood Ave, Boston, MA 02115 USA.	dwang@enders.tch.harvard.edu	Neppl, Ronald L/AAW-1257-2020	Neppl, Ronald L/0000-0003-1497-6058	NHLBI NIH HHS [R01 HL075251, R01 HL085635, T32 HL007572, U01 HL063411] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007572, U01HL063411, R01HL075251, R01HL085635] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cheng YH, 2009, CIRC RES, V105, P158, DOI 10.1161/CIRCRESAHA.109.197517; CORDES KR, 2009, NATURE IN PRESS, DOI DOI 10.1038/NATURE08195; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang ZG, 2004, NATURE, V428, P185, DOI 10.1038/nature02382; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030	10	8	9	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					130	132		10.1016/j.stem.2009.07.004	http://dx.doi.org/10.1016/j.stem.2009.07.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664984	Green Accepted, Bronze			2022-12-28	WOS:000269511900004
J	Garrett, RW; Emerson, SG				Garrett, Russell W.; Emerson, Stephen G.			Bone and Blood Vessels: The Hard and the Soft of Hematopoietic Stem Cell Niches	CELL STEM CELL			English	Review							PROGENITOR CELLS; RECONSTITUTION	Osteoblasts are important regulators of myelopoiesis and lymphopoiesis, producing several necessary soluble and membrane-associated factors. In addition, they may play important roles, along with other mesenchymal populations, in constructing an environment that is suitable for development of sinusoidal niches capable of supporting hematopoietic stem cells.	[Garrett, Russell W.; Emerson, Stephen G.] Haverford Coll, Haverford, PA 19041 USA	Haverford College	Emerson, SG (corresponding author), Haverford Coll, Haverford, PA 19041 USA.	semerson@haverford.edu						Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chan CKF, 2009, NATURE, V457, P490, DOI 10.1038/nature07547; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Grassinger J, 2007, CYTOKINE, V40, P165, DOI 10.1016/j.cyto.2007.09.004; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Li XM, 2008, EXP HEMATOL, V36, P1143, DOI 10.1016/j.exphem.2008.06.009; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Pereira JP, 2009, NAT IMMUNOL, V10, P403, DOI 10.1038/ni.1710; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; Taichman RS, 1997, BLOOD, V89, P1165, DOI 10.1182/blood.V89.4.1165; TAICHMAN RS, 1994, J EXP MED, V179, P1677, DOI 10.1084/jem.179.5.1677; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Wu JY, 2008, P NATL ACAD SCI USA, V105, P16976, DOI 10.1073/pnas.0802898105; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhu J, 2007, BLOOD, V109, P3706, DOI 10.1182/blood-2006-08-041384	20	83	87	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					503	506		10.1016/j.stem.2009.05.011	http://dx.doi.org/10.1016/j.stem.2009.05.011			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497278	Bronze			2022-12-28	WOS:000266793600012
J	Hanna, J; Markoulaki, S; Mitalipova, M; Cheng, AW; Cassady, JP; Staerk, J; Carey, BW; Lengner, CJ; Foreman, R; Love, J; Gao, Q; Kim, J; Jaenisch, R				Hanna, Jacob; Markoulaki, Styliani; Mitalipova, Maisam; Cheng, Albert W.; Cassady, John P.; Staerk, Judith; Carey, Bryce W.; Lengner, Christopher J.; Foreman, Ruth; Love, Jennifer; Gao, Qing; Kim, Jongpil; Jaenisch, Rudolf			Metastable Pluripotent States in NOD-Mouse-Derived ESCs	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER; RAT BLASTOCYSTS; GROUND-STATE; SELF-RENEWAL; FIBROBLASTS; INDUCTION; DERIVATION; CIRCUITRY; LINES	Embryonic stem cells (ESCs) are isolated from the inner cell mass (ICM) of blastocysts, whereas epiblast stem cells (EpiSCs) are derived from the postimplantation epiblast and display a restricted developmental potential. Here we characterize pluripotent states in the nonobese diabetic (NOD) mouse strain, which prior to this study was considered "nonpermissive" for ESC derivation. We find that NOD stem cells can be stabilized by providing constitutive expression of Klf4 or c-Myc or small molecules that can replace these factors during in vitro reprogramming. The NOD ESCs and iPSCs appear to be "metastable," as they acquire an alternative EpiSC-like identity after removal of the exogenous factors, while their reintroduction converts the cells back to ICM-like pluripotency. Our findings suggest that stem cells from different genetic backgrounds can assume distinct states of pluripotency in vitro, the stability of which is regulated by endogenous genetic determinants and can be modified by exogenous factors.	[Hanna, Jacob; Markoulaki, Styliani; Mitalipova, Maisam; Cheng, Albert W.; Cassady, John P.; Staerk, Judith; Carey, Bryce W.; Lengner, Christopher J.; Foreman, Ruth; Love, Jennifer; Gao, Qing; Kim, Jongpil; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Cheng, Albert W.] MIT, Computat & Syst Biol Program, Cambridge, MA 02142 USA; [Cassady, John P.; Carey, Bryce W.; Foreman, Ruth; Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Hanna, J (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	hanna@wi.mit.edu; jaenisch@wi.mit.edu	Hanna, Jacob/K-1339-2012	Hanna, Jacob/0000-0003-2042-9974; Cheng, Albert/0000-0003-2653-5743; Staerk, Judith/0000-0001-8698-6998; Lengner, Christopher/0000-0002-0574-5189	NIH [RO1-HDO45022, R37-CA084198, RO1-CA087869]; Helen Hay Whitney; HFSP; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA087869, R37CA084198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Helen Hay Whitney; HFSP(Human Frontier Science Program); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We would like to thank D. Mathis, C. Benoist, M. Wilson, A. Meissner, F. Soldner, and members of the Jaenisch lab for discussions. We thank Peter Andrews for discussing the concept of metastability of pluripotent states. We thank R. Mckay for EpiSC cells. We thank T. Di Cesare for graphics. R.J. is supported by grants from the NIH (RO1-HDO45022. R37-CA084198, and RO1-CA087869). This work was also supported by a generous gift from Landon Clay. J.H. is a Helen Hay Whitney fellow, and J.S. is a HFSP fellow. R.J. is an advisor to Stemgent, which may negotiate to obtain a license from MIT to distribute some of the reagents used in this study.	Bach JF, 1997, RES IMMUNOL, V148, P285, DOI 10.1016/S0923-2494(97)87235-5; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Byrne JA, 2007, NATURE, V450, P497, DOI 10.1038/nature06357; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hatano S, 2005, MECH DEVELOP, V122, P67, DOI 10.1016/j.mod.2004.08.008; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; JAHNER D, 1982, NATURE, V298, P623, DOI 10.1038/298623a0; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lovell-Badge R, 2007, NAT BIOTECHNOL, V25, P1114, DOI 10.1038/nbt1007-1114; LYSSIOTIS CA, 2009, REPROGRAMMI IN PRESS; Markoulaki S, 2008, METHODS, V45, P101, DOI 10.1016/j.ymeth.2008.04.002; Markoulaki S, 2009, NAT BIOTECHNOL, V27, P169, DOI 10.1038/nbt.1520; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Wakayama T, 1998, NATURE, V394, P369, DOI 10.1038/28615; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	35	266	281	0	13	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					513	524		10.1016/j.stem.2009.04.015	http://dx.doi.org/10.1016/j.stem.2009.04.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19427283	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000266793600014
J	Hung, CT				Hung, Clark T.			One Breath Closer to Making Engineered Tissues a Clinical Reality	CELL STEM CELL			English	Editorial Material									Columbia Univ, Dept Biomed Engn, Cellular Engn Lab, New York, NY 10027 USA	Columbia University	Hung, CT (corresponding author), Columbia Univ, Dept Biomed Engn, Cellular Engn Lab, New York, NY 10027 USA.	cth6@columbia.edu						Atala A, 2006, LANCET, V367, P1241, DOI 10.1016/S0140-6736(06)68438-9; Butler DL, 2000, J BIOMECH ENG-T ASME, V122, P570, DOI 10.1115/1.1318906; Cebotari S, 2006, CIRCULATION, V114, pI132, DOI 10.1161/CIRCULATIONAHA.105.001065; JUNGEBLUTH P, 2009, J THORAC CA IN PRESS; Macchiarini P, 2008, LANCET, V372, P2023, DOI 10.1016/S0140-6736(08)61598-6; Mauck RL, 2003, OSTEOARTHR CARTILAGE, V11, P879, DOI 10.1016/j.joca.2003.08.006; Moutos FT, 2007, NAT MATER, V6, P162, DOI 10.1038/nmat1822; Ochi M, 2004, ARTIF ORGANS, V28, P28, DOI 10.1111/j.1525-1594.2004.07317.x; Parenteau N, 1999, SCI AM, V280, P83; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					5	6		10.1016/j.stem.2008.12.005	http://dx.doi.org/10.1016/j.stem.2008.12.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128787	Bronze			2022-12-28	WOS:000262559500003
J	Crisan, M; Yap, S; Casteilla, L; Chen, CW; Corselli, M; Park, TS; Andriolo, G; Sun, B; Zheng, B; Zhang, L; Norotte, C; Teng, PN; Traas, J; Schugar, R; Deasy, BM; Badylak, S; Buhring, HJ; Giacobino, JP; Lazzari, L; Huard, J; Peault, B				Crisan, Mihaela; Yap, Solomon; Casteilla, Louis; Chen, Chien-Wen; Corselli, Mirko; Park, Tea Soon; Andriolo, Gabriella; Sun, Bin; Zheng, Bo; Zhang, Li; Norotte, Cyrille; Teng, Pang-Ning; Traas, Jeremy; Schugar, Rebecca; Deasy, Bridget M.; Badylak, Stephen; Buehring, Hans-Joerg; Giacobino, Jean-Paul; Lazzari, Lorenza; Huard, Johnny; Peault, Bruno			A perivascular origin for mesenchymal stem cells in multiple human organs	CELL STEM CELL			English	Article							HUMAN ADIPOSE-TISSUE; ENDOTHELIAL-CELLS; BONE-MARROW; DIFFERENTIAL EXPRESSION; MICROVASCULAR PERICYTES; PROGENITOR CELLS; MUSCLE; MARKERS; POPULATION; IDENTIFICATION	Mesenchymal stem cells (MSCs), the archetypal multipotent progenitor cells derived in cultures of developed organs, are of unknown identity and native distribution. We have prospectively identified perivascular cells, principally pericytes, in multiple human organs including skeletal muscle, pancreas, adipose tissue, and placenta, on CD146, NG2, and PDGF-R beta expression and absence of hematopoietic, endothelial, and myogenic cell markers. Perivascular cells purified from skeletal muscle or nonmuscle tissues were myogenic in culture and in vivo. Irrespective of their tissue origin, long-term cultured perivascular cells retained myogenicity; exhibited at the clonal level osteogenic, chondrogenic, and adipogenic potentials; expressed MSC markers; and migrated in a culture model of chemotaxis. Expression of MSC markers was also detected at the surface of native, noncultured perivascular cells. Thus, blood vessel walls harbor a reserve of progenitor cells that may be integral to the origin of the elusive MSCs and other related adult stem cells.	[Crisan, Mihaela; Yap, Solomon; Casteilla, Louis; Chen, Chien-Wen; Corselli, Mirko; Park, Tea Soon; Sun, Bin; Zheng, Bo; Norotte, Cyrille; Teng, Pang-Ning; Schugar, Rebecca; Deasy, Bridget M.; Giacobino, Jean-Paul; Huard, Johnny; Peault, Bruno] Childrens Hosp Pittsburgh, Dept Pediat, Stem Cell Res Ctr, Pittsburgh, PA 15213 USA; [Crisan, Mihaela; Yap, Solomon; Casteilla, Louis; Chen, Chien-Wen; Corselli, Mirko; Park, Tea Soon; Sun, Bin; Zheng, Bo; Norotte, Cyrille; Teng, Pang-Ning; Schugar, Rebecca; Deasy, Bridget M.; Giacobino, Jean-Paul; Huard, Johnny; Peault, Bruno] Childrens Hosp Pittsburgh, Dept Orthopaed Surg, Stem Cell Res Ctr, Pittsburgh, PA 15213 USA; [Andriolo, Gabriella; Lazzari, Lorenza] Fdn Osped Maggiore Policlin, Dept Regenerat Med, I-20122 Milan, Italy; [Casteilla, Louis] CNRS, UPS, UMR 5018, F-31059 Toulouse, France; [Zhang, Li; Badylak, Stephen; Peault, Bruno] McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Traas, Jeremy] Childrens Hosp Philadelphia, Div Surg, Philadelphia, PA 19104 USA; [Buehring, Hans-Joerg] Univ Clin Tubingen, Dept Internal Med, D-72076 Tubingen, Germany	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; IRCCS Ca Granda Ospedale Maggiore Policlinico; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Peault, B (corresponding author), Childrens Hosp Pittsburgh, Dept Pediat, Stem Cell Res Ctr, Pittsburgh, PA 15213 USA.	bruno.peault@chp.edu	Lazzari, Lorenza/J-4279-2015	Lazzari, Lorenza/0000-0002-9434-4538; Badylak, Stephen/0000-0003-3555-0689; Chen, William CW/0000-0002-6891-3557; Casteilla, Louis/0000-0001-9647-3248	Department of Defense; Commonwealth of Pennsylvania; Children's Hospital of Pittsburgh; University of Pittsburgh Cancer Institute; National Institutes of Health [RO1 #AR49684-01, R21 #HL083057-01A2]; Banca San Paolo of Turin, Italy; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL083057] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049684] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); Commonwealth of Pennsylvania; Children's Hospital of Pittsburgh; University of Pittsburgh Cancer Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Banca San Paolo of Turin, Italy(Compagnia di San Paolo); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Our thanks are due to Allison Logar for assistance with flow cytometry; Mitra Lavasani for help with in vivo assays; and Dr. Rita Bottino, Dr. Burhan Gharaibeh, Dr. Peter Rubin. and Lindsay Mock for procurement of human tissues. Dr. Simon Watkins assisted with confocal microscopy, Roseanne Perry helped with manuscript preparation, and David Humiston proofread this report. This work was supported in part by grants from the Department of Defense, Commonwealth of Pennsylvania, Children's Hospital of Pittsburgh, University of Pittsburgh Cancer Institute, and National Institutes of Health (RO1 #AR49684-01 and R21 #HL083057-01A2). M.C. was supported by Banca San Paolo of Turin, Italy.	Alliot F, 1999, J NEUROSCI RES, V58, P367; Alliot-Licht B, 2005, CELL TISSUE RES, V321, P391, DOI 10.1007/s00441-005-1115-7; Andreeva ER, 1998, TISSUE CELL, V30, P127, DOI 10.1016/S0040-8166(98)80014-1; Battula VL, 2007, DIFFERENTIATION, V75, P279, DOI 10.1111/j.1432-0436.2006.00139.x; Betsholtz C, 2005, EXP SUPPL, V94, P115; BOADO RJ, 1994, J NEUROSCI RES, V39, P430, DOI 10.1002/jnr.490390410; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Cerletti M, 2006, J CELL SCI, V119, P3117, DOI 10.1242/jcs.03056; Collett GDM, 2005, CIRC RES, V96, P930, DOI 10.1161/01.RES.0000163634.51301.0d; Cossu G, 2003, CURR OPIN GENET DEV, V13, P537, DOI 10.1016/j.gde.2003.08.001; Davidoff MS, 2004, J CELL BIOL, V167, P935, DOI 10.1083/jcb.200409107; De Angelis L, 1999, J CELL BIOL, V147, P869, DOI 10.1083/jcb.147.4.869; Deasy BM, 2005, MOL BIOL CELL, V16, P3323, DOI 10.1091/mbc.E05-02-0169; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Endo M, 2007, MOL THER, V15, P579, DOI 10.1038/sj.mt.6300092; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; Gronthos S, 2001, J CELL PHYSIOL, V189, P54, DOI 10.1002/jcp.1138; Gros J, 2005, NATURE, V435, P954, DOI 10.1038/nature03572; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Le Grand F, 2004, EXP CELL RES, V301, P232, DOI 10.1016/j.yexcr.2004.07.028; Li Q, 2003, J PATHOL, V201, P296, DOI 10.1002/path.1443; Meirelles LD, 2008, STEM CELLS, V26, P2287, DOI 10.1634/stemcells.2007-1122; Middleton J, 2005, J PATHOL, V206, P260, DOI 10.1002/path.1788; Morgan JE, 2003, INT J BIOCHEM CELL B, V35, P1151, DOI 10.1016/S1357-2725(03)00042-6; NEHLS V, 1991, J CELL BIOL, V113, P147, DOI 10.1083/jcb.113.1.147; Oberlin E, 2002, DEVELOPMENT, V129, P4147; OZERDEM U, 2002, DEV DYNAM, P218; PEAULT B, 1999, SCIENCE, V284, P143; Qu-Petersen ZQ, 2002, J CELL BIOL, V157, P851, DOI 10.1083/jcb.200108150; Reing JE, 2009, TISSUE ENG PT A, V15, P605, DOI 10.1089/ten.tea.2007.0425; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schwab KE, 2007, HUM REPROD, V22, P2903, DOI 10.1093/humrep/dem265; Seaberg RM, 2004, NAT BIOTECHNOL, V22, P1115, DOI 10.1038/nbt1004; Shih DTB, 2005, STEM CELLS, V23, P1012, DOI 10.1634/stemcells.2004-0125; Toma JG, 2001, NAT CELL BIOL, V3, P778, DOI 10.1038/ncb0901-778; Traktuev DO, 2008, CIRC RES, V102, P77, DOI 10.1161/CIRCRESAHA.107.159475; Zambidis ET, 2006, TRENDS CARDIOVAS MED, V16, P95, DOI 10.1016/j.tcm.2006.01.005; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	42	2793	2875	6	279	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					301	313		10.1016/j.stem.2008.07.003	http://dx.doi.org/10.1016/j.stem.2008.07.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786417	Bronze, Green Published			2022-12-28	WOS:000259665000013
J	Fantauzzo, KA; Christiano, AM				Fantauzzo, Katherine A.; Christiano, Angela M.			There and Back Again: Hair Follicle Stem Cell Dynamics	CELL STEM CELL			English	Editorial Material							MORPHOGENESIS; RENEWAL	Recently in Cell, Hsu et al. (2011) defined the relationship between stem cells and differentiated progeny within a hair follicle lineage. Their work reveals that stem cell descendants that have migrated out of the bulge can return to this niche and actively contribute to its function.	[Fantauzzo, Katherine A.; Christiano, Angela M.] Columbia Univ, Dept Dermatol, New York, NY 10032 USA; [Christiano, Angela M.] Columbia Univ, Dept Genet & Dev, New York, NY 10032 USA	Columbia University; Columbia University	Christiano, AM (corresponding author), Columbia Univ, Dept Dermatol, New York, NY 10032 USA.	amc65@columbia.edu		Fantauzzo, Katherine/0000-0003-0365-4168				Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Hsu YC, 2011, CELL, V144, P92, DOI 10.1016/j.cell.2010.11.049; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Panteleyev AA, 2001, J CELL SCI, V114, P3419	10	4	4	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					8	9		10.1016/j.stem.2010.12.018	http://dx.doi.org/10.1016/j.stem.2010.12.018			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211777	Bronze			2022-12-28	WOS:000286786200005
J	Ma, S; Tang, KH; Chan, YP; Lee, TK; Kwan, PS; Castilho, A; Ng, I; Man, K; Wong, N; To, KF; Zheng, BJ; Lai, PBS; Lo, CM; Chan, KW; Guan, XY				Ma, Stephanie; Tang, Kwan Ho; Chan, Yuen Piu; Lee, Terence K.; Kwan, Pak Shing; Castilho, Antonia; Ng, Irene; Man, Kwan; Wong, Nathalie; To, Ka-Fai; Zheng, Bo-Jian; Lai, Paul B. S.; Lo, Chung Mau; Chan, Kwok Wah; Guan, Xin-Yuan			miR-130b Promotes CD133(+) Liver Tumor-Initiating Cell Growth and Self-Renewal via Tumor Protein 53-Induced Nuclear Protein 1	CELL STEM CELL			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; CANCER STEM-CELLS; P53-INDUCED NUCLEAR-PROTEIN-1; MICRORNA EXPRESSION; DICER; MECHANISMS; IDENTIFICATION; PROGRESSION; SURVIVAL; DISEASE	A novel paradigm in tumor biology suggests that cancer growth is driven by stem-like cells within a tumor, called tumor-initiating cells (TICs) or cancer stem cells (CSCs). Here we describe the identification and characterization of such cells from hepatocellular carcinoma (HCC) using the marker CD133. CD133 accounts for approximately 1.3%-13.6% of the cells in the bulk tumor of human primary HCC samples. When compared with their CD133- counterparts, CD133(+) cells not only possess the preferential ability to form undifferentiated tumor spheroids in vitro but also express an enhanced level of stem cell-associated genes, have a greater ability to form tumors when implanted orthotopically in immunodeficient mice, and can be serially passaged into secondary animal recipients. Xenografts resemble the original human tumor and maintain a similar percentage of tumorigenic CD133(+) cells. Quantitative PCR analysis of 41 separate HCC tissue specimens with follow-up data found that CD133(+) tumor cells were frequently detected at low quantities in HCC, and their presence was also associated with worse overall survival and higher recurrence rates. Subsequent differential microRNA expression profiling of CD133(+) and CD133(-) cells from human HCC clinical specimens and cell lines identified an overexpression of miR-130b in CD133(+) TICs. Functional studies on miR-130b lentiviral-transduced CD133(-) cells demonstrated superior resistance to chemotherapeutic agents, enhanced tumorigenicity in vivo, and a greater potential for self renewal. Conversely, antagonizing miR-130b in CD133(+) TICs yielded an opposing effect. The increased miR-130b paralleled the reduced TP53INP1, a known miR-130b target. Silencing TP53INP1 in CD133(-) cells enhanced both self renewal and tumorigenicity in vivo. Collectively, miR-130b regulates CD133(+) liver TICs, in part, via silencing TP53INP1.	[Ma, Stephanie; Tang, Kwan Ho; Chan, Yuen Piu; Lee, Terence K.; Castilho, Antonia; Ng, Irene; Chan, Kwok Wah] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China; [Kwan, Pak Shing; Guan, Xin-Yuan] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Clin Oncol, Hong Kong, Hong Kong, Peoples R China; [Man, Kwan; Lo, Chung Mau] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Surg, Hong Kong, Hong Kong, Peoples R China; [Zheng, Bo-Jian] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Microbiol, Hong Kong, Hong Kong, Peoples R China; [Ma, Stephanie; Lee, Terence K.; Castilho, Antonia; Ng, Irene; Man, Kwan; Guan, Xin-Yuan] Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, State Key Lab Liver Res, Hong Kong, Hong Kong, Peoples R China; [Wong, Nathalie; To, Ka-Fai] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Hong Kong, Peoples R China; [Lai, Paul B. S.] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Surg, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Ma, S (corresponding author), Univ Hong Kong, Queen Mary Hosp, Li Ka Shing Fac Med, Dept Pathol, Hong Kong, Hong Kong, Peoples R China.	stefma@hkucc.hku.hk; kwchan@pathology.hku.hk; xyguan@hkucc.hku.hk	Lai, Paul BS/K-8556-2015; Ma, Stephanie Kwai Yee/C-4766-2009; /A-3639-2009; Guan, Xin-Yuan/A-3639-2009	Lai, Paul BS/0000-0002-9469-6728; Tang, Kwan Ho/0000-0001-7729-5159; Ma, Stephanie Kwai Yee/0000-0002-2029-7943; /0000-0003-1874-9805; Lee, Kin Wah/0000-0003-0682-322X; Ng, Irene Oi-lin/0000-0001-7532-2029; Guan, Xin-Yuan/0000-0002-4485-6017	Research Grant Council Collaborative Research Fund [HKU 1/06C, HKU 7/CRG/09, HKU5/CRF/08]; National Key Sci-Tech Special Project of Infectious Diseases [2008ZX1002-022]; University of Hong Kong Strategic Research Theme in Cancer; University of Hong Kong	Research Grant Council Collaborative Research Fund; National Key Sci-Tech Special Project of Infectious Diseases; University of Hong Kong Strategic Research Theme in Cancer; University of Hong Kong(University of Hong Kong)	The authors would like to thank Dr. Alice Carrier (INSERM; France) for her gift of the monoclonal rat anti-human TP53INP1 (E12) antibody, Drs. Man Lung Yeung and Kuan-The Jeang (NIH; USA) for their gift of the full-length 3'UTR TP53INP1 plasmid, Mr. Fai Ng (University of Hong Kong, HK) for his expert assistance with the cell-sorting facility and Professor George Tsao (Centre for Cancer Research, University of Hong Kong, HK) for his support on cancer stem cell studies. This work was generously supported by Sir Michael and Lady Kadoorie Funded Research into Cancer Genetics, Research Grant Council Collaborative Research Fund (HKU 1/06C, HKU 7/CRG/09 and HKU5/CRF/08), National Key Sci-Tech Special Project of Infectious Diseases (2008ZX1002-022), The University of Hong Kong Strategic Research Theme in Cancer, The University of Hong Kong Seed Funding Program, The University of Hong Kong Small Project Funding Program, and Donation of the Li Ka Shing Foundation of Matching Grants of The University of Hong Kong.	Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Chen JF, 2008, P NATL ACAD SCI USA, V105, P2111, DOI 10.1073/pnas.0710228105; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Davis TH, 2008, J NEUROSCI, V28, P4322, DOI 10.1523/JNEUROSCI.4815-07.2008; DeSano JT, 2009, AAPS J, V11, P682, DOI 10.1208/s12248-009-9147-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Gironella M, 2007, P NATL ACAD SCI USA, V104, P16170, DOI 10.1073/pnas.0703942104; Gommeaux J, 2007, MOL CELL BIOL, V27, P2215, DOI 10.1128/MCB.01454-06; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Ito Y, 2006, ANTICANCER RES, V26, P4391; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Ji JF, 2009, HEPATOLOGY, V50, P472, DOI 10.1002/hep.22989; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Jiang PH, 2006, WORLD J GASTROENTERO, V12, P691, DOI 10.3748/wjg.v12.i5.691; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Koralov SB, 2008, CELL, V132, P860, DOI 10.1016/j.cell.2008.02.020; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Ma S, 2007, GASTROENTEROLOGY, V132, P2542, DOI 10.1053/j.gastro.2007.04.025; Ogawa Kumiko, 2005, Medical Molecular Morphology, V38, P23, DOI 10.1007/s00795-004-0265-0; Okamura S, 2001, MOL CELL, V8, P85, DOI 10.1016/S1097-2765(01)00284-2; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Song W, 2008, INT J CLIN PRACT, V62, P1212, DOI 10.1111/j.1742-1241.2008.01777.x; Suetsugi A, 2006, BIOCHEM BIOPH RES CO, V351, P820, DOI 10.1016/j.bbrc.2006.10.128; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tomasin R, 2001, J BIOL CHEM, V276, P44185, DOI 10.1074/jbc.M105647200; Tomasini R, 2002, EUR J CELL BIOL, V81, P294, DOI 10.1078/0171-9335-00248; Ura S, 2009, HEPATOLOGY, V49, P1098, DOI 10.1002/hep.22749; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Yamashita T, 2009, GASTROENTEROLOGY, V136, P1012, DOI 10.1053/j.gastro.2008.12.004; Yang ZF, 2008, CANCER CELL, V13, P153, DOI 10.1016/j.ccr.2008.01.013; Yeung ML, 2008, CANCER RES, V68, P8976, DOI 10.1158/0008-5472.CAN-08-0769; Yin SY, 2007, INT J CANCER, V120, P1444, DOI 10.1002/ijc.22476; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868	44	323	342	0	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					694	707		10.1016/j.stem.2010.11.010	http://dx.doi.org/10.1016/j.stem.2010.11.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112564	Bronze			2022-12-28	WOS:000285537700011
J	Tonge, PD; Nagy, A				Tonge, Peter Dennis; Nagy, Andras			Extinction of Xist Improves Cloning	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; NUCLEAR TRANSFER	Mammalian cloning by somatic cell nuclear transfer is a notoriously inefficient process with a low birth rate. Recently in Science, Inoue et al. (2010) report that somatic cell nuclear transfer fails to regulate Xist expression from the X chromosome.	[Tonge, Peter Dennis; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Nagy, Andras] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Nagy, A (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	nagy@mshri.on.ca	Nagy, Andras/G-6465-2013	Nagy, Andras/0000-0003-4311-0413				Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Inoue K, 2010, SCIENCE, V330, P496, DOI 10.1126/science.1194174; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Tchieu J, 2010, CELL STEM CELL, V7, P329, DOI 10.1016/j.stem.2010.06.024	6	1	1	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					550	552		10.1016/j.stem.2010.10.003	http://dx.doi.org/10.1016/j.stem.2010.10.003			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040894	Bronze			2022-12-28	WOS:000284390500004
J	Liu, CM; Teng, ZQ; Santistevan, NJ; Szulwach, KE; Guo, WX; Jin, P; Zhao, XY				Liu, Changmei; Teng, Zhao-Qian; Santistevan, Nicholas J.; Szulwach, Keith E.; Guo, Weixiang; Jin, Peng; Zhao, Xinyu			Epigenetic Regulation of miR-184 by MBD1 Governs Neural Stem Cell Proliferation and Differentiation	CELL STEM CELL			English	Article							METHYL-CPG BINDING-PROTEIN-1; ADULT NEUROGENESIS; PROGENITOR CELLS; MATURE MIR-184; NUMB; MICRORNA; EXPRESSION; MECHANISMS; CARCINOMA; TARGETS	Methyl-CpG binding protein 1 (MBD1) regulates gene expression via a DNA methylation-mediated epigenetic mechanism. We have previously demonstrated that MBD1 deficiency impairs adult neural stem/ progenitor cell (aNSC) differentiation and neurogenesis, but the underlying mechanism was unclear. Here, we show that MBD1 regulates the expression of several microRNAs in aNSCs and, specifically, that miR-184 is directly repressed by MBD1. High levels of miR-184 promoted proliferation but inhibited differentiation of aNSCs, whereas inhibition of miR-184 rescued the phenotypes associated with MBD1 deficiency. We further found that miR-184 regulates the expression of Numb like (Numbl), a known regulator of brain development, by binding to the 3'-UTR of Numbl mRNA and affecting its translation. Expression of exogenous Numbl could rescue the aNSC defects that result from either miR-184 overexpression or MBD1 deficiency. Therefore, MBD1, miR-184, and Numbl form a regulatory network that helps control the balance between proliferation and differentiation of aNSCs.	[Liu, Changmei; Teng, Zhao-Qian; Santistevan, Nicholas J.; Guo, Weixiang; Zhao, Xinyu] Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA; [Szulwach, Keith E.; Jin, Peng] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Szulwach, Keith E.; Jin, Peng] Emory Univ, Sch Med, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA	University of New Mexico; Emory University; Emory University	Zhao, XY (corresponding author), Univ New Mexico, Sch Med, Dept Neurosci, Albuquerque, NM 87131 USA.	xzhao@salud.unm.edu	Santistevan, Nicholas/L-3233-2015; Teng, Zhao-Qian/J-6260-2015; Liu, Changmei/H-9600-2012; Jin, Peng/B-5977-2012; Teng, Zhao-Qian/AAD-1033-2021	Santistevan, Nicholas/0000-0002-4657-6860; Teng, Zhao-Qian/0000-0002-7232-3381; Jin, Peng/0000-0001-6137-6659; Teng, Zhao-Qian/0000-0002-7232-3381	International Rett Syndrome Foundation; NIH [MH080434, MH078972]; Autism Speaks Postdoctoral Fellowship; MARC [NIH/T34GM00851]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH080434, R01MH078972] Funding Source: NIH RePORTER	International Rett Syndrome Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Autism Speaks Postdoctoral Fellowship; MARC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Dr. M.C. Wilson, Dr. T. Xie, and Ms. C.T. Strauss for editing the manuscript and Dr. W. Zhong for providing Numbl antibody. Images were generated in the UNM Cancer Center Fluorescence Microscopy Facility. This work was supported by grants from the International Rett Syndrome Foundation and the NIH (MH080434 and MH078972) to X.Z., an Autism Speaks Postdoctoral Fellowship to CL., and a MARC fellowship to N.J.S. (NIH/T34GM00851).	Adams BD, 2007, MOL ENDOCRINOL, V21, P1132, DOI 10.1210/me.2007-0022; Allan AM, 2008, HUM MOL GENET, V17, P2047, DOI 10.1093/hmg/ddn102; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Barkho BZ, 2006, STEM CELLS DEV, V15, P407, DOI 10.1089/scd.2006.15.407; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Chapman G, 2006, J CELL BIOL, V175, P535, DOI 10.1083/jcb.200602009; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iovino N, 2009, DEV CELL, V17, P123, DOI 10.1016/j.devcel.2009.06.008; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Johnson JE, 2003, TRENDS NEUROSCI, V26, P395, DOI 10.1016/S0166-2236(03)00166-8; Jorgensen HF, 2004, MOL CELL BIOL, V24, P3387, DOI 10.1128/MCB.24.8.3387-3395.2004; Keverne EB, 2008, FRONT NEUROENDOCRIN, V29, P398, DOI 10.1016/j.yfrne.2008.03.001; Kishino T, 2006, CYTOGENET GENOME RES, V113, P209, DOI 10.1159/000090834; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HS, 2003, NEURON, V40, P1105, DOI 10.1016/S0896-6273(03)00755-4; Li XK, 2008, J BIOL CHEM, V283, P27644, DOI 10.1074/jbc.M804899200; Li XK, 2008, STEM CELLS DEV, V17, P1043, DOI 10.1089/scd.2008.0036; Liu CM, 2009, NEUROMOL MED, V11, P141, DOI 10.1007/s12017-009-8077-y; Nomura T, 2008, HUM MOL GENET, V17, P1192, DOI 10.1093/hmg/ddn011; Pandey DP, 2009, MOL CELL BIOL, V29, P3783, DOI 10.1128/MCB.01875-08; Petersen PH, 2004, NAT NEUROSCI, V7, P803, DOI 10.1038/nn1289; Petersen PH, 2006, DEV NEUROSCI-BASEL, V28, P156, DOI 10.1159/000090761; Petersen PH, 2002, NATURE, V419, P929, DOI 10.1038/nature01124; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Sansom OJ, 2007, NAT CLIN PRACT ONCOL, V4, P305, DOI 10.1038/ncponc0812; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Shen Q, 2002, DEVELOPMENT, V129, P4843; Shen Q, 2009, NAT NEUROSCI, V12, P369, DOI 10.1038/nn0409-369; Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313; Smrt RD, 2007, NEUROBIOL DIS, V27, P77, DOI 10.1016/j.nbd.2007.04.005; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wong TS, 2009, THESCIENTIFICWORLDJO, V9, P130, DOI 10.1100/tsw.2009.12; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao XY, 2003, P NATL ACAD SCI USA, V100, P6777, DOI 10.1073/pnas.1131928100; Zhong WM, 1997, DEVELOPMENT, V124, P1887	44	235	250	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					433	444		10.1016/j.stem.2010.02.017	http://dx.doi.org/10.1016/j.stem.2010.02.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452318	Green Accepted, Bronze			2022-12-28	WOS:000277844800011
J	Lemischka, IR				Lemischka, Ihor R.			Hooking Up with Oct4	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; PLURIPOTENCY	The transcription factor Oct4 plays a central role in controlling the undifferentiated state of embryonic and induced pluripotent stem cells. Two complementary papers in this issue of Cell Stem Cell describe the extended network of proteins that interact with Oct4. Together, these studies broaden our understanding of the control of pluripotency.	Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Lemischka, IR (corresponding author), Mt Sinai Sch Med, Black Family Stem Cell Inst, 1 Gustave L Levy Pl, New York, NY 10029 USA.							Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Lu R, 2009, NATURE, V462, P358, DOI 10.1038/nature08575; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Schaniel C, 2009, STEM CELLS, V27, P2979, DOI 10.1002/stem.223; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284	9	13	13	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					291	292		10.1016/j.stem.2010.03.011	http://dx.doi.org/10.1016/j.stem.2010.03.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362529	Bronze			2022-12-28	WOS:000276823300003
J	van den Berg, DLC; Snoek, T; Mullin, NP; Yates, A; Bezstarosti, K; Demmers, J; Chambers, I; Poot, RA				van den Berg, Debbie L. C.; Snoek, Tim; Mullin, Nick P.; Yates, Adam; Bezstarosti, Karel; Demmers, Jeroen; Chambers, Ian; Poot, Raymond A.			An Oct4-Centered Protein Interaction Network in Embryonic Stem Cells	CELL STEM CELL			English	Article							REGULATES SELF-RENEWAL; TRANSCRIPTIONAL REGULATION; RECEPTOR-BETA; PLURIPOTENCY; OCT4; NANOG; COMPLEX; MOUSE; SOX2; COACTIVATOR	Transcription factors, such as Oct4, are critical for establishing and maintaining pluripotent cell identity. Whereas the genomic locations of several pluripotency transcription factors have been reported, the spectrum of their interaction partners is underexplored. Here, we use an improved affinity protocol to purify Oct4-interacting proteins from mouse embryonic stem cells (ESCs). Subsequent purification of Oct4 partners Sall4, Tcfcp2l1, Dax1, and Esrrb resulted in an Oct4 interactome of 166 proteins, including transcription factors and chromatin-modifying complexes with documented roles in self-renewal, but also many factors not previously associated with the ESC network. We find that Esrrb associated with the basal transcription machinery and also detect interactions between transcription factors and components of the TGF-beta, Notch, and Wnt signaling pathways. Acute depletion of Oct4 reduced binding of Tcfcp2l1, Dax1, and Esrrb to several target genes. In conclusion, our purification protocol allowed us to bring greater definition to the circuitry controlling pluripotent cell identity.	[van den Berg, Debbie L. C.; Snoek, Tim; Poot, Raymond A.] Erasmus MC, Dept Cell Biol, NL-3015 GE Rotterdam, Netherlands; [Bezstarosti, Karel; Demmers, Jeroen] Erasmus MC, Prote Ctr, NL-3015 GE Rotterdam, Netherlands; [Mullin, Nick P.; Yates, Adam; Chambers, Ian] Univ Edinburgh, Sch Biol Sci, Inst Stem Cell Res, MRC Ctr Regenerat Med, Edinburgh EH9 3JQ, Midlothian, Scotland	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Edinburgh	Poot, RA (corresponding author), Erasmus MC, Dept Cell Biol, Dr Molewaterpl 50, NL-3015 GE Rotterdam, Netherlands.		Chambers, Ian/H-5416-2011; Demmers, Jeroen AA/F-4046-2016	Chambers, Ian/0000-0003-2605-1597; Demmers, Jeroen AA/0000-0002-8757-9611; van den Berg, Debbie L.C./0000-0001-6026-8808; Mullin, Nicholas/0000-0003-4802-440X; Snoek, Tim/0000-0002-5395-9034	NWO; EuTRACC consortium; Wellcome Trust; Juvenile Diabetes Research Foundation; Medical Research Council of the UK; Medical Research Council [G0700711B] Funding Source: researchfish	NWO(Netherlands Organization for Scientific Research (NWO)); EuTRACC consortium; Wellcome Trust(Wellcome TrustEuropean Commission); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Medical Research Council of the UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Erik Engelen for technical advice, Rooda Abdillahi Ibrahim for technical assistance, Nicola Festuccia for Dax1 cDNA. Drs Paul Wade and Matthias :Treir for antibodies. and Drs Austin Smith and Hitoshi Niwa for 46C and ZHBTc4 ESCs, respectively This work was supported by an NWO Vidi grant to the R A P lab, by the EuTRACC consortium, by the Wellcome Trust. by the Juvenile Diabetes Research Foundation, and by the Medical Research Council of the UK	Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Andersson T, 2009, J BIOL CHEM, V284, P3672, DOI 10.1074/jbc.M808119200; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Chambers I, 2009, DEVELOPMENT, V136, P2311, DOI 10.1242/dev.024398; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chen X, 2008, STEM CELLS, V26, P2759, DOI 10.1634/stemcells.2008-0398; deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Endoh M, 2008, DEVELOPMENT, V135, P1513, DOI 10.1242/dev.014340; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Fujiki R, 2009, NATURE, V459, P455, DOI 10.1038/nature07954; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; Issad T, 2008, TRENDS ENDOCRIN MET, V19, P380, DOI 10.1016/j.tem.2008.09.001; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kang YK, 2002, P NATL ACAD SCI USA, V99, P2642, DOI 10.1073/pnas.261715899; Kidder BL, 2009, STEM CELLS, V27, P317, DOI 10.1634/stemcells.2008-0710; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Levasseur DN, 2008, GENE DEV, V22, P575, DOI 10.1101/gad.1606308; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mo R, 2006, J BIOL CHEM, V281, P15714, DOI 10.1074/jbc.M513245200; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niakan KK, 2006, MOL GENET METAB, V88, P261, DOI 10.1016/j.ymgme.2005.12.010; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Parisi S, 2008, J CELL SCI, V121, P2629, DOI 10.1242/jcs.027599; Remenyi A, 2003, GENE DEV, V17, P2048, DOI 10.1101/gad.269303; Ren B, 2002, GENE DEV, V16, P245, DOI 10.1101/gad.949802; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Sikorski TW, 2009, CURR OPIN CELL BIOL, V21, P344, DOI 10.1016/j.ceb.2009.03.006; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taverna SD, 2007, NAT STRUCT MOL BIOL, V14, P1025, DOI 10.1038/nsmb1338; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Webster DM, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-28; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilanowski T, 2002, MECH DEVELOP, V114, P37, DOI 10.1016/S0925-4773(02)00046-1; Williams DC, 2004, J BIOL CHEM, V279, P1449, DOI 10.1074/jbc.M309790200; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yuri S, 2009, STEM CELLS, V27, P796, DOI 10.1002/stem.14; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	57	418	424	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					369	381		10.1016/j.stem.2010.02.014	http://dx.doi.org/10.1016/j.stem.2010.02.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362541	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000276823300015
J	Biernaskie, J; Paris, M; Morozova, O; Fagan, BM; Marra, M; Pevny, L; Miller, FD				Biernaskie, Jeffrey; Paris, Maryline; Morozova, Olena; Fagan, B. Matthew; Marra, Marco; Pevny, Larysa; Miller, Freda D.			SKPs Derive from Hair Follicle Precursors and Exhibit Properties of Adult Dermal Stem Cells	CELL STEM CELL			English	Article							SKIN; GROWTH; GENERATION; MOUSE; RAT; DIFFERENTIATE; IMPLANTATION; ASTROCYTES; CONTRIBUTE; INDUCTION	Despite the remarkable regenerative capacity of mammalian skin, an adult dermal stem cell has not yet been identified. Here, we investigated whether skin-derived precursors (SKPs) might fulfill such a role. We show that SKPs derive from Sox2(+) hair follicle dermal cells and that these two cell populations are similar with regard to their transcriptome and functional properties. Both clonal SKPs and endogenous Sox2(+) cells induce hair morphogenesis, differentiate into dermal cell types, and home to a hair follicle niche upon transplantation. Moreover, hair follicle-derived SKPs; self-renew, maintain their multipotency, and serially reconstitute hair follicles. Finally, grafting experiments show that follicle-associated dermal cells move out of their niche to contribute cells for dermal maintenance and wound-healing. Thus, SKPs derive from Sox2(+) follicle-associated dermal precursors and display functional properties predicted of a dermal stem cell, contributing to dermal maintenance, wound-healing, and hair follicle morphogenesis.	[Miller, Freda D.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Miller, Freda D.] Univ Toronto, Dept Physiol, Toronto, ON M5G 1X5, Canada; [Morozova, Olena; Marra, Marco] BC Canc Agcy, Genome Sci Ctr, Vancouver, BC V5Z 4S6, Canada; [Fagan, B. Matthew; Pevny, Larysa] Univ N Carolina, Dept Genet, Chapel Hill, NC 27599 USA; [Biernaskie, Jeffrey; Paris, Maryline; Miller, Freda D.] Univ Toronto, Hosp Sick Children, Dev & Stem Cell Biol Grp, Toronto, ON M5G 1X5, Canada	University of Toronto; University of Toronto; British Columbia Cancer Agency; University of North Carolina; University of North Carolina Chapel Hill; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Biernaskie, J (corresponding author), Univ Calgary, Fac Vet Med, Dept Comparat Biol & Expt Med, 3300 Hosp Dr, Calgary, AB T2N 4N1, Canada.	jeff.biernaskie@ucalgary.ca; fredam@sickkids.ca	Marra, Marco A/B-5987-2008	Marra, Marco A/0000-0001-7146-7175; Vaske, Olena/0000-0002-1677-417X; Fagan, Barry Matthew/0000-0003-2267-886X	CIHR; Canadian Stem Cell Network; HHMI; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH071822] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Stem Cell Network; HHMI(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by grants from CIHR, the Canadian Stem Cell Network, and HHMI. F.D.M. is an HHMI International Research Scholar and CRC chair-holder, and J.B. was funded by a CIHR fellowship during the course of this work. We thank Fabio Rossi (U.B.C.) for supplying MSCs, Ben Alman and Sophia Cheon (H.S.C.) for help with skin wounding assays, Akitsu Hotta and James Ellis for supplying RFP retrovirus, and Richard LeBaron (U.T.S.A.) and Pierre Coulombe (Johns Hopkins) for providing antibodies. We also thank Dennis Aquino and Sherry Zhao for valuable technical assistance.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Biernaskie JA, 2006, NAT PROTOC, V1, P2803, DOI 10.1038/nprot.2006.422; Driskell RR, 2009, DEVELOPMENT, V136, P2815, DOI 10.1242/dev.038620; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fernandes KJL, 2006, EXP NEUROL, V201, P32, DOI 10.1016/j.expneurol.2006.03.018; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; FUCHS E, 2003, EXP DERMATOL, V12, P126; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hunt DPJ, 2008, STEM CELLS, V26, P163, DOI 10.1634/stemcells.2007-0281; IBRAHIM L, 1982, J EMBRYOL EXP MORPH, V72, P209; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jahoda CAB, 2003, EXP DERMATOL, V12, P849, DOI 10.1111/j.0906-6705.2003.00161.x; Joannides A, 2004, LANCET, V364, P172, DOI 10.1016/S0140-6736(04)16630-0; Kragl M, 2009, NATURE, V460, P60, DOI 10.1038/nature08152; Lavoie JF, 2009, STEM CELLS DEV, V18, P893, DOI 10.1089/scd.2008.0260; McElwee KJ, 2003, J INVEST DERMATOL, V121, P1267, DOI 10.1111/j.1523-1747.2003.12568.x; McKenzie IA, 2006, J NEUROSCI, V26, P6651, DOI 10.1523/JNEUROSCI.1007-06.2006; MUNEOKA K, 1986, DEV BIOL, V116, P256, DOI 10.1016/0012-1606(86)90062-X; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; OLIVER RF, 1967, J EMBRYOL EXP MORPH, V18, P43; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Tobin DJ, 2003, J INVEST DERMATOL, V120, P895, DOI 10.1046/j.1523-1747.2003.12237.x; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Waters JM, 2007, SEMIN CELL DEV BIOL, V18, P245, DOI 10.1016/j.semcdb.2007.02.003; Wojciechowicz K, 2008, EXP DERMATOL, V17, P675, DOI 10.1111/j.1600-0625.2007.00689.x; Zheng Y, 2005, J INVEST DERMATOL, V124, P867, DOI 10.1111/j.0022-202X.2005.23716.x	27	254	267	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					610	623		10.1016/j.stem.2009.10.019	http://dx.doi.org/10.1016/j.stem.2009.10.019			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951689	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000273616700009
J	Merchant, AA; Matsui, W				Merchant, Akil A.; Matsui, William			Smoothening the Controversial Role of Hedgehog in Hematopoiesis	CELL STEM CELL			English	Editorial Material							STEM-CELLS; WNT; CANCER	The role of multiple developmental signaling pathways in the regulation of hematopoiesis has been controversial. In this issue of Cell Stem Cell, two separate reports (Hofmann et al., 2009; Gao et al., 2009) examine whether the Hedgehog signaling pathway modulates normal adult hematopoietic stem cells and blood formation.	[Merchant, Akil A.; Matsui, William] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Hematol Malignancies, Baltimore, MD 21231 USA	Johns Hopkins University; Johns Hopkins Medicine	Matsui, W (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Div Hematol Malignancies, Bunting Blaustein Canc Res Bldg,Room 245,1650 Orl, Baltimore, MD 21231 USA.	matsuwi@jhmi.edu	Matsui, William H/C-3383-2009	Matsui, William/0000-0002-3088-0964	NATIONAL CANCER INSTITUTE [P30CA006973, R01CA127574] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA006973, R01 CA127574] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hofmann I, 2009, CELL STEM CELL, V4, P559, DOI 10.1016/j.stem.2009.03.016; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	11	7	8	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					470	471		10.1016/j.stem.2009.05.006	http://dx.doi.org/10.1016/j.stem.2009.05.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497273	Bronze, Green Accepted			2022-12-28	WOS:000266793600004
J	Mendez-Ferrer, S; Frenette, PS				Mendez-Ferrer, Simon; Frenette, Paul S.			G alpha(s) Uncouples Hematopoietic Stem Cell Homing and Mobilization	CELL STEM CELL			English	Editorial Material							BONE-MARROW; SIGNALS	Defects of hematopoietic stem cell adhesion or migration generally lead to reduced homing to, and enhanced mobilization from, the bone marrow. In a recent publication in Nature, Adams et al. (2009) demonstrate that the guanine-nucleotide-binding stimulatory alpha subunit (G alpha(s)) can, unexpectedly, promote both phenomena.	[Mendez-Ferrer, Simon; Frenette, Paul S.] Mt Sinai Sch Med, Dept Med, New York, NY 10029 USA; [Mendez-Ferrer, Simon; Frenette, Paul S.] Mt Sinai Sch Med, Dept Gene & Cell Med, New York, NY 10029 USA; [Frenette, Paul S.] Mt Sinai Sch Med, Inst Immunol, New York, NY 10029 USA; [Frenette, Paul S.] Mt Sinai Sch Med, Tisch Canc Inst, New York, NY 10029 USA; [Frenette, Paul S.] Mt Sinai Sch Med, Black Family Stem Cell Inst, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Frenette, PS (corresponding author), Mt Sinai Sch Med, Dept Med, 1 Gustave L Levy Pl, New York, NY 10029 USA.	paul.frenette@mssm.edu	Méndez-Ferrer, Simón/ABG-8547-2020; Méndez-Ferrer, Simón/L-8088-2014; Frenette, Paul S/J-8272-2012	Méndez-Ferrer, Simón/0000-0002-9805-9988; Méndez-Ferrer, Simón/0000-0002-9805-9988; Frenette, Paul S/0000-0003-0862-9922				Adams GB, 2009, NATURE, V459, P103, DOI 10.1038/nature07859; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Hoggatt J, 2009, BLOOD, V113, P5444, DOI 10.1182/blood-2009-01-201335; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kollet O, 2001, BLOOD, V97, P3283, DOI 10.1182/blood.V97.10.3283; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Papayannopoulou T, 2003, BLOOD, V101, P4739, DOI 10.1182/blood-2002-09-2741; Papayannopoulou T, 2008, BLOOD, V111, P3923, DOI 10.1182/blood-2007-08-078147; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Weinstein LS, 2007, PHARMACOL THERAPEUT, V115, P271, DOI 10.1016/j.pharmthera.2007.03.013	10	7	8	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					379	380		10.1016/j.stem.2009.04.009	http://dx.doi.org/10.1016/j.stem.2009.04.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427288	Bronze			2022-12-28	WOS:000266071100005
J	Evans, T				Evans, Todd			Fishing for a WNT-PGE2 Link: beta-Catenin Is Caught in the Stem Cell Net-work	CELL STEM CELL			English	Editorial Material							WNT; HEMATOPOIESIS; ACTIVATION; POLYPOSIS; SULINDAC	WNT and PGE2 signaling pathways are each associated with stem cell activity in the hematopoietic system. In a recent issue of Cell, Goessling et al. (2009) use the zebrafish model to reveal a conserved PKA-dependent mechanism that connects the two pathways via beta-catenin, enhancing stem cell proliferation and tissue regeneration.	Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University	Evans, T (corresponding author), Cornell Univ, Dept Surg, Weill Cornell Med Coll, New York, NY 10021 USA.	tre2003@med.cornell.edu						Buchanan FG, 2006, CANCER CELL, V9, P6, DOI 10.1016/j.ccr.2005.12.029; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Goessling W, 2008, DEV BIOL, V320, P161, DOI 10.1016/j.ydbio.2008.05.526; Goessling W, 2009, CELL, V136, P1136, DOI 10.1016/j.cell.2009.01.015; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; WADDELL WR, 1983, J SURG ONCOL, V24, P83, DOI 10.1002/jso.2930240119	10	14	14	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					280	282		10.1016/j.stem.2009.03.006	http://dx.doi.org/10.1016/j.stem.2009.03.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341616	Bronze			2022-12-28	WOS:000265162700003
J	Koelling, S; Kruegel, J; Irmer, M; Path, JR; Sadowski, B; Miro, X; Miosgel, N				Koelling, Sebastian; Kruegel, Jenny; Irmer, Malte; Path, Jan Ragnar; Sadowski, Boguslawa; Miro, Xavier; Miosgel, Nicolai			Migratory Chondrogenic Progenitor Cells from Repair Tissue during the Later Stages of Human Osteoarthritis	CELL STEM CELL			English	Article							MESENCHYMAL STEM-CELLS; ARTICULAR-CARTILAGE; EXTRACELLULAR-MATRIX; INCREASED EXPRESSION; POTENTIAL ROLE; IN-VITRO; CHONDROCYTES; PATHOGENESIS; DIFFERENTIATION; IDENTIFICATION	The regeneration of diseased hyaline cartilage continues to be a great challenge, mainly because degeneration-caused either by major injury or by age-related processes-can overextend the tissue's self-renewal capacity. We show that repair tissue from human articular cartilage during the late stages of osteoarthritis harbors a unique progenitor cell population, termed chondrogenic progenitor cells (CPCs). These exhibit stem cell characteristics such as clonogenicity, multipotency, and migratory activity. The isolated CPCs, which exhibit a high chondrogenic potential, were shown to populate diseased tissue ex vivo. Moreover, downregulation of the osteogenic transcription factor runx-2 enhanced the expression of the chondrogenic transcription factor sox-9. This, in turn, increased the matrix synthesis potential of the CPCs without altering their migratory capacity. Our results offer new insights into the biology of progenitor cells in the context of diseased cartilage tissue. Our work may be relevant in the development of novel therapeutics for the later stages of osteoarthritis.	[Koelling, Sebastian; Kruegel, Jenny; Irmer, Malte; Path, Jan Ragnar; Sadowski, Boguslawa; Miosgel, Nicolai] Univ Gottingen, Tissue Regenerat Grp, Fac Med, Dept Prosthodont, D-37075 Gottingen, Germany; [Miro, Xavier] Max Planck Inst Biophys Chem, Dept Mol Cell Biol, D-37075 Gottingen, Germany	University of Gottingen; Max Planck Society	Miosgel, N (corresponding author), Univ Gottingen, Tissue Regenerat Grp, Fac Med, Dept Prosthodont, D-37075 Gottingen, Germany.	nmiosge@gwdg.de	Miosge, Nicolai/E-3244-2010		Deutsche Arthrose Stiftung; Medical Faculty, Goettingen University	Deutsche Arthrose Stiftung; Medical Faculty, Goettingen University	We would like to thank Mary Goldring of the Hospital for Special Surgery, New York, NY (for immortalized human fetal chondrocytes, T/C-28), and John D. Brunzell, University of Washington (for lipoprotein lipase [LPL]-specific antibody) for their kind donations; and Drs. Ennestina Schipani and Henry Kronenberg (Harvard Medical School, Boston, MA) for helpful discussion. We wish to thank Wolfgang Bocker, Ludwig-Maximilians-University, Munchen, for helping to immortalize CPCs. Proofreading of the manuscript by American Journal Experts, Durham, NC, and by Dr. David Tigwell was much appreciated, as was the professional Adobe Illustrator work by Julian Bierbaum. This work was sponsored by Deutsche Arthrose Stiftung and the Medical Faculty, Goettingen University. S.K. designed and performed the majority of experiments and analyzed the data. J.K. performed the in vitro migration and adhesion assays and the ultrastructural investigations, M.I. conducted the additional knockdown experiments, and J.R.P. is responsible for the ex vivo migration assays. B.S. performed the FACS analysis and produced the CPC clones, X.M. analyzed the microarray data, and N.M. designed the study and prepared the manuscript.	Alsalameh S, 2004, ARTHRITIS RHEUM-US, V50, P1522, DOI 10.1002/art.20269; ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Barbero A, 2003, ARTHRITIS RHEUM-US, V48, P1315, DOI 10.1002/art.10950; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Bock HC, 2001, OSTEOARTHR CARTILAGE, V9, P654, DOI 10.1053/joca.2001.0420; Buckwalter JA, 1998, AAOS INSTR COURS LEC, V47, P487; Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Cucchiarini M, 2007, ARTHRITIS RHEUM, V56, P158, DOI 10.1002/art.22299; Dell'Accio F, 2003, J ORTHOP RES, V21, P123, DOI 10.1016/S0736-0266(02)00090-6; Diaz-Romero J, 2005, J CELL PHYSIOL, V202, P731, DOI 10.1002/jcp.20164; DOCHEVA D, 2009, BIOMATERIALS; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Fickert S, 2004, ARTHRITIS RES THER, V6, pR422, DOI 10.1186/ar1210; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gersdorff N, 2005, J BIOL CHEM, V280, P22146, DOI 10.1074/jbc.M501875200; Goldring MB, 2007, J CELL PHYSIOL, V213, P626, DOI 10.1002/jcp.21258; GOLDRING MB, 1994, J CLIN INVEST, V94, P2307, DOI 10.1172/JCI117595; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; HAUSELMANN HJ, 1994, J CELL SCI, V107, P17; Hiraoka K, 2006, BIORHEOLOGY, V43, P447; Horton W. E. Jr., 2006, Journal of Musculoskeletal & Neuronal Interactions, V6, P379; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Johnstone B, 1998, EXP CELL RES, V238, P265, DOI 10.1006/excr.1997.3858; Kamekura S, 2006, ARTHRITIS RHEUM, V54, P2462, DOI 10.1002/art.22041; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kassem M, 2008, CELL TISSUE RES, V331, P157, DOI 10.1007/s00441-007-0509-0; Koelling S, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1922; Kruegel J, 2008, ARTHRITIS RHEUM-US, V58, P1422, DOI 10.1002/art.23480; KUETTNER KE, 1992, CLIN BIOCHEM, V25, P155, DOI 10.1016/0009-9120(92)90224-G; Li WJ, 2005, BIOMATERIALS, V26, P5158, DOI 10.1016/j.biomaterials.2005.01.002; Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200; Lohmander LS, 2007, LANCET, V370, P2082, DOI 10.1016/S0140-6736(07)61879-0; Mackay AM, 1998, TISSUE ENG, V4, P415, DOI 10.1089/ten.1998.4.415; Miosge N, 2004, HISTOCHEM CELL BIOL, V122, P229, DOI 10.1007/s00418-004-0697-6; Nakajima M, 2007, J BIOL CHEM, V282, P32185, DOI 10.1074/jbc.M700522200; Ponce ML, 2008, J CELL BIOCHEM, V104, P1342, DOI 10.1002/jcb.21711; Poole A. Robin, 1999, Frontiers in Bioscience, V4, pd662, DOI 10.2741/Poole; PRIDIE K H, 1955, Rheumatism, V11, P2; Pritzker KPH, 2006, OSTEOARTHR CARTILAGE, V14, P13, DOI 10.1016/j.joca.2005.07.014; Prockop DJ, 2001, CYTOTHERAPY, V3, P393, DOI 10.1080/146532401753277229; Reginster JY, 2002, RHEUMATOLOGY, V41, P3, DOI 10.1093/rheumatology/41.suppl_1.3; Sandell LJ, 2007, ARTHRITIS RHEUM, V56, P2474, DOI 10.1002/art.22760; Simon TM, 2006, SPORTS MED ARTHROSC, V14, P146, DOI 10.1097/00132585-200609000-00006; Sudo K, 2007, STEM CELLS, V25, P1610, DOI 10.1634/stemcells.2006-0504; Sunk IG, 2007, ARTHRITIS RHEUM, V56, P3685, DOI 10.1002/art.22970; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesche F, 2005, HISTOL HISTOPATHOL, V20, P329, DOI 10.14670/HH-20.329; Tuan RS, 2003, ARTHRITIS RES THER, V5, P32, DOI 10.1186/ar614; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Xu L, 2007, ARTHRITIS RHEUM, V56, P2663, DOI 10.1002/art.22761	51	268	284	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					324	335		10.1016/j.stem.2009.01.015	http://dx.doi.org/10.1016/j.stem.2009.01.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341622	Bronze, Green Submitted			2022-12-28	WOS:000265162700009
J	Steinhauser, ML; Lee, RT				Steinhauser, Matthew L.; Lee, Richard T.			Cardiovascular Regeneration: Pushing and Pulling on Progenitors	CELL STEM CELL			English	Editorial Material							CELL; THERAPY	In this issue of Cell Stem Cell, Zaruba et al. (2009) describe a pharmacoregenerative strategy for myocardial infarction. Using G-CSF to release progenitors from bone marrow and protease inhibition to prevent degradation of the homing signal, SDF-1, the authors achieve increased recruitment to the heart and improved heart function.	[Steinhauser, Matthew L.; Lee, Richard T.] Brigham & Womens Hosp, Dept Med, Div Cardiovasc, Boston, MA 02115 USA; [Steinhauser, Matthew L.; Lee, Richard T.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School		rlee@partners.org	Steinhauser, Matthew L./GVT-6393-2022	Steinhauser, Matthew L./0000-0001-5287-9246; Lee, Richard/0000-0003-4687-1381				Abdel-Latif A, 2008, AM HEART J, V156, P216, DOI 10.1016/j.ahj.2008.03.024; Belema-Bedada F, 2008, CELL STEM CELL, V2, P566, DOI 10.1016/j.stem.2008.03.003; Gallagher KA, 2007, J CLIN INVEST, V117, P1249, DOI 10.1172/JCI29710; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Segers VFM, 2007, CIRCULATION, V116, P1683, DOI 10.1161/CIRCULATIONAHA.107.718718; Sierra MD, 2004, BLOOD, V103, P2452; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Stewart S, 2001, EUR J HEART FAIL, V3, P315, DOI 10.1016/S1388-9842(00)00141-0; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013	10	9	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					277	278		10.1016/j.stem.2009.03.008	http://dx.doi.org/10.1016/j.stem.2009.03.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341614	Bronze			2022-12-28	WOS:000265162700001
J	Bleau, AM; Hambardzumyan, D; Ozawa, T; Fomchenko, EI; Huse, JT; Brennan, CW; Holland, EC				Bleau, Anne-Marie; Hambardzumyan, Dolores; Ozawa, Tatsuya; Fomchenko, Elena I.; Huse, Jason T.; Brennan, Cameron W.; Holland, Eric C.			PTEN/PI3K/Akt Pathway Regulates the Side Population Phenotype and ABCG2 Activity in Glioma Tumor Stem-like Cells	CELL STEM CELL			English	Article							MULTIDRUG-RESISTANCE; TEMOZOLOMIDE; TRANSPORTER; EXPRESSION; SURVIVAL; DISTINCT; PLASMA	In normal brain, the side population (SP) phenotype is generated by ABC transporter activity and identifies stem cell and endothelial cell subpopulations by dye exclusion. By drug efflux, the ABCG2 transporter provides chemoresistance in stem cells and contributes to the blood brain barrier (BBB) when active in endothelial cells. We investigated the SP phenotype of mouse and human gliomas. In glioma endothelial cells, ABC transporter function is impaired, corresponding to disruption of the BBB in these tumors. By contrast, the SP phenotype is increased in nonendothelial cells that form neurospheres and are highly tumorigenic. In this cell population, Akt, but not its downstream target mTOR, regulates ABCG2 activity, and loss of PTEN increases the SP. This Akt-induced ABCG2 activation results from its transport to the plasma membrane. Temozolomide, the standard treatment of gliomas, although not an ABCG2 substrate, increases the SP in glioma cells, especially in cells missing PTEN.	[Bleau, Anne-Marie; Hambardzumyan, Dolores; Ozawa, Tatsuya; Fomchenko, Elena I.; Huse, Jason T.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, New York, NY 10021 USA; [Bleau, Anne-Marie; Hambardzumyan, Dolores; Ozawa, Tatsuya; Fomchenko, Elena I.; Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Brain Tumor Ctr, New York, NY 10021 USA; [Huse, Jason T.] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Brennan, Cameron W.; Holland, Eric C.] Mem Sloan Kettering Canc Ctr, Dept Neurosurg & Surg, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Holland, EC (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Canc Biol & Genet, 1275 York Ave, New York, NY 10021 USA.	hollande@mskcc.org	Brennan, Cameron/R-7082-2019	Brennan, Cameron/0000-0003-4064-8891	NCI NIH HHS [U54 CA126518, U54 CA126518-010001, U54CA126518] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U54CA126518] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Casorelli I, 2007, DNA REPAIR, V6, P1170, DOI 10.1016/j.dnarep.2007.03.024; Chua C, 2008, J NEUROSURG, V109, P856, DOI 10.3171/JNS/2008/109/11/0856; Dai C, 2001, GENE DEV, V15, P1913, DOI 10.1101/gad.903001; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diop NK, 2005, BIOCHEMISTRY-US, V44, P5420, DOI 10.1021/bi0479858; Donnenberg VS, 2005, J CLIN PHARMACOL, V45, P872, DOI 10.1177/0091270005276905; Franklin K., 2007, MOUSE BRAIN STEREOTA; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hambardzumyan D, 2008, CELL CYCLE, V7, P1371, DOI 10.4161/cc.7.10.5954; Hambardzumyan D, 2008, GENE DEV, V22, P436, DOI 10.1101/gad.1627008; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu XY, 2005, NEOPLASIA, V7, P356, DOI 10.1593/neo.04595; Islam MO, 2005, NEUROSCI RES, V52, P75, DOI 10.1016/j.neures.2005.01.013; Kitange GJ, 2009, NEURO-ONCOLOGY, V11, P281, DOI 10.1215/15228517-2008-090; McConville P, 2007, CLIN CANCER RES, V13, P2897, DOI 10.1158/1078-0432.CCR-06-3058; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Ostermann S, 2004, CLIN CANCER RES, V10, P3728, DOI 10.1158/1078-0432.CCR-03-0807; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Provenzale JM, 2005, AM J ROENTGENOL, V185, P763, DOI 10.2214/ajr.185.3.01850763; Rabindran SK, 2000, CANCER RES, V60, P47; Regenbrecht CRA, 2008, STEM CELL REV, V4, P319, DOI 10.1007/s12015-008-9034-0; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Shih AH, 2004, CANCER RES, V64, P4783, DOI 10.1158/0008-5472.CAN-03-3831; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104	29	621	648	0	77	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					226	235		10.1016/j.stem.2009.01.007	http://dx.doi.org/10.1016/j.stem.2009.01.007			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265662	Green Accepted, Bronze			2022-12-28	WOS:000264369300013
J	Porter, RL; Calvi, LM				Porter, Rebecca L.; Calvi, Laura M.			Key Endothelial Signals Required for Hematopoietic Recovery	CELL STEM CELL			English	Editorial Material							STEM-CELL NICHE	In this issue of Cell Stem Cell, Hooper et al. (2009) use a combination of immunohistochemistry and flow cytometry to characterize the bone marrow vasculature both before and after injury. The authors demonstrate that recovery of normal hematopoiesis after myelosuppressive insult is dependent upon endothelial VEGFR2.	[Porter, Rebecca L.; Calvi, Laura M.] Univ Rochester, Sch Med, Wilmot Canc Ctr, Rochester, NY 14642 USA; [Porter, Rebecca L.; Calvi, Laura M.] Univ Rochester, Sch Med, Div Endocrine, Rochester, NY 14642 USA; [Porter, Rebecca L.; Calvi, Laura M.] Univ Rochester, Sch Med, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester; University of Rochester	Calvi, LM (corresponding author), Univ Rochester, Sch Med, Wilmot Canc Ctr, 601 Elmwood Ave,Box 693, Rochester, NY 14642 USA.	laura_calvi@urmc.rochester.edu	Calvi, Laura/P-6988-2019	Calvi, Laura/0000-0001-6969-239X	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076876, R01DK081843] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK081843, R01 DK076876-01A2] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Porter RL, 2008, ARCH BIOCHEM BIOPHYS, V473, P193, DOI 10.1016/j.abb.2008.04.001; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016	10	5	5	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					187	188		10.1016/j.stem.2009.02.005	http://dx.doi.org/10.1016/j.stem.2009.02.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265650	Bronze			2022-12-28	WOS:000264369300001
J	Ravin, R; Hoeppner, DJ; Munno, DM; Carmel, L; Sullivan, J; Levitt, DL; Miller, JL; Athaide, C; Panchision, DM; Mckay, RDG				Ravin, Rea; Hoeppner, Daniel J.; Munno, David M.; Carmel, Liran; Sullivan, Jim; Levitt, David L.; Miller, Jennifer L.; Athaide, Christopher; Panchision, David M.; Mckay, Ronald D. G.			Potency and Fate Specification in CNS Stem Cell Populations In Vitro	CELL STEM CELL			English	Article							CENTRAL-NERVOUS-SYSTEM; PROGENITOR CELLS; DIFFERENTIATION; NEURONS; PROLIFERATION; NEUROGENESIS; GLIOGENESIS; DIVISIONS; LINEAGES; REVEALS	To realize the promise of stem cell biology, it is important to identify the precise time in the history of the cell when developmental potential is restricted. To achieve this goal, we developed a real-time imaging system that captures the transitions in fate, generating neurons, astrocytes, and oligodendrocytes from single CNS stem cells in vitro. In the presence of bFGF, tripotent cells normally produce specified progenitors through a bipotent intermediate cell type. Surprisingly, the tripotent state is reset at each passage. The cytokine CNTF is thought to instruct multipotent cells to an astrocytic fate. We demonstrate that CNTF both directs astrogliogenesis from tripotent cells, bypassing two of the three normal bipotent intermediates, and later promotes the expansion of specified astrocytic progenitors. These results show how discrete cell types emerge from a multipotent cell and provide a strong basis for future studies to determine the molecular basis of fate specification.	[Ravin, Rea; Hoeppner, Daniel J.; Munno, David M.; Sullivan, Jim; Levitt, David L.; Miller, Jennifer L.; Mckay, Ronald D. G.] NINDS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA; [Carmel, Liran] Natl Lib Med, NIH, Bethesda, MD 20894 USA; [Athaide, Christopher] EYE Biomachines, Houston, TX 77005 USA; [Panchision, David M.] Childrens Natl Med Ctr, Neurosci Res Ctr, Childrens Res Inst, Washington, DC 20010 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Children's National Health System	Mckay, RDG (corresponding author), NINDS, Mol Biol Lab, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	mckay@codon.nih.gov			NIH; NINDS	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Several students contributed to the manual annotation of lineages in development of this project, including Daniel Ahmad, Kathleen Bandit, Elizabeth Baumel, Vince Beachley, Pavana Beerelli, Alissa Berliner, Sarah Gan, Brinda Gupta. Daniel Holohan, Josh Lieberman, Reut Mushkat, Christopher Nabel, Meghan Nelson, Emily Prentice, Nicole Ramsey, Jean Suh, and Sahar Zadeh. Professors Ralf Schnabel and Anja-Kristin Schulz provided a script for extracting data from SIMI'BioCell. The authors thank Kang Li and Takeo Kanade (Carnegie Mellon University) for the image stabilizer plugin to ImageJ and Wayne Rasband (NIH) for supporting ImageJ. This research was supported by the Intramural Research Program of the NIH, NINDS.	Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Blondel O, 2000, J NEUROSCI, V20, P8012; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; CATTANEO E, 1990, NATURE, V347, P762, DOI 10.1038/347762a0; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; CHENN A, 1995, CELL, V82, P631, DOI 10.1016/0092-8674(95)90035-7; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fukuda S, 2007, MOL CELL BIOL, V27, P4931, DOI 10.1128/MCB.02435-06; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Johe KK, 1996, GENE DEV, V10, P3129, DOI 10.1101/gad.10.24.3129; Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; OGAWA M, 1993, BLOOD, V81, P2844; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Panchision DM, 2007, STEM CELLS, V25, P1560, DOI 10.1634/stemcells.2006-0260; Qian XM, 2000, NEURON, V28, P69, DOI 10.1016/S0896-6273(00)00086-6; Rajan P, 1998, J NEUROSCI, V18, P3620; Schnabel R, 1997, DEV BIOL, V184, P234, DOI 10.1006/dbio.1997.8509; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Slack J. M. W, 1991, EGG EMBRYON REGIONAL; Song HJ, 2002, NAT NEUROSCI, V5, P438, DOI 10.1038/nn844; Song MR, 2004, NAT NEUROSCI, V7, P229, DOI 10.1038/nn1192; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Sun Y, 2005, NEURON, V45, P873, DOI 10.1016/j.neuron.2005.01.045; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; TILL JE, 1964, P NATL ACAD SCI USA, V51, P29, DOI 10.1073/pnas.51.1.29; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256; WEISSMAN IL, 1994, IMMUNITY, V1, P529, DOI 10.1016/1074-7613(94)90042-6	35	87	88	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					670	680		10.1016/j.stem.2008.09.012	http://dx.doi.org/10.1016/j.stem.2008.09.012			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041783	Bronze			2022-12-28	WOS:000261670900015
J	Yoshimoto, M; Porayette, P; Yoder, MC				Yoshimoto, Momoko; Porayette, Prashanth; Yoder, Mervin C.			Overcoming Obstacles in the Search for the Site of Hematopoietic Stem Cell Emergence	CELL STEM CELL			English	Review							YOLK-SAC; MOUSE EMBRYO; CIRCULATION; PROGENITORS; GENERATION; PLACENTA; REGION; ORIGIN	The murine embryo has become a valuable tool to examine the ontogeny of hematopoiesis. However, the onset of the systemic circulation has long been a confounding developmental variable that may mask the site of blood cell emergence. This Minireview examines some approaches that have been applied to overcome this obstacle.	[Yoshimoto, Momoko; Porayette, Prashanth; Yoder, Mervin C.] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Yoder, MC (corresponding author), Indiana Univ, Sch Med, Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	myoder@iupui.edu	Yoshimoto, Momoko/AFP-3523-2022; Yoshimoto, Momoko/N-4238-2014	Yoshimoto, Momoko/0000-0002-7272-6682; Yoshimoto, Momoko/0000-0002-7272-6682; Yoder, Mervin/0000-0003-4354-7631	NIH [HL063169]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL063169] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by NIH grant HL063169.	Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Emambokus NR, 2003, IMMUNITY, V19, P33, DOI 10.1016/S1074-7613(03)00173-0; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Koushik SV, 2001, FASEB J, V15, P1209, DOI 10.1096/fj.00-0696fje; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Lux CT, 2008, BLOOD, V111, P3435, DOI 10.1182/blood-2007-08-107086; Matsuoka S, 2001, BLOOD, V98, P6, DOI 10.1182/blood.V98.1.6; MOORE MAS, 1967, NATURE, V215, P1081, DOI 10.1038/2151081a0; MOORE MAS, 1970, BRIT J HAEMATOL, V18, P279, DOI 10.1111/j.1365-2141.1970.tb01443.x; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Sugiyama D, 2007, DEV BIOL, V301, P53, DOI 10.1016/j.ydbio.2006.09.042; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	20	24	24	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					583	586		10.1016/j.stem.2008.11.002	http://dx.doi.org/10.1016/j.stem.2008.11.002			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041773	Green Accepted, Bronze			2022-12-28	WOS:000261670900005
J	Zovein, AC; Hofmann, JJ; Lynch, M; French, WJ; Turlo, KA; Yang, Y; Becker, MS; Zanetta, L; Dejana, E; Gasson, JC; Tallquist, MD; Iruela-Arispe, ML				Zovein, Ann C.; Hofmann, Jennifer J.; Lynch, Maureen; French, Wendy J.; Turlo, Kirsten A.; Yang, Yanan; Becker, Michael S.; Zanetta, Lucia; Dejana, Elisabetta; Gasson, Judith C.; Tallquist, Michelle D.; Iruela-Arispe, M. Luisa			Fate Tracing Reveals the Endothelial Origin of Hematopoietic Stem Cells	CELL STEM CELL			English	Article							SMOOTH-MUSCLE-CELLS; VE-CADHERIN GENE; MOUSE EMBRYO; YOLK-SAC; DEFINITIVE HEMATOPOIESIS; SCLEROTOMAL ORIGIN; TRANSGENIC MOUSE; DORSAL AORTA; FETAL LIVER; EXPRESSION	Hematopoietic stem cells (HSCs) originate within the aortic-gonado-mesonephros (AGM) region of the midgestation embryo, but the cell type responsible for their emergence is unknown since critical hematopoietic factors are expressed in both the AGM endothelium and its underlying mesenchyme. Here we employ a temporally restricted genetic tracing strategy to selectively label the endothelium, and separately its underlying mesenchyme, during AGM development. Lineage tracing endothelium, via an inducible VE-cadherin Cre line, reveals that the endothelium is capable of HSC emergence. The endothelial progeny migrate to the fetal liver, and later to the bone marrow, and are capable of expansion, self-renewal, and multilineage hematopoietic differentiation. HSC capacity is exclusively endothelial, as ex vivo analyses demonstrate lack of VE-cadherin Cre induction in circulating and fetal liver hematopoietic populations. Moreover, AGM mesenchyme, as selectively traced via a myocardin Cre line, is incapable of hematopoiesis. Our genetic tracing strategy therefore reveals an endothelial origin of HSCs.	[Zovein, Ann C.; Becker, Michael S.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Hofmann, Jennifer J.; Turlo, Kirsten A.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Zovein, Ann C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Neonatol, Dept Pediat, Los Angeles, CA 90095 USA; [Lynch, Maureen; Gasson, Judith C.] Univ Calif Los Angeles, David Geffen Sch Med, Div Hematol Oncol, Dept Med,Dept Biol Chem, Los Angeles, CA 90095 USA; [Lynch, Maureen; Gasson, Judith C.; Iruela-Arispe, M. Luisa] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [French, Wendy J.; Tallquist, Michelle D.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Yang, Yanan] Agilent Technol, Santa Clara, CA 95051 USA; [Zanetta, Lucia; Dejana, Elisabetta] Univ Milan, FIRC Inst Mol Oncol, I-20139 Milan, Italy; [Zanetta, Lucia; Dejana, Elisabetta] Univ Milan, Dept Biomol & Biotechnol Sci, I-20139 Milan, Italy	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Texas System; University of Texas Southwestern Medical Center Dallas; Agilent Technologies; IFOM - FIRC Institute of Molecular Oncology; University of Milan; University of Milan	Iruela-Arispe, ML (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	arispe@mcdb.ucla.edu	Iruela-Arispe, M. Luisa/AAJ-1297-2020; Tallquist, Michelle/AAU-5277-2021; Zovein, Ann/L-8520-2013	Iruela-Arispe, M. Luisa/0000-0002-3050-4168; Tallquist, Michelle/0000-0002-1383-144X; Zovein, Ann/0000-0003-3298-7308; DEJANA, ELISABETTA/0000-0002-0007-0426; Becker, Michael/0000-0001-5502-7444	National Institute of Child Health and Human Development (NICHD) [K12-HD00850]; Pediatric Scientist and California Institute of Regenerative Medicine (CIRM) Fellowships [T-00005]; National Institutes of Health [HL074455, CA126935];  [AHA 0715053Y]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000850] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA126935] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085618, R01HL074455, R01HL074257] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Pediatric Scientist and California Institute of Regenerative Medicine (CIRM) Fellowships(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank Steven Smale and Carrie Miceli and the respective members of their laboratories for use of their FACSCalibur flow cytometers. We thank Liman Zhao for assistance with animal husbandry. We also thank the contribution of the Tissue Procurement Core Laboratory Shared Resource at UCLA. This work could not have been done without the generous gifts of transgenic animals from Eric Olson, Nancy Speck. and Robert Fell. This work was supported by National Institute of Child Health and Human Development (NICHD) K12-HD00850 Pediatric Scientist and California Institute of Regenerative Medicine (CIRM) Fellowships T-00005 (A.C.Z.), AHA 0715053Y Predoctoral Fellowship (J.J.H.) and National Institutes of Health (HL074455 and CA126935). Y.Y. is a paid employee of Agilent Technologies, Inc.	Alva JA, 2006, DEV DYNAM, V235, P759, DOI 10.1002/dvdy.20643; Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bollerot K, 2005, APMIS, V113, P790, DOI 10.1111/j.1600-0463.2005.apm_317.x; Breier G, 1996, BLOOD, V87, P630, DOI 10.1182/blood.V87.2.630.bloodjournal872630; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Carmeliet P, 1999, CELL, V98, P147, DOI 10.1016/S0092-8674(00)81010-7; Cumano A, 2001, IMMUNITY, V15, P477, DOI 10.1016/S1074-7613(01)00190-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Dejana E, 1999, EXP CELL RES, V252, P13, DOI 10.1006/excr.1999.4601; Delassus S, 1996, IMMUNITY, V4, P97, DOI 10.1016/S1074-7613(00)80302-7; Fraser ST, 2003, DEV GROWTH DIFFER, V45, P63; Fraser ST, 2002, EXP HEMATOL, V30, P1070, DOI 10.1016/S0301-472X(02)00887-1; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Godin I, 1999, J EXP MED, V190, P43, DOI 10.1084/jem.190.1.43; GODIN I, 1995, P NATL ACAD SCI USA, V92, P773, DOI 10.1073/pnas.92.3.773; Gory-Faure S, 1999, DEVELOPMENT, V126, P2093; Hisatsune H, 2005, BLOOD, V105, P4657, DOI 10.1182/blood-2004-09-3554; Holtwick R, 2002, P NATL ACAD SCI USA, V99, P7142, DOI 10.1073/pnas.102650499; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kim I, 2005, BLOOD, V106, P903, DOI 10.1182/blood-2004-12-4960; Kuhbandner S, 2000, GENESIS, V28, P15, DOI 10.1002/1526-968X(200009)28:1<15::AID-GENE20>3.0.CO;2-C; Li L, 1996, J CELL BIOL, V132, P849, DOI 10.1083/jcb.132.5.849; Li Z, 2006, BLOOD, V107, P106, DOI 10.1182/blood-2005-05-1955; Long XC, 2007, P NATL ACAD SCI USA, V104, P16570, DOI 10.1073/pnas.0708253104; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Monvoisin A, 2006, DEV DYNAM, V235, P3413, DOI 10.1002/dvdy.20982; Nadin BM, 2003, BLOOD, V102, P2436, DOI 10.1182/blood-2003-01-0118; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Nishikawa S, 1998, IMMUNITY, V8, P761, DOI 10.1016/S1074-7613(00)80581-6; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Pouget C, 2008, DEV BIOL, V315, P437, DOI 10.1016/j.ydbio.2007.12.045; Pouget C, 2006, DEVELOPMENT, V133, P1013, DOI 10.1242/dev.02269; Quirici N, 2001, BRIT J HAEMATOL, V115, P186, DOI 10.1046/j.1365-2141.2001.03077.x; Rampon C, 2003, INT J DEV BIOL, V47, P273; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; Samokhvalov IM, 2007, NATURE, V446, P1056, DOI 10.1038/nature05725; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Sugiyama D, 2003, BLOOD, V101, P4733, DOI 10.1182/blood-2002-09-2799; Taoudi S, 2005, DEVELOPMENT, V132, P4179, DOI 10.1242/dev.01974; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang LS, 2004, IMMUNITY, V21, P31, DOI 10.1016/j.immuni.2004.06.006; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wasteson P, 2008, DEVELOPMENT, V135, P1823, DOI 10.1242/dev.020958; Wiegreffe C, 2007, DEV DYNAM, V236, P2578, DOI 10.1002/dvdy.21279; Yokomizo T, 2007, EMBO J, V26, P184, DOI 10.1038/sj.emboj.7601480; Zhang JCL, 2001, MOL CELL BIOL, V21, P1336, DOI 10.1128/MCB.2001.21.4.1336-1344.2001	52	483	498	2	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					625	636		10.1016/j.stem.2008.09.018	http://dx.doi.org/10.1016/j.stem.2008.09.018			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041779	Green Accepted, Bronze			2022-12-28	WOS:000261670900011
J	Ema, M; Mori, D; Niwa, H; Hasegawa, Y; Yamanaka, Y; Hitoshi, S; Mimura, J; Kawabe, YI; Hosoya, T; Morita, M; Shimosato, D; Uchida, K; Suzuki, N; Yanagisawa, J; Sogawa, K; Rossant, J; Yamamoto, M; Takahashi, S; Fujii-Kuriyama, Y				Ema, Masatsugu; Mori, Daisuke; Niwa, Hitoshi; Hasegawa, Yoshikazu; Yamanaka, Yojiro; Hitoshi, Seiji; Mimura, Junsei; Kawabe, Yoh-ichi; Hosoya, Tomohiro; Morita, Masanobu; Shimosato, Daisuke; Uchida, Kazuhiko; Suzuki, Norio; Yanagisawa, Jun; Sogawa, Kazuhiro; Rossant, Janet; Yamamoto, Masayuki; Takahashi, Satoru; Fujii-Kuriyama, Yoshiaki			Kruppel-like factor 5 Is Essential for Blastocyst Development and the Normal Self-Renewal of Mouse ESCs	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; TRANSCRIPTION FACTOR; ESSENTIAL REGULATOR; DIFFERENTIATION; ACTIVATION; EXPRESSION; FIBROBLASTS; PROMOTER; EPIBLAST; KLF4	The transcription factor KIN has demonstrated activity in the reprogramming of somatic cells to a pluripotent state, but the molecular mechanism of this process remains unknown. It is, therefore, of great interest to understand the functional role of Klf4 and related genes in ESC regulation. Here, we show that homozygous disruption of Klf5 results in the failure of ESC derivation from ICM cells and early embryonic lethality due to an implantation defect. Klf5 KO ESCs show increased expression of several differentiation marker genes and frequent, spontaneous differentiation. Conversely, overexpression of Klf5 in ESCs suppressed the expression of differentiation marker genes and maintained pluripotency in the absence of LIF. Our results also suggest that Klf6 regulates ESC proliferation by promoting phosphorylation of Akt1 via induction of Tcl1. These results, therefore, provide new insights into the functional and mechanistic role of Klf5 in regulation of pluripotency.	[Ema, Masatsugu; Hasegawa, Yoshikazu; Takahashi, Satoru] Univ Tsukuba, Dept Anat & Embryol, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Uchida, Kazuhiko] Univ Tsukuba, Dept Mol Biol Oncol, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, Tsukuba, Ibaraki 3058575, Japan; [Yamamoto, Masayuki] Univ Tsukuba, JST ERATO Environm Response Project, Tsukuba, Ibaraki 3058575, Japan; [Mimura, Junsei; Hosoya, Tomohiro; Morita, Masanobu; Suzuki, Norio; Yamamoto, Masayuki; Fujii-Kuriyama, Yoshiaki] Univ Tsukuba, Tsukuba Adv Res Alliance Ctr, Tsukuba, Ibaraki 3058577, Japan; [Mori, Daisuke; Uchida, Kazuhiko] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Niwa, Hitoshi; Shimosato, Daisuke] RIKEN, Ctr Dev Biol, Lab Pluripotent Cell Studies, Chuo Ku, Kobe, Hyogo 6500047, Japan; [Yamanaka, Yojiro; Rossant, Janet] Hosp Sick Children, Dept Mol Biol Oncol, Toronto, ON M5G 1L7, Canada; [Hitoshi, Seiji] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 4448585, Japan; [Kawabe, Yoh-ichi; Yanagisawa, Jun] Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan; [Rossant, Janet] Univ Toronto, Dept Med Genet & Microbiol, Toronto, ON M5G 1X8, Canada; [Rossant, Janet] Univ Toronto, Dept Obstet & Gynecol, Toronto, ON M5G 1X8, Canada; [Fujii-Kuriyama, Yoshiaki] Japan Sci & Technol Agcy, SORST, Kawaguchi, Saitama 3320012, Japan	University of Tsukuba; University of Tsukuba; Japan Science & Technology Agency (JST); University of Tsukuba; University of Tsukuba; Tohoku University; RIKEN; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); National Institutes of Natural Sciences (NINS) - Japan; National Institute for Physiological Sciences (NIPS); University of Tsukuba; University of Toronto; University of Toronto; Japan Science & Technology Agency (JST)	Ema, M (corresponding author), Univ Tsukuba, Dept Anat & Embryol, Inst Basic Med Sci, Grad Sch Comprehens Human Sci, 1-1-1 Tennoudai, Tsukuba, Ibaraki 3058575, Japan.	masaema@md.tsukuba.ac.jp; ykfujii@tara.tsukuba.ac.jp	Yamamoto, Masayuki/A-4873-2010; Mimura, Junsei/E-7893-2013; Mori, Daisuke/M-4952-2014	Yamamoto, Masayuki/0000-0002-9073-9436; Mori, Daisuke/0000-0002-9072-2546; Ema, Masatsugu/0000-0003-0645-6183; Yamanaka, Yojiro/0000-0003-1483-8691	CREST; Japan Science Technology	CREST(Core Research for Evolutional Science and Technology (CREST)); Japan Science Technology(Japan Science & Technology Agency (JST))	We thank Drs. Satoshi Tanaka, Junko Tomizawa, Satoshi Ohtsuka, Yoshihiro Miwa, Junko Tanaka, Eiji Hara, and Noriko Gotoh for helpful discussion and reagents and Dr. Shinya Yamanaka and Masafumi Onodera for providing us with plasmids and GFP retrovirus. M.E. thanks Ms. Yuko Suzuki and Masami Ojima for technical assistance. M.E. thanks Drs. Amy Ralston and Vincent P. Kelly for critical reading of the manuscript K.U. thanks Makoto Asashima and members of CBIRI at Organ Development Research Laboratory, AIST for valuable discussion. This work was supported in part by a grant from CREST, Japan Science Technology (Y.F.-K), and a Grant-in-Aid for Scientific Research on Priority Areas (17045004, 20052008) (M.E.). M.E. and D.M. contributed equally to this work. M.E., D.M., J.M., Y.K., K.K., Y.H., K.U., and J.Y. performed biochemical and cell biological experiments. N.H. and D.S. performed blastocyst injections after LIF-free culture of Klf5-overexpressing ESCs. K.U. performed microarray analysis. D.S., T.H., M.M., and N.S. performed mouse experiments. Y.Y. contributed to confocal imaging. M.E., H.N., Y.Y., J.R., S.T., M.Y., and Y.F-K. contributed to hypothesis development, experimental design, and data interpretation. M.E. wrote the paper.	Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Basu P, 2007, BLOOD, V110, P3417, DOI 10.1182/blood-2006-11-057307; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Ema M, 2003, GENE DEV, V17, P380, DOI 10.1101/gad.1049803; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Gartel AL, 2001, P NATL ACAD SCI USA, V98, P4510, DOI 10.1073/pnas.081074898; Ghaleb AM, 2005, CELL RES, V15, P92, DOI 10.1038/sj.cr.7290271; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; IMATAKA H, 1992, EMBO J, V11, P3663, DOI 10.1002/j.1460-2075.1992.tb05451.x; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Lee JS, 2006, DEV CELL, V11, P845, DOI 10.1016/j.devcel.2006.09.006; Li Y, 2005, BLOOD, V105, P635, DOI 10.1182/blood-2004-07-2681; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; McConnell BB, 2007, BIOESSAYS, V29, P549, DOI 10.1002/bies.20581; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Oishi Y, 2008, NAT MED, V14, P656, DOI 10.1038/nm1756; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; SAUER F, 1991, NATURE, V353, P563, DOI 10.1038/353563a0; Savatier P, 1996, ONCOGENE, V12, P309; Segre JA, 1999, NAT GENET, V22, P356, DOI 10.1038/11926; Shindo T, 2002, NAT MED, V8, P856, DOI 10.1038/nm738; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; SOGAWA K, 1993, NUCLEIC ACIDS RES, V21, P1527, DOI 10.1093/nar/21.7.1527; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Suske G, 2005, GENOMICS, V85, P551, DOI 10.1016/j.ygeno.2005.01.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Watanabe S, 2006, ONCOGENE, V25, P2697, DOI 10.1038/sj.onc.1209307; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Yamanaka Y, 2006, DEV DYNAM, V235, P2301, DOI 10.1002/dvdy.20844; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang WQ, 2000, J BIOL CHEM, V275, P18391, DOI 10.1074/jbc.C000062200; Ziemer LT, 2001, MOL CELL BIOL, V21, P562, DOI 10.1128/MCB.21.2.562-574.2001	57	150	155	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					555	567		10.1016/j.stem.2008.09.003	http://dx.doi.org/10.1016/j.stem.2008.09.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983969	Bronze			2022-12-28	WOS:000260895100014
J	Chidgey, AP; Boyd, RL				Chidgey, Ann P.; Boyd, Richard L.			Immune Privilege for Stem Cells: Not as Simple as It Looked	CELL STEM CELL			English	Editorial Material							TOLERANCE	A recent paper in PNAS (Swijnenburg et al., 2008) reveals that human embryonic stem cells are not immune privileged. Potential therapeutic use of these cells will thus depend on the development of new strategies to counter foreign graft rejection by patient immune systems.	[Chidgey, Ann P.; Boyd, Richard L.] Monash Univ, Monash Immunol & Stem Cell Labs, Melbourne, Vic 3800, Australia	Monash University	Boyd, RL (corresponding author), Monash Univ, Monash Immunol & Stem Cell Labs, Level 3,Bldg 75,Wellington Rd, Melbourne, Vic 3800, Australia.	richard.boyd@med.monash.edu.au	Chidgey, Ann P/I-2737-2014	Chidgey, Ann P/0000-0001-7442-6125				Alexander SI, 2008, NEW ENGL J MED, V358, P369, DOI 10.1056/NEJMoa0707255; Chidgey AP, 2008, NATURE, V453, P330, DOI 10.1038/nature07041; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kawai T, 2008, NEW ENGL J MED, V358, P353, DOI 10.1056/NEJMoa071074; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Robertson NJ, 2007, P NATL ACAD SCI USA, V104, P20920, DOI 10.1073/pnas.0710265105; Swijnenburg RJ, 2008, P NATL ACAD SCI USA, V105, P12991, DOI 10.1073/pnas.0805802105; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395	10	19	19	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					357	358		10.1016/j.stem.2008.09.011	http://dx.doi.org/10.1016/j.stem.2008.09.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940724	Bronze			2022-12-28	WOS:000260149800002
J	English, K; French, A; Wood, KJ				English, Karen; French, Anna; Wood, Kathryn J.			Mesenchymal Stromal Cells: Facilitators of Successful Transplantation?	CELL STEM CELL			English	Review							HUMAN BONE-MARROW; SUPPRESS T-LYMPHOCYTE; UMBILICAL-CORD BLOOD; VERSUS-HOST-DISEASE; EX-VIVO CULTURE; STEM-CELLS; IFN-GAMMA; ALLOGRAFT-REJECTION; INTERFERON-GAMMA; PROGENITOR CELLS		[English, Karen; French, Anna; Wood, Kathryn J.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Transplantat Res Immunol Grp, Oxford OX3 9DU, England	University of Oxford	English, K (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Transplantat Res Immunol Grp, Oxford OX3 9DU, England.	karen.english@nds.ox.ac.uk		English, Karen/0000-0002-7932-4256	EU; European commission; MRC; Royal Society	EU(European Commission); European commission(European CommissionEuropean Commission Joint Research Centre); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society(Royal Society of London)	The authors are supported by the EU consortium grant Optistem and are members of the Oxford Stem Cell Institute. K.E. is supported by the European commission under a Marie Curie Intra-European Fellowship for Career Development. A.F. is supported by an MRC Ph.D. studentship at the Oxford Stem Cell Institute as part of the James Martin 21<SUP>st</SUP> century school. K.J.W. holds a Royal Society Wolfson Research Merit Award.	Aggarwal S, 2005, BLOOD, V105, P1815, DOI 10.1182/blood-2004-04-1559; Ankrum J, 2010, TRENDS MOL MED, V16, P203, DOI 10.1016/j.molmed.2010.02.005; Arinzeh TL, 2003, J BONE JOINT SURG AM, V85A, P1927, DOI 10.2106/00004623-200310000-00010; Asari S, 2009, EXP HEMATOL, V37, P604, DOI 10.1016/j.exphem.2009.01.005; Bartholomew A, 2002, EXP HEMATOL, V30, P42, DOI 10.1016/S0301-472X(01)00769-X; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Block GJ, 2009, STEM CELLS, V27, P670, DOI [10.1634/stemcells.stemcells.2008-0742, 10.1002/stem.20080742]; Bochev I, 2008, CELL BIOL INT, V32, P384, DOI 10.1016/j.cellbi.2007.12.007; BONAO MM, 2007, J IMMUNOL, V4, P50; Briquet A, 2010, HAEMATOL-HEMATOL J, V95, P47, DOI 10.3324/haematol.2009.008524; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Casiraghi F, 2008, J IMMUNOL, V181, P3933, DOI 10.4049/jimmunol.181.6.3933; Chan WK, 2008, EXP HEMATOL, V36, P1545, DOI 10.1016/j.exphem.2008.06.008; Chen FG, 2007, J CELL SCI, V120, P2875, DOI 10.1242/jcs.03478; Chen LW, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001886; Chen LW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007119; Christopeit M, 2008, LEUKEMIA, V22, P1062, DOI 10.1038/sj.leu.2404996; Colvin RB, 2005, NAT REV IMMUNOL, V5, P807, DOI 10.1038/nri1702; Comoli P, 2008, NEPHROL DIAL TRANSPL, V23, P1196, DOI 10.1093/ndt/gfm740; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Dai WD, 2005, CIRCULATION, V112, P214, DOI 10.1161/CIRCULATIONAHA.104.527937; DASILVA ML, 2006, J CELL SCI, V119, P2204, DOI DOI 10.1242/JCS.02932; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Ding YC, 2010, TRANSPLANTATION, V89, P270, DOI 10.1097/TP.0b013e3181c6ffbe; Ding YC, 2009, DIABETES, V58, P1797, DOI 10.2337/db09-0317; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; English K, 2009, CLIN EXP IMMUNOL, V156, P149, DOI 10.1111/j.1365-2249.2009.03874.x; English K, 2008, IMMUNOL LETT, V115, P50, DOI 10.1016/j.imlet.2007.10.002; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Francois M, 2009, BLOOD, V114, P2632, DOI 10.1182/blood-2009-02-207795; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; FRIEDENSTEIN AJ, 1970, CELL TISSUE KINET, V3, P393, DOI 10.1111/j.1365-2184.1970.tb00347.x; FRIEDENSTEIN AJ, 1976, EXP HEMATOL, V4, P267; Ge W, 2009, AM J TRANSPLANT, V9, P1760, DOI 10.1111/j.1600-6143.2009.02721.x; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Groh ME, 2005, EXP HEMATOL, V33, P928, DOI 10.1016/j.exphem.2005.05.002; HALL BM, 1978, J EXP MED, V148, P878, DOI 10.1084/jem.148.4.878; Haniffa MA, 2009, HAEMATOL-HEMATOL J, V94, P258, DOI 10.3324/haematol.13699; Harizi H, 2003, J LEUKOCYTE BIOL, V73, P756, DOI 10.1189/jlb.1002483; HAYNESWORTH SE, 1992, BONE, V13, P81, DOI 10.1016/8756-3282(92)90364-3; HAYNESWORTH SE, 1992, BONE, V13, P69, DOI 10.1016/8756-3282(92)90363-2; Hegyi B, 2010, INT IMMUNOL, V22, P551, DOI 10.1093/intimm/dxq039; Heidt S, 2010, CURR OPIN ORGAN TRAN, V15, P456, DOI 10.1097/MOT.0b013e32833b9bfb; Hoogduijn MJ, 2008, TRANSPLANTATION, V86, P1283, DOI 10.1097/TP.0b013e31818aa536; Hu XY, 2008, J THORAC CARDIOV SUR, V135, P799, DOI 10.1016/j.jtcvs.2007.07.071; Ivanova-Todorova E, 2009, IMMUNOL LETT, V126, P37, DOI 10.1016/j.imlet.2009.07.010; Jiang XX, 2005, BLOOD, V105, P4120, DOI 10.1182/blood-2004-02-0586; Karlsson H, 2008, BLOOD, V112, P532, DOI 10.1182/blood-2007-10-119370; Karp JM, 2009, CELL STEM CELL, V4, P206, DOI 10.1016/j.stem.2009.02.001; Kebriaei P, 2009, BIOL BLOOD MARROW TR, V15, P804, DOI 10.1016/j.bbmt.2008.03.012; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Koc ON, 2002, BONE MARROW TRANSPL, V30, P215, DOI 10.1038/sj.bmt.1703650; Kogler G, 2005, EXP HEMATOL, V33, P573, DOI 10.1016/j.exphem.2005.01.012; Kong QF, 2009, J NEUROIMMUNOL, V207, P83, DOI 10.1016/j.jneuroim.2008.12.005; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Kuo YR, 2009, TRANSPLANTATION, V87, P1769, DOI 10.1097/TP.0b013e3181a664f1; LaRosa DF, 2007, J IMMUNOL, V178, P7503, DOI 10.4049/jimmunol.178.12.7503; LAZARUS HM, 1995, BONE MARROW TRANSPL, V16, P557; Lazarus HM, 2005, BIOL BLOOD MARROW TR, V11, P389, DOI 10.1016/j.bbmt.2005.02.001; Le Blanc K, 2004, LANCET, V363, P1439, DOI 10.1016/S0140-6736(04)16104-7; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Li H, 2008, STEM CELLS, V26, P2531, DOI 10.1634/stemcells.2008-0146; Li YP, 2008, J IMMUNOL, V180, P1598, DOI 10.4049/jimmunol.180.3.1598; Long E, 2009, TRANSPLANTATION, V88, P1050, DOI 10.1097/TP.0b013e3181bb7913; Lu CL, 2010, BLOOD, V115, P221, DOI 10.1182/blood-2009-06-228494; MacMillan ML, 2009, BONE MARROW TRANSPL, V43, P447, DOI 10.1038/bmt.2008.348; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2003, NEUROSURGERY, V53, P702; McQuibban GA, 2002, BLOOD, V100, P1160, DOI 10.1182/blood.V100.4.1160.h81602001160_1160_1167; Mills C., 2009, OSIRIS THERAPEUTICS; Lopez MM, 2006, TRANSPL IMMUNOL, V17, P31, DOI 10.1016/j.trim.2006.09.018; Miura M, 2006, STEM CELLS, V24, P1095, DOI 10.1634/stemcells.2005-0403; Muraglia A, 2000, J CELL SCI, V113, P1161; Murphy JM, 2003, ARTHRITIS RHEUM-US, V48, P3464, DOI 10.1002/art.11365; Murphy KM, 2010, NAT IMMUNOL, V11, P674, DOI 10.1038/ni.1899; Nadig SN, 2010, NAT MED, V16, P809, DOI 10.1038/nm.2154; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; Nauta AJ, 2006, BLOOD, V108, P2114, DOI 10.1182/blood-2005-11-011650; Nauta AJ, 2006, J IMMUNOL, V177, P2080, DOI 10.4049/jimmunol.177.4.2080; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; OWEN M, 1988, J CELL SCI, P63; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Potian JA, 2003, J IMMUNOL, V171, P3426, DOI 10.4049/jimmunol.171.7.3426; Prigione I, 2009, STEM CELLS, V27, P693, DOI 10.1634/stemcells.2008-0687; Prockop DJ, 2009, MOL THER, V17, P939, DOI 10.1038/mt.2009.62; Rafei M, 2009, J IMMUNOL, V182, P5994, DOI 10.4049/jimmunol.0803962; Rafei M, 2008, BLOOD, V112, P4991, DOI 10.1182/blood-2008-07-166892; Ramasamy R, 2008, CELL IMMUNOL, V251, P131, DOI 10.1016/j.cellimm.2008.04.009; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Romieu-Mourez R, 2009, J IMMUNOL, V182, P7963, DOI 10.4049/jimmunol.0803864; Rosova I, 2008, STEM CELLS, V26, P2173, DOI 10.1634/stemcells.2007-1104; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Sato K, 2007, BLOOD, V109, P228, DOI 10.1182/blood-2006-02-002246; Sbano P, 2008, ARCH DERMATOL RES, V300, P115, DOI 10.1007/s00403-007-0827-9; Selmani Z, 2008, STEM CELLS, V26, P212, DOI 10.1634/stemcells.2007-0554; Sheng HM, 2008, CELL RES, V18, P846, DOI 10.1038/cr.2008.80; SHOSKES DA, 1994, IMMUNOL TODAY, V15, P32, DOI 10.1016/0167-5699(94)90023-X; Spaeth EL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004992; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spaggiari GM, 2009, BLOOD, V113, P6576, DOI 10.1182/blood-2009-02-203943; Stagg J, 2006, BLOOD, V107, P2570, DOI 10.1182/blood-2005-07-2793; Togel F, 2005, AM J PHYSIOL-RENAL, V289, pF31, DOI 10.1152/ajprenal.00007.2005; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wagner W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002213; Wan C, 2006, J ORTHOP RES, V24, P29, DOI 10.1002/jor.20010; Wehner R, 2009, HAEMATOL-HEMATOL J, V94, P1151, DOI 10.3324/haematol.2008.001735; Wood KJ, 2003, NAT REV IMMUNOL, V3, P199, DOI 10.1038/nri1027; Xu GW, 2009, STEM CELLS, V27, P942, DOI 10.1002/stem.22; Yoo KH, 2009, CELL IMMUNOL, V259, P150, DOI 10.1016/j.cellimm.2009.06.010; Zhang B, 2009, BLOOD, V113, P46, DOI 10.1182/blood-2008-04-154138; Zhang W, 2004, STEM CELLS DEV, V13, P263, DOI 10.1089/154732804323099190	119	246	260	1	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					431	442		10.1016/j.stem.2010.09.009	http://dx.doi.org/10.1016/j.stem.2010.09.009			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887949	Bronze, Green Accepted			2022-12-28	WOS:000283270600007
J	Yang, JA; van Oosten, AL; Theunissen, TW; Guo, G; Silva, JCR; Smith, A				Yang, Jian; van Oosten, Anouk L.; Theunissen, Thorold W.; Guo, Ge; Silva, Jose C. R.; Smith, Austin			Stat3 Activation Is Limiting for Reprogramming to Ground State Pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; EPIBLAST; DIFFERENTIATION; DERIVATION; INHIBITION; MAINTAINS; ROLES; NANOG; LINES	The cytokine leukemia inhibitory factor (Lif) sustains self-renewal of mouse embryonic and induced pluripotent stem cells by activating Jak kinase and the transcription factor Stat3. Here we investigate whether Jak/Stat3 may also contribute to induction of pluripotency. EpiSCs derived from postimplantation embryos express low levels of Lif receptor and Stat3. We introduced into EpiSCs a Jak/Stat3 activating receptor (GY118F) responsive to granulocyte colony stimulating factor (Gcsf). On transfer to ground state culture, in which MAPK signaling and glycogen synthase kinase are inhibited, Gcsf induced transcriptional resetting and functional reprogramming. Activation of a tamoxifen-regulatable fusion, Stat3ER(T2), also converted EpiSCs into chimera-competent iPSCs. We exploited GY118F to increase Jak/Stat3 activity during somatic cell reprogramming. Incompletely reprogrammed cells derived from neural stem cells or fibroblasts responded to Gcsf with elevated frequencies of progression to ground state pluripotency. These findings indicate that Jak/Stat3 participate directly in molecular reprogramming and that activation of this pathway is a limiting component.	[Yang, Jian; van Oosten, Anouk L.; Theunissen, Thorold W.; Guo, Ge; Silva, Jose C. R.; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Yang, Jian; van Oosten, Anouk L.; Theunissen, Thorold W.; Guo, Ge; Silva, Jose C. R.; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England	University of Cambridge; University of Cambridge	Smith, A (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	austin.smith@cscr.cam.ac.uk	Silva, Jose/G-1920-2014; Silva, Jose C R/X-5140-2019	Silva, Jose/0000-0001-5487-1117; Silva, Jose C R/0000-0001-5487-1117; Theunissen, Thorold/0000-0001-6943-7858; Smith, Austin/0000-0002-3029-4682	European Commission; Biotechnology and Biological Sciences Research Council; Medical Research Council; MRC [G0700665, G0800784] Funding Source: UKRI; Medical Research Council [G0300723B, G19/38, G0800784, G0800784B, G0700665] Funding Source: researchfish	European Commission(European CommissionEuropean Commission Joint Research Centre); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Jason Wray for comments on the manuscript and preparation of Gcsf. We are grateful to Jenny Nichols for EpiSCs, Rachel Walker for flow cytometry, Peter Humphreys for imaging, Bill Mansfield for chimera production, and Samuel Jameson and staff for mouse husbandry. Recombinant proteins were provided by Marko Hyvonen. We thank Pierre Savatier for generously providing the Stat3ER<SUP>T2</SUP> construct and Toshio Kitamura for Plat-E cells. This study was supported by the European Commission projects ESTOOLs and EuroSyStem, the Biotechnology and Biological Sciences Research Council, and the Medical Research Council. T.W.T. is a Wellcome Trust PhD Fellow, J.C.R.S. is a Wellcome Trust Career Development Fellow, and A.S. is a Medical Research Council Professor. Author contributions: J.Y. performed and analyzed EpiSC reprogramming experiments, T.W.T. and A.L.v.O. carried out somatic cell reprogramming supervised by J.C.R.S., G.G. provided constructs and advice, and A.S. designed the study and wrote the paper.	Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Batlle-Morera L, 2008, GENESIS, V46, P758, DOI 10.1002/dvg.20442; Bourillot PY, 2009, STEM CELLS, V27, P1760, DOI 10.1002/stem.110; BRADLEY A, 1984, NATURE, V309, P255, DOI 10.1038/309255a0; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Brook FA, 1997, P NATL ACAD SCI USA, V94, P5709, DOI 10.1073/pnas.94.11.5709; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Burdon T, 1999, CELLS TISSUES ORGANS, V165, P131, DOI 10.1159/000016693; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Dawson MR, 2009, NATURE, V461, pE4, DOI 10.1038/nature08254; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Greber B, 2010, CELL STEM CELL, V6, P215, DOI 10.1016/j.stem.2010.01.003; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hayashi K, 2009, DEVELOPMENT, V136, P3549, DOI 10.1242/dev.037747; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Matsuda T, 1999, EMBO J, V18, P4261, DOI 10.1093/emboj/18.15.4261; Nichols J, 2001, DEVELOPMENT, V128, P2333; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Peitz M, 2002, P NATL ACAD SCI USA, V99, P4489, DOI 10.1073/pnas.032068699; Schmitz J, 2000, J BIOL CHEM, V275, P12848, DOI 10.1074/jbc.275.17.12848; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Silva N, 2008, REVSTAT-STAT J, V6, P253; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	35	175	182	1	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					319	328		10.1016/j.stem.2010.06.022	http://dx.doi.org/10.1016/j.stem.2010.06.022			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804969	Green Published, hybrid			2022-12-28	WOS:000282037800009
J	Newman, AM; Cooper, JB				Newman, Aaron M.; Cooper, James B.			Lab-Specific Gene Expression Signatures in Pluripotent Stem Cells	CELL STEM CELL			English	Article							DIFFERENTIATION; EFFICIENCY	Pluripotent stem cells derived from both embryonic and reprogrammed somatic cells have significant potential for human regenerative medicine. Despite similarities in developmental potential, however, several groups have found fundamental differences between embryonic stem cell (ESC) and induced-pluripotent stem cell (iPSC) lines that may have important implications for iPSC-based medical therapies. Using an unsupervised clustering algorithm, we further studied the genetic homogeneity of iPSC and ESC lines by reanalyzing microarray gene expression data from seven different laboratories. Unexpectedly, this analysis revealed a strong correlation between gene expression signatures and specific laboratories in both ESC and iPSC lines. Nearly one-third of the genes with lab-specific expression signatures are also differentially expressed between ESCs and iPSCs. These data are consistent with the hypothesis that in vitro microenvironmental context differentially impacts the gene expression signatures of both iPSCs and ESCs.	[Newman, Aaron M.; Cooper, James B.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA; [Cooper, James B.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Cooper, JB (corresponding author), Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA.	jcooper@lifesci.ucsb.edu	Newman, Aaron M/ABE-1620-2021	Newman, Aaron M/0000-0002-1857-8172	University of California at Santa Barbara	University of California at Santa Barbara	We are grateful to the University of California at Santa Barbara for a Graduate Dissertation Fellowship awarded to A.M.N. and for an anonymous private gift that supported this work.	Allegrucci C, 2007, HUM REPROD UPDATE, V13, P103, DOI 10.1093/humupd/dml041; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Csete M, 2005, ANN NY ACAD SCI, V1049, P1, DOI 10.1196/annals.1334.001; Dolgin E, 2010, NATURE, V464, P663, DOI 10.1038/464663a; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Han JY, 2010, NATURE, V463, P1096, DOI 10.1038/nature08735; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hu BY, 2010, P NATL ACAD SCI USA, V107, P4335, DOI 10.1073/pnas.0910012107; Kim D, 2009, CELL STEM CELL, V4, P472, DOI 10.1016/j.stem.2009.05.005; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Masaki H, 2008, STEM CELL RES, V1, P105, DOI 10.1016/j.scr.2008.01.001; Newman AM, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-117; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tavakoli T, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-44; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002	23	165	168	1	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					258	262		10.1016/j.stem.2010.06.016	http://dx.doi.org/10.1016/j.stem.2010.06.016			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682451	Bronze			2022-12-28	WOS:000281107400017
J	Cherry, CM; Matunis, EL				Cherry, Christopher M.; Matunis, Erika L.			Epigenetic Regulation of Stem Cell Maintenance in the Drosophila Testis via the Nucleosome-Remodeling Factor NURF	CELL STEM CELL			English	Article							SELF-RENEWAL; JAK/STAT PATHWAY; CHROMATIN-STRUCTURE; BAM TRANSCRIPTION; GENE-EXPRESSION; GERM-CELLS; IN-VIVO; PROTEIN; DIFFERENTIATION; NICHE	Regulation of stem cells depends on both tissue-specific transcriptional regulators and changes in chromatin organization, yet the coordination of these events in endogenous niches is poorly understood. In the Drosophila testis, local JAK-STAT signaling maintains germline and somatic stem cells (GSCs and cyst progenitor cells, or CPCs) in a single niche. Here we show that epigenetic regulation via the nucleosome-remodeling factor (NURF) complex ensures GSC and CPC maintenance by positively regulating JAK-STAT signaling, thereby preventing premature differentiation. Conversely, NURF is not required in early differentiating daughter cells of either lineage. Because three additional ATP-dependent chromatin remodelers (ACF, CHRAC, and dMi-2/NuRD) are dispensable for stem cell maintenance in the testis, epigenetic regulation of stem cells within this niche may rely primarily on NURF. Thus, local signals cooperate with specific chromatin-remodeling complexes in intact niches to coordinately regulate a common set of target genes to prevent premature stem cell differentiation.	[Cherry, Christopher M.; Matunis, Erika L.] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21205 USA	Johns Hopkins University	Matunis, EL (corresponding author), Johns Hopkins Univ, Sch Med, Dept Cell Biol, 725 N Wolfe St, Baltimore, MD 21205 USA.	matunis@jhmi.edu			NIH [HD052937, HD040307-07]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD040307, R01HD052937] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank our colleagues who have generously supplied us with reagents, Dr. K. Hohenstein for the initial characterization of nurf301 mutant larval gonads, and Dr. M. de Cuevas and M. lssigonis for comments on the manuscript. This work was supported by NIH grants HD052937 and HD040307-07 (E.L.M.).	Arbouzova NI, 2006, CURR BIOL, V16, P80, DOI 10.1016/j.cub.2005.11.033; Arney KL, 2004, J CELL SCI, V117, P4355, DOI 10.1242/jcs.01390; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bernstein BE, 2005, CELL, V120, P169, DOI 10.1016/j.cell.2005.01.001; Bouazoune K, 2006, CHROMOSOME RES, V14, P433, DOI 10.1007/s10577-006-1067-0; Buaas FW, 2004, NAT GENET, V36, P647, DOI 10.1038/ng1366; Buszczak M, 2007, GENETICS, V175, P1505, DOI 10.1534/genetics.106.065961; Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen HW, 2002, GENE DEV, V16, P388, DOI 10.1101/gad.955202; Chen X, 2005, SCIENCE, V310, P869, DOI 10.1126/science.1118101; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Elfring LK, 1998, GENETICS, V148, P251; Flaherty MS, 2010, DEV CELL, V18, P556, DOI 10.1016/j.devcel.2010.02.006; Francastel C, 2000, NAT REV MOL CELL BIO, V1, P137, DOI 10.1038/35040083; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Gregory L, 2008, SEMIN CELL DEV BIOL, V19, P407, DOI 10.1016/j.semcdb.2008.06.003; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Karsten P, 2002, MECH DEVELOP, V117, P343, DOI 10.1016/S0925-4773(02)00216-2; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kehle J, 1998, SCIENCE, V282, P1897, DOI 10.1126/science.282.5395.1897; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Kwon SY, 2008, DEV BIOL, V316, P538, DOI 10.1016/j.ydbio.2008.01.033; Kwon SY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000574; Landry J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000241; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Loden M, 2005, CHROMOSOME RES, V13, P289, DOI 10.1007/s10577-005-2166-z; Matunis E, 1997, DEVELOPMENT, V124, P4383; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Silver DL, 2005, DEVELOPMENT, V132, P3483, DOI 10.1242/dev.01910; Terry NA, 2006, DEV BIOL, V294, P246, DOI 10.1016/j.ydbio.2006.02.048; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Van Doren M, 1998, CURR BIOL, V8, P243; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Yamasaki Y, 2006, DEV GROWTH DIFFER, V48, P411, DOI 10.1111/j.1440-169x.2006.00880.x	53	50	51	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					557	567		10.1016/j.stem.2010.04.018	http://dx.doi.org/10.1016/j.stem.2010.04.018			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569693	Green Accepted, Bronze			2022-12-28	WOS:000278840700016
J	Greber, B; Wu, GM; Bernemann, C; Joo, JY; Han, DW; Ko, K; Tapia, N; Sabour, D; Sterneckert, J; Tesar, P; Scholer, HR				Greber, Boris; Wu, Guangming; Bernemann, Christof; Joo, Jin Young; Han, Dong Wook; Ko, Kinarm; Tapia, Natalia; Sabour, Davood; Sterneckert, Jared; Tesar, Paul; Schoeler, Hans R.			Conserved and Divergent Roles of FGF Signaling in Mouse Epiblast Stem Cells and Human Embryonic Stem Cells	CELL STEM CELL			English	Article							FEEDER-FREE GROWTH; HUMAN ES CELLS; SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; MAINTAINS PLURIPOTENCY; DEFINED CONDITIONS; HUMAN BLASTOCYSTS; WNT/BETA-CATENIN; RNA INTERFERENCE; FATE DECISIONS	Mouse epiblast stem cells (EpiSCs) are cultured with FGF2 and Activin A, like human embryonic stem cells (hESCs), but the action of the associated pathways in EpiSCs has not been well characterized. Here, we show that activation of the Activin pathway promotes self-renewal of EpiSCs via direct activation of Nanog, whereas inhibition of this pathway induces neuroectodermal differentiation, like in hESCs. In contrast, the different roles of FGF signaling appear to be only partially conserved in the mouse. Our data suggest that FGF2 fails to cooperate with SMAD2/3 signaling in actively promoting EpiSC self-renewal through Nanog, in contrast to its role in hESCs. Rather, FGF appears to stabilize the epiblast state by dual inhibition of differentiation to neuroectoderm and of media-induced reversion to a mouse embryonic stem cell-like state. Our data extend the current model of cell fate decisions concerning EpiSCs by clarifying the distinct roles played by FGF signaling.	[Greber, Boris; Wu, Guangming; Bernemann, Christof; Joo, Jin Young; Han, Dong Wook; Ko, Kinarm; Tapia, Natalia; Sabour, Davood; Sterneckert, Jared; Schoeler, Hans R.] Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, D-48149 Munster, Germany; [Tesar, Paul] Case Western Reserve Univ, Dept Genet, Ctr Stem Cell & Regenerat Med, Sch Med, Cleveland, OH 44106 USA; [Schoeler, Hans R.] Univ Munster, Fac Med, D-48149 Munster, Germany	Max Planck Society; Case Western Reserve University; University of Munster	Scholer, HR (corresponding author), Max Planck Inst Mol Biomed, Dept Cell & Dev Biol, Rontgenstr 20, D-48149 Munster, Germany.	office@mpi-muenster.mpg.de	Tesar, Paul J/C-9848-2014; Sterneckert, Jared/E-6802-2015; Tesar, Paul/GPK-5942-2022; Han, Dong Wook/D-6041-2011; , HS/AAB-4434-2019; Tapia, Natalia/H-5500-2012	Tesar, Paul J/0000-0003-1532-3155; Tesar, Paul/0000-0003-1532-3155; , HS/0000-0003-2643-5136; Greber, Boris/0000-0002-9404-7293; Sterneckert, Jared/0000-0002-7688-3124; Tapia, Natalia/0000-0003-0226-1952; Wu, Guangming/0000-0003-1923-7609	Max Planck Society; German Federal Ministry of Education and Research BMBF [01GN0934]	Max Planck Society(Max Planck Society); German Federal Ministry of Education and Research BMBF(Federal Ministry of Education & Research (BMBF))	We thank Sandra Heising, Martina BleidiBel, Philipp Trepte, and Barbel Schafer for technical assistance, as well as Rebekka Schneider, University Hospital Aachen, for help with the teratoma analysis. This work was supported by the Max Planck Society and partly funded by a grant of the German Federal Ministry of Education and Research BMBF (01GN0934).	Adjaye J, 2005, STEM CELLS, V23, P1514, DOI 10.1634/stemcells.2005-0113; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Bao SQ, 2009, NATURE, V461, P1292, DOI 10.1038/nature08534; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CHAN KK, 2001, STEM CELLS, V27, P2114; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Furue MK, 2008, P NATL ACAD SCI USA, V105, P13409, DOI 10.1073/pnas.0806136105; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Greber B, 2008, STEM CELLS DEV, V17, P1065, DOI 10.1089/scd.2008.0035; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hall J, 2009, CELL STEM CELL, V5, P597, DOI 10.1016/j.stem.2009.11.003; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Larsen WJ, 2001, HUMAN EMBRYOLOGY, V3; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagy A., 2003, MANIPULATING MOUSE E; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; Pelton TA, 2002, J CELL SCI, V115, P329; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Wang XF, 2009, J BIOL CHEM, V284, P34054, DOI 10.1074/jbc.M109.052290; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yeom YI, 1996, DEVELOPMENT, V122, P881; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Yoshimizu T, 1999, DEV GROWTH DIFFER, V41, P675; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	58	259	273	0	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					215	226		10.1016/j.stem.2010.01.003	http://dx.doi.org/10.1016/j.stem.2010.01.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207225	Bronze			2022-12-28	WOS:000276254600009
J	Yamashita, YM				Yamashita, Yukiko M.			A New Member of the Spindle Orientation Club: Mammalian Intestinal Stem Cells	CELL STEM CELL			English	Editorial Material							IN-VITRO; INHERITANCE; CENTROSOME; LGR5	Mitotic spindles are stereotypically oriented in many stem cells, often leading to asymmetric outcomes of stem cell division. In this issue of Cell Stem Cell, Nathke and colleagues (Quyn et al., 2010) report that mammalian intestinal stem cells exhibit an oriented spindle and asymmetry during division.	Univ Michigan, Dept Cell & Dev Biol, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Yamashita, YM (corresponding author), Univ Michigan, Dept Cell & Dev Biol, Ctr Stem Cell Biol, Inst Life Sci, Ann Arbor, MI 48109 USA.	yukikomy@umich.edu		Yamashita, Yukiko/0000-0001-5541-0216				Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Farkas LM, 2008, CURR OPIN CELL BIOL, V20, P707, DOI 10.1016/j.ceb.2008.09.008; Potten CS, 2002, J CELL SCI, V115, P2381; Quyn AJ, 2010, CELL STEM CELL, V6, P175, DOI 10.1016/j.stem.2009.12.007; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	10	3	3	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					91	92		10.1016/j.stem.2010.01.009	http://dx.doi.org/10.1016/j.stem.2010.01.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144779	Bronze			2022-12-28	WOS:000274520800001
J	Sun, BG; Halabisky, B; Zhou, YG; Palop, JJ; Yu, GQ; Mucke, L; Gan, L				Sun, Binggui; Halabisky, Brian; Zhou, Yungui; Palop, Jorge J.; Yu, Guiqiu; Mucke, Lennart; Gan, Li			Imbalance between GABAergic and Glutamatergic Transmission Impairs Adult Neurogenesis in an Animal Model of Alzheimer's Disease	CELL STEM CELL			English	Article							NEWLY GENERATED NEURONS; ENHANCED SYNAPTIC PLASTICITY; HIPPOCAMPAL NEUROGENESIS; AMYLOID-BETA; TRANSGENIC MICE; DENTATE GYRUS; MOUSE MODEL; MEMORY; BRAIN; INTEGRATION	Adult neurogenesis regulates plasticity and function in the hippocampus, which is critical for memory and vulnerable to Alzheimer's disease (AD). Promoting neurogenesis may improve hippocampal function in AD brains. However, how amyloid 0 (AD), the key AD pathogen, affects the development and function of adult-born neurons remains unknown. Adult-born granule cells (GCs) in human amyloid precursor protein (hAPP) transgenic mice, an AD model, showed greater dendritic length, spine density, and functional responses than did controls early in development, but were impaired morphologically and functionally during later maturation. Early inhibition of GABA(A) receptors to suppress GABAergic signaling or late inhibition of calcineurin to enhance glutamatergic signaling normalized the development of adult-born GCs in hAPP mice with high A beta levels. A beta-induced increases in GABAergic neurotransmission or an imbalance between GABAergic and glutamatergic neurotransmission may contribute to impaired neurogenesis in AD.	[Sun, Binggui; Halabisky, Brian; Zhou, Yungui; Palop, Jorge J.; Yu, Guiqiu; Mucke, Lennart; Gan, Li] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Sun, Binggui; Halabisky, Brian; Palop, Jorge J.; Mucke, Lennart; Gan, Li] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco	Gan, L (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.	lgan@gladstone.ucsf.edu	Sun, Binggui/J-9028-2016; Palop, Jorge J./D-8128-2011; Sun, Binggui/B-2739-2010; Palop, Jorge/AAH-9014-2020	Sun, Binggui/0000-0002-0386-6569; Palop, Jorge/0000-0001-6086-1070	Whittier Foundation; NIH [AG022074, NS041787]; NIH/NCRR [C06 RRO18928]; Elan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041787] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG022074, P01AG004342] Funding Source: NIH RePORTER	Whittier Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Elan; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Chunmei Zhao, Xinyu Zhao, and Fred Gage for the CAG-EGFP retroviral vector, Sarah Mueller-Steiner for viral preparations, Robert W. Mahley and Anatol Kreitzer for insightful discussions, Xin Wang for excellent technical support, Stephen Ordway and Gary Howard for editorial review, and Kelley Nelson for administrative assistance. This work was supported in part by a grant from Whittier Foundation (to L.G.), NIH grants AG022074 and NS041787 (to L.M.), and NIH/NCRR C06 RRO18928 (a facility grant to the J. David Gladstone Institutes). L.G. has received research funding from Elan. L.M. consults for Merck, has received research funding from Elan, and serves on the scientific board of iPierian.	AGHAJANIAN GK, 1989, SYNAPSE, V3, P331, DOI 10.1002/syn.890030406; ALTMAN J, 1965, J COMP NEUROL, V124, P319, DOI 10.1002/cne.901240303; Ben-Ari Y, 2002, NAT REV NEUROSCI, V3, P728, DOI 10.1038/nrn920; Boekhoorn K, 2006, NEUROBIOL DIS, V24, P1, DOI 10.1016/j.nbd.2006.04.017; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Dineley KT, 2007, NEUROBIOL LEARN MEM, V88, P217, DOI 10.1016/j.nlm.2007.03.010; Donovan MH, 2006, J COMP NEUROL, V495, P70, DOI 10.1002/cne.20840; Duan X, 2007, CELL, V130, P1146, DOI 10.1016/j.cell.2007.07.010; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fernandez F, 2007, NAT NEUROSCI, V10, P411, DOI 10.1038/nn1860; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Gan L, 2008, NEUROBIOL DIS, V29, P71, DOI 10.1016/j.nbd.2007.08.002; Ganguly K, 2001, CELL, V105, P521, DOI 10.1016/S0092-8674(01)00341-5; Ge SY, 2008, J PHYSIOL-LONDON, V586, P3759, DOI 10.1113/jphysiol.2008.155655; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Haughey NJ, 2002, J NEUROCHEM, V83, P1509, DOI 10.1046/j.1471-4159.2002.01267.x; Hsieh H, 2006, NEURON, V52, P831, DOI 10.1016/j.neuron.2006.10.035; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Jin KL, 2004, P NATL ACAD SCI USA, V101, P13363, DOI 10.1073/pnas.0403678101; Jin KL, 2004, P NATL ACAD SCI USA, V101, P343, DOI 10.1073/pnas.2634794100; JohnsonWood K, 1997, P NATL ACAD SCI USA, V94, P1550, DOI 10.1073/pnas.94.4.1550; Li B, 2008, J NEUROPATH EXP NEUR, V67, P78, DOI 10.1097/nen.0b013e318160c5db; Lopez-Toledano MA, 2007, J ALZHEIMERS DIS, V12, P229; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; Moolman DL, 2004, J NEUROCYTOL, V33, P377, DOI 10.1023/B:NEUR.0000044197.83514.64; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Mueller-Steiner S, 2006, NEURON, V51, P703, DOI 10.1016/j.neuron.2006.07.027; Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919; Palop JJ, 2007, NEURON, V55, P697, DOI 10.1016/j.neuron.2007.07.025; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Snyder EM, 2005, NAT NEUROSCI, V8, P1051, DOI 10.1038/nn1503; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Taglialatela G, 2009, BEHAV BRAIN RES, V200, P95, DOI 10.1016/j.bbr.2008.12.034; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Tashiro A, 2006, NAT PROTOC, V1, P3049, DOI 10.1038/nprot.2006.473; Tashiro A, 2006, NATURE, V442, P929, DOI 10.1038/nature05028; Tozuka Y, 2005, NEURON, V47, P803, DOI 10.1016/j.neuron.2005.08.023; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Verret L, 2007, PSYCHONEUROENDOCRINO, V32, pS26, DOI 10.1016/j.psyneuen.2007.04.014; Yoshiike Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003029; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006	51	146	150	0	18	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					624	633		10.1016/j.stem.2009.10.003	http://dx.doi.org/10.1016/j.stem.2009.10.003			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951690	Green Accepted, Bronze			2022-12-28	WOS:000273616700010
J	Fox, DT; Spradling, AC				Fox, Donald T.; Spradling, Allan C.			The Drosophila Hindgut Lacks Constitutively Active Adult Stem Cells but Proliferates in Response to Tissue Damage	CELL STEM CELL			English	Article							BETA-CELLS; REGENERATION; REPOPULATION; MELANOGASTER; MAINTENANCE; GENERATION; EPITHELIUM; PANCREAS; ABLATION; BEHAVIOR	The adult Drosophila hindgut was recently reported to contain active, tissue-replenishing stem cells, like those of the midgut, but located within an anterior ring so as to comprise a single giant crypt. In contrast to this view, we observed no active stem cells and little cell turnover in adult hindgut tissue based on clonal marking and BrdU incorporation studies. Again contradicting the previous proposal, we showed that the adult hindgut is not generated by anterior stem cells during larval/pupal development. However, severe tissue damage within the hindgut elicits cell proliferation within a ring of putative quiescent stem cells at the anterior of the pylorus. Thus, the hindgut does not provide a model of tissue maintenance by constitutively active stem cells, but has great potential to illuminate mechanisms of stress-induced tissue repair.	[Fox, Donald T.; Spradling, Allan C.] Carnegie Inst, Howard Hughes Med Inst, Dept Embryol, Baltimore, MD 21218 USA	Carnegie Institution for Science; Howard Hughes Medical Institute	Spradling, AC (corresponding author), Carnegie Inst, Howard Hughes Med Inst, Dept Embryol, 3520 San Martin Dr, Baltimore, MD 21218 USA.	spradling@ciwemb.edu		Fox, Donald/0000-0002-0436-179X	Jane Coffin Childs Memorial Fund	Jane Coffin Childs Memorial Fund	We thank Ben Ohlstein for discussions and Shigeo Takashima, Toshie Kai, Hugo Bellen, and Jessica Treisman for stocks. Joe Gall, Lucy Morris, and Todd Nystul provided useful comments on the manuscript. D. T. F. is a fellow of the Jane Coffin Childs Memorial Fund.	Ahmad K, 1996, GENETICS, V144, P657; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Casali A, 2009, CELL STEM CELL, V4, P124, DOI 10.1016/j.stem.2009.01.009; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Fausto N, 2003, MECH DEVELOP, V120, P117, DOI 10.1016/S0925-4773(02)00338-6; Fox DT, 2009, STEMBOOK, DOI DOI 10.3824/STEMBOOK.1.33.1; Fuller MT, 2007, SCIENCE, V316, P402, DOI 10.1126/science.1140861; Han DD, 2000, DEVELOPMENT, V127, P573; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HIDALGO A, 1995, DEVELOPMENT, V121, P3703; Hong A, 2007, EMBO J, V26, P2071, DOI 10.1038/sj.emboj.7601648; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lengyel JA, 2002, DEV BIOL, V243, P1, DOI 10.1006/dbio.2002.0577; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Overturf K, 1999, AM J PATHOL, V155, P2135, DOI 10.1016/S0002-9440(10)65531-9; Pitsouli C, 2008, NATURE, V454, P592, DOI 10.1038/454592a; Rawlins EL, 2006, DEVELOPMENT, V133, P2455, DOI 10.1242/dev.02407; Rawlins EL, 2009, CELL STEM CELL, V4, P525, DOI 10.1016/j.stem.2009.04.002; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; Snodgrass RE, 1935, PRINCIPLES INSECT MO; STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Teta M, 2005, DIABETES, V54, P2557, DOI 10.2337/diabetes.54.9.2557; Vaillant F, 2007, STEM CELL REV, V3, P114, DOI 10.1007/s12015-007-0018-2; Xu XB, 2008, CELL, V132, P197, DOI 10.1016/j.cell.2007.12.015; Zaret KS, 2008, SCIENCE, V322, P1490, DOI 10.1126/science.1161431; Zhou L, 1997, P NATL ACAD SCI USA, V94, P5131, DOI 10.1073/pnas.94.10.5131	31	78	80	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					290	297		10.1016/j.stem.2009.06.003	http://dx.doi.org/10.1016/j.stem.2009.06.003			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19699165	Bronze, Green Accepted			2022-12-28	WOS:000272545700015
J	Lange, C; Huttner, WB; Calegari, F				Lange, Christian; Huttner, Wieland B.; Calegari, Federico			Cdk4/CyclinD1 Overexpression in Neural Stem Cells Shortens G1, Delays Neurogenesis, and Promotes the Generation and Expansion of Basal Progenitors	CELL STEM CELL			English	Article							CYCLIN-DEPENDENT KINASES; FIBROBLAST-GROWTH-FACTOR; NEURONAL DIFFERENTIATION; RNA INTERFERENCE; CEREBRAL-CORTEX; EXIT; INHIBITION; INDUCTION; EVOLUTION; MIGRATION	During mouse embryonic development, neural progenitors lengthen the G1 phase of the cell cycle and this has been suggested to be a cause, rather than a consequence, of neurogenesis. To investigate whether G1 lengthening alone may cause the switch of cortical progenitors from proliferation to neurogenesis, we manipulated the expression of cdk/cyclin complexes and found that cdk4/cyclinD1 overexpression prevents G1 lengthening without affecting cell growth, cleavage plane, or cell cycle synchrony with interkinetic nuclearmigration. Specifically, overexpression of cdk4/cyclinD1 inhibited neurogenesis while increasing the generation and expansion of basal ( intermediate) progenitors, resulting in a thicker subventricular zone and larger surface area of the postnatal cortex originating from cdk4/cyclinD1-transfected progenitors. Conversely, lengthening of G1 by cdk4/cyclinD1-RNAi displayed the opposite effects. Thus, G1 lengthening is necessary and sufficient to switch neural progenitors to neurogenesis, and overexpression of cdk4/cyclinD1 can be used to increase progenitor expansion and, perhaps, cortical surface area.	[Lange, Christian; Calegari, Federico] Tech Univ Dresden, Fac Med, DFG Res Ctr, D-01307 Dresden, Germany; [Lange, Christian; Calegari, Federico] Tech Univ Dresden, Fac Med, Cluster Excellence Regenerat Therapies Dresden, D-01307 Dresden, Germany; [Lange, Christian; Huttner, Wieland B.; Calegari, Federico] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Technische Universitat Dresden; Technische Universitat Dresden; Max Planck Society	Calegari, F (corresponding author), Tech Univ Dresden, Fac Med, DFG Res Ctr, Pfotenhauerstr 108, D-01307 Dresden, Germany.	federico.calegari@crt-dresden.de	Huttner, Wieland B./P-4080-2018; Calegari, Federico/N-7827-2019; Lange, Christian/F-6631-2013; Calegari, Federico/A-2422-2009	calegari, federico/0000-0002-3703-2802; Lange, Christian/0000-0002-7582-0076	DFG [249168.11-9-2007-1/2]	DFG(German Research Foundation (DFG))	We thank Dr. Charles J. Sherr and Dr. Pumin Zhang for cyclinD1 and cyclinD1-shRNA plasmids, respectively; Ina Nusslein, Christiane Rubbert, and the staff of the MPI-CBG animal house for excellent support; and Jeremy N. Pulvers for discussions. Animal experiments were approved by local authorities (249168.11-9-2007-1/2). C. L. and F. C. were supported by the DFG-funded Center for Regenerative Therapies and Medical Faculty of the Technical University, Dresden. Authors' contribution is as follows (C.L.-W. B. H.-F. C.): planning experiments 30%-5%-65%; performing experiments 95%-0%-5%; data analyses 45%-5%-50%, preparation of the manuscript 15%-5%-80%. Authors have no financial interest related to this work.	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Attardo A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002388; Bally-Cuif L, 2003, CURR OPIN NEUROBIOL, V13, P16, DOI 10.1016/S0959-4388(03)00015-1; Calegari F, 2003, J CELL SCI, V116, P4947, DOI 10.1242/jcs.00825; Calegari F, 2005, J NEUROSCI, V25, P6533, DOI 10.1523/JNEUROSCI.0778-05.2005; Calegari F, 2004, DIFFERENTIATION, V72, P92, DOI 10.1111/j.1432-0436.2004.07202002.x; Canzoniere D, 2004, J NEUROSCI, V24, P3355, DOI 10.1523/JNEUROSCI.3860-03.2004; CAVINESS VS, 1995, TRENDS NEUROSCI, V18, P379, DOI 10.1016/0166-2236(95)93933-O; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; Datar SA, 2006, CELL CYCLE, V5, P647; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Fu MF, 2004, ENDOCRINOLOGY, V145, P5439, DOI 10.1210/en.2004-0959; Georgopoulou N, 2006, J BIOL CHEM, V281, P33606, DOI 10.1074/jbc.M602689200; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Hodge RD, 2004, J NEUROSCI, V24, P10201, DOI 10.1523/JNEUROSCI.3246-04.2004; Iacopetti P, 1999, P NATL ACAD SCI USA, V96, P4639, DOI 10.1073/pnas.96.8.4639; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Lukaszewicz AS, 2002, J NEUROSCI, V22, P6610; Maric D, 2007, J NEUROSCI, V27, P1836, DOI 10.1523/JNEUROSCI.5141-06.2007; MCCONNELL SK, 1995, NEURON, V15, P761, DOI 10.1016/0896-6273(95)90168-X; McEvilly RJ, 2002, SCIENCE, V295, P1528, DOI 10.1126/science.1067132; Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Noctor SC, 2008, J COMP NEUROL, V508, P28, DOI 10.1002/cne.21669; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Ohnuma S, 2003, NEURON, V40, P199, DOI 10.1016/S0896-6273(03)00632-9; Peng SH, 2006, P NATL ACAD SCI USA, V103, P2252, DOI 10.1073/pnas.0511034103; Politis PK, 2007, P NATL ACAD SCI USA, V104, P17861, DOI 10.1073/pnas.0610973104; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Popken GJ, 2004, EUR J NEUROSCI, V19, P2056, DOI 10.1111/j.0953-816X.2004.03320.x; RAKIC P, 1995, TRENDS NEUROSCI, V18, P383, DOI 10.1016/0166-2236(95)93934-P; Regad T, 2009, NAT NEUROSCI, V12, P132, DOI 10.1038/nn.2251; Reis T, 2004, CELL, V117, P253, DOI 10.1016/S0092-8674(04)00247-8; SHERR CJ, 1994, CELL, V79, P551, DOI 10.1016/0092-8674(94)90540-1; TAKAHASHI T, 1995, J NEUROSCI, V15, P6046; Tapon N, 2001, CURR OPIN CELL BIOL, V13, P731, DOI 10.1016/S0955-0674(00)00284-2; Tonelli DDP, 2006, BIOTECHNIQUES, V41, P727, DOI 10.2144/000112296	44	391	409	0	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					320	331		10.1016/j.stem.2009.05.026	http://dx.doi.org/10.1016/j.stem.2009.05.026			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733543	Bronze			2022-12-28	WOS:000272545700018
J	Brill, LM; Xiong, W; Lee, KB; Ficarro, SB; Crain, A; Xu, Y; Terskikh, A; Snyder, EY; Ding, S				Brill, Laurence M.; Xiong, Wen; Lee, Ki-Bum; Ficarro, Scott B.; Crain, Andrew; Xu, Yue; Terskikh, Alexey; Snyder, Evan Y.; Ding, Sheng			Phosphoproteomic Analysis of Human Embryonic Stem Cells	CELL STEM CELL			English	Article							GENE-EXPRESSION PATTERNS; GROWTH-FACTOR; MASS-SPECTROMETRY; MAMMALIAN TARGET; SELF-RENEWAL; PHOSPHORYLATION; PLURIPOTENCY; MAINTENANCE; ACTIVATION; INHIBITOR	Protein phosphorylation, while critical to cellular behavior, has been undercharacterized in pluripotent cells. Therefore, we performed phosphoproteomic analyses of human embryonic stem cells (hESCs) and their differentiated derivatives. A total of 2546 phosphorylation sites were identified on 1602 phosphoproteins; 389 proteins contained more phosphorylation site identifications in undifferentiated hESCs, whereas 540 contained more such identifications in differentiated derivatives. Phosphoproteins in receptor tyrosine kinase (RTK) signaling pathways were numerous in undifferentiated hESCs. Cellular assays corroborated this observation by showing that multiple RTKs cooperatively supported undifferentiated hESCs. In addition to bFGF, EGFR, VEGFR, and PDGFR activation was critical to the undifferentiated state of hESCs. PDGF-AA complemented a subthreshold bFGF concentration to maintain undifferentiated hESCs. Also consistent with phosphoproteomics, JNK activity participated in maintenance of undifferentiated hESCs. These results support the utility of phosphoproteomic data, provide guidance for investigating protein function in hESCs, and complement transcriptomics/epigenetics for broadening our understanding of hESC fate determination.	[Brill, Laurence M.; Ficarro, Scott B.] Novartis Res Fdn, Genom Inst, San Diego, CA 92109 USA; [Brill, Laurence M.; Crain, Andrew; Terskikh, Alexey; Snyder, Evan Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Xiong, Wen; Lee, Ki-Bum; Xu, Yue; Ding, Sheng] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Crain, Andrew] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	Novartis; Sanford Burnham Prebys Medical Discovery Institute; Scripps Research Institute; University of California System; University of California San Diego	Brill, LM (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92109 USA.	lbrill@burnham.org; esnyder@burnham.org; sding@scripps.edu	Lee, KiBum/F-3702-2012; Lee, Ki-Bum/G-7503-2015; Terskikh, Alexey/U-8407-2019	LEE, Ki-Bum/0000-0002-8164-0047	California Institute for Regenerative Medicine (CIRM); Genomics Institute of the Novartis Research Foundation (GNF) [1 P20 GM 075059-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075059] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); Genomics Institute of the Novartis Research Foundation (GNF); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Lesperance, and Brandon Nelson for technical assistance. Support was from a postdoctoral fellowship from the California Institute for Regenerative Medicine (CIRM) (K.-B.L), the Genomics Institute of the Novartis Research Foundation (GNF), and the 1 P20 GM 075059-01.	Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Armstrong L, 2006, HUM MOL GENET, V15, P1894, DOI 10.1093/hmg/ddl112; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2008, P NATL ACAD SCI USA, V105, P1533, DOI 10.1073/pnas.0711632105; Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brandenberger R, 2004, NAT BIOTECHNOL, V22, P707, DOI 10.1038/nbt971; Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d; Cha TL, 2005, SCIENCE, V310, P306, DOI 10.1126/science.1118947; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200; Chu BY, 2005, BIOCHEM J, V392, P589, DOI 10.1042/BJ20050542; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Ficarro SB, 2005, RAPID COMMUN MASS SP, V19, P57, DOI 10.1002/rcm.1746; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Holzberg D, 2003, J BIOL CHEM, V278, P40213, DOI 10.1074/jbc.M304058200; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Kruger M, 2008, P NATL ACAD SCI USA, V105, P2451, DOI 10.1073/pnas.0711713105; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Li SW, 2003, MOL CARCINOGEN, V37, P98, DOI 10.1002/mc.10125; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333; Liu Y, 2006, J BIOL CHEM, V281, P31359, DOI 10.1074/jbc.M604478200; Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3; McCool KW, 2007, J BIOL CHEM, V282, P6696, DOI 10.1074/jbc.M609519200; Mukherji M, 2006, BIOCHEMISTRY-US, V45, P15529, DOI 10.1021/bi060971c; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Peponi E, 2006, AM J PATHOL, V169, P2171, DOI 10.2353/ajpath.2006.051078; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Rosner M, 2003, ONCOGENE, V22, P4786, DOI 10.1038/sj.onc.1206776; Sato N, 2003, DEV BIOL, V260, P404, DOI 10.1016/S0012-1606(03)00256-2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shin M, 2002, BBA-MOL CELL RES, V1589, P311, DOI 10.1016/S0167-4889(02)00195-7; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tan BCM, 2006, EMBO J, V25, P3975, DOI 10.1038/sj.emboj.7601271; Thingholm TE, 2008, J PROTEOME RES, V7, P3304, DOI 10.1021/pr800099y; Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Van Hoof D, 2006, MOL CELL PROTEOMICS, V5, P1261, DOI 10.1074/mcp.M500405-MCP200; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang L, 2007, BLOOD, V110, P4111, DOI 10.1182/blood-2007-03-082586; Washburn MP, 2003, ANAL CHEM, V75, P5054, DOI 10.1021/ac034120b; Western P, 2005, STEM CELLS, V23, P1436, DOI 10.1634/stemcells.2005-0146; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang Peilin, 2003, Mol Cancer, V2, P1	57	154	160	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					204	213		10.1016/j.stem.2009.06.002	http://dx.doi.org/10.1016/j.stem.2009.06.002			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664994	Bronze, Green Accepted			2022-12-28	WOS:000269511900013
J	Renstrom, J; Istvanffy, R; Gauthier, K; Shimono, A; Mages, J; Jardon-Alvarez, A; Kroger, M; Schiemann, M; Busch, DH; Esposito, I; Lang, R; Peschel, C; Oostendorp, RAJ				Renstroem, Jonas; Istvanffy, Rouzanna; Gauthier, Kerstin; Shimono, Akihiko; Mages, Joerg; Jardon-Alvarez, Ana; Kroeger, Monika; Schiemann, Matthias; Busch, Dirk H.; Esposito, Irene; Lang, Roland; Peschel, Christian; Oostendorp, Robert A. J.			Secreted Frizzled-Related Protein 1 Extrinsically Regulates Cycling Activity and Maintenance of Hematopoietic Stem Cells	CELL STEM CELL			English	Article							CANONICAL WNT PATHWAY; BETA-CATENIN; SELF-RENEWAL; LONG-TERM; TUMOR-SUPPRESSOR; DOWN-REGULATION; STROMAL CELLS; RECEPTOR; ACTIVATION; SFRP1	Secreted frizzled-related protein 1 (Sfrp1) is highly expressed by stromal cells maintaining hematopoietic stem cells (HSCs). Sfrp1 loss in stromal cells increases production of hematopoietic progenitors, and in knockout mice, dysregulates hemostasis and increases FIk2- Cd34- Lin- Sca1+ Kit+ (LSK) cell numbers in bone marrow. Also, LSK and multipotent progenitors (MPPs) resided mainly in the G0/G1 phase of cell cycle, with an accompanying decrease in intracellular beta-catenin levels. Gene-expression studies showed a concomitant decrease Ccnd1 and Dkk1 in Cd34- LSK cells and increased expression of Pparg, Hes1, and Runx1 in MPP. Transplantation experiments showed no intrinsic effect of Sfrp1 loss on the number of HSCs or their ability to engraft irradiated recipients. In contrast, serial transplantations of wild-type HSCs into Sfrp1(-/-) mice show a progressive decrease of wild-type LSK and MPP numbers. Our results demonstrate that Sfrp1 is required to maintain HSC homeostasis through extrinsic regulation of beta-catenin.	[Renstroem, Jonas; Istvanffy, Rouzanna; Gauthier, Kerstin; Jardon-Alvarez, Ana; Kroeger, Monika; Peschel, Christian; Oostendorp, Robert A. J.] Klinikum Rechts Der Isar, Dept Internal Med 3, D-81675 Munich, Germany; [Shimono, Akihiko] Natl Univ Singapore, Oncol Res Inst, Singapore 117456, Singapore; [Mages, Joerg; Schiemann, Matthias; Busch, Dirk H.; Lang, Roland] Tech Univ Munich, Dept Microbiol & Immunol, D-81675 Munich, Germany; [Schiemann, Matthias; Busch, Dirk H.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Antigen Specif Immunotherapy, D-85764 Neuherberg, Germany; [Schiemann, Matthias; Busch, Dirk H.] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Clin Cooperat Grp Immune Monitoring, D-85764 Neuherberg, Germany; [Esposito, Irene] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Pathol, D-85764 Neuherberg, Germany	Technical University of Munich; University of Munich; National University of Singapore; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Oostendorp, RAJ (corresponding author), Klinikum Rechts Der Isar, Dept Internal Med 3, D-81675 Munich, Germany.	oostendorp@lrz.tum.de	Oostendorp, Robert A. J./K-9841-2018; Lang, Roland/C-3287-2011; Tuluc, Petronel/C-2527-2011	Oostendorp, Robert A. J./0000-0002-4947-0412; Lang, Roland/0000-0003-0502-3677	German Research Foundation [SFB456-B2, OO 8/2-1, and -2]	German Research Foundation(German Research Foundation (DFG))	The authors would like to thank Dr. Ulrich Keller for critical reading of the manuscript, Dr. T. Brill, the animal caretakers of the Centre for Preclinical Research for mouse colony maintenance, S. Schill for help with irradiating the animals used in this procedure, and finally K. Gotsch for technical assistance. The authors gratefully acknowledge the financial support of the German Research Foundation (DFG, grants SFB456-B2, OO 8/2-1, and -2).	Altiok S, 1997, GENE DEV, V11, P1987, DOI 10.1101/gad.11.15.1987; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Burns CE, 2005, GENE DEV, V19, P2331, DOI 10.1101/gad.1337005; Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Dufourcq P, 2008, AM J PATHOL, V172, P37, DOI 10.2353/ajpath.2008.070130; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fukuda T, 2008, P NATL ACAD SCI USA, V105, P3047, DOI 10.1073/pnas.0712148105; Girnun GD, 2002, P NATL ACAD SCI USA, V99, P13771, DOI 10.1073/pnas.162480299; Hausler KD, 2004, J BONE MINER RES, V19, P1873, DOI 10.1359/JBMR.040807; Huang J, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-126; Ichikawa M, 2004, CELL CYCLE, V3, P722; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Keeble TR, 2006, INT J BIOCHEM CELL B, V38, P2011, DOI 10.1016/j.biocel.2006.07.005; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kortenjann M, 2001, EUR J IMMUNOL, V31, P3580, DOI 10.1002/1521-4141(200112)31:12<3580::AID-IMMU3580>3.0.CO;2-N; Levanon D, 1998, P NATL ACAD SCI USA, V95, P11590, DOI 10.1073/pnas.95.20.11590; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Matsuyama M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000427; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moldes M, 2003, BIOCHEM J, V376, P607, DOI 10.1042/BJ20030426; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nygren MK, 2007, BRIT J HAEMATOL, V136, P400, DOI 10.1111/j.1365-2141.2006.06442.x; Oostendorp RAJ, 2005, STEM CELLS, V23, P842, DOI 10.1634/stemcells.2004-0120; Oostendorp RAJ, 2002, BLOOD, V99, P1183, DOI 10.1182/blood.V99.4.1183; Orelio C, 2003, BLOOD, V101, P2246, DOI 10.1182/blood-2002-07-2260; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Rodriguez J, 2005, NAT NEUROSCI, V8, P1301, DOI 10.1038/nn1547; Satoh W, 2006, DEVELOPMENT, V133, P989, DOI 10.1242/dev.02274; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Si JT, 2008, CANCER RES, V68, P3733, DOI 10.1158/0008-5472.CAN-07-2509; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; Takada I, 2007, ANN NY ACAD SCI, V1116, P182, DOI 10.1196/annals.1402.034; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamane T, 2001, J IMMUNOL, V167, P765, DOI 10.4049/jimmunol.167.2.765; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Yu XB, 2006, STEM CELLS, V24, P876, DOI 10.1634/stemcells.2005-0598	49	62	64	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					157	167		10.1016/j.stem.2009.05.020	http://dx.doi.org/10.1016/j.stem.2009.05.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664990	Bronze			2022-12-28	WOS:000269511900009
J	Beaudry, VG; Attardi, LD				Beaudry, Veronica G.; Attardi, Laura D.			SKP-ing TAp63: Stem Cell Depletion, Senescence, and Premature Aging	CELL STEM CELL			English	Editorial Material							P63; PROLIFERATION; LIMB	The p53 family member p63 comprises multiple isoforms and is critical for stratified epithelial development. In this issue of Cell Stem Cell, by generating isoform-specific knockout mice, Su et al. (2009) reveal pivotal roles for TAp63 in the maintenance of dermal and epidermal precursors, genomic stability, and organismal longevity.	[Beaudry, Veronica G.; Attardi, Laura D.] Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA; [Attardi, Laura D.] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA	Stanford University; Stanford University	Attardi, LD (corresponding author), Stanford Univ, Sch Med, Dept Radiat Oncol, Stanford, CA 94305 USA.	attardi@stanford.edu						Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Keyes WM, 2005, GENE DEV, V19, P1986, DOI 10.1101/gad.342305; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Sharpless NE, 2007, NAT REV MOL CELL BIO, V8, P703, DOI 10.1038/nrm2241; Su XH, 2009, CELL STEM CELL, V5, P64, DOI 10.1016/j.stem.2009.04.003; Suh EK, 2006, NATURE, V444, P624, DOI 10.1038/nature05337; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539	10	13	13	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					1	2		10.1016/j.stem.2009.06.015	http://dx.doi.org/10.1016/j.stem.2009.06.015			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570504	Bronze			2022-12-28	WOS:000267879200001
J	Woolard, K; Fine, HA				Woolard, Kevin; Fine, Howard A.			Glioma Stem Cells: Better Flat Than Round	CELL STEM CELL			English	Editorial Material							TUMORS; NEUROSPHERE; EXPRESSION	Glioma-initiating cells/glioma stem cells (GIC/GSCs) are grown in vitro using a cumbersome and inefficient spheroid assay. In this issue of Cell Stern Cell, Pollard and coworkers present a protocol for the efficient derivation of GIC/GSC lines that may greatly improve the isolation and the potential clinical application of these cells.	[Woolard, Kevin; Fine, Howard A.] Natl Inst Neurol Disorders & Stroke, Neurooncol Branch, Natl Inst Hlth, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Fine, HA (corresponding author), Natl Inst Neurol Disorders & Stroke, Neurooncol Branch, Natl Inst Hlth, Bethesda, MD 20892 USA.	hfine@mail.nih.gov			NATIONAL CANCER INSTITUTE [ZIABC011099] Funding Source: NIH RePORTER	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Beier D, 2008, BRAIN PATHOL, V18, P370, DOI 10.1111/j.1750-3639.2008.00130.x; Bez A, 2003, BRAIN RES, V993, P18, DOI 10.1016/j.brainres.2003.08.061; Ekblom P, 2003, MATRIX BIOL, V22, P35, DOI 10.1016/S0945-053X(03)00015-5; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Laks DR, 2009, STEM CELLS, V27, P980, DOI 10.1002/stem.15; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Singh SK, 2003, CANCER RES, V63, P5821; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014	10	30	33	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					466	467		10.1016/j.stem.2009.05.013	http://dx.doi.org/10.1016/j.stem.2009.05.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497271	Bronze			2022-12-28	WOS:000266793600002
J	Feng, B; Ng, JH; Heng, JCD; Ng, HH				Feng, Bo; Ng, Jia-Hui; Heng, Jian-Chien Dominic; Ng, Huck-Hui			Molecules that Promote or Enhance Reprogramming of Somatic Cells to Induced Pluripotent Stem Cells	CELL STEM CELL			English	Review							SELF-RENEWAL; TRANSCRIPTIONAL NETWORK; REGULATORY CIRCUITRY; HUMAN FIBROBLASTS; C-MYC; MOUSE; GENERATION; ADULT; OCT4; INDUCTION	Reprogramming of somatic cells to induced pluripotent stem cells (iPSCs) can be achieved by viral-mediated transduction of defined transcription factors. Moving toward the eventual goal of clinical application, it is necessary to overcome limitations such as low reprogramming efficiency and genomic alterations due to viral integration. Here, we review recent progress made in the usage of genetic factors, chemical inhibitors, and signaling molecules that can either replace core reprogramming factors or enhance reprogramming efficiency. Current iPSC studies will provide a paradigm for the combinatorial use of genetic factors and chemicals for the broader applications to alter cellular states of potency.	[Feng, Bo; Ng, Jia-Hui; Heng, Jian-Chien Dominic; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Feng, Bo/D-7831-2014; Ng, Huck Hui/A-1135-2009	Feng, Bo/0000-0002-4018-3257; NG, HUCK HUI/0000-0001-6352-8417	Singapore Stem Cell Consortium; Agency for Science, Technology and Research; Biomedical Research Council	Singapore Stem Cell Consortium; Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	We are grateful to the Biomedical Research Council; the Agency for Science, Technology and Research; and the Singapore Stem Cell Consortium for funding. We thank Andrew Hutchins, Tara Huber, and Alan Colman for critical comments on the manuscript.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Burdon T, 1999, DEV BIOL, V210, P30, DOI 10.1006/dbio.1999.9265; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Duinsbegen D, 2008, EXP CELL RES, V314, P3255, DOI 10.1016/j.yexcr.2008.06.024; Dvorak P, 2005, STEM CELLS, V23, P1200, DOI 10.1634/stemcells.2004-0303; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Epsztejn-Litman S, 2008, NAT STRUCT MOL BIOL, V15, P1176, DOI 10.1038/nsmb.1476; Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Grigoryan T, 2008, GENE DEV, V22, P2308, DOI 10.1101/gad.1686208; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; He TC, 1998, SCIENCE, V281, P1509, DOI 10.1126/science.281.5382.1509; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Ivey KN, 2008, CELL STEM CELL, V2, P219, DOI 10.1016/j.stem.2008.01.016; Jacob HJ, 2002, NAT REV GENET, V3, P33, DOI 10.1038/nrg702; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Lengner CJ, 2008, CELL CYCLE, V7, P725, DOI 10.4161/cc.7.6.5573; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Loh YH, 2007, GENE DEV, V21, P2545, DOI 10.1101/gad.1588207; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Ma DK, 2008, STEM CELLS, V26, P2131, DOI 10.1634/stemcells.2008-0388; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Meissner A, 2007, NAT BIOTECHNOL, V25, P1177, DOI 10.1038/nbt1335; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishimoto M, 1999, MOL CELL BIOL, V19, P5453; Niwa H, 1998, GENE DEV, V12, P2048, DOI 10.1101/gad.12.13.2048; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Palii SS, 2008, MOL CELL BIOL, V28, P752, DOI 10.1128/MCB.01799-07; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; van den Berg DLC, 2008, MOL CELL BIOL, V28, P5986, DOI 10.1128/MCB.00301-08; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang W, 2008, P NATL ACAD SCI USA, V105, P9290, DOI 10.1073/pnas.0801017105; Wang W, 2009, GENOME RES, V19, P667, DOI 10.1101/gr.085621.108; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Xu Y, 2008, NATURE, V453, P338, DOI 10.1038/nature07042; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang XF, 2008, J BIOL CHEM, V283, P35825, DOI 10.1074/jbc.M803481200; Zhao Y, 2008, CELL STEM CELL, V3, P475, DOI 10.1016/j.stem.2008.10.002; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	96	294	333	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					301	312		10.1016/j.stem.2009.03.005	http://dx.doi.org/10.1016/j.stem.2009.03.005			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341620	Bronze			2022-12-28	WOS:000265162700007
J	Rugg-Gunn, PJ; Ogbogu, U; Rossant, J; Caulfield, T				Rugg-Gunn, Peter J.; Ogbogu, Ulbaka; Rossant, Janet; Caulfield, Timothy			The Challenge of Regulating Rapidly Changing Science: Stem Cell Legislation in Canada	CELL STEM CELL			English	Editorial Material							NUCLEAR TRANSFER; MOUSE EGGS; EMBRYO	We describe how recent advances in stem cell research may be interpreted by various regulatory regimes and use Canada as a model to demonstrate how broad-based prohibitive legislation can unintentionally restrict research direction. We encourage scientists and policymakers to collaborate to ensure a clear regulatory framework that accommodates future advances.	[Rugg-Gunn, Peter J.; Rossant, Janet] Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Ogbogu, Ulbaka; Caulfield, Timothy] Univ Alberta, Hlth Law Inst, Fac Law, Edmonton, AB T6G 2H5, Canada; [Rossant, Janet] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Ogbogu, Ulbaka] Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Alberta; University of Toronto; University of Toronto	Rugg-Gunn, PJ (corresponding author), Hosp Sick Children, Res Inst, Program Dev & Stem Cell Biol, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	pjrg@sickkids.ca; tcaulfld@law.ualberta.ca		Rugg-Gunn, Peter/0000-0002-9601-5949; Ogbogu, Ubaka/0000-0001-7764-6799				Beyhan Z, 2007, CELL STEM CELL, V1, P502, DOI 10.1016/j.stem.2007.10.009; Caulfield T, 2007, AM J BIOETHICS, V7, P51, DOI 10.1080/15265160601109655; Chan AWS, 2000, SCIENCE, V287, P317, DOI 10.1126/science.287.5451.317; Chung Y, 2008, CELL STEM CELL, V2, P113, DOI 10.1016/j.stem.2007.12.013; Isasi RM, 2006, EUR J HEALTH LAW, V13, P9, DOI 10.1163/157180906777036328; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; LINDER D, 1970, ANN HUM GENET, V34, P21, DOI 10.1111/j.1469-1809.1970.tb00216.x; Lovell-Badge R, 2008, NAT REV MOL CELL BIO, V9, P998, DOI 10.1038/nrm2550; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nisbet MC, 2007, SCIENCE, V316, P56, DOI 10.1126/science.1142030; OGBOGU U, 2008, J INT BIOTECHNOL LAW, V5, P186, DOI DOI 10.1515/JIBL.2008.32; OGBOGU U, 2008, MED LAW INT, V9, P227, DOI DOI 10.1177/096853320800900302; ROSSANT J, 1976, J EMBRYOL EXP MORPH, V36, P283; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; Tilgner K, 2008, STEM CELLS, V26, P3075, DOI 10.1634/stemcells.2008-0289	15	10	10	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					285	288		10.1016/j.stem.2009.03.004	http://dx.doi.org/10.1016/j.stem.2009.03.004			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341618	Bronze			2022-12-28	WOS:000265162700005
J	Lamba, DA; Gust, J; Reh, TA				Lamba, Deepak A.; Gust, Juliane; Reh, Thomas A.			Transplantation of Human Embryonic Stem Cell-Derived Photoreceptors Restores Some Visual Function in Crx-Deficient Mice	CELL STEM CELL			English	Article							RETINAL PROGENITOR CELLS; ROD; ELECTRORETINOGRAM; DIFFERENTIATION; PROLIFERATION; PRECURSORS; GENERATION; PATHWAYS; SURVIVAL; NEURONS	Some of the most common causes of blindness involve the degeneration of photoreceptors in the neural retina; photoreceptor replacement therapy might restore some vision in these individuals. Embryonic stem cells (ESCs) could, in principle, provide a source of photoreceptors to repair the retina. We have previously shown that retinal progenitors can be efficiently derived from human ESCs. We now show that retinal cells derived from human ESCs will migrate into mouse retinas following intraocular injection, settle into the appropriate layers, and express markers for differentiated cells, including both rod and cone photoreceptor cells. After transplantation of the cells into the subretinal space of adult Crx(-/-) mice (a model of Leber's Congenital Amaurosis), the hESC-derived retinal cells differentiate into functional photoreceptors and restore light responses to the animals. These results demonstrate that hESCs can, in principle, be used for photoreceptor replacement therapies.	[Lamba, Deepak A.; Gust, Juliane; Reh, Thomas A.] Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Reh, TA (corresponding author), Univ Washington, Dept Biol Struct, Seattle, WA 98195 USA.	tomreh@u.washington.edu		Gust, Juliane/0000-0001-5679-1989	NIGMS NIH HHS [P01 GM081619, P01 GM081619-010004] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081619] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ANCHAN RM, 1991, NEURON, V6, P923, DOI 10.1016/0896-6273(91)90233-P; Banin E, 2006, STEM CELLS, V24, P246, DOI 10.1634/stemcells.2005-0009; Coles BLK, 2004, P NATL ACAD SCI USA, V101, P15772, DOI 10.1073/pnas.0401596101; D'Amour KA, 2006, NAT BIOTECHNOL, V24, P1392, DOI 10.1038/nbt1259; Furukawa T, 1999, NAT GENET, V23, P466, DOI 10.1038/70591; Humayun MS, 2000, INVEST OPHTH VIS SCI, V41, P3100; Kang SM, 2007, STEM CELLS, V25, P419, DOI 10.1634/stemcells.2005-0482; KELLEY MW, 1995, INVEST OPHTH VIS SCI, V36, P1280; Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Lamba D, 2008, CELL STEM CELL, V2, P538, DOI 10.1016/j.stem.2008.05.002; Lamba DA, 2006, P NATL ACAD SCI USA, V103, P12769, DOI 10.1073/pnas.0601990103; LAVAIL MM, 1987, INVEST OPHTH VIS SCI, V28, P1043; Li JY, 2008, TRENDS NEUROSCI, V31, P146, DOI 10.1016/j.tins.2007.12.001; Machida S, 2000, INVEST OPHTH VIS SCI, V41, P3200; MacLaren RE, 2006, NATURE, V444, P203, DOI 10.1038/nature05161; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; REUTER JH, 1984, NEUROSCI LETT, V48, P231, DOI 10.1016/0304-3940(84)90024-7; Robson JG, 2004, VISION RES, V44, P3253, DOI 10.1016/j.visres.2004.09.002; Takahashi M, 1998, MOL CELL NEUROSCI, V12, P340, DOI 10.1006/mcne.1998.0721; Takahashi T, 2005, CURR EYE RES, V30, P703, DOI 10.1080/02713680590968592; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Yang HD, 2002, J COMP NEUROL, V443, P275, DOI 10.1002/cne.10116; Yang P, 2002, EXP NEUROL, V177, P326, DOI 10.1006/exnr.2002.7955	24	433	454	0	46	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					73	79		10.1016/j.stem.2008.10.015	http://dx.doi.org/10.1016/j.stem.2008.10.015			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128794	Bronze, Green Accepted			2022-12-28	WOS:000262559500013
J	Laurenti, E; Varnum-Finney, B; Wilson, A; Ferrero, I; Blanco-Bose, WE; Ehninger, A; Knoepfler, PS; Cheng, PF; MacDonald, HR; Eisenman, RN; Bernstein, ID; Trumpp, A				Laurenti, Elisa; Varnum-Finney, Barbara; Wilson, Anne; Ferrero, Isabel; Blanco-Bose, William E.; Ehninger, Armin; Knoepfler, Paul S.; Cheng, Pei-Feng; MacDonald, H. Robson; Eisenman, Robert N.; Bernstein, Irwin D.; Trumpp, Andreas			Hematopoietic Stem Cell Function and Survival Depend on c-Myc and N-Myc Activity	CELL STEM CELL			English	Article							SERINE-PROTEASE INHIBITOR-6; GRANZYME-B; PROGENITOR CELLS; SELF-RENEWAL; GENE; PROLIFERATION; ACTIVATION; EXPRESSION; FAMILY; DIFFERENTIATION	Myc activity is emerging as a key element in acquisition and maintenance of stem cell properties. We have previously shown that c-Myc deficiency results in accumulation of defective hematopoietic stem cells (HSCs) due to niche-dependent differentiation defects. Here we report that immature HSCs coexpress c-myc and N-myc mRNA at similar levels. Although conditional deletion of N-myc in the bone marrow does not affect hematopoiesis, combined deficiency of c-Myc and N-Myc (dKO) results in pancytopenia and rapid lethality. Interestingly, proliferation of HSCs depends on both myc genes during homeostasis, but is c-Myc/N-Myc independent during bone marrow repair after injury. Strikingly, while most dKO hematopoietic cells undergo apoptosis, only self-renewing HSCs accumulate the cytotoxic molecule GranzymeB, normally employed by the innate immune system, thereby revealing an unexpected mechanism of stem cell apoptosis. Collectively, Myc activity (c-Myc and N-Myc) controls crucial aspects of HSC function including proliferation, differentiation, and survival.	[Laurenti, Elisa; Blanco-Bose, William E.; Ehninger, Armin; Trumpp, Andreas] Swiss Inst Expt Canc Res, ISREC, Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1066 Epalinges, Switzerland; [Trumpp, Andreas] DKFZ ZMBH Alliance, Div Cell Biol, D-69120 Heidelberg, Germany; [Varnum-Finney, Barbara; Bernstein, Irwin D.] Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98109 USA; [Wilson, Anne; Ferrero, Isabel; MacDonald, H. Robson] Univ Lausanne, Lausanne Branch, Ludwig Inst Canc Res Ltd, CH-1066 Epalinges, Switzerland; [Knoepfler, Paul S.; Cheng, Pei-Feng; Eisenman, Robert N.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Swiss Institute Experimental Cancer Research; Helmholtz Association; German Cancer Research Center (DKFZ); Fred Hutchinson Cancer Center; Ludwig Institute for Cancer Research; University of Lausanne; Fred Hutchinson Cancer Center	Trumpp, A (corresponding author), Swiss Inst Expt Canc Res, ISREC, Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1066 Epalinges, Switzerland.	a.trumpp@dkfz.de	Wilson, Anne/A-7131-2011; Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Laurenti, Elisa/0000-0002-9917-9092; Knoepfler, Paul/0000-0001-5444-334X	Swiss National Science Foundation; Swiss Cancer League; EU-FP6 Program "INTACT,"; EU-FP7 Program "EuroSyStem"; NIH [PO1 HL084205, RO1CA20525]; NATIONAL CANCER INSTITUTE [R01CA020525] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL084205] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Cancer League; EU-FP6 Program "INTACT,"(European Commission); EU-FP7 Program "EuroSyStem"(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Sandra Offner and Christelle Dubey for animal husbandry, genetic screening, and technical help: Drs. Jos Doman for the H2K-BCL-2 mice: Fred Alt for the NCR mice: Mark Murphy for the initial breeding of the dKO mice: Keith Harshman, Otto Hagenbuchle, and other members of the Lausanne DNA Array Facility (DAFL) for their microarray service; and all members of the EPFL-MIM facility for outstanding help with microscopy and providing reagents. We would like to thank Steven Merlin and Joanna Roberts for FACS sorting. Tobias Vogt for TBP primers, and Rama for the mouse cartoon sketches, This work was supported in part by grants to A.T. from the Swiss National Science Foundation. the Swiss Cancer League, the EU-FP6 Program "INTACT," and the EU-FP7 Program "EuroSyStem," and by NIH grants PO1 HL084205 (to R.N.E. and I.D.B.) and RO1CA20525 (to R.N.E.).	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; BERTHOU C, 1995, BLOOD, V86, P3500, DOI 10.1182/blood.V86.9.3500.bloodjournal8693500; Bettess MD, 2005, MOL CELL BIOL, V25, P7868, DOI 10.1128/MCB.25.17.7868-7878.2005; CAPUTO A, 1993, J BIOL CHEM, V268, P17672; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; CHARRON J, 1992, GENE DEV, V6, P2248, DOI 10.1101/gad.6.12a.2248; Cole MD, 1999, ONCOGENE, V18, P2916, DOI 10.1038/sj.onc.1202748; DEPINHO R, 1987, J CELL BIOCHEM, V33, P257, DOI 10.1002/jcb.240330404; Domen J, 2000, J EXP MED, V192, P1707, DOI 10.1084/jem.192.12.1707; Dubois NC, 2008, DEVELOPMENT, V135, P2455, DOI 10.1242/dev.022707; Eisenman RN, 2001, GENE DEV, V15, P2023, DOI 10.1101/gad928101; Hatton KS, 1996, MOL CELL BIOL, V16, P1794; Ida H, 2003, EUR J IMMUNOL, V33, P3284, DOI 10.1002/eji.200324376; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Knoepfler PS, 2007, CANCER RES, V67, P5061, DOI 10.1158/0008-5472.CAN-07-0426; Knoepfler PS, 2006, EMBO J, V25, P2723, DOI 10.1038/sj.emboj.7601152; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Laforge M, 2006, J IMMUNOL, V176, P3966, DOI 10.4049/jimmunol.176.7.3966; Lewitzky M, 2007, CURR OPIN BIOTECH, V18, P467, DOI 10.1016/j.copbio.2007.09.007; Malynn BA, 2000, GENE DEV, V14, P1390; Murphy MJ, 2005, TRENDS CELL BIOL, V15, P128, DOI 10.1016/j.tcb.2005.01.008; Nilsson JA, 2003, ONCOGENE, V22, P9007, DOI 10.1038/sj.onc.1207261; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Oskarsson T, 2005, NAT CELL BIOL, V7, P215, DOI 10.1038/ncb0305-215; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pelengaris S, 2002, NAT REV CANCER, V2, P764, DOI 10.1038/nrc904; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; Phillips T, 2004, J IMMUNOL, V173, P3801, DOI 10.4049/jimmunol.173.6.3801; Purton LE, 2007, CELL STEM CELL, V1, P263, DOI 10.1016/j.stem.2007.08.016; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Randall TD, 1997, BLOOD, V89, P3596, DOI 10.1182/blood.V89.10.3596.3596_3596_3606; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Shizuru JA, 2005, ANNU REV MED, V56, P509, DOI 10.1146/annurev.med.54.101601.152334; Oskarsson T, 2006, GENE DEV, V20, P2024, DOI 10.1101/gad.381206; Sun JR, 1997, J BIOL CHEM, V272, P15434, DOI 10.1074/jbc.272.24.15434; Thoren LA, 2008, J IMMUNOL, V180, P2045, DOI 10.4049/jimmunol.180.4.2045; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; WILSON A, 2008, CELL IN PRESS; Wu SQ, 2003, ONCOGENE, V22, P351, DOI 10.1038/sj.onc.1206145; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang ML, 2006, IMMUNITY, V24, P451, DOI 10.1016/j.immuni.2006.02.002; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	54	208	223	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					611	624		10.1016/j.stem.2008.09.005	http://dx.doi.org/10.1016/j.stem.2008.09.005			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041778	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000261670900010
J	Spiegel, A; Kalinkovich, A; Shivtiel, S; Kollet, O; Lapidot, T				Spiegel, Asaf; Kalinkovich, Alexander; Shivtiel, Shoham; Kollet, Orit; Lapidot, Tsvee			Stem Cell Regulation via Dynamic Interactions of the Nervous and Immune Systems with the Microenvironment	CELL STEM CELL			English	Review							COLONY-STIMULATING FACTOR; HUMAN BONE-MARROW; HEMATOPOIETIC PROGENITOR CELLS; EARLY ALZHEIMERS-DISEASE; IN-VIVO; CD34(+) CELLS; ENDOGENOUS CATECHOLAMINES; CIRCADIAN VARIATIONS; ADHESION MOLECULES; LITHIUM TREATMENT	Physiological interactions between the nervous and immune systems with components of the local microenvironment are needed to maintain homeostasis throughout the body. Dynamic regulation of bone remodeling, hematopoietic stem cells, and their evolving niches via neurotransmitter signaling are part of the host defense and repair mechanisms. This crosstalk links activated leukocytes, neuronal, and stromal cells, which combine to directly and indirectly regulate hematopoietic stem cells. Together, interactions between diverse systems create a regulatory "brain-bone-blood triad," contributing an additional dimension to the concept of the hematopoietic stem cell niche.	[Spiegel, Asaf; Kalinkovich, Alexander; Shivtiel, Shoham; Kollet, Orit; Lapidot, Tsvee] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	tsvee.lapidot@weizmann.ac.il	Lapidot, Tsvee/A-1812-2010; Kollet, Orit/A-6861-2008		Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute; Gabriella Rich Center for Transplantation Biology; Legacy Heritage foundation; Human Frontiers Science Program	Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute; Gabriella Rich Center for Transplantation Biology; Legacy Heritage foundation; Human Frontiers Science Program(Human Frontier Science Program)	This work was supported in part by grants from the Helen and Martin Kimmel Institute for Stem Cell Research at the Weizmann Institute, the Gabriella Rich Center for Transplantation Biology, and the Legacy Heritage foundation. T.L. is incumbent of The Edith Arnoff Stein Professorial Chair in Stem Cell Research. A.S. is supported by a fellowship from the Human Frontiers Science Program. We thank Dr. E. Shezen for contributing to Figure 1, Professors M. Sela, G. Wagemaker, D. Zipori, and S. Berrih-Aknin for fruitful discussions. We regret that we could not cite important publications due to space limitations.	Abkowitz JL, 2003, BLOOD, V102, P1249, DOI 10.1182/blood-2003-01-0318; Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Aicher A, 2008, CIRC RES, V103, P796, DOI 10.1161/CIRCRESAHA.107.172718; Arai F, 2007, ANN NY ACAD SCI, V1106, P41, DOI 10.1196/annals.1392.005; Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; Ballin A, 1998, BRIT J HAEMATOL, V100, P219, DOI 10.1046/j.1365-2141.1998.00537.x; BARRETT AJ, 1978, EXP HEMATOL, V6, P590; Bartness TJ, 2001, J BIOL RHYTHM, V16, P196, DOI 10.1177/074873001129001908; BERGQUIST J, 1994, P NATL ACAD SCI USA, V91, P12912, DOI 10.1073/pnas.91.26.12912; Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Bliziotes M, 2000, BONE, V27, P367, DOI 10.1016/S8756-3282(00)00338-0; Bonnet N, 2007, BONE, V40, P1209, DOI 10.1016/j.bone.2007.01.006; Boyce BF, 2008, CELL METAB, V7, P283, DOI 10.1016/j.cmet.2008.03.013; Broxmeyer HE, 2005, J EXP MED, V201, P1307, DOI 10.1084/jem.20041385; Burt-Pichat B, 2005, ENDOCRINOLOGY, V146, P503, DOI 10.1210/en.2004-0884; BYRON JW, 1972, EXP CELL RES, V71, P228, DOI 10.1016/0014-4827(72)90283-2; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chan JYH, 2001, BRIT J HAEMATOL, V112, P541, DOI 10.1046/j.1365-2141.2001.02439.x; Cherruau M, 1999, BONE, V25, P545, DOI 10.1016/S8756-3282(99)00211-2; Cosentino M, 1998, J CHEMOTHERAPY, V10, P179, DOI 10.1179/joc.1998.10.2.179; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; D'Hondt L, 2004, J CELL PHYSIOL, V200, P63, DOI 10.1002/jcp.20032; Dar A, 2006, EXP HEMATOL, V34, P967, DOI 10.1016/j.exphem.2006.04.002; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Elefteriou F, 2005, CELL MOL LIFE SCI, V62, P2339, DOI 10.1007/s00018-005-5175-3; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fliedner T M, 1998, Stem Cells, V16 Suppl 1, P13; Flierl MA, 2007, NATURE, V449, P721, DOI 10.1038/nature06185; Grisaru D, 2001, MOL MED, V7, P93, DOI 10.1007/BF03401943; Haylock DN, 2006, REGEN MED, V1, P437, DOI 10.2217/17460751.1.4.437; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; Hill WD, 2004, J NEUROPATH EXP NEUR, V63, P84, DOI 10.1093/jnen/63.1.84; Idova G V, 2004, Neurosci Behav Physiol, V34, P417, DOI 10.1023/B:NEAB.0000018755.99063.05; Jung Y, 2006, BONE, V38, P497, DOI 10.1016/j.bone.2005.10.003; Jung YG, 2008, STEM CELLS, V26, P2042, DOI 10.1634/stemcells.2008-0149; Kast R, 2008, BONE MARROW TRANSPL, V41, P23, DOI 10.1038/sj.bmt.1705872; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kemeny ME, 2007, BRAIN BEHAV IMMUN, V21, P1009, DOI 10.1016/j.bbi.2007.07.010; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kim HK, 2007, J TRACE ELEM MED BIO, V21, P204, DOI 10.1016/j.jtemb.2007.03.001; Kin NW, 2006, J LEUKOCYTE BIOL, V79, P1093, DOI 10.1189/jlb.1105625; Kollet O, 2003, J CLIN INVEST, V112, P160, DOI 10.1172/JCI200317902; Kollet O, 2007, ANNU REV IMMUNOL, V25, P51, DOI 10.1146/annurev.immunol.25.022106.141631; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kondo H, 2005, J BIOL CHEM, V280, P30192, DOI 10.1074/jbc.M504179200; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Laird DJ, 2008, CELL, V132, P612, DOI 10.1016/j.cell.2008.01.041; Lambrechts D, 2006, BBA-MOL BASIS DIS, V1762, P1109, DOI 10.1016/j.bbadis.2006.04.005; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lapidot T, 2002, EXP HEMATOL, V30, P973, DOI 10.1016/S0301-472X(02)00883-4; Laske C, 2008, J ALZHEIMERS DIS, V15, P83; Levesque JP, 2001, BLOOD, V98, P1289, DOI 10.1182/blood.V98.5.1289; Lucas D, 2008, CELL STEM CELL, V3, P364, DOI 10.1016/j.stem.2008.09.004; MacLean C, 2008, ANN INTERN MED, V148, P197, DOI 10.7326/0003-4819-148-3-200802050-00198; Maler JM, 2006, MOL PSYCHIATR, V11, P1113, DOI 10.1038/sj.mp.4001913; MAUER AM, 1965, BLOOD-J HEMATOL, V26, P1; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Mendez-Ferrer S, 2007, ANN NY ACAD SCI, V1116, P392, DOI 10.1196/annals.1402.086; Mignini F., 2003, Autonomic & Autacoid Pharmacology, V23, P1, DOI 10.1046/j.1474-8673.2003.00280.x; MORLEY A, 1970, HEMOPOIETIC CELLULAR, P3; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; MURPHY DL, 1971, AM J PSYCHIAT, V127, P1559, DOI 10.1176/ajp.127.11.1559; Muthu K, 2007, J NEUROIMMUNOL, V186, P27, DOI 10.1016/j.jneuroim.2007.02.007; Nagasawa T, 2006, NAT REV IMMUNOL, V6, P107, DOI 10.1038/nri1780; Nanki T, 2000, J IMMUNOL, V165, P6590, DOI 10.4049/jimmunol.165.11.6590; Ohdo S, 1998, J PHARMACOL EXP THER, V285, P242; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2002, NAT IMMUNOL, V3, P687, DOI 10.1038/ni813; Ponomaryov T, 2000, J CLIN INVEST, V106, P1331, DOI 10.1172/JCI10329; Prosper F, 2001, J LEUKOCYTE BIOL, V69, P307; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sato S, 2002, AM J CLIN ONCOL-CANC, V25, P289, DOI 10.1097/00000421-200206000-00018; Scadden DT, 2008, NATURE, V452, P416, DOI 10.1038/452416a; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shivtiel S, 2008, J EXP MED, V205, P2381, DOI 10.1084/jem.20080072; Simmons PJ, 1997, BAILLIERE CLIN HAEM, V10, P485, DOI 10.1016/S0950-3536(97)80022-4; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Spiegel A, 2008, BLOOD, V111, P4934, DOI 10.1182/blood-2007-10-116145; Spiegel A, 2007, NAT IMMUNOL, V8, P1123, DOI 10.1038/ni1509; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tada T, 1997, ANNU REV IMMUNOL, V15, P1, DOI 10.1146/annurev.immunol.15.1.1; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; TISMAN G, 1973, BRIT J HAEMATOL, V24, P767, DOI 10.1111/j.1365-2141.1973.tb01704.x; Togari A, 2005, EXPERT OPIN THER TAR, V9, P931, DOI 10.1517/14728222.9.5.931; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Trowbridge JJ, 2006, NAT IMMUNOL, V7, P1021, DOI 10.1038/ni1006-1021; Tsinkalovsky O, 2007, J BIOL RHYTHM, V22, P140, DOI 10.1177/0748730406299078; VERFAILLIE CM, 1994, BLOOD, V84, P1802; Vico L, 2000, LANCET, V355, P1607, DOI 10.1016/S0140-6736(00)02217-0; Wojakowski W, 2005, FOLIA HISTOCHEM CYTO, V43, P229; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zaldivar F, 2007, PEDIATR RES, V61, P491, DOI 10.1203/pdr.0b013e3180332d36; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zimecki Michal, 2006, Postepy Hig Med Dosw (Online), V60, P1; ZIPORI D, 1980, EXP HEMATOL, V8, P816	99	97	102	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					484	492		10.1016/j.stem.2008.10.006	http://dx.doi.org/10.1016/j.stem.2008.10.006			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983964	Bronze			2022-12-28	WOS:000260895100008
J	Lapidot, T; Goichberg, P; Lapid, K; Avigdor, A; Kollet, O				Lapidot, Tsvee; Goichberg, Polina; Lapid, Kfir; Avigdor, Abraham; Kollet, Orit			The endosteum region keeps human leukemic stem cells alive	CELL STEM CELL			English	Editorial Material							ACUTE MYELOGENOUS LEUKEMIA; BONE-MARROW; CXCR4; CD44; MICE		Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; Weizmann Inst Sci, Helen & Martin Kimmel Ctr Stem Cell Biol, IL-76100 Rehovot, Israel; Chaim Sheba Med Ctr, Dept Hematol & Bone Marrow Transplantat, IL-52621 Tel Hashomer, Israel	Weizmann Institute of Science; Weizmann Institute of Science; Chaim Sheba Medical Center	Lapidot, T (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	tsvee.lapidot@weizmann.ac.il	Kollet, Orit/A-6861-2008; Lapidot, Tsvee/A-1812-2010; Lapid, Kfir/C-5265-2014	Lapid, Kfir/0000-0002-8898-8695				Avigdor A, 2004, BLOOD, V103, P2981, DOI 10.1182/blood-2003-10-3611; ISHIKAWA F, 2007, IN PRESS NAT BIOTECH; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Spoo AC, 2007, BLOOD, V109, P786, DOI 10.1182/blood-2006-05-024844; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Tavor S, 2004, CANCER RES, V64, P2817, DOI 10.1158/0008-5472.CAN-03-3693; VANDYKE D, 1969, BLOOD-J HEMATOL, V34, P257, DOI 10.1182/blood.V34.3.257.257	10	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					483	484		10.1016/j.stem.2007.10.013	http://dx.doi.org/10.1016/j.stem.2007.10.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18938742	Bronze			2022-12-28	WOS:000251276500003
J	Cherry, A; Daley, GQ				Cherry, Anne; Daley, George Q.			Another Horse in the Meta-Stable State of Pluripotency	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; SUBPOPULATIONS	Reports of heterogeneity within embryonic stem cell lines suggest that pluripotent stem cells captured in culture may be less homogeneous than previously assumed. In a recent issue of Cell, Scholer and colleagues (Han et al., 2010) demonstrate the existence of a dynamic subpopulation of epiblast stem cells that shows features of earlier pluripotent cells.	[Cherry, Anne; Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Manton Ctr Orphan Dis Res,Howard Hughes Med Inst, Boston, MA 02115 USA; [Cherry, Anne; Daley, George Q.] Brigham & Womens Hosp, Dana Farber Canc Inst, Div Hematol, Boston, MA 02115 USA; [Cherry, Anne; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Manton Ctr Orphan Dis Res,Howard Hughes Med Inst, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Cherry, Anne/E-7333-2011					Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Buecker C, 2010, CELL STEM CELL, V7, P759, DOI 10.1016/j.stem.2010.11.024; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Han DW, 2010, CELL, V143, P617, DOI 10.1016/j.cell.2010.10.015; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400	9	5	5	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					641	642		10.1016/j.stem.2010.11.020	http://dx.doi.org/10.1016/j.stem.2010.11.020			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112555	Bronze			2022-12-28	WOS:000285537700002
J	Monk, AC; Siddall, NA; Volk, T; Fraser, B; Quinn, LM; McLaughlin, EA; Hime, GR				Monk, Adrian C.; Siddall, Nicole A.; Volk, Talila; Fraser, Barbara; Quinn, Leonie M.; McLaughlin, Eileen A.; Hime, Gary R.			HOW Is Required for Stem Cell Maintenance in the Drosophila Testis and for the Onset of Transit-Amplifying Divisions	CELL STEM CELL			English	Article							RNA-BINDING PROTEIN; DEVELOPMENTAL REGULATORS; SELF-RENEWAL; 2 ISOFORMS; GERM-CELL; CYCLIN-A; DIFFERENTIATION; SPERMATOGENESIS; PROLIFERATION; DEGRADATION	The mechanisms by which germline stem cells (GSCs) in the Drosophila testis undergo asymmetric division to regenerate a stem cell as well as a daughter (gonialblast) that will only undergo a further four mitotic divisions prior to entering premeiotic S phase and differentiating into a cyst of spermatocytes are not fully resolved. Here we demonstrate that the HOW RNA-binding protein is required for maintenance of CycB and therefore mitotic progression in GSCs and gonialblasts as well as determining the timing of the spermatogonial divisions. HOW is normally expressed in a complementary pattern to Barn in the germline and barn mRNA is bound by HOW in vivo. Ectopic expression of the HOW(L) isoform is associated with a delay in accumulation of Barn to the level required for differentiation, resulting in extra mitotic divisions. Spatiotemporal regulation of HOW expression is therefore required to specify the four spermatogonial transit-amplifying divisions.	[Monk, Adrian C.; Siddall, Nicole A.; Quinn, Leonie M.; Hime, Gary R.] Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic 3010, Australia; [Monk, Adrian C.; Siddall, Nicole A.; Fraser, Barbara; McLaughlin, Eileen A.; Hime, Gary R.] ARC Ctr Excellence Biotechnol & Dev, Callaghan, NSW 2308, Australia; [Volk, Talila] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel; [Fraser, Barbara; McLaughlin, Eileen A.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia	University of Melbourne; Weizmann Institute of Science; University of Newcastle	Hime, GR (corresponding author), Univ Melbourne, Dept Anat & Cell Biol, Melbourne, Vic 3010, Australia.		Hime, Gary/B-7162-2015; McLaughlin, Eileen A/G-7620-2013; McLaughlin, Eileen/AAF-5588-2021	Hime, Gary/0000-0003-4732-3184; Quinn, Leonie/0000-0002-3911-6508; McLaughlin, Eileen/0000-0002-5837-3876	ARC Centre of Excellence in Biotechnology and Development; NHMRC	ARC Centre of Excellence in Biotechnology and Development(Australian Research Council); NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	We would like to thank the Developmental Studies Hybridoma Bank, Bloomington Drosophila Stock Center, Vienna Drosophila RNAi Centre, Australian Biomedical Drosophila Research Facility, Eric Baehrecke, Dennis McKearin, Helen White-Cooper, Zhi-Chun Lai, Helena Richardson. Ruth Lehmann, Shigeo Hayashi, Ting Xie. and David Glover for fly strains and antibodies We thank Ben Britten Smith for image analysis software We thank members of the G R H laboratory for ideas and technical help This work was supported by the ARC Centre of Excellence in Biotechnology and Development and partly by an NHMRC project grant awarded to G R H	Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431, DOI 10.1038/15666; Baehrecke EH, 1997, DEVELOPMENT, V124, P1323; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Bunt SM, 2004, GENESIS, V39, P84, DOI 10.1002/gene.20030; Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; Fuller Margaret T., 1993, P71; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Grewal SS, 2005, NAT CELL BIOL, V7, P295, DOI 10.1038/ncb1223; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Insco ML, 2009, P NATL ACAD SCI USA, V106, P22311, DOI 10.1073/pnas.0912454106; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2000, NATURE, V407, P750, DOI 10.1038/35037606; Krause DS, 2002, ONCOGENE, V21, P3262, DOI 10.1038/sj.onc.1205316; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lilly MA, 2000, DEV BIOL, V218, P53, DOI 10.1006/dbio.1999.9570; McCall K, 2004, METH MOL B, V247, P431; Nabel-Rosen H, 2005, CURR BIOL, V15, P295, DOI 10.1016/j.cub.2005.01.045; Nabel-Rosen H, 1999, MOL CELL, V4, P573, DOI 10.1016/S1097-2765(00)80208-7; Nabel-Rosen H, 2002, DEV CELL, V2, P183, DOI 10.1016/S1534-5807(01)00118-6; Prout M, 1997, GENETICS, V146, P275; Quinn LM, 2001, GENE DEV, V15, P2741, DOI 10.1101/gad.916201; Sarkar A, 2007, CURR BIOL, V17, P1253, DOI 10.1016/j.cub.2007.06.048; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Siddall NA, 2006, P NATL ACAD SCI USA, V103, P8402, DOI 10.1073/pnas.0600906103; SIGRIST S, 1995, EMBO J, V14, P4827, DOI 10.1002/j.1460-2075.1995.tb00164.x; Su TT, 1998, GENE DEV, V12, P1495, DOI 10.1101/gad.12.10.1495; Toledano-Katchalski H, 2007, DEVELOPMENT, V134, P3473, DOI 10.1242/dev.006080; Tran J, 2000, NATURE, V407, P754, DOI 10.1038/35037613; Van Doren M, 1998, CURR BIOL, V8, P243; Volk T, 2008, TRENDS GENET, V24, P94, DOI 10.1016/j.tig.2007.11.009; White-Cooper H, 1998, DEVELOPMENT, V125, P125; Xie T, 2005, DEV DYNAM, V232, P775, DOI 10.1002/dvdy.20317	36	35	37	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					348	360		10.1016/j.stem.2010.02.016	http://dx.doi.org/10.1016/j.stem.2010.02.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362539	Bronze			2022-12-28	WOS:000276823300013
J	Karayannis, T; Fishell, G				Karayannis, Theofanis; Fishell, Gordon			Inhibition as a Transplant-Mediated Therapy: A New Paradigm for Treating Parkinson's?	CELL STEM CELL			English	Editorial Material							DISEASE; INTERNEURONS; BRAIN	In this issue of Cell Stem Cell, Martinez-Cerdefio and colleagues (2010) transplant interneuron precursors from the MGE into the striatum of a rat model of Parkinson's disease and observe a 5% increase in the endogenous GABAergic interneuron population resulting in behavioral benefits in both lesioned and wildtype animals.	[Karayannis, Theofanis; Fishell, Gordon] NYU, Sch Med, Smilow Neurosci Program, New York, NY 10016 USA; [Karayannis, Theofanis; Fishell, Gordon] NYU, Sch Med, Smilow Res Ctr, Dept Cell Biol, New York, NY 10016 USA	New York University; New York University	Fishell, G (corresponding author), NYU, Sch Med, Smilow Neurosci Program, 522 1st Ave, New York, NY 10016 USA.	gordon.fishell@med.nyu.edu	Karayannis, Theofanis/GRR-3982-2022; Karayannis, Theofanis/O-5194-2014	Karayannis, Theofanis/0000-0002-3267-6254; Fishell, Gordon/0000-0002-9640-9278				Batista-Brito R, 2009, CURR TOP DEV BIOL, V87, P81, DOI 10.1016/S0070-2153(09)01203-4; BJORKLUND A, 1979, BRAIN RES, V177, P555, DOI 10.1016/0006-8993(79)90472-4; DeLong MR, 2007, ARCH NEUROL-CHICAGO, V64, P20, DOI 10.1001/archneur.64.1.20; Drucker-Colin R, 2004, CELL MOL NEUROBIOL, V24, P301, DOI 10.1023/B:CEMN.0000022764.94760.3f; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; FREEMAN TB, 1995, ANN NEUROL, V38, P379, DOI 10.1002/ana.410380307; LINDVALL O, 1994, ANN NEUROL, V35, P172, DOI 10.1002/ana.410350208; Martinez-Cerdeno V, 2010, CELL STEM CELL, V6, P238, DOI 10.1016/j.stem.2010.01.004; Tepper JM, 2004, CURR OPIN NEUROBIOL, V14, P685, DOI 10.1016/j.conb.2004.10.003; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131	10	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					184	185		10.1016/j.stem.2010.02.003	http://dx.doi.org/10.1016/j.stem.2010.02.003			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207216	Bronze			2022-12-28	WOS:000276254600002
J	Crockin, SL				Crockin, Susan L.			A Legal Defense for Compensating Research Egg Donors	CELL STEM CELL			English	Editorial Material							STEM-CELLS; PAYMENT	Given the continued need for human eggs for hESCs, this article analyzes and refutes the legal theories against compensating research egg donors, contrasts the legal histories of compensating reproductive donors and human subjects with noncompensation for ESC donors, and suggests that limited compensation is legally defensible.	Crockin Law & Policy Grp LLC, Newton, MA 02460 USA		Crockin, SL (corresponding author), Crockin Law & Policy Grp LLC, 29 Crafts St,Suite 500, Newton, MA 02460 USA.	scrockin@crockinlaw.com						*AM SOC REPR MED P, 2006, FERTIL STERIL, V86, pS38; Chong S, 2006, SCIENCE, V311, P22, DOI 10.1126/science.311.5757.22; Cibelli J, 2009, CELL STEM CELL, V5, P345, DOI 10.1016/j.stem.2009.09.009; Ethics Comm Amer Soc Reprod Med, 2007, FERTIL STERIL, V88, P305, DOI 10.1016/j.fertnstert2007.01.104; Grady C, 2005, J CLIN INVEST, V115, P1681, DOI 10.1172/JCI25694; Hutt Leah E, 2003, Health Law Rev, V12, P16; Hyun I, 2006, NATURE, V442, P629, DOI 10.1038/442629a; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; Vogel G, 2006, SCIENCE, V313, P155	9	10	10	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					99	102		10.1016/j.stem.2010.01.010	http://dx.doi.org/10.1016/j.stem.2010.01.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144783	Bronze			2022-12-28	WOS:000274520800005
J	Son, MJ; Woolard, K; Nam, DH; Lee, J; Fine, HA				Son, Myung Jin; Woolard, Kevin; Nam, Do-Hyun; Lee, Jeongwu; Fine, Howard A.			SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma	CELL STEM CELL			English	Article							CANCER STEM-CELLS; NERVOUS-SYSTEM; PROGENITOR CELLS; CD133; BRAIN; PROTEIN; GLIOMA; IDENTIFICATION; ANTIGEN; GROWTH	CD133+ populations of human glioblastoma multi-forme (GBM) cells are reportedly enriched for tumor stem cells (TSCs) or tumor-initiating cells (TICs). Approximately 40% of freshly isolated GBM specimens, however, do not contain CD133+ tumor cells, raising the possibility that CD133 may not be a universal enrichment marker for GBM TSCs/TiCs. Here we demonstrate that stage-specific embryonic antigen 1(SSEA-1/LeX)+ GBM cells fulfill the functional criteria for TSC/TIC, since (1) SSEA-1+ cells are highly tumorigenic in vivo, unlike SSEA-1-cells; (2) SSEA-1+ cells can give rise to both SSEA-1+ and SSEA-1-cells, thereby establishing a cellular hierarchy; and (3) SSEA-1+ cells have self-renewal and multilineage differentiation potentials. A distinct subpopulation of SSEA-1+ cells was present in all but one of the primary GBMsexamined (n = 24), and most CD133+ tumor cells were also SSEA-1+, suggesting that SSEA-1 may be a general TSC/TIC enrichment marker in human GBMs.	[Son, Myung Jin; Woolard, Kevin; Lee, Jeongwu; Fine, Howard A.] NCI, Neurooncol Branch, NINDS, NIH, Bethesda, MD 20892 USA; [Nam, Do-Hyun] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Neurosurg, Seoul 135710, South Korea	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); NIH National Institute of Neurological Disorders & Stroke (NINDS); Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, J (corresponding author), NCI, Neurooncol Branch, NINDS, NIH, Bethesda, MD 20892 USA.	leejeo@mail.nih.gov; hfine@mail.nih.gov	Nam, Do Hyun/C-9656-2011		Intramural Research Program of the NIH; National Cancer Institute; Center for Cancer Research; NINDS FACS Facility; NINDS Light Imaging Facility; NATIONAL CANCER INSTITUTE [Z01BC011098, ZIABC010839, ZIABC011099, ZIABC011100, ZIABC010840, Z01BC011086, ZIABC011102] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS FACS Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS Light Imaging Facility(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. We thank Dr. Dragan Maric (NINDS FACS Facility) for his valuable contributions to this work. We also thank Dr. Carolyn Smith (NINDS Light Imaging Facility) and Dr. Hong Sug Kim for their valuable contributions to this work.	Bao SD, 2008, CANCER RES, V68, P6043, DOI 10.1158/0008-5472.CAN-08-1079; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen HL, 2007, STEM CELLS, V25, P2291, DOI 10.1634/stemcells.2006-0609; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Corbeil D, 1998, BLOOD, V91, P2625, DOI 10.1182/blood.V91.7.2625.2625_2625_2626; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dirks PB, 2006, NATURE, V444, P687, DOI 10.1038/444687a; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Griguer CE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003655; Hall PE, 2006, STEM CELLS, V24, P2078, DOI 10.1634/stemcells.2005-0595; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Kim I, 2006, BLOOD, V108, P737, DOI 10.1182/blood-2005-10-4135; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LENDAHL U, 1990, CELL, V60, P585, DOI 10.1016/0092-8674(90)90662-X; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Liu GT, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-67; Miraglia S, 1997, BLOOD, V90, P5013, DOI 10.1182/blood.V90.12.5013.5013_5013_5021; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ogden AT, 2008, NEUROSURGERY, V62, P505, DOI 10.1227/01.neu.0000316019.28421.95; Patrawala L, 2007, CANCER RES, V67, P6796, DOI 10.1158/0008-5472.CAN-07-0490; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Potgens AJG, 2002, J HISTOCHEM CYTOCHEM, V50, P1131, DOI 10.1177/002215540205000814; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Richardson GD, 2004, J CELL SCI, V117, P3539, DOI 10.1242/jcs.01222; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Trumpp A, 2008, NAT CLIN PRACT ONCOL, V5, P337, DOI 10.1038/ncponc1110; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Vescovi AL, 2006, NAT REV CANCER, V6, P425, DOI 10.1038/nrc1889; Wang J, 2008, INT J CANCER, V122, P761, DOI 10.1002/ijc.23130; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	53	491	504	2	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					440	452		10.1016/j.stem.2009.03.003	http://dx.doi.org/10.1016/j.stem.2009.03.003			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427293	Green Accepted, Bronze			2022-12-28	WOS:000266071100012
J	Hooper, AT; Butler, JM; Nolan, DJ; Kranz, A; Iida, K; Kobayashi, M; Kopp, HG; Shido, K; Petit, I; Yanger, K; James, D; Witte, L; Zhu, ZP; Wu, Y; Pytowski, B; Rosenwaks, Z; Mittal, V; Sato, TN; Rafii, S				Hooper, Andrea T.; Butler, Jason M.; Nolan, Daniel J.; Kranz, Andrea; Iida, Kaoruko; Kobayashi, Mariko; Kopp, Hans-Georg; Shido, Koji; Petit, Isabelle; Yanger, Kilangsungla; James, Daylon; Witte, Larry; Zhu, Zhenping; Wu, Yan; Pytowski, Bronislaw; Rosenwaks, Zev; Mittal, Vivek; Sato, Thomas N.; Rafii, Shahin			Engraftment and Reconstitution of Hematopoiesis Is Dependent on VEGFR2-Mediated Regeneration of Sinusoidal Endothelial Cells	CELL STEM CELL			English	Article							MARROW VASCULAR NICHE; STEM-CELLS; PROGENITOR CELLS; GROWTH-FACTOR; DIFFERENTIATION; IDENTIFICATION; ANGIOGENESIS; MOBILIZATION; QUIESCENCE; SURVIVAL	Myelosuppression damages the bone marrow (BM) vascular niche, but it is unclear how regeneration of bone marrow vessels contributes to engraftment of transplanted hematopoietic stem and progenitor cells (HSPCs) and restoration of hematopoiesis. We found that chemotherapy and sublethal irradiation induced minor regression of BM sinusoidal endothelial cells (SECs), while lethal irradiation induced severe regression of SECs and required BM transplantation (BMT) for regeneration. Within the BM, VEGFR2 expression specifically demarcated a continuous network of arterioles and SECs, with arterioles uniquely expressing Sca1 and SECs uniquely expressing VEGFR3. Conditional deletion of VEGFR2 in adult mice blocked regeneration of SECs in sublethally irradiated animals and prevented hematopoietic reconstitution. Similarly, inhibition of VEGFR2 signaling in lethally irradiated wild-type mice rescued with BMT severely impaired SEC reconstruction and prevented engraftment and reconstitution of HSPCs. Therefore, regeneration of SECs via VEGFR2 signaling is essential for engraftment of HSPCs and restoration of hematopoiesis.	[Hooper, Andrea T.; Butler, Jason M.; Nolan, Daniel J.; Kobayashi, Mariko; Kopp, Hans-Georg; Shido, Koji; Petit, Isabelle; Yanger, Kilangsungla; James, Daylon; Rosenwaks, Zev; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Hooper, Andrea T.; Butler, Jason M.; Nolan, Daniel J.; Kobayashi, Mariko; Kopp, Hans-Georg; Shido, Koji; Petit, Isabelle; Yanger, Kilangsungla; James, Daylon; Rosenwaks, Zev; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10065 USA; [Hooper, Andrea T.; Butler, Jason M.; Nolan, Daniel J.; Kobayashi, Mariko; Kopp, Hans-Georg; Shido, Koji; Petit, Isabelle; Yanger, Kilangsungla; James, Daylon; Rosenwaks, Zev; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Kranz, Andrea; Iida, Kaoruko; Sato, Thomas N.] Weill Cornell Med Coll, Dept Cell & Dev Biol, New York, NY 10065 USA; [Witte, Larry; Zhu, Zhenping; Wu, Yan; Pytowski, Bronislaw] ImClone Syst Inc, New York, NY 10014 USA; [Mittal, Vivek] Weill Cornell Med Coll, Dept Surg, New York, NY 10065 USA; [Rosenwaks, Zev] Ronald O Perelman & Claudia Cohen Ctr Reprod Med, New York, NY 10065 USA	Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; Cornell University; Eli Lilly; Cornell University	Rafii, S (corresponding author), Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA.	srafii@med.cornell.edu	Yanger, Kilang/N-2888-2015; Petit, isabelle/AAF-5620-2020; Kranz, Andrea/D-3617-2012	Yanger, Kilang/0000-0002-1710-5306; Petit, isabelle/0000-0002-9782-0683; Hooper, Andrea/0000-0003-1131-1229; Kopp, Hans-Georg/0000-0002-0825-8888; de Witte, Luc/0000-0002-3013-2640	Howard Hughes Medical Institute; Ansary Stem Cell Institute; Deutsche Forschungsgerneinschaft [2154/2-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066952, R01HL075234, P01HL072942, R01HL097797, P01HL067839, P50HL084936, P01HL059312, R01HL061849, R21HL083222, R01HL058707] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Ansary Stem Cell Institute; Deutsche Forschungsgerneinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S.R. and T.N.S. are funded by NIH. S,R. is supported by Howard Hughes Medical Institute and Ansary Stem Cell Institute. A.K. was supported in part by Deutsche Forschungsgerneinschaft (KR 2154/2-1). We thank Mollie Goetz, Keith Kobylarz, and Allison Spencer for their excellent technical assistance.	Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Avecilla ST, 2004, NAT MED, V10, P64, DOI 10.1038/nm973; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Fong GH, 1999, DEVELOPMENT, V126, P3015; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Haruta H, 2001, FEBS LETT, V507, P45, DOI 10.1016/S0014-5793(01)02921-0; Hattori K, 2002, NAT MED, V8, P841, DOI 10.1038/nm740; Heissig B, 2002, CELL, V109, P625, DOI 10.1016/S0092-8674(02)00754-7; KATAOKA M, 1985, BLOOD, V65, P1163; Kiel MJ, 2006, IMMUNITY, V25, P862, DOI 10.1016/j.immuni.2006.11.005; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kollet O, 2006, NAT MED, V12, P657, DOI 10.1038/nm1417; Kopp HG, 2006, J CLIN INVEST, V116, P3277, DOI 10.1172/JCI29314; Kopp HG, 2005, PHYSIOLOGY, V20, P349, DOI 10.1152/physiol.00025.2005; Kopp HG, 2005, BLOOD, V106, P505, DOI 10.1182/blood-2004-11-4269; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Li XM, 2008, EXP HEMATOL, V36, P1143, DOI 10.1016/j.exphem.2008.06.009; Mohle R, 1997, P NATL ACAD SCI USA, V94, P663, DOI 10.1073/pnas.94.2.663; Naiyer AJ, 1999, BLOOD, V94, P4011, DOI 10.1182/blood.V94.12.4011.424k10_4011_4019; Prewett M, 1999, CANCER RES, V59, P5209; Pytowski B, 2005, JNCI-J NATL CANCER I, V97, P14, DOI 10.1093/jnci/dji003; RAFII S, 1994, BLOOD, V84, P10; RAFII S, 1995, BLOOD, V86, P3353, DOI 10.1182/blood.V86.9.3353.bloodjournal8693353; Sapoznikov A, 2008, NAT IMMUNOL, V9, P388, DOI 10.1038/ni1571; SHALABY F, 1995, NATURE, V376, P62, DOI 10.1038/376062a0; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Slayton WB, 2007, STEM CELLS, V25, P2945, DOI 10.1634/stemcells.2007-0158; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Takakura N, 2000, CELL, V102, P199, DOI 10.1016/S0092-8674(00)00025-8; Tammela T, 2008, NATURE, V454, P656, DOI 10.1038/nature07083; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	34	452	462	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					263	274		10.1016/j.stem.2009.01.006	http://dx.doi.org/10.1016/j.stem.2009.01.006			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265665	Green Accepted, Bronze			2022-12-28	WOS:000264369300016
J	Williams, JP; Wu, JQ; Johansson, G; Rizvi, TA; Miller, SC; Geiger, H; Malik, P; Li, WL; Mukouyama, YS; Cancelas, JA; Ratner, N				Williams, Jon P.; Wu, Jianqiang; Johansson, Gunnar; Rizvi, Tilat A.; Miller, Shyra C.; Geiger, Hartmut; Malik, Punam; Li, Wenling; Mukouyama, Yoh-suke; Cancelas, Jose A.; Ratner, Nancy			Nf1 Mutation Expands an EGFR-Dependent Peripheral Nerve Progenitor that Confers Neurofibroma Tumorigenic Potential	CELL STEM CELL			English	Article							CREST STEM-CELLS; GROWTH-FACTOR RECEPTOR; MAMMALIAN NEURAL CREST; SCHWANN-CELLS; SELF-RENEWAL; BOUNDARY CAP; GLIAL-CELLS; DIFFERENTIATION; TUMORS; EXPRESSION	Defining growth factor requirements for progenitors facilitates their characterization and amplification. We characterize a peripheral nervous system embryonic dorsal root ganglion progenitor population using in vitro clonal sphere-formation assays. Cells differentiate into glial cells, smooth muscle/fibroblast (SM/Fb)-like cells, and neurons. Genetic and pharmacologic tools revealed that sphere formation requires signaling from the EGFR tyrosine kinase. Nf1 loss of function amplifies this progenitor pool, which becomes hypersensitive to growth factors and confers tumorigenesis. DhhCre;Nf1(fl/fl) mouse neurofibromas contain a progenitor population with similar growth requirements, potential, and marker expression. In humans, NF1 mutation predisposes to benign neurofibromas, incurable peripheral nerve tumors. Prospective identification of human EGFR(+);P75(+) neurofibroma cells enriched EGF-dependent sphere-forming cells. Neurofibroma spheres contain glial-like progenitors that differentiate into neurons and SM/Fb-like cells in vitro and form benign neurofibroma-like lesions in nude mice. We suggest that expansion of an EGFR-expressing early glial progenitor contributes to neurofibroma formation.	[Williams, Jon P.; Wu, Jianqiang; Johansson, Gunnar; Rizvi, Tilat A.; Miller, Shyra C.; Geiger, Hartmut; Malik, Punam; Cancelas, Jose A.; Ratner, Nancy] Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Li, Wenling; Mukouyama, Yoh-suke] NHLBI, Dev Biol Lab, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA; [Cancelas, Jose A.] Univ Cincinnati, Coll Med, Hoxworth Blood Ctr, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); University System of Ohio; University of Cincinnati	Ratner, N (corresponding author), Cincinnati Childrens Hosp Med Ctr, Cincinnati Childrens Hosp Res Fdn, Div Expt Hematol & Canc Biol, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	nancy.ratner@cchmc.org	Cancelas, Jose/AAR-9324-2020; Williams, Jon/AAP-2761-2020	Malik, Punam/0000-0002-8942-2108; RATNER, NANCY/0000-0001-5030-9354; Mukouyama, Yoh-suke/0000-0002-9084-4922	National Institutes of Health (NIH) [R01-NS 28840]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028840] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank M. Nakafuku (Cincinnati Children's Hospital Medical Center) for numerous helpful suggestions, A. Stemmer-Racham imov (Massachusetts General Hospital) and M. Collins (Cincinnati Children's) for assistance with pathology, and B. Ehmer for assistance with confocal microscopy. We also thank the Cooperative Human Tissue Network for assistance in providing human neurofibroma. This work was supported by National Institutes of Health (NIH) R01-NS 28840 to N.R.	Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; ANUMUGAM PI, 2007, MOL THER, V15, P1863; BAROFFIO A, 1988, P NATL ACAD SCI USA, V85, P5325, DOI 10.1073/pnas.85.14.5325; Birnbaum RA, 2000, MOL CELL, V5, P189, DOI 10.1016/S1097-2765(00)80415-3; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; BRANNAN CI, 1994, GENE DEV, V8, P1019, DOI 10.1101/gad.8.9.1019; Burrows RC, 1997, NEURON, V19, P251, DOI 10.1016/S0896-6273(00)80937-X; Carroll SL, 2008, GLIA, V56, P1590, DOI 10.1002/glia.20776; Chen SY, 2004, CIRC RES, V94, P1195, DOI 10.1161/01.RES.0000126897.41658.81; DeClue JE, 2000, J CLIN INVEST, V105, P1233, DOI 10.1172/JCI7610; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Dong ZP, 1999, J NEUROSCI RES, V56, P334, DOI 10.1002/(SICI)1097-4547(19990515)56:4<334::AID-JNR2>3.0.CO;2-#; Fernandes KJL, 2004, NAT CELL BIOL, V6, P1082, DOI 10.1038/ncb1181; Geiger H, 2001, BLOOD, V98, P2966, DOI 10.1182/blood.V98.10.2966; Hagedorn L, 1999, DEVELOPMENT, V126, P3781; Harder A, 2006, HISTOPATHOLOGY, V49, P441, DOI 10.1111/j.1365-2559.2006.02492.x; Hjerling-Leffler J, 2005, DEVELOPMENT, V132, P2623, DOI 10.1242/dev.01852; ITO K, 1993, DEV BIOL, V157, P517, DOI 10.1006/dbio.1993.1154; Jessen KR, 2005, NAT REV NEUROSCI, V6, P671, DOI 10.1038/nrn1746; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Joseph NM, 2008, CANCER CELL, V13, P129, DOI 10.1016/j.ccr.2008.01.003; Joseph NM, 2004, DEVELOPMENT, V131, P5599, DOI 10.1242/dev.01429; Khalifa MA, 2000, AM J CLIN PATHOL, V114, P123, DOI 10.1309/C7N9-J2AU-5TB9-5FRL; KIM HA, 1995, ONCOGENE, V11, P325; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Leimeroth R, 2002, DEV BIOL, V246, P245, DOI 10.1006/dbio.2002.0670; Lillien L, 1998, MOL CELL NEUROSCI, V10, P296, DOI 10.1006/mcne.1997.0659; Ling BC, 2005, CANCER CELL, V7, P65, DOI 10.1016/j.ccr.2004.10.016; Lo LC, 2002, DEVELOPMENT, V129, P1553; Maertens O, 2007, AM J HUM GENET, V81, P243, DOI 10.1086/519562; Maro GS, 2004, NAT NEUROSCI, V7, P930, DOI 10.1038/nn1299; Miller SJ, 2003, MOL CELL BIOL, V23, P2213, DOI 10.1128/MCB.23.6.2213-2224.2003; Monk KR, 2007, NEURON GLIA BIOL, V3, P233, DOI 10.1017/S1740925X08000021; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; Muir D, 2001, AM J PATHOL, V158, P501, DOI 10.1016/S0002-9440(10)63992-2; Nagoshi N, 2008, CELL STEM CELL, V2, P392, DOI 10.1016/j.stem.2008.03.005; Norman P, 2001, Curr Opin Investig Drugs, V2, P298; Rasmussen SA, 2000, AM J EPIDEMIOL, V151, P33, DOI 10.1093/oxfordjournals.aje.a010118; Ratner N, 2006, METHOD ENZYMOL, V407, P22, DOI 10.1016/S0076-6879(05)07003-5; Represa A, 2001, EUR J NEUROSCI, V14, P452, DOI 10.1046/j.0953-816x.2001.01660.x; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Riccardi V. M., 1992, NEUROFIBROMATOSIS PH; Rizvi TA, 2002, J NEUROSCI, V22, P9831; Serra E, 2001, HUM GENET, V108, P416; Shah NM, 1996, CELL, V85, P331, DOI 10.1016/S0092-8674(00)81112-5; Sieber-Blum M, 2004, DEV DYNAM, V231, P258, DOI 10.1002/dvdy.20129; STEMPLE DL, 1992, CELL, V71, P973, DOI 10.1016/0092-8674(92)90393-Q; Tefferi A, 2008, LEUKEMIA, V22, P3, DOI 10.1038/sj.leu.2404946; Toma JG, 2005, STEM CELLS, V23, P727, DOI 10.1634/stemcells.2004-0134; VOGEL KS, 1995, CELL, V82, P733, DOI 10.1016/0092-8674(95)90470-0; Wu JQ, 2008, CANCER CELL, V13, P105, DOI 10.1016/j.ccr.2007.12.027; Wu JQ, 2006, AM J PATHOL, V168, P1686, DOI 10.2353/ajpath.2006.050859; Zhang YY, 1998, J EXP MED, V187, P1893, DOI 10.1084/jem.187.11.1893; Zheng H, 2008, CANCER CELL, V13, P117, DOI 10.1016/j.ccr.2008.01.002; Zhu Y, 2002, SCIENCE, V296, P920, DOI 10.1126/science.1068452	56	37	38	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					658	669		10.1016/j.stem.2008.10.003	http://dx.doi.org/10.1016/j.stem.2008.10.003			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041782	Green Accepted, Bronze			2022-12-28	WOS:000261670900014
J	Voskoboynik, A; Soen, Y; Rinkevich, Y; Rosner, A; Ueno, H; Reshef, R; Ishizuka, KJ; Palmeri, KJ; Moiseeva, E; Rinkevich, B; Weissman, IL				Voskoboynik, Ayelet; Soen, Yoav; Rinkevich, Yuval; Rosner, Amalia; Ueno, Hiroo; Reshef, Ram; Ishizuka, Katherine J.; Palmeri, Karla J.; Moiseeva, Elizabeth; Rinkevich, Baruch; Weissman, Irving L.			Identification of the Endostyle as a Stem Cell Niche in a Colonial Chordate	CELL STEM CELL			English	Article							UROCHORDATE BOTRYLLUS-SCHLOSSERI; ALDEHYDE DEHYDROGENASE-ACTIVITY; SELF-RENEWAL; CAENORHABDITIS-ELEGANS; DROSOPHILA OVARY; BLOOD-CELLS; GERM-LINE; REGENERATION; EXPRESSION; EVOLUTION	Stem cell populations exist in "niches" that hold them and regulate their fate decisions. Identification and characterization of these niches is essential for understanding stem cell maintenance and tissue regeneration. Here we report on the identification of a novel stem cell niche in Botryllus schlosseri, a colonial urochordate with high stem cell-mediated developmental activities. Using in vivo cell labeling, engraftment, confocal microscopy, and time-lapse imaging, we have identified cells with sternness capabilities in the anterior ventral region of the Botryllus' endostyle. These cells proliferate and migrate to regenerating organs in developing buds and buds of chimeric partners but do not contribute to the germ line. When cells are transplanted from the endostyle region, they contribute to tissue development and induce long-term chimerism in allogeneic tissues. In contrast, cells from other Botryllus' regions do not show comparable sternness capabilities. Cumulatively, these results define the Botryllus' endostyle region as an adult somatic stem cell niche.	[Voskoboynik, Ayelet; Ueno, Hiroo; Ishizuka, Katherine J.; Palmeri, Karla J.; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Soen, Yoav] Stanford Univ, Sch Med, Dept Biochem, Stanford, CA 94305 USA; [Voskoboynik, Ayelet; Ishizuka, Katherine J.; Palmeri, Karla J.; Weissman, Irving L.] Stanford Univ, Hopkins Marine Stn, Dept Dev Biol, Pacific Grove, CA 93950 USA; [Rinkevich, Yuval; Reshef, Ram] Technion Israel Inst Technol, Dept Biol, IL-32000 Haifa, Israel; [Rosner, Amalia; Moiseeva, Elizabeth; Rinkevich, Baruch] Natl Inst Oceanog Oceanog & Limnol Res, IL-31080 Haifa, Israel	Stanford University; Stanford University; Stanford University; Technion Israel Institute of Technology	Voskoboynik, A (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.	ayeletv@stanford.edu	Rinkevich, Yuval/B-7854-2018; Rinkevich, Yuval/B-7647-2018; Palmer, Theo/GSI-6635-2022	Rinkevich, Yuval/0000-0001-6290-7271; Rinkevich, Yuval/0000-0002-9022-7668; 	USPHS [DK54762]; US-Israel Binational Science Foundation [HL58770]; Israel Science Foundation [550-06]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054762] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100315] Funding Source: NIH RePORTER	USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation); Israel Science Foundation(Israel Science Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Amir Voskoboynik, T. Raveh, and A. De Tomaso for critical review, and P. Brown, R. Marinelli, R. Pesich L. Jerabek, C. Patton, K. Lee, and R. Will for generous support and helpful assistance. This study was supported by USPHS grant DK54762 and to a minor extent by HL58770 by a grant from the US-Israel Binational Science Foundation (2003-010) and by the Israel Science Foundation (project 550-06).	Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BOYD HC, 1986, BIOL BULL, V170, P91, DOI 10.2307/1541383; Bradford GB, 1997, EXP HEMATOL, V25, P445; Brown FD, 2007, EVOL DEV, V9, P165, DOI 10.1111/j.1525-142X.2007.00147.x; Burighel P, 1997, MICROSCOPICAL ANATOM, V15, P221; BURIGHEL P, 1971, B ZOOL, V38, P278; BURNET FM, 1971, NATURE, V232, P230, DOI 10.1038/232230a0; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Canestro C, 2008, DEV DYNAM, V237, P1490, DOI 10.1002/dvdy.21525; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Corti S, 2006, STEM CELLS, V24, P975, DOI 10.1634/stemcells.2005-0217; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Crittenden SL, 2002, NATURE, V417, P660, DOI 10.1038/nature754; De Tomaso AW, 1998, GENETICS, V149, P277; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DUNN AD, 1980, GEN COMP ENDOCR, V40, P484, DOI 10.1016/0016-6480(80)90012-X; ERMAK TH, 1982, AM ZOOL, V22, P795; Fallon P, 2003, BRIT J HAEMATOL, V122, P99, DOI 10.1046/j.1365-2141.2003.04357.x; FREEMAN G, 1964, J EXP ZOOL, V156, P157, DOI 10.1002/jez.1401560204; Gilboa L, 2006, NATURE, V443, P97, DOI 10.1038/nature05068; Harada H, 1999, J CELL BIOL, V147, P105, DOI 10.1083/jcb.147.1.105; Hiruta J, 2005, DEV DYNAM, V233, P1031, DOI 10.1002/dvdy.20401; HOSS M, 1993, NUCLEIC ACIDS RES, V21, P3913, DOI 10.1093/nar/21.16.3913; KAWAMURA K, 1986, BIOL BULL, V171, P580; Kawamura K, 2008, DEV DYNAM, V237, P1812, DOI 10.1002/dvdy.21592; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Laird DJ, 2005, CELL, V123, P1351, DOI 10.1016/j.cell.2005.10.026; Lauzon RJ, 2002, DEV BIOL, V249, P333, DOI 10.1006/dbio.2002.0772; LIN H, 1993, DEV BIOL, V159, P140, DOI 10.1006/dbio.1993.1228; Manni L, 2006, BIOESSAYS, V28, P902, DOI 10.1002/bies.20462; Moiseeva E, 2004, DIS AQUAT ORGAN, V60, P77, DOI 10.3354/dao060077; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; NEGM HI, 1991, COMP BIOCHEM PHYS B, V99, P741, DOI 10.1016/0305-0491(91)90137-3; NILSSON O, 1988, CELL TISSUE RES, V253, P137; NUNZI MG, 1979, DEV BIOL, V68, P371, DOI 10.1016/0012-1606(79)90211-2; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; OKA H, 1957, BIOL BULL, V112, P225, DOI 10.2307/1539200; OKA HIDEMITI, 1960, BULL MAR BIOL STA ASAMUSHI TOHOKU UNIV, V10, P153; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; PANCER Z, 1995, BIOL BULL, V189, P106, DOI 10.2307/1542460; Pennati R, 2001, DEV GROWTH DIFFER, V43, P647; Potten CS, 2002, J CELL SCI, V115, P2381; RINKEVICH B, 1995, P NATL ACAD SCI USA, V92, P7695, DOI 10.1073/pnas.92.17.7695; Rinkevich B, 1998, BIOL BULL-US, V195, P98, DOI 10.2307/1542816; Rinkevich Y, 2007, PLOS BIOL, V5, P900, DOI 10.1371/journal.pbio.0050071; Rosner A, 2007, DEV BIOL, V304, P687, DOI 10.1016/j.ydbio.2007.01.018; Rosner A, 2006, DEV DYNAM, V235, P1508, DOI 10.1002/dvdy.20728; SABBADIN A, 1979, J EXP ZOOL, V207, P289, DOI 10.1002/jez.1402070212; SABBADIN A, 1975, DEV BIOL, V46, P79, DOI 10.1016/0012-1606(75)90088-3; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schubert M, 2000, DEV DYNAM, V217, P205, DOI 10.1002/(SICI)1097-0177(200002)217:2<205::AID-DVDY7>3.0.CO;2-F; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Stoner DS, 1999, P NATL ACAD SCI USA, V96, P9148, DOI 10.1073/pnas.96.16.9148; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Storms RW, 1999, P NATL ACAD SCI USA, V96, P9118, DOI 10.1073/pnas.96.16.9118; Sunanaga T, 2006, DEV GROWTH DIFFER, V48, P87, DOI 10.1111/j.1440-169x.2006.00849.x; Tiozzo S, 2008, DEV BIOL, V315, P243, DOI 10.1016/j.ydbio.2007.12.035; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Villadsen R, 2007, J CELL BIOL, V177, P87, DOI 10.1083/jcb.200611114; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Voskoboynik A, 2007, FASEB J, V21, P1335, DOI 10.1096/fj.06-7337com; Weissman IL, 2000, CELL, V100, P157, DOI 10.1016/S0092-8674(00)81692-X; WIESCHAUS E, 1979, DEV BIOL, V68, P29, DOI 10.1016/0012-1606(79)90241-0; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	70	67	68	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					456	464		10.1016/j.stem.2008.07.023	http://dx.doi.org/10.1016/j.stem.2008.07.023			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940736	Bronze, Green Accepted			2022-12-28	WOS:000260149800015
J	Maherali, N; Ahfeldt, T; Rigamonti, A; Utikal, J; Cowan, C; Hochedlinger, K				Maherali, Nimet; Ahfeldt, Tim; Rigamonti, Alessandra; Utikal, Jochen; Cowan, Chad; Hochedlinger, Konrad			A high-efficiency system for the generation and study of human induced pluripotent stem cells	CELL STEM CELL			English	Article							FIBROBLASTS; DIFFERENTIATION; EXPRESSION; INDUCTION	Direct reprogramming of human fibroblasts to a pluripotent state has been achieved through ectopic expression of the transcription factors OCT4, SOX2, and either cMYC and KLF4 or NANOG and LIN28. Little is known, however, about the mechanisms by which reprogramming occurs, which is in part limited by the low efficiency of conversion. To this end, we sought to create a doxycycline-inclucible lentiviral system to convert primary human fibroblasts and keratinocytes into human induced pluripotent stem cells (hiPSCs). hiPSCs generated with this system were molecularly and functionally similar to human embryonic stem cells (hESCs), demonstrated by gene expression profiles, DNA methylation status, and differentiation potential. While expression of the viral transgenes was required for several weeks in fibroblasts, we found that 10 days was sufficient for the reprogramming of keratinocytes. Using our inducible system, we developed a strategy to induce hiPSC formation at high frequency. Upon addition of doxycycline to hiPSC-derived differentiated cells, we obtained "secondary" hiPSCs at a frequency at least 100-fold greater than the initial conversion. The ability to reprogram cells at high efficiency provides a unique platform to dissect the underlying molecular and biochemical processes that accompany nuclear reprogramming.	[Maherali, Nimet; Ahfeldt, Tim; Rigamonti, Alessandra; Utikal, Jochen; Cowan, Chad; Hochedlinger, Konrad] Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Ctr Regenerat Med, Boston, MA 02114 USA; [Maherali, Nimet; Utikal, Jochen; Hochedlinger, Konrad] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Cowan, Chad] Stowers Med Inst, Boston, MA 02114 USA; [Maherali, Nimet] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Ahfeldt, Tim] Univ Med Ctr Hamburg Eppendorf, Dept Biochem & Mol Biol Mol Cell Biol 2, D-20246 Hamburg, Germany	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Stowers Institute for Medical Research; Harvard University; University of Hamburg; University Medical Center Hamburg-Eppendorf	Cowan, C (corresponding author), Massachusetts Gen Hosp, Dept Stem Cell & Regenerat Biol, Harvard Stem Cell Inst, Ctr Regenerat Med, 185 Cambridge St, Boston, MA 02114 USA.	ccowan1@partners.org; khochedlinger@helix.mgh.harvard.edu	Ahfeldt, Tim/E-2935-2017	Ahfeldt, Tim/0000-0001-6377-7376; Utikal, Jochen/0000-0001-5316-0241	Natural Sciences and Engineering Research Council of Canada; Dr. Mildred Scheel Foundation for Cancer Research; Harvard Stem Cell Institute; Stowers Institute for Medical Research; National Institutes of Health (NIH); Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD003266] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Dr. Mildred Scheel Foundation for Cancer Research(Deutsche Krebshilfe); Harvard Stem Cell Institute; Stowers Institute for Medical Research; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kimmel Foundation; V Foundation; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Stowers Institute for Medical Research Microarray Group, Christopher Seidel, and Reddy Gali (Harvard FAS Life Sciences Research Computing) for assistance with transcriptional profiling and analysis; Jennifer Shay for technical assistance; and Matthias Stadtfeld and Jose Polo for critical reading of the manuscript. N.M. is supported by a graduate scholarship from the Natural Sciences and Engineering Research Council of Canada and a Sir James Lougheed Award from Alberta Scholarships. J.U. is supported by the Dr. Mildred Scheel Foundation for Cancer Research. C.C. is supported by the Harvard Stem Cell Institute and the Stowers Institute for Medical Research. K.H. is supported by a National Institutes of Health (NIH) Director's Innovator Award, the Harvard Stem Cell Institute, the Kimmel Foundation, and the V Foundation.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Kopp JL, 2008, STEM CELLS, V26, P903, DOI 10.1634/stemcells.2007-0951; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Stadtfeld M, 2008, CURR BIOL, V18, P890, DOI 10.1016/j.cub.2008.05.010; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Weng L, 2006, BIOINFORMATICS, V22, P1111, DOI 10.1093/bioinformatics/btl045; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yang J, 2008, DEV CELL, V14, P818, DOI 10.1016/j.devcel.2008.05.009; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	408	456	0	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					340	345		10.1016/j.stem.2008.08.003	http://dx.doi.org/10.1016/j.stem.2008.08.003			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786420	Green Accepted, Bronze			2022-12-28	WOS:000259665000016
J	Pang, R; Law, WL; Chu, ACY; Poon, JT; Lam, CSC; Chow, AKM; Ng, L; Cheung, LWH; Lan, XR; Lan, HY; Tan, VPY; Yau, TC; Poon, RT; Wong, BCY				Pang, Roberta; Law, Wai Lun; Chu, Andrew C. Y.; Poon, Jensen T.; Lam, Cohn S. C.; Chow, Ariel K. M.; Ng, Lui; Cheung, Leonard W. H.; Lan, Xiao R.; Lan, Hui Y.; Tan, Victoria P. Y.; Yau, Thomas C.; Poon, Ronnie T.; Wong, Benjamin C. Y.			A Subpopulation of CD26(+) Cancer Stem Cells with Metastatic Capacity in Human Colorectal Cancer	CELL STEM CELL			English	Article							DIPEPTIDYL-PEPTIDASE-IV; HUMAN PANCREATIC-CANCER; ACUTE MYELOID-LEUKEMIA; BREAST-CANCER; EXTRACELLULAR-MATRIX; INITIATING CELLS; CARCINOMA CELLS; TUMOR-GROWTH; E-CADHERIN; IDENTIFICATION	Recent evidence suggests that a subpopulation of cancer cells, cancer stem cells (CSCs), is responsible for tumor growth in colorectal cancer. However, the role of CSCs in colorectal cancer metastasis is unclear. Here, we identified a subpopulation of CD26(+) cells uniformly present in both the primary and metastatic tumors in colorectal cancer patients with liver metastasis. Furthermore, in patients without distant metastasis at the time of presentation, the presence of CD26(+) cells in their primary tumors predicted distant metastasis on follow-up. Isolated CD26(+) cells, but not CD26(-) cells, led to development of distant metastasis when injected into the mouse cecal wall. CD26(+) cells were also associated with enhanced invasiveness and chemoresistance. Our findings have uncovered a critical role of CSCs in metastatic progression of cancer. Furthermore, the ability to predict metastasis based on analysis of CSC subsets in the primary tumor may have important clinical implication as a selection criterion for adjuvant therapy.	[Pang, Roberta; Lam, Cohn S. C.; Ng, Lui; Cheung, Leonard W. H.; Lan, Xiao R.; Lan, Hui Y.; Tan, Victoria P. Y.; Yau, Thomas C.; Wong, Benjamin C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China; [Pang, Roberta; Chu, Andrew C. Y.; Chow, Ariel K. M.; Poon, Ronnie T.; Wong, Benjamin C. Y.] Univ Hong Kong, Li Ka Shing Fac Med, Ctr Canc Res, Pokfulam, Hong Kong, Peoples R China; [Law, Wai Lun; Poon, Jensen T.; Poon, Ronnie T.] Univ Hong Kong, Li Ka Shing Fac Med, Dept Surg, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Wong, BCY (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	bcywong@hku.hk	Lan, Hui Yao/C-9734-2015; Wong, Benjamin Chun Yu/ABB-1962-2020; Chow, Ariel/HGF-2363-2022; Poon, Jensen/E-1252-2012; Ng, Lui/AAG-4397-2019; Cheung, Leonard Wing Hong/E-8033-2010; Yau, Thomas Chung Cheung/B-3429-2011	Lan, Hui Yao/0000-0003-4283-9755; Ng, Lui/0000-0002-9010-2654; Cheung, Leonard Wing Hong/0000-0002-9293-8287; Yau, Thomas Chung Cheung/0000-0002-7114-0305; Chow, Ariel/0000-0002-5729-5415	Strategic Research Theme of Cancer; Seed Funding Research Grant; University of Hong Kong	Strategic Research Theme of Cancer; Seed Funding Research Grant; University of Hong Kong(University of Hong Kong)	We thank A.M. Cheung for technical assistance in flow cytometry analysis, R. De Maria and X.W. Wang for critical discussion of the manuscript, A. Chan and S.Y. Fan for specimen collection, and G.S.W. Tsao for support. This study is supported by Strategic Research Theme of Cancer, Seed Funding Research Grant, and Donation of the Li Ka Shing Foundation of Matching Grants of The University of Hong Kong.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Benoist S, 2006, J CLIN ONCOL, V24, P3939, DOI 10.1200/JCO.2006.05.8727; Bischoff SC, 1997, J IMMUNOL, V159, P5560; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Boyle P, 2005, ANN ONCOL, V16, P481, DOI 10.1093/annonc/mdi098; Chung DC, 1998, GASTROENTEROLOGY, V114, P1330, DOI 10.1016/S0016-5085(98)70441-X; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dallas NA, 2009, CANCER RES, V69, P1951, DOI 10.1158/0008-5472.CAN-08-2023; De La Haba-Rodriguez J, 2002, NEOPLASMA, V49, P307; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Ferrand A, 2009, BBA-MOL CELL RES, V1793, P477, DOI 10.1016/j.bbamcr.2009.01.004; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gutova M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000243; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Havre PA, 2008, FRONT BIOSCI-LANDMRK, V13, P1634, DOI 10.2741/2787; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hirai K, 1999, PATHOL INT, V49, P264, DOI 10.1046/j.1440-1827.1999.00859.x; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Inamoto T, 2006, CLIN CANCER RES, V12, P3470, DOI 10.1158/1078-0432.CCR-06-0361; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kajiyama H, 2003, CANCER RES, V63, P2278; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; LaBarge MA, 2008, J CLIN INVEST, V118, P2021, DOI 10.1172/JCI36046; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Moll R, 1998, Subcell Biochem, V31, P205; Mueller MT, 2009, GASTROENTEROLOGY, V137, P1102, DOI 10.1053/j.gastro.2009.05.053; Mulrooney JP, 2001, J CELL SCI, V114, P2525; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Peinado H, 2004, J CELL SCI, V117, P2827, DOI 10.1242/jcs.01145; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Pro B, 2004, HISTOL HISTOPATHOL, V19, P1345, DOI 10.14670/HH-19.1345; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Sato T, 2005, CANCER RES, V65, P6950, DOI 10.1158/0008-5472.CAN-05-0647; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; STANLEY R, 2000, PATHOLOGY GENETICS T; Sun YX, 2008, CLIN EXP METASTAS, V25, P765, DOI 10.1007/s10585-008-9188-9; Tang C, 2007, FASEB J, V21, P3777, DOI 10.1096/fj.07-8560rev; Thompson MA, 2007, MINI-REV MED CHEM, V7, P253, DOI 10.2174/138955707780059853; Wei J, 2008, CANCER CELL, V13, P483, DOI 10.1016/j.ccr.2008.04.020; Weigelt B, 2008, SEMIN CANCER BIOL, V18, P311, DOI 10.1016/j.semcancer.2008.03.013; Yamaguchi U, 2008, J CLIN ONCOL, V26, P4100, DOI 10.1200/JCO.2007.14.2331	47	408	435	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					603	615		10.1016/j.stem.2010.04.001	http://dx.doi.org/10.1016/j.stem.2010.04.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569697	Bronze			2022-12-28	WOS:000278840700020
J	Franco, CB; Chen, CC; Drukker, M; Weissman, IL; Galli, SJ				Franco, Christopher B.; Chen, Ching-Cheng; Drukker, Micha; Weissman, Irving L.; Galli, Stephen J.			Distinguishing Mast Cell and Granulocyte Differentiation at the Single-Cell Level	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; IN-VITRO; LINEAGES; EXPRESSION; PROGENITOR; IDENTIFICATION; GATA-1; ROLES; MICE	The lineage restriction of prospectively isolated hematopoietic progenitors has been traditionally assessed by bulk in vitro culture and transplantation of large number of cells in vivo. These methods, however, cannot distinguish between homogenous multipotent or heterogeneous lineage-restricted populations. Using clonal assays of 1 or 5 cells in vitro, single-cell quantitative gene expression analyses, and transplantation of mice with low numbers of cells, we show that a common myeloid progenitor (CMP) is Sca-1(lo)lin(-)c-Kit(+)CD27(+)Flk-2(-) (SL-CMP; Sca-1(lo) CMP) and a granulocyte/macrophage progenitor (GMP) is Sca-1(lo)lin(-)c-Kit(+)CD27(+)Flk-2(+)CD150(-/lo) (SL-GMP; Sca-1(lo) GMP). We found that mast cell progenitor potential is present in the SL-CMP fraction, but not in the more differentiated SL-GMP population, and is more closely related to megakaryocyte/erythrocyte specification. Our data provide criteria for the prospective isolation of SL-CMP and SL-GMP and support the conclusion that mast cells are specified during hematopoiesis earlier than and independently from granulocytes.	[Franco, Christopher B.; Chen, Ching-Cheng; Drukker, Micha; Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Galli, Stephen J.] Stanford Univ, Sch Med, Dept Microbiol & Immunol, Stanford, CA 94305 USA; [Franco, Christopher B.; Chen, Ching-Cheng; Weissman, Irving L.; Galli, Stephen J.] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University	Chen, CC (corresponding author), NGM Biopharmaceut Inc, 630 Gateway Blvd, San Francisco, CA 94080 USA.			Drukker, Micha/0000-0002-4279-1125; Chen, Ching-Cheng/0000-0003-4499-0889	NIH [AI23990, AI070813, CA72074, CA086065, HL058770, 5K99HL087936]; National Science Foundation Graduate Research Fellowship; Human Frontiers Science Program; NATIONAL CANCER INSTITUTE [R01CA086065, R01CA072074] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL058770, K99HL087936, R00HL087936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023990, R01AI070813, R37AI023990, T32AI007290] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation Graduate Research Fellowship(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank members of the I LW and S J G laboratories for helpful discussions, particularly R Lu, T Serwold, and J Seita We also thank L Jerabek for excellent lab management, C Muscat for antibody conjugation, and A Mosely for animal husbandry This work was supported by NIH grants AI23990, AI070813, and CA72074 (to S J G) and CA086065 and HL058770 (to I L W). a National Science Foundation Graduate Research Fellowship (to C B F), an NIH Pathway to Independence award 5K99HL087936 (to C -C C). and a Human Frontiers Science Program postdoctoral fellowship (to M D)	Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Baroni E, 2007, J LEUKOCYTE BIOL, V81, P250, DOI 10.1189/jlb.0506322; Bischoff SC, 2007, NAT REV IMMUNOL, V7, P93, DOI 10.1038/nri2018; Chen CC, 2005, P NATL ACAD SCI USA, V102, P11408, DOI 10.1073/pnas.0504197102; DVORAK AM, 1994, AM J PATHOL, V144, P160; Feyerabend TB, 2009, IMMUNITY, V30, P67, DOI 10.1016/j.immuni.2008.10.016; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Iwasaki H, 2003, IMMUNITY, V19, P451, DOI 10.1016/S1074-7613(03)00242-5; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; KITAMURA Y, 1977, NATURE, V268, P442, DOI 10.1038/268442a0; KITAMURA Y, 1989, ANNU REV IMMUNOL, V7, P59, DOI 10.1146/annurev.iy.07.040189.000423; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; OGAWA M, 1989, HEMATOL ONCOL CLIN N, V3, P453, DOI 10.1016/S0889-8588(18)30541-0; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Rao KN, 2008, ANN NY ACAD SCI, V1143, P83, DOI 10.1196/annals.1443.023; REYNOLDS DS, 1989, J BIOL CHEM, V264, P20094; Rodewald HR, 1996, SCIENCE, V271, P818, DOI 10.1126/science.271.5250.818; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Schmitt TM, 2004, NAT IMMUNOL, V5, P410, DOI 10.1038/ni1055; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SUDA T, 1983, P NATL ACAD SCI-BIOL, V80, P6689, DOI 10.1073/pnas.80.21.6689; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; Wagers AJ, 2002, EXP HEMATOL, V30, P176, DOI 10.1016/S0301-472X(01)00777-9	29	72	73	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					361	368		10.1016/j.stem.2010.02.013	http://dx.doi.org/10.1016/j.stem.2010.02.013			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362540	Green Accepted, Bronze			2022-12-28	WOS:000276823300014
J	Hanjaya-Putra, D; Gerecht, S				Hanjaya-Putra, Donny; Gerecht, Sharon			Mending the Failing Heart with a Vascularized Cardiac Patch	CELL STEM CELL			English	Editorial Material							MUSCLE; TISSUE; CELLS		[Gerecht, Sharon] Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA; Johns Hopkins Univ, Inst NanoBio Technol, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins University	Gerecht, S (corresponding author), Johns Hopkins Univ, Johns Hopkins Phys Sci Oncol Ctr, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA.	gerecht@jhu.edu	Hanjaya-Putra, Donny/P-1611-2017; Gerecht, Sharon/A-3388-2010	Hanjaya-Putra, Donny/0000-0002-3039-9206				Caspi O, 2007, CIRC RES, V100, P263, DOI 10.1161/01.RES.0000257776.05673.ff; Dvir T, 2009, P NATL ACAD SCI USA, V106, P14990, DOI 10.1073/pnas.0812242106; Hansson EM, 2009, CELL STEM CELL, V5, P364, DOI 10.1016/j.stem.2009.09.004; Hirschi KK, 1998, J CELL BIOL, V141, P805, DOI 10.1083/jcb.141.3.805; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Lesman A, 2010, TISSUE ENG PT A, V16, P115, DOI [10.1089/ten.tea.2009.0130, 10.1089/ten.TEA.2009.0130]; Levenberg S, 2005, NAT BIOTECHNOL, V23, P879, DOI 10.1038/nbt1109; Song H, 2010, P NATL ACAD SCI USA, V107, P3329, DOI 10.1073/pnas.0905729106; Vunjak-Novakovic G, 2010, TISSUE ENG PART B-RE, V16, P169, DOI [10.1089/ten.teb.2009.0352, 10.1089/ten.TEB.2009.0352]	9	12	12	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					575	576		10.1016/j.stem.2009.11.005	http://dx.doi.org/10.1016/j.stem.2009.11.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951684	Bronze			2022-12-28	WOS:000273616700004
J	Kohwi, M; Doe, CQ				Kohwi, Minoree; Doe, Chris Q.			Stem Cell Transcriptional Loops Generate Precise Temporal Identity	CELL STEM CELL			English	Editorial Material							SPECIFICATION; DROSOPHILA; LINEAGE		[Kohwi, Minoree; Doe, Chris Q.] Univ Oregon, Inst Neurosci, Eugene, OR 97405 USA; [Kohwi, Minoree; Doe, Chris Q.] Univ Oregon, Inst Mol Biol, Eugene, OR 97405 USA; [Kohwi, Minoree; Doe, Chris Q.] Univ Oregon, Howard Hughes Med Inst, Eugene, OR 97405 USA	University of Oregon; University of Oregon; Howard Hughes Medical Institute; University of Oregon	Doe, CQ (corresponding author), Univ Oregon, Inst Neurosci, Eugene, OR 97405 USA.	cdoe@uoneuro.uoregon.edu						Abrahante JE, 2003, DEV CELL, V4, P625, DOI 10.1016/S1534-5807(03)00127-8; Baumgardt M, 2009, CELL, V139, P969, DOI 10.1016/j.cell.2009.10.032; Elliott J, 2008, NEURON, V60, P26, DOI 10.1016/j.neuron.2008.08.008; Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379; Isshiki T, 2001, CELL, V106, P511, DOI 10.1016/S0092-8674(01)00465-2; Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034; Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142; Rubenstein JLR, 1998, ANNU REV NEUROSCI, V21, P445, DOI 10.1146/annurev.neuro.21.1.445; Tran KD, 2008, DEVELOPMENT, V135, P3491, DOI 10.1242/dev.024349	9	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					577	578		10.1016/j.stem.2009.11.004	http://dx.doi.org/10.1016/j.stem.2009.11.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951685	Bronze			2022-12-28	WOS:000273616700005
J	Idelson, M; Alper, R; Obolensky, A; Ben-Shushan, E; Hemo, I; Yachimovich-Cohen, N; Khaner, H; Smith, Y; Wiser, O; Gropp, M; Cohen, MA; Even-Ram, S; Berman-Zaken, Y; Matzrafi, L; Rechavi, G; Banin, E; Reubinoff, B				Idelson, Maria; Alper, Ruslana; Obolensky, Alexey; Ben-Shushan, Etti; Hemo, Itzhak; Yachimovich-Cohen, Nurit; Khaner, Hanita; Smith, Yoav; Wiser, Ofer; Gropp, Michal; Cohen, Malkiel A.; Even-Ram, Sharona; Berman-Zaken, Yael; Matzrafi, Limor; Rechavi, Gideon; Banin, Eyal; Reubinoff, Benjamin			Directed Differentiation of Human Embryonic Stem Cells into Functional Retinal Pigment Epithelium Cells	CELL STEM CELL			English	Article							RCS RATS; PHOTORECEPTOR DEGENERATION; EYE DEVELOPMENT; VISUAL FUNCTION; NICOTINAMIDE; TRANSPLANTATION; PRESERVATION; CONTRIBUTES; INHIBITOR; LONGEVITY	Dysfunction and loss of retinal pigment epithelium (RPE) leads to degeneration of photoreceptors in age-related macular degeneration and subtypes of retinitis pigmentosa. Human embryonic stem cells (hESCs) may serve as an unlimited source of RPE cells for transplantation in these blinding conditions. Here we show the directed differentiation of hESCs toward an RPE fate under defined culture conditions. We demonstrate that nicotinamide promotes the differentiation of hESCs to neural and subsequently to RPE fate. In the presence of nicotinamide, factors from the TGF-beta superfamily, which presumably pattern RIDE development during embryogenesis, further direct RPE differentiation. The hESC-derived pigmented cells exhibit the morphology, marker expression, and function of authentic RPE and rescue retinal structure and function after transplantation to an animal model of retinal degeneration caused by RPE dysfunction. These results are an important step toward the future use of hESCs to replenish RPE in blinding diseases.	[Idelson, Maria; Ben-Shushan, Etti; Yachimovich-Cohen, Nurit; Khaner, Hanita; Gropp, Michal; Cohen, Malkiel A.; Even-Ram, Sharona; Berman-Zaken, Yael; Reubinoff, Benjamin] Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, IL-91120 Jerusalem, Israel; [Idelson, Maria; Ben-Shushan, Etti; Yachimovich-Cohen, Nurit; Khaner, Hanita; Gropp, Michal; Cohen, Malkiel A.; Even-Ram, Sharona; Berman-Zaken, Yael; Reubinoff, Benjamin] Hadassah Hebrew Univ Med Ctr, Dept Gynecol, IL-91120 Jerusalem, Israel; [Smith, Yoav] Hadassah Hebrew Univ Med Ctr, Genom Data Anal Unit, IL-91120 Jerusalem, Israel; [Alper, Ruslana; Obolensky, Alexey; Hemo, Itzhak; Banin, Eyal] Hadassah Hebrew Univ Med Ctr, Ctr Retinal & Macular Degenerat, Dept Ophthalmol, IL-91120 Jerusalem, Israel; [Wiser, Ofer; Matzrafi, Limor] CellCure Neurosci Ltd, IL-91120 Jerusalem, Israel; [Rechavi, Gideon] Chaim Sheba Med Ctr, Pediat Hematooncol Dept, IL-52621 Tel Aviv, Israel; [Rechavi, Gideon] Chaim Sheba Med Ctr, Inst Hematol, IL-52621 Tel Aviv, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Hebrew University of Jerusalem; Chaim Sheba Medical Center; Chaim Sheba Medical Center	Reubinoff, B (corresponding author), Hadassah Hebrew Univ Med Ctr, Goldyne Savad Inst Gene Therapy, Hadassah Human Embryon Stem Cell Res Ctr, IL-91120 Jerusalem, Israel.	benjaminr@ekmd.huji.ac.il	Cohen, Malkiel/AAE-1115-2020	Cohen, Malkiel/0000-0002-4187-691X; Reubinoff, Benjamin/0000-0003-0353-1299; Even-Ram, Sharona/0000-0002-5540-3822	Hadassah Hebrew University Medical Center; Israel Science Foundation [989/07]; Chief Scientist Office of the Israel Ministry of Health [3000003274]; Israel Ministry of Science, Yedidut Research Grant; Sidney Swartz Chair in Human Embryonic Stem Cell Research; CellCure Neurosciences Ltd; CSO of CellCure Neurosciences	Hadassah Hebrew University Medical Center; Israel Science Foundation(Israel Science Foundation); Chief Scientist Office of the Israel Ministry of Health; Israel Ministry of Science, Yedidut Research Grant; Sidney Swartz Chair in Human Embryonic Stem Cell Research; CellCure Neurosciences Ltd; CSO of CellCure Neurosciences	We gratefully acknowledge the following members of the Hadassah Embryonic Stem Cell Research Center: Talia Mordechai, Michal Aharonowiz, and Galit Tzur for technical support and Shelly Tannenbaum for editing the manuscript. We also gratefully acknowledge Vitali Shilo from CellCure Neurosciences Ltd. for helping with cell counting and Temima Schnitzer Perlman from The Goldyne Savad Institute of Gene Therapy for helping with the deposit of the microarray data. We thank Ruth Yaul from the Hadassah Center for Retinal and Macular Degeneration for excellent technical assistance and to Israel Barzel and Marina Schulman from the department of Ophthalmology for their help in fundus imaging in vivo. We thank Michal Lotern (Sharett Institute of Oncology, Hadassah University Hospital) for her kind gift of human melanoma cell line M51 and WiCell Research Institute (Madison, WI) for providing H7 hESCs. Many thanks to John C. Saari (University of Washington, Seattle, WA) for providing the CRALBP antibody, to Micha Spira (Faculty of Science, Hebrew University, Jerusalem) for providing the green fluorescent beads, and to Naomi Feinstein and Hava Glickstein from The Department of Electron Microscopy (Hebrew University, Jerusalem) for their help in obtaining electron microscopy images. This research was supported in part by a grant to Hadassah Hebrew University Medical Center by the Israel Science Foundation (grant No. 989/07), the Chief Scientist Office of the Israel Ministry of Health (grant No. 3000003274), the Israel Ministry of Science, Yedidut Research Grant, and the Sidney Swartz Chair in Human Embryonic Stem Cell Research. N.Y.-C., H.K., M.G., and Y.B.-Z. are partially supported by a grant from CellCure Neurosciences Ltd. O.W. and L.M. are employees of CellCure Neurosciences, and B.R. is a founder, shareholder, and CSO of CellCure Neurosciences.	Aoki H, 2006, EXP EYE RES, V82, P265, DOI 10.1016/j.exer.2005.06.021; Ben-Dor I, 2006, MOL THER, V14, P255, DOI 10.1016/j.ymthe.2006.02.010; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P271, DOI 10.2174/156720205774322584; Cimadamore F, 2009, STEM CELLS, V27, P1772, DOI 10.1002/stem.107; Coffey PJ, 2002, NAT NEUROSCI, V5, P53, DOI 10.1038/nn782; D'Cruz PM, 2000, HUM MOL GENET, V9, P645, DOI 10.1093/hmg/9.4.645; da Cruz L, 2007, PROG RETIN EYE RES, V26, P598, DOI 10.1016/j.preteyeres.2007.07.001; Draghici S, 2003, NUCLEIC ACIDS RES, V31, P3775, DOI 10.1093/nar/gkg624; Fuhrmann S, 2000, DEVELOPMENT, V127, P4599; Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3; Harrison CA, 2003, J BIOL CHEM, V278, P21129, DOI 10.1074/jbc.M302015200; Haruta M, 2004, INVEST OPHTH VIS SCI, V45, P1020, DOI 10.1167/iovs.03-1034; Haruta Masathoshi, 2005, Semin Ophthalmol, V20, P17, DOI 10.1080/08820530590921846; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Klimanskaya I, 2004, CLONING STEM CELLS, V6, P217, DOI 10.1089/clo.2004.6.217; Kubota A, 2006, BIOMATERIALS, V27, P3639, DOI 10.1016/j.biomaterials.2006.02.018; Li FQ, 2006, CURR MED CHEM, V13, P883, DOI 10.2174/092986706776361058; Lin N, 1996, CURR EYE RES, V15, P1069, DOI 10.3109/02713689609017657; Little CW, 1996, INVEST OPHTH VIS SCI, V37, P204; Lund RD, 2006, CLONING STEM CELLS, V8, P189, DOI 10.1089/clo.2006.8.189; Martinez-Morales JR, 2004, BIOESSAYS, V26, P766, DOI 10.1002/bies.20064; Osakada F, 2008, NAT BIOTECHNOL, V26, P215, DOI 10.1038/nbt1384; OTONKOSKI T, 1993, J CLIN INVEST, V92, P1459, DOI 10.1172/JCI116723; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Paquet-Durand F, 2007, J NEUROSCI, V27, P10311, DOI 10.1523/JNEUROSCI.1514-07.2007; Prozorovski T, 2008, NAT CELL BIOL, V10, P385, DOI 10.1038/ncb1700; Reubinoff BE, 2000, NAT BIOTECHNOL, V18, P399, DOI 10.1038/74447; Sauve Y, 2002, NEUROSCIENCE, V114, P389, DOI 10.1016/S0306-4522(02)00271-3; Shen CC, 2004, J BIOMED SCI, V11, P472, DOI [10.1159/000077897, 10.1007/BF02256096]; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Tao W, 2002, INVEST OPHTH VIS SCI, V43, P3292; Taylor RA, 2006, NAT METHODS, V3, P179, DOI 10.1038/nmeth855; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vugler A, 2008, EXP NEUROL, V214, P347, DOI 10.1016/j.expneurol.2008.09.007	35	335	379	1	51	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					396	408		10.1016/j.stem.2009.07.002	http://dx.doi.org/10.1016/j.stem.2009.07.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796620	Bronze			2022-12-28	WOS:000271401900011
J	Robin, C; Bollerot, K; Mendes, S; Haak, E; Crisan, M; Cerisoli, F; Lauw, I; Kaimakis, P; Jorna, R; Vermeulen, M; Kayser, M; van der Linden, R; Imanirad, P; Verstegen, M; Nawaz-Yousaf, H; Papazian, N; Steegers, E; Cupedo, T; Dzierzak, E				Robin, Catherine; Bollerot, Karine; Mendes, Sandra; Haak, Esther; Crisan, Mihaela; Cerisoli, Francesco; Lauw, Ivoune; Kaimakis, Polynikis; Jorna, Ruud; Vermeulen, Mark; Kayser, Manfred; van der Linden, Reinier; Imanirad, Parisa; Verstegen, Monique; Nawaz-Yousaf, Humaira; Papazian, Natalie; Steegers, Eric; Cupedo, Tom; Dzierzak, Elaine			Human Placenta Is a Potent Hematopoietic Niche Containing Hematopoietic Stem and Progenitor Cells throughout Development	CELL STEM CELL			English	Article							BONE-MARROW; YOLK-SAC; DEFINITIVE HEMATOPOIESIS; CHORIONIC VILLI; BLOOD; MOUSE; LINEAGE; IDENTIFICATION; CIRCULATION; EMERGENCE	Hematopoietic stem cells (HSCs) are responsible for the life-long production of the blood system and are pivotal cells in hematologic transplantation therapies. During mouse and human development, the first HSCs are produced in the aorta-gonad-mesonephros region. Subsequent to this emergence, HSCs are found in other anatomical sites of the mouse conceptus. While the mouse placenta contains abundant HSCs at midgestation, little is known concerning whether HSCs or hematopoietic progenitors are present and supported in the human placenta during development. In this study we show, over a range of developmental times including term, that the human placenta contains hematopoietic progenitors and HSCs. Moreover, stromal cell lines generated from human placenta at several developmental time points are pericyte-like cells and support human hematopoiesis. Immunostaining of placenta sections during development localizes hematopoietic cells in close contact with pericytes/perivascular cells. Thus, the human placenta is a potent hematopoietic niche throughout development.	[Robin, Catherine; Bollerot, Karine; Mendes, Sandra; Haak, Esther; Crisan, Mihaela; Cerisoli, Francesco; Lauw, Ivoune; Kaimakis, Polynikis; Jorna, Ruud; van der Linden, Reinier; Imanirad, Parisa; Nawaz-Yousaf, Humaira; Dzierzak, Elaine] Erasmus Univ, Med Ctr, Dept Cell Biol, Erasmus MC Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands; [Verstegen, Monique; Papazian, Natalie; Cupedo, Tom] Erasmus Univ, Med Ctr, Dept Hematol, NL-3000 CA Rotterdam, Netherlands; [Vermeulen, Mark; Kayser, Manfred] Erasmus Univ, Med Ctr, Dept Forens Mol Biol, NL-3000 CA Rotterdam, Netherlands; [Steegers, Eric] Erasmus Univ, Med Ctr, Dept Obstet & Gynecol, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Dzierzak, E (corresponding author), Erasmus Univ, Med Ctr, Dept Cell Biol, Erasmus MC Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands.	e.dzierzak@erasmusmc.nl	Cupedo, Tom/GQQ-0614-2022	Kaimakis, Polynikis/0000-0002-2928-1729; Verstegen, Monique/0000-0001-9908-6673; van der Linden, Reinier/0000-0001-7437-8901	Landsteiner Society for Blood Research [0614]; NIH [DK51077]; Dutch BSIK Stem Cells in Development and Disease [03038]; Dutch BSIK Tissue Engineering; NWO VIDI [917.76.345]; Marie Curie Fellowship [CT-2006-025333]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK054077] Funding Source: NIH RePORTER	Landsteiner Society for Blood Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dutch BSIK Stem Cells in Development and Disease; Dutch BSIK Tissue Engineering; NWO VIDI(Netherlands Organization for Scientific Research (NWO)); Marie Curie Fellowship(European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the research nurses Joke van Rhee-Binkorst and Wilma Keller (Erasmus MC), the staff of the CASA clinics in Leiden and Rotterdam and other clinical personnel, and most importantly, the tissue donors for their pivotal contributions. We also thank Frederik Walberg, Christiane Kuhl, and Tomomasa Yokomizo for experimental assistance and Kay Ballantyne for assistance in the statistical interpretation of STR profiles. Support was kindly provided by the Landsteiner Society for Blood Research (0614), NIH R37 (DK51077), Dutch BSIK Stem Cells in Development and Disease (03038), Dutch BSIK Tissue Engineering, NWO VIDI (917.76.345) (C.R.), and a Marie Curie Fellowship (CT-2006-025333) (K.B.).	Alvarez-Silva M, 2003, DEVELOPMENT, V130, P5437, DOI 10.1242/dev.00755; Bailo M, 2004, TRANSPLANTATION, V78, P1439, DOI 10.1097/01.TP.0000144606.84234.49; Barcena A, 2009, DEV BIOL, V327, P24, DOI 10.1016/j.ydbio.2008.11.017; Becker M, 2002, BRIT J CANCER, V87, P1328, DOI 10.1038/sj.bjc.6600573; Bhatia M, 1998, NAT MED, V4, P1038, DOI 10.1038/2023; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Cashman J, 1997, BRIT J HAEMATOL, V98, P1026, DOI 10.1046/j.1365-2141.1997.3233140.x; Challier JC, 2005, PLACENTA, V26, P282, DOI 10.1016/j.placenta.2004.06.007; Chen YK, 2009, CANCER LETT, V278, P113, DOI 10.1016/j.canlet.2009.01.004; Corbel C, 2007, DEV BIOL, V301, P478, DOI 10.1016/j.ydbio.2006.08.069; Coulombel L, 2004, ONCOGENE, V23, P7210, DOI 10.1038/sj.onc.1207941; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Cumano A, 1996, CELL, V86, P907, DOI 10.1016/S0092-8674(00)80166-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Durand C, 2006, HAEMATOLOGICA, V91, P1172; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gekas C, 2005, DEV CELL, V8, P365, DOI 10.1016/j.devcel.2004.12.016; Gude NM, 2004, THROMB RES, V114, P397, DOI 10.1016/j.thromres.2004.06.038; HANN IM, 1983, BLOOD, V62, P118; Igura K, 2004, CYTOTHERAPY, V6, P543, DOI 10.1080/14653240410005366-1; in't Anker PS, 2004, STEM CELLS, V22, P1338, DOI 10.1634/stemcells.2004-0058; Kim SJ, 2007, STEM CELLS DEV, V16, P421, DOI 10.1089/scd.2006.0098; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Larochelle A, 1996, NAT MED, V2, P1329, DOI 10.1038/nm1296-1329; LI CD, 2005, PLACENTA IN PRESS; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Miao ZN, 2006, CELL BIOL INT, V30, P681, DOI 10.1016/j.cellbi.2006.03.009; Miyamoto K, 2004, STEM CELLS, V22, P433, DOI 10.1634/stemcells.22-4-433; Oberlin E, 2002, DEVELOPMENT, V129, P4147; Ottersbach K, 2005, DEV CELL, V8, P377, DOI 10.1016/j.devcel.2005.02.001; Palis J, 1999, DEVELOPMENT, V126, P5073; Parolini O, 2008, STEM CELLS, V26, P300, DOI 10.1634/stemcells.2007-0594; Pflumio F, 1996, BLOOD, V88, P3731, DOI 10.1182/blood.V88.10.3731.bloodjournal88103731; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Rhodes KE, 2008, CELL STEM CELL, V2, P252, DOI 10.1016/j.stem.2008.01.001; SULLIVAN KM, 1993, BIOTECHNIQUES, V15, P636; SULLIVAN KM, 1990, BIOTECHNIQUES, V15, P643; Tavian M, 2005, INT J DEV BIOL, V49, P243, DOI 10.1387/ijdb.041957mt; Tavian M, 2001, IMMUNITY, V15, P487, DOI 10.1016/S1074-7613(01)00193-5; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Tavian M, 1999, DEVELOPMENT, V126, P793; Tse W, 2008, CURR OPIN HEMATOL, V15, P279, DOI 10.1097/MOH.0b013e328304ae2c; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang JF, 2003, BLOOD, V101, P2924, DOI 10.1182/blood-2002-09-2782; WEIR BS, 2003, HDB STAT GENETICS, P830; Wulf GG, 2004, TISSUE ENG, V10, P1136, DOI 10.1089/ten.2004.10.1136; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; Zambidis ET, 2006, TRENDS CARDIOVAS MED, V16, P95, DOI 10.1016/j.tcm.2006.01.005; Zeigler BM, 2006, DEVELOPMENT, V133, P4183, DOI 10.1242/dev.02596; Zhang XH, 2006, BIOCHEM BIOPH RES CO, V340, P944, DOI 10.1016/j.bbrc.2005.12.091; Zhang Y, 2004, EXP HEMATOL, V32, P657, DOI 10.1016/j.exphem.2004.04.001	53	134	147	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					385	395		10.1016/j.stem.2009.08.020	http://dx.doi.org/10.1016/j.stem.2009.08.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796619	Green Accepted, Bronze			2022-12-28	WOS:000271401900010
J	Hofmann, I; Stover, EH; Cullen, DE; Mao, J; Morgan, KJ; Lee, BH; Kharas, MG; Miller, PG; Cornejo, MG; Okabe, R; Armstrong, SA; Ghilardi, N; Gould, S; de Sauvage, FJ; McMahon, AP; Gilliland, DG				Hofmann, Inga; Stover, Elizabeth H.; Cullen, Dana E.; Mao, Junhao; Morgan, Kelly J.; Lee, Benjamin H.; Kharas, Michael G.; Miller, Peter G.; Cornejo, Melanie G.; Okabe, Rachel; Armstrong, Scott A.; Ghilardi, Nico; Gould, Stephen; de Sauvage, Frederic J.; McMahon, Andrew P.; Gilliland, D. Gary			Hedgehog Signaling Is Dispensable for Adult Murine Hematopoietic Stem Cell Function and Hematopoiesis	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; SONIC HEDGEHOG; HUMAN HOMOLOG; BCR-ABL; CANCER; GENE; DIFFERENTIATION; MEDULLOBLASTOMA; PROLIFERATION; MAINTENANCE	We report the unexpected finding that loss of Hh signaling through conditional deletion of Smoothened (Smo) in the adult hematopoietic compartment has no apparent effect on adult hematopoiesis, including peripheral blood count, number or cell-cycle status of stem or progenitor cells, hematopoietic colony-forming potential, long-term repopulating activity in competitive repopulation assays, or stress response to serial 5-fluorouracil treatment. Furthermore, pharmacologic inhibition of Hh signaling with a potent and selective small molecule antagonist has no substantive effect on hematopoiesis in the mouse. In addition, Hh signaling is not required for the development of MLL-AF9-mediated acute myeloid leukemia (AML). Taken together, these data demonstrate that Hh signaling is dispensable for normal hematopoietic development and hematopoietic stem cell function, indicating that targeting of Hh signaling in solid tumors is not likely to result in hematopoietic toxicity. Furthermore, the Hh pathway may not be a compelling target in certain hematopoietic malignancies.	[Hofmann, Inga; Stover, Elizabeth H.; Cullen, Dana E.; Morgan, Kelly J.; Lee, Benjamin H.; Kharas, Michael G.; Miller, Peter G.; Cornejo, Melanie G.; Okabe, Rachel; Gilliland, D. Gary] Brigham & Womens Hosp, Div Hematol, Dept Med, Boston, MA 02115 USA; [Hofmann, Inga; Armstrong, Scott A.; Gilliland, D. Gary] Dana Farber Canc Inst, Boston, MA 02115 USA; [Hofmann, Inga; Stover, Elizabeth H.; Miller, Peter G.; Cornejo, Melanie G.; Armstrong, Scott A.; Gilliland, D. Gary] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Gilliland, D. Gary] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Gilliland, D. Gary] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Mao, Junhao; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Hofmann, Inga; Armstrong, Scott A.] Childrens Hosp, Boston, MA 02115 USA; [Ghilardi, Nico; Gould, Stephen; de Sauvage, Frederic J.] Genentech Inc, San Francisco, CA 94080 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Howard Hughes Medical Institute; Harvard University; Harvard University; Boston Children's Hospital; Roche Holding; Genentech	Gilliland, DG (corresponding author), Brigham & Womens Hosp, Div Hematol, Dept Med, 75 Francis St, Boston, MA 02115 USA.	ggilliland@rics.bwh.harvard.edu	McMahon, Andrew P/ABE-7520-2020; de Sauvage, Frederic/ABE-8400-2020	de Sauvage, Frederic/0000-0002-5275-2584; Miller, Peter/0000-0002-6797-9335; Cornejo, Melanie/0000-0001-6094-2719; Ghilardi, Nico/0000-0003-4945-3097	Leukemia and Lymphoma Society; National Institutes of Health (NIH); NIH/National Institute of Neurological Disorders and Stroke (NINDS) [R37NS033642]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642] Funding Source: NIH RePORTER	Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Emily Chan, Leslie Lee, and Maria Pitsiouni from Genentech and Allison Coburn, Elizabeth McDowell, and Sandra Moore from the Gilliland lab for technical support; and Thomas Mercher, Glen Raffel, Zuzanna Tothova, Claudia Scholl, and Stefan Frohling for valuable discussion. This work was supported in part by the Leukemia and Lymphoma Society and by National Institutes of Health (NIH) grants (D.G.G., E.H.S.). D.G.G is an Investigator of the Howard Hughes Medical Institute. Work in A.P.M.'s laboratory was supported in part by a grant from the NIH/National Institute of Neurological Disorders and Stroke (NINDS), R37NS033642. E.H.S. and I.H.Z. designed and performed research, analyzed data, and wrote the manuscript. F.J.d.S., N.G., and S.G. designed and performed research and analyzed data on the pharmacological experiments, participated in interpretation of data, and reviewed the manuscript. J.M. and A.P.M. generated the Smo mice, participated in design and interpretation of experiments, and reviewed the manuscript. S.A.A. participated in design and interpretation of experiments involving the MLL-AF9 fusion. D.G.G. designed research, analyzed data, and revised the paper. F.J.d.S., N.G., and S.G. are employees of Genentech, Inc. A.P.M. is a consultant for Merck.	Bhardwaj G, 2001, NAT IMMUNOL, V2, P172, DOI 10.1038/84282; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Corcoran RB, 2001, J NEURO-ONCOL, V53, P307, DOI 10.1023/A:1012260318979; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Detmer K, 2000, BLOOD CELL MOL DIS, V26, P360, DOI 10.1006/bcmd.2000.0318; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Dierks C, 2008, CANCER CELL, V14, P238, DOI 10.1016/j.ccr.2008.08.003; Dierks C, 2007, NAT MED, V13, P944, DOI 10.1038/nm1614; Dyer MA, 2001, DEVELOPMENT, V128, P1717; El Abdaloussi E, 2006, NAT IMMUNOL, V7, P418, DOI 10.1038/ni1313; Gao J, 2009, CELL STEM CELL, V4, P548, DOI 10.1016/j.stem.2009.03.015; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Hegde GV, 2008, MOL CANCER THER, V7, P1450, DOI 10.1158/1535-7163.MCT-07-2118; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Long FX, 2001, DEVELOPMENT, V128, P5099; Mikkola HKA, 2003, NATURE, V421, P547, DOI 10.1038/nature01345; Outram SV, 2000, IMMUNITY, V13, P187, DOI 10.1016/S1074-7613(00)00019-4; Peacock CD, 2007, P NATL ACAD SCI USA, V104, P4048, DOI 10.1073/pnas.0611682104; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Sacedon R, 2005, J IMMUNOL, V174, P1456, DOI 10.4049/jimmunol.174.3.1456; Scholl C, 2007, J CLIN INVEST, V117, P1037, DOI 10.1172/JCI30182; Sengupta A, 2007, LEUKEMIA, V21, P949, DOI 10.1038/sj.leu.2404657; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Taipale J, 2001, NATURE, V411, P349, DOI 10.1038/35077219; Trowbridge JJ, 2006, P NATL ACAD SCI USA, V103, P14134, DOI 10.1073/pnas.0604568103; Uhmann A, 2007, BLOOD, V110, P1814, DOI 10.1182/blood-2007-02-075648; Yauch RL, 2008, NATURE, V455, P406, DOI 10.1038/nature07275; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	36	136	143	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					559	567		10.1016/j.stem.2009.03.016	http://dx.doi.org/10.1016/j.stem.2009.03.016			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497284	Green Accepted, Bronze			2022-12-28	WOS:000266793600018
J	Fuchs, S; Herzog, D; Sumara, G; Buchmann-Moller, S; Civenni, G; Wu, XW; Chrostek-Grashoff, A; Suter, U; Ricci, R; Relvas, JB; Brakebusch, C; Sommer, L				Fuchs, Sebastian; Herzog, Dominik; Sumara, Grzegorz; Buechmann-Moller, Stine; Civenni, Gianluca; Wu, Xunwei; Chrostek-Grashoff, Anna; Suter, Ueli; Ricci, Romeo; Relvas, Joao B.; Brakebusch, Cord; Sommer, Lukas			Stage-Specific Control of Neural Crest Stem Cell Proliferation by the Small Rho GTPases Cdc42 and Rac1	CELL STEM CELL			English	Article							PERIPHERAL NERVOUS-SYSTEM; SELF-RENEWAL; DIGEORGE-SYNDROME; FAMILY GTPASES; GROWTH-FACTOR; BETA-CATENIN; MIGRATION; MAINTENANCE; PROGENITORS; FATE	The neural crest (NC) generates a variety of neural and non-neural tissues during vertebrate development. Both migratory NC cells and their target structures contain cells with stem cell features. Here we show that these populations of neural crest-derived stem cells (NCSCs) are differentially regulated by small Rho GTPases. Deletion of either Cdc42 or Rac1 in the NC results in size reduction of multiple NC target structures because of increased cell-cycle exit, while NC cells emigrating from the neural tube are not affected. Consistently, Cdc42 or Rac1 inactivation reduces self-renewal and proliferation of later stage, but not early migratory NCSCs. This stage-specific requirement for small Rho GTPases is due to changes in NCSCs that, during development, acquire responsiveness to mitogenic EGF acting upstream of both Cdc42 and Rac1. Thus, our data reveal distinct mechanisms for growth control of NCSCs from different developmental stages.	[Fuchs, Sebastian; Buechmann-Moller, Stine; Civenni, Gianluca; Sommer, Lukas] Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland; [Fuchs, Sebastian; Herzog, Dominik; Sumara, Grzegorz; Buechmann-Moller, Stine; Civenni, Gianluca; Suter, Ueli; Ricci, Romeo; Relvas, Joao B.; Sommer, Lukas] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Wu, Xunwei] Harvard Univ, Sch Med, MGH, CBRC, Charlestown, MA 02129 USA; [Chrostek-Grashoff, Anna] Univ Virginia Hlth Syst, Cardiovasc Res Ctr, Charlottesville, VA 22908 USA; [Brakebusch, Cord] Univ Copenhagen, Inst Mol Pathol, DK-2100 Copenhagen, Denmark	University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Harvard University; University of Virginia; University of Copenhagen	Sommer, L (corresponding author), Univ Zurich, Inst Anat, CH-8057 Zurich, Switzerland.	lukas.sommer@anatom.uzh.ch	Relvas, Joao B/A-1142-2008; Wu, Xunwei/J-9014-2018; Ricci, Romeo/K-3009-2013; Suter, Ueli/A-1624-2010	Relvas, Joao B/0000-0001-7636-0924; Wu, Xunwei/0000-0002-0822-1700; Ricci, Romeo/0000-0002-9766-4369; Sommer, Lukas/0000-0002-1143-7908; Brakebusch, Cord/0000-0002-9342-1634; Civenni, Gianluca/0000-0003-1921-161X; Sumara, Grzegorz/0000-0003-1502-6265	Swiss National Science Foundation; National Center of Competence in Research "Neural Plasticity and Repair,"; Vontobel Foundation; Oncosuisse/Swiss Cancer League; ETH; University of Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Center of Competence in Research "Neural Plasticity and Repair,"(Swiss National Science Foundation (SNSF)); Vontobel Foundation; Oncosuisse/Swiss Cancer League; ETH(ETH Zurich); University of Zurich	We thank A. McMahon and P. Soriano for providing transgenic animals and K. Wycisk for experimental support. This work was supported by the Swiss National Science Foundation, the National Center of Competence in Research "Neural Plasticity and Repair," the Vontobel Foundation, Oncosuisse/Swiss Cancer League, and the ETH and University of Zurich.	Benitah SA, 2005, SCIENCE, V309, P933, DOI 10.1126/science.1113579; Benninger Y, 2007, J CELL BIOL, V177, P1051, DOI 10.1083/jcb.200610108; Bixby S, 2002, NEURON, V35, P643, DOI 10.1016/S0896-6273(02)00825-5; Bondurand N, 2006, DEVELOPMENT, V133, P2075, DOI 10.1242/dev.02375; Cancelas JA, 2005, NAT MED, V11, P886, DOI 10.1038/nm1274; Cappello S, 2006, NAT NEUROSCI, V9, P1099, DOI 10.1038/nn1744; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Chen L, 2006, P NATL ACAD SCI USA, V103, P16520, DOI 10.1073/pnas.0603533103; Chrostek A, 2006, MOL CELL BIOL, V26, P6957, DOI 10.1128/MCB.00075-06; Ciccolini F, 2001, MOL CELL NEUROSCI, V17, P895, DOI 10.1006/mcne.2001.0980; Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Delfino-Machin M, 2007, DEV DYNAM, V236, P3242, DOI 10.1002/dvdy.21314; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Fanger GR, 1997, EMBO J, V16, P4961, DOI 10.1093/emboj/16.16.4961; Fukata M, 2003, CURR OPIN CELL BIOL, V15, P590, DOI 10.1016/S0955-0674(03)00097-8; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Guemar L, 2007, DEV BIOL, V310, P113, DOI 10.1016/j.ydbio.2007.07.031; Hari L, 2002, J CELL BIOL, V159, P867, DOI 10.1083/jcb.200209039; Ittner Lars M, 2005, J Biol, V4, P11, DOI 10.1186/jbiol29; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Kee Y, 2005, GENE DEV, V19, P744, DOI 10.1101/gad.1257405; Kleber M, 2005, J CELL BIOL, V169, P309, DOI 10.1083/jcb.200411095; Kruger GM, 2003, NEURON, V40, P917, DOI 10.1016/S0896-6273(03)00727-X; Le Douarin NM, 2003, CURR OPIN GENET DEV, V13, P529, DOI 10.1016/j.gde.2003.08.002; Lee HY, 2004, SCIENCE, V303, P1020, DOI 10.1126/science.1091611; Lillien L, 2000, DEVELOPMENT, V127, P4993; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Narumiya S, 2006, CURR OPIN CELL BIOL, V18, P199, DOI 10.1016/j.ceb.2006.02.002; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pietri T, 2004, DEVELOPMENT, V131, P3871, DOI 10.1242/dev.01264; Real C, 2006, DEV BIOL, V300, P656, DOI 10.1016/j.ydbio.2006.09.032; Schwartz MA, 2000, TRENDS BIOCHEM SCI, V25, P388, DOI 10.1016/S0968-0004(00)01605-4; Simpson MJ, 2007, DEV BIOL, V302, P553, DOI 10.1016/j.ydbio.2006.10.017; Sini P, 2004, NAT CELL BIOL, V6, P268, DOI 10.1038/ncb1096; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stewart AL, 2007, DEV BIOL, V307, P92, DOI 10.1016/j.ydbio.2007.04.024; Tallquist MD, 2003, DEVELOPMENT, V130, P507, DOI 10.1242/dev.00241; Vidali L, 2006, MOL BIOL CELL, V17, P2377, DOI 10.1091/mbc.e05-10-0955; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Wong CE, 2006, J CELL BIOL, V175, P1005, DOI 10.1083/jcb.200606062; Wu XW, 2006, GENE DEV, V20, P571, DOI 10.1101/gad.361406; Wurdak H, 2005, GENE DEV, V19, P530, DOI 10.1101/gad.317405; Wurdak H, 2006, BIOESSAYS, V28, P1078, DOI 10.1002/bies.20484; Yang L, 2007, P NATL ACAD SCI USA, V104, P5091, DOI 10.1073/pnas.0610819104	46	76	76	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					236	247		10.1016/j.stem.2009.01.017	http://dx.doi.org/10.1016/j.stem.2009.01.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265663	Green Accepted, Bronze			2022-12-28	WOS:000264369300014
J	Shen, XH; Orkin, SH				Shen, Xiaohua; Orkin, Stuart H.			Glimpses of the Epigenetic Landscape	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; GENOME; METHYLATION; PLURIPOTENT		[Shen, Xiaohua; Orkin, Stuart H.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute	Orkin, SH (corresponding author), Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu						Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	10	11	11	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					1	2		10.1016/j.stem.2008.12.006	http://dx.doi.org/10.1016/j.stem.2008.12.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128786	Bronze			2022-12-28	WOS:000262559500001
J	Di Giorgio, FP; Boulting, GL; Bobrowicz, S; Eggan, KC				Di Giorgio, Francesco Paolo; Boulting, Gabriella L.; Bobrowicz, Samuel; Eggan, Kevin C.			Human Embryonic Stem Cell-Derived Motor Neurons Are Sensitive to the Toxic Effect of Glial Cells Carrying an ALS-Causing Mutation	CELL STEM CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MOUSE MODEL; DRUG DISCOVERY; CYCLOOXYGENASE-2 INHIBITORS; HUMAN BLASTOCYSTS; SPINAL-CORD; DISEASE; DIFFERENTIATION; DISORDERS; LINES	It has been proposed that human embryonic stem cells could be used to provide an inexhaustible supply of differentiated cell types for the study of disease processes. Although methods for differentiating embryonic stem cells into specific cell types have become increasingly sophisticated, the utility of the resulting cells for modeling disease has not been determined. We have asked whether specific neuronal subtypes produced from human embryonic stem cells can be used to investigate the mechanisms leading to neural degeneration in amyotrophic lateral sclerosis (ALS). We show that human spinal motor neurons, but not interneurons, are selectively sensitive to the toxic effect of glial cells carrying an ALS-causing mutation in the SOD1 gene. Our findings demonstrate the relevance of these non-cell-autonomous effects to human motor neurons and more broadly demonstrate the utility of human embryonic stem cells for studying disease and identifying potential therapeutics.	[Di Giorgio, Francesco Paolo; Boulting, Gabriella L.; Bobrowicz, Samuel; Eggan, Kevin C.] Harvard Stem Cell Inst, Stowers Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA	Harvard University; Stowers Institute for Medical Research	Eggan, KC (corresponding author), Harvard Stem Cell Inst, Stowers Med Inst, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	eggan@mcb.harvard.edu	Eggan, Kevin/P-7119-2018	Boulting, Gabriella/0000-0003-2012-1259	Project ALS	Project ALS	Special thanks to Monica Carrasco and Tom Maniatis for kindly providing us with primary glial cultures from both nontransgenic and SOD1G93A animals, as well as for helpful discussions. We thank Lee Rubin for providing the small-molecule agonist of the Shh pathway; Hynek Wichterle and Stephane Nedelec for generating and providing the Hb9::GFP plasmid; Anastasie Kweudjeu for assistance with the microarray experiments; and Chris Henderson. Serge Przedborski. and Gist Croft for the helpful discussions. We also thank Tom M. Jessell and Susan Morlon for generously providing Hb9 antisera. We thank Project ALS for the donation of transgenic SOD1G93A mice and support of this work. F.P.D.G. is a NYSCF postdoctoral fellow. K.C.E. is a fellow of the John D. and Catherine T. MacArthur Foundation.	Almer G, 2001, ANN NEUROL, V49, P176, DOI 10.1002/1531-8249(20010201)49:2<176::AID-ANA37>3.0.CO;2-X; Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X; Ben-Nun IF, 2006, MOL CELL ENDOCRINOL, V252, P154, DOI 10.1016/j.mce.2006.03.034; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Brown RH, 1997, ARCH NEUROL-CHICAGO, V54, P1246, DOI 10.1001/archneur.1997.00550220050013; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Cole N, 1999, SEMIN NEUROL, V19, P407, DOI 10.1055/s-2008-1040855; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Cudkowicz ME, 2006, ANN NEUROL, V60, P22, DOI 10.1002/ana.20903; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Drachman DB, 2000, ANN NEUROL, V48, P792, DOI 10.1002/1531-8249(200011)48:5<792::AID-ANA14>3.3.CO;2-X; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; GAWARYLEWSKI A, 2007, SCIENTIST, V21, P45; Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541; Klimanskaya I, 2008, NAT REV DRUG DISCOV, V7, P131, DOI 10.1038/nrd2403; Klivenyi P, 2004, J NEUROCHEM, V88, P576, DOI 10.1046/j.1471-4159.2003.02160.x; Kondo M, 2002, P NATL ACAD SCI USA, V99, P7367, DOI 10.1073/pnas.112212599; Landers JE, 2008, NEUROLOGY, V70, P1179, DOI 10.1212/01.wnl.0000289760.85237.4e; Lensch MW, 2006, BLOOD, V107, P2605, DOI 10.1182/blood-2005-07-2991; Liem KF, 1997, CELL, V91, P127, DOI 10.1016/S0092-8674(01)80015-5; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Marchetto MCN, 2008, CELL STEM CELL, V3, P649, DOI 10.1016/j.stem.2008.10.001; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Osafune K, 2008, NAT BIOTECHNOL, V26, P313, DOI 10.1038/nbt1383; Pompl PN, 2003, FASEB J, V17, P725, DOI 10.1096/fj.02-0876fje; Pouton CW, 2007, NAT REV DRUG DISCOV, V6, P605, DOI 10.1038/nrd2194; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Roy NS, 2005, EXP NEUROL, V196, P224, DOI 10.1016/j.expneurol.2005.06.021; Rubin LL, 2008, CELL, V132, P549, DOI 10.1016/j.cell.2008.02.010; Sartipy P, 2007, DRUG DISCOV TODAY, V12, P688, DOI 10.1016/j.drudis.2007.07.005; Sturino CF, 2007, J MED CHEM, V50, P794, DOI 10.1021/jm0603668; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; van Es MA, 2008, NAT GENET, V40, P29, DOI 10.1038/ng.2007.52; Wichterle H, 2002, CELL, V110, P385, DOI 10.1016/S0092-8674(02)00835-8; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Zaheer A, 2007, J NEUROCHEM, V101, P364, DOI 10.1111/j.1471-4159.2006.04385.x; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	40	345	363	1	22	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					637	648		10.1016/j.stem.2008.09.017	http://dx.doi.org/10.1016/j.stem.2008.09.017			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041780	Bronze			2022-12-28	WOS:000261670900012
J	Hyun, I; Lindvall, O; Ahrlund-Richter, L; Cattaneo, E; Cavazzana-Calvo, M; Cossu, G; De Luca, M; Fox, IJ; Gerstle, C; Goldstein, RA; Hermeren, G; High, KA; Kim, HO; Lee, HP; Levy-Lahad, E; Li, L; Lo, B; Marshak, DR; Mcnab, A; Munsie, M; Nakauchi, H; Rao, M; Rooke, HM; Valles, CS; Srivastava, A; Sugarman, J; Taylor, PL; Veiga, A; Wong, AL; Zoloth, L; Daley, GQ				Hyun, Insoo; Lindvall, Olle; Ahrlund-Richter, Lars; Cattaneo, Elena; Cavazzana-Calvo, Marina; Cossu, Giulio; De Luca, Michele; Fox, Ira J.; Gerstle, Claude; Goldstein, Robert A.; Hermeren, Goran; High, Katherine A.; Kim, Hyun Ok; Lee, Hin Peng; Levy-Lahad, Ephrat; Li, Lingsong; Lo, Bernard; Marshak, Daniel R.; McNab, Angela; Munsie, Megan; Nakauchi, Hiromitsu; Rao, Mahendra; Rooke, Heather M.; Valles, Carlos Simon; Srivastava, Alok; Sugarman, Jeremy; Taylor, Patrick L.; Veiga, Anna; Wong, Adrianne L.; Zoloth, Laurie; Daley, George Q.			New ISSCR Guidelines Underscore Major Principles for Responsible Translational Stem Cell Research	CELL STEM CELL			English	Article									[Hyun, Insoo] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Lindvall, Olle] Wallenberg Neurosci Ctr, Sect Restorat Neurol, Lab Neurogenesis & Cell Therapy, SE-22184 Lund, Sweden; [Ahrlund-Richter, Lars] Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Cattaneo, Elena] Univ Milan, Ctr Stem Cell Res, I-20133 Milan, Italy; [Cavazzana-Calvo, Marina] Univ Paris 05, AP HP, Hop Necker, Dept Biotherapy, F-75015 Paris, France; [Cavazzana-Calvo, Marina] Univ Paris 05, AP HP, Hop Necker, Clin Investigat Ctr, F-75015 Paris, France; [Cossu, Giulio] Ist Sci San Raffaele, Stem Cell Res Inst, I-20132 Milan, Italy; [De Luca, Michele] Univ Modena & Reggio Emilia, Ctr Regenerat Med, I-41100 Modena, Italy; [Fox, Ira J.] Univ Pittsburgh, Dept Surg, McGowan Inst Regenerat Med, Pittsburgh, PA 15213 USA; [Goldstein, Robert A.; Wong, Adrianne L.] Juvenile Diabet Res Fdn Int, New York, NY 10005 USA; [Hermeren, Goran] Lund Univ, Dept Med Eth, S-22100 Lund, Sweden; [High, Katherine A.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Kim, Hyun Ok] Yonsei Univ, Coll Med, Severance Hosp Cell Therapy Ctr, Dept Lab Med, Seoul 120752, South Korea; [Lee, Hin Peng] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Levy-Lahad, Ephrat] Hebrew Univ Jerusalem, Sch Med, Inst Med Genet, Shaare Zedek Med Ctr, IL-91031 Jerusalem, Israel; [Li, Lingsong] Peking Univ, Stem Cell Res Ctr, Beijing 100083, Peoples R China; [Lo, Bernard] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Marshak, Daniel R.] PerkinElmer Inc, Shanghai 201203, Peoples R China; [McNab, Angela] NHS Luton, Luton LU1 1JD, Beds, England; [Munsie, Megan] Australian Stem Cell Ctr, Govt Affairs & Publ Policy, Clayton, Vic 3168, Australia; [Nakauchi, Hiromitsu] Univ Tokyo, Inst Med Sci, Tokyo 1088639, Japan; [Rao, Mahendra] Invitrogen, Frederick, MD 21704 USA; [Rooke, Heather M.] Int Soc Stem Cell Res, Boston, MA 02115 USA; [Valles, Carlos Simon] Ctr Invest Principe Felipe, ES-46110 Godella, Spain; [Srivastava, Alok] Christian Med Coll & Hosp, Vellore 632004, Tamil Nadu, India; [Sugarman, Jeremy] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [Sugarman, Jeremy] Johns Hopkins Univ, Dept Med, Baltimore, MD 21205 USA; [Taylor, Patrick L.] Childrens Hosp, Boston, MA 02115 USA; [Veiga, Anna] Regenerat Barcelona, Ctr Med, Barcelona 08003, Spain; [Zoloth, Laurie] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Daley, George Q.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02114 USA	Case Western Reserve University; Karolinska Institutet; University of Milan; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Universita di Modena e Reggio Emilia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Lund University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Yonsei University; Yonsei University Health System; National University of Singapore; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Peking University; University of California System; University of California San Francisco; University of Tokyo; Thermo Fisher Scientific; Prince Felipe Research Center; Christian Medical College & Hospital (CMCH) Vellore; Johns Hopkins University; Johns Hopkins University; Harvard University; Boston Children's Hospital; Northwestern University; Feinberg School of Medicine; Harvard University; Boston Children's Hospital	Hyun, I (corresponding author), Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA.	insoo.hyun@case.edu; olle.lindvall@med.lu.se	Levy-Lahad, Ephrat/F-2186-2018; De Luca, Michele/N-5883-2014; High, Katherine A./AAB-9322-2020; Ahrlund-Richter, Lars/C-6226-2012; Simon, Carlos/G-2186-2014	Levy-Lahad, Ephrat/0000-0002-2637-1921; De Luca, Michele/0000-0002-0850-8445; Simon, Carlos/0000-0003-0902-9531; Sugarman, Jeremy/0000-0001-7022-8332; CATTANEO, ELENA/0000-0002-0755-4917; Veiga, Anna/0000-0002-0943-9904; Cavazzana, Marina/0000-0002-0264-0891; Cossu, Giulio/0000-0001-5863-9593; Munsie, Megan/0000-0003-3588-8321				AHRLUNDRICHTER L, 2009, CELL STEM C IN PRESS, V4; Daley GQ, 2008, CELL STEM CELL, V3, P151, DOI 10.1016/j.stem.2008.07.007; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001	3	175	177	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					607	609		10.1016/j.stem.2008.11.009	http://dx.doi.org/10.1016/j.stem.2008.11.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041777	Bronze			2022-12-28	WOS:000261670900009
J	Hawryluk, GWJ; Fehlings, MG				Hawryluk, Gregory W. J.; Fehlings, Michael G.			The center of the spinal cord may be central to its repair	CELL STEM CELL			English	Editorial Material							PRECURSOR CELLS; INJURY; DIFFERENTIATION; GRAFTS; HOST	A recent PLoS Biology report from Meletis et al. (2008) strongly suggests that ependymal cells are a key source of endogenous stem cells in the spinal cord. Advances in understanding endogenous neural stem cells may facilitate repair of the injured central nervous system.	[Hawryluk, Gregory W. J.; Fehlings, Michael G.] Univ Toronto, Div Genet & Dev, Toronto Western Res Inst, Inst Med Sci, Toronto, ON M5T 2S8, Canada; [Hawryluk, Gregory W. J.; Fehlings, Michael G.] Univ Toronto, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Fehlings, Michael G.] Toronto Western Hosp, Univ Hlth Network, Spinal Program, Toronto, ON M5T 2S8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Fehlings, MG (corresponding author), Univ Toronto, Div Genet & Dev, Toronto Western Res Inst, Inst Med Sci, McLaughlin Pavil,Room 407,12th Floor,399 Bathurst, Toronto, ON M5T 2S8, Canada.	michael.fehlings@uhn.on.ca		Fehlings, Michael/0000-0002-5722-6364				ADRIAN EK, 1962, J NEUROPATH EXP NEUR, V21, P597, DOI 10.1097/00005072-196210000-00007; Baptiste DC, 2008, EXPERT OPIN EMERG DR, V13, P63, DOI [10.1517/14728214.13.1.63, 10.1517/14728214.13.1.63 ]; Cheng XX, 2007, STEM CELLS, V25, P3204, DOI 10.1634/stemcells.2007-0284; Hofstetter CP, 2005, NAT NEUROSCI, V8, P346, DOI 10.1038/nn1405; Karimi-Abdolrezaee S, 2006, J NEUROSCI, V26, P3377, DOI 10.1523/JNEUROSCI.4184-05.2006; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Namiki J, 1999, J NEUROPATH EXP NEUR, V58, P489, DOI 10.1097/00005072-199905000-00008; Ourednik V, 2004, J NEUROSCI RES, V76, P193, DOI 10.1002/jnr.20037; Rossignol S, 2007, J NEUROSCI, V27, P11782, DOI 10.1523/JNEUROSCI.3444-07.2007; Shetty AK, 2000, J NEUROSCI, V20, P8788	10	24	24	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					230	232		10.1016/j.stem.2008.08.009	http://dx.doi.org/10.1016/j.stem.2008.08.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786407	Bronze			2022-12-28	WOS:000259665000002
J	Li, XA; Zhu, LL; Yang, AC; Lin, JW; Tang, F; Jin, SB; Wei, Z; Li, JS; Jin, Y				Li, Xiang; Zhu, Lili; Yang, Acong; Lin, Jiangwei; Tang, Fan; Jin, Shibo; Wei, Zhe; Li, Jinsong; Jin, Ying			Calcineurin-NFAT Signaling Critically Regulates Early Lineage Specification in Mouse Embryonic Stem Cells and Embryos	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITIONS; DEPENDENT TRANSCRIPTIONAL PATHWAY; SELF-RENEWAL; LYMPHOCYTE-ACTIVATION; PRIMITIVE ENDODERM; GENE-EXPRESSION; KINASE-ACTIVITY; SRC FAMILY; C-SRC; DIFFERENTIATION	Self-renewal and pluripotency are hallmarks of embryonic stem cells (ESCs). However, the signaling pathways that trigger their transition from self-renewal to differentiation remain elusive. Here, we report that calcineurin-NFAT signaling is both necessary and sufficient to switch ESCs from an undifferentiated state to lineage-specific cells and that the inhibition of this pathway can maintain long-term ESC self-renewal independent of leukemia inhibitory factor. Mechanistically, this pathway converges with the Erk1/2 pathway to regulate Src expression and promote the epithelial-mesenchymal transition (EMT), a process required for lineage specification in response to differentiation stimuli. Furthermore, calcineurin-NFAT signaling is activated when the earliest differentiation event occurs in mouse embryos, and its inhibition disrupts extraembryonic lineage development. Collectively, our results demonstrate that the NFAT and Erk1/2 cascades form a signaling switch for early lineage segregation in mouse ESCs and provide significant insights into the regulation of the balance between ESC self-renewal and early lineage specification,	[Li, Xiang; Zhu, Lili; Yang, Acong; Tang, Fan; Jin, Shibo; Wei, Zhe; Jin, Ying] Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200025, Peoples R China; [Li, Xiang; Zhu, Lili; Wei, Zhe] Chinese Acad Sci, Grad Sch, Beijing 100000, Peoples R China; [Yang, Acong; Tang, Fan; Jin, Ying] Shanghai Jiao Tong Univ, Shanghai Stem Cell Inst, Sch Med, Shanghai 200025, Peoples R China; [Lin, Jiangwei; Li, Jinsong] Chinese Acad Sci, Shanghai Inst Biol Sci, Lab Mol Cell Biol, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China	Chinese Academy of Sciences; Shanghai Jiao Tong University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Jin, Y (corresponding author), Shanghai Jiao Tong Univ, Chinese Acad Sci, Sch Med, Key Lab Stem Cell Biol,Inst Hlth Sci,Shanghai Ins, Shanghai 200025, Peoples R China.	yjin@sibs.ac.cn	Yang, Acong/B-2929-2012; Wei, Zhe/N-8462-2015	Wei, Zhe/0000-0001-8558-4639; , jin ying/0000-0003-0070-2048; Yang, Acong/0000-0002-1279-566X; li, jin song/0000-0003-3456-662X; Zhu, Lili/0000-0003-2632-4786	National Natural Science Foundation [91019929, 30911130361, 31000625]; National High Technology Research and Development Program of China [2009CB941100, 2007CB947904, 2007CB948004, 2101CB945200, 2007CB947101]; Shanghai Science & Technology Developmental Foundations [08dj1400502, 07DZ22919]; Shanghai Leading Academic Discipline Project [S30201]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Shanghai Science & Technology Developmental Foundations; Shanghai Leading Academic Discipline Project(Shanghai Leading Academic Discipline Project)	The authors wish to thank Drs. H. Niwa, A. Rao, S. Miyatake, X. Cao, S. Hanks, T. Xu, and T. Takeya for generously providing plasmids; Drs. A. Smith and G. Daley for their mouse ESC lines, and Drs. A. Smith, R.D. McKinnon, D. Li, and A. Chong for critical reading of the manuscript. This study was supported by grants from the National Natural Science Foundation (91019929, 30911130361, and 31000625) and National High Technology Research and Development Program of China (2009CB941100, 2007CB947904, 2007CB948004, 2101CB945200, and 2007CB947101) and from Shanghai Science & Technology Developmental Foundations (08dj1400502 and 07DZ22919). The study was also supported by the Shanghai Leading Academic Discipline Project (S30201).	Anneren C, 2004, J BIOL CHEM, V279, P31590, DOI 10.1074/jbc.M403547200; Bianchi M, 2005, BIOCHEM J, V391, P359, DOI 10.1042/BJ20050282; Brabek J, 2004, ONCOGENE, V23, P7406, DOI 10.1038/sj.onc.1207965; Cavallaro U, 2004, NAT REV CANCER, V4, P118, DOI 10.1038/nrc1276; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; CLIPSTONE NA, 1992, NATURE, V357, P695, DOI 10.1038/357695a0; Crabtree GR, 2009, CELL, V138, DOI 10.1016/j.cell.2009.06.026; Crabtree GR, 1999, CELL, V96, P611, DOI 10.1016/S0092-8674(00)80571-1; Crabtree GR, 2002, CELL, V109, pS67, DOI 10.1016/S0092-8674(02)00699-2; de la Pompa JL, 1998, NATURE, V392, P182, DOI 10.1038/32419; Ding S, 2005, CELL, V122, P473, DOI 10.1016/j.cell.2005.07.013; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8; Graef IA, 2001, CELL, V105, P863, DOI 10.1016/S0092-8674(01)00396-8; Guarino M, 2010, J CELL PHYSIOL, V223, P14, DOI 10.1002/jcp.22011; Hamadi A, 2009, CELL MOL LIFE SCI, V66, P324, DOI 10.1007/s00018-008-8424-4; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiao XM, 2008, MOL BIOL CELL, V19, P1378, DOI 10.1091/mbc.E07-08-0753; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kobayashi T, 2006, MOL CELL BIOL, V26, P898, DOI 10.1128/MCB.26.3.898-911.2006; Kumagai N, 2004, BIOCHEM BIOPH RES CO, V325, P758, DOI 10.1016/j.bbrc.2004.10.094; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Li LJ, 2010, P NATL ACAD SCI USA, V107, P1402, DOI 10.1073/pnas.0905657107; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lu CW, 2008, NAT GENET, V40, P921, DOI 10.1038/ng.173; Macian F, 2000, EMBO J, V19, P4783, DOI 10.1093/emboj/19.17.4783; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Mandal M, 2008, CANCER-AM CANCER SOC, V112, P2088, DOI 10.1002/cncr.23410; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Meyn MA, 2005, MOL PHARMACOL, V68, P1320, DOI 10.1124/mol.104.010231; Meyn MA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000311; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Muller MR, 2009, P NATL ACAD SCI USA, V106, P7034, DOI 10.1073/pnas.0813296106; Nichols J, 2009, DEVELOPMENT, V136, P3215, DOI 10.1242/dev.038893; Rossant J, 2003, PHILOS T ROY SOC B, V358, P1341, DOI 10.1098/rstb.2003.1329; Rossant J, 2007, REPROD FERT DEVELOP, V19, P111, DOI 10.1071/RD06125; Sanna B, 2005, MOL CELL BIOL, V25, P865, DOI 10.1128/MCB.25.3.865-878.2005; Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435; Spencer HL, 2007, MOL BIOL CELL, V18, P2838, DOI 10.1091/mbc.E06-09-0875; Stankunas K, 1999, COLD SPRING HARB SYM, V64, P505, DOI 10.1101/sqb.1999.64.505; Tan TK, 2010, AM J PATHOL, V176, P1256, DOI 10.2353/ajpath.2010.090188; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Ullmann U, 2008, MOL HUM REPROD, V14, P169, DOI 10.1093/molehr/gan001; Wu XW, 2010, NATURE, V465, P368, DOI 10.1038/nature08996; Yamanaka Y, 2010, DEVELOPMENT, V137, P715, DOI 10.1242/dev.043471; Yang L, 2008, CARCINOGENESIS, V29, P291, DOI 10.1093/carcin/bgm262; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yu HX, 2007, CARDIOVASC DRUG REV, V25, P175, DOI 10.1111/j.1527-3466.2007.00011.x	54	78	85	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					46	58		10.1016/j.stem.2010.11.027	http://dx.doi.org/10.1016/j.stem.2010.11.027			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211781	Bronze			2022-12-28	WOS:000286786200010
J	Shoshani, O; Zipori, D				Shoshani, Ofer; Zipori, Dov			Transition of Endothelium to Cartilage and Bone	CELL STEM CELL			English	Editorial Material							MESENCHYMAL STEM-CELLS; CONVERSION	Mesenchymal stromal cells (MSCs) are capable of differentiating into bone-forming osteoblasts. A recent Nature Medicine study (Medici et al., 2010) shows that the mislocalized bone in the human disease fibrodisplasia ossificans progressiva (FOP) originates from vascular endothelium that gives rise to MSCs.	[Shoshani, Ofer; Zipori, Dov] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehvot, Israel	Weizmann Institute of Science	Zipori, D (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehvot, Israel.	dov.zipori@weizmann.ac.il		Shoshani, Ofer/0000-0001-8918-9935				Conrad C, 2009, CIRCULATION, V119, P281, DOI 10.1161/CIRCULATIONAHA.108.793208; Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; Medici D, 2010, NAT MED, V16, P1400, DOI 10.1038/nm.2252; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Thorel F, 2010, NATURE, V464, P1149, DOI 10.1038/nature08894; Zipori D, 2004, NAT REV GENET, V5, P873, DOI 10.1038/nrg1475; Zipori D, 2009	10	14	16	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					10	11		10.1016/j.stem.2010.12.004	http://dx.doi.org/10.1016/j.stem.2010.12.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211778	Bronze			2022-12-28	WOS:000286786200006
J	Dobreva, G; Braun, T				Dobreva, Gergana; Braun, Thomas			The Yin and Yang of Polycomb Repression in Regenerating Muscle	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; DIFFERENTIATION; NECROSIS; GENES		[Dobreva, Gergana; Braun, Thomas] Max Planck Inst Heart & Lung Res, D-31231 Bad Nauheim, Germany	Max Planck Society	Braun, T (corresponding author), Max Planck Inst Heart & Lung Res, Ludwigstr 43, D-31231 Bad Nauheim, Germany.	thomas.braun@mpi-bn.mpg.de	Braun, Thomas/B-2310-2008	Dobreva, Gergana/0000-0002-4814-9416; Braun, Thomas/0000-0002-6165-4804				Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160; Gillespie MA, 2009, J CELL BIOL, V187, P991, DOI 10.1083/jcb.200907037; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Palacios D, 2010, CELL STEM CELL, V7, P455, DOI 10.1016/j.stem.2010.08.013; Radley HG, 2008, NEUROMUSCULAR DISORD, V18, P227, DOI 10.1016/j.nmd.2007.11.002; Rampalli S, 2007, NAT STRUCT MOL BIOL, V14, P1150, DOI 10.1038/nsmb1316; Simone C, 2004, NAT GENET, V36, P738, DOI 10.1038/ng1378	10	1	1	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					422	424		10.1016/j.stem.2010.09.005	http://dx.doi.org/10.1016/j.stem.2010.09.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887945	Bronze			2022-12-28	WOS:000283270600003
J	Wilson, NK; Foster, SD; Wang, XN; Knezevic, K; Schutte, J; Kainnakis, P; Chilarska, PM; Kinston, S; Ouwehand, WH; Dzierzak, E; Pimanda, JE; de Bruijn, MFTR; Gottgens, B				Wilson, Nicola K.; Foster, Samuel D.; Wang, Xiaonan; Knezevic, Kathy; Schuette, Judith; Kainnakis, Polynikis; Chilarska, Paulina M.; Kinston, Sarah; Ouwehand, Willem H.; Dzierzak, Elaine; Pimanda, John E.; de Bruijn, Marella F. T. R.; Goettgens, Berthold			Combinatorial Transcriptional Control In Blood Stem/Progenitor Cells: Genome-wide Analysis of Ten Major Transcriptional Regulators	CELL STEM CELL			English	Article							HEMATOPOIETIC STEM-CELLS; CHROMATIN OCCUPANCY; LINEAGE COMMITMENT; GENE-EXPRESSION; MOUSE EMBRYO; FETAL LIVER; CHIP-SEQ; GATA-2; LEUKEMIA; RUNX1	Combinatorial transcription factor (TF) interactions control cellular phenotypes and, therefore, underpin stem cell formation, maintenance, and differentiation. Here, we report the genome-wide binding patterns and combinatorial interactions for ten key regulators of blood stem/progenitor cells (SCL/TAL1, LYL1, LMO2, GATA2, RUNX1, MEIS1, PU.1, ERG, FLI-1, and GFI1B), thus providing the most comprehensive IF data set for any adult stem/progenitor cell type to date. Genome-wide computational analysis of complex binding patterns, followed by functional validation, revealed the following: first, a previously unrecognized combinatorial interaction between a heptad of TFs (SCL, LYL1, LMO2, GATA2, RUNX1, ERG, and FLI-1). Second, we implicate direct protein-protein interactions between four key regulators (RUNX1, GATA2, SCL, and ERG) in stabilizing complex binding to DNA. Third, Runx1(+/-)::Gata2(+/-) compound heterozygous mice are not viable with severe hematopoietic defects at midgestation. Taken together, this study demonstrates the power of genome-wide analysis in generating novel functional insights into the transcriptional control of stem and progenitor cells.	[Wilson, Nicola K.; Foster, Samuel D.; Wang, Xiaonan; Schuette, Judith; Chilarska, Paulina M.; Kinston, Sarah; Ouwehand, Willem H.; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Cambridge CB2 0XY, England; [Knezevic, Kathy; Pimanda, John E.] Univ New S Wales, Lowy Canc Res Ctr, Sydney, NSW 2052, Australia; [Knezevic, Kathy; Pimanda, John E.] Univ New S Wales, Prince Wales Clin Sch, Sydney, NSW 2052, Australia; [Kainnakis, Polynikis; Dzierzak, Elaine] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Kainnakis, Polynikis; Dzierzak, Elaine] Erasmus Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands; [de Bruijn, Marella F. T. R.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England	University of Cambridge; University of New South Wales Sydney; University of New South Wales Sydney; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Oxford	Gottgens, B (corresponding author), Univ Cambridge, Dept Haematol, Cambridge Inst Med Res, Hills Rd, Cambridge CB2 0XY, England.	bg200@cam.ac.uk	cheng, yong/I-4270-2012	Gottgens, Berthold/0000-0001-6302-5705; Foster, Samuel/0000-0001-5375-7080; Ouwehand, Willem/0000-0002-7744-1790; Kaimakis, Polynikis/0000-0002-2928-1729; Wang, Xiaonan/0000-0003-3759-778X	Leukaemia and Lymphoma Research; Leukaemia and Lymphoma Foundation; UK Medical Research Council; National Institute for Health Research Cambridge Biomedical Research Centre; National Health and Medical Research Council of Australia; Australian Research Council; Medical Research Council [G0800784, MC_U137970202, G1000847, G0900951, G0800784B, G1000801h] Funding Source: researchfish; National Centre for the Replacement [G0900729/1] Funding Source: researchfish; MRC [G0900951, G0800784, MC_U137970202, G1000847] Funding Source: UKRI	Leukaemia and Lymphoma Research; Leukaemia and Lymphoma Foundation; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Centre for the Replacement; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We would like to thank A. Rendon and O. Burren for help with mapping ChIP-Seq reads, S. Anand for advice on immunoprecipitation assays, D. Hebenstreit for help with generating density profiles, and S. Teichmann and L. Wernisch for helpful discussions. Work in the authors' laboratories is supported by Leukaemia and Lymphoma Research, the Leukaemia and Lymphoma Foundation, the UK Medical Research Council, the National Institute for Health Research Cambridge Biomedical Research Centre, and the National Health and Medical Research Council of Australia and the Australian Research Council (K.K. and J.P.).	Anguita E, 2004, EMBO J, V23, P2841, DOI 10.1038/sj.emboj.7600274; BAILEY TL, 1994, ISMB, V2, P28; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Boyle AP, 2008, CELL, V132, P311, DOI 10.1016/j.cell.2007.12.014; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chapman MA, 2004, GENOME RES, V14, P313, DOI 10.1101/gr.1759004; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cheng Y, 2009, GENOME RES, V19, P2172, DOI 10.1101/gr.098921.109; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Donaldson IJ, 2005, HUM MOL GENET, V14, P595, DOI 10.1093/hmg/ddi056; Elagib KE, 2003, BLOOD, V101, P4333, DOI 10.1182/blood-2002-09-2708; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Gao JW, 2009, NANO LETT, V9, P4128, DOI 10.1021/nl902358m; GERING M, 2002, EMBO J, V21, P3039; Growney JD, 2005, BLOOD, V106, P494, DOI 10.1182/blood-2004-08-3280; Kassouf MT, 2008, BLOOD, V112, P1056, DOI 10.1182/blood-2007-12-128900; Lacombe J, 2010, BLOOD, V115, P792, DOI 10.1182/blood-2009-01-201384; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Landry JR, 2008, BLOOD, V111, P3005, DOI 10.1182/blood-2007-07-098830; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lebestky T, 2000, SCIENCE, V288, P146, DOI 10.1126/science.288.5463.146; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; McNagny KM, 1998, EMBO J, V17, P3669, DOI 10.1093/emboj/17.13.3669; Nerlov C, 1998, GENE DEV, V12, P2413, DOI 10.1101/gad.12.15.2413; Nerlov C, 1998, GENE DEV, V12, P2403, DOI 10.1101/gad.12.15.2403; Nishiyama A, 2009, CELL STEM CELL, V5, P420, DOI 10.1016/j.stem.2009.07.012; Nottingham WT, 2007, BLOOD, V110, P4188, DOI 10.1182/blood-2007-07-100883; Okuda T, 1996, CELL, V84, P321, DOI 10.1016/S0092-8674(00)80986-1; OSADA H, 1995, P NATL ACAD SCI USA, V92, P9585, DOI 10.1073/pnas.92.21.9585; Osato M, 2004, ONCOGENE, V23, P4284, DOI 10.1038/sj.onc.1207779; Ouyang ZQ, 2009, P NATL ACAD SCI USA, V106, P21521, DOI 10.1073/pnas.0904863106; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P840, DOI 10.1073/pnas.0607196104; Pinto do O P, 1998, EMBO J, V17, P5744, DOI 10.1093/emboj/17.19.5744; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Sanchez MJ, 1999, DEVELOPMENT, V126, P3891; Soler E, 2010, GENE DEV, V24, P277, DOI 10.1101/gad.551810; Spooner CJ, 2009, IMMUNITY, V31, P576, DOI 10.1016/j.immuni.2009.07.011; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun W, 2004, BLOOD, V104, P3565, DOI 10.1182/blood-2003-12-4349; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tipping AJ, 2009, BLOOD, V113, P2661, DOI 10.1182/blood-2008-06-161117; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Wadman IA, 1997, EMBO J, V16, P3145, DOI 10.1093/emboj/16.11.3145; Waltzer L, 2003, EMBO J, V22, P6516, DOI 10.1093/emboj/cdg622; Wang Q, 1996, P NATL ACAD SCI USA, V93, P3444, DOI 10.1073/pnas.93.8.3444; Wilson NK, 2009, BLOOD, V113, P5456, DOI 10.1182/blood-2009-01-200048; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130; Xie XH, 2007, P NATL ACAD SCI USA, V104, P7145, DOI 10.1073/pnas.0701811104; Xu G, 2006, LEUKEMIA, V20, P1002, DOI 10.1038/sj.leu.2404223; Ye M, 2007, CURR OPIN IMMUNOL, V19, P123, DOI 10.1016/j.coi.2007.02.007; Yu M, 2009, MOL CELL, V36, P682, DOI 10.1016/j.molcel.2009.11.002; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	60	492	500	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					532	544		10.1016/j.stem.2010.07.016	http://dx.doi.org/10.1016/j.stem.2010.07.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887958	Bronze			2022-12-28	WOS:000283270600014
J	Smith, KN; Singh, AM; Dalton, S				Smith, Keriayn N.; Singh, Amar M.; Dalton, Stephen			Myc Represses Primitive Endoderm Differentiation in Pluripotent Stem Cells	CELL STEM CELL			English	Article							EMBRYONIC STEM; C-MYC; N-MYC; TRANSCRIPTIONAL NETWORK; MIR-17-92 CLUSTER; MOUSE; NANOG; CYCLE; MICRORNA; PATHWAY	The generation of induced pluripotent stem cells (iPSCs) provides a novel method to facilitate investigations into the mechanisms that control stem cell pluripotency and self-renewal. Myc has previously been shown to be critical for murine embryonic stem cell (mESC) maintenance, while also enhancing directed reprogramming of fibroblasts by effecting widespread changes in gene expression. Despite several studies identifying in vivo target genes, the precise mechanism by which Myc regulates pluripotency remains unknown. Here we report that codeletion of c- and N-MYC in iPSCs and ESCs results in their spontaneous differentiation to primitive endoderm. We show that Myc sustains pluripotency through repression of the primitive endoderm master regulator GATA6, while also contributing to cell cycle control by regulation of the mir-17-92 miRNA cluster. Our findings demonstrate the indispensable requirement for c- or N-myc in pluripotency beyond proliferative and metabolic control.	[Smith, Keriayn N.; Singh, Amar M.; Dalton, Stephen] Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Dalton, S (corresponding author), Univ Georgia, Dept Biochem & Mol Biol, Paul D Coverdell Ctr Biomed & Hlth Sci, 500 DW Brooks Dr, Athens, GA 30602 USA.	sdalton@uga.edu	Smith, Keri/B-6560-2012	Smith, Keriayn/0000-0002-4351-2765; Dalton, Stephen/0000-0002-3450-1263	National Institute of Child Health and Human Development [HD049647]; National Institute for General Medical Sciences [GM75334]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD049647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM085354] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants to S.D. from the National Institute of Child Health and Human Development (HD049647) and the National Institute for General Medical Sciences (GM75334). We thank Paul Knoepfler for kindly providing c-myc<SUP>fl/fl</SUP>;N-myc<SUP>fl/fl</SUP> mice and c-myc<SUP>fl/fl</SUP>;N-myc<SUP>fl/fl</SUP> mESCs, John Cleveland for AB2.1 mESCs, Malgorzata Borowiak and Douglas Melton for the Sox17-GFP mESCs, Naohiro Terada for AFP-GFP mESCs, Shin-lchi Nishikawa for Gata6 shRNA constructs, and Xinmin Li for the Rb2-Luciferase Reporter. Thanks to Juan Cui and Ying Xu for assistance with bioinformatics analysis, Julie Nelson for assistance with FAGS sorting, David Reynolds and Tamas Nagy for assistance with teratoma analysis, and David Martin and Helen Zhang for assistance with blastocyst injections.	Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; APARICIO O, 2004, CURR PROTOC CELL BIO, V17, P1; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; Borowiak M, 2009, CELL STEM CELL, V4, P348, DOI 10.1016/j.stem.2009.01.014; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; CHARRON J, 1990, MOL CELL BIOL, V10, P1799, DOI 10.1128/MCB.10.4.1799; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r127; de Alboran IM, 2001, IMMUNITY, V14, P45, DOI 10.1016/S1074-7613(01)00088-7; Edel MJ, 2010, GENE DEV, V24, P561, DOI 10.1101/gad.1876710; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Hamazaki T, 2004, J CELL SCI, V117, P5681, DOI 10.1242/jcs.01489; Hamazaki T, 2006, MOL CELL BIOL, V26, P7539, DOI 10.1128/MCB.00508-06; Hanna J, 2009, CELL STEM CELL, V4, P513, DOI 10.1016/j.stem.2009.04.015; Izumi N, 2007, STEM CELLS, V25, P1664, DOI 10.1634/stemcells.2006-0681; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kidder BL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003932; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Malynn BA, 2000, GENE DEV, V14, P1390; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Meyer N, 2008, NAT REV CANCER, V8, P976, DOI 10.1038/nrc2231; Morrisey EE, 1998, GENE DEV, V12, P3579, DOI 10.1101/gad.12.22.3579; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677; Savatier P, 1996, ONCOGENE, V12, P309; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Stead E, 2002, ONCOGENE, V21, P8320, DOI 10.1038/sj.onc.1206015; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Wang Q, 2008, P NATL ACAD SCI USA, V105, P2889, DOI 10.1073/pnas.0800178105; White J, 2005, MOL BIOL CELL, V16, P2018, DOI 10.1091/mbc.e04-12-1056; Yu ZR, 2008, J CELL BIOL, V182, P509, DOI 10.1083/jcb.200801079; Zhang MX, 2005, P NATL ACAD SCI USA, V102, P16967, DOI 10.1073/pnas.0503853102	40	145	146	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					343	354		10.1016/j.stem.2010.06.023	http://dx.doi.org/10.1016/j.stem.2010.06.023			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804970	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000282037800011
J	Kokovay, E; Goderie, S; Wang, Y; Lotz, S; Lin, G; Sun, Y; Roysam, B; Shen, Q; Temple, S				Kokovay, Erzsebet; Goderie, Susan; Wang, Yue; Lotz, Steve; Lin, Gang; Sun, Yu; Roysam, Badrinath; Shen, Qin; Temple, Sally			Adult SVZ Lineage Cells Home to and Leave the Vascular Niche via Differential Responses to SDF1/CXCR4 Signaling	CELL STEM CELL			English	Article							NEURAL STEM-CELLS; POSTNATAL SUBVENTRICULAR ZONE; CHEMOKINE RECEPTOR CXCR4; PROGENITOR CELLS; NEUROBLAST MIGRATION; NEURONAL MIGRATION; MAMMALIAN BRAIN; NEUROGENESIS; STROKE; PRECURSORS	Neural progenitor cells (NPCs) in the adult subventricular zone (SVZ) are associated with ependymal and vasculature niches, which regulate stem cell self-renewal and differentiation. Activated Type B stem cells and their progeny, the transit-amplifying type C cells, which express EGFR, are most highly associated with vascular cells, indicating that this niche supports lineage progression. Here, we show that proliferative SVZ progenitor cells home to endothelial cells in a stromal-derived factor 1 (SDF1)- and CXC chemokine receptor 4 (CXCR4)-dependent manner. We show that SDF1 strongly upregulates EGFR and alpha 6 integrin in activated type B and type C cells, enhancing their activated state and their ability to bind laminin in the vascular niche. SDF1 increases the motility of type A neuroblasts, which migrate from the SVZ toward the olfactory bulb. Thus, differential responses to SDF1 can regulate progenitor cell occupancy of and exit from the adult SVZ vascular niche.	[Kokovay, Erzsebet; Goderie, Susan; Wang, Yue; Lotz, Steve; Shen, Qin; Temple, Sally] New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Kokovay, Erzsebet; Shen, Qin; Temple, Sally] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Lin, Gang; Roysam, Badrinath] Rensselaer Polytech Inst, Rensselaer, NY 12180 USA; [Sun, Yu] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA	Albany Medical College; Rensselaer Polytechnic Institute; Harvard University; Dana-Farber Cancer Institute	Temple, S (corresponding author), New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org			NIH [R01NS051531]; Regenerative Research Foundation; NIDA [5T32DA007307]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Regenerative Research Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Chris Fasano and Tim Phoenix for assistance in generating lentiviral shRNA contructs and Patty Lederman for invaluable technical support. This project was supported by NIH grant R01NS051531 and the Regenerative Research Foundation, and E.K. was supported in part by NIDA grant 5T32DA007307.	Aboody KS, 2000, P NATL ACAD SCI USA, V97, P12846, DOI 10.1073/pnas.97.23.12846; Aguirre A, 2005, J NEUROSCI, V25, P11092, DOI 10.1523/JNEUROSCI.2981-05.2005; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Ayuso-Sacido A, 2010, J NEURO-ONCOL, V97, P323, DOI 10.1007/s11060-009-0035-x; Bagri A, 2002, DEVELOPMENT, V129, P4249; Barkho BZ, 2008, STEM CELLS, V26, P3139, DOI 10.1634/stemcells.2008-0519; Benedetti S, 2000, NAT MED, V6, P447, DOI 10.1038/74710; Bolteus AJ, 2004, J NEUROSCI, V24, P7623, DOI 10.1523/JNEUROSCI.1999-04.2004; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; Chute JP, 2006, CURR OPIN HEMATOL, V13, P399, DOI 10.1097/01.moh.0000245698.62511.3d; De Clercq E, 2000, MOL PHARMACOL, V57, P833; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; GAGE FH, 1995, P NATL ACAD SCI USA, V92, P11879, DOI 10.1073/pnas.92.25.11879; Glass R, 2005, J NEUROSCI, V25, P2637, DOI 10.1523/JNEUROSCI.5118-04.2005; Guo ZG, 2007, COLLOID SURFACE B, V60, P1, DOI 10.1016/j.colsurfb.2007.05.013; Imitola J, 2004, P NATL ACAD SCI USA, V101, P18117, DOI 10.1073/pnas.0408258102; Jackson EL, 2008, CELLS TISSUES ORGANS, V188, P212, DOI 10.1159/000114541; Kaplan RN, 2007, TRENDS MOL MED, V13, P72, DOI 10.1016/j.molmed.2006.12.003; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Lapidot T, 2005, BLOOD, V106, P1901, DOI 10.1182/blood-2005-04-1417; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Liu XS, 2008, BRAIN RES, V1226, P18, DOI 10.1016/j.brainres.2008.06.013; Liu XX, 2006, GLIA, V54, P394, DOI 10.1002/glia.20392; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Ma Q, 1998, P NATL ACAD SCI USA, V95, P9448, DOI 10.1073/pnas.95.16.9448; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Ohab JJ, 2006, J NEUROSCI, V26, P13007, DOI 10.1523/JNEUROSCI.4323-06.2006; Paredes MF, 2006, J NEUROSCI, V26, P9404, DOI 10.1523/JNEUROSCI.2575-06.2006; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Peled A, 2000, BLOOD, V95, P3289, DOI 10.1182/blood.V95.11.3289.011k33_3289_3296; Platel JC, 2009, GLIA, V57, P66, DOI 10.1002/glia.20735; Porcile C, 2005, EXP CELL RES, V308, P241, DOI 10.1016/j.yexcr.2005.04.024; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Robin AM, 2006, J CEREBR BLOOD F MET, V26, P125, DOI 10.1038/sj.jcbfm.9600172; Schonemeier B, 2008, J COMP NEUROL, V510, P207, DOI 10.1002/cne.21780; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Stumm RK, 2003, J NEUROSCI, V23, P5123; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Thored P, 2006, STEM CELLS, V24, P739, DOI 10.1634/stemcells.2005-0281; Tiveron MC, 2006, J NEUROSCI, V26, P13273, DOI 10.1523/JNEUROSCI.4162-06.2006; Voermans C, 2001, EXP HEMATOL, V29, P1456, DOI 10.1016/S0301-472X(01)00740-8; Wong D, 2008, CLIN CANCER RES, V14, P7975, DOI 10.1158/1078-0432.CCR-07-4846; Yamashita T, 2006, J NEUROSCI, V26, P6627, DOI 10.1523/JNEUROSCI.0149-06.2006; Zhang RL, 2004, J CEREBR BLOOD F MET, V24, P441, DOI 10.1097/00004647-200404000-00009; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	53	273	282	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					163	173		10.1016/j.stem.2010.05.019	http://dx.doi.org/10.1016/j.stem.2010.05.019			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682445	Green Accepted, Bronze			2022-12-28	WOS:000281107400009
J	Curtis, SJ; Sinkevicius, KW; Li, DA; Lau, AN; Roach, RR; Zamponi, R; Woolfenden, AE; Kirsch, DG; Wong, KK; Kim, CF				Curtis, Stephen J.; Sinkevicius, Kerstin W.; Li, Danan; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Woolfenden, Amber E.; Kirsch, David G.; Wong, Kwok-Kin; Kim, Carla F.			Primary Tumor Genotype Is an Important Determinant in Identification of Lung Cancer Propagating Cells	CELL STEM CELL			English	Article							ADULT-MOUSE LUNG; STEM-CELLS; INITIATING CELLS; MARKER; MEDULLOBLASTOMA; HETEROGENEITY; EXPRESSION; MUTATIONS; HIERARCHY; MODEL	Successful cancer therapy requires the elimination or incapacitation of all tumor cells capable of regenerating a tumor. Therapeutic advances therefore necessitate the characterization of the cells that are able to propagate a tumor in vivo. We show an important link between tumor genotype and isolation of tumor-propagating cells (TPCs). Three mouse models of the most common form of human lung cancer each had TPCs with a unique cell-surface phenotype. The cell-surface marker Sca1 did not enrich for TPCs in tumors initiated with oncogenic Kras, and only Sca1-negative cells propagated EGFR mutant tumors. In contrast, Sca1-positive cells were enriched for tumor-propagating activity in Kras tumors with p53 deficiency. Primary tumors that differ in genotype at just one locus can therefore have tumor-propagating cell populations with distinct markers. Our studies show that the genotype of tumor samples must be considered in studies to identify, characterize, and target tumor-propagating cells.	[Curtis, Stephen J.; Sinkevicius, Kerstin W.; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Kim, Carla F.] Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Curtis, Stephen J.; Sinkevicius, Kerstin W.; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Kim, Carla F.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Curtis, Stephen J.; Sinkevicius, Kerstin W.; Lau, Allison N.; Roach, Rebecca R.; Zamponi, Raffaella; Kim, Carla F.] Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Li, Danan; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Brigham & Womens Hosp, Boston, MA 02115 USA; [Li, Danan; Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA; [Woolfenden, Amber E.] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Radiat Oncol, Durham, NC 27708 USA; [Kirsch, David G.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27708 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Novartis; Duke University; Duke University	Kim, CF (corresponding author), Childrens Hosp, Stem Cell Program, 300 Longwood Ave, Boston, MA 02115 USA.	carla.kim@childrens.harvard.edu	Zamponi, Raffaella/V-5683-2018	Zamponi, Raffaella/0000-0002-3313-1387; Lau, Allison/0000-0003-4250-7355; wong, kwok kin/0000-0001-6323-235X	DoD, Air Force Office of Scientific Research [32 CFR 168a]; American Cancer Society [PF-09-121-01-DDC]; Dana Farber Harvard Cancer Center Lung Cancer [P50 CA090578, R01 AG2400401, R01 CA122794, R01 CA140594]; V Foundation, American Cancer Society [RSG-08-082-01-MGO]; Harvard Stem Cell Institute; NIH/NCI [2P50CA090578]; Lung Cancer Alliance; NATIONAL CANCER INSTITUTE [P50CA090578, R01CA122794, R01CA140594] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090136] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG024004] Funding Source: NIH RePORTER	DoD, Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); American Cancer Society(American Cancer Society); Dana Farber Harvard Cancer Center Lung Cancer; V Foundation, American Cancer Society(American Cancer Society); Harvard Stem Cell Institute; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Lung Cancer Alliance; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank S. Lawrence, K. Mercer, E. Jackson, A. Dooley, S. Perera, the DFCI, CHB HemOnc, MIT FACS facilities, and members of the Kim Lab for technical assistance and discussions; E. Passegue for cell cycle protocol; R. Bronson for histopathology; T. Jacks for mouse strains and helpful discussions; and G. Evan, S. Ryeom, L. Zon, C. Cepko, S. Elledge, S. Armstrong, H. Hock, and K. Cichowski for critical reading. This work was supported by a DoD, Air Force Office of Scientific Research, National Defense Science and Engineering Graduate Fellowship, 32 CFR 168a (to S.J.C.), PF-09-121-01-DDC from the American Cancer Society (to K.W.S.), Dana Farber Harvard Cancer Center Lung Cancer SPORE grant P50 CA090578, R01 AG2400401, R01 CA122794, and R01 CA140594 (to K-K.W.), the V Foundation, American Cancer Society Research Scholar Grant #RSG-08-082-01-MGO, the Harvard Stem Cell Institute, NIH/NCI 2P50CA090578, and The Lung Cancer Alliance (to C.F.K.). We apologize for not citing primary references because of space constraints.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Chen YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002637; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eramo A, 2008, CELL DEATH DIFFER, V15, P504, DOI 10.1038/sj.cdd.4402283; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jiang F, 2009, MOL CANCER RES, V7, P330, DOI 10.1158/1541-7786.MCR-08-0393; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Liu JC, 2007, CANCER RES, V67, P8671, DOI 10.1158/0008-5472.CAN-07-1486; MCLEMORE TL, 1987, CANCER RES, V47, P5132; McQualter JL, 2010, P NATL ACAD SCI USA, V107, P1414, DOI 10.1073/pnas.0909207107; McQualter JL, 2009, STEM CELLS, V27, P623, DOI 10.1634/stemcells.2008-0866; Pece S, 2010, CELL, V140, P62, DOI 10.1016/j.cell.2009.12.007; Read TA, 2009, CANCER CELL, V15, P135, DOI 10.1016/j.ccr.2008.12.016; Riely Gregory J, 2009, Proc Am Thorac Soc, V6, P201, DOI 10.1513/pats.200809-107LC; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Teisanu RM, 2009, STEM CELLS, V27, P612, DOI 10.1634/stemcells.2008-0838; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Ward RJ, 2009, CANCER RES, V69, P4682, DOI 10.1158/0008-5472.CAN-09-0342	27	107	112	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					127	133		10.1016/j.stem.2010.05.021	http://dx.doi.org/10.1016/j.stem.2010.05.021			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621056	Green Accepted, Bronze			2022-12-28	WOS:000280222300019
J	Kokovay, E; Ganapathi, M; Morse, R; Temple, S				Kokovay, Erzsebet; Ganapathi, Mythily; Morse, Randy; Temple, Sally			Joanna Wysocka Wins ISSCR Outstanding Young Investigator Award	CELL STEM CELL			English	Biographical-Item									[Kokovay, Erzsebet; Temple, Sally] New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Ganapathi, Mythily; Morse, Randy] New York State Dept Hlth, Wadsworth Ctr, Albany, NY 12201 USA	State University of New York (SUNY) System; Wadsworth Center	Temple, S (corresponding author), New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org		Morse, Randall/0000-0003-0000-8718				WYSOCKA J, PUBLICATION LIST	1	1	1	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					533	534		10.1016/j.stem.2010.05.002	http://dx.doi.org/10.1016/j.stem.2010.05.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569690	Bronze			2022-12-28	WOS:000278840700013
J	Delaloy, C; Liu, L; Lee, JA; Su, H; Shen, FX; Yang, GY; Young, WL; Ivey, KN; Gao, FB				Delaloy, Celine; Liu, Lei; Lee, Jin-A; Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.; Ivey, Kathy N.; Gao, Fen-Biao			MicroRNA-9 Coordinates Proliferation and Migration of Human Embryonic Stem Cell-Derived Neural Progenitors	CELL STEM CELL			English	Article							IN-VITRO DIFFERENTIATION; POSTTRANSCRIPTIONAL REGULATION; TRANSCRIPTION FACTORS; ADULT NEUROGENESIS; EXPRESSION; STATHMIN; MECHANISMS; PRECURSORS; IDENTIFICATION; REPRESSION	Human pluripotent stem cells offer promise for use in cell-based therapies for brain injury and diseases. However, their cellular behavior is poorly understood. Here we show that the expression of the brain-specific microRNA-9 (miR-9) is turned on in human neural progenitor cells (hNPCs) derived from human embryonic stem cells. Loss of miR-9 suppressed proliferation but promoted migration of hNPCs cultured in vitro. hNPCs without miR-9 activity also showed enhanced migration when transplanted into mouse embryonic brains or adult brains of a mouse model of stroke. These effects were not due to precocious differentiation of hNPCs. One of the key targets directly regulated by miR-9 encodes stathmin, which increases microtubule instability and whose expression in hNPCs correlates inversely with that of miR-9. Partial inhibition of stathmin activity suppressed the effects of miR-9 loss on proliferation and migration of human or embryonic rat neural progenitors. These results identify miR-9 as a novel regulator that coordinates the proliferation and migration of hNPCs.	[Delaloy, Celine; Liu, Lei; Lee, Jin-A; Gao, Fen-Biao] Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA; [Delaloy, Celine; Liu, Lei; Lee, Jin-A; Gao, Fen-Biao] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Anesthesia, San Francisco, CA 94110 USA; [Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Perioperat Care, San Francisco, CA 94110 USA; [Su, Hua; Shen, Fanxia; Yang, Guo-Yuan; Young, William L.] Univ Calif San Francisco, Cerebrovasc Res Ctr, Dept Neurol & Neurosurg, San Francisco, CA 94110 USA; [Ivey, Kathy N.] Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA 01605 USA; [Gao, Fen-Biao] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; The J David Gladstone Institutes; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Gao, FB (corresponding author), Univ Calif San Francisco, Gladstone Inst Neurol Dis, San Francisco, CA 94158 USA.			DELALOY, Celine/0000-0003-1510-6484	California Institute for Regenerative Medicine (CIRM); NIH; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS066586] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J Rubenstein, D Srivastava. and our lab members for discussions and comments, G Howard and S Ordway for editorial assistance, and S Mitchell for administrative assistance C D would like to thank Bettencourt Schueller Foundation for help with relocation to San Francisco C D and J -A L are supported by fellowships from the California Institute for Regenerative Medicine (CIRM) This work is supported by grants from the CIRM (F -B G) and the NIH (F -B G and W L Y)	Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Ayala R, 2007, CELL, V128, P29, DOI 10.1016/j.cell.2006.12.021; Baldassarre G, 2005, CANCER CELL, V7, P51, DOI 10.1016/j.ccr.2004.11.025; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belletti B, 2008, MOL BIOL CELL, V19, P2003, DOI 10.1091/mbc.E07-09-0894; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; Biryukova I, 2009, DEV BIOL, V327, P487, DOI 10.1016/j.ydbio.2008.12.036; Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Delaloy C, 2008, NAT NEUROSCI, V11, P625, DOI 10.1038/nn0608-625; Deo M, 2006, DEV DYNAM, V235, P2538, DOI 10.1002/dvdy.20847; Duan X, 2008, CURR OPIN NEUROBIOL, V18, P108, DOI 10.1016/j.conb.2008.04.001; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Gadea G, 2007, J CELL BIOL, V178, P23, DOI 10.1083/jcb.200701120; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Giampietro C, 2005, ENDOCRINOLOGY, V146, P1825, DOI 10.1210/en.2004-0972; Hobert O, 2008, SCIENCE, V319, P1785, DOI 10.1126/science.1151651; Hochedlinger K, 2003, NEW ENGL J MED, V349, P275, DOI 10.1056/NEJMra035397; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li XJ, 2006, METH MOL B, V331, P169; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Mao YW, 2009, CELL, V136, P1017, DOI 10.1016/j.cell.2008.12.044; Pietrzykowski AZ, 2008, NEURON, V59, P274, DOI 10.1016/j.neuron.2008.05.032; Politz JCR, 2006, P NATL ACAD SCI USA, V103, P18957, DOI 10.1073/pnas.0609466103; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; Shibata M, 2008, J NEUROSCI, V28, P10415, DOI 10.1523/JNEUROSCI.3219-08.2008; Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006; Zhu W, 2008, STROKE, V39, P1254, DOI 10.1161/STROKEAHA.107.500801	44	254	273	1	38	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					323	335		10.1016/j.stem.2010.02.015	http://dx.doi.org/10.1016/j.stem.2010.02.015			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362537	Bronze, Green Accepted			2022-12-28	WOS:000276823300011
J	Green, DR				Green, Douglas R.			Cell Competition: Pirates on the Tangled Bank	CELL STEM CELL			English	Editorial Material							APOPTOTIC CELLS	Competition by stem cells for occupation of a limited niche is a well-described phenomenon. Two recent studies highlight competition between hematopoietic stem cells based on p53. These findings have implications for both normal homeostasis and tumorigenesis.	St Jude Childrens Hosp, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA.		Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417				Amaravadi RK, 2007, J CLIN INVEST, V117, P326, DOI 10.1172/JCI28833; Bondar T, 2010, CELL STEM CELL, V6, P309, DOI 10.1016/j.stem.2010.03.002; Johnston LA, 2009, SCIENCE, V324, P1679, DOI 10.1126/science.1163862; Khare A, 2009, NATURE, V461, P980, DOI 10.1038/nature08472; Li F, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000634; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715	9	7	7	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					287	288		10.1016/j.stem.2010.03.006	http://dx.doi.org/10.1016/j.stem.2010.03.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362527	Bronze			2022-12-28	WOS:000276823300001
J	Hosokawa, K; Arai, F; Yoshihara, H; Iwasaki, H; Hembree, M; Yin, T; Nakamura, Y; Gomei, Y; Takubo, K; Shiama, H; Matsuoka, S; Li, L; Suda, T				Hosokawa, Kentaro; Arai, Fumio; Yoshihara, Hiroki; Iwasaki, Hiroko; Hembree, Mark; Yin, Tong; Nakamura, Yuka; Gomei, Yumiko; Takubo, Keiyo; Shiama, Haruko; Matsuoka, Sahoko; Li, Linheng; Suda, Toshio			Cadherin-Based Adhesion Is a Potential Target for Niche Manipulation to Protect Hematopoietic Stem Cells in Adult Bone Marrow	CELL STEM CELL			English	Article							N-CADHERIN; QUIESCENCE; EXPRESSION; CATENIN		[Hosokawa, Kentaro; Arai, Fumio; Yoshihara, Hiroki; Iwasaki, Hiroko; Nakamura, Yuka; Gomei, Yumiko; Takubo, Keiyo; Shiama, Haruko; Matsuoka, Sahoko; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, Tokyo 1608582, Japan; [Hembree, Mark; Yin, Tong; Li, Linheng] Stowers Inst Med Res, Kansas City, MO 64110 USA	Keio University; Stowers Institute for Medical Research	Arai, F (corresponding author), Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Dept Cell Differentiat,Shinjuku Ku, 35 Shinano Machi, Tokyo 1608582, Japan.	farai@sc.itc.keio.ac.jp; sudato@sc.itc.keio.ac.jp	Iwasaki, Hiroko/D-1702-2009; Suda, Toshio/H-6761-2013; Takubo, Keiyo/AAX-5546-2020; Arai, Fumio/J-5241-2013	Iwasaki, Hiroko/0000-0001-9661-0919; Suda, Toshio/0000-0001-7540-1771; Takubo, Keiyo/0000-0002-1736-7592; Arai, Fumio/0000-0003-1936-4907; Li, Linheng/0000-0001-9963-430X; Yoshihara, Hiroki/0000-0001-5128-4515	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Takeda Science Foundation	The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Takeda Science Foundation(Takeda Science Foundation (TSF))	We thank Dr. Masatoshi Takeichi (Center for Developmental Biology, RIKEN Kobe, Kobe, Japan) for providing the cDNAs of wild-type and mutant N-cads. We also thank Ayako Kumakubo and Kana Fukushima for technical assistance. This work was supported by a Grant-in-Aid for Specially Promoted Research and a Grant-in-Aid for Young Scientists (A) from The Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and by the Takeda Science Foundation.	Adams GB, 2007, NAT BIOTECHNOL, V25, P238, DOI 10.1038/nbt1281; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; FUJIMORI T, 1993, MOL BIOL CELL, V4, P37, DOI 10.1091/mbc.4.1.37; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2009, CELL STEM CELL, V4, P170, DOI 10.1016/j.stem.2008.10.005; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Li PL, 2010, CELL STEM CELL, V6, P199, DOI 10.1016/j.stem.2010.02.007; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yin T, 2006, J CLIN INVEST, V116, P1195, DOI 10.1172/JCI28568; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	21	71	73	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					194	198		10.1016/j.stem.2009.04.013	http://dx.doi.org/10.1016/j.stem.2009.04.013			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207221	Bronze			2022-12-28	WOS:000276254600007
J	Voog, J; Jones, DL				Voog, Justin; Jones, D. Leanne			Stem Cells and the Niche: A Dynamic Duo	CELL STEM CELL			English	Review							SKELETAL-MUSCLE FIBERS; HEMATOPOIETIC STEM; SELF-RENEWAL; BONE-MARROW; DROSOPHILA OVARY; HAIR FOLLICLE; PROGENITOR CELLS; IN-VIVO; GERM-LINE; SMALL-INTESTINE	Stem cell niches are dynamic microenvironments that balance stem cell activity to maintain tissue homeostasis and repair throughout the lifetime of an organism. The development of strategies to monitor and perturb niche components has provided insight into the responsive nature of the niche and offers a framework to uncover how disruption of normal stem cell niche function may contribute to aging and disease onset and progression. Additional work in the identification of genetic factors that regulate the formation, activity, and size of stem cell niches will facilitate incorporation of the niche into stem cell-based therapies and regenerative medicine.	[Voog, Justin; Jones, D. Leanne] Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Voog, Justin] Univ Calif San Diego, Dept Biomed Sci, La Jolla, CA 92037 USA; [Jones, D. Leanne] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Jones, DL (corresponding author), Univ Calif San Diego, Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA.	ljones@salk.edu			ACS; NIH; CIRM; Emerald Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE ON AGING [R01AG028092] Funding Source: NIH RePORTER	ACS(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Emerald Foundation; G. Harold and Leila Y. Mathers Charitable Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We would like to thank V. Greco, A. Wagers, and three anonymous reviewers for comments on the manuscript, and we apologize to those colleagues whose work could not be referenced directly due to space constraints. D.L.J. is funded by the ACS, NIH, CIRM, the Emerald Foundation, and the G. Harold and Leila Y. Mathers Charitable Foundation.	Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; AMSEL S, 1971, CELL TISSUE KINET, V4, P255, DOI 10.1111/j.1365-2184.1971.tb01536.x; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; AUSTIN J, 1987, CELL, V51, P589, DOI 10.1016/0092-8674(87)90128-0; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; BISCHOFF R, 1990, DEVELOPMENT, V109, P943; Bissell MJ, 2007, BIOCHEM SOC T, V35, P18, DOI 10.1042/BST0350018; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; BOYLE M, 1995, DEVELOPMENT, V121, P1815; Boyle M, 2007, CELL STEM CELL, V1, P470, DOI 10.1016/j.stem.2007.08.002; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; Cabernard C, 2009, DEV CELL, V17, P134, DOI 10.1016/j.devcel.2009.06.009; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; CHANG LR, 1974, P SOC EXP BIOL MED, V145, P1220, DOI 10.3181/00379727-145-37985; Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Colmone A, 2008, SCIENCE, V322, P1861, DOI 10.1126/science.1164390; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Coppe JP, 2008, PLOS BIOL, V6, P2853, DOI 10.1371/journal.pbio.0060301; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Decotto E, 2005, DEV CELL, V9, P501, DOI 10.1016/j.devcel.2005.08.012; Deneault E, 2009, CELL, V137, P369, DOI 10.1016/j.cell.2009.03.026; Dominici M, 2009, BLOOD, V114, P2333, DOI 10.1182/blood-2008-10-183459; Enshell-Seijffers D, 2008, DEVELOPMENT, V135, P217, DOI 10.1242/dev.011031; Essers MAG, 2009, NATURE, V458, P904, DOI 10.1038/nature07815; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Fichelson P, 2009, NAT CELL BIOL, V11, P685, DOI 10.1038/ncb1874; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Flatt T, 2008, P NATL ACAD SCI USA, V105, P6368, DOI 10.1073/pnas.0709128105; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Fox DT, 2009, CELL STEM CELL, V5, P290, DOI 10.1016/j.stem.2009.06.003; Garrett RW, 2009, CELL STEM CELL, V4, P503, DOI 10.1016/j.stem.2009.05.011; Ghazizadeh S, 2005, J INVEST DERMATOL, V124, P367, DOI 10.1111/j.0022-202X.2004.23599.x; Gonczy P, 1996, DEVELOPMENT, V122, P2437; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gregorieff A, 2005, GASTROENTEROLOGY, V129, P626, DOI 10.1053/j.gastro.2005.06.007; HARRISON DA, 1993, CURR BIOL, V3, P424, DOI 10.1016/0960-9822(93)90349-S; HENDERSON ST, 1994, DEVELOPMENT, V120, P2913; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Hodohara K, 2000, BLOOD, V95, P769, DOI 10.1182/blood.V95.3.769.003a49_769_775; Hooper AT, 2009, CELL STEM CELL, V4, P263, DOI 10.1016/j.stem.2009.01.006; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; JAHODA CAB, 1984, NATURE, V311, P560, DOI 10.1038/311560a0; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jin DK, 2006, NAT MED, V12, P557, DOI 10.1038/nm1400; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; JONES PH, 1993, CELL, V73, P713, DOI 10.1016/0092-8674(93)90251-K; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kaplan RN, 2005, NATURE, V438, P820, DOI 10.1038/nature04186; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KIMBLE JE, 1981, DEV BIOL, V81, P208, DOI 10.1016/0012-1606(81)90284-0; Kobielak K, 2003, J CELL BIOL, V163, P609, DOI 10.1083/jcb.200309042; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kortesidis A, 2005, BLOOD, V105, P3793, DOI 10.1182/blood-2004-11-4349; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Le Bras S, 2006, DEV BIOL, V294, P92, DOI 10.1016/j.ydbio.2006.02.030; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Mayack SR, 2010, NATURE, V463, P495, DOI 10.1038/nature08749; McGovern M, 2009, P NATL ACAD SCI USA, V106, P11617, DOI 10.1073/pnas.0903768106; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Naveiras O, 2009, NATURE, V460, P259, DOI 10.1038/nature08099; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Nowak JA, 2008, CELL STEM CELL, V3, P33, DOI 10.1016/j.stem.2008.05.009; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Orimo A, 2005, CELL, V121, P335, DOI 10.1016/j.cell.2005.02.034; Paget S., 1889, LANCET, V1, P571, DOI DOI 10.1016/S0140-6736(00)49915-0; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Pan L, 2007, CELL STEM CELL, V1, P458, DOI 10.1016/j.stem.2007.09.010; POTTEN CS, 1974, CELL TISSUE KINET, V7, P271, DOI 10.1111/j.1365-2184.1974.tb00907.x; Rieger MA, 2008, CELLS TISSUES ORGANS, V188, P139, DOI 10.1159/000114540; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Ryu BY, 2006, STEM CELLS, V24, P1505, DOI 10.1634/stemcells.2005-0580; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Schroeder T, 2008, NATURE, V453, P345, DOI 10.1038/nature07043; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; Sherwood RI, 2004, CELL, V119, P543, DOI 10.1016/j.cell.2004.10.021; Shinohara T, 2000, P NATL ACAD SCI USA, V97, P8346, DOI 10.1073/pnas.97.15.8346; SHIROTA T, 1991, EXP HEMATOL, V19, P369; Singh SR, 2007, CELL STEM CELL, V1, P191, DOI 10.1016/j.stem.2007.07.003; Sipkins DA, 2005, NATURE, V435, P969, DOI 10.1038/nature03703; Sneddon JB, 2006, P NATL ACAD SCI USA, V103, P14842, DOI 10.1073/pnas.0606857103; Song XQ, 2007, DEVELOPMENT, V134, P1071, DOI 10.1242/dev.003392; Stier S, 2005, J EXP MED, V201, P1781, DOI 10.1084/jem.20041992; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Takashima S, 2008, NATURE, V454, P651, DOI 10.1038/nature07156; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; TEGELENBOSCH RAJ, 1993, MUTAT RES, V290, P193; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Trimboli AJ, 2009, NATURE, V461, P1084, DOI 10.1038/nature08486; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; VANSCOTT EJ, 1961, J INVEST DERMATOL, V36, P109, DOI 10.1038/jid.1961.21; Visnjic D, 2004, BLOOD, V103, P3258, DOI 10.1182/blood-2003-11-4011; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173; Wagers AJ, 2005, CELL, V121, P967, DOI 10.1016/j.cell.2005.06.017; Ward EJ, 2006, CURR BIOL, V16, P2352, DOI 10.1016/j.cub.2006.10.022; Weissman IL, 2001, ANNU REV CELL DEV BI, V17, P387, DOI 10.1146/annurev.cellbio.17.1.387; Wels J, 2008, GENE DEV, V22, P559, DOI 10.1101/gad.1636908; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041; Zhang YV, 2009, CELL STEM CELL, V5, P267, DOI 10.1016/j.stem.2009.06.004	156	258	271	0	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					103	115		10.1016/j.stem.2010.01.011	http://dx.doi.org/10.1016/j.stem.2010.01.011			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144784	Bronze, Green Accepted			2022-12-28	WOS:000274520800006
J	Panning, B				Panning, Barbara			Fine-Tuning Silencing	CELL STEM CELL			English	Editorial Material							POLYCOMB-REPRESSIVE COMPLEX-2; STEM-CELLS; DIFFERENTIATION; DEMETHYLASES; MECHANISMS; GENES		Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Panning, B (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA.	barbara.panning@ucsf.edu			NIGMS NIH HHS [R01 GM088506, R01 GM100341] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088506, R01GM100341] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026	10	5	5	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					3	4		10.1016/j.stem.2009.12.013	http://dx.doi.org/10.1016/j.stem.2009.12.013			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085734	Bronze, Green Accepted			2022-12-28	WOS:000274029700002
J	Chen, E; Finkel, T				Chen, Edmund; Finkel, Toren			The Tortoise, the Hare, and the FoxO	CELL STEM CELL			English	Editorial Material							OXIDATIVE STRESS; CELLS; MAINTENANCE; HOMEOSTASIS	Maintaining stem cell quiescence is intimately connected to preserving long-term self-renewal potential. In this issue of Cell Stem Cell, Paik et al. (2009) and Renault et al. (2009) demonstrate a role for FoxO transcription factors in regulating neural stem cell proliferation and in maintaining stem and progenitor cell homeostasis.	[Chen, Edmund; Finkel, Toren] NHLBI, Translat Med Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Finkel, T (corresponding author), NHLBI, Translat Med Branch, NIH, Bldg 10, Bethesda, MD 20892 USA.	finkelt@nih.gov						Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003	11	9	9	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					451	452		10.1016/j.stem.2009.10.011	http://dx.doi.org/10.1016/j.stem.2009.10.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896431	Bronze			2022-12-28	WOS:000272019500001
J	Corsini, NS; Sancho-Martinez, I; Laudenklos, S; Glagow, D; Kumar, S; Letellier, E; Koch, P; Teodorczyk, M; Kleber, S; Klussmann, S; Wiestler, B; Brustle, O; Mueller, W; Gieffers, C; Hill, O; Thiemann, M; Seedorf, M; Gretz, N; Sprengel, R; Celikel, T; Martin-Villalba, A				Corsini, Nina S.; Sancho-Martinez, Ignacio; Laudenklos, Sabrina; Glagow, Desiree; Kumar, Sachin; Letellier, Elisabeth; Koch, Philipp; Teodorczyk, Marcin; Kleber, Susanne; Klussmann, Stefan; Wiestler, Benedict; Bruestle, Oliver; Mueller, Wolf; Gieffers, Christian; Hill, Oliver; Thiemann, Meinolf; Seedorf, Matthias; Gretz, Norbert; Sprengel, Rolf; Celikel, Tansu; Martin-Villalba, Ana			The Death Receptor CD95 Activates Adult Neural Stem Cells for Working Memory Formation and Brain Repair	CELL STEM CELL			English	Article							FAS-INDUCED APOPTOSIS; HIPPOCAMPAL NEUROGENESIS; SUBVENTRICULAR ZONE; MICE; NEURONS; PROGENITORS; DIFFERENTIATION; REGENERATION; TRANSLATION; REPLACEMENT	Adult neurogenesis persists in the subventricular zone and the dentate gyrus and can be induced upon central nervous system injury. However, the final contribution of newborn neurons to neuronal networks is limited. Here we show that in neural stem cells, stimulation of the "death receptor" CD95 does not trigger apoptosis but unexpectedly leads to increased stem cell survival and neuronal specification. These effects are mediated via activation of the Src/PI3K/AKT/mTOR signaling pathway, ultimately leading to a global increase in protein translation. Induction of neurogenesis by CD95 was further confirmed in the ischemic CA1 region, in the naive dentate gyrus, and after forced expression of CD95L in the adult subventricular zone. Lack of hippocampal CD95 resulted in a reduction in neurogenesis and working memory deficits. Following global ischemia, CD95-mediated brain repair rescued behavioral impairment. Thus, we identify the CD95/CD95L system as an instructive signal for ongoing and injury-induced neurogenesis.	[Corsini, Nina S.; Sancho-Martinez, Ignacio; Laudenklos, Sabrina; Glagow, Desiree; Kumar, Sachin; Letellier, Elisabeth; Teodorczyk, Marcin; Kleber, Susanne; Klussmann, Stefan; Wiestler, Benedict; Martin-Villalba, Ana] German Canc Res Ctr, D-69120 Heidelberg, Germany; [Seedorf, Matthias] Univ Heidelberg, Zentrum Mol Biol, D-69120 Heidelberg, Germany; [Sprengel, Rolf] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Celikel, Tansu] Univ So Calif, Lab Neural Circuits & Plast, Los Angeles, CA 90089 USA; [Gieffers, Christian; Hill, Oliver; Thiemann, Meinolf] Apogenix GmbH, D-69120 Heidelberg, Germany; [Koch, Philipp; Bruestle, Oliver] Univ Bonn, Life & Brain Ctr, Inst Reconstruct Neurobiol, D-53127 Bonn, Germany; [Koch, Philipp; Bruestle, Oliver] Hertie Fdn, D-53127 Bonn, Germany; [Gretz, Norbert] Univ Heidelberg, Med Res Ctr, Med Fac Mannheim, D-68135 Mannheim, Germany; [Mueller, Wolf] Univ Heidelberg, Inst Pathol, Dept Neuropathol, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Max Planck Society; University of Southern California; University of Bonn; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Martin-Villalba, A (corresponding author), German Canc Res Ctr, D-69120 Heidelberg, Germany.	a.martin-villalba@dkfz.de	Letellier, Elisabeth/I-9515-2016; Koch, Philipp/AAZ-3751-2020; Koch, Philipp/M-1186-2016; Seib, Desiree/AAF-2801-2021; Celikel, Tansu/P-4235-2018	Letellier, Elisabeth/0000-0001-8242-9393; Seib, Desiree/0000-0001-9953-8270; Corsini, Nina/0000-0001-6731-3544; Koch, Philipp/0000-0003-3713-8786; Martin-Villalba, Ana/0000-0002-9405-8910; Wiestler, Benedikt/0000-0002-2963-7772; Sancho-Martinez, Ignacio/0000-0003-4348-1038	DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG); German Federal Ministry of Education and Research (BMBF); Systems Biology of Signaling in Cancer (Helmholtz Alliance on Systems Biology)	DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg; German Research Foundation (DFG)(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Systems Biology of Signaling in Cancer (Helmholtz Alliance on Systems Biology)	We thank Gunther Schutz for the Nestin-Cre and Nestin-CreERT2 mouse lines. We thank Klaus Rajewski for the CD95flox mouse line. Support by the DKFZ Light Microscopy Facility and the Nikon Imaging Center at the University of Heidelberg is gratefully acknowledged. We thank Trevor C. Dale and Till Wenger for plasmid constructs. We further thank Alexandra Beisel and Jennifer Hermes for excellent technical support. This work was supported by the German Research Foundation (DFG), the German Federal Ministry of Education and Research (BMBF), and Systems Biology of Signaling in Cancer (Helmholtz Alliance on Systems Biology).	ADACHI M, 1993, P NATL ACAD SCI USA, V90, P1756, DOI 10.1073/pnas.90.5.1756; Aimone JB, 2006, NAT NEUROSCI, V9, P723, DOI 10.1038/nn1707; ANDREWS BS, 1978, J EXP MED, V148, P1198, DOI 10.1084/jem.148.5.1198; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Demjen D, 2004, NAT MED, V10, P389, DOI 10.1038/nm1007; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Diehn M, 2000, NAT GENET, V25, P58, DOI 10.1038/75603; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; EISCHEN CM, 1994, J IMMUNOL, V153, P1947; Emsley JG, 2005, PROG NEUROBIOL, V75, P321, DOI 10.1016/j.pneurobio.2005.04.002; Ferron SR, 2007, NAT PROTOC, V2, P849, DOI 10.1038/nprot.2007.104; Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201; Gould E, 1999, NAT NEUROSCI, V2, P260, DOI 10.1038/6365; Kleber S, 2008, CANCER CELL, V13, P235, DOI 10.1016/j.ccr.2008.02.003; Krammer PH, 2000, NATURE, V407, P789, DOI 10.1038/35037728; Lindvall O, 2004, NAT MED, V10, pS42, DOI 10.1038/nm1064; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Magavi SS, 2000, NATURE, V405, P951, DOI 10.1038/35016083; Martin LJ, 2000, J CEREBR BLOOD F MET, V20, P153, DOI 10.1097/00004647-200001000-00020; Martin-Villalba A, 1999, J NEUROSCI, V19, P3809; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Parent JM, 2002, ANN NEUROL, V52, P802, DOI 10.1002/ana.10393; Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Sakic B, 1997, NEUROSCI BIOBEHAV R, V21, P327; Sampath P, 2008, CELL STEM CELL, V2, P448, DOI 10.1016/j.stem.2008.03.013; Sancho-Martinez I, 2009, CELL CYCLE, V8, P838, DOI 10.4161/cc.8.6.7906; Schlottmann KE, 1996, J LEUKOCYTE BIOL, V60, P546, DOI 10.1002/jlb.60.4.546; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2008, CELL STEM CELL, V3, P253, DOI 10.1016/j.stem.2008.08.010; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Sisti HM, 2007, LEARN MEMORY, V14, P368, DOI 10.1101/lm.488707; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van Praag H, 2005, J NEUROSCI, V25, P8680, DOI 10.1523/JNEUROSCI.1731-05.2005; Whishaw IQ, 1996, PHYSIOL BEHAV, V60, P1191, DOI 10.1016/S0031-9384(96)00176-X; Yang Z, 2006, NEUROSCIENCE, V139, P555, DOI 10.1016/j.neuroscience.2005.12.059; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zuliani C, 2006, CELL DEATH DIFFER, V13, P31, DOI 10.1038/sj.cdd.4401720	45	98	102	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					178	190		10.1016/j.stem.2009.05.004	http://dx.doi.org/10.1016/j.stem.2009.05.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664992	Bronze, Green Submitted			2022-12-28	WOS:000269511900011
J	Liu, YQ; Clem, B; Zuba-Surma, EK; El-Naggar, S; Telang, S; Jenson, AB; Wang, YL; Shao, H; Ratajczak, MZ; Chesney, J; Dean, DC				Liu, Yongqing; Clem, Brian; Zuba-Surma, Ewa K.; El-Naggar, Shahencla; Telang, Sucheta; Jenson, Alfred B.; Wang, Yali; Shao, Hui; Ratajczak, Mariusz Z.; Chesney, Jason; Dean, Douglas C.			Mouse Fibroblasts Lacking RB1 Function Form Spheres and Undergo Reprogramming to a Cancer Stem Cell Phenotype	CELL STEM CELL			English	Article							SELF-RENEWAL; G(1) CONTROL; RETINOBLASTOMA; BIOLOGY; GENE; IMMORTALIZATION; MECHANISMS; EXPRESSION; REPRESSION; ORDER	Activation of the RB1 pathway triggers the cell-cycle arrest that mediates cell-cell contact inhibition. Accordingly, mutation of all three RB1 family members leads to loss of contact inhibition and outgrowth of fibroblasts into spheres where cell-cell contacts predominate. We present evidence that such outgrowth triggers reprogramming to generate cells with properties of cancer stem cells. Fibroblasts with only a single RB1 mutation remain contact inhibited; however, if this contact inhibition is bypassed by forcing the RB1(-/-) cells to form spheres in suspension, cells with properties of cancer stem cells are also generated. These cells not only form tumors in nude mice but also generate differentiated cells. We propose that contact inhibition imposed by the RB1 pathway performs an unexpected tumor suppressor function by preventing cell outgrowth into structures where cells with properties of cancer stem cells can be generated from differentiated somatic cells in advancing cancers.	[Liu, Yongqing; Clem, Brian; El-Naggar, Shahencla; Telang, Sucheta; Jenson, Alfred B.; Chesney, Jason; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Mol Targets Program, Brown Canc Ctr, Louisville, KY 40202 USA; [Liu, Yongqing; El-Naggar, Shahencla; Wang, Yali; Shao, Hui; Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Ophthalmol & Visual Sci, Louisville, KY 40202 USA; [Zuba-Surma, Ewa K.; Ratajczak, Mariusz Z.] Univ Louisville, Hlth Sci Ctr, Stem Cell Biol Program, Brown Canc Ctr, Louisville, KY 40202 USA; [Dean, Douglas C.] Univ Louisville, Hlth Sci Ctr, Dept Biochem & Mol Biol, Louisville, KY 40202 USA	University of Louisville; University of Louisville; University of Louisville; University of Louisville	Dean, DC (corresponding author), Univ Louisville, Hlth Sci Ctr, Mol Targets Program, Brown Canc Ctr, Louisville, KY 40202 USA.	dcdean01@louisville.edu	Ratajczak, Mariusz Z/I-2376-2014; Ratajczak, Mariusz Zdzisław MZR/N-1599-2014; El-Naggar, Shahenda/Y-9778-2019; Zuba-Surma, Ewa/GZM-7140-2022	Ratajczak, Mariusz Z/0000-0002-0071-0198; El-Naggar, Shahenda/0000-0001-6465-9881; Zuba-Surma, Ewa/0000-0001-6814-6127	NIH; NATIONAL EYE INSTITUTE [R21EY019113] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank T. Jacks, J. Sage, and G. Leone for TKOs, RB1 null, RB1/RBL2 double null, and littermate control wild-type MEFs; D. Darling for antibodies; J. Sundberg for comments on tumor pathology; and Qiutang Li for assistance with Zeb1 and Zeb2 lentivirus shRNA constructs. These studies were supported in part by grants from the NIH.	Ajioka I, 2007, CELL, V131, P378, DOI 10.1016/j.cell.2007.09.036; Alvarez CS, 2008, CLIN TRANSL ONCOL, V10, P389, DOI 10.1007/s12094-008-0220-y; BURKERT U, 1991, NEW BIOL, V3, P698; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Dannenberg JH, 2000, GENE DEV, V14, P3051, DOI 10.1101/gad.847700; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Dick JE, 2005, ANN NY ACAD SCI, V1044, P1, DOI 10.1196/annals.1349.001; Dirks PB, 2008, J CLIN ONCOL, V26, P2916, DOI 10.1200/JCO.2008.17.6792; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Hirschmann-Jax C, 2005, CELL CYCLE, V4, P203; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Kansara M, 2007, DNA CELL BIOL, V26, P1, DOI 10.1089/dna.2006.0505; Kaye FJ, 2002, ONCOGENE, V21, P6908, DOI 10.1038/sj.onc.1205834; Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007; Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Liu YQ, 2008, DEVELOPMENT, V135, P579, DOI 10.1242/dev.007047; Liu Y, 2007, BIOCHEM J, V408, P79, DOI 10.1042/BJ20070344; Lobo NA, 2007, ANNU REV CELL DEV BI, V23, P675, DOI 10.1146/annurev.cellbio.22.010305.104154; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; MacPherson D, 2007, CANCER RES, V67, P7547, DOI 10.1158/0008-5472.CAN-07-0276; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Neth P, 2007, STEM CELL REV, V3, P18, DOI 10.1007/s12015-007-0001-y; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131; Riele HT, 2007, CELL, V131, P227, DOI 10.1016/j.cell.2007.10.007; Robey RW, 2007, CANCER METAST REV, V26, P39, DOI 10.1007/s10555-007-9042-6; Sage J, 2000, GENE DEV, V14, P3037, DOI 10.1101/gad.843200; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; Seigel GM, 2007, MOL VIS, V13, P823; Seigel GM, 2005, MOL VIS, V11, P729; Stemmer V, 2008, ONCOGENE, V27, P5075, DOI 10.1038/onc.2008.140; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Telang S, 2006, ONCOGENE, V25, P7225, DOI 10.1038/sj.onc.1209709; Trimboli AJ, 2008, CANCER RES, V68, P937, DOI 10.1158/0008-5472.CAN-07-2148; Trosko JE, 2006, ANN NY ACAD SCI, V1089, P36, DOI 10.1196/annals.1386.018; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Zhang HS, 1999, CELL, V97, P53, DOI 10.1016/S0092-8674(00)80714-X; Zhang M, 2006, CURR OPIN GENET DEV, V16, P60, DOI 10.1016/j.gde.2005.12.008	44	75	78	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					336	347		10.1016/j.stem.2009.02.015	http://dx.doi.org/10.1016/j.stem.2009.02.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341623	Green Accepted, Bronze			2022-12-28	WOS:000265162700010
J	Jamieson, C				Jamieson, Catriona			The MLLgnant Consequences of Reverting to an Embryonic Transcriptional Program	CELL STEM CELL			English	Editorial Material							STEM-CELLS; LEUKEMIA; PROGENITORS; MLL		Univ Calif San Diego, Moores UCSD Canc Ctr, Div Hematol Oncol, Stem Cell Res Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Jamieson, C (corresponding author), Univ Calif San Diego, Moores UCSD Canc Ctr, Div Hematol Oncol, Stem Cell Res Program, 3855 Hlth Sci Dr, La Jolla, CA 92093 USA.	cjamieson@ucsd.edu						Barabe F, 2007, SCIENCE, V316, P600, DOI 10.1126/science.1139851; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Cozzio A, 2003, GENE DEV, V17, P3029, DOI 10.1101/gad.1143403; Emerling BM, 2002, ONCOGENE, V21, P4849, DOI 10.1038/sj.onc.1205615; Ernst P, 2004, DEV CELL, V6, P437, DOI 10.1016/S1534-5807(04)00061-9; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jude CD, 2007, CELL STEM CELL, V1, P324, DOI 10.1016/j.stem.2007.05.019; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; McMahon KA, 2007, CELL STEM CELL, V1, P338, DOI 10.1016/j.stem.2007.07.002; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015	10	4	4	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					97	98		10.1016/j.stem.2009.01.008	http://dx.doi.org/10.1016/j.stem.2009.01.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200795	Bronze			2022-12-28	WOS:000263213400002
J	Shen, Q; Wang, Y; Kokovay, E; Lin, G; Chuang, SM; Goderie, SK; Roysam, B; Temple, S				Shen, Qin; Wang, Yue; Kokovay, Erzsebet; Lin, Gang; Chuang, Shu-Mien; Goderie, Susan K.; Roysam, Badrinath; Temple, Sally			Adult SVZ stem cells lie in a vascular niche: A quantitative analysis of niche cell-cell interactions	CELL STEM CELL			English	Article							SUBVENTRICULAR ZONE; MAMMALIAN BRAIN; NEURONAL PRECURSORS; MIGRATION; MOUSE; NEUROGENESIS; OLIGODENDROCYTES; ANGIOGENESIS; ASTROCYTES; EXPRESSION	There is an emerging understanding of the importance of the vascular system within stem cell niches. Here, we examine whether neural stem cells (NSCs) in the adult subventricular zone (SVZ) lie close to blood vessels, using three-dimensional whole mounts, confocal microscopy, and automated computer-based image quantification. We found that the SVZ contains a rich plexus of blood vessels that snake along and within neuroblast chains. Cells expressing stem cell markers, including GFAP, and proliferation markers are closely apposed to the laminin-containing extracellular matrix (ECM) surrounding vascular endothelial cells. Apical GFAP+ cells are admixed within the ependymal layer and some span between the ventricle and blood vessels, occupying a specialized microenvironment. Adult SVZ progenitor cells express the laminin receptor alpha 6 beta 1 integrin, and blocking this inhibits their adhesion to endothelial cells, altering their position and proliferation in vivo, indicating that it plays a functional role in binding SVZ stem cells within the vascular niche.	[Shen, Qin; Wang, Yue; Kokovay, Erzsebet; Goderie, Susan K.; Temple, Sally] New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA; [Shen, Qin; Kokovay, Erzsebet; Temple, Sally] Albany Med Coll, Ctr Neuropharmacol & Neurosci, Albany, NY 12208 USA; [Lin, Gang; Roysam, Badrinath] Rensselaer Polytech Inst, Rensselaer, NY 12180 USA; [Chuang, Shu-Mien] Kaohsiung Med Univ, Grad Inst Med, Kaohsiung, Taiwan	Albany Medical College; Rensselaer Polytechnic Institute; Kaohsiung Medical University	Temple, S (corresponding author), New York Neural Stem Cell Inst, Rensselaer, NY 12144 USA.	sallytemple@nynsci.org			NIH [R01NS051531]; NYS [022044]; Regenerative Research Foundation; NIDA [5T32DA007307]; Center for Subsurface Sensing and Imaging Systems; NSF Engineering Research Centers Program [EEC-9986821]; Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051531] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [T32DA007307] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYS; Regenerative Research Foundation; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Center for Subsurface Sensing and Imaging Systems; NSF Engineering Research Centers Program(National Science Foundation (NSF)); Rensselaer Polytechnic Institute; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank Rebecca Stern for assistance with the summary figure, Patricia Lederman and Cindy Butler for technical help, and Adreinne Dorr and Michael Dipersio, for discussions on the SVZ vasculature. We are grateful for antibodies from Drs. Charles Stiles, David Anderson, and Jeffrey Miner. This project was supported by NINDS through NIH grant R01NS051531, NYS contract C#022044, and the Regenerative Research Foundation. EX was supported by NIDA grant 5T32DA007307. Portions of this work were supported by the Center for Subsurface Sensing and Imaging Systems, NSF Engineering Research Centers Program (Award Number EEC-9986821), and Rensselaer Polytechnic Institute.	Alvarez-Buylla A, 1998, J NEUROSCI, V18, P1020; Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Baker KL, 2006, J COMP NEUROL, V498, P747, DOI 10.1002/cne.21090; BREIER G, 1992, DEVELOPMENT, V114, P521; BRIGHTMA.MW, 1965, J CELL BIOL, V26, P99, DOI 10.1083/jcb.26.1.99; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Emsley JG, 2003, EXP NEUROL, V183, P273, DOI 10.1016/S0014-4886(03)00209-7; Fortunel NO, 2003, SCIENCE, V302, P393; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; HUNTER DD, 1989, NATURE, V338, P229, DOI 10.1038/338229a0; Jacobson M., 1991, DEV NEUROBIOLOGY; Johansson CB, 1999, EXP CELL RES, V253, P733, DOI 10.1006/excr.1999.4678; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lawson DA, 2007, P NATL ACAD SCI USA, V104, P181, DOI 10.1073/pnas.0609684104; Li A, 1998, P NATL ACAD SCI USA, V95, P3902, DOI 10.1073/pnas.95.7.3902; Lin G, 2005, CYTOM PART A, V66A, P9, DOI 10.1002/cyto.a.20149; Lois C, 1996, SCIENCE, V271, P978, DOI 10.1126/science.271.5251.978; LOIS C, 1993, P NATL ACAD SCI USA, V90, P2074, DOI 10.1073/pnas.90.5.2074; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Menn B, 2006, J NEUROSCI, V26, P7907, DOI 10.1523/JNEUROSCI.1299-06.2006; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Simard M, 2003, J NEUROSCI, V23, P9254; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; STRONG LH, 1964, J COMP NEUROL, V123, P151, DOI 10.1002/cne.901230111; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Weinstein BM, 2005, CELL, V120, P299, DOI 10.1016/j.cell.2005.01.010; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601	44	761	782	0	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					289	300		10.1016/j.stem.2008.07.026	http://dx.doi.org/10.1016/j.stem.2008.07.026			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786416	Green Accepted, Bronze			2022-12-28	WOS:000259665000012
J	Hochmuth, CE; Biteau, B; Bohmann, D; Jasper, H				Hochmuth, Christine E.; Biteau, Benoit; Bohmann, Dirk; Jasper, Heinrich			Redox Regulation by Keap1 and Nrf2 Controls Intestinal Stem Cell Proliferation in Drosophila	CELL STEM CELL			English	Article							OXIDATIVE STRESS; REACTIVE OXYGEN; SELF-RENEWAL; DUAL OXIDASE; LIFE-SPAN; HOMEOSTASIS; PATHWAY; MIDGUT; DIFFERENTIATION; ACTIVATION	In Drosophila, intestinal stem cells (ISCs) respond to oxidative challenges and inflammation by increasing proliferation rates. This phenotype is part of a regenerative response, but can lead to hyperproliferation and epithelial degeneration in the aging animal. Here we show that Nrf2, a master regulator of the cellular redox state, specifically controls the proliferative activity of ISCs, promoting intestinal homeostasis. We find that Nrf2 is constitutively active in ISCs and that repression of Nrf2 by its negative regulator Keap1 is required for ISC proliferation. We further show that Nrf2 and Keap1 exert this function in ISCs by regulating the intracellular redox balance. Accordingly, loss of Nrf2 in ISCs causes accumulation of reactive oxygen species and accelerates age-related degeneration of the intestinal epithelium. Our findings establish Keap1 and Nrf2 as a critical redox management system that regulates stem cell function in high-turnover tissues.	[Hochmuth, Christine E.; Biteau, Benoit; Jasper, Heinrich] Univ Rochester, Dept Biol, Rochester, NY 14627 USA; [Bohmann, Dirk] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14620 USA	University of Rochester; University of Rochester	Jasper, H (corresponding author), Univ Rochester, Dept Biol, River Campus Box 270211, Rochester, NY 14627 USA.	henri_jasper@urmc.rochester.edu			National Institute on Aging [NIH RO1 AG028127]; NYSTEM [N08G-048]; Ellison Medical Foundation [AG-SS-2224-08]; AFAR/Ellison postdoctoral fellowship; NATIONAL INSTITUTE ON AGING [R01AG028127] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NYSTEM; Ellison Medical Foundation(Lawrence Ellison Foundation); AFAR/Ellison postdoctoral fellowship; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the National Institute on Aging (NIH RO1 AG028127 to H.J.), NYSTEM (grant # N08G-048), and the Ellison Medical Foundation (AG-SS-2224-08), as well as an AFAR/Ellison postdoctoral fellowship to B.B. We would like to thank Mark Noble for comments and Olga Dunaevsky for technical assistance.	Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; An JH, 2003, GENE DEV, V17, P1882, DOI 10.1101/gad.1107803; Bashan N, 2009, PHYSIOL REV, V89, P27, DOI 10.1152/physrev.00014.2008; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Biteau B, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001159; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Curran SP, 2009, NATURE, V459, P1079, DOI 10.1038/nature08106; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Hayes JD, 2009, TRENDS BIOCHEM SCI, V34, P176, DOI 10.1016/j.tibs.2008.12.008; Inoue H, 2005, GENE DEV, V19, P2278, DOI 10.1101/gad.1324805; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Lee JM, 2005, FASEB J, V19, P1061, DOI 10.1096/fj.04-2591hyp; Lee KS, 2009, J BIOL CHEM, V284, P29454, DOI 10.1074/jbc.M109.028027; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Maher J, 2010, TOXICOL APPL PHARM, V244, P4, DOI 10.1016/j.taap.2010.01.011; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; McMahon M, 2001, CANCER RES, V61, P3299; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Miyamoto K, 2008, BLOOD, V112, P4485, DOI 10.1182/blood-2008-05-159848; Motohashi H, 2002, GENE, V294, P1, DOI 10.1016/S0378-1119(02)00788-6; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Orr WC, 2005, J BIOL CHEM, V280, P37331, DOI 10.1074/jbc.M508272200; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Radyuk SN, 2003, BIOCHEM J, V371, P743, DOI 10.1042/BJ20021522; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Sykiotis GP, 2008, DEV CELL, V14, P76, DOI 10.1016/j.devcel.2007.12.002; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Toledano MB, 2010, CELL, V140, P454, DOI 10.1016/j.cell.2010.02.003; Toledano MB, 2009, MOL CELL, V34, P637, DOI 10.1016/j.molcel.2009.06.005; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Veraksa A, 2000, DEVELOPMENT, V127, P4023; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Woo HA, 2010, CELL, V140, P517, DOI 10.1016/j.cell.2010.01.009	49	249	257	4	29	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					188	199		10.1016/j.stem.2010.12.006	http://dx.doi.org/10.1016/j.stem.2010.12.006			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295275	Green Accepted, Bronze			2022-12-28	WOS:000287633400012
J	Jiang, HQ; Grenley, MO; Bravo, MJ; Blumhagen, RZ; Edgar, BA				Jiang, Huaqi; Grenley, Marc O.; Bravo, Maria-Jose; Blumhagen, Rachel Z.; Edgar, Bruce A.			EGFR/Ras/MAPK Signaling Mediates Adult Midgut Epithelial Homeostasis and Regeneration in Drosophila	CELL STEM CELL			English	Article							STEM-CELL PROLIFERATION; METASTATIC COLORECTAL-CANCER; GROWTH-FACTOR RECEPTOR; ONCOGENIC K-RAS; EGF RECEPTOR; BACTERIAL-INFECTION; TGF-ALPHA; TISSUE HOMEOSTASIS; SELF-RENEWAL; COLON	Many tissues in higher animals undergo dynamic homeostatic growth, wherein damaged or aged cells are replaced by the progeny of resident stem cells. TO maintain homeostasis, stem cells must respond to tissue needs. Here we show that in response to damage or stress in the intestinal (midgut) epithelium of adult Drosophila, multiple EGFR ligands and rhomboids (intramembrane proteases that activate some EGFR ligands) are induced, leading to the activation of EGFR signaling in intestinal stem cells (ISCs). Activation of EGFR signaling promotes ISC division and midgut epithelium regeneration, thereby maintaining tissue homeostasis. ISCs defective in EGFR signaling cannot grow or divide, are poorly maintained, and cannot support midgut epithelium regeneration after enteric infection by the bacterium Pseudomonas entomophila. Furthermore, ISC proliferation induced by Jak/Stat signaling is dependent upon EGFR signaling. Thus the EGFR/Ras/MAPK signaling pathway plays central, essential roles in ISC maintenance and the feedback system that mediates intestinal homeostasis.	[Jiang, Huaqi; Grenley, Marc O.; Bravo, Maria-Jose; Blumhagen, Rachel Z.; Edgar, Bruce A.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Edgar, Bruce A.] German Canc Res Ctr, Ctr Mol Biol Heidelberg ZMBH Alliance, D-69120 Heidelberg, Germany	Fred Hutchinson Cancer Center; Helmholtz Association; German Cancer Research Center (DKFZ)	Edgar, BA (corresponding author), Fred Hutchinson Canc Res Ctr, Div Basic Sci, 1100 Fairview Ave N, Seattle, WA 98109 USA.	b.edgar@dkfz.de			NIH [R01 GM51186]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051186] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Celeste Berg, Denise Montell, Gyeong-Hun Baeg, Erika Bach, Jocelyn McDonald, Matthew Freeman, and the VDRC (Austria), NIG (Japan), Bloomington (USA) Drosophila Stock Centers for fly stocks; the Moen's lab for confocal imaging; Xiaohang Yang for Pdm-1 antibody; David D. O'Keefe for advice on anti-dpERK staining; and members of the B.A.E. lab for comments. This work was supported by NIH grant R01 GM51186 to B.A.E.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Amcheslavsky A, 2009, CELL STEM CELL, V4, P49, DOI 10.1016/j.stem.2008.10.016; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Apidianakis Y, 2009, P NATL ACAD SCI USA, V106, P20883, DOI 10.1073/pnas.0911797106; Astigarraga S, 2007, EMBO J, V26, P668, DOI 10.1038/sj.emboj.7601532; Bardin AJ, 2010, DEVELOPMENT, V137, P705, DOI 10.1242/dev.039404; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Beebe K, 2010, DEV BIOL, V338, P28, DOI 10.1016/j.ydbio.2009.10.045; Bilger A, 2008, CARCINOGENESIS, V29, P1825, DOI 10.1093/carcin/bgn038; Biteau B, 2008, CELL STEM CELL, V3, P442, DOI 10.1016/j.stem.2008.07.024; Buchon N, 2009, GENE DEV, V23, P2333, DOI 10.1101/gad.1827009; Buchon N, 2009, CELL HOST MICROBE, V5, P200, DOI 10.1016/j.chom.2009.01.003; Calcagno SR, 2008, INT J CANCER, V122, P2462, DOI 10.1002/ijc.23383; CLIFFORD RJ, 1989, GENETICS, V123, P771; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Fransen K, 2004, CARCINOGENESIS, V25, P527, DOI 10.1093/carcin/bgh049; Fuchs E, 2009, CELL, V137, P811, DOI 10.1016/j.cell.2009.05.002; Gabay L, 1997, DEVELOPMENT, V124, P3535; Haigis KM, 2008, NAT GENET, V40, P600, DOI 10.1038/ng.115; Hime GR, 1997, ONCOGENE, V14, P2709, DOI 10.1038/sj.onc.1201223; Jiang HQ, 2009, CELL, V137, P1343, DOI 10.1016/j.cell.2009.05.014; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Karim FD, 1998, DEVELOPMENT, V125, P1; Lee D, 2004, MOL CELL BIOL, V24, P8907, DOI 10.1128/MCB.24.20.8907-8916.2004; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Lin GN, 2008, NATURE, V455, P1119, DOI 10.1038/nature07329; McDonald JA, 2006, DEV BIOL, V296, P94, DOI 10.1016/j.ydbio.2006.04.438; Meisner H, 1997, MOL CELL BIOL, V17, P2217, DOI 10.1128/MCB.17.4.2217; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nishimura T, 2008, ONCOL REP, V19, P105; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pellettieri J, 2007, ANNU REV GENET, V41, P83, DOI 10.1146/annurev.genet.41.110306.130244; Phelps RA, 2009, CELL, V137, P623, DOI 10.1016/j.cell.2009.02.037; Queenan AM, 1997, DEVELOPMENT, V124, P3871; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Reich A, 2002, EMBO J, V21, P4287, DOI 10.1093/emboj/cdf439; Rintelen F, 2003, DEVELOPMENT, V130, P3479, DOI 10.1242/dev.00568; Roberts RB, 2002, P NATL ACAD SCI USA, V99, P1521, DOI 10.1073/pnas.032678499; Roth AD, 2010, J CLIN ONCOL, V28, P466, DOI 10.1200/JCO.2009.23.3452; SANDGREN EP, 1990, CELL, V61, P1121, DOI 10.1016/0092-8674(90)90075-P; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schnepp B, 1998, GENE DEV, V12, P908, DOI 10.1101/gad.12.7.908; Schnorr JD, 1996, GENETICS, V144, P1545; SCHWEITZER R, 1995, GENE DEV, V9, P1518, DOI 10.1101/gad.9.12.1518; Silver DL, 2001, CELL, V107, P831, DOI 10.1016/S0092-8674(01)00607-9; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Troyer KL, 2001, GASTROENTEROLOGY, V121, P68, DOI 10.1053/gast.2001.25478; Urban S, 2002, EMBO J, V21, P4277, DOI 10.1093/emboj/cdf434; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Walther A, 2009, NAT REV CANCER, V9, P489, DOI 10.1038/nrc2645	56	316	325	1	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					84	95		10.1016/j.stem.2010.11.026	http://dx.doi.org/10.1016/j.stem.2010.11.026			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21167805	Green Accepted, Bronze			2022-12-28	WOS:000286786200013
J	Schaffer, DV				Schaffer, David V.			Microarraying for Mechanosensivitity	CELL STEM CELL			English	Editorial Material								In a recent issue of Science, Gilbert et al. combine biomaterial microarrays with lineage tracking to demonstrate that muscle stem cell survival is sensitive to the microenvironment's mechanical stiffness (Gilbert et al., 2010). This work enhances the breadth and depth of knowledge in stem cell mechanobiology.	[Schaffer, David V.] Univ Calif Berkeley, Dept Chem & Biol Engn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Schaffer, David V.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Schaffer, DV (corresponding author), Univ Calif Berkeley, Dept Chem & Biol Engn, Berkeley, CA 94720 USA.	schaffer@berkeley.edu						Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Gilbert PM, 2010, SCIENCE, V329, P1078, DOI 10.1126/science.1191035; KEUNG AJ, 2010, ANN REV CEL IN PRESS, V26, DOI DOI 10.10.1146/ANNUREV-CELLBIO-100109-104042; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Pelham RJ, 1997, P NATL ACAD SCI USA, V94, P13661, DOI 10.1073/pnas.94.25.13661; Saha K, 2008, BIOPHYS J, V95, P4426, DOI 10.1529/biophysj.108.132217; Wang HB, 2000, AM J PHYSIOL-CELL PH, V279, pC1345, DOI 10.1152/ajpcell.2000.279.5.C1345	10	1	1	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					273	274		10.1016/j.stem.2010.08.007	http://dx.doi.org/10.1016/j.stem.2010.08.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804961	Bronze			2022-12-28	WOS:000282037800002
J	Milyavsky, M; Gan, OI; Trottier, M; Komosa, M; Tabach, O; Notta, F; Lechman, E; Hermans, KG; Eppert, K; Konovalova, Z; Ornatsky, O; Domany, E; Meyn, MS; Dick, JE				Milyavsky, Michael; Gan, Olga I.; Trottier, Magan; Komosa, Martin; Tabach, Ofer; Notta, Faiyaz; Lechman, Eric; Hermans, Karin G.; Eppert, Kolja; Konovalova, Zhanna; Ornatsky, Olga; Domany, Eytan; Meyn, M. Stephen; Dick, John E.			A Distinctive DNA Damage Response in Human Hematopoietic Stem Cells Reveals an Apoptosis-Independent Role for p53 in Self-Renewal	CELL STEM CELL			English	Article							DOUBLE-STRAND BREAKS; RADIATION SENSITIVITY; MAMMALIAN-CELLS; REPAIR; VIVO; PHENOTYPE; EXPANSION; CULTURE; BLOOD; MICE	Highly regenerative tissues such as blood must possess effective DNA damage responses (DDR) that balance long-term regeneration with protection from leukemogenesis. Hematopoietic stem cells (HSCs) sustain life-long blood production, yet their response to DNA damage remains largely unexplored. We report that human HSCs exhibit delayed DNA double-strand break rejoining, persistent gamma H2AX foci, and enhanced p53- and ASPP1-dependent apoptosis after gamma-radiation compared to progenitors. p53 inactivation or Bcl-2 overexpression reduced radiation-induced apoptosis and preserved in vivo repopulating HSC function. Despite similar protection from irradiation-induced apoptosis, only Bcl-2-overexpressing HSCs showed higher self-renewal capacity, establishing that intact p53 positively regulates self-renewal independently from apoptosis. The reduced self-renewal of HSCs with inactivated p53 was associated with increased spontaneous gamma H2AX foci in secondary transplants of HSCs. Our data reveal distinct physiological roles of p53 that together ensure optimal HSC function: apoptosis regulation and prevention of gamma H2AX foci accumulation upon HSC self-renewal.	[Milyavsky, Michael; Gan, Olga I.; Notta, Faiyaz; Lechman, Eric; Hermans, Karin G.; Eppert, Kolja; Konovalova, Zhanna; Dick, John E.] Univ Toronto, Dept Stem Cell & Dev Biol, Campbell Family Canc Res Inst,Univ Hlth Network, Ontario Canc Inst,Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada; [Milyavsky, Michael; Gan, Olga I.; Trottier, Magan; Notta, Faiyaz; Lechman, Eric; Hermans, Karin G.; Eppert, Kolja; Konovalova, Zhanna; Meyn, M. Stephen; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1L7, Canada; [Ornatsky, Olga] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5G 1L7, Canada; [Meyn, M. Stephen] Univ Toronto, Dept Pediat, Toronto, ON M5G 1L7, Canada; [Trottier, Magan; Komosa, Martin; Meyn, M. Stephen] Hosp Sick Children, Res Inst, Program Genet & Genome Biol, Toronto, ON M5G 1X8, Canada; [Tabach, Ofer; Domany, Eytan] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Weizmann Institute of Science	Dick, JE (corresponding author), Univ Toronto, Dept Stem Cell & Dev Biol, Campbell Family Canc Res Inst,Univ Hlth Network, Ontario Canc Inst,Toronto Gen Res Inst, Toronto, ON M5G 1L7, Canada.	jdick@uhnres.utoronto.ca	DOMANY, EYTAN/K-1560-2012	Eppert, Kolja/0000-0001-9061-8856; Lechman, Eric/0000-0001-8874-2874; Dick, John/0000-0002-9527-8317	European Molecular Biology Organization (EMBO); European Hematology Association; The Netherland Society for Scientific Research (NOW); The Stem Cell Network of National Centers of Excellence; Canadian Cancer Society Research Institute; Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute; Ontario Institute for Cancer Research; Premier's Summit Award funded from the province of Ontario; Leukemia and Lymphoma Society; Canadian Institutes for Health Research (CHIR); Canada Research Chair; Ontario Ministry of Health and Long Term Care (OMOHLTC)	European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); European Hematology Association; The Netherland Society for Scientific Research (NOW); The Stem Cell Network of National Centers of Excellence; Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; Genome Canada through the Ontario Genomics Institute(Genome Canada); Ontario Institute for Cancer Research; Premier's Summit Award funded from the province of Ontario; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Canadian Institutes for Health Research (CHIR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Ontario Ministry of Health and Long Term Care (OMOHLTC)(Ministry of Health and Long-Term Care, Ontario)	We thank S. Harding and Dr. R.G. Bristow (Princess Margaret Hospital, Toronto, Ontario) for helping with immunofluorescent imaging; P. Scheufler, P. Savage, and the obstetrics unit of Trillium Hospital (Mississauga, Ontario) for providing cord blood samples and co-op students for processing cord blood samples; S. Zhao, L. Jamieson, and P.A. Penttila (Hospital for Sick Children, Toronto, Ontario) for sorting; and the J.E.D. lab members for critical review of the manuscript. This work was supported by postdoctoral fellowships from the European Molecular Biology Organization (EMBO) and European Hematology Association and Canadian Institutes for Health Research (CIHR) (MM.) and The Netherland Society for Scientific Research (NOW) (K.G.H.) and grants from The Stem Cell Network of National Centers of Excellence, Canadian Cancer Society Research Institute, Terry Fox Foundation, Genome Canada through the Ontario Genomics Institute, Ontario Institute for Cancer Research, Premier's Summit Award funded from the province of Ontario, Leukemia and Lymphoma Society, and Canadian Institutes for Health Research, and a Canada Research Chair. This research was funded in part by the Ontario Ministry of Health and Long Term Care (OMOHLTC). The views expressed do not necessarily reflect those of the OMOHLTC.	Benveniste P, 2003, NAT IMMUNOL, V4, P708, DOI 10.1038/ni940; Bertrand P, 2004, TRENDS GENET, V20, P235, DOI 10.1016/j.tig.2004.04.003; Chen JC, 2008, EXP HEMATOL, V36, P1236, DOI 10.1016/j.exphem.2008.04.012; Dainiak N, 2002, EXP HEMATOL, V30, P513, DOI 10.1016/S0301-472X(02)00802-0; Danet GH, 2001, EXP HEMATOL, V29, P1465, DOI 10.1016/S0301-472X(01)00750-0; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Domen J, 2003, EXP HEMATOL, V31, P631, DOI 10.1016/S0301-472X(03)00084-5; Domen J, 1998, BLOOD, V91, P2272, DOI 10.1182/blood.V91.7.2272.2272_2272_2282; Dorrell C, 2000, BLOOD, V95, P102; DOWN JD, 1995, BLOOD, V86, P122, DOI 10.1182/blood.V86.1.122.bloodjournal861122; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Gudkov AV, 2003, NAT REV CANCER, V3, P117, DOI 10.1038/nrc992; Guenechea G, 2001, NAT IMMUNOL, V2, P75, DOI 10.1038/83199; Gulston M, 2004, NUCLEIC ACIDS RES, V32, P1602, DOI 10.1093/nar/gkh306; JI WZ, 1995, CANCER RES, V55, P2876; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Mari PO, 2006, P NATL ACAD SCI USA, V103, P18597, DOI 10.1073/pnas.0609061103; Marusyk A, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000324; Mazurier F, 2004, BLOOD, V103, P545, DOI 10.1182/blood-2003-05-1558; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Meng AM, 2003, CANCER RES, V63, P5414; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Niedernhofer LJ, 2008, DNA REPAIR, V7, P523, DOI 10.1016/j.dnarep.2007.11.012; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Ossovskaya VS, 1996, P NATL ACAD SCI USA, V93, P10309, DOI 10.1073/pnas.93.19.10309; Palacios R, 1996, P NATL ACAD SCI USA, V93, P5247, DOI 10.1073/pnas.93.11.5247; Piacibello W, 2002, BLOOD, V100, P4391, DOI 10.1182/blood.V100.13.4391; PROKOCIMER M, 1994, BLOOD, V84, P2391; Rangarajan A, 2004, CANCER CELL, V6, P171, DOI 10.1016/j.ccr.2004.07.009; Raphael BJ, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r59; Rossi DJ, 2008, CELL, V132, P681, DOI 10.1016/j.cell.2008.01.036; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Samuels-Lev Y, 2001, MOL CELL, V8, P781, DOI 10.1016/S1097-2765(01)00367-7; Stenerlow B, 2003, RADIAT RES, V159, P502, DOI 10.1667/0033-7587(2003)159[0502:MOPDDS]2.0.CO;2; STRASSER A, 1994, CELL, V79, P329, DOI 10.1016/0092-8674(94)90201-1; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; VANBEKKUM DW, 1991, RADIAT RES, V128, pS4, DOI 10.2307/3577994; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; WAGEMAKER G, 1995, STEM CELLS, V13, P257, DOI 10.1002/stem.5530130731; Wang Y, 2006, BLOOD, V107, P358, DOI 10.1182/blood-2005-04-1418; Wilson PF, 2010, MUTAT RES-FUND MOL M, V683, P91, DOI 10.1016/j.mrfmmm.2009.10.013; Wouters A, 2007, ONCOLOGIST, V12, P690, DOI 10.1634/theoncologist.12-6-690; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yip KW, 2008, ONCOGENE, V27, P6398, DOI 10.1038/onc.2008.307; Yoshida K, 2002, LEUKEMIA RES, V26, P1085, DOI 10.1016/S0145-2126(02)00032-2	50	201	209	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					186	197		10.1016/j.stem.2010.05.016	http://dx.doi.org/10.1016/j.stem.2010.05.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20619763	Bronze			2022-12-28	WOS:000281107400011
J	Deans, TL; Elisseeff, JH				Deans, Tara L.; Elisseeff, Jennifer H.			The Life of a Cell: Probing the Complex Relationships with the World	CELL STEM CELL			English	Editorial Material							MATRIX	Stem cells live within a complex environment containing an array of signals that impact cell fate. Recently in Nature Materials, Huebsch et. al. (2010) probed the role of mechanical properties on stem cell integrin binding and differentiation in three dimensions.	[Deans, Tara L.; Elisseeff, Jennifer H.] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA	Johns Hopkins University	Elisseeff, JH (corresponding author), Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA.	jhe@jhu.edu	Elisseeff, Jennifer/A-3324-2010	Elisseeff, Jennifer/0000-0002-5066-1996				Bryant SJ, 2002, J BIOMED MATER RES, V59, P63, DOI 10.1002/jbm.1217; Cukierman E, 2001, SCIENCE, V294, P1708, DOI 10.1126/science.1064829; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Guilak F, 2009, CELL STEM CELL, V5, P17, DOI 10.1016/j.stem.2009.06.016; Hoemann CD, 2005, OSTEOARTHR CARTILAGE, V13, P318, DOI 10.1016/j.joca.2004.12.001; Huebsch N, 2010, NAT MATER, V9, P518, DOI [10.1038/NMAT2732, 10.1038/nmat2732]; Hwang NS, 2006, STEM CELLS, V24, P284, DOI 10.1634/stemcells.2005-0024; Skloot R., 2011, IMMORTAL LIFE HENRIE; Wirtz D, 2009, ANNU REV BIOPHYS, V38, P301, DOI 10.1146/annurev.biophys.050708.133724	9	6	7	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					499	501		10.1016/j.stem.2010.05.009	http://dx.doi.org/10.1016/j.stem.2010.05.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569684	Bronze			2022-12-28	WOS:000278840700005
J	Zawadzka, M; Rivers, LE; Fancy, SPJ; Zhao, C; Tripathi, R; Jamen, F; Young, K; Goncharevich, A; Pohl, H; Rizzi, M; Rowitch, DH; Kessaris, N; Suter, U; Richardson, WD; Franklin, RJM				Zawadzka, Malgorzata; Rivers, Leanne E.; Fancy, Stephen P. J.; Zhao, Chao; Tripathi, Richa; Jamen, Francoise; Young, Kaylene; Goncharevich, Alexander; Pohl, Hartmut; Rizzi, Matteo; Rowitch, David H.; Kessaris, Nicoletta; Suter, Ueli; Richardson, William D.; Franklin, Robin J. M.			CNS-Resident Glial Progenitor/Stem Cells Produce Schwann Cells as well as Oligodendrocytes during Repair of CNS Demyelination	CELL STEM CELL			English	Article							MULTIPLE-SCLEROSIS LESIONS; CENTRAL-NERVOUS-SYSTEM; EMBRYONIC SPINAL-CORD; PDGF ALPHA-RECEPTOR; NEURAL PROGENITOR; PRECURSOR CELLS; RAT-BRAIN; INTRASPINAL INJECTION; REMYELINATION OCCURS; NG2 PROTEOGLYCAN	After central nervous system (CNS) demyelination such as occurs during multiple sclerosis there is often spontaneous regeneration of myelin sheaths, mainly by oligodendrocytes but also by Schwann cells. The origins of the remyelinating cells have not previously been established. We have used Cre-lox fate mapping in transgenic mice to show that PDGFRA/NG2-expressing glia, a distributed population of stem/progenitor cells in the adult CNS, produce the remyelinating oligodendrocytes and almost all of the Schwann cells in chemically induced demyelinated lesions. In contrast, the great majority of reactive astrocytes in the vicinity of the lesions are derived from preexisting FGFR3-expressing cells, likely to be astrocytes. These data resolve a long-running debate about the origins of the main players in CNS remyelination and reveal a surprising capacity of CNS precursors to generate Schwann cells, which normally develop from the embryonic neural crest and are restricted to the peripheral nervous system.	[Rivers, Leanne E.; Tripathi, Richa; Jamen, Francoise; Young, Kaylene; Rizzi, Matteo; Kessaris, Nicoletta; Richardson, William D.] UCL, Wolfson Inst Biomed Res, London WC1E 6BT, England; [Rivers, Leanne E.; Tripathi, Richa; Young, Kaylene; Kessaris, Nicoletta; Richardson, William D.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England; [Rizzi, Matteo] UCL, Res Dept Neurosci Physiol & Pharmacol, London WC1E 6BT, England; [Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA; [Fancy, Stephen P. J.; Rowitch, David H.] Univ Calif San Francisco, Inst Regenerat Med, Dept Pediat, San Francisco, CA 94143 USA; [Pohl, Hartmut; Suter, Ueli] ETH, Inst Cell Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Zawadzka, Malgorzata] M Nencki Inst Expt Biol, Lab Transcript Regulat, Dept Cell Biol, PL-02093 Warsaw, Poland; [Zawadzka, Malgorzata; Fancy, Stephen P. J.; Zhao, Chao; Goncharevich, Alexander; Franklin, Robin J. M.] Univ Cambridge, MRC Cambridge Ctr Stem Cell Biol & Regenerat Med, Cambridge CB3 0ES, England; [Zawadzka, Malgorzata; Fancy, Stephen P. J.; Zhao, Chao; Goncharevich, Alexander; Franklin, Robin J. M.] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England	University of London; University College London; University of London; University College London; University of London; University College London; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; Polish Academy of Sciences; Nencki Institute of Experimental Biology of the Polish Academy of Sciences; University of Cambridge; University of Cambridge	Richardson, WD (corresponding author), UCL, Wolfson Inst Biomed Res, Gower St, London WC1E 6BT, England.	w.richardson@ucl.ac.uk; rjf1000@cam.ac.uk	Suter, Ueli/A-1624-2010; Messier, Claude/A-2322-2008; Kessaris, Nicoletta/AAD-6774-2019; Zawadzka, Malgorzata/AAB-1979-2020; Zawadzka, Malgorzata/A-5297-2012; Richardson FMedSci FRS, William D/C-1762-2008	Messier, Claude/0000-0002-4791-1763; Kessaris, Nicoletta/0000-0003-1191-6009; Zawadzka, Malgorzata/0000-0002-3637-2709; Zawadzka, Malgorzata/0000-0002-3637-2709; Jamen, Francoise/0000-0003-4116-395X; Rizzi, Matteo/0000-0003-4922-397X; Rowitch, David/0000-0002-0079-0060; Franklin, Robin/0000-0001-6522-2104; Pohl, Hartmut/0000-0001-6827-1665; Richardson FMedSci FRS, William D/0000-0001-7261-2485; Tripathi, Richa/0000-0002-3810-0328; Young, Kaylene/0000-0002-1686-3463	European Union (EU); Biotechnology and Biological Sciences Research Council with Eisai Research London; Wellcome Trust; Swiss National Science Foundation; National Competence Center in Research (NCCR); UK Medical Research Council; UK MS Society; National MS Society; MRC [G0501173, G9708005, G0800575] Funding Source: UKRI; Medical Research Council [G0800575, G0501173, G9708005] Funding Source: researchfish	European Union (EU)(CGIAREuropean Commission); Biotechnology and Biological Sciences Research Council with Eisai Research London(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); National Competence Center in Research (NCCR)(Swiss National Science Foundation (SNSF)); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK MS Society; National MS Society(National Multiple Sclerosis Society); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	M.Z. was supported by a Marie Curie Fellowship from the European Union (EU). L.E.R. was supported by a studentship from the Biotechnology and Biological Sciences Research Council with Eisai Research London, M.R. by a Wellcome Trust Prize Studentship, and F.J. by an EU Marie Curie Fellowship. D.H.R. is an HHMI investigator. U.S. is supported by the Swiss National Science Foundation and the National Competence Center in Research (NCCR) "Neural Plasticity and Repair." N.K. and W.D.R. are funded by the UK Medical Research Council and The Wellcome Trust. S.P.J.F., C.Z., and R.J.M.F. are supported by grants from the UK MS Society and the National MS Society.	Arnett HA, 2004, SCIENCE, V306, P2111, DOI 10.1126/science.1103709; BaronVanEvercooren A, 1996, GLIA, V16, P147, DOI 10.1002/(SICI)1098-1136(199602)16:2<147::AID-GLIA7>3.0.CO;2-0; Belachew S, 2003, J CELL BIOL, V161, P169, DOI 10.1083/jcb.200210110; Blakemore WF, 2008, CURR TOP MICROBIOL, V318, P193; BLAKEMORE WF, 1975, J NEUROCYTOL, V4, P745, DOI 10.1007/BF01181634; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Cassiani-Ingoni R, 2006, EXP NEUROL, V201, P349, DOI 10.1016/j.expneurol.2006.04.030; CAVANAGH JB, 1970, J ANAT, V106, P471; Chandran S, 2004, GLIA, V47, P314, DOI 10.1002/glia.20011; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; Crang AJ, 2004, EUR J NEUROSCI, V20, P1445, DOI 10.1111/j.1460-9568.2004.03606.x; Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x; Dimou L, 2008, J NEUROSCI, V28, P10434, DOI 10.1523/JNEUROSCI.2831-08.2008; Duncan ID, 1997, J ANAT, V190, P35, DOI 10.1046/j.1469-7580.1997.19010035.x; DUSART I, 1992, NEUROSCIENCE, V51, P137, DOI 10.1016/0306-4522(92)90478-K; Fancy SPJ, 2004, MOL CELL NEUROSCI, V27, P247, DOI 10.1016/j.mcn.2004.06.015; Felts PA, 2005, BRAIN, V128, P1649, DOI 10.1093/brain/awh516; FRANKLIN RJM, 1993, INT J DEV NEUROSCI, V11, P641, DOI 10.1016/0736-5748(93)90052-F; Franklin RJM, 2008, NAT REV NEUROSCI, V9, P839, DOI 10.1038/nrn2480; Gensert JM, 1997, NEURON, V19, P197, DOI 10.1016/S0896-6273(00)80359-1; GILLESPIE CS, 1994, NEURON, V12, P497, DOI 10.1016/0896-6273(94)90208-9; Gudino-Cabrera G, 2000, GLIA, V30, P49, DOI 10.1002/(SICI)1098-1136(200003)30:1<49::AID-GLIA6>3.0.CO;2-M; ITOYAMA Y, 1985, ACTA NEUROPATHOL, V65, P217, DOI 10.1007/BF00687001; ITOYAMA Y, 1983, ANN NEUROL, V14, P339, DOI 10.1002/ana.410140313; Keirstead HS, 1999, J NEUROSCI, V19, P7529, DOI 10.1523/JNEUROSCI.19-17-07529.1999; Keirstead HS, 1997, J NEUROPATH EXP NEUR, V56, P1191, DOI 10.1097/00005072-199711000-00003; Kessaris N, 2006, NAT NEUROSCI, V9, P173, DOI 10.1038/nn1620; Kondo T, 2004, DEV BIOL, V267, P242, DOI 10.1016/j.ydbio.2003.11.013; Lee MJ, 1997, MOL CELL NEUROSCI, V8, P336, DOI 10.1006/mcne.1996.0589; Leone DP, 2003, MOL CELL NEUROSCI, V22, P430, DOI 10.1016/S1044-7431(03)00029-0; LEVISON SW, 1993, NEURON, V10, P201, DOI 10.1016/0896-6273(93)90311-E; Ligon KL, 2006, P NATL ACAD SCI USA, V103, P7853, DOI 10.1073/pnas.0511001103; Magnus T, 2007, J NEUROSCI RES, V85, P2126, DOI 10.1002/jnr.21368; Masahira N, 2006, DEV BIOL, V293, P358, DOI 10.1016/j.ydbio.2006.02.029; Mujtaba T, 1998, DEV BIOL, V200, P1, DOI 10.1006/dbio.1998.8913; Nagelhus EA, 1998, J NEUROSCI, V18, P2506; Nave KA, 2008, ANNU REV NEUROSCI, V31, P535, DOI 10.1146/annurev.neuro.30.051606.094309; Nishiyama A, 1996, J NEUROSCI RES, V43, P299, DOI 10.1002/(SICI)1097-4547(19960201)43:3<299::AID-JNR5>3.0.CO;2-E; Nunes MC, 2003, NAT MED, V9, P439, DOI 10.1038/nm837; Patrikios P, 2006, BRAIN, V129, P3165, DOI 10.1093/brain/awl217; PRINGLE NP, 1992, DEVELOPMENT, V115, P535; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAIVICH G, 1987, J NEUROCYTOL, V16, P701, DOI 10.1007/BF01637661; Rivers LE, 2008, NAT NEUROSCI, V11, P1392, DOI 10.1038/nn.2220; Shields SA, 1999, GLIA, V28, P77, DOI 10.1002/(SICI)1098-1136(199910)28:1<77::AID-GLIA9>3.0.CO;2-F; Sim FJ, 2002, MOL CELL NEUROSCI, V20, P669, DOI 10.1006/mcne.2002.1145; Sim FJ, 2002, J NEUROSCI, V22, P2451, DOI 10.1523/JNEUROSCI.22-07-02451.2002; SMITH KJ, 1979, NATURE, V280, P395, DOI 10.1038/280395a0; SNYDER DH, 1975, J NEUROPATH EXP NEUR, V34, P209, DOI 10.1097/00005072-197505000-00001; Steindler DA, 2003, GLIA, V43, P62, DOI 10.1002/glia.10242; Talbott JF, 2006, GLIA, V54, P147, DOI 10.1002/glia.20369; Talbott JF, 2005, EXP NEUROL, V192, P11, DOI 10.1016/j.expneurol.2004.05.038; Trapp BD, 2008, ANNU REV NEUROSCI, V31, P247, DOI 10.1146/annurev.neuro.30.051606.094313; Watanabe M, 2002, J NEUROSCI RES, V69, P826, DOI 10.1002/jnr.10338; Woodruff RH, 1999, GLIA, V25, P216, DOI 10.1002/(SICI)1098-1136(19990201)25:3<216::AID-GLIA2>3.0.CO;2-L; YOUNG KM, 2010, GLIA IN PRESS; Zhang SC, 1999, P NATL ACAD SCI USA, V96, P4089, DOI 10.1073/pnas.96.7.4089; Zhu XQ, 2008, DEVELOPMENT, V135, P145, DOI 10.1242/dev.004895	58	426	435	1	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					578	590		10.1016/j.stem.2010.04.002	http://dx.doi.org/10.1016/j.stem.2010.04.002			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569695	Green Accepted, Bronze			2022-12-28	WOS:000278840700018
J	Song, H; Chung, SK; Xu, Y				Song, Hoseok; Chung, Sun-Ku; Xu, Yang			Modeling Disease in Human ESCs Using an Efficient BAC-Based Homologous Recombination System	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; ATAXIA-TELANGIECTASIA; HUMAN BLASTOCYSTS; DEFICIENT MICE; DNA-DAMAGE; P53; ATM; PROTEIN; GENOME; GENE	Although mouse models have been valuable for studying human disease, the cellular and physiological differences between mouse and human have made it increasingly important to develop more relevant human disease models for mechanistic studies and drug discovery. Human embryonic stem cells (hESCs), which can undergo unlimited self-renewal and retain the potential to differentiate into all cell types, present a possible solution. To improve the efficiency of genetic manipulation of hESCs, we have developed bacterial artificial chromosome (BAC) based approach that enables high efficiency homologous recombination. By sequentially disrupting both alleles of ATM or p53 with BAC targeting vectors, we have established ATM(-/-) and p53(-/-) hESCs as models for two major human genetic instability syndromes and used the generated cells to reveal the importance of p53 in maintaining genome stability of hESCs. Our findings suggest that it will be feasible to develop genetically modified hESCs as relevant human disease models.	[Song, Hoseok; Chung, Sun-Ku; Xu, Yang] Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Xu, Y (corresponding author), Univ Calif San Diego, Div Biol Sci, Mol Biol Sect, 9500 Gilman Dr, La Jolla, CA 92093 USA.	yangxu@ucsd.edu		Song, Hoseok/0000-0001-5723-3057; Xu, Yang/0000-0001-5574-921X	California Institute of Regenerative Medicine [RC1-148]	California Institute of Regenerative Medicine(California Institute for Regenerative Medicine)	We thank Dr. Melton's lab and Harvard University for providing the HUES cell lines and Drs. T. Zhao and J.-Y. Jung for technical help. This work was supported by a grant from California Institute of Regenerative Medicine to YX (RC1-148).	Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Chao C, 2006, EMBO J, V25, P2615, DOI 10.1038/sj.emboj.7601167; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Costa M, 2007, NAT PROTOC, V2, P792, DOI 10.1038/nprot.2007.105; Cowan CA, 2004, NEW ENGL J MED, V350, P1353, DOI 10.1056/NEJMsr040330; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Deng WB, 2009, TRENDS GENET, V25, P425, DOI 10.1016/j.tig.2009.09.004; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Elson A, 1996, P NATL ACAD SCI USA, V93, P13084, DOI 10.1073/pnas.93.23.13084; Hockemeyer D, 2009, NAT BIOTECHNOL, V27, P851, DOI 10.1038/nbt.1562; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Johnson BV, 2008, MOL HUM REPROD, V14, P513, DOI 10.1093/molehr/gan048; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Krizhanovsky V, 2009, NATURE, V460, P1085, DOI 10.1038/4601085a; Lara-Tejero M, 2000, SCIENCE, V290, P354, DOI 10.1126/science.290.5490.354; Lin TX, 2005, NAT CELL BIOL, V7, P165, DOI 10.1038/ncb1211; Mills AA, 2005, GENE DEV, V19, P2091, DOI 10.1101/gad.1362905; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; Ruby KM, 2009, STEM CELLS, V27, P1496, DOI 10.1002/stem.73; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 2001, ADV CANCER RES, V83, P209, DOI 10.1016/S0065-230X(01)83007-4; SHILOH Y, 1995, EUR J HUM GENET, V3, P116; Song H, 2007, NAT CELL BIOL, V9, P573, DOI 10.1038/ncb1571; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Xu Y, 2006, NAT REV IMMUNOL, V6, P261, DOI 10.1038/nri1804; Xu Y, 2005, CELL CYCLE, V4, P363, DOI 10.4161/cc.4.3.1529; Xu Y, 1996, GENE DEV, V10, P2401, DOI 10.1101/gad.10.19.2401; Xu Y, 1996, GENE DEV, V10, P2411, DOI 10.1101/gad.10.19.2411; Xue HP, 2009, STEM CELLS, V27, P1836, DOI 10.1002/stem.129; Zou JZ, 2009, CELL STEM CELL, V5, P97, DOI 10.1016/j.stem.2009.05.023; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	39	133	139	0	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					80	89		10.1016/j.stem.2009.11.016	http://dx.doi.org/10.1016/j.stem.2009.11.016			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074536	Bronze			2022-12-28	WOS:000274029700014
J	Yamada, Y; Aoki, H; Kunisada, T; Hara, A				Yamada, Yasuhiro; Aoki, Hitomi; Kunisada, Takahiro; Hara, Akira			Rest Promotes the Early Differentiation of Mouse ESCs but Is Not Required for Their Maintenance	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; RESTRICTIVE SILENCER FACTOR; SELF-RENEWAL; GENE-EXPRESSION; TARGET GENES; IN-VITRO; PLURIPOTENCY; ENDODERM; NANOG; NEUROGENESIS		[Yamada, Yasuhiro; Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan; [Aoki, Hitomi; Kunisada, Takahiro] Gifu Univ, Grad Sch Med, Dept Tissue & Organ Dev Regenerat & Adv Med Sci, Gifu 5011194, Japan; [Yamada, Yasuhiro] Kyoto Univ, Inst Integrated Cell Mat Sci, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan; [Yamada, Yasuhiro] Japan Sci & Technol Agcy, PRESTO, Saitama, Japan	Gifu University; Gifu University; Kyoto University; Japan Science & Technology Agency (JST)	Yamada, Y (corresponding author), Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu 5011194, Japan.	y-yamada@cira.kyoto-u.ac.jp		Kunisada, Takahiro/0000-0003-1651-2716	PRESTO; Ministry of Health, Labour and Welfare of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency (JST)	PRESTO; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	We would like to thank Hitoshi Niwa for helpful discussions, comments on the manuscript, and a plasmid expressing EGFP-ires-Zeocin. We would also like to thank HongQiang Sheng, Takeru Oyama, and Huilan Zhi for generating the Rest floxed ESCs. We thank Caroline Beard for a Colla-tetOP-cre allele, Konrad Hochedlinger for a targeting plasmid containing ires-GFP, Kazutoshi Takahashi and Shinya Yamanaka for a Nanog-expressing plasmid, and Gail Mandel for a REST-expressing plasmid and a protocol for Rest western blot. We also thank Kyoko Takahashi, Ayako Suga, and Yoshitaka Kinjyo for their valuable technical assistance. This study was supported by grants from PRESTO, from the Ministry of Health, Labour and Welfare of Japan, from the Ministry of Education, Culture, Sports, Science and Technology of Japan, and from the Japan Science and Technology Agency (JST).	Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Buckley NJ, 2009, NATURE, V457, pE5, DOI 10.1038/nature07784; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Fujikura J, 2002, GENE DEV, V16, P784, DOI 10.1101/gad.968802; Grimes JA, 2000, J BIOL CHEM, V275, P9461, DOI 10.1074/jbc.275.13.9461; Hochedlinger K, 2005, CELL, V121, P465, DOI 10.1016/j.cell.2005.02.018; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; Jorgensen HF, 2009, NATURE, V457, pE4, DOI 10.1038/nature07783; Jorgensen HF, 2009, DEVELOPMENT, V136, P715, DOI 10.1242/dev.028548; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kunath T, 2007, DEVELOPMENT, V134, P2895, DOI 10.1242/dev.02880; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Schoenherr CJ, 1996, P NATL ACAD SCI USA, V93, P9881, DOI 10.1073/pnas.93.18.9881; Shimoda M, 2007, J CELL SCI, V120, P3859, DOI 10.1242/jcs.007856; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; SOUDAIS C, 1995, DEVELOPMENT, V121, P3877; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Yamada M, 2004, NEUROSCIENCE, V124, P173, DOI 10.1016/j.neuroscience.2003.10.040; Yang DH, 2002, DEV BIOL, V251, P27, DOI 10.1006/dbio.2002.0810	29	44	45	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					10	15		10.1016/j.stem.2009.12.003	http://dx.doi.org/10.1016/j.stem.2009.12.003			6	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085738	Bronze, Green Published			2022-12-28	WOS:000274029700006
J	Renault, VM; Rafalski, VA; Morgan, AA; Salih, DAM; Brett, JO; Webb, AE; Villeda, SA; Thekkat, PU; Guillerey, C; Denko, NC; Palmer, TD; Bufte, AJ; Brunet, A				Renault, Valerie M.; Rafalski, Victoria A.; Morgan, Alex A.; Salih, Dervis A. M.; Brett, Jamie O.; Webb, Ashley E.; Villeda, Saul A.; Thekkat, Pramod U.; Guillerey, Camille; Denko, Nicholas C.; Palmer, Theo D.; Bufte, Atul J.; Brunet, Anne			FoxO3 Regulates Neural Stem Cell Homeostasis	CELL STEM CELL			English	Article							SELF-RENEWAL; VASCULAR NICHE; DENTATE GYRUS; NEUROGENESIS; PROLIFERATION; PTEN; DIFFERENTIATION; SURVIVAL; HYPOXIA; MAINTENANCE	In the nervous system, neural stem cells (NSCs) are necessary for the generation of new neurons and for cognitive function. Here we show that FoxO3, a member of a transcription factor family known to extend lifespan in invertebrates, regulates the NSC pool. We find that adult FoxO3(-/-) mice have fewer NSCs in vivo than wild-type counterparts. NSCs isolated from adult FoxO3(-/-) mice have decreased self-renewal and an impaired ability to generate different neural lineages. Identification of the FoxO3-dependent gene expression profile in NSCs suggests that FoxO3 regulates the NSC pool by inducing a program of genes that preserves quiescence, prevents premature differentiation, and controls oxygen metabolism. The ability of FoxO3 to prevent the premature depletion of NSCs; might have important implications for counteracting brain aging in long-lived species.	[Renault, Valerie M.; Rafalski, Victoria A.; Salih, Dervis A. M.; Brett, Jamie O.; Webb, Ashley E.; Villeda, Saul A.; Thekkat, Pramod U.; Guillerey, Camille; Brunet, Anne] Stanford Univ, Dept Genet, Stanford, CA 94305 USA; [Rafalski, Victoria A.; Villeda, Saul A.; Brunet, Anne] Stanford Univ, Neurosci Program, Stanford, CA 94305 USA; [Morgan, Alex A.; Bufte, Atul J.] Stanford Univ, Biomed Informat Program, Stanford, CA 94305 USA; [Denko, Nicholas C.] Stanford Univ, Dept Radiat Oncol, Stanford, CA 94305 USA; [Palmer, Theo D.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Morgan, Alex A.; Bufte, Atul J.] Stanford Univ, Lucile Packard Childrens Hosp, Dept Pediat, Stanford, CA 94304 USA; [Morgan, Alex A.; Bufte, Atul J.] Stanford Univ, Lucile Packard Childrens Hosp, Dept Med, Stanford, CA 94304 USA	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University; Lucile Packard Children's Hospital (LPCH); Stanford University	Brunet, A (corresponding author), Stanford Univ, Dept Genet, Stanford, CA 94305 USA.	anne.brunet@stanford.edu	Palmer, Theo/GSI-6635-2022; Guillerey, Camille/N-1061-2014; denko, nicholas/F-8444-2010	Guillerey, Camille/0000-0002-7917-2432; Palmer, Theo/0000-0002-6266-1862; Salih, Dervis/0000-0001-7651-8998	NIH/NIA [R01 AG026648]; CIRM; Brain Tumor Society; Klingenstein Fellowship; AFAR; Stanford University; NSF; NIH/NRSA [5T32 CA09302]; Lucile Packard Foundation for Children's Health; NLM [R01 LM009719, T15 LM007033]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026648] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [T15LM007033, R01LM009719] Funding Source: NIH RePORTER	NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); CIRM(California Institute for Regenerative Medicine); Brain Tumor Society; Klingenstein Fellowship(Klingenstein Philanthropies); AFAR; Stanford University(Stanford University); NSF(National Science Foundation (NSF)); NIH/NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lucile Packard Foundation for Children's Health; NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	Work supported by an NIH/NIA grant R01 AG026648, a CIRM grant, a Brain Tumor Society grant, a Klingenstein Fellowship, and an AFAR grant (A.B.), a Stanford University Dean's fellowship (V.M.R.), an NSF graduate fellowship (V.A.R.), an NIH/NRSA 5T32 CA09302 (A.E.W.), the Lucile Packard Foundation for Children's Health and NLM grant R01 LM009719 (A.J.B.), and NLM grant T15 LM007033 (A.A.M.). We thank Kimmi Hoang for help with mouse colony management, Michael Stadler for help with Luxol blue staining, Ben Barres for the generous gift of the 04 antibody, Brandon Cord (T.D.P.'s lab) for help in NSC; cultures, and Nathan Woodling (Katrin Andreasson's lab) for help with the BrdU protocol. We thank Ioanna Papandreou (N.C.D.'s lab) for her help with low-oxygen experiments. We thank Ron DePinho for the generous gift of the FoxO3<SUP>-/-</SUP> and FoxO3<SUP>lox/lox</SUP> mice and for discussing results prepublication. We thank Steve Artandi, Michael Greenberg, Tom Rando, Julien Sage, and members of the Brunet lab for critically reading the manuscript.	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Alvarez-Buylla A, 1998, J NEUROBIOL, V36, P105, DOI 10.1002/(SICI)1097-4695(199808)36:2<105::AID-NEU1>3.0.CO;2-5; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bondolfi L, 2004, NEUROBIOL AGING, V25, P333, DOI 10.1016/S0197-4580(03)00083-6; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Clelland CD, 2009, SCIENCE, V325, P210, DOI 10.1126/science.1173215; Emerling BM, 2008, P NATL ACAD SCI USA, V105, P2622, DOI 10.1073/pnas.0706790105; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Gheusi C, 2000, P NATL ACAD SCI USA, V97, P1823, DOI 10.1073/pnas.97.4.1823; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; Johnson MA, 2009, BMB REP, V42, P245, DOI 10.5483/BMBRep.2009.42.5.245; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kinney BA, 2001, HORM BEHAV, V39, P277, DOI 10.1006/hbeh.2001.1654; Kippin TE, 2005, GENE DEV, V19, P756, DOI 10.1101/gad.1272305; Li L, 2002, MOL CELL NEUROSCI, V20, P21, DOI 10.1006/mcne.2002.1115; McElwee JJ, 2004, J BIOL CHEM, V279, P44533, DOI 10.1074/jbc.M406207200; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Palmer TD, 1997, MOL CELL NEUROSCI, V8, P389, DOI 10.1006/mcne.1996.0595; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; REYNOLDS BA, 1992, SCIENCE, V255, P1707, DOI 10.1126/science.1553558; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Sinor AD, 2004, J NEUROSCI, V24, P8531, DOI 10.1523/JNEUROSCI.1470-04.2004; Studer L, 2000, J NEUROSCI, V20, P7377; Sun LY, 2005, ENDOCRINOLOGY, V146, P1138, DOI 10.1210/en.2004-1115; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tropepe V, 1997, J NEUROSCI, V17, P7850; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zhu LL, 2005, MOL NEUROBIOL, V31, P231, DOI 10.1385/MN:31:1-3:231	43	414	423	0	24	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					527	539		10.1016/j.stem.2009.09.014	http://dx.doi.org/10.1016/j.stem.2009.09.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896443	Bronze, Green Accepted			2022-12-28	WOS:000272019500014
J	Sockanathan, S; Gaiano, N				Sockanathan, Shanthini; Gaiano, Nicholas			Meninges Play a RAdical Role in Embryonic Neural Stem Cell Regulation	CELL STEM CELL			English	Editorial Material							RETINOIC ACID; DIFFERENTIATION; NEUROGENESIS; EXPRESSION; DEFECTS; MOUSE	During corticogenesis, neural stem cells switch from symmetric to asymmetric divisions to generate intermediate progenitor cells and neurons. Recently published in Cell, Siegenthaler et al. (2009) show that retinoic acid derived from the meninges is a key signal controlling this transition.	[Sockanathan, Shanthini; Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Gaiano, Nicholas] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Sockanathan, S (corresponding author), Johns Hopkins Univ, Sch Med, Solomon Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssockan1@jhmi.edu; gaiano@jhmi.edu						Borrell V, 2006, NAT NEUROSCI, V9, P1284, DOI 10.1038/nn1764; Ito Y, 2003, DEVELOPMENT, V130, P5269, DOI 10.1242/dev.00708; Maden M, 2002, NAT REV NEUROSCI, V3, P843, DOI 10.1038/nrn963; Niederreither K, 2002, MECH DEVELOP, V110, P165, DOI 10.1016/S0925-4773(01)00561-5; Pontious A, 2008, DEV NEUROSCI-BASEL, V30, P24, DOI 10.1159/000109848; Romand R, 2008, J COMP NEUROL, V508, P879, DOI 10.1002/cne.21707; Sharpe CR, 1997, DEVELOPMENT, V124, P515; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Siegenthaler JA, 2009, CELL, V139, P597, DOI 10.1016/j.cell.2009.10.004; Zarbalis K, 2007, P NATL ACAD SCI USA, V104, P14002, DOI 10.1073/pnas.0702618104	10	6	6	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					455	456		10.1016/j.stem.2009.10.010	http://dx.doi.org/10.1016/j.stem.2009.10.010			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896433	Bronze			2022-12-28	WOS:000272019500003
J	Sacchetti, P; Sousa, KM; Hall, AC; Liste, I; Steffensen, KR; Theofilopoulos, S; Parish, CL; Hazenberg, C; Ahrlund-Richter, L; Hovatta, O; Gustafsson, JA; Arenas, E				Sacchetti, Paola; Sousa, Kyle M.; Hall, Anita C.; Liste, Isabel; Steffensen, Knut R.; Theofilopoulos, Spyridon; Parish, Clare L.; Hazenberg, Carin; Ahrlund-Richter, Lars; Hovatta, Outti; Gustafsson, Jan-Ake; Arenas, Ernest			Liver X Receptors and Oxysterols Promote Ventral Midbrain Neurogenesis In Vivo and in Human Embryonic Stem Cells	CELL STEM CELL			English	Article							DOPAMINERGIC NEURON DEVELOPMENT; CENTRAL-NERVOUS-SYSTEM; NUCLEAR RECEPTOR; PROGENITOR CELLS; LXR-ALPHA; BETA; FATE; DEGENERATION; METABOLISM; EXPRESSION	Control over progenitor proliferation and neurogenesis remains a key challenge for stem cell neurobiology and a prerequisite for successful stem cell replacement therapies for neurodegenerative diseases like Parkinson's disease (PD). Here, we examined the function of two nuclear receptors, liver X receptors (Lxroc and P) and their ligands, oxysterols, as regulators of cell division, ventral midbrain (VM) neurogenesis, and dopaminergic (DA) neuron development. Deletion of Lxrs reduced cell cycle progression and VM neurogenesis, resulting in decreased DA neurons at birth. Activation of Lxrs with oxysterol ligands increased the number of DA neurons in mouse embryonic stem cells (ESCs) and in wildtype but not Lxr alpha beta(-/-) VM progenitor cultures. Likewise, oxysterol treatment of human ESCs (hESCs) during DA differentiation increased neurogenesis and the number of mature DA neurons, while reducing proliferating progenitors. Thus, Lxr ligands may improve current hESC replacement strategies for PD by selectively augmenting the generation of DA neurons.	[Sacchetti, Paola; Sousa, Kyle M.; Hall, Anita C.; Liste, Isabel; Theofilopoulos, Spyridon; Hazenberg, Carin; Arenas, Ernest] Karolinska Inst, Ctr Dev Biol & Regenerat Med, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden; [Sousa, Kyle M.] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Hall, Anita C.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AY, England; [Steffensen, Knut R.; Gustafsson, Jan-Ake] Karolinska Inst, Dept Biosci & Nutr Novum, S-14157 Huddinge, Sweden; [Parish, Clare L.] Univ Melbourne, Florey Neurosci Inst, Parkville, Vic 3010, Australia; [Parish, Clare L.] Univ Melbourne, Ctr Neurosci, Parkville, Vic 3010, Australia; [Ahrlund-Richter, Lars] Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Hovatta, Outti] Karolinska Univ Hosp, Dept Clin Sci Intervent & Technol, S-14186 Huddinge, Sweden; [Gustafsson, Jan-Ake] Univ Houston, Dept Biol & Biochem, Ctr Nucl Receptors & Cell Signaling, Houston, TX 77004 USA	Karolinska Institutet; University of Michigan System; University of Michigan; Imperial College London; Karolinska Institutet; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Houston System; University of Houston	Arenas, E (corresponding author), Karolinska Inst, Ctr Dev Biol & Regenerat Med, Dept Med Biochem & Biophys, Mol Neurobiol Lab, S-17177 Stockholm, Sweden.	ernest.arenas@ki.se	Theofilopoulos, Spyridon/B-2075-2015; Parish, Clare/A-3380-2014; Theofilopoulos, Spyridon/E-1508-2011; Arenas, Ernest/AAO-5231-2020; Sacchetti, Paola/ABC-8884-2021	Theofilopoulos, Spyridon/0000-0003-1986-0943; Arenas, Ernest/0000-0003-0197-6577; Sacchetti, Paola/0000-0002-6390-2744; Parish, Clare/0000-0001-8212-9884; Steffensen, Knut/0000-0001-6093-2801; Liste, Isabel/0000-0002-3294-9558	Michael J. Fox Foundation; Swedish Foundation for Strategic Research (INGVAR and CEDB); European Union (Strokemap, NeuroStemCell); Petrus and Augusta Hedlunds Foundation; Swedish Research Council [VR2008:3287]; Norwegian Research Council; Swedish Royal Academy of Sciences and Knut and Alice Wallenberg Foundation; Australian National Health and Medical Research Council (NHMRC); CJ Martin Fellowship and NHMRC Career Development Award	Michael J. Fox Foundation; Swedish Foundation for Strategic Research (INGVAR and CEDB)(Swedish Foundation for Strategic Research); European Union (Strokemap, NeuroStemCell); Petrus and Augusta Hedlunds Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Norwegian Research Council(Research Council of NorwayEuropean Commission); Swedish Royal Academy of Sciences and Knut and Alice Wallenberg Foundation; Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); CJ Martin Fellowship and NHMRC Career Development Award(National Health and Medical Research Council (NHMRC) of Australia)	The authors are grateful to Drs. Magdalena Gbtz, Weimin Zhong, and Franqois Guillemot for their invaluable comments and critical support of this work. We also thank Heider Andre for comments and suggestions on the manuscript, Dr. Ruani Fernando for invaluable discussion and technical help on histology and imaging, and Johnny Soderlund for technical assistance. This work was supported by the Michael J. Fox Foundation, Swedish Foundation for Strategic Research (INGVAR and CEDB), European Union (Strokemap, NeuroStemCell), Karolinska Institutet, Petrus and Augusta Hedlunds Foundation, Swedish Research Council (VR2008:3287 and DBRM), and Norwegian Research Council to E.A., and grants from VIR to O.H., L.A.R., and J.-A.G. E.A. was supported by Swedish Royal Academy of Sciences and Knut and Alice Wallenberg Foundation, P.S. was supported by Norwegian Research Council, and A.C.H. was supported by Human Frontiers Science Program. C.L.P. was supported by an Australian National Health and Medical Research Council (NHMRC) CJ Martin Fellowship and NHMRC Career Development Award. J.-A.G. is shareholder and consultant of KaroBio AB and was supported by a grant from KaroBio AB.	Alberti S, 2001, J CLIN INVEST, V107, P565, DOI 10.1172/JCI9794; Andersson E, 2006, CELL, V124, P393, DOI [10.1016/j.cell.2005.10.037, 10.1016/J.CELL.2005.10.037]; Andersson E, 2006, DEVELOPMENT, V133, P507, DOI 10.1242/dev.02224; Andersson S, 2005, P NATL ACAD SCI USA, V102, P3857, DOI 10.1073/pnas.0500634102; Barberi T, 2003, NAT BIOTECHNOL, V21, P1200, DOI 10.1038/nbt870; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Bonilla S, 2008, GLIA, V56, P809, DOI 10.1002/glia.20654; Castelo-Branco GA, 2003, P NATL ACAD SCI USA, V100, P12747, DOI 10.1073/pnas.1534900100; Cho MS, 2008, P NATL ACAD SCI USA, V105, P3392, DOI 10.1073/pnas.0712359105; Dehay C, 2007, NAT REV NEUROSCI, V8, P438, DOI 10.1038/nrn2097; Fan X, 2008, P NATL ACAD SCI USA, V105, P13445, DOI 10.1073/pnas.0806974105; Ferri ALM, 2007, DEVELOPMENT, V134, P2761, DOI 10.1242/dev.000141; Goto T, 2004, DEV NEUROSCI-BASEL, V26, P208, DOI 10.1159/000082138; Huang X, 2005, CELL PROLIFERAT, V38, P223, DOI 10.1111/j.1365-2184.2005.00344.x; Imreh MP, 2006, J CELL BIOCHEM, V99, P508, DOI 10.1002/jcb.20897; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kele J, 2006, DEVELOPMENT, V133, P495, DOI 10.1242/dev.02223; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P2094, DOI 10.1073/pnas.0711599105; Kittappa R, 2007, PLOS BIOL, V5, P2875, DOI 10.1371/journal.pbio.0050325; Levine EM, 2000, DEV BIOL, V219, P299, DOI 10.1006/dbio.2000.9622; Matsunaga E, 2002, DEVELOPMENT, V129, P5269; Miller FD, 2007, NEURON, V54, P357, DOI 10.1016/j.neuron.2007.04.019; Nguyen L, 2006, GENE DEV, V20, P1511, DOI 10.1101/gad.377106; Nieto M, 2001, NEURON, V29, P401, DOI 10.1016/S0896-6273(01)00214-8; Ohnuma S, 1999, CELL, V99, P499, DOI 10.1016/S0092-8674(00)81538-X; Parish CL, 2007, NEURODEGENER DIS, V4, P339, DOI 10.1159/000101892; Perrier AL, 2004, P NATL ACAD SCI USA, V101, P12543, DOI 10.1073/pnas.0404700101; Prakash N, 2006, DEVELOPMENT, V133, P89, DOI 10.1242/dev.02181; Prakash N, 2006, J PHYSIOL-LONDON, V575, P403, DOI 10.1113/jphysiol.2006.113464; Rawal N, 2006, EXP CELL RES, V312, P1626, DOI 10.1016/j.yexcr.2006.01.032; Repa JJ, 2002, J BIOL CHEM, V277, P18793, DOI 10.1074/jbc.M109927200; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Smidt MP, 2000, NAT NEUROSCI, V3, P337, DOI 10.1038/73902; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tomita K, 2000, EMBO J, V19, P5460, DOI 10.1093/emboj/19.20.5460; van den Munckhof P, 2003, DEVELOPMENT, V130, P2535, DOI 10.1242/dev.00464; Venkateswaran A, 2000, P NATL ACAD SCI USA, V97, P12097, DOI 10.1073/pnas.200367697; Wang L, 2002, P NATL ACAD SCI USA, V99, P13878, DOI 10.1073/pnas.172510899; WILKINSON DG, 1993, METHOD ENZYMOL, V225, P361; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Willy PJ, 1997, GENE DEV, V11, P289, DOI 10.1101/gad.11.3.289; Yang DL, 2008, STEM CELLS, V26, P55, DOI 10.1634/stemcells.2007-0494; Ye WL, 1998, CELL, V93, P755, DOI 10.1016/S0092-8674(00)81437-3; Ye WL, 2001, NAT NEUROSCI, V4, P1175, DOI 10.1038/nn761; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883; Zervas M, 2004, NEURON, V43, P345, DOI 10.1016/j.neuron.2004.07.010	50	101	108	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					409	419		10.1016/j.stem.2009.08.019	http://dx.doi.org/10.1016/j.stem.2009.08.019			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796621	Bronze			2022-12-28	WOS:000271401900012
J	Gupta, R; Vyas, P; Enver, T				Gupta, Rajeev; Vyas, Paresh; Enver, Tariq			Molecular Targeting of Cancer Stem Cells	CELL STEM CELL			English	Editorial Material								Cancer stem cells may be important targets for new anticancer drugs. In two recent articles in Cell Stem Cell, Jin et al. (2009) and Hoey et al. (2009) provide proof of principle for this idea in experimental models of solid tumors and leukemias, respectively.	[Gupta, Rajeev; Vyas, Paresh; Enver, Tariq] Univ Oxford, John Radcliffe Hosp, MRC Mol Haematol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England	University of Oxford	Enver, T (corresponding author), Univ Oxford, John Radcliffe Hosp, MRC Mol Haematol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England.	tariq.enver@imm.ox.ac.uk	Vyas, Paresh/B-5708-2009	Vyas, Paresh/0000-0003-3931-0914; Gupta, Rajeev/0000-0001-9573-0505	MRC [MC_U137973817] Funding Source: UKRI; Medical Research Council [G1000729, MC_U137973817] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		BRUCE WR, 1963, NATURE, V199, P79, DOI 10.1038/199079a0; Campbell PJ, 2008, P NATL ACAD SCI USA, V105, P13081, DOI 10.1073/pnas.0801523105; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Hoey T, 2009, CELL STEM CELL, V5, P168, DOI 10.1016/j.stem.2009.05.019; Jin LQ, 2009, CELL STEM CELL, V5, P31, DOI 10.1016/j.stem.2009.04.018; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Weiner LM, 2009, LANCET, V373, P1033, DOI 10.1016/S0140-6736(09)60251-8	11	15	21	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					125	126		10.1016/j.stem.2009.07.006	http://dx.doi.org/10.1016/j.stem.2009.07.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664981	Bronze			2022-12-28	WOS:000269511900001
J	Hoey, T; Yen, WC; Axelrod, F; Basi, J; Donigian, L; Dylla, S; Fitch-Bruhns, M; Lazetic, S; Park, IK; Sato, A; Satyal, S; Wang, XH; Clarke, MF; Lewicki, J; Gurney, A				Hoey, Timothy; Yen, Wan-Ching; Axelrod, Fumiko; Basi, Jesspreet; Donigian, Lucas; Dylla, Scott; Fitch-Bruhns, Maureen; Lazetic, Sasha; Park, In-Kyung; Sato, Aaron; Satyal, Sanjeev; Wang, Xinhao; Clarke, Michael F.; Lewicki, John; Gurney, Austin			DLL4 Blockade Inhibits Tumor Growth and Reduces Tumor-Initiating Cell Frequency	CELL STEM CELL			English	Article							ACUTE MYELOID-LEUKEMIA; CANCER STEM-CELLS; NOTCH; IDENTIFICATION; TRANSCRIPTION; DELTA; CATENIN/TCF; LETHALITY; VESSELS; LIGAND	Previous studies have shown that blocking DLL4 signaling reduced tumor growth by disrupting productive angiogenesis. We developed selective anti-human and anti-mouse DLL4 antibodies to dissect the mechanisms involved by analyzing the contributions of selectively targeting DLL4 in the tumor or in the host vasculature and stroma in xenograft models derived from primary human tumors. We found that each antibody inhibited tumor growth and that the combination of the two antibodies was more effective than either alone. Treatment with anti-human DLL4 inhibited the expression of Notch target genes and reduced proliferation of tumor cells. Furthermore, we found that specifically inhibiting human DLL4 in the tumor, either alone or in combination with the chemotherapeutic agent irinotecan, reduced cancer stem cell frequency, as shown by flow cytometric and in vivo tumorigenicity studies.	[Hoey, Timothy; Yen, Wan-Ching; Axelrod, Fumiko; Basi, Jesspreet; Donigian, Lucas; Dylla, Scott; Fitch-Bruhns, Maureen; Lazetic, Sasha; Park, In-Kyung; Sato, Aaron; Satyal, Sanjeev; Wang, Xinhao; Lewicki, John; Gurney, Austin] OncoMed Pharmaceut Inc, Redwood City, CA 94063 USA; [Clarke, Michael F.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Palo Alto, CA 94063 USA	Stanford University	Hoey, T (corresponding author), OncoMed Pharmaceut Inc, Redwood City, CA 94063 USA.	timothy.hoey@oncomed.com	Nam, Jae Do/F-2201-2013					Ailles LE, 2007, CURR OPIN BIOTECH, V18, P460, DOI 10.1016/j.copbio.2007.10.007; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; BREEMS DA, 1994, LEUKEMIA, V8, P1095; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; Costello RT, 2000, CANCER RES, V60, P4403; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Duarte A, 2004, GENE DEV, V18, P2474, DOI 10.1101/gad.1239004; Dylla SJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002428; Gale NW, 2004, P NATL ACAD SCI USA, V101, P15949, DOI 10.1073/pnas.0407290101; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; HENDY GN, 1995, CLIN INVEST MED, V18, P47; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Krebs LT, 2004, GENE DEV, V18, P2469, DOI 10.1101/gad.1239204; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Matsui W, 2004, BLOOD, V103, P2332, DOI 10.1182/blood-2003-09-3064; Noguera-Troise I, 2006, NATURE, V444, P1032, DOI 10.1038/nature05355; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Parks AL, 2006, GENETICS, V174, P1947, DOI 10.1534/genetics.106.061630; Patel NS, 2005, CANCER RES, V65, P8690, DOI 10.1158/0008-5472.CAN-05-1208; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; Phng LK, 2009, DEV CELL, V16, P70, DOI 10.1016/j.devcel.2008.12.009; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Ridgway J, 2006, NATURE, V444, P1083, DOI 10.1038/nature05313; Rothe C, 2008, J MOL BIOL, V376, P1182, DOI 10.1016/j.jmb.2007.12.018; Sainson RCA, 2007, TRENDS MOL MED, V13, P389, DOI 10.1016/j.molmed.2007.07.002; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Scehnet JS, 2007, BLOOD, V109, P4753, DOI 10.1182/blood-2006-12-063933; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; TAX FE, 1994, NATURE, V368, P150, DOI 10.1038/368150a0; Thurston G, 2007, NAT REV CANCER, V7, P327, DOI 10.1038/nrc2130; Tothova Z, 2007, CELL STEM CELL, V1, P140, DOI 10.1016/j.stem.2007.07.017; van Es JH, 2005, NATURE, V435, P959, DOI 10.1038/nature03659; Wang JCY, 1997, BLOOD, V89, P3919, DOI 10.1182/blood.V89.11.3919; Wang Q, 2008, ONCOGENE, V27, P1527, DOI 10.1038/sj.onc.1210793; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wilson A, 2006, FEBS LETT, V580, P2860, DOI 10.1016/j.febslet.2006.03.024; Yan XQ, 2001, BLOOD, V98, P3793, DOI 10.1182/blood.V98.13.3793; Zhang L, 2006, J BIOL CHEM, V281, P8607, DOI 10.1074/jbc.M600274200	45	316	357	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					168	177		10.1016/j.stem.2009.05.019	http://dx.doi.org/10.1016/j.stem.2009.05.019			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19664991	Bronze			2022-12-28	WOS:000269511900010
J	Papagiannakopoulos, T; Kosik, KS				Papagiannakopoulos, Thales; Kosik, Kenneth S.			MicroRNA-124: Micromanager of Neurogenesis	CELL STEM CELL			English	Editorial Material							MIR-124	In a recent issue of Nature Neuroscience, Cheng et al. (2009) demonstrate that miR-124, the most abundant of the microRNAs in the adult brain, positively modulates the transitory progression of adult subventricular zone (SVZ) neurogenesis.	[Papagiannakopoulos, Thales; Kosik, Kenneth S.] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Papagiannakopoulos, Thales; Kosik, Kenneth S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Kosik, KS (corresponding author), Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA.	kosik@lifesci.ucsb.edu						Cao XW, 2007, GENE DEV, V21, P531, DOI 10.1101/gad.1519207; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Gangaraju VK, 2009, NAT REV MOL CELL BIO, V10, P116, DOI 10.1038/nrm2621; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lledo PM, 2006, NAT REV NEUROSCI, V7, P179, DOI 10.1038/nrn1867; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107	10	57	59	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					375	376		10.1016/j.stem.2009.04.007	http://dx.doi.org/10.1016/j.stem.2009.04.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427286	Bronze			2022-12-28	WOS:000266071100003
J	Kiuru, M; Boyer, JL; O'Connor, TP; Crystal, RG				Kiuru, Maija; Boyer, Julie L.; O'Connor, Timothy P.; Crystal, Ronald G.			Genetic Control of Wayward Pluripotent Stem Cells and Their Progeny after Transplantation	CELL STEM CELL			English	Article							MARROW-DERIVED CELLS; ADENOVIRUS-MEDIATED TRANSFER; RADIATION-INDUCED APOPTOSIS; DONOR T-CELLS; SUICIDE-GENE; IN-VIVO; EPITHELIAL-CELLS; SOMATIC-CELLS; SELECTIVE ABLATION; THYMIDINE KINASE	The proliferative capacity of pluripotent stem cells and their progeny brings a unique aspect to therapeutics, in that once a transplant is initiated the therapist no longer has control of the therapy. In the context of the recent FDA approval of a human ESC trial and report of a neuronal-stem-cell-derived tumor in a human trial, strategies need to be developed to control wayward pluripotent stem cells. Here, we focus on one approach: direct genetic modification of the cells prior to transplantation with genes that can prevent the adverse events and/or eliminate the transplanted cells and their progeny.	[Kiuru, Maija; Boyer, Julie L.; O'Connor, Timothy P.; Crystal, Ronald G.] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA	Cornell University	Crystal, RG (corresponding author), Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA.	geneticmedicine@med.cornell.edu		Kiuru, Maija/0000-0002-7010-5516	The Starr Foundation [U01 HL66952, U01 NS047458]; The Malcolm Hewitt Wiener Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066952] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS047458] Funding Source: NIH RePORTER	The Starr Foundation; The Malcolm Hewitt Wiener Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Downey (Department of Surgery, Memorial Sloan-Kettering Cancer Center) for helpful discussions and N. Mohamed for help in preparing this manuscript. Relevant to this review, the authors are supported, in part, by U01 HL66952, U01 NS047458, The Starr Foundation, and The Malcolm Hewitt Wiener Foundation.	Addis RC, 2008, CLIN PHARMACOL THER, V83, P386, DOI 10.1038/sj.clpt.6100384; Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; Amit M, 2002, J ANAT, V200, P225, DOI 10.1046/j.1469-7580.2002.00032.x; Aractingi S, 2005, CANCER RES, V65, P1755, DOI 10.1158/0008-5472.CAN-04-2783; Arafat WO, 2000, MOL THER, V1, P545, DOI 10.1006/mthe.2000.0071; Asahina Kinji, 2006, Curr Stem Cell Res Ther, V1, P139, DOI 10.2174/157488806776956878; Avital I, 2007, STEM CELLS, V25, P2903, DOI 10.1634/stemcells.2007-0409; Barozzi P, 2003, NAT MED, V9, P554, DOI 10.1038/nm862; Ben-Hur T, 2004, STEM CELLS, V22, P1246, DOI 10.1634/stemcells.2004-0094; Berger C, 2006, BLOOD, V107, P2294, DOI 10.1182/blood-2005-08-3503; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Bonini C, 1997, SCIENCE, V276, P1719, DOI 10.1126/science.276.5319.1719; Bonini C, 2007, MOL THER, V15, P1248, DOI 10.1038/sj.mt.6300190; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Brickman JM, 2002, NAT GENET, V32, P557, DOI 10.1038/ng1202-557; Brooks AR, 2004, J GENE MED, V6, P395, DOI 10.1002/jgm.516; Burcin Mark M., 1998, Frontiers in Bioscience, V3, pC1; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Cao F, 2007, CLONING STEM CELLS, V9, P107, DOI 10.1089/clo.2006.0E16; Carpenter MK, 2003, CLONING STEM CELLS, V5, P79, DOI 10.1089/153623003321512193; Corsten MF, 2008, LANCET ONCOL, V9, P376, DOI 10.1016/S1470-2045(08)70099-8; Couzin J, 2009, SCIENCE, V323, P568, DOI 10.1126/science.323.5914.568; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Cross D, 2006, CLIN MED RES, V4, P218, DOI 10.3121/cmr.4.3.218; Crystal RG, 1999, CANCER CHEMOTH PHARM, V43, pS90, DOI 10.1007/s002800051105; Curtin James F., 2008, V434, P239, DOI 10.1007/978-1-60327-248-3_15; Darabi R, 2008, NAT MED, V14, P134, DOI 10.1038/nm1705; Denny WA, 2004, CANCER INVEST, V22, P604, DOI 10.1081/CNV-200027148; Docherty K, 2007, SEMIN CELL DEV BIOL, V18, P827, DOI 10.1016/j.semcdb.2007.09.009; Draper JS, 2004, NAT BIOTECHNOL, V22, P53, DOI 10.1038/nbt922; Dubernard G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1860; Durcova-Hills G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003531; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fairchild PJ, 2004, TRENDS IMMUNOL, V25, P465, DOI 10.1016/j.it.2004.07.005; Fan LF, 1999, HUM GENE THER, V10, P2273, DOI 10.1089/10430349950016924; Fehse B, 2000, MOL THER, V1, P448, DOI 10.1006/mthe.2000.0068; Fischbach GD, 2004, J CLIN INVEST, V114, P1364, DOI 10.1172/JCI200423549; FOECKING MK, 1986, GENE, V45, P101, DOI 10.1016/0378-1119(86)90137-X; Freed CR, 2001, NEW ENGL J MED, V344, P710, DOI 10.1056/NEJM200103083441002; Fujikawa T, 2005, AM J PATHOL, V166, P1781, DOI 10.1016/S0002-9440(10)62488-1; Gadi VK, 2003, J PHARMACOL EXP THER, V304, P1280, DOI 10.1124/jpet.102.044743; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gerrard L, 2005, STEM CELLS, V23, P124, DOI 10.1634/stemcells.2004-0102; Giudice A, 2008, CELL STEM CELL, V2, P422, DOI 10.1016/j.stem.2008.04.003; Golfinopouloss V, 2009, BREAST CANCER RES TR, V113, P211, DOI 10.1007/s10549-008-9922-7; Gordon MY, 2008, EXP HEMATOL, V36, P726, DOI 10.1016/j.exphem.2008.01.013; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; Goverdhana S, 2005, MOL THER, V12, P189, DOI 10.1016/j.ymthe.2005.03.022; Greaves MF, 2006, LEUKEMIA, V20, P1633, DOI 10.1038/sj.leu.2404293; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hara A, 2008, STEM CELLS DEV, V17, P619, DOI 10.1089/scd.2007.0235; Harrison NJ, 2007, INT J ANDROL, V30, P275, DOI 10.1111/j.1365-2605.2007.00762.x; Hedley D, 2007, NAT REV CANCER, V7, P870, DOI 10.1038/nrc2247; Hedlund E, 2007, EUR J NEUROSCI, V26, P1721, DOI 10.1111/j.1460-9568.2007.05780.x; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Hewitt Z, 2007, STEM CELLS, V25, P10, DOI 10.1634/stemcells.2005-0481; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; Hodges H, 2007, CELL TRANSPLANT, V16, P101; HU MCT, 1988, GENE, V62, P301; Introna M, 2000, HUM GENE THER, V11, P611, DOI 10.1089/10430340050015798; Jung J, 2007, HUM GENE THER, V18, P1182, DOI 10.1089/hum.2007.078; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kirn D, 2002, TRENDS MOL MED, V8, pS68, DOI 10.1016/S1471-4914(02)02318-3; KLEINSMITH LJ, 1964, CANCER RES, V24, P1544; Klimanskaya I, 2006, NATURE, V444, P481, DOI 10.1038/nature05142; Kock H, 1996, INT J CANCER, V67, P808; Koehne G, 2000, BLOOD, V96, P109, DOI 10.1182/blood.V96.1.109.013k44_109_117; Korbling M, 2002, NEW ENGL J MED, V346, P738, DOI 10.1056/NEJMoa3461002; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lau D, 2008, CELL STEM CELL, V3, P591, DOI 10.1016/j.stem.2008.11.001; Lawrenz B, 2004, CYTOTHERAPY, V6, P212, DOI 10.1080/14653240410006031; Lerou PH, 2005, BLOOD REV, V19, P321, DOI 10.1016/j.blre.2005.01.005; Li CW, 2005, CANCER GENE THER, V12, P913, DOI 10.1038/sj.cgt.7700876; Li M, 2001, EXPTL BIOL REV, P29; LIU TJ, 1994, CANCER RES, V54, P3662; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Martin MJ, 2005, NAT MED, V11, P228, DOI 10.1038/nm1181; Mattson J, 2004, TRANSPLANTATION, V78, P154, DOI 10.1097/01.TP.0000132326.08628.74; Mayhall EA, 2004, CURR OPIN CELL BIOL, V16, P713, DOI 10.1016/j.ceb.2004.09.007; Miccio A, 2008, P NATL ACAD SCI USA, V105, P10547, DOI 10.1073/pnas.0711666105; Miletic H, 2007, CLIN CANCER RES, V13, P6761, DOI 10.1158/1078-0432.CCR-07-1240; Minami E, 2005, CIRCULATION, V112, P2951, DOI 10.1161/CIRCULATIONAHA.105.576017; Nair V, 2008, CURR OPIN MOL THER, V10, P431; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Nakayama K, 2005, CANCER RES, V65, P254; Naumann U, 2003, HUM GENE THER, V14, P1235, DOI 10.1089/104303403767740777; Ngan ESW, 2002, P NATL ACAD SCI USA, V99, P11187, DOI 10.1073/pnas.172366199; Niculescu-Duvaz Ion, 2004, Methods Mol Med, V90, P1; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; Noggle SA, 2005, STEM CELL REV, V1, P111, DOI 10.1385/SCR:1:2:111; O'Connor TP, 2006, NAT REV GENET, V7, P261, DOI 10.1038/nrg1829; Oh SKW, 2006, CLIN EXP PHARMACOL P, V33, P489, DOI 10.1111/j.1440-1681.2006.04397.x; Okamoto R, 2002, NAT MED, V8, P1011, DOI 10.1038/nm755; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orchard PJ, 2002, HUM GENE THER, V13, P979, DOI 10.1089/10430340252939087; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Park K, 2008, FRONT BIOSCI-LANDMRK, V13, P2653, DOI 10.2741/2872; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Portsmouth D, 2007, MOL ASPECTS MED, V28, P4, DOI 10.1016/j.mam.2006.12.001; Price FD, 2007, BBA-MOL BASIS DIS, V1772, P272, DOI 10.1016/j.bbadis.2006.08.011; Quaini F, 2002, NEW ENGL J MED, V346, P5, DOI 10.1056/NEJMoa012081; Raki M, 2006, MOL THER, V14, P154, DOI 10.1016/j.ymthe.2006.02.019; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Rippon HJ, 2004, CELL PROLIFERAT, V37, P23, DOI 10.1111/j.1365-2184.2004.00298.x; Rivera VM, 1996, NAT MED, V2, P1028, DOI 10.1038/nm0996-1028; Robinet E, 2005, CYTOTHERAPY, V7, P150, DOI 10.1080/14653240510018190; Roorda BD, 2009, CRIT REV ONCOL HEMAT, V69, P187, DOI 10.1016/j.critrevonc.2008.06.004; Roy NS, 2006, NAT MED, V12, P1259, DOI 10.1038/nm1495; Sauce D, 2002, BLOOD, V99, P1165, DOI 10.1182/blood.V99.4.1165; Schaedel O, 2006, CURR PHARM DESIGN, V12, P363, DOI 10.2174/138161206775201983; Scheidemann F, 2008, ARCH DERMATOL RES, V300, P415, DOI 10.1007/s00403-008-0878-6; Schuldiner M, 2003, STEM CELLS, V21, P257, DOI 10.1634/stemcells.21-3-257; Shinoura N, 2000, JPN J CANCER RES, V91, P1044, DOI 10.1111/j.1349-7006.2000.tb00883.x; Shinoura N, 2000, CANCER GENE THER, V7, P224, DOI 10.1038/sj.cgt.7700110; Shinoura N, 2001, INT J CANCER, V93, P252, DOI 10.1002/ijc.1327; Shinoura N, 2001, JPN J CANCER RES, V92, P467, DOI 10.1111/j.1349-7006.2001.tb01117.x; Shinoura N, 1999, ONCOGENE, V18, P5703, DOI 10.1038/sj.onc.1202966; Shinoura N, 1998, HUM GENE THER, V9, P1983, DOI 10.1089/hum.1998.9.14-1983; Shinoura N, 2000, HUM GENE THER, V11, P1123, DOI 10.1089/10430340050015185; Shinoura Nobusada, 2003, Current Gene Therapy, V3, P147, DOI 10.2174/1566523034578410; Sinn PL, 2005, GENE THER, V12, P1089, DOI 10.1038/sj.gt.3302570; SPENCER DM, 1993, SCIENCE, V262, P1019, DOI 10.1126/science.7694365; Spyridonidis A, 2004, AM J PATHOL, V164, P1147, DOI 10.1016/S0002-9440(10)63203-8; STEVENS LC, 1958, J NATL CANCER I, V20, P1257, DOI 10.1093/jnci/20.6.1257; Strelchenko N, 2004, REPROD BIOMED ONLINE, V9, P623, DOI 10.1016/S1472-6483(10)61772-5; Strulovici Y, 2007, MOL THER, V15, P850, DOI 10.1038/mt.sj.6300125; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor HS, 2004, JAMA-J AM MED ASSOC, V292, P81, DOI 10.1001/jama.292.1.81; Templeton N. S., 2008, GENE CELL THERAPY TH; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tiberghien P, 2001, BLOOD, V97, P63, DOI 10.1182/blood.V97.1.63; Tolar J, 2003, J PEDIAT HEMATOL ONC, V25, P430, DOI 10.1097/00043426-200306000-00002; Tran SD, 2003, LANCET, V361, P1084, DOI 10.1016/S0140-6736(03)12894-2; Traversari C, 2007, BLOOD, V109, P4708, DOI 10.1182/blood-2006-04-015230; Unfer RC, 2003, CANCER RES, V63, P987; Vogel G, 2005, SCIENCE, V308, P1534, DOI 10.1126/science.308.5728.1534; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu AM, 2005, NAT BIOTECHNOL, V23, P1137, DOI 10.1038/nbt1141; Wu X, 2004, CELL MOL LIFE SCI, V61, P2588, DOI 10.1007/s00018-004-4206-9; Xie XM, 2001, CANCER RES, V61, P6795; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yerushalmi N, 2000, CANCER GENE THER, V7, P91, DOI 10.1038/sj.cgt.7700115; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zanzonico P, 2006, EUR J NUCL MED MOL I, V33, P988, DOI 10.1007/s00259-005-0057-3; Zhang X, 2006, STEM CELLS, V24, P2669, DOI 10.1634/stemcells.2006-0377	156	57	63	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					289	300		10.1016/j.stem.2009.03.010	http://dx.doi.org/10.1016/j.stem.2009.03.010			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341619	Green Accepted, Bronze			2022-12-28	WOS:000265162700006
J	Lo, B; Parham, L; Broom, C; Cedars, M; Gates, E; Giudice, L; Halme, DG; Hershon, W; Kriegstein, A; Kwok, PY; Oberman, M; Roberts, C; Wagner, R				Lo, Bernard; Parham, Lindsay; Broom, Christopher; Cedars, Marcelle; Gates, Elena; Giudice, Linda; Halme, Dina Gould; Hershon, William; Kriegstein, Arnold; Kwok, Pui-yan; Oberman, Michelle; Roberts, Clifford; Wagner, Richard			Importing Human Pluripotent Stem Cell Lines Derived at Another Institution: Tailoring Review to Ethical Concerns	CELL STEM CELL			English	Article							CONSENT	Stem cell researchers commonly use human pluripotent stem cell lines derived by other investigators. Researchers may use lines derived elsewhere, provided that their derivation met consensus core standards. Some types of derivation raise heightened levels of ethical concern and require greater scrutiny. To maintain public trust, research institutions need to justify why they allow researchers to use lines whose derivation would not have been permitted locally.	[Lo, Bernard; Parham, Lindsay; Broom, Christopher] Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; [Lo, Bernard; Parham, Lindsay; Broom, Christopher] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cedars, Marcelle; Gates, Elena; Giudice, Linda] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Giudice, Linda; Kriegstein, Arnold] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Halme, Dina Gould] Univ Calif San Francisco, Off Dean, Sch Med, San Francisco, CA 94143 USA; [Kriegstein, Arnold] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Kwok, Pui-yan] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Roberts, Clifford] Univ Calif San Francisco, Off Vice Chancellor Res, San Francisco, CA 94143 USA; [Wagner, Richard] Univ Calif San Francisco, Human Res Protect Program, San Francisco, CA 94143 USA; [Hershon, William] Disabil Rights Calif, San Francisco, CA 94501 USA; [Oberman, Michelle] Santa Clara Univ, Sch Law, Santa Clara, CA 95053 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Santa Clara University	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA.	bernard.lo@ucsf.edu	Kwok, Pui-Yan/F-7725-2014	Kwok, Pui-Yan/0000-0002-5087-3059	NIH [1 UL1 RR024131-01]; National Center for Research Resources (NCRR); Greenwall Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Greenwall Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors would like to thank Elizabeth Blackburn, Arturo Alvarez-Buylla, and Greta Schnetzler for their thoughtful and insightful contributions to the UCSF Human Gamete and Embryonic Stem Cell Research Oversight Committee. We also thank three anonymous reviewers for their thoughtful and detailed criticisms, suggestions, and questions. B.L. is chair of the UCSF Stem Cell Research Oversight Committee and is cochair of the Standards Working Group of the California Institute for Regenerative Medicine, which recommends regulations for state-funded stem cell research. This work is supported by NIH Grant Number 1 UL1 RR024131-01 from the National Center for Research Resources (NCRR) and NIH Roadmap for Medical Research and by the Greenwall Foundation. Its contents are solely the responsibility of the authors and do not necessarily represent the official view of NCRR or NIH or the Greenwall Foundation. B.L. is cochair of the Standards Working Group of the California Institute for Regenerative Medicine, which recommends regulations for state-funded stem cell research. All authors are members of or staff for the UCSF Stem Cell Research Oversight Committee.	Aalto-Setala K, 2009, PLOS BIOL, V7, P204, DOI 10.1371/journal.pbio.1000042; BEAUCHAMP TL, 2001, PRINCIPLES BIOMEDICA, P15; BROWN S, 2007, CHRON HIGH ED, V53, pA15; Chong S, 2006, SCIENCE, V311, P754, DOI 10.1126/science.311.5762.754; Chong S, 2006, SCIENCE, V311, P22, DOI 10.1126/science.311.5757.22; Cohen CB, 2008, CELL STEM CELL, V2, P416, DOI 10.1016/j.stem.2008.04.002; CULLITON BJ, 1983, SCIENCE, V220, P31, DOI 10.1126/science.6828878; Daley GQ, 2007, SCIENCE, V315, P603, DOI 10.1126/science.1139337; Gutman A., 1996, DEMOCRACY DISAGREEME; Heng BC, 2006, INT J GYNECOL OBSTET, V95, P302, DOI 10.1016/j.ijgo.2006.07.008; hhs, 1979, BELM REP ETH PRINC G; Holden C, 2006, SCIENCE, V311, P928, DOI 10.1126/science.311.5763.928; Hyun I, 2006, NATURE, V442, P629, DOI 10.1038/442629a; Kaveny MC, 2000, THEOL STUD, V61, P280, DOI 10.1177/004056390006100204; Lo B, 2003, SCIENCE, V301, P921, DOI 10.1126/science.1087038; Lomax GP, 2007, PLOS MED, V4, P803, DOI 10.1371/journal.pmed.0040114; Mathews DJH, 2006, SCIENCE, V313, P921, DOI 10.1126/science.1127990; *NAT AC SCI, 2005, GUID HUM EMBR STEM C; National Bioethics Advisory Commission, 1997, CLON HUM BEINGS; National Bioethics Advisory Commission, 1999, ETH ISS HUM STEM CEL; National Institute of Health, 1994, REP HUM EMBR RES PAN; National Research Council and Institute of Medicine, 2005, GUID HUM EMBR STEM C; Normile D, 2006, SCIENCE, V311, P156, DOI 10.1126/science.311.5758.156; RENNIE D, 2008, OXFORD TXB CLIN RES, P795; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Skene L, 2007, PLOS MED, V4, P243, DOI 10.1371/journal.pmed.0040010; Spar D, 2007, NEW ENGL J MED, V356, P1289, DOI 10.1056/NEJMp078012; Streiffer R, 2008, HASTINGS CENT REP, V38, P40; Sugarman J, 2008, SCIENCE, V322, P379, DOI 10.1126/science.1164441; Sugarman J, 2008, CELL STEM CELL, V3, P238, DOI 10.1016/j.stem.2008.08.012; The President's Council on Bioethics, 2002, HUM CLON HUM DIGN ET; [No title captured]	32	11	11	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					115	123		10.1016/j.stem.2009.01.013	http://dx.doi.org/10.1016/j.stem.2009.01.013			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200800	Bronze			2022-12-28	WOS:000263213400008
J	Marchetto, MCN; Muotri, AR; Mu, YL; Smith, AM; Cezar, GG; Gage, FH				Marchetto, Maria C. N.; Muotri, Alysson R.; Mu, Yangling; Smith, Alan M.; Cezar, Galbriela G.; Gage, Fred H.			Non-Cell-Autonomous Effect of Human SOD1(G37R) Astrocytes on Motor Neurons Derived from Human Embryonic Stem Cells	CELL STEM CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; NADPH OXIDASE; GLIAL-CELLS; ALS; GENE; SURVIVAL; MOTONEURONS; MUTATIONS; MECHANISM; DISEASE	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by motor neuron death. ALS can be induced by mutations in the superoxide dismutase 1 gene (SOD1). Evidence for the non-cell-autonomous nature of ALS emerged from the observation that wild-type glial cells extended the survival of SOD1 mutant motor neurons in chimeric mice. To uncover the contribution of astrocytes to human motor neuron degeneration, we cocultured hESC-derived motor neurons with human primary astrocytes expressing mutated SOD1. We detected a selective motor neuron toxicity that was correlated with increased inflammatory response in SOD1-mutated astrocytes. Furthermore, we present evidence that astrocytes can activate NOX2 to produce superoxide and that effect can be reversed by antioxidants. We show that NOX2 inhibitor, apocynin, can prevent the loss of motor neurons caused by SOD1-mutated astrocytes. These results provide an assay for drug screening using a human ALS in vitro astrocyte-based cell model.	[Marchetto, Maria C. N.; Muotri, Alysson R.; Mu, Yangling; Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA; [Smith, Alan M.; Cezar, Galbriela G.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA	Salk Institute; University of Wisconsin System; University of Wisconsin Madison	Gage, FH (corresponding author), Salk Inst Biol Studies, Genet Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gage@salk.edu			George E. Hewitt Foundation; Rett Syndrome Research Foundation; Project ALS; Dara and Christopher Reeve Foundation; California Institute for Regenerative Medicine [RC1-0015-1]; Lookout Fund	George E. Hewitt Foundation; Rett Syndrome Research Foundation; Project ALS; Dara and Christopher Reeve Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Lookout Fund	M.C.N.M. is supported by the George E. Hewitt Foundation for Medical Research; A.R.M. is supported by the Rett Syndrome Research Foundation; and F.H.G. is supported by Project ALS, the Dara and Christopher Reeve Foundation, the California Institute for Regenerative Medicine (Grant RC1-0015-1), and the Lookout Fund. We are also indebted to Inder Verma (Salk Institute, La Jolla, CA) for providing us with the lentiviral vector backbone; the Hb9::GFP and Hb9::RFP constructs were a gift from Samuel Pfaff (Salk Institute, La Jolla, CA): the SOD1<SUP>WT</SUP> and the SOD1<SUP>G37R</SUP> constructs were a gift from Don Cleveland (University of California, San Diego, La Jolla, CA). The authors would like to thank M.L. Gage for editorial comments and S. Genoud and E. Mepa for experimental assistance.	Almer G, 1999, J NEUROCHEM, V72, P2415, DOI 10.1046/j.1471-4159.1999.0722415.x; Anneser J, 2000, NEUROL SCI, V21, pS913, DOI 10.1007/s100720070003; Arce V, 1999, J NEUROSCI RES, V55, P119, DOI 10.1002/(SICI)1097-4547(19990101)55:1<119::AID-JNR13>3.0.CO;2-6; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Barber SC, 2006, BBA-MOL BASIS DIS, V1762, P1051, DOI 10.1016/j.bbadis.2006.03.008; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Clement AM, 2003, SCIENCE, V302, P113, DOI 10.1126/science.1086071; Consiglio A, 2004, P NATL ACAD SCI USA, V101, P14835, DOI 10.1073/pnas.0404180101; DENG HX, 1993, SCIENCE, V261, P1047, DOI 10.1126/science.8351519; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; DiBernardo AB, 2006, BBA-MOL BASIS DIS, V1762, P1139, DOI 10.1016/j.bbadis.2006.03.007; Doble A, 1996, NEUROLOGY, V47, pS233, DOI 10.1212/WNL.47.6_Suppl_4.233S; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; HENDERSON CE, 1993, NEUROMUSCULAR DISORD, V3, P455, DOI 10.1016/0960-8966(93)90096-3; Lee SK, 2004, DEVELOPMENT, V131, P3295, DOI 10.1242/dev.01179; Li XJ, 2005, NAT BIOTECHNOL, V23, P215, DOI 10.1038/nbt1063; Lobsiger CS, 2007, NAT NEUROSCI, V10, P1355, DOI 10.1038/nn1988; Marden JJ, 2007, J CLIN INVEST, V117, P2913, DOI 10.1172/JCI31265; Mills DM, 2004, JARO-J ASSOC RES OTO, V5, P1, DOI 10.1007/s10162-003-4004-3; Muotri AR, 2005, P NATL ACAD SCI USA, V102, P18644, DOI 10.1073/pnas.0509315102; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; OKAMOTO K, 1993, NEUROSCI LETT, V162, P125, DOI 10.1016/0304-3940(93)90576-7; Pasinetti GM, 2006, NEUROLOGY, V66, P1218, DOI 10.1212/01.wnl.0000203129.82104.07; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300; Taupin P, 2000, NEURON, V28, P385, DOI 10.1016/S0896-6273(00)00119-7; Urushitani M, 2006, NAT NEUROSCI, V9, P108, DOI 10.1038/nn1603; Watanabe M, 2006, BRAIN RES, V1073, P20, DOI 10.1016/j.brainres.2005.12.046; Wu DC, 2006, P NATL ACAD SCI USA, V103, P12132, DOI 10.1073/pnas.0603670103; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047	33	339	350	2	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					649	657		10.1016/j.stem.2008.10.001	http://dx.doi.org/10.1016/j.stem.2008.10.001			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041781	Bronze			2022-12-28	WOS:000261670900013
J	Eiraku, M; Watanabe, K; Matsuo-Takasaki, M; Kawada, M; Yonemura, S; Matsumura, M; Wataya, T; Nishiyama, A; Muguruma, K; Sasail, Y				Eiraku, Mototsugu; Watanabe, Kiichi; Matsuo-Takasaki, Marni; Kawada, Masako; Yonemura, Shigenobu; Matsumura, Michiru; Wataya, Takafumi; Nishiyama, Ayaka; Muguruma, Keiko; Sasail, Yoshiki			Self-Organized Formation of Polarized Cortical Tissues from ESCs and Its Active Manipulation by Extrinsic Signals	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; PROGENITOR CELLS; DEVELOPING NEOCORTEX; CAJAL-RETZIUS; CALCIUM WAVES; BIRTH-DATE; DIFFERENTIATION; TELENCEPHALON; CORTEX; FATE	Here, we demonstrate self-organized formation of apico-basally polarized cortical tissues from ESCs using an efficient three-dimensional aggregation culture (SFEBq culture). The generated cortical neurons are functional, transplantable, and capable of forming proper long-range connections in vivo and in vitro. The regional identity of the generated pallial tissues can be selectively controlled (into olfactory bulb, rostral and caudal cortices, hem, and choroid plexus) by secreted patterning factors such as Fgf, Wnt, and BMP. In addition, the in vivo-mimicking birth order of distinct cortical neurons permits the selective generation of particular layer-specific neurons by timed induction of cell-cycle exit. Importantly, cortical tissues generated from mouse and human ESCs form a self-organized structure that includes four distinct zones (ventricular, early and late cortical-plate, and Cajal-Retzius cell zones) along the apico-basal direction. Thus, spatial and temporal aspects of early corticogenesis are recapitulated and can be manipulated in this ESC culture.	[Eiraku, Mototsugu; Watanabe, Kiichi; Matsuo-Takasaki, Marni; Kawada, Masako; Matsumura, Michiru; Wataya, Takafumi; Nishiyama, Ayaka; Muguruma, Keiko; Sasail, Yoshiki] RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan; [Yonemura, Shigenobu] RIKEN, Ctr Dev Biol, Electron Microscope Lab, Kobe, Hyogo 6500047, Japan	RIKEN; RIKEN	Sasail, Y (corresponding author), RIKEN, Ctr Dev Biol, Organogenesis & Neurogenesis Grp, Kobe, Hyogo 6500047, Japan.	yoshikisasai@cdb.riken.jp	Watanabe, Kiichi/ABA-4854-2020	Muguruma, Keiko/0000-0002-3149-4408; Eiraku, Mototsugu/0000-0002-9433-9085	MEXT; Kobe Cluster Project; Leading Project	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kobe Cluster Project; Leading Project	We are grateful to Drs. H. Enomoto and C. Hanashima for invaluable comments, to Dr. A. Miyawaki for Venus cDNA, to Dr. Y. Yoshihara for Tbx21 antibody, to Dr. Y. Ono for Lmx1 a antibody, to Dr. K. Mori for Telencephalin antibody, to Dr. M. Ikeya for advice on homologous recombination, and to members of the Sasai lab for discussion and advice. This work was supported by grants-in-aid from MEXT, the Kobe Cluster Project, and the Leading Project (Y.S.).	Adelsberger H, 2005, NAT NEUROSCI, V8, P988, DOI 10.1038/nn1502; Ajioka I, 2005, EUR J NEUROSCI, V22, P331, DOI 10.1111/j.1460-9568.2005.04214.x; Arlotta P, 2005, NEURON, V45, P207, DOI 10.1016/j.neuron.2004.12.036; Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Frantz GD, 1996, NEURON, V17, P55, DOI 10.1016/S0896-6273(00)80280-9; Garaschuk O, 2000, NAT NEUROSCI, V3, P452, DOI 10.1038/74823; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Gonzalez JL, 1997, J NEUROSCI, V17, P9204; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; Hanashima C, 2004, SCIENCE, V303, P56, DOI 10.1126/science.1090674; Hebert JM, 2003, GENESIS, V35, P214, DOI 10.1002/gene.10183; Hebert JM, 2003, DEVELOPMENT, V130, P1101, DOI 10.1242/dev.00334; Hevner RF, 2003, DEV BRAIN RES, V141, P39, DOI 10.1016/S0165-3806(02)00641-7; Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263; Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2; Ikegaya Y, 2005, NEUROSCI RES, V52, P132, DOI 10.1016/j.neures.2005.02.004; Kinney JW, 2006, J NEUROSCI, V26, P1604, DOI 10.1523/JNEUROSCI.4722-05.2006; Lee SMK, 2000, DEVELOPMENT, V127, P457; Mangale VS, 2008, SCIENCE, V319, P304, DOI 10.1126/science.1151695; Mitsui S, 2007, CEREB CORTEX, V17, P522, DOI 10.1093/cercor/bhj177; Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151; Monuki ES, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn752; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nelson BR, 2007, DEV BIOL, V304, P479, DOI 10.1016/j.ydbio.2007.01.001; O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010; Puelles L, 2000, J COMP NEUROL, V424, P409, DOI 10.1002/1096-9861(20000828)424:3<409::AID-CNE3>3.0.CO;2-7; Rallu M, 2002, NAT REV NEUROSCI, V3, P943, DOI 10.1038/nrn989; Shen Q, 2006, NAT NEUROSCI, V9, P743, DOI 10.1038/nn1694; Shimogori T, 2005, J NEUROSCI, V25, P6550, DOI 10.1523/JNEUROSCI.0453-05.2005; Soriano E, 2005, NEURON, V46, P389, DOI 10.1016/j.neuron.2005.04.019; Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; TAO W, 1992, NEURON, V8, P957, DOI 10.1016/0896-6273(92)90210-5; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wataya T, 2008, P NATL ACAD SCI USA, V105, P11796, DOI 10.1073/pnas.0803078105; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; YUSTE R, 1995, NEURON, V14, P7, DOI 10.1016/0896-6273(95)90236-8; Zhou C, 2001, GENE DEV, V15, P2054, DOI 10.1101/gad.913601	42	880	921	4	111	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					519	532		10.1016/j.stem.2008.09.002	http://dx.doi.org/10.1016/j.stem.2008.09.002			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983967	Bronze			2022-12-28	WOS:000260895100011
J	Lluis, F; Pedone, E; Pepe, S; Cosma, MP				Lluis, Frederic; Pedone, Elisa; Pepe, Stefano; Cosma, Maria Pia			Periodic Activation of Wnt/beta-Catenin Signaling Enhances Somatic Cell Reprogramming Mediated by Cell Fusion	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; SELF-RENEWAL; DEVELOPMENTAL REGULATORS; NEGATIVE REGULATOR; DIFFERENTIATION; REGENERATION; FIBROBLASTS; EXPRESSION; PATHWAY; PROLIFERATION	Reprogramming of nuclei allows the dedifferentiation of differentiated cells. Somatic cells can undergo epigenetic modifications and reprogramming through their fusion with embryonic stem cells (ESCs) or after overexpression of a specific blend of ESC transcription factor-encoding genes. We show here that cyclic activation of Wnt/beta-catenin signaling in ESCs with Wnt3a or the glycogen synthase kinase-3 (GSK-3) inhibitor 6-bromoindirubin-3'-oxime (BIO) strikingly enhances the ability of ESCs to reprogram somatic cells after fusion. In addition, we show that reprogramming is triggered by a dose-dependent accumulation of active beta-catenin. Reprogrammed clones express ESC-specific genes, lose somatic differentiation markers, become demethylated on Oct4 and Nanog CpG islands, and can differentiate into cardiomyocytes in vitro and generate teratomas in vivo. Our data thus demonstrate that in ESCs, periodic P-catenin accumulation via the Wnt/beta-catenin pathway provides a specific threshold that leads to the reprogramming of somatic cells after fusion.	[Lluis, Frederic; Pedone, Elisa; Pepe, Stefano; Cosma, Maria Pia] Telethon Inst Genet & Med, I-80131 Naples, Italy	Fondazione Telethon; Telethon Institute of Genetics & Medicine (TIGEM)	Cosma, MP (corresponding author), Telethon Inst Genet & Med, Via P Castellino 111, I-80131 Naples, Italy.	cosma@tigem.it	Pedone, Elisa/AAP-7448-2020; Cosma, Maria Pia/E-8731-2015	Pedone, Elisa/0000-0001-9467-8207; Cosma, Maria Pia/0000-0003-4207-5097; Lluis, Frederic/0000-0002-7296-7611	IGB FACS; EMBO YIP; EMBO Long-Term Fellowship; Telethon Foundation	IGB FACS; EMBO YIP(European Molecular Biology Organization (EMBO)); EMBO Long-Term Fellowship(European Molecular Biology Organization (EMBO)); Telethon Foundation(Fondazione Telethon)	We thank A. Baldini, A. Ballabio, M. Buono, G. Cossu, G. Diez-Roux, S. Nicolis, and A. Smith for suggestions and critical reading of the manuscript; B.W. Doble for providing ES GSK-3 DKO cells; F. Costantini for providing mouse Axin2 cDNA; F. D'Acquisto for thymocyte purification; A. Romito and G. Cobellis for suggestions on ESC culturing and ESC differentiation experiments; L. Pisapia for IGB FACS core support; and E. Nusco and N. D'Alessio for technical support. We are grateful for support from the EMBO YIP (M.P.C.), EMBO Long-Term Fellowship (F.L.), and the Telethon Foundation (M.P.C.).	Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bazzi H, 2007, DEV BIOL, V305, P498, DOI 10.1016/j.ydbio.2007.02.035; Behrens J, 2005, BIOCHEM SOC T, V33, P672, DOI 10.1042/BST0330672; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boheler KR, 2002, CIRC RES, V91, P189, DOI 10.1161/01.RES.0000027865.61704.32; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2006, CURR OPIN GENET DEV, V16, P455, DOI 10.1016/j.gde.2006.08.009; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jho EH, 2002, MOL CELL BIOL, V22, P1172, DOI 10.1128/MCB.22.4.1172-1183.2002; Karner C, 2006, SEMIN CELL DEV BIOL, V17, P214, DOI 10.1016/j.semcdb.2006.05.007; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kikuchi A, 2007, CELL SIGNAL, V19, P659, DOI 10.1016/j.cellsig.2006.11.001; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lengner CJ, 2007, CELL STEM CELL, V1, P403, DOI 10.1016/j.stem.2007.07.020; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Ogle BM, 2005, NAT REV MOL CELL BIO, V6, P567, DOI 10.1038/nrm1678; Osakada F, 2007, J NEUROSCI, V27, P4210, DOI 10.1523/JNEUROSCI.4193-06.2007; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Stoick-Cooper CL, 2007, GENE DEV, V21, P1292, DOI 10.1101/gad.1540507; Tada M, 1997, EMBO J, V16, P6510, DOI 10.1093/emboj/16.21.6510; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Vajta G, 2007, REPROD BIOMED ONLINE, V15, P582, DOI 10.1016/S1472-6483(10)60391-4; Wharton KA, 2001, DEV BIOL, V234, P93, DOI 10.1006/dbio.2001.0238; Wiese C, 2006, STEM CELLS, V24, P2085, DOI 10.1634/stemcells.2006-0008; Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006; Yan D, 2001, P NATL ACAD SCI USA, V98, P14973, DOI 10.1073/pnas.261574498; Yeom YI, 1996, DEVELOPMENT, V122, P881; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zito E, 2005, EMBO REP, V6, P655, DOI 10.1038/sj.embor.7400454	56	115	126	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					493	507		10.1016/j.stem.2008.08.017	http://dx.doi.org/10.1016/j.stem.2008.08.017			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983965	Bronze			2022-12-28	WOS:000260895100009
J	Colman, A				Colman, Alan			Induced pluripotent stem cells and human disease	CELL STEM CELL			English	Editorial Material							GENERATION	Two recent studies report the generation of induced pluripotent stem cells from patients presenting with a total of eleven different diseases (Park et al., 2008; Dimos et al., 2008). Future differentiation studies using these lines may offer insight on specific disease pathophysiology and aid the design of protective drug therapies.	[Colman, Alan] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England; [Colman, Alan] Singapore Stem Cell Consortium, Inst Med Biol, Singapore 138648, Singapore	University of London; King's College London; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB)	Colman, A (corresponding author), Kings Coll London, Wolfson Ctr Age Related Dis, Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	alan.colman@imb.a-star.edu.sg						Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pickering SJ, 2005, REPROD BIOMED ONLINE, V10, P390, DOI 10.1016/S1472-6483(10)61801-9; Tada T, 2008, CELL STEM CELL, V3, P121, DOI 10.1016/j.stem.2008.07.005; van Laake LW, 2007, STEM CELL RES, V1, P9, DOI 10.1016/j.scr.2007.06.001; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	9	16	16	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					236	237		10.1016/j.stem.2008.08.007	http://dx.doi.org/10.1016/j.stem.2008.08.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786410	Bronze			2022-12-28	WOS:000259665000005
J	Tavazoie, M; Van der Veken, L; Silva-Vargas, V; Louissaint, M; Colonna, L; Zaidi, B; Garcia-Verdugo, JM; Doetsch, F				Tavazoie, Masoud; Van der Veken, Lieven; Silva-Vargas, Violeta; Louissaint, Marjorie; Colonna, Lucrezia; Zaidi, Bushra; Manuel Garcia-Verdugo, Jose; Doetsch, Fiona			A specialized vascular niche for adult neural stem cells	CELL STEM CELL			English	Article							BLOOD-BRAIN-BARRIER; AGE-RELATED-CHANGES; HEMATOPOIETIC STEM; SUBVENTRICULAR ZONE; GROWTH-FACTOR; NEUROGENESIS; EXPRESSION; MIGRATION; RECRUITMENT; PROLIFERATE	Stem cells reside in specialized niches that regulate their self-renewal and differentiation. The vasculature is emerging as an important component of stem cell niches. Here, we show that the adult sub-ventricular zone (SVZ) neural stem cell niche contains an extensive planar vascular plexus that has specialized properties. Dividing stem cells and their transitamplifying progeny are tightly apposed to SVZ blood vessels both during homeostasis and regeneration. They frequently contact the vasculature at sites that lack astrocyte endfeet and pericyte coverage, a modification of the blood-brain barrier unique to the SVZ. Moreover, regeneration often occurs at these sites. Finally, we find that circulating small molecules in the blood enter the SVZ. Thus, the vasculature is a key component of the adult SVZ neural stem cell niche, with SVZ stem cells and transit-amplifying cells uniquely poised to receive spatial cues and regulatory signals from diverse elements of the vascular system.	[Tavazoie, Masoud; Van der Veken, Lieven; Doetsch, Fiona] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA; [Silva-Vargas, Violeta; Louissaint, Marjorie; Colonna, Lucrezia; Zaidi, Bushra; Doetsch, Fiona] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Doetsch, Fiona] Columbia Univ, Coll Phys & Surg, Dept Neurol, New York, NY 10032 USA; [Manuel Garcia-Verdugo, Jose] Univ Valencia, Inst Cavanilles, Ctr Invest Principe Felipe, E-46100 Valencia, Spain	Columbia University; Columbia University; Columbia University; Prince Felipe Research Center; University of Valencia	Doetsch, F (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.	fkd2101@columbia.edu	García-Verdugo, José Manuel/L-8421-2017	García-Verdugo, José Manuel/0000-0001-9872-6499	NIH [T32 GM007367, T32 GM008224]; Belgian American Educational Foundation (BAEF); Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; Anne and Bernard Spitzer Fund for Cell Replacement Therapy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224, T32GM007367] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS053884] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Belgian American Educational Foundation (BAEF); Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies; Anne and Bernard Spitzer Fund for Cell Replacement Therapy; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Brown for EM processing and N. Tjoe and A.J.P. Fink for technical assistance. We thank Jane Johnson for the Mash1 antibody and E. Crouch, E. Drapeau, D. Medina, E. Pastrana, P. Riquelme, and S. Tavazoie for critical reading of the manuscript. M.T. is supported by MSTP fellowship T32 GM007367 from NIH, and L.V.d.V. is supported by a Belgian American Educational Foundation (BAEF) Fellowship for Graduate Study. V.S.-V. is a long-term HFSP fellow. L.C. is supported by T32 GM008224 from NIH, and F.D. is a Packard Foundation Fellow and Irma T. Hirschl Fellow. This work was partially supported by the Jerry and Emily Spiegel Laboratory for Cell Replacement Therapies and the Anne and Bernard Spitzer Fund for Cell Replacement Therapy.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Aguirre AA, 2004, J CELL BIOL, V165, P575, DOI 10.1083/jcb.200311141; Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Arismendi-Morillo G, 2005, J NEURO-ONCOL, V73, P211, DOI 10.1007/s11060-004-5674-3; BIRO S, 1994, CIRC RES, V74, P485, DOI 10.1161/01.RES.74.3.485; Bovetti S, 2007, J NEUROSCI, V27, P5976, DOI 10.1523/JNEUROSCI.0678-07.2007; BURNS EM, 1981, NEUROBIOL AGING, V2, P285, DOI 10.1016/0197-4580(81)90037-3; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Calaora V, 1996, NEUROSCIENCE, V73, P581, DOI 10.1016/0306-4522(96)00042-5; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 2003, NAT NEUROSCI, V6, P1127, DOI 10.1038/nn1144; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Doetsch F, 1997, J NEUROSCI, V17, P5046; Doetsch F, 1996, P NATL ACAD SCI USA, V93, P14895, DOI 10.1073/pnas.93.25.14895; Farin A, 2006, GLIA, V53, P799, DOI 10.1002/glia.20334; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Gleeson JG, 1999, NEURON, V23, P257, DOI 10.1016/S0896-6273(00)80778-3; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; GROSS PM, 1992, PROG BRAIN RES, V91, P219; Hawkins BT, 2006, J NEUROSCI METH, V151, P262, DOI 10.1016/j.jneumeth.2005.08.006; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; HICKS P, 1983, NEUROBIOL AGING, V4, P69, DOI 10.1016/0197-4580(83)90057-X; Imura T, 2003, J NEUROSCI, V23, P2824; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Kerever A, 2007, STEM CELLS, V25, P2146, DOI 10.1634/stemcells.2007-0082; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Laywell ED, 2000, P NATL ACAD SCI USA, V97, P13883, DOI 10.1073/pnas.250471697; Leventhal C, 1999, MOL CELL NEUROSCI, V13, P450, DOI 10.1006/mcne.1999.0762; Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Mercier F, 2002, J COMP NEUROL, V451, P170, DOI 10.1002/cne.10342; Molofsky AV, 2006, NATURE, V443, P448, DOI 10.1038/nature05091; Nico B, 2001, J CELL SCI, V114, P1297; Nikolova G, 2006, DEV CELL, V10, P397, DOI 10.1016/j.devcel.2006.01.015; Nishiyama A, 2002, J NEUROCYTOL, V31, P437, DOI 10.1023/A:1025783412651; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Parras CM, 2004, EMBO J, V23, P4495, DOI 10.1038/sj.emboj.7600447; POTTEN CS, 1988, J CELL SCI, P45; Rafalowska Janina, 1992, Neuropatologia Polska, V30, P73; Ramirez-Castillejo C, 2006, NAT NEUROSCI, V9, P331, DOI 10.1038/nn1657; Riquelme PA, 2008, PHILOS T R SOC B, V363, P123, DOI 10.1098/rstb.2006.2016; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Tanaka A, 2007, MECH AGEING DEV, V128, P303, DOI 10.1016/j.mad.2007.01.002; WILKINSON JH, 1981, NEUROPATH APPL NEURO, V7, P451, DOI 10.1111/j.1365-2990.1981.tb00245.x; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885; Zhuo L, 1997, DEV BIOL, V187, P36, DOI 10.1006/dbio.1997.8601; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	55	749	770	1	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					279	288		10.1016/j.stem.2008.07.025	http://dx.doi.org/10.1016/j.stem.2008.07.025			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786415	Green Accepted, Bronze			2022-12-28	WOS:000259665000011
J	Jiang, JM; Ng, HH				Jiang, Jianming; Ng, Huck-Hui			TGF beta and SMADs talk to NANOG in human embryonic stem cells	CELL STEM CELL			English	Editorial Material							DIFFERENTIATION	The TGF beta/activin signaling pathway is important for the maintenance of human embryonic stem cells. In this issue of Cell Stem Cell, Xu et al. (2008) show that this pathway upregulates the expression of a key pluripotency gene NANOG through SMAD2/3.	[Jiang, Jianming; Ng, Huck-Hui] Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore; [Jiang, Jianming; Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore	Ng, HH (corresponding author), Genome Inst Singapore, Gene Regulat Lab, Singapore 138672, Singapore.	nghh@gis.a-star.edu.sg	Ng, Huck Hui/A-1135-2009; jiang, jianming/B-3421-2012	jiang, jianming/0000-0003-3251-2716				Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Fujita J, 2008, CELL STEM CELL, V2, P595, DOI 10.1016/j.stem.2008.04.001; Rao BM, 2005, CURR OPIN BIOTECH, V16, P568, DOI 10.1016/j.copbio.2005.08.001; Rossant J, 2008, CELL, V132, P527, DOI 10.1016/j.cell.2008.01.039; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	10	17	20	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					127	128		10.1016/j.stem.2008.07.011	http://dx.doi.org/10.1016/j.stem.2008.07.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682233	Bronze			2022-12-28	WOS:000258523300004
J	Kobayashi, A; Valerius, MT; Mugford, JW; Carroll, TJ; Self, M; Oliver, G; McMahon, AP				Kobayashi, Akio; Valerius, M. Todd; Mugford, Joshua W.; Carroll, Thomas J.; Self, Michelle; Oliver, Guillermo; McMahon, Andrew P.			Six2 defines and regulates a multipotent self-renewing nephron progenitor population throughout mammalian kidney development	CELL STEM CELL			English	Article							METANEPHRIC MESENCHYME; RECOMBINASE ACTIVITY; MOUSE KIDNEY; STEM-CELLS; MORPHOGENESIS; GENES; NEPHROGENESIS; EXPRESSION; SYSTEM; GROWTH	Nephrons, the basic functional units of the kidney, are generated repetitively during kidney organogenesis from a mesenchymal progenitor population. Which cells within this pool give rise to nephrons and how multiple nephron lineages form during this protracted developmental process are unclear. We demonstrate that the Six2-expressing cap mesenchyme represents a multipotent nephron progenitor population. Six2-expressing cells give rise to all cell types of the main body of the nephron during all stages of nephrogenesis. Pulse labeling of Six2-expressing nephron progenitors at the onset of kidney development suggests that the Six2-expressing population is maintained by self-renewal. Clonal analysis indicates that at least some Six2-expressing cells are multipotent, contributing to multiple domains of the nephron. Furthermore, Six2 functions cell autonomously to maintain a progenitor cell status, as cap mesenchyme cells lacking Six2 activity contribute to ectopic nephron tubules, a mechanism dependent on a Wnt9b inductive signal. Taken together, our observations suggest that Six2 activity cell-autonomously regulates a multipotent nephron progenitor population.	[Kobayashi, Akio; Valerius, M. Todd; Mugford, Joshua W.; Carroll, Thomas J.; McMahon, Andrew P.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Self, Michelle; Oliver, Guillermo] St Jude Childrens Res Hosp, Dept Genet & Tumor Cell Biol, Memphis, TN 38105 USA	Harvard University; St Jude Children's Research Hospital	McMahon, AP (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, 16 Divin Ave, Cambridge, MA 02138 USA.	mcmahon@mcb.harvard.edu	Wilson, Matthew H/K-3193-2013; Valerius, M. Todd/AAK-3063-2020; McMahon, Andrew P/ABE-7520-2020	Valerius, M. Todd/0000-0001-8143-9231; 	National Research Service Award (NRSA) [NIH-NIDDK F32DK060319]; Cancer Center Support [CA-21765]; American Lebanese Syrian Associated Charities (ALSAC); National Institutes of Health [NIH-NIDDK DK054364]; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054364, R37DK054364, F32DK060319] Funding Source: NIH RePORTER	National Research Service Award (NRSA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; American Lebanese Syrian Associated Charities (ALSAC)(American Lebanese Syrian Associated Charities (ALSAC)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Kevin Eggan for 129/Sv x C57BL/6J F1 hybrid ES cells, Neal Copeland for reagents for BAC recombination, Brian Sauer for eGFPCre construct, and Daniel Metzger and Pierre Chambon for CreER<SUP>T2</SUP> construct. A. K. was supported by a Research Fellowship from the National Kidney Foundation. M.T.V. was supported by a National Research Service Award (NRSA) award (NIH-NIDDK F32DK060319). Work in G.O.'s laboratory was supported by Cancer Center Support (CA-21765) and the American Lebanese Syrian Associated Charities (ALSAC). Work in A.P.M.'s laboratory was supported by a grant from the National Institutes of Health (NIH-NIDDK DK054364). A.P.M. is a consultant for Merck. This consultancy does not relate to the work herein.	Barasch J, 1997, AM J PHYSIOL-RENAL, V273, pF757, DOI 10.1152/ajprenal.1997.273.5.F757; Barasch J, 1999, J CLIN INVEST, V103, P1299, DOI 10.1172/JCI4586; Barasch J, 1999, CELL, V99, P377, DOI 10.1016/S0092-8674(00)81524-X; Bond CT, 2000, SCIENCE, V289, P1942, DOI 10.1126/science.289.5486.1942; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Cebrian C, 2004, DEV DYNAM, V231, P601, DOI 10.1002/dvdy.20143; Cheng HT, 2003, DEVELOPMENT, V130, P5031, DOI 10.1242/dev.00697; Cheng HT, 2007, DEVELOPMENT, V134, P801, DOI 10.1242/dev.02773; Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357; Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x; Cullen-McEwen LA, 2003, HYPERTENSION, V41, P335, DOI 10.1161/01.HYP.0000050961.70182.56; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340; DUDLEY AT, 1995, GENE DEV, V9, P2795, DOI 10.1101/gad.9.22.2795; Dudley AT, 1999, GENE DEV, V13, P1601, DOI 10.1101/gad.13.12.1601; Eggan K, 2001, P NATL ACAD SCI USA, V98, P6209, DOI 10.1073/pnas.101118898; Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; FRIEDRICH G, 1991, GENE DEV, V5, P1513, DOI 10.1101/gad.5.9.1513; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; He CJ, 1996, J CLIN INVEST, V97, P1242, DOI 10.1172/JCI118539; HERZLINGER D, 1992, DEVELOPMENT, V114, P565; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Le YZ, 1999, ANAL BIOCHEM, V270, P334, DOI 10.1006/abio.1999.4110; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; LUO G, 1995, GENE DEV, V9, P2808, DOI 10.1101/gad.9.22.2808; Moreno E, 2002, NATURE, V416, P755, DOI 10.1038/416755a; Nagy A., 2003, MANIPULATING MOUSE E; OLIVER G, 1995, DEVELOPMENT, V121, P693; Osafune K, 2006, DEVELOPMENT, V133, P151, DOI 10.1242/dev.02174; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; PERANTONI AO, 1995, P NATL ACAD SCI USA, V92, P4696, DOI 10.1073/pnas.92.10.4696; Plisov SY, 2001, DEVELOPMENT, V128, P1045; QIAO J, 1995, DEVELOPMENT, V121, P3207; Reggiani L, 2007, GENE DEV, V21, P2358, DOI 10.1101/gad.450707; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Saxen L., 1987, ORGANOGENESIS KIDNEY; Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Wang P, 2003, DEVELOPMENT, V130, P5019, DOI 10.1242/dev.00682; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; Wingert RA, 2007, PLOS GENET, V3, P1922, DOI 10.1371/journal.pgen.0030189	45	647	660	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					169	181		10.1016/j.stem.2008.05.020	http://dx.doi.org/10.1016/j.stem.2008.05.020			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682239	Green Accepted, Bronze			2022-12-28	WOS:000258523300012
J	Wang, JCY				Wang, Jean C. Y.			Evaluating therapeutic efficacy against cancer stem cells: New challenges posed by a new paradigm	CELL STEM CELL			English	Article							MYELOGENOUS LEUKEMIA STEM; ACUTE MYELOID-LEUKEMIA; INITIATING CELLS; PROGENITOR CELLS; DISEASE; TRIAL; AML	Current measures of anticancer drug efficacy reflect bulk cell killing and are poorly suited to detect activity against cancer stem cells (CSCs), which sustain tumor growth. The CSC paradigm necessitates a reexamination of methodologies used to evaluate clinical efficacy of anticancer therapies, as well as strategies employed during preclinical drug development.	Univ Toronto, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; Univ Toronto, Univ Hlth Network, Dept Med, Div Hematol & Med Oncol, Toronto, ON M5G 1L7, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Wang, JCY (corresponding author), Univ Toronto, Toronto Gen Res Inst, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada.	jwang@uhnres.utoronto.ca		Wang, Jean/0000-0001-7543-3917				Ardeshna KM, 2003, LANCET, V362, P516, DOI 10.1016/S0140-6736(03)14110-4; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; DiMasi JA, 2007, J CLIN ONCOL, V25, P209, DOI 10.1200/JCO.2006.09.0803; Durie BGM, 2004, J CLIN ONCOL, V22, P1857, DOI 10.1200/JCO.2004.05.111; Ferrari M, 2005, NAT REV CANCER, V5, P161, DOI 10.1038/nrc1566; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Huff CA, 2006, BLOOD, V107, P431, DOI 10.1182/blood-2005-06-2517; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jordan CT, 2006, NEW ENGL J MED, V355, P1253, DOI 10.1056/NEJMra061808; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Krutzik PO, 2006, NAT METHODS, V3, P361, DOI 10.1038/NMETH872; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lee JH, 2007, NAT MED, V13, P95, DOI [10.1038/nm1467, 10.20659/jfp.13.1_95]; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rosner GL, 2002, J CLIN ONCOL, V20, P4478, DOI 10.1200/JCO.2002.11.126; Smith-Jones PM, 2004, NAT BIOTECHNOL, V22, P701, DOI 10.1038/nbt968; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703	27	46	46	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					497	501		10.1016/j.stem.2007.10.005	http://dx.doi.org/10.1016/j.stem.2007.10.005			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18938746	Bronze			2022-12-28	WOS:000251276500008
J	Vyas, P; Jacobsen, SEW				Vyas, Paresh; Jacobsen, Sten Eirik W.			Clever Leukemic Stem Cells Branch Out	CELL STEM CELL			English	Editorial Material							ACUTE LYMPHOBLASTIC-LEUKEMIA; CANCER	Individual tumors harbor heterogeneous populations of genetically distinct subclones. Two recent papers in Nature by Notta et al. (2011) and Anderson et al. (2011) reveal genetic heterogeneity in functional leukemic stem cells, which has important implications for how both cancer and normal stem cell populations may adapt to selective pressure.	[Vyas, Paresh; Jacobsen, Sten Eirik W.] Univ Oxford, MRC Mol Haematol Unit, Oxford OX3 9DU, England; [Jacobsen, Sten Eirik W.] Univ Oxford, Haematopoiet Stem Cell Lab, Oxford OX3 9DU, England; [Vyas, Paresh] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DU, England; Oxford Radcliffe Hosp, Dept Haematol, Oxford OX3 9DU, England	University of Oxford; University of Oxford; University of Oxford; University of Oxford	Vyas, P (corresponding author), Univ Oxford, MRC Mol Haematol Unit, Oxford OX3 9DU, England.	paresh.vyas@imm.ox.ac.uk	Jacobsen, Sten Eirik W/D-3974-2018; Vyas, Paresh/B-5708-2009	Jacobsen, Sten Eirik W/0000-0002-1362-3659; Vyas, Paresh/0000-0003-3931-0914	Medical Research Council [G1000729] Funding Source: Medline; MRC [G1000729] Funding Source: UKRI; Medical Research Council [G1000801c] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Anderson K, 2011, NATURE, V469, P356, DOI 10.1038/nature09650; Boiko AD, 2010, NATURE, V466, P133, DOI 10.1038/nature09161; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; le Viseur C, 2008, CANCER CELL, V14, P47, DOI 10.1016/j.ccr.2008.05.015; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Notta F, 2011, NATURE, V469, P362, DOI 10.1038/nature09733; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Quintana E, 2008, NATURE, V456, P593, DOI 10.1038/nature07567; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027	11	5	5	0	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 4	2011	8	3					242	244		10.1016/j.stem.2011.02.015	http://dx.doi.org/10.1016/j.stem.2011.02.015			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	735HI	21362561	Bronze			2022-12-28	WOS:000288404400002
J	Murai, KK; Pasquale, EB				Murai, Keith K.; Pasquale, Elena B.			Restraining Stem Cell Niche Plasticity: A New Talent of Eph Receptors	CELL STEM CELL			English	Editorial Material							SUBVENTRICULAR ZONE; PROLIFERATION	Multiple Eph receptor tyrosine kinases and ephrin ligands are expressed in stem cells and their niches, where their complex roles are under intense investigation. Nomura et al. (2010) reveal an unexpected function of Eph signaling in suppressing cell fate plasticity of niche cells in the adult brain.	[Murai, Keith K.] McGill Univ, Ctr Hlth, Ctr Res Neurosci, Dept Neurol & Neurosurg,Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada; [Pasquale, Elena B.] Sanford Burnham Med Res Inst, La Jolla, CA 92037 USA; [Pasquale, Elena B.] Univ Calif San Diego, Dept Pathol, La Jolla, CA 92093 USA	McGill University; Sanford Burnham Prebys Medical Discovery Institute; University of California System; University of California San Diego	Murai, KK (corresponding author), McGill Univ, Ctr Hlth, Ctr Res Neurosci, Dept Neurol & Neurosurg,Montreal Gen Hosp, 1650 Cedar Ave, Montreal, PQ H3G 1A4, Canada.	keith.murai@mcgill.ca; elenap@sanfordburnham.org			NCI NIH HHS [P01 CA138390, P01 CA138390-01A1, P01 CA102583-05, R01 CA116099, R01 CA116099-05, P01 CA102583] Funding Source: Medline; NINDS NIH HHS [R21 NS067502, R21 NS067502-02] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA116099, P01CA102583, P01CA138390] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS067502] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Gomez-Roldan MDC, 2008, J COMP NEUROL, V507, P1571, DOI 10.1002/cne.21618; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Nomura T, 2010, CELL STEM CELL, V7, P730, DOI 10.1016/j.stem.2010.11.009; Parrinello S, 2010, CELL, V143, P145, DOI 10.1016/j.cell.2010.08.039; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; ZHAO C, 2008, D, V132, P645	10	6	6	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					647	648		10.1016/j.stem.2010.11.023	http://dx.doi.org/10.1016/j.stem.2010.11.023			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112558	Green Accepted, Bronze			2022-12-28	WOS:000285537700005
J	Kieslinger, M; Hiechinger, S; Dobreva, G; Consalez, GG; Grosschedl, R				Kieslinger, Matthias; Hiechinger, Silvia; Dobreva, Gergana; Consalez, G. Giacomo; Grosschedl, Rudolf			Early B Cell Factor 2 Regulates Hematopoietic Stem Cell Homeostasis in a Cell-Nonautonomous Manner	CELL STEM CELL			English	Article							FRIZZLED-RELATED PROTEIN-1; BONE-MARROW; BETA-CATENIN; SELF-RENEWAL; LONG-TERM; LYMPHOID PROGENITORS; WNT; MAINTENANCE; NICHE; DIFFERENTIATION	Hematopoiesis requires the interaction of hematopoietic stem cells (HSCs) with various stromal microenvironments. Here, we examine the role of early B cell factor 2 (Ebf2), a transcription factor expressed in a subset of immature osteoblastic cells. Ebf2(-/-) mice show decreased frequencies of HSCs and lineage-committed progenitors. This defect is cell nonautonomous, as shown by the fact that transplantation of Ebf2-deficient bone marrow into wild-type hosts results in normal hematopoiesis. In coculture experiments, Ebf2(-/-) osteoblastic cells have reduced potential to support short-term proliferation of HSCs. Expression profiling of sorted Ebf2(-/-) osteoblastic cells indicated that several genes implicated in the maintenance of HSCs are downregulated relative to Ebf2(+/-) cells, whereas genes encoding secreted frizzled-related proteins are upregulated. Moreover, wild-type HSCs cocultured with Ebf2(-/-) osteoblastic cells show a reduced Wnt response relative to coculture with Ebf2(+/-) cells. Thus, Ebf2 acts as a transcriptional determinant of an osteoblastic niche that regulates the maintenance of hematopoietic progenitors, in part by modulating Wnt signaling.	[Kieslinger, Matthias; Dobreva, Gergana; Grosschedl, Rudolf] Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany; [Kieslinger, Matthias; Hiechinger, Silvia] Natl Res Ctr Environm Hlth, Helmholtz Ctr Munich, D-81377 Munich, Germany; [Consalez, G. Giacomo] Ist Sci San Raffaele, I-20132 Milan, Italy	Max Planck Society; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Munich; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Kieslinger, M (corresponding author), Max Planck Inst Immunobiol, Dept Cellular & Mol Immunol, D-79108 Freiburg, Germany.	matthias.kieslinger@helmholtz-muenchen.de; grosschedl@immunbio.mpg.de	Consalez, Giacomo/AAA-2146-2019	Consalez, Giacomo/0000-0003-4594-6273; Dobreva, Gergana/0000-0002-4814-9416	Max Planck Society; Bavarian research foundation [T1]; German Research Foundation [TRR54, SFB620]	Max Planck Society(Max Planck Society); Bavarian research foundation; German Research Foundation(German Research Foundation (DFG))	We thank Dr. T. Reya for providing lentiviral vectors. We are grateful to I. Falk, R. Istvanffy, and R. Oostendorp for help with FACS analysis and B. Ksienzyk, C. Buske, M. Feuring-Buske, J. Ellwart, and K. Nispel for FAGS sorting. We thank V. Erben and C. Petritsch for help with confocal microscopy. This work was supported by funds of the Max Planck Society and grants of the Bavarian research foundation (Forimmun, T1) and German Research Foundation (TRR54 and SFB620). Author contributions: M.K. performed most of the experiments; S.H. performed the experiments in Figure 4 and G.D. performed the microarray analysis shown in Table Si; G.G.C. provided the Ebf2<SUP>+/-</SUP> mice and performed the immunohistochemistry shown in Figure S3; and R.G. supervised the study and wrote the manuscript.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Choong ML, 2003, FEBS LETT, V550, P155, DOI 10.1016/S0014-5793(03)00844-5; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; Crozatier M, 2004, PLOS BIOL, V2, P1107, DOI 10.1371/journal.pbio.0020196; DiMascio L, 2007, J IMMUNOL, V178, P3511, DOI 10.4049/jimmunol.178.6.3511; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Garel S, 1997, DEV DYNAM, V210, P191, DOI 10.1002/(SICI)1097-0177(199711)210:3<191::AID-AJA1>3.0.CO;2-B; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; HAGMAN J, 1993, GENE DEV, V7, P760, DOI 10.1101/gad.7.5.760; Hattori K, 2003, LEUKEMIA LYMPHOMA, V44, P575, DOI 10.1080/1042819021000037985; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kieslinger M, 2005, DEV CELL, V9, P757, DOI 10.1016/j.devcel.2005.10.009; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kim JA, 2009, STEM CELLS, V27, P1318, DOI 10.1002/stem.52; Kincade PW, 1998, CELL ADHES COMMUN, V6, P211, DOI 10.3109/15419069809004476; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5; Krzemien J, 2007, NATURE, V446, P325, DOI 10.1038/nature05650; Lebestky T, 2003, GENE DEV, V17, P348, DOI 10.1101/gad.1052803; Li LH, 2005, ANNU REV CELL DEV BI, V21, P605, DOI 10.1146/annurev.cellbio.21.012704.131525; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lo Celso C, 2009, NATURE, V457, P92, DOI 10.1038/nature07434; Luis TC, 2009, BLOOD, V113, P546, DOI 10.1182/blood-2008-06-163774; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Malgaretti N, 1997, J BIOL CHEM, V272, P17632, DOI 10.1074/jbc.272.28.17632; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Malhotra S, 2009, CELL STEM CELL, V4, P27, DOI 10.1016/j.stem.2008.12.004; Mandal L, 2007, NATURE, V446, P320, DOI 10.1038/nature05585; Medina KL, 2004, DEV CELL, V7, P607, DOI 10.1016/j.devcel.2004.08.006; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; Moore KA, 1997, BLOOD, V89, P4337, DOI 10.1182/blood.V89.12.4337; Moore KA, 2006, SCIENCE, V311, P1880, DOI 10.1126/science.1110542; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nemeth MJ, 2009, STEM CELLS, V27, P1109, DOI 10.1002/stem.32; Phillips RL, 2000, SCIENCE, V288, P1635, DOI 10.1126/science.288.5471.1635; PLOEMACHER RE, 1991, BLOOD, V78, P2527; Renstrom J, 2009, CELL STEM CELL, V5, P157, DOI 10.1016/j.stem.2009.05.020; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Taichman RS, 2005, BLOOD, V105, P2631, DOI 10.1182/blood-2004-06-2480; Tokoyoda K, 2004, IMMUNITY, V20, P707, DOI 10.1016/j.immuni.2004.05.001; Xie YC, 2009, NATURE, V457, P97, DOI 10.1038/nature07639; Yokota T, 2008, J IMMUNOL, V181, P6061, DOI 10.4049/jimmunol.181.9.6061; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	67	42	42	1	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 8	2010	7	4					496	507		10.1016/j.stem.2010.07.015	http://dx.doi.org/10.1016/j.stem.2010.07.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	668LJ	20887955	Bronze			2022-12-28	WOS:000283270600011
J	Klein, AM; Nakagawa, T; Ichikawa, R; Yoshida, S; Simons, BD				Klein, Allon M.; Nakagawa, Toshinori; Ichikawa, Rie; Yoshida, Shosei; Simons, Benjamin D.			Mouse Germ Line Stem Cells Undergo Rapid and Stochastic Turnover	CELL STEM CELL			English	Article							DROSOPHILA OVARY; SPERMATOGONIA; NICHE; SPERMATOGENESIS; PROGENITOR; RECOMBINATION; EPIDERMIS; PROTEIN; TESTIS	In cycling tissues, adult stem cells may be lost and subsequently replaced to ensure homeostasis. To examine the frequency of stem cell replacement, we analyzed the population dynamics of labeled stem cells in steady-state mouse spermatogenesis. Our results show that spermatogenic stem cells are continuously replaced, on average within 2 weeks. The analysis exposes a simple and robust scaling behavior of clone size distributions that shows stem cell replacement to be stochastic, meaning that stem cells are equipotent and equally likely to be lost or to multiply to replace their neighbors, irrespective of their clonal history. The surprisingly fast rate of stem cell replacement is supported experimentally by 3D clone morphology and by live-imaging of spermatogonial migration. These results suggest that short-lived stem cells may be a common feature of mammalian stem cell systems and reveal a natural mechanism for matching the rates of cell proliferation and loss in tissue.	[Nakagawa, Toshinori; Yoshida, Shosei] Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan; [Klein, Allon M.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Klein, Allon M.; Simons, Benjamin D.] Univ Cambridge, Cavendish Lab, Dept Phys, Cambridge CB3 0HE, England; [Ichikawa, Rie; Yoshida, Shosei] Natl Inst Nat Sci, Natl Inst Basic Biol, Div Germ Cell Biol, Okazaki, Aichi 4448787, Japan; [Yoshida, Shosei] Grad Univ Adv Studies Sokendai, Sch Life Sci, Dept Basic Biol, Okazaki, Aichi 4448787, Japan; [Simons, Benjamin D.] Hutchison MRC Res Ctr, MRC Canc Cell Unit, Cambridge CB2 0XZ, England	Kyoto University; Harvard University; Harvard Medical School; University of Cambridge; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Graduate University for Advanced Studies - Japan; National Institutes of Natural Sciences (NINS) - Japan; National Institute for Basic Biology (NIBB); Okazaki Institute for Integrative Bioscience (OIIB)	Yoshida, S (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol & Tumor Biol, Kyoto 6068501, Japan.	shosei@nibb.ac.jp; bds10@cam.ac.uk	Simons, Benjamin/AAY-8920-2020	Simons, Benjamin/0000-0002-3875-7071; Yoshida, Shosei/0000-0001-8861-1866; Nakagawa, Toshinori/0000-0001-7620-1720	MEXT, Japan [20116004]; EPSRC LSI [EP/F043325/1]; EPSRC [EP/F043325/1, EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1, EP/F043325/1] Funding Source: researchfish; Grants-in-Aid for Scientific Research [20116004] Funding Source: KAKEN	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); EPSRC LSI(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We are grateful to A. Philpott and T. Ogawa for their insightful comments and discussions. We thank Y. Nabeshima for his continuous support and encouragement, R Sugimoto for discussions and technical instruction, and M. Sukeno and T. Obata for their technical assistance. We also thank T. Sasaoka and the staff of the Division of Model Animal Research, NIBB Bio-Resource Center, and Institute of Laboratory Animals, Graduate School of Medicine, Kyoto University, for support on animal experiments. The experimental work was partly supported by Grant-in-Aid for Scientific Research (KAKENHI) on Innovative Areas, 'Regulatory Mechanism of Gamete Stem Cells' from MEXT, Japan to S.Y. (no. 20116004). A.M.K. is supported by an EPSRC LSI fellowship ref. EP/F043325/1.	ARAKI K, 1995, P NATL ACAD SCI USA, V92, P160, DOI 10.1073/pnas.92.1.160; Bachelier L., 1900, THEORIE SPECULATION; Barroca V, 2009, NAT CELL BIOL, V11, P190, DOI 10.1038/ncb1826; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; De Rooij DG, 2000, J ANDROL, V21, P776; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Kawamoto S, 2000, FEBS LETT, V470, P263, DOI 10.1016/S0014-5793(00)01338-7; Kimura M., 1983, NEUTRAL THEORY MOL E; Nakagawa T, 2007, DEV CELL, V12, P195, DOI 10.1016/j.devcel.2007.01.002; Nakagawa T, 2010, SCIENCE, V328, P62, DOI 10.1126/science.1182868; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Russell L. D., 1990, HISTOLOGICAL HISTOPA; Sada A, 2009, SCIENCE, V325, P1394, DOI 10.1126/science.1172645; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Spence AJ, 2009, CURR BIOL, V19, pR57, DOI 10.1016/j.cub.2008.10.042; Suzuki H, 2009, DEV BIOL, V336, P222, DOI 10.1016/j.ydbio.2009.10.002; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yoshida S, 2004, DEV BIOL, V269, P447, DOI 10.1016/j.ydbio.2004.01.036; Yoshida S, 2006, DEVELOPMENT, V133, P1495, DOI 10.1242/dev.02316; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	22	174	180	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					214	224		10.1016/j.stem.2010.05.017	http://dx.doi.org/10.1016/j.stem.2010.05.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682447	Bronze			2022-12-28	WOS:000281107400013
J	Seki, T; Yuasa, S; Oda, M; Egashira, T; Yae, K; Kusumoto, D; Nakata, H; Tohyama, S; Hashimoto, H; Kodaira, M; Okada, Y; Seimiya, H; Fusaki, N; Hasegawa, M; Fukuda, K				Seki, Tomohisa; Yuasa, Shinsuke; Oda, Mayumi; Egashira, Toru; Yae, Kojiro; Kusumoto, Dai; Nakata, Hikari; Tohyama, Shugo; Hashimoto, Hisayuki; Kodaira, Masaki; Okada, Yohei; Seimiya, Hiroyuki; Fusaki, Noemi; Hasegawa, Mamoru; Fukuda, Keiichi			Generation of Induced Pluripotent Stem Cells from Human Terminally Differentiated Circulating T Cells	CELL STEM CELL			English	Article							SENDAI-VIRUS; EFFICIENT		[Seki, Tomohisa; Yuasa, Shinsuke; Egashira, Toru; Yae, Kojiro; Kusumoto, Dai; Nakata, Hikari; Tohyama, Shugo; Hashimoto, Hisayuki; Kodaira, Masaki; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan; [Yuasa, Shinsuke; Oda, Mayumi; Okada, Yohei] Keio Univ, Sch Med, Ctr Integrated Med Res, Tokyo 1608582, Japan; [Okada, Yohei] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Seimiya, Hiroyuki] Japanese Fdn Canc Res, Ctr Canc Chemotherapy, Div Mol Biotherapy, Tokyo 1358550, Japan; [Fusaki, Noemi; Hasegawa, Mamoru] DNAVEC Corp, Ibaraki 12511, Japan; [Fusaki, Noemi] JST, PRESTO, Kawaguchi, Saitama 3320012, Japan	Keio University; Keio University; Keio University; Japanese Foundation for Cancer Research; DNAVEC Corporation; Japan Science & Technology Agency (JST)	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo 1608582, Japan.	kfukuda@sc.itc.keio.ac.jp	Oda, Mayumi/Z-2010-2019; Fusaki, Noemi/U-1628-2019; Hashimoto, Hisayuki/AAS-1938-2020; Seki, Tomohisa/L-3524-2013; Okada, Yohei/L-1662-2013; Oda, Mayumi/AAU-4837-2020; Fukuda, Keiichi/L-3777-2013; Yuasa, Shinsuke/L-8310-2013	Oda, Mayumi/0000-0001-5102-7076; Hashimoto, Hisayuki/0000-0001-7367-4805; Seimiya, Hiroyuki/0000-0003-3314-9736; Yae, Kojiro/0000-0002-3766-2812; Yuasa, Shinsuke/0000-0001-5593-7552; Seki, Tomohisa/0000-0002-4281-135X; Kodaira, Masaki/0000-0002-7293-617X	project for realization of regenerative medicine; Ministry of Education, Science, and Culture, Japan; New Energy and Industrial Technology Development Organization (NEDO)	project for realization of regenerative medicine(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Education, Science, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Industrial Technology Development Organization (NEDO)(New Energy and Industrial Technology Development Organization (NEDO))	This study was supported in part by research grants from the project for realization of regenerative medicine, the Ministry of Education, Science, and Culture, Japan, and by a grant from the New Energy and Industrial Technology Development Organization (NEDO). We thank Dr. Kyotaro Hirashima for technical assistance with TRAP assay. N.F. is an employee of DNAVEC Corporation and M.H. is a founder and shareholder of DNAVEC Corporation	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; DesaiMehta A, 1996, J CLIN INVEST, V97, P2063, DOI 10.1172/JCI118643; Douglas NC, 2001, NAT IMMUNOL, V2, P307, DOI 10.1038/86308; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; Kim JB, 2009, NATURE, V461, P649, DOI 10.1038/nature08436; Krangel MS, 2009, CURR OPIN IMMUNOL, V21, P133, DOI 10.1016/j.coi.2009.03.009; Li HO, 2000, J VIROL, V74, P6564, DOI 10.1128/JVI.74.14.6564-6569.2000; Okano S, 2003, GENE THER, V10, P1381, DOI 10.1038/sj.gt.3301998; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Ye ZH, 2009, BLOOD, V114, P5473, DOI 10.1182/blood-2009-04-217406; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	13	382	432	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					11	14		10.1016/j.stem.2010.06.003	http://dx.doi.org/10.1016/j.stem.2010.06.003			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621043	Bronze			2022-12-28	WOS:000280222300006
J	Urbach, A; Bar-Nur, O; Daley, GQ; Benvenisty, N				Urbach, Achia; Bar-Nur, Ori; Daley, George Q.; Benvenisty, Nissim			Differential Modeling of Fragile X Syndrome by Human Embryonic Stem Cells and Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							FMR1 GENE; METHYLATION; INSTABILITY; DISEASE; ALLELE; GENERATION; LENGTH		[Urbach, Achia; Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA; [Urbach, Achia; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Urbach, Achia; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Bar-Nur, Ori; Benvenisty, Nissim] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, Stem Cell Unit, IL-91904 Jerusalem, Israel; [Urbach, Achia; Daley, George Q.] Harvard Univ, Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Urbach, Achia; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Hebrew University of Jerusalem; Harvard University; Harvard Medical School; Harvard University	Daley, GQ (corresponding author), Childrens Hosp, Howard Hughes Med Inst, Manton Ctr Orphan Dis Res, Stem Cell Transplantat Program,Div Pediat Hematol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu; nissimb@cc.huji.ac.il	/GLR-9975-2022; Bar-Nur, Ori/GWQ-5917-2022	Urbach, Achia/0000-0001-9393-4504	Israel Science Foundation [227/06]; European Community [018739]; Legacy Heritage Fund of New York; National Institutes of Health; Howard Hughes Medical Institute; Manton Center for Orphan Disease Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK070055] Funding Source: NIH RePORTER	Israel Science Foundation(Israel Science Foundation); European Community(European Commission); Legacy Heritage Fund of New York; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Manton Center for Orphan Disease Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We would like to thank Tamar Lev-Golan and Inbal Caspi for technical assistance and Phil Manos for help with IHC. A.U. is an EMBO fellow. N.B. is the Herbert Cohn Chair in Cancer Research. This research was partially supported by funds from the Israel Science Foundation (Grant number 227/06) and the European Community (ESTOOLS, Grant number 018739). We gratefully acknowledge support for this project provided by a grant from the Legacy Heritage Fund of New York. G.Q.D. was supported by grants from the National Institutes of Health, the Howard Hughes Medical Institute, and the Manton Center for Orphan Disease Research. G.Q.D. is a member of the Scientific Advisory Boards of iPierian, Inc., Epizyme, and MPM Capital.	Amabile G, 2009, TRENDS MOL MED, V15, P59, DOI 10.1016/j.molmed.2008.12.003; Baker DEC, 2007, NAT BIOTECHNOL, V25, P207, DOI 10.1038/nbt1285; Belmonte JCI, 2009, NAT REV GENET, V10, P878, DOI 10.1038/nrg2700; Bontekoe CJM, 1997, EUR J HUM GENET, V5, P293, DOI 10.1159/000484780; Brakensiek K, 2007, CLIN CHEM, V53, P17, DOI 10.1373/clinchem.2007.072629; Burman RW, 1999, HUM MOL GENET, V8, P2293, DOI 10.1093/hmg/8.12.2293; Burman RW, 1999, AM J HUM GENET, V65, P1375, DOI 10.1086/302628; Chan EM, 2009, NAT BIOTECHNOL, V27, P1033, DOI 10.1038/nbt.1580; Coffee B, 2002, AM J HUM GENET, V71, P923, DOI 10.1086/342931; Coffee B, 1999, NAT GENET, V22, P98, DOI 10.1038/8807; Crawford DC, 2001, GENET MED, V3, P359, DOI 10.1097/00125817-200109000-00006; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Dupont JM, 2004, ANAL BIOCHEM, V333, P119, DOI 10.1016/j.ab.2004.05.007; Eiges R, 2007, CELL STEM CELL, V1, P568, DOI 10.1016/j.stem.2007.09.001; Lavedan CN, 1997, HUM GENET, V100, P407, DOI 10.1007/s004390050525; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Lengerke C, 2009, ANN NY ACAD SCI, V1176, P191, DOI 10.1111/j.1749-6632.2009.04962.x; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maitra A, 2005, NAT GENET, V37, P1099, DOI 10.1038/ng1631; Muller LUW, 2009, MOL THER, V17, P947, DOI 10.1038/mt.2009.72; Nishikawa S, 2008, NAT REV MOL CELL BIO, V9, P725, DOI 10.1038/nrm2466; O'Donnell WT, 2002, ANNU REV NEUROSCI, V25, P315, DOI 10.1146/annurev.neuro.25.112701.142909; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pearson CE, 2005, NAT REV GENET, V6, P729, DOI 10.1038/nrg1689; Pietrobono R, 2005, HUM MOL GENET, V14, P267, DOI 10.1093/hmg/ddi024; Rousseau Francois, 1992, Human Mutation, V1, P91, DOI 10.1002/humu.1380010202; Schuldiner M, 2000, P NATL ACAD SCI USA, V97, P11307, DOI 10.1073/pnas.97.21.11307; Shaw RJ, 2006, BRIT J CANCER, V94, P561, DOI 10.1038/sj.bjc.6602972; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stoyanova V, 2004, FASEB J, V18, P1964, DOI 10.1096/fj.04-2499fje; Sutcliffe James S., 1992, Human Molecular Genetics, V1, P397, DOI 10.1093/hmg/1.6.397; Tabolacci E, 2005, EUR J HUM GENET, V13, P641, DOI 10.1038/sj.ejhg.5201393; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Tost J, 2007, NAT PROTOC, V2, P2265, DOI 10.1038/nprot.2007.314; Urbach A, 2004, STEM CELLS, V22, P635, DOI 10.1634/stemcells.22-4-635; VERKERK AJMH, 1991, CELL, V65, P905, DOI 10.1016/0092-8674(91)90397-H; Willemsen R, 2002, HUM GENET, V110, P601, DOI 10.1007/s00439-002-0723-5; Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739; Wong HL, 2006, BIOTECHNIQUES, V41, P734, DOI 10.2144/000112305; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	44	306	318	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					407	411		10.1016/j.stem.2010.04.005	http://dx.doi.org/10.1016/j.stem.2010.04.005			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452313	Bronze, Green Accepted			2022-12-28	WOS:000277844800006
J	Somervaille, TCP; Cleary, ML				Somervaille, Tim C. P.; Cleary, Michael L.			Mutant CEBPA: Priming Stem Cells for Myeloid Leukemogenesis	CELL STEM CELL			English	Editorial Material							LEUKEMIA; TRANSFORMATION; PROGENITORS; MLL-AF9	In a recent study published in Cancer Cell, Bereshchenko and colleagues (2009) report a knockin mouse model that represents the most frequently occurring biallelic combination of CEBPA mutations found in human acute myeloid leukemia.	[Somervaille, Tim C. P.] Univ Manchester, Paterson Inst Canc Res, Canc Res UK Leukaemia Biol Grp, Manchester M20 4BX, Lancs, England; [Cleary, Michael L.] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA	Paterson Institute for Cancer Research; University of Manchester; Stanford University	Somervaille, TCP (corresponding author), Univ Manchester, Paterson Inst Canc Res, Canc Res UK Leukaemia Biol Grp, Manchester M20 4BX, Lancs, England.	tsomervaille@picr.man.ac.uk; mcleary@stanford.edu		Somervaille, Tim/0000-0002-9188-4379				Bereshchenko O, 2009, CANCER CELL, V16, P390, DOI 10.1016/j.ccr.2009.09.036; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Koschmieder S, 2009, J CLIN ONCOL, V27, P619, DOI 10.1200/JCO.2008.17.9812; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Miyamoto T, 2000, P NATL ACAD SCI USA, V97, P7521, DOI 10.1073/pnas.97.13.7521; Pabst T, 2007, ONCOGENE, V26, P6829, DOI 10.1038/sj.onc.1210765; Somervaille TCP, 2006, CANCER CELL, V10, P257, DOI 10.1016/j.ccr.2006.08.020; Somervaille TCP, 2009, CELL STEM CELL, V4, P129, DOI 10.1016/j.stem.2008.11.015; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331	10	6	6	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					453	454		10.1016/j.stem.2009.10.008	http://dx.doi.org/10.1016/j.stem.2009.10.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896432	Bronze			2022-12-28	WOS:000272019500002
J	Woltjen, K; Stanford, WL				Woltjen, Knut; Stanford, William L.			Inhibition of Tgf-beta Signaling Improves Mouse Fibroblast Reprogramming	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; INDUCTION; OCT4; SOX2	Circumventing genomic modification in induced pluripotent stem cell (iPSC) derivation is a clear requirement to realize safe clinical applications. In this issue of Cell Stem Cell, Ichida et al., (2009) describe a small molecule capable of replacing Sox2, offering insight into the reprogramming process.	[Woltjen, Knut; Stanford, William L.] Ontario Human Induced Pluripotent Stem Cell Facil, Toronto, ON M5G 1L7, Canada; [Woltjen, Knut] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M53 3H7, Canada; [Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Stanford, William L.] Inst Syst Biol, Seattle, WA 98103 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; Institute for Systems Biology (ISB)	Woltjen, K (corresponding author), Ontario Human Induced Pluripotent Stem Cell Facil, Toronto, ON M5G 1L7, Canada.	woltjen@lunenfeld.ca; william.stanford@utoronto.ca		Stanford, William/0000-0002-5813-8016; Woltjen, Knut/0000-0003-2293-1183				Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; O'Malley J, 2009, CURR OPIN BIOTECH, V20, P516, DOI 10.1016/j.copbio.2009.09.005; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001	10	11	14	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					457	458		10.1016/j.stem.2009.10.007	http://dx.doi.org/10.1016/j.stem.2009.10.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896434	Bronze			2022-12-28	WOS:000272019500004
J	Mathews, DJH; Donovan, PJ; Harris, J; Lovell-Badge, R; Savulescu, J; Faden, R				Mathews, Debra J. H.; Donovan, Peter J.; Harris, John; Lovell-Badge, Robin; Savulescu, Julian; Faden, Ruth			Pluripotent Stem Cell-Derived Gametes: Truth and (Potential) Consequences	CELL STEM CELL			English	Editorial Material							GERM-CELLS; IN-VITRO; DERIVATION	An emerging body of data suggests that pluripotent stem cells may be able to differentiate to form eggs and sperm. We discuss the state of the science and the potential social implications and offer recommendations for addressing some of the ethical and policy issues that would be raised by the availability of stem cell-derived gametes.	[Mathews, Debra J. H.; Faden, Ruth] Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA; [Donovan, Peter J.] Univ Calif Irvine, Sue & Bill Gross Stem Cell Res Ctr, Irvine, CA 92697 USA; [Harris, John] Univ Manchester, Inst Sci Eth & Innovat, Manchester M13 9PL, Lancs, England; [Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Stem Cell Biol & Dev Genet, London NW7 1AA, England; [Savulescu, Julian] Univ Oxford, Oxford Uehiro Ctr Practical Eth, Oxford OX1 1PT, England	Johns Hopkins University; University of California System; University of California Irvine; University of Manchester; MRC National Institute for Medical Research; University of Oxford	Mathews, DJH (corresponding author), Johns Hopkins Univ, Berman Inst Bioeth, Baltimore, MD 21205 USA.	dmathews@jhmi.edu		Mathews, Debra/0000-0002-4897-7617; Lovell-Badge, Robin/0000-0001-9364-4179	Greenwall Foundation; Wellcome Trust; Biotechnology and Biological Sciences Research Council; British Embassy in Washington, DC; Medical Research Council; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	Greenwall Foundation; Wellcome Trust(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Embassy in Washington, DC; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was generously supported by funding from the Greenwall Foundation, the Wellcome Trust, the Biotechnology and Biological Sciences Research Council, the British Embassy in Washington, DC, and the Medical Research Council.	Allen VM, 2006, J OBSTET GYNAECOL CA, V28, P220, DOI 10.1016/S1701-2163(16)32112-0; Clark AT, 2004, HUM MOL GENET, V13, P727, DOI 10.1093/hmg/ddh088; Cohen J, 2005, HUM REPROD UPDATE, V11, P439, DOI 10.1093/humupd/dmi016; Devroey P, 2004, HUM REPROD UPDATE, V10, P19, DOI 10.1093/humupd/dmh004; Geijsen N, 2004, NATURE, V427, P148, DOI 10.1038/nature02247; Hubner K, 2003, SCIENCE, V300, P1251, DOI 10.1126/science.1083452; Kennedy D, 2006, SCIENCE, V314, P1353, DOI 10.1126/science.1137840; Mathews DJH, 2006, SCIENCE, V313, P921, DOI 10.1126/science.1127990; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Nayernia K, 2006, LAB INVEST, V86, P654, DOI 10.1038/labinvest.3700429; Novak I, 2006, STEM CELLS, V24, P1931, DOI 10.1634/stemcells.2005-0520; Park TS, 2009, STEM CELLS, V27, P783, DOI 10.1002/stem.13; Picton HM, 2008, REPRODUCTION, V136, P703, DOI 10.1530/REP-08-0290; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyooka Y, 2003, P NATL ACAD SCI USA, V100, P11457, DOI 10.1073/pnas.1932826100	15	40	40	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					11	14		10.1016/j.stem.2009.06.005	http://dx.doi.org/10.1016/j.stem.2009.06.005			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570509	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000267879200006
J	Pollard, SM; Yoshikawa, K; Clarke, ID; Danovi, D; Stricker, S; Russell, R; Bayani, J; Head, R; Lee, M; Bernstein, M; Squire, JA; Smith, A; Dirks, P				Pollard, Steven M.; Yoshikawa, Koichi; Clarke, Ian D.; Danovi, Davide; Stricker, Stefan; Russell, Roslin; Bayani, Jane; Head, Renee; Lee, Marco; Bernstein, Mark; Squire, Jeremy A.; Smith, Austin; Dirks, Peter			Glioma Stem Cell Lines Expanded in Adherent Culture Have Tumor-Specific Phenotypes and Are Suitable for Chemical and Genetic Screens	CELL STEM CELL			English	Article							CANCER; IDENTIFICATION; GLIOBLASTOMA; ASTROCYTES; DIFFERENTIATION; BIOLOGY	Human brain tumors appear to have a hierarchical cellular organization suggestive of a stern cell foundation. In vitro expansion of the putative cancer stem cells as stable cell lines would provide a powerful model system to study their biology. Here, we demonstrate routine and efficient derivation of adherent cell lines from malignant glioma that display stem cell properties and initiate high-grade gliomas following xenotransplantation. Significantly, glioma neural stem (GNS) cell lines from different tumors exhibit divergent gene expression signatures and differentiation behavior that correlate with specific neural progenitor subtypes. The diversity of gliomas may, therefore, reflect distinct cancer stem cell phenotypes. The purity and stability of adherent GNS cell lines offer significant advantages compared to "sphere" cultures, enabling refined studies of cancer stem cell behavior. A proof-of-principle live cell imaging-based chemical screen (450 FDA-approved drugs) identifies both differential sensitivities of GNS cells and a common susceptibility to perturbation of serotonin signaling.	[Pollard, Steven M.; Danovi, Davide; Stricker, Stefan; Russell, Roslin; Smith, Austin] Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Cambridge CB2 1QR, England; [Pollard, Steven M.; Danovi, Davide; Stricker, Stefan; Russell, Roslin; Smith, Austin] Univ Cambridge, Dept Biochem, Cambridge CB2 1QR, England; [Yoshikawa, Koichi; Clarke, Ian D.; Head, Renee; Dirks, Peter] Univ Toronto, Arthur & Sonia Labatt Brain Tumor Res Ctr, Program Dev & Stem Cell Biol, Hosp Sick Children, Toronto, ON M5G 1X8, Canada; [Lee, Marco] Western Gen Hosp, Div Clin Neurosci, Edinburgh EH4 2XU, Midlothian, Scotland; [Bayani, Jane] Univ Toronto, Dept Appl Mol Oncol, Ontario Canc Inst, Univ Hlth Network, Toronto, ON M5G 2M9, Canada; [Bernstein, Mark] Univ Toronto, Toronto Western Hosp, Div Neurosurg, Toronto, ON M5T 2S8, Canada; [Squire, Jeremy A.] Queens Univ, Dept Pathol & Mol Med, Kingston, ON K7L 3N6, Canada	University of Cambridge; University of Cambridge; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Edinburgh; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; McMaster University; Queens University - Canada	Pollard, SM (corresponding author), Univ Cambridge, Wellcome Trust Ctr Stem Cell Res, Tennis Court Rd, Cambridge CB2 1QR, England.	steve.pollard@cscr.cam.ac.uk; peter.dirks@sickkids.ca	Squire, Jeremy A/A-9352-2012; Stricker, Stefan/A-7410-2013; Squire, Jeremy A/F-4437-2012; Stricker, Stefan H/A-4930-2015; Danovi, Davide/P-2874-2019; Pollard, Steven/B-7966-2010	Squire, Jeremy A/0000-0002-9863-468X; Stricker, Stefan H/0000-0002-5488-8530; Danovi, Davide/0000-0003-4119-5337; Smith, Austin/0000-0002-3029-4682; Pollard, Steven/0000-0001-6428-0492	Biotechnology and Biological Sciences Research Council (BBSRC); Medical Research Council (MRC) of the United Kingdom; Cancer Research UK; EC Framework VI Integrated Project; Canadian Cancer Society; National Cancer Institute of Canada; Genome Canada and the Ontario Genomics Institute; Ontario Institute for Cancer Research; Jessica's Footprint Foundation; Canadian Institutes for Health Research; Canada's Stem Cell Network; Hospital for Sick Children Foundation; Kaye Fellowship; Beit Memorial Research; MRC [G9806702, G0800784] Funding Source: UKRI; Medical Research Council [G9806702, G0800784B, G0800784] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council (MRC) of the United Kingdom(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); EC Framework VI Integrated Project(European Commission); Canadian Cancer Society(Canadian Cancer Society (CCS)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Genome Canada and the Ontario Genomics Institute; Ontario Institute for Cancer Research; Jessica's Footprint Foundation; Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canada's Stem Cell Network; Hospital for Sick Children Foundation; Kaye Fellowship; Beit Memorial Research; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Kathreena Kurian for assistance with examination of histopathological sections and Gillian Morrison for helpful comments on the manuscript. Peter Humphries assisted with imaging. Rachael Walker performed the single-cell deposition. This work was supported by the Biotechnology and Biological Sciences Research Council (BBSRC), the Medical Research Council (MRC) of the United Kingdom, Cancer Research UK, and the EC Framework VI Integrated Project "EuroStem Cell" and STREP "Neuroscreen." The Dirks laboratory is supported by the Canadian Cancer Society and National Cancer Institute of Canada, Genome Canada and the Ontario Genomics Institute, the Ontario Institute for Cancer Research, Jessica's Footprint Foundation, the Canadian Institutes for Health Research, and Canada's Stem Cell Network, and the Hospital for Sick Children Foundation. S.P. is supported by a Kaye Fellowship (Christ's College, Cambridge) and is a Beit Memorial Research Fellow. A.S. is an MRC Professor. A patent relating to this study has been filed by the University of Edinburgh and University of Toronto. S.P., P.D., and A.S. conceived and initiated the study. S.P., I.C., and K.Y. designed, carried out, and interpreted experiments. M.L. and M.B. provided tumor samples. S.P. and I.C. derived all GNS cell lines. J.B. and J.A.S. performed and interpreted the molecular cytogenetic analyses. S.P. and D.D. carried out the drug screen, R.R. carried out microarray data analysis. S.P. wrote the paper, and P.D. and A.S. edited.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Diamandis P, 2007, NAT CHEM BIOL, V3, P268, DOI 10.1038/nchembio873; Dirks PB, 2001, J NEURO-ONCOL, V53, P203, DOI 10.1023/A:1012273922478; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; DOETSCHMAN TC, 1985, J EMBRYOL EXP MORPH, V87, P27; Furnari FB, 2007, GENE DEV, V21, P2683, DOI 10.1101/gad.1596707; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Glaser T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000298; Gunther HS, 2008, ONCOGENE, V27, P2897, DOI 10.1038/sj.onc.1210949; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Ignatova TN, 2002, GLIA, V39, P193, DOI 10.1002/glia.10094; Kleihues P, 2000, PATHOLOGY GENETICS T; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; LEVITT P, 1980, J COMP NEUROL, V193, P815, DOI 10.1002/cne.901930316; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Mischel PS, 2003, ONCOGENE, V22, P2361, DOI 10.1038/sj.onc.1206344; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Patrawala L, 2006, ONCOGENE, V25, P1696, DOI 10.1038/sj.onc.1209327; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Pollard SM, 2008, MOL CELL NEUROSCI, V38, P393, DOI 10.1016/j.mcn.2008.03.012; Pollard SM, 2006, CEREB CORTEX, V16, pI112, DOI 10.1093/cercor/bhj167; Prince ME, 2007, P NATL ACAD SCI USA, V104, P973, DOI 10.1073/pnas.0610117104; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Reynolds BA, 2005, NAT METHODS, V2, P333, DOI 10.1038/nmeth758; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Singec I, 2006, NAT METHODS, V3, P801, DOI 10.1038/nmeth926; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stiles CD, 2008, NEURON, V58, P832, DOI 10.1016/j.neuron.2008.05.031; Sun Y, 2008, MOL CELL NEUROSCI, V38, P245, DOI 10.1016/j.mcn.2008.02.014; Sun YR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005498; Suslov ON, 2002, P NATL ACAD SCI USA, V99, P14506, DOI 10.1073/pnas.212525299; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Ward RJ, 2007, ANNU REV PATHOL-MECH, V2, P175, DOI 10.1146/annurev.pathol.2.010506.091847; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	47	712	737	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					568	580		10.1016/j.stem.2009.03.014	http://dx.doi.org/10.1016/j.stem.2009.03.014			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497285	Bronze, Green Submitted			2022-12-28	WOS:000266793600019
J	Enver, T; Pera, M; Peterson, C; Andrews, PW				Enver, Tariq; Pera, Martin; Peterson, Carsten; Andrews, Peter W.			Stem Cell States, Fates, and the Rules of Attraction	CELL STEM CELL			English	Review							SELF-RENEWAL; REGULATORY NETWORKS; LINEAGE-COMMITMENT; DIFFERENTIATION; PLURIPOTENCY; EPIBLAST; NICHE; IDENTIFICATION; HETEROGENEITY; SPECIFICATION	Understanding cell-fate decisions in stem cell populations is a major goal of modern biology. Stem and progenitor cell populations are often heterogeneous, which may reflect stem cell subsets that express subtly different properties, including different propensities for lineage selection upon differentiation, yet remain able to interconvert. We discuss these properties with examples both from the hematopoietic and embryonic stem cell (ESC) systems. The nature of the stem cell substates and their relationship to commitment to differentiate and lineage selection can be elucidated in terms of a landscape picture in which stable states can be defined mathematically as attractors.	[Andrews, Peter W.] Univ Sheffield, Dept Biomed Sci, Sheffield S10 2TN, S Yorkshire, England; [Andrews, Peter W.] Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England; [Pera, Martin] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA; [Peterson, Carsten] Lund Univ, Lund Strateg Res Ctr Stem Cell Biol & Cell Therap, SE-22184 Lund, Sweden; [Enver, Tariq] Weatherall Inst Mol Med, Mol Haematol Unit, Oxford OX3 9DS, England; [Peterson, Carsten] Lund Univ, Dept Theoret Phys, SE-22362 Lund, Sweden	University of Sheffield; University of Sheffield; University of Southern California; Lund University; University of Oxford; Lund University	Andrews, PW (corresponding author), Univ Sheffield, Ctr Stem Cell Biol, Sheffield S10 2TN, S Yorkshire, England.	p.w.andrews@sheffield.ac.uk	PERA, MARTIN/A-9812-2012	PERA, MARTIN/0000-0001-6239-0428; Andrews, Peter/0000-0001-7215-4410	ESTOOLS; EuroSystem, European Union Sixth; Seventh Framework Programme Integrated Projects; Medical Research Council; Leukaemia Research Foundation; Yorkshire Cancer Research; Swedish Foundation for Strategic Research; Medical Research Council [G0700785, MC_U137973817] Funding Source: researchfish; MRC [MC_U137973817, G0700785] Funding Source: UKRI	ESTOOLS(European Commission); EuroSystem, European Union Sixth; Seventh Framework Programme Integrated Projects(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Research Foundation; Yorkshire Cancer Research; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by ESTOOLS and EuroSystem, European Union Sixth, and Seventh Framework Programme Integrated Projects, respectively. Additional support was provided by the Medical Research Council, the Leukaemia Research Foundation, and Yorkshire Cancer Research. C.P. was supported by a Senior Individual Grant from the Swedish Foundation for Strategic Research.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Andrews PW, 2002, PHILOS T R SOC B, V357, P405, DOI 10.1098/rstb.2002.1058; Bendall SC, 2007, NATURE, V448, P1015, DOI 10.1038/nature06027; Booth C, 2000, J CLIN INVEST, V105, P1493, DOI 10.1172/JCI10229; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Chickarmane V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003478; Chickarmane V, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000268; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Delassus S, 1999, BLOOD, V94, P1495, DOI 10.1182/blood.V94.5.1495.417a08_1495_1503; Dietrich JE, 2007, DEVELOPMENT, V134, P4219, DOI 10.1242/dev.003798; Draper JS, 2002, J ANAT, V200, P249, DOI 10.1046/j.1469-7580.2002.00030.x; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Enver T, 2005, HUM MOL GENET, V14, P3129, DOI 10.1093/hmg/ddi345; FENDERSON BA, 1987, DEV BIOL, V122, P21, DOI 10.1016/0012-1606(87)90328-9; Frontelo P, 2007, BLOOD, V110, P3871, DOI 10.1182/blood-2007-03-082065; Goodwin B.C, 1963, TEMPORAL ORG CELLS D; Gurdon JB, 2008, SCIENCE, V322, P1811, DOI 10.1126/science.1160810; HADORN E, 1968, SCI AM, V219, P110, DOI 10.1038/scientificamerican1168-110; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Heyworth C, 2002, EMBO J, V21, P3770, DOI 10.1093/emboj/cdf368; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Huang S, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.128701; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Humphrey RK, 2004, STEM CELLS, V22, P522, DOI 10.1634/stemcells.22-4-522; Jones PH, 2007, CELL STEM CELL, V1, P371, DOI 10.1016/j.stem.2007.09.014; Kauffman S.A., 1993, ORIGINS ORDER; KAUFFMAN SA, 1969, J THEOR BIOL, V22, P437, DOI 10.1016/0022-5193(69)90015-0; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslett AL, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-12; Lee TI, 2002, SCIENCE, V298, P799, DOI 10.1126/science.1075090; Loose M, 2004, DEV BIOL, V271, P467, DOI 10.1016/j.ydbio.2004.04.014; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Nakajima A, 2008, J THEOR BIOL, V253, P779, DOI 10.1016/j.jtbi.2008.04.007; Peerani R, 2007, EMBO J, V26, P4744, DOI 10.1038/sj.emboj.7601896; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rathjen J, 1999, J CELL SCI, V112, P601; Ravin R, 2008, CELL STEM CELL, V3, P670, DOI 10.1016/j.stem.2008.09.012; Roeder I, 2006, J THEOR BIOL, V241, P852, DOI 10.1016/j.jtbi.2006.01.021; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Slack JMW, 2007, NAT REV MOL CELL BIO, V8, P369, DOI 10.1038/nrm2146; Stewart MH, 2006, NAT METHODS, V3, P807, DOI 10.1038/nmeth939; Sumi T, 2004, STEM CELLS, V22, P861, DOI 10.1634/stemcells.22-5-861; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takaoka K, 2006, DEV CELL, V10, P451, DOI 10.1016/j.devcel.2006.02.017; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Waddington C., 1957, STRATEGY GENES; WRIGHT S, 1988, AM NAT, V131, P115, DOI 10.1086/284777; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	67	249	254	1	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					387	397		10.1016/j.stem.2009.04.011	http://dx.doi.org/10.1016/j.stem.2009.04.011			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427289	Bronze			2022-12-28	WOS:000266071100008
J	Fontana, S; Cohn, RD				Fontana, Stefani; Cohn, Ronald D.			SP-litting the Satellite Niche to Repopulate Muscle	CELL STEM CELL			English	Editorial Material							SELF-RENEWAL; STEM-CELLS	Multiple myogenic populations have been highlighted in past publications. In this issue of Cell Stem Cell, Tanaka et al. (2009) advance our understanding of the cells that contribute to muscle regeneration by identifying an ABCG2-expressing population that exhibits excellent engraftment potential, particularly within the satellite cell niche.	[Fontana, Stefani; Cohn, Ronald D.] Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Pediat & Neurol, Baltimore, MD 21205 USA	Johns Hopkins University	Cohn, RD (corresponding author), Johns Hopkins Univ, Sch Med, McKusick Nathans Inst Genet Med, Dept Pediat & Neurol, 733 N Broadway,BRB 529, Baltimore, MD 21205 USA.	rcohn2@jhmi.edu	Cohn, Ronald/AAC-5835-2021					Cerletti M, 2008, CELL, V134, P37, DOI 10.1016/j.cell.2008.05.049; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Tanaka KK, 2009, CELL STEM CELL, V4, P217, DOI 10.1016/j.stem.2009.01.016	8	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					194	195		10.1016/j.stem.2009.02.002	http://dx.doi.org/10.1016/j.stem.2009.02.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265654	Bronze			2022-12-28	WOS:000264369300005
J	Tothova, Z; Gilliland, DG				Tothova, Zuzana; Gilliland, D. Gary			A Radical Bailout Strategy for Cancer Stem Cells	CELL STEM CELL			English	Editorial Material							OXIDATIVE STRESS		[Tothova, Zuzana; Gilliland, D. Gary] Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA; [Tothova, Zuzana; Gilliland, D. Gary] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Tothova, Zuzana; Gilliland, D. Gary] Howard Hughes Med Inst, Boston, MA 02115 USA; [Tothova, Zuzana; Gilliland, D. Gary] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University	Tothova, Z (corresponding author), Brigham & Womens Hosp, Dept Med, Div Hematol, Boston, MA 02115 USA.	zuzana_tothova@hms.harvard.edu; ggilliland@rics.bwh.harvard.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Radisky DC, 2005, NATURE, V436, P123, DOI 10.1038/nature03688; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Veal EA, 2007, MOL CELL, V26, P1, DOI 10.1016/j.molcel.2007.03.016	9	16	17	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					196	197		10.1016/j.stem.2009.02.008	http://dx.doi.org/10.1016/j.stem.2009.02.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265655	Bronze			2022-12-28	WOS:000264369300006
J	Davy, P; Allsopp, R				Davy, Phil; Allsopp, Richard			Balancing Out the Ends during iPSC Nuclear Reprogramming	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS; TELOMERASE		[Davy, Phil; Allsopp, Richard] Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96813 USA	University of Hawaii System	Allsopp, R (corresponding author), Univ Hawaii, John A Burns Sch Med, Inst Biogenesis Res, Honolulu, HI 96813 USA.	allsopp@hawaii.edu						Allsopp RC, 2003, NAT MED, V9, P369, DOI 10.1038/nm0403-369; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012	10	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					95	96		10.1016/j.stem.2009.01.004	http://dx.doi.org/10.1016/j.stem.2009.01.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200794	Bronze			2022-12-28	WOS:000263213400001
J	Kiel, MJ; Acar, M; Radice, GL; Morrison, SJ				Kiel, Mark J.; Acar, Melih; Radice, Glenn L.; Morrison, Sean J.			Hematopoietic Stem Cells Do Not Depend on N-Cadherin to Regulate Their Maintenance	CELL STEM CELL			English	Article							SELF-RENEWAL; NICHES; QUIESCENCE; GENE	According to the "osteoblastic niche" model, hematopoietic stem cells (HSCs) are maintained by N-cadherin-mediated homophilic adhesion to osteoblasts at the bone marrow endosteum. In contrast to this model, we cannot detect N-cadherin expression by HSCs, and most HSCs do not localize to the endosteal surface. It has nonetheless been suggested that HSCs express low levels of N-cadherin that regulate HSC maintenance. To test this, we conditionally deleted N-cadherin from HSCs and other hernatopoietic cells in adult Mx-1-Cre(+)N-cadherin(fl/-) mice. N-cadherin deficiency had no detectable effect on HSC maintenance or hematopoiesis. N-cadherin deficiency did not affect bone marrow cellularity or lineage composition, the numbers of colony-forming progenitors, the frequency of HSCs, the ability of HSCs to sustain hematopoiesis over time, or their ability to reconstitute irradiated mice in primary or secondary transplants. Loss of N-cadherin does not lead to HSC depletion. N-cadherin expression by HSCs is not necessary for niche function.	[Kiel, Mark J.; Acar, Melih; Morrison, Sean J.] Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA; [Kiel, Mark J.; Acar, Melih; Morrison, Sean J.] Univ Michigan, Inst Life Sci, Ctr Stem Cell Biol, Ann Arbor, MI 48109 USA; [Radice, Glenn L.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Med, Ctr Translat Med, Philadelphia, PA 19107 USA	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Jefferson University	Morrison, SJ (corresponding author), Univ Michigan, Howard Hughes Med Inst, Dept Internal Med, Ann Arbor, MI 48109 USA.	seanjm@umich.edu	Morrison, Sean/ABD-5326-2021	Morrison, Sean/0000-0003-1587-8329	Howard Hughes Medical Institute; U.S. Army Research Office [DAAD19-03-1-0168]; University of Michigan (UM) Cancer Biology; UM-Comprehensive Cancer; NIH [CA46592]; Rheumatic Core Disease Center [P30 AR48310]; NATIONAL CANCER INSTITUTE [P30CA046592] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048310] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Army Research Office; University of Michigan (UM) Cancer Biology(University of Michigan System); UM-Comprehensive Cancer; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rheumatic Core Disease Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Howard Hughes Medical Institute and the U.S. Army Research Office (DAAD19-03-1-0168). M.J.K. was supported by a fellowship from the University of Michigan (UM) Cancer Biology program. Thanks to David Adams, Martin White, and the UM Flow-cytometry Core. Flow cytometry was supported in part by the UM-Comprehensive Cancer, NIH CA46592. Thanks to Elizabeth Smith (Hybridoma Core Facility) for antibody production, supported in part through the Rheumatic Core Disease Center (P30 AR48310). Author contributions: M.J.K. performed most experiments and participated in the design and interpretation of experiments. M.A. performed experiments in Figures S4C, S5C, and S7-S9 as well as one of the secondary transplantation experiments. G.L.R. provided N-cadhefin<SUP>fl/-</SUP> mice and commented on experiments to assess the specificity of MNCD2 antibody. S.J.M. participated in the design and interpretation of experiments and wrote the paper with M.J.K. and M.A.	Adams GB, 2006, NAT IMMUNOL, V7, P333, DOI 10.1038/ni1331; Adams GB, 2006, NATURE, V439, P599, DOI 10.1038/nature04247; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Cheng SL, 2000, J BONE MINER RES, V15, P2362, DOI 10.1359/jbmr.2000.15.12.2362; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Hooper AT, 2007, CELL STEM CELL, V1, P127, DOI 10.1016/j.stem.2007.07.012; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kadowaki M, 2007, DEV BIOL, V304, P22, DOI 10.1016/j.ydbio.2006.12.014; Kiel MJ, 2008, BLOOD, V111, P4413, DOI 10.1182/blood-2007-12-129601; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kiel MJ, 2007, NATURE, V449, P238, DOI 10.1038/nature06115; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kostetskii I, 2005, CIRC RES, V96, P346, DOI 10.1161/01.RES.0000156274.72390.2c; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Li JF, 2008, J MOL CELL CARDIOL, V44, P597, DOI 10.1016/j.yjmcc.2007.11.013; Luo Y, 2006, DEV BIOL, V299, P517, DOI 10.1016/j.ydbio.2006.09.003; Maillard I, 2008, CELL STEM CELL, V2, P356, DOI 10.1016/j.stem.2008.02.011; Mancini SJC, 2005, BLOOD, V105, P2340, DOI 10.1182/blood-2004-08-3207; Matsunami H, 1995, DEV BIOL, V172, P466, DOI 10.1006/dbio.1995.8029; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Radice GL, 1997, DEV BIOL, V181, P64, DOI 10.1006/dbio.1996.8443; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Suda T, 2005, TRENDS IMMUNOL, V26, P426, DOI 10.1016/j.it.2005.06.006; Sugiyama T, 2006, IMMUNITY, V25, P977, DOI 10.1016/j.immuni.2006.10.016; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	34	130	137	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					170	179		10.1016/j.stem.2008.10.005	http://dx.doi.org/10.1016/j.stem.2008.10.005			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19119091	Bronze, Green Accepted			2022-12-28	WOS:000263213400013
J	Trounson, A				Trounson, Alan			Rats, Cats, and Elephants, but Still No Unicorn: Induced Pluripotent Stem Cells from New Species	Cell Stem Cell			English	Editorial Material							NUCLEAR TRANSFER; GENERATION; LINES		Calif Inst Regenerat Med, San Francisco, CA 94107 USA		Trounson, A (corresponding author), Calif Inst Regenerat Med, San Francisco, CA 94107 USA.	atrounson@cirm.ca.gov		Trounson, Alan/0000-0001-5469-0500				Beyhan Z, 2007, CELL STEM CELL, V1, P502, DOI 10.1016/j.stem.2007.10.009; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Keefer CL, 2007, ANIM REPROD SCI, V98, P147, DOI 10.1016/j.anireprosci.2006.10.009; LI W, 2009, CELL STEM C IN PRESS, V4; LIAO J, 2009, CELL STEM C IN PRESS, V4; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Tecirlioglu RT, 2006, STEM CELL REV, V2, P277, DOI 10.1007/BF02698054; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Ueda S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002800	10	12	14	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					3	4		10.1016/j.stem.2008.12.002	http://dx.doi.org/10.1016/j.stem.2008.12.002			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19097957	Bronze			2022-12-28	WOS:000262559500002
J	Hedlund, E; Isacson, O				Hedlund, Eva; Isacson, Ole			ALS Model Glia Can Mediate Toxicity to Motor Neurons Derived from Human Embryonic Stem Cells	CELL STEM CELL			English	Editorial Material							AMYOTROPHIC-LATERAL-SCLEROSIS; TRANSGENIC MICE; DEATH	In this issue of Cell Stem Cell, Di Giorgio et al. (2008) and Marchetto et al. (2008) culture motor neurons derived from human embryonic stem cells with astrocytes expressing mutant SOD1. In these human ALS models, motor neurons are selectively destroyed by mutant astrocyte-secreted factors, and potential neuroprotective pathways are revealed.	[Hedlund, Eva] Karolinska Inst, Ludwig Inst Canc Res, Dept Cell & Mol Biol, S-17177 Stockholm, Sweden; [Isacson, Ole] Harvard Univ, Dept Neurol, Sch Med, Belmont, MA 02478 USA; [Isacson, Ole] Harvard Univ, Dept Psychiat, Sch Med, Belmont, MA 02478 USA; [Isacson, Ole] Harvard Univ, Ctr Neuroregenerat Res, Sch Med, McLean Hosp, Belmont, MA 02478 USA	Karolinska Institutet; Ludwig Institute for Cancer Research; Harvard University; Harvard University; Harvard University; McLean Hospital	Hedlund, E (corresponding author), Karolinska Inst, Ludwig Inst Canc Res, Dept Cell & Mol Biol, Nobelsv 3, S-17177 Stockholm, Sweden.	eva.hedlund@licr.ki.se; isacson@hms.harvard.edu		Hedlund, Eva/0000-0001-6347-0075; Isacson, Ole/0000-0001-8091-8302				Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Nishitoh H, 2008, GENE DEV, V22, P1451, DOI 10.1101/gad.1640108; Pehar M, 2004, J NEUROCHEM, V89, P464, DOI 10.1111/j.1471-4159.2004.02357.x; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155	9	18	18	2	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 4	2008	3	6					575	576		10.1016/j.stem.2008.11.004	http://dx.doi.org/10.1016/j.stem.2008.11.004			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	383JW	19041769	Bronze			2022-12-28	WOS:000261670900001
J	Graf, T; Stadtfeld, M				Graf, Thomas; Stadtfeld, Matthias			Heterogeneity of Embryonic and Adult Stem Cells	CELL STEM CELL			English	Review							LINEAGE-COMMITMENT; PROGENITOR CELLS; IN-VIVO; DIFFERENTIATION; STATES; IDENTIFICATION; PLURIPOTENCY; MAINTENANCE; NANOG; NOISE	New studies suggest that stem cells of embryonic, neural, and hematopoietic origin are heterogeneous, with cells moving between two or more metastable states. These cell states show a bias in their differentiation potential and correlate with specific patterns of transcription factor expression and chromatin modifications.	[Graf, Thomas] ICREA, Ctr Genom Regulat, Barcelona 08003, Spain; [Graf, Thomas] Pompeu Fabra Univ, Barcelona 08003, Spain; [Stadtfeld, Matthias] Ctr Regenerat Med, Boston, MA 02114 USA; [Stadtfeld, Matthias] Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Stadtfeld, Matthias] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); ICREA; Pompeu Fabra University; Harvard University; Massachusetts General Hospital; Harvard University	Graf, T (corresponding author), ICREA, Ctr Genom Regulat, Barcelona 08003, Spain.	thomas.graf@crg.es	Graf, Thomas/B-4252-2015	Graf, Thomas/0000-0003-2774-4117; Stadtfeld, Matthias/0000-0002-5852-9906	ICREA Funding Source: Custom	ICREA(ICREA)		Arias AM, 2006, NAT REV GENET, V7, P34, DOI 10.1038/nrg1750; Arinobu Y, 2007, CELL STEM CELL, V1, P416, DOI 10.1016/j.stem.2007.07.004; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chazaud C, 2006, DEV CELL, V10, P615, DOI 10.1016/j.devcel.2006.02.020; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; FAIRBAIRN LJ, 1993, CELL, V74, P823, DOI 10.1016/0092-8674(93)90462-Y; Graf T, 2002, BLOOD, V99, P3089, DOI 10.1182/blood.V99.9.3089; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Hayashi K, 2008, CELL STEM CELL, V3, P391, DOI 10.1016/j.stem.2008.07.027; Huang S, 2007, DEV BIOL, V305, P695, DOI 10.1016/j.ydbio.2007.02.036; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Miyamoto T, 2002, DEV CELL, V3, P137, DOI 10.1016/S1534-5807(02)00201-0; Nakamura T, 2007, NAT CELL BIOL, V9, P64, DOI 10.1038/ncb1519; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; Singh AM, 2007, STEM CELLS, V25, P2534, DOI 10.1634/stemcells.2007-0126; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	24	245	254	0	38	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					480	483		10.1016/j.stem.2008.10.007	http://dx.doi.org/10.1016/j.stem.2008.10.007			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983963	Bronze			2022-12-28	WOS:000260895100007
J	Kirouac, DC; Zandstra, PW				Kirouac, Daniel C.; Zandstra, Peter W.			The Systematic Production of Cells for Cell Therapies	CELL STEM CELL			English	Review							EMBRYONIC STEM-CELLS; UMBILICAL-CORD BLOOD; EX-VIVO EXPANSION; HEMATOPOIETIC PROGENITOR CELLS; SCID-REPOPULATING CELLS; LONG-TERM CULTURE; BONE-MARROW; SELF-RENEWAL; IN-VITRO; GENE-EXPRESSION	Stem cells have emerged as the starting material of choice for bioprocesses to produce cells and tissues to treat degenerative, genetic, and immunological disease. Translating the biological properties and potential of stem cells into therapies will require overcoming significant cell-manufacturing and regulatory challenges. Bioprocess engineering fundamentals, including bioreactor design and process control, need to be combined with cellular systems biology principles to guide the development of next-generation technologies capable of producing cell-based products in a safe, robust, and cost-effective manner. The step-wise implementation of these bioengineering strategies will enhance cell therapy product quality and safety, expediting clinical development.	[Kirouac, Daniel C.; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada; [Zandstra, Peter W.] Univ Toronto, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Zandstra, Peter W.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E1, Canada; [Zandstra, Peter W.] Univ Hlth Network, McEwen Ctr Regenerat Med, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1L7, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Zandstra, PW (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3E1, Canada.	peter.zandstra@utoronto.ca			Guggenheim Foundation; Canadian Stem Cell Network; NSERC; CIHR	Guggenheim Foundation; Canadian Stem Cell Network; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR))	Helpful discussion with many colleagues in both industry and academia is gratefully acknowledged. Support for this work was provided by the Guggenheim Foundation, the Canadian Stem Cell Network, NSERC, and the CIHR. D.K. is a NSERC PGS-D scholar and P.W.Z. is the Canada Research Chair in Stem Cell Bioengineering.	Alberti K, 2008, NAT METHODS, V5, P645, DOI 10.1038/nmeth.1222; Aldridge BB, 2006, NAT CELL BIOL, V8, P1195, DOI 10.1038/ncb1497; Audet J, 2002, BIOTECHNOL BIOENG, V80, P393, DOI 10.1002/bit.10399; Bailey JE, 1998, BIOTECHNOL PROGR, V14, P8, DOI 10.1021/bp9701269; Baksh D, 2005, BLOOD, V106, P3012, DOI 10.1182/blood-2005-01-0433; Baksh D, 2007, BIOTECHNOL BIOENG, V98, P1195, DOI 10.1002/bit.21556; Balducci E, 2003, STEM CELLS, V21, P33, DOI 10.1634/stemcells.21-1-33; Bauwens C, 2005, BIOTECHNOL BIOENG, V90, P452, DOI 10.1002/bit.20445; Becker T, 2007, ADV BIOCHEM ENG BIOT, V105, P249, DOI 10.1007/10_2006_036; BLACKETT NM, 1981, BLOOD CELLS, V7, P417; Blum B, 2008, ADV CANCER RES, V100, P133, DOI 10.1016/S0065-230X(08)00005-5; Boiron JM, 2006, TRANSFUSION, V46, P1934, DOI 10.1111/j.1537-2995.2006.01001.x; Bonnet D, 1999, BONE MARROW TRANSPL, V23, P203, DOI 10.1038/sj.bmt.1701564; Burger SR, 2003, CYTOTHERAPY, V5, P289, DOI 10.1080/14653240310002324; Butcher EC, 2005, NAT REV DRUG DISCOV, V4, P461, DOI 10.1038/nrd1754; Cameron CM, 2006, BIOTECHNOL BIOENG, V94, P938, DOI 10.1002/bit.20919; Carswell KS, 2000, BIOTECHNOL BIOENG, V68, P328, DOI 10.1002/(SICI)1097-0290(20000505)68:3<328::AID-BIT11>3.0.CO;2-V; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen SB, 2006, P NATL ACAD SCI USA, V103, P17266, DOI 10.1073/pnas.0608156103; Collins PC, 1998, BIOTECHNOL BIOENG, V59, P534, DOI 10.1002/(SICI)1097-0290(19980905)59:5<534::AID-BIT2>3.0.CO;2-B; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; Dang SM, 2004, STEM CELLS, V22, P275, DOI 10.1634/stemcells.22-3-275; Dang SM, 2002, BIOTECHNOL BIOENG, V78, P442, DOI 10.1002/bit.10220; Dang Stephen M, 2005, Methods Mol Biol, V290, P353; de Jong H, 2006, BRIEF BIOINFORM, V7, P354, DOI 10.1093/bib/bbl034; de Lima M, 2008, BONE MARROW TRANSPL, V41, P771, DOI 10.1038/sj.bmt.1705979; Deasy BM, 2003, STEM CELLS, V21, P536, DOI 10.1634/stemcells.21-5-536; Dennis JE, 2007, STEM CELLS, V25, P2575, DOI 10.1634/stemcells.2007-0204; Diao JP, 2008, BIOTECHNOL BIOENG, V100, P72, DOI 10.1002/bit.21751; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Dutton R.L., 2007, ADV TECHNOLOGIES BIO; Dykstra B, 2006, P NATL ACAD SCI USA, V103, P8185, DOI 10.1073/pnas.0602548103; EAVES CJ, 1992, BLOOD CELLS, V18, P301; Ezashi T, 2005, P NATL ACAD SCI USA, V102, P4783, DOI 10.1073/pnas.0501283102; Flaim CJ, 2005, NAT METHODS, V2, P119, DOI 10.1038/NMETH736; Fok EYL, 2005, STEM CELLS, V23, P1333, DOI 10.1634/stemcells.2005-0112; Food and Drug Administration, 1998, GUID IND GUID HUM SO; Gan OI, 1997, BLOOD, V90, P641, DOI 10.1182/blood.V90.2.641.641_641_650; Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V86, P493, DOI 10.1002/bit.20045; Gerecht-Nir S, 2004, BIOTECHNOL BIOENG, V88, P313, DOI 10.1002/bit.20248; Gilbertson JA, 2006, BIOTECHNOL BIOENG, V94, P783, DOI 10.1002/bit.20900; Gilmore GL, 2000, EXP HEMATOL, V28, P1297, DOI 10.1016/S0301-472X(00)00531-2; Glover CH, 2006, PLOS COMPUT BIOL, V2, P1463, DOI 10.1371/journal.pcbi.0020158; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gomez-Sjoberg R, 2007, ANAL CHEM, V79, P8557, DOI 10.1021/ac071311w; Goncalves R, 2006, BIOTECHNOL LETT, V28, P335, DOI 10.1007/s10529-005-5932-2; Grayson WL, 2007, BIOCHEM BIOPH RES CO, V358, P948, DOI 10.1016/j.bbrc.2007.05.054; Greco D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001880; Griffith LG, 2006, NAT REV MOL CELL BIO, V7, P211, DOI 10.1038/nrm1858; Gundry RL, 2008, PROTEOM CLIN APPL, V2, P892, DOI 10.1002/prca.200780122; Halme DG, 2006, NEW ENGL J MED, V355, P1730, DOI 10.1056/NEJMhpr063086; HENNEY A, 2008, 9 INT C SYST BIOL GO; Hentze H, 2007, TRENDS BIOTECHNOL, V25, P24, DOI 10.1016/j.tibtech.2006.10.010; Horn PA, 2003, BLOOD, V102, P4329, DOI 10.1182/blood-2003-01-0082; ICH, 2005, ICH HARM TRIP GUID Q; INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE (ICH), 2004, ICH HARM TRIP GUID Q; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Jamshidi N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.8; Jansen EM, 2007, TRANSFUSION, V47, P817, DOI 10.1111/j.1537-2995.2007.01195.x; Jaroscak J, 2003, BLOOD, V101, P5061, DOI 10.1182/blood-2001-12-0290; Jiang YH, 2002, EXP HEMATOL, V30, P896, DOI 10.1016/S0301-472X(02)00869-X; Joshi C, 2003, CURR OPIN HEMATOL, V10, P220, DOI 10.1097/00062752-200305000-00005; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; King JA, 2007, CURR OPIN CHEM BIOL, V11, P394, DOI 10.1016/j.cbpa.2007.05.034; Kirouac DC, 2006, CURR OPIN BIOTECH, V17, P538, DOI 10.1016/j.copbio.2006.07.003; Klein-Marcuschamer D, 2008, P NATL ACAD SCI USA, V105, P2319, DOI 10.1073/pnas.0712177105; Kluger Y, 2004, P NATL ACAD SCI USA, V101, P6508, DOI 10.1073/pnas.0401136101; Koller M R, 1995, J Hematother, V4, P159, DOI 10.1089/scd.1.1995.4.159; KOLLER MR, 1992, EXP HEMATOL, V20, P264; Kourti T, 2006, ANAL BIOANAL CHEM, V384, P1043, DOI 10.1007/s00216-006-0303-y; Kumar D, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100197; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; LAIPDOT T, 1994, NATURE, V367, P645; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lambert JF, 2003, J EXP MED, V197, P1563, DOI 10.1084/jem.20030031; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lu SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r240; Lutolf MR, 2003, NAT BIOTECHNOL, V21, P513, DOI 10.1038/nbt818; Ma HW, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100177; Mackin W, 2001, CANCER J, V7, pS95; Madlambayan GJ, 2006, BIOL BLOOD MARROW TR, V12, P1020, DOI 10.1016/j.bbmt.2006.07.005; Madlambayan GJ, 2005, EXP HEMATOL, V33, P1229, DOI 10.1016/j.exphem.2005.05.018; Mahdavi A, 2007, PLOS COMPUT BIOL, V3, P1257, DOI 10.1371/journal.pcbi.0030130; Mansbridge J, 2006, J ANAT, V209, P527, DOI 10.1111/j.1469-7580.2006.00631.x; Mikos AG, 2006, TISSUE ENG, V12, P3307, DOI 10.1089/ten.2006.12.3307; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Natsoulis G, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.9; Parson AB, 2008, CELL, V132, P511, DOI 10.1016/j.cell.2008.02.004; Peng CA, 1996, BIOTECHNOL BIOENG, V52, P24, DOI 10.1002/(SICI)1097-0290(19961005)52:1<24::AID-BIT3>3.0.CO;2-0; Prudhomme W, 2004, P NATL ACAD SCI USA, V101, P2900, DOI 10.1073/pnas.0308768101; Purpura KA, 2008, STEM CELLS, V26, P2832, DOI 10.1634/stemcells.2008-0237; Rao M, 2008, GENE THER, V15, P82, DOI 10.1038/sj.gt.3303061; Rocci A, 2007, EXP HEMATOL, V35, P673, DOI 10.1016/j.exphem.2006.12.006; Sands RW, 2007, CURR OPIN BIOTECH, V18, P448, DOI 10.1016/j.copbio.2007.10.004; SAVAGEAU MA, 1971, NATURE, V229, P542, DOI 10.1038/229542a0; Schroeder M, 2005, BIOTECHNOL BIOENG, V92, P920, DOI 10.1002/bit.20668; Shpall EJ, 2002, BIOL BLOOD MARROW TR, V8, P368, DOI 10.1053/bbmt.2002.v8.pm12171483; Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Sud D, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2355665; Tang YJ, 2007, BIOTECHNOL PROGR, V23, P255, DOI 10.1021/bp060299a; Terakura S, 2007, BIOL BLOOD MARROW TR, V13, P822, DOI 10.1016/j.bbmt.2007.03.006; Terstegge S, 2007, BIOTECHNOL BIOENG, V96, P195, DOI 10.1002/bit.21061; THOMAS ED, 1957, NEW ENGL J MED, V257, P491, DOI 10.1056/NEJM195709122571102; Tran CA, 2007, J IMMUNOTHER, V30, P644, DOI 10.1097/CJI.0b013e318052e1f4; Ungrin MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001565; US Food & Drug Administration, 2004, GUID IND PAT FRAM IN; van Riel NAW, 2006, BRIEF BIOINFORM, V7, P364, DOI 10.1093/bib/bbl040; VARMA A, 1992, EXP HEMATOL, V20, P87; VERFAILLIE CM, 1992, BLOOD, V79, P2821; Viswanathan S, 2003, CYTOTECHNOLOGY, V41, P75, DOI 10.1023/A:1024866504538; Wagner W, 2004, BLOOD, V104, P675, DOI 10.1182/blood-2003-10-3423; Weber DJ, 2006, METHOD ENZYMOL, V420, P410, DOI 10.1016/S0076-6879(06)20020-X; WICHMANN HE, 1984, INT J CELL CLONING, V2, P408, DOI 10.1002/stem.5530020608; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Woo KS, 2007, CYTOTHERAPY, V9, P555, DOI 10.1080/14653240701561337; Xu RL, 2000, TRANSFUSION, V40, P1299, DOI 10.1046/j.1537-2995.2000.40111299.x; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yang ST, 2008, CURR OPIN DRUG DISC, V11, P111; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338; Zandstra PW, 2000, BLOOD, V96, P1215, DOI 10.1182/blood.V96.4.1215.h8001215_1215_1222; Zandstra PW, 2003, TISSUE ENG, V9, P767, DOI 10.1089/107632703768247449; Zandstra PW, 1998, BRIT J HAEMATOL, V101, P770; ZANDSTRA PW, 1994, BIO-TECHNOL, V12, P909, DOI 10.1038/nbt0994-909; Zandstra PW, 1997, P NATL ACAD SCI USA, V94, P4698, DOI 10.1073/pnas.94.9.4698; Zhang XB, 2008, J CLIN INVEST, V118, P1502, DOI 10.1172/JCI34371; Zhang XW, 2001, CELL PROLIFERAT, V34, P321, DOI 10.1046/j.0960-7722.2001.00210.x; Zhao F, 2005, BIOTECHNOL BIOENG, V91, P482, DOI 10.1002/bit.20532; ZHOU Q, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07314; Zilliox MJ, 2007, NAT METHODS, V4, P911, DOI 10.1038/NMETH1102	135	214	218	0	36	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					369	381		10.1016/j.stem.2008.09.001	http://dx.doi.org/10.1016/j.stem.2008.09.001			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940729	Bronze			2022-12-28	WOS:000260149800008
J	Ferreira, L; Karp, JM; Nobre, L; Langer, R				Ferreira, Lino; Karp, Jeffrey M.; Nobre, Luis; Langer, Robert			New opportunities: The use of Nanotechnologies to manipulate and track stem cells	CELL STEM CELL			English	Review							MAGNETIC-RESONANCE TRACKING; CONJUGATED QUANTUM DOTS; IN-VIVO TRACKING; CARBON NANOTUBES; OSTEOGENIC DIFFERENTIATION; PROGENITOR CELLS; GENE-EXPRESSION; PALMITIC ACID; E-CADHERIN; DELIVERY	Nanotechnologies are emerging platforms that could be useful in measuring, understanding, and manipulating stem cells. Examples include magnetic nanoparticles and quantum dots for stem cell labeling and in vivo tracking; nanoparticles, carbon nanotubes, and polyplexes for the intracellular delivery of genes/oligonucleotides and protein/peptides; and engineered nanometer-scale scaffolds for stem cell differentiation and transplantation. This review examines the use of nanotechnologies for stem cell tracking, differentiation, and transplantation. We further discuss their utility and the potential concerns regarding their cytotoxicity.	[Ferreira, Lino; Nobre, Luis] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal; [Ferreira, Lino; Nobre, Luis] Biotechnol Innovat Ctr, Biocant Ctr, P-3060197 Cantanhede, Portugal; [Karp, Jeffrey M.] MIT, Harvard MIT Div Hlth Sci & Technol, Cambridge, MA 02139 USA; [Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA; [Karp, Jeffrey M.] Harvard Univ, Sch Med, HST Ctr Biomed Engn, Brigham & Womens Hosp, Cambridge, MA 02139 USA	Universidade de Coimbra; Harvard University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Harvard University; Brigham & Women's Hospital	Ferreira, L (corresponding author), Univ Coimbra, Ctr Neurosci & Cell Biol, P-3004517 Coimbra, Portugal.	lino@biocant.pt; rlanger@mit.edu		ferreira, lino/0000-0001-8985-9302	MIT-Portugal program (focus in bioengineering); Crioestaminal; NIH [HL060435]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060435] Funding Source: NIH RePORTER	MIT-Portugal program (focus in bioengineering); Crioestaminal; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the MIT-Portugal program (focus in bioengineering), Crioestaminal, and NIH grant HL060435.	Ahrens ET, 2005, NAT BIOTECHNOL, V23, P983, DOI 10.1038/nbt1121; Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; Allport JR, 2001, EXP HEMATOL, V29, P1237, DOI 10.1016/S0301-472X(01)00739-1; Aluigi M, 2006, STEM CELLS, V24, P454, DOI 10.1634/stemcells.2005-0198; Arai T, 2006, MAGN RESON MED, V55, P203, DOI 10.1002/mrm.20702; Arbab AS, 2006, STEM CELLS, V24, P671, DOI 10.1634/stemcells.2005-0017; Arbab AS, 2004, BLOOD, V104, P1217, DOI 10.1182/blood-2004-02-0655; Bettinger CJ, 2008, ADV MATER, V20, P99, DOI 10.1002/adma.200702487; Bianco A, 2005, CURR OPIN CHEM BIOL, V9, P674, DOI 10.1016/j.cbpa.2005.10.005; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; BRUNS RR, 1976, J CELL BIOL, V68, P521, DOI 10.1083/jcb.68.3.521; Bulte JWM, 2001, NAT BIOTECHNOL, V19, P1141, DOI 10.1038/nbt1201-1141; Bulte JWM, 2005, NAT BIOTECHNOL, V23, P945, DOI 10.1038/nbt0805-945; Bulte JWM, 2004, BLOOD, V104, P3410, DOI 10.1182/blood-2004-06-2117; Cao F, 2006, CIRCULATION, V113, P1005, DOI 10.1161/CIRCULATIONAHA.105.588954; Chakraborty SK, 2007, NANO LETT, V7, P2618, DOI 10.1021/nl0709930; Chan WCW, 1998, SCIENCE, V281, P2016, DOI 10.1126/science.281.5385.2016; Chang E, 2006, SMALL, V2, P1412, DOI 10.1002/smll.200600218; Chen HF, 2007, BIOPHYS J, V92, P1399, DOI 10.1529/biophysj.106.094896; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Clements BA, 2007, BIOMATERIALS, V28, P4693, DOI 10.1016/j.biomaterials.2007.07.023; Clements MO, 2006, TISSUE ENG, V12, P1741, DOI 10.1089/ten.2006.12.1741; Corsi K, 2003, BIOMATERIALS, V24, P1255, DOI 10.1016/S0142-9612(02)00507-0; Curtis A, 2001, TRENDS BIOTECHNOL, V19, P97, DOI 10.1016/S0167-7799(00)01536-5; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; Dalby MJ, 2006, BIOMATERIALS, V27, P1306, DOI 10.1016/j.biomaterials.2005.08.028; Dang JM, 2007, ADV MATER, V19, P2775, DOI 10.1002/adma.200602159; Derda R, 2007, ACS CHEM BIOL, V2, P347, DOI 10.1021/cb700032u; Derfus AM, 2004, NANO LETT, V4, P11, DOI 10.1021/nl0347334; Duan YY, 2007, STEM CELLS, V25, P3058, DOI 10.1634/stemcells.2007-0291; Dubertret B, 2002, SCIENCE, V298, P1759, DOI 10.1126/science.1077194; Dzenis Y, 2004, SCIENCE, V304, P1917, DOI 10.1126/science.1099074; Ferreira L, 2008, ADV MATER, V20, P2285, DOI 10.1002/adma.200702404; Geissler M, 2004, ADV MATER, V16, P1249, DOI 10.1002/adma.200400835; Gerecht S, 2007, BIOMATERIALS, V28, P4068, DOI 10.1016/j.biomaterials.2007.05.027; Glover DJ, 2005, NAT REV GENET, V6, P299, DOI 10.1038/nrg1577; Gropp M, 2006, METHOD ENZYMOL, V420, P64, DOI 10.1016/S0076-6879(06)20005-3; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Hashi CK, 2007, P NATL ACAD SCI USA, V104, P11915, DOI 10.1073/pnas.0704581104; Helmus M, 2007, NAT NANOTECHNOL, V2, P333, DOI 10.1038/nnano.2007.165; Heyn C, 2005, MAGN RESON MED, V53, P312, DOI 10.1002/mrm.20356; Hoehn M, 2002, P NATL ACAD SCI USA, V99, P16267, DOI 10.1073/pnas.242435499; Hoepken HH, 2004, J NEUROCHEM, V88, P1194, DOI 10.1046/j.1471-4159.2003.02236.x; Hough SR, 2006, STEM CELLS, V24, P1467, DOI 10.1634/stemcells.2005-0475; Hsiao JK, 2007, MAGN RESON MED, V58, P717, DOI 10.1002/mrm.21377; Hsieh SC, 2006, BIOMATERIALS, V27, P1656, DOI 10.1016/j.biomaterials.2005.09.004; Hsieh SC, 2006, J BIOMED MATER RES B, V79B, P95, DOI 10.1002/jbm.b.30517; Huang DM, 2005, FASEB J, V19, P2014, DOI 10.1096/fj.05-4288fje; Incani V, 2007, J BIOMED MATER RES A, V81A, P493, DOI 10.1002/jbm.a.31249; Jan E, 2007, NANO LETT, V7, P1123, DOI 10.1021/nl0620132; Joshi A, 2008, NAT NANOTECHNOL, V3, P41, DOI 10.1038/nnano.2007.386; Kim W, 2007, J AM CHEM SOC, V129, P7228, DOI 10.1021/ja071456k; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Kraitchman DL, 2005, CIRCULATION, V112, P1451, DOI 10.1161/CIRCULATIONAHA.105.537480; Kutsuzawa K, 2008, BIOMATERIALS, V29, P370, DOI 10.1016/j.biomaterials.2007.09.011; Kutsuzawa K, 2006, BIOCHEM BIOPH RES CO, V350, P514, DOI 10.1016/j.bbrc.2006.09.081; Laflamme MA, 2005, NAT BIOTECHNOL, V23, P845, DOI 10.1038/nbt1117; Lakshmipathy U, 2004, STEM CELLS, V22, P531, DOI 10.1634/stemcells.22-4-531; Lei Y, 2008, BIOCONJUGATE CHEM, V19, P421, DOI 10.1021/bc0700685; Lewin M, 2000, NAT BIOTECHNOL, V18, P410, DOI 10.1038/74464; Li WJ, 2005, BIOMATERIALS, V26, P599, DOI 10.1016/j.biomaterials.2004.03.005; LI WJ, 2008, TISSUE EN A IN PRESS; Lin S, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-67; Lipski AM, 2007, ADV MATER, V19, P553, DOI 10.1002/adma.200502617; Lovric J, 2005, CHEM BIOL, V12, P1227, DOI 10.1016/j.chembiol.2005.09.008; Lovric J, 2005, J MOL MED, V83, P377, DOI 10.1007/s00109-004-0629-x; Lu CW, 2007, NANO LETT, V7, P149, DOI 10.1021/nl0624263; Magrez A, 2006, NANO LETT, V6, P1121, DOI 10.1021/nl060162e; Meinel L, 2006, BIOMATERIALS, V27, P4993, DOI 10.1016/j.biomaterials.2006.05.021; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Moghimi SM, 2005, FASEB J, V19, P311, DOI 10.1096/fj.04-2747rev; Mooney DJ, 2008, CELL STEM CELL, V2, P205, DOI 10.1016/j.stem.2008.02.005; Murugan R, 2007, TISSUE ENG, V13, P1845, DOI 10.1089/ten.2006.0078; Muschler GE, 2004, J BONE JOINT SURG AM, V86A, P1541, DOI 10.2106/00004623-200407000-00029; Norman J, 2006, ANN BIOMED ENG, V34, P89, DOI 10.1007/s10439-005-9005-4; Nur-E-Kamal A, 2006, STEM CELLS, V24, P426, DOI 10.1634/stemcells.2005-0170; Pack DW, 2005, NAT REV DRUG DISCOV, V4, P581, DOI 10.1038/nrd1775; Park J, 2007, NANO LETT, V7, P1686, DOI 10.1021/nl070678d; Popat KC, 2007, J BIOMED MATER RES A, V80A, P955, DOI 10.1002/jbm.a.31028; Reimer P, 2003, EUR RADIOL, V13, P1266, DOI 10.1007/s00330-002-1721-7; Rikans LE, 2000, J BIOCHEM MOL TOXIC, V14, P110, DOI 10.1002/(SICI)1099-0461(2000)14:2<110::AID-JBT7>3.0.CO;2-J; Rota M, 2007, P NATL ACAD SCI USA, V104, P17783, DOI 10.1073/pnas.0706406104; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; Seleverstov O, 2006, NANO LETT, V6, P2826, DOI 10.1021/nl0619711; Shah LS, 2007, NANO LETT, V7, P3071, DOI 10.1021/nl071547f; Shih YRV, 2006, STEM CELLS, V24, P2391, DOI 10.1634/stemcells.2006-0253; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Slotkin JR, 2007, DEV DYNAM, V236, P3393, DOI 10.1002/dvdy.21235; Sniadecki N, 2006, ANN BIOMED ENG, V34, P59, DOI 10.1007/s10439-005-9006-3; Song YS, 2007, NEUROUROL URODYNAM, V26, P584, DOI 10.1002/nau.20351; Stroh A, 2005, NEUROIMAGE, V24, P635, DOI 10.1016/j.neuroimage.2004.09.014; Sykova E, 2005, ANN NY ACAD SCI, V1049, P146, DOI 10.1196/annals.1334.014; Tran DN, 2007, FERTIL STERIL, V87, P965, DOI 10.1016/j.fertnstert.2006.07.1520; Walczak P, 2005, MAGN RESON MED, V54, P769, DOI 10.1002/mrm.20701; Wang FH, 2006, NANOTECHNOLOGY, V17, P1911, DOI 10.1088/0957-4484/17/8/018; Wang YXJ, 2001, EUR RADIOL, V11, P2319, DOI 10.1007/s003300100908; Wilson CJ, 2005, TISSUE ENG, V11, P1, DOI 10.1089/ten.2005.11.1; Yang F, 2005, BIOMATERIALS, V26, P2603, DOI 10.1016/j.biomaterials.2004.06.051; YEH TC, 1993, MAGN RESON MED, V30, P617, DOI 10.1002/mrm.1910300513; Zhu JH, 2006, NEW ENGL J MED, V355, P2376, DOI 10.1056/NEJMc055304; Zhu L, 2007, NANO LETT, V7, P3592, DOI 10.1021/nl071303v; Zwaka TP, 2003, NAT BIOTECHNOL, V21, P319, DOI 10.1038/nbt788	103	223	234	2	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					136	146		10.1016/j.stem.2008.07.020	http://dx.doi.org/10.1016/j.stem.2008.07.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682237	Bronze			2022-12-28	WOS:000258523300008
J	Golebiewska, A; Brons, NHC; Bjerkvig, R; Niclou, SP				Golebiewska, Anna; Brons, Nicolaas H. C.; Bjerkvig, Rolf; Niclou, Simone P.			Critical Appraisal of the Side Population Assay in Stem Cell and Cancer Stem Cell Research	CELL STEM CELL			English	Review							DRUG EFFLUX TRANSPORTERS; BLOOD-BRAIN-BARRIER; P-GLYCOPROTEIN; BONE-MARROW; NEURAL STEM; IN-VIVO; RESISTANCE PROTEIN; ABCG2 EXPRESSION; MOUSE MODEL; DYE EFFLUX	The "Side Population" (SP) discrimination assay is a flow cytometry method used to detect stem cells based on the dye efflux properties of ABC transporters. We discuss the SP assay and its applications in stem cell biology, with an emphasis on the technical challenges related to sample preparation, data acquisition, analysis, and interpretation. We highlight the value of multicolor phenotyping, the impact of DNA ploidy, and the importance of distinguishing graft versus host cells for an appropriate SP discrimination. To improve the consistency and reliability of data between laboratories, we propose a set of recommendations for SP assay data reporting.	[Golebiewska, Anna; Bjerkvig, Rolf; Niclou, Simone P.] Ctr Rech Publ Sante, Dept Oncol, NorLux Neurooncol Lab, L-1526 Luxembourg, Luxembourg; [Brons, Nicolaas H. C.] Ctr Rech Publ Sante, Core Facil Flow Cytometry, L-1526 Luxembourg, Luxembourg; [Bjerkvig, Rolf] Univ Bergen, Dept Biomed, N-5009 N Bergen, Norway	Luxembourg Institute of Health; Luxembourg Institute of Health; University of Bergen	Niclou, SP (corresponding author), Ctr Rech Publ Sante, Dept Oncol, NorLux Neurooncol Lab, 84 Val Fleuri, L-1526 Luxembourg, Luxembourg.	simone.niclou@crp-sante.lu	Niclou, Simone/P-2304-2018; Golebiewska, Anna/E-1332-2015	Niclou, Simone/0000-0002-3417-9534; Golebiewska, Anna/0000-0002-4160-2521				Adamski D, 2007, FEBS LETT, V581, P3076, DOI 10.1016/j.febslet.2007.05.073; Alexander CM, 2009, CELL STEM CELL, V5, P579, DOI 10.1016/j.stem.2009.11.008; ARNDTJOVIN DJ, 1977, J HISTOCHEM CYTOCHEM, V25, P585, DOI 10.1177/25.7.70450; Asakura A, 2002, J CELL BIOL, V159, P123, DOI 10.1083/jcb.200202092; Bjerkvig R, 2009, SEMIN CANCER BIOL, V19, P279, DOI 10.1016/j.semcancer.2009.09.001; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Camargo FD, 2006, BLOOD, V107, P501, DOI 10.1182/blood-2005-02-0655; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005-0116; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Choo EF, 2000, DRUG METAB DISPOS, V28, P655; Chua C, 2008, J NEUROSURG, V109, P856, DOI 10.3171/JNS/2008/109/11/0856; Clark MJ, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000832; Clayton H, 2004, EXP CELL RES, V297, P444, DOI 10.1016/j.yexcr.2004.03.029; COMPTON MM, 1992, CANCER METAST REV, V11, P105, DOI 10.1007/BF00048058; Cooray HC, 2002, NEUROREPORT, V13, P2059, DOI 10.1097/00001756-200211150-00014; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Falciatori I, 2003, FASEB J, V17, P376, DOI 10.1096/fj.03-0744fje; Fromm MF, 2000, INT J CLIN PHARM TH, V38, P69; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Goodell Margaret A, 2005, Methods Mol Biol, V290, P343; Goodell Margaret A, 2005, Curr Protoc Cytom, VChapter 9, DOI 10.1002/0471142956.cy0918s34; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Haraguchi N, 2006, STEM CELLS, V24, P506, DOI 10.1634/stemcells.2005-0282; Harris MA, 2008, CANCER RES, V68, P10051, DOI 10.1158/0008-5472.CAN-08-0786; Hirschmann-Jax C, 2004, P NATL ACAD SCI USA, V101, P14228, DOI 10.1073/pnas.0400067101; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hori S, 2004, J NEUROCHEM, V90, P526, DOI 10.1111/j.1471-4159.2004.02537.x; Iwatani H, 2004, KIDNEY INT, V65, P1604, DOI 10.1111/j.1523-1755.2004.00561.x; Kim M, 2003, J NEUROSCI, V23, P10703; LALANDE ME, 1979, J HISTOCHEM CYTOCHEM, V27, P394, DOI 10.1177/27.1.86569; Lankas GR, 1998, REPROD TOXICOL, V12, P457, DOI 10.1016/S0890-6238(98)00027-6; Lassalle B, 2004, DEVELOPMENT, V131, P479, DOI 10.1242/dev.00918; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; LI CL, 1992, J EXP MED, V175, P1443, DOI 10.1084/jem.175.6.1443; Lin KK, 2006, METHOD ENZYMOL, V420, P255, DOI 10.1016/S0076-6879(06)20011-9; Ling V, 1995, AM J MED, V99, pS31, DOI 10.1016/S0002-9343(99)80283-6; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Loscher Wolfgang, 2005, NeuroRx, V2, P86, DOI 10.1007/BF03206645; Mayer U, 1996, BRIT J PHARMACOL, V119, P1038, DOI 10.1111/j.1476-5381.1996.tb15775.x; MCALISTER I, 1990, BLOOD, V75, P1240; Mitsutake N, 2007, ENDOCRINOLOGY, V148, P1797, DOI 10.1210/en.2006-1553; Montanaro F, 2004, EXP CELL RES, V298, P144, DOI 10.1016/j.yexcr.2004.04.010; Mouthon MA, 2006, J NEUROCHEM, V99, P807, DOI 10.1111/j.1471-4159.2006.04118.x; Niclou SP, 2008, FASEB J, V22, P3120, DOI 10.1096/fj.08-109611; Orford M, 2009, BIOCHEM BIOPH RES CO, V384, P199, DOI 10.1016/j.bbrc.2009.04.089; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Petriz J., 2007, CURR PROTOC CYTOM, V23; Potschka H, 2001, EPILEPSIA, V42, P1231, DOI 10.1046/j.1528-1157.2001.01901.x; Rabindran SK, 2000, CANCER RES, V60, P47; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Schinkel AH, 2003, ADV DRUG DELIVER REV, V55, P3, DOI 10.1016/S0169-409X(02)00169-2; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Segal MB, 2000, CELL MOL NEUROBIOL, V20, P183, DOI 10.1023/A:1007045605751; Shimano K, 2003, AM J PATHOL, V163, P3, DOI 10.1016/S0002-9440(10)63624-3; Smit JW, 1998, BRIT J PHARMACOL, V124, P416, DOI 10.1038/sj.bjp.0701845; Storms RW, 2000, BLOOD, V96, P2125; Summer R, 2003, AM J PHYSIOL-LUNG C, V285, pL97, DOI 10.1152/ajplung.00009.2003; Summer R, 2004, AM J PHYSIOL-LUNG C, V287, pL477, DOI 10.1152/ajplung.00020.2004; Sun HY, 2003, ADV DRUG DELIVER REV, V55, P83, DOI 10.1016/S0169-409X(02)00172-2; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Tavaluc RT, 2007, CELL CYCLE, V6, P2554, DOI 10.4161/cc.6.20.4911; Telford WG, 2004, CYTOM PART A, V57A, P45, DOI 10.1002/cyto.a.10109; Telford WG, 2007, STEM CELLS, V25, P1029, DOI 10.1634/stemcells.2006-0567; Terunuma A, 2003, J INVEST DERMATOL, V121, P1095, DOI 10.1046/j.1523-1747.2003.12531.x; Triel C, 2004, EXP CELL RES, V295, P79, DOI 10.1016/j.yexcr.2003.11.032; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wan F, 2010, BRAIN PATHOL, V20, P877, DOI 10.1111/j.1750-3639.2010.00379.x; WOLF NS, 1993, EXP HEMATOL, V21, P614; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Wu CL, 2007, CANCER RES, V67, P8216, DOI 10.1158/0008-5472.CAN-07-0999; Wulf GG, 2003, HAEMATOLOGICA, V88, P368; Yin LQ, 2008, CANCER RES, V68, P800, DOI 10.1158/0008-5472.CAN-07-2545; Zeng H, 2009, STEM CELLS, V27, P2435, DOI 10.1002/stem.192; Zhang WD, 2003, FASEB J, V17, P2085, DOI 10.1096/fj.02-1131fje; Zheng XS, 2007, CANCER RES, V67, P3691, DOI 10.1158/0008-5472.CAN-06-3912; Zhou JB, 2007, P NATL ACAD SCI USA, V104, P16158, DOI 10.1073/pnas.0702596104; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028; Ziu M, 2006, J NEURO-ONCOL, V79, P125, DOI 10.1007/s11060-006-9121-5	81	236	246	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					136	147		10.1016/j.stem.2011.01.007	http://dx.doi.org/10.1016/j.stem.2011.01.007			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295271	Bronze			2022-12-28	WOS:000287633400008
J	Le Belle, JE; Orozco, NM; Paucar, AA; Saxe, JP; Mottahedeh, J; Pyle, AD; Wu, H; Kornblum, HI				Le Belle, Janel E.; Orozco, Nicolas M.; Paucar, Andres A.; Saxe, Jonathan P.; Mottahedeh, Jack; Pyle, April D.; Wu, Hong; Kornblum, Harley I.			Proliferative Neural Stem Cells Have High Endogenous ROS Levels that Regulate Self-Renewal and Neurogenesis in a PI3K/Akt-Dependant Manner	CELL STEM CELL			English	Article							OLIGODENDROCYTE PRECURSOR CELLS; REACTIVE OXYGEN; REDOX REGULATION; DEPENDENT REGULATION; SUBVENTRICULAR ZONE; NADPH OXIDASES; PTEN; RECEPTOR; DIFFERENTIATION; BRAIN	The majority of research on reactive oxygen species (ROS) has focused on their cellular toxicities. Stem cells generally have been thought to maintain low levels of ROS as a protection against these processes. However, recent studies suggest that ROS can also play roles as second messengers, activating normal cellular processes. Here, we investigated ROS function in primary brain-derived neural progenitors. Somewhat surprisingly, we found that proliferative, self-renewing multipotent neural progenitors with the phenotypic characteristics of neural stem cells (NSC) maintained a high ROS status and were highly responsive to ROS stimulation. ROS-mediated enhancements in self-renewal and neurogenesis were dependent on PI3K/Akt signaling. Pharmacological or genetic manipulations that diminished cellular ROS levels also interfered with normal NSC and/or multipotent progenitor function both in vitro and in vivo. This study has identified a redox-mediated regulatory mechanism of NSC function that may have significant implications for brain injury, disease, and repair.	[Le Belle, Janel E.; Orozco, Nicolas M.; Paucar, Andres A.; Mottahedeh, Jack; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA; [Le Belle, Janel E.; Orozco, Nicolas M.; Paucar, Andres A.; Mottahedeh, Jack; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Saxe, Jonathan P.; Wu, Hong; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Pyle, April D.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Pyle, April D.; Wu, Hong; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA; [Pyle, April D.; Wu, Hong; Kornblum, Harley I.] Univ Calif Los Angeles, David Geffen Sch Med, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA; [Wu, Hong] Univ Calif Los Angeles, David Geffen Sch Med, Inst Mol Med, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Kornblum, HI (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, NPI Semel Inst Neurosci & Human Behav, Los Angeles, CA 90095 USA.	harley@ucla.edu		Saxe, Jonathan/0000-0001-7301-6423	Cure Autism Now Fellowship; Autism Speaks Basic and Clinical grant; Autism Speaks Environmental Sciences; Center for Autism Research and Treatment (CART) [06LEB2008]; NIH/NICHD [11 P50-HD-055784]; NIH [MH65756]; Henry Singleton Brain Cancer Research Program; James S. McDonnell Foundation; Miriam and Sheldon Adelson Program in Neural Repair and Rehabilitation; University of California, Cancer Research Coordinating Committee; National Institutes of Health [CA-16042, AI-28697]; JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA; UCLA Chancellor's Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD055784] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH065756] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS052563] Funding Source: NIH RePORTER	Cure Autism Now Fellowship; Autism Speaks Basic and Clinical grant; Autism Speaks Environmental Sciences; Center for Autism Research and Treatment (CART); NIH/NICHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Henry Singleton Brain Cancer Research Program; James S. McDonnell Foundation; Miriam and Sheldon Adelson Program in Neural Repair and Rehabilitation; University of California, Cancer Research Coordinating Committee(University of California System); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); JCCC; UCLA AIDS Institute; David Geffen School of Medicine at UCLA(University of California System); UCLA Chancellor's Office; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by the following grants and awards: Cure Autism Now Fellowship (to J.E.L.), Autism Speaks Basic and Clinical grant (to H.I.K.), Autism Speaks Environmental Sciences grant (to J.E.L.), Center for Autism Research and Treatment (CART) Pilot Grant Award #06LEB2008, which is supported by NIH/NICHD grant 11 P50-HD-055784 (to J.E.L.), NIH MH65756 (to H.I.K. and H.W.), Henry Singleton Brain Cancer Research Program and James S. McDonnell Foundation Award (to H.W.), Miriam and Sheldon Adelson Program in Neural Repair and Rehabilitation (to H.W. and H.I.K.), University of California, Cancer Research Coordinating Committee grant (to A.D.P.), and the Jonsson Comprehensive Cancer Center grant (to A.D.P.). Flow cytometry and cell sorting was performed in the UCLA Jonsson Comprehensive Cancer Center (JCCC) and Center for AIDS Research Flow Cytometry Core Facility, which is supported by National Institutes of Health awards CA-16042 and AI-28697, and by the JCCC, the UCLA AIDS Institute, the David Geffen School of Medicine at UCLA, and the UCLA Chancellor's Office.	Abid MR, 2004, J BIOL CHEM, V279, P44030, DOI 10.1074/jbc.M408285200; Behrens MM, 2008, J NEUROSCI, V28, P13957, DOI 10.1523/JNEUROSCI.4457-08.2008; Blanchetot C, 2008, CRIT REV EUKAR GENE, V18, P35, DOI 10.1615/CritRevEukarGeneExpr.v18.i1.30; Burch PM, 2005, ANTIOXID REDOX SIGN, V7, P741, DOI 10.1089/ars.2005.7.741; Capela A, 2002, NEURON, V35, P865, DOI 10.1016/S0896-6273(02)00835-8; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Chiarugi P, 2007, CELL SIGNAL, V19, P672, DOI 10.1016/j.cellsig.2006.11.009; Chuikov S, 2010, NAT CELL BIOL, V12, P999, DOI 10.1038/ncb2101; Delgado-Esteban M, 2007, J NEUROCHEM, V102, P194, DOI 10.1111/j.1471-4159.2007.04450.x; Diehn M, 2009, NATURE, V458, P780, DOI 10.1038/nature07733; Doetsch F, 1997, J NEUROSCI, V17, P5046; Garrido AM, 2009, MOL CELL ENDOCRINOL, V302, P148, DOI 10.1016/j.mce.2008.11.003; Goldstein BJ, 2005, ANTIOXID REDOX SIGN, V7, P1021, DOI 10.1089/ars.2005.7.1021; Gregorian C, 2009, J NEUROSCI, V29, P1874, DOI 10.1523/JNEUROSCI.3095-08.2009; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Groszer M, 2001, SCIENCE, V294, P2186, DOI 10.1126/science.1065518; Guo SH, 2008, J NEUROCHEM, V105, P1849, DOI 10.1111/j.1471-4159.2008.05287.x; Infanger DW, 2006, ANTIOXID REDOX SIGN, V8, P1583, DOI 10.1089/ars.2006.8.1583; Islam O, 2009, CURR NEUROVASC RES, V6, P42, DOI 10.2174/156720209787466028; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kunz A, 2007, J CEREBR BLOOD F MET, V27, P545, DOI 10.1038/sj.jcbfm.9600369; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lambeth JD, 2008, SEMIN IMMUNOPATHOL, V30, P339, DOI 10.1007/s00281-008-0123-6; Leslie NR, 2006, ANTIOXID REDOX SIGN, V8, P1765, DOI 10.1089/ars.2006.8.1765; Leslie NR, 2003, EMBO J, V22, P5501, DOI 10.1093/emboj/cdg513; Li ZB, 2007, PLOS BIOL, V5, P212, DOI 10.1371/journal.pbio.0050035; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Madhavan L, 2008, STEM CELLS, V26, P254, DOI 10.1634/stemcells.2007-0221; Madhavan L, 2006, STEM CELLS, V24, P2110, DOI 10.1634/stemcells.2006-0018; Nam HS, 2009, CELL STEM CELL, V5, P515, DOI 10.1016/j.stem.2009.08.017; Paik JH, 2009, CELL STEM CELL, V5, P540, DOI 10.1016/j.stem.2009.09.013; Park L, 2008, P NATL ACAD SCI USA, V105, P1347, DOI 10.1073/pnas.0711568105; Pastrana E, 2009, P NATL ACAD SCI USA, V106, P6387, DOI 10.1073/pnas.0810407106; Power J, 2002, DEV BIOL, V245, P362, DOI 10.1006/dbio.2002.0610; Renault VM, 2009, CELL STEM CELL, V5, P527, DOI 10.1016/j.stem.2009.09.014; Romanko MJ, 2004, J CEREBR BLOOD F MET, V24, P814, DOI 10.1097/01.WCB.0000123906.17746.00; Ross SH, 2007, CELL SIGNAL, V19, P1521, DOI 10.1016/j.cellsig.2007.01.026; Smith J, 2000, P NATL ACAD SCI USA, V97, P10032, DOI 10.1073/pnas.170209797; Studer L, 2000, J NEUROSCI, V20, P7377; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tang XB, 2007, J NEUROSCI, V27, P5837, DOI 10.1523/JNEUROSCI.5048-06.2007; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; Tsatmali M, 2005, BRAIN RES, V1040, P137, DOI 10.1016/j.brainres.2005.01.087; Vivanco I, 2010, P NATL ACAD SCI USA, V107, P6459, DOI 10.1073/pnas.0911188107; Wang Y, 2009, INVEST OPHTH VIS SCI, V50, P2291, DOI 10.1167/iovs.08-2568; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoneyama M, 2010, NEUROCHEM INT, V56, P740, DOI 10.1016/j.neuint.2009.11.018; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhou J, 2009, J NEUROSCI, V29, P1773, DOI 10.1523/JNEUROSCI.5685-08.2009	52	550	555	6	64	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 7	2011	8	1					59	71		10.1016/j.stem.2010.11.028	http://dx.doi.org/10.1016/j.stem.2010.11.028			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	714CX	21211782	Green Accepted, Bronze			2022-12-28	WOS:000286786200011
J	Guenther, MG; Frampton, GM; Soldner, F; Hockemeyer, D; Mitalipova, M; Jaenisch, R; Young, RA				Guenther, Matthew G.; Frampton, Garrett M.; Soldner, Frank; Hockemeyer, Dirk; Mitalipova, Maya; Jaenisch, Rudolf; Young, Richard A.			Chromatin Structure and Gene Expression Programs of Human Embryonic and Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							DEVELOPMENTAL REGULATORS; HISTONE-H3 LYSINE-4; POLYCOMB COMPLEXES; GENERATION; METHYLATION; MEMORY; MOUSE; SIGNATURE; SYSTEM; TISSUE	Knowledge of both the global chromatin structure and the gene expression programs of human embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) should provide a robust means to assess whether the genomes of these cells have similar pluripotent states. Recent studies have suggested that ESCs and iPSCs represent different pluripotent states with substantially different gene expression profiles. We describe here a comparison of global chromatin structure and gene expression data for a panel of human ESCs and iPSCs. Genome-wide maps of nucleosomes with histone H3K4me3 and H3K27me3 modifications indicate that there is little difference between ESCs and iPSCs with respect to these marks. Gene expression profiles confirm that the transcriptional programs of ESCs and iPSCs show very few consistent differences. Although some variation in chromatin structure and gene expression was observed in these cell lines, these variations did not serve to distinguish ESCs from iPSCs.	[Guenther, Matthew G.; Frampton, Garrett M.; Soldner, Frank; Hockemeyer, Dirk; Mitalipova, Maya; Jaenisch, Rudolf; Young, Richard A.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Frampton, Garrett M.; Jaenisch, Rudolf; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Young, RA (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	young@wi.mit.edu	Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Frampton, Garrett/0000-0002-2361-2750; Hockemeyer, Dirk/0000-0002-5598-5092	NCI NIH HHS [R01 CA084198, R01 CA146445-02, R01 CA146445] Funding Source: Medline; NHGRI NIH HHS [R01 HG002668, R01 HG002668-07] Funding Source: Medline; NICHD NIH HHS [R37 HD045022] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA146445, R01CA084198] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002668] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Ebert BL, 2004, BLOOD, V104, P923, DOI 10.1182/blood-2004-01-0274; Feng Q, 2010, STEM CELLS, V28, P704, DOI 10.1002/stem.321; Ghosh Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008975; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kang L, 2009, CELL STEM CELL, V5, P135, DOI 10.1016/j.stem.2009.07.001; KIM K, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE09342; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marchetto MCN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007076; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pietersen AM, 2008, CURR OPIN CELL BIOL, V20, P201, DOI 10.1016/j.ceb.2008.01.004; Ringrose L, 2004, ANNU REV GENET, V38, P413, DOI 10.1146/annurev.genet.38.072902.091907; Saha K, 2009, CELL STEM CELL, V5, P584, DOI 10.1016/j.stem.2009.11.009; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2008, CURR OPIN CELL BIOL, V20, P266, DOI 10.1016/j.ceb.2008.03.002; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Smith KP, 2009, J CELL PHYSIOL, V220, P21, DOI 10.1002/jcp.21681; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2010, NATURE, V465, P175, DOI 10.1038/nature09017; Takahashi K, 2007, NAT PROTOC, V2, P3081, DOI 10.1038/nprot.2007.418; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	52	332	340	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					249	257		10.1016/j.stem.2010.06.015	http://dx.doi.org/10.1016/j.stem.2010.06.015			9	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682450	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000281107400016
J	Johnston, MA; Lim, DA				Johnston, Mantissa A.; Lim, Daniel A.			Keeping Them Quiet: BMPs Maintain Adult Neural Stem Cell Quiescence	CELL STEM CELL			English	Editorial Material							NEUROGENESIS	Neural stem cells (NSCs) in the adult dentate gyrus divide relatively infrequently, a trait that may prevent premature NSC depletion. In this issue of Cell Stem Cell, Mira et al. (2010) demonstrate that BMP signaling regulates the quiescence of dentate gyrus NSCs, restraining their proliferation to maintain long-term adult neurogenesis.	[Johnston, Mantissa A.; Lim, Daniel A.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Johnston, Mantissa A.; Lim, Daniel A.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Lim, Daniel A.] Univ Calif San Francisco, Vet Affairs Med Ctr, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Lim, DA (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 505 Parnassus Ave,M779, San Francisco, CA 94143 USA.	limd@neurosurg.ucsf.edu		Lim, Daniel/0000-0001-7221-3425				Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Gobeske KT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007506; Kriegstein A, 2009, ANNU REV NEUROSCI, V32, P149, DOI 10.1146/annurev.neuro.051508.135600; Li LH, 2010, SCIENCE, V327, P542, DOI 10.1126/science.1180794; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Lugert S, 2010, CELL STEM CELL, V6, P445, DOI 10.1016/j.stem.2010.03.017; Mira H, 2010, CELL STEM CELL, V7, P78, DOI 10.1016/j.stem.2010.04.016; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	10	5	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					9	10		10.1016/j.stem.2010.06.006	http://dx.doi.org/10.1016/j.stem.2010.06.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621042	Bronze			2022-12-28	WOS:000280222300005
J	Ridky, TW; Khavari, PA				Ridky, Todd W.; Khavari, Paul A.			The Hair Follicle Bulge Stem Cell Niche Resists Transformation by the Hedgehog Pathway	CELL STEM CELL			English	Editorial Material							SONIC-HEDGEHOG; CARCINOMA; SKIN	Similarities between basal cell carcinoma (BCC) tumor cells and hair follicle keratinocytes had previously suggested that BCC originates within the hair follicle bulge stem cell niche. However, in the current Nature Cell Biology, Youssef et al. (2010) show that BCC instead originates in the interfollicular epidermis.	[Ridky, Todd W.; Khavari, Paul A.] Palo Alto Healthcare Syst, Vet Affairs, Palo Alto, CA 94304 USA; [Ridky, Todd W.; Khavari, Paul A.] Stanford Univ, Sch Med, Dept Dermatol, Program Epithelial Biol, Stanford, CA 94305 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University	Khavari, PA (corresponding author), Palo Alto Healthcare Syst, Vet Affairs, Palo Alto, CA 94304 USA.			Ridky, Todd/0000-0001-8482-1284	NCI NIH HHS [R01 CA142635] Funding Source: Medline; NIAMS NIH HHS [R01 AR049737-08, R01 AR049737-07, R01 AR049737, R01 AR049737-06A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049737] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Chiang C, 1999, DEV BIOL, V205, P1, DOI 10.1006/dbio.1998.9103; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fan HR, 1997, NAT MED, V3, P788, DOI 10.1038/nm0797-788; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Wang LC, 2000, J INVEST DERMATOL, V114, P901, DOI 10.1046/j.1523-1747.2000.00951.x; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031	8	7	7	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					292	294		10.1016/j.stem.2010.03.009	http://dx.doi.org/10.1016/j.stem.2010.03.009			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362530	Bronze, Green Accepted			2022-12-28	WOS:000276823300004
J	Uchida, N				Uchida, Nobuko			MicroRNA-9 Controls a Migratory Mechanism in Human Neural Progenitor Cells	CELL STEM CELL			English	Editorial Material							STEM-CELLS; PRECURSORS	MicroRNAs play roles in developmental switching; however, their roles in human neural progenitor cells (hNPCs) is poorly understood. In this issue of Cell Stem Cell, Delaloy et al. (2010) report that proliferation and migration choices in hNPCs are regulated by miR-9.	StemCells Inc, Palo Alto, CA 94301 USA		Uchida, N (corresponding author), StemCells Inc, 3155 Porter Dr, Palo Alto, CA 94301 USA.							Delaloy C, 2010, CELL STEM CELL, V6, P323, DOI 10.1016/j.stem.2010.02.015; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Jin KL, 2004, FASEB J, V18, P287, DOI 10.1096/fj.03-0973com; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Leucht C, 2008, NAT NEUROSCI, V11, P641, DOI 10.1038/nn.2115; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Okada Y, 2008, STEM CELLS, V26, P3086, DOI 10.1634/stemcells.2008-0293; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhao C, 2009, NAT STRUCT MOL BIOL, V16, P365, DOI 10.1038/nsmb.1576	10	14	19	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					294	296		10.1016/j.stem.2010.03.010	http://dx.doi.org/10.1016/j.stem.2010.03.010			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362531	Bronze			2022-12-28	WOS:000276823300005
J	Oakley, EJ; Van Zant, G				Oakley, Erin J.; Van Zant, Gary			Age-Related Changes in Niche Cells Influence Hematopoietic Stem Cell Function	CELL STEM CELL			English	Editorial Material							PROGENITOR CELLS	In a recent issue of Nature, Mayack et al. (2010) use young and old parabiotic mice to show that systemic signals from the young parabiont rejuvenate hematopoietic stem cell function via the microenvironmental niche.	[Oakley, Erin J.; Van Zant, Gary] Univ Kentucky, Dept Internal Med, Lexington, KY 40536 USA; [Oakley, Erin J.; Van Zant, Gary] Univ Kentucky, Lucille P Markey Canc Ctr, Lexington, KY 40536 USA	University of Kentucky; University of Kentucky	Van Zant, G (corresponding author), Univ Kentucky, Dept Internal Med, 800 Rose St, Lexington, KY 40536 USA.	gvzant1@uky.edu		Oakley, Erin/0000-0001-7853-0982				Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; FINERTY JC, 1952, PHYSIOL REV, V32, P277, DOI 10.1152/physrev.1952.32.3.277; Harrison DE, 1997, EXP HEMATOL, V25, P293; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Janzen V, 2006, NATURE, V443, P421, DOI 10.1038/nature05159; Liang Y, 2005, BLOOD, V106, P1479, DOI 10.1182/blood-2004-11-4282; MAYACK SR, 2010, NATURE IN PRESS, DOI DOI 10.1038/NATURE08749; Morrison SJ, 1996, NAT MED, V2, P1011, DOI 10.1038/nm0996-1011; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Sudo K, 2000, J EXP MED, V192, P1273, DOI 10.1084/jem.192.9.1273	10	7	7	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					93	94		10.1016/j.stem.2010.01.008	http://dx.doi.org/10.1016/j.stem.2010.01.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144780	Bronze			2022-12-28	WOS:000274520800002
J	Wu, DC; Johnston, LA				Wu, D. Christine; Johnston, Laura A.			Competition Among Stem Cells Gets Sticky	CELL STEM CELL			English	Editorial Material							DROSOPHILA TESTIS; NICHE OCCUPANCY; SELF-RENEWAL; DIFFERENTIATION; OVARY	In a recent report in Science, Issigonis et al. (2009) demonstrate that an inhibitor of JAK-STAT signaling controls integrin-mediated niche adhesion in the Drosophila testis, thereby limiting competition between germline and somatic stem cells for niche space.	[Johnston, Laura A.] Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA; [Wu, D. Christine] Columbia Univ, Med Ctr, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Columbia University	Johnston, LA (corresponding author), Columbia Univ, Med Ctr, Dept Genet & Dev, New York, NY 10032 USA.	lj180@columbia.edu	Johnston, Laura A/ABC-1945-2021	JOHNSTON, LAURA A/0000-0001-9477-7897	NIGMS NIH HHS [R01 GM078464, R01 GM078464-04] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078464] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Callus BA, 2002, ONCOGENE, V21, P4812, DOI 10.1038/sj.onc.1205618; Davies EL, 2008, COLD SH Q B, V73, P137, DOI 10.1101/sqb.2008.73.063; Ellis SJ, 2010, CELL TISSUE RES, V339, P121, DOI 10.1007/s00441-009-0828-4; Issigonis M, 2009, SCIENCE, V326, P153, DOI 10.1126/science.1176817; Jin ZG, 2008, CELL STEM CELL, V2, P39, DOI 10.1016/j.stem.2007.10.021; Nystul T, 2007, CELL STEM CELL, V1, P277, DOI 10.1016/j.stem.2007.07.009; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Sheng XR, 2009, CELL STEM CELL, V5, P191, DOI 10.1016/j.stem.2009.05.024; Spradling AC, 2008, COLD SH Q B, V73, P49, DOI 10.1101/sqb.2008.73.023; Voog J, 2008, NATURE, V454, P1132, DOI 10.1038/nature07173	10	0	0	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					459	460		10.1016/j.stem.2009.10.006	http://dx.doi.org/10.1016/j.stem.2009.10.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896435	Green Accepted, Bronze			2022-12-28	WOS:000272019500005
J	Kang, L; Wang, JL; Zhang, Y; Kou, ZH; Gao, SR				Kang, Lan; Wang, Jianle; Zhang, Yu; Kou, Zhaohui; Gao, Shaorong			iPS Cells Can Support Full-Term Development of Tetraploid Blastocyst-Complemented Embryos	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; FIBROBLASTS; GENERATION; MOUSE		[Kang, Lan; Wang, Jianle; Zhang, Yu; Kou, Zhaohui; Gao, Shaorong] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Kang, Lan] Chinese Acad Med Sci, Grad Program, Beijing 100730, Peoples R China; [Kang, Lan] Peking Union Med Coll, Beijing 100730, Peoples R China	National Institute of Biological Sciences, Beijing; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Gao, SR (corresponding author), Natl Inst Biol Sci, Beijing 102206, Peoples R China.	gaoshaorong@nibs.ac.cn			Ministry of Science and Technology [2008AA022311, 2006AA02A101, 2009CB941100]; National Science Foundation of China [30670302]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank Professor Rudolf Jaenisch from the Whitehead Institute of the Massachusetts Institute of Technology for generously supplying the vectors for lentiviruses containing the cDNAs of four transcription factors, and Dr. Konrad Hochedlinger for personal communications. We are also grateful to the other colleagues in our laboratory for useful help during experiments and preparation of the manuscript. This project was supported by the Ministry of Science and Technology (grants 2008AA022311, 2006AA02A101, and 2009CB941100) and the National Science Foundation of China (grant 30670302).	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Glaser V, 2008, REJUV RES, V11, P849, DOI 10.1089/rej.2008.0778; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayashi K, 2009, CELL STEM CELL, V4, P493, DOI 10.1016/j.stem.2009.05.007; Kim JB, 2008, NATURE, V454, P646, DOI 10.1038/nature07061; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	20	335	386	1	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2009	5	2					135	138		10.1016/j.stem.2009.07.001	http://dx.doi.org/10.1016/j.stem.2009.07.001			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	490PB	19631602	Bronze			2022-12-28	WOS:000269511900006
J	Zhu, ST; Wurdak, H; Wang, J; Lyssiotis, CA; Peters, EC; Cho, CY; Wu, X; Schultz, PG				Zhu, Shoutian; Wurdak, Heiko; Wang, Jian; Lyssiotis, Costas A.; Peters, Eric C.; Cho, Charles Y.; Wu, Xu; Schultz, Peter G.			A Small Molecule Primes Embryonic Stem Cells for Differentiation	CELL STEM CELL			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; NUCLEASE HYPERSENSITIVE ELEMENT; DEFINITIVE ENDODERM; C-MYC; TRANSCRIPTION FACTOR; SERUM-FREE; IN-VITRO; MOUSE; PLURIPOTENCY; LOCALIZATION	Embryonic stem cells (ESCs) are an attractive source of cells for disease modeling in vitro and may eventually provide access to cells/tissues for the treatment of many degenerative diseases. However, applications of ESC-derived cell types are largely hindered by the lack of highly efficient methods for lineage-specific differentiation. Using a high-content screen, we have identified a small molecule, named stauprimide, that increases the efficiency of the directed differentiation of mouse and human ESCs in synergy with defined extracellular signaling cues. Affinity-based methods revealed that stauprimide interacts with NME2 and inhibits its nuclear localization. This, in turn, leads to downregulation of c-Myc, a key regulator of the pluripotent state. Thus, our findings identify a chemical tool that primes ESCs for efficient differentiation through a mechanism that affects c-Myc expression, and this study points to an important role for NME2 in ESC self-renewal.	[Peters, Eric C.; Cho, Charles Y.; Wu, Xu; Schultz, Peter G.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Zhu, Shoutian; Wurdak, Heiko; Wang, Jian; Lyssiotis, Costas A.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Zhu, Shoutian; Wurdak, Heiko; Wang, Jian; Lyssiotis, Costas A.; Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute; Scripps Research Institute	Wu, X (corresponding author), Novartis Res Fdn, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	xwu@gnf.org; schultz@scripps.edu	Zhu, Shoutian/M-2108-2018; Peters, Eric/W-2739-2019; Lyssiotis, Costas A/AAI-1923-2019	Zhu, Shoutian/0000-0001-6748-225X; Lyssiotis, Costas A/0000-0001-9309-6141; Wurdak, Heiko/0000-0003-4385-4324	Skaggs Institute of Chemical Biology of the Scripps Research Institute; Novartis Research Foundation	Skaggs Institute of Chemical Biology of the Scripps Research Institute; Novartis Research Foundation	We would like to thank Dr. Sheng Ding for providing the Sox-1 GFP knockin mouse ESCs and Dr. Anthony Boitano for technical help and informative discussions. This work is supported by the Skaggs Institute of Chemical Biology of the Scripps Research Institute (P.G.S.) and the Novartis Research Foundation (P.G.S. and X.W.).	Aleckovic M, 2008, REPROD BIOMED ONLINE, V17, P270, DOI 10.1016/S1472-6483(10)60206-4; ALITALO K, 1986, ADV CANCER RES, V47, P235, DOI 10.1016/S0065-230X(08)60201-8; Baetge EE, 2008, DIABETES OBES METAB, V10, P186, DOI 10.1111/j.1463-1326.2008.00956.x; Baudino TA, 2002, GENE DEV, V16, P2530, DOI 10.1101/gad.1024602; BERBERICH SJ, 1995, ONCOGENE, V10, P2343; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Byrne JA, 2006, BIOL REPROD, V75, P908, DOI 10.1095/biolreprod.106.053868; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; CHENG D, 2005, Patent No. 2005016528; COLE MD, 1986, ANNU REV GENET, V20, P361, DOI 10.1146/annurev.ge.20.120186.002045; Czyz J, 2001, DIFFERENTIATION, V68, P167, DOI 10.1046/j.1432-0436.2001.680404.x; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; DAVIS AC, 1993, GENE DEV, V7, P671, DOI 10.1101/gad.7.4.671; Denker HW, 2007, CELLS TISSUES ORGANS, V185, P48, DOI 10.1159/000101302; Ding S, 2005, CURR TOP MED CHEM, V5, P383, DOI 10.2174/1568026053828402; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Eastham AM, 2007, CANCER RES, V67, P11254, DOI 10.1158/0008-5472.CAN-07-2253; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; Gouon-Evans V, 2006, NAT BIOTECHNOL, V24, P1402, DOI 10.1038/nbt1258; Hikita ST, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003312; IRM LLC, 2008, Patent No. 2008073480; JI L, 1995, J BIOL CHEM, V270, P13392, DOI 10.1074/jbc.270.22.13392; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kraeft SK, 1996, EXP CELL RES, V227, P63, DOI 10.1006/excr.1996.0250; Kroon E, 2008, NAT BIOTECHNOL, V26, P443, DOI 10.1038/nbt1393; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Lyssiotis CA, 2007, P NATL ACAD SCI USA, V104, P14982, DOI 10.1073/pnas.0707044104; Micallef SJ, 2005, DIABETES, V54, P301, DOI 10.2337/diabetes.54.2.301; Morrison GM, 2008, CELL STEM CELL, V3, P402, DOI 10.1016/j.stem.2008.07.021; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Pinon VPB, 1999, EXP CELL RES, V246, P355, DOI 10.1006/excr.1998.4318; Purpura KA, 2008, EXP HEMATOL, V36, P1186, DOI 10.1016/j.exphem.2008.04.003; Qu XB, 2008, DEV GROWTH DIFFER, V50, P585, DOI 10.1111/j.1440-169X.2008.01056.x; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; Schier AF, 2000, NATURE, V403, P385, DOI 10.1038/35000126; Shiraki N, 2008, GENES CELLS, V13, P731, DOI 10.1111/j.1365-2443.2008.01201.x; Soto-Gutierrez A, 2007, NAT PROTOC, V2, P347, DOI 10.1038/nprot.2007.18; Suemori Hirofumi, 2006, Hum Cell, V19, P65, DOI 10.1111/j.1749-0774.2006.00011.x; Tada S, 2005, DEVELOPMENT, V132, P4363, DOI 10.1242/dev.02005; Tahaa MF, 2008, INT J CARDIOL, V127, P78, DOI 10.1016/j.ijcard.2007.04.173; Tam PPL, 2003, CURR OPIN GENET DEV, V13, P393, DOI 10.1016/S0959-437X(03)00085-6; TAMAOKI T, 1990, BIO-TECHNOL, V8, P732, DOI 10.1038/nbt0890-732; Thakur RK, 2009, NUCLEIC ACIDS RES, V37, P172, DOI 10.1093/nar/gkn919; Tian T, 2006, CELL MOL LIFE SCI, V63, P672, DOI 10.1007/s00018-005-5503-7; Wiese C, 2006, METH MOL B, V325, P181; WOBUS AM, 1984, EXP CELL RES, V152, P212, DOI 10.1016/0014-4827(84)90246-5; Yamanaka S, 2008, CELL TISSUE RES, V331, P5, DOI 10.1007/s00441-007-0520-5; Yang AX, 2005, STEM CELLS DEV, V14, P270, DOI 10.1089/scd.2005.14.270; Yasunaga M, 2005, NAT BIOTECHNOL, V23, P1542, DOI 10.1038/nbt1167; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	51	142	155	0	20	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					416	426		10.1016/j.stem.2009.04.001	http://dx.doi.org/10.1016/j.stem.2009.04.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19427291	Bronze			2022-12-28	WOS:000266071100010
J	Payne, CJ; Braun, RE				Payne, Christopher J.; Braun, Robert E.			Human Adult Testis-Derived Pluripotent Stem Cells: Revealing Plasticity from the Germline	CELL STEM CELL			English	Editorial Material							MOUSE TESTIS; GENERATION	A recent publication in Nature by Conrad et al. (2008) reports the generation of pluripotent stem cells from isolated human adult testicular germ cells. This work identifies a new source of stem cells for potential autologous therapeutic applications in men.	[Payne, Christopher J.; Braun, Robert E.] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Braun, RE (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	bob.braun@jax.org						Conrad S, 2008, NATURE, V456, P344, DOI 10.1038/nature07404; Daheron L, 2004, STEM CELLS, V22, P770, DOI 10.1634/stemcells.22-5-770; Guan K, 2006, NATURE, V440, P1199, DOI 10.1038/nature04697; Kanatsu-Shinohara M, 2004, CELL, V119, P1001, DOI 10.1016/j.cell.2004.11.011; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Seandel M, 2007, NATURE, V449, P346, DOI 10.1038/nature06129; Seydoux G, 2006, CELL, V127, P891, DOI 10.1016/j.cell.2006.11.016; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Tada T, 2008, CELL STEM CELL, V3, P121, DOI 10.1016/j.stem.2008.07.005; Yu JY, 2008, GENE DEV, V22, P1987, DOI 10.1101/gad.1689808	10	10	10	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV 6	2008	3	5					471	472		10.1016/j.stem.2008.10.009	http://dx.doi.org/10.1016/j.stem.2008.10.009			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	372IK	18983960	Bronze			2022-12-28	WOS:000260895100004
J	Hayashi, K; Lopes, SMCD; Tang, F; Surani, MA				Hayashi, Katsuhiko; Lopes, Susana M. Chuva de Sousa; Tang, Fuchou; Surani, M. Azim			Dynamic Equilibrium and Heterogeneity of Mouse Pluripotent Stem Cells with Distinct Functional and Epigenetic States	CELL STEM CELL			English	Article							OLIGONUCLEOTIDE MICROARRAY ANALYSIS; DNA METHYLATION; HISTONE ACETYLATION; CDNA AMPLIFICATION; SELF-RENEWAL; GERM-CELLS; IN-VITRO; GENE; DIFFERENTIATION; EXPRESSION	Embryonic stem cells (ESCs) are apparently homogeneous self-renewing cells, but we observed heterogeneous expression of Stella in ESCs, which is a marker of pluripotency and germ cells. Here we show that, whereas Stella-positive ESCs were like the inner cell mass (ICM), Stella-negative cells were like the epiblast cells. These states were interchangeable, which reflects the metastability and plasticity of ESCs. The established equilibrium was skewed reversibly in the absence of signals from feeder cells, which caused a marked shift toward an epiblast-like state, while trichostatin A, an inhibitor of histone deactelylase, restored Stella-positive population. The two populations also showed different histone modifications and striking functional differences, as judged by their potential for differentiation. The Stella-negative ESCs were more like the postimplantation epiblast-derived stem cells (EpiSCs), albeit the stella locus was repressed by DNA methylation in the latter, which signifies a robust epigenetic boundary between ESCs and EpiSCs.	[Hayashi, Katsuhiko; Lopes, Susana M. Chuva de Sousa; Tang, Fuchou; Surani, M. Azim] Univ Cambridge, Henry Wellcome Bldg Canc & Dev Biol, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England	University of Cambridge	Surani, MA (corresponding author), Univ Cambridge, Henry Wellcome Bldg Canc & Dev Biol, Wellcome Trust Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	10021@mole.bio.cam.ac.uk		Surani, Azim/0000-0002-8640-4318	Netherlands Organization for Scientific Research (NWO) [TALENT 809.67.024]; Japan Society for Promotion of Science; CellCentric Ltd [TP/4/BIO/6/I/22020]; Department for Innovation, Universities, and Skills (DIUS); Wellcome Trust [062801]	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); CellCentric Ltd; Department for Innovation, Universities, and Skills (DIUS); Wellcome Trust(Wellcome TrustEuropean Commission)	We are grateful to T. Nakano for anti-PGC7 and P. Beverly for mouse anti-SSEA1. We thank C. Lee for technical support; C. Mummery for continuing support; and A. McLaren, B. Payer, P. Hajkova, and S. Jeffries for useful comments on the manuscript. This work was supported by the Netherlands Organization for Scientific Research (NWO, TALENT 809.67.024) to S.M.C.S.L.; the Japan Society for Promotion of Science to K.H.; and The Technology Programme (DTI Project Number TP/4/BIO/6/I/22020) of CellCentric Ltd and The Technology Strategy Board sponsored by the Department for Innovation, Universities, and Skills (DIUS); and the Wellcome Trust (062801).	Ansel KM, 2003, NAT IMMUNOL, V4, P616, DOI 10.1038/ni0703-616; Avilion AA, 2003, GENE DEV, V17, P126, DOI 10.1101/gad.224503; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Chambers I, 2004, ONCOGENE, V23, P7150, DOI 10.1038/sj.onc.1207930; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chapman G, 1997, GENOMICS, V46, P223, DOI 10.1006/geno.1997.4969; Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003; Clark AT, 2004, STEM CELLS, V22, P169, DOI 10.1634/stemcells.22-2-169; Cui L, 2004, J HISTOCHEM CYTOCHEM, V52, P1447, DOI 10.1369/jhc.3A6241.2004; Furusawa T, 2004, BIOL REPROD, V70, P1452, DOI 10.1095/biolreprod.103.024190; Furusawa T, 2006, BIOL REPROD, V75, P555, DOI 10.1095/biolreprod.105.049502; KAFRI T, 1992, GENE DEV, V6, P705, DOI 10.1101/gad.6.5.705; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kang JH, 2005, CELL, V123, P833, DOI 10.1016/j.cell.2005.09.011; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kurimoto K, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl050; Kurimoto K, 2007, NAT PROTOC, V2, P739, DOI 10.1038/nprot.2007.79; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lee JH, 2004, GENESIS, V38, P32, DOI 10.1002/gene.10250; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Lopes SMCD, 2004, GENE DEV, V18, P1838, DOI 10.1101/gad.294004; McCool KW, 2007, J BIOL CHEM, V282, P6696, DOI 10.1074/jbc.M609519200; MONK M, 1987, DEVELOPMENT, V99, P371; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Ohinata Y, 2005, NATURE, V436, P207, DOI 10.1038/nature03813; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Payer B, 2006, GENESIS, V44, P75, DOI 10.1002/gene.20187; Pelton TA, 2002, J CELL SCI, V115, P329; Pesce M, 1998, BIOESSAYS, V20, P722, DOI 10.1002/(SICI)1521-1878(199809)20:9&lt;722::AID-BIES5&gt;3.0.CO;2-I; Rathjen J, 1999, J CELL SCI, V112, P601; Robson P, 2001, DEV BIOL, V234, P317, DOI 10.1006/dbio.2001.0274; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; Sato M, 2002, MECH DEVELOP, V113, P91, DOI 10.1016/S0925-4773(02)00002-3; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Toyooka Y, 2008, DEVELOPMENT, V135, P909, DOI 10.1242/dev.017400; van Grunsven LA, 2005, CYTOKINE GROWTH F R, V16, P495, DOI 10.1016/j.cytogfr.2005.05.006; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zwaka TP, 2005, DEVELOPMENT, V132, P227, DOI 10.1242/dev.01586	44	481	497	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 9	2008	3	4					391	401		10.1016/j.stem.2008.07.027	http://dx.doi.org/10.1016/j.stem.2008.07.027			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	361TK	18940731	Bronze, Green Accepted			2022-12-28	WOS:000260149800010
J	Currle, DS; Gilbertson, RJ				Currle, D. Spencer; Gilbertson, Richard J.			The niche revealed	CELL STEM CELL			English	Editorial Material							NEURAL STEM-CELLS; SUBVENTRICULAR ZONE; NEUROGENESIS; BRAIN	A trio of studies in this issue of Cell Stem Cell from Mirzadeh et al., Shen et al., and Tavazoie et al. use three-dimensional imaging techniques to reveal microanatomical details of the adult neural stem cell niche. Combined, the results also provide a framework for future functional studies.	[Currle, D. Spencer; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Dev Neurobiol, Memphis, TN 38105 USA; [Currle, D. Spencer; Gilbertson, Richard J.] St Jude Childrens Hosp, Dept Oncol, Memphis, TN 38105 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital	Gilbertson, RJ (corresponding author), St Jude Childrens Hosp, Dept Dev Neurobiol, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	richard.gilbertson@stjude.org	Gilbertson, Richard James/ABE-1346-2021	Gilbertson, Richard James/0000-0001-7539-9472				Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Merkle FT, 2004, P NATL ACAD SCI USA, V101, P17528, DOI 10.1073/pnas.0407893101; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Palmer TD, 2000, J COMP NEUROL, V425, P479, DOI 10.1002/1096-9861(20001002)425:4<479::AID-CNE2>3.0.CO;2-3; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Tanentzapf G, 2007, NAT CELL BIOL, V9, P1413, DOI 10.1038/ncb1660; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Yoshida S, 2007, SCIENCE, V317, P1722, DOI 10.1126/science.1144885	11	11	11	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					234	236		10.1016/j.stem.2008.08.011	http://dx.doi.org/10.1016/j.stem.2008.08.011			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786409	Bronze			2022-12-28	WOS:000259665000004
J	Hockemeyer, D; Soldner, F; Cook, EG; Gao, Q; Mitalipova, M; Jaenisch, R				Hockemeyer, Dirk; Soldner, Frank; Cook, Elizabeth G.; Gao, Qing; Mitalipova, Maisam; Jaenisch, Rudolf			A drug-inducible system for direct reprogramming of human somatic cells to pluripotency	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; MOUSE; FIBROBLASTS; GENERATION; MYC	Current approaches to reprogram human somatic cells to pluripotent iPSCs utilize viral transduction of different combinations of transcription factors. These protocols are highly inefficient because only a small fraction of cells carry the appropriate number and stoichiometry of proviral insertions to initiate the reprogramming process. Here we have generated genetically homogeneous "secondary" somatic cells, which carry the reprogramming factors as defined doxycycline (DOX)-inducible transgenes. These cells were obtained by infecting fibroblasts with DOX-inducible lentiviruses, isolating "primary" iPSCs in the presence of the drug, and finally differentiating to "secondary" fibroblasts. When "secondary" fibroblast lines were cultured in the presence of DOX without further viral infection, up to 2% of the cells were reprogrammed to pluripotent "secondary" human iPSCs. This system will facilitate the characterization of the reprogramming process and provides a unique platform for genetic or chemical screens to enhance reprogramming or replace individual factors.	[Hockemeyer, Dirk; Soldner, Frank; Cook, Elizabeth G.; Gao, Qing; Mitalipova, Maisam; Jaenisch, Rudolf] Whitehead Inst, Cambridge, MA 02142 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu		Hockemeyer, Dirk/0000-0002-5598-5092	National Institute of Health [RO1-HD045022, R37-CA084198]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Raaji Alagappan and Ping Xu for support with tissue culture and Jessica Dausman, Ruth Flannery, and Dongdong Fu fortheir help with animal husbandry and processing of teratomas. We thank all the members of the Jaenisch lab for helpful discussions and comments on the manuscript. D.H. is a Merck Fellow of the Life Science Research Foundation. R.J. was supported by National Institute of Health grants RO1-HD045022 and R37-CA084198. R.J. is an advisor to Sterrigent, which has obtained a license from the Massachusetts Institute of Technology (MIT) to distribute some of the reagents used in this paper.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Lensch MW, 2007, CELL STEM CELL, V1, P253, DOI 10.1016/j.stem.2007.07.019; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Xu CH, 2004, STEM CELLS, V22, P972, DOI 10.1634/stemcells.22-6-972; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	18	248	281	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					346	353		10.1016/j.stem.2008.08.014	http://dx.doi.org/10.1016/j.stem.2008.08.014			8	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786421	Green Accepted, Bronze			2022-12-28	WOS:000259665000017
J	Rando, TA				Rando, Thomas A.			Turning back time: Reversing tissue pathology to enhance stem cell engraftment	CELL STEM CELL			English	Editorial Material								Histopathologic changes in diseased tissues may render them inhospitable to engraftment by transplanted stem cells. A recent report in Nature Medicine (Gargioli et al., 2008) demonstrates that pretreatment of dystrophic mouse muscles with tissue-modifying factors leads to reduced fibrosis, increased vascularity, and enhanced stem cell engraftment.	[Rando, Thomas A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Rando, Thomas A.] VA Palo Alto Hlth Care Syst, Stanford, CA 94305 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Rando, TA (corresponding author), Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.	rando@stanford.edu		Rando, Thomas/0000-0001-5843-8564				Andreetta F, 2006, J NEUROIMMUNOL, V175, P77, DOI 10.1016/j.jneuroim.2006.03.005; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Emery AEH, 2002, LANCET, V359, P687, DOI 10.1016/S0140-6736(02)07815-7; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Gopinath SD, 2008, AGING CELL, V7, P590, DOI 10.1111/j.1474-9726.2008.00399.x; Hidestrand M, 2008, J GERONTOL A-BIOL, V63, P566, DOI 10.1093/gerona/63.6.566; Minasi MG, 2002, DEVELOPMENT, V129, P2773; PARTRIDGE TA, 1977, J NEUROL SCI, V33, P425, DOI 10.1016/0022-510X(77)90138-1; Scadden DT, 2006, NATURE, V441, P1075, DOI 10.1038/nature04957; WEBSTER DF, 1982, BRIT J EXP PATHOL, V63, P50	10	2	2	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					232	234		10.1016/j.stem.2008.08.006	http://dx.doi.org/10.1016/j.stem.2008.08.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786408	Bronze			2022-12-28	WOS:000259665000003
J	White, RM; Zon, LI				White, Richard Mark; Zon, Leonard I.			Melanocytes in development, regeneration, and cancer	CELL STEM CELL			English	Review							NEURAL CREST DEVELOPMENT; PRIMARY MELANOMA PROGRESSION; RECEPTOR TYROSINE KINASE; ENDOTHELIN-B RECEPTOR; C-KIT PROTOONCOGENE; TRANSCRIPTION FACTOR; STEM-CELLS; METASTATIC MELANOMA; IN-VITRO; DOPACHROME-TAUTOMERASE	The genes required for stem cell specification and lineage restriction during embryogenesis also play fundamental roles in adult tissue regeneration and cancer. This "development-regeneration-cancer" axis is exemplified by the vertebrate pigmentation system. Melanocytes exhibit almost unlimited self-renewal capacity during regenerative processes such as mammalian hair recoloration and zebrafish fin regeneration. Melanoma utilizes many regulatory signals and pathways required during ontogeny and regeneration. A discussion of these interconnections highlights how studies of stem cell function in embryonic and regenerative contexts can yield insights into melanoma biology.	[White, Richard Mark; Zon, Leonard I.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [White, Richard Mark; Zon, Leonard I.] Childrens Hosp, Stem Cell Program, Div Hematol Oncol, Boston, MA 02115 USA; [White, Richard Mark; Zon, Leonard I.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Zon, LI (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA.	zon@enders.tch.harvard.edu						Antonescu CR, 2007, INT J CANCER, V121, P257, DOI 10.1002/ijc.22681; Aoki H, 2002, LIFE SCI, V71, P2171, DOI 10.1016/S0024-3205(02)01996-3; Bagnato A, 2004, CANCER RES, V64, P1436, DOI 10.1158/0008-5472.CAN-03-2344; Baker CVH, 1997, DEVELOPMENT, V124, P3077; Balint K, 2005, J CLIN INVEST, V115, P3166, DOI 10.1172/JCI25001; Bardeesy N, 2001, MOL CELL BIOL, V21, P2144, DOI 10.1128/MCB.21.6.2144-2153.2001; BAYNASH AG, 1994, CELL, V79, P1277, DOI 10.1016/0092-8674(94)90018-3; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; BRONNERFRASER M, 1988, NATURE, V335, P161, DOI 10.1038/335161a0; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Carreira S, 2005, NATURE, V433, P764, DOI 10.1038/nature03269; Chaine AS, 2008, SCIENCE, V319, P459, DOI 10.1126/science.1149167; Christensen C, 2005, ONCOGENE, V24, P6292, DOI 10.1038/sj.onc.1208758; Cornell RA, 2005, SEMIN CELL DEV BIOL, V16, P663, DOI 10.1016/j.semcdb.2005.06.009; Cornell RA, 2002, DEVELOPMENT, V129, P2639; Curtin JA, 2006, J CLIN ONCOL, V24, P4340, DOI 10.1200/JCO.2006.06.2984; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Dissanayake SK, 2007, J BIOL CHEM, V282, P17259, DOI 10.1074/jbc.M700075200; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Du JY, 2002, J BIOL CHEM, V277, P402, DOI 10.1074/jbc.M110229200; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Dupin E, 2000, P NATL ACAD SCI USA, V97, P7882, DOI 10.1073/pnas.97.14.7882; Endo Y, 2003, DEV GROWTH DIFFER, V45, P241; Erickson CA, 1998, CURR TOP DEV BIOL, V40, P177, DOI 10.1016/S0070-2153(08)60367-1; ETON O, 2004, P AN M AM SOC CLIN, V23, P713; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; GEISSLER EN, 1988, CELL, V55, P185, DOI 10.1016/0092-8674(88)90020-7; GIEBEL LB, 1991, P NATL ACAD SCI USA, V88, P8696, DOI 10.1073/pnas.88.19.8696; Glavic A, 2004, DEVELOPMENT, V131, P347, DOI 10.1242/dev.00945; Grimshaw MJ, 2007, ENDOCR-RELAT CANCER, V14, P233, DOI 10.1677/ERC-07-0057; Gupta PB, 2005, NAT GENET, V37, P1047, DOI 10.1038/ng1634; Hemesath TJ, 1998, NATURE, V391, P298, DOI 10.1038/34681; Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984; Hodi FS, 2008, J CLIN ONCOL, V26, P2046, DOI 10.1200/JCO.2007.14.0707; Hoek K, 2004, CANCER RES, V64, P5270, DOI 10.1158/0008-5472.CAN-04-0731; Hornyak TJ, 2001, MECH DEVELOP, V101, P47, DOI 10.1016/S0925-4773(00)00569-4; Ikeya M, 1997, NATURE, V389, P966, DOI 10.1038/40146; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Jiao ZX, 2006, DEV BIOL, V296, P396, DOI 10.1016/j.ydbio.2006.06.006; Kanzler B, 2000, DEVELOPMENT, V127, P1095; Kefford R, 2007, INVEST NEW DRUG, V25, P247, DOI 10.1007/s10637-006-9014-7; Kelsh RN, 1996, DEVELOPMENT, V123, P369; King R, 2001, AM J SURG PATHOL, V25, P51, DOI 10.1097/00000478-200101000-00005; Kumano K, 2008, PIGM CELL MELANOMA R, V21, P70, DOI 10.1111/j.1755-148X.2007.00423.x; Lahav R, 1998, P NATL ACAD SCI USA, V95, P14214, DOI 10.1073/pnas.95.24.14214; Lahav R, 1999, P NATL ACAD SCI USA, V96, P11496, DOI 10.1073/pnas.96.20.11496; Lahav R, 1996, P NATL ACAD SCI USA, V93, P3892, DOI 10.1073/pnas.93.9.3892; Lang D, 2005, NATURE, V433, P884, DOI 10.1038/nature03292; Lee HO, 2003, DEV BIOL, V259, P162, DOI 10.1016/S0012-1606(03)00160-X; Lister JA, 1999, DEVELOPMENT, V126, P3757; Liu ZJ, 2006, CANCER RES, V66, P4182, DOI 10.1158/0008-5472.CAN-05-3589; Loercher AE, 2005, J CELL BIOL, V168, P35, DOI 10.1083/jcb.200410115; McGill GG, 2002, CELL, V109, P707, DOI 10.1016/S0092-8674(02)00762-6; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; MOORE KJ, 1995, TRENDS GENET, V11, P442, DOI 10.1016/S0168-9525(00)89143-X; Moriyama M, 2006, J CELL BIOL, V173, P333, DOI 10.1083/jcb.200509084; Morrison SJ, 1999, CELL, V96, P737, DOI 10.1016/S0092-8674(00)80583-8; NATALI PG, 1992, INT J CANCER, V52, P197, DOI 10.1002/ijc.2910520207; Nechiporuk A, 2002, DEVELOPMENT, V129, P2607; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Osawa M, 2005, DEVELOPMENT, V132, P5589, DOI 10.1242/dev.02161; Oshima H, 2001, CELL, V104, P233, DOI 10.1016/S0092-8674(01)00208-2; Ozsolak F, 2007, NAT BIOTECHNOL, V25, P244, DOI 10.1038/nbt1279; Pak BJ, 2004, ONCOGENE, V23, P30, DOI 10.1038/sj.onc.1207007; Parichy DM, 1999, DEVELOPMENT, V126, P3425; Parichy DM, 2000, DEV BIOL, V227, P294, DOI 10.1006/dbio.2000.9899; PAVAN WJ, 1994, P NATL ACAD SCI USA, V91, P7159, DOI 10.1073/pnas.91.15.7159; Poleo G, 2001, DEV DYNAM, V221, P380, DOI 10.1002/dvdy.1152; Pollock PM, 2002, MELANOMA RES, V12, P183, DOI 10.1097/00008390-200204000-00013; Poss KD, 2003, DEV DYNAM, V226, P202, DOI 10.1002/dvdy.10220; Qin JZ, 2004, MOL CANCER THER, V3, P895; Rawls JF, 2000, DEVELOPMENT, V127, P3715; Rawls JF, 2001, DEVELOPMENT, V128, P1943; Rehli M, 1999, GENOMICS, V56, P111, DOI 10.1006/geno.1998.5588; Schatton T, 2008, NATURE, V451, P345, DOI 10.1038/nature06489; SIEBERBLUM M, 1980, DEV BIOL, V80, P96, DOI 10.1016/0012-1606(80)90501-1; SIMONSON MS, 1992, J AM SOC NEPHROL, V2, pS116; Spinella F, 2007, CANCER RES, V67, P1725, DOI 10.1158/0008-5472.CAN-06-2606; Takeda K, 2000, J BIOL CHEM, V275, P14013, DOI 10.1074/jbc.C000113200; Tsujimura T, 1996, BLOOD, V88, P1225, DOI 10.1182/blood.V88.4.1225.bloodjournal8841225; Ugurel S, 2005, BRIT J CANCER, V92, P1398, DOI 10.1038/sj.bjc.6602529; WEHRLEHALLER B, 1995, DEVELOPMENT, V121, P731; Widlund HR, 2003, ONCOGENE, V22, P3035, DOI 10.1038/sj.onc.1206443; WILLIAMS DE, 1990, CELL, V63, P167, DOI 10.1016/0092-8674(90)90297-R; Wu M, 2000, GENE DEV, V14, P301; Wyman K, 2006, CANCER-AM CANCER SOC, V106, P2005, DOI 10.1002/cncr.21834; Yang CT, 2007, PLOS GENET, V3, P886, DOI 10.1371/journal.pgen.0030088; Yang CT, 2006, DEVELOPMENT, V133, P3563, DOI 10.1242/dev.02533; Yang GA, 2005, J INVEST DERMATOL, V125, P1242, DOI 10.1111/j.0022-202X.2005.23931.x; Yasumoto K, 2002, EMBO J, V21, P2703, DOI 10.1093/emboj/21.11.2703; Yasumoto K, 1997, J BIOL CHEM, V272, P503; YASUMOTO KI, 1994, MOL CELL BIOL, V14, P8058, DOI 10.1128/MCB.14.12.8058	95	96	100	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 11	2008	3	3					242	252		10.1016/j.stem.2008.08.005	http://dx.doi.org/10.1016/j.stem.2008.08.005			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	354UR	18786412	Bronze			2022-12-28	WOS:000259665000008
J	Tada, T				Tada, Takashi			Genetic modification-free reprogramming to induced pluripotent cells: Fantasy or reality?	CELL STEM CELL			English	Editorial Material							STEM-CELLS; GENERATION	Significant development in the reprogramming of somatic cells into induced pluripotent stem cells (iPSCs) has been achieved by retroviral infection of defined genes. Several recent reports, including one in this issue of Cell Stem Cell (Marson et al., 2008), have started to replace these genetic changes with specific chemical stimulation.	Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, Kyoto 6068507, Japan	Kyoto University	Tada, T (corresponding author), Kyoto Univ, Inst Frontier Med Sci, Sakyo Ku, 53 Kawahara Cho, Kyoto 6068507, Japan.	ttada@frontier.kyoto-u.ac.jp						Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; KIM JB, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07061; Knoepfler PS, 2008, CELL STEM CELL, V2, P18, DOI 10.1016/j.stem.2007.12.004; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Sridharan R, 2008, CELL STEM CELL, V2, P295, DOI 10.1016/j.stem.2008.03.015; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968	11	6	6	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					121	122		10.1016/j.stem.2008.07.005	http://dx.doi.org/10.1016/j.stem.2008.07.005			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682230	Bronze			2022-12-28	WOS:000258523300001
J	Xu, RH; Sampsell-Barron, TL; Gu, F; Root, S; Peck, RM; Pan, GJ; Yu, JY; Antosiewicz-Bourget, J; Tian, SL; Stewart, R; Thomson, JA				Xu, Ren-He; Sampsell-Barron, Tori L.; Gu, Feng; Root, Sierra; Peck, Ruthann M.; Pan, Guangjin; Yu, Junying; Antosiewicz-Bourget, Jessica; Tian, Shulan; Stewart, Ron; Thomson, James A.			NANOG is a direct target of TGF beta/Activin-mediated SMAD signaling in human ESCs	CELL STEM CELL			English	Article							HUMAN EMBRYONIC STEM; FIBROBLAST-GROWTH-FACTOR; FEEDER-FREE GROWTH; SELF-RENEWAL; MAINTAIN PLURIPOTENCY; CELL DIFFERENTIATION; DEFINED CONDITIONS; GENE-EXPRESSION; ACTIVATION; CULTURE	Self-renewal of human embryonic stem cells (ESCs) is promoted by FGF and TGF beta/Activin signaling, and differentiation is promoted by BMP signaling, but how these signals regulate genes critical to the maintenance of pluripotency has been unclear. Using a defined medium, we show here that both TGF beta and FGF signals synergize to inhibit BMP signaling; sustain expression of pluripotency-associated genes such as NANOG, OCT4, and SOX2; and promote long-term undifferentiated proliferation of human ESCs. We also show that both TGF beta- and BMP-responsive SMADs can bind with the NANOG proximal promoter. NANOG promoter activity is enhanced by TGF beta/Activin and FGF signaling and is decreased by BMP signaling. Mutation of putative SMAD binding elements reduces NANOG promoter activity to basal levels and makes NANOG unresponsive to BMP and TGF beta signaling. These results suggest that direct binding of TGF beta/Activin-responsive SMADs to the NANOG promoter plays an essential role in sustaining human ESC self-renewal.	[Xu, Ren-He; Gu, Feng; Root, Sierra] Univ Connecticut, Stem Cell Inst, Dept Genet & Dev Biol, Ctr Hlth, Farmington, CT 06030 USA; [Xu, Ren-He; Sampsell-Barron, Tori L.; Peck, Ruthann M.; Pan, Guangjin; Yu, Junying; Antosiewicz-Bourget, Jessica; Thomson, James A.] WiCell Res Inst, Madison, WI 53707 USA; [Yu, Junying; Antosiewicz-Bourget, Jessica; Thomson, James A.] Univ Wisconsin, Natl Primate Res Ctr, Madison, WI 53706 USA; [Tian, Shulan; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53707 USA; [Thomson, James A.] Univ Wisconsin, Dept Anat, Madison, WI 53706 USA	University of Connecticut; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Xu, RH (corresponding author), Univ Connecticut, Stem Cell Inst, Dept Genet & Dev Biol, Ctr Hlth, Farmington, CT 06030 USA.	renhexu@uchc.edu; thomson@primate.wisc.edu	Xu, Ren-He/AAK-7392-2021; Xu, Ren-He/M-3125-2016	Sampsell, Tori/0000-0001-9032-7055; Gu, Feng/0000-0002-9019-2960	National Institutes of Health [P51 RR000167, P20 GM069981]; W.M. Keck Foundation; Connecticut Stem Cell Research [06SCB14, 06SCD02]; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM069981] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W.M. Keck Foundation(W.M. Keck Foundation); Connecticut Stem Cell Research; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tenneille Ludwig and Jenny Frane for providing TeSR1 media; Marian Piekarczyk, Leann Crandall, and Tiwanna Compton for laboratory support; and Deborah Faupel for editing the manuscript. We also thank Gudrun Jonsdottir and Karen Heidarsdottir from the WiCell Research Institute in Iceland for conducting the microarray experiments and Mark Kronenberg for helpful discussion on the EMSA. This work was supported by funding from private donations, National Institutes of Health grants P51 RR000167 and P20 GM069981, the W.M. Keck Foundation to J.A.T., and the Connecticut Stem Cell Research Grants 06SCB14 and 06SCD02 to R.-H.X. The contents in this work are solely the responsibility of the authors and do not necessarily represent the official views of the State of Connecticut. The authors declare competing financial interests. J.A.T. is a cofounder and shareholder of Cellular Dynamics International.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Besser D, 2004, J BIOL CHEM, V279, P45076, DOI 10.1074/jbc.M404979200; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Darr H, 2006, DEVELOPMENT, V133, P1193, DOI 10.1242/dev.02286; Greber B, 2007, STEM CELLS, V25, P455, DOI 10.1634/stemcells.2006-0476; Hay DC, 2004, STEM CELLS, V22, P225, DOI 10.1634/stemcells.22-2-225; Hyslop L, 2005, STEM CELLS, V23, P1035, DOI 10.1634/stemcells.2005-0080; James D, 2005, DEVELOPMENT, V132, P1273, DOI 10.1242/dev.01706; Kang HB, 2005, STEM CELLS DEV, V14, P395, DOI 10.1089/scd.2005.14.395; Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906; Kuroda T, 2005, MOL CELL BIOL, V25, P2475, DOI 10.1128/MCB.25.6.2475-2485.2005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Li Y, 2005, BIOTECHNOL BIOENG, V91, P688, DOI 10.1002/bit.20536; Lopez-Rovira T, 2002, J BIOL CHEM, V277, P3176, DOI 10.1074/jbc.M106826200; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Ma Y, 2003, STEM CELLS, V21, P111, DOI 10.1634/stemcells.21-1-111; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Matin MM, 2004, STEM CELLS, V22, P659, DOI 10.1634/stemcells.22-5-659; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Pera MF, 2004, J CELL SCI, V117, P1269, DOI 10.1242/jcs.00970; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1; Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X; Sperger JM, 2003, P NATL ACAD SCI USA, V100, P13350, DOI 10.1073/pnas.2235735100; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Wang LS, 2005, BLOOD, V105, P4598, DOI 10.1182/blood-2004-10-4065; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Xu CH, 2005, STEM CELLS, V23, P315, DOI 10.1634/stemcells.2004-0211; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971; Xu RH, 2002, NAT BIOTECHNOL, V20, P1261, DOI 10.1038/nbt761; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Yao S, 2006, P NATL ACAD SCI USA, V103, P6907, DOI 10.1073/pnas.0602280103; Zaehres H, 2005, STEM CELLS, V23, P299, DOI 10.1634/stemcells.2004-0252	42	364	390	1	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	AUG 7	2008	3	2					196	206		10.1016/j.stem.2008.07.001	http://dx.doi.org/10.1016/j.stem.2008.07.001			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	338QT	18682241	Green Accepted, Bronze			2022-12-28	WOS:000258523300014
J	Tropepe, V				Tropepe, Vincent			Kinship and descent: Redefining the stem cell compartment in the adult hippocampus	CELL STEM CELL			English	Editorial Material							DENTATE GYRUS; PROGENITOR; NEUROGENESIS; NICHE		Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; Univ Toronto, Ctr Anal Genome Evolut & Funct, Toronto, ON M5S 3G5, Canada	University of Toronto; University of Toronto	Tropepe, V (corresponding author), Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada.	v.tropepe@utoronto.ca						Bull ND, 2005, J NEUROSCI, V25, P10815, DOI 10.1523/JNEUROSCI.3249-05.2005; Bylund M, 2003, NAT NEUROSCI, V6, P1162, DOI 10.1038/nn1131; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; Gage FH, 1998, J NEUROBIOL, V36, P249, DOI 10.1002/(SICI)1097-4695(199808)36:2<249::AID-NEU11>3.0.CO;2-9; Graham V, 2003, NEURON, V39, P749, DOI 10.1016/S0896-6273(03)00497-5; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002	10	2	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					481	483		10.1016/j.stem.2007.10.014	http://dx.doi.org/10.1016/j.stem.2007.10.014			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18938741	Bronze			2022-12-28	WOS:000251276500002
J	Quyn, AJ; Appleton, PL; Carey, FA; Steele, RJC; Barker, N; Clevers, H; Ridgway, RA; Sansom, OJ; Nathke, IS				Quyn, Aaron J.; Appleton, Paul L.; Carey, Francis A.; Steele, Robert J. C.; Barker, Nick; Clevers, Hans; Ridgway, Rachel A.; Sansom, Owen J.; Naethke, Inke S.			Spindle Orientation Bias in Gut Epithelial Stem Cell Compartments Is Lost in Precancerous Tissue	CELL STEM CELL			English	Article							TUMOR-SUPPRESSOR; SMALL-INTESTINE; DIVISION; APC; CANCER; MICROTUBULES; CENTROSOME; MUTATION; LEAD; MICE	The importance of asymmetric divisions for stem cell function and maintenance is well established in the developing nervous system and the skin; however, its role in gut epithelium and its importance for tumorigenesis is still debated. We demonstrate alignment of mitotic spindles perpendicular to the apical surface specifically in the stem cell compartments of mouse and human intestine and colon. This orientation correlates with the asymmetric retention of label-retaining DNA. Both the preference for perpendicular spindle alignment and asymmetric label retention are lost in precancerous tissue heterozygous for the adenomatous polyposis coli tumor suppressor (Apc). This loss correlates with cell shape changes specifically in the stem cell compartment. Our data suggest that loss of asymmetric division in stem cells might contribute to the oncogenic effect of Apc mutations in gut epithelium.	[Quyn, Aaron J.; Appleton, Paul L.; Naethke, Inke S.] Univ Dundee, Dundee DD1 5EH, Scotland; [Quyn, Aaron J.; Carey, Francis A.; Steele, Robert J. C.] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Barker, Nick; Clevers, Hans] Hubrecht Lab, NL-3508 AD Utrecht, Netherlands; [Ridgway, Rachel A.; Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland	University of Dundee; University of Dundee; Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Beatson Institute	Nathke, IS (corresponding author), Univ Dundee, Dundee DD1 5EH, Scotland.	i.s.nathke@dundee.ac.uk	Barker, Nick/AAS-2774-2020; Barker, Nick/AAE-9833-2021; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Nathke, Inke/0000-0003-2420-4385; Quyn, Aaron/0000-0002-4333-5658; Sansom, Owen J./0000-0001-9540-3010; Steele, Robert JC/0000-0003-4248-6785	Cancer Research UK Bobby Moore Fund; Cancer Research UK; Cancer Research UK [11243] Funding Source: researchfish	Cancer Research UK Bobby Moore Fund; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	The authors wish to thank all the members of the Light Microscopy Facility of the University of Dundee for their imaging expertise and Professor Mark Chaplain and Ignacio Ramis-Conde (University of Dundee) for developing the Xcode program used to calculate spindle angles. This work was supported by the Cancer Research UK Bobby Moore Fund (A.J.Q.) and a programme grant from Cancer Research UK (I.S.N.).	Ahringer J, 2003, CURR OPIN CELL BIOL, V15, P73, DOI 10.1016/S0955-0674(02)00018-2; Appleton PL, 2009, J MICROSC-OXFORD, V234, P196, DOI 10.1111/j.1365-2818.2009.03163.x; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; BJERKNES M, 1989, BIOPHYS J, V55, P1011, DOI 10.1016/S0006-3495(89)82899-1; CAIRNS J, 1975, NATURE, V255, P197, DOI 10.1038/255197a0; Caldwell CM, 2007, J CELL BIOL, V178, P1109, DOI 10.1083/jcb.200703186; Fleming ES, 2007, J HISTOCHEM CYTOCHEM, V55, P1173, DOI 10.1369/jhc.7A7234.2007; Fleming ES, 2009, MOL CARCINOGEN, V48, P592, DOI 10.1002/mc.20506; Green RA, 2005, MOL BIOL CELL, V16, P4609, DOI 10.1091/mbc.E05-03-0259; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Judson H, 2006, J PATHOL, V210, P344, DOI 10.1002/path.2044; Li ZY, 2008, J CELL SCI, V121, P1916, DOI 10.1242/jcs.029470; Li ZY, 2005, CANCER RES, V65, P5195, DOI 10.1158/0008-5472.CAN-04-4609; Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956; Pearson CG, 2004, NAT REV MOL CELL BIO, V5, P481, DOI 10.1038/nrm1402; Potten CS, 2009, CELL PROLIFERAT, V42, P731, DOI 10.1111/j.1365-2184.2009.00642.x; Potten CS, 2002, J CELL SCI, V115, P2381; Schuyler SC, 2001, J CELL SCI, V114, P247; Thery M, 2006, CURR OPIN CELL BIOL, V18, P648, DOI 10.1016/j.ceb.2006.10.001; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	22	182	184	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					175	181		10.1016/j.stem.2009.12.007	http://dx.doi.org/10.1016/j.stem.2009.12.007			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144789	Bronze			2022-12-28	WOS:000274520800012
J	Barker, N; Huch, M; Kujala, P; van de Wetering, M; Snippert, HJ; van Es, JH; Sato, T; Stange, DE; Begthel, H; van den Born, M; Danenberg, E; van den Brink, S; Korving, J; Abo, A; Peters, PJ; Wright, N; Poulsom, R; Clevers, H				Barker, Nick; Huch, Meritxell; Kujala, Pekka; van de Wetering, Marc; Snippert, Hugo J.; van Es, Johan H.; Sato, Toshiro; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; van den Brink, Stieneke; Korving, Jeroen; Abo, Arie; Peters, Peter J.; Wright, Nick; Poulsom, Richard; Clevers, Hans			Lgr5(+ve) Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro	CELL STEM CELL			English	Article							EPITHELIAL-CELLS; MOUSE STOMACH; BETA-CATENIN; SMALL-INTESTINE; DYNAMICS; CANCER; CORPUS; IDENTIFICATION; ACTIVATION; MIGRATION	The study of gastric epithelial homeostasis and cancer has been hampered by the lack of stem cell markers and in vitro culture methods. The Writ target gene Lgr5 marks stem cells in the small intestine, colon, and hair follicle. Here, we investigated Lgr5 expression in the stomach and assessed the stem cell potential of the Lgr5(+ve) cells by using in vivo lineage tracing. In neonatal stomach, Lgr5 was expressed at the base of prospective corpus and pyloric glands, whereas expression in the adult was predominantly restricted to the base of mature pyloric glands. Lineage tracing revealed these Lgr5(+ve) cells to be self-renewing, multipotent stem cells responsible for the long-term renewal of the gastric epithelium. With an in vitro culture system, single Lgr5(+ve) cells efficiently generated long-lived organoids resembling mature pyloric epithelium. The Lgr5 stem cell marker and culture method described here will be invaluable tools for accelerating research into gastric epithelial renewal, inflammation/infection, and cancer.	[Barker, Nick; Huch, Meritxell; van de Wetering, Marc; Snippert, Hugo J.; van Es, Johan H.; Sato, Toshiro; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; van den Brink, Stieneke; Korving, Jeroen; Clevers, Hans] Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands; [Barker, Nick; Huch, Meritxell; van de Wetering, Marc; Snippert, Hugo J.; van Es, Johan H.; Sato, Toshiro; Stange, Daniel E.; Begthel, Harry; van den Born, Maaike; Danenberg, Esther; van den Brink, Stieneke; Korving, Jeroen; Clevers, Hans] Univ Med Ctr Utrecht, Utrecht, Netherlands; [Kujala, Pekka; Peters, Peter J.] Antoni Van Leeuwenhoek Hosp, Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Abo, Arie] Nuvelo Inc, San Carlos, CA 94070 USA; [Peters, Peter J.] Delft Univ Technol, Kavli Inst Nanosci, NL-2628 CJ Delft, Netherlands; [Wright, Nick] Barts & London Queen Marys Sch Med & Dent, London E1 2AD, England; [Poulsom, Richard] Canc Res UK London Res Inst, London WC2A 3PX, England	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Netherlands Cancer Institute; Delft University of Technology; University of London; Queen Mary University London; Cancer Research UK	Clevers, H (corresponding author), Hubrecht Inst Dev Biol & Stem Cell Res, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Wright, Nicholas/HHY-7227-2022; Barker, Nick/AAE-9833-2021; van+Es, Johan/ABD-5411-2021; Barker, Nick/AAS-2774-2020; Sato, Toshiro/J-3522-2014; Stange, Daniel E/O-1837-2015; Barker, Nick/A-5535-2011	Barker, Nick/0000-0003-3566-4475; Sato, Toshiro/0000-0001-8353-8137; Stange, Daniel E/0000-0003-4246-2230; Danenberg, Esther/0000-0002-1799-4457; Wright, Nicholas/0000-0002-5525-3457	KWF [PF-HUBR-2007-3956]; Marie Curie Actions-European commission	KWF; Marie Curie Actions-European commission	N.B. and H.C. are supported by KWF program grant # PF-HUBR-2007-3956. M.H. is supported by an Intra-European Fellowship from Marie Curie Actions-European commission. We thank Rob Vries for help with the BrdU injections and Nico Ong for help with EM imaging and Ramesh Shivdasani for providing reagents.	Barker N, 2008, COLD SH Q B, V73, P351, DOI 10.1101/sqb.2008.72.003; Barker N, 2008, GENE DEV, V22, P1856, DOI 10.1101/gad.1674008; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bjerknes M, 2002, AM J PHYSIOL-GASTR L, V283, pG767, DOI 10.1152/ajpgi.00415.2001; Clements WM, 2002, CANCER RES, V62, P3503; Correa P, 1996, CANCER EPIDEM BIOMAR, V5, P477; Gravaghi C, 2008, INT J OBESITY, V32, P1716, DOI 10.1038/ijo.2008.149; HATTORI T, 1976, CELL TISSUE RES, V172, P171; Huch M, 2009, NEOPLASIA, V11, P518, DOI 10.1593/neo.81674; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; KARAM SM, 1993, ANAT RECORD, V236, P280, DOI 10.1002/ar.1092360203; KARAM SM, 1993, ANAT REC, V236, P333, DOI 10.1002/ar.1092360206; KARAM SM, 1993, ANAT REC, V236, P297, DOI 10.1002/ar.1092360204; KARAM SM, 1993, ANAT REC, V236, P259, DOI 10.1002/ar.1092360202; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEE ER, 1982, AM J ANAT, V164, P187, DOI 10.1002/aja.1001640302; Lustig B, 2002, MOL CELL BIOL, V22, P1184, DOI 10.1128/MCB.22.4.1184-1193.2002; Mcdonald SAC, 2008, GASTROENTEROLOGY, V134, P500, DOI 10.1053/j.gastro.2007.11.035; NAKATSURU S, 1992, HUM MOL GENET, V1, P559, DOI 10.1093/hmg/1.8.559; Nomura S, 1998, DEV BIOL, V204, P124, DOI 10.1006/dbio.1998.9055; OFFERHAUS GJA, 1992, GASTROENTEROLOGY, V102, P1980, DOI 10.1016/0016-5085(92)90322-P; Ootani A, 2003, AM J PATHOL, V162, P1905, DOI 10.1016/S0002-9440(10)64324-6; Park WS, 1999, CANCER RES, V59, P4257; Peters PJ, 2006, CURR PROTOC CELL BIO, DOI [10.1002/0471143030.CB0407S30, DOI 10.1002/0471143030.CB0407S30]; Poulsom R, 1998, EUR J HISTOCHEM, V42, P121; Qiao XT, 2007, GASTROENTEROLOGY, V133, P1989, DOI 10.1053/j.gastro.2007.09.031; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Shibata H, 1997, SCIENCE, V278, P120, DOI 10.1126/science.278.5335.120; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; TATEMATSU M, 1994, CANCER LETT, V83, P37, DOI 10.1016/0304-3835(94)90296-8; Tomita H, 2007, CANCER RES, V67, P4079, DOI 10.1158/0008-5472.CAN-06-4025; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589	38	1039	1100	5	123	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					25	36		10.1016/j.stem.2009.11.013	http://dx.doi.org/10.1016/j.stem.2009.11.013			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085740	Bronze			2022-12-28	WOS:000274029700009
J	Castilho, RM; Squarize, CH; Chodosh, LA; Williams, BO; Gutkind, JS				Castilho, Rogerio M.; Squarize, Cristiane H.; Chodosh, Lewis A.; Williams, Bart O.; Gutkind, J. Silvio			mTOR Mediates Wnt-Induced Epidermal Stem Cell Exhaustion and Aging	CELL STEM CELL			English	Article							HAIR FOLLICLE; BETA-CATENIN; SIGNALING CONTROLS; EXPRESSION; PATHWAY; CANCER; SKIN; TOR; PHOSPHORYLATION; DIFFERENTIATION	Epidermal integrity is a complex process established during embryogenesis and maintained throughout the organism lifespan by epithelial stem cells. Although Wnt regulates normal epithelial stem cell renewal, aberrant Wnt signaling can contribute to cancerous growth. Here, we explored the consequences of persistent expressing Wnt1 in an epidermal compartment that includes the epithelial stem cells. Surprisingly, Wnt caused the rapid growth of the hair follicles, but this was followed by epithelial cell senescence, disappearance of the epidermal stem cell compartment, and progressive hair loss. Although Wnt1 induced the activation of beta-catenin and the mTOR pathway, both hair follicle hyperproliferation and stem cell exhaustion were strictly dependent on mTOR function. These findings suggest that whereas activation of beta-catenin contributes to tumor growth, epithelial stem cells may be endowed with a protective mechanism that results in cell senescence upon the persistent stimulation of proliferative pathways that activate mTOR, ultimately suppressing tumor formation.	[Castilho, Rogerio M.; Squarize, Cristiane H.; Gutkind, J. Silvio] Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA; [Chodosh, Lewis A.] Univ Penn, Sch Med, Dept Canc Biol, Philadelphia, PA 19104 USA; [Chodosh, Lewis A.] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Williams, Bart O.] Van Andel Res Inst, Lab Cell Signaling & Carcinogenesis, Grand Rapids, MI 49503 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Van Andel Institute	Gutkind, JS (corresponding author), Natl Inst Dent & Craniofacial Res, Oral & Pharyngeal Canc Branch, NIH, Bethesda, MD 20892 USA.	sg39v@nih.gov	Williams, Bart/A-3539-2013; Gutkind, J. Silvio/A-1053-2009; Castilho, Rogerio M/E-4987-2010; Gutkind, J. Silvio/J-1201-2016	Williams, Bart/0000-0002-5261-5301; Castilho, Rogerio M/0000-0001-5358-612X; Gutkind, J. Silvio/0000-0002-5150-4482; Squarize, Cristiane/0000-0002-6782-3429	Intramural Research Program; Craniofacial Tissue Remodeling Initiative of the NIH; NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000558, ZIADE000551] Funding Source: NIH RePORTER	Intramural Research Program; Craniofacial Tissue Remodeling Initiative of the NIH; NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	a We are grateful to Dr. R. M. Porter (Wales College of Medicine) for the polyclonal antibody against IRS and to Dr. T. Finkel (National Heart, Lung, and Blood Institute/ National Institutes of Health [NIH]) for critical reading of the manuscript. This research was supported by the Intramural Research Program and the Craniofacial Tissue Remodeling Initiative of the NIH, NIDCR.	Abraham RT, 2002, CELL, V111, P9, DOI 10.1016/S0092-8674(02)01009-7; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Blau HM, 2001, CELL, V105, P829, DOI 10.1016/S0092-8674(01)00409-3; Brennan KR, 2004, J MAMMARY GLAND BIOL, V9, P119, DOI 10.1023/B:JOMG.0000037157.94207.33; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Castilho RM, 2007, ONCOGENE, V26, P5078, DOI 10.1038/sj.onc.1210322; Chang CH, 2004, MECH DEVELOP, V121, P157, DOI 10.1016/j.mod.2003.12.004; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Cho RW, 2008, STEM CELLS, V26, P364, DOI 10.1634/stemcells.2007-0440; Debies MT, 2008, J CLIN INVEST, V118, P51, DOI 10.1172/JCI33320; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Fuchs E, 1995, ANNU REV CELL DEV BI, V11, P123, DOI 10.1146/annurev.cb.11.110195.001011; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Greco V, 2009, CELL STEM CELL, V4, P155, DOI 10.1016/j.stem.2008.12.009; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; ITO M, 1986, ARCH DERMATOL RES, V279, P112, DOI 10.1007/BF00417531; Katoh M, 2007, CLIN CANCER RES, V13, P4042, DOI 10.1158/1078-0432.CCR-06-2316; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Kobielak K, 2007, P NATL ACAD SCI USA, V104, P10063, DOI 10.1073/pnas.0703004104; Li Y, 2000, ONCOGENE, V19, P1002, DOI 10.1038/sj.onc.1203273; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Liu F, 2008, CELL SIGNAL, V20, P999, DOI 10.1016/j.cellsig.2007.11.011; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; LYNCH MH, 1986, J CELL BIOL, V103, P2593, DOI 10.1083/jcb.103.6.2593; Maretto S, 2003, P NATL ACAD SCI USA, V100, P3299, DOI 10.1073/pnas.0434590100; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Motoyama N, 2004, CURR OPIN GENET DEV, V14, P11, DOI 10.1016/j.gde.2003.12.003; Nusse R, 2008, CELL RES, V18, P523, DOI 10.1038/cr.2008.47; Olivera-Martinez I, 2001, MECH DEVELOP, V100, P233, DOI 10.1016/S0925-4773(00)00540-2; Paus R, 1999, J INVEST DERMATOL, V113, P523, DOI 10.1046/j.1523-1747.1999.00740.x; Porter RM, 2004, BRIT J DERMATOL, V150, P195, DOI 10.1111/j.1365-2133.2004.05720.x; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; Reddy ST, 2004, J INVEST DERMATOL, V123, P275, DOI 10.1111/j.0022-202X.2004.23215.x; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; Schieke SM, 2006, BIOL CHEM, V387, P1357, DOI 10.1515/BC.2006.170; Serrano M, 2001, CURR OPIN CELL BIOL, V13, P748, DOI 10.1016/S0955-0674(00)00278-7; Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869; Squarize CH, 2006, NEOPLASIA, V8, P733, DOI 10.1593/neo.06274; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Vitale-Cross L, 2004, CANCER RES, V64, P8804, DOI 10.1158/0008-5472.CAN-04-2623; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369; Xu LF, 2000, GENE DEV, V14, P585; Zechner D, 2003, DEV BIOL, V258, P406, DOI 10.1016/S0012-1606(03)00123-4; Zhu AJ, 1999, DEVELOPMENT, V126, P2285	55	296	312	1	23	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					279	289		10.1016/j.stem.2009.06.017	http://dx.doi.org/10.1016/j.stem.2009.06.017			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733540	Green Accepted, Bronze			2022-12-28	WOS:000272545700014
J	Kim, D; Kim, CH; Moon, JI; Chung, YG; Chang, MY; Han, BS; Ko, S; Yang, E; Cha, KY; Lanza, R; Kim, KS				Kim, Dohoon; Kim, Chun-Hyung; Moon, Jung-Il; Chung, Young-Gie; Chang, Mi-Yoon; Han, Baek-Soo; Ko, Sanghyeok; Yang, Eungi; Cha, Kwang Yul; Lanza, Robert; Kim, Kwang-Soo			Generation of Human Induced Pluripotent Stem Cells by Direct Delivery of Reprogramming Proteins	CELL STEM CELL			English	Article							HUMAN FIBROBLASTS; CELLULAR UPTAKE; TAT PROTEIN; INDUCTION; MACROMOLECULES; OCT4		[Chung, Young-Gie; Lanza, Robert] Stern Cell & Regenerat Med Int, Worcester, MA 01605 USA; [Kim, Dohoon; Kim, Chun-Hyung; Moon, Jung-Il; Chang, Mi-Yoon; Han, Baek-Soo; Ko, Sanghyeok; Yang, Eungi; Kim, Kwang-Soo] Harvard Univ, Sch Med, Mol Neurobiol Lab, Dept Psychiat, Belmont, MA 02478 USA; [Kim, Dohoon; Kim, Chun-Hyung; Moon, Jung-Il; Chang, Mi-Yoon; Han, Baek-Soo; Ko, Sanghyeok; Yang, Eungi; Kim, Kwang-Soo] Harvard Univ, Sch Med, McLean Hosp, Belmont, MA 02478 USA; [Kim, Kwang-Soo] Harvard Stem Cell Inst, Belmont, MA 02478 USA	Harvard University; Harvard University; McLean Hospital; Harvard University	Lanza, R (corresponding author), Stern Cell & Regenerat Med Int, 381 Plantat St, Worcester, MA 01605 USA.	rlanza@advancedcell.com; kskim@mclean.harvard.edu	Chung, Young Gie/AAC-8149-2020	Lanza, Robert/0000-0002-3047-3074	National Institutes of Health (NIH) [MH48866, DC 006501]; CHA University; Korean Stem Cell Research Center; Dongyang Corporation Co. in Korea; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH048866, R01MH048866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006501] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CHA University; Korean Stem Cell Research Center; Dongyang Corporation Co. in Korea; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by National Institutes of Health (NIH) grants MH48866 and DC 006501 and by International Grants from the CHA University, Korean Stem Cell Research Center, and Dongyang Corporation Co. in Korea. The authors thank Dr. V. Morgan (Harvard Partners Center for Genetics and Genomics), Dr. J. Kim (Harvard Medical School), and Dr. J. Lee (Shippensburg University) for microarray analysis and Ms. J. Johnson (Cell Line Genetics) for karyotyping analysis. R.L. is an employee and shareholder of Advanced Cell Technology and a scientific advisor for Stem Cell and Regenerative Medicine International. K.Y.C. is a shareholder of CHA Bio and Diostech Co., Ltd., and Stem Cell and Regenerative Medicine International.	Belting M, 2005, ADV DRUG DELIVER REV, V57, P505, DOI 10.1016/j.addr.2004.10.004; Chung Y, 2009, CLONING STEM CELLS, V11, P213, DOI 10.1089/clo.2009.0004; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P1269, DOI 10.1038/nbt.1502; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; FRANKEL AD, 1988, SCIENCE, V240, P70, DOI 10.1126/science.2832944; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; French AJ, 2008, STEM CELLS, V26, P485, DOI 10.1634/stemcells.2007-0252; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003; Wernig M, 2008, P NATL ACAD SCI USA, V105, P5856, DOI 10.1073/pnas.0801677105; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005; Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604	30	1292	1519	0	252	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					472	476		10.1016/j.stem.2009.05.005	http://dx.doi.org/10.1016/j.stem.2009.05.005			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19481515	Green Accepted, Bronze			2022-12-28	WOS:000266793600005
J	Doble, BW; Woodgett, JR				Doble, Bradley W.; Woodgett, James R.			Exploring Pluripotency with Chemical Genetics	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; SELF-RENEWAL; ACTIVATION; FATE		[Woodgett, James R.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Doble, Bradley W.] McMaster Univ, McMaster Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Woodgett, James R.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1X5, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; McMaster University; University of Toronto	Woodgett, JR (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave, Toronto, ON M5G 1X5, Canada.	woodgett@lunenfeld.ca	Woodgett, Jim/F-1087-2010; Doble, Bradley/V-7848-2019; Doble, Brad/L-7551-2016	Woodgett, Jim/0000-0003-3731-5797; Doble, Bradley/0000-0002-0260-2983; Doble, Brad/0000-0002-0260-2983	CIHR [12858, 74711] Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR))		Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Ding S, 2003, P NATL ACAD SCI USA, V100, P7632, DOI 10.1073/pnas.0732087100; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Welham MJ, 2007, BIOCHEM SOC T, V35, P225, DOI 10.1042/BST0350225; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	10	12	12	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					98	100		10.1016/j.stem.2009.01.005	http://dx.doi.org/10.1016/j.stem.2009.01.005			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200796	Green Accepted, Bronze			2022-12-28	WOS:000263213400003
J	Amcheslavsky, A; Jiang, J; Ip, YT				Amcheslavsky, Alla; Jiang, Jin; Ip, Y. Tony			Tissue Damage-Induced Intestinal Stem Cell Division in Drosophila	CELL STEM CELL			English	Article							INSULIN-LIKE PEPTIDES; NICHE; GROWTH; NOTCH; BIOLOGY; MIDGUT; SPECIFICATION; CHECKPOINT; EXPRESSION; APOPTOSIS	Stem cell division is essential for tissue integrity during growth, aging, and pathogenic assaults. Adult gastrointestinal tract encounters numerous stimulations, and impaired tissue regeneration may lead to inflammatory diseases and cancer. Intestinal stem cells in adult Drosophila have recently been identified and shown to replenish the various cell types within the midgut. However, it is not known whether these intestinal stem cells can respond to environmental challenges. By feeding dextran sulfate sodium and bleomycin to flies and by expressing apoptotic proteins, we show that Drosophila intestinal stem cells can increase the rate of division in response to tissue damage. Moreover, if tissue damage results in epithelial cell loss, the newly formed enteroblasts can differentiate into mature epithelial cells. By using this newly established system of intestinal stem cell proliferation and tissue regeneration, we find that the insulin receptor signaling pathway is required for intestinal stem cell division.	[Amcheslavsky, Alla; Ip, Y. Tony] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA; [Ip, Y. Tony] Univ Massachusetts, Sch Med, Program Cell Dynam, Worcester, MA 01605 USA; [Ip, Y. Tony] Univ Massachusetts, Sch Med, Dept Cell Biol, Worcester, MA 01605 USA; [Jiang, Jin] Univ Texas SW Med Ctr Dallas, Ctr Dev Biol, Dallas, TX 75390 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ip, YT (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA.	tony.ip@umassmed.edu			NIH [DK75545, GM53269]; Worcester Foundation for Biomedical Research; NIH, Welch Foundation; Leukemia and Lymphoma Society; Diabetes Endocrinology Research [DK32520]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK075545, P30DK032520, R01DK083450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269, R01GM053269, R01GM067045] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Worcester Foundation for Biomedical Research; NIH, Welch Foundation(The Welch FoundationUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); Diabetes Endocrinology Research; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tzumin Lee for MARCM flies, Bill Theurkauf for H2AvD antibody, Ping Shen for DILP flies, and Lynn Cooley for collagen IV-GFP flies originated from Bill Chia. We also thank Michael Brodsky, John Abrams, Marc Tatar, Norbert Perrimon, and Allan Spradling for sharing fly stocks. The work in YTI laboratory was supported by grants from NIH (DK75545 and GM53269) and Worcester Foundation for Biomedical Research, The work in J.J.'s laboratory was supported by grants from NIH, Welch Foundation, and Leukemia and Lymphoma Society. Core resources supported by the Diabetes Endocrinology Research Center grant DK32520 were also used.	Baba Y, 2007, J GASTROENTEROL, V42, P874, DOI 10.1007/s00535-007-2112-2; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Choi NH, 2008, AGING CELL, V7, P318, DOI 10.1111/j.1474-9726.2008.00380.x; Clarkson MJ, 1999, NATURE, V399, P694, DOI 10.1038/21436; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Demidov ON, 2007, CELL STEM CELL, V1, P180, DOI 10.1016/j.stem.2007.05.020; Domingos PM, 2007, CURR OPIN GENET DEV, V17, P294, DOI 10.1016/j.gde.2007.05.009; Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Goberdhan DCI, 2003, DIFFERENTIATION, V71, P375, DOI 10.1046/j.1432-0436.2003.7107001.x; Hagimori K, 2007, BIOL PHARM BULL, V30, P1379, DOI 10.1248/bpb.30.1379; He XC, 2007, NAT GENET, V39, P189, DOI 10.1038/ng1928; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Kawada M, 2007, WORLD J GASTROENTERO, V13, P5581, DOI 10.3748/wjg.v13.i42.5581; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; Kitajima S, 2000, EXP ANIM TOKYO, V49, P9, DOI 10.1538/expanim.49.9; Klattenhoff C, 2007, DEV CELL, V12, P45, DOI 10.1016/j.devcel.2006.12.001; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Metcalfe AD, 2008, CELL MOL LIFE SCI, V65, P24, DOI 10.1007/s00018-007-7427-x; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Morel F, 2008, MUTAT RES-FUND MOL M, V637, P111, DOI 10.1016/j.mrfmmm.2007.07.007; Nakamura T, 2007, J GASTROENTEROL, V42, P705, DOI 10.1007/s00535-007-2087-z; Niemeyer Philipp, 2006, Curr Stem Cell Res Ther, V1, P21, DOI 10.2174/157488806775269151; Nystul TG, 2006, CURR OPIN GENET DEV, V16, P463, DOI 10.1016/j.gde.2006.08.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Pull SL, 2005, P NATL ACAD SCI USA, V102, P99, DOI 10.1073/pnas.0405979102; Radtke F, 2005, SCIENCE, V307, P1904, DOI 10.1126/science.1104815; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sangiorgi E, 2008, NAT GENET, V40, P915, DOI 10.1038/ng.165; Scoville DH, 2008, GASTROENTEROLOGY, V134, P849, DOI 10.1053/j.gastro.2008.01.079; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2; Theise ND, 2006, STEM CELL REV, V2, P169, DOI 10.1007/s12015-006-0044-5; Tlaskalova-Hogenova H, 2005, ANN NY ACAD SCI, V1051, P787, DOI 10.1196/annals.1361.122; Walker MR, 2008, CURR OPIN GASTROEN, V24, P115, DOI 10.1097/MOG.0b013e3282f4954f; Wallenfang MR, 2007, DEV CELL, V13, P603, DOI 10.1016/j.devcel.2007.10.011; Williams MJ, 2007, J IMMUNOL, V178, P4711, DOI 10.4049/jimmunol.178.8.4711; Wilson AA, 2008, BIOESSAYS, V30, P107, DOI 10.1002/bies.20710; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Yen TH, 2006, STEM CELL REV, V2, P203, DOI 10.1007/s12015-006-0048-1	48	355	364	3	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					49	61		10.1016/j.stem.2008.10.016	http://dx.doi.org/10.1016/j.stem.2008.10.016			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128792	Green Accepted, Bronze			2022-12-28	WOS:000262559500011
J	Liu, Y; Elf, SE; Miyata, Y; Sashida, G; Liu, YH; Huang, G; Di Giandomenico, S; Lee, JM; Deblasio, A; Menendez, S; Antipin, J; Reva, B; Koff, A; Nimer, SD				Liu, Yan; Elf, Shannon E.; Miyata, Yasuhiko; Sashida, Goro; Liu, Yuhui; Huang, Gang; Di Giandomenico, Silvana; Lee, Jennifer M.; Deblasio, Anthony; Menendez, Silvia; Antipin, Jack; Reva, Boris; Koff, Andrew; Nimer, Stephen D.			p53 Regulates Hematopoietic Stem Cell Quiescence	CELL STEM CELL			English	Article							GROWTH SUPPRESSOR NECDIN; WILD-TYPE P53; SELF-RENEWAL; TUMOR-SUPPRESSOR; GENE-EXPRESSION; IN-VITRO; PROLIFERATION; PROGENITOR; APOPTOSIS; DISRUPTION	The importance of the p53 protein in the cellular response to DNA damage is well known, but its function during steady-state hematopoiesis has not been established. We have defined a critical role of p53 in regulating hematopoietic stem cell quiescence, especially in promoting the enhanced quiescence seen in HSCs that lack the MEF/ELF4 transcription factor. Transcription profiling of HSCs; isolated from wild-type and p53 null mice identified Gfi-1 and Necdin as p53 target genes, and using lentiviral vectors to upregulate or knockdown the expression of these genes, we show their importance in regulating HSC quiescence. Establishing the role of p53 (and its target genes) in controlling the cell-cycle entry of HSCs may lead to therapeutic strategies capable of eliminating quiescent cancer (stem) cells.	[Liu, Yan; Elf, Shannon E.; Miyata, Yasuhiko; Sashida, Goro; Huang, Gang; Di Giandomenico, Silvana; Lee, Jennifer M.; Deblasio, Anthony; Menendez, Silvia; Nimer, Stephen D.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Phamacol & Chem Program, New York, NY 10021 USA; [Liu, Yuhui; Koff, Andrew] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Biol Program, New York, NY 10021 USA; [Antipin, Jack; Reva, Boris] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Computat Biol Program, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Nimer, SD (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Mol Phamacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.	s-nimer@mskcc.org	Reva, Boris/AAB-8932-2022; Reva, Boris A./B-6436-2014; Sashida, Goro/N-5259-2014	Reva, Boris A./0000-0002-8805-389X; Sashida, Goro/0000-0003-2318-5987; Koff, Andrew/0000-0003-3271-3067	NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052208, R01DK052208] Funding Source: NIH RePORTER; NCI NIH HHS [P30 CA008748] Funding Source: Medline; NIDDK NIH HHS [R01 DK052208, R56 DK052208, R01 DK52208, R01 DK052208-09A2] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Arai F, 2004, CELL, V118, P149, DOI 10.1016/j.cell.2004.07.004; Attar EC, 2004, LEUKEMIA, V18, P1760, DOI 10.1038/sj.leu.2403515; Boiko AD, 2006, GENE DEV, V20, P236, DOI 10.1101/gad.1372606; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen JC, 2008, EXP HEMATOL, V36, P1236, DOI 10.1016/j.exphem.2008.04.012; Cheng T, 2000, SCIENCE, V287, P1804, DOI 10.1126/science.287.5459.1804; Dumble M, 2007, BLOOD, V109, P1736, DOI 10.1182/blood-2006-03-010413; Forsberg EC, 2005, PLOS GENET, V1, P281, DOI 10.1371/journal.pgen.0010028; Gerard M, 1999, NAT GENET, V23, P199, DOI 10.1038/13828; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Groszer M, 2006, P NATL ACAD SCI USA, V103, P111, DOI 10.1073/pnas.0509939103; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Hu B, 2003, P NATL ACAD SCI USA, V100, P10008, DOI 10.1073/pnas.1737765100; Ito K, 2006, NAT MED, V12, P446, DOI 10.1038/nm1388; Jankovic V, 2007, P NATL ACAD SCI USA, V104, P1260, DOI 10.1073/pnas.0607894104; Janzen V, 2008, CELL STEM CELL, V2, P584, DOI 10.1016/j.stem.2008.03.012; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jordan CT, 2004, ONCOGENE, V23, P7178, DOI 10.1038/sj.onc.1207935; KASTAN MB, 1991, CANCER RES, V51, P4279; Komarova NL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000990; Krosl J, 2003, NAT MED, V9, P1428, DOI 10.1038/nm951; Kuwako K, 2005, J NEUROSCI, V25, P7090, DOI 10.1523/JNEUROSCI.2083-05.2005; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Ling KW, 2004, J EXP MED, V200, P871, DOI 10.1084/jem.20031556; LOTEM J, 1993, BLOOD, V82, P1092, DOI 10.1182/blood.V82.4.1092.bloodjournal8241092; Melchior K, 2008, BIOL CHEM, V389, P897, DOI 10.1515/BC.2008.108; Meletis K, 2006, DEVELOPMENT, V133, P363, DOI 10.1242/dev.02208; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; Muscatelli F, 2000, HUM MOL GENET, V9, P3101, DOI 10.1093/hmg/9.20.3101; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; PLOEMACHER RE, 1991, BLOOD, V78, P2527; PROKOCIMER M, 1994, BLOOD, V84, P2391; Qian H, 2007, CELL STEM CELL, V1, P671, DOI 10.1016/j.stem.2007.10.008; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; SHAULSKY G, 1991, P NATL ACAD SCI USA, V88, P8982, DOI 10.1073/pnas.88.20.8982; Shounan Y, 1996, LEUKEMIA, V10, P1619; Taniura H, 1999, J BIOL CHEM, V274, P16242, DOI 10.1074/jbc.274.23.16242; Taniura H, 2005, J CELL BIOCHEM, V94, P804, DOI 10.1002/jcb.20345; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Van Os R, 2007, STEM CELLS, V25, P836, DOI 10.1634/stemcells.2006-0631; Venezia TA, 2004, PLOS BIOL, V2, P1640, DOI 10.1371/journal.pbio.0020301; Vousden KH, 2007, NAT REV MOL CELL BIO, V8, P275, DOI 10.1038/nrm2147; Wilson A, 2006, NAT REV IMMUNOL, V6, P93, DOI 10.1038/nri1779; Wlodarski P, 1998, BLOOD, V91, P2998, DOI 10.1182/blood.V91.8.2998.2998_2998_3006; Wu WS, 2005, CELL, V123, P641, DOI 10.1016/j.cell.2005.09.029; Yilmaz OH, 2006, NATURE, V441, P475, DOI 10.1038/nature04703; Yoshihara H, 2007, CELL STEM CELL, V1, P685, DOI 10.1016/j.stem.2007.10.020; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zeng H, 2004, EMBO J, V23, P4116, DOI 10.1038/sj.emboj.7600419; Zhang JW, 2006, NATURE, V441, P518, DOI 10.1038/nature04747; Zhao RB, 2000, GENE DEV, V14, P981; Zhu JF, 2002, IMMUNITY, V16, P733, DOI 10.1016/S1074-7613(02)00317-5	57	397	407	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					37	48		10.1016/j.stem.2008.11.006	http://dx.doi.org/10.1016/j.stem.2008.11.006			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128791	Bronze, Green Accepted			2022-12-28	WOS:000262559500010
J	Malhotra, S; Kincade, PW				Malhotra, Sachin; Kincade, Paul W.			Wnt-Related Molecules and Signaling Pathway Equilibrium in Hematopoiesis	CELL STEM CELL			English	Review							GLYCOGEN-SYNTHASE KINASE-3; FRIZZLED-RELATED PROTEIN-1; STEM-CELL NICHE; BETA-CATENIN; SELF-RENEWAL; TUMOR-SUPPRESSOR; GENE FAMILY; EXPRESSION; DIFFERENTIATION; ACTIVATION		[Malhotra, Sachin; Kincade, Paul W.] Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA; [Malhotra, Sachin; Kincade, Paul W.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	Oklahoma Medical Research Foundation; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center	Kincade, PW (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Oklahoma Med Res Fdn, Immunobiol & Canc Program, Oklahoma City, OK 73104 USA.	kincade@omrf.ouhsc.edu			National Institutes of Health [A1020069, A1058162, A1069024]; Rita Bell Endowed Chair in Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI069024, R01AI020069, R01AI058162] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Rita Bell Endowed Chair in Biomedical Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Work in our laboratory is supported by grants A1020069. A1058162 ' and A1069024 from the National Institutes of Health. P.W.K. holds the William H. and Rita Bell Endowed Chair in Biomedical Research.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Austin TW, 1997, BLOOD, V89, P3624, DOI 10.1182/blood.V89.10.3624.3624_3624_3635; Baba Y, 2005, IMMUNITY, V23, P599, DOI 10.1016/j.immuni.2005.10.009; Baba Y, 2006, J IMMUNOL, V177, P2294, DOI 10.4049/jimmunol.177.4.2294; Baksh D, 2007, J CELL BIOCHEM, V101, P1109, DOI 10.1002/jcb.21097; Balciunaite G, 2002, NAT IMMUNOL, V3, P1102, DOI 10.1038/ni850; Barolo S, 2006, ONCOGENE, V25, P7505, DOI 10.1038/sj.onc.1210057; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Brawley C, 2004, SCIENCE, V304, P1331, DOI 10.1126/science.1097676; CELSO CL, 2008, NATURE IN PRESS, DOI DOI 10.1038/NATURE07434; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Cobaleda C, 2008, CURR OPIN IMMUNOL, V20, P139, DOI 10.1016/j.coi.2008.03.017; Cobas M, 2004, J EXP MED, V199, P221, DOI 10.1084/jem.20031615; Congdon KL, 2008, STEM CELLS, V26, P1202, DOI 10.1634/stemcells.2007-0768; Daugherty RL, 2007, PHYSIOLOGY, V22, P303, DOI 10.1152/physiol.00020.2007; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dosen G, 2006, BMC IMMUNOL, V7, DOI 10.1186/1471-2172-7-13; Duncan AW, 2005, NAT IMMUNOL, V6, P314, DOI 10.1038/ni1164; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Ferrell CM, 2005, STEM CELLS, V23, P644, DOI 10.1634/stemcells.2004-0198; Fleming HE, 2008, CELL STEM CELL, V2, P274, DOI 10.1016/j.stem.2008.01.003; Graf T, 2008, CELL STEM CELL, V3, P480, DOI 10.1016/j.stem.2008.10.007; Habibian HK, 1998, J EXP MED, V188, P393, DOI 10.1084/jem.188.2.393; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Haug JS, 2008, CELL STEM CELL, V2, P367, DOI 10.1016/j.stem.2008.01.017; Holmes T, 2008, STEM CELLS, V26, P1288, DOI 10.1634/stemcells.2007-0600; Hsu W, 2001, J CELL BIOL, V155, P1055, DOI 10.1083/jcb.200107066; Jeannet G, 2008, BLOOD, V111, P142, DOI 10.1182/blood-2007-07-102558; Kai T, 2004, NATURE, V428, P564, DOI 10.1038/nature02436; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Kim I, 2007, CELL, V130, P470, DOI 10.1016/j.cell.2007.06.011; Kirstetter P, 2006, NAT IMMUNOL, V7, P1048, DOI 10.1038/ni1381; Koch U, 2008, BLOOD, V111, P160, DOI 10.1182/blood-2007-07-099754; Kockeritz L, 2006, CURR DRUG TARGETS, V7, P1377, DOI 10.2174/1389450110607011377; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Lako M, 2001, MECH DEVELOP, V103, P49, DOI 10.1016/S0925-4773(01)00331-8; Leuker CE, 2001, J EXP MED, V193, P755, DOI 10.1084/jem.193.6.755; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Louis I, 2008, IMMUNITY, V29, P57, DOI 10.1016/j.immuni.2008.04.023; LUIS TC, 2008, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2008-06-163774; Lyons JP, 2004, EXP CELL RES, V298, P369, DOI 10.1016/j.yexcr.2004.04.036; MacDonald BT, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.036; MALHOTRA S, 2008, EXP HEMATOL IN PRESS, DOI DOI 10.1016/J.EX-PHEM.2008.08.008; Malhotra S, 2008, J IMMUNOL, V181, P3955, DOI 10.4049/jimmunol.181.6.3955; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; McKenzie JL, 2007, EXP HEMATOL, V35, P1429, DOI 10.1016/j.exphem.2007.05.017; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Mulroy T, 2002, EUR J IMMUNOL, V32, P967, DOI 10.1002/1521-4141(200204)32:4<967::AID-IMMU967>3.0.CO;2-6; Murdoch B, 2003, P NATL ACAD SCI USA, V100, P3422, DOI 10.1073/pnas.0130233100; Nemeth MJ, 2007, CELL RES, V17, P746, DOI 10.1038/cr.2007.69; Nemeth MJ, 2007, P NATL ACAD SCI USA, V104, P15436, DOI 10.1073/pnas.0704747104; Nemeth MJ, 2006, P NATL ACAD SCI USA, V103, P13783, DOI 10.1073/pnas.0604006103; Nusse R, 2005, CELL RES, V15, P28, DOI 10.1038/sj.cr.7290260; Petropoulos K, 2008, J EXP MED, V205, P515, DOI 10.1084/jem.20071875; PINZONE JJ, 2008, BLOOD IN PRESS, DOI DOI 10.1182/BLOOD-2008-03-145169; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ruiz P, 1996, J CELL BIOL, V135, P215, DOI 10.1083/jcb.135.1.215; Scheller M, 2006, NAT IMMUNOL, V7, P1037, DOI 10.1038/ni1387; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Semenov MV, 2007, CELL, V131, DOI 10.1016/j.cell.2007.12.011; Sieburg HB, 2006, BLOOD, V107, P2311, DOI 10.1182/blood-2005-07-2970; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Staal FJT, 2008, EUR J IMMUNOL, V38, P1788, DOI 10.1002/eji.200738118; Tao W, 2007, STEM CELLS, V25, P670, DOI 10.1634/stemcells.2006-0553; Templin C, 2008, EXP HEMATOL, V36, P204, DOI 10.1016/j.exphem.2007.10.005; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/jcb.200303158; Trowbridge JJ, 2006, NAT MED, V12, P89, DOI 10.1038/nm1339; Tu XL, 2007, DEV CELL, V12, P113, DOI 10.1016/j.devcel.2006.11.003; Ulyanova T, 2007, EXP HEMATOL, V35, P565, DOI 10.1016/j.exphem.2007.01.031; Uren A, 2000, J BIOL CHEM, V275, P4374, DOI 10.1074/jbc.275.6.4374; Van den Berg DJ, 1998, BLOOD, V92, P3189, DOI 10.1182/blood.V92.9.3189.421k45_3189_3202; Weerkamp F, 2006, P NATL ACAD SCI USA, V103, P3322, DOI 10.1073/pnas.0511299103; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Wilson A, 2007, ANN NY ACAD SCI, V1106, P64, DOI 10.1196/annals.1392.021; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamane T, 2001, J IMMUNOL, V167, P765, DOI 10.4049/jimmunol.167.2.765; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; YOKOTA T, 2008, J IMMUNOL IN PRESS; Yu Q, 2008, J IMMUNOL, V181, P3777, DOI 10.4049/jimmunol.181.6.3777; Zhang JW, 2008, J BIOL CHEM, V283, P9499, DOI 10.1074/jbc.R700043200; Zhao C, 2007, CANCER CELL, V12, P528, DOI 10.1016/j.ccr.2007.11.003; Zhong XT, 2007, J BIOL CHEM, V282, P20523, DOI 10.1074/jbc.M609096200	87	134	144	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					27	36		10.1016/j.stem.2008.12.004	http://dx.doi.org/10.1016/j.stem.2008.12.004			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128790	Green Accepted, Bronze			2022-12-28	WOS:000262559500009
J	van Os, R; de Haan, G; Dykstra, BJ				van Os, Ronald; de Haan, Gerald; Dykstra, Brad J.			Hematopoietic Stem Cell Quiescence: Yet Another Role for p53	CELL STEM CELL			English	Editorial Material							CANCER; MICE		[van Os, Ronald; de Haan, Gerald; Dykstra, Brad J.] Univ Groningen, Univ Med Ctr Groningen, Sect Stem Cell Biol, Dept Cell Biol, NL-9713 AV Groningen, Netherlands	University of Groningen	de Haan, G (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Sect Stem Cell Biol, Dept Cell Biol, NL-9713 AV Groningen, Netherlands.	g.de.haan@med.umcg.nl	van Os, Ronald/I-1516-2013; de Haan, Gerald/D-2081-2015; de Haan, Gerald/AAF-8963-2019	de Haan, Gerald/0000-0001-9706-0138; de Haan, Gerald/0000-0001-9706-0138				Hock H, 2004, NATURE, V431, P1002, DOI 10.1038/nature02994; Lacorazza HD, 2006, CANCER CELL, V9, P175, DOI 10.1016/j.ccr.2006.02.017; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; Pardal R, 2003, NAT REV CANCER, V3, P895, DOI 10.1038/nrc1232; TeKippe M, 2003, EXP HEMATOL, V31, P521, DOI 10.1016/S0301-472X(03)00072-9; Tyner SD, 2002, NATURE, V415, P45, DOI 10.1038/415045a; Yao JJ, 2007, ONCOGENE, V26, P4032, DOI 10.1038/sj.onc.1210170; Yoshikawa K, 2000, NEUROSCI RES, V37, P1, DOI 10.1016/S0168-0102(00)00101-2; Zon LI, 2008, NATURE, V453, P306, DOI 10.1038/nature07038	9	9	9	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 9	2009	4	1					7	8		10.1016/j.stem.2008.12.007	http://dx.doi.org/10.1016/j.stem.2008.12.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	395YN	19128788	Bronze			2022-12-28	WOS:000262559500004
J	Vodyanik, MA; Yu, JY; Zhang, X; Tian, SL; Stewart, R; Thomson, JA; Slukvin, II				Vodyanik, Maxim A.; Yu, Junying; Zhang, Xin; Tian, Shulan; Stewart, Ron; Thomson, James A.; Slukvin, Igor I.			A Mesoderm-Derived Precursor for Mesenchymal Stem and Endothelial Cells	CELL STEM CELL			English	Article							STROMAL CELLS; NEURAL CREST; IN-VITRO; HEMATOPOIETIC PROGENITORS; AORTIC ENDOTHELIUM; COMMON PRECURSOR; RECEPTOR APJ; DORSAL AORTA; DIFFERENTIATION; LINEAGE	Among the three embryonic germ layers, the mesoderm is a major source of the mesenchymal precursors giving rise to skeletal and connective tissues, but these precursors have not previously been identified and characterized. Using human embryonic stem cells directed toward mesendodermal differentiation, we show that mesenchymal stem/stromal cells (MSCs) originate from a population of mesodermal cells identified by expression of apelin receptor. In semisolid medium, these precursors form FGF2-dependent compact spheroid colonies containing mesenchymal cells with a transcriptional profile representative of mesoderm-derived embryonic mesenchyme. When transferred to adherent cultures, individual colonies give rise to MSC lines with chondro-, osteo-, and adipogenic differentiation potentials. Although the MSC lines lacked endothelial potential, endothelial cells could be derived from the mesenchymal colonies, suggesting that, similar to hematopoietic cells, MSCs arise from precursors with angiogenic potential. Together, these studies identified a common precursor of mesenchymal and endothelial cells, mesenchy-moangioblast, as the source of mesoderm-derived MSCs.	[Vodyanik, Maxim A.; Yu, Junying; Thomson, James A.; Slukvin, Igor I.] Univ Wisconsin, Grad Sch, Natl Primate Res Ctr, Madison, WI 53715 USA; [Zhang, Xin] WiCell Res Inst, Madison, WI 53726 USA; [Tian, Shulan; Stewart, Ron; Thomson, James A.] Morgridge Inst Res, Madison, WI 53706 USA; [Slukvin, Igor I.] Univ Wisconsin, Sch Med, Dept Pathol & Lab Med, Madison, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; WiCell Research Institute; University of Wisconsin System; University of Wisconsin Madison; The Morgridge Institute for Research, Inc.; University of Wisconsin System; University of Wisconsin Madison	Slukvin, II (corresponding author), Univ Wisconsin, Grad Sch, Natl Primate Res Ctr, 1220 Capitol Court, Madison, WI 53715 USA.	islukvin@wisc.edu			National Institutes of Health [R01 HL081962, P01 GM081629, P51 RR000167]; Charlotte Geyer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P51RR000167] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081962] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM081629] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Charlotte Geyer Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Toru Nakano for providing OP9 cells, Dietmar Vestweber for providing endomucin antibodies, Gordon Keller for providing HES2.R26tdRFP hESC line, Mitchell Probasco for cell sorting, Clay Glennon for time-lapse photography, and Joan Larson and Krista Eastman for editorial assistance. This work was supported by funds from the National Institutes of Health (R01 HL081962, P01 GM081629, and P51 RR000167) and the Charlotte Geyer Foundation. J.A.T. owns stock, serves on the Board of Directors, and serves as Chief Scientific Officer of Cellular Dynamics International. J.A.T. also serves as Scientific Director of the WiCell Research Institute. I.I.S. owns stock and is the scientific founder of Cellular Dynamics International.	Amit M, 2000, DEV BIOL, V227, P271, DOI 10.1006/dbio.2000.9912; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Blazsek I, 2000, BLOOD, V96, P3763, DOI 10.1182/blood.V96.12.3763.h8003763_3763_3771; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Boyd NL, 2009, TISSUE ENG PT A, V15, P1897, DOI 10.1089/ten.tea.2008.0351; Choi K, 1998, DEVELOPMENT, V125, P725; Ciruna B, 2001, DEV CELL, V1, P37, DOI 10.1016/S1534-5807(01)00017-X; Cleaver O, 1998, DEVELOPMENT, V125, P3905; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; D'Aniello C, 2009, CIRC RES, V105, P231, DOI 10.1161/CIRCRESAHA.109.201186; D'Souza SL, 2005, BLOOD, V105, P3862, DOI 10.1182/blood-2004-09-3611; Delorme B, 2006, REGEN MED, V1, P497, DOI 10.2217/17460751.1.4.497; Dennis JE, 2002, STEM CELLS, V20, P205, DOI 10.1634/stemcells.20-3-205; Devic E, 1996, MECH DEVELOP, V59, P129, DOI 10.1016/0925-4773(96)00585-0; Evans DJR, 2006, DEV DYNAM, V235, P1310, DOI 10.1002/dvdy.20663; FRIEDENSTEIN AJ, 1974, TRANSPLANTATION, V17, P331, DOI 10.1097/00007890-197404000-00001; Gadue P, 2005, EXP HEMATOL, V33, P955, DOI 10.1016/j.exphem.2005.06.009; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Inui M, 2006, DEV BIOL, V298, P188, DOI 10.1016/j.ydbio.2006.06.028; Irion S, 2007, NAT BIOTECHNOL, V25, P1477, DOI 10.1038/nbt1362; Karlsson C, 2009, STEM CELL RES; Kennedy M, 1997, NATURE, V386, P488, DOI 10.1038/386488a0; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lian QZ, 2007, STEM CELLS, V25, P425, DOI 10.1634/stemcells.2006-0420; Lian QZ, 2010, CIRCULATION, V121, P1113, DOI 10.1161/CIRCULATIONAHA.109.898312; Mendes SC, 2005, DEVELOPMENT, V132, P1127, DOI 10.1242/dev.01615; Minasi MG, 2002, DEVELOPMENT, V129, P2773; Morikawa S, 2009, BIOCHEM BIOPH RES CO, V379, P1114, DOI 10.1016/j.bbrc.2009.01.031; Muguruma Y, 2006, BLOOD, V107, P1878, DOI 10.1182/blood-2005-06-2211; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Nishikawa S, 1998, DEVELOPMENT, V125, P1747; NODEN DM, 1978, DEV BIOL, V67, P296, DOI 10.1016/0012-1606(78)90201-4; NODEN DM, 1990, ANN NY ACAD SCI, V588, P236, DOI 10.1111/j.1749-6632.1990.tb13214.x; Olivier EN, 2006, STEM CELLS, V24, P1914, DOI 10.1634/stemcells.2005-0648; ORRURTREGER A, 1992, DEVELOPMENT, V115, P289; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Sakurai H, 2006, STEM CELLS, V24, P575, DOI 10.1634/stemcells.2005-0256; Schroeder T, 2003, P NATL ACAD SCI USA, V100, P4018, DOI 10.1073/pnas.0438008100; Scott IC, 2007, DEV CELL, V12, P403, DOI 10.1016/j.devcel.2007.01.012; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Trentin A, 2004, P NATL ACAD SCI USA, V101, P4495, DOI 10.1073/pnas.0400629101; Trivedi P, 2008, EXP HEMATOL, V36, P350, DOI 10.1016/j.exphem.2007.10.007; Tsutsumi S, 2001, BIOCHEM BIOPH RES CO, V288, P413, DOI 10.1006/bbrc.2001.5777; Vodyanik MA, 2005, BLOOD, V105, P617, DOI 10.1182/blood-2004-04-1649; VODYANIK MA, 2007, CURR PROTOC CELL BIO, V27, P559; Vodyanik MA, 2006, BLOOD, V108, P2095, DOI 10.1182/blood-2006-02-003327; YAMAGUCHI TP, 1993, DEVELOPMENT, V118, P489; Yamashita J, 2000, NATURE, V408, P92, DOI 10.1038/35040568; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482; Zambidis ET, 2005, BLOOD, V106, P860, DOI 10.1182/blood-2004-11-4522; Zeng XXI, 2007, DEV CELL, V12, P391, DOI 10.1016/j.devcel.2007.01.011; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	63	213	231	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					718	729		10.1016/j.stem.2010.11.011	http://dx.doi.org/10.1016/j.stem.2010.11.011			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112566	Bronze, Green Accepted			2022-12-28	WOS:000285537700013
J	Simsek, T; Kocabas, F; Zheng, JK; DeBerardinis, RJ; Mahmoud, AI; Olson, EN; Schneider, JW; Zhang, CC; Sadek, HA				Simsek, Tugba; Kocabas, Fatih; Zheng, Junke; DeBerardinis, Ralph J.; Mahmoud, Ahmed I.; Olson, Eric N.; Schneider, Jay W.; Zhang, Cheng Cheng; Sadek, Hesham A.			The Distinct Metabolic Profile of Hematopoietic Stem Cells Reflects Their Location in a Hypoxic Niche	CELL STEM CELL			English	Article							MODELING PO(2) DISTRIBUTIONS; ENDOTHELIAL GROWTH-FACTOR; BONE-MARROW; PROGENITOR CELLS; OXYGEN-TENSION; HIF-ALPHA; KAPPA-B; EXPRESSION; GENES; MEIS1	Bone marrow transplantation is the primary therapy for numerous hematopoietic disorders. The efficiency of bone marrow transplantation depends on the function of long-term hematopoietic stem cells (LT-HSCs), which is markedly influenced by their hypoxic niche. Survival in this low-oxygen microenvironment requires significant metabolic adaptation. Here, we show that LT-HSCs utilize glycolysis instead of mitochondrial oxidative phosphorylation to meet their energy demands. We used flow cytometry to identify a unique low mitochondrial activity/glycolysis-dependent subpopulation that houses the majority of hematopoietic progenitors and LT-HSCs. Finally, we demonstrate that Meis1 and Hif-1 alpha are markedly enriched in LT-HSCs and that Meis1 regulates HSC metabolism through transcriptional activation of Hif-1 alpha. These findings reveal an important transcriptional network that regulates HSC metabolism.	[Zheng, Junke; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Zheng, Junke; Zhang, Cheng Cheng] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Simsek, Tugba; Kocabas, Fatih; Mahmoud, Ahmed I.; Schneider, Jay W.; Sadek, Hesham A.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Div Cardiol, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Pediat, Dallas, TX 75390 USA; [DeBerardinis, Ralph J.] Univ Texas SW Med Ctr Dallas, Dept Genet, Dallas, TX 75390 USA; [Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Zhang, CC (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	alec.zhang@utsouthwestern.edu; hesham.sadek@utsouthwestestern.edu	Kocabas, Fatih/B-2975-2012; Kocabas, Fatih/AAM-6391-2021; Zhang, Cheng/GRS-8698-2022	Kocabas, Fatih/0000-0001-8096-6056; Kocabas, Fatih/0000-0001-8096-6056; Mahmoud, Ahmed/0000-0003-1528-7393; Kocabas, Fatih/0000-0002-2854-9180	American Heart Association; Donald W. Reynolds Center for Clinical Cardiovascular Research; Welch Foundation [I-1701]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115275] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Donald W. Reynolds Center for Clinical Cardiovascular Research; Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank Dr. Joseph Garcia for his valuable input and Sean Goetsch for technical assistance. Work in the laboratory of H.A.S. was supported by grants from the American Heart Association and the Donald W. Reynolds Center for Clinical Cardiovascular Research. Support for C.C.Z. was provided by the Welch Foundation (I-1701).	Argiropoulos B, 2007, GENE DEV, V21, P2845, DOI 10.1101/gad.1619407; Azcoitia V, 2005, DEV BIOL, V280, P307, DOI 10.1016/j.ydbio.2005.01.004; BelAiba RS, 2007, MOL BIOL CELL, V18, P4691, DOI 10.1091/mbc.E07-04-0391; Blouin CC, 2004, BLOOD, V103, P1124, DOI 10.1182/blood-2003-07-2427; BRADLEY TR, 1978, J CELL PHYSIOL, V97, P517, DOI 10.1002/jcp.1040970327; Challen GA, 2009, CYTOM PART A, V75A, P14, DOI 10.1002/cyto.a.20674; CHANCE B, 1959, J BIOL CHEM, V234, P3044; Chow DC, 2001, BIOPHYS J, V81, P675, DOI 10.1016/S0006-3495(01)75732-3; Chow DC, 2001, BIOPHYS J, V81, P685, DOI 10.1016/S0006-3495(01)75733-5; CIPOLLESCHI MG, 1993, BLOOD, V82, P2031; Danet GH, 2003, J CLIN INVEST, V112, P126, DOI 10.1172/JCI200317669; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Eliasson P, 2010, J CELL PHYSIOL, V222, P17, DOI 10.1002/jcp.21908; Fuchs E, 2004, CELL, V116, P769, DOI 10.1016/S0092-8674(04)00255-7; Goodell MA, 1997, NAT MED, V3, P1337, DOI 10.1038/nm1297-1337; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Hagg M, 2005, EXP CELL RES, V306, P180, DOI 10.1016/j.yexcr.2005.01.017; Hirota K, 2004, J BIOL CHEM, V279, P41521, DOI 10.1074/jbc.M405164200; Hisa T, 2004, EMBO J, V23, P450, DOI 10.1038/sj.emboj.7600038; Imamura T, 2002, BRIT J HAEMATOL, V119, P119, DOI 10.1046/j.1365-2141.2002.03803.x; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jiang BH, 1997, CANCER RES, V57, P5328; Kamura T, 2000, P NATL ACAD SCI USA, V97, P10430, DOI 10.1073/pnas.190332597; KATAHIRA J, 1987, INT J CELL CLONING, V5, P412, DOI 10.1002/stem.5530050506; Kiel MJ, 2007, CELL STEM CELL, V1, P204, DOI 10.1016/j.stem.2007.06.001; Kim CG, 2006, MOL CELLS, V21, P343; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; KOLLER MR, 1992, EXP HEMATOL, V20, P264; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kubota Y, 2008, BIOCHEM BIOPH RES CO, V366, P335, DOI 10.1016/j.bbrc.2007.11.086; LaIuppa JA, 1998, EXP HEMATOL, V26, P835; Laughner E, 2001, MOL CELL BIOL, V21, P3995, DOI 10.1128/MCB.21.12.3995-4004.2001; Li ZB, 2005, EMBO REP, V6, P373, DOI 10.1038/sj.embor.7400377; Li ZX, 2006, TRENDS BIOCHEM SCI, V31, P589, DOI 10.1016/j.tibs.2006.08.001; Liu Q, 2004, BLOOD, V104, P3993, DOI 10.1182/blood-2004-03-1017; Lo Celso C, 2009, J BIOPHOTONICS, V2, P619, DOI 10.1002/jbio.200910072; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Maxwell PJ, 2007, ONCOGENE, V26, P7333, DOI 10.1038/sj.onc.1210536; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MURRAY L, 1995, BLOOD, V85, P368; Nakayama K, 2004, CELL, V117, P941, DOI 10.1016/j.cell.2004.06.001; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; PEAULT B, 1993, LEUKEMIA, V7, pS98; Pineault N, 2002, EXP HEMATOL, V30, P49, DOI 10.1016/S0301-472X(01)00757-3; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Qi JF, 2008, P NATL ACAD SCI USA, V105, P16713, DOI 10.1073/pnas.0804063105; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Salceda S, 1997, J BIOL CHEM, V272, P22642, DOI 10.1074/jbc.272.36.22642; Scharenberg CW, 2002, BLOOD, V99, P507, DOI 10.1182/blood.V99.2.507; SEMENZA GL, 2007, SCI STKE, pCM8, DOI DOI 10.1126/STKE.4072007CM8; Spradling A, 2001, NATURE, V414, P98, DOI 10.1038/35102160; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhang CC, 2005, BLOOD, V105, P4314, DOI 10.1182/blood-2004-11-4418; Zhang CC, 2004, BLOOD, V103, P2513, DOI 10.1182/blood-2003-08-2955; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zhou S, 2001, NAT MED, V7, P1028, DOI 10.1038/nm0901-1028	60	718	742	3	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					380	390		10.1016/j.stem.2010.07.011	http://dx.doi.org/10.1016/j.stem.2010.07.011			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804973	Bronze, Green Accepted			2022-12-28	WOS:000282037800014
J	Passier, R; Mummery, C				Passier, Robert; Mummery, Christine			Getting to the Heart of the Matter: Direct Reprogramming to Cardiomyocytes	CELL STEM CELL			English	Editorial Material							DEFINED FACTORS; CELLS; FIBROBLASTS; THERAPY		[Passier, Robert; Mummery, Christine] Leiden Univ, Med Ctr, Dept Anat & Embryol, NL-2333 ZC Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Passier, R (corresponding author), Leiden Univ, Med Ctr, Dept Anat & Embryol, Einthovenweg 20, NL-2333 ZC Leiden, Netherlands.	r.passier@lumc.nl; c.l.mummery@lumc.nl		Mummery, Christine/0000-0002-4549-6535				CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; Hochedlinger K, 2006, NATURE, V441, P1061, DOI 10.1038/nature04955; IEDA M, 2010, CELL IN PRESS, V142; Izumikawa M, 2005, NAT MED, V11, P271, DOI 10.1038/nm1193; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takeuchi JK, 2009, NATURE, V459, P708, DOI 10.1038/nature08039; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	10	12	14	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	AUG 6	2010	7	2					139	141		10.1016/j.stem.2010.07.004	http://dx.doi.org/10.1016/j.stem.2010.07.004			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	641EK	20682439	Bronze			2022-12-28	WOS:000281107400003
J	Samavarchi-Tehrani, P; Golipour, A; David, L; Sung, HK; Beyer, TA; Datti, A; Woltjen, K; Nagy, A; Wrana, JL				Samavarchi-Tehrani, Payman; Golipour, Azadeh; David, Laurent; Sung, Hoon-Ki; Beyer, Tobias A.; Datti, Alessandro; Woltjen, Knut; Nagy, Andras; Wrana, Jeffrey L.			Functional Genomics Reveals a BMP-Driven Mesenchymal-to-Epithelial Transition in the Initiation of Somatic Cell Reprogramming	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; MIR-200 FAMILY; NANOG; FIBROBLASTS; EXPRESSION; DIFFERENTIATION; GENERATION; SALL4; INDUCTION; SYSTEM	Somatic cells can be reprogrammed to induced pluripotent stem cells (iPSCs) by expression of defined embryonic factors. However, little is known of the molecular mechanisms underlying the reprogramming process. Here we explore somatic cell reprogramming by exploiting a secondary mouse embryonic fibroblast model that forms iPSCs with high efficiency upon inducible expression of Oct4, Klf4, c-Myc, and Sox2. Temporal analysis of gene expression revealed that reprogramming is a multistep process that is characterized by initiation, maturation, and stabilization phases. Functional analysis by systematic RNAi screening further uncovered a key role for BMP signaling and the induction of mesenchymal-to-epithelial transition (MET) during the initiation phase. We show that this is linked to BMP-dependent induction of miR-205 and the miR-200 family of microRNAs that are key regulators of MET. These studies thus define a multistep mechanism that incorporates a BMP-miRNA-MET axis during somatic cell reprogramming.	[Samavarchi-Tehrani, Payman; Golipour, Azadeh; David, Laurent; Beyer, Tobias A.; Datti, Alessandro; Wrana, Jeffrey L.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Syst Biol, Toronto, ON M5G 1X5, Canada; [Sung, Hoon-Ki; Woltjen, Knut; Nagy, Andras] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Ctr Stem Cells & Tissue Engn, Toronto, ON M5G 1X5, Canada; [Samavarchi-Tehrani, Payman; Golipour, Azadeh; Nagy, Andras; Wrana, Jeffrey L.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Woltjen, K (corresponding author), Kyoto Univ, Inst Integrated Cell Mat Sci iCeMS, Ctr iPS Cell Res & Applicat CiRA, Kyoto 6068507, Japan.	woltjen@cira.kyoto-u.ac.jp; nagy@lunenfeld.ca; wrana@lunenfeld.ca	Sung, Hoon-Ki/A-1922-2016; Wrana, Jeffrey/F-8857-2013; Datti, Alessandro/ABA-1108-2021; Nagy, Andras/G-6465-2013; Sung, Hoon-Ki/G-3049-2013	Sung, Hoon-Ki/0000-0001-6677-9385; Datti, Alessandro/0000-0001-6824-7382; Nagy, Andras/0000-0003-4311-0413; Woltjen, Knut/0000-0003-2293-1183; David, Laurent/0000-0003-3594-0353	CIHR [MOP12860, MOP-210751]; Canadian Stem Cell Network; Ontario Ministry of Resource and Innovation; Swish National Science Foundation	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Stem Cell Network; Ontario Ministry of Resource and Innovation; Swish National Science Foundation	The authors thank T. Sun and F. Vizeacoumar for assistance with robotics, J. Audet for the FACS machine, M. Gertsenstein and M. Pereira for the chimera production, M. Narimatsu for helping with chimera processing, M. Mileikovkaia for advice, J. Ellis for discussions, and L. Attisano for critical review of the manuscript. This work was supported by funds from CIHR (to J.L.W. grant #MOP12860 and A.N. grant #MOP-210751), the Canadian Stem Cell Network (J.L.W. and A.N.), and the Ontario Ministry of Resource and Innovation (J.L.W.). L.D. and P.S.-T. are CIHR Fellowship recipients and T.A.B. is a Swish National Science Foundation Fellowship recipient. A.N. is a CRC Chair in Stem Cell and Regeneration. J.L.W. is an HHMI International Scholar and CRC Chair in Systems Biology.	Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bracken CP, 2008, CANCER RES, V68, P7846, DOI 10.1158/0008-5472.CAN-08-1942; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; Furusawa T, 2006, BIOL REPROD, V75, P555, DOI 10.1095/biolreprod.105.049502; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; GURDON J. B., 1964, ADVANCE MORPHO GENESIS, V4, P1; Herrera B, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-20; Ichida JK, 2009, CELL STEM CELL, V5, P491, DOI 10.1016/j.stem.2009.09.012; Korpal M, 2008, J BIOL CHEM, V283, P14910, DOI 10.1074/jbc.C800074200; Lin CH, 2009, EMBO J, V28, P3157, DOI 10.1038/emboj.2009.254; Maherali N, 2008, CELL STEM CELL, V3, P340, DOI 10.1016/j.stem.2008.08.003; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Silva J, 2009, CELL, V138, P722, DOI 10.1016/j.cell.2009.07.039; Sridharan R, 2009, CELL, V136, P364, DOI 10.1016/j.cell.2009.01.001; Suzuki A, 2006, P NATL ACAD SCI USA, V103, P10294, DOI 10.1073/pnas.0506945103; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tsubooka N, 2009, GENES CELLS, V14, P683, DOI 10.1111/j.1365-2443.2009.01301.x; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Varga AC, 2005, ONCOGENE, V24, P5713, DOI 10.1038/sj.onc.1208919; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Xu D, 2009, P NATL ACAD SCI USA, V106, P808, DOI 10.1073/pnas.0812090106; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zhao TBA, 2010, TRENDS CELL BIOL, V20, P170, DOI 10.1016/j.tcb.2009.12.004	38	757	790	3	107	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					64	77		10.1016/j.stem.2010.04.015	http://dx.doi.org/10.1016/j.stem.2010.04.015			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621051	Bronze			2022-12-28	WOS:000280222300014
J	Aiden, AP; Rivera, MN; Rheinbay, E; Ku, MC; Coffman, EJ; Truong, TT; Vargas, SO; Lander, ES; Haber, DA; Bernstein, BE				Aiden, Aviva Presser; Rivera, Miguel N.; Rheinbay, Esther; Ku, Manching; Coffman, Erik J.; Truong, Thanh T.; Vargas, Sara O.; Lander, Eric S.; Haber, Daniel A.; Bernstein, Bradley E.			Wilms Tumor Chromatin Profiles Highlight Stem Cell Properties and a Renal Developmental Network	CELL STEM CELL			English	Article							WOLF-HIRSCHHORN-SYNDROME; MICE LACKING GDNF; GENE-EXPRESSION; KIDNEY DEVELOPMENT; HUMAN CANCER; MAMMALIAN KIDNEY; NONCODING RNAS; GENOME; METHYLATION; LOCUS	Wilms tumor is the most common pediatric kidney cancer. To identify transcriptional and epigenetic mechanisms that drive this disease, we compared genome-wide chromatin profiles of Wilms tumors, embryonic stem cells (ESCs), and normal kidney. Wilms tumors prominently exhibit large active chromatin domains previously observed in ESCs. In the cancer, these domains frequently correspond to genes that are critical for kidney development and expressed in the renal stem cell compartment. Wilms cells also express "embryonic" chromatin regulators and maintain stem cell-like p16 silencing. Finally, Wilms and ESCs both exhibit "bivalent" chromatin modifications at silent promoters that may be poised for activation. In Wilms tumor, bivalent promoters correlate to genes expressed in specific kidney compartments and point to a kidney-specific differentiation program arrested at an early-progenitor stage. We suggest that Wilms cells share a transcriptional and epigenetic landscape with a normal renal stem cell, which is inherently susceptible to transformation and may represent a cell of origin for this disease.	[Aiden, Aviva Presser; Rivera, Miguel N.; Rheinbay, Esther; Ku, Manching; Truong, Thanh T.; Lander, Eric S.; Haber, Daniel A.; Bernstein, Bradley E.] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Aiden, Aviva Presser] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Rivera, Miguel N.; Rheinbay, Esther; Ku, Manching; Truong, Thanh T.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Rivera, Miguel N.; Rheinbay, Esther; Ku, Manching; Truong, Thanh T.; Bernstein, Bradley E.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Rivera, Miguel N.; Rheinbay, Esther; Ku, Manching; Coffman, Erik J.; Truong, Thanh T.; Haber, Daniel A.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Canc Res, Boston, MA 02114 USA; [Rheinbay, Esther; Ku, Manching; Truong, Thanh T.; Bernstein, Bradley E.] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Rivera, Miguel N.; Rheinbay, Esther; Ku, Manching; Coffman, Erik J.; Truong, Thanh T.; Haber, Daniel A.; Bernstein, Bradley E.] Boston Univ, Howard Hughes Med Inst, Boston, MA 02115 USA; [Rheinbay, Esther] Boston Univ, Bioinformat Program, Boston, MA 02115 USA; [Rheinbay, Esther] Boston Univ, Dept Biomed Engn, Boston, MA 02115 USA; [Vargas, Sara O.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Vargas, Sara O.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Howard Hughes Medical Institute; Boston University; Boston University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Bernstein, BE (corresponding author), Broad Inst Harvard & MIT, Cambridge, MA 02142 USA.	bernstein.bradley@mgh.harvard.edu			National Defense Science and Engineering; NIDDK [K08DK080175]; Burroughs Wellcome Fund; Howard Hughes Medical Institute; MGH; Croucher Foundation; National Cancer Institute [R37CA058596, P50CA101942]; National Human Genome Research Institute; NATIONAL CANCER INSTITUTE [R37CA058596, P50CA101942] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG004570] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080175] Funding Source: NIH RePORTER	National Defense Science and Engineering; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Howard Hughes Medical Institute(Howard Hughes Medical Institute); MGH; Croucher Foundation; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Mazhar Adli, Alexa Burger, Chuck Epstein, and Noam Shoresh for helpful discussions and Erez Lieberman-Aiden for editing the manuscript. A.P.A. was supported by a National Defense Science and Engineering Graduate Fellowship. M.N.R. is supported by awards from the NIDDK (K08DK080175), the Burroughs Wellcome Fund, the Howard Hughes Medical Institute, and MGH. M.K. was supported by a fellowship from the Croucher Foundation. D.A.H. is an Investigator of the Howard Hughes Medical Institute and is also supported by grants from the National Cancer Institute (R37CA058596 and P50CA101942). B.E.B. is a Charles E. Culpeper Medical Scholar and an Early Career Scientist of the Howard Hughes Medical Institute. This research was supported by funds from the National Human Genome Research Institute, the National Cancer Institute, and the Burroughs Wellcome Fund.	Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; BARDEESY N, 1994, NAT GENET, V7, P91, DOI 10.1038/ng0594-91; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; BECKWITH J B, 1990, Pediatric Pathology, V10, P1; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bergemann AD, 2005, TRENDS GENET, V21, P188, DOI 10.1016/j.tig.2005.01.008; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Brodbeck S, 2004, PEDIATR NEPHROL, V19, P249, DOI 10.1007/s00467-003-1374-z; Brunskill EW, 2008, DEV CELL, V15, P781, DOI 10.1016/j.devcel.2008.09.007; CALL KM, 1990, CELL, V60, P509, DOI 10.1016/0092-8674(90)90601-A; Cui KR, 2009, CELL STEM CELL, V4, P80, DOI 10.1016/j.stem.2008.11.011; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; Dekel B, 2006, CANCER RES, V66, P6040, DOI 10.1158/0008-5472.CAN-05-4528; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Fukuzawa R, 2009, ONCOGENE, V28, P1063, DOI 10.1038/onc.2008.455; GESSLER M, 1990, NATURE, V343, P774, DOI 10.1038/343774a0; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Herman JG, 1996, P NATL ACAD SCI USA, V93, P9821, DOI 10.1073/pnas.93.18.9821; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; Kirmizis A, 2003, MOL CANCER THER, V2, P113; Kobayashi A, 2005, DEVELOPMENT, V132, P2809, DOI 10.1242/dev.01858; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Koesters R, 1999, CANCER RES, V59, P3880; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kubo H, 2009, GENES CELLS, V14, P407, DOI 10.1111/j.1365-2443.2009.01281.x; Kurotaki N, 2002, NAT GENET, V30, P365, DOI 10.1038/ng863; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li CM, 2004, AM J PATHOL, V165, P1943, DOI 10.1016/S0002-9440(10)63246-4; Li CM, 2002, AM J PATHOL, V160, P2181, DOI 10.1016/S0002-9440(10)61166-2; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Li W, 2009, J MED GENET, V46, P358, DOI 10.1136/jmg.2008.063123; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Moore AW, 1999, DEVELOPMENT, V126, P1845; Moore MW, 1996, NATURE, V382, P76, DOI 10.1038/382076a0; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Natrajan R, 2008, J CLIN PATHOL, V61, P95, DOI 10.1136/jcp.2007.047159; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; OGAWA O, 1993, NATURE, V362, P749, DOI 10.1038/362749a0; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Park JS, 2007, DEVELOPMENT, V134, P2533, DOI 10.1242/dev.006155; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rivera MN, 2007, SCIENCE, V315, P642, DOI 10.1126/science.1137509; Rivera MN, 2009, P NATL ACAD SCI USA, V106, P8338, DOI 10.1073/pnas.0811349106; Rivera MN, 2005, NAT REV CANCER, V5, P699, DOI 10.1038/nrc1696; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; WEKSBERG R, 1993, NAT GENET, V5, P143, DOI 10.1038/ng1093-143; Wong DJ, 2008, CELL STEM CELL, V2, P333, DOI 10.1016/j.stem.2008.02.009; Wu MQ, 2008, CARCINOGENESIS, V29, P1710, DOI 10.1093/carcin/bgn073; Wu WG, 2009, EUR J CANCER PREV, V18, P50, DOI 10.1097/CEJ.0b013e328305a07a; Yusenko MV, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-152; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	70	61	61	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					591	602		10.1016/j.stem.2010.03.016	http://dx.doi.org/10.1016/j.stem.2010.03.016			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569696	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000278840700019
J	Cuende, N; Izeta, A				Cuende, Natividad; Izeta, Ander			Clinical Translation of Stem Cell Therapies: A Bridgeable Gap	CELL STEM CELL			English	Editorial Material								Stem cell scientists trying to reach patients often lack the multidisciplinary skills needed to overcome complex regulatory barriers and may feel deterred from pursuing clinical implementation. In order to help bridge this gap, we offer a European perspective based on our hands-on experience at the Andalusian Initiative for Advanced Therapies.	[Cuende, Natividad] Andalusian Initiat Adv Therapies, Seville 41101, Spain; [Izeta, Ander] Hosp Donostia, Inst Biodonostia, San Sebastian 20014, Spain	Instituto de Investigacion Sanitaria Biodonostia; University Hospital Donostia	Cuende, N (corresponding author), Andalusian Initiat Adv Therapies, Seville 41101, Spain.	natividad.cuende.sspa@juntadeandalucia.es	Izeta, Ander/ABG-8973-2020; Izeta, Ander/H-6376-2011	Izeta, Ander/0000-0003-1879-7401; 				Ahrlund-Richter L, 2009, CELL STEM CELL, V4, P20, DOI 10.1016/j.stem.2008.11.012; Aiuti Alessandro, 2009, Hematology Am Soc Hematol Educ Program, P682, DOI 10.1182/asheducation-2009.1.682; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Daniels JT, 2006, REGEN MED, V1, P715, DOI 10.2217/17460751.1.5.715; Hyun I, 2008, CELL STEM CELL, V3, P607, DOI 10.1016/j.stem.2008.11.009; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Lysaght MJ, 2008, TISSUE ENG PT A, V14, P305, DOI 10.1089/tea.2007.0267; McKernan R, 2010, CELL STEM CELL, V6, P517, DOI 10.1016/j.stem.2010.05.012; Trounson A, 2010, CELL STEM CELL, V6, P513, DOI 10.1016/j.stem.2010.05.008; WAX PM, 1995, ANN INTERN MED, V122, P456, DOI 10.7326/0003-4819-122-6-199503150-00009; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935	11	35	37	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					508	512		10.1016/j.stem.2010.05.005	http://dx.doi.org/10.1016/j.stem.2010.05.005			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569686	Bronze			2022-12-28	WOS:000278840700009
J	Swiers, G; Speck, NA; de Bruijn, MFTR				Swiers, Gemma; Speck, Nancy A.; de Bruijn, Marella F. T. R.			Visualizing Blood Cell Emergence from Aortic Endothelium	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; HAEMOGENIC ENDOTHELIUM; TRANSITION	Three recent Nature papers use time-lapse confocal imaging to visualize the birth of blood cells from the aortic endothelium. Two studies (Bertrand et al., 2010; Kissa and Herbomel, 2010) utilize the zebrafish embryo, while the third (Boisset et al., 2010) develops a novel technique to image the mouse aorta.	[Speck, Nancy A.] Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA; [Swiers, Gemma; de Bruijn, Marella F. T. R.] Univ Oxford, MRC, Mol Haematol Unit, Weatherall Inst Mol Med, Oxford OX3 9DS, England; [Speck, Nancy A.] Univ Penn, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Oxford; University of Pennsylvania	Speck, NA (corresponding author), Univ Penn, Abramson Family Canc Res Inst, Philadelphia, PA 19104 USA.				NATIONAL CANCER INSTITUTE [R01CA058343] Funding Source: NIH RePORTER; Medical Research Council [G1000801h] Funding Source: researchfish; NCI NIH HHS [R01 CA058343] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Jaffredo T, 2005, EXP HEMATOL, V33, P1029, DOI 10.1016/j.exphem.2005.06.005; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	11	12	12	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 2	2010	6	4					289	290		10.1016/j.stem.2010.03.007	http://dx.doi.org/10.1016/j.stem.2010.03.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	585KD	20362528	Bronze			2022-12-28	WOS:000276823300002
J	Peter, ME				Peter, Marcus E.			Regulating Cancer Stem Cells the miR Way	CELL STEM CELL			English	Editorial Material							EPITHELIAL-MESENCHYMAL TRANSITION; MIR-200 FAMILY; ZEB1; TUMORIGENICITY; MICRORNAS		Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	University of Chicago	Peter, ME (corresponding author), Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA.	mpeter@uchicago.edu		Peter, Marcus Ernst/0000-0003-3216-036X				Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Lin SL, 2008, RNA, V14, P2115, DOI 10.1261/rna.1162708; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Spaderna S, 2006, GASTROENTEROLOGY, V131, P830, DOI 10.1053/j.gastro.2006.06.016; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	10	18	18	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					4	6		10.1016/j.stem.2009.12.006	http://dx.doi.org/10.1016/j.stem.2009.12.006			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085735	Bronze			2022-12-28	WOS:000274029700003
J	Bussmann, LH; Schubert, A; Manh, TPV; De Andres, L; Desbordes, SC; Parra, M; Zimmermann, T; Rapino, F; Rodriguez-Ubreva, J; Ballestar, E; Graf, T				Bussmann, Lars H.; Schubert, Alexis; Vu Manh, Thien Phong; De Andres, Luisa; Desbordes, Sabrina C.; Parra, Maribel; Zimmermann, Timo; Rapino, Francesca; Rodriguez-Ubreva, Javier; Ballestar, Esteban; Graf, Thomas			A Robust and Highly Efficient Immune Cell Reprogramming System	CELL STEM CELL			English	Article							C/EBP-ALPHA; IN-VIVO; TRANSCRIPTIONAL CONTROL; RHO-GTPASES; B-CELLS; GENES; PU.1; DIFFERENTIATION; MACROPHAGES; EXPRESSION	Here we describe a lineage reprogramming system consisting of a B cell line with an estradiol-inducible form of C/EBP alpha where cells can be converted into macrophage-like cells at 100% efficiency within 2 to 3 days. The reprogrammed cells are larger, contain altered organelle and cytoskeletal structures, are phagocytic, and exhibit an inflammatory response. Time-lapse experiments showed that the cells acquire a macrophage morphology and increased migratory activity as early as 10 hr. During induction, thousands of genes become up- or downregulated, including several dozen transcription and chromatin-remodeling factors. Time-limited exposure of cells to the inducer showed that the reprogrammed cells become transgene independent within 1 to 2 days. The reprogramming can be inhibited, at least partially, by perturbation experiments with B cell and macrophage transcription factors. The tightness, robustness, and speed of the system described make it a versatile tool to study biochemical and biological aspects of lineage reprogramming.	[Bussmann, Lars H.; Schubert, Alexis; Vu Manh, Thien Phong; De Andres, Luisa; Desbordes, Sabrina C.; Parra, Maribel; Zimmermann, Timo; Rapino, Francesca; Graf, Thomas] Ctr Genom Regulat, Barcelona 08003, Spain; [Bussmann, Lars H.; Schubert, Alexis; Vu Manh, Thien Phong; De Andres, Luisa; Desbordes, Sabrina C.; Parra, Maribel; Zimmermann, Timo; Rapino, Francesca; Graf, Thomas] Univ Pompeu Fabra, Barcelona 08003, Spain; [Desbordes, Sabrina C.; Rodriguez-Ubreva, Javier; Ballestar, Esteban] Bellvitge Inst Biomed Res IDIBELL, Barcelona 08907, Spain; [Graf, Thomas] Inst Catalana Recerca & Estudis Avancats, Catalonia, Spain	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); Pompeu Fabra University; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); ICREA	Graf, T (corresponding author), Ctr Genom Regulat, Barcelona 08003, Spain.	thomas.graf@crg.es	Ballestar, Esteban/ABG-8561-2020; Graf, Thomas/B-4252-2015; Zimmermann, Timo/G-1681-2015	Graf, Thomas/0000-0003-2774-4117; Zimmermann, Timo/0000-0001-7098-0700; RODRIGUEZ-UBREVA, JAVIER/0000-0003-4707-4536; Vu Manh, Thien-Phong/0000-0002-0294-342X; de Andres-Aguayo, Luisa/0000-0001-6717-242X; Parra, Maribel/0000-0002-9072-5763; Ballestar, Esteban/0000-0002-1400-2440	HEROIC; German Academic Exchange Service; Marie Curie; Ramon y Cajal; Juan de la Cierva; ICREA Funding Source: Custom	HEROIC(European Commission); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD)); Marie Curie(European Commission); Ramon y Cajal(Spanish Government); Juan de la Cierva(Instituto de Salud Carlos III); ICREA(ICREA)	We thank Drs. C. Murre, R. Grosschedl, and M. Busslinger for the E47, EBf, and Pax5 cDNA constructs, respectively; Dr. H. Xie for the C/EBP alpha ER, E47-GFP, EBF-GFP, and Pax5-EGFP retroviral constructs; Dr. R. Copin for the dsRed E coli strain; and Drs. M. Stadtfeld, C. Gekas, H. Xie, and M. Ye for comments on the manuscript. This work was supported by grants from HEROIC and Consolider to T.G., as well as by fellowships from the German Academic Exchange Service (L.B.), Marie Curie (A.S.), Ramon y Cajal (M.P.), and Juan de la Cierva (S.D.). Salary for T.G. provided by Institucio Catalana de Recerca I Estudis Avancats, Catalonia.	ALESSANDRINI A, 1987, P NATL ACAD SCI USA, V84, P1799, DOI 10.1073/pnas.84.7.1799; Brady G, 2005, J BIOL CHEM, V280, P30723, DOI 10.1074/jbc.M500435200; Busslinger M, 2004, ANNU REV IMMUNOL, V22, P55, DOI 10.1146/annurev.immunol.22.012703.104807; Cai DH, 2008, ONCOGENE, V27, P2772, DOI 10.1038/sj.onc.1210940; COOPER C, 1995, NUCLEIC ACIDS RES, V23, P4371, DOI 10.1093/nar/23.21.4371; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DeKoter RP, 2000, SCIENCE, V288, P1439, DOI 10.1126/science.288.5470.1439; Dengler HS, 2008, NAT IMMUNOL, V9, P1388, DOI 10.1038/ni.1667; Faust N, 1997, EXP HEMATOL, V25, P432; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; Friedman AD, 2007, ONCOGENE, V26, P6816, DOI 10.1038/sj.onc.1210764; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828; Horb ME, 2003, CURR BIOL, V13, P105, DOI 10.1016/S0960-9822(02)01434-3; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Laiosa CV, 2006, IMMUNITY, V25, P731, DOI 10.1016/j.immuni.2006.09.011; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Laslo P, 2006, CELL, V126, P755, DOI 10.1016/j.cell.2006.06.052; Lim JP, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-58; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Parada LA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-7-r44; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Porse BT, 2001, CELL, V107, P247, DOI 10.1016/S0092-8674(01)00516-5; Pridans C, 2008, J IMMUNOL, V180, P1719, DOI 10.4049/jimmunol.180.3.1719; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Schebesta A, 2007, IMMUNITY, V27, P49, DOI 10.1016/j.immuni.2007.05.019; Shen CN, 2003, MECH DEVELOP, V120, P107, DOI 10.1016/S0925-4773(02)00337-4; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomas MD, 2005, IMMUNITY, V23, P275, DOI 10.1016/j.immuni.2005.08.005; Wang W, 2001, LEUKEMIA, V15, P779, DOI 10.1038/sj.leu.2402094; Wang Xia, 2008, Chinese Journal of Zoology, V43, P109; Weigelt K, 2009, BIOCHEM BIOPH RES CO, V380, P308, DOI 10.1016/j.bbrc.2009.01.067; Weigelt K, 2008, BIOTECHNIQUES, V45, P131, DOI 10.2144/000112819; WEINTRAUB H, 1989, P NATL ACAD SCI USA, V86, P5434, DOI 10.1073/pnas.86.14.5434; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	42	105	107	0	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 6	2009	5	5					554	566		10.1016/j.stem.2009.10.004	http://dx.doi.org/10.1016/j.stem.2009.10.004			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	522SR	19896445	Bronze			2022-12-28	WOS:000272019500016
J	Marion, RM; Strati, K; Li, H; Tejera, A; Schoeftner, S; Ortega, S; Serrano, M; Blasco, MA				Marion, Rosa M.; Strati, Katerina; Li, Han; Tejera, Agueda; Schoeftner, Stefan; Ortega, Sagrario; Serrano, Manuel; Blasco, Maria A.			Telomeres Acquire Embryonic Stem Cell Characteristics in Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							HUMAN FIBROBLASTS; CHROMOSOMAL INSTABILITY; EPIGENETIC REGULATION; MAMMALIAN TELOMERES; PULMONARY-FIBROSIS; HUMAN-DISEASE; LIFE-SPAN; C-MYC; MOUSE; LENGTH	Telomere shortening is associated with organismal aging. PS cells have been recently derived from old patients; however, it is not known whether telomere chromatin acquires the same characteristics as in ES cells. We show here that telomeres are elongated in PS cells compared to the parental differentiated cells both when using four (Oct3/4, Sox2, Klf4, cMyc) or three (Oct3/4, Sox2, Klf4) reprogramming factors and both from young and aged individuals. We demonstrate genetically that, during reprogramming, telomere elongation is usually mediated by telomerase and that PS telomeres acquire the epigenetic marks of ES cells, including a low density of tri-methylated histones H3K9 and H4K20 and increased abundance of telomere transcripts. Finally, reprogramming efficiency of cells derived from increasing generations of telomerase-deficient mice shows a dramatic decrease in PS cell efficiency, a defect that is restored by telomerase reintroduction. Together, these results highlight the importance of telomere biology for PS cell generation and functionality.	[Marion, Rosa M.; Strati, Katerina; Tejera, Agueda; Schoeftner, Stefan; Blasco, Maria A.] Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, E-28029 Madrid, Spain; [Li, Han; Serrano, Manuel] Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Tumor Suppress Grp, E-28029 Madrid, Spain; [Ortega, Sagrario] Spanish Natl Canc Ctr CNIO, Biotechnol Program, Transgen Mice Unit, E-28029 Madrid, Spain	Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO); Centro Nacional de Investigaciones Oncologicas (CNIO)	Blasco, MA (corresponding author), Spanish Natl Canc Ctr CNIO, Mol Oncol Program, Telomeres & Telomerase Grp, Melchor Fernandez Almagro 3, E-28029 Madrid, Spain.	mblasco@cnio.es	Tejera, Agueda/Z-1938-2019; Tejera, Agueda M./AAU-2000-2021; Blasco, Maria A./M-1694-2014; Marión, Rosa/AAE-8657-2020; Serrano, Manuel/H-2634-2015; Strati, Katerina/GSN-2131-2022; Marión, Rosa/L-1488-2015; Tejera, Agueda/L-1946-2015	Blasco, Maria A./0000-0002-4211-233X; Marión, Rosa/0000-0002-0374-3884; Serrano, Manuel/0000-0001-7177-9312; Strati, Katerina/0000-0002-2332-787X; Marión, Rosa/0000-0002-0374-3884; Tejera, Agueda M/0000-0002-6703-9466; SCHOEFTNER, Stefan/0000-0002-8918-6627	Spanish Ministry of innovation and Science; Consolider-Ingenio 2010 Program; European Union; Korber European Science Award; Spanish Association Against Cancer (AECC)	Spanish Ministry of innovation and Science(Spanish Government); Consolider-Ingenio 2010 Program(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Korber European Science Award; Spanish Association Against Cancer (AECC)	M.A.B.'s laboratory is funded by the Spanish Ministry of innovation and Science, the Consolider-Ingenio 2010 Program, the European Union, the Korber European Science Award, and the Spanish Association Against Cancer (AECC). K.S. is funded by the AECC.	Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Benetti R, 2007, J CELL BIOL, V178, P925, DOI 10.1083/jcb.200703081; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Blasco MA, 2007, NAT REV GENET, V8, P299, DOI 10.1038/nrg2047; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Ferron S, 2004, DEVELOPMENT, V131, P4059, DOI 10.1242/dev.01215; Flores I, 2005, SCIENCE, V309, P1253, DOI 10.1126/science.1115025; Flores I, 2008, GENE DEV, V22, P654, DOI 10.1101/gad.451008; Flores I, 2006, MOL CELL BIOL, V26, P6130, DOI 10.1128/MCB.00543-06; Flores I, 2006, CURR OPIN CELL BIOL, V18, P254, DOI 10.1016/j.ceb.2006.03.003; Garcia-Cao M, 2004, NAT GENET, V36, P94, DOI 10.1038/ng1278; Gonzalo S, 2006, NAT CELL BIOL, V8, P416, DOI 10.1038/ncb1386; GRELDER CW, 1985, CELL, V43, P405; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950; Lanza RP, 2000, SCIENCE, V288, P665, DOI 10.1126/science.288.5466.665; Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Meeker AK, 2004, AM J PATHOL, V164, P925, DOI 10.1016/S0002-9440(10)63180-X; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Munoz P, 2005, NAT GENET, V37, P1063, DOI 10.1038/ng1633; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Samper E, 2002, BLOOD, V99, P2767, DOI 10.1182/blood.V99.8.2767; Samper E, 2001, EMBO REP, V2, P800, DOI 10.1093/embo-reports/kve174; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Shiels PG, 1999, NATURE, V399, P316, DOI 10.1038/20580; Siegl-Cachedenier I, 2007, J CELL BIOL, V179, P277, DOI 10.1083/jcb.200704141; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Vogel G, 2000, SCIENCE, V288, P586, DOI 10.1126/science.288.5466.586; Wakayama T, 2000, NATURE, V407, P318, DOI 10.1038/35030301; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Zhao R, 2008, J CELL BIOCHEM, V105, P949, DOI 10.1002/jcb.21871; Zijlmans JMJM, 1997, P NATL ACAD SCI USA, V94, P7423, DOI 10.1073/pnas.94.14.7423	54	357	381	1	45	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					141	154		10.1016/j.stem.2008.12.010	http://dx.doi.org/10.1016/j.stem.2008.12.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19200803	Bronze			2022-12-28	WOS:000263213400011
J	Wong, KM				Wong, Kathleen M.			New Administration Likely to Bring Change to Stem Cell Research	CELL STEM CELL			English	News Item																			0	4	4	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 6	2009	4	2					111	112		10.1016/j.stem.2009.01.011	http://dx.doi.org/10.1016/j.stem.2009.01.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	405HI	19209466	Bronze			2022-12-28	WOS:000263213400007
J	Kattman, SJ; Witty, AD; Gagliardi, M; Dubois, NC; Niapour, M; Hotta, A; Ellis, J; Keller, G				Kattman, Steven J.; Witty, Alec D.; Gagliardi, Mark; Dubois, Nicole C.; Niapour, Maryam; Hotta, Akitsu; Ellis, James; Keller, Gordon			Stage-Specific Optimization of Activin/Nodal and BMP Signaling Promotes Cardiac Differentiation of Mouse and Human Pluripotent Stem Cell Lines	CELL STEM CELL			English	Article							CARDIOVASCULAR PROGENITOR CELLS; BONE MORPHOGENETIC PROTEIN-4; PRIMITIVE STREAK; SMOOTH-MUSCLE; DEFINITIVE HEMATOPOIESIS; WNT/BETA-CATENIN; RECEPTOR-ALPHA; EXPRESSION; MESODERM; INDUCTION	Efficient differentiation of embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) to a variety of lineages requires step-wise approaches replicating the key commitment stages found during embryonic development. Here we show that expression of PdgfR-alpha segregates mouse ESC-derived Flk-1 mesoderm into Flk-1(+)PdgfR-alpha(+) cardiac and Flk-1(+)PdgfR-alpha(-) hematopoietic subpopulations. By monitoring Flk-1 and PdgfR-alpha expression, we found that specification of cardiac mesoderm and cardiomyocytes is determined by remarkably small changes in levels of Activin/Nodal and BMP signaling. Translation to human ESCs and iPSCs revealed that the emergence of cardiac mesoderm could also be monitored by coexpression of KDR and PDGFR-alpha and that this process was similarly dependent on optimal levels of Activin/Nodal and BMP signaling. Importantly, we found that individual mouse and human pluripotent stem cell lines require optimization of these signaling pathways for efficient cardiac differentiation, illustrating a principle that may well apply in other contexts.	[Kattman, Steven J.; Witty, Alec D.; Gagliardi, Mark; Dubois, Nicole C.; Niapour, Maryam; Keller, Gordon] Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada; [Witty, Alec D.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Hotta, Akitsu; Ellis, James] SickKids Toronto, Dev & Stem Cell Biol Program, Toronto, ON M5G 1X8, Canada; [Ellis, James] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto	Keller, G (corresponding author), Univ Hlth Network, McEwen Ctr Regenerat Med, Toronto, ON M5G 1L7, Canada.	gkeller@uhnresearch.ca	Ellis, James/F-4789-2011	Ellis, James/0000-0002-4400-0091; Hotta, Akitsu/0000-0002-2619-7441; Keller, Gordon/0000-0001-9309-9297	National Institutes of Health [R01 HL080627, CIHR 84524, F32 HL078112]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080627, F32HL078112] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We would like to thank members of the G.K. laboratory and Dr. Ian Scott for discussions and critical reading of the manuscript, Konrad Hochedlinger (Massachusetts General Hospital, Boston) for providing the Oct4-GFP and Sox2-GFP m-iPSC lines, George Daley (Harvard Medical School, Boston) for providing the MSC-iPS1 and 38-2 cell line, and Pier-Andree Penttila and the Sick Kids/UHN Flow Cytometry Facility for their assistance with cell sorting. This work was supported by National Institutes of Health grants R01 HL080627, CIHR 84524 to G.K. and F32 HL078112 to S.J.K. S.J.K. is currently an employee at Cellular Dynamics International.	Agius E, 2000, DEVELOPMENT, V127, P1173; CONLON FL, 1994, DEVELOPMENT, V120, P1919; Davis S, 2004, DEV BIOL, V270, P47, DOI 10.1016/j.ydbio.2004.01.048; Ema M, 2006, BLOOD, V107, P111, DOI 10.1182/blood-2005-05-1970; Ferkowicz MJ, 2003, DEVELOPMENT, V130, P4393, DOI 10.1242/dev.00632; Fujiwara T, 2002, DEVELOPMENT, V129, P4685; Gadue P, 2006, P NATL ACAD SCI USA, V103, P16806, DOI 10.1073/pnas.0603916103; Gritsman K, 2000, DEVELOPMENT, V127, P921; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hao JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002904; Hirata H, 2007, J BIOSCI BIOENG, V103, P412, DOI 10.1263/jbb.103.412; Hotta A, 2009, NAT METHODS, V6, P370, DOI [10.1038/NMETH.1325, 10.1038/nmeth.1325]; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; JOHANSSON BM, 1995, MOL CELL BIOL, V15, P141, DOI 10.1128/MCB.15.1.141; Kataoka H, 1997, DEV GROWTH DIFFER, V39, P729; Kattman SJ, 2006, DEV CELL, V11, P723, DOI 10.1016/j.devcel.2006.10.002; Kennedy M, 2007, BLOOD, V109, P2679, DOI 10.1182/blood-2006-09-047704; Klaus A, 2007, P NATL ACAD SCI USA, V104, P18531, DOI 10.1073/pnas.0703113104; Kouskoff V, 2005, P NATL ACAD SCI USA, V102, P13170, DOI 10.1073/pnas.0501672102; Kubo A, 2004, DEVELOPMENT, V131, P1651, DOI 10.1242/dev.01044; Kuzmenkin A, 2009, FASEB J, V23, P4168, DOI 10.1096/fj.08-128546; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Laflamme MA, 2007, NAT BIOTECHNOL, V25, P1015, DOI 10.1038/nbt1327; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Liu Y, 2007, P NATL ACAD SCI USA, V104, P3859, DOI 10.1073/pnas.0609100104; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Lu CC, 2004, DEV BIOL, V273, P149, DOI 10.1016/j.ydbio.2004.06.004; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Mauritz C, 2008, CIRCULATION, V118, P507, DOI 10.1161/CIRCULATIONAHA.108.778795; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Moretti A, 2006, CELL, V127, P1151, DOI 10.1016/j.cell.2006.10.029; Motoike T, 2003, GENESIS, V35, P153, DOI 10.1002/gene.10175; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Narazaki G, 2008, CIRCULATION, V118, P498, DOI 10.1161/CIRCULATIONAHA.108.769562; Ng ES, 2005, DEVELOPMENT, V132, P873, DOI 10.1242/dev.01657; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; NOSTRO MC, 2011, DEVELOPMENT IN PRESS; Paige SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011134; Park C, 2004, DEVELOPMENT, V131, P2749, DOI 10.1242/dev.01130; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Pfannkuche K, 2009, CELL PHYSIOL BIOCHEM, V24, P73, DOI 10.1159/000227815; Prall OWJ, 2007, CELL, V128, P947, DOI 10.1016/j.cell.2007.01.042; RUZICKA DL, 1988, J CELL BIOL, V107, P2575, DOI 10.1083/jcb.107.6.2575; Saga Y, 1999, DEVELOPMENT, V126, P3437; Saga Y, 1996, DEVELOPMENT, V122, P2769; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; SUGI Y, 1992, DEV DYNAM, V193, P116, DOI 10.1002/aja.1001930203; Thisse B, 2000, NATURE, V403, P425, DOI 10.1038/35000200; Tzahor E, 2001, GENE DEV, V15, P255, DOI 10.1101/gad.871501; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Yang L, 2008, NATURE, V453, P524, DOI 10.1038/nature06894; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54; Zhang JH, 2009, CIRC RES, V104, pE30, DOI 10.1161/CIRCRESAHA.108.192237	57	801	851	3	116	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					228	240		10.1016/j.stem.2010.12.008	http://dx.doi.org/10.1016/j.stem.2010.12.008			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295278	Bronze			2022-12-28	WOS:000287633400015
J	Nomura, T; Goritz, C; Catchpole, T; Henkemeyer, M; Frisen, J				Nomura, Tadashi; Goritz, Christian; Catchpole, Timothy; Henkemeyer, Mark; Frisen, Jonas			EphB Signaling Controls Lineage Plasticity of Adult Neural Stem Cell Niche Cells	CELL STEM CELL			English	Article							EPENDYMAL CELLS; RECOMBINANT ADENOVIRUS; GENE-TRANSFER; GLIAL-CELLS; PROLIFERATION; PROGENITOR; ZONE; NEUROGENESIS; SURFACE; MANIPULATION	Stem cells remain in specialized niches over the life-span of the organism in many organs to ensure tissue homeostasis and enable regeneration. How the niche is maintained is not understood, but is probably as important as intrinsic stem cell self-renewal capacity for tissue integrity. We here demonstrate a high degree of phenotypic plasticity of the two main niche cell types, ependymal cells and astrocytes, in the neurogenic lateral ventricle walls in the adult mouse brain. In response to a lesion, astrocytes give rise to ependymal cells and ependymal cells give rise to niche astrocytes. We identify EphB2 forward signaling as a key pathway regulating niche cell plasticity. EphB2 acts downstream of Notch and is required for the maintenance of ependymal cell characteristics, thereby inhibiting the transition from ependymal cell to astrocyte. Our results show that niche cell identity is actively maintained and that niche cells retain a high level of plasticity.	[Nomura, Tadashi; Goritz, Christian; Frisen, Jonas] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Catchpole, Timothy; Henkemeyer, Mark] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA	Karolinska Institutet; University of Texas System; University of Texas Southwestern Medical Center Dallas	Frisen, J (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.	jonas.frisen@ki.se	Göritz, Christian/AAK-5348-2021	Göritz, Christian/0000-0003-0799-766X; Henkemeyer, Mark/0000-0002-7525-1061	Swedish Research Council; Swedish Cancer Society; Swedish Agency for Innovation Systems; Karolinska Institute; Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse; NIH [RO1 MH066332]; Uehara Memorial Foundation; Scandinavia-Japan Sasakawa Foundation; Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066332] Funding Source: NIH RePORTER	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); Swedish Agency for Innovation Systems(Vinnova); Karolinska Institute(Karolinska Institutet); Tobias Stiftelsen; Knut och Alice Wallenbergs Stiftelse(Knut & Alice Wallenberg Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Uehara Memorial Foundation(Uehara Memorial Foundation); Scandinavia-Japan Sasakawa Foundation; Wenner-Gren Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We are grateful to Drs. U. Lendahl for NICD, dnRbpj, and 12xRbpj-dsGFP expression vectors, T. Pawson for EphB2 and EphB2<SUP>Y604F,Y61F</SUP> vectors, M. Genander for ephrin-Bl vector, F. Farnebo for ephrin-B2 expression vector, K. Tanigaki and T. Honjo for Rbe<SUP>loxP/loxP</SUP> mice, F. Pfrieger for Cx30-CreER mice, T. Li for the Rootletin antibody, and A. Simon and members of the J.F. laboratory for valuable discussions. This study was supported by grants from the Swedish Research Council, the Swedish Cancer Society, the Swedish Agency for Innovation Systems, the Karolinska Institute, Tobias Stiftelsen, Knut och Alice Wallenbergs Stiftelse, and NIH grant RO1 MH066332. T.N. is supported by fellowships from the Uehara Memorial Foundation and Scandinavia-Japan Sasakawa Foundation and C.G. by a postdoctoral fellowship from the Wenner-Gren Foundation.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; BAJOCCHI G, 1993, NAT GENET, V3, P229, DOI 10.1038/ng0393-229; Barnabe-Heider F, 2008, NAT METHODS, V5, P189, DOI 10.1038/NMETH.1174; Barnabe-Heider F, 2010, CELL STEM CELL, V7, P470, DOI 10.1016/j.stem.2010.07.014; Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268; Chumley MJ, 2007, J NEUROSCI, V27, P13481, DOI 10.1523/JNEUROSCI.4158-07.2007; Conover JC, 2000, NAT NEUROSCI, V3, P1091, DOI 10.1038/80606; Davidson BL, 1997, EXP NEUROL, V144, P125, DOI 10.1006/exnr.1996.6398; Depaepe V, 2005, NATURE, V435, P1244, DOI 10.1038/nature03651; Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Doetsch F, 1997, J NEUROSCI, V17, P5046; Dravis C, 2004, DEV BIOL, V271, P272, DOI 10.1016/j.ydbio.2004.03.027; Egea J, 2007, TRENDS CELL BIOL, V17, P230, DOI 10.1016/j.tcb.2007.03.004; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Ferri ALM, 2004, DEVELOPMENT, V131, P3805, DOI 10.1242/dev.01204; Genander M, 2010, CURR OPIN CELL BIOL, V22, P611, DOI 10.1016/j.ceb.2010.08.005; Genander M, 2010, STEM CELLS, V28, P1196, DOI 10.1002/stem.442; Genander M, 2009, CELL, V139, P679, DOI 10.1016/j.cell.2009.08.048; Gomez-Roldan MDC, 2008, J COMP NEUROL, V507, P1571, DOI 10.1002/cne.21618; Grondona JM, 1996, J NEUROPATH EXP NEUR, V55, P999, DOI 10.1097/00005072-199609000-00007; Hara Y, 2010, STEM CELLS, V28, P974, DOI 10.1002/stem.427; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Holmberg J, 2006, CELL, V125, P1151, DOI 10.1016/j.cell.2006.04.030; Imayoshi I, 2010, J NEUROSCI, V30, P3489, DOI 10.1523/JNEUROSCI.4987-09.2010; Jiao JW, 2008, P NATL ACAD SCI USA, V105, P8778, DOI 10.1073/pnas.0708861105; Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3; Kuo CT, 2006, CELL, V127, P1253, DOI 10.1016/j.cell.2006.10.041; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Luo J, 2006, AGING CELL, V5, P139, DOI 10.1111/j.1474-9726.2006.00197.x; Luo J, 2008, J NEUROSCI, V28, P3804, DOI 10.1523/JNEUROSCI.0224-08.2008; Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182; Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; Qiu RX, 2008, J CELL BIOL, V181, P973, DOI 10.1083/jcb.200708091; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; ROBINSON SP, 1991, DRUG METAB DISPOS, V19, P36; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sawamoto K, 2006, SCIENCE, V311, P629, DOI 10.1126/science.1119133; Simon A, 2007, CELL, V128, P825, DOI 10.1016/j.cell.2007.02.026; Slezak M, 2007, GLIA, V55, P1565, DOI 10.1002/glia.20570; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Spassky N, 2005, J NEUROSCI, V25, P10, DOI 10.1523/JNEUROSCI.1108-04.2005; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tanigakik K, 2002, NAT IMMUNOL, V3, P443, DOI 10.1038/ni793; Weigmann A, 1997, P NATL ACAD SCI USA, V94, P12425, DOI 10.1073/pnas.94.23.12425; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	50	76	77	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					730	743		10.1016/j.stem.2010.11.009	http://dx.doi.org/10.1016/j.stem.2010.11.009			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112567	Green Accepted, Bronze			2022-12-28	WOS:000285537700014
J	Staerk, J; Dawlaty, MM; Gao, Q; Maetzel, D; Hanna, J; Sommer, CA; Mostoslavsky, G; Jaenisch, R				Staerk, Judith; Dawlaty, Meelad M.; Gao, Qing; Maetzel, Dorothea; Hanna, Jacob; Sommer, Cesar A.; Mostoslavsky, Gustavo; Jaenisch, Rudolf			Reprogramming of Human Peripheral Blood Cells to Induced Pluripotent Stem Cells	CELL STEM CELL			English	Article							COLONY-STIMULATING FACTOR; HUMAN SOMATIC-CELLS; MATURE B; RECEPTOR; GENERATION; DIFFERENTIATION; PURIFICATION; SELECTION; LEUKEMIA; HYPAQUE		[Staerk, Judith; Dawlaty, Meelad M.; Gao, Qing; Maetzel, Dorothea; Hanna, Jacob; Jaenisch, Rudolf] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Dept Med, Gastroenterol Sect, Boston, MA 02118 USA; [Sommer, Cesar A.; Mostoslavsky, Gustavo] Boston Univ, Sch Med, Ctr Regenerat Med CReM, Boston, MA 02118 USA; [Jaenisch, Rudolf] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Boston University; Boston University; Massachusetts Institute of Technology (MIT)	Jaenisch, R (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	jaenisch@wi.mit.edu	Sommer, Cesar A/H-7062-2012; Hanna, Jacob/K-1339-2012; Sommer, Cesar A/H-9187-2013	Hanna, Jacob/0000-0003-2042-9974; Mostoslavsky, Gustavo/0000-0002-0784-2169; Staerk, Judith/0000-0001-8698-6998	NIH [5-RO1-HDO45022, 5-R37-CA084198, 5-RO1-CA087869]; Harvard Clinical and Translational Science Center, from the National Center for Research Resources [UL1 RR025758]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R37HD045022] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD045022] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA084198, R37CA084198, R01CA087869] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Clinical and Translational Science Center, from the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	We thank Raaji Alaggapan and Ping Xu for support with tissue culture and Jessie Dausman, Ruth Flannery, and Dongdong Fu for help with animal husbandry and teratoma processing. We thank all volunteers for donating blood, Catherine Ricciardi at CRC for taking blood, Dirk Hockemeyer for providing the 800 bp TTAGGG telomere probe and advice with telomere Southern blots, and members of the Jaenisch lab for critical reading of the manuscript. R.J. is supported by NIH grants 5-RO1-HDO45022, 5-R37-CA084198, and 5-RO1-CA087869. J.S. is a long-term HFSP postdoctoral fellow; M.M.D. is a Damon Runyon postdoctoral fellow. R.J. is an advisor to Stemgent and Fate Therapeutics. Blood donations were conducted at the Clinical Research Center (CRC) at the Massachusetts Institute of Technology, supported by Grant Number UL1 RR025758-Harvard Clinical and Translational Science Center, from the National Center for Research Resources. Experiments with human subjects have been approved by the MIT Committee on the Use of Humans as Experimental Subjects.	Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FERRANTE A, 1980, J IMMUNOL METHODS, V36, P109, DOI 10.1016/0022-1759(80)90036-8; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Hockemeyer D, 2008, CELL STEM CELL, V3, P346, DOI 10.1016/j.stem.2008.08.014; Hong H, 2009, NATURE, V460, P1132, DOI 10.1038/nature08235; KISIELOW P, 1995, ADV IMMUNOL, V58, P87, DOI 10.1016/S0065-2776(08)60620-3; Loh YH, 2009, BLOOD, V113, P5476, DOI 10.1182/blood-2009-02-204800; Lowry WE, 2008, P NATL ACAD SCI USA, V105, P2883, DOI 10.1073/pnas.0711983105; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MARTIN GR, 1975, P NATL ACAD SCI USA, V72, P1441, DOI 10.1073/pnas.72.4.1441; Miller CP, 2009, STEM CELLS, V27, P2353, DOI 10.1002/stem.156; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Sommer CA, 2010, STEM CELLS, V28, P64, DOI 10.1002/stem.255; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Touw IP, 1997, BAILLIERE CLIN HAEM, V10, P577, DOI 10.1016/S0950-3536(97)80027-3; Touw IP, 2007, FRONT BIOSCI-LANDMRK, V12, P800, DOI 10.2741/2103; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; VISSERS MCM, 1988, J IMMUNOL METHODS, V110, P203, DOI 10.1016/0022-1759(88)90104-4; von Bergwelt-Baildon MS, 2002, BLOOD, V99, P3319, DOI 10.1182/blood.V99.9.3319; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yu JY, 2009, SCIENCE, V324, P797, DOI 10.1126/science.1172482	30	286	314	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2010	7	1					20	24		10.1016/j.stem.2010.06.002	http://dx.doi.org/10.1016/j.stem.2010.06.002			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	629TJ	20621045	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000280222300008
J	McKernan, R; McNeish, J; Smith, D				McKernan, Ruth; McNeish, John; Smith, Devyn			Pharma's Developing Interest in Stem Cells	CELL STEM CELL			English	Editorial Material								Human stem cell biology is driving the promise of novel regenerative therapies into clinical trials. Although the pharmaceutical industry has embraced stem cells as tools in drug discovery, few companies have taken the risk to deliver stem cell-based medicines. Here, we evaluate the various cell-based opportunities and corporate strategies.	[McKernan, Ruth] Pfizer Regenerat Med, Cambridge CB21 6GP, England; [McNeish, John] Pfizer Regenerat Med, Cambridge, MA 02139 USA; [Smith, Devyn] Pfizer Strateg Management Grp, New London, CT 06340 USA	Pfizer; Pfizer; Pfizer	McKernan, R (corresponding author), Pfizer Regenerat Med, Cambridge CB21 6GP, England.	ruth.mckernan@pfizer.com						Abdel-Latif A, 2007, ARCH INTERN MED, V167, P989, DOI 10.1001/archinte.167.10.989; Chen S, 2009, NAT CHEM BIOL, V5, P258, DOI 10.1038/nchembio.154; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Flomenberg N, 2010, BIOL BLOOD MARROW TR, V16, P695, DOI 10.1016/j.bbmt.2009.12.538; Klyushnenkova E, 2005, J BIOMED SCI, V12, P47, DOI 10.1007/s11373-004-8183-7; Martin-Rendon E, 2008, EUR HEART J, V29, P1807, DOI 10.1093/eurheartj/ehn220; ROWNTREE R, 2010, REGEN MED IN PRESS; SMITH D, 2009, WORLD STEM CELL REPO, P131; Trounson A, 2010, CELL STEM CELL, V6, P513, DOI 10.1016/j.stem.2010.05.008; Uccelli A, 2008, NAT REV IMMUNOL, V8, P726, DOI 10.1038/nri2395; Wu X, 2004, J AM CHEM SOC, V126, P1590, DOI 10.1021/ja038950i	11	64	64	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					517	520		10.1016/j.stem.2010.05.012	http://dx.doi.org/10.1016/j.stem.2010.05.012			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20569688	Bronze			2022-12-28	WOS:000278840700011
J	Kawakami, M; Sipp, D; Kato, K				Kawakami, Masahiro; Sipp, Douglas; Kato, Kazuto			Regulatory Impacts on Stem Cell Research in Japan	CELL STEM CELL			English	Editorial Material							LINES	Although it is a leader in many fields of stem cell research, Japan's policies on many areas of stem cell research have not been widely reported or analyzed in the international literature. In this report, we provide an overview of Japan's centralized approach to regulation and analyze its policy implementation.	[Kawakami, Masahiro; Kato, Kazuto] Kyoto Univ, Inst Res Humanities, Kyoto 6068501, Japan; [Kato, Kazuto] Kyoto Univ, Grad Sch Biostudies, Lab Sci Commun & Bioeth, Kyoto 6068501, Japan; [Kato, Kazuto] Kyoto Univ, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan; [Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo 6500047, Japan	Kyoto University; Kyoto University; Kyoto University; RIKEN	Kato, K (corresponding author), Kyoto Univ, Inst Res Humanities, Kyoto 6068501, Japan.	kato@zinbun.kyoto-u.ac.jp	Sipp, Doug/C-9218-2017	Sipp, Doug/0000-0002-5979-0938; Kato, Kazuto/0000-0001-9006-9551	MEXT, Japan; Research Institute for Science and Technology for Society (RISTEX), Japan	MEXT, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Institute for Science and Technology for Society (RISTEX), Japan	This work was partly supported by a grant under the Leading Project of MEXT, Japan, to K.K. and the "Development for Deliberation and Cooperation between Citizens and Scientists" project from the Research Institute for Science and Technology for Society (RISTEX), Japan, to Hideyuki Hirakawa (in which K.K. is a collaborator).	Colman A, 2008, CELL, V132, P519, DOI 10.1016/j.cell.2008.01.037; Kato Kazuto, 2005, CROSSING BORDERS CUL, P369; Levine AD, 2008, CELL STEM CELL, V2, P521, DOI 10.1016/j.stem.2008.05.008; Suemori H, 2006, BIOCHEM BIOPH RES CO, V345, P926, DOI 10.1016/j.bbrc.2006.04.135; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145	7	15	16	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 7	2010	6	5					415	418		10.1016/j.stem.2010.04.010	http://dx.doi.org/10.1016/j.stem.2010.04.010			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	598NO	20452315	Bronze			2022-12-28	WOS:000277844800008
J	Shimoji, K; Yuasa, S; Onizuka, T; Hattori, F; Tanaka, T; Hara, M; Ohno, Y; Chen, H; Egasgira, T; Seki, T; Yae, K; Koshimizu, U; Ogawa, S; Fukuda, K				Shimoji, Kenichiro; Yuasa, Shinsuke; Onizuka, Takeshi; Hattori, Fumiyuki; Tanaka, Tomofumi; Hara, Mie; Ohno, Yohei; Chen, Hao; Egasgira, Toru; Seki, Tomohisa; Yae, Kojiro; Koshimizu, Uichi; Ogawa, Satoshi; Fukuda, Keiichi			G-CSF Promotes the Proliferation of Developing Cardiomyocytes In Vivo and in Derivation from ESCs and iPSCs	CELL STEM CELL			English	Article							COLONY-STIMULATING FACTOR; STEM-CELLS; MYOCYTE PROLIFERATION; RXR-ALPHA; GRANULOCYTE; DIFFERENTIATION; HEART; DEFICIENCY; PATHWAY; GROWTH	During a screen for humoral factors that promote cardiomyocyte differentiation from embryonic stem cells (ESCs), we found marked elevation of granulocyte colony-stimulating factor receptor (G-CSFR) mRNA in developing cardiomyocytes. We confirmed that both G-CSFR and G-CSF were specifically expressed in embryonic mouse heart at the midgestational stage, and expression levels were maintained throughout embryogenesis. Intrauterine G-CSF administration induced embryonic cardiomyocyte proliferation and caused hyperplasia. In contrast, approximately 50% of csf3r(-/-) mice died during late embryogenesis because of the thinning of atrioventricular walls. ESC-derived developing cardiomyocytes also strongly expressed G-CSFR. When extrinsic G-CSF was administered to the ESC- and human iPSC-derived cardiomyocytes, it markedly augmented their proliferation. Moreover, G-CSF-neutralizing antibody inhibited their proliferation. These findings indicated that G-CSF is critically involved in cardiomyocyte proliferation during development, and may be used to boost the yield of cardiomyocytes from ESCs for their potential application to regenerative medicine.	[Shimoji, Kenichiro; Yuasa, Shinsuke; Onizuka, Takeshi; Hattori, Fumiyuki; Tanaka, Tomofumi; Hara, Mie; Ohno, Yohei; Chen, Hao; Egasgira, Toru; Seki, Tomohisa; Yae, Kojiro; Fukuda, Keiichi] Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo 1608582, Japan; [Shimoji, Kenichiro; Yuasa, Shinsuke; Onizuka, Takeshi; Ohno, Yohei; Chen, Hao; Egasgira, Toru; Seki, Tomohisa; Ogawa, Satoshi] Keio Univ, Sch Med, Dept Internal Med, Div Cardiol, Tokyo 1608582, Japan; [Hattori, Fumiyuki; Tanaka, Tomofumi; Koshimizu, Uichi] Asubio Pharma Co Ltd, Biomed Res Labs, Tokyo 6188513, Japan	Keio University; Keio University; Asubio Pharma Co., Ltd.	Fukuda, K (corresponding author), Keio Univ, Sch Med, Dept Regenerat Med & Adv Cardiac Therapeut, Tokyo 1608582, Japan.	kfukuda@sc.itc.keio.ac.jp	Shimoji, Kenichiro/U-3203-2019; Seki, Tomohisa/L-3524-2013; Ohno, Yohei/GZA-6285-2022; Fukuda, Keiichi/L-3777-2013; Yuasa, Shinsuke/L-8310-2013	Yuasa, Shinsuke/0000-0001-5593-7552; Seki, Tomohisa/0000-0002-4281-135X	Ministry of Education, Science and Culture, Japan; National Institute of Biomedical Innovation, Japan	Ministry of Education, Science and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Institute of Biomedical Innovation, Japan(National Institute of Biomedical Innovation)	This study was supported in part by research grants from the Ministry of Education, Science and Culture, Japan, and by the Program for Promotion of Fundamental Studies in Health Science of the National Institute of Biomedical Innovation, Japan.	Arnold SJ, 2000, MECH DEVELOP, V91, P249, DOI 10.1016/S0925-4773(99)00309-3; Behfar A, 2002, FASEB J, V16, P1558, DOI 10.1096/fj.02-0072com; Chen C, 2006, IMMUNITY, V25, P895, DOI 10.1016/j.immuni.2006.10.013; Chen HY, 2004, DEVELOPMENT, V131, P2219, DOI 10.1242/dev.01094; DEMETRI GD, 1991, BLOOD, V78, P2791; FUKUNAGA R, 1990, P NATL ACAD SCI USA, V87, P8702, DOI 10.1073/pnas.87.22.8702; Goddeeris MM, 2007, DEVELOPMENT, V134, P1593, DOI 10.1242/dev.02824; Grego-Bessa J, 2007, DEV CELL, V12, P415, DOI 10.1016/j.devcel.2006.12.011; Harada M, 2005, NAT MED, V11, P305, DOI 10.1038/nm1199; Hattori F, 2010, NAT METHODS, V7, P61, DOI [10.1038/NMETH.1403, 10.1038/nmeth.1403]; KAJSTURA J, 1994, EXP CELL RES, V215, P273, DOI 10.1006/excr.1994.1343; Kastner P, 1997, DEVELOPMENT, V124, P4749; Kawada H, 2004, BLOOD, V104, P3581, DOI 10.1182/blood-2004-04-1488; Lavine KJ, 2005, DEV CELL, V8, P85, DOI 10.1016/j.devcel.2004.12.002; LIESCHKE GJ, 1994, BLOOD, V84, P1737; Morrison SJ, 1997, P NATL ACAD SCI USA, V94, P1908, DOI 10.1073/pnas.94.5.1908; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Olson EN, 2003, GENE DEV, V17, P1937, DOI 10.1101/gad.1110103; Reiss K, 1996, P NATL ACAD SCI USA, V93, P8630, DOI 10.1073/pnas.93.16.8630; Richards MK, 2003, BLOOD, V102, P3562, DOI 10.1182/blood-2003-02-0593; Sasaki E, 2005, STEM CELLS, V23, P1304, DOI 10.1634/stemcells.2004-0366; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; SOUZA LM, 1986, SCIENCE, V232, P61, DOI 10.1126/science.2420009; Srivastava D, 2006, CELL, V126, P1037, DOI 10.1016/j.cell.2006.09.003; SUCOV HM, 1994, GENE DEV, V8, P1007, DOI 10.1101/gad.8.9.1007; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tanaka T, 2009, BIOCHEM BIOPH RES CO, V385, P497, DOI 10.1016/j.bbrc.2009.05.073; Welte K, 1996, BLOOD, V88, P1907, DOI 10.1182/blood.V88.6.1907.bloodjournal8861907; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Yuasa S, 2005, NAT BIOTECHNOL, V23, P607, DOI 10.1038/nbt1093	31	86	92	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 5	2010	6	3					227	237		10.1016/j.stem.2010.01.002	http://dx.doi.org/10.1016/j.stem.2010.01.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	577WL	20207226	Bronze			2022-12-28	WOS:000276254600010
J	Shi, Y; Zhao, Y; Deng, HK				Shi, Yan; Zhao, Yang; Deng, Hongkui			Powering Reprogramming with Vitamin C	CELL STEM CELL			English	Editorial Material							PLURIPOTENT STEM-CELLS		[Shi, Yan; Deng, Hongkui] Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Zhao, Yang; Deng, Hongkui] Peking Univ, Coll Life Sci, Dept Cell Biol & Genet, Beijing 100871, Peoples R China	Peking University; University Town of Shenzhen; Peking University	Deng, HK (corresponding author), Peking Univ, Shenzhen Grad Sch, Sch Chem Biol & Biotechnol, Lab Chem Genom, Shenzhen 518055, Peoples R China.	hongkui_deng@pku.edu.cn						Deng WB, 2009, CELL STEM CELL, V5, P349, DOI 10.1016/j.stem.2009.09.002; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Kim JE, 2008, INT J MOL MED, V22, P651, DOI 10.3892/ijmm_00000068; Li WL, 2009, STEM CELLS, V27, P2992, DOI 10.1002/stem.240; Lyssiotis CA, 2009, P NATL ACAD SCI USA, V106, P8912, DOI 10.1073/pnas.0903860106; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Woltjen K, 2009, CELL STEM CELL, V5, P457, DOI 10.1016/j.stem.2009.10.007; Yoshida Y, 2009, CELL STEM CELL, V5, P237, DOI 10.1016/j.stem.2009.08.001	10	26	31	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					1	2		10.1016/j.stem.2009.12.012	http://dx.doi.org/10.1016/j.stem.2009.12.012			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085733	Bronze			2022-12-28	WOS:000274029700001
J	Alexander, CM; Puchalski, J; Klos, KS; Badders, N; Ailles, L; Kim, CF; Dirks, P; Smalley, MJ				Alexander, Caroline M.; Puchalski, Joel; Klos, Kristine S.; Badders, Nisha; Ailles, Laurie; Kim, Carla F.; Dirks, Peter; Smalley, Matthew J.			Separating Stem Cells by Flow Cytometry: Reducing Variability for Solid Tissues	CELL STEM CELL			English	Editorial Material							QUALITY		[Alexander, Caroline M.; Puchalski, Joel; Klos, Kristine S.; Badders, Nisha] Univ Wisconsin, McArdle Lab Canc Res, Madison, WI 53706 USA; [Ailles, Laurie] Ontario Canc Inst, Div Stem Cell & Dev Biol, MaRS Ctr, Toronto, ON M5G 1L7, Canada; [Kim, Carla F.] Harvard Univ, Sch Med, Harvard Stem Cell Inst, Dept Genet,Childrens Hosp Stem Cell Program, Boston, MA 02115 USA; [Dirks, Peter] Univ Toronto, Hosp Sick Children, Div Neurosurg, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Smalley, Matthew J.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England	University of Wisconsin System; University of Wisconsin Madison; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Alexander, CM (corresponding author), Univ Wisconsin, McArdle Lab Canc Res, 1400 Univ Ave, Madison, WI 53706 USA.	alexander@oncology.wisc.edu	Smalley, Matthew J/M-7000-2015	Smalley, Matthew J/0000-0001-9540-1146	NCI NIH HHS [R01 CA090877, R01 CA090877-09] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090877] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Britt KL, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2245; Chattopadhyay PK, 2008, IMMUNOLOGY, V125, P441, DOI 10.1111/j.1365-2567.2008.02989.x; Herzenberg LA, 2006, NAT IMMUNOL, V7, P681, DOI 10.1038/ni0706-681; KANTOR AB, 1997, HDB EXPT IMMUNOLOGY; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Moore J, 2009, CYTOM PART A, V75A, P643, DOI 10.1002/cyto.a.20742; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; Perfetto SP, 2006, NAT PROTOC, V1, P1522, DOI 10.1038/nprot.2006.250; Roederer M, 2004, METHOD CELL BIOL, V75, P241; Roederer M., 2002, CURR PROTOC CYTOM, V22:Unit 1.14; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; Roederer Mario, 2002, Curr Protoc Immunol, VChapter 5, DOI 10.1002/0471142735.im0508s49; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Tung JW, 2004, CLIN IMMUNOL, V110, P277, DOI 10.1016/j.clim.2003.11.016	16	43	44	1	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					579	583		10.1016/j.stem.2009.11.008	http://dx.doi.org/10.1016/j.stem.2009.11.008			5	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951686	Bronze, Green Accepted			2022-12-28	WOS:000273616700006
J	Kranc, KR; Schepers, H; Rodrigues, NP; Bamforth, S; Villadsen, E; Ferry, H; Bouriez-Jones, T; Sigvardsson, M; Bhattacharya, S; Jacobsen, SE; Enver, T				Kranc, Kamil R.; Schepers, Hein; Rodrigues, Neil P.; Bamforth, Simon; Villadsen, Ellen; Ferry, Helen; Bouriez-Jones, Tiphaine; Sigvardsson, Mikael; Bhattacharya, Shoumo; Jacobsen, Sten Eirik; Enver, Tariq			Cited2 Is an Essential Regulator of Adult Hematopoietic Stem Cells	CELL STEM CELL			English	Article							CREB-BINDING-PROTEIN; MULTIPOTENT PROGENITORS; GENE-EXPRESSION; COACTIVATOR; SURVIVAL; MICE; IDENTIFICATION; MAINTENANCE; DEFECTS; PRODUCT	The regulatory pathways necessary for the maintenance of adult hematopoietic stem cells (HSCs) remain poorly defined. By using loss-of-function approaches, we report a selective and cell-autonomous requirement for the p300/CBP-binding transcriptional coactivator Cited2 in adult HSC maintenance. Conditional deletion of Cited2 in the adult mouse results in loss of HSCs causing multilineage bone marrow failure and increased lethality. In contrast, conditional ablation of Cited2 after lineage specification in lymphoid and myeloid lineages has no impact on the maintenance of these lineages. Additional deletion of Ink4a/Arf (encoding p16(Ink4a) and p19(Arf)) or Trp53 (encoding p53, a downstream target of p19(Arf)) in a Cited2-deficient background restores HSC functionality and rescues mice from bone marrow failure. Furthermore, we show that the critical role of Cited2 in primitive hematopoietic cells is conserved in humans. Taken together, our studies provide genetic evidence that Cited2 selectively maintains adult HSC functions, at least in part, via Ink4a/Arf and Trp53.	[Kranc, Kamil R.; Rodrigues, Neil P.; Villadsen, Ellen; Enver, Tariq] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Kranc, Kamil R.; Schepers, Hein; Villadsen, Ellen; Ferry, Helen; Bouriez-Jones, Tiphaine; Jacobsen, Sten Eirik] Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, Haematopoiet Stem Cell Lab, Oxford OX3 9DS, England; [Bamforth, Simon] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Sigvardsson, Mikael] Linkoping Univ, Dept Clin & Expt Res, S-58185 Linkoping, Sweden; [Bhattacharya, Shoumo] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England	University of Oxford; University of Oxford; Newcastle University - UK; Linkoping University; University of Oxford; Wellcome Centre for Human Genetics	Kranc, KR (corresponding author), Univ Oxford, John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England.	kamil.kranc@ndm.ox.ac.uk	Bamforth, Simon David/I-1277-2019; Jacobsen, Sten Eirik W/D-3974-2018; Bhattacharya, Shoumo/F-4127-2010	Bamforth, Simon David/0000-0002-5666-4485; Jacobsen, Sten Eirik W/0000-0002-1362-3659; Bhattacharya, Shoumo/0000-0002-5571-0478; Sigvardsson, Mikael/0000-0001-8527-7276; Rodrigues, Neil/0000-0002-1925-7733; Schepers, Hein/0000-0002-7731-3318	John Fell OUP Research Fund; Leukaemia Research Fund; Medical Research Council; Wellcome Trust; MRC [MC_U137973817, G0801073, G0501838] Funding Source: UKRI; Medical Research Council [G0501838, MC_U137973817, G0801073] Funding Source: researchfish	John Fell OUP Research Fund; Leukaemia Research Fund; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	K.R.K. is a Beit Memorial Fellow for Medical Research. H.S. is an EMBO long-term fellow. N.P.R. is a MRC Career Development Fellow. The authors' laboratories are supported by John Fell OUP Research Fund (K.R.K.), Leukaemia Research Fund (K.R.K., T.E., S.E.J.), Medical Research Council (S.E.J., T.E.), and Wellcome Trust (K.R.K., S.B.).	Akala OO, 2008, NATURE, V453, P228, DOI 10.1038/nature06869; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Chou YT, 2006, ONCOGENE, V25, P5547, DOI 10.1038/sj.onc.1209552; Glenn DJ, 1999, J BIOL CHEM, V274, P36159, DOI 10.1074/jbc.274.51.36159; Gomes I, 2002, BLOOD, V100, P107, DOI 10.1182/blood.V100.1.107; Hock H, 2004, GENE DEV, V18, P2336, DOI 10.1101/gad.1239604; Kranc KR, 2003, MOL CELL BIOL, V23, P7658, DOI 10.1128/MCB.23.21.7658-7666.2003; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Kung AL, 2000, GENE DEV, V14, P272; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Liu Y, 2009, CELL STEM CELL, V4, P37, DOI 10.1016/j.stem.2008.11.006; MacDonald ST, 2008, CARDIOVASC RES, V79, P448, DOI 10.1093/cvr/cvn101; Mansson R, 2007, IMMUNITY, V26, P407, DOI 10.1016/j.immuni.2007.02.013; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Pomerantz J, 1998, CELL, V92, P713, DOI 10.1016/S0092-8674(00)81400-2; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Qian ZJ, 2008, J EXP MED, V205, P2163, DOI 10.1084/jem.20080578; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Sperling S, 2005, HUM MUTAT, V26, P575, DOI 10.1002/humu.20262; Sun HB, 1998, P NATL ACAD SCI USA, V95, P13555, DOI 10.1073/pnas.95.23.13555; Tien ES, 2004, J BIOL CHEM, V279, P24053, DOI 10.1074/jbc.M401489200; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zhong JF, 2005, P NATL ACAD SCI USA, V102, P2448, DOI 10.1073/pnas.0409459102	32	85	86	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 4	2009	5	6					659	665		10.1016/j.stem.2009.11.001	http://dx.doi.org/10.1016/j.stem.2009.11.001			7	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	543YH	19951693	Green Published, hybrid			2022-12-28	WOS:000273616700013
J	Stanley, ER				Stanley, E. Richard			Lineage Commitment: Cytokines Instruct, At Last!	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC STEM-CELLS; MAFB		Albert Einstein Coll Med, Dept Dev & Mol Biol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Stanley, ER (corresponding author), Albert Einstein Coll Med, Dept Dev & Mol Biol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	rstanley@aecom.yu.edu	Stanley, Evan R/J-9154-2013	Stanley, Evan R/0000-0002-2910-2065	NATIONAL CANCER INSTITUTE [R37CA026504, R01CA032551] Funding Source: NIH RePORTER; NCI NIH HHS [R37 CA026504, R01 CA032551] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Enver T, 1998, BLOOD, V92, P348, DOI 10.1182/blood.V92.2.348.Con3_348_351; Iwasaki H, 2007, IMMUNITY, V26, P726, DOI 10.1016/j.immuni.2007.06.004; Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; Laiosa CV, 2006, ANNU REV IMMUNOL, V24, P705, DOI 10.1146/annurev.immunol.24.021605.090742; Metcalf D, 1998, BLOOD, V92, P345, DOI 10.1182/blood.V92.2.345b.Con2_345_347; Pixley FJ, 2004, TRENDS CELL BIOL, V14, P628, DOI 10.1016/j.tcb.2004.09.016; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Sarrazin S, 2009, CELL, V138, P300, DOI 10.1016/j.cell.2009.04.057; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048	11	11	17	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					234	236		10.1016/j.stem.2009.08.015	http://dx.doi.org/10.1016/j.stem.2009.08.015			4	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733531	Green Accepted, Bronze			2022-12-28	WOS:000272545700005
J	Tamaki, SJ; Jacobs, Y; Dohse, M; Capela, A; Cooper, JD; Reitsma, M; He, DP; Tushinski, R; Belichenko, PV; Salehi, A; Mobley, W; Gage, FH; Huhn, S; Tsukamoto, AS; Weissman, IL; Uchida, N				Tamaki, Stanley J.; Jacobs, Yakop; Dohse, Monika; Capela, Alexandra; Cooper, Jonathan D.; Reitsma, Michael; He, Dongping; Tushinski, Robert; Belichenko, Pavel V.; Salehi, Ahmad; Mobley, William; Gage, Fred H.; Huhn, Stephen; Tsukamoto, Ann S.; Weissman, Irving L.; Uchida, Nobuko			Neuroprotection of Host Cells by Human Central Nervous System Stem Cells in a Mouse Model of Infantile Neuronal Ceroid Lipofuscinosis	CELL STEM CELL			English	Article							TRIPEPTIDYL PEPTIDASE-I; GENE-THERAPY; MURINE MODEL; BRAIN; ACTIVATION; NEURODEGENERATION; DIFFERENTIATE; PURIFICATION; MECHANISMS; DIAGNOSIS	Infantile neuronal ceroid lipofuscinosis (INCL) is a fatal neurodegenerative disease caused by a deficiency in the lysosomal enzyme palmitoyl protein thioesterase-1 (PPT1). Ppt1 knockout mice display hallmarks of INCL and mimic the human pathology: accumulation of lipofuscin, degeneration of CNS neurons, and a shortened life span. Purified non-genetically modified human CNS stem cells, grown as neurospheres (hCNS-SCns), were transplanted into the brains of immunodeficient Ppt1(-/-) mice where they engrafted robustly, migrated extensively, and produced sufficient levels of PPT1 to alter host neuropathology. Grafted mice displayed reduced autofluorescent lipofuscin, significant neuroprotection of host hippocampal and cortical neurons, and delayed loss of motor coordination. Early intervention with cellular transplants of hCNS-SCns into the brains of INCL patients may supply a continuous and long-lasting source of the missing PPT1 and provide some therapeutic benefit through protection of endogenous neurons. These data provide the experimental basis for human clinical trials with these banked hCNS-SCns.	[Tamaki, Stanley J.; Jacobs, Yakop; Dohse, Monika; Capela, Alexandra; Reitsma, Michael; He, Dongping; Tushinski, Robert; Huhn, Stephen; Tsukamoto, Ann S.; Uchida, Nobuko] StemCells Inc, Palo Alto, CA 94304 USA; [Cooper, Jonathan D.] Kings Coll London, Dept Neurosci, Ctr Cellular Basis Behav, MRC Ctr Neurodegenerat Res,Inst Psychiat, London SE5 9NU, England; [Belichenko, Pavel V.; Salehi, Ahmad; Mobley, William] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Stanford, CA 94305 USA; [Weissman, Irving L.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Gage, Fred H.] Salk Inst Biol Studies, Genet Lab, La Jolla, CA 92037 USA	University of London; King's College London; Stanford University; Stanford University; Stanford University; Salk Institute	Uchida, N (corresponding author), StemCells Inc, 3155 Porter Dr, Palo Alto, CA 94304 USA.	nobuko.uchida@stemcellsinc.com	Salehi, Ahmad/H-2746-2019; Cooper, Jonathan/C-8117-2009; Cooper, Jonathan/V-9962-2019	Salehi, Ahmad/0000-0001-8257-3280; Cooper, Jonathan/0000-0003-1339-4750; Cooper, Jonathan/0000-0003-1339-4750	StemCells, Inc.	StemCells, Inc.	We would like to thank Drs. Sandy Hofmann, Mark Sands, Krystyna Wisniewski, Aileen Anderson, Brian Cummings, and Tonya Bliss for the generous gifts of the Ppt1<SUP>-/-</SUP> mice, the antibody against PPT1, and fibroblasts from Ppt1<SUP>-/-</SUP> mice CLN1 and CLN2 patients and expert advice. S.J.T., Y.J., M. D., A. C., M. R., D. H., R. T., S. H., A. S. T., and N.U. are employees of, J.D.C. and W. M. are past consultants of, and F. H. G. and I. L. W. are scientific founders of StemCells, Inc.	Abbott NJ, 2002, J ANAT, V200, P629, DOI 10.1046/j.1469-7580.2002.00064.x; Alvarez-Buylla A, 2002, J NEUROSCI, V22, P629, DOI 10.1523/JNEUROSCI.22-03-00629.2002; Bible E, 2004, NEUROBIOL DIS, V16, P346, DOI 10.1016/j.nbd.2004.02.010; Cabrera-Salazar MA, 2007, MOL THER, V15, P1782, DOI 10.1038/sj.mt.6300249; Castaneda JA, 2008, ACTA NEUROPATHOL, V115, P159, DOI 10.1007/s00401-007-0296-4; Cummings BJ, 2005, P NATL ACAD SCI USA, V102, P14069, DOI 10.1073/pnas.0507063102; Das AK, 2001, HUM MOL GENET, V10, P1431, DOI 10.1093/hmg/10.13.1431; Das AK, 1998, J CLIN INVEST, V102, P361, DOI 10.1172/JCI3112; Doetsch F, 1999, CELL, V97, P703, DOI 10.1016/S0092-8674(00)80783-7; Escolar ML, 2006, PEDIATRICS, V118, pE879, DOI 10.1542/peds.2006-0747; Escolar ML, 2005, NEW ENGL J MED, V352, P2069, DOI 10.1056/NEJMoa042604; Frisella WA, 2001, MOL THER, V3, P351, DOI 10.1006/mthe.2001.0274; Griffey M, 2004, NEUROBIOL DIS, V16, P360, DOI 10.1016/j.nbd.2004.03.005; Griffey M, 2005, MOL THER, V12, P413, DOI 10.1016/j.ymthe.2005.04.018; Griffey MA, 2006, MOL THER, V13, P538, DOI 10.1016/j.ymthe.2005.11.008; Gupta P, 2001, P NATL ACAD SCI USA, V98, P13566, DOI 10.1073/pnas.251485198; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Haskell RE, 2003, GENE THER, V10, P34, DOI 10.1038/sj.gt.3301843; Hofmann SL, 1999, MOL GENET METAB, V66, P234, DOI 10.1006/mgme.1999.2803; Kandel E., 2000, PRINCIPLES NEURAL SC; Kelly S, 2004, P NATL ACAD SCI USA, V101, P11839, DOI 10.1073/pnas.0404474101; Kielar C, 2007, NEUROBIOL DIS, V25, P150, DOI 10.1016/j.nbd.2006.09.001; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Mole SE, 2004, BRAIN PATHOL, V14, P70, DOI 10.1111/j.1750-3639.2004.tb00500.x; Oswald MJ, 2005, NEUROBIOL DIS, V20, P49, DOI 10.1016/j.nbd.2005.01.025; PAGE AE, 1993, ARCH BIOCHEM BIOPHYS, V306, P354, DOI 10.1006/abbi.1993.1523; Passini MA, 2007, P NATL ACAD SCI USA, V104, P9505, DOI 10.1073/pnas.0703509104; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Pontikis CC, 2004, BRAIN RES, V1023, P231, DOI 10.1016/j.brainres.2004.07.030; Raivich G, 1999, BRAIN RES REV, V30, P77, DOI 10.1016/S0165-0173(99)00007-7; Sanai N, 2004, NATURE, V427, P740, DOI 10.1038/nature02301; Sly WS, 2002, P NATL ACAD SCI USA, V99, P5760, DOI 10.1073/pnas.102175599; Sohar I, 2000, CLIN CHEM, V46, P1005; Tamaki S, 2002, J NEUROSCI RES, V69, P976, DOI 10.1002/jnr.10412; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Vines D, 1998, BBA-PROTEIN STRUCT M, V1384, P233, DOI 10.1016/S0167-4838(98)00012-0; Voznyi YV, 1999, J MED GENET, V36, P471; Wisniewski KE, 2001, ADV GENET, V45, P1, DOI 10.1016/S0065-2660(01)45002-4	38	97	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 4	2009	5	3					310	319		10.1016/j.stem.2009.05.022	http://dx.doi.org/10.1016/j.stem.2009.05.022			10	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	529VA	19733542	Bronze			2022-12-28	WOS:000272545700017
J	Jin, LQ; Lee, EM; Ramshaw, HS; Busfield, SJ; Peoppl, AG; Wilkinson, L; Guthridge, MA; Thomas, D; Barry, EF; Boyd, A; Gearing, DP; Vairo, G; Lopez, AF; Dick, JE; Lock, RB				Jin, Liqing; Lee, Erwin M.; Ramshaw, Hayley S.; Busfield, Samantha J.; Peoppl, Armando G.; Wilkinson, Lucy; Guthridge, Mark A.; Thomas, Daniel; Barry, Emma F.; Boyd, Andrew; Gearing, David P.; Vairo, Gino; Lopez, Angel F.; Dick, John E.; Lock, Richard B.			Monoclonal Antibody-Mediated Targeting of CD123, IL-3 Receptor alpha Chain, Eliminates Human Acute Myeloid Leukemic Stem Cells	CELL STEM CELL			English	Article							ACUTE MYELOGENOUS LEUKEMIA; COLONY-STIMULATING FACTOR; ACUTE LYMPHOBLASTIC-LEUKEMIA; INTERLEUKIN-3 RECEPTOR; HEMATOPOIETIC-CELL; BONE-MARROW; SHORT-TERM; G-CSF; INTRAFEMORAL TRANSPLANTATION; GROWTH-FACTORS	Leukemia stem cells (LSCs) initiate and sustain the acute myeloid leukemia (AML) clonal hierarchy and possess biological properties rendering them resistant to conventional chemotherapy. The poor survival of AML patients raises expectations that LSC-targeted therapies might achieve durable remissions. We report that an anti-interleukin-3 (IL-3) receptor a chain (CD123)-neutralizing antibody (7133) targeted AML-LSCs, impairing homing to bone marrow (BM) and activating innate immunity of nonobese diabetic/severe-combined immunodeficient (NOD/SCID) mice. 7133 treatment profoundly reduced AML-LSC engraftment and improved mouse survival. Mice with preestablished disease showed reduced AML burden in the BM and periphery and impaired secondary transplantation upon treatment, establishing that AML-LSCs were directly targeted. 7133 inhibited IL-3-mediated intracellular signaling of isolated AML CD34(+) CD38(-) cells in vitro and reduced their survival. These results provide clear validation for therapeutic monoclonal antibody (mAb) targeting of AML-LSCs and for translation of in vivo preclinical research findings toward a clinical application.	[Lee, Erwin M.; Lock, Richard B.] Univ New S Wales, Childrens Canc Inst Australia Med Res, Sydney, NSW 2031, Australia; [Jin, Liqing; Peoppl, Armando G.; Dick, John E.] Univ Hlth Network, Div Cell & Mol Biol, Toronto, ON M5G 1L7, Canada; [Ramshaw, Hayley S.; Guthridge, Mark A.; Thomas, Daniel; Barry, Emma F.; Lopez, Angel F.] Inst Med & Vet Sci, Div Human Immunol, Ctr Canc Biol, Adelaide, SA 5000, Australia; [Busfield, Samantha J.; Gearing, David P.; Vairo, Gino] CSL Ltd, Melbourne, Vic 3052, Australia; [Wilkinson, Lucy; Boyd, Andrew] Queensland Inst Med Res, Brisbane, Qld 4029, Australia	Children's Cancer Institute; Children's Medical Research Institute - Australia; University of New South Wales Sydney; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Centre for Cancer Biology; Institute Medical & Veterinary Science Australia; CSL; QIMR Berghofer Medical Research Institute	Lock, RB (corresponding author), Univ New S Wales, Childrens Canc Inst Australia Med Res, Sydney, NSW 2031, Australia.	rlock@ccia.unsw.edu.au	guthridge, mark a/I-1889-2014; Boyd, Andrew/G-2083-2010; Lock, Richard/G-4253-2013; Ramshaw, Hayley/F-3828-2013; Lopez, Angel F/E-2260-2011	guthridge, mark a/0000-0002-0536-3471; Lopez, Angel F/0000-0001-7430-0135; Barry, Emma/0000-0003-2742-5650; Ramshaw, Hayley/0000-0001-9909-282X; Lock, Richard/0000-0002-3436-9071; Dick, John/0000-0002-9527-8317	Children's Cancer Institute Australia for Medical Research; CSL Limited	Children's Cancer Institute Australia for Medical Research; CSL Limited	This work was supported by Children's Cancer Institute Australia for Medical Research and by research grants from CSL Limited (A.B., A.F.L., J.E.D., and R.B.L.). Children's Cancer Institute Australia for Medical Research is affiliated with the University of New South Wales and Sydney Children's Hospital. H.S.R. is the Peter Nelson Leukaemia ResearchFund Senior Research Fellow. The authors wish to thank Dr. Mark Minden (University Health Network, Toronto, Canada) and Naomi Sprigg, Rosemary Hoyt, and Dr. Andrew Roberts (Royal Melbourne Hospital, Melbourne, Australia) for providing patient biopsy specimens; Thu Tran, Soo Min Heng, and Dean Inwood (Department of Radiation Oncology, Prince of Wales Hospital, Sydney, Australia) for mouse irradiation; CSL Protein Group for antibody reagents; and Dr. Andrew Roberts for helpful discussions. The authors wish to declare the following potential conflicts of interest: employees of- CSL Limited (S.J.B., D.P.G., and G.V.) and consultants of CSL Limited (A.F.L. and R.B.L.).	Abutalib SA, 2006, CURR PHARM BIOTECHNO, V7, P343, DOI 10.2174/138920106778521578; Aribi A, 2006, CANCER J, V12, P77; Bagley CJ, 1997, BLOOD, V89, P1471, DOI 10.1182/blood.V89.5.1471.1471_1471_1482; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; BUDEL LM, 1989, BLOOD, V74, P565; De Bruyn C, 2000, BONE MARROW TRANSPL, V25, P377, DOI 10.1038/sj.bmt.1702145; Elbaz Osama, 2001, Hematology, V5, P383; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Florian S, 2006, LEUKEMIA LYMPHOMA, V47, P207, DOI 10.1080/10428190500272507; Fujii H, 2007, BLOOD, V109, P2008, DOI 10.1182/blood-2006-02-002055; Graf M, 2004, EUR J HAEMATOL, V72, P89, DOI 10.1046/j.0902-4441.2003.00184.x; Guan Y, 2000, LEUKEMIA, V14, P2135, DOI 10.1038/sj.leu.2401975; Guan YH, 2003, BLOOD, V101, P3142, DOI 10.1182/blood-2002-10-3062; Guthridge MA, 2006, EMBO J, V25, P479, DOI 10.1038/sj.emboj.7600948; Guthridge MA, 2000, MOL CELL, V6, P99, DOI 10.1016/S1097-2765(00)00011-3; Guthridge MA, 2004, BLOOD, V103, P820, DOI 10.1182/blood-2003-06-1999; Guzman ML, 2001, BLOOD, V98, P2301, DOI 10.1182/blood.V98.8.2301; Hauswirth AW, 2007, EUR J CLIN INVEST, V37, P73, DOI 10.1111/j.1365-2362.2007.01746.x; Hope KJ, 2004, NAT IMMUNOL, V5, P738, DOI 10.1038/ni1080; Ishikawa F, 2007, NAT BIOTECHNOL, V25, P1315, DOI 10.1038/nbt1350; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jin LQ, 2006, NAT MED, V12, P1167, DOI 10.1038/nm1483; Jordan CT, 2000, LEUKEMIA, V14, P1777, DOI 10.1038/sj.leu.2401903; LAPIDOT T, 1994, NATURE, V367, P645, DOI 10.1038/367645a0; Lock RB, 2002, BLOOD, V99, P4100, DOI 10.1182/blood.V99.11.4100; LOPEZ AF, 1988, BLOOD, V72, P1797; Mazurier F, 2003, NAT MED, V9, P959, DOI 10.1038/nm886; McKenzie JL, 2005, BLOOD, V106, P1259, DOI 10.1182/blood-2005-03-1081; McKenzie JL, 2006, NAT IMMUNOL, V7, P1225, DOI 10.1038/ni1393; MIYAJIMA A, 1993, BLOOD, V82, P1960; MIYAUCHI J, 1987, BLOOD, V70, P657; Morgan MA, 2006, ANN HEMATOL, V85, P139, DOI 10.1007/s00277-005-0051-7; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Nishinakamura R, 1996, BLOOD, V88, P2458, DOI 10.1182/blood.V88.7.2458.bloodjournal8872458; Nowak R, 1999, CYTOKINE, V11, P435, DOI 10.1006/cyto.1998.0445; Pearce DJ, 2006, BLOOD, V107, P1166, DOI 10.1182/blood-2005-06-2325; PEBUSQUE MJ, 1989, LEUKEMIA, V3, P200; Riccioni R, 2004, LEUKEMIA LYMPHOMA, V45, P1511, DOI 10.1080/104281090310001646031; Rich JN, 2007, CELL STEM CELL, V1, P353, DOI 10.1016/j.stem.2007.09.011; Sperr WR, 2004, EUR J CLIN INVEST, V34, P31, DOI 10.1111/j.0960-135X.2004.01368.x; Stone RM, 2007, EXP HEMATOL, V35, P163, DOI 10.1016/j.exphem.2007.01.025; Sun QY, 1996, BLOOD, V87, P83; TANAKA T, 1993, J EXP MED, V178, P1103, DOI 10.1084/jem.178.3.1103; Taussig DC, 2008, BLOOD, V112, P568, DOI 10.1182/blood-2007-10-118331; Testa U, 2004, LEUKEMIA, V18, P219, DOI 10.1038/sj.leu.2403224; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; Tsuzuki M, 1997, LEUKEMIA, V11, P2125, DOI 10.1038/sj.leu.2400870; van Rhenen A, 2005, CLIN CANCER RES, V11, P6520, DOI 10.1158/1078-0432.CCR-05-0468; VELLENGA E, 1987, LEUKEMIA, V1, P584; Wang JCY, 2005, TRENDS CELL BIOL, V15, P494, DOI 10.1016/j.tcb.2005.07.004; Wang JCY, 2007, CELL STEM CELL, V1, P497, DOI 10.1016/j.stem.2007.10.005; Yalcintepe L, 2006, BLOOD, V108, P3530, DOI 10.1182/blood-2006-04-013813	53	382	417	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					31	42		10.1016/j.stem.2009.04.018	http://dx.doi.org/10.1016/j.stem.2009.04.018			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570512	Green Submitted, Bronze			2022-12-28	WOS:000267879200008
J	Lee, J; Kanatsu-Shinohara, M; Morimoto, H; Kazuki, Y; Takashima, S; Oshimura, M; Toyokuni, S; Shinohara, T				Lee, Jiyoung; Kanatsu-Shinohara, Mito; Morimoto, Hiroko; Kazuki, Yasuhiro; Takashima, Seiji; Oshimura, Mitsuo; Toyokuni, Shinya; Shinohara, Takashi			Genetic Reconstruction of Mouse Spermatogonial Stem Cell Self-Renewal In Vitro by Ras-Cyclin D2 Activation	CELL STEM CELL			English	Article							EMBRYONIC-DEVELOPMENT; PROLIFERATION; TUMORS; DEREGULATION; REPLACEMENT; KINASES; PATHWAY; CULTURE; FAMILY; CANCER	Spermatogonial stem cells (SSCs) undergo self-renewal division and support spermatogenesis. Although several cytokines coordinate to drive SSC self-renewal, little is known about the mechanisms underlying this process. We investigated the molecular mechanism by reconstructing SSC self-renewal in vitro without exogenous cytokines. Activation of Ras or overexpression of cyclins D2 and E1, both of which were induced by Ras; enabled long-term self-renewal of cultured spermatogonia. SSCs with activated Ras responded properly to differentiation signals and underwent spermatogenesis, whereas differentiation was abrogated in cyclin transfectants after spermatogonial transplantation. Both Ras- and cyclin-transfected cells produced seminomatous tumors, suggesting that excessive self-renewing stimulus induces oncogenic transformation. In contrast, cells that overexpressed cyclin D1 or D3 failed to make germ cell colonies after transplantation, which indicated that cyclin expression pattern is an important determinant to long-term SSC recolonization. Thus, the Ras-cyclin D2 pathway regulates the balance between tissue maintenance and tumorigenesis in the SSC population.	[Lee, Jiyoung; Kanatsu-Shinohara, Mito; Morimoto, Hiroko; Takashima, Seiji; Shinohara, Takashi] Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan; [Kazuki, Yasuhiro; Oshimura, Mitsuo] Tottori Univ, Fac Med, Sch Life Sci, Dept Mol & Cell Genet, Tottori 6838503, Japan; [Toyokuni, Shinya] Nagoya Univ, Grad Sch Med, Dept Pathol & Biol Responses, Nagoya, Aichi 4668550, Japan; [Shinohara, Takashi] CREST, Japan Sci & Technol Agcy, Kyoto 6068501, Japan	Kyoto University; Tottori University; Nagoya University; Japan Science & Technology Agency (JST)	Shinohara, T (corresponding author), Kyoto Univ, Grad Sch Med, Dept Mol Genet, Kyoto 6068501, Japan.	tshinoha@virus.kyoto-u.ac.jp	Toyokuni, Shinya/ABE-7714-2021; Takashima, Seiji/I-4993-2019; Toyokuni, Shinya/C-1358-2010	Toyokuni, Shinya/0000-0002-5757-1109; Takashima, Seiji/0000-0002-9176-3139; Toyokuni, Shinya/0000-0002-5757-1109	Genome Network Project; Japan Science and Technology Agency (CREST); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan	Genome Network Project(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank Dr. C. Sherr for cyclin plasmids and Ms. Y. Ogata for technical assistance. This research was supported by the Genome Network Project, Japan Science and Technology Agency (CREST), and Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Bartkova J, 2003, APMIS, V111, P252, DOI 10.1034/j.1600-0463.2003.1110129.x; Beumer TL, 2000, BIOL REPROD, V63, P1893, DOI 10.1095/biolreprod63.6.1893; Beumer TL, 1999, ENDOCRINOLOGY, V140, P1834, DOI 10.1210/en.140.4.1834; Braydich-Stolle L, 2007, DEV BIOL, V304, P34, DOI 10.1016/j.ydbio.2006.12.013; BRINSTER RL, 1994, P NATL ACAD SCI USA, V91, P11298, DOI 10.1073/pnas.91.24.11298; Carthon BC, 2005, MOL CELL BIOL, V25, P1081, DOI 10.1128/MCB.25.3.1081-1088.2005; Danielsen AJ, 2002, GROWTH FACTORS, V20, P1, DOI 10.1080/08977190290022185; De Rooij DG, 2000, J ANDROL, V21, P776; Fotovati A, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-4; Goddard NC, 2007, INT J ANDROL, V30, P337, DOI 10.1111/j.1365-2605.2007.00769.x; He ZP, 2008, STEM CELLS, V26, P266, DOI 10.1634/stemcells.2007-0436; Kanatsu-Shinohara M, 2003, BIOL REPROD, V69, P612, DOI 10.1095/biolreprod.103.017012; Kanatsu-Shinohara M, 2008, CELL STEM CELL, V3, P533, DOI 10.1016/j.stem.2008.08.002; Kanatsu-Shinohara M, 2008, BIOL REPROD, V78, P611, DOI 10.1095/biolreprod.107.065615; Kanatsu-Shinohara M, 2006, P NATL ACAD SCI USA, V103, P8018, DOI 10.1073/pnas.0601139103; Kozar K, 2004, CELL, V118, P477, DOI 10.1016/j.cell.2004.07.025; Lee J, 2007, DEVELOPMENT, V134, P1853, DOI 10.1242/dev.003004; Li WQ, 2004, J BIOL CHEM, V279, P37398, DOI 10.1074/jbc.M405730200; Looijenga LHJ, 2007, ANN NY ACAD SCI, V1120, P187, DOI 10.1196/annals.1411.000; Malumbres M, 2002, NAT REV CANCER, V3, P7; Meistrich ML, 1993, CELL MOL BIOL TESTIS, P266; Meng XJ, 2000, SCIENCE, V287, P1489, DOI 10.1126/science.287.5457.1489; Meng XJ, 2001, CANCER RES, V61, P3267; Nagano M, 1999, BIOL REPROD, V60, P1429, DOI 10.1095/biolreprod60.6.1429; Oatley JA, 2008, ANNU REV CELL DEV BI, V24, P263, DOI 10.1146/annurev.cellbio.24.110707.175355; Omerovic J, 2007, CELL MOL LIFE SCI, V64, P2575, DOI 10.1007/s00018-007-7133-8; Potenza N, 2005, EMBO REP, V6, P432, DOI 10.1038/sj.embor.7400397; Sherr CJ, 2004, GENE DEV, V18, P2699, DOI 10.1101/gad.1256504; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Slingerland J, 2000, J CELL PHYSIOL, V183, P10, DOI 10.1002/(SICI)1097-4652(200004)183:1<10::AID-JCP2>3.0.CO;2-I; Susaki E, 2007, MOL CELL BIOL, V27, P4626, DOI 10.1128/MCB.00862-06; Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052	35	106	117	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUL 2	2009	5	1					76	86		10.1016/j.stem.2009.04.020	http://dx.doi.org/10.1016/j.stem.2009.04.020			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	469ET	19570516	Bronze, Green Published			2022-12-28	WOS:000267879200012
J	Le Grand, F; Jones, AE; Seale, V; Scime, A; Rudnicki, MA				Le Grand, Fabien; Jones, Andrew E.; Seale, Vanessa; Scime, Anthony; Rudnicki, Michael A.			Wnt7a Activates the Planar Cell Polarity Pathway to Drive the Symmetric Expansion of Satellite Stem Cells	CELL STEM CELL			English	Article							SELF-RENEWAL; MYOGENIC DIFFERENTIATION; MUSCLE; EXPRESSION; PAX7; SPECIFICATION; SYNDECAN-4; GENES; CONVERGENT; EXTENSION	Satellite cells in skeletal muscle are a heterogeneous population of stem cells and committed progenitors. We found that quiescent satellite stem cells expressed the Wnt receptor Fzd7 and that its candidate ligand Wnt7a was upregulated during regeneration. Wnt7a. markedly stimulated the symmetric expansion of satellite stem cells but did not affect the growth or differentiation of myoblasts. Silencing of Fzd7 abrogated Wnt7a binding and stimulation of stem cell expansion. Wnt7a. signaling induced the polarized distribution of the planar cell polarity effector Vangl2. Silencing of Vangl2 inhibited Wnt7a action on satellite stem cell expansion. Wnt7a overexpression enhanced muscle regeneration and increased both satellite cell numbers and the proportion of satellite stem cells. Muscle lacking Wnt7a exhibited a marked decrease in satellite cell number following regeneration. Therefore, Wnt7a signaling through the planar cell polarity pathway controls the homeostatic level of satellite stem cells and hence regulates the regenerative potential of muscle.	[Le Grand, Fabien; Jones, Andrew E.; Seale, Vanessa; Scime, Anthony; Rudnicki, Michael A.] Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, Ottawa, ON K1H 8L6, Canada; [Le Grand, Fabien; Jones, Andrew E.; Scime, Anthony; Rudnicki, Michael A.] Univ Ottawa, Dept Med, Ottawa, ON K1H 8M5, Canada	University of Ottawa; Ottawa Hospital Research Institute; University of Ottawa	Rudnicki, MA (corresponding author), Ottawa Hosp Res Inst, Sprott Ctr Stem Cell Res, Regenerat Med Program, 501 Smyth Rd, Ottawa, ON K1H 8L6, Canada.	mrudnicki@ohri.ca	Le Grand, Fabien/D-8803-2019	Le Grand, Fabien/0000-0002-7843-3899; Rudnicki, Michael/0000-0002-3866-5249	Canadian Institutes of Health Research; Muscular Dystrophy Association; National Institutes of Health; HHMI; Canadian Stem Cell Network; Canada Research Chair Program; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR044031] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); Canadian Stem Cell Network; Canada Research Chair Program(Canada Research Chairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank Shihuan Kuang, Feodor Price, lain McKinnell, Mark Gillespie, and Jeffrey Dilworth for helpful discussions throughout the study and Caroline Vergette and Paul Oleynick for cell sorting. We thank Drs. P. Soriano for the Myf5-Cre mice, F. Costantini for the ROSA-YFP mice, and Alysia vandenBerg and David Sassoon forthe Wnt7a<SUP>-/-</SUP> mice. M.A.R. holds the Canada Research Chair in Molecular Genetics and is an International Research Scholar of the Howard Hughes Medical Institute (HHMI). This work was supported by grants to M.A.R. from the Canadian Institutes of Health Research, Muscular Dystrophy Association, the National Institutes of Health, HHMI, the Canadian Stem Cell Network, and the Canada Research Chair Program. The authors declare no conflict of interest.	Anakwe K, 2003, DEVELOPMENT, V130, P3503, DOI 10.1242/dev.00538; Borello U, 2006, DEVELOPMENT, V133, P3723, DOI 10.1242/dev.02517; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Charge SBP, 2002, AM J PHYSIOL-CELL PH, V283, pC1228, DOI 10.1152/ajpcell.00206.2002; Chen AE, 2005, NATURE, V433, P317, DOI 10.1038/nature03126; Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Cornelison DDW, 2004, GENE DEV, V18, P2231, DOI 10.1101/gad.1214204; Cornelison DDW, 2001, DEV BIOL, V239, P79, DOI 10.1006/dbio.2001.0416; Cossu G, 1999, EMBO J, V18, P6867, DOI 10.1093/emboj/18.24.6867; del Alamo D, 2006, DEV CELL, V11, P887, DOI 10.1016/j.devcel.2006.09.016; Diatchenko L, 1996, P NATL ACAD SCI USA, V93, P6025, DOI 10.1073/pnas.93.12.6025; Egger-Adam D, 2008, FRONT BIOSCI-LANDMRK, V13, P4740, DOI 10.2741/3036; Goto T, 2005, CURR BIOL, V15, P787, DOI 10.1016/j.cub.2005.03.040; Gros J, 2009, NATURE, V457, P589, DOI 10.1038/nature07564; Hirabayashi Y, 2004, DEVELOPMENT, V131, P2791, DOI 10.1242/dev.01165; Ishibashi J, 2005, J CELL BIOL, V171, P471, DOI 10.1083/jcb.200502101; Kengaku M, 1998, SCIENCE, V280, P1274, DOI 10.1126/science.280.5367.1274; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kuang S, 2008, CELL STEM CELL, V2, P22, DOI 10.1016/j.stem.2007.12.012; Kuang SH, 2007, CELL, V129, P999, DOI 10.1016/j.cell.2007.03.044; Matthews HK, 2008, DEVELOPMENT, V135, P1771, DOI 10.1242/dev.017350; McKinnell IW, 2008, NAT CELL BIOL, V10, P77, DOI 10.1038/ncb1671; Miller C, 1998, DEVELOPMENT, V125, P3201; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Montcouquiol M, 2003, NATURE, V423, P173, DOI 10.1038/nature01618; Montcouquiol M, 2006, J NEUROSCI, V26, P5265, DOI 10.1523/JNEUROSCI.4680-05.2006; Munoz R, 2006, NAT CELL BIOL, V8, P492, DOI 10.1038/ncb1399; Oustanina S, 2004, EMBO J, V23, P3430, DOI 10.1038/sj.emboj.7600346; Park M, 2002, NAT CELL BIOL, V4, P20, DOI 10.1038/ncb716; Polesskaya A, 2003, CELL, V113, P841, DOI 10.1016/S0092-8674(03)00437-9; Rochat A, 2004, MOL BIOL CELL, V15, P4544, DOI 10.1091/mbc.E03-11-0816; Sacco A, 2008, NATURE, V456, P502, DOI 10.1038/nature07384; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Seifert JRK, 2007, NAT REV GENET, V8, P126, DOI 10.1038/nrg2042; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tallquist MD, 2000, DEVELOPMENT, V127, P5059; Torban E, 2004, TRENDS GENET, V20, P570, DOI 10.1016/j.tig.2004.09.003; Torban E, 2008, P NATL ACAD SCI USA, V105, P3449, DOI 10.1073/pnas.0712126105; Torrente Y, 2004, J CLIN INVEST, V114, P182, DOI 10.1172/JCI200420325; Zallen JA, 2007, CELL, V129, P1051, DOI 10.1016/j.cell.2007.05.050	44	332	343	0	22	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JUN 5	2009	4	6					535	547		10.1016/j.stem.2009.03.013	http://dx.doi.org/10.1016/j.stem.2009.03.013			13	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	455UY	19497282	Green Accepted, Bronze			2022-12-28	WOS:000266793600016
J	Khan, IM; Williams, R; Archer, CW				Khan, Ilyas M.; Williams, Rebecca; Archer, Charles W.			One Flew over the Progenitor's Nest: Migratory Cells Find a Home in Osteoarthritic Cartilage	CELL STEM CELL			English	Editorial Material							CHONDROCYTES	Articular cartilage is the target tissue of osteoarthritis (OA), a degenerative disease with no cure. In this issue of Cell Stem Cell, Miosge and colleagues (Koelling et al., 2009) report that migratory progenitor cells occupy degenerating OA tissue but that this population is not present in healthy cartilage.	[Khan, Ilyas M.; Williams, Rebecca; Archer, Charles W.] Cardiff Univ, Connect Tissue Biol Labs, Cardiff Sch Biosci, Cardiff CF10 3AX, S Glam, Wales	Cardiff University	Archer, CW (corresponding author), Cardiff Univ, Connect Tissue Biol Labs, Cardiff Sch Biosci, Museum Ave, Cardiff CF10 3AX, S Glam, Wales.	archer@cardiff.ac.uk		Williams, Rebecca/0000-0003-2168-7369; Khan, Ilyas/0000-0002-3886-1987				CAMERON G, 1949, NOTES REC R SOC LOND, V7, P43; Hunter W., 1743, SURGEON, V42, P514, DOI [10.1098/rstl.1742.0079, DOI 10.1098/RSTL.1742.0079)]; Koelling S, 2009, CELL STEM CELL, V4, P324, DOI 10.1016/j.stem.2009.01.015; Kouri JB, 1996, OSTEOARTHR CARTILAGE, V4, P111, DOI 10.1016/S1063-4584(05)80320-6; McBeath R, 2004, DEV CELL, V6, P483, DOI 10.1016/S1534-5807(04)00075-9; MUIR H, 1995, BIOESSAYS, V17, P1039, DOI 10.1002/bies.950171208; Nakashima K, 2003, TRENDS GENET, V19, P458, DOI 10.1016/S0168-9525(03)00176-8; Tesche F, 2005, HISTOL HISTOPATHOL, V20, P329, DOI 10.14670/HH-20.329; Tew S, 2001, CLIN ORTHOP RELAT R, pS142; Woods A, 2005, J BIOL CHEM, V280, P11626, DOI 10.1074/jbc.M409158200	10	17	23	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					282	284		10.1016/j.stem.2009.03.007	http://dx.doi.org/10.1016/j.stem.2009.03.007			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341617	Bronze			2022-12-28	WOS:000265162700004
J	te Riele, H				te Riele, Hein			Recreating Stem Cells: A Novel Entrance to the Fountain of Youth	CELL STEM CELL			English	Editorial Material							SOMATIC-CELLS; FIBROBLASTS	Differentiated cells can be reprogrammed to form pluripotent embryonic stem cell-like cells by ectopic expression of four transcription factors. In this issue of Cell Stem Cell, Liu et al. (2009) demonstrate that a similar transition can be achieved by culturing retinoblastoma-deficient mouse embryonic fibroblasts in suspension.	Netherlands Canc Inst, Div Mol Biol, NL-1066 CX Amsterdam, Netherlands	Netherlands Cancer Institute	te Riele, H (corresponding author), Netherlands Canc Inst, Div Mol Biol, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	h.t.riele@nki.nl						Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Liu YQ, 2009, CELL STEM CELL, V4, P336, DOI 10.1016/j.stem.2009.02.015; Maherali N, 2008, CELL STEM CELL, V3, P595, DOI 10.1016/j.stem.2008.11.008; Scheres B, 2007, NAT REV MOL CELL BIO, V8, P345, DOI 10.1038/nrm2164; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0	10	2	4	1	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	APR 3	2009	4	4					279	280		10.1016/j.stem.2009.03.011	http://dx.doi.org/10.1016/j.stem.2009.03.011			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	432VP	19341615	Bronze			2022-12-28	WOS:000265162700002
J	Kelly, KF; Ng, DY; Jayakumaran, G; Wood, GA; Koide, H; Doble, BW				Kelly, Kevin F.; Ng, Deborah Y.; Jayakumaran, Gowtham; Wood, Geoffrey A.; Koide, Hiroshi; Doble, Bradley W.			beta-Catenin Enhances Oct-4 Activity and Reinforces Pluripotency through a TCF-Independent Mechanism	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; NANOG EXPRESSION; WNT; ACTIVATION; DIFFERENTIATION; BLASTOCYST; TRANSCRIPTION; COMPETENCE; GENERATION	Understanding the mechanisms regulating pluripotency in embryonic and induced pluripotent stem cells is required to ensure their safe use in clinical applications. Glycogen synthase kinase-3 (GSK-3) has emerged as an important regulator of pluripotency, based primarily on studies with small-molecule GSK-3 inhibitors. Here, we use mouse embryonic stem cells (ESCs) lacking GSK-3 to demonstrate that a single GSK-3 substrate, beta-catenin, controls the ability of ESCs to exit the pluripotent state and to differentiate into neurectoderm. Unexpectedly, the effects of beta-catenin on pluripotency do not appear to be dependent on TCF-mediated signaling, based on experiments utilizing a beta-catenin C-terminal truncation mutant or highly efficient dominant-negative TCF strategies. Alternatively, we find that stabilized beta-catenin forms a complex with and enhances the activity of Oct-4, a core component of the transcriptional network regulating pluripotency. Collectively, our data suggest previously underappreciated, divergent TCF-dependent and TCF-independent roles for beta-catenin in ESCs.	[Kelly, Kevin F.; Ng, Deborah Y.; Doble, Bradley W.] McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada; [Ng, Deborah Y.; Jayakumaran, Gowtham; Doble, Bradley W.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON L8N 3Z5, Canada; [Wood, Geoffrey A.] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada; [Koide, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Stem Cell Biol, Kanazawa, Ishikawa 9208640, Japan	McMaster University; McMaster University; University of Guelph; Kanazawa University	Doble, BW (corresponding author), McMaster Univ, Stem Cell & Canc Res Inst, Hamilton, ON L8N 3Z5, Canada.	dobleb@mcmaster.ca	Doble, Bradley/V-7848-2019; Koide, Hiroshi/E-9000-2011; Doble, Brad/L-7551-2016; Wood, Geoffrey/ABB-2052-2021	Doble, Bradley/0000-0002-0260-2983; Doble, Brad/0000-0002-0260-2983; Wood, Geoffrey/0000-0003-1756-8607; Koide, Hiroshi/0000-0001-5916-3179	Canadian Institutes of Health Research [MOP85057, MOP89359, MOP102490]; Canada Research Chairs Program; Ontario Ministry of Research and Innovation; Ontario Ministry of Training, Colleges, and Universities; Canada Foundation for Innovation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Ministry of Research and Innovation(Ministry of Research and Innovation, Ontario); Ontario Ministry of Training, Colleges, and Universities; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR)	We thank Melissa Coubrough, Shravanti Rampalli, and Mary Jo Smith for their technical assistance and advice. We thank the following investigators who generously provided plasmid reagents: Dr. Randall Moon (TCF reporter), Dr. Bert Vogelstein (TCF4DN), Drs. Marian Waterman and Hans Clevers (TCF1DN), Dr. Hans Scholer (Oct reporter), and Dr. Jun-ichi Miyazaki (pCAGG). Funding was provided by the Canadian Institutes of Health Research to SW. D. (MOP85057, MOP89359, MOP102490) and K.F.K. (postdoctoral fellowship), the Canada Research Chairs Program (B.W.D.), the Ontario Ministry of Research and Innovation (B.W.D. and K.F.K.), the Ontario Ministry of Training, Colleges, and Universities (D.Y.N.), and the Canada Foundation for Innovation (B.W.D.).	Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056; Aubert J, 2002, NAT BIOTECHNOL, V20, P1240, DOI 10.1038/nbt763; Bakre MM, 2007, J BIOL CHEM, V282, P31703, DOI 10.1074/jbc.M704287200; Bechard M, 2009, MOL CELL BIOL, V29, P2092, DOI 10.1128/MCB.01405-08; Bone HK, 2009, CHEM BIOL, V16, P15, DOI 10.1016/j.chembiol.2008.11.003; Buehr M, 2008, CELL, V135, P1287, DOI 10.1016/j.cell.2008.12.007; Cajanek L, 2009, STEM CELLS, V27, P2917, DOI 10.1002/stem.210; Chen TT, 2010, STEM CELLS, V28, P1315, DOI 10.1002/stem.456; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chou YF, 2008, CELL, V135, P449, DOI 10.1016/j.cell.2008.08.035; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Dravid G, 2005, STEM CELLS, V23, P1489, DOI 10.1634/stemcells.2005-0034; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Haegele L, 2003, MOL CELL NEUROSCI, V24, P696, DOI 10.1016/S1044-7431(03)00232-X; Kemp C, 2005, DEV DYNAM, V233, P1064, DOI 10.1002/dvdy.20408; Kielman MF, 2002, NAT GENET, V32, P594, DOI 10.1038/ng1045; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Kolligs FT, 1999, MOL CELL BIOL, V19, P5696; Le NH, 2008, BRIT J CANCER, V98, P1886, DOI 10.1038/sj.bjc.6604401; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Lluis F, 2008, CELL STEM CELL, V3, P493, DOI 10.1016/j.stem.2008.08.017; Lochhead PA, 2006, MOL CELL, V24, P627, DOI 10.1016/j.molcel.2006.10.009; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Ogawa K, 2006, BIOCHEM BIOPH RES CO, V343, P159, DOI 10.1016/j.bbrc.2006.02.127; Pardo M, 2010, CELL STEM CELL, V6, P382, DOI 10.1016/j.stem.2010.03.004; Pereira L, 2006, MOL CELL BIOL, V26, P7479, DOI 10.1128/MCB.00368-06; Sato H, 2009, GENESIS, V47, P414, DOI 10.1002/dvg.20514; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Storm MP, 2007, J BIOL CHEM, V282, P6265, DOI 10.1074/jbc.M610906200; Takao Y, 2007, BIOCHEM BIOPH RES CO, V353, P699, DOI 10.1016/j.bbrc.2006.12.072; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Tomilin A, 2000, CELL, V103, P853, DOI 10.1016/S0092-8674(00)00189-6; van den Berg DLC, 2010, CELL STEM CELL, V6, P369, DOI 10.1016/j.stem.2010.02.014; Xie HR, 2008, DEVELOPMENT, V135, P717, DOI 10.1242/dev.015339; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2008, NATURE, V453, P519, DOI 10.1038/nature06968; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X	46	179	188	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 4	2011	8	2					214	227		10.1016/j.stem.2010.12.010	http://dx.doi.org/10.1016/j.stem.2010.12.010			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	725GO	21295277	Green Accepted, Bronze			2022-12-28	WOS:000287633400014
J	Yoder, MC				Yoder, Mervin C.			A Bipotent Mesoderm Subset Identified via Colony-Forming Assay	CELL STEM CELL			English	Editorial Material							EMBRYONIC STEM-CELLS; HAEMOGENIC ENDOTHELIUM; HEMATOPOIETIC-CELLS; PRIMITIVE STREAK; DIFFERENTIATION; GENERATION; COMMITMENT	The use of an in vitro colony-forming assay has previously led to identification of a mesoderm-derived bipotent hemangioblast from differentiating hESCs. In this issue of Cell Stem Cell, Vodyanik et al. have used a similar approach to herald the presence of a bipotent mesoderm-derived precursor for mesenchymal stem and endothelial cells, termed the mesenchymoangioblast.	Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA	Indiana University System; Indiana University-Purdue University Indianapolis	Yoder, MC (corresponding author), Indiana Univ, Sch Med, Herman B Wells Ctr Pediat Res, Indianapolis, IN 46202 USA.	myoder@iupui.edu		Yoder, Mervin/0000-0003-4354-7631				Caplan AI, 2007, J CELL PHYSIOL, V213, P341, DOI 10.1002/jcp.21200; Choi K, 1998, DEVELOPMENT, V125, P725; Davis RP, 2008, BLOOD, V111, P1876, DOI 10.1182/blood-2007-06-093609; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Evseenko D, 2010, P NATL ACAD SCI USA, V107, P13742, DOI 10.1073/pnas.1002077107; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Trivedi P, 2007, EXP HEMATOL, V35, P146, DOI 10.1016/j.exphem.2006.09.003; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011	10	1	2	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	DEC 3	2010	7	6					643	644		10.1016/j.stem.2010.11.022	http://dx.doi.org/10.1016/j.stem.2010.11.022			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	697SU	21112556	Bronze			2022-12-28	WOS:000285537700003
J	Ables, ET; Drummond-Barbosa, D				Ables, Elizabeth T.; Drummond-Barbosa, Daniela			The Steroid Hormone Ecdysone Functions with Intrinsic Chromatin Remodeling Factors to Control Female Germline Stem Cells in Drosophila	CELL STEM CELL			English	Article							BREAST-CANCER; NUCLEAR RECEPTORS; BROAD-COMPLEX; INSULIN; GENE; METAMORPHOSIS; TRANSCRIPTION; MELANOGASTER; MAINTENANCE; OOGENESIS	Steroid hormones are known systemic regulators of multiple normal and cancerous tissues; however, whether or how they impact the fate and function of adult stem cells is unclear. In the Drosophila ovary, insulin signals modulate the proliferation and self-renewal of germline stem cells (GSCs), yet despite evidence that additional systemic factors control GSC activity, these have remained largely unknown. Here, we report that ecdysone, a steroid hormone structurally related to mammalian sex steroids, directly regulates adult GSC proliferation and self-renewal independently of insulin signaling. Ecdysone controls GSCs through a functional interaction with the chromatin remodeling factors ISWI, an intrinsic epigenetic factor required for GSC fate and activity, and Nurf301, the largest subunit of the ISWI-containing NURF chromatin remodeling complex. Our findings support a link between systemic steroid hormones and the intrinsic chromatin remodeling machinery as a potential mechanism to promote broad transcriptional programs required for adult stem cell self-renewal.	[Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA; [Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21205 USA; [Ables, Elizabeth T.; Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Div Reprod Biol, Baltimore, MD 21205 USA; [Drummond-Barbosa, Daniela] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Environm Hlth Sci, Baltimore, MD 21205 USA	Vanderbilt University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Drummond-Barbosa, D (corresponding author), Vanderbilt Univ, Med Ctr, Dept Cell & Dev Biol, Nashville, TN 37232 USA.	dbarbosa@jhsph.edu		Ables, Elizabeth/0000-0002-6934-9302	National Institutes of Health [R01 GM069875, T32 DK007563, F32 GM086031]; American Cancer Society [RSG-DDC-112316]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007563] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069875, F32GM086031] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We wish to thank M. Bender, E. Hafen, T. Lee, E. Matunis, C. Cherry, D. Montell, J. Truman, J. Tamkun, J. Maines, W.-M. Deng, T. Nystul, A. Spradling, the Bloomington Stock Center, and the Developmental Studies Hybridoma Bank for reagents; the Vanderbilt and Johns Hopkins Microscopy Facilities; and V. Culotta, B. Zirkin, H.-J. Hsu, and L. LaFever for critical reading of this manuscript. E.T.A. and D.D.-B. designed experiments, interpreted results, and wrote the manuscript. E.T.A. performed all experiments. This work was supported by National Institutes of Health R01 GM069875 and American Cancer Society RSG-DDC-112316. E.T.A. was supported by training grant T32 DK007563 and National Research Service Award F32 GM086031 from the National Institutes of Health.	Asselin-Labat ML, 2010, NATURE, V465, P798, DOI 10.1038/nature09027; Badenhorst P, 2005, GENE DEV, V19, P2540, DOI 10.1101/gad.1342605; Bai JW, 2000, CELL, V103, P1047, DOI 10.1016/S0092-8674(00)00208-7; Bialecki M, 2002, DEV CELL, V3, P209, DOI 10.1016/S1534-5807(02)00204-6; Britt K, 2007, ENDOCR-RELAT CANCER, V14, P907, DOI 10.1677/ERC-07-0137; Britt KL, 2004, BIOL REPROD, V71, P1712, DOI 10.1095/biolreprod.104.028175; Buszczak M, 1999, DEVELOPMENT, V126, P4581; Carney GE, 2000, GENETICS, V154, P1203; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; D'Errico I, 2008, CELL MOL LIFE SCI, V65, P1523, DOI 10.1007/s00018-008-7552-1; de Cuevas M, 1998, DEVELOPMENT, V125, P2781; Deng WM, 1997, DEVELOPMENT, V124, P4639; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Dilworth FJ, 2000, MOL CELL, V6, P1049, DOI 10.1016/S1097-2765(00)00103-9; DiRenzo J, 2000, MOL CELL BIOL, V20, P7541, DOI 10.1128/MCB.20.20.7541-7549.2000; Drummond-Barbosa D, 2001, DEV BIOL, V231, P265, DOI 10.1006/dbio.2000.0135; Drummond-Barbosa D, 2008, GENETICS, V180, P1787, DOI 10.1534/genetics.108.098244; Eliassen AH, 2008, ADV EXP MED BIOL, V630, P148; Fair Alecia Malin, 2009, V472, P57, DOI 10.1007/978-1-60327-492-0_3; Flajollet S, 2007, MOL CELL ENDOCRINOL, V270, P23, DOI 10.1016/j.mce.2007.02.004; FLETCHER JC, 1995, GENETICS, V141, P1025; FLETCHER JC, 1995, DEVELOPMENT, V121, P1455; GAREN A, 1977, P NATL ACAD SCI USA, V74, P5099, DOI 10.1073/pnas.74.11.5099; Ghbeish N, 2001, P NATL ACAD SCI USA, V98, P3867, DOI 10.1073/pnas.061437798; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Hsu HJ, 2008, DEV BIOL, V313, P700, DOI 10.1016/j.ydbio.2007.11.006; Huang X, 2008, J GENET GENOMICS, V35, P1, DOI 10.1016/S1673-8527(08)60001-6; IRISH VF, 1987, GENE DEV, V1, P868, DOI 10.1101/gad.1.8.868; Jang ACC, 2009, NAT CELL BIOL, V11, P569, DOI 10.1038/ncb1863; Jeong Y, 2009, EXP MOL MED, V41, P525, DOI 10.3858/emm.2009.41.8.091; Kai TS, 2003, P NATL ACAD SCI USA, V100, P4633, DOI 10.1073/pnas.0830856100; Kirilly D, 2007, CELL RES, V17, P15, DOI 10.1038/sj.cr.7310123; LaFever L, 2005, SCIENCE, V309, P1071, DOI 10.1126/science.1111410; Lanzino M, 2008, CURR CANCER DRUG TAR, V8, P597, DOI 10.2174/156800908786241104; Lee T, 2000, NEURON, V28, P807, DOI 10.1016/S0896-6273(00)00155-0; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; MARGOLIS J, 1995, DEVELOPMENT, V121, P3797; Marvin KA, 2009, BIOCHEMISTRY-US, V48, P7056, DOI 10.1021/bi900697c; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Ninov N, 2009, PLOS BIOL, V7, P892, DOI 10.1371/journal.pbio.1000079; Privalsky ML, 2004, ANNU REV PHYSIOL, V66, P315, DOI 10.1146/annurev.physiol.66.032802.155556; Ray R, 2008, MOL MED, V14, P493, DOI 10.2119/2008-00004.Ray; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Riehle MA, 1999, INSECT BIOCHEM MOLEC, V29, P855, DOI 10.1016/S0965-1748(99)00084-3; Schubiger M, 2005, DEVELOPMENT, V132, P5239, DOI 10.1242/dev.02093; SCHWARTZ MB, 1985, J INSECT PHYSIOL, V31, P947, DOI 10.1016/0022-1910(85)90029-0; Spradling Allan C., 1993, P1; Thorne JL, 2009, INT J BIOCHEM CELL B, V41, P164, DOI 10.1016/j.biocel.2008.08.029; Tsai CC, 1999, MOL CELL, V4, P175, DOI 10.1016/S1097-2765(00)80365-2; Tu MP, 2002, AGING CELL, V1, P158, DOI 10.1046/j.1474-9728.2002.00016.x; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Xi RW, 2005, SCIENCE, V310, P1487, DOI 10.1126/science.1120140; Xiao H, 2001, MOL CELL, V8, P531, DOI 10.1016/S1097-2765(01)00345-8; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Xu W, 2005, BIOCHEM CELL BIOL, V83, P418, DOI 10.1139/O05-057	58	108	110	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	NOV 5	2010	7	5					581	592		10.1016/j.stem.2010.10.001	http://dx.doi.org/10.1016/j.stem.2010.10.001			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	682GX	21040900	Green Accepted, Bronze			2022-12-28	WOS:000284390500010
J	Sauvageau, M; Sauvageau, G				Sauvageau, Martin; Sauvageau, Guy			Polycomb Group Proteins: Multi-Faceted Regulators of Somatic Stem Cells and Cancer	CELL STEM CELL			English	Review							RNA-POLYMERASE-II; HISTONE METHYLTRANSFERASE ACTIVITY; TUMOR-SUPPRESSIVE MICRORNAS; BREAST EPITHELIAL-CELLS; ACUTE MYELOID-LEUKEMIA; DNA-DAMAGE RESPONSE; H3 LYSINE 27; HEMATOPOIETIC STEM; SELF-RENEWAL; GENE-EXPRESSION	Polycomb Group (PcG) proteins are transcriptional repressors that epigenetically modify chromatin and participate in the establishment and maintenance of cell fates. These proteins play important roles in both stem cell self-renewal and in cancer development. Our understanding of their mechanism of action has greatly advanced over the past 10 years, but many unanswered questions remain. In this review, we present the currently available experimental data that connect PcG protein function with some of the key processes which govern somatic stem cell activity. We also highlight recent studies suggesting that a delicate balance in PcG gene dosage is crucial for proper stem cell homeostasis and prevention of cancer stem cell development.	[Sauvageau, Martin; Sauvageau, Guy] Univ Montreal, Mol Genet Stem Cells Lab, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada; [Sauvageau, Guy] Maisonneuve Rosemont Hosp, Div Hematol & Leukemia Cell Bank Quebec, Montreal, PQ H1T 2M4, Canada	Universite de Montreal; Universite de Montreal	Sauvageau, G (corresponding author), Univ Montreal, Mol Genet Stem Cells Lab, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada.	guy.sauvageau@umontreal.ca	Sauvageau, Martin/A-8967-2013	Sauvageau, Martin/0000-0001-9487-5016; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institutes of Health Research; Terry Fox Foundation	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Terry Fox Foundation	The authors would like to thank J. Krosl, T. MacRae, and J. Chagraoui for critical comments and helpful discussions. This work was supported by a Grant from the Canadian Institutes of Health Research to G.S. and by a Terry Fox Foundation Research Studentship to M.S.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Agherbi H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005622; Akasaka T, 2002, GENES CELLS, V7, P835, DOI 10.1046/j.1365-2443.2002.00565.x; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Beck SA, 2010, DEV BIOL, V339, P320, DOI 10.1016/j.ydbio.2009.12.031; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bergink S, 2006, GENE DEV, V20, P1343, DOI 10.1101/gad.373706; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein E, 2006, MOL CELL BIOL, V26, P2560, DOI 10.1128/MCB.26.7.2560-2569.2006; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Boukarabila H, 2009, GENE DEV, V23, P1195, DOI 10.1101/gad.512009; Boultwood J, 2010, LEUKEMIA, V24, P1062, DOI 10.1038/leu.2010.20; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Cao P, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-108; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Carbuccia N, 2010, LEUKEMIA, V24, P469, DOI 10.1038/leu.2009.218; Carbuccia N, 2009, LEUKEMIA, V23, P2183, DOI 10.1038/leu.2009.141; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; Chagraoui J, 2006, GENE DEV, V20, P2110, DOI 10.1101/gad.1453406; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chatoo W, 2009, J NEUROSCI, V29, P529, DOI 10.1523/JNEUROSCI.5303-08.2009; Choi D, 2008, ONCOGENE, V27, P1716, DOI 10.1038/sj.onc.1210806; Clarke PR, 2008, NAT REV MOL CELL BIO, V9, P464, DOI 10.1038/nrm2410; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Dahiya A, 2001, MOL CELL, V8, P557, DOI 10.1016/S1097-2765(01)00346-X; Dalgliesh GL, 2010, NATURE, V463, P360, DOI 10.1038/nature08672; de Napoles M, 2004, DEV CELL, V7, P663, DOI 10.1016/j.devcel.2004.10.005; Denisenko O, 1998, MOL CELL BIOL, V18, P5634, DOI 10.1128/MCB.18.10.5634; Deshpande AM, 2007, ONCOGENE, V26, P1714, DOI 10.1038/sj.onc.1209988; Ernst T, 2010, NAT GENET, V42, P722, DOI 10.1038/ng.621; Ezhkova E, 2009, CELL, V136, P1122, DOI 10.1016/j.cell.2008.12.043; Fajas L, 2000, P NATL ACAD SCI USA, V97, P7738, DOI 10.1073/pnas.130198397; Fasano CA, 2007, CELL STEM CELL, V1, P87, DOI 10.1016/j.stem.2007.04.001; Fisher CL, 2010, BLOOD, V115, P38, DOI 10.1182/blood-2009-07-230698; Francis NJ, 2009, CELL, V137, P110, DOI 10.1016/j.cell.2009.02.017; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Friedman JM, 2009, CANCER RES, V69, P2623, DOI 10.1158/0008-5472.CAN-08-3114; Furuta M, 2010, CARCINOGENESIS, V31, P766, DOI 10.1093/carcin/bgp250; Garcia-Cuellar MP, 2001, ONCOGENE, V20, P411, DOI 10.1038/sj.onc.1204108; Gelsi-Boyer V, 2009, BRIT J HAEMATOL, V145, P788, DOI 10.1111/j.1365-2141.2009.07697.x; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gong YH, 2006, NUCLEIC ACIDS RES, V34, P6158, DOI 10.1093/nar/gkl834; Gonzalez I, 2009, CELL CYCLE, V8, P4103, DOI 10.4161/cc.8.24.10212; Grimm C, 2009, EMBO J, V28, P1965, DOI 10.1038/emboj.2009.147; Guo WJ, 2007, CANCER RES, V67, P5083, DOI 10.1158/0008-5472.CAN-06-4368; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; HAUPT Y, 1993, ONCOGENE, V8, P3161; Hemenway CS, 2001, ONCOGENE, V20, P3798, DOI 10.1038/sj.onc.1204478; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; Hong ZH, 2008, NUCLEIC ACIDS RES, V36, P2939, DOI 10.1093/nar/gkn146; Huen MSY, 2008, J BIOL CHEM, V283, P11073, DOI 10.1074/jbc.C700242200; Ito K, 2004, NATURE, V431, P997, DOI 10.1038/nature02989; Iwata S, 2010, CANCER SCI, V101, P1646, DOI 10.1111/j.1349-7006.2010.01586.x; Jacobs JJL, 1999, GENE DEV, V13, P2678, DOI 10.1101/gad.13.20.2678; Jang YY, 2007, BLOOD, V110, P3056, DOI 10.1182/blood-2007-05-087759; Jin BL, 2009, CANCER RES, V69, P7412, DOI 10.1158/0008-5472.CAN-09-0116; Jorgensen S, 2007, J CELL BIOL, V179, P1337, DOI 10.1083/jcb.200706150; Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109; Juan AH, 2009, MOL CELL, V36, P61, DOI 10.1016/j.molcel.2009.08.008; Kalakonda N, 2008, ONCOGENE, V27, P4293, DOI 10.1038/onc.2008.67; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kerppola TK, 2009, TRENDS CELL BIOL, V19, P692, DOI 10.1016/j.tcb.2009.10.001; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kia SK, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-16; Kim SH, 2008, INT J BIOCHEM CELL B, V40, P2462, DOI 10.1016/j.biocel.2008.04.018; Kirmizis A, 2004, GENE DEV, V18, P1592, DOI 10.1101/gad.1200204; Kleer CG, 2003, P NATL ACAD SCI USA, V100, P11606, DOI 10.1073/pnas.1933744100; Klein UR, 2009, J CELL SCI, V122, P3312, DOI 10.1242/jcs.050245; Koga H, 1999, ONCOGENE, V18, P3799, DOI 10.1038/sj.onc.1202732; Kotake Y, 2007, GENE DEV, V21, P49, DOI 10.1101/gad.1499407; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Krivtsov AV, 2007, NAT REV CANCER, V7, P823, DOI 10.1038/nrc2253; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Landeira D, 2010, NAT CELL BIOL, V12, P618, DOI 10.1038/ncb2065; Le Cam L, 2006, CELL, V127, P775, DOI 10.1016/j.cell.2006.09.031; Lee K, 2008, J INVEST DERMATOL, V128, P9, DOI 10.1038/sj.jid.5700949; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Levine SS, 2002, MOL CELL BIOL, V22, P6070, DOI 10.1128/MCB.22.17.6070-6078.2002; Li CW, 2007, CANCER RES, V67, P1030, DOI 10.1158/0008-5472.CAN-06-2030; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Lu JR, 2007, P NATL ACAD SCI USA, V104, P9381, DOI 10.1073/pnas.0610279104; Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305; Maertens GN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006380; Majewski IJ, 2008, PLOS BIOL, V6, P796, DOI 10.1371/journal.pbio.0060093; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Martinez R, 2009, EPIGENETICS-US, V4, P255, DOI 10.4161/epi.9130; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miyagishima H, 2003, HISTOCHEM CELL BIOL, V120, P111, DOI 10.1007/s00418-003-0551-2; Mohammad HP, 2009, CANCER RES, V69, P6322, DOI 10.1158/0008-5472.CAN-09-0065; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Morin RD, 2010, NAT GENET, V42, P181, DOI 10.1038/ng.518; Negishi M, 2007, BIOCHEM BIOPH RES CO, V353, P992, DOI 10.1016/j.bbrc.2006.12.166; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Dor E, 2006, DEV BIOL, V290, P312, DOI 10.1016/j.ydbio.2005.11.015; O'Riain C, 2009, LEUKEMIA, V23, P1858, DOI 10.1038/leu.2009.114; Oda H, 2009, MOL CELL BIOL, V29, P2278, DOI 10.1128/MCB.01768-08; Oguro H, 2006, J EXP MED, V203, P2247, DOI 10.1084/jem.20052477; Oguro H, 2010, CELL STEM CELL, V6, P279, DOI 10.1016/j.stem.2010.01.005; Ohm JE, 2007, NAT GENET, V39, P237, DOI 10.1038/ng1972; Ohtsubo M, 2008, P NATL ACAD SCI USA, V105, P10396, DOI 10.1073/pnas.0800672105; Owusu-Ansah E, 2009, NATURE, V461, P537, DOI 10.1038/nature08313; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peng JC, 2009, CELL, V139, P1290, DOI 10.1016/j.cell.2009.12.002; Peterson AJ, 2004, GENETICS, V167, P1225, DOI 10.1534/genetics.104.027474; Peterson AJ, 1997, MOL CELL BIOL, V17, P6683, DOI 10.1128/MCB.17.11.6683; Rajasekhar VK, 2007, STEM CELLS, V25, P2498, DOI 10.1634/stemcells.2006-0608; Rice JC, 2002, GENE DEV, V16, P2225, DOI 10.1101/gad.1014902; Richie ER, 2002, ONCOGENE, V21, P299, DOI 10.1038/sj.onc.1205051; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Roscic A, 2006, MOL CELL, V24, P77, DOI 10.1016/j.molcel.2006.08.004; Rossi DJ, 2007, CELL CYCLE, V6, P2371, DOI 10.4161/cc.6.19.4759; Rouleau M, 2007, J CELL BIOCHEM, V100, P385, DOI 10.1002/jcb.21051; Ruzankina Y, 2007, CELL STEM CELL, V1, P113, DOI 10.1016/j.stem.2007.03.002; Sanchez C, 2007, MOL CELL PROTEOMICS, V6, P820, DOI 10.1074/mcp.M600275-MCP200; Sander S, 2008, BLOOD, V112, P4202, DOI 10.1182/blood-2008-03-147645; Saramaki OR, 2006, GENE CHROMOSOME CANC, V45, P639, DOI 10.1002/gcc.20327; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sauvageau M, 2008, BLOOD, V111, P790, DOI 10.1182/blood-2007-07-098236; Scheuermann JC, 2010, NATURE, V465, P243, DOI 10.1038/nature08966; Schlesinger Y, 2007, NAT GENET, V39, P232, DOI 10.1038/ng1950; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Schumacher A, 1996, NATURE, V383, P250, DOI 10.1038/383250a0; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2009, CELL, V139, P1303, DOI 10.1016/j.cell.2009.12.003; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shimono Y, 2009, CELL, V138, P592, DOI 10.1016/j.cell.2009.07.011; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Singh SK, 2003, CANCER RES, V63, P5821; Sparmann A, 2006, NAT REV CANCER, V6, P846, DOI 10.1038/nrc1991; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Su H, 2009, CANCER RES, V69, P1135, DOI 10.1158/0008-5472.CAN-08-2886; Surface LE, 2010, CELL STEM CELL, V7, P288, DOI 10.1016/j.stem.2010.08.004; Suzuki A, 2010, J IMMUNOL, V184, P4510, DOI 10.4049/jimmunol.0903426; Tardat M, 2007, J CELL BIOL, V179, P1413, DOI 10.1083/jcb.200706179; Teschendorff AE, 2010, GENOME RES, V20, P440, DOI 10.1101/gr.103606.109; Tetsu O, 1998, IMMUNITY, V9, P439, DOI 10.1016/S1074-7613(00)80627-5; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; Tonini T, 2004, ONCOGENE, V23, P4930, DOI 10.1038/sj.onc.1207608; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; van der Stoop P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002235; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; van Lohuizen M, 1998, MOL CELL BIOL, V18, P3572, DOI 10.1128/MCB.18.6.3572; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Varambally S, 2008, SCIENCE, V322, P1695, DOI 10.1126/science.1165395; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Vire E, 2006, NATURE, V439, P871, DOI 10.1038/nature04431; Voncken JW, 1999, J CELL SCI, V112, P4627; Wang GG, 2009, NATURE, V459, P847, DOI 10.1038/nature08036; Wang HB, 2004, NATURE, V431, P873, DOI 10.1038/nature02985; Wellner U, 2009, NAT CELL BIOL, V11, P1487, DOI 10.1038/ncb1998; Whitcomb SJ, 2007, TRENDS GENET, V23, P494, DOI 10.1016/j.tig.2007.08.006; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941; Wong CK, 2007, BBA-MOL CELL RES, V1773, P844, DOI 10.1016/j.bbamcr.2007.02.005; Wu ZL, 2010, CELL DEATH DIFFER, V17, P801, DOI 10.1038/cdd.2009.162; Xiang Y, 2007, P NATL ACAD SCI USA, V104, P19226, DOI 10.1073/pnas.0700735104; Yamashita M, 2008, J EXP MED, V205, P1109, DOI 10.1084/jem.20072000; Yang XJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005011; Yap KL, 2010, MOL CELL, V38, P662, DOI 10.1016/j.molcel.2010.03.021; Yu JD, 2010, CANCER CELL, V17, P443, DOI 10.1016/j.ccr.2010.03.018; Zeidler M, 2005, NEOPLASIA, V7, P1011, DOI 10.1593/neo.05472; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005; Zhang J, 2008, BIOCHEM BIOPH RES CO, V375, P252, DOI 10.1016/j.bbrc.2008.08.012; Zhang J, 2008, J BIOL CHEM, V283, P7464, DOI 10.1074/jbc.M707122200; Zhang S, 2008, CANCER RES, V68, P4311, DOI 10.1158/0008-5472.CAN-08-0364; Zhang XL, 2007, J CELL SCI, V120, P1572, DOI 10.1242/jcs.003152; Zhou W, 2008, MOL CELL, V29, P69, DOI 10.1016/j.molcel.2007.11.002; Zhu QZ, 2009, DNA REPAIR, V8, P262, DOI 10.1016/j.dnarep.2008.11.007	189	528	565	0	53	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					299	313		10.1016/j.stem.2010.08.002	http://dx.doi.org/10.1016/j.stem.2010.08.002			15	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20804967	Bronze, Green Accepted			2022-12-28	WOS:000282037800008
J	Tchieu, J; Kuoy, E; Chin, MH; Trinh, H; Patterson, M; Sherman, SP; Aimiuwu, O; Lindgren, A; Hakimian, S; Zack, JA; Clark, AT; Pyle, AD; Lowry, WE; Plath, K				Tchieu, Jason; Kuoy, Edward; Chin, Mark H.; Trinh, Hung; Patterson, Michaela; Sherman, Sean P.; Aimiuwu, Otaren; Lindgren, Anne; Hakimian, Shahrad; Zack, Jerome A.; Clark, Amander T.; Pyle, April D.; Lowry, William E.; Plath, Kathrin			Female Human iPSCs Retain an Inactive X Chromosome	CELL STEM CELL			English	Article							PLURIPOTENT STEM-CELLS; DOSAGE COMPENSATION; FIBROBLASTS; MICE; METHYLATION; GENERATION	Generating induced pluripotent stem cells (iPSCs) requires massive epigenome reorganization. It is unclear whether reprogramming of female human cells reactivates the inactive X chromosome (Xi), as in mouse. Here we establish that human (h)iPSCs derived from several female fibroblasts under standard culture conditions carry an Xi. Despite the lack of reactivation, the Xi undergoes defined chromatin changes, and expansion of hiPSCs can lead to partial loss of XIST RNA. These results indicate that hiPSCs are epigenetically dynamic and do not display a pristine state of X inactivation with two active Xs as found in some female human embryonic stem cell lines. Furthermore, whereas fibroblasts are mosaic for the Xi, hiPSCs are clonal. This nonrandom pattern of X chromosome inactivation in female hiPSCs, which is maintained upon differentiation, has critical implications for clinical applications and disease modeling, and could be exploited for a unique form of gene therapy for X-linked diseases.	[Tchieu, Jason; Kuoy, Edward; Chin, Mark H.; Trinh, Hung; Patterson, Michaela; Sherman, Sean P.; Aimiuwu, Otaren; Lindgren, Anne; Hakimian, Shahrad; Zack, Jerome A.; Clark, Amander T.; Pyle, April D.; Lowry, William E.; Plath, Kathrin] Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Jonsson Comprehens Canc Ctr,Mol Biol Inst, Los Angeles, CA 90024 USA; [Tchieu, Jason; Kuoy, Edward; Chin, Mark H.; Trinh, Hung; Patterson, Michaela; Sherman, Sean P.; Aimiuwu, Otaren; Lindgren, Anne; Hakimian, Shahrad; Zack, Jerome A.; Clark, Amander T.; Pyle, April D.; Lowry, William E.; Plath, Kathrin] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90024 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Plath, K (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Biol Chem, Jonsson Comprehens Canc Ctr,Mol Biol Inst, Los Angeles, CA 90024 USA.	kplath@mednet.ucla.edu	Tchieu, Jason/AAG-1551-2020	Tchieu, Jason/0000-0002-9793-9836; Sherman, Sean/0000-0002-6295-0680; Kuoy, Edward/0000-0003-4721-1254; Plath, Kathrin/0000-0001-7796-3372	Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NRSA [T32CA009056]; CIRM [TG2-01169]; NIH [DP20D001686]; CIRM Young Investigator Award [RN1-00564]; NATIONAL CANCER INSTITUTE [T32CA009056] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057230] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD001686] Funding Source: NIH RePORTER	Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA; NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM Young Investigator Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We are grateful to Alissa Minkovsky for critical reading of the manuscript; Dr. Gustavo Mostoslavsky (Boston University) for providing the STEMCCA reprogramming vector; Dr. Donald Kohn (UCLA) for generating concentrated lentiviral STEMCCA preparations; Dr. Michael Grunstein (UCLA) for providing antibodies; Dr. Nissim Benvenisty (Hebrew University) for expression profiling and karyotyping of various hiPSC lines; Dr. Silvia Diaz-Perez (UCLA). for consultation on X chromosome painting; and Genevieve Kendall, Rebecca Anderson, and Drs. Stan Nelson and Carrie Miceli (ULCA) for providing assistance with DMD-hiPSC RNA isolation and PCR experiments. J.T. is supported by a training grant of the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA, M.H.C. by a Ruth L. Kirschstein Institutional Training Grant (NRSA # T32CA009056), S.P.S. by CIRM TG2-01169, K.P. by the NIH Director's Young Innovator Award (DP20D001686) and a CIRM Young Investigator Award (RN1-00564), and A.D.P. by the NIH P30 Supplement-# 3P30AR057230-01S1 and Department of Defense (DOD) funds #08109003. W.E.L. holds the Maria Rowena Ross Term Chair in Cell Biology and Biochemistry and is supported by CIRM #RS1-00259-1 and the Basil O'Connor Starter Scholar Award of The March of Dimes. This work was also supported by the CIRM New Cell Line grant to J.A.Z., W.E.L., and K.P.	Aartsma-Rus A, 2003, HUM MOL GENET, V12, P907, DOI 10.1093/hmg/ddg100; Adewumi O, 2007, NAT BIOTECHNOL, V25, P803, DOI 10.1038/nbt1318; Agarwal S, 2010, NATURE, V464, P292, DOI 10.1038/nature08792; Boland MJ, 2009, NATURE, V461, P91, DOI 10.1038/nature08310; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Clemson CM, 1996, J CELL BIOL, V132, P259, DOI 10.1083/jcb.132.3.259; Dhara SK, 2004, NUCLEIC ACIDS RES, V32, P3995, DOI 10.1093/nar/gkh746; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Gecz J, 2009, TRENDS GENET, V25, P308, DOI 10.1016/j.tig.2009.05.002; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Gupta Vaijayanti, 2006, J Biol, V5, P3, DOI 10.1186/jbiol30; Hall LL, 2008, J CELL PHYSIOL, V216, P445, DOI 10.1002/jcp.21411; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Hoffman LM, 2005, STEM CELLS, V23, P1468, DOI 10.1634/stemcells.2004-0371; Karumbayaram S, 2009, STEM CELLS, V27, P806, DOI 10.1002/stem.31; Lengner CJ, 2010, CELL, V141, P872, DOI 10.1016/j.cell.2010.04.010; Lin H, 2007, PLOS BIOL, V5, P2809, DOI 10.1371/journal.pbio.0050326; Maherali N, 2007, CELL STEM CELL, V1, P55, DOI 10.1016/j.stem.2007.05.014; Marahrens Y, 1997, GENE DEV, V11, P156, DOI 10.1101/gad.11.2.156; Nguyen DK, 2006, NAT GENET, V38, P47, DOI 10.1038/ng1705; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Payer B, 2008, ANNU REV GENET, V42, P733, DOI 10.1146/annurev.genet.42.110807.091711; Plath K, 2003, SCIENCE, V300, P131, DOI 10.1126/science.1084274; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4709, DOI 10.1073/pnas.0712018105; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Silva SS, 2008, P NATL ACAD SCI USA, V105, P4820, DOI 10.1073/pnas.0712136105; Sommer CA, 2009, STEM CELLS, V27, P543, DOI 10.1634/stemcells.2008-1075; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Urbach A, 2010, CELL STEM CELL, V6, P407, DOI 10.1016/j.stem.2010.04.005; van den Berg IM, 2009, AM J HUM GENET, V84, P771, DOI 10.1016/j.ajhg.2009.05.003; Ware CB, 2009, CELL STEM CELL, V4, P359, DOI 10.1016/j.stem.2009.03.001; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wutz A, 2000, MOL CELL, V5, P695, DOI 10.1016/S1097-2765(00)80248-8; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhao XY, 2009, NATURE, V461, P86, DOI 10.1038/nature08267	41	196	203	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	SEP 3	2010	7	3					329	342		10.1016/j.stem.2010.06.024	http://dx.doi.org/10.1016/j.stem.2010.06.024			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	652VC	20727844	Green Accepted, Bronze			2022-12-28	WOS:000282037800010
J	Wong, KM				Wong, Kathleen M.			Elaine Fuchs: ISSCR's President-Elect	CELL STEM CELL			English	Biographical-Item																		FUCHS E, PUBLICATION LIST	1	0	0	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	JUN 4	2010	6	6					506	507		10.1016/j.stem.2010.05.007	http://dx.doi.org/10.1016/j.stem.2010.05.007			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	611SB	20578344	Bronze			2022-12-28	WOS:000278840700008
J	Blanpain, C; Sotiropoulou, PA				Blanpain, Cedric; Sotiropoulou, Panagiota A.			A Dominant Role of the Hair Follicle Stem Cell Niche in Regulating Melanocyte Sternness	CELL STEM CELL			English	Editorial Material							SKIN; HOMEOSTASIS	Melanocyte and hair follicle bulge stem cells share a common niche. In this issue of Cell Stem Cell, Nishimura et al. (2010) show that hair follicle stem cells, by expressing high levels of TGF-beta 2, regulate the quiescence, the sternness, and the long-term renewal of melanocyte stem cells.	[Blanpain, Cedric; Sotiropoulou, Panagiota A.] Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium	Universite Libre de Bruxelles	Blanpain, C (corresponding author), Univ Libre Bruxelles, IRIBHM, B-1070 Brussels, Belgium.	cedric.blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021					Blanpain C, 2009, NAT REV MOL CELL BIO, V10, P207, DOI 10.1038/nrm2636; Guasch G, 2007, CANCER CELL, V12, P313, DOI 10.1016/j.ccr.2007.08.020; Inomata K, 2009, CELL, V137, P1088, DOI 10.1016/j.cell.2009.03.037; Lin JY, 2007, NATURE, V445, P843, DOI 10.1038/nature05660; Nishimura EK, 2005, SCIENCE, V307, P720, DOI 10.1126/science.1099593; Nishimura EK, 2002, NATURE, V416, P854, DOI 10.1038/416854a; Nishimura EK, 2010, CELL STEM CELL, V6, P130, DOI 10.1016/j.stem.2009.12.010; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Yang G, 2008, MOL CELL, V32, P554, DOI 10.1016/j.molcel.2008.11.002; Yang LL, 2009, MOL BIOL CELL, V20, P882, DOI 10.1091/mbc.E08-07-0731	10	4	8	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					95	96		10.1016/j.stem.2010.01.006	http://dx.doi.org/10.1016/j.stem.2010.01.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144781	Bronze			2022-12-28	WOS:000274520800003
J	Walker, E; Chang, WY; Hunkapiller, J; Cagney, G; Garcha, K; Torchia, J; Krogan, NJ; Reiter, JF; Stanford, WL				Walker, Emily; Chang, Wing Y.; Hunkapiller, Julie; Cagney, Gerard; Garcha, Kamal; Torchia, Joseph; Krogan, Nevan J.; Reiter, Jeremy F.; Stanford, William L.			Polycomb-like 2 Associates with PRC2 and Regulates Transcriptional Networks during Mouse Embryonic Stem Cell Self-Renewal and Differentiation	CELL STEM CELL			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; LEFT-RIGHT ASYMMETRY; ES CELLS; DEVELOPMENTAL REGULATORS; PROTEIN COMPLEXES; RNA INTERFERENCE; ZESTE PROTEIN; PLURIPOTENCY; EXPRESSION; DROSOPHILA	Polycomb group (PcG) proteins are conserved epigenetic transcriptional repressors that control numerous developmental gene expression programs and have recently been implicated in modulating embryonic stem cell (ESC) fate. We identified the PcG protein PCL2 (polycomb-like 2) in a genome-wide screen for regulators of self-renewal and pluri-potency and predicted that it would play an important role in mouse ESC-fate determination. Using multiple biochemical strategies, we provide evidence that PCL2 is a Polycomb Repressive Complex 2 (PRC2)-associated protein in mouse ESCs. Knockdown of Pcl2 in ESCs resulted in heightened self-renewal characteristics, defects in differentiation, and altered patterns of histone methylation. Integration of global gene expression and promoter occupancy analyses allowed us to identify PCL2 and PRC2 transcriptional targets and draft regulatory networks. We describe the role of PCL2 in both modulating transcription of ESC self-renewal genes in undifferentiated ESCs as well as developmental regulators during early commitment and differentiation.	[Walker, Emily; Chang, Wing Y.; Garcha, Kamal; Stanford, William L.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada; [Stanford, William L.] Univ Toronto, Inst Med Sci, Toronto, ON M5S 1A8, Canada; [Stanford, William L.] Univ Toronto, Dept Chem Engn & Appl Chem, Toronto, ON M5S 3E5, Canada; [Hunkapiller, Julie; Reiter, Jeremy F.] Univ Calif San Francisco, Cardiovasc Res Inst, Dept Biochem & Biophys, San Francisco, CA 94158 USA; [Cagney, Gerard; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Cagney, Gerard] Natl Univ Ireland Univ Coll Dublin, Conway Inst, Dublin 4, Ireland; [Torchia, Joseph] Lawson Hlth Res Inst, London Reg Canc Program, Dept Oncol & Biochem, London, ON N6A 4L6, Canada; [Torchia, Joseph] Univ Western Ontario, London, ON N6A 4L6, Canada; [Stanford, William L.] Inst Syst Biol, Seattle, WA 98103 USA	University of Toronto; University of Toronto; University of Toronto; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University College Dublin; Western University (University of Western Ontario); Western University (University of Western Ontario); Institute for Systems Biology (ISB)	Stanford, WL (corresponding author), Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5S 3G9, Canada.	william.stanford@utoronto.ca		Cagney, Gerard/0000-0001-7189-9496; Stanford, William/0000-0002-5813-8016	CIHR [MOP-74528]; Canadian Cancer Society [19122]; NIH [RO1AR054396]; CIRM [RN2-00919]; Burroughs Wellcome Fund; Packard Foundation; Sandler Family Supporting Foundation; Keck Foundation; Searle Foundation; Ontario Graduate Studentship in Science and Technology; MRI; Canada Research Chair; NCIC; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054396] Funding Source: NIH RePORTER	CIHR(Canadian Institutes of Health Research (CIHR)); Canadian Cancer Society(Canadian Cancer Society (CCS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CIRM(California Institute for Regenerative Medicine); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); Sandler Family Supporting Foundation; Keck Foundation(W.M. Keck Foundation); Searle Foundation; Ontario Graduate Studentship in Science and Technology; MRI; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); NCIC(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank H. Bolouri and J. Wysocka for critical reading of the manuscript; B. Panning for critical reading of the manuscript and the generous gift of the Eed antibody; D. Pasini and K. Helin for providing the Suz12 microarray data sets; T. Reid, Q. Lan, C. To, P. Cassar, A. Omelyanenko, and J. Manias of the Stanford lab; and J. Zhang, X. Wang, Z. Hu, and C. Lu at TCAG and J. Gu for technical expertise. The mass spectrometry analysis was carried out in the UCSF mass spectrometry facility, which is headed by A. Burlingame. This work was supported by operating grants from CIHR (MOP-74528) and Canadian Cancer Society (19122) and infrastructure from Genome Canada, CA, and Ontario (MRI) to W.L.S. The Suz12 affinity tag targeting, mass spectrometry analysis, and confirmation studies were supported by NIH (RO1AR054396), CIRM (RN2-00919), the Burroughs Wellcome Fund, the Packard Foundation, and the Sandler Family Supporting Foundation grants to J.F.R. and NIH, Keck Foundation, and Searle Foundation grants to N.J.K. E.W. was supported by from Ontario Graduate Studentship in Science and Technology and a CIHR Banting and Best CGS Doctoral Research Award; W.Y.C. was supported by a MRI Postdoctoral Fellowship; and W.L.S. was supported by a Canada Research Chair. J.T. is supported by operating grant from the CIHR and NCIC.	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Ambrosetti DC, 1997, MOL CELL BIOL, V17, P6321, DOI 10.1128/MCB.17.11.6321; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Davey RE, 2006, STEM CELLS, V24, P2538, DOI 10.1634/stemcells.2006-0216; Deng CH, 2009, MOL CELL PROTEOMICS, V8, P1413, DOI 10.1074/mcp.M800397-MCP200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; DUNCAN IM, 1982, GENETICS, V102, P49; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; FAUST C, 1995, DEVELOPMENT, V121, P273; Furuyama T, 2003, GENESIS, V35, P114, DOI 10.1002/gene.10173; Guo G, 2009, DEVELOPMENT, V136, P1063, DOI 10.1242/dev.030957; Hanna LA, 2002, GENE DEV, V16, P2650, DOI 10.1101/gad.1020502; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; KIM H, 2002, NUCLEIC ACIDS RES, V37, P2940; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kitaguchi T, 2001, DEV GENES EVOL, V211, P309, DOI 10.1007/s004270100157; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Morrison GM, 2006, DEVELOPMENT, V133, P2011, DOI 10.1242/dev.02362; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2009, NATURE, V460, P118, DOI 10.1038/nature08113; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; O'Connell S, 2001, J BIOL CHEM, V276, P43065, DOI 10.1074/jbc.M104294200; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Peerani Raheem, 2009, V482, P21, DOI 10.1007/978-1-59745-060-7_2; Remondelli P, 1997, BIOCHEM J, V323, P79, DOI 10.1042/bj3230079; Remondelli P, 1997, FEBS LETT, V416, P254, DOI 10.1016/S0014-5793(97)01212-X; Rodda DJ, 2005, J BIOL CHEM, V280, P24731, DOI 10.1074/jbc.M502573200; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Silva J, 2003, DEV CELL, V4, P481, DOI 10.1016/S1534-5807(03)00068-6; Singla V, 2010, NAT METHODS, V7, P50, DOI [10.1038/NMETH.1406, 10.1038/nmeth.1406]; SMITH AG, 1987, DEV BIOL, V121, P1, DOI 10.1016/0012-1606(87)90132-1; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tie F, 2003, MOL CELL BIOL, V23, P3352, DOI 10.1128/MCB.23.9.3352-3362.2003; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang SS, 2007, DEV DYNAM, V236, P853, DOI 10.1002/dvdy.21070; Wang SS, 2004, DEVELOPMENT, V131, P4381, DOI 10.1242/dev.01269; WILLIAMS RL, 1988, NATURE, V336, P684, DOI 10.1038/336684a0; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yi F, 2008, STEM CELLS, V26, P1951, DOI 10.1634/stemcells.2008-0229; Ying QL, 2003, NAT BIOTECHNOL, V21, P183, DOI 10.1038/nbt780; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl400; Zhang W, 2006, NUCLEIC ACIDS RES, V34, P4780, DOI 10.1093/nar/gkl631	70	143	156	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	FEB 5	2010	6	2					153	166		10.1016/j.stem.2009.12.014	http://dx.doi.org/10.1016/j.stem.2009.12.014			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	555OC	20144788	Green Accepted, Bronze			2022-12-28	WOS:000274520800010
J	Chng, ZZ; Teo, A; Pedersen, RA; Vallier, L				Chng, Zhenzhi; Teo, Adrian; Pedersen, Roger A.; Vallier, Ludovic			SIP1 Mediates Cell-Fate Decisions between Neuroectoderm and Mesendoderm in Human Pluripotent Stem Cells	CELL STEM CELL			English	Article							SMAD-INTERACTING PROTEIN-1; MOUSE EMBRYO; MAINTAINS PLURIPOTENCY; NEURAL DIFFERENTIATION; E-CADHERIN; EXPRESSION; XENOPUS; ENDODERM; EPIBLAST; XSIP1	Human embryonic stem cells (hESCs) rely on fibroblast growth factor and Activin-Nodal signaling to maintain their pluripotency. However, Activin-Nodal signaling is also known to induce mesendoderm differentiation. The mechanisms by which Activin-Nodal signaling can achieve these contradictory functions remain unknown. Here, we demonstrate that Smad-interacting protein 1 (SIP1) limits the mesendoderm-inducing effects of Activin-Nodal signaling without inhibiting the pluripotency-maintaining effects exerted by SMAD2/3. In turn, Activin-Nodal signaling cooperates with NANOG, OCT4, and SOX2 to control the expression of SIP1 in hESCs, thereby limiting the neuroectoderm-promoting effects of SIP1. Similar results were obtained with mouse epiblast stem cells, implying that these mechanisms are evolutionarily conserved and may operate in vivo during mammalian development. Overall, our results reveal the mechanisms by which Activin-Nodal signaling acts through SIP1 to regulate the cell-fate decision between neuroectoderm and mesendoderm in the progression from pluripotency to primary germ layer differentiation.	[Chng, Zhenzhi; Teo, Adrian; Pedersen, Roger A.; Vallier, Ludovic] Univ Cambridge, Lab Regenerat Med, Cambridge CB2 0SZ, England	University of Cambridge	Vallier, L (corresponding author), Univ Cambridge, Lab Regenerat Med, W Forvie Bldg,Robinson Way, Cambridge CB2 0SZ, England.	lv225@cam.ac.uk	vallier, ludovic/C-6368-2011; Teo, Adrian Kee Keong/A-4009-2013	Teo, Adrian Kee Keong/0000-0001-5901-7075; Vallier, Ludovic/0000-0002-3848-2602	Singapore Agency for Science, Technology and Research; MRC Programme and Centre Development; Cambridge Hospitals National Institute for Health Research Biomedical Research Center; MRC/Diabetes UK Career Development; MRC Senior Research fellowship; MRC [G0701448, G0800784, G0600275] Funding Source: UKRI; Medical Research Council [G0300723B, G0600275, G0800784B, G0800784, G0701448] Funding Source: researchfish	Singapore Agency for Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); MRC Programme and Centre Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cambridge Hospitals National Institute for Health Research Biomedical Research Center; MRC/Diabetes UK Career Development(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)Diabetes UK); MRC Senior Research fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The authors thank Dr. Morag Park for the human SIP1 cDNA, Miss Stephanie Brown for technical advice on the ChIP experiments, Dr. Matthew Trotter for help with microarray, Prof. Danny Huylebroeck for helpful discussions, and members of the Pedersen lab for comments on the manuscript. This work was supported by the Singapore Agency for Science, Technology and Research (Z.C.), MRC Programme and Centre Development grants, and Cambridge Hospitals National Institute for Health Research Biomedical Research Center funding (R.A.P. and L.V.), and MRC/Diabetes UK Career Development fellowship and MRC Senior Research fellowship (L.V.).	Arnold SJ, 2009, NAT REV MOL CELL BIO, V10, P91, DOI 10.1038/nrm2618; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Brons IGM, 2007, NATURE, V448, P191, DOI 10.1038/nature05950; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; Chambers I, 2004, CLONING STEM CELLS, V6, P386, DOI 10.1089/clo.2004.6.386; Comijn J, 2001, MOL CELL, V7, P1267, DOI 10.1016/S1097-2765(01)00260-X; D'Amour KA, 2005, NAT BIOTECHNOL, V23, P1534, DOI 10.1038/nbt1163; Delalande JM, 2008, DEV DYNAM, V237, P1060, DOI 10.1002/dvdy.21485; Lerchner W, 2000, DEVELOPMENT, V127, P2729; Long JY, 2005, J BIOL CHEM, V280, P35477, DOI 10.1074/jbc.M504477200; Meno C, 1997, GENES CELLS, V2, P513, DOI 10.1046/j.1365-2443.1997.1400338.x; Mesnard D, 2006, DEVELOPMENT, V133, P2497, DOI 10.1242/dev.02413; Miyoshi T, 2006, DEV DYNAM, V235, P1941, DOI 10.1002/dvdy.20799; Moal FDL, 2007, HUM MUTAT, V28, P313, DOI 10.1002/humu.20452; Ninomiya H, 1999, DEV GROWTH DIFFER, V41, P391; Nitta KR, 2007, INT J DEV BIOL, V51, P321, DOI 10.1387/ijdb.062252kn; Nitta KR, 2004, DEV BIOL, V275, P258, DOI 10.1016/j.ydbio.2004.08.010; Nostro MC, 2008, CELL STEM CELL, V2, P60, DOI 10.1016/j.stem.2007.10.011; Papin C, 2002, MECH DEVELOP, V111, P37, DOI 10.1016/S0925-4773(01)00599-8; Postigo AA, 2003, EMBO J, V22, P2453, DOI 10.1093/emboj/cdg226; Pratt T, 2000, DEV BIOL, V228, P19, DOI 10.1006/dbio.2000.9935; Sheng GJ, 2003, CELL, V115, P603, DOI 10.1016/S0092-8674(03)00927-9; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Sumi T, 2008, DEVELOPMENT, V135, P2969, DOI 10.1242/dev.021121; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2004, STEM CELLS, V22, P2, DOI 10.1634/stemcells.22-1-2; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006082; Vallier L, 2009, DEVELOPMENT, V136, P1339, DOI 10.1242/dev.033951; Van de Putte T, 2003, AM J HUM GENET, V72, P465, DOI 10.1086/346092; van Grunsven LA, 2001, J BONE JOINT SURG AM, V83A, pS40; van Grunsven LA, 2000, MECH DEVELOP, V94, P189, DOI 10.1016/S0925-4773(00)00318-X; van Grunsven LA, 2007, DEV BIOL, V306, P34, DOI 10.1016/j.ydbio.2007.02.045; Verschueren K, 1999, J BIOL CHEM, V274, P20489, DOI 10.1074/jbc.274.29.20489; Xu RH, 2008, CELL STEM CELL, V3, P196, DOI 10.1016/j.stem.2008.07.001; Xu RH, 2006, METH MOLEC MED, V121, P189	38	97	100	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					59	70		10.1016/j.stem.2009.11.015	http://dx.doi.org/10.1016/j.stem.2009.11.015			12	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20074535	Bronze			2022-12-28	WOS:000274029700012
J	Wurdak, H; Zhu, ST; Romero, A; Lorger, M; Watson, J; Chiang, CY; Zhang, J; Natu, VS; Lairson, LL; Walker, JR; Trussell, CM; Harsh, GR; Vogels, H; Felding-Habermann, B; Orth, AP; Miraglia, LJ; Rines, DR; Skirboll, SL; Schultz, PG				Wurdak, Heiko; Zhu, Shoutian; Romero, Angelica; Lorger, Mihaela; Watson, James; Chiang, Chih-yuan; Zhang, Jay; Natu, Vanita S.; Lairson, Luke L.; Walker, John R.; Trussell, Christopher M.; Harsh, Griffith R.; Vogels, Hannes; Felding-Habermann, Brunhilde; Orth, Anthony P.; Miraglia, Loren J.; Rines, Daniel R.; Skirboll, Stephen L.; Schultz, Peter G.			An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation	CELL STEM CELL			English	Article							CANCER STEM-CELL; GLIOBLASTOMA-MULTIFORME; COFACTOR TRRAP; SELF-RENEWAL; C-MYC; EXPRESSION; LINES; ACETYLATION; DERIVATION; APOPTOSIS	Glioblastoma multiforme (GBM) is a highly aggressive form of brain cancer associated with a very poor prognosis. Recently, the initiation and growth of GBM has been linked to brain tumor-initiating cells (BTICs), which are poorly differentiated and share features with neural stem cells (NSCs). Here we describe a kinome-wide RNA interference screen to identify factors that control the tumorigenicity of BTICs. We identified several genes whose silencing induces differentiation of BTICs derived from multiple GBM patients. In particular, knockdown of the adaptor protein TRRAP significantly increased differentiation of cultured BTICs, sensitized the cells to apoptotic stimuli, and negatively affected cell cycle progression. TRRAP knockdown also significantly suppressed tumor formation upon intracranial BTIC implantation into mice. Together, these findings support a critical role for TRRAP in maintaining a tumorigenic, stem cell-like state.	[Wurdak, Heiko; Zhu, Shoutian; Lairson, Luke L.; Schultz, Peter G.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Wurdak, Heiko; Zhu, Shoutian; Lairson, Luke L.; Schultz, Peter G.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Romero, Angelica; Watson, James; Chiang, Chih-yuan; Zhang, Jay; Walker, John R.; Trussell, Christopher M.; Orth, Anthony P.; Miraglia, Loren J.; Rines, Daniel R.; Schultz, Peter G.] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Lorger, Mihaela; Felding-Habermann, Brunhilde] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Natu, Vanita S.; Harsh, Griffith R.; Skirboll, Stephen L.] Stanford Univ, Dept Neurosurg, Med Ctr, Stanford, CA 94305 USA; [Vogels, Hannes] Stanford Univ, Neuropathol Lab, Med Ctr, Dept Pathol, Stanford, CA 94305 USA; [Skirboll, Stephen L.] VA Palo Alto Hlth Care Syst, Sect Neurosurg, Palo Alto, CA 94304 USA	Scripps Research Institute; Scripps Research Institute; Novartis; Scripps Research Institute; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Schultz, PG (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schultz@scripps.edu	zhu, shoutian/M-2108-2018	zhu, shoutian/0000-0001-6748-225X; Rines, Daniel/0000-0002-1830-2926; Vogel, Otto Hannes/0000-0002-0960-3508; Wurdak, Heiko/0000-0003-4385-4324; Lairson, Luke/0000-0001-6701-996X	EMBO; AACR	EMBO(European Molecular Biology Organization (EMBO)); AACR	We thank M. O'Neil, B.P. Tu, G. Welch, M. Ruiz, B. Chandler, C. Wright, J. To, and M. Medina for excellent technical assistance. We thank E. Remba and I. Taylor for excellent administrative assistance. We thank K.M. Smith, J. Alves, and V.A. Reddy for helpful comments on the manuscript. H.W. was funded by EMBO and AACR fellowships.	Al-Mayhani TMF, 2009, J NEUROSCI METH, V176, P192, DOI 10.1016/j.jneumeth.2008.07.022; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bashyam MD, 2005, NEOPLASIA, V7, P556, DOI 10.1593/neo.04586; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Demuth T, 2007, MOL CANCER THER, V6, P1212, DOI 10.1158/1535-7163.MCT-06-0711; Enomoto A, 2008, ONCOGENE, V27, P1930, DOI 10.1038/sj.onc.1210828; GAGE FH, 1995, ANNU REV NEUROSCI, V18, P159, DOI 10.1146/annurev.neuro.18.1.159; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gangemi RMR, 2009, STEM CELLS, V27, P40, DOI 10.1634/stemcells.2008-0493; Grossman SA, 2004, SEMIN ONCOL, V31, P635, DOI 10.1053/j.seminoncol.2004.07.005; Herceg Z, 2003, NUCLEIC ACIDS RES, V31, P7011, DOI 10.1093/nar/gkg902; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kucharczak J, 2001, ONCOGENE, V20, P7021, DOI 10.1038/sj.onc.1204882; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Li GH, 2009, ONCOL REP, V21, P419, DOI 10.3892/or_00000239; Loukopoulos P, 2007, CANCER SCI, V98, P392, DOI 10.1111/j.1349-7006.2007.00395.x; Mangiola A, 2007, CLIN CANCER RES, V13, P6970, DOI 10.1158/1078-0432.CCR-07-1229; McKay R, 1997, SCIENCE, V276, P66, DOI 10.1126/science.276.5309.66; McMahon SB, 1998, CELL, V94, P363, DOI 10.1016/S0092-8674(00)81479-8; MISHIMA K, 1994, BIOCHEM BIOPH RES CO, V201, P363, DOI 10.1006/bbrc.1994.1710; Murr R, 2007, ONCOGENE, V26, P5358, DOI 10.1038/sj.onc.1210605; Murr R, 2006, NAT CELL BIOL, V8, P91, DOI 10.1038/ncb1343; Nakano I, 2006, PEDIATR RES, V59, p54R, DOI 10.1203/01.pdr.0000203568.63482.f9; Nightingale KP, 2007, J BIOL CHEM, V282, P4408, DOI 10.1074/jbc.M606773200; Nowak D, 2009, BLOOD, V113, P3655, DOI 10.1182/blood-2009-01-198911; Oishi H, 2006, J BIOL CHEM, V281, P20, DOI 10.1074/jbc.M510157200; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Pollard SM, 2009, CELL STEM CELL, V4, P568, DOI 10.1016/j.stem.2009.03.014; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Robert F, 2006, MOL CELL BIOL, V26, P402, DOI 10.1128/MCB.26.2.402-412.2006; Roos WP, 2007, ONCOGENE, V26, P186, DOI 10.1038/sj.onc.1209785; Salhia B, 2008, AM J PATHOL, V173, P1828, DOI 10.2353/ajpath.2008.080043; Sanai N, 2005, NEW ENGL J MED, V353, P811, DOI 10.1056/NEJMra043666; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2003, CANCER RES, V63, P5821; Walton NM, 2006, DEVELOPMENT, V133, P3671, DOI 10.1242/dev.02541; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; XIAO HG, 1994, J NEUROSURG, V81, P734, DOI 10.3171/jns.1994.81.5.0734; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhu ST, 2009, CELL STEM CELL, V4, P416, DOI 10.1016/j.stem.2009.04.001	46	93	97	0	7	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	JAN 8	2010	6	1					37	47		10.1016/j.stem.2009.11.002	http://dx.doi.org/10.1016/j.stem.2009.11.002			11	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	549EW	20085741	Bronze			2022-12-28	WOS:000274029700010
J	Nishiyama, A; Xin, L; Sharov, AA; Thomas, M; Mowrer, G; Meyers, E; Piao, YL; Mehta, S; Yee, S; Nakatake, Y; Stagg, C; Sharova, L; Correa-Cerro, LS; Bassey, U; Hoang, H; Kim, E; Tapnio, R; Qian, Y; Dudekula, D; Zalzman, M; Li, MX; Falco, G; Yang, HT; Lee, SL; Monti, M; Stanghellini, I; Islam, MN; Nagaraja, R; Goldberg, I; Wang, WD; Longo, DL; Schlessinger, D; Ko, MSH				Nishiyama, Akira; Xin, Li; Sharov, Alexei A.; Thomas, Marshall; Mowrer, Gregory; Meyers, Emily; Piao, Yulan; Mehta, Samir; Yee, Sarah; Nakatake, Yuhki; Stagg, Carole; Sharova, Lioudmila; Correa-Cerro, Lina S.; Bassey, Uwem; Hoang, Hien; Kim, Eugene; Tapnio, Richard; Qian, Yong; Dudekula, Dawood; Zalzman, Michal; Li, Manxiang; Falco, Geppino; Yang, Hsih-Te; Lee, Sung-Lim; Monti, Manuela; Stanghellini, Ilaria; Islam, Md. Nurul; Nagaraja, Ramaiah; Goldberg, Ilya; Wang, Weidong; Longo, Dan L.; Schlessinger, David; Ko, Minoru S. H.			Uncovering Early Response of Gene Regulatory Networks in ESCs by Systematic Induction of Transcription Factors	CELL STEM CELL			English	Article							EMBRYONIC STEM-CELLS; GENOME-WIDE; DEVELOPMENTAL REGULATORS; SIGNALING PATHWAYS; SELF-RENEWAL; MOUSE; PLURIPOTENCY; EXPRESSION; CHROMATIN; NANOG	To examine transcription factor (TF) network(s), we created mouse ESC lines, in each of which 1 of 50 TFs tagged with a FLAG moiety is inserted into a ubiquitously controllable tetracycline-repressible locus. Of the 50 TFs, Cdx2 provoked the most extensive transcriptome perturbation in ESCs, followed by Esx1, Sox9, Tcf3, KIN, and Gata3. ChIP-Seq revealed that CDX2 binds to promoters of upregulated target genes. By contrast, genes downregulated by CDX2 did not show CDX2 binding but were enriched with binding sites for POU5F1, SOX2, and NANOG. Genes with binding sites for these core TFs were also downregulated by the induction of at least 15 other TFs, suggesting a common initial step for ESC differentiation mediated by interference with the binding of core TFs to their target genes. These ESC lines provide a fundamental resource to study biological networks in ESCs and mice.	[Nishiyama, Akira; Xin, Li; Sharov, Alexei A.; Thomas, Marshall; Mowrer, Gregory; Meyers, Emily; Piao, Yulan; Mehta, Samir; Yee, Sarah; Nakatake, Yuhki; Stagg, Carole; Sharova, Lioudmila; Correa-Cerro, Lina S.; Bassey, Uwem; Hoang, Hien; Kim, Eugene; Tapnio, Richard; Qian, Yong; Dudekula, Dawood; Zalzman, Michal; Li, Manxiang; Falco, Geppino; Yang, Hsih-Te; Lee, Sung-Lim; Monti, Manuela; Stanghellini, Ilaria; Islam, Md. Nurul; Nagaraja, Ramaiah; Goldberg, Ilya; Wang, Weidong; Longo, Dan L.; Schlessinger, David; Ko, Minoru S. H.] NIA, NIH, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Ko, MSH (corresponding author), NIA, NIH, Baltimore, MD 21224 USA.	kom@mail.nih.gov	Ko, Minoru S. H./B-7969-2009; Longo, Dan L./F-6022-2011; Zalzman, Michal/Z-2121-2019; Wang, Weidong/AAV-2446-2021; Nakatake, Yuhki/K-5405-2013; Monti, Manuela/Z-2232-2019; Goldberg, Ilya/H-5307-2011	Ko, Minoru S. H./0000-0002-3530-3015; Monti, Manuela/0000-0001-9651-7490; Goldberg, Ilya/0000-0001-8514-6110; Wang, Weidong/0000-0002-0658-7928; YANG, HSIH-TE/0000-0002-4851-1374; Zalzman, Michal/0000-0002-4689-2951; Dudekula, Dawood/0000-0002-4054-1827; falco, geppino/0000-0001-6193-7233	Intramural Research Program of the NIH, National Institute on Aging; NATIONAL INSTITUTE ON AGING [ZIAAG000702, ZIAAG000647, ZIAAG000646, ZIAAG000678, ZIAAG000650, ZIAAG000704, ZIAAG000700, ZIAAG000662, ZIAAG000701, ZIAAG000706, ZICAG000674, ZIAAG000656, ZIAAG000703] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank Dr. Hitoshi Niwa for providing the Tet-inducible vector system and some cDNA clones and for discussion. This research was supported entirely by the Intramural Research Program of the NIH, National Institute on Aging.	Aiba K, 2009, DNA RES, V16, P73, DOI 10.1093/dnares/dsn035; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Carter MG, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-r61; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Collins FS, 2007, CELL, V128, P9, DOI 10.1016/j.cell.2006.12.018; Davidson EH, 2006, REG GEN GEN REG; Denslow SA, 2007, ONCOGENE, V26, P5433, DOI 10.1038/sj.onc.1210611; Diez del Corral R, 2001, NAT REV NEUROSCI, V2, P835; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kanamori M, 2004, BIOCHEM BIOPH RES CO, V322, P787, DOI 10.1016/j.bbrc.2004.07.179; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Klaffky E, 2001, DEV BIOL, V239, P161, DOI 10.1006/dbio.2001.0404; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; Masui S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni043; Matoba R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000026; Meshorer E, 2006, NAT REV MOL CELL BIO, V7, P540, DOI 10.1038/nrm1938; Messina DN, 2004, GENOME RES, V14, P2041, DOI 10.1101/gr.2584104; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; Nakatake Y, 2006, MOL CELL BIOL, V26, P7772, DOI 10.1128/MCB.00468-06; Natale DR, 2002, MECH DEVELOP, V119, pS21, DOI 10.1016/S0925-4773(03)00086-8; Naya FJ, 1999, CURR OPIN CELL BIOL, V11, P683, DOI 10.1016/S0955-0674(99)00036-8; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Pritsker M, 2006, P NATL ACAD SCI USA, V103, P6946, DOI 10.1073/pnas.0509861103; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; SCHOLER HR, 1991, CELL, V66, P291, DOI 10.1016/0092-8674(91)90619-A; Sharov AA, 2005, BIOINFORMATICS, V21, P2548, DOI 10.1093/bioinformatics/bti343; SHAROV AA, 2009, DNA RES IN PRESS; Sharov AA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-269; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Simmons DG, 2005, DEV BIOL, V284, P12, DOI 10.1016/j.ydbio.2005.05.010; Skarnes WC, 2004, NAT GENET, V36, P543, DOI 10.1038/ng0604-543; Solter D, 2006, NAT REV GENET, V7, P319, DOI 10.1038/nrg1827; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yang JC, 2008, P NATL ACAD SCI USA, V105, P19756, DOI 10.1073/pnas.0809321105; YUAN HB, 1995, GENE DEV, V9, P2635, DOI 10.1101/gad.9.21.2635; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	59	146	150	1	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	OCT 2	2009	5	4					420	433		10.1016/j.stem.2009.07.012	http://dx.doi.org/10.1016/j.stem.2009.07.012			14	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	514NP	19796622	Green Accepted, Bronze			2022-12-28	WOS:000271401900013
J	Saini, A				Saini, Angela			The Value of a Good Debate	CELL STEM CELL			English	Editorial Material																			0	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	MAY 8	2009	4	5					385	386		10.1016/j.stem.2009.04.008	http://dx.doi.org/10.1016/j.stem.2009.04.008			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	445SF	19437609	Bronze			2022-12-28	WOS:000266071100007
J	Dieterlen-Lievre, F; Jaffredo, T				Dieterlen-Lievre, Francoise; Jaffredo, Thierry			Decoding the Hemogenic Endothelium in Mammals	CELL STEM CELL			English	Editorial Material							HEMATOPOIETIC-CELLS; LINEAGES	A collection of recent Nature papers examines the relationship between endothelial precursors and hematopoietic cells. Two of these studies (Eilken et al., 2009; Lancrin et al., 2009) use time-lapse imaging with live markers and genetic analysis of differentiating ESCs to reveal that even non-aortic-derived endothelial cells are hemogenic.	[Dieterlen-Lievre, Francoise; Jaffredo, Thierry] Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, F-75252 Paris 05, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Dieterlen-Lievre, F (corresponding author), Univ Paris 06, CNRS, UMR7622, Dev Biol Lab, Bat C,6Eme Etage,Case 24, F-75252 Paris 05, France.	francoise.dieterlen@club-internet.fr; thierry.jaffredo@upmc.fr	JAFFREDO, Thierry/K-7870-2017	JAFFREDO, Thierry/0000-0002-8724-3261				Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Choi K, 1998, DEVELOPMENT, V125, P725; Eichmann A, 1997, P NATL ACAD SCI USA, V94, P5141, DOI 10.1073/pnas.94.10.5141; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Huber TL, 2004, NATURE, V432, P625, DOI 10.1038/nature03122; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Pardanaud L, 1996, DEVELOPMENT, V122, P1363; Yoshimoto M, 2008, CELL STEM CELL, V3, P583, DOI 10.1016/j.stem.2008.11.002; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	10	18	18	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	1934-5909	1875-9777		CELL STEM CELL	Cell Stem Cell	MAR 6	2009	4	3					189	190		10.1016/j.stem.2009.02.006	http://dx.doi.org/10.1016/j.stem.2009.02.006			2	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	421OX	19265651	Bronze			2022-12-28	WOS:000264369300002
J	Balicki, D				Balicki, Danuta			Moving forward in human mammary stem cell biology and breast cancer prognostication using ALDH1	CELL STEM CELL			English	Editorial Material							ALDEHYDE DEHYDROGENASE	In this issue of Cell Stem Cell, the seminal work of Ginestier et al. (2007) elegantly demonstrates that aldehyde dehydrogenase 1 (ALDH1) facilitates the identification and isolation of normal and malignant human mammary stem cells in vitro, in vivo, and in situ in fixed tissues.	Univ Montreal, Hotel Dieu, Ctr Hosp, Dept Med, Montreal, PQ H2W 1T7, Canada; Univ Montreal, Hotel Dieu, Ctr Hosp, Res Ctr, Montreal, PQ H2W 1T7, Canada; Univ Montreal, Dept Med, Montreal, PQ H3C 3J7, Canada; Ville Marie Multidisciplinary Breast Ctr, Breast Canc Risk Assessment Clin, Montreal, PQ H3G 1L5, Canada	Laval University; Universite de Montreal; Laval University; Universite de Montreal; Universite de Montreal	Balicki, D (corresponding author), Univ Montreal, Hotel Dieu, Ctr Hosp, Dept Med, 3850 Rue St Urbain, Montreal, PQ H2W 1T7, Canada.	danuta.balicki@umontreal.ca						Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; BALLICKI D, 2007, PHARMACOGENETICS BRE; BALLICKI D, 2007, IN PRESS CANC STEM C; Chute JP, 2006, P NATL ACAD SCI USA, V103, P11707, DOI 10.1073/pnas.0603806103; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Hadnagy A, 2006, EXP CELL RES, V312, P3701, DOI 10.1016/j.yexcr.2006.08.030; Hess DA, 2004, BLOOD, V104, P1648, DOI 10.1182/blood-2004-02-0448; Jelski W, 2007, PANCREAS, V35, P142, DOI 10.1097/MPA.0b013e318053eae2; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; Minegishi Y, 2007, CANCER-AM CANCER SOC, V110, P353, DOI 10.1002/cncr.22795	10	77	84	0	8	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	1934-5909			CELL STEM CELL	Cell Stem Cell	NOV	2007	1	5					485	487		10.1016/j.stem.2007.10.015	http://dx.doi.org/10.1016/j.stem.2007.10.015			3	Cell & Tissue Engineering; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	236AX	18938743	Bronze			2022-12-28	WOS:000251276500004
